archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00011241,1.537,1.2608,1,1
1,GO BLEB ASSEMBLY,7.5427e-07,1.4154,1.3489,1,1
1,GO MEMBRANE RAFT ASSEMBLY,4.4712e-06,1.2358,1.5163,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00021167,1.2056,0.95503,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,9.8628e-07,1.1754,1.0451,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.547e-05,1.1571,1.0689,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.3441e-06,1.1242,0.91694,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.2308e-06,1.1203,0.98856,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.2308e-06,1.1023,0.88733,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.4268e-07,1.0912,0.96573,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.7343e-05,1.0659,1.0305,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.0571e-06,1.0451,0.84663,1,1
1,GO NEUTROPHIL HOMEOSTASIS,6.8936e-07,1.0348,0.95632,1,1
1,GO HYALURONAN CATABOLIC PROCESS,8.8325e-08,1.0272,1.0677,1,1
1,GO RESPONSE TO INTERFERON BETA,5.2837e-06,1.0058,0.95522,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,6.8936e-07,1.005,0.97272,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,6.6003e-08,0.99651,0.93643,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,9.0179e-06,0.97374,0.88506,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.0833e-05,0.96933,0.86163,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,5.9841e-06,0.92892,0.81475,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.0184e-05,0.92141,0.85013,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,2.2524e-05,0.9193,0.83878,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.9532e-05,0.91599,0.76443,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.8251e-06,0.90962,0.8913,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,6.8936e-07,0.90337,0.8783,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,8.2505e-07,0.89939,0.9415,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.0311e-06,0.89792,0.86043,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0833e-05,0.89618,0.8202,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.4039e-05,0.88685,0.90152,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00017796,0.88164,0.67859,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.1964e-05,0.87587,1.0178,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.0311e-06,0.8661,0.79589,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,8.2505e-07,0.86521,0.73738,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.725e-07,0.86182,0.85373,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,5.6999e-08,0.85508,0.86054,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,4.3218e-05,0.84298,0.69293,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.906e-06,0.84221,0.79432,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,1.4963e-07,0.83936,0.88264,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,8.628e-07,0.83891,0.79643,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.7955e-07,0.83422,0.76919,1,1
1,GO CD40 SIGNALING PATHWAY,2.6322e-07,0.82693,0.75279,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,6.5896e-07,0.82175,0.75757,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,8.628e-07,0.81759,0.9393,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0001547,0.81247,0.80749,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,0.80802,0.65228,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.7118e-05,0.80747,0.79519,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,3.7791e-06,0.80446,0.61049,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,4.4712e-06,0.80137,0.63953,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.2366e-07,0.79893,0.77862,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.4609e-05,0.78483,0.71869,1,1
1,GO BONE TRABECULA FORMATION,0.0013872,0.77688,0.68728,1,1
1,GO CYSTEINE METABOLIC PROCESS,9.0179e-06,0.77326,0.70772,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,9.7801e-06,0.77167,0.65368,1,1
1,GO HEMIDESMOSOME ASSEMBLY,8.7323e-05,0.7686,0.96727,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.9263e-05,0.76795,0.76236,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,9.0551e-05,0.76685,0.59459,1,1
1,GO MEMBRANE RAFT ORGANIZATION,3.4728e-06,0.76502,0.90504,1,1
1,GO ENDODERM FORMATION,1.9873e-07,0.76452,0.7813,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,5.0226e-05,0.75597,0.61585,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.3916e-06,0.75467,0.60584,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.4039e-05,0.75269,0.81062,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,3.6228e-06,0.74902,0.79816,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,3.3287e-06,0.74535,0.69776,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.0198e-07,0.74381,0.73628,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00032948,0.74124,0.68579,1,1
1,GO EPIBOLY,8.2505e-07,0.73565,0.74625,1,1
1,GO FIBRINOLYSIS,4.5813e-07,0.73217,0.84192,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.5774e-06,0.73207,0.72211,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,1.071e-07,0.72741,0.70426,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,6.5896e-07,0.72416,0.70257,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.4728e-06,0.71898,0.62269,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.4205e-05,0.71653,0.54698,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,9.3916e-06,0.71488,0.59952,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.1237e-07,0.7087,0.76602,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.3763e-07,0.70559,0.65939,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.9263e-05,0.7019,0.62981,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.1267e-06,0.69998,0.66072,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.2879e-07,0.69817,0.63569,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,3.0689e-05,0.69677,0.5846,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00026903,0.69422,0.59941,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.0833e-05,0.69285,0.65659,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.7578e-07,0.69195,0.65986,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,5.4977e-07,0.6903,0.68842,1,1
1,GO VASCULOGENESIS,2.8891e-07,0.68204,0.60772,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.9926e-07,0.67903,0.82883,1,1
1,GO ZYMOGEN INHIBITION,9.8628e-07,0.67684,0.76927,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,4.2876e-06,0.67397,0.58869,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.2876e-06,0.66972,0.61669,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,5.2533e-07,0.66879,0.67063,1,1
1,GO MUCUS SECRETION,0.0010206,0.66378,0.54299,1,1
1,GO LATERAL MESODERM DEVELOPMENT,0.00013433,0.6614,0.51919,1,1
1,GO GAP JUNCTION ASSEMBLY,1.906e-06,0.65852,0.64444,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.906e-06,0.65837,0.64209,1,1
1,GO T CELL EXTRAVASATION,7.9801e-06,0.65778,0.67023,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00079435,0.65408,0.59279,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.4609e-05,0.65247,0.63607,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00021167,0.65225,0.43711,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.3418e-05,0.64875,0.58355,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00019079,0.64754,0.61095,1,1
1,GO APOPTOTIC CELL CLEARANCE,1.9873e-07,0.64512,0.6998,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,2.2658e-06,0.64417,0.57289,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.4772e-07,0.64148,0.62079,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,5.2837e-06,0.64011,0.58999,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.6015e-06,0.64007,0.63919,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00047456,0.63816,0.57281,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,4.6597e-05,0.63785,0.69186,1,1
1,GO CYTOLYSIS,6.5896e-07,0.63631,0.52563,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016595,0.6359,0.61335,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,8.3127e-06,0.6355,0.55588,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00011241,0.63336,0.52638,1,1
1,GO PLASMINOGEN ACTIVATION,0.00012074,0.632,0.59402,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.2658e-06,0.63149,0.72703,1,1
1,GO PIGMENT GRANULE MATURATION,5.8301e-05,0.63062,0.45628,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00016595,0.63061,0.60135,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.7413e-06,0.62864,0.5387,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,5.0683e-06,0.6273,0.62028,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,5.9841e-06,0.62689,0.54878,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,4.5813e-07,0.6261,0.58698,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00021909,0.62305,0.4791,1,1
1,GO AMYLOID BETA CLEARANCE,8.8325e-08,0.61524,0.54771,1,1
1,GO ENDODERM DEVELOPMENT,5.2533e-07,0.61414,0.62754,1,1
1,GO VAGINA DEVELOPMENT,1.8251e-06,0.61256,0.63281,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,3.3132e-05,0.61217,0.5207,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.0604e-05,0.61142,0.69842,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0011199,0.60891,0.68414,1,1
1,GO SNRNA PROCESSING,0.0014299,0.60744,0.61019,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,3.9418e-06,0.60598,0.65011,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.1493e-05,0.60518,0.44499,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.0571e-06,0.60394,0.54883,1,1
1,GO DNA DEAMINATION,0.00017796,0.60388,0.54412,1,1
1,GO HIPPO SIGNALING,4.0073e-05,0.60314,0.52158,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,4.1617e-05,0.60059,0.45143,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.6015e-06,0.60033,0.58713,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.6623e-06,0.60007,0.60259,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00038934,0.59872,0.59526,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.071e-07,0.59871,0.52846,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0017641,0.59711,0.44239,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,7.3528e-06,0.59621,0.4713,1,1
1,GO LIVER REGENERATION,7.2756e-08,0.59611,0.58887,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,3.4728e-06,0.59505,0.62581,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0015653,0.59432,0.41219,1,1
1,GO HEME METABOLIC PROCESS,8.628e-07,0.59409,0.5417,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0017123,0.59369,0.71293,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,0.00010092,0.59323,0.52915,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,1.1493e-05,0.59277,0.52879,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.2111e-07,0.59276,0.57948,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,9.3916e-06,0.59215,0.56794,1,1
1,GO CELLULAR RESPONSE TO IRON ION,2.1663e-05,0.59125,0.52586,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2454e-05,0.59078,0.51763,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,1.104e-05,0.58993,0.54238,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7791e-06,0.58951,0.60575,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,2.0033e-05,0.5891,0.54928,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.5331e-06,0.58654,0.63837,1,1
1,GO VASCULAR TRANSPORT,0.00040247,0.58499,0.60959,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,3.4728e-06,0.58346,0.51086,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0001165,0.58306,0.53845,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.547e-05,0.58261,0.48879,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00044439,0.58163,0.50904,1,1
1,GO NOTOCHORD DEVELOPMENT,4.4712e-06,0.58159,0.62701,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.011904,0.58136,0.47177,1,1
1,GO MACROPHAGE PROLIFERATION,2.9532e-05,0.57999,0.57871,1,1
1,GO GERMINAL CENTER FORMATION,7.8282e-05,0.5783,0.49181,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,8.628e-07,0.57664,0.56484,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.57606,0.61619,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,7.6603e-06,0.5743,0.4517,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.3441e-06,0.57329,0.58982,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,2.9301e-06,0.57042,0.78019,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.7145e-05,0.56884,0.44019,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00011241,0.5673,0.55614,1,1
1,GO SALIVARY GLAND DEVELOPMENT,9.3916e-06,0.56562,0.57411,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.4994e-06,0.56519,0.48699,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,7.6603e-06,0.56348,0.58536,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0001165,0.56287,0.48441,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,2.6322e-07,0.5619,0.60744,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0073363,0.55977,0.4192,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.8077e-06,0.55959,0.50285,1,1
1,GO REGULATION OF PINOCYTOSIS,8.1192e-05,0.55809,0.59329,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.047551,0.55357,0.3317,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.906e-06,0.55258,0.48156,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00036427,0.5513,0.44875,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00010845,0.5513,0.55142,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.6015e-06,0.55084,0.57227,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00019079,0.5507,0.44553,1,1
1,GO TYPE 2 IMMUNE RESPONSE,1.6455e-05,0.5506,0.52926,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,1.4674e-06,0.5505,0.53454,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00037661,0.54938,0.66246,1,1
1,GO OLIGOPEPTIDE TRANSPORT,4.6597e-05,0.54807,0.58807,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.3287e-06,0.54645,0.50099,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0027346,0.54596,0.47813,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.8521e-05,0.54574,0.57904,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00017796,0.54443,0.47833,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.00084609,0.54281,0.39211,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0014738,0.54243,0.41268,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,6.2367e-06,0.53952,0.49564,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4878e-05,0.53714,0.47846,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4609e-05,0.53683,0.50142,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.8891e-07,0.53474,0.5653,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,6.5149e-05,0.53468,0.59405,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,8.3127e-06,0.53405,0.60437,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.9532e-05,0.53243,0.53651,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.1192e-05,0.53094,0.50812,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00026903,0.53002,0.4861,1,1
1,GO BLOOD VESSEL REMODELING,1.4039e-05,0.52826,0.45572,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.8301e-05,0.5282,0.56509,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.0311e-06,0.52641,0.5637,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,2.4692e-06,0.52558,0.45121,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00074557,0.52543,0.41595,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.5122e-07,0.52369,0.48616,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.0779e-06,0.52137,0.49501,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00013917,0.52118,0.45354,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.6307e-05,0.52103,0.45467,1,1
1,GO RESPONSE TO X RAY,1.7474e-06,0.51835,0.48479,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00022676,0.51653,0.52593,1,1
1,GO RESPONSE TO ANGIOTENSIN,4.5813e-07,0.51612,0.49285,1,1
1,GO CELLULAR RESPONSE TO DSRNA,7.889e-07,0.51519,0.54181,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00044439,0.51399,0.4838,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,2.0784e-06,0.51344,0.44181,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.1904e-06,0.51198,0.61663,1,1
1,GO CERAMIDE CATABOLIC PROCESS,3.0689e-05,0.51182,0.41253,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,8.6584e-06,0.51169,0.42884,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00055855,0.51114,0.39945,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00026903,0.51094,0.41409,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.030383,0.51089,0.27329,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,4.1617e-05,0.51052,0.48797,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00011241,0.50936,0.49799,1,1
1,GO SKIN MORPHOGENESIS,4.1617e-05,0.50895,0.70181,1,1
1,GO REGULATION OF MYOBLAST FUSION,0.0001547,0.50823,0.52942,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00055855,0.50777,0.54666,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,4.1802e-07,0.50775,0.53009,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,2.1831e-07,0.50662,0.58609,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00044439,0.50574,0.46614,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,7.2754e-05,0.5042,0.52851,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.010773,0.50407,0.30699,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.5813e-07,0.50241,0.4823,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,5.4977e-07,0.50231,0.48178,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.8084e-07,0.50054,0.48803,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.2505e-07,0.49918,0.49475,1,1
1,GO PEPTIDE CROSS LINKING,0.00010462,0.49844,0.4696,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.6452e-07,0.49828,0.50718,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.8958e-07,0.49818,0.49215,1,1
1,GO NCRNA 3 END PROCESSING,0.011326,0.49751,0.39701,1,1
1,GO SNRNA METABOLIC PROCESS,0.00050664,0.49715,0.49267,1,1
1,GO LYMPHANGIOGENESIS,4.8612e-06,0.49659,0.46652,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.6902e-06,0.49539,0.42828,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0010528,0.49536,0.42819,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,4.2876e-06,0.49519,0.53925,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.0033e-05,0.49238,0.43112,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,2.8077e-06,0.49232,0.55277,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.0184e-05,0.492,0.43273,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,9.389e-05,0.49198,0.43036,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00063551,0.49094,0.4742,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.8891e-07,0.49069,0.48807,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00057693,0.49024,0.43283,1,1
1,GO ENTRY INTO HOST,1.2308e-06,0.4882,0.54455,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,7.9801e-06,0.48819,0.40833,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00023468,0.48593,0.46465,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0013457,0.48586,0.37887,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,6.5896e-07,0.48568,0.46434,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,5.753e-07,0.48462,0.48376,1,1
1,GO BIOLOGICAL PHASE,0.0016129,0.48375,0.47289,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0001165,0.48285,0.39629,1,1
1,GO PROTEIN OXIDATION,0.0021062,0.48177,0.44301,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,7.5427e-07,0.48147,0.49939,1,1
1,GO TOLERANCE INDUCTION,0.00054072,0.4814,0.44512,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.9841e-06,0.48118,0.49495,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,2.7343e-05,0.48075,0.43882,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.00029782,0.48075,0.46732,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0041716,0.47847,0.34278,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0028141,0.47736,0.39927,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,7.547e-05,0.47731,0.48538,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00042998,0.47719,0.58203,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.1237e-07,0.4766,0.42098,1,1
1,GO LEUKOCYTE AGGREGATION,0.0017123,0.47612,0.50773,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0028141,0.47559,0.36338,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,2.1702e-06,0.47554,0.37848,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.6902e-06,0.47487,0.4906,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9263e-05,0.47429,0.42041,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00024286,0.47378,0.44706,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.0689e-05,0.47298,0.46362,1,1
1,GO HYALURONAN METABOLIC PROCESS,3.6414e-07,0.47297,0.50332,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.2876e-06,0.47292,0.65896,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.1663e-05,0.47181,0.45684,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.3916e-06,0.47118,0.39525,1,1
1,GO REGULATION OF TRANSPOSITION,0.00067758,0.47114,0.4247,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,1.104e-05,0.47006,0.44936,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.001662,0.46949,0.4101,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.508e-06,0.4693,0.50794,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,5.2139e-05,0.46878,0.38492,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00090094,0.46854,0.37228,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.7145e-05,0.46805,0.43633,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,7.2754e-05,0.46771,0.45471,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,3.9418e-06,0.46564,0.6276,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.5201e-05,0.46553,0.47111,1,1
1,GO MATURATION OF LSU RRNA,0.00012512,0.46526,0.43215,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00072223,0.46486,0.42236,1,1
1,GO RESPONSE TO HYPEROXIA,0.00017186,0.4646,0.45097,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.7413e-06,0.46434,0.44191,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,1.7806e-05,0.46419,0.46842,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.7343e-05,0.46346,0.49951,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00098941,0.46336,0.4039,1,1
1,GO PROTEIN ACTIVATION CASCADE,2.9301e-06,0.46284,0.48885,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.00013433,0.46245,0.41804,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.011612,0.46232,0.34341,1,1
1,GO VIRAL RNA GENOME REPLICATION,2.4692e-06,0.46228,0.40926,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.4609e-05,0.46103,0.58362,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.9926e-07,0.46054,0.51588,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,1.8521e-05,0.46005,0.47417,1,1
1,GO REGULATION OF MRNA BINDING,5.8301e-05,0.45842,0.3778,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,2.7343e-05,0.45818,0.47404,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00012512,0.45815,0.40308,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.3132e-05,0.45784,0.49634,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,2.2658e-06,0.45774,0.48419,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.1493e-05,0.45741,0.42755,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.8612e-06,0.45695,0.41531,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,7.0571e-06,0.45694,0.44243,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,9.3916e-06,0.45662,0.40273,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,1.906e-06,0.45594,0.4245,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.8077e-06,0.4558,0.44992,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.0576e-06,0.45481,0.38617,1,1
1,GO PROTEASOME ASSEMBLY,3.3132e-05,0.45437,0.34344,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,4.4712e-06,0.45315,0.50815,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00026903,0.453,0.4399,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.0779e-06,0.4525,0.47427,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00018427,0.4524,0.39437,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2308e-06,0.45234,0.47015,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,9.389e-05,0.45187,0.34083,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.8131e-07,0.4502,0.4325,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00026003,0.45014,0.41233,1,1
1,GO ZYMOGEN ACTIVATION,6.2786e-05,0.4498,0.46659,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.9904e-06,0.44963,0.37917,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.2837e-06,0.44934,0.51209,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.7791e-06,0.44908,0.43108,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,4.3763e-07,0.44889,0.44875,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0073363,0.44839,0.35817,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00014418,0.44817,0.37272,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.6455e-05,0.44693,0.39643,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,1.8521e-05,0.44634,0.33629,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,9.0179e-06,0.44429,0.34274,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0001547,0.4436,0.39892,1,1
1,GO ANIMAL ORGAN REGENERATION,2.8891e-07,0.44352,0.49892,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,9.389e-05,0.44332,0.41742,1,1
1,GO RETINAL METABOLIC PROCESS,0.0062634,0.44287,0.3278,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.001986,0.44264,0.34268,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0779e-06,0.44195,0.47215,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0010859,0.44193,0.32697,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,3.6414e-07,0.44172,0.39394,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00022676,0.44142,0.36744,1,1
1,GO PINOCYTOSIS,2.0833e-05,0.44128,0.55129,1,1
1,GO VIRAL TRANSLATION,1.0184e-05,0.44097,0.43034,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.8418e-05,0.44096,0.43973,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00019079,0.43955,0.53118,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.0833e-05,0.43912,0.40917,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.5896e-07,0.43851,0.39324,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.7806e-05,0.43848,0.39092,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00011241,0.43709,0.44855,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,7.889e-07,0.43604,0.47937,1,1
1,GO CYTOKINE METABOLIC PROCESS,5.7413e-06,0.43528,0.38378,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.0311e-06,0.43504,0.59842,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.43425,0.42242,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.7343e-05,0.434,0.45995,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0056288,0.43397,0.30406,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.8418e-05,0.4337,0.41835,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00010092,0.43306,0.39178,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.6729e-06,0.43302,0.39028,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.4205e-05,0.43301,0.44875,1,1
1,GO T CELL MEDIATED IMMUNITY,2.3418e-05,0.43294,0.43132,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016129,0.43223,0.31898,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0039469,0.43152,0.3404,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00011241,0.43024,0.37407,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,9.7346e-05,0.42954,0.3678,1,1
1,GO REGULATION OF STEROL TRANSPORT,5.4977e-07,0.42921,0.38506,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0010859,0.4288,0.38788,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.7474e-06,0.42879,0.41779,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,0.00057693,0.42801,0.44989,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.1888e-05,0.42797,0.31308,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,9.7346e-05,0.42792,0.36368,1,1
1,GO RIBOSOME ASSEMBLY,0.00014935,0.42689,0.38359,1,1
1,GO VIRAL GENOME REPLICATION,9.0551e-05,0.42635,0.38899,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.7955e-07,0.42457,0.53885,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,4.0073e-05,0.42431,0.5105,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.6902e-06,0.42352,0.4317,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017641,0.42316,0.36181,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00020448,0.42292,0.41788,1,1
1,GO RESPONSE TO INTERLEUKIN 12,8.2505e-07,0.42189,0.42007,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.4121e-05,0.42162,0.37435,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,7.0571e-06,0.42144,0.40671,1,1
1,GO IMMATURE T CELL PROLIFERATION,2.6307e-05,0.42026,0.49836,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5813e-07,0.41976,0.37619,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.6623e-06,0.41936,0.45435,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0018173,0.41897,0.34452,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00081984,0.41897,0.41049,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,9.3916e-06,0.4188,0.38159,1,1
1,GO DETECTION OF BIOTIC STIMULUS,2.9532e-05,0.41854,0.43909,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00017796,0.41852,0.35019,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,6.0504e-05,0.41844,0.38278,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0006154,0.41814,0.3531,1,1
1,GO ARGININE METABOLIC PROCESS,0.00010462,0.4181,0.41107,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00074557,0.41809,0.42156,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00063551,0.41768,0.5798,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,9.0179e-06,0.41632,0.42222,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.024288,0.41519,0.26605,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.9926e-07,0.41452,0.41836,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.8379e-05,0.41433,0.45873,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0011199,0.41409,0.46453,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00081984,0.41356,0.41999,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.02268,0.41255,0.42416,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.5759e-05,0.41234,0.37726,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.0264e-07,0.41168,0.36706,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,9.0221e-07,0.41158,0.35183,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.02166,0.41127,0.47968,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.41106,0.33093,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,4.1617e-05,0.41104,0.37512,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.7806e-05,0.41091,0.55035,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.8077e-06,0.41089,0.55163,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,7.6603e-06,0.41081,0.45724,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00040247,0.41069,0.35544,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0015653,0.41068,0.31208,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.104e-05,0.41012,0.39364,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00042998,0.41007,0.58424,1,1
1,GO BONE GROWTH,1.7806e-05,0.40957,0.49196,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,2.9301e-06,0.40911,0.47525,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00081984,0.40881,0.33209,1,1
1,GO PLATELET AGGREGATION,9.7801e-06,0.40867,0.35177,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00022676,0.40834,0.34613,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00016023,0.40829,0.42981,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.6623e-06,0.40786,0.36784,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.4121e-05,0.40756,0.40881,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,3.1888e-05,0.40731,0.41164,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.9904e-06,0.40661,0.45923,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00028792,0.4064,0.45695,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.7801e-06,0.40615,0.40005,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.2837e-06,0.40585,0.37506,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0056288,0.40564,0.29879,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.6455e-05,0.40522,0.47059,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00059588,0.4051,0.34899,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,3.3132e-05,0.40466,0.35495,1,1
1,GO I KAPPAB PHOSPHORYLATION,0.00069957,0.40407,0.25504,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.7791e-06,0.40407,0.4811,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,4.2876e-06,0.40378,0.46616,1,1
1,GO EMBRYO IMPLANTATION,1.8251e-06,0.40352,0.49936,1,1
1,GO RESPONSE TO SALT STRESS,3.6228e-06,0.40292,0.36979,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,7.2754e-05,0.40291,0.3783,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,6.2985e-07,0.40182,0.39726,1,1
1,GO TRANSLATIONAL INITIATION,0.00012512,0.40113,0.34676,1,1
1,GO COPPER ION HOMEOSTASIS,7.013e-05,0.40065,0.43269,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0039469,0.40052,0.40235,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.5331e-06,0.40003,0.35478,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,8.4205e-05,0.39932,0.38771,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00353,0.39848,0.28745,1,1
1,GO RECEPTOR CATABOLIC PROCESS,5.0683e-06,0.39806,0.41105,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,2.6307e-05,0.3978,0.43566,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00054072,0.39738,0.56699,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,5.8301e-05,0.39652,0.36412,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.2308e-06,0.39626,0.42411,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012512,0.39596,0.32744,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0050528,0.39577,0.44972,1,1
1,GO ENAMEL MINERALIZATION,0.0060989,0.3951,0.35062,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.4609e-05,0.39508,0.47439,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.001662,0.39493,0.31427,1,1
1,GO MATURATION OF SSU RRNA,0.00018427,0.39468,0.35995,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00063551,0.39437,0.35727,1,1
1,GO PHAGOCYTOSIS RECOGNITION,9.0551e-05,0.39416,0.53215,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.001662,0.39414,0.30097,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.004408,0.39382,0.34936,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7806e-05,0.39375,0.36255,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.001872,0.39327,0.39788,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00025131,0.39326,0.38694,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,1.2862e-06,0.3928,0.36984,1,1
1,GO PLATELET DEGRANULATION,6.2367e-06,0.39201,0.44332,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.1493e-05,0.39129,0.34242,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6015e-06,0.39081,0.39597,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,8.6584e-06,0.38981,0.33762,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00092958,0.3896,0.43877,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0016129,0.38956,0.44264,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.4772e-07,0.38928,0.36477,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,8.1192e-05,0.38855,0.34552,1,1
1,GO NIK NF KAPPAB SIGNALING,2.8077e-06,0.38828,0.37791,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,7.3528e-06,0.38815,0.34372,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00027832,0.38806,0.33187,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.8521e-05,0.38784,0.37162,1,1
1,GO INTERLEUKIN 1 PRODUCTION,2.6307e-05,0.38763,0.42949,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,2.6307e-05,0.38715,0.40294,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.4609e-05,0.38665,0.37361,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.007729,0.38663,0.26781,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,2.2658e-06,0.38657,0.36238,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0042883,0.38622,0.2631,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.5896e-07,0.38616,0.36261,1,1
1,GO RESPONSE TO ESTROGEN,1.8251e-06,0.38605,0.38527,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.7118e-05,0.38565,0.34917,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.001191,0.38558,0.39717,1,1
1,GO INTERACTION WITH SYMBIONT,1.4609e-05,0.38551,0.3132,1,1
1,GO MUSCLE FILAMENT SLIDING,8.3127e-06,0.38506,0.38801,1,1
1,GO REGULATION OF GASTRULATION,3.8131e-07,0.38483,0.3985,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0019282,0.38462,0.3193,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,0.38394,0.35213,1,1
1,GO ERAD PATHWAY,4.3763e-07,0.3822,0.3356,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00050664,0.3818,0.35294,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.01282,0.38142,0.44127,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0016129,0.3813,0.34476,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.3132e-05,0.38085,0.37999,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00065623,0.38048,0.33666,1,1
1,GO MATURATION OF 5 8S RRNA,0.00054072,0.38036,0.29417,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0022332,0.38035,0.39456,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,5.4121e-05,0.38004,0.3727,1,1
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.011612,0.37971,0.31224,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0037331,0.37968,0.29113,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00032948,0.37959,0.40143,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,3.7145e-05,0.37932,0.35011,1,1
1,GO MRNA TRANSCRIPTION,1.7806e-05,0.37828,0.37027,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,4.8612e-06,0.37824,0.32762,1,1
1,GO TRACHEA MORPHOGENESIS,0.001228,0.37823,0.28537,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,1.2454e-05,0.37795,0.32154,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.2658e-06,0.37791,0.45673,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,9.7801e-06,0.37751,0.41373,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.5308e-05,0.37681,0.39881,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.4334e-07,0.37668,0.41834,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,0.00017186,0.37616,0.39524,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00023468,0.37615,0.3754,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00098941,0.37609,0.31495,1,1
1,GO VIRAL LIFE CYCLE,4.1112e-06,0.37592,0.37706,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00052342,0.37505,0.28395,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,6.7596e-05,0.37455,0.40034,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,8.6584e-06,0.37454,0.30846,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,4.1112e-06,0.37434,0.3106,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,2.9532e-05,0.37424,0.32414,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0062634,0.37378,0.29908,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00063551,0.37329,0.28967,1,1
1,GO B CELL MEDIATED IMMUNITY,3.6228e-06,0.37314,0.34566,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.2139e-05,0.37214,0.32511,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0022992,0.3718,0.31992,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.2366e-07,0.37145,0.36907,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.7145e-05,0.37105,0.57021,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.038561,0.37062,0.21752,1,1
1,GO INTERLEUKIN 17 PRODUCTION,5.2837e-06,0.37025,0.45293,1,1
1,GO PROTEIN DEGLYCOSYLATION,6.2786e-05,0.36992,0.36676,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.4039e-05,0.36944,0.40058,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,4.3218e-05,0.36943,0.34803,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00037661,0.36934,0.42686,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,3.3287e-06,0.36899,0.44836,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0022332,0.36879,0.2984,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010859,0.36839,0.3766,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0031536,0.36793,0.27519,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.7145e-05,0.3679,0.31367,1,1
1,GO FOREGUT MORPHOGENESIS,2.1663e-05,0.36774,0.42836,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00026903,0.36747,0.32269,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0013054,0.36729,0.45634,1,1
1,GO MEMBRANE INVAGINATION,2.7578e-07,0.36711,0.3797,1,1
1,GO VIRAL GENE EXPRESSION,5.6174e-05,0.36689,0.35832,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.36683,0.4031,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00031859,0.36675,0.29582,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00012964,0.36654,0.36218,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0012662,0.36646,0.31732,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00049035,0.36612,0.34316,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.3916e-06,0.36579,0.41093,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,6.0504e-05,0.36524,0.34463,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00047456,0.36523,0.35379,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,7.547e-05,0.36486,0.36554,1,1
1,GO REGULATION OF COAGULATION,2.2524e-05,0.3648,0.41692,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.014138,0.36446,0.24899,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,0.00011241,0.36424,0.42569,1,1
1,GO INTERFERON BETA PRODUCTION,0.00098941,0.36403,0.25876,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,2.0033e-05,0.36381,0.41762,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,2.4346e-05,0.3636,0.31759,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,7.8282e-05,0.3634,0.46777,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.6623e-06,0.36329,0.47993,1,1
1,GO EOSINOPHIL MIGRATION,0.0020453,0.36287,0.39334,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00057693,0.36221,0.29613,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,6.5149e-05,0.36169,0.35785,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.4421e-05,0.36163,0.32911,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.00030804,0.36159,0.33424,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00040247,0.36122,0.45759,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00010462,0.36098,0.35786,1,1
1,GO MEMBRANE DISASSEMBLY,0.00081984,0.36097,0.28046,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011326,0.36038,0.22668,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0050528,0.36023,0.28442,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013433,0.36021,0.3424,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00098941,0.36016,0.33777,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00045924,0.35941,0.28838,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0012662,0.35931,0.44728,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00035231,0.3591,0.33544,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,6.0504e-05,0.35868,0.31711,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.35858,0.35493,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,0.0028141,0.35804,0.30273,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00038934,0.35803,0.39665,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00024286,0.35799,0.26362,1,1
1,GO COMPLEMENT ACTIVATION,1.9904e-06,0.35716,0.33147,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,4.6597e-05,0.35696,0.29767,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,6.4994e-06,0.35555,0.36526,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0059384,0.35551,0.38726,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,3.7791e-06,0.35539,0.37605,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.0001547,0.35531,0.33966,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,8.4205e-05,0.35492,0.38537,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0029794,0.3548,0.43176,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8418e-05,0.35458,0.29481,1,1
1,GO CELL REDOX HOMEOSTASIS,7.0571e-06,0.35446,0.31273,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.7806e-05,0.35382,0.38829,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.4878e-05,0.35382,0.36658,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.5816e-05,0.35343,0.33267,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.0504e-05,0.35295,0.32595,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,5.9841e-06,0.35225,0.31952,1,1
1,GO INTERACTION WITH HOST,3.4728e-06,0.35211,0.38531,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0014299,0.35206,0.3438,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.2837e-06,0.35194,0.40041,1,1
1,GO PEPTIDE CATABOLIC PROCESS,2.2658e-06,0.3514,0.33042,1,1
1,GO PIGMENT ACCUMULATION,0.00017186,0.35138,0.30007,1,1
1,GO RESPONSE TO MANGANESE ION,5.6174e-05,0.35094,0.31756,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00040247,0.35092,0.32178,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0013457,0.35078,0.26783,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,8.3127e-06,0.35072,0.35452,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.1964e-05,0.35064,0.3842,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.001662,0.35002,0.3871,1,1
1,GO STEROL IMPORT,0.00014935,0.34946,0.48474,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00040247,0.3493,0.35453,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.4121e-05,0.34914,0.42489,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00016023,0.34882,0.31859,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.8521e-05,0.34857,0.45195,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2139e-05,0.34844,0.37431,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,7.8282e-05,0.34756,0.27125,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.033894,0.34753,0.24139,1,1
1,GO DEFENSE RESPONSE TO VIRUS,0.00018427,0.34722,0.3618,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.00049035,0.34701,0.26388,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0017641,0.34645,0.37603,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00030804,0.34625,0.32705,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00092958,0.346,0.32294,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.027188,0.34586,0.26881,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00041602,0.34569,0.3965,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0001165,0.34546,0.3106,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014138,0.34523,0.26141,1,1
1,GO FIBROBLAST PROLIFERATION,7.2754e-05,0.34473,0.31209,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.029719,0.34465,0.38839,1,1
1,GO T CELL APOPTOTIC PROCESS,1.349e-05,0.34464,0.32233,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.104e-05,0.34461,0.36997,1,1
1,GO NCRNA PROCESSING,8.4205e-05,0.34461,0.28622,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0034322,0.34434,0.25027,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00079435,0.34412,0.31669,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,5.6174e-05,0.34369,0.36476,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,6.5149e-05,0.34364,0.31605,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0014299,0.34361,0.32341,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.7118e-05,0.34358,0.3233,1,1
1,GO INTERLEUKIN 8 PRODUCTION,4.8379e-05,0.34287,0.34114,1,1
1,GO L GLUTAMATE IMPORT,0.00069957,0.34248,0.34083,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0015189,0.3422,0.26861,1,1
1,GO NUCLEOSIDE SALVAGE,0.0075304,0.34187,0.39781,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0013872,0.34158,0.35852,1,1
1,GO GASTRULATION,5.753e-07,0.34155,0.35375,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.00069957,0.34141,0.25457,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00047456,0.34091,0.43601,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.001662,0.34048,0.60189,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.2862e-06,0.34036,0.42252,1,1
1,GO TYPE I INTERFERON PRODUCTION,0.00012964,0.34016,0.29242,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00069957,0.33985,0.28992,1,1
1,GO PENTOSE METABOLIC PROCESS,0.0012662,0.33969,0.24122,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0071468,0.33959,0.27577,1,1
1,GO STEROID ESTERIFICATION,0.015574,0.3394,0.26258,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,9.0551e-05,0.33819,0.41442,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0012662,0.33799,0.29857,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.6597e-05,0.33793,0.30707,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00079435,0.33769,0.27747,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.001872,0.33762,0.34175,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.8583e-05,0.33751,0.2902,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,1.4609e-05,0.33744,0.28317,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00047456,0.3374,0.29433,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0031536,0.33719,0.29311,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0013054,0.33709,0.29155,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00042998,0.33702,0.37908,1,1
1,GO REGULATION OF LIPASE ACTIVITY,2.0033e-05,0.33699,0.27071,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,2.6307e-05,0.33693,0.31502,1,1
1,GO FIBROBLAST MIGRATION,6.2786e-05,0.33648,0.36292,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00026903,0.33586,0.42069,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.8077e-06,0.33562,0.37146,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00090094,0.33556,0.32385,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.3287e-06,0.33541,0.30406,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.1831e-07,0.33511,0.3177,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.2754e-05,0.33476,0.28537,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,2.9301e-06,0.33466,0.4082,1,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.027803,0.33462,0.21742,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.00021167,0.33426,0.38879,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.0576e-06,0.3341,0.41314,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.0033e-05,0.33349,0.40429,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.046579,0.33342,0.29811,1,1
1,GO DECIDUALIZATION,0.0042883,0.33303,0.39013,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00019753,0.33299,0.34253,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.02068,0.33282,0.33429,1,1
1,GO CELL SUBSTRATE ADHESION,8.3127e-06,0.33236,0.36747,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,9.7801e-06,0.33194,0.38149,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00065623,0.33181,0.3048,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00052342,0.3317,0.37624,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00029782,0.33169,0.31674,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00057693,0.33142,0.24826,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.6307e-05,0.33137,0.44931,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0085714,0.33093,0.24478,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.8583e-05,0.33059,0.28725,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00019753,0.33016,0.31645,1,1
1,GO SPROUTING ANGIOGENESIS,5.6174e-05,0.3294,0.32542,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,3.5759e-05,0.32917,0.29849,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.2658e-06,0.3284,0.3232,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.016339,0.32801,0.42791,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0031536,0.32797,0.30753,1,1
1,GO MESODERM MORPHOGENESIS,4.4712e-06,0.32796,0.33244,1,1
1,GO PIGMENT METABOLIC PROCESS,5.2837e-06,0.32794,0.31617,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0022992,0.32768,0.27284,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.32752,0.30053,1,1
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.046579,0.3275,0.24827,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.7806e-05,0.32725,0.37807,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.0226e-05,0.3271,0.37941,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00012074,0.32695,0.25945,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0021062,0.32691,0.34883,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.349e-05,0.32683,0.35903,1,1
1,GO GLIAL CELL ACTIVATION,8.7323e-05,0.32655,0.33759,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,3.6228e-06,0.32641,0.36147,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00032948,0.32625,0.25598,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00079435,0.32567,0.2931,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00028792,0.32549,0.36101,1,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.035393,0.32506,0.18889,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00038934,0.32476,0.27149,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.036164,0.32433,0.2982,1,1
1,GO PSEUDOURIDINE SYNTHESIS,0.0075304,0.32422,0.24519,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00017186,0.32402,0.28187,1,1
1,GO XENOBIOTIC TRANSPORT,0.00012964,0.32348,0.34371,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00024286,0.32296,0.34319,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,1.1964e-05,0.3221,0.35049,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.025994,0.32175,0.1945,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.001986,0.32125,0.27967,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0001547,0.32093,0.38266,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.2862e-06,0.32031,0.31402,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.104e-05,0.32021,0.3217,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00032948,0.32,0.40818,1,1
1,GO STEROL TRANSPORT,1.5816e-05,0.3199,0.27835,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.1617e-05,0.31989,0.27908,1,1
1,GO REGENERATION,2.4692e-06,0.31985,0.29033,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,9.7801e-06,0.31928,0.25774,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0040578,0.31924,0.19311,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.7118e-05,0.31917,0.37203,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.6174e-05,0.31903,0.35121,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00019753,0.31827,0.28433,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,9.3916e-06,0.31788,0.29115,1,1
1,GO PROTEIN TARGETING TO VACUOLE,1.4609e-05,0.31767,0.28005,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00022676,0.3167,0.26454,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010859,0.31639,0.2379,1,1
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.011612,0.31575,0.28647,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,0.3152,0.26446,1,1
1,GO LIPOPROTEIN LOCALIZATION,1.5201e-05,0.31491,0.42758,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.5816e-05,0.31482,0.3313,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,1.6455e-05,0.31461,0.34434,1,1
1,GO ASTROCYTE ACTIVATION,0.0040578,0.3141,0.2812,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00069957,0.31353,0.32601,1,1
1,GO FOCAL ADHESION ASSEMBLY,4.3218e-05,0.3134,0.3458,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.9263e-05,0.31318,0.31931,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.8521e-05,0.31282,0.2931,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9532e-05,0.31274,0.31394,1,1
1,GO MULTI ORGANISM LOCALIZATION,9.2696e-08,0.31267,0.39481,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.035393,0.31188,0.22418,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0057817,0.31176,0.24307,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.1493e-05,0.31173,0.29015,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,7.8282e-05,0.31172,0.29648,1,1
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.034637,0.31141,0.24022,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.508e-06,0.31138,0.32949,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,1.5816e-05,0.31079,0.30918,1,1
1,GO VESICLE CARGO LOADING,0.00012074,0.31075,0.28228,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0028957,0.31042,0.28734,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0038387,0.31041,0.2579,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,7.6603e-06,0.30986,0.38895,1,1
1,GO MUSCLE CELL PROLIFERATION,8.3127e-06,0.30978,0.30248,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,6.2786e-05,0.30967,0.28478,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00026003,0.30939,0.29388,1,1
1,GO RESPONSE TO PROGESTERONE,0.0028957,0.30884,0.28714,1,1
1,GO RRNA METABOLIC PROCESS,0.00059588,0.30865,0.2759,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,4.4878e-05,0.30839,0.32298,1,1
1,GO TRNA 5 LEADER REMOVAL,7.547e-05,0.30833,0.32904,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.020205,0.30809,0.25944,1,1
1,GO VASCULATURE DEVELOPMENT,2.1663e-05,0.30803,0.27843,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0025083,0.30794,0.24473,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,2.6307e-05,0.30763,0.2608,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.5816e-05,0.30761,0.31313,1,1
1,GO SYNCYTIUM FORMATION,0.00014935,0.30751,0.30735,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,3.4421e-05,0.30748,0.24653,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00014935,0.30748,0.25314,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.906e-06,0.30743,0.27574,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.7806e-05,0.30724,0.27564,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00029782,0.30683,0.26034,1,1
1,GO RNA 5 END PROCESSING,0.0006154,0.30678,0.27477,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017137,0.30664,0.45029,1,1
1,GO CHOLESTEROL EFFLUX,2.9301e-06,0.30658,0.32701,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00055855,0.30656,0.36215,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,2.0833e-05,0.30651,0.34083,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,4.8379e-05,0.30647,0.33515,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,3.7791e-06,0.30577,0.46217,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,3.8583e-05,0.30552,0.28185,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0025817,0.30549,0.25958,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,9.7346e-05,0.30525,0.25152,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,1.8521e-05,0.30497,0.34962,1,1
1,GO NCRNA METABOLIC PROCESS,0.00020448,0.30479,0.25039,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.02166,0.30457,0.291,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00047456,0.3043,0.20931,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00017186,0.30383,0.29238,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0006154,0.3038,0.28275,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,0.0007696,0.30362,0.27073,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00040247,0.30354,0.27221,1,1
1,GO REPLICATIVE SENESCENCE,0.0056288,0.3035,0.35725,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0053338,0.30343,0.34291,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.8583e-05,0.30314,0.26005,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,7.6603e-06,0.30281,0.3271,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0019282,0.3027,0.30538,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.013798,0.30232,0.32532,1,1
1,GO TRANSLATIONAL TERMINATION,0.00020448,0.30227,0.26005,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.1267e-06,0.30227,0.39455,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.4692e-06,0.30181,0.34719,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00026003,0.30164,0.27295,1,1
1,GO SELECTIVE AUTOPHAGY,5.753e-07,0.30121,0.31157,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,4.4878e-05,0.30117,0.29564,1,1
1,GO IRON ION HOMEOSTASIS,3.9418e-06,0.30112,0.2716,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.8379e-05,0.30087,0.3547,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,0.30077,0.32689,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00023468,0.3006,0.27651,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.5816e-05,0.30054,0.30942,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00065623,0.30023,0.30066,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00040247,0.30018,0.32099,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0022332,0.30016,0.28472,1,1
1,GO T CELL CYTOKINE PRODUCTION,1.1964e-05,0.29996,0.40171,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.033166,0.29984,0.18303,1,1
1,GO SPERM EGG RECOGNITION,7.0571e-06,0.29954,0.26285,1,1
1,GO ETHANOL OXIDATION,0.025994,0.2994,0.34528,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.024846,0.29933,0.17885,1,1
1,GO COAGULATION,9.3916e-06,0.29928,0.29345,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,7.0571e-06,0.29871,0.33008,1,1
1,GO FOAM CELL DIFFERENTIATION,0.00021909,0.29858,0.32187,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00037661,0.29845,0.3388,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.9801e-06,0.29839,0.31096,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00044439,0.29837,0.24867,1,1
1,GO ENDOTHELIAL CELL MIGRATION,3.8583e-05,0.29833,0.32035,1,1
1,GO HISTONE PHOSPHORYLATION,7.013e-05,0.29794,0.26461,1,1
1,GO GENITALIA MORPHOGENESIS,0.0051916,0.29794,0.26145,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.6902e-06,0.29785,0.37812,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,9.0179e-06,0.29783,0.28229,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0022332,0.29761,0.28685,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.5308e-05,0.29729,0.30696,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.014841,0.29695,0.33142,1,1
1,GO RIBOSOME BIOGENESIS,0.00022676,0.29663,0.30191,1,1
1,GO RESPONSE TO INTERLEUKIN 1,6.2367e-06,0.29659,0.32397,1,1
1,GO RRNA MODIFICATION,0.0064317,0.29658,0.20815,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0059384,0.2965,0.28176,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,4.3218e-05,0.29604,0.33321,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0025083,0.29562,0.2379,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.9301e-06,0.2948,0.27844,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,1.349e-05,0.2947,0.2881,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,8.4205e-05,0.29465,0.46101,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,2.7343e-05,0.29455,0.31929,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.00044439,0.2945,0.41243,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,2.1702e-06,0.29382,0.32347,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,9.7346e-05,0.29352,0.30949,1,1
1,GO RNA CATABOLIC PROCESS,1.0604e-05,0.29348,0.25048,1,1
1,GO GLAND MORPHOGENESIS,0.00025131,0.29338,0.34541,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.001872,0.29263,0.22975,1,1
1,GO NUCLEOTIDE SALVAGE,0.0085714,0.29261,0.35796,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.7806e-05,0.29254,0.33553,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,7.0571e-06,0.29254,0.29431,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2139e-05,0.29231,0.25315,1,1
1,GO CYTOKINETIC PROCESS,0.00059588,0.29205,0.24649,1,1
1,GO ACUTE PHASE RESPONSE,0.0081404,0.29174,0.26684,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,8.4205e-05,0.29144,0.28589,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0022332,0.29141,0.23291,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.0025083,0.29091,0.26861,1,1
1,GO HYPOTONIC RESPONSE,0.001872,0.29084,0.27435,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00021167,0.29074,0.33648,1,1
1,GO NATURAL KILLER CELL ACTIVATION,3.0689e-05,0.29073,0.29608,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.015203,0.29056,0.27687,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00095906,0.29044,0.34307,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,9.0179e-06,0.2904,0.2884,1,1
1,GO MYOBLAST DIFFERENTIATION,2.8418e-05,0.29037,0.29657,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.2786e-05,0.29035,0.25548,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.5201e-05,0.29034,0.28593,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.0833e-05,0.29014,0.25417,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,0.29011,0.30343,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.2454e-05,0.28985,0.24381,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00014418,0.28974,0.29344,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,6.5149e-05,0.28965,0.42812,1,1
1,GO REGULATION OF CELL AGING,7.9801e-06,0.28901,0.29885,1,1
1,GO TRNA 5 END PROCESSING,0.00019753,0.28894,0.29483,1,1
1,GO FATTY ACID BETA OXIDATION,0.0001547,0.28883,0.26101,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0011199,0.28817,0.28423,1,1
1,GO AMYLOID FIBRIL FORMATION,0.041093,0.28798,0.23184,1,1
1,GO PLASMA MEMBRANE TUBULATION,8.3127e-06,0.28789,0.32541,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00037661,0.28779,0.28148,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.9263e-05,0.28753,0.28626,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,5.8301e-05,0.2875,0.30316,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00081984,0.28737,0.29265,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0049174,0.28678,0.1505,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0001165,0.28677,0.2568,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0037331,0.28653,0.26852,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00022676,0.28627,0.27082,1,1
1,GO TISSUE REGENERATION,0.00028792,0.286,0.27952,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0075304,0.28584,0.43039,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0001547,0.28566,0.28832,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.001228,0.2856,0.20845,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.28493,0.20442,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00059588,0.28472,0.29144,1,1
1,GO REGULATION OF RNA BINDING,9.7346e-05,0.28465,0.27196,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.0010206,0.28428,0.36524,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,0.00012512,0.2842,0.23611,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,6.2367e-06,0.28364,0.22215,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.0073e-05,0.28352,0.26008,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0024367,0.28352,0.25791,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00010845,0.28284,0.27477,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,4.6623e-06,0.28283,0.30362,1,1
1,GO MACROPHAGE MIGRATION,7.2754e-05,0.2827,0.31274,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.7791e-06,0.28258,0.23106,1,1
1,GO RESPONSE TO REDOX STATE,0.014138,0.28225,0.22447,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,3.7145e-05,0.28186,0.2801,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0053338,0.28167,0.30166,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.28105,0.26236,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00038934,0.2808,0.21745,1,1
1,GO RESPONSE TO VIRUS,0.00011241,0.28059,0.31142,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.035393,0.28043,0.22074,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0037331,0.28031,0.32364,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00014418,0.2802,0.30751,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00079435,0.28011,0.28781,1,1
1,GO CELL CELL RECOGNITION,2.3654e-06,0.27998,0.27849,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00074557,0.27998,0.2521,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0039469,0.27995,0.27049,1,1
1,GO CARTILAGE DEVELOPMENT,0.00010462,0.27982,0.26426,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00074557,0.27969,0.24075,1,1
1,GO CERAMIDE TRANSPORT,0.00072223,0.27968,0.28907,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0022332,0.27913,0.22429,1,1
1,GO TISSUE REMODELING,0.00027832,0.27882,0.26003,1,1
1,GO RIG I SIGNALING PATHWAY,0.00022676,0.2788,0.32239,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.8251e-06,0.27864,0.27152,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0019282,0.27833,0.23393,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,7.6603e-06,0.27832,0.25706,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.015203,0.27828,0.25675,1,1
1,GO NECROTIC CELL DEATH,0.00032948,0.27799,0.36252,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0040578,0.27774,0.23828,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,8.4205e-05,0.27769,0.2571,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0017123,0.27753,0.27471,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00027832,0.27752,0.33925,1,1
1,GO RESPONSE TO THYROID HORMONE,0.00010092,0.27749,0.33802,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00016595,0.27727,0.27958,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0013872,0.2772,0.282,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.3528e-06,0.27713,0.27992,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00035231,0.27707,0.31298,1,1
1,GO FATTY ACID HOMEOSTASIS,0.02068,0.27702,0.19798,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0010528,0.2769,0.22858,1,1
1,GO PROTEIN FOLDING,4.6623e-06,0.27687,0.25493,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,6.7596e-05,0.27685,0.27706,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0029794,0.27677,0.23845,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.1904e-06,0.27661,0.43311,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,2.2524e-05,0.27631,0.25036,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,8.1192e-05,0.27628,0.25984,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,7.013e-05,0.27611,0.31835,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0011549,0.27596,0.26297,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00072223,0.27573,0.2931,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0017641,0.27462,0.24484,1,1
1,GO T CELL MIGRATION,0.00013433,0.27459,0.28752,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00040247,0.27412,0.28372,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.0179e-06,0.27378,0.23665,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00024286,0.27365,0.25213,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00353,0.27355,0.26567,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.00057693,0.27264,0.29138,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.1964e-05,0.27254,0.24116,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022332,0.27247,0.30455,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.27242,0.24876,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.27235,0.33254,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00065623,0.27225,0.27178,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0031536,0.27215,0.24825,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00023468,0.27167,0.29317,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,4.4878e-05,0.27138,0.24915,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0025083,0.27045,0.20339,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.1493e-05,0.27039,0.24042,1,1
1,GO AUTOPHAGOSOME MATURATION,2.0033e-05,0.27008,0.27774,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,3.1888e-05,0.26991,0.24044,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,3.3287e-06,0.26972,0.35679,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0017123,0.26948,0.22757,1,1
1,GO WOUND HEALING,1.7118e-05,0.26848,0.31277,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5201e-05,0.26843,0.30732,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0097392,0.26835,0.25864,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00041602,0.26831,0.24864,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00040247,0.26828,0.25305,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0028141,0.26827,0.39803,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00040247,0.26823,0.22811,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0046564,0.26799,0.21459,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.0689e-05,0.26769,0.21093,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00059588,0.26756,0.22398,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.007729,0.26744,0.20208,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,9.0551e-05,0.26705,0.2558,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.6623e-06,0.26683,0.33035,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.001191,0.26681,0.22061,1,1
1,GO RESPONSE TO WOUNDING,2.5308e-05,0.26666,0.26625,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0012662,0.26639,0.25762,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0042883,0.26596,0.26721,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.033894,0.26595,0.17465,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00059588,0.2659,0.32457,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00010092,0.2657,0.36794,1,1
1,GO EOSINOPHIL CHEMOTAXIS,0.020205,0.26561,0.36374,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0012662,0.26553,0.2286,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0011199,0.26549,0.24274,1,1
1,GO KERATINOCYTE MIGRATION,0.0010859,0.26548,0.30483,1,1
1,GO ERK1 AND ERK2 CASCADE,1.6455e-05,0.26541,0.24267,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0017123,0.26522,0.34044,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00047456,0.26516,0.23725,1,1
1,GO SEQUESTERING OF METAL ION,0.0022992,0.265,0.26248,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0028957,0.26489,0.26142,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00092958,0.26471,0.27358,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.104e-05,0.26463,0.27783,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00035231,0.26455,0.21453,1,1
1,GO TRANSPOSITION,0.033166,0.26424,0.2001,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0013872,0.26397,0.22525,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.001986,0.26389,0.22297,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00087311,0.26365,0.25668,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00047456,0.2636,0.23742,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00047456,0.26352,0.4075,1,1
1,GO OSTEOBLAST DIFFERENTIATION,4.3218e-05,0.26351,0.27413,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.050569,0.26345,0.26964,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00019753,0.2633,0.29087,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.01282,0.26327,0.24,1,1
1,GO RESPONSE TO DSRNA,4.4712e-06,0.26311,0.35276,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00038934,0.26306,0.35165,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00018427,0.26292,0.20817,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00040247,0.2628,0.23588,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00030804,0.26219,0.24028,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.2139e-05,0.2621,0.3582,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.1702e-06,0.26207,0.26085,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0081404,0.26201,0.33709,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00084609,0.26192,0.27023,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0010859,0.26192,0.20667,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.021165,0.26173,0.2186,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00059588,0.26168,0.25116,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00098941,0.2616,0.2968,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.4044e-06,0.26143,0.32046,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.3418e-05,0.26141,0.30087,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,5.4121e-05,0.261,0.21045,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.0033e-05,0.26079,0.25306,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.042857,0.26057,0.16455,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.9418e-06,0.26056,0.30914,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,3.3287e-06,0.26052,0.21318,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00026903,0.26035,0.29849,1,1
1,GO REGULATION OF GENE SILENCING,4.8612e-06,0.25966,0.23508,1,1
1,GO RNA DESTABILIZATION,2.9532e-05,0.25959,0.2442,1,1
1,GO TRANSLATIONAL ELONGATION,0.00023468,0.25944,0.22865,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00026903,0.2593,0.27559,1,1
1,GO GTP METABOLIC PROCESS,0.0011199,0.25925,0.28396,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0013457,0.25898,0.21123,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,7.8282e-05,0.25867,0.27227,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.0604e-05,0.25854,0.26951,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,4.3218e-05,0.25835,0.24482,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00049035,0.25819,0.23027,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00059588,0.25753,0.28494,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00069957,0.25728,0.24972,1,1
1,GO CELL MATRIX ADHESION,6.2786e-05,0.25728,0.30955,1,1
1,GO COPPER ION TRANSPORT,0.00012964,0.25727,0.26811,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00063551,0.25712,0.24306,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00012964,0.25682,0.28251,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.0011199,0.25661,0.23054,1,1
1,GO PEROXISOMAL TRANSPORT,0.0010859,0.25657,0.20495,1,1
1,GO DE NOVO PROTEIN FOLDING,0.00040247,0.25653,0.20866,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00020448,0.25642,0.25059,1,1
1,GO PROTEIN DENEDDYLATION,0.00037661,0.25587,0.21676,1,1
1,GO PEPTIDE METABOLIC PROCESS,3.7791e-06,0.25568,0.22655,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0006154,0.25555,0.22148,1,1
1,GO REGULATION OF VASOCONSTRICTION,8.1192e-05,0.25539,0.26592,1,1
1,GO P38MAPK CASCADE,5.0226e-05,0.25495,0.32666,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.014841,0.25492,0.22429,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.001986,0.25489,0.23494,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.024846,0.25432,0.2084,1,1
1,GO PROTEIN KINASE B SIGNALING,2.7343e-05,0.25431,0.21321,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.8583e-05,0.25405,0.24707,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0006154,0.25399,0.29968,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0022332,0.25386,0.21283,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001662,0.25378,0.30928,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,5.508e-06,0.25366,0.23089,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,7.547e-05,0.25329,0.23484,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.0051916,0.25309,0.15727,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,9.7346e-05,0.25285,0.24654,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013872,0.25269,0.28184,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0012662,0.25267,0.2615,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,4.3218e-05,0.25241,0.29873,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.4346e-05,0.25239,0.36995,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.001228,0.2522,0.21407,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0017123,0.25203,0.25859,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,3.7145e-05,0.25203,0.28064,1,1
1,GO REGULATION OF HEART GROWTH,0.00012512,0.25195,0.253,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,5.4121e-05,0.25174,0.27464,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0062634,0.25169,0.30384,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.547e-05,0.25155,0.27506,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,2.9532e-05,0.25146,0.20936,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,7.547e-05,0.25138,0.31439,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0015653,0.25053,0.22678,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00047456,0.25046,0.2385,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00031859,0.25006,0.26585,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0069616,0.24987,0.1668,1,1
1,GO FIBROBLAST ACTIVATION,0.0017123,0.24974,0.31119,1,1
1,GO INNATE IMMUNE RESPONSE,7.8282e-05,0.24955,0.24117,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0024367,0.24951,0.25624,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,9.0179e-06,0.24942,0.20866,1,1
1,GO LYMPHOCYTE MIGRATION,0.00044439,0.24937,0.20977,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0066042,0.24934,0.18346,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,0.24926,0.27419,1,1
1,GO SYMBIOTIC PROCESS,2.1702e-06,0.24921,0.25465,1,1
1,GO REGULATION OF ORGAN GROWTH,1.7474e-06,0.24884,0.2961,1,1
1,GO DETECTION OF OTHER ORGANISM,0.014138,0.24871,0.25884,1,1
1,GO LIPID IMPORT INTO CELL,0.010506,0.24871,0.21907,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.1192e-05,0.24866,0.18607,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.1112e-06,0.24865,0.27965,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0001165,0.24857,0.22413,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.9904e-06,0.2484,0.24239,1,1
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00013917,0.24825,0.29861,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.24795,0.24763,1,1
1,GO TOXIN TRANSPORT,0.00353,0.24783,0.16488,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.2454e-05,0.24769,0.22989,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.6603e-06,0.2467,0.33632,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0075304,0.24667,0.24946,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.033166,0.24652,0.307,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00029782,0.24651,0.29361,1,1
1,GO UV PROTECTION,0.035393,0.24647,0.21394,1,1
1,GO RESPONSE TO CYTOKINE,3.4421e-05,0.24614,0.27416,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,3.7145e-05,0.24599,0.25647,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00095906,0.24564,0.18294,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0022332,0.24528,0.22393,1,1
1,GO PHAGOCYTOSIS,3.7791e-06,0.2452,0.30331,1,1
1,GO LUNG MORPHOGENESIS,0.0087944,0.24487,0.18886,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,7.0571e-06,0.24477,0.2447,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,4.3218e-05,0.24469,0.25139,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.029068,0.24469,0.12373,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00059588,0.2446,0.18566,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037747,0.24452,0.15409,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.0033e-05,0.24432,0.23734,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00074557,0.244,0.22176,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00063551,0.24394,0.21521,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0010859,0.24364,0.25578,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.013e-05,0.24311,0.20688,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0025083,0.24281,0.36934,1,1
1,GO REGULATION OF MITOPHAGY,0.015203,0.24256,0.19602,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0060989,0.24249,0.24991,1,1
1,GO LIPID STORAGE,0.00032948,0.24203,0.24591,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0016129,0.242,0.18816,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.0038387,0.24167,0.18055,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.9532e-05,0.24101,0.27936,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026903,0.2409,0.20714,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0050528,0.24076,0.20615,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00038934,0.24076,0.23237,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00042998,0.2407,0.2695,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,4.6597e-05,0.24051,0.19471,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00021167,0.24023,0.22143,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00031859,0.24011,0.32537,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.8583e-05,0.24009,0.25335,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0006154,0.24005,0.20228,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,9.7801e-06,0.24005,0.2344,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.0311e-06,0.23991,0.25795,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.0049174,0.23945,0.20956,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,9.0551e-05,0.23943,0.21103,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0015189,0.23939,0.17646,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00019079,0.23932,0.20562,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0087944,0.23915,0.28976,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0010528,0.23891,0.24992,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.9532e-05,0.23874,0.36917,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0097392,0.23864,0.20217,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.23845,0.29123,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.02068,0.23809,0.23026,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0010528,0.23799,0.25792,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0087944,0.23785,0.27543,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,0.00010092,0.23777,0.27645,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.2376,0.22836,1,1
1,GO PLATELET ACTIVATION,0.00084609,0.23675,0.21716,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00052342,0.23659,0.30264,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.001872,0.23651,0.26648,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00021167,0.23563,0.22252,1,1
1,GO MACROPHAGE CHEMOTAXIS,0.00010462,0.2356,0.31174,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.0033e-05,0.23525,0.28973,1,1
1,GO DNA LIGATION,0.0011199,0.23519,0.24137,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.4346e-05,0.23499,0.27588,1,1
1,GO AMINE CATABOLIC PROCESS,0.00063551,0.23447,0.26221,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.001662,0.23439,0.1937,1,1
1,GO PROTEIN TARGETING,2.8418e-05,0.2342,0.20124,1,1
1,GO TRNA PROCESSING,0.00098941,0.23411,0.1781,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0032441,0.23404,0.28693,1,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.033166,0.23352,0.15885,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00065623,0.23347,0.21636,1,1
1,GO MESODERM DEVELOPMENT,0.00037661,0.23329,0.17728,1,1
1,GO SULFUR COMPOUND TRANSPORT,4.4712e-06,0.23329,0.26602,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00028792,0.23319,0.28166,1,1
1,GO RESPONSE TO PH,0.00041602,0.23317,0.26305,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,1.7474e-06,0.23313,0.26392,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0036303,0.23311,0.17998,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,4.1112e-06,0.2331,0.26075,1,1
1,GO MEMBRANE BIOGENESIS,0.035393,0.23287,0.1775,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.2754e-05,0.23272,0.23448,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031748,0.23255,0.18525,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00030804,0.23253,0.30301,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0034322,0.23194,0.18264,1,1
1,GO CRISTAE FORMATION,0.012203,0.23155,0.20042,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019282,0.23144,0.21763,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.017969,0.23124,0.16584,1,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0025083,0.2312,0.18091,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.026586,0.23105,0.16121,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,4.4878e-05,0.23071,0.28204,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00084609,0.2307,0.33682,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,1.5816e-05,0.23069,0.22498,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.023205,0.23068,0.1924,1,1
1,GO TRNA METHYLATION,0.0010206,0.23037,0.19904,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.012203,0.23012,0.34967,1,1
1,GO MITOPHAGY,5.8301e-05,0.2301,0.25019,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.029719,0.22985,0.3475,1,1
1,GO HISTONE H4 DEACETYLATION,0.0090226,0.22953,0.20996,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0019282,0.22952,0.2642,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.027803,0.2295,0.17556,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,8.1192e-05,0.22948,0.22999,1,1
1,GO RRNA METHYLATION,0.014486,0.22941,0.17624,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,3.3287e-06,0.22929,0.23198,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00079435,0.22915,0.17578,1,1
1,GO PODOSOME ASSEMBLY,0.0011199,0.22897,0.30391,1,1
1,GO PEROXISOME ORGANIZATION,0.00065623,0.22882,0.19624,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.017137,0.22833,0.34774,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.5759e-05,0.22807,0.23393,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0097392,0.22804,0.36295,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00020448,0.22771,0.19873,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00074557,0.2277,0.24524,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0029794,0.22763,0.23455,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0085714,0.22756,0.2165,1,1
1,GO MYOBLAST FUSION,0.00092958,0.22732,0.29882,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0001547,0.22729,0.32015,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0066042,0.22693,0.17165,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00072223,0.22633,0.20584,1,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.023741,0.22623,0.1912,1,1
1,GO SUPEROXIDE ANION GENERATION,0.0028957,0.22601,0.25458,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,8.4205e-05,0.22582,0.21601,1,1
1,GO RNA 3 END PROCESSING,0.0029794,0.22577,0.17401,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00353,0.22558,0.17691,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.3218e-05,0.22528,0.21702,1,1
1,GO CELL PROLIFERATION IN HINDBRAIN,0.023741,0.22489,0.18009,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.22483,0.22143,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0007696,0.22451,0.29784,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00021167,0.2244,0.21491,1,1
1,GO VIRION ASSEMBLY,0.0031536,0.22433,0.15878,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.8521e-05,0.22396,0.33896,1,1
1,GO RESPONSE TO RETINOIC ACID,0.00026003,0.22393,0.2271,1,1
1,GO T CELL CHEMOTAXIS,0.00010092,0.22383,0.24521,1,1
1,GO RESPONSE TO BACTERIUM,3.5759e-05,0.22374,0.25043,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00014418,0.22367,0.24554,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0011549,0.22232,0.2016,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.001228,0.22224,0.23928,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.0014299,0.22224,0.23157,1,1
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.010506,0.22222,0.17829,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,5.6174e-05,0.22182,0.20397,1,1
1,GO OSTEOCLAST DIFFERENTIATION,0.00050664,0.22122,0.18974,1,1
1,GO TISSUE MIGRATION,0.00012964,0.22101,0.27629,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00074557,0.22086,0.2022,1,1
1,GO INTEGRIN ACTIVATION,0.0087944,0.22079,0.19335,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.8521e-05,0.22065,0.27193,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0007696,0.22058,0.18725,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0054795,0.22049,0.15573,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0011549,0.22031,0.37458,1,1
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0060989,0.22025,0.18127,1,1
1,GO IMMUNE EFFECTOR PROCESS,2.7343e-05,0.21949,0.25781,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00034072,0.21924,0.21958,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.349e-05,0.21904,0.23556,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0071468,0.21884,0.15974,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.00042998,0.21848,0.19938,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.001228,0.21844,0.18741,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.014841,0.21837,0.26201,1,1
1,GO REGULATION OF VASCULOGENESIS,0.025994,0.2178,0.27389,1,1
1,GO DNA DEALKYLATION,0.010506,0.21762,0.18777,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00079435,0.21761,0.32068,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,9.0551e-05,0.2176,0.18842,1,1
1,GO TRNA METABOLIC PROCESS,0.0022332,0.21758,0.16383,1,1
1,GO URETER DEVELOPMENT,0.019283,0.21691,0.2134,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.0689e-05,0.2169,0.24889,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0056288,0.21662,0.26556,1,1
1,GO RNA MODIFICATION,0.00019753,0.21654,0.1872,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0056288,0.21653,0.1954,1,1
1,GO REGULATION OF URINE VOLUME,0.00026003,0.21647,0.24333,1,1
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.0051916,0.2164,0.37149,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,7.547e-05,0.21637,0.2547,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00067758,0.21617,0.17887,1,1
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0016129,0.21614,0.24424,1,1
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.030383,0.21604,0.17602,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.216,0.18635,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0097392,0.21594,0.14677,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.009256,0.21593,0.21181,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6597e-05,0.21583,0.21554,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.010773,0.2155,0.18745,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0025817,0.21477,0.20658,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.001191,0.21465,0.2486,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.6597e-05,0.21463,0.18851,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00052342,0.21436,0.21518,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0026572,0.21412,0.21996,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.21411,0.26717,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00038934,0.21398,0.1916,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00044439,0.21394,0.24524,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.011612,0.21359,0.19559,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.00057693,0.21325,0.23537,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,7.5427e-07,0.21325,0.2127,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0021062,0.21323,0.18102,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0017123,0.21315,0.22164,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.7145e-05,0.21259,0.26038,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.7323e-05,0.21252,0.23964,1,1
1,GO TRNA MODIFICATION,0.0013872,0.21222,0.18275,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00041602,0.21162,0.27415,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00057693,0.21094,0.21144,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0006154,0.2109,0.21137,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,4.3218e-05,0.21076,0.19207,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0042883,0.21057,0.20764,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001872,0.21035,0.23326,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0025083,0.21008,0.2039,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.1663e-05,0.21005,0.23867,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00025131,0.21005,0.20279,1,1
1,GO HEAD MORPHOGENESIS,0.0016129,0.21003,0.23744,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0066042,0.20969,0.15718,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,7.013e-05,0.20964,0.22466,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00024286,0.20959,0.19367,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00063551,0.20948,0.19846,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,6.7596e-05,0.20944,0.19811,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.015203,0.20934,0.20268,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.026586,0.20931,0.15378,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0030654,0.20929,0.17862,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.029068,0.20847,0.22748,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.027803,0.20823,0.23139,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.014841,0.20819,0.15681,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0099891,0.20806,0.1628,1,1
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0081404,0.20762,0.22912,1,1
1,GO REGULATION OF CELLULAR RESPIRATION,0.04854,0.20735,0.13198,1,1
1,GO RESPONSE TO KETONE,0.0037331,0.2073,0.15105,1,1
1,GO REGULATION OF LIPID STORAGE,0.00090094,0.20727,0.23765,1,1
1,GO BLASTOCYST GROWTH,0.001662,0.20725,0.23881,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00034072,0.20696,0.18331,1,1
1,GO CYTOKINE PRODUCTION,6.7596e-05,0.20687,0.24059,1,1
1,GO PLATELET MORPHOGENESIS,0.0027346,0.2068,0.18649,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.050569,0.20646,0.13341,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,7.547e-05,0.20632,0.19292,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00063551,0.20625,0.22606,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0015653,0.2057,0.19745,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,4.8379e-05,0.20569,0.22161,1,1
1,GO COENZYME A METABOLIC PROCESS,0.0056288,0.20558,0.18203,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00072223,0.20538,0.18739,1,1
1,GO CELLULAR RESPONSE TO ATP,6.2786e-05,0.2048,0.22956,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.1904e-06,0.20451,0.19158,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00045924,0.20436,0.16143,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,5.4121e-05,0.20401,0.26813,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.015203,0.20391,0.14333,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0053338,0.20333,0.21691,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.00027832,0.20285,0.19223,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.0039469,0.20285,0.23706,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,1.0184e-05,0.2026,0.18584,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00016595,0.20259,0.22825,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0050528,0.20253,0.1806,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0046564,0.2023,0.21458,1,1
1,GO REGULATION OF PROTEOLYSIS,4.4878e-05,0.20227,0.18819,1,1
1,GO RESPONSE TO VITAMIN A,0.029068,0.2018,0.20832,1,1
1,GO MYELOID CELL HOMEOSTASIS,5.8301e-05,0.2016,0.19613,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.043763,0.20151,0.17615,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00041602,0.20144,0.23486,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,1.7118e-05,0.20137,0.20491,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00353,0.20123,0.22492,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,7.5427e-07,0.20121,0.16593,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0015189,0.20117,0.18085,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0029794,0.20055,0.15339,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00038934,0.20037,0.21244,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00054072,0.20027,0.21725,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.9904e-06,0.20027,0.18311,1,1
1,GO ETHANOL METABOLIC PROCESS,0.010773,0.19997,0.21652,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00044439,0.19975,0.21679,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00072223,0.19966,0.19195,1,1
1,GO PROTEIN REFOLDING,0.033166,0.19938,0.16315,1,1
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.029719,0.19893,0.14399,1,1
1,GO NUCLEAR EXPORT,2.5308e-05,0.19868,0.17592,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.049546,0.19839,0.1668,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.011326,0.19838,0.18058,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,4.4878e-05,0.19829,0.22937,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00084609,0.19824,0.25885,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.00050664,0.19783,0.17903,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.011904,0.19754,0.14355,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.013465,0.19748,0.18192,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0027346,0.19748,0.20325,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.001191,0.19739,0.17131,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0060989,0.19738,0.22686,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00026903,0.19711,0.22214,1,1
1,GO CELL AGING,6.5149e-05,0.19708,0.19676,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.031059,0.19694,0.099016,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.043763,0.1968,0.22342,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00017186,0.19663,0.24126,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.9532e-05,0.19651,0.20253,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.041093,0.19618,0.19627,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001191,0.19604,0.21682,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.011612,0.19602,0.27393,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00029782,0.196,0.24369,1,1
1,GO VESICLE TARGETING,0.00019753,0.19585,0.21512,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.050569,0.19568,0.13477,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,0.19561,0.17211,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00040247,0.1955,0.18762,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0013054,0.1954,0.20548,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.024288,0.19506,0.16905,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00036427,0.19487,0.2301,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.02166,0.19479,0.26578,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.050569,0.19444,0.17051,1,1
1,GO OXALATE TRANSPORT,0.0024367,0.19428,0.17281,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0015653,0.19376,0.20578,1,1
1,GO REGULATION OF HEMOPOIESIS,0.00017796,0.19367,0.17188,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0029794,0.19352,0.17088,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00054072,0.19346,0.1934,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.033166,0.19313,0.13798,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0037331,0.19292,0.17585,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.015203,0.19275,0.1257,1,1
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00095906,0.19266,0.17756,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.0784e-06,0.19244,0.18052,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.025414,0.19226,0.12251,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028957,0.19214,0.20358,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0046564,0.19172,0.2187,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0083534,0.19166,0.32409,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00012074,0.19156,0.19386,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.017969,0.19106,0.13369,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0015653,0.19097,0.15238,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00021167,0.19085,0.18422,1,1
1,GO BODY FLUID SECRETION,0.00030804,0.1905,0.20494,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.02068,0.1905,0.14566,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0013872,0.19043,0.20103,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.2524e-05,0.19027,0.19624,1,1
1,GO SECRETION BY TISSUE,0.025994,0.18996,0.16438,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.18985,0.1755,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0017641,0.18973,0.19389,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00011241,0.18966,0.19656,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00036427,0.18966,0.14411,1,1
1,GO INFLAMMATORY RESPONSE,0.00013433,0.18964,0.23165,1,1
1,GO BONE REMODELING,0.001228,0.18964,0.1998,1,1
1,GO MITOTIC CYTOKINESIS,0.015203,0.18938,0.14429,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0022992,0.18912,0.2938,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00041602,0.1887,0.23182,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00042998,0.18864,0.15948,1,1
1,GO BODY MORPHOGENESIS,0.0069616,0.18856,0.16146,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011612,0.18844,0.17893,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.18839,0.14197,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00020448,0.1883,0.19676,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,5.2139e-05,0.1879,0.1827,1,1
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.015574,0.18789,0.20187,1,1
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0049174,0.18748,0.18559,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,4.5813e-07,0.18718,0.1775,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.017969,0.18713,0.16553,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.3132e-05,0.18678,0.21959,1,1
1,GO RESPONSE TO TUMOR CELL,0.034637,0.18641,0.15849,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,6.4994e-06,0.18634,0.22356,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0013872,0.18605,0.14893,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0010859,0.18591,0.18684,1,1
1,GO DEFENSE RESPONSE,0.0001547,0.1859,0.20176,1,1
1,GO DRUG METABOLIC PROCESS,0.0032441,0.18571,0.15716,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00020448,0.18567,0.18437,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,5.0226e-05,0.18534,0.19726,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.018398,0.1848,0.14923,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0071468,0.18468,0.27192,1,1
1,GO CELLULAR RESPONSE TO PH,0.02268,0.18423,0.13389,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00016595,0.18421,0.17208,1,1
1,GO FACE DEVELOPMENT,0.00054072,0.18399,0.22677,1,1
1,GO TUBE MORPHOGENESIS,0.00042998,0.18388,0.18362,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.009256,0.18374,0.13591,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.00013433,0.18355,0.19307,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.5813e-07,0.18352,0.17865,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0090226,0.18339,0.21099,1,1
1,GO RNA METHYLATION,0.00092958,0.18327,0.17456,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00032948,0.18319,0.15661,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00010845,0.18318,0.15641,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.027188,0.18316,0.14589,1,1
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.034637,0.18268,0.12608,1,1
1,GO PEPTIDYL ARGININE METHYLATION,0.010773,0.18262,0.14353,1,1
1,GO MESENCHYME DEVELOPMENT,0.0022992,0.18252,0.18625,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00092958,0.18244,0.27006,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.9841e-06,0.18241,0.20403,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0013872,0.18194,0.16516,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00012964,0.18187,0.17916,1,1
1,GO OVULATION,0.033894,0.18151,0.2627,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0018173,0.18071,0.14682,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,0.00069957,0.18018,0.23089,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,2.6902e-06,0.18013,0.18546,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0041716,0.18,0.1462,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0022332,0.17979,0.15832,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0029794,0.17969,0.14267,1,1
1,GO T CELL PROLIFERATION,0.0018173,0.17934,0.17807,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00011241,0.1793,0.19226,1,1
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.033166,0.17914,0.19029,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00084609,0.17888,0.16935,1,1
1,GO PROTEIN KINASE A SIGNALING,0.0001547,0.17858,0.21538,1,1
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.03939,0.17852,0.10462,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.0018173,0.17844,0.35723,1,1
1,GO ANION HOMEOSTASIS,0.0067808,0.17785,0.17167,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.011612,0.1778,0.13423,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024286,0.17718,0.23667,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.8521e-05,0.17676,0.19562,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014935,0.17673,0.20373,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00092958,0.17672,0.16669,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0059384,0.17666,0.17945,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.0029794,0.17648,0.18655,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00054072,0.1761,0.23454,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.004408,0.17602,0.13656,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.041967,0.17592,0.20342,1,1
1,GO CELL ACTIVATION,5.8301e-05,0.17569,0.21438,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00026003,0.17564,0.14802,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00014935,0.17562,0.18547,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0028957,0.1756,0.13733,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00040247,0.17514,0.18312,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.027803,0.17493,0.20602,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,7.9801e-06,0.17487,0.16646,1,1
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.015953,0.17475,0.14728,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.036948,0.17454,0.14395,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0029794,0.17445,0.16573,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0047853,0.17402,0.14301,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.052669,0.17397,0.15423,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0079323,0.17384,0.14892,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.02268,0.17357,0.12989,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00063551,0.17353,0.15789,1,1
1,GO HISTONE H2B UBIQUITINATION,0.047551,0.17351,0.11235,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,4.3218e-05,0.17328,0.16006,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0045306,0.17324,0.14326,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00019753,0.17295,0.19293,1,1
1,GO AGING,0.0001165,0.17285,0.17198,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.0027346,0.17279,0.13282,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.17276,0.21929,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.0311e-06,0.17273,0.16812,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00031859,0.17247,0.17471,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00063551,0.17242,0.16713,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0015653,0.17233,0.17409,1,1
1,GO RESPONSE TO CHEMOKINE,0.010506,0.17226,0.1937,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.004408,0.17219,0.15038,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0053338,0.17213,0.14796,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.012203,0.17202,0.12345,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,6.0504e-05,0.17194,0.18266,1,1
1,GO LYSOSOMAL TRANSPORT,0.00016023,0.17172,0.17593,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00041602,0.1715,0.23614,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.035393,0.17149,0.17172,1,1
1,GO GOLGI VESICLE TRANSPORT,1.7118e-05,0.17119,0.16327,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00049035,0.17119,0.16844,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00090094,0.17104,0.14414,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,0.00026903,0.17057,0.18771,1,1
1,GO VACUOLAR TRANSPORT,0.00050664,0.17011,0.14489,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,0.00025131,0.16984,0.15981,1,1
1,GO REGULATION OF IMMUNE RESPONSE,9.389e-05,0.16961,0.19226,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.9263e-05,0.16941,0.17695,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0031536,0.16934,0.16578,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,0.00041602,0.16914,0.18842,1,1
1,GO NEURAL TUBE PATTERNING,0.029068,0.16812,0.14849,1,1
1,GO AEROBIC RESPIRATION,0.025994,0.1676,0.10393,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,5.0683e-06,0.16748,0.15451,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.011612,0.16736,0.25925,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.014841,0.16732,0.17006,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00059588,0.16683,0.16525,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0069616,0.16679,0.13913,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.026586,0.16599,0.18423,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0047853,0.16556,0.12184,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.889e-07,0.16539,0.18005,1,1
1,GO SPINDLE LOCALIZATION,0.00034072,0.16534,0.16821,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.0040578,0.16529,0.13787,1,1
1,GO RNA CAPPING,0.00028792,0.16511,0.16155,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0053338,0.16487,0.17361,1,1
1,GO FATTY ACID METABOLIC PROCESS,0.0013457,0.16474,0.13468,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0017641,0.16429,0.12938,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0019282,0.16417,0.1501,1,1
1,GO REGULATION OF RESPONSE TO STRESS,8.4205e-05,0.16413,0.14832,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.014138,0.16405,0.13503,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0015653,0.1638,0.14961,1,1
1,GO VACUOLE ORGANIZATION,8.1192e-05,0.16375,0.15449,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,7.547e-05,0.16367,0.15474,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0014299,0.16351,0.14179,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,5.7413e-06,0.16349,0.24456,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00067758,0.16347,0.20729,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.017549,0.16333,0.17875,1,1
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.05161,0.16328,0.21767,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00019753,0.16327,0.18155,1,1
1,GO RNA DECAPPING,0.00079435,0.16313,0.16857,1,1
1,GO REGULATION OF ERAD PATHWAY,5.508e-06,0.16299,0.19997,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.00019079,0.16282,0.17744,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,7.2111e-07,0.16273,0.16007,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00017186,0.16272,0.23239,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0033369,0.16251,0.17216,1,1
1,GO SULFATE TRANSPORT,3.1888e-05,0.16227,0.18152,1,1
1,GO ORGANELLE INHERITANCE,0.0027346,0.16215,0.16437,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.001191,0.16207,0.14492,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0017123,0.16205,0.21821,1,1
1,GO MYELOID CELL DIFFERENTIATION,0.00016023,0.16177,0.15119,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0036303,0.16174,0.11042,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.026586,0.16173,0.1307,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,2.4346e-05,0.16168,0.1835,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.0017123,0.16122,0.20934,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00034072,0.16094,0.1535,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00353,0.1607,0.12855,1,1
1,GO TRANSLESION SYNTHESIS,0.023741,0.16065,0.11507,1,1
1,GO MUSCLE ADAPTATION,0.015953,0.1606,0.11035,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.010506,0.16022,0.13772,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0050528,0.16009,0.22129,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00026903,0.159,0.1453,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021689,0.1587,0.28981,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0010206,0.15852,0.17217,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,7.889e-07,0.15824,0.17142,1,1
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00098941,0.15804,0.1463,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0016129,0.15767,0.19632,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.00059588,0.15752,0.11977,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.00021167,0.15735,0.13349,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.014841,0.1573,0.13989,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0056288,0.15718,0.15719,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.02843,0.15712,0.17911,1,1
1,GO LIPID CATABOLIC PROCESS,0.0017123,0.15687,0.12025,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00025131,0.15682,0.15007,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0017641,0.15647,0.18786,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00041602,0.15622,0.16288,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.014486,0.15558,0.11678,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.012508,0.15539,0.16851,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.015574,0.15529,0.16438,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00020448,0.15474,0.1697,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.046579,0.15454,0.19197,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0023671,0.15449,0.20261,1,1
1,GO RRNA 3 END PROCESSING,0.011326,0.15438,0.16464,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.024846,0.15429,0.1288,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.029719,0.15399,0.13957,1,1
1,GO PROTEIN IMPORT,0.00017796,0.15338,0.14214,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.033894,0.1531,0.11471,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,9.4334e-07,0.15283,0.16324,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.6597e-05,0.15261,0.16028,1,1
1,GO TELOMERE ORGANIZATION,0.0030654,0.15251,0.10648,1,1
1,GO MAINTENANCE OF LOCATION,5.8301e-05,0.15245,0.16646,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0064317,0.15232,0.15718,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.017969,0.15217,0.18717,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0021062,0.15197,0.14681,1,1
1,GO PROTEIN STABILIZATION,0.00012512,0.15163,0.14007,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.040234,0.15162,0.10915,1,1
1,GO HEART GROWTH,0.0071468,0.15054,0.15243,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00036427,0.15054,0.13107,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.0081404,0.15051,0.12033,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0073363,0.15048,0.15646,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,3.3287e-06,0.15033,0.14399,1,1
1,GO MACROPHAGE ACTIVATION,0.016339,0.14995,0.15586,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.013139,0.14992,0.12982,1,1
1,GO CELL KILLING,0.013798,0.14984,0.1285,1,1
1,GO GOLGI VESICLE BUDDING,0.0010528,0.14979,0.17832,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0015189,0.14968,0.12168,1,1
1,GO VACUOLAR ACIDIFICATION,0.0024367,0.14956,0.17,1,1
1,GO PROTEIN CATABOLIC PROCESS,2.4692e-06,0.14928,0.14378,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00010092,0.1492,0.12053,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00013917,0.14841,0.13167,1,1
1,GO NEUTROPHIL MIGRATION,0.0036303,0.1484,0.22611,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00024286,0.14825,0.12998,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00031859,0.14819,0.12762,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0081404,0.1481,0.15544,1,1
1,GO RESPONSE TO LIPID,0.0010528,0.148,0.15452,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.014841,0.1479,0.13304,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.013798,0.14695,0.23566,1,1
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0099891,0.14694,0.11183,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.04854,0.1468,0.096196,1,1
1,GO REGULATION OF CATABOLIC PROCESS,1.8251e-06,0.14674,0.1534,1,1
1,GO PROTEOLYSIS,3.3132e-05,0.14668,0.13285,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.024846,0.14664,0.11223,1,1
1,GO RESPONSE TO LEPTIN,0.040234,0.14618,0.16901,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.0090226,0.14538,0.11596,1,1
1,GO MITOTIC RECOMBINATION,0.021165,0.14529,0.14765,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0059384,0.14525,0.10739,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00092958,0.14507,0.13924,1,1
1,GO CELLULAR RESPONSE TO UV,0.0022332,0.14497,0.1358,1,1
1,GO NUCLEAR TRANSPORT,9.389e-05,0.14458,0.12429,1,1
1,GO RNA LOCALIZATION,0.00072223,0.14429,0.16848,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0037331,0.14414,0.14374,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00010092,0.14377,0.13671,1,1
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.0022992,0.14338,0.12807,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.001191,0.14326,0.13364,1,1
1,GO ELECTRON TRANSPORT CHAIN,0.004408,0.14311,0.11693,1,1
1,GO TRNA TRANSPORT,0.016734,0.14284,0.13769,1,1
1,GO RESPONSE TO UV,0.001228,0.14281,0.13018,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00029782,0.1427,0.15963,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.012508,0.14261,0.13551,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0010206,0.14239,0.14346,1,1
1,GO COPII COATED VESICLE BUDDING,0.0027346,0.14234,0.17351,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00016023,0.14229,0.14699,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.029068,0.14156,0.083702,1,1
1,GO HISTONE DEACETYLATION,0.0032441,0.14151,0.11148,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.0017641,0.14151,0.10732,1,1
1,GO RNA PROCESSING,0.00081984,0.14111,0.14663,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0040578,0.14109,0.11285,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00042998,0.14103,0.15178,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.00081984,0.14087,0.16713,1,1
1,GO GOLGI ORGANIZATION,0.00079435,0.14082,0.12747,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.012508,0.14055,0.098786,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.034637,0.14052,0.13358,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,9.0221e-07,0.14045,0.16487,1,1
1,GO PROTEIN NEDDYLATION,0.0079323,0.14027,0.16006,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00021909,0.14025,0.18092,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0010859,0.14011,0.12621,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00041602,0.13999,0.13417,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,8.1192e-05,0.13975,0.16103,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.0047853,0.13958,0.12705,1,1
1,GO DNA BIOSYNTHETIC PROCESS,5.0683e-06,0.13951,0.14674,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0015653,0.13918,0.13088,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0024367,0.13907,0.15564,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00054072,0.13896,0.16604,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.4712e-06,0.13892,0.16024,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.01282,0.13823,0.11367,1,1
1,GO REGULATION OF MAPK CASCADE,0.00037661,0.13812,0.15013,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.050569,0.13794,0.12028,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00074557,0.13775,0.1546,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.0057817,0.13752,0.14792,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00019079,0.13733,0.1878,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0050528,0.13659,0.13214,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.045624,0.13656,0.19835,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0024367,0.13656,0.18657,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0060989,0.13651,0.11176,1,1
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.009256,0.13643,0.12188,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.040234,0.13629,0.10284,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.037747,0.13625,0.10553,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.030383,0.13559,0.13415,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00021167,0.1353,0.15152,1,1
1,GO POSTREPLICATION REPAIR,0.019283,0.13502,0.093146,1,1
1,GO CELLULAR RESPIRATION,0.0079323,0.13492,0.11775,1,1
1,GO RECEPTOR RECYCLING,0.011047,0.13488,0.1176,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00081984,0.13462,0.14953,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0021689,0.13435,0.14069,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.040234,0.1342,0.20488,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0054795,0.13398,0.15623,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00055855,0.13374,0.15661,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0006154,0.13345,0.13871,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.011326,0.13339,0.10542,1,1
1,GO REGULATION OF TUBE SIZE,0.0028957,0.13331,0.15857,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0062634,0.1333,0.10197,1,1
1,GO REGULATION OF CHEMOTAXIS,0.0087944,0.13307,0.12612,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0037331,0.13234,0.12712,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.012203,0.13223,0.096783,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0099891,0.13161,0.11896,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00098941,0.13161,0.11007,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0046564,0.13123,0.083306,1,1
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.0056288,0.13122,0.095844,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.0045306,0.1312,0.21379,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.033166,0.13109,0.1099,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.04854,0.13023,0.12712,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00074557,0.13009,0.14656,1,1
1,GO STEM CELL DIFFERENTIATION,0.00074557,0.13003,0.14406,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.00063551,0.12983,0.14221,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,9.7346e-05,0.12978,0.15804,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001872,0.12972,0.16018,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00021909,0.12951,0.16883,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.023205,0.1295,0.1359,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.0054795,0.12937,0.15265,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00034072,0.12898,0.14932,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00036427,0.12896,0.11852,1,1
1,GO LIPID HOMEOSTASIS,0.0075304,0.12884,0.11767,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00020448,0.12869,0.15823,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00016595,0.12868,0.12138,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.013798,0.12798,0.14332,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0039469,0.12772,0.11019,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0032441,0.12766,0.11237,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.015203,0.12687,0.11635,1,1
1,GO SPHINGOID METABOLIC PROCESS,0.038561,0.12687,0.091166,1,1
1,GO EXOCYTOSIS,0.0011549,0.12645,0.1365,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00079435,0.12642,0.11659,1,1
1,GO MRNA METABOLIC PROCESS,0.00063551,0.12576,0.13509,1,1
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.045624,0.12563,0.088238,1,1
1,GO RESPONSE TO HORMONE,0.0013872,0.12561,0.11326,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.013465,0.12488,0.11042,1,1
1,GO MRNA CLEAVAGE,0.0038387,0.12463,0.11476,1,1
1,GO BLASTOCYST FORMATION,0.0069616,0.12461,0.14698,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0014738,0.1243,0.12751,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00069957,0.1236,0.1215,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.9801e-06,0.12358,0.12318,1,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.016734,0.12307,0.10088,1,1
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0045306,0.12232,0.095736,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00065623,0.12208,0.12198,1,1
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.036164,0.12201,0.094771,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00013433,0.12199,0.13636,1,1
1,GO MODIFIED AMINO ACID TRANSPORT,0.0049174,0.12174,0.22391,1,1
1,GO APOPTOTIC PROCESS,0.00049035,0.12164,0.1131,1,1
1,GO RUFFLE ORGANIZATION,0.033166,0.12151,0.11262,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.033894,0.12121,0.10027,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.015574,0.12119,0.23406,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.010245,0.12118,0.082715,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0011199,0.12107,0.095532,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0024367,0.12088,0.099654,1,1
1,GO B CELL ACTIVATION,0.0041716,0.12078,0.11358,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.00095906,0.12045,0.091814,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.019283,0.12031,0.095259,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.024288,0.11968,0.071051,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0036303,0.11961,0.098563,1,1
1,GO GENE SILENCING,0.00047456,0.11959,0.1052,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.052669,0.11952,0.10832,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.0036303,0.11934,0.088891,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.021165,0.11915,0.086832,1,1
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0066042,0.1189,0.084199,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0039469,0.11889,0.10019,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.018836,0.11866,0.12005,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00057693,0.11806,0.12714,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00098941,0.11784,0.12546,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.04854,0.11724,0.12419,1,1
1,GO RESPONSE TO PEPTIDE,0.00095906,0.11713,0.10566,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0012662,0.11674,0.12603,1,1
1,GO ORGANELLE DISASSEMBLY,6.7596e-05,0.11624,0.13366,1,1
1,GO CELL DIVISION,0.033166,0.11603,0.064421,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.001872,0.1157,0.098597,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.001872,0.11558,0.10881,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0029794,0.11529,0.11674,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0013457,0.11487,0.1161,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.009256,0.11482,0.12054,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0017123,0.11406,0.10015,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.041093,0.114,0.082113,1,1
1,GO NUCLEUS ORGANIZATION,0.0022332,0.11397,0.11021,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00014418,0.11372,0.12071,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.015203,0.11346,0.08548,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.6174e-05,0.1134,0.12098,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0031536,0.11331,0.11122,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,9.7346e-05,0.11317,0.13437,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.009256,0.1119,0.084189,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00084609,0.11173,0.16788,1,1
1,GO RNA SURVEILLANCE,0.0025817,0.11171,0.18862,1,1
1,GO MEMBRANE ORGANIZATION,0.0019282,0.11121,0.10019,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.046579,0.1108,0.085237,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.0021689,0.11067,0.091016,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,9.3916e-06,0.11022,0.12181,1,1
1,GO ALCOHOL METABOLIC PROCESS,0.017969,0.10979,0.09155,1,1
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.049546,0.10976,0.1203,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.010773,0.10955,0.073269,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.038561,0.10947,0.10366,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.0010859,0.10897,0.12139,1,1
1,GO MRNA TRANSPORT,0.0023671,0.10885,0.14504,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00045924,0.10882,0.20137,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.015203,0.10828,0.081241,1,1
1,GO REGULATION OF AUTOPHAGY,0.00020448,0.10801,0.12626,1,1
1,GO REGULATION OF BINDING,0.004408,0.10774,0.11089,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.031059,0.10726,0.060164,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.037747,0.10726,0.12695,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0041716,0.10665,0.097192,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.0018173,0.10649,0.10604,1,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.10637,0.079326,1,1
1,GO ENDOSOME ORGANIZATION,0.0067808,0.10635,0.11225,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.0032441,0.10498,0.15251,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.026586,0.10408,0.10074,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.052669,0.10386,0.12376,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012512,0.10295,0.14151,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0023671,0.10227,0.11742,1,1
1,GO MACROAUTOPHAGY,3.3132e-05,0.10204,0.13102,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0026572,0.10156,0.10504,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.022165,0.10081,0.098573,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.031059,0.10072,0.064933,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.016734,0.099295,0.08854,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.052669,0.099202,0.085092,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.0020453,0.099168,0.1049,1,1
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.013465,0.098844,0.10236,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.02068,0.098714,0.090272,1,1
1,GO MITOTIC CELL CYCLE,0.017137,0.097865,0.073566,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.041967,0.097753,0.11532,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.010506,0.097647,0.067536,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.007729,0.097529,0.17094,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0020453,0.096464,0.089919,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.05161,0.095704,0.11133,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.024846,0.095113,0.072107,1,1
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.0090226,0.094927,0.079496,1,1
1,GO REGULATION OF PROTEIN TARGETING,0.033894,0.094425,0.076724,1,1
1,GO IRON ION TRANSPORT,0.0059384,0.094137,0.092237,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0012662,0.093582,0.073772,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.01282,0.093459,0.09369,1,1
1,GO FEMALE GAMETE GENERATION,0.010506,0.092027,0.081161,1,1
1,GO ORGANELLE FISSION,0.041967,0.09179,0.064505,1,1
1,GO RESPONSE TO ACID CHEMICAL,0.029068,0.091766,0.12058,1,1
1,GO CELL CYCLE PROCESS,0.016734,0.091379,0.061397,1,1
1,GO POLYOL BIOSYNTHETIC PROCESS,0.0060989,0.091314,0.1095,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0050528,0.091064,0.10055,1,1
1,GO CARBOHYDRATE METABOLIC PROCESS,0.0013054,0.090818,0.090659,1,1
1,GO ENDOCYTOSIS,0.00052342,0.090729,0.13266,1,1
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.017137,0.090032,0.084838,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.025994,0.089848,0.086138,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0011199,0.089732,0.10857,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0039469,0.089576,0.094815,1,1
1,GO MACROMOLECULE DEACYLATION,0.019283,0.089207,0.073475,1,1
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0090226,0.089186,0.12063,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036303,0.089055,0.098192,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0033369,0.087693,0.092003,1,1
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.012508,0.087675,0.13449,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0062634,0.08754,0.062304,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0062634,0.087472,0.11474,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0045306,0.087284,0.087382,1,1
1,GO VESICLE ORGANIZATION,0.02166,0.087253,0.078672,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0051916,0.086983,0.11228,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0001165,0.086551,0.095347,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00090094,0.086383,0.07513,1,1
1,GO REGULATION OF CELL CYCLE,0.021165,0.086329,0.051161,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0036303,0.085498,0.090485,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.033894,0.085489,0.088794,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.015203,0.085441,0.081388,1,1
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.014486,0.084745,0.13555,1,1
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.024288,0.083651,0.079901,1,1
1,GO CELL CELL SIGNALING BY WNT,0.049546,0.083516,0.079892,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0021062,0.083293,0.077974,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0079323,0.082353,0.074466,1,1
1,GO PROTEIN TETRAMERIZATION,0.0032441,0.081875,0.10924,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.052669,0.081689,0.067064,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.081321,0.081777,1,1
1,GO POLYOL METABOLIC PROCESS,0.015953,0.081257,0.072481,1,1
1,GO MULTI ORGANISM PROCESS,0.0051916,0.081029,0.063897,1,1
1,GO CHROMOSOME CONDENSATION,0.012508,0.080985,0.10983,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.047551,0.080774,0.074369,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0027346,0.080359,0.073048,1,1
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.05161,0.07979,0.094005,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.011047,0.079508,0.066618,1,1
1,GO AMMONIUM TRANSPORT,0.038561,0.079287,0.16962,1,1
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.016734,0.077648,0.11198,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.02843,0.07644,0.075022,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00065623,0.075665,0.074404,1,1
1,GO DNA METABOLIC PROCESS,0.004408,0.07527,0.065823,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.02843,0.075054,0.074653,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00090094,0.07495,0.073843,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0062634,0.074384,0.070916,1,1
1,GO MITOCHONDRION ORGANIZATION,0.0021062,0.073405,0.080775,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.049546,0.071957,0.067535,1,1
1,GO CELL CYCLE,0.02166,0.071665,0.048243,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.052669,0.06974,0.055211,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.047551,0.068365,0.07433,1,1
1,GO SNRNA TRANSCRIPTION,0.0054795,0.066311,0.081546,1,1
1,GO REGULATION OF DNA REPLICATION,0.0087944,0.065776,0.079769,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.038561,0.064163,0.069412,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.040234,0.063539,0.089051,1,1
1,GO INTRACELLULAR TRANSPORT,0.0015653,0.063527,0.06897,1,1
1,GO RESPONSE TO NITROGEN COMPOUND,0.05161,0.062695,0.054534,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0027346,0.060104,0.11703,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0032441,0.054613,0.064768,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.014138,0.51381,0.37508,1,0
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0030654,0.46719,0.41668,1,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,5.508e-06,0.46301,0.65301,1,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.0049174,0.4317,0.42077,1,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0017641,0.43133,0.31494,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0028957,0.40512,0.41674,1,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,1.7806e-05,0.40265,0.47147,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.038561,0.39009,0.43007,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.004408,0.37671,0.39976,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0017123,0.37538,0.36463,1,0
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.00023468,0.36535,0.38754,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.00063551,0.36215,0.39509,1,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0025083,0.36107,0.39992,1,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00032948,0.35111,0.38547,1,0
1,GO HAIR FOLLICLE MATURATION,0.013139,0.34834,0.24196,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0010206,0.34033,0.35128,1,0
1,GO NADPH REGENERATION,0.00013917,0.33842,0.34121,1,0
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00024286,0.3383,0.34272,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.00014935,0.33415,0.36226,1,0
1,GO PARAXIAL MESODERM DEVELOPMENT,0.0011199,0.31864,0.31829,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0041716,0.31665,0.37183,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00087311,0.31534,0.32619,1,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00024286,0.31185,0.40798,1,0
1,GO HEPARIN METABOLIC PROCESS,0.0028141,0.29926,0.38995,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00031859,0.2987,0.32752,1,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.009256,0.29657,0.25754,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.02268,0.29646,0.18977,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00098941,0.29628,0.27291,1,0
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.010245,0.29376,0.27879,1,0
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0037331,0.2912,0.38334,1,0
1,GO PROTEIN HYDROXYLATION,0.0062634,0.2873,0.36063,1,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0017641,0.28595,0.27531,1,0
1,GO MYOBLAST PROLIFERATION,0.025414,0.2849,0.17548,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0023671,0.28403,0.34208,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0064317,0.28375,0.24739,1,0
1,GO MACROPHAGE DIFFERENTIATION,0.00042998,0.27938,0.31408,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0056288,0.27928,0.30061,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0059384,0.27878,0.20371,1,0
1,GO MUSCLE CELL MIGRATION,0.030383,0.27703,0.20333,1,0
1,GO ASYMMETRIC CELL DIVISION,0.0006154,0.27633,0.2671,1,0
1,GO GLYCINE METABOLIC PROCESS,0.020205,0.27465,0.22228,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0050528,0.27267,0.27392,1,0
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0010859,0.27069,0.27304,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00010845,0.2694,0.26344,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,8.7323e-05,0.2693,0.31086,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0012662,0.26717,0.31953,1,0
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0059384,0.26669,0.30031,1,0
1,GO MONOCYTE CHEMOTAXIS,0.00092958,0.2614,0.30752,1,0
1,GO ACTIVATION OF MAPKK ACTIVITY,5.8301e-05,0.26053,0.29154,1,0
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00084609,0.25947,0.2843,1,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0081404,0.25787,0.21788,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0073363,0.25772,0.2204,1,0
1,GO CHONDROCYTE PROLIFERATION,0.0083534,0.25635,0.33533,1,0
1,GO MONONUCLEAR CELL MIGRATION,0.00067758,0.25605,0.27957,1,0
1,GO CELLULAR RESPONSE TO ETHANOL,0.0050528,0.2558,0.26621,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0028957,0.25344,0.25908,1,0
1,GO SERTOLI CELL DEVELOPMENT,0.035393,0.25307,0.20498,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00022676,0.24863,0.33167,1,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0087944,0.24674,0.22858,1,0
1,GO NADP METABOLIC PROCESS,0.014841,0.24624,0.19099,1,0
1,GO RESPONSE TO PROTOZOAN,0.0025817,0.24492,0.25704,1,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.033894,0.24259,0.35673,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,0.0057817,0.24247,0.31467,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0083534,0.24155,0.32104,1,0
1,GO RESPONSE TO CORTICOSTEROID,0.00032948,0.2415,0.23871,1,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.017137,0.24021,0.23084,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,4.6597e-05,0.24007,0.29004,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.001872,0.23997,0.27262,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.052669,0.23892,0.25197,1,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.013465,0.23889,0.251,1,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.007729,0.236,0.22298,1,0
1,GO LIPID OXIDATION,0.0015189,0.23544,0.19584,1,0
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0056288,0.2343,0.18511,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0028141,0.23423,0.23819,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00052342,0.23282,0.21221,1,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.013465,0.23201,0.17373,1,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.014841,0.23112,0.25277,1,0
1,GO CELL JUNCTION DISASSEMBLY,0.0087944,0.23111,0.20217,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0085714,0.23088,0.22731,1,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00014935,0.22762,0.24166,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0049174,0.22739,0.28803,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.013465,0.22533,0.19823,1,0
1,GO RRNA TRANSCRIPTION,0.0030654,0.22162,0.17716,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013054,0.22103,0.23507,1,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.00353,0.22049,0.20997,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0057817,0.22008,0.19272,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.007729,0.2196,0.2008,1,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.034637,0.21877,0.30633,1,0
1,GO ETHER METABOLIC PROCESS,0.018836,0.21754,0.18034,1,0
1,GO METANEPHROS DEVELOPMENT,0.0071468,0.21727,0.16327,1,0
1,GO REGULATION OF WOUND HEALING,0.00065623,0.2163,0.27508,1,0
1,GO CHEMOKINE PRODUCTION,0.007729,0.21626,0.21076,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0014299,0.21518,0.18012,1,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0014299,0.2106,0.24165,1,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0028957,0.2098,0.19104,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028141,0.20909,0.2525,1,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00057693,0.20909,0.2462,1,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.00353,0.20744,0.17179,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.0056288,0.20728,0.25872,1,0
1,GO TOOTH MINERALIZATION,0.044685,0.2058,0.20521,1,0
1,GO RETINOL METABOLIC PROCESS,0.0025083,0.20526,0.26604,1,0
1,GO PROSTATE GLAND DEVELOPMENT,0.0047853,0.20338,0.26387,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0056288,0.20239,0.26155,1,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.011047,0.20144,0.26269,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00052342,0.20139,0.21775,1,0
1,GO HOMOTYPIC CELL CELL ADHESION,0.0033369,0.20026,0.22317,1,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,5.6174e-05,0.20019,0.23506,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00010845,0.19958,0.26307,1,0
1,GO CAMP METABOLIC PROCESS,0.02268,0.19701,0.22716,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0066042,0.19663,0.30776,1,0
1,GO SUPEROXIDE METABOLIC PROCESS,0.01282,0.19586,0.13807,1,0
1,GO GRANULOCYTE MIGRATION,0.00034072,0.19483,0.2609,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00090094,0.1948,0.22922,1,0
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.004408,0.1944,0.22723,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.047551,0.19424,0.13177,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.050569,0.19337,0.18086,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00353,0.1919,0.19615,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0054795,0.19035,0.23448,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.019283,0.18723,0.13865,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0060989,0.18689,0.18466,1,0
1,GO PROTEIN DEMANNOSYLATION,0.0083534,0.18607,0.23504,1,0
1,GO AMINO ACID ACTIVATION,0.015574,0.18597,0.17915,1,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0069616,0.1858,0.24856,1,0
1,GO REGULATION OF RECEPTOR BINDING,0.044685,0.18577,0.26225,1,0
1,GO STEROL HOMEOSTASIS,0.02268,0.18324,0.12976,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.004408,0.18319,0.18307,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0011549,0.18257,0.19277,1,0
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00059588,0.18182,0.23001,1,0
1,GO FLUID TRANSPORT,0.00087311,0.18171,0.18846,1,0
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0079323,0.18139,0.18011,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.024288,0.18025,0.16284,1,0
1,GO STRESS FIBER ASSEMBLY,0.0024367,0.17983,0.19675,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025083,0.17982,0.20421,1,0
1,GO REGULATION OF CELL KILLING,0.0097392,0.17899,0.17175,1,0
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00016023,0.1768,0.2551,1,0
1,GO LEUKOCYTE PROLIFERATION,0.0045306,0.17649,0.15313,1,0
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00012512,0.17575,0.18015,1,0
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00095906,0.17561,0.19831,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0056288,0.17479,0.1412,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0013054,0.17419,0.17739,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.011326,0.17354,0.20987,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.047551,0.17286,0.19519,1,0
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0038387,0.17268,0.19195,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.0066042,0.1716,0.22069,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.033166,0.17153,0.11873,1,0
1,GO SERTOLI CELL DIFFERENTIATION,0.012203,0.17124,0.19538,1,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.027803,0.17077,0.19466,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0071468,0.17023,0.20451,1,0
1,GO POSITIVE CHEMOTAXIS,0.011904,0.17006,0.20483,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0036303,0.17001,0.15965,1,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00055855,0.16996,0.18211,1,0
1,GO RESPONSE TO MINERALOCORTICOID,0.0087944,0.1699,0.23229,1,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.022165,0.16941,0.18341,1,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.041967,0.1691,0.16031,1,0
1,GO REGULATION OF BIOMINERALIZATION,0.0059384,0.16796,0.22134,1,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.042857,0.16763,0.15171,1,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.036948,0.16664,0.16179,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00031859,0.16619,0.21434,1,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.017137,0.16616,0.17919,1,0
1,GO ASTROCYTE DIFFERENTIATION,0.019739,0.16589,0.14262,1,0
1,GO OSSIFICATION,0.0013872,0.16572,0.18465,1,0
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0019282,0.16525,0.16262,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.004408,0.16483,0.14411,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.1648,0.16968,1,0
1,GO RESPONSE TO GONADOTROPIN,0.0067808,0.16422,0.26316,1,0
1,GO LEUKOCYTE CELL CELL ADHESION,0.0006154,0.16192,0.19177,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.014138,0.16176,0.20915,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0030654,0.16135,0.1808,1,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0060989,0.16095,0.30948,1,0
1,GO GLOMERULUS DEVELOPMENT,0.00095906,0.16071,0.30176,1,0
1,GO RESPONSE TO ISCHEMIA,0.001191,0.16011,0.18138,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.010245,0.16002,0.1526,1,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.052669,0.15949,0.10296,1,0
1,GO T CELL ACTIVATION,0.00074557,0.15913,0.17288,1,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0067808,0.15855,0.17187,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00023468,0.15773,0.27416,1,0
1,GO DETOXIFICATION,0.015203,0.15753,0.13283,1,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.0097392,0.15696,0.15233,1,0
1,GO ERBB SIGNALING PATHWAY,0.00095906,0.1568,0.20645,1,0
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0010206,0.15661,0.20956,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00044439,0.15647,0.1907,1,0
1,GO RESPONSE TO GAMMA RADIATION,0.00020448,0.15624,0.18716,1,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.041967,0.15615,0.26399,1,0
1,GO REGULATION OF EXOSOMAL SECRETION,0.05161,0.15441,0.15714,1,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.031748,0.15415,0.20239,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.013798,0.15383,0.18928,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.020205,0.15377,0.14434,1,0
1,GO POSITIVE REGULATION OF COAGULATION,0.0083534,0.15371,0.28133,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0021062,0.1537,0.15512,1,0
1,GO REGULATION OF BONE MINERALIZATION,0.012203,0.15364,0.21697,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.024846,0.15346,0.19777,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0021062,0.15319,0.20901,1,0
1,GO PLACENTA DEVELOPMENT,0.0054795,0.15292,0.16837,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00027832,0.15289,0.18016,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.02843,0.15166,0.14401,1,0
1,GO REGULATION OF DEFENSE RESPONSE,0.00040247,0.15087,0.17696,1,0
1,GO AMYLOID BETA FORMATION,0.05161,0.14939,0.14359,1,0
1,GO REGULATION OF LIPID TRANSPORT,0.00090094,0.14923,0.13881,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.02268,0.14921,0.10072,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.001872,0.14899,0.12804,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0097392,0.14874,0.15546,1,0
1,GO ALPHA BETA T CELL ACTIVATION,0.0017123,0.14809,0.18845,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.021165,0.14616,0.20813,1,0
1,GO IMPORT INTO NUCLEUS,0.0006154,0.14596,0.10718,1,0
1,GO LEUKOCYTE MIGRATION,0.004408,0.14574,0.17027,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0047853,0.14471,0.13412,1,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.009256,0.14388,0.20218,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0038387,0.14376,0.23148,1,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0032441,0.14364,0.13886,1,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0010206,0.14352,0.20597,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.027803,0.14327,0.12527,1,0
1,GO CELLULAR RESPONSE TO HEAT,0.0021689,0.14308,0.13969,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00029782,0.14275,0.15571,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.023205,0.1422,0.17899,1,0
1,GO RESPONSE TO UV C,0.018398,0.14159,0.16791,1,0
1,GO RESPONSE TO STEROL,0.045624,0.14152,0.15511,1,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015203,0.14074,0.19463,1,0
1,GO PROTEIN MATURATION,0.00035231,0.14056,0.13927,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0064317,0.14013,0.18109,1,0
1,GO PORE COMPLEX ASSEMBLY,0.02268,0.13964,0.1408,1,0
1,GO LEUKOCYTE HOMEOSTASIS,0.0045306,0.13858,0.15431,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0021062,0.13853,0.16544,1,0
1,GO PROTEIN PROCESSING,0.00065623,0.13703,0.17764,1,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0027346,0.13679,0.21182,1,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.014841,0.13628,0.20903,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.036948,0.13586,0.14741,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.0024367,0.13554,0.14722,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.042857,0.1334,0.090761,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0038387,0.13337,0.17088,1,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.009256,0.13301,0.16506,1,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.034637,0.13289,0.13456,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0031536,0.13271,0.1861,1,0
1,GO EPITHELIAL CELL PROLIFERATION,0.0036303,0.13195,0.15698,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.004408,0.1317,0.15371,1,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.042857,0.13114,0.14857,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0046564,0.1311,0.15485,1,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.015203,0.1306,0.14498,1,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.014486,0.13045,0.1403,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.018398,0.13042,0.17991,1,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.046579,0.13034,0.1532,1,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.033166,0.13024,0.11645,1,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.042857,0.12968,0.21711,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.011904,0.12914,0.12305,1,0
1,GO OXIDATION REDUCTION PROCESS,0.001986,0.12885,0.11257,1,0
1,GO REGULATION OF CELL ADHESION,0.0071468,0.12826,0.14991,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.041093,0.12739,0.19779,1,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.049546,0.12702,0.1834,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0099891,0.12658,0.16782,1,0
1,GO TERPENOID METABOLIC PROCESS,0.052669,0.12653,0.14032,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.021165,0.12632,0.11872,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.042857,0.12629,0.21919,1,0
1,GO RESPONSE TO HEAT,0.00040247,0.12605,0.15304,1,0
1,GO CELLULAR EXTRAVASATION,0.0019282,0.1259,0.18302,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0056288,0.12472,0.12821,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0059384,0.12466,0.13618,1,0
1,GO REGULATION OF OSSIFICATION,0.0053338,0.12455,0.17635,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.026586,0.12423,0.12257,1,0
1,GO RESPONSE TO DRUG,0.027188,0.12422,0.0933,1,0
1,GO TUBE DEVELOPMENT,0.0022992,0.12345,0.1417,1,0
1,GO LEUKOCYTE DIFFERENTIATION,0.0027346,0.12257,0.13204,1,0
1,GO AMINE METABOLIC PROCESS,0.015574,0.12209,0.09778,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0051916,0.12099,0.10284,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0021062,0.12063,0.10171,1,0
1,GO BONE RESORPTION,0.016734,0.12039,0.13276,1,0
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.019283,0.11973,0.096853,1,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.033894,0.11912,0.083656,1,0
1,GO REGULATION OF PROTEIN BINDING,0.0011199,0.11912,0.13759,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.015953,0.11832,0.12716,1,0
1,GO REGULATION OF CELL DEATH,0.0007696,0.11828,0.11533,1,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.043763,0.11798,0.13912,1,0
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0041716,0.11793,0.11511,1,0
1,GO RESPONSE TO NUTRIENT,0.041093,0.11721,0.12098,1,0
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00353,0.11704,0.15824,1,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.041967,0.11677,0.2058,1,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0090226,0.11602,0.10396,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.014841,0.11572,0.1154,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0023671,0.11557,0.12127,1,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.04854,0.11413,0.12805,1,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.11342,0.11666,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.041967,0.11328,0.07489,1,0
1,GO TISSUE MORPHOGENESIS,0.0034322,0.11287,0.13088,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0010859,0.11276,0.1519,1,0
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.004408,0.11266,0.12768,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.022165,0.11229,0.15175,1,0
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.018398,0.11212,0.092914,1,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.050569,0.11187,0.065912,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00087311,0.11126,0.13647,1,0
1,GO OXIDATIVE PHOSPHORYLATION,0.030383,0.11085,0.11257,1,0
1,GO OVULATION CYCLE,0.024846,0.11029,0.13649,1,0
1,GO REGULATION OF PROTEIN STABILITY,0.001228,0.10983,0.099934,1,0
1,GO PIGMENT GRANULE ORGANIZATION,0.030383,0.10963,0.1429,1,0
1,GO LIPID LOCALIZATION,0.019739,0.10962,0.08383,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.033894,0.1092,0.1072,1,0
1,GO RESPONSE TO ANTIBIOTIC,0.019283,0.10883,0.12535,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0023671,0.10743,0.11347,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00098941,0.10715,0.10501,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.035393,0.10662,0.12219,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.0090226,0.1066,0.099623,1,0
1,GO CELL CHEMOTAXIS,0.015953,0.10515,0.15754,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.03939,0.10365,0.10656,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE,0.024288,0.10342,0.090589,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.045624,0.10277,0.10458,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.049546,0.10225,0.16041,1,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.043763,0.10153,0.10739,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.018836,0.10034,0.070884,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.013465,0.10021,0.13225,1,0
1,GO RNA POLYADENYLATION,0.0099891,0.099815,0.12449,1,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0075304,0.099043,0.1249,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.038561,0.098958,0.097689,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0032441,0.098007,0.29961,1,0
1,GO HORMONE METABOLIC PROCESS,0.0071468,0.097909,0.1354,1,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.052669,0.097713,0.16227,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,0.010773,0.097659,0.10043,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0064317,0.09764,0.19658,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.022165,0.096985,0.1069,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.05161,0.096974,0.12482,1,0
1,GO LIPID MODIFICATION,0.015574,0.096851,0.088338,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.01282,0.096648,0.12794,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0062634,0.096153,0.19151,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0018173,0.094944,0.092787,1,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.052669,0.094119,0.12079,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01282,0.094044,0.11085,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0083534,0.094028,0.16484,1,0
1,GO T CELL DIFFERENTIATION,0.029068,0.093564,0.088791,1,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.009256,0.092602,0.085195,1,0
1,GO RESPONSE TO GROWTH FACTOR,0.0050528,0.092486,0.12975,1,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011904,0.092341,0.077757,1,0
1,GO REGULATION OF ATP METABOLIC PROCESS,0.03939,0.09195,0.084328,1,0
1,GO LIPID METABOLIC PROCESS,0.009256,0.090616,0.074221,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.019283,0.0906,0.08505,1,0
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.052669,0.089708,0.12396,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,0.010773,0.088977,0.085759,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.011904,0.088142,0.066116,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.03245,0.088046,0.05433,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.033166,0.087044,0.12974,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.034637,0.086486,0.078391,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.02268,0.085261,0.055854,1,0
1,GO HEART DEVELOPMENT,0.0057817,0.084846,0.11847,1,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.019739,0.084262,0.09466,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.025994,0.084052,0.078974,1,0
1,GO ATP METABOLIC PROCESS,0.019739,0.083907,0.080388,1,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.023205,0.083748,0.10155,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.031059,0.082329,0.098216,1,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.045624,0.082012,0.082398,1,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.018398,0.079559,0.10988,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.023741,0.079459,0.071401,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.033894,0.07915,0.054772,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.0081404,0.078995,0.099493,1,0
1,GO NCRNA TRANSCRIPTION,0.043763,0.076101,0.068752,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.025994,0.074512,0.059689,1,0
1,GO KERATINOCYTE PROLIFERATION,0.043763,0.074333,0.21034,1,0
1,GO VITAMIN METABOLIC PROCESS,0.016339,0.073716,0.12707,1,0
1,GO MIRNA METABOLIC PROCESS,0.031059,0.0724,0.10841,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0051916,0.071891,0.084881,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.011904,0.070786,0.11101,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.049546,0.0681,0.069051,1,0
1,GO SKELETAL SYSTEM DEVELOPMENT,0.016339,0.067127,0.13129,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0025083,0.06686,0.089346,1,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.004408,0.066826,0.12945,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.029719,0.065266,0.087271,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011326,0.064378,0.081993,1,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.043763,0.058932,0.045445,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.023741,0.055721,0.07687,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0030654,0.054857,0.083361,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0090226,0.054601,0.073468,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.052669,0.052954,0.097486,1,0
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.014841,0.051543,0.11681,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.026586,0.051121,0.15261,1,0
1,GO SECRETION,0.036164,0.04739,0.064008,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.031748,0.046887,0.071983,1,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.010506,0.043367,0.10868,1,0
1,GO BIOLOGICAL ADHESION,0.049546,0.043035,0.08995,1,0
1,GO HEART MORPHOGENESIS,0.041967,0.040037,0.1117,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.036948,0.03874,0.070059,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.036164,0.031189,0.067121,1,0
1,GO REGULATION OF CILIUM MOVEMENT,0.026586,-0.046098,-0.11253,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0064317,-0.052434,-0.10821,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.05161,-0.059381,-0.077648,1,0
1,GO COVALENT CHROMATIN MODIFICATION,0.044685,-0.061812,-0.053858,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.046579,-0.061912,-0.10564,1,0
1,GO RHYTHMIC PROCESS,0.052669,-0.06252,-0.057281,1,0
1,GO PROTEIN ACETYLATION,0.0030654,-0.067968,-0.096638,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.012203,-0.068315,-0.095007,1,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0079323,-0.073011,-0.12707,1,0
1,GO NUCLEOSOME ORGANIZATION,0.036948,-0.074116,-0.086992,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.050569,-0.077175,-0.05845,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.03939,-0.079161,-0.18558,1,0
1,GO CELL MORPHOGENESIS,0.016339,-0.081443,-0.095572,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.013798,-0.08204,-0.087411,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.029719,-0.083315,-0.081107,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0083534,-0.083589,-0.084601,1,0
1,GO METAL ION TRANSPORT,0.0087944,-0.086656,-0.090644,1,0
1,GO CIRCADIAN RHYTHM,0.0012662,-0.087676,-0.1096,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.012508,-0.088432,-0.07535,1,0
1,GO NEURON DEATH,0.047551,-0.089457,-0.054216,1,0
1,GO VESICLE LOCALIZATION,0.023741,-0.090324,-0.066287,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.0087944,-0.092481,-0.099567,1,0
1,GO PEPTIDE SECRETION,0.0090226,-0.096216,-0.094862,1,0
1,GO MAST CELL ACTIVATION,0.041093,-0.097174,-0.14514,1,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.046579,-0.097473,-0.062468,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0081404,-0.09836,-0.20182,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.041093,-0.098725,0.021693,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.0081404,-0.099892,-0.09866,1,0
1,GO FEAR RESPONSE,0.0023671,-0.1021,-0.17458,1,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.015203,-0.10244,-0.093187,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.047551,-0.10287,-0.092891,1,0
1,GO MULTICELLULAR ORGANISM AGING,0.0083534,-0.1037,-0.16086,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.044685,-0.10379,-0.11529,1,0
1,GO PH REDUCTION,0.0083534,-0.10444,-0.11344,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.0062634,-0.10468,-0.1232,1,0
1,GO REGULATION OF CELL CYCLE ARREST,0.030383,-0.10516,-0.067973,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0039469,-0.10646,-0.14037,1,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.019739,-0.10647,-0.089905,1,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.042857,-0.10799,-0.16184,1,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.017549,-0.10822,-0.17397,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0056288,-0.10919,-0.10049,1,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.020205,-0.10926,-0.08771,1,0
1,GO EAR MORPHOGENESIS,0.015574,-0.11007,-0.13728,1,0
1,GO ADULT FEEDING BEHAVIOR,0.036164,-0.11069,-0.14279,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0042883,-0.11132,-0.12306,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.029068,-0.11148,-0.13078,1,0
1,GO ION TRANSPORT,0.010773,-0.11224,-0.085235,1,0
1,GO SOMITOGENESIS,0.013465,-0.11326,-0.12162,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.029068,-0.11363,-0.11282,1,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.0049174,-0.11372,-0.1243,1,0
1,GO REGULATION OF APPETITE,0.040234,-0.11396,-0.105,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.014138,-0.11402,-0.19416,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.011904,-0.11443,-0.094232,1,0
1,GO CELL PROJECTION ORGANIZATION,0.0010206,-0.11446,-0.11692,1,0
1,GO RESPONSE TO FUNGUS,0.031059,-0.11539,-0.13823,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.029068,-0.11564,-0.11484,1,0
1,GO REGULATION OF HORMONE LEVELS,0.015953,-0.11647,-0.10211,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.033894,-0.11791,-0.087001,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0017641,-0.1188,-0.11467,1,0
1,GO DETECTION OF STIMULUS,0.00092958,-0.11999,-0.097967,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.010245,-0.12019,-0.12093,1,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.027188,-0.12146,-0.14997,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.0051916,-0.1219,-0.1013,1,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.02068,-0.1223,-0.070087,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0064317,-0.12339,-0.11441,1,0
1,GO REGULATION OF CELL DEVELOPMENT,0.001872,-0.12597,-0.13313,1,0
1,GO REGULATION OF ACTIN NUCLEATION,0.0014299,-0.12626,-0.20226,1,0
1,GO NEURON APOPTOTIC PROCESS,0.00037661,-0.12694,-0.1257,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0053338,-0.12726,-0.10909,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0081404,-0.12886,-0.13876,1,0
1,GO CHLORIDE TRANSPORT,0.036164,-0.13153,-0.088039,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.041093,-0.13156,-0.14691,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0059384,-0.1321,-0.15698,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02268,-0.13214,-0.13756,1,0
1,GO CELL CELL SIGNALING,0.00035231,-0.13282,-0.11991,1,0
1,GO MAST CELL MEDIATED IMMUNITY,0.023205,-0.1335,-0.14529,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.001872,-0.13386,-0.12202,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.0014738,-0.13555,-0.12115,1,0
1,GO CELL FATE COMMITMENT,0.0028957,-0.13578,-0.15411,1,0
1,GO KETONE BODY METABOLIC PROCESS,0.023741,-0.13779,-0.26173,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00034072,-0.13787,-0.16975,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0085714,-0.13807,-0.18566,1,0
1,GO WATER HOMEOSTASIS,0.013798,-0.13962,-0.1338,1,0
1,GO CATION TRANSPORT,0.0007696,-0.13988,-0.12063,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00055855,-0.1401,-0.13149,1,0
1,GO OXIDATIVE DEMETHYLATION,0.0036303,-0.14045,-0.14666,1,0
1,GO CELL JUNCTION ORGANIZATION,0.0064317,-0.1408,-0.11386,1,0
1,GO STRIATUM DEVELOPMENT,0.029719,-0.14179,-0.20411,1,0
1,GO NOTCH SIGNALING PATHWAY,0.050569,-0.14254,-0.094574,1,0
1,GO CELL MATURATION,0.00050664,-0.14294,-0.13537,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.052669,-0.14315,-0.10524,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.033894,-0.14351,-0.15812,1,0
1,GO REGULATION OF SYSTEM PROCESS,0.0014738,-0.14496,-0.12264,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.0028141,-0.14516,-0.14402,1,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0090226,-0.14522,-0.13085,1,0
1,GO REGULATION OF SECRETION,0.00016595,-0.14554,-0.13913,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0054795,-0.14558,-0.1615,1,0
1,GO CHROMATIN REMODELING,0.0034322,-0.14678,-0.12216,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00032948,-0.14738,-0.15188,1,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.016339,-0.14754,-0.16935,1,0
1,GO SENSORY PERCEPTION,0.00029782,-0.14818,-0.12714,1,0
1,GO DEVELOPMENTAL CELL GROWTH,0.0007696,-0.1487,-0.16648,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.0033369,-0.15002,-0.13407,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.004408,-0.151,-0.17437,1,0
1,GO COCHLEA DEVELOPMENT,0.0060989,-0.15149,-0.23324,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.001191,-0.15161,-0.1226,1,0
1,GO SODIUM ION TRANSPORT,0.0020453,-0.15174,-0.1443,1,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.045624,-0.15203,-0.14926,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0013872,-0.15287,-0.14755,1,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.031059,-0.15291,-0.13541,1,0
1,GO PEPTIDYL LYSINE METHYLATION,0.0028141,-0.15346,-0.14414,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.010773,-0.15411,-0.11425,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0014738,-0.15416,-0.15725,1,0
1,GO PROTEIN DEMETHYLATION,0.010506,-0.15475,-0.176,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0085714,-0.15855,-0.13747,1,0
1,GO INNER EAR MORPHOGENESIS,0.001986,-0.15896,-0.19645,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.009256,-0.1595,-0.13502,1,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.02068,-0.1607,-0.16151,1,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.011612,-0.16086,-0.19721,1,0
1,GO HEAD DEVELOPMENT,0.00031859,-0.16095,-0.16316,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0018173,-0.16132,-0.1534,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.021165,-0.16136,-0.20082,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.0062634,-0.16226,-0.21108,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.0033369,-0.16238,-0.14606,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.001986,-0.16282,-0.1586,1,0
1,GO REGULATION OF ION TRANSPORT,0.00026903,-0.16317,-0.15091,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.001191,-0.16318,-0.16304,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.036164,-0.16328,-0.11402,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0010528,-0.16339,-0.18851,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0038387,-0.16424,-0.14233,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00019079,-0.16679,-0.18066,1,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.0042883,-0.16701,-0.15921,1,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.018398,-0.16702,-0.15356,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0015653,-0.16766,-0.12671,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.0025817,-0.16848,-0.20804,1,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.044685,-0.16889,-0.21767,1,0
1,GO REGULATION OF BLOOD CIRCULATION,0.0034322,-0.16908,-0.13656,1,0
1,GO STRIATED MUSCLE CONTRACTION,0.031748,-0.16926,-0.11445,1,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.029068,-0.16968,-0.10232,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00010092,-0.16969,-0.18677,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0054795,-0.17006,-0.1699,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.036164,-0.17042,-0.10626,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.015203,-0.17069,-0.19393,1,0
1,GO HEART PROCESS,0.0030654,-0.1712,-0.14189,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00031859,-0.17196,-0.19341,1,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.036164,-0.17196,-0.094833,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0025817,-0.17217,-0.14001,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.023741,-0.17362,-0.12059,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.034637,-0.17368,-0.17025,1,0
1,GO LIPID DROPLET ORGANIZATION,0.00353,-0.17397,-0.18178,1,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.030383,-0.17462,-0.10817,1,0
1,GO NEUROGENESIS,0.00014418,-0.17462,-0.17359,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00026003,-0.17538,-0.16595,1,0
1,GO ACROSOME REACTION,0.036164,-0.17609,-0.13103,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.026586,-0.17654,-0.26016,1,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.03939,-0.17753,-0.098799,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.041093,-0.17791,-0.16991,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.0010859,-0.1782,-0.20598,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00030804,-0.17862,-0.18578,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.031059,-0.17905,-0.11445,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.015574,-0.17993,-0.14419,1,0
1,GO EATING BEHAVIOR,0.0024367,-0.18045,-0.16148,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.042857,-0.18133,-0.15455,1,0
1,GO RESPONSE TO AMPHETAMINE,0.0033369,-0.18397,-0.24066,1,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.052669,-0.18479,-0.1819,1,0
1,GO NEUROMUSCULAR PROCESS,0.00065623,-0.18582,-0.18673,1,0
1,GO SLEEP,0.0016129,-0.18585,-0.17356,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,6.2786e-05,-0.18602,-0.17041,1,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.012203,-0.1861,-0.195,1,0
1,GO EAR DEVELOPMENT,0.00074557,-0.1862,-0.20282,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00050664,-0.18629,-0.15512,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.027188,-0.18691,-0.19402,1,0
1,GO TELENCEPHALON DEVELOPMENT,0.00029782,-0.18794,-0.18803,1,0
1,GO NERVOUS SYSTEM PROCESS,1.4039e-05,-0.18872,-0.17886,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.010506,-0.18921,-0.18502,1,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0059384,-0.18927,-0.14931,1,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.035393,-0.19092,-0.098392,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.011904,-0.19138,-0.13187,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.03939,-0.19233,-0.15418,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.024288,-0.1924,-0.1938,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0031536,-0.19251,-0.1961,1,0
1,GO DEVELOPMENTAL INDUCTION,0.014841,-0.1944,-0.16226,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0025083,-0.19459,-0.18873,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.010506,-0.19487,-0.18366,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.5816e-05,-0.19511,-0.1898,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00017796,-0.19517,-0.19741,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00019079,-0.19543,-0.22916,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00010462,-0.19556,-0.2062,1,0
1,GO DIGESTION,0.0079323,-0.19629,-0.14271,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.03245,-0.19654,-0.18367,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.018398,-0.19747,-0.22328,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,8.7323e-05,-0.19768,-0.18226,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.025414,-0.198,-0.18347,1,0
1,GO ORGANIC CATION TRANSPORT,0.0011199,-0.19806,-0.21103,1,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.0062634,-0.19848,-0.14892,1,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00087311,-0.19872,-0.3513,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0056288,-0.20084,-0.20632,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0071468,-0.2013,-0.17275,1,0
1,GO LIPID TRANSLOCATION,0.016734,-0.20292,-0.16733,1,0
1,GO REGULATION OF GLIOGENESIS,0.0016129,-0.20335,-0.1566,1,0
1,GO HISTONE H4 ACETYLATION,4.6597e-05,-0.20336,-0.18651,1,0
1,GO DEVELOPMENTAL MATURATION,6.0504e-05,-0.20359,-0.19086,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,6.0504e-05,-0.20392,-0.20951,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0040578,-0.20461,-0.19553,1,0
1,GO V D J RECOMBINATION,0.02166,-0.2048,-0.18708,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,4.1617e-05,-0.20545,-0.22575,1,0
1,GO KERATINIZATION,0.049546,-0.20685,-0.14789,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00079435,-0.20786,-0.20586,1,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0019282,-0.2088,-0.25441,1,0
1,GO PHAGOSOME ACIDIFICATION,0.0010859,-0.21008,-0.2029,1,0
1,GO AMINO ACID TRANSPORT,0.0059384,-0.21014,-0.14499,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.00067758,-0.21082,-0.1957,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.016734,-0.2112,-0.20399,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.031059,-0.2121,-0.20096,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0001547,-0.21384,-0.23484,1,0
1,GO ACID SECRETION,0.0006154,-0.21393,-0.19838,1,0
1,GO MEMORY,0.00017186,-0.21395,-0.19913,1,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.023205,-0.21496,-0.21997,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.014138,-0.21544,-0.18976,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,9.7801e-06,-0.21569,-0.24744,1,0
1,GO SODIUM ION HOMEOSTASIS,0.00063551,-0.21594,-0.25733,1,0
1,GO HAIR CELL DIFFERENTIATION,0.00059588,-0.21671,-0.29376,1,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0014738,-0.21713,-0.26235,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00028792,-0.21853,-0.18894,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.036164,-0.21904,-0.14639,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0071468,-0.2194,-0.14547,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.0015189,-0.2198,-0.19043,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,4.3218e-05,-0.22057,-0.24012,1,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0018173,-0.22167,-0.19271,1,0
1,GO REGULATION OF HORMONE SECRETION,1.5816e-05,-0.22532,-0.22798,1,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00038934,-0.22551,-0.29414,1,0
1,GO RESPONSE TO PAIN,0.0028957,-0.22578,-0.22595,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.011326,-0.22584,-0.28415,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.01282,-0.22677,-0.15531,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,7.013e-05,-0.22735,-0.28508,1,0
1,GO TUBULIN DEACETYLATION,0.014138,-0.2279,-0.25547,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00035231,-0.22816,-0.23598,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.00074557,-0.22835,-0.23523,1,0
1,GO REGULATION OF CELL MATURATION,1.2962e-05,-0.22855,-0.27927,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00030804,-0.22918,-0.30504,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00022676,-0.22921,-0.28011,1,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.001872,-0.2294,-0.21615,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.019283,-0.23,-0.18656,1,0
1,GO SECONDARY PALATE DEVELOPMENT,0.0025083,-0.23134,-0.2196,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0030654,-0.23162,-0.22687,1,0
1,GO HISTONE H3 K4 METHYLATION,0.00036427,-0.2318,-0.23939,1,0
1,GO HORMONE TRANSPORT,1.1964e-05,-0.23286,-0.23515,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,5.508e-06,-0.23357,-0.21357,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0030654,-0.23466,-0.26941,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00055855,-0.23577,-0.24234,1,0
1,GO REGULATION OF CHROMATIN BINDING,3.4421e-05,-0.23634,-0.27294,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0015189,-0.23652,-0.22937,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.5308e-05,-0.23659,-0.27877,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.3287e-06,-0.23676,-0.2309,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0069616,-0.23684,-0.2408,1,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.036164,-0.23719,-0.13926,1,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.031748,-0.2376,-0.15153,1,0
1,GO BEHAVIOR,4.1112e-06,-0.23774,-0.22442,1,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0001165,-0.23934,-0.19472,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00040247,-0.23993,-0.21466,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.019283,-0.23995,-0.16662,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,1.7806e-05,-0.24041,-0.24433,1,0
1,GO REGULATION OF HEART RATE,0.0051916,-0.24199,-0.19018,1,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.00041602,-0.24213,-0.18248,1,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.04854,-0.24281,-0.11873,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.046579,-0.24295,-0.16986,1,0
1,GO BILE ACID METABOLIC PROCESS,0.0053338,-0.24305,-0.15273,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.010506,-0.24464,-0.26628,1,0
1,GO MEMBRANE FISSION,0.00054072,-0.24506,-0.30192,1,0
1,GO RESPONSE TO CATECHOLAMINE,2.5308e-05,-0.2454,-0.22685,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0025817,-0.2475,-0.18795,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,1.4039e-05,-0.24818,-0.30423,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.017969,-0.24854,-0.15983,1,0
1,GO REGULATION OF ICOSANOID SECRETION,0.0022332,-0.24873,-0.2008,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.0025817,-0.24962,-0.18405,1,0
1,GO CARDIAC CONDUCTION,0.00023468,-0.25079,-0.24623,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.00079435,-0.25314,-0.26104,1,0
1,GO FEEDING BEHAVIOR,2.8077e-06,-0.25467,-0.25428,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.011904,-0.25481,-0.22573,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.02166,-0.25497,-0.1686,1,0
1,GO RESPONSE TO DOPAMINE,2.1702e-06,-0.25522,-0.24986,1,0
1,GO CRANIAL NERVE DEVELOPMENT,0.00019753,-0.25697,-0.28359,1,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.029719,-0.25712,-0.26674,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0026572,-0.25786,-0.26121,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00045924,-0.25787,-0.25557,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.03939,-0.25845,-0.17094,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0028957,-0.25975,-0.19457,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0028141,-0.25991,-0.27126,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.017137,-0.26266,-0.18373,1,0
1,GO NOREPINEPHRINE SECRETION,0.0071468,-0.26329,-0.19264,1,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.00072223,-0.26433,-0.20635,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,2.8077e-06,-0.26457,-0.23804,1,0
1,GO LIPOXYGENASE PATHWAY,0.019283,-0.26614,-0.2791,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.0075304,-0.26678,-0.20241,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0053338,-0.26819,-0.23974,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,8.1192e-05,-0.26841,-0.21364,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,7.0571e-06,-0.26995,-0.26871,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.013139,-0.2715,-0.23281,1,0
1,GO PEPTIDE HORMONE SECRETION,5.508e-06,-0.27336,-0.28026,1,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0079323,-0.27336,-0.21889,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,9.7346e-05,-0.2739,-0.25427,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0097392,-0.27616,-0.25671,1,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,1.8521e-05,-0.27772,-0.38211,1,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0099891,-0.2789,-0.25013,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0010528,-0.27998,-0.35109,1,0
1,GO SIGNAL RELEASE,8.2505e-07,-0.28052,-0.25831,1,0
1,GO THYMUS DEVELOPMENT,0.0033369,-0.28117,-0.18947,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0024367,-0.28232,-0.26905,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0079323,-0.28303,-0.2197,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,5.2139e-05,-0.28329,-0.23128,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00081984,-0.28445,-0.25871,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,1.5201e-05,-0.28584,-0.2137,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0033369,-0.2861,-0.33789,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0045306,-0.28809,-0.25537,1,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.02166,-0.28842,-0.28464,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.017969,-0.28851,-0.22646,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00014418,-0.29036,-0.30427,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0036303,-0.29157,-0.29707,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0015189,-0.29438,-0.36085,1,0
1,GO ASSOCIATIVE LEARNING,8.1192e-05,-0.29605,-0.24636,1,0
1,GO PROTEIN PALMITOYLATION,2.5308e-05,-0.29612,-0.27213,1,0
1,GO HINDBRAIN DEVELOPMENT,4.1112e-06,-0.29671,-0.28966,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0028957,-0.29809,-0.23424,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00031859,-0.3005,-0.29698,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,6.5896e-07,-0.30221,-0.3047,1,0
1,GO POTASSIUM ION HOMEOSTASIS,0.00063551,-0.30379,-0.2518,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.034637,-0.30411,-0.29018,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,2.1663e-05,-0.30427,-0.27913,1,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.023205,-0.30642,-0.23794,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.013798,-0.30711,-0.19866,1,0
1,GO SKELETAL MUSCLE ADAPTATION,0.0037331,-0.30721,-0.23407,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.018398,-0.30827,-0.23667,1,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.00032948,-0.30827,-0.24806,1,0
1,GO ENERGY HOMEOSTASIS,0.0021062,-0.30937,-0.25711,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.018398,-0.31009,-0.22191,1,0
1,GO GENETIC IMPRINTING,0.00016595,-0.31081,-0.23587,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00030804,-0.31099,-0.53108,1,0
1,GO RESPONSE TO MAGNESIUM ION,0.004408,-0.31211,-0.28249,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,1.0604e-05,-0.31241,-0.31373,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,3.0576e-06,-0.31344,-0.29748,1,0
1,GO ADRENAL GLAND DEVELOPMENT,0.00067758,-0.314,-0.32794,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.04854,-0.31489,-0.15203,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.013798,-0.32028,-0.33793,1,0
1,GO SECRETORY GRANULE LOCALIZATION,0.00013433,-0.3209,-0.58548,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.4728e-06,-0.3212,-0.3255,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0016129,-0.32265,-0.21354,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.0029794,-0.32272,-0.31575,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.2786e-05,-0.32272,-0.30682,1,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.025414,-0.32355,-0.40541,1,0
1,GO ACTION POTENTIAL,7.547e-05,-0.32453,-0.29762,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0011199,-0.32501,-0.28768,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00081984,-0.32543,-0.23824,1,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.041093,-0.32608,-0.24403,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0034322,-0.32672,-0.26284,1,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.017549,-0.32839,-0.27245,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,5.508e-06,-0.32961,-0.31619,1,0
1,GO NERVE DEVELOPMENT,2.7343e-05,-0.33006,-0.30779,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,2.5774e-06,-0.33061,-0.29443,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.049546,-0.33303,-0.18577,1,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.014486,-0.33404,-0.23291,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,2.0784e-06,-0.33419,-0.37926,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,1.4609e-05,-0.33482,-0.29764,1,0
1,GO MEMBRANE DEPOLARIZATION,0.00016023,-0.33694,-0.27659,1,0
1,GO CELL MIGRATION IN HINDBRAIN,3.7145e-05,-0.33921,-0.4443,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0040578,-0.33985,-0.36011,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.4044e-06,-0.34233,-0.31842,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.009256,-0.3437,-0.27692,1,0
1,GO LEARNING,1.0184e-05,-0.34827,-0.3029,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0020453,-0.35115,-0.2779,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.5816e-05,-0.35184,-0.32542,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0013054,-0.35248,-0.32321,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0025083,-0.35315,-0.26998,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0011199,-0.35486,-0.27635,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,3.3132e-05,-0.35543,-0.39018,1,0
1,GO RESPONSE TO LEUCINE,0.033894,-0.35627,-0.29122,1,0
1,GO REGULATION OF EXOCYTOSIS,5.0683e-06,-0.35666,-0.29304,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.0021062,-0.35687,-0.41288,1,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0097392,-0.35882,-0.28702,1,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.020205,-0.35889,-0.24746,1,0
1,GO LOCOMOTORY BEHAVIOR,1.4268e-07,-0.36024,-0.39256,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00074557,-0.36178,-0.27243,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00030804,-0.36214,-0.27636,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,1.0184e-05,-0.3625,-0.41867,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.4728e-06,-0.36368,-0.33872,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00014935,-0.36487,-0.30577,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.1964e-05,-0.36675,-0.42895,1,0
1,GO POTASSIUM ION TRANSPORT,9.4334e-07,-0.36758,-0.32786,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,2.3654e-06,-0.37388,-0.34265,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.001228,-0.37421,-0.27379,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0028957,-0.37478,-0.29716,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00030804,-0.3763,-0.3427,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00027832,-0.37914,-0.34261,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,7.547e-05,-0.37921,-0.39685,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.024288,-0.37976,-0.51932,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.8379e-05,-0.38064,-0.32796,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0097392,-0.38066,-0.41867,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,2.3654e-06,-0.38304,-0.34898,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.037747,-0.38313,-0.18183,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00017796,-0.38397,-0.43499,1,0
1,GO OTIC VESICLE MORPHOGENESIS,0.010245,-0.38421,-0.40632,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0026572,-0.38468,-0.33282,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0081404,-0.38595,-0.46718,1,0
1,GO RESPONSE TO INSECTICIDE,0.00010845,-0.38749,-0.38985,1,0
1,GO LIPID DROPLET FORMATION,0.0033369,-0.38829,-0.36974,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00014418,-0.38869,-0.43032,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,3.3132e-05,-0.395,-0.4058,1,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.014841,-0.39588,-0.25207,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00041602,-0.39824,-0.34182,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0015189,-0.4,-0.42764,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,2.1663e-05,-0.40178,-0.37197,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,1.1776e-06,-0.40284,-0.43969,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0028957,-0.4048,-0.31895,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,7.2111e-07,-0.40504,-0.48327,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00030804,-0.40677,-0.35227,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,7.6603e-06,-0.4069,-0.42008,1,0
1,GO MRNA SPLICE SITE SELECTION,6.0198e-07,-0.41236,-0.41272,1,0
1,GO N GLYCAN PROCESSING,6.7596e-05,-0.4126,-0.38211,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00050664,-0.41407,-0.39728,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,2.6902e-06,-0.41447,-0.43301,1,0
1,GO RESPONSE TO NICOTINE,0.00016595,-0.41615,-0.30291,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.014486,-0.41897,-0.38141,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.0083534,-0.42284,-0.26244,1,0
1,GO MALE SEX DETERMINATION,0.00063551,-0.42581,-0.37674,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,1.0207e-07,-0.4272,-0.44706,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0018173,-0.42796,-0.34291,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,1.4039e-05,-0.43092,-0.42603,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,4.6623e-06,-0.43093,-0.3703,1,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.00090094,-0.43326,-0.39453,1,0
1,GO RESPONSE TO L GLUTAMATE,0.0010206,-0.43447,-0.45471,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00026903,-0.43491,-0.42533,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.00081984,-0.43768,-0.34335,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.016339,-0.4391,-0.29651,1,0
1,GO EXOCYTIC PROCESS,7.889e-07,-0.43991,-0.39978,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012074,-0.44006,-0.41545,1,0
1,GO SUBPALLIUM DEVELOPMENT,0.00026003,-0.44163,-0.3866,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,7.8282e-05,-0.44442,-0.33074,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,2.9532e-05,-0.44488,-0.39294,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,9.4334e-07,-0.44613,-0.4594,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,9.389e-05,-0.44637,-0.40354,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.4044e-06,-0.44752,-0.40056,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,4.1617e-05,-0.45042,-0.51225,1,0
1,GO DIENCEPHALON DEVELOPMENT,1.906e-06,-0.45163,-0.41172,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.4609e-05,-0.45385,-0.44612,1,0
1,GO LIMB BUD FORMATION,0.025994,-0.46115,-0.34927,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,3.5759e-05,-0.46147,-0.45261,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00011241,-0.46242,-0.55636,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,9.389e-05,-0.46274,-0.38055,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.00087311,-0.46429,-0.45672,1,0
1,GO SUCKLING BEHAVIOR,0.00011241,-0.46444,-0.43785,1,0
1,GO FOREBRAIN REGIONALIZATION,0.00022676,-0.46517,-0.39595,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00026903,-0.4684,-0.44584,1,0
1,GO NEURON MATURATION,1.2862e-06,-0.4691,-0.46464,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,2.5308e-05,-0.46947,-0.47032,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00023468,-0.47054,-0.36145,1,0
1,GO OTIC VESICLE DEVELOPMENT,0.00054072,-0.47828,-0.41794,1,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0071468,-0.47917,-0.47768,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0021062,-0.47981,-0.31658,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00026903,-0.48329,-0.41216,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.016339,-0.48405,-0.33481,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,4.1112e-06,-0.48487,-0.42531,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.1112e-06,-0.48539,-0.43026,1,0
1,GO CEREBELLAR CORTEX FORMATION,9.8628e-07,-0.48788,-0.50882,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.00059588,-0.4916,-0.46053,1,0
1,GO ENDOCARDIUM DEVELOPMENT,0.00084609,-0.49748,-0.3867,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00045924,-0.50684,-0.47162,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.017549,-0.50915,-0.34256,1,0
1,GO CGMP METABOLIC PROCESS,1.7118e-05,-0.51359,-0.50075,1,0
1,GO SYNAPTIC VESICLE MATURATION,3.7145e-05,-0.51414,-0.67872,1,0
1,GO EPITHELIAL CELL MATURATION,2.9301e-06,-0.51935,-0.53642,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0014738,-0.51969,-0.40233,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.8131e-07,-0.52415,-0.52019,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,6.0198e-07,-0.52809,-0.48421,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,2.6307e-05,-0.54539,-0.46773,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,3.1904e-06,-0.54756,-0.56711,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,1.349e-05,-0.55268,-0.56185,1,0
1,GO REGULATION OF NEURON MATURATION,3.9418e-06,-0.56085,-0.58553,1,0
1,GO REFLEX,4.3218e-05,-0.56442,-0.52995,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,8.4205e-05,-0.56974,-0.49581,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,3.9926e-07,-0.5719,-0.53377,1,0
1,GO DOPAMINE METABOLIC PROCESS,1.5691e-07,-0.57283,-0.58717,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00050664,-0.57347,-0.37427,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,9.0551e-05,-0.57483,-0.46301,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,5.4977e-07,-0.57509,-0.54104,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0011199,-0.5778,-0.51953,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.4044e-06,-0.58789,-0.58243,1,0
1,GO RESPONSE TO HISTAMINE,4.1617e-05,-0.5879,-0.59664,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,2.8891e-07,-0.5896,-0.51014,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.00059588,-0.58992,-0.56654,1,0
1,GO DETECTION OF CALCIUM ION,9.0179e-06,-0.58999,-0.56428,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,5.2533e-07,-0.59134,-0.60063,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,3.4772e-07,-0.59338,-0.62562,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,3.4728e-06,-0.59485,-0.51631,1,0
1,GO LUNG CELL DIFFERENTIATION,0.0015653,-0.59552,-0.46439,1,0
1,GO SIALYLATION,1.104e-05,-0.59554,-0.51875,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,3.8131e-07,-0.59617,-0.53711,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0022332,-0.59841,-0.41257,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,6.6003e-08,-0.59904,-0.65052,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,8.6584e-06,-0.60295,-0.57217,1,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00040247,-0.60377,-0.56146,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00012964,-0.60404,-0.56127,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00034072,-0.60694,-0.59955,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00016595,-0.60794,-0.49699,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.8958e-07,-0.60951,-0.56871,1,0
1,GO STARTLE RESPONSE,2.9301e-06,-0.61158,-0.52408,1,0
1,GO REGULATION OF GLUTAMATE SECRETION,5.508e-06,-0.61251,-0.52382,1,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0021062,-0.62505,-0.45102,1,0
1,GO REGULATION OF SYNAPSE MATURATION,2.8418e-05,-0.63237,-0.61774,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,9.3916e-06,-0.63427,-0.59474,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,4.8612e-06,-0.63903,-0.71848,1,0
1,GO NEURONAL ACTION POTENTIAL,2.5122e-07,-0.63973,-0.66983,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.00013433,-0.6433,-0.51117,1,0
1,GO DENTATE GYRUS DEVELOPMENT,9.389e-05,-0.64548,-0.59019,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,5.6174e-05,-0.65474,-0.66939,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.65841,-0.56214,1,0
1,GO RESPONSE TO LITHIUM ION,4.1617e-05,-0.67459,-0.56926,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,2.5122e-07,-0.68263,-0.59545,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,4.1802e-07,-0.7019,-0.65859,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.9873e-07,-0.70577,-0.67441,1,0
1,GO THALAMUS DEVELOPMENT,2.5774e-06,-0.72111,-0.63717,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,0.00011241,-0.72123,-0.68743,1,0
1,GO MONOAMINE TRANSPORT,5.2533e-07,-0.73409,-0.62398,1,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0062634,-0.74485,-0.46278,1,0
1,GO SYNAPSE MATURATION,6.2367e-06,-0.74947,-0.77073,1,0
1,GO AMINE TRANSPORT,3.9926e-07,-0.76692,-0.59139,1,0
1,GO INNERVATION,5.508e-06,-0.76895,-0.6185,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.6015e-06,-0.77378,-0.76486,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.906e-06,-0.77848,-0.77434,1,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0040578,-0.77924,-0.52955,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,8.6584e-06,-0.78722,-0.6295,1,0
1,GO SEROTONIN METABOLIC PROCESS,1.4674e-06,-0.80773,-0.7009,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,1.5691e-07,-0.82029,-0.81706,1,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7145e-05,-0.82605,-0.61919,1,0
1,GO NEURON CELL CELL ADHESION,5.0194e-07,-0.82878,-0.97178,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,1.2962e-05,-0.83173,-0.78933,1,0
1,GO PROTEIN LOCALIZATION TO AXON,4.1112e-06,-0.83901,-0.92114,1,0
1,GO DOPAMINE TRANSPORT,4.3763e-07,-0.84347,-0.746,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,3.17e-07,-0.85528,-0.87544,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,4.1617e-05,-0.8649,-0.7681,1,0
1,GO SYNAPTIC VESICLE PRIMING,3.9418e-06,-0.88096,-0.73267,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,1.3605e-07,-0.88979,-0.81193,1,0
1,GO REGULATION OF DENDRITE EXTENSION,3.3202e-07,-0.89271,-0.81993,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,1.1493e-05,-0.90131,-0.85718,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,8.6584e-06,-0.90845,-0.77596,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,7.547e-05,-0.96013,-0.83195,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,4.7955e-07,-0.97149,-0.86456,1,0
1,GO GANGLION DEVELOPMENT,3.3202e-07,-1.0795,-0.91242,1,0
1,GO GABAERGIC NEURON DIFFERENTIATION,1.6729e-06,-1.0796,-0.98538,1,0
1,GO NOSE DEVELOPMENT,1.0311e-06,-1.1182,-0.92219,1,0
1,GO MECHANOSENSORY BEHAVIOR,1.8521e-05,-1.1257,-0.91593,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,5.0683e-06,-1.2957,-1.1331,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,5.7413e-06,-1.5731,-1.3968,1,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,4.7955e-07,-1.5971,-1.4187,1,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.079444,0.42765,0.19236,0,1
1,GO PHOSPHOLIPID EFFLUX,0.073629,0.41422,0.27961,0,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.068167,0.35447,0.22182,0,1
1,GO RESPONSE TO MUSCLE STRETCH,0.2839,0.3445,0.1536,0,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.15264,0.31136,0.21602,0,1
1,GO L SERINE METABOLIC PROCESS,0.11434,0.30828,0.13747,0,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.20937,0.2746,0.18112,0,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.25729,0.2693,0.090799,0,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.097379,0.25411,0.17824,0,1
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.061812,0.24772,0.20231,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.15264,0.24225,0.091704,0,1
1,GO OXYGEN TRANSPORT,0.55487,0.23956,0.10032,0,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.055956,0.23543,0.13581,0,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.23245,0.23363,0.094306,0,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.063042,0.23247,0.13935,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.24643,0.23138,0.16325,0,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.072231,0.23007,0.17577,0,1
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.18219,0.22417,0.11572,0,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.13355,0.22125,0.15502,0,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.055956,0.2175,0.13972,0,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.079444,0.21521,0.18201,0,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.084046,0.21291,0.094365,0,1
1,GO RESPONSE TO INTERLEUKIN 6,0.064293,0.21095,0.12957,0,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.10096,0.21066,0.13476,0,1
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.16559,0.20722,0.10557,0,1
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.19095,0.20562,0.20808,0,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,0.20254,0.17264,0,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.18219,0.19785,0.08262,0,1
1,GO FOREBRAIN MORPHOGENESIS,0.15264,0.19702,0.13491,0,1
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.12908,0.1961,0.14063,0,1
1,GO TONGUE DEVELOPMENT,0.11039,0.19356,0.15826,0,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.54903,0.19221,0.030752,0,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.055956,0.19129,0.14714,0,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.11039,0.1911,0.14839,0,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.23245,0.19001,0.088534,0,1
1,GO GAS TRANSPORT,0.15773,0.18942,0.18834,0,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.065563,0.18885,0.14405,0,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.13583,0.18445,0.11053,0,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.055956,0.1818,0.1434,0,1
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.13814,0.1814,0.20353,0,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.37932,0.18053,0.088586,0,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.053746,0.17794,0.15043,0,1
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.085627,0.17581,0.13517,0,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.065563,0.17515,0.1455,0,1
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.16032,0.17461,0.10197,0,1
1,GO VITAMIN D METABOLIC PROCESS,0.11039,0.17298,0.19033,0,1
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.44402,0.17193,0.16302,0,1
1,GO ATP TRANSPORT,0.065563,0.17122,0.08114,0,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.43883,0.17115,0.063934,0,1
1,GO NUCLEUS LOCALIZATION,0.082489,0.17038,0.10907,0,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.10654,0.16919,0.14003,0,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.077957,0.16865,0.15575,0,1
1,GO REGULATION OF GONAD DEVELOPMENT,0.59059,0.1679,0.0064821,0,1
1,GO FOLIC ACID METABOLIC PROCESS,0.12473,0.16684,0.12091,0,1
1,GO INOSITOL METABOLIC PROCESS,0.14769,0.16565,0.078089,0,1
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.080955,0.16541,0.12088,0,1
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.54321,0.16538,0.058368,0,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.94073,0.16482,-0.019596,0,1
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.31653,0.16028,0.086691,0,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.10845,0.15901,0.14811,0,1
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.54321,0.15896,0.082877,0,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.26471,0.15864,0.070643,0,1
1,GO ER NUCLEUS SIGNALING PATHWAY,0.080955,0.15559,0.1087,0,1
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.1313,0.15463,0.15315,0,1
1,GO AMP METABOLIC PROCESS,0.10845,0.15248,0.21789,0,1
1,GO ANIMAL ORGAN FORMATION,0.0695,0.15173,0.14211,0,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.188,0.15129,0.086671,0,1
1,GO ACETYL COA METABOLIC PROCESS,0.17653,0.15113,0.05298,0,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.2,0.15109,0.10839,0,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.21256,0.15106,0.078444,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.35153,0.14931,0.13246,0,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.0695,0.14828,0.12596,0,1
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.087232,0.14766,0.094943,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.17099,0.14699,0.073951,0,1
1,GO NEURAL TUBE FORMATION,0.066855,0.14497,0.10438,0,1
1,GO REGULATION OF GTP BINDING,0.14048,0.14481,0.15628,0,1
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.16559,0.14332,0.13024,0,1
1,GO REGULATION OF MYELINATION,0.060602,0.14237,0.10946,0,1
1,GO ENGULFMENT OF APOPTOTIC CELL,0.063042,0.14115,0.10789,0,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.21579,0.14025,0.071216,0,1
1,GO REGULATION OF MRNA POLYADENYLATION,0.16559,0.13928,0.079884,0,1
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.12908,0.1391,0.14465,0,1
1,GO DNA DEMETHYLATION,0.25729,0.13882,0.092423,0,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0695,0.13766,0.13464,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.48131,0.13748,0.033673,0,1
1,GO HISTONE ARGININE METHYLATION,0.068167,0.13575,0.090267,0,1
1,GO NCRNA CATABOLIC PROCESS,0.16294,0.13542,0.11403,0,1
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.26471,0.13397,0.083326,0,1
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.33812,0.13255,0.079696,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.22568,0.13169,0.078934,0,1
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.10654,0.12984,0.080639,0,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.079444,0.1288,0.1088,0,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.065563,0.12816,0.11208,0,1
1,GO REGULATION OF SENSORY PERCEPTION,0.12473,0.12648,0.085475,0,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.31653,0.12639,0.075929,0,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.23937,0.12541,0.14478,0,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.077957,0.12518,0.10841,0,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.19393,0.12487,0.13492,0,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.079444,0.12402,0.19242,0,1
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.31232,0.12395,0.063934,0,1
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.188,0.12381,0.18618,0,1
1,GO BICARBONATE TRANSPORT,0.19393,0.12366,0.09775,0,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.2,0.12345,0.077223,0,1
1,GO PIRNA METABOLIC PROCESS,0.16294,0.12242,0.18083,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.12237,0.056081,0,1
1,GO REGULATION OF DNA BINDING,0.32938,0.12024,0.031469,0,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.066855,0.11954,0.17751,0,1
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.19393,0.11864,0.11208,0,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.16294,0.1182,0.1163,0,1
1,GO MIDBODY ABSCISSION,0.20621,0.11794,0.077417,0,1
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.1313,0.11659,0.11315,0,1
1,GO RESPIRATORY SYSTEM PROCESS,0.29586,0.11579,0.061797,0,1
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.14769,0.11385,0.06281,0,1
1,GO PYRUVATE METABOLIC PROCESS,0.19695,0.11358,0.055906,0,1
1,GO LAMELLIPODIUM ASSEMBLY,0.1028,0.11318,0.097976,0,1
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.072231,0.11284,0.080881,0,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.1028,0.1123,0.077747,0,1
1,GO PHOSPHOLIPID HOMEOSTASIS,0.079444,0.11223,0.21482,0,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.82348,0.11207,-0.091749,0,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.22568,0.1117,0.083107,0,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.16294,0.1117,0.063844,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.30815,0.11163,0.052011,0,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.055956,0.10947,0.10371,0,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.082489,0.10891,0.1609,0,1
1,GO DEFINITIVE HEMOPOIESIS,0.31653,0.10854,0.068352,0,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.053746,0.10765,0.14814,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.35607,0.10706,0.02845,0,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.22235,0.10705,0.072782,0,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.11841,0.10697,0.080299,0,1
1,GO ADHERENS JUNCTION ASSEMBLY,0.50337,0.10668,0.047887,0,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.27611,0.10653,0.063481,0,1
1,GO REGULATION OF HISTONE DEACETYLATION,0.11434,0.10638,0.096894,0,1
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.39371,0.1057,0.071163,0,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.32506,0.10539,0.087845,0,1
1,GO NEGATIVE T CELL SELECTION,0.084046,0.10499,0.14839,0,1
1,GO SPINDLE ORGANIZATION,0.063042,0.10392,0.074242,0,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.27611,0.10288,0.056879,0,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.23589,0.10123,0.12168,0,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.088862,0.10051,0.10023,0,1
1,GO HEART TRABECULA MORPHOGENESIS,0.059411,0.10014,0.15523,0,1
1,GO REGULATION OF DNA REPAIR,0.10654,0.099424,0.05153,0,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.40843,0.098951,0.03544,0,1
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.25001,0.098765,0.052307,0,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.13583,0.098528,0.099728,0,1
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.18508,0.09799,0.097184,0,1
1,GO CYTOKINESIS,0.075049,0.096771,0.073018,0,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.50896,0.096437,0.062986,0,1
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.10465,0.096206,0.079772,0,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.34702,0.095885,0.049262,0,1
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.093897,0.095769,0.053561,0,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.10654,0.094172,0.091401,0,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.188,0.093582,0.039082,0,1
1,GO VIRAL BUDDING,0.055956,0.092451,0.089788,0,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.25363,0.091926,0.075745,0,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.065563,0.090947,0.06476,0,1
1,GO ALANINE TRANSPORT,0.59059,0.090932,0.047673,0,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.070855,0.088742,0.076408,0,1
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.066855,0.088713,0.15313,0,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.12049,0.087658,0.077686,0,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.22568,0.086746,0.035836,0,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.082489,0.08614,0.10517,0,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.079444,0.085605,0.098102,0,1
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.15264,0.083799,0.12473,0,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.23245,0.082826,0.056502,0,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.44924,0.082228,0.034215,0,1
1,GO METAPHASE PLATE CONGRESSION,0.2,0.080379,0.063396,0,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.91293,0.077465,-0.026736,0,1
1,GO MUSCLE FIBER DEVELOPMENT,0.40843,0.077346,0.031296,0,1
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.061812,0.076946,0.11948,0,1
1,GO RESPONSE TO INSULIN,0.15517,0.076314,0.030037,0,1
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.076492,0.0758,0.066578,0,1
1,GO BASE EXCISION REPAIR,0.15517,0.075158,0.086171,0,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.14285,0.075131,0.10729,0,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.072231,0.074367,0.10508,0,1
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.46512,0.074184,0.03092,0,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.17653,0.073479,0.061258,0,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.12908,0.07213,0.11107,0,1
1,GO CENTRIOLE ASSEMBLY,0.30402,0.071252,0.046187,0,1
1,GO FERTILIZATION,0.13583,0.070662,0.049269,0,1
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.14048,0.07059,0.059983,0,1
1,GO MRNA 3 END PROCESSING,0.12049,0.070501,0.063362,0,1
1,GO STEM CELL PROLIFERATION,0.97557,0.069337,-0.031345,0,1
1,GO NEUTROPHIL CHEMOTAXIS,0.10845,0.068602,0.1691,0,1
1,GO SPINDLE ASSEMBLY,0.097379,0.067873,0.046795,0,1
1,GO CHOLESTEROL STORAGE,0.17653,0.067769,0.15961,0,1
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.49227,0.066944,0.0097325,0,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.099158,0.065762,0.062034,0,1
1,GO RESPONSE TO RADIATION,0.05824,0.064521,0.050433,0,1
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.088862,0.063428,0.0614,0,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0695,0.062647,0.089724,0,1
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13814,0.062551,0.051139,0,1
1,GO CHROMOSOME SEPARATION,0.054842,0.062233,0.098427,0,1
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.20309,0.062121,0.093218,0,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.057089,0.061272,0.10827,0,1
1,GO RESPONSE TO CAMP,0.12689,0.059979,0.11756,0,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.46512,0.059334,0.01338,0,1
1,GO DNA GEOMETRIC CHANGE,0.26471,0.057954,0.058184,0,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.079444,0.057616,0.06884,0,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.24643,0.057541,0.041682,0,1
1,GO PROTEIN MONOUBIQUITINATION,0.29992,0.057527,0.037787,0,1
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.22905,0.054678,0.028022,0,1
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.32938,0.053877,0.098268,0,1
1,GO DNA CATABOLIC PROCESS,0.17099,0.050874,0.027909,0,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.13814,0.049955,0.031492,0,1
1,GO DNA REPAIR,0.079444,0.049007,0.044163,0,1
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.24643,0.048877,0.040528,0,1
1,GO DOUBLE STRAND BREAK REPAIR,0.088862,0.047564,0.049239,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.54903,0.047304,0.02936,0,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.060602,0.047153,0.08024,0,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.32077,0.047151,0.048676,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.25001,0.045849,0.027423,0,1
1,GO CELL CYCLE CHECKPOINT,0.16559,0.043875,0.029439,0,1
1,GO CHROMOSOME SEGREGATION,0.26098,0.043665,0.039183,0,1
1,GO DNA RECOMBINATION,0.1313,0.041885,0.049694,0,1
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.92682,0.041101,0.0065719,0,1
1,GO DNA INTEGRITY CHECKPOINT,0.27611,0.040682,0.031307,0,1
1,GO ORGANELLE ASSEMBLY,0.063042,0.039794,0.044152,0,1
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.25001,0.036958,0.025815,0,1
1,GO POSITIVE REGULATION OF TRANSPORT,0.32077,0.03497,0.02398,0,1
1,GO MITOCHONDRIAL FUSION,0.33373,0.031797,0.041076,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE,0.63354,0.028793,0.002547,0,1
1,GO DNA MODIFICATION,0.29184,0.028473,0.042023,0,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.42347,0.026009,0.02721,0,1
1,GO ELASTIC FIBER ASSEMBLY,0.00028792,0.57588,0.6732,0,0
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.00036427,0.47379,0.49039,0,0
1,GO BONE TRABECULA MORPHOGENESIS,0.023741,0.44343,0.38215,0,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.060602,0.40223,0.2666,0,0
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0031536,0.38451,0.46419,0,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.038561,0.36277,0.36805,0,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0001165,0.35638,0.38927,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.021165,0.35445,0.35448,0,0
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0081404,0.35323,0.27821,0,0
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0014299,0.33884,0.44823,0,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.8418e-05,0.33688,0.36014,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.060602,0.33581,0.25458,0,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0087944,0.32174,0.3836,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00042998,0.31336,0.28864,0,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.061812,0.30894,0.28035,0,0
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0049174,0.29098,0.32068,0,0
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00023468,0.29,0.2791,0,0
1,GO PROSTATIC BUD FORMATION,0.0071468,0.28454,0.39466,0,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.18508,0.28058,0.17178,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.097379,0.27353,0.20381,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.077957,0.27275,0.17164,0,0
1,GO CORONARY VASCULATURE DEVELOPMENT,0.00027832,0.27043,0.28966,0,0
1,GO NEURAL CREST CELL MIGRATION,0.024846,0.26889,0.213,0,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.012508,0.26606,0.2532,0,0
1,GO TRABECULA FORMATION,0.0051916,0.26432,0.38548,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0057817,0.26309,0.32674,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.033166,0.25147,0.48299,0,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.025414,0.25068,0.28347,0,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.16294,0.24512,0.20263,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.60272,0.24453,0.092016,0,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0030654,0.2422,0.216,0,0
1,GO ACTIN FILAMENT SEVERING,0.20621,0.23799,0.11971,0,0
1,GO GONADOTROPIN SECRETION,0.033894,0.23735,0.21726,0,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.079444,0.23509,0.34977,0,0
1,GO MITRAL VALVE DEVELOPMENT,0.28785,0.23057,0.18377,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.077957,0.22974,0.16227,0,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.095625,0.22955,0.17946,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.17099,0.22888,0.15487,0,0
1,GO BONE MORPHOGENESIS,0.00067758,0.22448,0.23455,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.060602,0.22203,0.11263,0,0
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.017969,0.22171,0.15606,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.43883,0.21983,0.11758,0,0
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.025414,0.21811,0.17751,0,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0695,0.21642,0.14191,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.093897,0.21476,0.16171,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.53167,0.20354,0.031269,0,0
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0064317,0.20192,0.25524,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.095625,0.20154,0.21827,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.14526,0.19991,0.11639,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.12049,0.19631,0.1193,0,0
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.004408,0.19587,0.19322,0,0
1,GO TRACHEA DEVELOPMENT,0.018836,0.19555,0.20642,0,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.092194,0.19458,0.15813,0,0
1,GO PROTEIN AUTOPROCESSING,0.070855,0.1944,0.14688,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.10845,0.19439,0.15918,0,0
1,GO INTERLEUKIN 5 PRODUCTION,0.059411,0.19106,0.20307,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.33373,0.18944,0.094232,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.15015,0.18834,0.33731,0,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0047853,0.18812,0.22023,0,0
1,GO CARNITINE SHUTTLE,0.053746,0.18677,0.15195,0,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0032441,0.1862,0.19007,0,0
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0039469,0.18589,0.21415,0,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.16559,0.18549,0.13206,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.05161,0.18388,0.14181,0,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0087944,0.18297,0.36444,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.3746,0.18294,0.109,0,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.12908,0.1812,0.12533,0,0
1,GO RENAL FILTRATION,0.088862,0.18115,0.23312,0,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.020205,0.18114,0.14962,0,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00010462,0.1795,0.18965,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.066855,0.17896,0.2535,0,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.60272,0.17827,0.039462,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.4598,0.17727,0.0809,0,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.15015,0.17706,0.25375,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.3746,0.17648,0.072109,0,0
1,GO HEPATOCYTE DIFFERENTIATION,0.29992,0.17548,0.14129,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.10654,0.17272,0.088649,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.1313,0.17129,0.16219,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.27227,0.17093,0.13248,0,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.070855,0.16894,0.17492,0,0
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.004408,0.16855,0.16765,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.016734,0.1675,0.21204,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.070855,0.16687,0.11539,0,0
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.053746,0.1665,0.20365,0,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.22905,0.16522,0.097377,0,0
1,GO HINDLIMB MORPHOGENESIS,0.15264,0.16497,0.13591,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.38888,0.16444,0.09162,0,0
1,GO MIDGUT DEVELOPMENT,0.10465,0.16436,0.19942,0,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0056288,0.16433,0.21496,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.10845,0.16402,0.22762,0,0
1,GO INTERMEMBRANE LIPID TRANSFER,0.0028141,0.16311,0.17001,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.19095,0.16246,0.12877,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.31232,0.16245,0.083888,0,0
1,GO LAMELLIPODIUM MORPHOGENESIS,0.52594,0.16161,0.087153,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.56075,0.1614,0.068467,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.17934,0.1609,0.20304,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.25001,0.16076,0.15662,0,0
1,GO BONE DEVELOPMENT,0.00047456,0.16064,0.18843,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.063042,0.15917,0.13268,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.18219,0.15895,0.089805,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.21905,0.15862,0.07857,0,0
1,GO NEUROBLAST DIVISION,0.25001,0.15779,0.16257,0,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.12908,0.15739,0.3137,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.23589,0.15701,0.23096,0,0
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.27999,0.15663,0.093452,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.077957,0.15501,0.19211,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.12473,0.15445,0.097794,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.26471,0.15438,0.19732,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.35607,0.15404,0.08085,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0064317,0.15401,0.15353,0,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.050569,0.15363,0.20207,0,0
1,GO REGULATION OF ANOIKIS,0.10845,0.15337,0.16006,0,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.12473,0.15274,0.11133,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.22568,0.1495,0.13605,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.16294,0.14862,0.11416,0,0
1,GO LIPID DIGESTION,0.16032,0.14786,0.12269,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.11636,0.14717,0.091889,0,0
1,GO AMINO ACID IMPORT,0.19095,0.1466,0.14546,0,0
1,GO HEART VALVE DEVELOPMENT,0.0033369,0.14631,0.24859,0,0
1,GO CARDIAC SEPTUM DEVELOPMENT,0.0019282,0.14623,0.20615,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.053746,0.14524,0.185,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.16828,0.1452,0.076321,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.073629,0.14491,0.12602,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.085627,0.14491,0.1868,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.20937,0.14451,0.081763,0,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00081984,0.14389,0.15324,0,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.061812,0.14355,0.17811,0,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.15773,0.14349,0.11378,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.29586,0.14344,0.094755,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.27999,0.14328,0.07492,0,0
1,GO INCLUSION BODY ASSEMBLY,0.61497,0.14277,0.0073637,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.76948,0.14273,-0.00072397,0,0
1,GO AMELOGENESIS,0.17653,0.14176,0.13207,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.092194,0.14149,0.074279,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.68418,0.14146,0.055941,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.16032,0.14059,0.07187,0,0
1,GO TRABECULA MORPHOGENESIS,0.0087944,0.14038,0.2327,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.26471,0.14034,0.10196,0,0
1,GO PROTEIN ADP RIBOSYLATION,0.16032,0.14008,0.1014,0,0
1,GO MYELIN MAINTENANCE,0.21905,0.13982,0.11083,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.088862,0.13972,0.1352,0,0
1,GO ORGAN GROWTH,0.00081984,0.13827,0.17608,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.46512,0.137,0.079411,0,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.077957,0.13644,0.32231,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.05824,0.13503,0.10356,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.16828,0.13479,0.10391,0,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.019283,0.13471,0.20065,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.061812,0.13467,0.12044,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.087232,0.13463,0.1731,0,0
1,GO AXIS ELONGATION,0.077957,0.13301,0.13744,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.30402,0.13289,0.079803,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.35607,0.13238,0.088009,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.063042,0.13238,0.13792,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.62113,0.1323,0.0331,0,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.10845,0.13229,0.098804,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.1313,0.13213,0.2106,0,0
1,GO MANGANESE ION TRANSPORT,0.090515,0.132,0.12914,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.29992,0.13195,0.038239,0,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.015574,0.13079,0.13943,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.079444,0.13073,0.069673,0,0
1,GO GENITALIA DEVELOPMENT,0.024288,0.13028,0.10052,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.093897,0.13027,0.13016,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.23245,0.1297,0.076474,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.14285,0.1297,0.25114,0,0
1,GO LYMPHOCYTE COSTIMULATION,0.087232,0.12944,0.083376,0,0
1,GO REGULATION OF PLATELET ACTIVATION,0.21256,0.12876,0.093273,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.22568,0.12852,0.11317,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.15015,0.12798,0.12929,0,0
1,GO MUSCLE HYPERTROPHY,0.26847,0.12741,0.067988,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.33373,0.12728,0.034626,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.12259,0.12696,0.26068,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.10465,0.12564,0.20055,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.27611,0.12563,0.042785,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.095625,0.12534,0.13124,0,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.188,0.12451,0.10785,0,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.25363,0.12436,0.10345,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.50337,0.12435,0.032278,0,0
1,GO MYOBLAST MIGRATION,0.28785,0.12401,0.13238,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.12908,0.12374,0.13289,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.1313,0.12339,0.121,0,0
1,GO PROTEIN KINASE C SIGNALING,0.11636,0.12293,0.085302,0,0
1,GO THIOESTER METABOLIC PROCESS,0.057089,0.1229,0.086336,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.065563,0.12289,0.23868,0,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.064293,0.1223,0.13875,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.085627,0.12193,0.090725,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.11235,0.12192,0.15859,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.14769,0.12158,0.12378,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.68418,0.12101,0.027699,0,0
1,GO CELLULAR SENESCENCE,0.0049174,0.12096,0.11824,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.23937,0.12093,0.11269,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.31653,0.12067,0.073338,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.53742,0.11964,0.035321,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.40843,0.11901,0.065299,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29992,0.11872,0.16539,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.031748,0.11871,0.10847,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.86455,0.11827,0.068474,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.079444,0.11814,0.080853,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.12259,0.11808,0.12617,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.10845,0.11794,0.15673,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.27227,0.11782,0.093455,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.053746,0.11746,0.094867,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.44924,0.1173,0.037758,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.22235,0.11702,0.15478,0,0
1,GO LYSINE METABOLIC PROCESS,0.19695,0.11698,0.11968,0,0
1,GO GOLGI LOCALIZATION,0.48131,0.11647,0.033503,0,0
1,GO RESPONSE TO ACIDIC PH,0.093897,0.11618,0.12945,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.56075,0.11603,0.12026,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.084046,0.11556,0.081034,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.047551,0.11537,0.12759,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.12689,0.11529,0.12868,0,0
1,GO DISTAL TUBULE DEVELOPMENT,0.30815,0.11471,0.17429,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.23937,0.1142,0.056891,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.11235,0.11409,0.089505,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.087232,0.11396,0.15431,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.14526,0.11396,0.079384,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.26847,0.11376,0.047047,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.12049,0.11324,0.086027,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.32506,0.11261,0.25964,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.30815,0.11191,0.15894,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.43367,0.11182,0.13852,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.20621,0.11148,0.19037,0,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.11434,0.11112,0.061951,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.092194,0.11109,0.096257,0,0
1,GO REGULATION OF TISSUE REMODELING,0.065563,0.11089,0.098009,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.34256,0.11084,0.11602,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.064293,0.11069,0.075127,0,0
1,GO NEURAL CREST CELL DIFFERENTIATION,0.13583,0.11007,0.13726,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.65234,0.10974,0.072059,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.60883,0.10949,0.063227,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.55487,0.10919,0.03737,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.43367,0.10911,0.084814,0,0
1,GO VASODILATION,0.87833,0.10875,-0.029167,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.37932,0.10865,0.15328,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.16294,0.1077,0.071777,0,0
1,GO KINETOCHORE ASSEMBLY,0.32077,0.1075,0.089147,0,0
1,GO VITAMIN TRANSPORT,0.10845,0.10722,0.11207,0,0
1,GO MESENCHYME MORPHOGENESIS,0.042857,0.10713,0.22646,0,0
1,GO EXTRACELLULAR TRANSPORT,0.24643,0.10686,0.090953,0,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.1028,0.10653,0.077411,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.050569,0.10638,0.15144,0,0
1,GO RESPONSE TO ATP,0.0049174,0.10628,0.12389,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.86455,0.10606,-0.10207,0,0
1,GO OVULATION CYCLE PROCESS,0.19695,0.10602,0.081857,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.25363,0.10591,0.04846,0,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.072231,0.10544,0.084126,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.65234,0.10409,0.11155,0,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.10465,0.10378,0.12541,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.57857,0.10279,0.0061978,0,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.25001,0.10259,0.057207,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.14048,0.10245,0.1061,0,0
1,GO PERICARDIUM DEVELOPMENT,0.033166,0.10224,0.1954,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.38888,0.10208,0.082353,0,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.082489,0.10153,0.27005,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.082489,0.10147,0.19982,0,0
1,GO FAT CELL DIFFERENTIATION,0.072231,0.10133,0.072077,0,0
1,GO LACTATION,0.033166,0.10132,0.14073,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.11039,0.10117,0.15097,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.20309,0.10115,0.041958,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.16294,0.10095,0.089225,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.24288,0.10069,0.063152,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.19393,0.10057,0.11285,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.33812,0.1004,0.11036,0,0
1,GO GLIAL CELL MIGRATION,0.12049,0.09957,0.12826,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.021165,0.09938,0.21723,0,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.061812,0.098875,0.10249,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.11235,0.09848,0.11496,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.073629,0.098443,0.074737,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.090515,0.097647,0.17087,0,0
1,GO REGULATION OF PROTEIN SUMOYLATION,0.30815,0.097492,0.077012,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.14285,0.097103,0.12077,0,0
1,GO STEROL METABOLIC PROCESS,0.13583,0.097022,0.054633,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.070855,0.096499,0.14385,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.43883,0.095781,0.05609,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.19695,0.09568,0.14594,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.070855,0.095178,0.11618,0,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.18508,0.095138,0.055495,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.8303,0.094931,0.064956,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.087232,0.094865,0.098757,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.1028,0.094705,0.072006,0,0
1,GO RESPONSE TO VITAMIN,0.11636,0.093502,0.11615,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.32506,0.093484,0.050138,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.24643,0.093299,0.074724,0,0
1,GO ERYTHROCYTE MATURATION,0.085627,0.093218,0.13291,0,0
1,GO REGULATION OF T CELL MIGRATION,0.19695,0.092845,0.094724,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.15773,0.092789,0.034127,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.61497,0.092606,0.010971,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.097379,0.092186,0.090381,0,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.14048,0.09215,0.052793,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.05824,0.091843,0.076885,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.12689,0.091513,0.092445,0,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.25729,0.09109,0.086686,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.12259,0.091034,0.056112,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.038561,0.090919,0.13672,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.60272,0.090574,0.079988,0,0
1,GO GLIAL CELL DEVELOPMENT,0.34256,0.090275,0.033547,0,0
1,GO LAMELLIPODIUM ORGANIZATION,0.063042,0.09014,0.12011,0,0
1,GO IMP METABOLIC PROCESS,0.18508,0.089957,0.19421,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.71006,0.088947,0.023485,0,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.068167,0.08894,0.085073,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.36064,0.088726,0.065905,0,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.054842,0.088145,0.13002,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.56666,0.088084,0.042349,0,0
1,GO DIOL METABOLIC PROCESS,0.32506,0.088059,0.044342,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.16032,0.087887,0.094476,0,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.10654,0.087804,0.095602,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.56075,0.087562,0.047134,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.2,0.087491,0.084783,0,0
1,GO REPLACEMENT OSSIFICATION,0.12908,0.087243,0.16139,0,0
1,GO REGULATION OF GLIAL CELL MIGRATION,0.10845,0.087243,0.12852,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.23937,0.0864,0.021985,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.24643,0.086393,0.14993,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.50896,0.086282,0.062856,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.65866,0.086149,0.027639,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.22905,0.085922,0.10513,0,0
1,GO CELLULAR PIGMENTATION,0.15773,0.085719,0.045731,0,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.24288,0.085343,0.10253,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.064293,0.085319,0.24199,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.41341,0.085043,0.031635,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.19095,0.084933,0.12843,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.027803,0.084929,0.16125,0,0
1,GO CHROMOSOME LOCALIZATION,0.21256,0.084605,0.075275,0,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.13583,0.084058,0.070514,0,0
1,GO L AMINO ACID TRANSPORT,0.44924,0.084034,0.077328,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.082489,0.083955,0.12652,0,0
1,GO RECEPTOR INTERNALIZATION,0.050569,0.083887,0.085122,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.13814,0.083694,0.093472,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.20937,0.083126,0.055095,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.13814,0.083004,0.14693,0,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.16294,0.082716,0.056356,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32938,0.082643,0.032691,0,0
1,GO LEUKOCYTE CHEMOTAXIS,0.099158,0.082507,0.12073,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.21579,0.082441,0.065259,0,0
1,GO RESPONSE TO CADMIUM ION,0.62732,0.082228,0.055506,0,0
1,GO RESPONSE TO IRON ION,0.17374,0.08222,0.067146,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.18219,0.082075,0.14792,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.26471,0.08165,0.079373,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.057089,0.08151,0.088758,0,0
1,GO REGULATION OF SPINDLE ORGANIZATION,0.04854,0.081368,0.089792,0,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0695,0.081139,0.066926,0,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.14048,0.081131,0.11868,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.10845,0.080977,0.11159,0,0
1,GO STEROID METABOLIC PROCESS,0.1028,0.080366,0.062414,0,0
1,GO FATTY ACID TRANSPORT,0.085627,0.080255,0.063295,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.31653,0.079901,0.062735,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.33812,0.079801,0.059483,0,0
1,GO TONGUE MORPHOGENESIS,0.27999,0.079797,0.14838,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.049546,0.079753,0.083091,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.12908,0.079256,0.1438,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.14048,0.079231,0.085935,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.27999,0.079112,0.082747,0,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.027188,0.07911,0.06214,0,0
1,GO MICROVILLUS ASSEMBLY,0.85768,0.078632,0.0019761,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.50896,0.078468,0.19351,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.20309,0.078466,0.069175,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.26847,0.07803,0.044171,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.55487,0.077932,0.070106,0,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.12259,0.07755,0.041916,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.55487,0.077536,0.041454,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.17653,0.077431,0.061817,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36526,0.077045,0.063672,0,0
1,GO AORTA DEVELOPMENT,0.17934,0.07674,0.18353,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.55487,0.076562,0.026035,0,0
1,GO B CELL APOPTOTIC PROCESS,0.69707,0.076486,0.0051204,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.12049,0.076399,0.14273,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.62113,0.076365,0.10189,0,0
1,GO RNA INTERFERENCE,0.62113,0.076106,0.034759,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.20937,0.075809,0.13604,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.24643,0.075745,0.05934,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.78962,0.075619,0.031212,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.58456,0.07555,0.040815,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.095625,0.075186,0.074886,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.063042,0.074679,0.069652,0,0
1,GO CELL CYCLE ARREST,0.041093,0.074587,0.061981,0,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.10465,0.074587,0.10051,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.35607,0.074417,0.10311,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.074391,0.064325,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.23245,0.074333,0.051506,0,0
1,GO NUCLEOTIDE TRANSPORT,0.31653,0.074217,0.027847,0,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.063042,0.074194,0.085917,0,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.16294,0.074101,0.08238,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.44924,0.0741,0.072984,0,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.10465,0.074033,0.1129,0,0
1,GO TRNA CATABOLIC PROCESS,0.41842,0.073786,0.094132,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.24288,0.073711,0.042626,0,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.71006,0.073515,0.0089606,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.30402,0.073171,0.039597,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.32077,0.07276,0.11759,0,0
1,GO RNA STABILIZATION,0.16032,0.072717,0.072005,0,0
1,GO KETONE CATABOLIC PROCESS,0.61497,0.072333,0.051931,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.33373,0.072214,0.11015,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.188,0.07217,0.085023,0,0
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.076492,0.07176,0.068469,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.3746,0.071716,0.053336,0,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.91987,0.071516,-0.0058567,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.16559,0.071422,0.065225,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.98255,0.071333,-0.06878,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.2839,0.071325,0.041609,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.42855,0.071277,0.15114,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.71658,0.071167,0.060713,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.16828,0.071149,0.10579,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.022165,0.071122,0.13938,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.27999,0.071092,0.15313,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.53167,0.070978,0.075317,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.095625,0.070703,0.14634,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.8303,0.070555,0.06688,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.32938,0.070513,0.092788,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.061812,0.070464,0.070357,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.21256,0.070447,0.13714,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.47588,0.070378,0.026343,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.2,0.07032,0.095553,0,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.12049,0.070136,0.11444,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.71006,0.069739,0.066401,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.50337,0.069735,0.033568,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.26471,0.069678,0.09622,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.61497,0.06956,0.095055,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.14285,0.069457,0.10106,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.62732,0.069384,0.016289,0,0
1,GO REGULATION OF CENTROSOME CYCLE,0.20937,0.069149,0.050866,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.15517,0.0691,0.079871,0,0
1,GO LIVER MORPHOGENESIS,0.25729,0.068979,0.10696,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.11636,0.068915,0.15636,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.13355,0.068668,0.095693,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.29184,0.068503,0.041508,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.22568,0.068473,0.064645,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.80312,0.068318,0.11032,0,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.066855,0.068286,0.10722,0,0
1,GO STEM CELL DIVISION,0.17934,0.068002,0.10705,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.29184,0.067924,0.061342,0,0
1,GO RESPONSE TO AMYLOID BETA,0.2,0.067672,0.14942,0,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.087232,0.067642,0.074867,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.53742,0.067591,0.046303,0,0
1,GO CELLULAR RESPONSE TO DRUG,0.10465,0.067579,0.087393,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.36064,0.067345,0.061284,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.19393,0.067292,0.039121,0,0
1,GO MAMMARY GLAND DEVELOPMENT,0.11235,0.067228,0.097319,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.092194,0.067221,0.13934,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.50337,0.06705,0.062115,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.33373,0.066986,0.10068,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.090515,0.066769,0.075646,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.60272,0.066711,0.02991,0,0
1,GO MYOTUBE DIFFERENTIATION,0.15773,0.066491,0.095633,0,0
1,GO NEURON PROJECTION REGENERATION,0.47049,0.066317,0.040324,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.30815,0.06614,0.12281,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.12689,0.066134,0.060537,0,0
1,GO PLASMA MEMBRANE FUSION,0.27999,0.065842,0.10283,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.75615,0.065827,0.034885,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.46512,0.065718,0.016525,0,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14285,0.065694,0.060138,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.29992,0.065481,0.040812,0,0
1,GO OOCYTE MATURATION,0.42855,0.065429,0.032505,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.54903,0.065299,0.010244,0,0
1,GO RESPONSE TO ESTRADIOL,0.087232,0.065103,0.091672,0,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.11841,0.064836,0.054758,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.49227,0.064772,0.070959,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.72969,0.064752,0.0054394,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.24643,0.064411,0.049249,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.38888,0.064383,0.05099,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.63978,0.064293,0.02598,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.26098,0.064231,0.060278,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.066855,0.063351,0.044495,0,0
1,GO ENSHEATHMENT OF NEURONS,0.28785,0.063347,0.037317,0,0
1,GO ODONTOGENESIS,0.04854,0.06304,0.15603,0,0
1,GO HOMEOSTATIC PROCESS,0.12473,0.062829,0.028966,0,0
1,GO TISSUE HOMEOSTASIS,0.12473,0.062816,0.051686,0,0
1,GO KINETOCHORE ORGANIZATION,0.5726,0.062385,0.035934,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17934,0.062181,0.069618,0,0
1,GO GOLGI RIBBON FORMATION,0.65234,0.062114,0.037936,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.68418,0.061868,0.053248,0,0
1,GO ARTERY DEVELOPMENT,0.02068,0.061505,0.2173,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.54903,0.061312,0.018493,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.50896,0.061298,0.051389,0,0
1,GO EPITHELIUM DEVELOPMENT,0.17934,0.060936,0.047967,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0097392,0.060909,0.12475,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.12908,0.060884,0.082691,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.10096,0.0607,0.050495,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.57857,0.060692,0.030436,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.35153,0.060584,0.091749,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.16294,0.060474,0.19003,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.11841,0.060463,0.14668,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.35607,0.060444,0.029641,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.65866,0.06035,0.010757,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.25363,0.059764,0.13222,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.67137,0.059643,0.050826,0,0
1,GO PANCREATIC JUICE SECRETION,0.57857,0.05948,0.065817,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.52594,0.059449,0.026775,0,0
1,GO ION HOMEOSTASIS,0.17934,0.059062,0.037533,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.40843,0.058957,0.034407,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.39858,0.058786,0.036646,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.7495,0.058707,0.0025744,0,0
1,GO REGULATION OF EXCRETION,0.91987,0.05854,0.0070861,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.63978,0.05851,-0.0053909,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.084046,0.058204,0.061145,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.80989,0.057978,-0.021497,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.74288,0.057914,0.031406,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.53167,0.057816,-0.13911,0,0
1,GO RESPIRATORY BURST,0.72313,0.057569,0.0011998,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.30815,0.057302,0.021355,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.15517,0.057223,0.068088,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.90599,0.056063,-0.021834,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.16294,0.055695,0.035008,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.13355,0.055547,0.065566,0,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.075049,0.055534,0.080324,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.24643,0.055352,0.038653,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.69061,0.05526,0.019914,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.32938,0.055073,0.17989,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.19695,0.055,0.054741,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.63978,0.054994,0.04363,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.27999,0.054943,0.1001,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.7495,0.054901,0.031075,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.15773,0.054766,0.081468,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.22568,0.054578,0.040639,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.44402,0.054485,0.033154,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.20621,0.054434,0.12439,0,0
1,GO MUSCLE SYSTEM PROCESS,0.25729,0.054403,0.04636,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.21579,0.054331,0.053808,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.90599,0.054213,0.023918,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.11636,0.054191,0.086215,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.67776,0.054103,0.057803,0,0
1,GO LOCOMOTOR RHYTHM,0.65234,0.054025,0.046342,0,0
1,GO T CELL LINEAGE COMMITMENT,0.26098,0.052976,0.068055,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.36526,0.052544,0.060023,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.41842,0.052543,0.035842,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.84397,0.052478,-0.0070997,0,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.072231,0.052343,0.088751,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.088862,0.052266,0.069732,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.11841,0.052215,0.0631,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.27611,0.052113,0.074099,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.50337,0.05192,0.037235,0,0
1,GO NEGATIVE REGULATION OF GROWTH,0.12473,0.051856,0.05642,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.1313,0.051834,0.061579,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.12689,0.051703,0.063831,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.63354,0.051594,0.019537,0,0
1,GO HISTONE H3 DEACETYLATION,0.32938,0.051391,0.063919,0,0
1,GO POSITIVE REGULATION OF CELL DIVISION,0.47049,0.051367,0.067295,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.2839,0.051331,0.10316,0,0
1,GO REGULATION OF CELL DIVISION,0.33812,0.051171,0.038267,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.11434,0.051148,0.082514,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.23937,0.051116,0.052392,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.29184,0.051051,0.092501,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.23245,0.05094,0.070655,0,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.16294,0.050787,0.02674,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.097379,0.050728,0.061428,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.47588,0.050559,0.057458,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.62732,0.050414,0.060023,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.11235,0.0504,0.055645,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.059411,0.050216,0.065512,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.36991,0.050143,0.091291,0,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.4545,0.050112,0.036711,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.16828,0.050024,0.044365,0,0
1,GO REGULATION OF CELL SHAPE,0.090515,0.050017,0.10213,0,0
1,GO PROTEIN DESTABILIZATION,0.4545,0.04981,0.023951,0,0
1,GO DNA REPLICATION INITIATION,0.72313,0.049697,-0.0069126,0,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.67137,0.049643,0.091249,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.74288,0.049473,0.030579,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.20937,0.049442,0.080159,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.21905,0.049376,0.040427,0,0
1,GO PEPTIDYL THREONINE MODIFICATION,0.24288,0.049332,0.047811,0,0
1,GO CELL MOTILITY,0.073629,0.049224,0.076765,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.22235,0.048978,0.077764,0,0
1,GO ANOIKIS,0.5726,0.048974,0.0503,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.67137,0.048794,0.038577,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.91293,0.048757,-0.025475,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.060602,0.048658,0.10695,0,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.11039,0.048559,0.098757,0,0
1,GO MALE SEX DIFFERENTIATION,0.65234,0.048441,0.017508,0,0
1,GO TRANSCYTOSIS,0.36991,0.048409,0.078743,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.99651,0.048383,-0.00013636,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.41842,0.048339,0.047825,0,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.27999,0.04814,0.079436,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.2839,0.048077,0.053565,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.088862,0.047968,0.039568,0,0
1,GO EPITHELIAL TUBE FORMATION,0.50337,0.047891,0.035929,0,0
1,GO RUFFLE ASSEMBLY,0.40349,0.047816,0.044435,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.20309,0.047639,0.039249,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.088862,0.047637,0.083442,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.30402,0.047564,0.077729,0,0
1,GO REGULATION OF CYTOKINESIS,0.47049,0.047283,0.018723,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.33812,0.047077,0.046375,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.88523,0.047057,0.00096878,0,0
1,GO RESPONSE TO COPPER ION,0.77618,0.04697,0.02506,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.16294,0.04664,0.088805,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.057089,0.046604,0.058523,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.16559,0.046237,0.050783,0,0
1,GO MRNA EXPORT FROM NUCLEUS,0.090515,0.046232,0.060956,0,0
1,GO PRO B CELL DIFFERENTIATION,0.78962,0.045908,-0.035044,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.48131,0.045858,0.060892,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.47049,0.045846,0.045905,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.34702,0.045615,0.060321,0,0
1,GO NEGATIVE CHEMOTAXIS,0.188,0.045497,0.14192,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.11841,0.045444,0.05312,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.84397,0.045369,-0.028468,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.96163,0.045201,-0.0030665,0,0
1,GO TRANSFERRIN TRANSPORT,0.79636,0.045175,-0.0010626,0,0
1,GO MITOCHONDRIAL FISSION,0.29586,0.044935,0.048215,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.69707,0.044651,0.013332,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.5726,0.044629,0.031367,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.54903,0.044512,0.048178,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.79636,0.0444,0.039958,0,0
1,GO CELLULAR HOMEOSTASIS,0.10096,0.04418,0.044569,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.21256,0.044159,0.022807,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.18508,0.044062,0.051579,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.25363,0.043989,0.069372,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.17099,0.043982,0.10274,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.52594,0.043754,0.045968,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.11636,0.043738,0.13464,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.12689,0.043689,0.14184,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.31232,0.04366,0.06129,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.29184,0.043531,0.060339,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.1313,0.043496,0.042931,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.77618,0.043435,0.037402,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.16828,0.043285,0.060478,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.47588,0.043121,0.022603,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.21905,0.043,0.050397,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.42347,0.04277,0.0531,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.26098,0.042622,0.050277,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.55487,0.042468,0.020539,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.90599,0.042384,-0.00028044,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.51459,0.042183,0.02047,0,0
1,GO REGULATION OF CELL SIZE,0.65234,0.042108,0.0071955,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.22568,0.042066,0.034127,0,0
1,GO RESPONSE TO ALCOHOL,0.53742,0.042002,0.019609,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.1313,0.041995,0.21998,0,0
1,GO POSITIVE REGULATION OF CELL SIZE,0.63354,0.041856,0.095407,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.89907,0.041772,-0.0086772,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.32506,0.041551,0.025852,0,0
1,GO NEGATIVE REGULATION OF BINDING,0.16032,0.04134,0.065497,0,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.14285,0.041264,0.11218,0,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.093897,0.040901,0.07284,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.41341,0.040883,0.032442,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.77618,0.040871,0.011621,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.14769,0.040681,0.088557,0,0
1,GO PROTEIN TRIMERIZATION,0.59664,0.040629,0.052557,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.53167,0.040472,0.047087,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.17934,0.040467,0.020826,0,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.093897,0.040393,0.038944,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.4598,0.040373,0.022809,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.16828,0.040313,0.064111,0,0
1,GO REGULATION OF GTPASE ACTIVITY,0.25363,0.040283,0.03492,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.15517,0.040215,0.047269,0,0
1,GO MALE GENITALIA DEVELOPMENT,1,0.040092,-0.022296,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.85082,0.040087,0.027962,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.44402,0.040079,0.0047505,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.65866,0.040058,0.018836,0,0
1,GO ENDOCRINE PROCESS,0.066855,0.039995,0.10289,0,0
1,GO ACTIN FILAMENT BASED PROCESS,0.2,0.039949,0.053625,0,0
1,GO MICROTUBULE NUCLEATION,0.38408,0.039848,0.051961,0,0
1,GO POSITIVE REGULATION OF SIGNALING,0.066855,0.039844,0.054149,0,0
1,GO TUBE FORMATION,0.22568,0.039844,0.058583,0,0
1,GO MRNA METHYLATION,0.63354,0.039841,0.027471,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.61497,0.039831,0.057287,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.24288,0.039747,0.075452,0,0
1,GO B CELL PROLIFERATION,0.90599,0.039737,-0.014099,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.72313,0.039736,-0.0088432,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.43367,0.039603,0.071628,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.80989,0.039554,0.013733,0,0
1,GO DENDRITIC CELL MIGRATION,0.9686,0.039529,0.010452,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.36064,0.0392,0.071859,0,0
1,GO REPRODUCTION,0.14048,0.039184,0.032425,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.16294,0.039071,0.045067,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.20309,0.038978,0.053381,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.66501,0.038977,-0.031101,0,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.18219,0.038318,0.12908,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.65234,0.038298,0.03108,0,0
1,GO METAL ION HOMEOSTASIS,0.23245,0.038153,0.036573,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.63978,0.038113,0.042426,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.36991,0.038082,0.080959,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.4598,0.037627,0.028243,0,0
1,GO MEMBRANE FUSION,0.44402,0.037534,0.020579,0,0
1,GO SKIN DEVELOPMENT,0.52025,0.037221,0.059136,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.46512,0.036966,0.028764,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.52594,0.036842,0.032691,0,0
1,GO ERYTHROCYTE DEVELOPMENT,0.22905,0.036614,0.08235,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.98255,0.036457,0.029875,0,0
1,GO CENTROSOME DUPLICATION,0.78962,0.036272,0.004328,0,0
1,GO SULFATION,0.59059,0.036169,0.052362,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.96163,0.036169,-0.0258,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.78962,0.035562,0.031172,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.23245,0.035552,0.04285,0,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.26098,0.035533,0.038325,0,0
1,GO BIOMINERALIZATION,0.14048,0.035428,0.12156,0,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,0.035321,0.046739,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.23937,0.03527,0.034216,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.44924,0.035223,0.10251,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.54903,0.035127,0.022774,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.37932,0.035091,0.059514,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.62732,0.034685,-0.00049648,0,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.50337,0.034595,0.030248,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.29586,0.03421,0.022318,0,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.12049,0.03392,0.084867,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.76948,0.033795,-0.00071626,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.35607,0.033668,0.10238,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.51459,0.033559,0.066544,0,0
1,GO SPECIFICATION OF SYMMETRY,0.26471,0.033546,0.039967,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.64605,0.033414,0.02696,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.33373,0.033387,0.04946,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.9686,0.033207,0.013955,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.2839,0.033006,0.048915,0,0
1,GO JNK CASCADE,0.15773,0.032793,0.038421,0,0
1,GO NEPHRON DEVELOPMENT,0.17934,0.032651,0.096677,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.52025,0.032148,0.06264,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.54321,0.03173,0.11713,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.57857,0.031617,0.022117,0,0
1,GO GLUCOSE IMPORT,0.71658,0.031488,0.005797,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.69707,0.031395,-0.069411,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.070855,0.031338,0.092141,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.24643,0.0312,0.1189,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.53167,0.031014,0.044346,0,0
1,GO PHOSPHATE ION TRANSPORT,0.80312,0.030929,0.012072,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.4598,0.030895,0.020184,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.68418,0.030814,0.013046,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.95466,0.030713,-0.0049192,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.92682,0.030653,0.0033961,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.87144,0.030331,-0.027075,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.53742,0.030157,0.0031553,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.62732,0.030023,0.025107,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.80312,0.029976,0.028291,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.188,0.029968,0.092584,0,0
1,GO PROSTAGLANDIN SECRETION,0.26471,0.029937,0.087974,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.80312,0.029717,0.00038657,0,0
1,GO APPENDAGE DEVELOPMENT,0.64605,0.029515,0.027199,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.88523,0.029486,-0.0081766,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.48678,0.029442,0.050947,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.62113,0.029399,0.032045,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.79636,0.029383,0.0080157,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.42347,0.029363,0.02422,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.22905,0.029231,0.085373,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.2,0.029192,0.10233,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.16294,0.029191,0.15497,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.40349,0.029166,0.027602,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.87833,0.029123,-0.0039705,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.62113,0.029074,0.0065472,0,0
1,GO NUCLEAR MIGRATION,0.93377,0.029066,0.0193,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.56666,0.029055,0.028493,0,0
1,GO LACTATE METABOLIC PROCESS,0.71006,0.029039,0.021059,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.85768,0.028968,0.009252,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.15264,0.028455,0.059269,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.27999,0.028427,0.084526,0,0
1,GO SECONDARY METABOLIC PROCESS,0.37932,0.028233,0.088464,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.39858,0.028218,0.062465,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.75615,0.028199,0.015488,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.2839,0.028118,0.038014,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.5726,0.028081,0.040894,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.96163,0.027909,-0.007202,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.17653,0.02784,0.039674,0,0
1,GO MRNA MODIFICATION,0.60883,0.027591,0.048024,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.21579,0.027561,0.10468,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.092194,0.027504,0.062475,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.65866,0.027445,0.025561,0,0
1,GO GLYCOSYLATION,0.66501,0.027161,-0.017612,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.67776,0.026986,0.0021563,0,0
1,GO MUSCLE ATROPHY,0.81668,0.026889,0.010289,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.79636,0.026854,-0.010616,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.56075,0.026671,0.021153,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.24643,0.026669,0.075157,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.91293,0.026561,0.028732,0,0
1,GO PROTEIN POLYMERIZATION,0.69707,0.026431,0.010821,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.41341,0.026336,0.049556,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.51459,0.026251,0.050825,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.95466,0.026228,0.00051608,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.54903,0.026094,0.070201,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.5726,0.025977,0.022893,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.65866,0.025665,0.031113,0,0
1,GO MISMATCH REPAIR,0.59664,0.02548,0.022011,0,0
1,GO OSTEOBLAST PROLIFERATION,0.36064,0.025463,0.12033,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.41842,0.025365,0.033898,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.71006,0.025247,0.017043,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.69707,0.02516,0.029632,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.47049,0.024882,0.064223,0,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.20621,0.024806,0.071579,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.44402,0.02478,0.095833,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.18508,0.024521,0.031654,0,0
1,GO CARBOHYDRATE TRANSPORT,0.44402,0.024384,0.013623,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.89215,0.024289,0.012713,0,0
1,GO EMBRYO DEVELOPMENT,0.21256,0.024158,0.041676,0,0
1,GO RESPONSE TO ACTIVITY,0.75615,0.024097,-0.0009328,0,0
1,GO QUINONE METABOLIC PROCESS,0.37932,0.024087,0.12475,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.97557,0.024042,-0.011561,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.41842,0.024001,0.052189,0,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.4545,0.023919,0.087825,0,0
1,GO RRNA CATABOLIC PROCESS,0.92682,0.023731,-0.024331,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.32077,0.023686,0.087784,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.46512,0.023612,0.049071,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.80312,0.023568,0.054916,0,0
1,GO NADH METABOLIC PROCESS,0.43367,0.02353,0.061303,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.29586,0.02337,0.029056,0,0
1,GO SINGLE FERTILIZATION,0.71658,0.023287,0.011654,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.48131,0.023176,0.054136,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.94769,0.023166,-0.0057817,0,0
1,GO B CELL DIFFERENTIATION,0.21256,0.022996,0.056474,0,0
1,GO COCHLEA MORPHOGENESIS,0.73628,0.022887,-0.0077795,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.48678,0.022786,0.02025,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.97557,0.022703,-0.0089605,0,0
1,GO RNA SPLICING,0.63978,0.022592,0.0080401,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.31232,0.022578,0.020867,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.33812,0.022432,0.012723,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.2839,0.022266,0.16389,0,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.98953,0.022174,0.009897,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.42855,0.022096,0.018538,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.64605,0.021988,0.036277,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.94769,0.021965,-0.0070756,0,0
1,GO DRUG CATABOLIC PROCESS,0.53167,0.02181,0.023337,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.76281,0.021805,-0.048653,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.88523,0.021674,-0.023005,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.62732,0.021378,0.01093,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.26098,0.021075,0.051794,0,0
1,GO MICROTUBULE ANCHORING,0.79636,0.020879,0.019314,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.87833,0.02076,0.0080166,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.21579,0.020438,0.068427,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.96163,0.020045,-0.0025561,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.67137,0.020039,0.014515,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.85768,0.01985,0.023608,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.69707,0.019845,0.012791,0,0
1,GO FUCOSE METABOLIC PROCESS,0.8303,0.019839,-0.0091742,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.71006,0.019178,0.020978,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,1,0.01895,0.002283,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.75615,0.018942,0.0025485,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.70355,0.01894,0.0093497,0,0
1,GO CYTOKINE SECRETION,0.77618,0.018768,0.021293,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.90599,0.018667,-0.00060193,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.69061,0.018625,0.0089437,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.56075,0.018377,0.070444,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.65866,0.01826,0.015314,0,0
1,GO ADULT HEART DEVELOPMENT,1,0.01822,-0.030107,0,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.39371,0.018188,0.031697,0,0
1,GO MUSCLE CONTRACTION,0.35153,0.018108,0.042246,0,0
1,GO HEART TRABECULA FORMATION,0.4978,0.017976,0.15709,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.82348,0.017843,0.0042177,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.26098,0.01762,0.10238,0,0
1,GO SISTER CHROMATID SEGREGATION,0.86455,0.017576,0.0031783,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.71006,0.017512,-0.0042411,0,0
1,GO GLAND DEVELOPMENT,0.42347,0.017313,0.035329,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.32506,0.017298,0.034547,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.9686,0.017255,-0.017783,0,0
1,GO ENDOSOMAL TRANSPORT,0.38408,0.017127,0.026196,0,0
1,GO REGULATION OF HAIR CYCLE,0.68418,0.016897,0.070304,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.91987,0.016864,-0.025242,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.92682,0.016669,-0.018206,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.76948,0.016368,0.006801,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.33373,0.016366,0.094388,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.21579,0.016291,0.13833,0,0
1,GO MRNA PROCESSING,0.7495,0.016035,0.0080762,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.41341,0.01603,0.021238,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.73628,0.015984,0.018218,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.50337,0.015852,0.045846,0,0
1,GO HISTONE EXCHANGE,0.92682,0.015696,0.021026,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.68418,0.015654,0.022526,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.81668,0.015617,0.031433,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.32938,0.015389,0.093438,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.38408,0.015227,0.039034,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.94769,0.015178,0.037365,0,0
1,GO PROTEIN SUMOYLATION,0.35607,0.014863,0.038163,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.82348,0.014857,0.0099092,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.62113,0.014734,-0.041802,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.83713,0.014732,0.017984,0,0
1,GO PHOTOPERIODISM,0.93377,0.014614,-0.014044,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.89215,0.014375,-0.0048002,0,0
1,GO SEXUAL REPRODUCTION,0.67776,0.014131,0.0073058,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.40349,0.014047,0.060356,0,0
1,GO METHIONINE METABOLIC PROCESS,0.91987,0.014042,-0.041051,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.64605,0.013635,0.028677,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.44924,0.01359,0.025111,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.88523,0.013572,-0.0055904,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.41842,0.013531,0.051677,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.95466,0.013296,-0.02341,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,1,0.013025,0.014215,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.17653,0.012996,0.042656,0,0
1,GO CELL PROJECTION ASSEMBLY,0.71658,0.012912,0.011372,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.5726,0.012867,0.022698,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.7495,0.01249,0.016509,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.67137,0.012336,0.00012518,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.63354,0.01203,-0.054257,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.44924,0.01199,0.028991,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.22235,0.011988,0.038442,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0119,0.022813,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.94073,0.011855,-0.009708,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.91987,0.011831,0.022795,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.78962,0.011725,-0.041422,0,0
1,GO APPENDAGE MORPHOGENESIS,0.92682,0.011655,-0.0095892,0,0
1,GO DNA CONFORMATION CHANGE,0.92682,0.011452,0.0037278,0,0
1,GO BLASTODERM SEGMENTATION,0.35607,0.011208,0.15433,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.7495,0.011175,0.021803,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.66501,0.011156,0.016649,0,0
1,GO DIVALENT METAL ION EXPORT,0.72313,0.011072,0.024108,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.98255,0.010802,0.0015916,0,0
1,GO CHEMICAL HOMEOSTASIS,0.78289,0.010753,0.0015527,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.91293,0.010629,-0.0073568,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.63978,0.010615,0.068215,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.20309,0.010349,0.15004,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.98255,0.010101,-0.01387,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.93377,0.010018,0.0090231,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.83713,0.009984,-0.042315,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.95466,0.00965,0.013734,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.60272,0.009575,0.012416,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.53167,0.0094272,-0.033408,0,0
1,GO CYTOSKELETON ORGANIZATION,0.4978,0.009311,0.024263,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.49227,0.0089747,0.049409,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.91987,0.0089561,0.01163,0,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.62732,0.0086611,0.022237,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.18508,0.0086104,0.053825,0,0
1,GO ARTERY MORPHOGENESIS,0.66501,0.0085965,0.12949,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,1,0.0085898,-0.0044389,0,0
1,GO NAD METABOLIC PROCESS,0.34256,0.0085115,0.086127,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.8303,0.0083418,0.011199,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.43367,0.0083347,-0.061534,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.80989,0.0082025,-0.0099773,0,0
1,GO ACTIVATED T CELL PROLIFERATION,0.57857,0.0081431,0.03065,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.94073,0.0080999,-0.0017781,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.63354,0.0080108,-0.026566,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.87144,0.0079761,0.002748,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.78289,0.0079322,0.013834,0,0
1,GO DNA REPLICATION,0.53742,0.0078542,0.0062754,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.29992,0.0078275,0.039134,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.80312,0.0074836,0.018588,0,0
1,GO HISTONE H3 ACETYLATION,0.85768,0.007064,0.0034204,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.68418,0.0068882,0.0080354,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,0.0068856,0.034519,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.58456,0.0067313,-0.019335,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.64605,0.0067251,0.023971,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.8303,0.0067018,0.0018566,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.4978,0.0066564,0.033451,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.66501,0.0066156,0.0060862,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.85768,0.0063538,0.035517,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.76281,0.0063455,0.057276,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.92682,0.006109,-0.0034292,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.87144,0.0056284,0.00085354,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.50896,0.0055483,0.050217,0,0
1,GO ZINC ION TRANSPORT,0.46512,0.0053888,0.044436,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.91987,0.0052955,-0.01884,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.50896,0.0052667,0.018458,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.80989,0.0049806,-0.035395,0,0
1,GO REGULATION OF GROWTH,0.33373,0.0047398,0.028186,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.65234,0.0046735,-0.018924,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.68418,0.0044527,0.034292,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.81668,0.0044289,0.014171,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.47588,0.0043921,0.097121,0,0
1,GO MAINTENANCE OF CELL NUMBER,0.58456,0.004237,0.036167,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.65866,0.00371,0.048458,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.88523,0.003638,0.0021152,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.72313,0.0033873,0.018999,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.8303,0.0032863,-0.020467,0,0
1,GO LYMPH NODE DEVELOPMENT,0.70355,0.0032849,0.087394,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.8303,0.0032766,0.015832,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.96163,0.0031032,0.0047769,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.62732,0.0030262,0.062565,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.72313,0.0028631,0.023348,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.90599,0.0027542,-0.011241,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,1,0.0025162,0.014011,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.67137,0.00228,-0.060115,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.72969,0.0020122,0.018914,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.55487,0.0019989,-0.083369,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.8303,0.0019248,-0.034456,0,0
1,GO ACTIN FILAMENT ORGANIZATION,0.47049,0.0018925,0.042326,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.89215,0.0018439,0.0011564,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.55487,0.0017137,0.027779,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1,0.0014288,0.022616,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.40349,0.0013746,0.071681,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,1,0.0013543,0.073888,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.87833,0.0012256,-0.056269,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.85768,0.0011268,0.0012732,0,0
1,GO MYELIN ASSEMBLY,0.72313,0.0008571,0.040872,0,0
1,GO CELL CELL ADHESION,0.48678,0.00075557,0.023761,0,0
1,GO NEPHRON TUBULE FORMATION,0.67137,0.00055891,0.049085,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.3746,0.00051687,0.042356,0,0
1,GO CENTROSOME SEPARATION,0.54321,0.00036474,0.053359,0,0
1,GO GROWTH,0.36064,-0.00016626,0.029127,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.90599,-0.00021799,-0.0058781,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.89907,-0.00023215,-0.0020739,0,0
1,GO EPIDERMIS DEVELOPMENT,0.96163,-0.00029416,0.016506,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.75615,-0.0003035,-0.033027,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.73628,-0.00031436,0.045983,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.71006,-0.00032005,-0.022769,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.67137,-0.00035819,0.041271,0,0
1,GO TAXIS,0.67137,-0.00061046,0.010416,0,0
1,GO RENAL SODIUM EXCRETION,0.65866,-0.00067146,-0.03437,0,0
1,GO PENILE ERECTION,0.91293,-0.00074146,-0.025759,0,0
1,GO REGULATION OF FERTILIZATION,0.74288,-0.00080319,0.0093199,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.60272,-0.00081044,0.051053,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.91987,-0.0010596,-0.022025,0,0
1,GO PRE MIRNA PROCESSING,0.78289,-0.0011086,0.01755,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.93377,-0.001125,0.046201,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.56075,-0.0012078,-0.018911,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.87833,-0.0013098,0.0010891,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.35607,-0.0015287,0.060418,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.60883,-0.0016425,0.066601,0,0
1,GO VIRAL LATENCY,0.98255,-0.0020848,-0.0028111,0,0
1,GO ADAPTIVE THERMOGENESIS,0.93377,-0.0021392,-0.00574,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,-0.0023256,0.072293,0,0
1,GO RESPONSE TO UV B,0.73628,-0.0023844,0.05814,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.59059,-0.0024347,-0.030608,0,0
1,GO HISTONE DEUBIQUITINATION,0.59664,-0.0027848,0.029194,0,0
1,GO RESPONSE TO STARVATION,0.84397,-0.0028254,0.0022218,0,0
1,GO RESPONSE TO BMP,0.39371,-0.0029235,0.054766,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.80312,-0.0029405,0.056498,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.96163,-0.0029491,0.0039517,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.87144,-0.0030064,-0.025886,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.60883,-0.003387,0.033092,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.98953,-0.0034284,-0.0096446,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.72313,-0.0034598,-0.027278,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.86455,-0.0035244,0.00063186,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.85768,-0.0035252,0.0060179,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.43883,-0.0035747,-0.08755,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.84397,-0.0040489,0.013079,0,0
1,GO RETINA HOMEOSTASIS,0.83713,-0.0040532,0.018812,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.96163,-0.0040781,-0.0048882,0,0
1,GO ENDOCYTIC RECYCLING,0.98953,-0.004168,-0.0065994,0,0
1,GO RESPONSE TO WATER,0.93377,-0.004231,0.029448,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.62113,-0.0044206,-0.031489,0,0
1,GO MIDBRAIN DEVELOPMENT,0.62732,-0.0046353,0.020638,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.82348,-0.0046696,-0.043141,0,0
1,GO ORGAN INDUCTION,0.71658,-0.0048771,0.044222,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.9686,-0.0049403,0.0072519,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.94769,-0.0049642,-0.0059642,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.80312,-0.005098,0.021915,0,0
1,GO RECOMBINATIONAL REPAIR,0.85082,-0.0054466,-0.0023439,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.57857,-0.0055463,-0.02692,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.43883,-0.0056576,-0.031293,0,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.42347,-0.0058853,0.03602,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.95466,-0.0059212,0.083498,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.89215,-0.0060474,0.0041913,0,0
1,GO RESPONSE TO COLD,0.52025,-0.0061696,-0.071392,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.98255,-0.0064268,-0.0060927,0,0
1,GO GAMETE GENERATION,0.8303,-0.0064943,0.0063158,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.66501,-0.0065039,-0.016292,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.5726,-0.0065337,-0.043391,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98255,-0.0065943,-0.046594,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.97557,-0.0068255,0.012299,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.79636,-0.0071016,-0.035374,0,0
1,GO RESPONSE TO GLUCAGON,0.88523,-0.0073071,-0.01173,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.85082,-0.0074621,-0.0066157,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.74288,-0.0077819,-0.02942,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.66501,-0.0077865,0.030839,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.89907,-0.0078124,-0.0059955,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.59059,-0.0078185,0.063139,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.98953,-0.0078851,-0.0007146,0,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.90599,-0.0081334,0.017158,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.30402,-0.00823,-0.041968,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.83713,-0.0082839,-0.01128,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.91987,-0.0083239,-0.0013288,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.71006,-0.0085413,-0.00037165,0,0
1,GO PRENYLATION,0.98255,-0.0085747,0.032267,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.73628,-0.0086346,-0.056878,0,0
1,GO CELL RECOGNITION,0.53742,-0.0086487,-0.030391,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.37932,-0.0087254,-0.1192,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.71658,-0.0088543,-0.031614,0,0
1,GO RESPONSE TO LEAD ION,0.60272,-0.0088741,0.049249,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.89907,-0.0088847,-0.0090249,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.59059,-0.0088944,-0.043545,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.85768,-0.0089133,0.061239,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.87144,-0.0091939,-0.012244,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.31653,-0.0093122,0.14972,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.66501,-0.00932,-0.021251,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.50337,-0.0094236,-0.068853,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.88523,-0.0094576,-0.013702,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.82348,-0.0094784,-0.018048,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.48131,-0.0099767,0.048613,0,0
1,GO REGULATION OF CELLULAR PH,0.83713,-0.0099831,-0.014517,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.54321,-0.010368,0.03842,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.85082,-0.010522,-0.0015101,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.89907,-0.010637,-0.0066217,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.89907,-0.010708,0.020688,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.80989,-0.010858,0.007042,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.47588,-0.010869,-0.10461,0,0
1,GO PROSTATE GLAND GROWTH,0.85768,-0.010952,0.057194,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.87833,-0.011327,-0.00031415,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.87144,-0.011351,0.028376,0,0
1,GO METHYLATION,0.67776,-0.011373,-0.0089762,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.99651,-0.011482,-0.0037029,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.86455,-0.011534,-0.019872,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.60883,-0.011572,0.10918,0,0
1,GO RESPONSE TO FATTY ACID,0.88523,-0.011587,0.032783,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.91987,-0.011666,-0.0097484,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.67776,-0.01181,-0.026114,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.96163,-0.012084,0.027996,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.44924,-0.01214,-0.022515,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.51459,-0.012194,-0.034025,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.14048,-0.012303,-0.083172,0,0
1,GO DNA REPLICATION CHECKPOINT,0.80989,-0.012489,-0.036428,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.27999,-0.012497,-0.13033,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.38888,-0.012553,-0.067822,0,0
1,GO HISTAMINE TRANSPORT,0.83713,-0.012581,-0.056156,0,0
1,GO RESPONSE TO AXON INJURY,0.71658,-0.012632,-0.028215,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.4978,-0.012711,-0.02791,0,0
1,GO ACTIN NUCLEATION,0.67137,-0.012729,-0.044057,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.76281,-0.012809,0.011401,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.4978,-0.012918,-0.027267,0,0
1,GO BONE CELL DEVELOPMENT,0.94769,-0.013057,-0.0042082,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.78962,-0.013122,-0.016422,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.61497,-0.013136,0.048455,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.61497,-0.013238,-0.022013,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.91987,-0.013287,0.0075592,0,0
1,GO THYROID GLAND DEVELOPMENT,0.74288,-0.013331,-0.026163,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.71658,-0.013529,-0.023665,0,0
1,GO INORGANIC ANION TRANSPORT,0.89215,-0.013969,-0.0018821,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.78289,-0.01406,-0.006061,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.7495,-0.014218,-0.032008,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.4598,-0.014259,-0.061828,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.76948,-0.014288,0.024798,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.74288,-0.014297,0.058981,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.57857,-0.014298,0.059692,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.35607,-0.014354,-0.13056,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.36991,-0.014565,-0.16748,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.82348,-0.014569,-0.025396,0,0
1,GO CYTOSOLIC TRANSPORT,0.66501,-0.014764,0.023519,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.84397,-0.014805,-0.0092016,0,0
1,GO REGULATION OF RNA SPLICING,0.24288,-0.014811,-0.060814,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.85082,-0.014816,0.0061555,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.81668,-0.014996,-0.0032645,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.88523,-0.015148,-0.0090053,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.47049,-0.015204,-0.02529,0,0
1,GO LIPID PHOSPHORYLATION,0.36526,-0.015309,-0.039908,0,0
1,GO ORGANIC ANION TRANSPORT,0.72969,-0.015604,-0.010879,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.53167,-0.015642,-0.058532,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.61497,-0.015725,-0.012342,0,0
1,GO GMP METABOLIC PROCESS,0.79636,-0.015894,-0.036225,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.87144,-0.015995,-0.001107,0,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.25363,-0.016013,0.1708,0,0
1,GO WATER TRANSPORT,0.81668,-0.01603,-0.0087243,0,0
1,GO SNORNA 3 END PROCESSING,0.80312,-0.016105,-0.011183,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.66501,-0.016193,0.078695,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.99651,-0.016414,0.03046,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.7495,-0.016473,-0.0062126,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.85082,-0.016889,-0.010122,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.87144,-0.016959,-0.0012596,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.63354,-0.017129,-0.026816,0,0
1,GO TOR SIGNALING,0.71658,-0.017162,0.0013925,0,0
1,GO ANION TRANSPORT,0.65866,-0.017597,-0.010504,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.29586,-0.017773,0.090833,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.94073,-0.017978,0.046569,0,0
1,GO MICROVILLUS ORGANIZATION,0.11039,-0.01807,-0.16043,0,0
1,GO EXPLORATION BEHAVIOR,0.30402,-0.018083,-0.11915,0,0
1,GO RENAL ABSORPTION,0.86455,-0.018212,0.035125,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.78289,-0.018305,-0.032527,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.55487,-0.018488,-0.087381,0,0
1,GO DEPHOSPHORYLATION,0.43883,-0.018712,-0.027944,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.70355,-0.018785,-0.012397,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.36064,-0.018818,-0.040173,0,0
1,GO PLASMA MEMBRANE REPAIR,0.69061,-0.018946,-0.050313,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.35607,-0.018979,0.088974,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.50896,-0.018984,0.060912,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.50337,-0.018986,-0.020154,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.93377,-0.019292,0.025897,0,0
1,GO SEX DIFFERENTIATION,0.78962,-0.019303,-0.018036,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.53742,-0.019355,-0.074102,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.13583,-0.019376,-0.092794,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.8303,-0.019382,-0.046306,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.59664,-0.019487,0.033665,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.32077,-0.019599,-0.068139,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.33812,-0.019616,0.085005,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.18219,-0.019903,-0.12096,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.52594,-0.01992,-0.035345,0,0
1,GO MYELOID CELL DEVELOPMENT,0.86455,-0.020031,0.012881,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.8303,-0.02017,-0.0022517,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.9686,-0.020273,0.0066882,0,0
1,GO O GLYCAN PROCESSING,0.27999,-0.0203,-0.10594,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.95466,-0.020312,0.01761,0,0
1,GO TELOMERE CAPPING,0.82348,-0.020676,0.013994,0,0
1,GO CALCIUM ION IMPORT,0.088862,-0.020732,-0.087162,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.76281,-0.021165,-0.031639,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.72313,-0.021174,-0.016236,0,0
1,GO CGMP MEDIATED SIGNALING,0.79636,-0.021307,-0.020671,0,0
1,GO STEROID CATABOLIC PROCESS,0.5726,-0.021345,0.040191,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.64605,-0.021397,-0.0020159,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.077957,-0.021549,-0.067503,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.9686,-0.022162,0.073239,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.73628,-0.02223,0.019684,0,0
1,GO ORGANELLE FUSION,0.95466,-0.022544,-0.0011129,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.36991,-0.022562,-0.093826,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.92682,-0.022634,0.080671,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.35153,-0.022664,-0.11363,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.90599,-0.022777,-0.0069527,0,0
1,GO ER OVERLOAD RESPONSE,0.60272,-0.023044,0.052433,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.44924,-0.023069,-0.043213,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.72969,-0.023284,-0.01546,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.33373,-0.023311,-0.042464,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.59664,-0.023359,0.06007,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.36991,-0.023557,-0.040472,0,0
1,GO HISTONE H3 K27 METHYLATION,0.9686,-0.023692,-0.0076952,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.26847,-0.023704,-0.077103,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.59664,-0.023837,0.050958,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.27999,-0.024096,-0.065902,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.42855,-0.0241,0.076681,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.46512,-0.024342,-0.04602,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.71006,-0.024992,-0.013295,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.89907,-0.025043,0.0020026,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.82348,-0.025231,0.013367,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.7495,-0.025347,-0.0043788,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.99651,-0.025438,-0.0075495,0,0
1,GO PIGMENTATION,0.49227,-0.025498,-0.023626,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.3746,-0.025529,-0.074716,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.53167,-0.025545,0.064409,0,0
1,GO RESPONSE TO ZINC ION,0.86455,-0.025548,-0.018575,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.86455,-0.025755,0.045136,0,0
1,GO ARACHIDONIC ACID SECRETION,0.26471,-0.026078,-0.11695,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.55487,-0.026097,-0.048747,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.93377,-0.026113,-0.025294,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.9686,-0.026114,0.0039628,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.94073,-0.026223,0.028531,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.44924,-0.026303,-0.049957,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.40843,-0.026349,-0.041132,0,0
1,GO CHROMOSOME ORGANIZATION,0.57857,-0.027009,-0.010654,0,0
1,GO MALE GAMETE GENERATION,0.76948,-0.027407,-0.0028045,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.57857,-0.027418,-0.045621,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.31232,-0.027449,-0.076904,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.75615,-0.027853,0.059643,0,0
1,GO DEVELOPMENTAL GROWTH,0.59664,-0.02788,-0.017139,0,0
1,GO MANNOSYLATION,0.7495,-0.027968,0.033025,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.13583,-0.028141,-0.053843,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.79636,-0.02828,0.009669,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.67776,-0.028333,-0.010762,0,0
1,GO BONE MINERALIZATION,0.56666,-0.028439,0.087346,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.54321,-0.0285,-0.017329,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.59059,-0.028794,-0.011117,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.58456,-0.028846,-0.0010429,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.43883,-0.028854,-0.067664,0,0
1,GO PROTEIN NITROSYLATION,0.73628,-0.02903,-0.039379,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.89215,-0.029495,-0.004426,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.32938,-0.029639,-0.18104,0,0
1,GO RESPONSE TO CALCIUM ION,0.60272,-0.029673,-0.030339,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.95466,-0.029707,0.073653,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.4978,-0.02981,-0.029536,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.8303,-0.03001,-0.0023486,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.50896,-0.030069,-0.049094,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.59664,-0.030146,-0.010959,0,0
1,GO HISTAMINE SECRETION,0.8303,-0.030177,-0.043164,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.38408,-0.030509,-0.040236,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.42855,-0.03059,-0.054742,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.88523,-0.030635,0.02889,0,0
1,GO THYMIC T CELL SELECTION,0.43367,-0.030702,-0.014714,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.7495,-0.031508,0.012801,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.21905,-0.031704,-0.055744,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.43367,-0.031799,-0.073021,0,0
1,GO GLIOGENESIS,0.48678,-0.031936,-0.031093,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.7495,-0.031948,0.014655,0,0
1,GO SNORNA METABOLIC PROCESS,0.87144,-0.032256,0.0028673,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.67137,-0.032654,0.0054022,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.33812,-0.032693,-0.15393,0,0
1,GO REGULATION OF PH,0.8303,-0.03273,-0.010867,0,0
1,GO STRESS GRANULE ASSEMBLY,0.26098,-0.032896,-0.060217,0,0
1,GO ORGANELLE LOCALIZATION,0.060602,-0.033062,-0.041464,0,0
1,GO DNA METHYLATION,0.51459,-0.033316,-0.034838,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.46512,-0.033559,-0.042962,0,0
1,GO MICROTUBULE BASED PROCESS,0.17374,-0.033714,-0.044484,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.33373,-0.033976,-0.090604,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.23245,-0.034082,-0.04305,0,0
1,GO OOGENESIS,0.23589,-0.034085,-0.041914,0,0
1,GO BLASTOCYST DEVELOPMENT,0.35607,-0.034196,-0.032225,0,0
1,GO MEIOTIC CELL CYCLE,0.74288,-0.034252,0.0098251,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.43883,-0.034277,-0.070867,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.67776,-0.034433,-0.14083,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.20937,-0.034541,-0.061709,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.69707,-0.034813,-0.0155,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.56666,-0.034859,-0.068143,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.29992,-0.035,-0.069575,0,0
1,GO MOLTING CYCLE,0.82348,-0.035489,0.044915,0,0
1,GO RESPONSE TO METAL ION,0.61497,-0.035558,-0.020318,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.90599,-0.035647,0.017185,0,0
1,GO BONE MATURATION,0.88523,-0.035674,-0.018662,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.78289,-0.035779,0.0090824,0,0
1,GO HISTONE UBIQUITINATION,0.69707,-0.035804,-0.012288,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.71006,-0.036059,-0.042217,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.093897,-0.036151,-0.060353,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.85768,-0.036333,0.00095989,0,0
1,GO ECTODERM DEVELOPMENT,0.72313,-0.036342,-0.013218,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.9686,-0.03643,0.0078716,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.98255,-0.03644,0.008462,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.94073,-0.03666,-0.0025575,0,0
1,GO CELL GROWTH,0.68418,-0.036691,-0.0047824,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.24288,-0.036815,-0.090821,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.65866,-0.037016,-0.015526,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.29184,-0.037401,-0.032695,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.84397,-0.037509,0.022994,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.89215,-0.037535,-0.019024,0,0
1,GO P BODY ASSEMBLY,0.44402,-0.03772,-0.029891,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.53742,-0.037859,-0.020221,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.188,-0.038242,-0.034028,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.75615,-0.038445,0.0023876,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.72969,-0.038644,-0.034444,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.39371,-0.038727,-0.058331,0,0
1,GO REGULATION OF MRNA PROCESSING,0.26098,-0.039238,-0.054416,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.67137,-0.039276,-0.019631,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.90599,-0.039457,0.023972,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.29992,-0.039592,-0.061638,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.039735,0.017719,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.37932,-0.039826,-0.066257,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.18219,-0.039882,-0.075835,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.27611,-0.039914,-0.087008,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.4545,-0.040137,-0.043345,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.54903,-0.04015,-0.021208,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.3746,-0.040159,-0.042512,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.13814,-0.040306,-0.051433,0,0
1,GO RESPONSE TO POTASSIUM ION,0.2,-0.040722,-0.18378,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.86455,-0.041259,0.052909,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.59059,-0.042022,-0.045021,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.81668,-0.042048,-0.014962,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.98255,-0.042104,0.025931,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.20621,-0.042151,-0.058201,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.78289,-0.042182,0.038211,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.054842,-0.042256,-0.070237,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.91293,-0.042271,-0.002693,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.87144,-0.042494,0.022946,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.54321,-0.04261,-0.017215,0,0
1,GO REGULATION OF AXON GUIDANCE,0.76281,-0.042876,-0.03062,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.51459,-0.042936,-0.0097805,0,0
1,GO REGULATION OF OOGENESIS,0.38408,-0.043009,-0.02873,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.86455,-0.043184,0.016114,0,0
1,GO NODAL SIGNALING PATHWAY,0.73628,-0.043425,-0.02286,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.054842,-0.043489,-0.099141,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.87833,-0.043721,-0.00045691,0,0
1,GO RESPONSE TO SALT,0.82348,-0.043846,-0.053744,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.17374,-0.043973,-0.15513,0,0
1,GO REGULATION OF BONE REMODELING,0.98255,-0.043973,0.00058933,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.12689,-0.04398,-0.14396,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.55487,-0.044052,-0.039849,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.29184,-0.044178,-0.038897,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.92682,-0.044343,-0.004644,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.12473,-0.045065,-0.091779,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.89215,-0.045256,0.0022197,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.98255,-0.045399,0.063602,0,0
1,GO MALE MEIOSIS I,0.56075,-0.045446,-0.064277,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.21579,-0.045488,-0.16336,0,0
1,GO AUTOPHAGIC CELL DEATH,0.80312,-0.045573,0.054053,0,0
1,GO FUCOSYLATION,0.32077,-0.045647,-0.066568,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.31232,-0.046041,-0.056144,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.061812,-0.046196,-0.052067,0,0
1,GO REGULATION OF ANION TRANSPORT,0.064293,-0.046227,-0.097404,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.52025,-0.046362,-0.027815,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.68418,-0.046363,0.13439,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.53167,-0.046434,-0.035348,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.25363,-0.046467,-0.10992,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.78962,-0.046683,-0.0096703,0,0
1,GO SPERM CAPACITATION,0.62732,-0.046736,-0.030759,0,0
1,GO DIET INDUCED THERMOGENESIS,0.21256,-0.047087,-0.11031,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.84397,-0.047103,-0.021318,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.43883,-0.047119,-0.035017,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.62113,-0.047129,0.0041388,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.80989,-0.047212,0.0094585,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.20309,-0.04773,-0.058018,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.28785,-0.047966,-0.1216,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.78962,-0.048229,0.013972,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.048572,0.025481,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.65234,-0.04867,0.0033605,0,0
1,GO LYSOSOME LOCALIZATION,0.1313,-0.049037,-0.059635,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.18219,-0.049848,-0.061594,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.89907,-0.049945,0.006947,0,0
1,GO REGULATION OF ODONTOGENESIS,0.62113,-0.050038,-0.022057,0,0
1,GO ORGANIC ACID TRANSPORT,0.27611,-0.050206,-0.032296,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.0695,-0.050393,-0.080101,0,0
1,GO SEGMENTATION,0.26847,-0.050397,-0.058358,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.36526,-0.050688,-0.10496,0,0
1,GO NEPHRON MORPHOGENESIS,0.4598,-0.050716,-0.019424,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.12908,-0.050834,-0.15436,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.15264,-0.050914,-0.049837,0,0
1,GO SPERM MOTILITY,0.090515,-0.051172,-0.064679,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.43883,-0.051242,-0.11315,0,0
1,GO DRINKING BEHAVIOR,0.21256,-0.051287,-0.11804,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.43883,-0.05164,-0.059484,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.21905,-0.051753,-0.076402,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.78289,-0.052349,0.07195,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.92682,-0.052398,-0.016732,0,0
1,GO MICROTUBULE SEVERING,0.19393,-0.052549,-0.088044,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.67776,-0.052692,-0.00061923,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.32938,-0.052912,-0.051518,0,0
1,GO NEUROBLAST PROLIFERATION,0.188,-0.053249,-0.11909,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.44402,-0.05437,-0.074923,0,0
1,GO EXIT FROM MITOSIS,0.23937,-0.054406,-0.044142,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.60272,-0.054503,-0.011813,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.11434,-0.054912,-0.051373,0,0
1,GO PROTEIN MANNOSYLATION,0.86455,-0.054923,-0.0013646,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.53742,-0.054984,-0.026465,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.21256,-0.05517,-0.067838,0,0
1,GO CELL CYCLE DNA REPLICATION,0.20937,-0.055736,-0.083378,0,0
1,GO RESPONSE TO MONOSACCHARIDE,0.60883,-0.055878,-0.0042486,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.75615,-0.056099,0.060383,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0695,-0.056246,-0.078493,0,0
1,GO LONG TERM MEMORY,0.4545,-0.056364,-0.054922,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.46512,-0.056419,-0.10387,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.24643,-0.056516,-0.038014,0,0
1,GO AXON EXTENSION,0.30402,-0.056545,-0.065636,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.4598,-0.05658,-0.078232,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.38408,-0.057293,-0.059849,0,0
1,GO CILIUM MOVEMENT,0.17099,-0.058044,-0.054382,0,0
1,GO REGULATION OF ACROSOME REACTION,0.78289,-0.05807,-0.026859,0,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.16294,-0.058176,-0.081497,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.48678,-0.058272,-0.080932,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.12908,-0.058366,-0.1185,0,0
1,GO MEMBRANE DOCKING,0.11841,-0.058383,-0.048157,0,0
1,GO B CELL HOMEOSTASIS,0.19695,-0.058544,-0.085159,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.21256,-0.058692,-0.059366,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.60272,-0.05871,-0.026459,0,0
1,GO REGULATION OF TRANSPORT,0.085627,-0.058922,-0.048119,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.35607,-0.058981,-0.075841,0,0
1,GO TRANSMEMBRANE TRANSPORT,0.1028,-0.059289,-0.0491,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.15773,-0.059317,-0.083455,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.54321,-0.059322,-0.026506,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.014138,-0.059344,-0.12604,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.80312,-0.059373,0.010782,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.17099,-0.059451,-0.076364,0,0
1,GO RESPONSE TO INACTIVITY,0.58456,-0.059873,-0.052658,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.97557,-0.060142,0.012804,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.51459,-0.060146,-0.047942,0,0
1,GO GLIAL CELL PROLIFERATION,0.73628,-0.060183,-0.0037145,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.36526,-0.060303,-0.015205,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.10096,-0.060735,-0.11482,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.24643,-0.060786,-0.067205,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.48678,-0.06119,-0.0077441,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.7495,-0.061478,0.051786,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.14769,-0.061809,-0.10007,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.65234,-0.061889,-0.043667,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.34702,-0.061928,-0.049365,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.50896,-0.061996,-0.020329,0,0
1,GO DNA PACKAGING,0.10845,-0.062111,-0.056336,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.21579,-0.062347,-0.076314,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.68418,-0.062455,-0.0294,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.072231,-0.062457,-0.05812,0,0
1,GO HEART VALVE FORMATION,0.77618,-0.062533,-0.010266,0,0
1,GO HISTONE H2A ACETYLATION,0.3746,-0.062817,-0.049698,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.88523,-0.063023,-0.013128,0,0
1,GO T CELL SELECTION,0.19095,-0.063024,-0.041364,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.50896,-0.063364,-0.042734,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.62732,-0.063458,0.003717,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.076492,-0.063666,-0.064671,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.30815,-0.063731,-0.030495,0,0
1,GO GERM CELL DEVELOPMENT,0.073629,-0.063786,-0.053686,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.21905,-0.063895,-0.081746,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.3746,-0.064049,-0.044627,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.27611,-0.064058,-0.1068,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.25729,-0.064315,-0.036857,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.079444,-0.064481,-0.098843,0,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.070855,-0.065133,-0.10464,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.065312,-0.049484,0,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.14526,-0.06542,-0.27563,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.2,-0.065431,-0.080119,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.29992,-0.0657,-0.089519,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.080955,-0.06573,-0.18178,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.23245,-0.065735,-0.074365,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.52594,-0.065788,-0.033144,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.9686,-0.065934,-0.0072689,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.11434,-0.066049,-0.095845,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.31653,-0.06641,-0.092643,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.19095,-0.066925,-0.03865,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.30402,-0.066974,-0.051927,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.084046,-0.067302,-0.23319,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.49227,-0.067534,-0.036899,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.25001,-0.06778,-0.046991,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.15773,-0.067823,-0.040287,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.92682,-0.06795,0.0049486,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.63978,-0.067966,-0.00036374,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.56666,-0.068124,0.0035755,0,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.0013054,-0.06813,-0.10579,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.2839,-0.068178,-0.049359,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.082489,-0.068238,-0.080639,0,0
1,GO REPLICATION FORK PROCESSING,0.33812,-0.068325,-0.020461,0,0
1,GO ZINC ION HOMEOSTASIS,0.61497,-0.068331,-0.055178,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.78289,-0.06841,0.036582,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.69707,-0.068531,-0.017145,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.44402,-0.068858,-0.067477,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.90599,-0.068879,0.002835,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.86455,-0.06895,0.0090039,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.38408,-0.069288,-0.041822,0,0
1,GO RESPONSE TO ETHANOL,0.064293,-0.069333,-0.082563,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.60883,-0.069417,-0.036984,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.62732,-0.06942,-0.032405,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.087232,-0.06971,-0.066739,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.81668,-0.06978,-0.0042387,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.80312,-0.069819,0.018758,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.18508,-0.06983,-0.055574,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.055956,-0.070478,-0.11969,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.15773,-0.071041,-0.070907,0,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31232,-0.071351,-0.037566,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.36526,-0.071582,-0.039972,0,0
1,GO PHAGOSOME MATURATION,0.51459,-0.071674,-0.03556,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.23937,-0.071979,-0.15434,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.85768,-0.072077,0.031795,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.75615,-0.072491,0.027837,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.33812,-0.072584,-0.023982,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.60883,-0.072668,-0.0022632,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.15264,-0.073114,-0.039072,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.070855,-0.073352,-0.1144,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.65866,-0.073401,-0.0041338,0,0
1,GO HISTONE MONOUBIQUITINATION,0.32938,-0.073463,-0.041081,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.20937,-0.073572,-0.042977,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.36526,-0.074143,-0.077225,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.53742,-0.074208,-0.019773,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.63978,-0.074325,-0.037044,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.17653,-0.07445,-0.096987,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.025414,-0.074517,-0.084028,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.16032,-0.074751,-0.071715,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.69707,-0.074826,0.011323,0,0
1,GO CILIUM ORGANIZATION,0.21579,-0.074994,-0.032939,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.68418,-0.07591,-0.049415,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.22568,-0.075925,-0.055476,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.36064,-0.076217,-0.053699,0,0
1,GO CHROMATIN ORGANIZATION,0.0090226,-0.076688,-0.068015,0,0
1,GO POLYOL TRANSPORT,0.33812,-0.076851,-0.048908,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.35607,-0.076877,-0.03884,0,0
1,GO PARTURITION,0.59664,-0.076936,-0.068591,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.48131,-0.077085,-0.026611,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.033166,-0.077396,-0.16728,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.026586,-0.077839,-0.10703,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.10096,-0.077968,-0.087556,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.99651,-0.078124,0.027367,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.082489,-0.078303,-0.089104,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.11434,-0.078871,-0.10285,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.59664,-0.079157,-0.020845,0,0
1,GO REGULATION OF TOR SIGNALING,0.16828,-0.079197,-0.03766,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.27611,-0.079319,-0.11411,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.94769,-0.079533,-0.0053052,0,0
1,GO OOCYTE DIFFERENTIATION,0.041967,-0.079564,-0.083828,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.10654,-0.079828,-0.080615,0,0
1,GO HISTONE H3 K36 METHYLATION,0.10845,-0.080364,-0.11685,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.073629,-0.080368,-0.1068,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.43883,-0.080649,-0.056995,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.22568,-0.080718,-0.10295,0,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.25001,-0.08072,-0.029819,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.080955,-0.080871,-0.057582,0,0
1,GO NUCLEOSOME ASSEMBLY,0.02268,-0.081042,-0.11532,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.40349,-0.081189,-0.074732,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.17934,-0.082078,-0.070115,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.63978,-0.082091,-0.032326,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.62732,-0.082379,-0.042601,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.71006,-0.082398,-0.0017612,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.16032,-0.08245,-0.036056,0,0
1,GO REGULATION OF BEHAVIOR,0.024846,-0.08251,-0.13243,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.17653,-0.0826,-0.094343,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.31232,-0.082799,-0.058256,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.21905,-0.08296,-0.054096,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.15264,-0.083094,-0.045957,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.56075,-0.08354,0.00010221,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.16032,-0.083775,-0.075446,0,0
1,GO CELL JUNCTION ASSEMBLY,0.14048,-0.083981,-0.060255,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.15264,-0.083988,-0.079791,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.17653,-0.084012,-0.074563,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.91293,-0.084349,0.0095449,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.055956,-0.084438,-0.10606,0,0
1,GO RECEPTOR CLUSTERING,0.041093,-0.085227,-0.16627,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.22235,-0.085488,-0.049975,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.054842,-0.085573,-0.075144,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.082489,-0.08625,-0.070467,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.33373,-0.086391,-0.11938,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.092194,-0.086441,-0.070868,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.041967,-0.086559,-0.068562,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.4545,-0.086561,-0.055343,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.22568,-0.08665,-0.14015,0,0
1,GO REGULATION OF DNA METHYLATION,0.1028,-0.086741,-0.10818,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.23937,-0.086787,-0.057447,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.34702,-0.08701,-0.078516,0,0
1,GO PROTEIN ACYLATION,0.00016023,-0.087762,-0.11188,0,0
1,GO MAGNESIUM ION TRANSPORT,0.19393,-0.087865,-0.079751,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.71006,-0.087919,-0.0092698,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.05824,-0.088025,-0.13247,0,0
1,GO TORC1 SIGNALING,0.19095,-0.088256,-0.049892,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.43883,-0.088448,-0.053794,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.25729,-0.089566,-0.099723,0,0
1,GO POSITIVE T CELL SELECTION,0.19393,-0.089576,-0.014392,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.29992,-0.08986,-0.04032,0,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.070855,-0.089891,-0.062727,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.17374,-0.091076,-0.072709,0,0
1,GO SPLEEN DEVELOPMENT,0.44402,-0.091086,-0.02429,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.15015,-0.091414,-0.069389,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.4978,-0.091627,-0.096002,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.09163,-0.11002,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.068167,-0.091637,-0.14318,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.19393,-0.09171,-0.079674,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.13814,-0.091841,-0.067914,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.46512,-0.092128,-0.059741,0,0
1,GO DEMETHYLATION,0.11434,-0.092298,-0.046852,0,0
1,GO EYE MORPHOGENESIS,0.31232,-0.092318,-0.051104,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0075304,-0.092363,-0.094792,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.20937,-0.092502,-0.20826,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.90599,-0.092564,0.0060277,0,0
1,GO HORMONE CATABOLIC PROCESS,0.84397,-0.0929,0.035229,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.13355,-0.092996,-0.085275,0,0
1,GO RENAL SYSTEM PROCESS,0.27999,-0.093631,-0.043372,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.0028957,-0.093755,-0.11221,0,0
1,GO T CELL HOMEOSTASIS,0.011326,-0.094037,-0.13307,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.51459,-0.09437,-0.016205,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.52025,-0.095541,-0.031746,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.5726,-0.095809,-0.016672,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.1313,-0.095932,-0.11632,0,0
1,GO REGULATION OF NEURON MIGRATION,0.10096,-0.096182,-0.1445,0,0
1,GO EXCRETION,0.5726,-0.096233,-0.017917,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.068167,-0.096466,-0.090882,0,0
1,GO BRAIN MORPHOGENESIS,0.035393,-0.096651,-0.13987,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.059411,-0.096957,-0.086371,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.059411,-0.097014,-0.085662,0,0
1,GO MATING,0.049546,-0.097115,-0.084378,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.36526,-0.097366,-0.05346,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.29992,-0.097418,-0.041395,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.18508,-0.097453,-0.050069,0,0
1,GO ANIMAL ORGAN MATURATION,0.85768,-0.097505,-0.0065184,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0695,-0.097832,-0.071059,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.12049,-0.097873,-0.12898,0,0
1,GO ESTROUS CYCLE,0.86455,-0.098024,-0.0073176,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.61497,-0.098339,-0.061532,0,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.088862,-0.099251,-0.11307,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.39858,-0.099369,-0.047589,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.11841,-0.099802,-0.095298,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.34256,-0.099856,-0.062691,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.017137,-0.099969,-0.1013,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.35607,-0.10008,-0.052654,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.05161,-0.10023,-0.10399,0,0
1,GO MITOTIC DNA REPLICATION,0.12689,-0.10061,-0.1182,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.23937,-0.10089,-0.038802,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.12473,-0.10102,-0.10134,0,0
1,GO RHYTHMIC BEHAVIOR,0.076492,-0.10134,-0.1149,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.20621,-0.102,-0.04495,0,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.15773,-0.10251,-0.047798,0,0
1,GO INTRACILIARY TRANSPORT,0.16294,-0.10303,-0.093778,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.58456,-0.10348,-0.059314,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.2,-0.10367,-0.098925,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.52025,-0.10425,-0.0084117,0,0
1,GO HEART INDUCTION,1,-0.10538,0.020369,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.62113,-0.10556,0.0028095,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.29992,-0.10567,-0.034287,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.26847,-0.10589,-0.038395,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.33373,-0.10599,-0.059675,0,0
1,GO DOSAGE COMPENSATION,0.064293,-0.10619,-0.092871,0,0
1,GO MYOFIBRIL ASSEMBLY,0.56075,-0.10655,0.014394,0,0
1,GO ACTIN CROSSLINK FORMATION,0.26098,-0.10658,-0.14445,0,0
1,GO UTERUS DEVELOPMENT,0.082489,-0.1068,-0.17303,0,0
1,GO CHROMATIN DISASSEMBLY,0.23937,-0.10699,-0.10436,0,0
1,GO MESONEPHROS DEVELOPMENT,0.40349,-0.10716,-0.022735,0,0
1,GO HISTONE H2A UBIQUITINATION,0.18219,-0.10736,-0.056195,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.40843,-0.10736,0.0028616,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.15015,-0.10765,-0.084671,0,0
1,GO MEMBRANE REPOLARIZATION,0.12259,-0.10846,-0.10943,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.095625,-0.10871,-0.083443,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.12259,-0.10894,-0.16906,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.47049,-0.10913,-0.044391,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.023741,-0.10952,-0.14095,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.13355,-0.10952,-0.072604,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.19393,-0.10975,-0.069175,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.019739,-0.10977,-0.13499,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.080955,-0.10988,-0.087199,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.17374,-0.11009,-0.072424,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.070855,-0.11025,-0.070965,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.35607,-0.11027,-0.076913,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.12908,-0.11036,-0.10324,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.079444,-0.11053,-0.078186,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.18219,-0.11121,-0.133,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.10096,-0.11152,-0.090896,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.74288,-0.1119,-0.011941,0,0
1,GO MATING BEHAVIOR,0.087232,-0.11207,-0.1102,0,0
1,GO AXIS SPECIFICATION,0.02843,-0.11212,-0.14766,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.12049,-0.11215,-0.13226,0,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.05824,-0.11225,-0.12729,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.36064,-0.11324,-0.053685,0,0
1,GO REGIONALIZATION,0.092194,-0.11325,-0.10419,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.34256,-0.11332,-0.064638,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.14285,-0.11336,-0.090862,0,0
1,GO GLUTAMATE METABOLIC PROCESS,0.37932,-0.1135,-0.051257,0,0
1,GO SOMITE DEVELOPMENT,0.0015653,-0.11386,-0.1569,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.093897,-0.114,-0.18109,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.23937,-0.11435,-0.086702,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.11636,-0.11439,-0.095909,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.12473,-0.11453,-0.087092,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.73628,-0.11458,-0.019102,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.2,-0.11467,-0.12236,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.44924,-0.11516,-0.030143,0,0
1,GO G0 TO G1 TRANSITION,0.017549,-0.11521,-0.11013,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.26471,-0.11564,-0.0863,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0024367,-0.11593,-0.13914,0,0
1,GO SPERMATID DIFFERENTIATION,0.10845,-0.11684,-0.06398,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.010773,-0.11696,-0.15434,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.64605,-0.117,-0.063929,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.79636,-0.1175,-0.016689,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.26098,-0.11756,-0.053855,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.16294,-0.11767,-0.08206,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.066855,-0.11784,-0.14398,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.38888,-0.11804,-0.095076,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.50896,-0.11844,-0.044532,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.090515,-0.11877,-0.11282,0,0
1,GO CHROMATIN SILENCING,0.015574,-0.11955,-0.089026,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.1313,-0.11958,-0.1233,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.35153,-0.11968,-0.059169,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.19695,-0.11979,-0.11144,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.073629,-0.12018,-0.10256,0,0
1,GO DNA STRAND ELONGATION,0.082489,-0.12041,-0.13512,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.16828,-0.12046,-0.084651,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.042857,-0.12068,-0.10899,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.32506,-0.12072,-0.087368,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.15773,-0.1209,-0.060754,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.10845,-0.12097,-0.10501,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.099158,-0.12103,-0.1418,0,0
1,GO RESPONSE TO CAFFEINE,0.60883,-0.12231,-0.030994,0,0
1,GO VESICLE DOCKING,0.0081404,-0.12257,-0.13917,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.03245,-0.12304,-0.0853,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.38408,-0.12319,-0.091369,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.10845,-0.12335,-0.097795,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.092194,-0.12425,0.031822,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.32506,-0.12467,-0.059781,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.13355,-0.12476,-0.052053,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.05161,-0.12521,-0.15136,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00059588,-0.12588,-0.14231,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0056288,-0.12607,-0.1187,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.055956,-0.12616,-0.26321,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.1028,-0.12625,-0.083339,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.32077,-0.12842,-0.067659,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0075304,-0.1288,-0.10009,0,0
1,GO IMPORT INTO CELL,0.11235,-0.12911,-0.077315,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.20937,-0.12913,-0.065517,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.11434,-0.12978,-0.079711,0,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.054842,-0.12992,-0.16789,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.25001,-0.13015,-0.064598,0,0
1,GO DENDRITE SELF AVOIDANCE,0.56666,-0.13042,-0.018959,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.023205,-0.13069,-0.12811,0,0
1,GO FEVER GENERATION,0.20309,-0.13098,-0.018914,0,0
1,GO LIPID EXPORT FROM CELL,0.32938,-0.13106,-0.059969,0,0
1,GO PHOTOTRANSDUCTION,0.0033369,-0.13223,-0.02162,0,0
1,GO SISTER CHROMATID COHESION,0.02843,-0.13245,-0.12053,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.2839,-0.13278,-0.12083,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.12473,-0.13278,-0.2842,0,0
1,GO RESPONSE TO ETHER,0.10096,-0.13289,-0.15042,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.15015,-0.1331,-0.13983,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.98953,-0.13377,0.038058,0,0
1,GO POLYOL CATABOLIC PROCESS,0.010506,-0.13598,-0.14188,0,0
1,GO COLLATERAL SPROUTING,0.16032,-0.13639,-0.083477,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.05161,-0.13645,-0.16722,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.022165,-0.13658,-0.17425,0,0
1,GO BRONCHUS DEVELOPMENT,0.82348,-0.13662,-0.033744,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.023205,-0.13666,-0.18673,0,0
1,GO RESPONSE TO AMINE,0.072231,-0.13686,-0.12502,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.58456,-0.13727,-0.031459,0,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.11841,-0.13827,-0.16823,0,0
1,GO AXO DENDRITIC TRANSPORT,0.0085714,-0.13835,-0.17736,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00079435,-0.13856,-0.16718,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.3746,-0.13964,-0.24636,0,0
1,GO RESPONSE TO VITAMIN D,0.50337,-0.13974,-0.047757,0,0
1,GO KIDNEY MORPHOGENESIS,0.13355,-0.14008,-0.074299,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.10654,-0.14035,-0.1251,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12049,-0.14043,-0.16081,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.33812,-0.14054,-0.07522,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.059411,-0.14056,-0.11806,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.27999,-0.14086,-0.069588,0,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.011612,-0.14154,-0.15621,0,0
1,GO MICROTUBULE POLYMERIZATION,0.0071468,-0.14158,-0.14646,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.0015653,-0.14181,-0.17254,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.12049,-0.14237,-0.094704,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.22235,-0.14365,-0.037032,0,0
1,GO METANEPHROS MORPHOGENESIS,0.18508,-0.14432,-0.11588,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.12049,-0.14533,-0.17623,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.11039,-0.14668,-0.15186,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.27611,-0.14683,-0.084113,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.36526,-0.14684,-0.075133,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.015574,-0.14726,-0.15965,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.084046,-0.14809,-0.09557,0,0
1,GO CONVERGENT EXTENSION,0.17653,-0.14817,-0.13574,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.065563,-0.14839,-0.21464,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.30815,-0.14851,-0.12411,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.16032,-0.14852,-0.074271,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.1028,-0.14868,-0.13997,0,0
1,GO SARCOMERE ORGANIZATION,0.50896,-0.14893,-0.0017895,0,0
1,GO RENAL WATER HOMEOSTASIS,0.019739,-0.14899,-0.11467,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0041716,-0.14911,-0.14513,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.16032,-0.14956,-0.069976,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.038561,-0.15004,-0.13335,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.0017641,-0.15061,-0.15486,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.05824,-0.15073,-0.12632,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0069616,-0.15193,-0.12686,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.047551,-0.15212,-0.18053,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.085627,-0.15251,-0.12455,0,0
1,GO STEROID HORMONE SECRETION,0.13355,-0.15313,-0.12532,0,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.15517,-0.15397,-0.2339,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.068167,-0.15406,-0.10507,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.26847,-0.15526,-0.086148,0,0
1,GO AXONEME ASSEMBLY,0.090515,-0.15541,-0.13011,0,0
1,GO COPULATION,0.31653,-0.15589,-0.080627,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0017123,-0.15599,-0.18415,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.14769,-0.15695,-0.10728,0,0
1,GO DETECTION OF VISIBLE LIGHT,0.001872,-0.15811,-0.043664,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.34702,-0.15815,-0.091802,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.15517,-0.15851,-0.085942,0,0
1,GO AORTA MORPHOGENESIS,0.27227,-0.15855,0.014636,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.099158,-0.15891,-0.077006,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.065563,-0.15911,-0.18624,0,0
1,GO DETECTION OF LIGHT STIMULUS,0.00050664,-0.16027,-0.055504,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.0025817,-0.16034,-0.14881,0,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.040234,-0.16042,-0.2141,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.0090226,-0.16068,-0.16592,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.099158,-0.16118,-0.10789,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.13355,-0.16204,-0.15116,0,0
1,GO HISTONE METHYLATION,0.00069957,-0.16257,-0.14367,0,0
1,GO AXONAL TRANSPORT,0.0037331,-0.1633,-0.20772,0,0
1,GO PROTEIN METHYLATION,0.0013054,-0.16377,-0.14016,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.17653,-0.16429,-0.092386,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.064293,-0.16473,-0.1193,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.03245,-0.16494,-0.14168,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.15773,-0.16522,-0.17032,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0081404,-0.1654,-0.15393,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.28785,-0.16553,-0.062541,0,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00055855,-0.16572,-0.17411,0,0
1,GO RESPONSE TO FOOD,0.00059588,-0.16619,-0.16717,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.35153,-0.16678,-0.051952,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.13814,-0.16838,-0.14083,0,0
1,GO GASTRIC ACID SECRETION,0.2,-0.16948,-0.085248,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.24643,-0.16954,-0.10966,0,0
1,GO INTESTINAL ABSORPTION,0.064293,-0.16999,-0.13472,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0057817,-0.17032,-0.13234,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.090515,-0.1712,-0.085848,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0099891,-0.17137,-0.19278,0,0
1,GO CYTOPLASM ORGANIZATION,0.41842,-0.17158,-0.0634,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.017969,-0.1716,-0.16093,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0094949,-0.17212,-0.16656,0,0
1,GO RESPONSE TO ALKALOID,1.7806e-05,-0.17279,-0.20072,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.16032,-0.17288,-0.12682,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0011549,-0.1737,-0.1983,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.23245,-0.1746,-0.13822,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0695,-0.17538,-0.19176,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.004408,-0.1757,-0.12221,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.13355,-0.17615,-0.13775,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.0010859,-0.17624,-0.16386,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.11841,-0.17634,-0.13109,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.030383,-0.1764,-0.14326,0,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0034322,-0.17666,-0.14572,0,0
1,GO REGULATION OF AXONOGENESIS,0.00035231,-0.17669,-0.21806,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.14285,-0.17672,-0.087735,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.084046,-0.17702,-0.14263,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.082489,-0.17828,-0.11871,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.0013054,-0.17832,-0.19121,0,0
1,GO TOXIN METABOLIC PROCESS,0.077957,-0.17859,-0.20544,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.1028,-0.17891,-0.13902,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00024286,-0.17913,-0.19711,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.11235,-0.17954,-0.13753,0,0
1,GO GDP METABOLIC PROCESS,0.026586,-0.18017,-0.25154,0,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.05824,-0.18053,-0.19954,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.43883,-0.1811,-0.051114,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.036948,-0.18116,-0.12458,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.21256,-0.1813,-0.084054,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.00010092,-0.1816,-0.2027,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.26847,-0.18216,0.0086968,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.80989,-0.18257,0.0027063,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.030383,-0.18287,-0.19782,0,0
1,GO NEURON PROJECTION GUIDANCE,0.0021689,-0.1842,-0.206,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.027188,-0.18425,-0.14941,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.018836,-0.18474,-0.15665,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.016734,-0.18474,-0.1783,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.18508,-0.18485,-0.17758,0,0
1,GO SPERM AXONEME ASSEMBLY,0.10096,-0.18489,-0.12817,0,0
1,GO NEURAL CREST FORMATION,0.11841,-0.18491,-0.14474,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.065563,-0.18524,-0.17738,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.13583,-0.18535,-0.16215,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.075049,-0.18562,-0.13861,0,0
1,GO CELL AGGREGATION,0.1313,-0.18579,-0.10893,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.011904,-0.18612,-0.14699,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.093897,-0.18642,-0.19788,0,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.001986,-0.18644,-0.27706,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.27227,-0.187,-0.09469,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.031059,-0.18705,-0.13872,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.001191,-0.18874,-0.22814,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.14285,-0.18933,-0.12426,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.10465,-0.18976,-0.16755,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.011047,-0.18979,-0.16581,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.18219,-0.19057,-0.15207,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.23245,-0.19095,-0.17019,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.2,-0.19104,-0.11706,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.31653,-0.19187,-0.13083,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0029794,-0.19214,-0.12459,0,0
1,GO RESPONSE TO EPINEPHRINE,0.14526,-0.19225,-0.16011,0,0
1,GO RESPONSE TO FORSKOLIN,0.097379,-0.19247,-0.17013,0,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.057089,-0.19294,-0.13503,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.00034072,-0.19402,-0.16164,0,0
1,GO RELAXATION OF MUSCLE,0.17099,-0.19509,-0.13306,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.0064317,-0.19538,-0.19354,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.059411,-0.19563,-0.13459,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.020205,-0.19663,-0.25101,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0011549,-0.19681,-0.38661,0,0
1,GO HISTONE H3 K9 METHYLATION,0.00014418,-0.19701,-0.20558,0,0
1,GO FORELIMB MORPHOGENESIS,0.092194,-0.1972,-0.12335,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.01282,-0.19798,-0.2207,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.31232,-0.19966,-0.12597,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0037331,-0.19973,-0.21002,0,0
1,GO AXON DEVELOPMENT,0.00026903,-0.2016,-0.22256,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.061812,-0.2034,-0.19061,0,0
1,GO VASCULAR WOUND HEALING,0.15517,-0.20394,-0.17069,0,0
1,GO PALLIUM DEVELOPMENT,0.00022676,-0.20428,-0.21308,0,0
1,GO GLYCINE TRANSPORT,0.16828,-0.20633,-0.12834,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,7.013e-05,-0.20634,-0.23577,0,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,2.3418e-05,-0.20687,-0.23403,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.0038387,-0.20759,-0.22719,0,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00041602,-0.20791,-0.25504,0,0
1,GO POSTSYNAPSE ORGANIZATION,0.00017796,-0.20824,-0.25092,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.013465,-0.20835,-0.24275,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.14769,-0.21029,-0.12004,0,0
1,GO NEURON REMODELING,0.31232,-0.21029,-0.079985,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.188,-0.21107,-0.10069,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.52594,-0.21158,-0.047282,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.59664,-0.21318,-0.11597,0,0
1,GO CORNIFICATION,0.097379,-0.21421,-0.14521,0,0
1,GO CELL PART MORPHOGENESIS,8.1192e-05,-0.21523,-0.22482,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00025131,-0.21531,-0.19548,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0040578,-0.21553,-0.20193,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.00067758,-0.21575,-0.21213,0,0
1,GO NEURON PROJECTION EXTENSION,0.00072223,-0.21912,-0.20674,0,0
1,GO CARDIAC CHAMBER FORMATION,0.14526,-0.22097,-0.31509,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.15264,-0.22149,-0.098816,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.090515,-0.22203,-0.12355,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0094949,-0.22211,-0.22363,0,0
1,GO NEURON DEVELOPMENT,3.3132e-05,-0.22235,-0.21035,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.088862,-0.22245,-0.11798,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00084609,-0.22261,-0.23312,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.0011549,-0.22278,-0.19635,0,0
1,GO MITOCHONDRION LOCALIZATION,0.0069616,-0.22395,-0.22624,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,0.0047853,-0.22496,-0.16308,0,0
1,GO NEURON DIFFERENTIATION,1.2962e-05,-0.22496,-0.21649,0,0
1,GO CELL JUNCTION MAINTENANCE,0.018398,-0.22571,-0.22744,0,0
1,GO RESPONSE TO LIGHT INTENSITY,0.0099891,-0.22968,-0.21706,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,9.0551e-05,-0.23014,-0.23142,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.00030804,-0.2308,-0.24543,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.082489,-0.23124,-0.18239,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.71006,-0.23176,0.043034,0,0
1,GO FOREBRAIN DEVELOPMENT,4.8379e-05,-0.23226,-0.211,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.12049,-0.2356,-0.15749,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0087944,-0.23586,-0.21875,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0099891,-0.23616,-0.27064,0,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0056288,-0.2364,-0.17838,0,0
1,GO HISTONE H4 K16 ACETYLATION,1.2454e-05,-0.23684,-0.30705,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00059588,-0.23742,-0.20941,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.00055855,-0.2382,-0.26804,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.1313,-0.23975,-0.20163,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.00012512,-0.24141,-0.31211,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00032948,-0.24334,-0.25341,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.025994,-0.24418,-0.2621,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0011199,-0.24438,-0.17488,0,0
1,GO SPINAL CORD DEVELOPMENT,8.1192e-05,-0.24452,-0.2833,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.017969,-0.24699,-0.21328,0,0
1,GO PROTEIN DEPOLYMERIZATION,4.6597e-05,-0.24704,-0.23775,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00019079,-0.25098,-0.18372,0,0
1,GO FOREBRAIN CELL MIGRATION,0.0056288,-0.25199,-0.21869,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0026572,-0.25234,-0.29517,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.097379,-0.25261,-0.14495,0,0
1,GO REGULATION OF INSULIN SECRETION,6.5149e-05,-0.25273,-0.24956,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,2.0033e-05,-0.25359,-0.27942,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,8.1192e-05,-0.25368,-0.2253,0,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00021167,-0.254,-0.24512,0,0
1,GO COGNITION,3.0689e-05,-0.25402,-0.21082,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.019283,-0.25406,-0.2185,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00084609,-0.25442,-0.22889,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,6.5149e-05,-0.25483,-0.33314,0,0
1,GO VISUAL BEHAVIOR,6.0504e-05,-0.25617,-0.21283,0,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00021909,-0.25661,-0.28698,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0054795,-0.25798,-0.3225,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.087232,-0.25849,-0.14694,0,0
1,GO SEX DETERMINATION,0.00021167,-0.25923,-0.28551,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.00037661,-0.26053,-0.25945,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,2.8077e-06,-0.26123,-0.32742,0,0
1,GO INSEMINATION,0.11841,-0.26515,-0.14318,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,7.8282e-05,-0.26571,-0.32836,0,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0006154,-0.2692,-0.26925,0,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00049035,-0.26928,-0.27841,0,0
1,GO HEART FORMATION,0.026586,-0.27122,-0.19174,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00014935,-0.273,-0.20413,0,0
1,GO CELL FATE DETERMINATION,0.017137,-0.27301,-0.2163,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,0.0006154,-0.27403,-0.21785,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00050664,-0.27424,-0.22235,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0047853,-0.27505,-0.21388,0,0
1,GO PANCREAS DEVELOPMENT,0.0013457,-0.27529,-0.20216,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,2.1663e-05,-0.27789,-0.29376,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,1.6015e-06,-0.27984,-0.27381,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00049035,-0.27986,-0.2361,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.05161,-0.28037,-0.42805,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.15773,-0.28221,-0.15823,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.066855,-0.28276,-0.35176,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00025131,-0.28278,-0.28,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,5.9841e-06,-0.28381,-0.29483,0,0
1,GO SENSORY PERCEPTION OF PAIN,1.1267e-06,-0.2845,-0.27404,0,0
1,GO SYNAPTIC VESICLE RECYCLING,7.6603e-06,-0.28603,-0.33155,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,6.4994e-06,-0.28664,-0.29611,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.047551,-0.28697,-0.24644,0,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.00054072,-0.28774,-0.24824,0,0
1,GO INSULIN SECRETION,2.3418e-05,-0.28775,-0.26997,0,0
1,GO ACROSOME ASSEMBLY,0.00023468,-0.28782,-0.25559,0,0
1,GO FILOPODIUM ASSEMBLY,4.8379e-05,-0.28913,-0.28654,0,0
1,GO CARTILAGE MORPHOGENESIS,0.075049,-0.29022,-0.21695,0,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.01282,-0.29144,-0.25832,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.0025083,-0.29145,-0.25521,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0018173,-0.29427,-0.24934,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00022676,-0.29967,-0.37065,0,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,1.6455e-05,-0.30185,-0.27266,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00020448,-0.30253,-0.31503,0,0
1,GO RESPONSE TO HYDROXYUREA,0.00017186,-0.30461,-0.29994,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0085714,-0.30524,-0.27341,0,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0001547,-0.30591,-0.30815,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.50896,-0.30838,-0.080244,0,0
1,GO SHORT TERM MEMORY,0.012203,-0.30861,-0.25157,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.095625,-0.31116,-0.15143,0,0
1,GO SYNAPSE ORGANIZATION,1.2454e-05,-0.31157,-0.30009,0,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.00020448,-0.31232,-0.24306,0,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,8.6584e-06,-0.3134,-0.29729,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.2454e-05,-0.31433,-0.32412,0,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,1.349e-05,-0.31434,-0.32154,0,0
1,GO HEAT GENERATION,0.035393,-0.3147,-0.1954,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0057817,-0.31786,-0.3055,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,6.5149e-05,-0.31822,-0.30637,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00090094,-0.31859,-0.35962,0,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,2.7343e-05,-0.32225,-0.30328,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0056288,-0.32338,-0.25219,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.016734,-0.32414,-0.38421,0,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,2.2524e-05,-0.32417,-0.38113,0,0
1,GO CELL FATE SPECIFICATION,2.9532e-05,-0.32505,-0.37441,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.00072223,-0.32525,-0.33926,0,0
1,GO DENDRITE DEVELOPMENT,4.4712e-06,-0.32669,-0.30358,0,0
1,GO HISTONE H4 K5 ACETYLATION,2.7343e-05,-0.32763,-0.31273,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.070855,-0.32961,-0.19811,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.00067758,-0.33331,-0.27945,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0012662,-0.33468,-0.35135,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.01282,-0.33473,-0.28259,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.011326,-0.33586,-0.24133,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.00018427,-0.33657,-0.32185,0,0
1,GO NEUROTRANSMITTER REUPTAKE,0.00042998,-0.33721,-0.31097,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,6.7728e-06,-0.33722,-0.37052,0,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00030804,-0.3375,-0.30128,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,7.0571e-06,-0.33931,-0.40228,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.010506,-0.34055,-0.23995,0,0
1,GO PRESYNAPSE ORGANIZATION,0.00072223,-0.34171,-0.27924,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,2.1702e-06,-0.34314,-0.32243,0,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,3.3287e-06,-0.34377,-0.35558,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00014935,-0.34423,-0.35581,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.040234,-0.34925,-0.3057,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00016595,-0.35125,-0.33105,0,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00045924,-0.35135,-0.36411,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,3.0689e-05,-0.3528,-0.36745,0,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00010092,-0.35324,-0.31367,0,0
1,GO NEURAL RETINA DEVELOPMENT,2.6307e-05,-0.35603,-0.40465,0,0
1,GO METENCEPHALON DEVELOPMENT,1.3441e-06,-0.35615,-0.36905,0,0
1,GO DENDRITE MORPHOGENESIS,4.4712e-06,-0.36036,-0.33615,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,1.1493e-05,-0.36038,-0.35236,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.12049,-0.36109,-0.18593,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00017796,-0.3629,-0.32482,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0081404,-0.36478,-0.26422,0,0
1,GO SYNAPTIC SIGNALING,1.0311e-06,-0.3675,-0.31935,0,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,4.6597e-05,-0.36788,-0.33887,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.0011549,-0.36813,-0.28228,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,2.2658e-06,-0.36838,-0.34435,0,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00017186,-0.36879,-0.30164,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,7.3528e-06,-0.36949,-0.36225,0,0
1,GO DENDRITIC TRANSPORT,0.0015189,-0.36963,-0.35125,0,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00084609,-0.37116,-0.32688,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.4044e-06,-0.37306,-0.36678,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00065623,-0.37339,-0.31387,0,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,5.508e-06,-0.37655,-0.41616,0,0
1,GO WALKING BEHAVIOR,0.00016023,-0.37669,-0.33142,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,9.3916e-06,-0.38337,-0.3442,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.5816e-05,-0.3841,-0.46052,0,0
1,GO FAT CELL PROLIFERATION,0.00016023,-0.38476,-0.37626,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,4.0073e-05,-0.38554,-0.40049,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,7.547e-05,-0.38644,-0.35779,0,0
1,GO GROOMING BEHAVIOR,3.4421e-05,-0.38644,-0.39565,0,0
1,GO REGULATION OF VESICLE FUSION,0.0053338,-0.38645,-0.33673,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.001191,-0.38679,-0.40301,0,0
1,GO NEUROTRANSMITTER UPTAKE,0.00074557,-0.39143,-0.28394,0,0
1,GO PARENTAL BEHAVIOR,0.0006154,-0.39326,-0.3727,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.024288,-0.39639,-0.33527,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00098941,-0.39912,-0.33624,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0067808,-0.40102,-0.30278,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.053746,-0.40124,-0.23467,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0001547,-0.40141,-0.53887,0,0
1,GO RESPONSE TO COCAINE,1.0207e-07,-0.40183,-0.4533,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.076492,-0.40264,-0.22963,0,0
1,GO HEART FIELD SPECIFICATION,0.044685,-0.40383,-0.2358,0,0
1,GO NEURON MIGRATION,1.1493e-05,-0.40478,-0.38822,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0037331,-0.40918,-0.29053,0,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.00030804,-0.41069,-0.54173,0,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00038934,-0.41082,-0.34829,0,0
1,GO RESPONSE TO ACETYLCHOLINE,8.1192e-05,-0.41467,-0.3782,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,1.5331e-06,-0.41481,-0.4292,0,0
1,GO PITUITARY GLAND DEVELOPMENT,1.1964e-05,-0.41687,-0.45213,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,6.5896e-07,-0.41814,-0.42319,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.042857,-0.42028,-0.24959,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00026903,-0.42031,-0.42238,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,3.4728e-06,-0.4208,-0.42265,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.42238,-0.35803,0,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,8.4205e-05,-0.42312,-0.38597,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.00012512,-0.42705,-0.36254,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.6623e-06,-0.42952,-0.4166,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.349e-05,-0.43047,-0.49397,0,0
1,GO SEROTONIN TRANSPORT,1.6015e-06,-0.43436,-0.54684,0,0
1,GO ADULT BEHAVIOR,8.8325e-08,-0.43465,-0.48269,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00012074,-0.43795,-0.37726,0,0
1,GO CATECHOLAMINE UPTAKE,0.00069957,-0.44176,-0.34044,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.017969,-0.44331,-0.27798,0,0
1,GO SYNAPSE ASSEMBLY,3.9926e-07,-0.44959,-0.45876,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,6.5896e-07,-0.45289,-0.42395,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,2.0784e-06,-0.45302,-0.47582,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.018398,-0.45647,-0.44249,0,0
1,GO SEGMENT SPECIFICATION,1.5201e-05,-0.45782,-0.51998,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,1.6455e-05,-0.46072,-0.43757,0,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00047456,-0.46466,-0.38037,0,0
1,GO NEURON RECOGNITION,3.3132e-05,-0.46521,-0.439,0,0
1,GO SOMATIC STEM CELL DIVISION,0.02843,-0.46841,-0.29697,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00010092,-0.47106,-0.36968,0,0
1,GO GLUTAMATE SECRETION,2.6307e-05,-0.47254,-0.40581,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.3441e-06,-0.47778,-0.53314,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,3.5759e-05,-0.47791,-0.43578,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,1.1493e-05,-0.47881,-0.45473,0,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00013433,-0.48121,-0.46405,0,0
1,GO MAST CELL MIGRATION,0.0036303,-0.48999,-0.39773,0,0
1,GO AXONAL FASCICULATION,8.1192e-05,-0.49154,-0.52032,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.00044439,-0.49258,-0.41184,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.00017796,-0.4966,-0.5005,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.3218e-05,-0.50665,-0.56044,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.6455e-05,-0.51129,-0.59537,0,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,7.889e-07,-0.51299,-0.47108,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.0026572,-0.52001,-0.45363,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0054795,-0.5202,-0.36982,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.2862e-06,-0.52845,-0.47204,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,2.0833e-05,-0.53281,-0.48337,0,0
1,GO DENSE CORE GRANULE TRANSPORT,4.2876e-06,-0.53817,-0.91075,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,2.5308e-05,-0.54165,-0.46832,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,3.0689e-05,-0.54227,-0.4679,0,0
1,GO GROWTH HORMONE SECRETION,1.5331e-06,-0.54266,-0.51499,0,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.00017186,-0.54493,-0.49692,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,7.5427e-07,-0.54554,-0.50531,0,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,6.4994e-06,-0.55845,-0.55527,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,3.3287e-06,-0.57226,-0.6711,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,5.508e-06,-0.57289,-0.58593,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,1.0311e-06,-0.57696,-0.52707,0,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,1.5816e-05,-0.58344,-0.59794,0,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.8891e-07,-0.58526,-0.61705,0,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00027832,-0.58553,-0.52139,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,1.4609e-05,-0.58637,-0.57716,0,0
1,GO NEUROTRANSMITTER TRANSPORT,1.2308e-06,-0.60784,-0.51319,0,0
1,GO SPINAL CORD PATTERNING,5.9841e-06,-0.61927,-0.58423,0,0
1,GO CATECHOLAMINE METABOLIC PROCESS,3.3202e-07,-0.62089,-0.55189,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.2524e-05,-0.62132,-0.50048,0,0
1,GO CARDIOBLAST PROLIFERATION,0.0041716,-0.62291,-0.47761,0,0
1,GO REGULATION OF HEAT GENERATION,0.0029794,-0.62961,-0.39766,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.0031536,-0.63039,-0.41795,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.2308e-06,-0.63091,-0.6118,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,2.5122e-07,-0.63093,-0.62574,0,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.0683e-06,-0.64095,-0.49592,0,0
1,GO NEUROTRANSMITTER SECRETION,1.1776e-06,-0.65295,-0.56552,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,2.5774e-06,-0.66092,-0.65946,0,0
1,GO NEURON FATE COMMITMENT,5.4977e-07,-0.68474,-0.7207,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,3.5759e-05,-0.69226,-0.65216,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1904e-06,-0.69841,-0.58479,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,3.5759e-05,-0.70256,-0.62778,0,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,3.4772e-07,-0.72341,-0.67944,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.3441e-06,-0.7295,-0.66599,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.7413e-06,-0.73789,-0.56382,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,3.6414e-07,-0.73801,-0.67874,0,0
1,GO SYNAPTIC VESICLE DOCKING,2.2524e-05,-0.74256,-0.66137,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,6.5149e-05,-0.74826,-0.63845,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.9263e-05,-0.74999,-0.78216,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.6729e-06,-0.75045,-0.65951,0,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.0683e-06,-0.79042,-0.6974,0,0
1,GO SEROTONIN SECRETION,6.6003e-08,-0.79114,-0.71843,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.0689e-05,-0.79211,-0.71365,0,0
1,GO PREPULSE INHIBITION,5.9841e-06,-0.81764,-0.73881,0,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.9904e-06,-0.8381,-0.74228,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,8.3127e-06,-0.84231,-0.78966,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,1.9873e-07,-0.86819,-0.80718,0,0
1,GO VOCALIZATION BEHAVIOR,2.3654e-06,-0.86899,-0.83727,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,2.9532e-05,-0.8758,-0.77607,0,0
1,GO DENDRITE EXTENSION,5.6999e-08,-0.88462,-0.80999,0,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,4.2876e-06,-0.88749,-0.78449,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,2.1831e-07,-0.89506,-0.84149,0,0
1,GO RETINA LAYER FORMATION,5.508e-06,-0.89975,-0.705,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,5.2837e-06,-0.90692,-0.74119,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,1.2454e-05,-0.91301,-0.6782,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,7.2111e-07,-0.92161,-0.92127,0,0
1,GO CATECHOLAMINE SECRETION,8.2505e-07,-0.92713,-0.74508,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.9904e-06,-0.95863,-0.88545,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,1.4674e-06,-0.96241,-0.9021,0,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.7806e-05,-0.99483,-0.84924,0,0
1,GO NEURON FATE SPECIFICATION,2.7578e-07,-1.0126,-0.99553,0,0
1,GO REGULATION OF DOPAMINE SECRETION,3.9926e-07,-1.0539,-0.93866,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.4674e-06,-1.2163,-1.0997,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,7.889e-07,1.2188,0.9552,1,1
2,GO ETHANOL OXIDATION,2.9301e-06,0.97262,0.82318,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00016023,0.96721,0.73654,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,7.8282e-05,0.82445,0.70794,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.6015e-06,0.82265,0.75691,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.1192e-05,0.799,0.54757,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0014738,0.78829,0.58927,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.2879e-07,0.77703,0.70378,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,1.1493e-05,0.764,0.68603,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00034072,0.75365,0.63141,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0027346,0.72299,0.44713,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00034072,0.71623,0.56991,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.4609e-05,0.70935,0.69537,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.007729,0.70136,0.32585,1,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.025414,0.69156,0.74252,1,1
2,GO RESPONSE TO INTERLEUKIN 18,9.7346e-05,0.68969,0.68465,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.8612e-06,0.68144,0.51343,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.6414e-07,0.68021,0.52869,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.4977e-07,0.67989,0.6221,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,4.8612e-06,0.67581,0.64131,1,1
2,GO BIOLOGICAL PHASE,2.1663e-05,0.67252,0.67402,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00027832,0.65953,0.46611,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00020448,0.65356,0.53952,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00087311,0.65048,0.49737,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0021689,0.64671,0.48034,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00041602,0.63924,0.58755,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.389e-05,0.62672,0.52091,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00024286,0.62238,0.48207,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,1.6455e-05,0.61743,0.5325,1,1
2,GO MYOBLAST MIGRATION,0.0037331,0.61589,0.53006,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0025083,0.6153,0.40231,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.3287e-06,0.61141,0.56732,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00067758,0.60615,0.38948,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00055855,0.59988,0.47251,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.4674e-06,0.59842,0.5472,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0027346,0.59403,0.44583,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,0.59147,0.46613,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019079,0.58885,0.54153,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0026572,0.58809,0.44817,1,1
2,GO PROSTATE GLAND GROWTH,1.0604e-05,0.58277,0.62851,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00052342,0.5746,0.4175,1,1
2,GO HAIR FOLLICLE MATURATION,4.2876e-06,0.57317,0.50929,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.7791e-06,0.5727,0.42028,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0226e-05,0.5693,0.54481,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.3218e-05,0.56446,0.57641,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,5.4121e-05,0.5639,0.51084,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0040578,0.56154,0.40596,1,1
2,GO MUCUS SECRETION,0.0015189,0.5613,0.54353,1,1
2,GO ETHER METABOLIC PROCESS,1.1493e-05,0.55969,0.49063,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00055855,0.55842,0.37715,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0010206,0.55619,0.51876,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0087944,0.54879,0.39014,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.00011241,0.54863,0.55457,1,1
2,GO OTIC VESICLE DEVELOPMENT,5.0226e-05,0.54762,0.49616,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.0028957,0.54436,0.38993,1,1
2,GO LYSINE METABOLIC PROCESS,0.00047456,0.54427,0.49105,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.1702e-06,0.53953,0.52154,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0025083,0.539,0.417,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0032441,0.53516,0.40135,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00014935,0.53459,0.46176,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0013054,0.53424,0.38285,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,7.0571e-06,0.53315,0.46472,1,1
2,GO ACTIN FILAMENT SEVERING,0.0067808,0.53247,0.37707,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0030654,0.53143,0.35165,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0024367,0.52756,0.50617,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.906e-06,0.52628,0.49368,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0001547,0.52516,0.43691,1,1
2,GO PROSTANOID METABOLIC PROCESS,3.8583e-05,0.51843,0.45281,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00024286,0.51167,0.45479,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.4044e-06,0.50989,0.45644,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00028792,0.5091,0.38389,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.0226e-05,0.50824,0.40987,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,3.3132e-05,0.50532,0.55247,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,7.547e-05,0.50048,0.46764,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0016129,0.49837,0.42673,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,7.547e-05,0.49801,0.3979,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0057817,0.49763,0.39211,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0013054,0.49496,0.35703,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00041602,0.48942,0.43739,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0016129,0.48346,0.35981,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.015574,0.48307,0.39056,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00044439,0.48059,0.46447,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.4728e-06,0.47901,0.42254,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00030804,0.47764,0.40799,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00050664,0.47722,0.42927,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0049174,0.47674,0.42337,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,8.1192e-05,0.4752,0.43373,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.2962e-05,0.47187,0.43418,1,1
2,GO RESPONSE TO INTERFERON BETA,0.0099891,0.46842,0.35115,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.020205,0.46834,0.2461,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7118e-05,0.46809,0.41513,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2862e-06,0.46665,0.48481,1,1
2,GO NEURAL CREST FORMATION,0.00025131,0.46561,0.36549,1,1
2,GO MUSCLE ATROPHY,0.023741,0.4645,0.3159,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.46238,0.34531,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.046579,0.46191,0.30855,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,7.2754e-05,0.45356,0.33365,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,9.3916e-06,0.45162,0.42813,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0022992,0.45013,0.36154,1,1
2,GO NEPHRON TUBULE FORMATION,0.0027346,0.44818,0.31656,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0010859,0.44741,0.4971,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,3.3132e-05,0.44716,0.41667,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.104e-05,0.44531,0.3719,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00057693,0.44499,0.4096,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.7596e-05,0.44416,0.38692,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.7145e-05,0.44402,0.44577,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.013798,0.44249,0.40489,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001872,0.44144,0.2784,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00044439,0.43886,0.41696,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00010092,0.43707,0.36734,1,1
2,GO DENDRITIC CELL MIGRATION,2.0833e-05,0.43567,0.3916,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0030654,0.43454,0.36715,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0038387,0.43358,0.35544,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00021909,0.43184,0.44266,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00017796,0.43045,0.36444,1,1
2,GO REGULATION OF PROTEIN IMPORT,7.8282e-05,0.42768,0.30988,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0049174,0.42459,0.33675,1,1
2,GO REGULATION OF GLOMERULAR FILTRATION,0.012508,0.42068,0.36337,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,2.3654e-06,0.41888,0.40362,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00035231,0.41597,0.3914,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0045306,0.41386,0.36477,1,1
2,GO ETHANOL METABOLIC PROCESS,1.2454e-05,0.41328,0.49637,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.2524e-05,0.41126,0.32599,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0045306,0.40954,0.36044,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.001986,0.40915,0.33747,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00017186,0.40752,0.45169,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00036427,0.40309,0.33092,1,1
2,GO OXYGEN TRANSPORT,0.017137,0.40266,0.41156,1,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.031059,0.40254,0.42595,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.031748,0.39751,0.26461,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00028792,0.39535,0.3855,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00063551,0.39496,0.38613,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.012203,0.39338,0.27462,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.7806e-05,0.39275,0.35727,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0060989,0.39196,0.34619,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.050569,0.39146,0.18448,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0032441,0.39103,0.35845,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00014935,0.391,0.30692,1,1
2,GO PORE COMPLEX ASSEMBLY,5.0683e-06,0.39017,0.37634,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00024286,0.38945,0.35612,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0032441,0.38886,0.36542,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0050528,0.38886,0.24038,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0085714,0.38851,0.33522,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.001986,0.38839,0.31981,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,2.5308e-05,0.38812,0.33751,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.035393,0.38807,0.22265,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,2.8891e-07,0.38804,0.4015,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00095906,0.38802,0.35929,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.021165,0.38378,0.33778,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00040247,0.38307,0.29639,1,1
2,GO HEME METABOLIC PROCESS,0.00019079,0.38291,0.3461,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.013798,0.38097,0.2391,1,1
2,GO PENTOSE METABOLIC PROCESS,7.2754e-05,0.37984,0.3666,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00025131,0.379,0.32135,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0011549,0.3771,0.33166,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00098941,0.37689,0.34472,1,1
2,GO LIMB BUD FORMATION,0.0025817,0.37637,0.47345,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,4.2876e-06,0.37556,0.34868,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00054072,0.3738,0.32363,1,1
2,GO RESPONSE TO CADMIUM ION,0.0041716,0.37301,0.26983,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00017186,0.37234,0.31354,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0010859,0.37187,0.23635,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,5.9841e-06,0.3715,0.34682,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0034322,0.37143,0.23402,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.001872,0.36948,0.28068,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,7.2754e-05,0.36599,0.30981,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.5759e-05,0.36571,0.30245,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.007729,0.36497,0.25223,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.027188,0.36279,0.2515,1,1
2,GO CYSTEINE METABOLIC PROCESS,0.001872,0.35924,0.35908,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,7.547e-05,0.35899,0.34698,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0054795,0.35869,0.25094,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.8418e-05,0.35784,0.31859,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.001228,0.3574,0.22918,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00019753,0.35727,0.30906,1,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.034637,0.35712,0.28081,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00041602,0.3557,0.31329,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,7.013e-05,0.35549,0.3547,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00017186,0.35413,0.28419,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00016595,0.35355,0.29327,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,7.6603e-06,0.35275,0.38288,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.05161,0.35217,0.2133,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00023468,0.35038,0.32538,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00042998,0.34998,0.26846,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,6.7728e-06,0.3499,0.31293,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0033369,0.34927,0.26525,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00063551,0.34843,0.35516,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00029782,0.34839,0.3119,1,1
2,GO FATTY ACID HOMEOSTASIS,0.014138,0.34829,0.20772,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00052342,0.34769,0.30775,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00019079,0.34747,0.26544,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00022676,0.34744,0.29864,1,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.023741,0.34735,0.27251,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0019282,0.34718,0.37952,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.7728e-06,0.34683,0.3541,1,1
2,GO RETINAL METABOLIC PROCESS,0.035393,0.34646,0.2657,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.017969,0.34269,0.24991,1,1
2,GO PRE MIRNA PROCESSING,0.001872,0.34144,0.22852,1,1
2,GO REGULATION OF DNA METHYLATION,4.6597e-05,0.34129,0.2736,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0011199,0.33906,0.29875,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0039469,0.33816,0.24768,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0007696,0.33813,0.29412,1,1
2,GO TONGUE MORPHOGENESIS,0.0060989,0.33749,0.34097,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.029068,0.33733,0.20486,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0041716,0.33607,0.30784,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.0010528,0.33547,0.32311,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00013433,0.33505,0.4769,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0079323,0.33474,0.24572,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.029068,0.33405,0.20609,1,1
2,GO RNA DECAPPING,3.8583e-05,0.33388,0.23697,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0025083,0.3337,0.44137,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,5.2139e-05,0.33295,0.36286,1,1
2,GO MICROVILLUS ASSEMBLY,0.0019282,0.3326,0.35386,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0022992,0.33239,0.23539,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.024288,0.33166,0.34474,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.0012662,0.33092,0.24905,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,8.6584e-06,0.33032,0.36231,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.001986,0.32972,0.32609,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00017796,0.3288,0.27356,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0081404,0.32827,0.20526,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00067758,0.32825,0.28442,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.00019079,0.3282,0.32944,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00074557,0.32799,0.25551,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.014138,0.32789,0.29309,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00079435,0.32675,0.31189,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0087944,0.32616,0.20662,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.001986,0.32514,0.35791,1,1
2,GO ZINC ION HOMEOSTASIS,0.013798,0.32435,0.32015,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0025817,0.32427,0.21957,1,1
2,GO IMP METABOLIC PROCESS,0.034637,0.3242,0.27509,1,1
2,GO EPIBOLY,0.034637,0.32415,0.18403,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0022992,0.32379,0.22993,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00059588,0.32312,0.25202,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0062634,0.32299,0.25842,1,1
2,GO RETINOL METABOLIC PROCESS,0.00069957,0.32205,0.24299,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.007729,0.3201,0.28802,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0081404,0.3199,0.30841,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00016595,0.31908,0.42139,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0007696,0.31892,0.26076,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0032441,0.31862,0.3256,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.906e-06,0.31751,0.2648,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00052342,0.3174,0.48821,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.5149e-05,0.31702,0.28095,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0028141,0.31633,0.26712,1,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.030383,0.31618,0.20965,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0014299,0.31594,0.27115,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00028792,0.31551,0.28241,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0045306,0.31534,0.19096,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.013798,0.31389,0.23237,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0083534,0.31384,0.29439,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0099891,0.31381,0.28726,1,1
2,GO GAS TRANSPORT,0.0064317,0.31363,0.35374,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0050528,0.31333,0.32658,1,1
2,GO PIGMENT GRANULE MATURATION,0.012203,0.31312,0.25517,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0034322,0.31298,0.38202,1,1
2,GO CARNITINE SHUTTLE,5.6174e-05,0.31298,0.31693,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022332,0.31212,0.25561,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0036303,0.31111,0.21981,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.8418e-05,0.31107,0.251,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0056288,0.31092,0.29792,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0007696,0.3107,0.28635,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0021062,0.31043,0.26669,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00063551,0.30986,0.21016,1,1
2,GO DETOXIFICATION,0.00019079,0.3095,0.26205,1,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.021165,0.30928,0.24237,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0069616,0.3082,0.24922,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,9.7801e-06,0.30811,0.31182,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0032441,0.30795,0.23311,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010845,0.3076,0.28209,1,1
2,GO AMP METABOLIC PROCESS,0.016734,0.30722,0.2298,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00019753,0.30708,0.39671,1,1
2,GO DNA LIGATION,0.0014738,0.30662,0.22878,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0023671,0.30655,0.37875,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0016129,0.30612,0.26385,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0090226,0.30593,0.24352,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00055855,0.30575,0.26379,1,1
2,GO MONONUCLEAR CELL MIGRATION,9.7346e-05,0.3057,0.27038,1,1
2,GO INTERLEUKIN 2 PRODUCTION,3.8583e-05,0.30565,0.2651,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.043763,0.30557,0.18349,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.004408,0.30532,0.29172,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00081984,0.30438,0.22969,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00020448,0.3038,0.31849,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0083534,0.30363,0.18841,1,1
2,GO RESPIRATORY BURST,0.0025083,0.30358,0.237,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00036427,0.30352,0.26929,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0021062,0.30294,0.24919,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0007696,0.30237,0.24679,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0028141,0.30198,0.23833,1,1
2,GO ENTRY INTO HOST,0.0019282,0.30169,0.22172,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.04854,0.30114,0.21181,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,9.7346e-05,0.3008,0.29486,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,7.013e-05,0.30064,0.32568,1,1
2,GO KERATINOCYTE PROLIFERATION,0.02843,0.30059,0.28596,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.04854,0.30058,0.16851,1,1
2,GO FOREGUT MORPHOGENESIS,0.0025817,0.29939,0.34239,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00014418,0.29938,0.33314,1,1
2,GO OVULATION,0.0013872,0.29899,0.25418,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0017641,0.29864,0.28391,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,2.7343e-05,0.29814,0.29384,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.01282,0.29792,0.19036,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00057693,0.29755,0.24186,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0015189,0.29678,0.24938,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00072223,0.29601,0.2591,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0017123,0.29582,0.19052,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001191,0.29556,0.20799,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0013457,0.29527,0.29306,1,1
2,GO NUCLEAR PORE ORGANIZATION,1.4039e-05,0.29527,0.34743,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,5.4121e-05,0.29466,0.25256,1,1
2,GO VIRAL TRANSLATION,0.00012512,0.29435,0.33713,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,3.3202e-07,0.29425,0.27593,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0017123,0.29374,0.26928,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0030654,0.2937,0.27438,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00057693,0.29317,0.31209,1,1
2,GO PODOSOME ASSEMBLY,0.0010528,0.29268,0.27419,1,1
2,GO RESPONSE TO TUMOR CELL,0.0067808,0.29259,0.22318,1,1
2,GO GASTRIC ACID SECRETION,0.001228,0.29234,0.24359,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00049035,0.29142,0.25472,1,1
2,GO MATURATION OF LSU RRNA,0.0013457,0.29137,0.32786,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0038387,0.29041,0.22133,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.012203,0.28901,0.20823,1,1
2,GO RESPONSE TO COPPER ION,0.033894,0.28891,0.27089,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0050528,0.28853,0.2686,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.001228,0.28853,0.22133,1,1
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011904,0.28848,0.22255,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00028792,0.28845,0.28614,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00026903,0.28826,0.26289,1,1
2,GO RIG I SIGNALING PATHWAY,4.0073e-05,0.2881,0.26385,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00065623,0.28801,0.27519,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0015189,0.28773,0.26772,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.00054072,0.2875,0.29619,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.016734,0.28737,0.23287,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.00030804,0.28722,0.23232,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.00025131,0.28659,0.44109,1,1
2,GO BLASTODERM SEGMENTATION,0.019283,0.28649,0.2911,1,1
2,GO FIBROBLAST ACTIVATION,0.00081984,0.28636,0.32039,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00045924,0.28599,0.28621,1,1
2,GO T CELL CHEMOTAXIS,0.00011241,0.28576,0.25846,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.037747,0.28563,0.14697,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00081984,0.28519,0.26861,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.28494,0.26199,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0073363,0.2848,0.21557,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00022676,0.28472,0.21443,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.7343e-05,0.28428,0.28317,1,1
2,GO MATURATION OF 5 8S RRNA,0.00040247,0.28384,0.29683,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00016023,0.28381,0.25682,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0025817,0.28291,0.34626,1,1
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.022165,0.28275,0.37956,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.027803,0.28248,0.18709,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,4.0073e-05,0.28207,0.27596,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0027346,0.28166,0.22208,1,1
2,GO REGULATION OF LIPASE ACTIVITY,5.2139e-05,0.2814,0.22573,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010773,0.2812,0.21009,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00026903,0.28082,0.31561,1,1
2,GO HYPEROSMOTIC RESPONSE,0.00095906,0.28062,0.27633,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.3418e-05,0.28029,0.31852,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0066042,0.28016,0.20091,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.001191,0.2798,0.23862,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.00029782,0.27925,0.22482,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0034322,0.27907,0.17663,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.0011549,0.27896,0.44222,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.27855,0.27879,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0007696,0.27849,0.21344,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00032948,0.27777,0.28294,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0019282,0.27752,0.24763,1,1
2,GO HIPPO SIGNALING,0.0006154,0.27723,0.34983,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,3.1888e-05,0.27718,0.24309,1,1
2,GO CHROMATIN DISASSEMBLY,0.00055855,0.2771,0.22681,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0028957,0.27671,0.21457,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0028141,0.27646,0.18976,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00065623,0.27632,0.25228,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.021165,0.27533,0.19528,1,1
2,GO VIRAL GENE EXPRESSION,0.00054072,0.27526,0.25999,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0019282,0.27515,0.24374,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.001228,0.27447,0.18005,1,1
2,GO ARACHIDONIC ACID SECRETION,7.8282e-05,0.274,0.28469,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00059588,0.27392,0.28376,1,1
2,GO MIRNA METABOLIC PROCESS,3.6228e-06,0.27377,0.23931,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.024288,0.2733,0.26082,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.035393,0.27318,0.23067,1,1
2,GO VESICLE CARGO LOADING,5.6174e-05,0.27306,0.27992,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.033894,0.27298,0.24783,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00041602,0.2726,0.39181,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0028957,0.27225,0.18841,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0013054,0.27208,0.20445,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0011549,0.27153,0.25688,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00095906,0.2714,0.25086,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.014138,0.27083,0.30597,1,1
2,GO REGULATION OF CELL KILLING,0.0060989,0.27078,0.18864,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00017186,0.27047,0.35446,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0012662,0.26947,0.21521,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0099891,0.2692,0.17031,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00055855,0.26874,0.25877,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,9.0551e-05,0.26805,0.24172,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0027346,0.26734,0.24392,1,1
2,GO GTP METABOLIC PROCESS,0.00084609,0.26711,0.28782,1,1
2,GO MRNA MODIFICATION,0.001986,0.26692,0.2032,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.00010092,0.26647,0.25791,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017549,0.26631,0.32264,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00037661,0.26616,0.3567,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00016023,0.26608,0.21856,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.0054795,0.26545,0.20872,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0056288,0.26544,0.31048,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.8418e-05,0.26504,0.24453,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0039469,0.26433,0.26018,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0025083,0.26382,0.25223,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.02166,0.26376,0.19274,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0025817,0.26369,0.21768,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0017123,0.26309,0.23199,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.021165,0.263,0.22577,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.001986,0.26282,0.18957,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00052342,0.26278,0.24923,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00017186,0.26265,0.23069,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0054795,0.26253,0.2678,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,1.6455e-05,0.26201,0.24882,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.0015653,0.26198,0.20012,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00016595,0.26186,0.22582,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0040578,0.26155,0.19656,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00026003,0.26047,0.26666,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0051916,0.2603,0.2011,1,1
2,GO FOREBRAIN MORPHOGENESIS,0.033166,0.25902,0.17177,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00032948,0.25894,0.24645,1,1
2,GO RNA 5 END PROCESSING,0.00054072,0.25877,0.24139,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.00057693,0.25867,0.30394,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0011549,0.25857,0.20856,1,1
2,GO NUCLEAR MIGRATION,0.0032441,0.25854,0.19574,1,1
2,GO LAMELLIPODIUM ORGANIZATION,7.0571e-06,0.25798,0.27198,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0017123,0.25764,0.23167,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0018173,0.25744,0.20467,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.02268,0.25722,0.21145,1,1
2,GO MATURATION OF SSU RRNA,0.00063551,0.25673,0.29897,1,1
2,GO AMINE CATABOLIC PROCESS,0.0039469,0.25667,0.28814,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00017186,0.25637,0.25222,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0067808,0.25616,0.18758,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.043763,0.25595,0.16439,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010773,0.25504,0.31234,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0014299,0.25469,0.29201,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00067758,0.25468,0.25147,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.011326,0.25458,0.16623,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.8418e-05,0.2542,0.27233,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.7118e-05,0.25402,0.24833,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.001228,0.25355,0.22522,1,1
2,GO MICROVILLUS ORGANIZATION,0.010506,0.25289,0.29662,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0034322,0.25283,0.28348,1,1
2,GO HISTONE H3 K9 ACETYLATION,1.1964e-05,0.2527,0.25829,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.041967,0.25241,0.12555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.020205,0.2524,0.21537,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0097392,0.25117,0.25537,1,1
2,GO PLATELET MORPHOGENESIS,0.00010092,0.2509,0.24738,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001872,0.25044,0.24803,1,1
2,GO TRNA METHYLATION,0.00018427,0.25004,0.2326,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,2.7343e-05,0.24997,0.21133,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00049035,0.249,0.21458,1,1
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00045924,0.24878,0.22397,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0050528,0.24796,0.25006,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00072223,0.24791,0.29233,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00084609,0.24754,0.28323,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,0.2471,0.24016,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.041093,0.247,0.21567,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.033894,0.24699,0.21548,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0015189,0.2469,0.20119,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.004408,0.24683,0.17847,1,1
2,GO PEPTIDE CROSS LINKING,0.02166,0.2463,0.19565,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.037747,0.24593,0.30436,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00021909,0.24535,0.22389,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.013139,0.24511,0.21954,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,6.0504e-05,0.24489,0.27913,1,1
2,GO AMINO ACID ACTIVATION,0.00016023,0.2448,0.2837,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00353,0.24479,0.37055,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00090094,0.24478,0.22728,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,7.547e-05,0.24431,0.20645,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.013465,0.24397,0.22501,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.001191,0.24303,0.17099,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.016339,0.24257,0.14627,1,1
2,GO CYTOPLASM ORGANIZATION,0.0016129,0.24231,0.29117,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0011549,0.2422,0.18878,1,1
2,GO NADP METABOLIC PROCESS,0.0047853,0.24197,0.2056,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.01282,0.24172,0.22703,1,1
2,GO LAMELLIPODIUM ASSEMBLY,3.3132e-05,0.24152,0.23922,1,1
2,GO RESPONSE TO X RAY,0.00024286,0.24149,0.32402,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.02068,0.24086,0.17471,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.2401,0.22733,1,1
2,GO HISTONE H4 DEACETYLATION,0.00050664,0.2399,0.29464,1,1
2,GO ERYTHROCYTE MATURATION,0.0045306,0.2397,0.30878,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.00090094,0.23959,0.18272,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00092958,0.23909,0.23647,1,1
2,GO CHONDROCYTE PROLIFERATION,0.013139,0.23834,0.3206,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.036948,0.2383,0.17781,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.0037331,0.23817,0.23767,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00020448,0.23789,0.22389,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0017123,0.23779,0.23085,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00021167,0.23774,0.2392,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0028141,0.23771,0.20837,1,1
2,GO PROTEASOME ASSEMBLY,0.0054795,0.23755,0.169,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0021689,0.23742,0.21593,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0024367,0.23698,0.18731,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0006154,0.23666,0.24345,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.0007696,0.23604,0.227,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00013917,0.23598,0.20923,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,4.8379e-05,0.23583,0.20121,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0019282,0.23438,0.21695,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.024288,0.23399,0.24526,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0032441,0.23371,0.23687,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.031059,0.23369,0.18083,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0056288,0.23315,0.20294,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.00042998,0.2324,0.1869,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.027188,0.232,0.22664,1,1
2,GO RESPONSE TO MANGANESE ION,0.0013872,0.23176,0.22346,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00037661,0.23138,0.19719,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,6.0504e-05,0.23121,0.20817,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00098941,0.23059,0.21719,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.009256,0.23053,0.29304,1,1
2,GO RNA STABILIZATION,0.00044439,0.23037,0.16942,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00057693,0.22963,0.21305,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,1.0604e-05,0.22963,0.20316,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0028141,0.22959,0.23036,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00055855,0.22916,0.2428,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.011326,0.22907,0.19088,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0056288,0.22855,0.13906,1,1
2,GO ZYMOGEN INHIBITION,0.024288,0.22834,0.21583,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00087311,0.22811,0.15602,1,1
2,GO PEPTIDYL PROLINE MODIFICATION,0.0016129,0.22811,0.17565,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00022676,0.22791,0.28044,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.016734,0.22789,0.18534,1,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.02268,0.22781,0.17166,1,1
2,GO REGULATION OF HAIR CYCLE,0.001872,0.22735,0.25656,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.024288,0.22724,0.20338,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0045306,0.22699,0.1506,1,1
2,GO THYMUS DEVELOPMENT,0.00019753,0.22665,0.2155,1,1
2,GO PIGMENT METABOLIC PROCESS,0.0015653,0.22658,0.20479,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.001191,0.22652,0.17774,1,1
2,GO SECRETION BY TISSUE,0.0024367,0.22636,0.22809,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.038561,0.2261,0.14064,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00035231,0.22558,0.23081,1,1
2,GO RIBOSOME BIOGENESIS,0.00016595,0.22553,0.26312,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001872,0.22512,0.16017,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.22422,0.20102,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.010245,0.22405,0.18815,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0010206,0.22342,0.23372,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.049546,0.22297,0.12435,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001662,0.22269,0.16027,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0049174,0.22256,0.21257,1,1
2,GO NUCLEUS LOCALIZATION,0.00079435,0.22255,0.1868,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.010773,0.22243,0.19285,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0022332,0.22167,0.19115,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00079435,0.22102,0.23142,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.2454e-05,0.22099,0.22174,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00040247,0.22049,0.21836,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0014299,0.21939,0.26816,1,1
2,GO MAINTENANCE OF CELL NUMBER,2.6307e-05,0.21917,0.21794,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,7.8282e-05,0.21882,0.18569,1,1
2,GO ENAMEL MINERALIZATION,0.033166,0.21831,0.30052,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0038387,0.2183,0.23292,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.21796,0.18633,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.0028957,0.2176,0.18385,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.00081984,0.2173,0.24259,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.027188,0.21718,0.23403,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00049035,0.21673,0.19453,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00041602,0.21655,0.15771,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.019739,0.21655,0.20314,1,1
2,GO REGULATION OF NEURON MATURATION,0.04854,0.21638,0.20985,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00021167,0.21578,0.24325,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.016339,0.21563,0.18642,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00036427,0.21554,0.23995,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00041602,0.21534,0.22117,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0085714,0.21529,0.22025,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0015189,0.21507,0.15272,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0022992,0.21502,0.20257,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0064317,0.21476,0.17098,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0040578,0.21452,0.15301,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0023671,0.21432,0.1737,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.023741,0.21428,0.15194,1,1
2,GO B CELL HOMEOSTASIS,0.018836,0.21403,0.12761,1,1
2,GO INTESTINAL ABSORPTION,0.015574,0.2139,0.161,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.016339,0.21382,0.17499,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0013457,0.21381,0.18279,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,2.3418e-05,0.21369,0.19953,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00049035,0.2133,0.218,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00026903,0.21311,0.18568,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00024286,0.21304,0.22839,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00092958,0.2129,0.17685,1,1
2,GO LIPID OXIDATION,0.0042883,0.21207,0.1526,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0087944,0.21191,0.20875,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0010528,0.21185,0.20067,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0001547,0.21182,0.22917,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0057817,0.2118,0.19447,1,1
2,GO B CELL APOPTOTIC PROCESS,0.016339,0.21164,0.13949,1,1
2,GO INTERACTION WITH HOST,0.0010206,0.21138,0.18325,1,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047551,0.21123,0.13068,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0011549,0.21117,0.32387,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.0184e-05,0.21036,0.20298,1,1
2,GO RNA POLYADENYLATION,0.00031859,0.21025,0.16167,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00069957,0.21022,0.19874,1,1
2,GO RRNA TRANSCRIPTION,0.00047456,0.21018,0.23609,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.033166,0.21012,0.178,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0028957,0.20965,0.15391,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.027803,0.20962,0.21634,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012662,0.20928,0.2034,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.012203,0.2092,0.17019,1,1
2,GO REGULATION OF CELL MATURATION,0.016339,0.20845,0.15292,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00040247,0.2083,0.16718,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.036164,0.20821,0.13773,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.018398,0.20819,0.13833,1,1
2,GO PIGMENT ACCUMULATION,0.0042883,0.20811,0.21453,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.1964e-05,0.20772,0.1959,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0006154,0.2075,0.27214,1,1
2,GO RRNA MODIFICATION,0.0022992,0.20725,0.22037,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.00041602,0.20714,0.26655,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0041716,0.20711,0.17516,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.012203,0.20661,0.20024,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0066042,0.20642,0.153,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0032441,0.20625,0.17197,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0097392,0.20598,0.21145,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0032441,0.20555,0.21581,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.022165,0.20545,0.23801,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00020448,0.20513,0.18087,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.013139,0.20513,0.18246,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0062634,0.20473,0.27546,1,1
2,GO GOLGI LOCALIZATION,0.041967,0.20466,0.15169,1,1
2,GO BLASTOCYST FORMATION,0.00028792,0.20426,0.19953,1,1
2,GO NCRNA PROCESSING,0.00021167,0.20423,0.22567,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,1.1493e-05,0.20398,0.2503,1,1
2,GO CORNIFICATION,0.0033369,0.20373,0.26876,1,1
2,GO COPPER ION TRANSPORT,0.0083534,0.2032,0.18904,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.0025083,0.20275,0.16388,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0039469,0.20256,0.21596,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0083534,0.2022,0.17764,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0081404,0.20207,0.20708,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.014841,0.202,0.14098,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.017137,0.20196,0.15114,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0097392,0.2018,0.24301,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00044439,0.2018,0.19348,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00054072,0.20151,0.18924,1,1
2,GO TRNA 5 LEADER REMOVAL,0.00092958,0.20129,0.22494,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.010245,0.20114,0.14867,1,1
2,GO CELL CELL JUNCTION MAINTENANCE,0.0071468,0.20095,0.26426,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.007729,0.20066,0.20563,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.037747,0.20016,0.12294,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0053338,0.2001,0.20011,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.024846,0.19993,0.16812,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0001547,0.19988,0.19481,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0087944,0.19964,0.18318,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.042857,0.19931,0.12085,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,0.19921,0.13185,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.001191,0.19911,0.25754,1,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.023205,0.1984,0.22334,1,1
2,GO RNA DESTABILIZATION,0.0081404,0.19819,0.13718,1,1
2,GO RNA METHYLATION,0.0013872,0.19798,0.15871,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.001872,0.19782,0.18255,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017796,0.1976,0.21277,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0059384,0.19753,0.20271,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.001662,0.19743,0.16348,1,1
2,GO HISTONE DEUBIQUITINATION,8.4205e-05,0.19705,0.18145,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.03939,0.19613,0.12527,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0056288,0.19613,0.20436,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00036427,0.19609,0.16007,1,1
2,GO RESPONSE TO SALT STRESS,0.017549,0.19588,0.20532,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0064317,0.19572,0.156,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0053338,0.19557,0.25304,1,1
2,GO FATTY ACID BETA OXIDATION,0.016339,0.19511,0.11874,1,1
2,GO RRNA METABOLIC PROCESS,0.00017796,0.1949,0.2428,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,2.8418e-05,0.19463,0.22081,1,1
2,GO REGULATION OF GENE SILENCING,7.3528e-06,0.19462,0.19869,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.011904,0.19456,0.13933,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011612,0.19441,0.16649,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.029719,0.19381,0.17445,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.012508,0.19358,0.15932,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.0034322,0.19339,0.19301,1,1
2,GO PINOCYTOSIS,0.0032441,0.19334,0.14961,1,1
2,GO TRANSLATIONAL TERMINATION,0.0020453,0.19306,0.21297,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00084609,0.19286,0.19104,1,1
2,GO POSITIVE REGULATION OF CELL AGING,0.036948,0.19285,0.13854,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.026586,0.19272,0.14154,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.0067808,0.19259,0.20547,1,1
2,GO INTERACTION WITH SYMBIONT,0.00026003,0.19257,0.21133,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.043763,0.19232,0.11543,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0031536,0.19195,0.14251,1,1
2,GO V D J RECOMBINATION,0.011047,0.19192,0.22247,1,1
2,GO AEROBIC RESPIRATION,0.0015189,0.19184,0.19142,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0062634,0.19174,0.23677,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00040247,0.19153,0.23328,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.035393,0.19144,0.12765,1,1
2,GO TRNA TRANSPORT,1.2454e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00044439,0.19126,0.21118,1,1
2,GO AMYLOID BETA CLEARANCE,0.016339,0.19123,0.15252,1,1
2,GO B CELL PROLIFERATION,0.0022332,0.19115,0.15619,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.040234,0.19099,0.15912,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.036948,0.19088,0.1628,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.015953,0.19062,0.1778,1,1
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.001986,0.19051,0.18065,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0085714,0.19047,0.13959,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0099891,0.19038,0.176,1,1
2,GO TRNA METABOLIC PROCESS,0.00011241,0.19017,0.19466,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.6902e-06,0.18902,0.20025,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00069957,0.18899,0.15451,1,1
2,GO TRANSLATIONAL INITIATION,0.019283,0.18881,0.19098,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.037747,0.18875,0.11938,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.015574,0.18871,0.14948,1,1
2,GO NCRNA METABOLIC PROCESS,0.00021167,0.18855,0.20332,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00063551,0.18838,0.1691,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0067808,0.18827,0.1506,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.018836,0.18819,0.18593,1,1
2,GO RESPONSE TO ZINC ION,0.047551,0.18803,0.20233,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0041716,0.18801,0.17313,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.00017796,0.18795,0.20671,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.015203,0.18787,0.16961,1,1
2,GO NEGATIVE T CELL SELECTION,0.036164,0.18694,0.091995,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.0023671,0.18686,0.17654,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.05161,0.18685,0.29973,1,1
2,GO LIVER REGENERATION,0.037747,0.18645,0.13785,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00063551,0.18622,0.24136,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.02843,0.18611,0.11896,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0060989,0.18602,0.17283,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00012964,0.18602,0.19013,1,1
2,GO RNA INTERFERENCE,0.009256,0.18581,0.17558,1,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.024288,0.18579,0.17767,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0007696,0.18571,0.1903,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00016595,0.18563,0.20033,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0022332,0.18543,0.12667,1,1
2,GO PIGMENT GRANULE ORGANIZATION,0.00012512,0.18527,0.22399,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.023741,0.18466,0.12192,1,1
2,GO AXIS ELONGATION,0.011904,0.18446,0.27909,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.00017186,0.18423,0.20917,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.02268,0.18404,0.13676,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.013139,0.18333,0.1907,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0090226,0.18317,0.1929,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00079435,0.18306,0.15624,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.021165,0.18281,0.18305,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0030654,0.18176,0.16886,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00050664,0.18169,0.17714,1,1
2,GO TRNA MODIFICATION,0.00065623,0.18139,0.17772,1,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.036164,0.18061,0.11407,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00016595,0.18052,0.19441,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.018836,0.1805,0.13101,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.029719,0.18044,0.13715,1,1
2,GO FEVER GENERATION,0.029068,0.18031,0.17002,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.0045306,0.18021,0.192,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0011199,0.18012,0.1781,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.018836,0.18006,0.12433,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.020205,0.18005,0.26963,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0046564,0.17973,0.17011,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.031059,0.17946,0.13126,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0036303,0.1791,0.23964,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.036164,0.17876,0.19281,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00013433,0.17868,0.18281,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0067808,0.17854,0.13156,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0011199,0.17842,0.16062,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00026903,0.17836,0.22362,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0006154,0.17821,0.18389,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0087944,0.17817,0.17025,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0024367,0.17801,0.21298,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0039469,0.17768,0.22167,1,1
2,GO RNA MODIFICATION,0.00034072,0.17762,0.16128,1,1
2,GO SYMBIOTIC PROCESS,8.7323e-05,0.17731,0.16324,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00087311,0.17713,0.17085,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010245,0.1771,0.14983,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00034072,0.17669,0.1801,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00010845,0.17655,0.16698,1,1
2,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17624,0.24067,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,7.0571e-06,0.17621,0.16539,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0017641,0.17617,0.18807,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00057693,0.17616,0.15202,1,1
2,GO FATTY ACID TRANSPORT,0.00074557,0.17603,0.14663,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00038934,0.17601,0.17811,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00024286,0.17577,0.17109,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00026003,0.1756,0.21319,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0056288,0.17553,0.14183,1,1
2,GO TRANSLATIONAL ELONGATION,0.013465,0.17542,0.16158,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.027188,0.17509,0.13759,1,1
2,GO RESPONSE TO IRON ION,0.033894,0.17507,0.16452,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.034637,0.17498,0.13349,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.025414,0.17464,0.13194,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.010773,0.17429,0.13354,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,7.013e-05,0.1737,0.18929,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.011326,0.17337,0.18942,1,1
2,GO VIRAL LIFE CYCLE,0.0014299,0.17329,0.16852,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.001191,0.17325,0.2014,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.029719,0.17318,0.10427,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0059384,0.17227,0.16833,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0011549,0.1718,0.17388,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.0014299,0.17143,0.14822,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.018398,0.17105,0.15897,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.023741,0.17074,0.14362,1,1
2,GO TRNA PROCESSING,0.00028792,0.17067,0.18298,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00047456,0.1704,0.19324,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.0047853,0.17033,0.16739,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00065623,0.17018,0.18945,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00067758,0.17004,0.16651,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.024288,0.16959,0.17512,1,1
2,GO HISTONE H3 K14 ACETYLATION,3.8583e-05,0.16925,0.19803,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.01282,0.16906,0.18254,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0011549,0.16896,0.19383,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.015574,0.16886,0.20077,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00020448,0.16832,0.15555,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0037331,0.16819,0.1292,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.012203,0.16811,0.14494,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.001986,0.16732,0.14286,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02068,0.16725,0.14061,1,1
2,GO IRON ION HOMEOSTASIS,0.0062634,0.16724,0.14771,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.016339,0.16622,0.20905,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0029794,0.16586,0.1598,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010245,0.16534,0.17512,1,1
2,GO PROTEIN IMPORT,0.0012662,0.1648,0.13747,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0046564,0.16474,0.13857,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0010528,0.16474,0.14218,1,1
2,GO RNA CATABOLIC PROCESS,0.00014935,0.16465,0.1721,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.011612,0.16398,0.15501,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001228,0.16389,0.17584,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.013139,0.16388,0.12266,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0017123,0.1636,0.14697,1,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014299,0.16358,0.1406,1,1
2,GO RRNA 3 END PROCESSING,0.0099891,0.16344,0.16479,1,1
2,GO LIPID MODIFICATION,0.0041716,0.16339,0.11393,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0011199,0.16319,0.14502,1,1
2,GO PHOTOPERIODISM,0.03939,0.163,0.10823,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.012203,0.16294,0.15343,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.011326,0.16221,0.10233,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0087944,0.16216,0.15047,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00055855,0.16207,0.19833,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0034322,0.16194,0.18439,1,1
2,GO TRNA 5 END PROCESSING,0.0014738,0.16194,0.20031,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.043763,0.16185,0.15047,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.029068,0.16183,0.088742,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0039469,0.16178,0.15564,1,1
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0071468,0.16149,0.16946,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.018836,0.1614,0.1086,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00038934,0.16111,0.20516,1,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.04854,0.16062,0.10231,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.040234,0.16054,0.14725,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0067808,0.16039,0.12688,1,1
2,GO TERPENOID METABOLIC PROCESS,0.026586,0.16011,0.13546,1,1
2,GO P BODY ASSEMBLY,0.00063551,0.1601,0.14729,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.0025817,0.16009,0.18119,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00054072,0.15975,0.16627,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0045306,0.1597,0.14624,1,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.011904,0.15959,0.14195,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0026572,0.15939,0.14108,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.031059,0.15928,0.13353,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0030654,0.15912,0.17973,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0015189,0.15906,0.17625,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0071468,0.15846,0.22047,1,1
2,GO EPIDERMIS DEVELOPMENT,0.010506,0.1582,0.17522,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0034322,0.15803,0.21994,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0079323,0.15797,0.16325,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0099891,0.15793,0.13075,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0050528,0.15741,0.17989,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.0041716,0.15723,0.15216,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00019753,0.15679,0.19295,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0025083,0.15635,0.15286,1,1
2,GO ERBB SIGNALING PATHWAY,0.0057817,0.1556,0.12517,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00081984,0.15548,0.15897,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.043763,0.15543,0.098774,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.0017123,0.15536,0.13833,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0042883,0.1552,0.11266,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.02843,0.155,0.15954,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0071468,0.15475,0.14191,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.013465,0.15451,0.13066,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.037747,0.15387,0.10327,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00054072,0.15353,0.19197,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00045924,0.15322,0.17236,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0028957,0.15321,0.20756,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.0011549,0.15296,0.11773,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00042998,0.15295,0.15057,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.00079435,0.15283,0.1899,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0014299,0.15279,0.2028,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.5308e-05,0.15277,0.15972,1,1
2,GO CHYLOMICRON ASSEMBLY,0.020205,0.15267,0.10948,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.001986,0.15244,0.17054,1,1
2,GO TOXIN TRANSPORT,0.011612,0.15187,0.13264,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.049546,0.15186,0.11553,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0042883,0.15178,0.16581,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.15147,0.13985,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,2.3418e-05,0.15134,0.17493,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0081404,0.15133,0.23203,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,8.7323e-05,0.15103,0.14832,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.013798,0.15094,0.11287,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0042883,0.15077,0.14092,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.0066042,0.15075,0.12867,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0012662,0.14967,0.14197,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0021689,0.14943,0.18399,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0053338,0.14932,0.14643,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.025414,0.14926,0.12859,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00069957,0.14889,0.11609,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.009256,0.14849,0.15098,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.018836,0.14834,0.12912,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0025083,0.14824,0.13442,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0045306,0.14791,0.18977,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0059384,0.14788,0.20213,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0025083,0.14771,0.16408,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.019283,0.14744,0.13175,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.8583e-05,0.14657,0.14386,1,1
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.045624,0.14632,0.19152,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0085714,0.14602,0.11719,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.027803,0.14583,0.10977,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0083534,0.14582,0.18035,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00052342,0.1457,0.15615,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.0013457,0.14555,0.13664,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0013054,0.14554,0.15599,1,1
2,GO IMPORT INTO NUCLEUS,0.022165,0.14532,0.11197,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.03245,0.14522,0.14506,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00092958,0.14511,0.13625,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0059384,0.1451,0.11218,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0069616,0.1451,0.1561,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.017137,0.14507,0.13089,1,1
2,GO GMP METABOLIC PROCESS,0.024846,0.14505,0.16515,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0054795,0.14496,0.15685,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0033369,0.14488,0.1124,1,1
2,GO HISTONE PHOSPHORYLATION,0.00081984,0.14481,0.13203,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0059384,0.14475,0.14674,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.011047,0.1447,0.20577,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.00072223,0.14451,0.13866,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.017969,0.1445,0.20887,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0030654,0.14404,0.12769,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.14395,0.22883,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.014486,0.14348,0.10733,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.035393,0.1434,0.13458,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.001872,0.14324,0.14252,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0025817,0.14295,0.14807,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0026572,0.1428,0.16588,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.012203,0.14273,0.10797,1,1
2,GO GOLGI RIBBON FORMATION,0.031059,0.14271,0.13085,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0083534,0.14243,0.20176,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,4.1617e-05,0.14217,0.19552,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0025083,0.14206,0.18039,1,1
2,GO HISTONE H2B UBIQUITINATION,0.014138,0.14186,0.13774,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.013139,0.14184,0.12243,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,9.0551e-05,0.14169,0.15154,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0006154,0.14149,0.121,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0051916,0.14111,0.1198,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.0604e-05,0.14079,0.16829,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0019282,0.14069,0.1252,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.041093,0.14062,0.15157,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012508,0.14059,0.14893,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.025994,0.14045,0.14335,1,1
2,GO MALE SEX DIFFERENTIATION,0.015574,0.14021,0.13832,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.016734,0.14017,0.15993,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00353,0.13959,0.11711,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.001986,0.13931,0.16377,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0040578,0.13911,0.16199,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0014299,0.13901,0.11734,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.047551,0.13859,0.13394,1,1
2,GO REGULATION OF ORGAN GROWTH,0.033894,0.13834,0.12596,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0022992,0.13778,0.12507,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.037747,0.13743,0.093374,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.015953,0.13733,0.11238,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.001872,0.13732,0.14293,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,5.4121e-05,0.13709,0.13758,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0053338,0.13708,0.19361,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001986,0.13672,0.12658,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.018398,0.13665,0.13636,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0057817,0.13629,0.12634,1,1
2,GO BASE EXCISION REPAIR,0.0010206,0.13621,0.13639,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,8.1192e-05,0.13601,0.12954,1,1
2,GO KERATINOCYTE MIGRATION,0.026586,0.13589,0.14024,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00052342,0.13545,0.15553,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.041093,0.13541,0.098591,1,1
2,GO TISSUE HOMEOSTASIS,0.013139,0.1354,0.092127,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.025994,0.13531,0.16907,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00049035,0.13527,0.14849,1,1
2,GO NUCLEAR EXPORT,5.0226e-05,0.13523,0.16528,1,1
2,GO DNA GEOMETRIC CHANGE,1.6455e-05,0.13397,0.16783,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0050528,0.13364,0.15621,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0020453,0.13316,0.17094,1,1
2,GO TELOMERE ORGANIZATION,0.00029782,0.13287,0.13882,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0022332,0.13282,0.11892,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.037747,0.13276,0.12785,1,1
2,GO MRNA 3 END PROCESSING,8.1192e-05,0.13165,0.15532,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0075304,0.13125,0.14154,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.030383,0.13121,0.15578,1,1
2,GO MRNA TRANSCRIPTION,0.014138,0.13119,0.14171,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00012964,0.13118,0.13134,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.022165,0.13007,0.098426,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00353,0.12974,0.12888,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0014299,0.12965,0.13797,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0033369,0.12951,0.12847,1,1
2,GO HISTONE UBIQUITINATION,0.031059,0.12923,0.081861,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.025994,0.12906,0.10994,1,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.036948,0.12901,0.12515,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.017549,0.12876,0.14172,1,1
2,GO RUFFLE ORGANIZATION,0.041093,0.12865,0.085359,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.0037331,0.12848,0.13599,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0097392,0.12848,0.14773,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.014138,0.12839,0.10456,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0045306,0.128,0.13562,1,1
2,GO EXIT FROM MITOSIS,0.01282,0.1279,0.098681,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.018836,0.12784,0.17201,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00017186,0.12781,0.12316,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0037331,0.12779,0.18489,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.046579,0.12769,0.12112,1,1
2,GO OXIDATIVE DEMETHYLATION,0.025994,0.12765,0.090446,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.038561,0.1275,0.1283,1,1
2,GO CELL CELL RECOGNITION,0.026586,0.12718,0.098306,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.011904,0.12678,0.18035,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0024367,0.12657,0.10739,1,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.041967,0.12579,0.12027,1,1
2,GO RNA PROCESSING,3.4421e-05,0.12572,0.16152,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00079435,0.12562,0.1332,1,1
2,GO KERATINIZATION,0.025994,0.12552,0.18132,1,1
2,GO POLYOL METABOLIC PROCESS,0.001191,0.12529,0.14861,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0010206,0.12506,0.15564,1,1
2,GO RESPONSE TO ESTROGEN,0.023205,0.12488,0.13343,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,7.547e-05,0.12488,0.11946,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.021165,0.12444,0.083458,1,1
2,GO HISTONE H3 DEACETYLATION,0.011904,0.12442,0.12474,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0007696,0.12418,0.16681,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0041716,0.12386,0.11172,1,1
2,GO GENE SILENCING,5.508e-06,0.12385,0.13907,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.023741,0.12359,0.09924,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00087311,0.12353,0.16414,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0015189,0.12331,0.12039,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.015574,0.12307,0.12466,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0045306,0.12301,0.11022,1,1
2,GO PROTEIN SUMOYLATION,3.4421e-05,0.12271,0.13421,1,1
2,GO MRNA METABOLIC PROCESS,1.7118e-05,0.12248,0.14894,1,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0094949,0.12242,0.13812,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0047853,0.12222,0.13145,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0021689,0.12218,0.18815,1,1
2,GO MRNA CLEAVAGE,0.00021167,0.12208,0.14874,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00074557,0.12201,0.15557,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.047551,0.12194,0.12688,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.018836,0.12185,0.11987,1,1
2,GO MRNA TRANSPORT,0.00022676,0.1215,0.14785,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.001986,0.12111,0.11249,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0010206,0.1211,0.11727,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0021062,0.12089,0.12252,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0038387,0.12049,0.10945,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.012203,0.1204,0.099253,1,1
2,GO LIPID METABOLIC PROCESS,0.0029794,0.12016,0.093843,1,1
2,GO LIPID CATABOLIC PROCESS,0.027188,0.12006,0.07731,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.016734,0.11975,0.17436,1,1
2,GO ACTIN NUCLEATION,0.0085714,0.11917,0.12397,1,1
2,GO BODY FLUID SECRETION,0.0049174,0.11914,0.1296,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.02843,0.11904,0.11588,1,1
2,GO PROTEIN NEDDYLATION,0.02166,0.11873,0.10961,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.023205,0.11866,0.086651,1,1
2,GO REGULATION OF MYELINATION,0.026586,0.11862,0.11447,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00019079,0.11822,0.14927,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00057693,0.11795,0.14871,1,1
2,GO NUCLEAR TRANSPORT,0.0012662,0.11762,0.12208,1,1
2,GO EPITHELIAL TUBE FORMATION,0.0071468,0.1167,0.14776,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0025083,0.11639,0.10776,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.020205,0.11613,0.12997,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.0013457,0.11565,0.096928,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0028141,0.11562,0.11311,1,1
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0014299,0.11549,0.11659,1,1
2,GO RESPONSE TO UV,0.001662,0.11535,0.13673,1,1
2,GO RNA CAPPING,0.0075304,0.11512,0.09999,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0022332,0.11423,0.12333,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.011612,0.11377,0.095786,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.041967,0.11371,0.11386,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0025083,0.11348,0.12878,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0022992,0.1134,0.11392,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0029794,0.11337,0.14379,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023205,0.11295,0.092148,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.0094949,0.11289,0.10223,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00084609,0.11254,0.13447,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.011047,0.11244,0.094214,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0067808,0.11242,0.089633,1,1
2,GO RESPONSE TO ALCOHOL,0.042857,0.11204,0.084471,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00016595,0.11197,0.12128,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0006154,0.11191,0.13088,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.029068,0.11173,0.09598,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.043763,0.11167,0.076771,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0075304,0.11163,0.084019,1,1
2,GO POLYAMINE METABOLIC PROCESS,0.027188,0.11154,0.12868,1,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0075304,0.11133,0.097153,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.038561,0.11132,0.070021,1,1
2,GO CRISTAE FORMATION,0.050569,0.1113,0.13952,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00084609,0.11121,0.13329,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0073363,0.11097,0.086476,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.018836,0.11092,0.14196,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.011612,0.11083,0.080932,1,1
2,GO RNA EXPORT FROM NUCLEUS,9.0551e-05,0.11068,0.17069,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.001228,0.11053,0.14689,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0034322,0.11001,0.12959,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.014841,0.10997,0.11472,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.007729,0.10989,0.13571,1,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.020205,0.10979,0.11394,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.026586,0.10972,0.11891,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0001165,0.10956,0.14472,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.040234,0.10911,0.093241,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0069616,0.10818,0.12496,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0090226,0.10781,0.10079,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.004408,0.10774,0.080633,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.016734,0.107,0.10545,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.0007696,0.10681,0.11294,1,1
2,GO MRNA PROCESSING,0.00013433,0.10673,0.12377,1,1
2,GO MITOCHONDRIAL TRANSPORT,0.0033369,0.10672,0.10286,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0067808,0.1067,0.10033,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.1067,0.057698,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00035231,0.10664,0.11339,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00016023,0.10552,0.11528,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.1617e-05,0.10498,0.11054,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0037331,0.10495,0.13495,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.045624,0.10488,0.10611,1,1
2,GO TUBE FORMATION,0.0087944,0.10442,0.13705,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0066042,0.10376,0.16795,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.034637,0.1036,0.1171,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0028957,0.10273,0.087268,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.011326,0.1026,0.090222,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022165,0.10246,0.078972,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0033369,0.10225,0.12672,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.001872,0.10198,0.11746,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00084609,0.10158,0.11675,1,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.036948,0.1012,0.071555,1,1
2,GO RNA 3 END PROCESSING,0.0010859,0.10116,0.13378,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0085714,0.10065,0.1843,1,1
2,GO HISTONE H3 ACETYLATION,0.00038934,0.10023,0.10638,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00024286,0.099617,0.12281,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00016023,0.099248,0.10584,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0013872,0.098422,0.13266,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.050569,0.098371,0.092757,1,1
2,GO RNA LOCALIZATION,9.0551e-05,0.098195,0.15685,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.025414,0.097938,0.092131,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0025083,0.097412,0.15343,1,1
2,GO DNA METHYLATION,0.001191,0.097405,0.11385,1,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.036164,0.097182,0.078226,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.00032948,0.097151,0.15323,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.031748,0.097136,0.0924,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.018836,0.096858,0.064618,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0060989,0.096121,0.072845,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0087944,0.096056,0.10869,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.010506,0.095767,0.11516,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0017123,0.09529,0.11351,1,1
2,GO REGULATION OF DNA REPAIR,0.027803,0.095058,0.072378,1,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.029068,0.094905,0.1139,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0057817,0.094424,0.14149,1,1
2,GO STEM CELL DIFFERENTIATION,0.010773,0.094058,0.12095,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00353,0.093801,0.099404,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.049546,0.093738,0.097834,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00072223,0.093578,0.089556,1,1
2,GO SNRNA PROCESSING,0.009256,0.093359,0.096868,1,1
2,GO RESPONSE TO HEAT,0.02268,0.093356,0.097181,1,1
2,GO RNA SPLICING,0.00032948,0.093084,0.12073,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.0094949,0.092643,0.08035,1,1
2,GO DNA CONFORMATION CHANGE,0.0022992,0.092533,0.094702,1,1
2,GO CHROMATIN REMODELING,0.00029782,0.092448,0.11632,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.009256,0.092202,0.098224,1,1
2,GO CELL AGING,0.012203,0.092119,0.088626,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,2.4346e-05,0.090771,0.1302,1,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.0051916,0.090737,0.078205,1,1
2,GO REGULATION OF NUCLEASE ACTIVITY,0.042857,0.090515,0.12173,1,1
2,GO REGULATION OF PROTEIN STABILITY,0.011612,0.090253,0.072783,1,1
2,GO NEURAL TUBE FORMATION,0.023205,0.09019,0.14562,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.023741,0.089775,0.1034,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011904,0.08948,0.086803,1,1
2,GO NCRNA CATABOLIC PROCESS,0.017137,0.088972,0.13617,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00047456,0.088858,0.12069,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0075304,0.088757,0.10111,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.02843,0.087968,0.060325,1,1
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.001228,0.087903,0.084858,1,1
2,GO CELLULAR RESPONSE TO UV,0.0060989,0.087743,0.11549,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.02843,0.08723,0.082009,1,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.041093,0.086364,0.078517,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.0073363,0.086257,0.08139,1,1
2,GO PEROXISOMAL TRANSPORT,0.014486,0.085778,0.11286,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.041967,0.085751,0.082296,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0057817,0.085542,0.083036,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0051916,0.085516,0.089922,1,1
2,GO SNRNA METABOLIC PROCESS,0.0022992,0.085496,0.10364,1,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0038387,0.084422,0.077762,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.03939,0.08426,0.099183,1,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.017969,0.083117,0.075529,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00072223,0.0828,0.098703,1,1
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.007729,0.082147,0.11327,1,1
2,GO RRNA METHYLATION,0.02843,0.081485,0.1597,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0019282,0.08097,0.10037,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.041967,0.080511,0.07287,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.018398,0.080462,0.053569,1,1
2,GO NCRNA TRANSCRIPTION,0.0079323,0.080268,0.098014,1,1
2,GO HISTONE DEACETYLATION,0.0062634,0.079882,0.090372,1,1
2,GO SELECTIVE AUTOPHAGY,0.017969,0.079739,0.093905,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0016129,0.079692,0.10174,1,1
2,GO CHROMOSOME SEPARATION,0.026586,0.078615,0.076513,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015203,0.078474,0.089141,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001986,0.078376,0.089469,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.025414,0.077301,0.065926,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.018836,0.07674,0.095021,1,1
2,GO PEROXISOME ORGANIZATION,0.018398,0.075617,0.098051,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY,0.034637,0.075331,0.060103,1,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.014138,0.075052,0.091265,1,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.019283,0.073885,0.068889,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.049546,0.072709,0.099896,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0051916,0.072273,0.070045,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0090226,0.071385,0.10286,1,1
2,GO REGULATION OF RNA SPLICING,0.017137,0.071372,0.089751,1,1
2,GO RESPONSE TO RADIATION,0.0075304,0.071316,0.071314,1,1
2,GO DNA METABOLIC PROCESS,0.00065623,0.069042,0.076051,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0085714,0.06879,0.068234,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0029794,0.068134,0.078725,1,1
2,GO DNA DEPENDENT DNA REPLICATION,0.041967,0.067885,0.086184,1,1
2,GO DNA MODIFICATION,0.0015653,0.06723,0.078711,1,1
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.009256,0.067219,0.079738,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.046579,0.066806,0.11709,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.050569,0.066325,0.045383,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.014138,0.066172,0.087766,1,1
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.02843,0.065806,0.083378,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.029068,0.065549,0.081761,1,1
2,GO MACROAUTOPHAGY,0.027803,0.065165,0.054319,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0020453,0.063603,0.10135,1,1
2,GO MITOTIC NUCLEAR DIVISION,0.03939,0.06225,0.069712,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0083534,0.061894,0.11858,1,1
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.041967,0.060539,0.091235,1,1
2,GO DNA REPAIR,0.0016129,0.060215,0.077932,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.004408,0.058792,0.059091,1,1
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.037747,0.057915,0.083609,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.036164,0.057595,0.041506,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.042857,0.057435,0.049978,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.02068,0.056633,0.048629,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.023741,0.053938,0.075505,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.027188,0.053593,0.06027,1,1
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.05161,0.05213,0.06606,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.03245,0.051571,0.06987,1,1
2,GO SNRNA TRANSCRIPTION,0.0090226,0.05122,0.078967,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0085714,0.049786,0.06961,1,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.033894,0.048029,0.064391,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.024288,0.047121,0.047038,1,1
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.05161,0.045971,0.15185,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.04854,0.045496,0.091348,1,1
2,GO METHYLATION,0.004408,0.04502,0.072683,1,1
2,GO MITOCHONDRION ORGANIZATION,0.038561,0.044294,0.060444,1,1
2,GO CHROMOSOME ORGANIZATION,0.0099891,0.040902,0.062854,1,1
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.020205,0.040675,0.04923,1,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.04854,0.03906,0.059534,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02268,0.036689,0.053422,1,1
2,GO COVALENT CHROMATIN MODIFICATION,0.033894,0.036669,0.05146,1,1
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.046579,0.035657,0.049754,1,1
2,GO PEPTIDYL LYSINE MODIFICATION,0.034637,0.02977,0.046309,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0047853,1.0935,0.83412,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0046564,0.93198,0.67111,1,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.029068,0.65217,0.39426,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.024288,0.59266,0.33433,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.03245,0.54723,0.33319,1,0
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0036303,0.43261,0.29506,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0036303,0.41489,0.37695,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0025817,0.3999,0.39563,1,0
2,GO TOLERANCE INDUCTION,0.015953,0.38541,0.26007,1,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00092958,0.36619,0.34981,1,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.013465,0.35094,0.23794,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00054072,0.34749,0.39512,1,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.019283,0.34352,0.31716,1,0
2,GO T CELL MEDIATED IMMUNITY,0.0010528,0.34174,0.25702,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.023205,0.32977,0.29568,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.018836,0.31361,0.29639,1,0
2,GO MATURE B CELL DIFFERENTIATION,0.0066042,0.31301,0.1932,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0064317,0.29291,0.17559,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.034637,0.28904,0.17012,1,0
2,GO URETER DEVELOPMENT,0.033166,0.28875,0.25547,1,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.017549,0.28657,0.2425,1,0
2,GO NADPH REGENERATION,0.0021689,0.28635,0.25457,1,0
2,GO RESPONSE TO TYPE I INTERFERON,0.035393,0.28208,0.18837,1,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.049546,0.28097,0.15917,1,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.007729,0.27922,0.25443,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.052669,0.2783,0.16494,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.042857,0.27425,0.2203,1,0
2,GO PHAGOCYTOSIS RECOGNITION,0.011047,0.27337,0.24005,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.011047,0.26922,0.20271,1,0
2,GO RESPONSE TO INTERFERON GAMMA,0.0071468,0.26871,0.20565,1,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.016734,0.26689,0.15739,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.012508,0.26687,0.22116,1,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00074557,0.26667,0.2251,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.010506,0.26036,0.24739,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0007696,0.26031,0.21388,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.001228,0.26006,0.18818,1,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.029719,0.2579,0.19586,1,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.02843,0.25569,0.19065,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.011326,0.25369,0.20407,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0062634,0.25361,0.25855,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.017969,0.25313,0.12963,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0062634,0.25176,0.15598,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.010773,0.25126,0.18432,1,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.022165,0.24866,0.15322,1,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.047551,0.24699,0.20009,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.038561,0.24537,0.1164,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.00063551,0.24069,0.19014,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00087311,0.23939,0.2057,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0023671,0.23774,0.16768,1,0
2,GO L SERINE METABOLIC PROCESS,0.011047,0.23703,0.27423,1,0
2,GO REGULATION OF PLATELET ACTIVATION,0.040234,0.23696,0.15596,1,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0017123,0.23472,0.25322,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.052669,0.2334,0.1973,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0045306,0.23315,0.18011,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0046564,0.22867,0.15022,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00057693,0.22693,0.18435,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.013465,0.22488,0.15005,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0022992,0.22478,0.20416,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0038387,0.22477,0.24672,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0026572,0.22434,0.18462,1,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0020453,0.22158,0.15786,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.02268,0.22068,0.17333,1,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0050528,0.21931,0.18213,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0099891,0.21766,0.12924,1,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0034322,0.21729,0.19112,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.017969,0.21547,0.1857,1,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.038561,0.21489,0.21355,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0016129,0.21353,0.17232,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0015653,0.21348,0.16442,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0037331,0.21046,0.1388,1,0
2,GO LEUKOCYTE PROLIFERATION,0.00057693,0.20964,0.16711,1,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0073363,0.20875,0.17631,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0006154,0.20857,0.20397,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.031748,0.20715,0.2287,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.010245,0.20668,0.16088,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.023741,0.20644,0.18316,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.001986,0.20549,0.15385,1,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.015953,0.20548,0.15999,1,0
2,GO VIRAL GENOME REPLICATION,0.013139,0.2051,0.17025,1,0
2,GO RESPONSE TO PROTOZOAN,0.037747,0.20346,0.13549,1,0
2,GO DEFENSE RESPONSE TO VIRUS,0.017137,0.20245,0.1518,1,0
2,GO CYTOPLASMIC TRANSLATION,0.025994,0.20244,0.19204,1,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.016734,0.20208,0.19384,1,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,0.20191,0.2049,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.033166,0.20108,0.14835,1,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.05161,0.19981,0.13175,1,0
2,GO RIBOSOME ASSEMBLY,0.0045306,0.199,0.23771,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.018836,0.19848,0.14087,1,0
2,GO SERTOLI CELL DEVELOPMENT,0.0051916,0.19842,0.28271,1,0
2,GO VASCULOGENESIS,0.045624,0.1984,0.15471,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.019739,0.19643,0.1774,1,0
2,GO POSITIVE REGULATION OF COAGULATION,0.0075304,0.19637,0.20568,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.03245,0.19618,0.22964,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.031059,0.19474,0.2108,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.045624,0.19402,0.1316,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0054795,0.19362,0.20584,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0021062,0.19218,0.16557,1,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.015203,0.19184,0.18418,1,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.042857,0.19158,0.17083,1,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00092958,0.191,0.15539,1,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.031748,0.18975,0.14015,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.012203,0.18946,0.12389,1,0
2,GO T CELL PROLIFERATION,0.0010528,0.1891,0.16864,1,0
2,GO RESPONSE TO INTERLEUKIN 15,0.0071468,0.18863,0.15279,1,0
2,GO HYPOTONIC RESPONSE,0.041967,0.1885,0.15412,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.042857,0.1885,0.15079,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0049174,0.18782,0.14443,1,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0025083,0.18731,0.18374,1,0
2,GO COPPER ION HOMEOSTASIS,0.02068,0.18705,0.13995,1,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.047551,0.18537,0.14968,1,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.18414,0.24377,1,0
2,GO INTERFERON BETA PRODUCTION,0.007729,0.18382,0.17168,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.0038387,0.18338,0.17894,1,0
2,GO B CELL MEDIATED IMMUNITY,0.009256,0.1829,0.12908,1,0
2,GO CHEMOKINE PRODUCTION,0.0032441,0.18209,0.20343,1,0
2,GO RENAL TUBULE DEVELOPMENT,0.041967,0.18137,0.14458,1,0
2,GO NECROTIC CELL DEATH,0.012508,0.18127,0.17261,1,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.010506,0.18116,0.20325,1,0
2,GO INTERLEUKIN 1 PRODUCTION,0.0099891,0.18054,0.21593,1,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00095906,0.18026,0.15491,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.027803,0.17979,0.18745,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0050528,0.17863,0.17043,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.011904,0.1774,0.19314,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0034322,0.17656,0.13476,1,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0067808,0.17631,0.11602,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.016339,0.17591,0.1374,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0087944,0.17583,0.13553,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.02843,0.17461,0.11306,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0064317,0.17424,0.14088,1,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.018398,0.1734,0.21404,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0081404,0.1732,0.14886,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0022992,0.17269,0.17724,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0010859,0.17259,0.1763,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0021689,0.17254,0.19368,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0053338,0.17181,0.15754,1,0
2,GO PLACENTA DEVELOPMENT,0.025414,0.17178,0.13085,1,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0018173,0.17103,0.16244,1,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010506,0.17058,0.15908,1,0
2,GO T CELL DIFFERENTIATION,0.001986,0.17001,0.14288,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.040234,0.1698,0.093254,1,0
2,GO METANEPHROS DEVELOPMENT,0.03245,0.16974,0.15369,1,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.018398,0.16959,0.17415,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0090226,0.16955,0.12382,1,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.044685,0.16862,0.13601,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.015574,0.16839,0.11578,1,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.040234,0.1681,0.11258,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.017549,0.16756,0.14457,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.05161,0.16655,0.15409,1,0
2,GO MACROPHAGE CHEMOTAXIS,0.031059,0.16607,0.14899,1,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0085714,0.16583,0.13942,1,0
2,GO REGULATION OF PHAGOCYTOSIS,0.01282,0.1637,0.12406,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.0041716,0.16281,0.13644,1,0
2,GO CYTOKINE PRODUCTION,0.0047853,0.16274,0.12987,1,0
2,GO RESPONSE TO VIRUS,0.017969,0.16269,0.12297,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.024846,0.1624,0.13578,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0049174,0.16221,0.14647,1,0
2,GO POSITIVE CHEMOTAXIS,0.02166,0.16138,0.13505,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.017549,0.16112,0.10428,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.020205,0.16092,0.10877,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.02843,0.16082,0.1053,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0046564,0.16065,0.11612,1,0
2,GO INNATE IMMUNE RESPONSE,0.0047853,0.16021,0.13688,1,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.024288,0.1601,0.15318,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.0032441,0.15981,0.12273,1,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0028141,0.15952,0.15662,1,0
2,GO REGULATION OF CELL CELL ADHESION,0.010506,0.1585,0.12545,1,0
2,GO SKIN DEVELOPMENT,0.023741,0.15835,0.17089,1,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.045624,0.15776,0.13661,1,0
2,GO STEROL HOMEOSTASIS,0.040234,0.15773,0.099474,1,0
2,GO DIGESTIVE SYSTEM PROCESS,0.0075304,0.15736,0.1316,1,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.035393,0.1572,0.088486,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0057817,0.15673,0.23897,1,0
2,GO REGULATION OF CELL ACTIVATION,0.0031536,0.15647,0.12607,1,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.019283,0.15533,0.16392,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.0064317,0.15512,0.14959,1,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0073363,0.15477,0.1548,1,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.03245,0.15448,0.10485,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.029719,0.15335,0.26247,1,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0051916,0.15296,0.15748,1,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.007729,0.15259,0.23371,1,0
2,GO RESPONSE TO CYTOKINE,0.0090226,0.15167,0.11362,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.052669,0.15158,0.10575,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.030383,0.15112,0.11379,1,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.024846,0.15084,0.1302,1,0
2,GO T CELL ACTIVATION,0.0042883,0.15054,0.13279,1,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0097392,0.14944,0.1116,1,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0036303,0.14938,0.11453,1,0
2,GO PHAGOCYTOSIS,0.010245,0.14918,0.13454,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0069616,0.14907,0.12357,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.047551,0.14907,0.28731,1,0
2,GO B CELL DIFFERENTIATION,0.0087944,0.14779,0.11694,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.037747,0.14767,0.096891,1,0
2,GO STEROL METABOLIC PROCESS,0.024288,0.14728,0.092281,1,0
2,GO REGULATION OF ACTION POTENTIAL,0.044685,0.14703,0.12209,1,0
2,GO REGULATION OF T CELL ACTIVATION,0.0045306,0.14699,0.13208,1,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.0037331,0.1469,0.14366,1,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0053338,0.14637,0.12007,1,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.0015653,0.14556,0.12959,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.001872,0.14556,0.13049,1,0
2,GO CELL KILLING,0.0094949,0.14501,0.12834,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.02843,0.14491,0.12756,1,0
2,GO INNER EAR MORPHOGENESIS,0.020205,0.14476,0.12936,1,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.024288,0.14469,0.4073,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.0097392,0.14415,0.1058,1,0
2,GO DIGESTION,0.030383,0.14378,0.090594,1,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.0032441,0.14267,0.11376,1,0
2,GO CD40 SIGNALING PATHWAY,0.025414,0.14264,0.12147,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0062634,0.14227,0.12602,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.0071468,0.14144,0.12292,1,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.013798,0.14105,0.17542,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.025414,0.14071,0.11566,1,0
2,GO CYTOKINETIC PROCESS,0.033894,0.14027,0.12855,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0079323,0.14016,0.12103,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.014138,0.13947,0.11096,1,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.010773,0.13947,0.11202,1,0
2,GO PROTEIN KINASE B SIGNALING,0.047551,0.13855,0.086269,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0083534,0.13836,0.10469,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.031748,0.13821,0.11238,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0087944,0.13793,0.092534,1,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.013798,0.13782,0.17517,1,0
2,GO ALPHA BETA T CELL ACTIVATION,0.0015189,0.13743,0.16443,1,0
2,GO MACROPHAGE MIGRATION,0.014841,0.13734,0.14811,1,0
2,GO LEUKOCYTE HOMEOSTASIS,0.040234,0.1371,0.083054,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0053338,0.13685,0.10992,1,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.02068,0.13683,0.12415,1,0
2,GO REGULATION OF HEMOPOIESIS,0.010245,0.13664,0.1148,1,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.013465,0.13643,0.12684,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.014138,0.1355,0.1115,1,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.049546,0.13522,0.14745,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.025414,0.13436,0.13781,1,0
2,GO LYMPHOCYTE ACTIVATION,0.0066042,0.13245,0.10937,1,0
2,GO VESICLE TARGETING,0.0062634,0.13223,0.10448,1,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0081404,0.13166,0.14947,1,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.019283,0.13073,0.11449,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.017969,0.13047,0.24841,1,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.02268,0.13047,0.14898,1,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0054795,0.13031,0.14644,1,0
2,GO VIRAL RELEASE FROM HOST CELL,0.010773,0.12974,0.1335,1,0
2,GO DEFENSE RESPONSE,0.017137,0.12953,0.085146,1,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.038561,0.12915,0.1139,1,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.04854,0.12901,0.1769,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0069616,0.12886,0.16988,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.007729,0.12883,0.10134,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.045624,0.12877,0.10004,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.033166,0.12816,0.10108,1,0
2,GO REGULATION OF CELL ADHESION,0.033166,0.12796,0.10603,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015953,0.12783,0.090982,1,0
2,GO RESPONSE TO BACTERIUM,0.02166,0.12668,0.092533,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.021165,0.12629,0.086477,1,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.021165,0.12617,0.094706,1,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.016734,0.12586,0.12472,1,0
2,GO KERATINOCYTE DIFFERENTIATION,0.0097392,0.12543,0.21557,1,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.046579,0.12542,0.11777,1,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.05161,0.1245,0.16765,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.025414,0.12427,0.098656,1,0
2,GO CELL ACTIVATION,0.016339,0.12343,0.095461,1,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.044685,0.1228,0.11808,1,0
2,GO MYELOID CELL HOMEOSTASIS,0.017969,0.1218,0.11152,1,0
2,GO STRESS GRANULE ASSEMBLY,0.011326,0.12125,0.11766,1,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.046579,0.12124,0.10904,1,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.04854,0.1209,0.099132,1,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.034637,0.12053,0.13567,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.021165,0.12052,0.19607,1,0
2,GO EAR MORPHOGENESIS,0.0062634,0.12018,0.14534,1,0
2,GO GOLGI VESICLE BUDDING,0.00353,0.11956,0.09649,1,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.017137,0.11931,0.12803,1,0
2,GO MOLTING CYCLE,0.027188,0.11816,0.15228,1,0
2,GO LIPID HOMEOSTASIS,0.023205,0.11811,0.084156,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.014138,0.11797,0.090691,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.021165,0.11793,0.085754,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.02166,0.11676,0.09689,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.03939,0.11632,0.10791,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.036948,0.11605,0.10613,1,0
2,GO LEUKOCYTE DIFFERENTIATION,0.010773,0.11272,0.09734,1,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.021165,0.11264,0.16842,1,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.019739,0.11196,0.089363,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.015203,0.11089,0.13612,1,0
2,GO MYOBLAST DIFFERENTIATION,0.030383,0.11043,0.16691,1,0
2,GO CELL CHEMOTAXIS,0.049546,0.10986,0.093034,1,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0038387,0.10927,0.12839,1,0
2,GO CELLULAR RESPIRATION,0.015953,0.10918,0.13518,1,0
2,GO B CELL ACTIVATION,0.0046564,0.10902,0.10297,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.045624,0.10887,0.10684,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.042857,0.10864,0.085346,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.030383,0.10862,0.10562,1,0
2,GO COPII COATED VESICLE BUDDING,0.0027346,0.1082,0.10059,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.036164,0.10815,0.13529,1,0
2,GO SENSORY PERCEPTION OF TASTE,0.0019282,0.1079,0.27769,1,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.02268,0.10697,0.083028,1,0
2,GO SPROUTING ANGIOGENESIS,0.04854,0.10622,0.12267,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.02068,0.10612,0.1474,1,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.046579,0.10605,0.097911,1,0
2,GO RESPONSE TO OXYGEN LEVELS,0.050569,0.10586,0.070356,1,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.0073363,0.10562,0.12938,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.04854,0.1041,0.10621,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.023741,0.10381,0.12898,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.023205,0.10205,0.13596,1,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.019283,0.10107,0.11214,1,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.043763,0.10086,0.14201,1,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.024846,0.10003,0.082695,1,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.022165,0.099971,0.078876,1,0
2,GO REGULATION OF CELL SHAPE,0.02268,0.099748,0.13339,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.02268,0.099552,0.070269,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.023741,0.098407,0.14759,1,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.031748,0.098225,0.11822,1,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.038561,0.098218,0.077351,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.014138,0.097919,0.091327,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.040234,0.097259,0.10641,1,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.036164,0.097096,0.088946,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.033894,0.096531,0.099116,1,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.017549,0.096221,0.11338,1,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.05161,0.096186,0.06984,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.033166,0.09567,0.094026,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.029719,0.095448,0.082843,1,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.040234,0.09533,0.12404,1,0
2,GO ENDOCRINE PROCESS,0.018836,0.095323,0.11866,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,0.094986,0.1221,1,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.036948,0.094327,0.078922,1,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.019283,0.092965,0.10837,1,0
2,GO RESPONSE TO INTERLEUKIN 4,0.015574,0.09271,0.11053,1,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.0921,0.06739,1,0
2,GO ACTIN FILAMENT BASED PROCESS,0.023741,0.091637,0.084245,1,0
2,GO ELECTRON TRANSPORT CHAIN,0.021165,0.09143,0.10984,1,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.038561,0.09126,0.16633,1,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.022165,0.091224,0.094518,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.010773,0.090664,0.13724,1,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.030383,0.090241,0.076051,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.031748,0.089925,0.10887,1,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.052669,0.089171,0.12303,1,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.02166,0.088762,0.10133,1,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.04854,0.086203,0.07307,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.027188,0.085905,0.087144,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.02268,0.085765,0.10049,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.041093,0.085051,0.12291,1,0
2,GO POSTREPLICATION REPAIR,0.037747,0.085044,0.071008,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.015953,0.083406,0.11148,1,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.02843,0.083088,0.072255,1,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012508,0.083066,0.075718,1,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.025414,0.082421,0.094417,1,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0039469,0.081934,0.09326,1,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.033894,0.081705,0.097138,1,0
2,GO ERK1 AND ERK2 CASCADE,0.033894,0.081651,0.10355,1,0
2,GO ERAD PATHWAY,0.016734,0.081021,0.0811,1,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.014841,0.080452,0.10521,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.038561,0.080223,0.066305,1,0
2,GO STEROID METABOLIC PROCESS,0.026586,0.08016,0.066894,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.041093,0.079717,0.069405,1,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.047551,0.078707,0.10895,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.017969,0.077976,0.11981,1,0
2,GO GLUCOSE METABOLIC PROCESS,0.049546,0.077599,0.048049,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.019739,0.077307,0.098388,1,0
2,GO CELLULAR RESPONSE TO LIPID,0.031748,0.077143,0.089052,1,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.03939,0.074162,0.088346,1,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.018398,0.074118,0.074147,1,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.033166,0.07269,0.0648,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.025414,0.0725,0.076027,1,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.046579,0.070156,0.17531,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.035393,0.069261,0.064537,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.023741,0.06894,0.13147,1,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.02068,0.068177,0.077531,1,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.05161,0.066359,0.084532,1,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.041967,0.064935,0.057759,1,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.038561,0.062912,0.12902,1,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.05161,0.062204,0.058705,1,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.018398,0.061532,0.092842,1,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.015574,0.061012,0.063124,1,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.027188,0.060788,0.066093,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.046579,0.058202,0.06435,1,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0049174,0.057979,0.066854,1,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.038561,0.056371,0.050705,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.042857,0.05087,0.076788,1,0
2,GO DNA RECOMBINATION,0.017137,0.049753,0.079231,1,0
2,GO TISSUE MIGRATION,0.045624,0.045963,0.11694,1,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.038561,0.045261,0.10592,1,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.038561,-0.049313,-0.086107,1,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.036948,-0.05111,-0.22259,1,0
2,GO CIRCADIAN RHYTHM,0.023205,-0.052637,-0.06337,1,0
2,GO REGULATION OF VASOCONSTRICTION,0.035393,-0.062224,-0.1238,1,0
2,GO PEPTIDE SECRETION,0.026586,-0.062393,-0.092613,1,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.033166,-0.065196,-0.10164,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.03939,-0.068924,-0.064548,1,0
2,GO CELL PROJECTION ORGANIZATION,0.029719,-0.069727,-0.08034,1,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.026586,-0.070177,-0.071244,1,0
2,GO METAL ION TRANSPORT,0.030383,-0.073308,-0.081459,1,0
2,GO REGULATION OF DNA BINDING,0.03939,-0.075098,-0.097993,1,0
2,GO CATION TRANSPORT,0.029719,-0.076805,-0.082139,1,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.02268,-0.077243,-0.096808,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0056288,-0.077544,-0.18101,1,0
2,GO GERM CELL DEVELOPMENT,0.004408,-0.077626,-0.09631,1,0
2,GO CELL CELL SIGNALING,0.0099891,-0.078327,-0.094155,1,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.027803,-0.079628,-0.11154,1,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0094949,-0.080302,-0.10934,1,0
2,GO REGULATION OF CELL DEVELOPMENT,0.017549,-0.08097,-0.093886,1,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.033166,-0.081976,-0.080843,1,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.041967,-0.082943,-0.078209,1,0
2,GO RESPONSE TO INTERLEUKIN 6,0.05161,-0.083912,-0.13526,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.004408,-0.085082,-0.10615,1,0
2,GO TRANSPORT ALONG MICROTUBULE,0.0062634,-0.08669,-0.089772,1,0
2,GO MICROTUBULE BASED TRANSPORT,0.0060989,-0.08682,-0.095271,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.024288,-0.087816,-0.11004,1,0
2,GO SUCKLING BEHAVIOR,0.041093,-0.088114,-0.18784,1,0
2,GO REGULATION OF SECRETION,0.018398,-0.088713,-0.09328,1,0
2,GO REGULATION OF ANION TRANSPORT,0.036164,-0.08903,-0.1056,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0073363,-0.090757,-0.13376,1,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.019739,-0.090832,-0.09155,1,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.019283,-0.095444,-0.095967,1,0
2,GO REGULATION OF SYSTEM PROCESS,0.0087944,-0.095897,-0.10776,1,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.027803,-0.097954,-0.1281,1,0
2,GO NEUROGENESIS,0.0051916,-0.098197,-0.10678,1,0
2,GO REGULATION OF ION TRANSPORT,0.016339,-0.099181,-0.10115,1,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0085714,-0.10069,-0.12893,1,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.017137,-0.10191,-0.13733,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.012508,-0.10199,-0.10979,1,0
2,GO ADULT FEEDING BEHAVIOR,0.052669,-0.10199,-0.14423,1,0
2,GO REGULATION OF BLOOD CIRCULATION,0.02843,-0.10223,-0.10144,1,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.015203,-0.10244,-0.13722,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.038561,-0.10279,-0.10337,1,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.046579,-0.10349,-0.12881,1,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.033166,-0.10401,-0.090215,1,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0099891,-0.10402,-0.1036,1,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.018398,-0.10428,-0.096031,1,0
2,GO REGULATION OF RESPONSE TO FOOD,0.02068,-0.10476,-0.15461,1,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.0079323,-0.10532,-0.11413,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.024288,-0.10569,-0.16067,1,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.016339,-0.10578,-0.073218,1,0
2,GO CHLORIDE TRANSPORT,0.02843,-0.1081,-0.10098,1,0
2,GO NERVOUS SYSTEM PROCESS,0.02268,-0.11061,-0.088964,1,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.015953,-0.11176,-0.11274,1,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0025817,-0.11275,-0.15445,1,0
2,GO DEVELOPMENTAL CELL GROWTH,0.0018173,-0.11368,-0.14946,1,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.052669,-0.11428,-0.088349,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.029719,-0.11525,-0.079576,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0079323,-0.11564,-0.11591,1,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.013798,-0.11585,-0.11178,1,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.026586,-0.11649,-0.13226,1,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0054795,-0.11657,-0.11237,1,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0083534,-0.11764,-0.097916,1,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.037747,-0.1178,-0.092463,1,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.013465,-0.11789,-0.14331,1,0
2,GO IMPORT INTO CELL,0.030383,-0.11792,-0.10902,1,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.007729,-0.11792,-0.13339,1,0
2,GO CELL MATURATION,0.0034322,-0.11822,-0.12282,1,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.021165,-0.11827,-0.15009,1,0
2,GO HEAD DEVELOPMENT,0.0085714,-0.11897,-0.10579,1,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.027188,-0.11983,-0.097826,1,0
2,GO CRANIAL NERVE DEVELOPMENT,0.016734,-0.12134,-0.15224,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.001228,-0.12254,-0.15739,1,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.0017123,-0.12577,-0.14336,1,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.049546,-0.12649,-0.10952,1,0
2,GO REGULATION OF HORMONE SECRETION,0.0059384,-0.12654,-0.12072,1,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.025994,-0.12872,-0.17699,1,0
2,GO SPERM CAPACITATION,0.0057817,-0.12876,-0.17173,1,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.02268,-0.12902,-0.10574,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.018398,-0.13365,-0.10337,1,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.050569,-0.13416,-0.082218,1,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.001662,-0.13722,-0.16202,1,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.0066042,-0.13819,-0.15059,1,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0039469,-0.13857,-0.099727,1,0
2,GO REPRODUCTIVE BEHAVIOR,0.011047,-0.13916,-0.17873,1,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.05161,-0.14183,-0.11,1,0
2,GO COCHLEA DEVELOPMENT,0.02268,-0.14188,-0.13174,1,0
2,GO REGULATION OF APPETITE,0.0050528,-0.14222,-0.14492,1,0
2,GO SODIUM ION TRANSPORT,0.0036303,-0.14244,-0.13494,1,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.015953,-0.14244,-0.10344,1,0
2,GO CARDIAC CONDUCTION,0.026586,-0.1425,-0.13616,1,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.041093,-0.14539,-0.16528,1,0
2,GO HORMONE TRANSPORT,0.0060989,-0.14561,-0.12694,1,0
2,GO LYMPH NODE DEVELOPMENT,0.0054795,-0.14679,-0.19679,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.012203,-0.14724,-0.14138,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.02268,-0.14853,-0.12125,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,9.389e-05,-0.15014,-0.1736,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00057693,-0.15063,-0.17306,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0013872,-0.15076,-0.15712,1,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0051916,-0.15077,-0.27933,1,0
2,GO NEUROMUSCULAR PROCESS,0.031748,-0.1521,-0.12544,1,0
2,GO TELENCEPHALON DEVELOPMENT,0.00055855,-0.15453,-0.15846,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0054795,-0.15462,-0.1517,1,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0039469,-0.15538,-0.12453,1,0
2,GO CELLULAR RESPONSE TO PH,0.0079323,-0.15695,-0.14887,1,0
2,GO RESPONSE TO CALCIUM ION,0.0019282,-0.15715,-0.16034,1,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.024846,-0.15755,-0.12081,1,0
2,GO SKELETAL MUSCLE CONTRACTION,0.041093,-0.16008,-0.12994,1,0
2,GO HINDBRAIN DEVELOPMENT,0.00045924,-0.16078,-0.18774,1,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.0024367,-0.16153,-0.18813,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00059588,-0.16178,-0.18943,1,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0049174,-0.16203,-0.14691,1,0
2,GO MEMBRANE BIOGENESIS,0.026586,-0.16319,-0.17376,1,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.014486,-0.16364,-0.14368,1,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.020205,-0.1638,-0.17084,1,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.017549,-0.16417,-0.14253,1,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0007696,-0.16469,-0.18438,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00092958,-0.16698,-0.18606,1,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00067758,-0.16845,-0.14353,1,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0050528,-0.16934,-0.1956,1,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.0053338,-0.16997,-0.15463,1,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.011047,-0.17113,-0.15492,1,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.014138,-0.17256,-0.17203,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0021062,-0.17397,-0.19351,1,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0033369,-0.17569,-0.15495,1,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0017123,-0.17712,-0.23775,1,0
2,GO BEHAVIOR,0.00020448,-0.17764,-0.1679,1,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.041093,-0.17792,-0.12738,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0081404,-0.17893,-0.26457,1,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.029068,-0.17897,-0.24151,1,0
2,GO ANDROGEN METABOLIC PROCESS,0.0053338,-0.17953,-0.1834,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.001228,-0.17982,-0.15853,1,0
2,GO MEMORY,0.00037661,-0.18141,-0.19692,1,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0066042,-0.18272,-0.22384,1,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0019282,-0.18401,-0.17976,1,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.013798,-0.18626,-0.21273,1,0
2,GO AMINO ACID TRANSPORT,0.00063551,-0.1863,-0.19484,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00065623,-0.18694,-0.20233,1,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.019283,-0.18978,-0.13722,1,0
2,GO PROTEIN KINASE C SIGNALING,0.0036303,-0.19075,-0.22443,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0059384,-0.19171,-0.20571,1,0
2,GO DEVELOPMENTAL MATURATION,0.00013433,-0.19179,-0.17704,1,0
2,GO THALAMUS DEVELOPMENT,0.034637,-0.19188,-0.18599,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00095906,-0.19204,-0.18145,1,0
2,GO ASSOCIATIVE LEARNING,0.0060989,-0.19361,-0.18346,1,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.012508,-0.19449,-0.16691,1,0
2,GO SIGNAL RELEASE,0.00052342,-0.19617,-0.15669,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00087311,-0.19835,-0.18292,1,0
2,GO RESPONSE TO FUNGUS,0.011904,-0.19839,-0.13179,1,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.023741,-0.19901,-0.16128,1,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0030654,-0.19929,-0.21448,1,0
2,GO PEPTIDE HORMONE SECRETION,0.0010528,-0.20102,-0.16905,1,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0025083,-0.20133,-0.18267,1,0
2,GO SECONDARY PALATE DEVELOPMENT,0.033894,-0.20167,-0.18748,1,0
2,GO STRIATUM DEVELOPMENT,0.0024367,-0.20188,-0.25804,1,0
2,GO POTASSIUM ION TRANSPORT,0.00041602,-0.20209,-0.19948,1,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.001191,-0.20252,-0.16292,1,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00032948,-0.20405,-0.20879,1,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0099891,-0.20677,-0.18301,1,0
2,GO RESPONSE TO AMYLOID BETA,0.007729,-0.20699,-0.16052,1,0
2,GO REGULATION OF FERTILIZATION,5.2139e-05,-0.20823,-0.25471,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0071468,-0.20897,-0.22032,1,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0047853,-0.20968,-0.20469,1,0
2,GO REGULATION OF CILIUM MOVEMENT,9.3916e-06,-0.2099,-0.21218,1,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.029719,-0.21052,-0.19791,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.00050664,-0.21056,-0.22945,1,0
2,GO RESPONSE TO PH,0.010245,-0.21215,-0.15996,1,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0001547,-0.2131,-0.20208,1,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.00012074,-0.21445,-0.22122,1,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00025131,-0.21458,-0.24171,1,0
2,GO MEMBRANE FISSION,0.027188,-0.21853,-0.17776,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0057817,-0.21968,-0.18433,1,0
2,GO EPITHELIAL CELL MATURATION,0.02268,-0.22031,-0.23844,1,0
2,GO CAMP METABOLIC PROCESS,0.0083534,-0.22123,-0.21166,1,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0011199,-0.2218,-0.21194,1,0
2,GO FACIAL NERVE MORPHOGENESIS,0.035393,-0.22369,-0.3049,1,0
2,GO COPULATION,0.029719,-0.22384,-0.14349,1,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0062634,-0.22386,-0.18611,1,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00055855,-0.22428,-0.20221,1,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.009256,-0.22758,-0.20974,1,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.033894,-0.22761,-0.12306,1,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0049174,-0.22798,-0.17934,1,0
2,GO REGULATION OF EXOCYTOSIS,0.0067808,-0.2305,-0.18635,1,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00050664,-0.23064,-0.25715,1,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.011047,-0.23113,-0.18656,1,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00055855,-0.2363,-0.21409,1,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.023741,-0.23892,-0.24508,1,0
2,GO LEARNING,0.0022992,-0.23991,-0.20875,1,0
2,GO CELL MIGRATION IN HINDBRAIN,0.037747,-0.24139,-0.20775,1,0
2,GO INSEMINATION,0.019739,-0.24222,-0.21931,1,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00072223,-0.2434,-0.21141,1,0
2,GO PROTEIN PALMITOYLATION,0.014841,-0.24462,-0.16771,1,0
2,GO VITAMIN CATABOLIC PROCESS,0.0066042,-0.24538,-0.27401,1,0
2,GO SECRETORY GRANULE LOCALIZATION,0.016339,-0.24624,-0.2997,1,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.00024286,-0.24929,-0.21908,1,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0085714,-0.25051,-0.21344,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.004408,-0.25188,-0.3059,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00045924,-0.25537,-0.2592,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.010773,-0.25632,-0.2122,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.014841,-0.25755,-0.16415,1,0
2,GO MICROTUBULE BUNDLE FORMATION,6.7596e-05,-0.25836,-0.26072,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.00014935,-0.25952,-0.24699,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.010245,-0.26284,-0.22312,1,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.0079323,-0.26396,-0.2524,1,0
2,GO RESPONSE TO CATECHOLAMINE,8.1192e-05,-0.26455,-0.24133,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.001986,-0.26558,-0.27538,1,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.011047,-0.2669,-0.29912,1,0
2,GO NOTCH RECEPTOR PROCESSING,0.029068,-0.26756,-0.25231,1,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00047456,-0.2678,-0.31012,1,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1776e-06,-0.26834,-0.27515,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.037747,-0.2691,-0.24403,1,0
2,GO ACROSOME REACTION,4.3218e-05,-0.26936,-0.26173,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.0090226,-0.26986,-0.1886,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.01282,-0.27012,-0.21274,1,0
2,GO TUBULIN DEACETYLATION,0.0075304,-0.27037,-0.22164,1,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.015574,-0.27044,-0.26467,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0050528,-0.27139,-0.28017,1,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.010506,-0.27243,-0.33,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.011612,-0.27352,-0.28858,1,0
2,GO NEURON MATURATION,0.0028957,-0.27384,-0.21133,1,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.027803,-0.27422,-0.25893,1,0
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.016339,-0.27433,-0.28305,1,0
2,GO NERVE DEVELOPMENT,4.8379e-05,-0.27625,-0.28177,1,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,4.8379e-05,-0.27743,-0.31003,1,0
2,GO MEMBRANE DEPOLARIZATION,0.00024286,-0.27841,-0.28153,1,0
2,GO OPTIC NERVE DEVELOPMENT,0.0056288,-0.2801,-0.29784,1,0
2,GO DIENCEPHALON DEVELOPMENT,0.00035231,-0.28144,-0.25935,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00084609,-0.28237,-0.32809,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,7.2754e-05,-0.28243,-0.31888,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.001986,-0.28346,-0.31835,1,0
2,GO ALANINE TRANSPORT,0.015574,-0.28426,-0.19018,1,0
2,GO SKELETAL MUSCLE ADAPTATION,0.023205,-0.2861,-0.20642,1,0
2,GO LOCOMOTORY BEHAVIOR,6.2786e-05,-0.28698,-0.24705,1,0
2,GO HORMONE CATABOLIC PROCESS,0.02068,-0.29056,-0.24386,1,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0012662,-0.2914,-0.24557,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.022165,-0.29231,-0.196,1,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.0012662,-0.2953,-0.30729,1,0
2,GO RESPONSE TO DOPAMINE,1.5201e-05,-0.29538,-0.26579,1,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.03245,-0.29651,-0.22642,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00021167,-0.29653,-0.25612,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.0001165,-0.30148,-0.25428,1,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00021909,-0.304,-0.36586,1,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0056288,-0.30581,-0.33342,1,0
2,GO NOREPINEPHRINE TRANSPORT,0.00038934,-0.3096,-0.28459,1,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.018398,-0.31125,-0.24068,1,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.013465,-0.31189,-0.25954,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.020205,-0.31398,-0.25263,1,0
2,GO RESPONSE TO MUSCLE STRETCH,0.00069957,-0.32156,-0.35437,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0006154,-0.32321,-0.30721,1,0
2,GO DORSAL AORTA DEVELOPMENT,0.00013917,-0.32349,-0.34635,1,0
2,GO NOREPINEPHRINE SECRETION,0.00012964,-0.32373,-0.34996,1,0
2,GO REGULATION OF AMINO ACID TRANSPORT,4.6597e-05,-0.32373,-0.31778,1,0
2,GO EXOCYTIC PROCESS,0.00045924,-0.3242,-0.25854,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,2.0033e-05,-0.32927,-0.29634,1,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.00013433,-0.32965,-0.27546,1,0
2,GO REGULATION OF ACROSOME REACTION,0.00017186,-0.33065,-0.3544,1,0
2,GO REFLEX,0.0031536,-0.33447,-0.36126,1,0
2,GO FOREBRAIN REGIONALIZATION,5.2139e-05,-0.33698,-0.40563,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0017123,-0.33964,-0.38641,1,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00023468,-0.34589,-0.303,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0049174,-0.34668,-0.24218,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0012662,-0.35005,-0.35624,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,5.4121e-05,-0.35141,-0.3575,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00069957,-0.35143,-0.36649,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00079435,-0.35411,-0.31864,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.5759e-05,-0.35759,-0.3858,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00079435,-0.35875,-0.34561,1,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00095906,-0.35917,-0.27045,1,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00023468,-0.36027,-0.33522,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00054072,-0.36369,-0.30493,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,4.0073e-05,-0.36419,-0.42261,1,0
2,GO RESPONSE TO DIETARY EXCESS,0.00014418,-0.36612,-0.41439,1,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00047456,-0.37017,-0.37428,1,0
2,GO TRANSMISSION OF NERVE IMPULSE,1.7806e-05,-0.37042,-0.36173,1,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,2.0033e-05,-0.37254,-0.46369,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00012964,-0.3743,-0.35031,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0046564,-0.37514,-0.33052,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0066042,-0.38511,-0.25758,1,0
2,GO CEREBELLAR CORTEX FORMATION,5.0226e-05,-0.38593,-0.34616,1,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0017641,-0.38708,-0.39581,1,0
2,GO NEURONAL ACTION POTENTIAL,0.00045924,-0.38967,-0.35591,1,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00041602,-0.3907,-0.25895,1,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0066042,-0.39075,-0.32556,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0033369,-0.39131,-0.33119,1,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.8521e-05,-0.39358,-0.34535,1,0
2,GO ADRENAL GLAND DEVELOPMENT,2.9532e-05,-0.39755,-0.41861,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,4.6597e-05,-0.39824,-0.37402,1,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.00011241,-0.40016,-0.36987,1,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0094949,-0.41315,-0.31802,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0059384,-0.4163,-0.39774,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0067808,-0.41804,-0.33631,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,3.0689e-05,-0.41953,-0.40572,1,0
2,GO STARTLE RESPONSE,0.00038934,-0.42577,-0.38571,1,0
2,GO OLFACTORY LOBE DEVELOPMENT,8.1192e-05,-0.42704,-0.38208,1,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00026003,-0.43007,-0.41267,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.001986,-0.43263,-0.40151,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.0037331,-0.43651,-0.31257,1,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0021689,-0.43689,-0.30675,1,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00023468,-0.43879,-0.35356,1,0
2,GO PROTEIN LOCALIZATION TO AXON,0.0075304,-0.44697,-0.47077,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,2.7343e-05,-0.45131,-0.38639,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,6.2367e-06,-0.45535,-0.39191,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.007729,-0.45936,-0.37279,1,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00098941,-0.4602,-0.33944,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0027346,-0.46083,-0.56064,1,0
2,GO PLASMA MEMBRANE REPAIR,0.00026003,-0.46581,-0.54237,1,0
2,GO RESPONSE TO HISTAMINE,0.00098941,-0.46764,-0.48239,1,0
2,GO POSTSYNAPSE ASSEMBLY,0.00067758,-0.46966,-0.44734,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.001872,-0.47411,-0.49251,1,0
2,GO DETECTION OF CALCIUM ION,4.8379e-05,-0.47921,-0.43945,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.011612,-0.4825,-0.26419,1,0
2,GO TELENCEPHALON REGIONALIZATION,0.0010859,-0.48665,-0.42479,1,0
2,GO DOPAMINE METABOLIC PROCESS,0.00012512,-0.48807,-0.39637,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS,1.7806e-05,-0.48987,-0.4636,1,0
2,GO RESPONSE TO LITHIUM ION,0.00017186,-0.48996,-0.39199,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.0028141,-0.49399,-0.37768,1,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00098941,-0.49417,-0.38242,1,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.0017123,-0.50115,-0.38758,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,5.7413e-06,-0.50173,-0.50214,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0010528,-0.50502,-0.52338,1,0
2,GO SEROTONIN METABOLIC PROCESS,0.00026003,-0.50596,-0.45855,1,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0085714,-0.50641,-0.44739,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00065623,-0.52796,-0.41199,1,0
2,GO GLIAL CELL FATE COMMITMENT,0.0015653,-0.54891,-0.44384,1,0
2,GO NEURONAL ION CHANNEL CLUSTERING,4.1617e-05,-0.5493,-0.57272,1,0
2,GO AMINE TRANSPORT,2.7343e-05,-0.55393,-0.45855,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,3.6228e-06,-0.55775,-0.49852,1,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013139,-0.56015,-0.45307,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,2.0833e-05,-0.56533,-0.56128,1,0
2,GO SUBPALLIUM DEVELOPMENT,3.6228e-06,-0.56698,-0.52343,1,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,6.2367e-06,-0.56804,-0.63466,1,0
2,GO REGULATION OF GLUTAMATE SECRETION,1.2962e-05,-0.5753,-0.50058,1,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.7806e-05,-0.59905,-0.52503,1,0
2,GO MONOAMINE TRANSPORT,4.8379e-05,-0.61289,-0.47027,1,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,1.5816e-05,-0.61804,-0.51151,1,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,2.6902e-06,-0.6223,-0.57905,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.7413e-06,-0.62336,-0.60923,1,0
2,GO REGULATION OF DENDRITE EXTENSION,6.4994e-06,-0.63373,-0.64816,1,0
2,GO RESPONSE TO INSECTICIDE,1.1493e-05,-0.64525,-0.54813,1,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,9.7346e-05,-0.66093,-0.50387,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.5816e-05,-0.6665,-0.62052,1,0
2,GO SYNAPSE MATURATION,0.00019079,-0.66908,-0.57202,1,0
2,GO NEURON CELL CELL ADHESION,7.547e-05,-0.67433,-0.62589,1,0
2,GO NOSE DEVELOPMENT,0.00092958,-0.68387,-0.49443,1,0
2,GO SYNAPTIC VESICLE PRIMING,4.1617e-05,-0.68553,-0.57212,1,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00057693,-0.69392,-0.47901,1,0
2,GO INNERVATION,1.7474e-06,-0.69684,-0.69318,1,0
2,GO MECHANOSENSORY BEHAVIOR,0.0022992,-0.70331,-0.57914,1,0
2,GO SYNAPTIC VESICLE MATURATION,2.5308e-05,-0.70729,-0.74317,1,0
2,GO DOPAMINE TRANSPORT,0.00029782,-0.71466,-0.53243,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,3.0576e-06,-0.71975,-0.65879,1,0
2,GO GANGLION DEVELOPMENT,4.6623e-06,-0.72491,-0.72524,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,4.8612e-06,-0.72655,-0.70448,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,2.9532e-05,-0.76375,-0.67236,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0011199,-0.81523,-0.6184,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,2.5308e-05,-0.92275,-0.7472,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.6015e-06,-0.94969,-0.79829,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.2862e-06,-0.99956,-0.98187,1,0
2,GO GABAERGIC NEURON DIFFERENTIATION,4.6597e-05,-1.0677,-0.77311,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.012203,-1.0924,-0.83341,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,3.4728e-06,-1.3246,-1.241,1,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,6.0504e-05,-1.4303,-1.0716,1,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.076492,0.51854,0.4427,0,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.05824,0.4351,0.33785,0,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.077957,0.36104,0.31274,0,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.13355,0.33992,0.18597,0,1
2,GO LIPID DROPLET FORMATION,0.13583,0.33649,0.20966,0,1
2,GO RESPONSE TO HYDROPEROXIDE,0.072231,0.32846,0.21761,0,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.099158,0.32508,0.12298,0,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0695,0.32157,0.14341,0,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.073629,0.31177,0.21178,0,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.072231,0.29623,0.2157,0,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.084046,0.27972,0.22496,0,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.092194,0.27839,0.25672,0,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.061812,0.27104,0.13316,0,1
2,GO LATERAL MESODERM DEVELOPMENT,0.71658,0.26822,0.065851,0,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.10845,0.2557,0.18292,0,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.1028,0.24333,0.13809,0,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.057089,0.24267,0.15778,0,1
2,GO REPLICATIVE SENESCENCE,0.24288,0.24128,0.099938,0,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.10654,0.24107,0.1504,0,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.15773,0.22586,0.13958,0,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.075049,0.22297,0.1031,0,1
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.44924,0.22167,0.057087,0,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.065563,0.21867,0.19108,0,1
2,GO REGULATION OF ANOIKIS,0.12259,0.21851,0.13032,0,1
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.057089,0.21849,0.090822,0,1
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.28785,0.21838,0.11702,0,1
2,GO RESPONSE TO UV B,0.20937,0.21293,0.12408,0,1
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.50896,0.21042,0.050278,0,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.063042,0.20628,0.1509,0,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.057089,0.20567,0.11243,0,1
2,GO EPITHELIAL CELL MORPHOGENESIS,0.095625,0.20394,0.18219,0,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.075049,0.20182,0.16141,0,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.1313,0.19994,0.12627,0,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.097379,0.19812,0.1129,0,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.068167,0.19752,0.14163,0,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.082489,0.19724,0.12313,0,1
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.053746,0.19604,0.1508,0,1
2,GO PIGMENT CELL DIFFERENTIATION,0.057089,0.19319,0.097604,0,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.18508,0.19236,0.043618,0,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.35607,0.19149,0.048927,0,1
2,GO VIRAL LATENCY,0.13355,0.19147,0.098042,0,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.59664,0.19032,0.083642,0,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.10096,0.18848,0.17151,0,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.54903,0.18702,0.022063,0,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.055956,0.18575,0.16665,0,1
2,GO GENITALIA MORPHOGENESIS,0.066855,0.18364,0.16524,0,1
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.21905,0.18192,0.076712,0,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.16032,0.18182,0.086555,0,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.36526,0.17875,0.02479,0,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.11841,0.1774,0.090264,0,1
2,GO EMBRYO IMPLANTATION,0.060602,0.17722,0.12683,0,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.093897,0.17551,0.096509,0,1
2,GO INTERLEUKIN 5 PRODUCTION,0.11434,0.17493,0.16731,0,1
2,GO MAST CELL ACTIVATION,0.061812,0.171,0.12634,0,1
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.21256,0.16986,0.14176,0,1
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.31232,0.16972,0.12086,0,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.064293,0.16674,0.1256,0,1
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.15517,0.16669,0.10368,0,1
2,GO CERAMIDE TRANSPORT,0.2,0.16584,0.10881,0,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.061812,0.16568,0.14709,0,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.088862,0.16556,0.18424,0,1
2,GO NEGATIVE REGULATION OF CELL AGING,0.29992,0.16551,0.1008,0,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.055956,0.16487,0.13761,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.11039,0.16435,0.089078,0,1
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.070855,0.16396,0.15505,0,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.063042,0.16197,0.19494,0,1
2,GO NAD METABOLIC PROCESS,0.10845,0.16039,0.12996,0,1
2,GO MYELIN ASSEMBLY,0.16559,0.15982,0.11409,0,1
2,GO DEVELOPMENTAL PIGMENTATION,0.14048,0.15818,0.06676,0,1
2,GO PERICARDIUM DEVELOPMENT,0.059411,0.1579,0.16733,0,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.070855,0.15653,0.15171,0,1
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.32077,0.15557,0.14452,0,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.088862,0.15352,0.092231,0,1
2,GO MAST CELL MEDIATED IMMUNITY,0.12049,0.15239,0.11772,0,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.10096,0.15173,0.13767,0,1
2,GO MALE SEX DETERMINATION,0.12049,0.15167,0.13342,0,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.32938,0.15115,0.074441,0,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.10465,0.15066,0.12599,0,1
2,GO GOLGI TO VACUOLE TRANSPORT,0.34256,0.15007,0.060904,0,1
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.055956,0.14923,0.16068,0,1
2,GO PROTEIN AUTOPROCESSING,0.36064,0.14778,0.040286,0,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.075049,0.14753,0.16627,0,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.1313,0.1472,0.138,0,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.16828,0.1459,0.10664,0,1
2,GO TRACHEA MORPHOGENESIS,0.26098,0.14488,0.049606,0,1
2,GO MRNA METHYLATION,0.0695,0.14483,0.12837,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.075049,0.14346,0.097057,0,1
2,GO FILOPODIUM ASSEMBLY,0.19695,0.14163,0.07474,0,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.19393,0.14053,0.070855,0,1
2,GO RESPONSE TO CORTICOSTEROID,0.092194,0.14021,0.10701,0,1
2,GO HAIR CELL DIFFERENTIATION,0.079444,0.13999,0.1138,0,1
2,GO HISTONE MONOUBIQUITINATION,0.065563,0.13944,0.09156,0,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.11039,0.13847,0.071765,0,1
2,GO NUCLEOTIDE SALVAGE,0.38408,0.13847,0.096841,0,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.11636,0.13829,0.10244,0,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.082489,0.13814,0.077387,0,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.1028,0.13616,0.10926,0,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.11235,0.13486,0.073338,0,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.054842,0.13442,0.083947,0,1
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.11841,0.13418,0.083499,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.29586,0.13388,0.086432,0,1
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.092194,0.13364,0.08355,0,1
2,GO RESPONSE TO DEXAMETHASONE,0.073629,0.13357,0.14207,0,1
2,GO PANCREATIC JUICE SECRETION,0.29992,0.13319,0.081989,0,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.14769,0.13217,0.08249,0,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.22235,0.13206,0.14017,0,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.070855,0.13204,0.071719,0,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.079444,0.13074,0.07637,0,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.063042,0.12998,0.083354,0,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.16828,0.12975,0.15559,0,1
2,GO LYMPHANGIOGENESIS,0.11636,0.12965,0.11565,0,1
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.073629,0.1291,0.13823,0,1
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.35607,0.12893,0.069838,0,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.068167,0.12848,0.09973,0,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.18508,0.12843,0.080965,0,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.17653,0.12816,0.077301,0,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.099158,0.12671,0.069123,0,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.27611,0.12664,0.20489,0,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.17934,0.12629,0.12896,0,1
2,GO NEGATIVE REGULATION OF CELL SIZE,0.063042,0.12625,0.10772,0,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.079444,0.12583,0.10925,0,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0695,0.12482,0.12083,0,1
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.066855,0.12434,0.12008,0,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.082489,0.12334,0.099562,0,1
2,GO CELLULAR RESPONSE TO X RAY,0.088862,0.12252,0.18138,0,1
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.05824,0.12242,0.068775,0,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.065563,0.12157,0.084914,0,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.073629,0.12139,0.061902,0,1
2,GO PROTEIN MATURATION,0.10465,0.11988,0.060044,0,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.13583,0.1196,0.082989,0,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.15773,0.11916,0.050253,0,1
2,GO CARNITINE METABOLIC PROCESS,0.25001,0.11888,0.059096,0,1
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.34256,0.11884,0.084528,0,1
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.087232,0.11779,0.097305,0,1
2,GO IMMATURE B CELL DIFFERENTIATION,0.15517,0.11772,0.12007,0,1
2,GO CELLULAR PIGMENTATION,0.063042,0.11644,0.099707,0,1
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.46512,0.1163,0.019158,0,1
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.12259,0.11492,0.11163,0,1
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.13583,0.11481,0.090736,0,1
2,GO VIRION ASSEMBLY,0.17374,0.11481,0.053766,0,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26847,0.11466,0.052213,0,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0695,0.11292,0.14517,0,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.29184,0.11227,0.092489,0,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.22568,0.11153,0.072666,0,1
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.29992,0.11091,0.10143,0,1
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.31232,0.11065,0.044667,0,1
2,GO AUTOPHAGIC CELL DEATH,0.48131,0.11038,0.03309,0,1
2,GO SEQUESTERING OF METAL ION,0.12473,0.11012,0.12577,0,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.54903,0.11005,0.025219,0,1
2,GO NEURAL TUBE DEVELOPMENT,0.063042,0.11004,0.12345,0,1
2,GO SPLEEN DEVELOPMENT,0.088862,0.10899,0.11594,0,1
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.33812,0.10877,0.15622,0,1
2,GO REGULATION OF GASTRULATION,0.21905,0.10854,0.079461,0,1
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.054842,0.10839,0.075668,0,1
2,GO TRANSCYTOSIS,0.085627,0.10804,0.096796,0,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.088862,0.10753,0.094676,0,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.10465,0.10676,0.10367,0,1
2,GO COBALAMIN METABOLIC PROCESS,0.25729,0.10587,0.061023,0,1
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.19695,0.10499,0.044019,0,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.42347,0.10496,0.029511,0,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.053746,0.10479,0.081071,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.093897,0.10337,0.050929,0,1
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.76948,0.1026,-0.00054557,0,1
2,GO METHIONINE METABOLIC PROCESS,0.17099,0.102,0.058311,0,1
2,GO HISTONE H2A UBIQUITINATION,0.16032,0.10155,0.066811,0,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.1028,0.10138,0.083988,0,1
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.088862,0.10015,0.083604,0,1
2,GO PROTEIN MONOUBIQUITINATION,0.060602,0.098914,0.066031,0,1
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.085627,0.097706,0.084267,0,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.065563,0.097072,0.15581,0,1
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.78962,0.096537,0.011197,0,1
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.064293,0.096202,0.15831,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.13583,0.096082,0.081824,0,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.17374,0.095764,0.051142,0,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.17374,0.095002,0.059714,0,1
2,GO MANGANESE ION TRANSPORT,0.26098,0.094835,0.081694,0,1
2,GO REGULATION OF HELICASE ACTIVITY,0.1313,0.094649,0.10692,0,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.29184,0.094374,0.06814,0,1
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.11841,0.093413,0.088175,0,1
2,GO POSITIVE REGULATION OF MYELINATION,0.19695,0.093256,0.078851,0,1
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.12689,0.092703,0.13129,0,1
2,GO DNA REPLICATION INITIATION,0.13355,0.092476,0.082918,0,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.068167,0.091642,0.061983,0,1
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.093897,0.090322,0.10551,0,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.19393,0.090209,0.071089,0,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.17374,0.089962,0.062916,0,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0695,0.089196,0.10661,0,1
2,GO PROTEIN STABILIZATION,0.11235,0.089151,0.058041,0,1
2,GO ORGANELLE INHERITANCE,0.063042,0.089061,0.061435,0,1
2,GO BILE ACID METABOLIC PROCESS,0.12259,0.087884,0.083811,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.24643,0.086725,0.066839,0,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.53167,0.08618,0.020963,0,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.10096,0.085706,0.084091,0,1
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.89215,0.084825,-0.00078325,0,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.063042,0.084611,0.086926,0,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.099158,0.08347,0.0853,0,1
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.081489,0.070974,0,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.079444,0.081074,0.069088,0,1
2,GO RETROGRADE AXONAL TRANSPORT,0.10465,0.080585,0.11482,0,1
2,GO CELLULAR SENESCENCE,0.24288,0.079575,0.046859,0,1
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.068167,0.079551,0.075541,0,1
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.188,0.079495,0.052328,0,1
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.14048,0.079093,0.065798,0,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.12908,0.078719,0.054498,0,1
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.43367,0.07855,0.027837,0,1
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.41341,0.076254,0.049391,0,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.05824,0.076054,0.064507,0,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.055956,0.075678,0.15302,0,1
2,GO HISTONE H2A ACETYLATION,0.27611,0.07561,0.04532,0,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.15015,0.075066,0.13399,0,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.090515,0.074584,0.071366,0,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.057089,0.073917,0.093119,0,1
2,GO REGULATION OF CELL AGING,0.18219,0.073724,0.054161,0,1
2,GO ADHERENS JUNCTION ORGANIZATION,0.32506,0.073602,0.03892,0,1
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.17934,0.073177,0.093608,0,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.50337,0.07296,0.026552,0,1
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.068167,0.072033,0.075471,0,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.18508,0.071651,0.038724,0,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.34702,0.071632,0.030942,0,1
2,GO POSITIVE REGULATION OF RNA SPLICING,0.56075,0.070624,0.0085928,0,1
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.12908,0.070615,0.054605,0,1
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.16828,0.0705,0.10903,0,1
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.28785,0.07025,0.074248,0,1
2,GO REGULATION OF FEEDING BEHAVIOR,0.068167,0.069672,0.13641,0,1
2,GO O GLYCAN PROCESSING,0.31232,0.06909,0.036689,0,1
2,GO PROTEIN INSERTION INTO MEMBRANE,0.30815,0.068981,0.031709,0,1
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.085627,0.068518,0.067519,0,1
2,GO REGULATION OF SPINDLE ASSEMBLY,0.10654,0.067819,0.10824,0,1
2,GO LIPID PHOSPHORYLATION,0.082489,0.066729,0.05841,0,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.28785,0.065404,0.06355,0,1
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.26098,0.065055,0.025599,0,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.59059,0.063907,0.038627,0,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.74288,0.06364,0.018208,0,1
2,GO GLYCOSYLATION,0.39371,0.063382,-0.005074,0,1
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.43883,0.062882,0.032327,0,1
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.33812,0.062631,0.053424,0,1
2,GO CELLULAR RESPONSE TO RADIATION,0.055956,0.062614,0.086124,0,1
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.24643,0.062134,0.089325,0,1
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.2839,0.06123,0.064391,0,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.059411,0.060705,0.11518,0,1
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.26471,0.060694,0.021496,0,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.12473,0.060158,0.091784,0,1
2,GO SPINDLE ASSEMBLY,0.11636,0.059852,0.048363,0,1
2,GO CERAMIDE METABOLIC PROCESS,0.21256,0.059721,0.026578,0,1
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.26847,0.058502,0.021186,0,1
2,GO MITOTIC CYTOKINESIS,0.079444,0.057488,0.095263,0,1
2,GO RETINA HOMEOSTASIS,0.15015,0.057135,0.079949,0,1
2,GO ARTERY MORPHOGENESIS,0.22905,0.053948,0.085609,0,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.13814,0.053939,0.047256,0,1
2,GO SPHINGOLIPID METABOLIC PROCESS,0.41341,0.05315,0.0088447,0,1
2,GO HETEROCHROMATIN ORGANIZATION,0.19095,0.051863,0.038617,0,1
2,GO REGULATION OF MITOTIC CELL CYCLE,0.082489,0.051548,0.054792,0,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.097379,0.051068,0.10447,0,1
2,GO MACROMOLECULE DEACYLATION,0.15773,0.050151,0.041132,0,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.29992,0.049785,0.062412,0,1
2,GO MITOTIC CELL CYCLE,0.063042,0.049151,0.055821,0,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.065563,0.048844,0.074669,0,1
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.52025,0.048118,0.031667,0,1
2,GO REGULATION OF ATPASE ACTIVITY,0.079444,0.048109,0.05916,0,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.057089,0.047949,0.066243,0,1
2,GO REGULATION OF PROTEIN ACETYLATION,0.087232,0.045625,0.063115,0,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.084046,0.045577,0.050273,0,1
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.13355,0.043571,0.033044,0,1
2,GO INTRACELLULAR TRANSPORT,0.092194,0.042005,0.037352,0,1
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.15015,0.037673,0.030446,0,1
2,GO REGULATION OF MRNA PROCESSING,0.13583,0.037671,0.05622,0,1
2,GO ATP METABOLIC PROCESS,0.099158,0.036376,0.064149,0,1
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.10845,0.036351,0.042738,0,1
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.42347,0.032914,0.02443,0,1
2,GO BLASTOCYST DEVELOPMENT,0.16032,0.032582,0.047057,0,1
2,GO POSITIVE REGULATION OF DNA REPAIR,0.26847,0.031521,0.047979,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.12689,0.03058,0.053379,0,1
2,GO CHROMATIN ORGANIZATION,0.077957,0.0298,0.043052,0,1
2,GO CELL CYCLE PROCESS,0.059411,0.027887,0.048902,0,1
2,GO CELL CYCLE,0.11039,0.027347,0.038396,0,1
2,GO PEPTIDYL LYSINE ACETYLATION,0.18508,0.025187,0.044034,0,1
2,GO CELL DIVISION,0.15264,0.023158,0.057702,0,1
2,GO PROTEIN ACETYLATION,0.36526,0.021434,0.029627,0,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00022676,0.3868,0.37012,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.012508,0.35986,0.36744,0,0
2,GO BLEB ASSEMBLY,0.12689,0.33974,0.19859,0,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.099158,0.32015,0.23488,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.077957,0.31374,0.15279,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.0054795,0.30486,0.24629,0,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.1028,0.30145,0.17926,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.57857,0.29797,0.034416,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.055956,0.29077,0.37322,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.070855,0.28096,0.21601,0,0
2,GO GERMINAL CENTER FORMATION,0.093897,0.28057,0.12898,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.060602,0.27885,0.24118,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.092194,0.27371,0.19139,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.022165,0.26844,0.25348,0,0
2,GO NEUROBLAST DIVISION,0.0017641,0.26468,0.3465,0,0
2,GO REGULATION OF TOLERANCE INDUCTION,0.061812,0.26118,0.15672,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.23937,0.2577,0.10686,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.27611,0.24414,0.064834,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.24288,0.23828,0.066677,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.47049,0.23692,0.012974,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.084046,0.23499,0.1641,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.17099,0.2316,0.1155,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.14048,0.22942,0.10616,0,0
2,GO HEART VALVE FORMATION,0.13583,0.22788,0.18922,0,0
2,GO TRACHEA DEVELOPMENT,0.026586,0.22787,0.19285,0,0
2,GO SOMATIC STEM CELL DIVISION,0.17934,0.22672,0.17662,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.059411,0.21984,0.20745,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.015953,0.21971,0.27628,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.21905,0.21861,0.14138,0,0
2,GO STEM CELL DIVISION,0.0019282,0.21697,0.23401,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.29586,0.21596,0.12111,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.063042,0.2142,0.20474,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.12259,0.21357,0.15373,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.059411,0.2133,0.14963,0,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.097379,0.21317,0.15968,0,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.1028,0.21225,0.13597,0,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.099158,0.21155,0.14991,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.17653,0.2105,0.1462,0,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.084046,0.20974,0.12641,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.087232,0.20819,0.14165,0,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.093897,0.20802,0.15451,0,0
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.14048,0.20656,0.15174,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.11636,0.20626,0.16532,0,0
2,GO LIPID IMPORT INTO CELL,0.11434,0.20551,0.12182,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.16032,0.20521,0.10164,0,0
2,GO DETECTION OF OTHER ORGANISM,0.20309,0.20472,0.060443,0,0
2,GO GAP JUNCTION ASSEMBLY,0.36991,0.20448,0.066647,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.13355,0.20395,0.22646,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.21256,0.20147,0.10552,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.11235,0.20133,0.16119,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0695,0.20119,0.10224,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.40349,0.20094,0.069965,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.97557,0.2001,-0.075825,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.16032,0.19993,0.22693,0,0
2,GO LIPOXYGENASE PATHWAY,0.10096,0.19901,0.18988,0,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.080955,0.19808,0.12942,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.15517,0.19668,0.081786,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.065563,0.19654,0.12072,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.088862,0.19479,0.12192,0,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.027188,0.19468,0.13298,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.11636,0.19376,0.14205,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.1028,0.19244,0.178,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.12473,0.1924,0.14951,0,0
2,GO HISTAMINE SECRETION,0.053746,0.19119,0.18718,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.080955,0.19109,0.11879,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.065563,0.1896,0.16444,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.070855,0.18908,0.14709,0,0
2,GO CYTIDINE TO URIDINE EDITING,0.061812,0.18903,0.31052,0,0
2,GO EPOXYGENASE P450 PATHWAY,0.061812,0.18786,0.15481,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.03245,0.18784,0.15501,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.10096,0.18711,0.15937,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.11636,0.18683,0.1322,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.32506,0.18519,0.10919,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0695,0.18487,0.17996,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.15517,0.18416,0.079552,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.055956,0.18337,0.15871,0,0
2,GO HISTAMINE TRANSPORT,0.15517,0.1811,0.11734,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.20621,0.17898,0.10209,0,0
2,GO POSITIVE REGULATION OF WOUND HEALING,0.072231,0.1789,0.15682,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0695,0.1773,0.1863,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.38888,0.17713,0.068642,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.085627,0.17672,0.12201,0,0
2,GO TONGUE DEVELOPMENT,0.041967,0.176,0.18708,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.12908,0.17583,0.13829,0,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.059411,0.17541,0.12466,0,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.12473,0.1751,0.11231,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.14285,0.17504,0.21802,0,0
2,GO ARGININE METABOLIC PROCESS,0.085627,0.17404,0.16935,0,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.079444,0.17372,0.085207,0,0
2,GO ZYMOGEN ACTIVATION,0.12473,0.17347,0.18151,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.12259,0.17281,0.21812,0,0
2,GO CELL AGGREGATION,0.05824,0.1722,0.14802,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.17374,0.17121,0.17414,0,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.065563,0.17062,0.10775,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16032,0.17057,0.13735,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.16294,0.1699,0.11235,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.15264,0.1694,0.13898,0,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.14526,0.16906,0.081651,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.66501,0.16829,-0.00050559,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.50337,0.16721,0.043226,0,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.13355,0.16705,0.12816,0,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.13583,0.16663,0.086763,0,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.090515,0.16636,0.20873,0,0
2,GO BONE GROWTH,0.072231,0.1651,0.16245,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.2839,0.16501,0.094752,0,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.097379,0.16491,0.080095,0,0
2,GO SKIN MORPHOGENESIS,0.38408,0.16451,0.086945,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.44924,0.16438,0.11756,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.97557,0.1641,-0.0058543,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.54903,0.16366,0.025659,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.079444,0.16304,0.13689,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.054842,0.16233,0.082445,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0695,0.16212,0.13167,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.40349,0.16203,0.060027,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.072231,0.16119,0.13587,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.21579,0.16119,0.14094,0,0
2,GO ASTROCYTE DEVELOPMENT,0.33812,0.16033,0.070071,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.34256,0.16014,0.074279,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.10096,0.16001,0.13653,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.095625,0.15997,0.11328,0,0
2,GO GRANULOCYTE CHEMOTAXIS,0.054842,0.1599,0.085825,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.079444,0.15829,0.12427,0,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.10654,0.15829,0.14206,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.31653,0.15783,0.087136,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.045624,0.15644,0.1865,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.082489,0.15621,0.12815,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.13583,0.15581,0.11506,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.085627,0.15545,0.1895,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.10654,0.15496,0.15144,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.17934,0.15469,0.082429,0,0
2,GO GONADOTROPIN SECRETION,0.23245,0.15449,0.092773,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.16032,0.15443,0.075873,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.17934,0.15367,0.19013,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.093897,0.15307,0.12882,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.13583,0.15261,0.13299,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.29586,0.15223,0.11109,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.38408,0.15205,0.099307,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.67776,0.15166,-0.00069196,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.13355,0.15107,0.1231,0,0
2,GO MIDGUT DEVELOPMENT,0.60272,0.15043,0.098326,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.11039,0.14993,0.10204,0,0
2,GO ASYMMETRIC CELL DIVISION,0.066855,0.1496,0.14195,0,0
2,GO COCHLEA MORPHOGENESIS,0.031059,0.14914,0.1519,0,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.076492,0.14909,0.1536,0,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.084046,0.14902,0.07251,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.26471,0.14901,0.070509,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.092194,0.14893,0.080321,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.15517,0.14869,0.075382,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.090515,0.14862,0.10481,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.2,0.14846,0.082641,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.088862,0.14815,0.14231,0,0
2,GO RENAL FILTRATION,0.20309,0.14811,0.11824,0,0
2,GO RESPONSE TO THYROID HORMONE,0.082489,0.14797,0.14293,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.070855,0.14712,0.14137,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.13355,0.14626,0.14875,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.095625,0.14577,0.14198,0,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.080955,0.1449,0.09778,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.22568,0.14428,0.089502,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.2839,0.14406,0.052526,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.063042,0.14405,0.097329,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.070855,0.1439,0.14174,0,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.11039,0.14268,0.095797,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.12049,0.14171,0.098463,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.18508,0.14111,0.10037,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.099158,0.1411,0.14859,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.32077,0.1405,0.041122,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.21256,0.14033,0.066417,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.15773,0.13973,0.084943,0,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.5726,0.13933,0.018461,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.12473,0.13914,0.17555,0,0
2,GO ANOIKIS,0.19393,0.13864,0.08583,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.44924,0.13849,0.061648,0,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.077957,0.13818,0.10586,0,0
2,GO REGULATION OF GTP BINDING,0.092194,0.13777,0.15204,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.19695,0.13776,0.060715,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.059411,0.13776,0.11406,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.23245,0.13774,0.11829,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.53167,0.13768,0.037367,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.18508,0.13761,0.07405,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.22235,0.13738,0.078969,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.29586,0.13727,0.08713,0,0
2,GO PLASMA MEMBRANE FUSION,0.13583,0.13713,0.098939,0,0
2,GO RESPONSE TO UV C,0.1028,0.13699,0.14542,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.031059,0.13678,0.1006,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.084046,0.13672,0.077145,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.50896,0.13607,0.095289,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.14526,0.13592,0.10011,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.11039,0.13587,0.10573,0,0
2,GO GRANULOCYTE MIGRATION,0.088862,0.13552,0.074519,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.14048,0.13537,0.11013,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.061812,0.1351,0.1135,0,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.14048,0.13494,0.064477,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.14285,0.13486,0.094337,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.55487,0.13482,0.041488,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.080955,0.13458,0.12348,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.66501,0.13437,-0.00039267,0,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.25001,0.13433,0.0094464,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.064293,0.13427,0.13013,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.20621,0.13391,0.12281,0,0
2,GO ANIMAL ORGAN REGENERATION,0.060602,0.13374,0.092932,0,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.26098,0.13364,0.070871,0,0
2,GO PLATELET ACTIVATION,0.057089,0.13345,0.086008,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.085627,0.13318,0.13489,0,0
2,GO CYTOLYSIS,0.46512,0.13231,0.050649,0,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.27611,0.1322,0.044988,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.2,0.13205,0.075108,0,0
2,GO POSITIVE REGULATION OF CELL SIZE,0.064293,0.13199,0.16831,0,0
2,GO ACTIN CROSSLINK FORMATION,0.47588,0.13198,0.025213,0,0
2,GO CELLULAR RESPONSE TO DSRNA,0.11636,0.13163,0.084397,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.98255,0.13139,0.074577,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.64605,0.13123,0.060634,0,0
2,GO GDP METABOLIC PROCESS,0.24288,0.13079,0.10132,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.11841,0.1307,0.17792,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.11235,0.12996,0.068598,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.080955,0.12949,0.087521,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.13355,0.12935,0.070897,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.079444,0.12919,0.10975,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.049546,0.1283,0.1424,0,0
2,GO LEUKOCYTE AGGREGATION,0.39858,0.12819,0.093561,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.21905,0.12806,0.049426,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.061812,0.12746,0.10151,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.18508,0.12726,0.1183,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.42855,0.12722,0.049742,0,0
2,GO RESPONSE TO HYPEROXIA,0.4598,0.12697,0.035696,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.12473,0.12666,0.13723,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.057089,0.12644,0.33517,0,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.092194,0.12577,0.13315,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.088862,0.12531,0.14107,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0062634,0.12522,0.14841,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.13355,0.125,0.09356,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.59664,0.12482,0.080864,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.5726,0.1229,0.057672,0,0
2,GO RESPONSE TO VITAMIN A,0.14048,0.12268,0.099032,0,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.076492,0.1225,0.12515,0,0
2,GO PENILE ERECTION,0.44924,0.12159,0.035569,0,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.15773,0.12137,0.072318,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.33812,0.12105,0.096291,0,0
2,GO STRESS FIBER ASSEMBLY,0.05824,0.12101,0.12194,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.60883,0.12081,-0.012764,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.30402,0.12061,0.074164,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.070855,0.12041,0.11173,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.16828,0.12038,0.073312,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.045624,0.12022,0.087673,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.60883,0.12005,0.040613,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.62732,0.1196,-0.002702,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.20309,0.11942,0.1188,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.11235,0.11927,0.10056,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.27999,0.11925,0.054583,0,0
2,GO RENAL ABSORPTION,0.29992,0.11918,0.11576,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.35607,0.11917,0.065899,0,0
2,GO T CELL MIGRATION,0.34256,0.11896,0.05706,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.24288,0.11867,0.17894,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.084046,0.11787,0.10311,0,0
2,GO NEPHRON DEVELOPMENT,0.084046,0.1177,0.11855,0,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.13814,0.11768,0.080626,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.099158,0.11721,0.14355,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.68418,0.11714,-0.0011501,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.35607,0.11704,0.035484,0,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.082489,0.1169,0.053842,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.41842,0.11687,0.082641,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.063042,0.11685,0.14827,0,0
2,GO ANION HOMEOSTASIS,0.13355,0.11649,0.089598,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.2839,0.11635,0.057272,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.39371,0.11634,0.034191,0,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.11636,0.11597,0.15871,0,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.053746,0.11596,0.18903,0,0
2,GO FORELIMB MORPHOGENESIS,0.53742,0.11567,0.034032,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.085627,0.11561,0.080609,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.15517,0.11526,0.1224,0,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.092194,0.1149,0.066243,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.14526,0.11472,0.064464,0,0
2,GO NEPHRON MORPHOGENESIS,0.12259,0.11469,0.08245,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.96163,0.11446,-0.00065455,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.69061,0.11428,-0.017449,0,0
2,GO WOUND HEALING,0.15264,0.1142,0.074278,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.10845,0.11417,0.077708,0,0
2,GO LIPID LOCALIZATION,0.088862,0.11397,0.052968,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.11039,0.11318,0.14059,0,0
2,GO REGULATION OF COAGULATION,0.69061,0.11302,0.015276,0,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.076492,0.113,0.084365,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.017549,0.11256,0.095068,0,0
2,GO RESPONSE TO ETHANOL,0.070855,0.1124,0.085293,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.73628,0.11229,-0.0036445,0,0
2,GO PYRUVATE METABOLIC PROCESS,0.092194,0.11227,0.075818,0,0
2,GO REGULATION OF WOUND HEALING,0.26847,0.11227,0.07198,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.30815,0.11221,0.0798,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.10465,0.11201,0.091201,0,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.065563,0.11197,0.080301,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.075049,0.11196,0.1083,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.046579,0.11187,0.19069,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.63978,0.11173,0.038603,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.51459,0.11157,0.024823,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.03939,0.11157,0.42822,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.60272,0.11151,0.02431,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.061812,0.1114,0.12061,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.18508,0.11139,0.09019,0,0
2,GO MYOTUBE DIFFERENTIATION,0.13355,0.11131,0.061602,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.23589,0.11127,0.11483,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.080955,0.11116,0.10492,0,0
2,GO RESPONSE TO SALT,0.024288,0.11095,0.16747,0,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.11039,0.11073,0.082718,0,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.095625,0.11053,0.14854,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.47049,0.11021,0.053488,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0085714,0.11007,0.13481,0,0
2,GO PROTEIN PROCESSING,0.33812,0.11005,0.047524,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25363,0.10965,0.066676,0,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.095625,0.10954,0.14625,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.16828,0.10925,0.10749,0,0
2,GO PRO B CELL DIFFERENTIATION,0.2,0.10925,0.16111,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.072231,0.10895,0.073432,0,0
2,GO REGULATION OF PROTEOLYSIS,0.082489,0.10884,0.070333,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.58456,0.1088,0.0262,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.71006,0.10849,0.010302,0,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.077957,0.10844,0.27385,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.77618,0.10798,-0.040852,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.22905,0.1079,0.093324,0,0
2,GO RESPONSE TO DSRNA,0.079444,0.10786,0.078146,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.44402,0.10764,0.074449,0,0
2,GO BODY MORPHOGENESIS,0.9686,0.10764,-0.0088706,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.12908,0.10715,0.16987,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.62732,0.10701,0.0076206,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.34702,0.10693,0.10652,0,0
2,GO RESPONSE TO INACTIVITY,0.29184,0.10681,0.070624,0,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.17934,0.10652,0.039096,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.063042,0.10633,0.23722,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.11636,0.10622,0.10281,0,0
2,GO NEURAL CREST CELL MIGRATION,0.26847,0.10617,0.076404,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.19095,0.10612,0.080146,0,0
2,GO RESPONSE TO ISCHEMIA,0.079444,0.10592,0.078048,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.13355,0.10583,0.08402,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.077957,0.10578,0.079365,0,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.079444,0.1055,0.10507,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.13814,0.10545,0.11124,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.22905,0.10529,0.074741,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.084046,0.10524,0.11741,0,0
2,GO RESPONSE TO LEPTIN,0.56075,0.10499,0.038264,0,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.17653,0.10473,0.061179,0,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.13355,0.10459,0.065865,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.23245,0.1045,0.12133,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.30815,0.10439,0.058171,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.46512,0.10433,0.040884,0,0
2,GO INTERLEUKIN 12 PRODUCTION,0.053746,0.10427,0.10876,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.27227,0.1042,0.075261,0,0
2,GO DIOL METABOLIC PROCESS,0.25363,0.10418,0.079834,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.35607,0.10414,0.033856,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.18508,0.10405,0.10027,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.33373,0.10402,0.091372,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.21256,0.104,0.069578,0,0
2,GO CELL CELL ADHESION,0.12689,0.10372,0.061617,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.059411,0.10359,0.07857,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.43883,0.10355,0.041084,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.36991,0.10354,0.060936,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.13355,0.10349,0.1502,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.30815,0.10341,0.038621,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.12049,0.10323,0.073732,0,0
2,GO RESPONSE TO STEROID HORMONE,0.064293,0.10312,0.088366,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.10654,0.1031,0.089125,0,0
2,GO MUSCLE FILAMENT SLIDING,0.46512,0.10294,0.052478,0,0
2,GO CELLULAR DEFENSE RESPONSE,0.21256,0.10288,0.024876,0,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.059411,0.10285,0.081557,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.12259,0.10279,0.10391,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.099158,0.10275,0.27408,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.27999,0.1027,0.11493,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.16294,0.10261,0.058407,0,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.23245,0.10243,0.067527,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.065563,0.10232,0.16391,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.11039,0.10226,0.14346,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23245,0.10226,0.092405,0,0
2,GO ENDODERM DEVELOPMENT,0.33812,0.10189,0.092926,0,0
2,GO LEUKOCYTE CHEMOTAXIS,0.061812,0.10188,0.078792,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.040234,0.1018,0.13191,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.22235,0.10154,0.077226,0,0
2,GO COAGULATION,0.21579,0.10135,0.04442,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.60883,0.10131,0.01522,0,0
2,GO PLATELET AGGREGATION,0.11434,0.10113,0.10257,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.087232,0.1011,0.071028,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.057089,0.10091,0.10109,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.10845,0.10069,0.087169,0,0
2,GO DNA DEAMINATION,0.11235,0.10026,0.15703,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.1028,0.10013,0.080899,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.40843,0.09975,-0.074863,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.76281,0.099693,0.010192,0,0
2,GO RESPONSE TO NUTRIENT,0.55487,0.099491,0.024843,0,0
2,GO NATURAL KILLER CELL PROLIFERATION,0.11841,0.099439,0.13749,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.56075,0.099267,0.023993,0,0
2,GO LYMPHOCYTE MIGRATION,0.4978,0.099218,0.03237,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.55487,0.099176,0.036996,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.72969,0.099032,0.015321,0,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.14048,0.099009,0.15152,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.52025,0.09897,0.017467,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.25001,0.098849,0.12259,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.44402,0.098846,0.066021,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.12689,0.098564,0.05625,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.13355,0.098529,0.074894,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.20937,0.098298,0.048385,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.060602,0.098234,0.10872,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.95466,0.098219,-0.017836,0,0
2,GO STEROL IMPORT,0.053746,0.098134,0.094196,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.31653,0.097921,0.10665,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.25363,0.097829,0.062092,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.23937,0.097736,0.035329,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.9686,0.097726,-0.028277,0,0
2,GO UV PROTECTION,0.24643,0.097526,0.089996,0,0
2,GO THYROID GLAND DEVELOPMENT,0.31232,0.097518,0.05079,0,0
2,GO PIGMENTATION,0.188,0.097502,0.056976,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.34702,0.09748,0.040668,0,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.05824,0.097444,0.069279,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.24288,0.097122,0.048539,0,0
2,GO INTERLEUKIN 4 PRODUCTION,0.12049,0.097106,0.091308,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.099158,0.097102,0.082488,0,0
2,GO INFLAMMATORY RESPONSE,0.11434,0.096851,0.054416,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.12049,0.096697,0.14593,0,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.19695,0.096531,0.055913,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.29184,0.096344,0.10869,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.25729,0.096201,0.043257,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.13583,0.096189,0.065859,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.10096,0.096015,0.14962,0,0
2,GO TISSUE REGENERATION,0.066855,0.095834,0.11689,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.36526,0.095636,0.071913,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.12689,0.095561,0.049276,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.42855,0.095442,0.055024,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.20937,0.095412,0.088988,0,0
2,GO LIPID STORAGE,0.2,0.095367,0.052031,0,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.076492,0.095261,0.054349,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0059384,0.094865,0.11924,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.47049,0.094719,0.053722,0,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.12689,0.094591,0.091684,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.14048,0.094585,0.13657,0,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.38888,0.09445,0.017863,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.11841,0.094219,0.13046,0,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.46512,0.094125,0.024299,0,0
2,GO COENZYME A METABOLIC PROCESS,0.19393,0.094107,0.063144,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.36991,0.094103,0.078291,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.33812,0.094096,0.061567,0,0
2,GO RESPONSE TO FATTY ACID,0.17099,0.094021,0.069814,0,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.3746,0.093847,0.1088,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.13814,0.093667,0.076279,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.076492,0.093614,0.067423,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.86455,0.093431,-0.0056016,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.15517,0.093351,0.090004,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.32077,0.093293,0.02567,0,0
2,GO OSTEOBLAST PROLIFERATION,0.14285,0.093068,0.12183,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.65866,0.092954,0.014381,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.60272,0.092866,0.017895,0,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.32938,0.092828,0.051674,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.14285,0.092678,0.12038,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.31232,0.092668,0.069205,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.29184,0.092409,0.039293,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.63978,0.092287,0.034212,0,0
2,GO MESONEPHROS DEVELOPMENT,0.30815,0.092199,0.074426,0,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.34702,0.092106,0.067371,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.26098,0.092023,0.050364,0,0
2,GO HUMORAL IMMUNE RESPONSE,0.10654,0.091782,0.043769,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.22568,0.091709,0.088468,0,0
2,GO RESPONSE TO LIGHT INTENSITY,0.51459,0.091689,0.080547,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.17099,0.091681,0.042832,0,0
2,GO LUNG MORPHOGENESIS,0.093897,0.091553,0.20556,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.44402,0.091438,0.075394,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.1028,0.091312,0.13107,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.072231,0.091298,0.12484,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.076492,0.091289,0.22231,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.12689,0.091277,0.10912,0,0
2,GO BRONCHUS DEVELOPMENT,0.47588,0.091162,0.056768,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.14048,0.090787,0.066882,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.60883,0.090465,0.051403,0,0
2,GO GLOMERULUS DEVELOPMENT,0.12689,0.090139,0.16513,0,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.0695,0.090115,0.12673,0,0
2,GO REGULATION OF BODY FLUID LEVELS,0.15773,0.089802,0.048162,0,0
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.33373,0.089527,0.084876,0,0
2,GO RESPONSE TO ACTIVITY,0.0695,0.089392,0.08218,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.066855,0.089093,0.058137,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.29992,0.088921,0.052342,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.24288,0.088799,0.087433,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.17653,0.088675,0.18268,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.087232,0.088419,0.10304,0,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.18508,0.088418,0.041267,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.99651,0.088383,-0.028314,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.89215,0.088299,0.00037367,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.20621,0.088017,0.060523,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.60883,0.087947,0.0067497,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.62113,0.087567,0.038725,0,0
2,GO AORTA MORPHOGENESIS,0.46512,0.087484,0.057372,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.75615,0.08732,-0.035032,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.35153,0.08728,0.048929,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.39858,0.087118,0.068366,0,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.24288,0.087117,0.050345,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.24288,0.087069,0.064318,0,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.23245,0.087022,0.14275,0,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.15264,0.086829,0.064105,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.31232,0.086756,0.0028281,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.39371,0.08674,0.048899,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.38888,0.086494,0.033904,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.29992,0.086477,0.095705,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.41842,0.086439,0.078683,0,0
2,GO RESPONSE TO KETONE,0.12473,0.086286,0.068323,0,0
2,GO AGING,0.188,0.086057,0.047638,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14285,0.085984,0.065391,0,0
2,GO PROTEIN HYDROXYLATION,0.32077,0.08598,0.050912,0,0
2,GO GENITALIA DEVELOPMENT,0.099158,0.085775,0.075034,0,0
2,GO LEUKOCYTE MIGRATION,0.12473,0.085586,0.060768,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1313,0.085503,0.079841,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.40349,0.085388,0.012975,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.53742,0.084925,0.0103,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.188,0.084876,0.052322,0,0
2,GO SEGMENTATION,0.11235,0.084866,0.074106,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.23589,0.084302,0.067185,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.20309,0.083961,0.085363,0,0
2,GO RNA SURVEILLANCE,0.070855,0.0839,0.10901,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.64605,0.083659,0.011648,0,0
2,GO MUSCLE CELL MIGRATION,0.13814,0.083517,0.10757,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.47588,0.083463,0.015076,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.92682,0.083423,0.0092788,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.11235,0.082969,0.075922,0,0
2,GO RENAL SYSTEM PROCESS,0.2,0.082937,0.05349,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.082489,0.082895,0.13446,0,0
2,GO TRNA CATABOLIC PROCESS,0.23245,0.082742,0.14071,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.11434,0.082676,0.066856,0,0
2,GO MYOBLAST FUSION,0.34256,0.082319,0.039396,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.15015,0.082288,0.090074,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.093897,0.082229,0.057245,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.55487,0.082174,0.04551,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.040234,0.082136,0.084889,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.13355,0.082109,0.064882,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.14285,0.082068,0.11472,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.65234,0.081927,0.024439,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69061,0.08188,0.02041,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.20309,0.081828,0.12333,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.23245,0.081781,0.15716,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.25001,0.081776,0.059038,0,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.093897,0.081764,0.081999,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.50337,0.08162,0.050838,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.084046,0.081609,0.043552,0,0
2,GO PROTEOLYSIS,0.077957,0.081447,0.052379,0,0
2,GO MACROPHAGE ACTIVATION,0.14285,0.081392,0.044558,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.22568,0.081075,0.049114,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.48131,0.081065,0.025968,0,0
2,GO TRANSLESION SYNTHESIS,0.077957,0.081063,0.0621,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.94769,0.080988,0.062329,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.65234,0.080931,0.017499,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.70355,0.080884,0.026257,0,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.11434,0.080543,0.065671,0,0
2,GO RESPONSE TO LIPID,0.11434,0.080517,0.062965,0,0
2,GO REGULATION OF HEAT GENERATION,0.35153,0.080361,0.084545,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.097379,0.080181,0.05909,0,0
2,GO RESPONSE TO DRUG,0.14285,0.080113,0.060895,0,0
2,GO REGULATION OF CELL DEATH,0.0695,0.080025,0.063552,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.29586,0.079992,0.063942,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.36991,0.07987,0.036307,0,0
2,GO GLIAL CELL DEVELOPMENT,0.4978,0.079844,0.022521,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.21905,0.079784,0.058768,0,0
2,GO CHOLESTEROL STORAGE,0.36526,0.079746,0.071433,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.077957,0.079399,0.1375,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.079444,0.079372,0.15067,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.83713,0.079324,0.01423,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.057089,0.079249,0.12378,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.92682,0.079179,-0.0070681,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.11636,0.079117,0.09281,0,0
2,GO RESPONSE TO TESTOSTERONE,0.22568,0.079028,0.085393,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.093897,0.079017,0.092457,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.73628,0.078934,0.051912,0,0
2,GO NEURAL TUBE PATTERNING,0.84397,0.07877,0.020775,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.20309,0.078723,0.12356,0,0
2,GO REGENERATION,0.12908,0.078719,0.077648,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.095625,0.078706,0.070822,0,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,0.078551,0.069626,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.48131,0.078228,0.062521,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.13355,0.077965,0.075981,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.34256,0.077943,0.083261,0,0
2,GO STEROID ESTERIFICATION,0.22235,0.077939,0.050429,0,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.17653,0.077864,0.10376,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.52025,0.077859,0.017871,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.054842,0.077711,0.093019,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.092194,0.077677,0.053148,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.066855,0.077643,0.049816,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0695,0.077561,0.068042,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.17653,0.077391,0.041093,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.47049,0.077381,0.020687,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.43883,0.077215,0.036978,0,0
2,GO BIOLOGICAL ADHESION,0.2,0.077152,0.049894,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.98255,0.077114,-0.043908,0,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.12908,0.076993,0.13995,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.12908,0.07689,0.038715,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.71658,0.076884,0.046381,0,0
2,GO LIPID DROPLET ORGANIZATION,0.25729,0.076472,0.07469,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.075049,0.07619,0.057403,0,0
2,GO PLASMINOGEN ACTIVATION,0.27999,0.076178,0.080152,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.29992,0.076145,0.12715,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.36991,0.076113,0.07521,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.37932,0.076,0.017198,0,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.054842,0.075743,0.077756,0,0
2,GO XENOBIOTIC TRANSPORT,0.73628,0.075706,-0.0096303,0,0
2,GO TISSUE REMODELING,0.95466,0.075662,-0.013963,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.80312,0.075582,0.066774,0,0
2,GO NCRNA 3 END PROCESSING,0.064293,0.075565,0.082329,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.40349,0.075529,0.0091241,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.56666,0.075435,0.078232,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.89215,0.075426,-0.030905,0,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.36991,0.075269,-0.14012,0,0
2,GO HISTONE ARGININE METHYLATION,0.2839,0.075256,0.056423,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.27611,0.07503,0.023251,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.12473,0.075028,0.10346,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.11434,0.075023,0.12963,0,0
2,GO DNA STRAND ELONGATION,0.12049,0.074949,0.083671,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.87144,0.074782,-0.0027689,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.27227,0.07446,0.035099,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.10845,0.074418,0.1164,0,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.32938,0.074234,0.028696,0,0
2,GO KIDNEY MORPHOGENESIS,0.14285,0.074182,0.075903,0,0
2,GO PROTEIN OXIDATION,0.30402,0.074105,0.10376,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.073629,0.073954,0.14214,0,0
2,GO TRABECULA FORMATION,0.29586,0.073566,0.073231,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.1028,0.073543,0.14111,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.34702,0.073504,0.068626,0,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.26847,0.07345,0.070578,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.39858,0.073187,0.14402,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.19695,0.073116,0.062084,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.49227,0.073115,0.064222,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.19095,0.07291,0.043357,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.20937,0.072879,0.048538,0,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.097379,0.072794,0.09717,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.40843,0.072712,0.09829,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.19393,0.072562,0.042668,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.070855,0.072401,0.10686,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.39858,0.072368,0.032692,0,0
2,GO RUFFLE ASSEMBLY,0.13355,0.072357,0.065431,0,0
2,GO REGULATION OF URINE VOLUME,0.25001,0.072355,0.10231,0,0
2,GO MEMBRANE INVAGINATION,0.32077,0.072228,0.048919,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.188,0.07219,0.050064,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.2,0.072177,0.057626,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.05161,0.072105,0.15886,0,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.1028,0.072074,0.06018,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.75615,0.071882,0.090745,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.13583,0.071748,0.08768,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.34256,0.071668,0.060181,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.57857,0.071665,0.044752,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.32077,0.071639,0.022453,0,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.10845,0.071435,0.053841,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.3746,0.071197,0.037346,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.52594,0.071096,0.017712,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.87144,0.071084,-0.055823,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.64605,0.071068,0.011445,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.94769,0.071039,-0.015882,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.26847,0.070911,0.060552,0,0
2,GO AUTOPHAGOSOME MATURATION,0.25001,0.070855,0.05014,0,0
2,GO GLIAL CELL ACTIVATION,0.23245,0.070847,0.054502,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.31232,0.070746,0.033979,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.4598,0.070742,0.063859,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.34702,0.070723,0.13238,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.18219,0.070701,0.085067,0,0
2,GO RESPONSE TO RETINOIC ACID,0.20621,0.070599,0.10298,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.49227,0.070572,0.026625,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.095625,0.070512,0.11531,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.063042,0.070349,0.091581,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.23937,0.070323,0.085673,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.13814,0.070307,0.098118,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.47588,0.070244,0.025384,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.33373,0.070182,0.063594,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.12049,0.070162,0.12614,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.73628,0.070038,0.014572,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.14769,0.069992,0.054594,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.14285,0.06988,0.11294,0,0
2,GO MESODERM DEVELOPMENT,0.11636,0.069875,0.081004,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.47588,0.069698,0.046606,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.29184,0.069567,0.10368,0,0
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.50896,0.069351,0.0873,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.087232,0.069308,0.084981,0,0
2,GO OOCYTE DIFFERENTIATION,0.32077,0.069302,0.035667,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.94073,0.06929,-0.031282,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.20621,0.069282,0.0554,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.188,0.069256,0.056271,0,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.080955,0.069256,0.06202,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.054842,0.069083,0.084323,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.068167,0.068909,0.059835,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.38408,0.068886,0.037297,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.19393,0.068864,0.07713,0,0
2,GO INTERLEUKIN 6 PRODUCTION,0.11841,0.068808,0.069477,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.16559,0.068798,0.20495,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.94073,0.068724,-0.029288,0,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.10654,0.068642,0.075801,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.17099,0.068553,0.066003,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.28785,0.068537,0.044348,0,0
2,GO RESPONSE TO HORMONE,0.2839,0.068508,0.031936,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.4598,0.068389,0.073231,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.10465,0.068312,0.10531,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.18508,0.068216,0.087215,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.15517,0.068122,0.059303,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.4598,0.068109,0.016085,0,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.16032,0.068054,0.063058,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.24288,0.06802,0.054474,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.60883,0.067874,-0.0076898,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.3746,0.067826,0.075463,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.12908,0.067698,0.12618,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.22905,0.067564,0.058309,0,0
2,GO EPITHELIUM DEVELOPMENT,0.37932,0.067398,0.054114,0,0
2,GO SUPEROXIDE ANION GENERATION,0.26847,0.067255,0.085879,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.13583,0.067186,0.23747,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.44924,0.067167,0.031801,0,0
2,GO NADH METABOLIC PROCESS,0.31232,0.067056,0.076871,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.63354,0.067043,0.095396,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.48131,0.066972,0.028519,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.28785,0.066958,0.037906,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.74288,0.066847,0.010147,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.16294,0.066842,0.055165,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.41842,0.066832,0.016901,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.25729,0.066805,0.075011,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.061812,0.066803,0.067828,0,0
2,GO ENDOSOME ORGANIZATION,0.188,0.066743,0.063612,0,0
2,GO RESPONSE TO WOUNDING,0.33812,0.066617,0.04742,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.73628,0.066378,-0.014514,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.39371,0.066363,0.057712,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.54903,0.066333,0.018659,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.18219,0.066161,0.078695,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.20937,0.066119,0.0315,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.83713,0.066061,0.010927,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.29992,0.0658,0.029986,0,0
2,GO EXOCYTOSIS,0.26847,0.065642,0.02896,0,0
2,GO FIBROBLAST PROLIFERATION,0.33373,0.065585,0.065392,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.084046,0.06547,0.11296,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.59664,0.064931,0.0010018,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.34256,0.064908,0.081556,0,0
2,GO REGULATION OF LIPID STORAGE,0.26847,0.064867,0.04167,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.19095,0.064825,0.059533,0,0
2,GO NEUTROPHIL MIGRATION,0.20309,0.064782,0.025509,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.29586,0.064739,0.057349,0,0
2,GO REGULATION OF MRNA BINDING,0.16032,0.064513,0.096062,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.35153,0.064502,0.042028,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.1313,0.064498,0.071496,0,0
2,GO ER OVERLOAD RESPONSE,0.67137,0.06436,0.022374,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.27999,0.064247,0.061596,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.15773,0.06417,0.1651,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.42347,0.064104,0.050888,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.065563,0.064047,0.069798,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.90599,0.064041,0.011561,0,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.099158,0.064012,0.065644,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.095625,0.063775,0.13879,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.54903,0.063774,0.0094757,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.23245,0.063767,0.073559,0,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.14048,0.063621,0.12402,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.80312,0.063472,-0.0099438,0,0
2,GO CYTOKINE SECRETION,0.23589,0.063468,0.051831,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.41341,0.063383,0.029246,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.75615,0.063251,-0.07041,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.19095,0.063073,0.087718,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.78289,0.063049,0.021578,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.075049,0.062876,0.092531,0,0
2,GO CENTRIOLE ASSEMBLY,0.18508,0.062835,0.068731,0,0
2,GO HORMONE METABOLIC PROCESS,0.23937,0.062731,0.044018,0,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.10654,0.06268,0.05586,0,0
2,GO VASCULATURE DEVELOPMENT,0.23589,0.062578,0.070156,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.5726,0.062557,0.03104,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.80312,0.062531,0.005892,0,0
2,GO REGULATION OF RNA BINDING,0.24643,0.062378,0.071402,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.31232,0.062231,0.070977,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.11434,0.062107,0.12282,0,0
2,GO APOPTOTIC PROCESS,0.097379,0.062024,0.047401,0,0
2,GO HOMEOSTATIC PROCESS,0.14769,0.06184,0.025671,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.37932,0.061795,0.060651,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.69707,0.061722,0.012705,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.99651,0.06169,-0.026534,0,0
2,GO MAINTENANCE OF LOCATION,0.20621,0.06152,0.041074,0,0
2,GO DE NOVO PROTEIN FOLDING,0.80989,0.061453,0.005114,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.72313,0.061434,-0.01836,0,0
2,GO ORGAN GROWTH,0.14285,0.06143,0.10958,0,0
2,GO PROTEIN DESTABILIZATION,0.16828,0.061293,0.061793,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.43367,0.061213,0.082464,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.17099,0.061073,0.11856,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.25363,0.061069,0.031648,0,0
2,GO CHROMOSOME CONDENSATION,0.061812,0.061065,0.073834,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.49227,0.060976,0.03809,0,0
2,GO SARCOMERE ORGANIZATION,0.41341,0.060936,0.046797,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.35153,0.060923,0.03215,0,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.31232,0.060897,0.025203,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.21579,0.060872,0.10583,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.22235,0.060831,0.092114,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.41842,0.06079,0.054398,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.35153,0.060625,0.031009,0,0
2,GO RESPONSE TO CHEMOKINE,0.14769,0.060617,0.049582,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.23589,0.060208,0.054202,0,0
2,GO POLYOL CATABOLIC PROCESS,0.39371,0.060186,0.032053,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.088862,0.060012,0.05434,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.15773,0.059935,0.082187,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.50896,0.059866,0.018273,0,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.090515,0.059851,0.059646,0,0
2,GO VAGINA DEVELOPMENT,0.8303,0.059747,-0.043121,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.11841,0.059666,0.29971,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.43367,0.059544,0.061181,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.26847,0.05951,0.097264,0,0
2,GO LIPID DIGESTION,0.94073,0.059464,-0.031255,0,0
2,GO RECOMBINATIONAL REPAIR,0.097379,0.059424,0.07753,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.40349,0.05942,0.01652,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.85082,0.059265,-0.011903,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.11636,0.059264,0.048717,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.20309,0.059228,0.047318,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.50337,0.05905,0.05522,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.11235,0.05904,0.070532,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.4545,0.059025,0.034929,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.13814,0.058896,0.074757,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.18508,0.058738,0.058465,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.39371,0.058703,0.10958,0,0
2,GO PROTEIN POLYMERIZATION,0.11039,0.05864,0.045393,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.47588,0.058629,0.041431,0,0
2,GO HINDLIMB MORPHOGENESIS,0.10096,0.058536,0.11967,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.1313,0.058521,0.14339,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.29184,0.05852,0.059612,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.47049,0.058494,0.11299,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.72313,0.058315,0.077082,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.66501,0.058302,0.002173,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.12689,0.058282,0.040072,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.27611,0.058189,0.054426,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.33812,0.058164,0.039268,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.58456,0.05816,0.017516,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.21256,0.05816,0.044633,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.21905,0.058115,0.084185,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.69707,0.05796,0.026983,0,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.10096,0.057862,0.066634,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.063042,0.057639,0.057341,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.35153,0.057503,0.041674,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.15264,0.057446,0.092526,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.22905,0.057393,0.091158,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.079444,0.057372,0.040873,0,0
2,GO BLASTOCYST GROWTH,0.13814,0.056992,0.0661,0,0
2,GO FEMALE GAMETE GENERATION,0.15773,0.056912,0.039131,0,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.16828,0.056906,0.062198,0,0
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.74288,0.056898,0.0017097,0,0
2,GO RESPONSE TO INSULIN,0.10845,0.056716,0.035724,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.3746,0.056661,0.066477,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.14769,0.056615,0.067678,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.24643,0.056532,0.07541,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.12689,0.056524,0.038078,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.1313,0.056201,0.038433,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.63354,0.056172,0.026991,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.32938,0.055956,0.13399,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.092194,0.055906,0.058702,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.15015,0.055791,0.14778,0,0
2,GO CARTILAGE MORPHOGENESIS,0.51459,0.055791,0.058315,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.19393,0.055576,0.12522,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.34702,0.0555,0.059067,0,0
2,GO BONE REMODELING,0.8303,0.055495,-0.011648,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.26098,0.055475,0.070101,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.16828,0.055451,0.044807,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.74288,0.055363,0.0044657,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.4545,0.055328,0.064995,0,0
2,GO METANEPHROS MORPHOGENESIS,0.59664,0.055324,0.021564,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.21905,0.055312,0.10803,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.25363,0.055305,0.12011,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.48131,0.055285,0.012916,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.74288,0.055266,0.0045132,0,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.49227,0.05498,0.011586,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.41341,0.054957,0.017058,0,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.36064,0.054847,0.042591,0,0
2,GO MEMBRANE DISASSEMBLY,0.69061,0.054697,0.020061,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.076492,0.054671,0.11618,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.41341,0.054538,0.037454,0,0
2,GO CELLULAR EXTRAVASATION,0.23245,0.054495,0.051801,0,0
2,GO RESPONSE TO VITAMIN,0.4598,0.054491,0.044464,0,0
2,GO REGULATION OF PROTEIN BINDING,0.31653,0.054481,0.039017,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.3746,0.054363,0.061758,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.18219,0.054282,0.048864,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.72969,0.054216,0.033028,0,0
2,GO PEPTIDYL ARGININE N METHYLATION,0.22235,0.054112,0.1113,0,0
2,GO LACTATION,0.060602,0.054089,0.10205,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.13583,0.053983,0.074557,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.12473,0.053981,0.086866,0,0
2,GO NUCLEOSOME ORGANIZATION,0.40349,0.05388,0.045516,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.76948,0.053687,-0.017988,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.79636,0.053661,0.0033714,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.21905,0.053497,0.05327,0,0
2,GO PROTEIN TARGETING,0.11636,0.053461,0.07056,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.70355,0.053241,-0.052804,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.082489,0.053195,0.060995,0,0
2,GO FOAM CELL DIFFERENTIATION,0.5726,0.052945,0.0046793,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.24643,0.052857,0.031746,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.21256,0.05278,0.037122,0,0
2,GO ACUTE PHASE RESPONSE,0.27227,0.052761,0.051598,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.88523,0.052616,-0.018922,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.25363,0.052596,0.047676,0,0
2,GO BONE MORPHOGENESIS,0.11039,0.052551,0.11269,0,0
2,GO APPENDAGE DEVELOPMENT,0.10096,0.052534,0.10192,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.38888,0.052499,0.017291,0,0
2,GO ATP TRANSPORT,0.82348,0.052492,0.010466,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.92682,0.052474,-0.0029684,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.87144,0.052325,-0.038795,0,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.19695,0.052313,0.064728,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.24643,0.052285,0.056179,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.15773,0.052233,0.03027,0,0
2,GO SPERM EGG RECOGNITION,0.188,0.052163,0.054911,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.24288,0.052154,0.024749,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.81668,0.052062,0.0013288,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.31232,0.051829,0.047114,0,0
2,GO SEX DIFFERENTIATION,0.51459,0.051757,0.026185,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,0.051709,0.026878,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.82348,0.051702,-0.0029825,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.33373,0.051684,0.066866,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.50337,0.051655,0.024874,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.38408,0.051607,0.012998,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.9686,0.051597,-0.046389,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.2,0.051585,0.076708,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.19393,0.051573,0.036724,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.12049,0.05149,0.069702,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.42347,0.051282,0.051226,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.26471,0.051277,0.10498,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.188,0.051231,0.066854,0,0
2,GO REGULATION OF PINOCYTOSIS,0.36526,0.051012,0.065152,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.72313,0.050841,0.0074296,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.64605,0.050764,0.022915,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.63978,0.050737,0.041633,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.15773,0.050581,0.039746,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.56075,0.050544,0.050116,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.16828,0.050369,0.12375,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.91293,0.050211,-0.013079,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.50896,0.050179,0.0028097,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.35153,0.050057,0.031523,0,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.50337,0.049942,0.042177,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.061812,0.049854,0.074777,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.43883,0.049816,0.031106,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.35607,0.049815,0.080739,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.15773,0.049791,0.047505,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.080955,0.049709,0.11884,0,0
2,GO MYOBLAST PROLIFERATION,0.63354,0.049606,0.01973,0,0
2,GO SYNCYTIUM FORMATION,0.27227,0.049583,0.048953,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.188,0.049531,0.052918,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.58456,0.049513,0.0082399,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.35153,0.049472,0.057193,0,0
2,GO REPLICATION FORK PROCESSING,0.16294,0.049469,0.084256,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.14769,0.049405,0.044781,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.027188,0.049354,0.066968,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.69061,0.04929,0.020832,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.43883,0.049059,0.026729,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.97557,0.049016,-0.033229,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.11841,0.048946,0.066571,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.32506,0.048945,0.068305,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94769,0.048933,-0.00099045,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.83713,0.048812,-0.017979,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.77618,0.048754,0.015262,0,0
2,GO REPLACEMENT OSSIFICATION,0.26847,0.048461,0.13405,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.18219,0.048443,0.05334,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.49227,0.048425,0.01732,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.33373,0.048398,0.035231,0,0
2,GO BRAIN MORPHOGENESIS,0.81668,0.048356,-0.0056329,0,0
2,GO MUSCLE HYPERTROPHY,0.85082,0.047933,0.012867,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.14526,0.047907,0.053649,0,0
2,GO SISTER CHROMATID COHESION,0.29184,0.047877,0.071291,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.51459,0.047805,0.027508,0,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.079444,0.047744,0.0837,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.73628,0.047669,0.012131,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.9686,0.047633,-0.0039583,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.4978,0.047607,0.031042,0,0
2,GO REGULATION OF ERAD PATHWAY,0.22235,0.047491,0.039703,0,0
2,GO RENAL SODIUM EXCRETION,0.66501,0.047487,0.055829,0,0
2,GO G0 TO G1 TRANSITION,0.49227,0.047383,0.0443,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.52025,0.047351,0.034159,0,0
2,GO REGULATION OF T CELL MIGRATION,0.31232,0.047276,0.043283,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.082489,0.047265,0.087916,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.23937,0.047132,0.057636,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.4598,0.04702,0.030973,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.44924,0.046928,0.047211,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.16032,0.046921,0.080086,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.14769,0.046883,0.060456,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.41842,0.046872,0.12194,0,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.27999,0.046857,0.031499,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.63354,0.046802,0.021434,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.48678,0.046772,0.023072,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.71658,0.046764,-0.0098877,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.40843,0.046734,0.020418,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.068167,0.046702,0.074862,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.32077,0.046656,0.030865,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.14526,0.046618,0.047379,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.36991,0.046607,0.060157,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.25001,0.046566,0.052838,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.44924,0.04654,0.014197,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.42855,0.046504,0.040547,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.066855,0.046332,0.061176,0,0
2,GO RESPONSE TO AMINE,0.77618,0.046229,0.0089666,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.30402,0.046154,0.057096,0,0
2,GO GASTRULATION,0.36064,0.046065,0.075223,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.38888,0.045936,0.040095,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.56666,0.045867,0.063734,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.29992,0.045791,0.063869,0,0
2,GO TUBE MORPHOGENESIS,0.32077,0.045719,0.062161,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.12049,0.04556,0.061274,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.085627,0.045497,0.059046,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.32938,0.045474,0.029679,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.25363,0.045448,0.053881,0,0
2,GO AMMONIUM TRANSPORT,0.62113,0.045406,0.035089,0,0
2,GO PROSTATIC BUD FORMATION,0.65866,0.04529,0.042443,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.057089,0.045243,0.071195,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.42855,0.045223,0.0065609,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.34702,0.045152,0.039928,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.31232,0.045139,0.078272,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.33812,0.044923,0.15179,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.31232,0.044901,0.027168,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.21256,0.044901,0.031246,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.41842,0.044822,-0.093515,0,0
2,GO QUINONE METABOLIC PROCESS,0.5726,0.044673,-0.017713,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.23937,0.044517,0.075134,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.18219,0.044475,0.050218,0,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.29992,0.044383,0.073764,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.26471,0.044309,0.059175,0,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.17653,0.044289,0.040489,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.44924,0.044273,0.031953,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.19695,0.044084,0.052081,0,0
2,GO JNK CASCADE,0.24643,0.043964,0.040204,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.48131,0.043887,0.049497,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.49227,0.043855,0.033974,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.85768,0.043477,0.046218,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.16032,0.043309,0.068905,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.59059,0.043299,-0.048605,0,0
2,GO LIPID EXPORT FROM CELL,0.3746,0.043223,0.038346,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.39858,0.04309,0.021377,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.48131,0.043035,0.088406,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.46512,0.043014,0.020461,0,0
2,GO MUSCLE CELL PROLIFERATION,0.33373,0.042991,0.05735,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.2,0.042985,0.049029,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.60883,0.042952,0.0087679,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.54321,0.042892,0.032828,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.095625,0.042833,0.11699,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.94769,0.042794,-0.0079984,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.075049,0.042751,0.14164,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.36991,0.042686,0.016346,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.39858,0.042628,0.052247,0,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.11039,0.042564,0.090846,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.40349,0.042558,0.017796,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.25363,0.04255,0.080168,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.39858,0.042463,0.04091,0,0
2,GO REGULATION OF AUTOPHAGY,0.16294,0.042453,0.035331,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.14048,0.042412,0.068608,0,0
2,GO PH REDUCTION,0.34256,0.042369,0.03248,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.38408,0.042338,0.023134,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.63354,0.042106,0.027301,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.41842,0.042022,0.028828,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.38408,0.041995,0.042541,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.23245,0.041864,0.073452,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.72969,0.041845,0.009748,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.27999,0.04183,0.038212,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.33812,0.04181,0.033901,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.60883,0.041801,0.027013,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.79636,0.041646,0.0075,0,0
2,GO CELL SUBSTRATE ADHESION,0.28785,0.041455,0.07243,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.44402,0.041338,0.031534,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.5726,0.041223,-0.071673,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.17374,0.041015,0.052664,0,0
2,GO AMELOGENESIS,0.11841,0.041009,0.17526,0,0
2,GO FACE DEVELOPMENT,0.70355,0.040916,0.042102,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.36064,0.040885,0.076898,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.71006,0.040842,0.011822,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.60883,0.040832,0.048657,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.65866,0.040758,0.00048052,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.62113,0.040714,0.050416,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.5726,0.040671,0.031851,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.31653,0.040642,0.042778,0,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.11434,0.040341,0.087046,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.087232,0.040316,0.073451,0,0
2,GO PROTEIN NITROSYLATION,0.71006,0.040273,0.045299,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.73628,0.040271,-0.0021553,0,0
2,GO SISTER CHROMATID SEGREGATION,0.082489,0.040261,0.074869,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.61497,0.040175,0.031925,0,0
2,GO T CELL HOMEOSTASIS,0.79636,0.04007,0.001667,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.3746,0.04002,0.034657,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.54903,0.039991,0.034331,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.35153,0.039991,0.067395,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.20621,0.039869,0.28704,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.43367,0.039868,0.08237,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.50337,0.039667,0.018711,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.79636,0.039659,0.013651,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.27611,0.039652,0.068618,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.14285,0.039517,0.079624,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22235,0.039502,0.039273,0,0
2,GO CELLULAR RESPONSE TO ATP,0.54903,0.0395,-0.053965,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.3746,0.039428,0.058661,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.59059,0.039216,0.050286,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.35153,0.039193,0.024067,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.60883,0.039032,0.023571,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.15773,0.039028,0.031976,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.80989,0.03867,-0.023553,0,0
2,GO CELL MOTILITY,0.48131,0.038565,0.021913,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.36526,0.038557,0.018475,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.25001,0.03854,0.051025,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.40349,0.038335,0.021489,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.64605,0.038324,0.070348,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.69707,0.038313,0.042673,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.21905,0.03826,0.032762,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.43367,0.038056,0.01141,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.94073,0.03805,0.045376,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.29992,0.037788,0.045164,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.62732,0.037743,0.043855,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.61497,0.03765,0.041798,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.26847,0.037582,0.075847,0,0
2,GO VIRAL BUDDING,0.90599,0.037544,0.022235,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.66501,0.037485,0.026042,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.12259,0.037446,0.29055,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.29184,0.037287,0.027541,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.47588,0.037215,0.021039,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.16828,0.03715,0.033816,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.50896,0.037112,0.020947,0,0
2,GO SECRETION,0.63354,0.037036,-0.0020831,0,0
2,GO LIVER MORPHOGENESIS,0.41842,0.036915,0.038533,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.85082,0.036865,0.0067225,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.1313,0.036837,0.028764,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.53742,0.036794,0.011869,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.39858,0.036694,0.054044,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.4598,0.036654,0.039753,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.38888,0.03663,0.020665,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.77618,0.036604,-0.061092,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.32077,0.036552,0.056935,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.52025,0.036531,0.016336,0,0
2,GO EMBRYO DEVELOPMENT,0.26471,0.036525,0.048521,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.78289,0.036491,0.0055788,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.36991,0.036446,0.078624,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.90599,0.036392,0.017366,0,0
2,GO AXONAL FASCICULATION,0.65866,0.036389,0.025289,0,0
2,GO PROTEIN TRIMERIZATION,0.29586,0.036297,0.078671,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.86455,0.036247,0.00041853,0,0
2,GO DRUG CATABOLIC PROCESS,0.54321,0.036215,0.024317,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.85082,0.036143,-0.054905,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.4598,0.0359,0.021951,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.64605,0.035892,0.030496,0,0
2,GO RESPONSE TO PROGESTERONE,0.44402,0.035701,0.07679,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.27611,0.035671,0.052746,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.48131,0.035671,0.057386,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.16828,0.035614,0.10596,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.86455,0.035332,0.042598,0,0
2,GO REGULATION OF CELL DIVISION,0.76948,0.035181,0.01653,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.73628,0.035167,0.042367,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.8303,0.035161,-0.0037604,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047551,0.035158,0.067746,0,0
2,GO TUBE DEVELOPMENT,0.63978,0.03512,0.038812,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.13583,0.035017,0.082066,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.52594,0.034913,0.018544,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.7495,0.034904,-0.041878,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.51459,0.034825,0.023561,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.67137,0.034796,0.053079,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.96163,0.034519,-0.027495,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.95466,0.034414,0.011796,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.38888,0.034339,0.0246,0,0
2,GO DNA REPLICATION CHECKPOINT,0.20937,0.034293,0.095598,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.65234,0.034239,0.017871,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.23937,0.034182,0.069062,0,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.69061,0.034122,0.021403,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.2839,0.034092,0.03608,0,0
2,GO NODAL SIGNALING PATHWAY,0.43367,0.034061,0.040371,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.25729,0.034057,0.037246,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.25729,0.033946,0.057739,0,0
2,GO REGULATION OF PH,0.78962,0.03388,-0.01273,0,0
2,GO LYSOSOME LOCALIZATION,0.44924,0.033619,0.024405,0,0
2,GO PROTEIN KINASE A SIGNALING,0.26098,0.03345,0.042363,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.50896,0.033371,0.016285,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.78962,0.033339,-0.0047983,0,0
2,GO EAR DEVELOPMENT,0.44402,0.03324,0.031725,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.37932,0.033169,0.050946,0,0
2,GO BONE DEVELOPMENT,0.55487,0.033162,0.045902,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.80989,0.033141,-0.014117,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.5726,0.033078,0.014995,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.4978,0.033051,0.061301,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.5726,0.03301,0.063541,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.86455,0.032932,0.011669,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.24643,0.032909,0.09823,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.41842,0.032898,0.038681,0,0
2,GO MICROTUBULE ANCHORING,1,0.032815,-0.0093808,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.66501,0.032781,-0.042115,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.56075,0.032752,0.065188,0,0
2,GO HEAD MORPHOGENESIS,0.95466,0.032695,-0.016027,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.4598,0.032675,0.021053,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.2,0.03267,0.030845,0,0
2,GO HEAT GENERATION,0.26471,0.032605,0.075357,0,0
2,GO GLAND DEVELOPMENT,0.80989,0.03255,0.025644,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.94073,0.032534,-0.018107,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.72969,0.032493,0.02342,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.20309,0.032262,0.070777,0,0
2,GO PHOSPHOLIPID EFFLUX,0.54903,0.032237,0.060411,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.12908,0.032126,0.037172,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.087232,0.032057,0.05545,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.62732,0.032053,0.019022,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.23589,0.032008,0.084091,0,0
2,GO CELL CYCLE CHECKPOINT,0.12908,0.031907,0.061234,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.57857,0.031905,0.038283,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.48678,0.03173,0.026306,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.59664,0.031658,0.027317,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.19095,0.031597,0.048329,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.055956,0.031532,0.053608,0,0
2,GO PLATELET DEGRANULATION,0.8303,0.031469,-0.0082298,0,0
2,GO RESPONSE TO ESTRADIOL,0.53742,0.0312,0.022292,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.50896,0.031199,0.01324,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.4545,0.031131,0.024293,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.74288,0.031104,-0.0055599,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.30402,0.031,0.032081,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.13583,0.030974,0.23424,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.9686,0.03097,0.0022861,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.83713,0.030965,-0.019074,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.94073,0.030963,-0.0046669,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.67776,0.030908,0.0042182,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.38888,0.030673,0.069069,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.68418,0.030609,0.0096951,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.98255,0.030566,0.014679,0,0
2,GO PRENYLATION,0.52025,0.030561,0.06394,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.81668,0.030472,-0.014808,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.22568,0.030447,0.044592,0,0
2,GO DECIDUALIZATION,0.86455,0.030409,-0.013648,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.44924,0.030378,0.041093,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.30815,0.030367,0.041542,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.53167,0.030289,0.028686,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.28785,0.03021,0.061859,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.068167,0.030202,0.076122,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.31232,0.030026,0.034959,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.36991,0.029981,0.068881,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.67776,0.029981,-0.037757,0,0
2,GO RESPONSE TO STEROL,0.46512,0.029937,0.026125,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.82348,0.029902,-0.025837,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.53742,0.029873,0.040777,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.65866,0.029843,0.052461,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.9686,0.029788,-0.038401,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.78962,0.029768,-0.004024,0,0
2,GO SINGLE FERTILIZATION,0.92682,0.029667,-0.016069,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.89907,0.029602,-0.0040761,0,0
2,GO RECEPTOR INTERNALIZATION,0.47588,0.029602,0.036779,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.43367,0.029547,0.036218,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.66501,0.029415,0.020412,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.22235,0.029375,0.037356,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.95466,0.029323,-0.022385,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.27227,0.029318,0.031763,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.89907,0.029277,0.010277,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.91987,0.029212,0.023306,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.43883,0.029187,0.059958,0,0
2,GO MIDBODY ABSCISSION,0.50337,0.029158,0.073767,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.5726,0.029015,0.012704,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.4978,0.028797,0.020276,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.62732,0.028782,0.0094842,0,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.26847,0.028665,0.11789,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.5726,0.028641,0.0070713,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.36064,0.028601,0.043228,0,0
2,GO CHROMATIN SILENCING,0.18219,0.028449,0.074907,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.44402,0.028448,0.027206,0,0
2,GO FERTILIZATION,0.67137,0.028316,0.0026147,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.35153,0.028173,0.02497,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.40843,0.027942,0.074033,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.28785,0.027841,0.04721,0,0
2,GO REGULATION OF CHEMOTAXIS,0.81668,0.027756,0.0016204,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.9686,0.027672,-0.022423,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.22235,0.027626,0.045317,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.49227,0.027481,0.011705,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.41842,0.027472,0.030717,0,0
2,GO CHOLESTEROL EFFLUX,0.51459,0.027359,0.036982,0,0
2,GO STEROL TRANSPORT,0.63978,0.02726,0.015795,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.33812,0.027256,0.053921,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.77618,0.027188,0.011942,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.53167,0.027138,0.0060814,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.68418,0.027137,-0.032406,0,0
2,GO RECEPTOR RECYCLING,0.85768,0.026881,0.0034264,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.84397,0.026824,0.0039897,0,0
2,GO VACUOLE ORGANIZATION,0.78962,0.026761,-0.0039865,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.75615,0.026755,-0.015934,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.41341,0.026603,0.02781,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.36064,0.026404,0.10711,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.89215,0.026345,-8.2811e-05,0,0
2,GO RESPONSE TO VITAMIN D,0.81668,0.026294,-0.048248,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.96163,0.026175,-0.017757,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.25001,0.026081,0.034106,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.67776,0.025941,0.033861,0,0
2,GO PROTEIN ACYLATION,0.87833,0.025894,0.0041499,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.53742,0.025832,0.0163,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.59059,0.025738,0.034918,0,0
2,GO REGULATION OF MAPK CASCADE,0.36526,0.025712,0.032343,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.61497,0.025636,0.032559,0,0
2,GO NEGATIVE CHEMOTAXIS,0.9686,0.025563,-0.037356,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.23937,0.025503,0.10034,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.74288,0.025486,-0.034378,0,0
2,GO RESPONSE TO ATP,0.87833,0.025382,-0.011862,0,0
2,GO CELL JUNCTION ASSEMBLY,0.80989,0.025376,0.0072934,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.40843,0.025151,0.059942,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.62732,0.025125,0.092484,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.92682,0.025079,-0.013365,0,0
2,GO NEURON REMODELING,0.83713,0.024973,0.018988,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.83713,0.024882,0.01876,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,0.024824,0.0075785,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.91293,0.024784,-0.014398,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.80989,0.02477,-0.014278,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.48131,0.024756,0.012712,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.9686,0.024479,-0.0012045,0,0
2,GO REGULATION OF CELL CYCLE,0.34702,0.024321,0.030868,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.73628,0.024192,-0.067395,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.50337,0.02416,0.015535,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.86455,0.024138,-0.075643,0,0
2,GO MYOFIBRIL ASSEMBLY,0.34256,0.023967,0.040897,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.29184,0.023914,0.065447,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.67137,0.023721,0.02817,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.98255,0.023712,-0.0072966,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.78289,0.023672,-0.055391,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.85768,0.023668,-0.0032361,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.62113,0.023465,-0.042676,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.9686,0.02345,-0.028127,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.58456,0.023439,0.019557,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.89215,0.023335,-0.050095,0,0
2,GO DNA PACKAGING,0.42855,0.023279,0.031242,0,0
2,GO BONE TRABECULA FORMATION,0.35607,0.023025,0.13848,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.52594,0.022929,0.008988,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.96163,0.022832,0.002417,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.82348,0.022795,0.0024769,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.15773,0.02277,0.039049,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.88523,0.02256,-0.017022,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.82348,0.02254,0.013111,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.59059,0.022534,-0.0010757,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.89215,0.022411,-0.014922,0,0
2,GO VACUOLAR ACIDIFICATION,0.92682,0.022273,-0.01213,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.62732,0.022176,0.019681,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.26847,0.022112,0.055381,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.35607,0.022072,0.087224,0,0
2,GO MATING BEHAVIOR,0.86455,0.022062,-0.0033528,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.87833,0.02204,0.0023024,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.5726,0.02195,0.023083,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.72969,0.021801,0.013041,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.92682,0.021796,-0.017403,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.5726,0.021724,0.030916,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.75615,0.021712,0.0011754,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.41341,0.021675,0.022768,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.39858,0.021638,0.038292,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.27611,0.021629,0.040169,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.67137,0.021516,0.018986,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.21579,0.021488,0.028398,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.90599,0.021431,0.00265,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.98255,0.021369,-0.012316,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.67776,0.021276,0.021803,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.54321,0.021251,0.033616,0,0
2,GO CHROMOSOME SEGREGATION,0.18219,0.021176,0.050064,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.59059,0.021146,0.047855,0,0
2,GO UTERUS DEVELOPMENT,0.78962,0.020986,-0.039375,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.61497,0.020916,0.035096,0,0
2,GO SEX DETERMINATION,0.7495,0.020867,-0.0030095,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.55487,0.020862,0.028692,0,0
2,GO METAPHASE PLATE CONGRESSION,0.35607,0.020765,0.051671,0,0
2,GO GOLGI ORGANIZATION,0.50896,0.02072,0.016268,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.49227,0.020627,0.022135,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.42855,0.02061,0.020482,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.94769,0.020562,0.002776,0,0
2,GO APPENDAGE MORPHOGENESIS,0.31232,0.020457,0.084527,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.53167,0.020394,0.031027,0,0
2,GO MUSCLE ADAPTATION,0.98953,0.020365,0.0083274,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.60883,0.020329,0.045949,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.81668,0.020293,-0.015168,0,0
2,GO TELOMERE CAPPING,0.48678,0.020199,0.023322,0,0
2,GO SPECIFICATION OF SYMMETRY,0.54321,0.020146,0.023239,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.74288,0.020108,-0.0029547,0,0
2,GO METAL ION HOMEOSTASIS,0.73628,0.020034,0.0099426,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.23937,0.019865,0.052937,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.53167,0.019819,0.026125,0,0
2,GO ENSHEATHMENT OF NEURONS,0.79636,0.019815,-0.0016946,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.88523,0.019763,-0.0040736,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.60883,0.01962,0.023639,0,0
2,GO MESODERM MORPHOGENESIS,0.36064,0.019545,0.067206,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.48131,0.019476,0.020467,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.85082,0.019403,-0.0016569,0,0
2,GO WALKING BEHAVIOR,0.95466,0.019265,-0.014496,0,0
2,GO BLOOD VESSEL REMODELING,0.71006,0.019247,-0.025714,0,0
2,GO CGMP MEDIATED SIGNALING,0.92682,0.019229,-0.022056,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.81668,0.019209,-0.045269,0,0
2,GO HISTONE EXCHANGE,0.58456,0.019187,0.025688,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.91987,0.019078,-0.0061867,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.31653,0.018993,0.066525,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.72969,0.018982,-0.025288,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.83713,0.018744,-0.0018584,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.78962,0.018742,0.053536,0,0
2,GO COMPLEMENT ACTIVATION,0.66501,0.018705,0.013863,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.48678,0.018696,0.021269,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.67137,0.018581,0.04462,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.91987,0.018508,-0.0010295,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.53742,0.018479,0.039571,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.72969,0.018444,0.019435,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.48131,0.018146,0.056931,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.27999,0.018131,0.037655,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.74288,0.018124,0.062647,0,0
2,GO SPINDLE ORGANIZATION,0.48131,0.018041,0.024727,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.51459,0.017962,0.012978,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.96163,0.017886,0.0023389,0,0
2,GO REGULATION OF CELLULAR PH,0.58456,0.017802,0.0019376,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.67137,0.017735,0.060251,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.80312,0.017733,0.019143,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.80312,0.017701,-0.0053639,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.50337,0.017621,0.011402,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.80312,0.017475,-0.042122,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.58456,0.017416,0.010545,0,0
2,GO LIPID TRANSLOCATION,0.80989,0.017406,-0.02895,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.46512,0.017278,0.040406,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.37932,0.016864,0.044605,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.7495,0.016771,0.012491,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.78289,0.016716,0.0066683,0,0
2,GO SENSORY PERCEPTION,0.89215,0.016695,0.0004651,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.70355,0.016672,-0.031028,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.7495,0.016662,-0.0097619,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.66501,0.016647,-0.012567,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.8303,0.016558,-0.00018159,0,0
2,GO PROTEIN REFOLDING,0.80989,0.016486,0.010819,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.40843,0.016356,0.039441,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.5726,0.016314,0.021497,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.25001,0.016293,0.080345,0,0
2,GO RESPONSE TO ETHER,0.31653,0.016208,0.056791,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.41341,0.015979,0.064861,0,0
2,GO T CELL SELECTION,0.56075,0.015962,0.040896,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.42347,0.015919,0.026646,0,0
2,GO CELL MATRIX ADHESION,0.41842,0.015913,0.056869,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.53167,0.015853,-0.03731,0,0
2,GO ORGANELLE ASSEMBLY,0.71006,0.015732,0.0038027,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.76281,0.015643,0.030383,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.41341,0.015485,0.022204,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.33373,0.015412,0.13269,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.75615,0.015398,0.0058541,0,0
2,GO TISSUE MORPHOGENESIS,0.44402,0.015253,0.046891,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48131,0.01517,0.055067,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.58456,0.015062,0.058303,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.73628,0.015052,-0.025721,0,0
2,GO TAXIS,0.91987,0.014985,-0.0084573,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.74288,0.014858,0.005456,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.63978,0.014842,0.07023,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.76281,0.014839,0.077822,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.42855,0.014819,0.045228,0,0
2,GO CELLULAR HOMEOSTASIS,0.62113,0.014606,0.0094662,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.73628,0.014581,0.023886,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.89215,0.014438,0.0017735,0,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.56075,0.014087,0.014587,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.53167,0.014014,0.056533,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.93377,0.013951,-0.018158,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.49227,0.013943,0.044,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.77618,0.013651,-0.022381,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.71658,0.013625,0.0053623,0,0
2,GO GLIAL CELL PROLIFERATION,0.36991,0.013621,0.049368,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.74288,0.013495,0.0012895,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.43367,0.013443,0.02111,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.80312,0.013291,-0.0056399,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.36064,0.013147,0.040981,0,0
2,GO RESPONSE TO LEAD ION,0.43367,0.013088,0.063661,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.99651,0.013078,0.013475,0,0
2,GO ARTERY DEVELOPMENT,0.63978,0.012857,0.05271,0,0
2,GO PHOTOTRANSDUCTION,0.39858,0.012838,0.134,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.3746,0.012765,0.079138,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.65866,0.012654,0.021415,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.51459,0.012652,0.01805,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.66501,0.012635,-0.032457,0,0
2,GO MYELOID CELL DEVELOPMENT,0.48131,0.012618,0.042586,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.59664,0.012544,0.077289,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.42347,0.012283,0.034255,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.91293,0.012203,0.0061826,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.59664,0.012192,0.024794,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.63978,0.012162,0.020457,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.71006,0.012091,0.0037145,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.60883,0.012039,0.034583,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.85768,0.012032,-0.015126,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.89215,0.012017,-0.048329,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.79636,0.012006,0.00096538,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.75615,0.011969,0.057695,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.56666,0.011882,0.029233,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.59664,0.011822,-0.036478,0,0
2,GO RESPONSE TO PEPTIDE,0.52594,0.011765,0.013631,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.76948,0.01175,0.010813,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.89215,0.011579,0.0061834,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.80312,0.01157,0.022543,0,0
2,GO GROWTH,0.9686,0.011482,-0.0043796,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.53167,0.011464,0.072573,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.77618,0.01144,-0.020374,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.14526,0.011381,0.054503,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.32077,0.011251,-0.080414,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.70355,0.011111,0.01236,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.87144,0.011109,-0.0093409,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.61497,0.011051,0.034827,0,0
2,GO CHEMICAL HOMEOSTASIS,0.89907,0.011002,-0.0064667,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.99651,0.010946,-0.015777,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.95466,0.01085,-0.0034728,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.35607,0.010745,0.056569,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.7495,0.010732,0.028464,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.76281,0.010728,0.024463,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.71006,0.010708,0.038792,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.89907,0.010683,-0.014508,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.91293,0.010589,0.00016149,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.76948,0.010525,0.0087662,0,0
2,GO RESPONSE TO L GLUTAMATE,0.89907,0.01036,0.010403,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.80312,0.010342,0.0017285,0,0
2,GO MISMATCH REPAIR,0.76281,0.010326,0.015222,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.86455,0.010318,-0.0021543,0,0
2,GO MEMBRANE ORGANIZATION,0.98255,0.010177,-0.0060445,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.83713,0.010171,0.012339,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.87144,0.010063,-0.0040671,0,0
2,GO ENDOSOMAL TRANSPORT,0.42855,0.0099629,0.030935,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13814,0.0099098,0.082402,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.52025,0.0099087,-0.032786,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.48131,0.0098922,0.07091,0,0
2,GO CYTOSOLIC TRANSPORT,0.87833,0.0098905,0.0042568,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.78289,0.0096995,0.0023676,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.87144,0.0096623,0.0016199,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.65234,0.0096105,0.011384,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.98953,0.0094649,-0.012234,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.65866,0.0094318,0.06918,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.8303,0.009406,-0.012638,0,0
2,GO P38MAPK CASCADE,0.96163,0.0092738,-0.013171,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.91987,0.0092565,-0.02555,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.87144,0.0091789,-0.024134,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.43367,0.0090997,0.091241,0,0
2,GO MAGNESIUM ION TRANSPORT,0.70355,0.00906,-0.061826,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.76948,0.0089028,0.043178,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.82348,0.00886,0.017892,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.96163,0.0087607,-0.035539,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.47588,0.00876,0.042565,0,0
2,GO REGULATION OF TISSUE REMODELING,0.93377,0.0086779,-0.019777,0,0
2,GO REGULATION OF DNA REPLICATION,0.76281,0.0085241,0.030784,0,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.47588,0.0084861,0.055835,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,1,0.0084836,-0.0057133,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.74288,0.0084545,0.0068427,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.79636,0.0083358,0.012237,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.73628,0.0081348,0.010196,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.56666,0.0080355,0.055684,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.77618,0.0080181,-0.043784,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.57857,0.0080104,0.025281,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.72969,0.0079577,0.0073943,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.55487,0.0077749,-0.037614,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.98953,0.0077517,-0.0013496,0,0
2,GO INOSITOL METABOLIC PROCESS,0.86455,0.0077052,-0.019355,0,0
2,GO CELL CYCLE DNA REPLICATION,0.60883,0.0075946,0.03359,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.90599,0.00751,-0.0037549,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.82348,0.0074276,-0.012368,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.87144,0.0073751,0.013248,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.33812,0.00734,0.14114,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.69061,0.0072565,0.015102,0,0
2,GO REGULATION OF AXON GUIDANCE,0.96163,0.0071827,-0.03107,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.80312,0.0071708,0.015357,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.56666,0.0071061,0.0010232,0,0
2,GO DEPHOSPHORYLATION,0.94073,0.0068665,-0.0035618,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.76281,0.0067867,0.011478,0,0
2,GO CYTOSKELETON ORGANIZATION,0.36991,0.0066741,0.026216,0,0
2,GO MACROPHAGE PROLIFERATION,0.56666,0.0065063,0.04362,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.80312,0.0063797,0.010479,0,0
2,GO FLUID TRANSPORT,0.74288,0.0062741,-0.032865,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.71006,0.0060849,0.0076353,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.4598,0.006082,0.057925,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.98953,0.0060804,-0.023312,0,0
2,GO BONE RESORPTION,0.98255,0.0060643,-0.032259,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.39371,0.005949,0.13353,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.56666,0.0058594,0.025411,0,0
2,GO SODIUM ION HOMEOSTASIS,0.81668,0.0057869,-0.024046,0,0
2,GO STEM CELL PROLIFERATION,0.96163,0.00577,0.0065672,0,0
2,GO KETONE CATABOLIC PROCESS,0.61497,0.005628,-0.017184,0,0
2,GO REPRODUCTION,0.89907,0.0055911,-0.0091368,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.73628,0.0053241,0.011311,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1,0.0053055,0.0037065,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.97557,0.005232,0.023973,0,0
2,GO DNA DEALKYLATION,0.38408,0.0051465,0.050198,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.94073,0.0051401,0.036093,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.8303,0.0050441,0.0052254,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.89215,0.0048482,-0.0176,0,0
2,GO MICROTUBULE NUCLEATION,0.94769,0.0048167,-0.035455,0,0
2,GO WATER HOMEOSTASIS,0.88523,0.0048013,-0.0056995,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.55487,0.0047843,0.032359,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.48131,0.0047193,0.0479,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.76281,0.0046956,0.052791,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.83713,0.0046943,0.0038409,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,1,0.0045322,0.0024773,0,0
2,GO FAT CELL DIFFERENTIATION,0.87833,0.0044176,0.012124,0,0
2,GO MIDBRAIN DEVELOPMENT,0.78289,0.0043856,0.052075,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.71658,0.0042397,-0.023401,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.81668,0.0041299,0.0083131,0,0
2,GO OOCYTE MATURATION,0.7495,0.0040174,-0.03816,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.47588,0.00398,0.073872,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.72969,0.0038717,-0.031951,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.42855,0.0038218,0.03874,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1,0.0038125,-0.009967,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.94769,0.0037383,-0.0017274,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.90599,0.0036899,-0.055822,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.72969,0.003595,0.0042679,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.83713,0.0035051,0.011945,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.85768,0.0034267,0.00035933,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.67137,0.0033468,0.011695,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.79636,0.003297,-0.01656,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.92682,0.0031353,0.010254,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.22905,0.0027861,0.072655,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.61497,0.0027692,0.018648,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.33373,0.00266,-0.092995,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.87833,0.0026383,0.0066549,0,0
2,GO REGULATION OF BINDING,0.80312,0.0025468,-0.007104,0,0
2,GO BICARBONATE TRANSPORT,0.72969,0.0025355,0.017774,0,0
2,GO RESPONSE TO PAIN,0.89907,0.0022692,-0.034104,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.60883,0.0021851,-0.013474,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.69061,0.0021654,-0.039604,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.72969,0.002126,0.028948,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.75615,0.0021253,0.017278,0,0
2,GO WATER TRANSPORT,0.48131,0.0020258,-0.060896,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.87144,0.0019425,-0.0069768,0,0
2,GO TOR SIGNALING,0.54321,0.0019056,-0.02086,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.90599,0.0019009,0.004366,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.9686,0.0018274,0.0017194,0,0
2,GO ORGANELLE DISASSEMBLY,0.65234,0.0017757,0.0095502,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.78289,0.001766,0.0043845,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.15517,0.0015581,0.099224,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.68418,0.001533,-0.067591,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.84397,0.0014176,0.0070902,0,0
2,GO VESICLE ORGANIZATION,0.78289,0.0013084,0.00028221,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.87144,0.0012242,0.0033023,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.89907,0.0011973,0.011473,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.51459,0.00116,-0.044675,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.87144,0.0011231,0.01355,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.36064,0.0010619,-0.03466,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.61497,0.0010595,0.015184,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.66501,0.0010347,-0.012907,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.80312,0.00092343,0.039724,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.91987,0.00056386,0.1223,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.68418,0.00053261,-0.019411,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.81668,0.00045568,0.014667,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.75615,0.00036424,0.051242,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.57857,0.00026735,0.039406,0,0
2,GO ADAPTIVE THERMOGENESIS,0.61497,0.00026167,-0.028232,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.76281,0.00024665,-0.014249,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.40349,0.0002208,0.1206,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.63354,0.00018928,0.028863,0,0
2,GO DNA REPLICATION,0.46512,7.0285e-05,0.049482,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.8303,-4.9541e-05,0.0044613,0,0
2,GO CELL CELL SIGNALING BY WNT,0.65866,-8.736e-05,0.035505,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.72969,-0.0001191,-0.027501,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.85082,-0.00012537,0.0075302,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.97557,-0.00047198,0.043064,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.32938,-0.0006517,-0.072399,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.91293,-0.0007684,0.011857,0,0
2,GO POSITIVE REGULATION OF BINDING,0.9686,-0.00089924,-0.0019886,0,0
2,GO POSITIVE T CELL SELECTION,0.72313,-0.0009085,0.028055,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.43367,-0.0010306,-0.069368,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.50896,-0.0010394,-0.10454,0,0
2,GO GLAND MORPHOGENESIS,0.36064,-0.0012119,0.12043,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.62732,-0.0012299,0.040425,0,0
2,GO MUSCLE CONTRACTION,0.65866,-0.0012409,-0.026152,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.4598,-0.00126,-0.075553,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.56075,-0.0013449,0.041338,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.51459,-0.0013866,0.018247,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.66501,-0.0014106,-0.034506,0,0
2,GO ION HOMEOSTASIS,0.88523,-0.0014913,0.00064221,0,0
2,GO HISTONE H4 ACETYLATION,0.92682,-0.0015084,0.0059071,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.66501,-0.0015183,0.037718,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.91293,-0.001591,0.020117,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.50337,-0.0017411,-0.036451,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.99651,-0.0017429,-0.0051699,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.60272,-0.0019414,0.089787,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.72313,-0.0020074,-0.042834,0,0
2,GO HISTONE H3 K9 METHYLATION,0.89215,-0.0020835,0.020255,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.85082,-0.0021736,0.032165,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.57857,-0.0021773,-0.015063,0,0
2,GO AMINE METABOLIC PROCESS,0.65866,-0.0022021,0.021726,0,0
2,GO SNORNA METABOLIC PROCESS,0.65234,-0.0022261,0.021478,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.79636,-0.0022879,-0.011191,0,0
2,GO ENDOCYTOSIS,0.67137,-0.0023516,0.0072655,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.50896,-0.0024489,0.11528,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.74288,-0.0024702,0.068178,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.43883,-0.0025183,-0.039399,0,0
2,GO RRNA CATABOLIC PROCESS,0.66501,-0.0027738,0.015592,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.59059,-0.0028035,-0.028975,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.83713,-0.0028604,-0.0025859,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.55487,-0.0028913,0.02713,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.85082,-0.0028998,-0.072088,0,0
2,GO AMYLOID BETA FORMATION,0.44924,-0.0029539,0.047613,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.9686,-0.002971,-0.0058354,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.77618,-0.0029781,-0.036471,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.75615,-0.0029798,-0.014653,0,0
2,GO SNORNA 3 END PROCESSING,0.90599,-0.0030298,-0.012817,0,0
2,GO ASTROCYTE ACTIVATION,0.87833,-0.0031401,-0.014759,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.91293,-0.0031724,-0.0055074,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.69707,-0.0032039,0.032522,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.71658,-0.0032594,-0.025127,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.87833,-0.0032754,0.044079,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.71006,-0.0033138,-0.022825,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.56075,-0.0033211,0.052969,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.72313,-0.0033442,0.011716,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.4545,-0.0033693,-0.047769,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.64605,-0.0033806,0.013814,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.47588,-0.0035456,0.057856,0,0
2,GO PROTEIN TETRAMERIZATION,0.85768,-0.0036673,0.0062736,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.93377,-0.0037123,-0.003999,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.30402,-0.0037298,-0.068021,0,0
2,GO NUCLEUS ORGANIZATION,0.66501,-0.0037733,0.0091453,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.68418,-0.003832,-0.023615,0,0
2,GO VASODILATION,0.72313,-0.0038696,-0.065333,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.72969,-0.0039408,0.038732,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.98953,-0.0040037,0.012826,0,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.76948,-0.0040478,-0.029922,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.73628,-0.0041763,0.018948,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.78289,-0.0042448,0.0073072,0,0
2,GO MANNOSYLATION,0.98953,-0.0042661,-0.02444,0,0
2,GO CYTOKINESIS,0.93377,-0.0042985,0.0054217,0,0
2,GO VITAMIN METABOLIC PROCESS,0.30815,-0.0043602,0.045781,0,0
2,GO BONE MATURATION,0.44402,-0.0044726,-0.058388,0,0
2,GO SULFATE TRANSPORT,0.94073,-0.0045515,0.015592,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.9686,-0.0046019,0.0057162,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.77618,-0.0047939,-0.012282,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.42347,-0.004795,-0.047915,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.78962,-0.0048028,-0.025903,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.65234,-0.0048152,0.018509,0,0
2,GO CELL JUNCTION ORGANIZATION,0.50337,-0.0050662,-0.03509,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.56075,-0.0050725,0.038182,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.76948,-0.0051075,0.012612,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.83713,-0.0054215,-0.030967,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.94073,-0.0054368,0.006086,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.47588,-0.0054495,-0.035082,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.90599,-0.0054609,0.014174,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.36064,-0.0054768,0.057251,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.70355,-0.0056226,-0.023508,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.7495,-0.0057147,-0.064709,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.71658,-0.005731,0.027173,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.99651,-0.0058966,0.0080598,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.92682,-0.0059073,0.058784,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.71658,-0.0059148,-0.03269,0,0
2,GO SECONDARY METABOLIC PROCESS,0.59059,-0.0059259,-0.050267,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.9686,-0.0059378,-0.00020582,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.93377,-0.0060723,-0.016654,0,0
2,GO CHROMOSOME LOCALIZATION,0.81668,-0.0062871,0.0041536,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.54903,-0.006407,0.030985,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.42347,-0.0065622,0.085423,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.73628,-0.0066685,-0.042374,0,0
2,GO AXIS SPECIFICATION,0.72969,-0.0067562,0.017448,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.61497,-0.0069095,-0.022153,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.4978,-0.0070185,-0.087467,0,0
2,GO L GLUTAMATE IMPORT,0.59664,-0.0070604,-0.058131,0,0
2,GO TOOTH MINERALIZATION,0.55487,-0.0071022,0.10424,0,0
2,GO LACTATE METABOLIC PROCESS,0.51459,-0.0072825,0.049836,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.57857,-0.0073265,-0.039642,0,0
2,GO ORGANELLE FISSION,0.67137,-0.0074995,0.014075,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.87833,-0.0076107,-0.013639,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.7495,-0.0076962,-0.026369,0,0
2,GO NOTCH SIGNALING PATHWAY,0.42855,-0.0078258,-0.043735,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.82348,-0.0078298,0.0058407,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.86455,-0.0078352,0.012839,0,0
2,GO IRON ION TRANSPORT,0.99651,-0.0079143,-0.0060504,0,0
2,GO CENTROSOME DUPLICATION,0.96163,-0.0080788,0.016151,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.7495,-0.0080912,-0.01513,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.69707,-0.008264,0.017836,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.63978,-0.008273,-0.022757,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.95466,-0.0083756,-0.010181,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.92682,-0.0085292,0.014927,0,0
2,GO MEMBRANE FUSION,0.58456,-0.0085795,-0.030595,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.40843,-0.0086112,-0.049162,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.46512,-0.0086299,-0.059395,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.27611,-0.0086688,-0.11423,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.93377,-0.008701,0.0065878,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.76948,-0.0087503,-0.019838,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.81668,-0.0088427,0.014968,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.59059,-0.0088635,-0.037339,0,0
2,GO OOGENESIS,0.87833,-0.0092334,-0.027197,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.59664,-0.0092886,-0.026783,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.89215,-0.0093159,-0.0095913,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.53742,-0.0096777,0.063334,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.53742,-0.0098818,0.039259,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.98255,-0.010051,0.0082096,0,0
2,GO EOSINOPHIL MIGRATION,0.91987,-0.01006,-0.052764,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.65234,-0.010098,-0.041412,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.95466,-0.010102,0.0015762,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.47049,-0.010201,-0.080964,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.70355,-0.01024,0.0049893,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.62113,-0.010267,-0.067388,0,0
2,GO VACUOLAR TRANSPORT,0.96163,-0.010383,-0.0066589,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.74288,-0.010426,0.042717,0,0
2,GO EYE MORPHOGENESIS,0.91293,-0.010561,0.012082,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.87144,-0.010636,-0.010995,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.63354,-0.010887,-0.017093,0,0
2,GO SOMITOGENESIS,0.73628,-0.010913,0.031784,0,0
2,GO MUSCLE SYSTEM PROCESS,0.89215,-0.010999,-0.01476,0,0
2,GO DETECTION OF STIMULUS,0.87833,-0.011115,-0.003388,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.31232,-0.011295,-0.044217,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.9686,-0.011568,0.0041237,0,0
2,GO EXCRETION,0.91987,-0.011851,-0.011747,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.85768,-0.011859,0.010733,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.98255,-0.012062,-0.038688,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.94769,-0.012099,0.010388,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.93377,-0.012111,-0.0070885,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.53167,-0.012366,0.036243,0,0
2,GO REGULATION OF BONE REMODELING,0.71658,-0.012425,-0.05832,0,0
2,GO CARTILAGE DEVELOPMENT,0.92682,-0.012518,0.0053434,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.81668,-0.012829,-0.017805,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.71658,-0.012924,-0.016035,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.98953,-0.01294,-0.0039555,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.76948,-0.012953,-0.024804,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.76281,-0.013032,-0.010577,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.79636,-0.013042,-0.028944,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.82348,-0.013204,-0.00299,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.72969,-0.013235,0.046592,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.54903,-0.013267,-0.026913,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.60883,-0.013369,-0.031527,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.95466,-0.01347,0.0050277,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.67776,-0.013481,-0.087073,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.37932,-0.013666,-0.041623,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.78289,-0.013686,-0.0080534,0,0
2,GO REGULATION OF ODONTOGENESIS,0.89215,-0.013859,-0.02389,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.73628,-0.013871,-0.0099123,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.82348,-0.013905,-0.030575,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.43883,-0.013952,-0.034782,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.75615,-0.014215,0.014835,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.99651,-0.014458,-0.00835,0,0
2,GO EATING BEHAVIOR,0.84397,-0.014476,0.0040688,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.29586,-0.014545,0.18821,0,0
2,GO CELL FATE COMMITMENT,0.34256,-0.014837,-0.046628,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.20621,-0.014922,-0.064537,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.73628,-0.015522,0.062582,0,0
2,GO ZINC ION TRANSPORT,0.63978,-0.015523,0.025798,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.7495,-0.015719,0.025668,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.47049,-0.015822,-0.025028,0,0
2,GO MITOCHONDRIAL FUSION,0.87144,-0.015912,0.0038405,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.72313,-0.015941,0.0041594,0,0
2,GO VESICLE LOCALIZATION,0.85082,-0.016024,-0.018758,0,0
2,GO MULTI ORGANISM PROCESS,0.44402,-0.016092,-0.02788,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.31653,-0.016125,-0.043976,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.87144,-0.016205,0.0049678,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.95466,-0.016252,-0.0049767,0,0
2,GO SPINDLE LOCALIZATION,0.7495,-0.016421,-0.017228,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.75615,-0.01662,-0.020592,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.38408,-0.016694,-0.03476,0,0
2,GO DEVELOPMENTAL GROWTH,0.50896,-0.016748,-0.023465,0,0
2,GO RESPONSE TO STARVATION,0.4598,-0.016949,-0.039375,0,0
2,GO ORGANELLE FUSION,0.60883,-0.017171,-0.027475,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.77618,-0.017173,0.015513,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.34256,-0.017183,-0.083746,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.62732,-0.017257,-0.032857,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.69061,-0.017368,-0.027618,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.94073,-0.017592,0.0026307,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.25363,-0.017631,-0.04895,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.69707,-0.01768,-0.026646,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.51459,-0.017693,-0.1172,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.96163,-0.017796,-0.0054831,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.50896,-0.017808,-0.025397,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.9686,-0.017913,-0.01186,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.87144,-0.017935,0.025727,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.74288,-0.018273,-0.014848,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.85768,-0.018356,0.0038308,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.19695,-0.01842,-0.10992,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.60883,-0.018462,0.025553,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.22905,-0.018484,-0.06719,0,0
2,GO REGULATION OF HEART GROWTH,0.69061,-0.018521,0.01794,0,0
2,GO TRABECULA MORPHOGENESIS,0.77618,-0.018634,0.039966,0,0
2,GO DNA CATABOLIC PROCESS,0.97557,-0.018867,0.0020741,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.62113,-0.019001,-0.011619,0,0
2,GO REGULATION OF GROWTH,0.59059,-0.019136,-0.020384,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.82348,-0.019162,0.0069074,0,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.98953,-0.019299,-0.00019361,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.76948,-0.019308,0.045103,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.75615,-0.019467,-0.035096,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.48678,-0.019565,-0.061428,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.62113,-0.019648,-0.064379,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.79636,-0.019666,-0.02465,0,0
2,GO OSSIFICATION,0.65234,-0.019761,-0.01543,0,0
2,GO SHORT TERM MEMORY,0.89907,-0.019992,0.034855,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.85082,-0.020032,-0.0066922,0,0
2,GO SOMITE DEVELOPMENT,0.46512,-0.020136,-0.0088471,0,0
2,GO PROTEIN DENEDDYLATION,0.72969,-0.02029,-0.02793,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.60883,-0.020337,0.080373,0,0
2,GO HEART VALVE DEVELOPMENT,0.85082,-0.020363,-0.012814,0,0
2,GO ENDODERM FORMATION,0.67776,-0.020382,0.053993,0,0
2,GO REGULATION OF TRANSPORT,0.2,-0.020694,-0.044917,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.64605,-0.020734,-0.016077,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.34702,-0.020925,-0.033676,0,0
2,GO CENTROSOME SEPARATION,0.99651,-0.021151,0.010092,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.41842,-0.021249,-0.048628,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.26847,-0.021302,-0.047825,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.77618,-0.021326,-0.005266,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.89907,-0.021381,0.021659,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.47049,-0.021416,-0.057651,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.63978,-0.021446,-0.0013895,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.67776,-0.02147,0.066667,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.94769,-0.021563,0.02192,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.62113,-0.021674,-0.016308,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.4978,-0.021683,-0.012,0,0
2,GO HEART DEVELOPMENT,0.80312,-0.021917,0.007833,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.56075,-0.022033,0.034587,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.98255,-0.022262,0.089924,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.79636,-0.022302,-0.019647,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.70355,-0.022308,-0.0097195,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.59664,-0.022392,-0.011544,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,-0.022409,-0.050255,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.74288,-0.022594,-0.012238,0,0
2,GO KINETOCHORE ASSEMBLY,0.76948,-0.022648,-0.013999,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.73628,-0.022757,-0.029755,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.78289,-0.022936,-0.044096,0,0
2,GO REGULATION OF TOR SIGNALING,0.39858,-0.02316,-0.029629,0,0
2,GO REGULATION OF CELL SIZE,0.26098,-0.023268,-0.057576,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.42855,-0.023286,-0.036705,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.72969,-0.023423,-0.0011874,0,0
2,GO RHYTHMIC BEHAVIOR,0.52594,-0.023578,-0.044433,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.92682,-0.02364,-0.016126,0,0
2,GO CELL PROJECTION ASSEMBLY,0.71006,-0.023994,-0.004016,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.95466,-0.024007,-0.019875,0,0
2,GO MITOCHONDRIAL FISSION,0.25363,-0.024205,-0.068821,0,0
2,GO GAMETE GENERATION,0.29992,-0.024278,-0.036864,0,0
2,GO SEXUAL REPRODUCTION,0.29992,-0.024443,-0.036946,0,0
2,GO PROTEIN FOLDING,0.94073,-0.024472,-0.005405,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.97557,-0.024497,0.008391,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.55487,-0.024572,-0.032902,0,0
2,GO ENDOCYTIC RECYCLING,0.9686,-0.024777,-0.0019488,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.36064,-0.024938,-0.029972,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.94073,-0.025025,0.035443,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.29184,-0.025364,-0.058327,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.90599,-0.025424,-0.0023006,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,-0.025741,-0.0050649,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.86455,-0.02576,0.00995,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.65234,-0.025788,-0.019837,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.16828,-0.02647,-0.11697,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.62732,-0.026487,-0.017879,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.48131,-0.026505,-0.041511,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.85768,-0.026586,-0.0053017,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.42347,-0.026618,0.041355,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.97557,-0.026846,0.0038558,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.35607,-0.026855,-0.021667,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.40349,-0.026921,-0.032566,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.59664,-0.027009,-0.062629,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.99651,-0.027086,0.0029926,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.95466,-0.027315,0.0011346,0,0
2,GO HISTONE H3 K36 METHYLATION,0.90599,-0.027321,0.033774,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.87144,-0.027322,-0.0076203,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.58456,-0.027356,-0.031217,0,0
2,GO NUCLEOSIDE SALVAGE,1,-0.027422,-0.0077333,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,1,-0.027458,-0.011208,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.9686,-0.027639,0.012745,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.41842,-0.027695,-0.035685,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.9686,-0.027728,-0.010332,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.48678,-0.027739,-0.083841,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.87833,-0.028138,-0.021331,0,0
2,GO ORGANIC ANION TRANSPORT,0.76948,-0.028141,-0.015844,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.74288,-0.028239,-0.0016117,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.52594,-0.028241,-0.057944,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.47588,-0.028264,-0.012564,0,0
2,GO CELL RECOGNITION,0.188,-0.028368,-0.059389,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.68418,-0.028589,-0.01309,0,0
2,GO GLUCOSE IMPORT,0.18219,-0.02869,-0.063799,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.62113,-0.02876,0.04753,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.56666,-0.028909,-0.012416,0,0
2,GO RESPONSE TO GLUCAGON,0.37932,-0.029117,-0.045042,0,0
2,GO HEART TRABECULA FORMATION,0.74288,-0.029148,-0.046726,0,0
2,GO MESENCHYME DEVELOPMENT,0.97557,-0.029185,0.02006,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.32938,-0.029197,0.059355,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.44924,-0.029283,-0.048383,0,0
2,GO MITOPHAGY,0.62732,-0.029367,-0.020582,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.21256,-0.029586,-0.042006,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.58456,-0.02959,-0.046437,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.62732,-0.029708,-0.029097,0,0
2,GO SULFATION,0.8303,-0.030031,0.035778,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.57857,-0.030076,-0.03305,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.36064,-0.030114,-0.024026,0,0
2,GO MALE GAMETE GENERATION,0.34256,-0.030132,-0.036712,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.38408,-0.030165,-0.033734,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.71658,-0.030294,0.010585,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.48131,-0.030451,-0.033881,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.11434,-0.030462,-0.076357,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.98953,-0.030539,-0.016438,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.56666,-0.030543,-0.042791,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.55487,-0.030547,0.023783,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.81668,-0.030586,0.012322,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.49227,-0.030682,-0.031055,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.20621,-0.030726,-0.04858,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.98255,-0.030886,0.052404,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.85768,-0.030907,0.029682,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.58456,-0.030932,0.10176,0,0
2,GO INORGANIC ANION TRANSPORT,0.2839,-0.030947,-0.039047,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.83713,-0.030971,0.0053893,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.63978,-0.031142,-0.087363,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.94073,-0.031273,0.010949,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.83713,-0.031472,0.0030399,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.92682,-0.031512,0.0049845,0,0
2,GO CELL GROWTH,0.12908,-0.031613,-0.058806,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.92682,-0.031616,-0.01564,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.68418,-0.031729,0.016292,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.58456,-0.031751,-0.037916,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.86455,-0.031898,0.0010697,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.27999,-0.031925,-0.06376,0,0
2,GO ACID SECRETION,0.89907,-0.031949,0.0025484,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.78289,-0.032064,-0.0023353,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.59059,-0.032205,-0.022278,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.60883,-0.032218,-0.026401,0,0
2,GO MATING,0.27611,-0.032222,-0.05983,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.76948,-0.032319,-0.028295,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.88523,-0.032696,-0.030556,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.31653,-0.032702,-0.029415,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.89215,-0.032709,0.0066327,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.65866,-0.032712,0.024905,0,0
2,GO NEURON DEATH,0.063042,-0.032799,-0.057668,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.47049,-0.032828,-0.031722,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.80312,-0.033057,0.046897,0,0
2,GO ANION TRANSPORT,0.57857,-0.033115,-0.023777,0,0
2,GO MEIOTIC CELL CYCLE,0.35153,-0.033216,-0.02207,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.56666,-0.033415,-0.025267,0,0
2,GO AORTA DEVELOPMENT,0.82348,-0.033787,-0.0069682,0,0
2,GO REGULATION OF BEHAVIOR,0.40349,-0.033868,-0.044169,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.28785,-0.033875,-0.050954,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.79636,-0.033971,0.035314,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.26471,-0.033978,-0.040538,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.59059,-0.03421,-0.031285,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.5726,-0.034227,-0.062791,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.27227,-0.03426,-0.046367,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.80989,-0.034335,-0.013961,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.62732,-0.034358,-0.079618,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.92682,-0.034429,-0.00085155,0,0
2,GO REGULATION OF CYTOKINESIS,0.69707,-0.034573,-0.013625,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.87833,-0.034617,-0.001139,0,0
2,GO VASCULAR WOUND HEALING,0.67137,-0.03512,-0.048024,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.74288,-0.035198,-0.13211,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.95466,-0.03544,0.02591,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.35153,-0.035593,-0.04171,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.30815,-0.035853,-0.083014,0,0
2,GO DEMETHYLATION,0.7495,-0.036035,-0.0016498,0,0
2,GO CELL CYCLE ARREST,0.94769,-0.036188,0.0043449,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.67776,-0.036338,0.0028661,0,0
2,GO OXALATE TRANSPORT,0.36991,-0.03635,-0.073299,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.67776,-0.036477,-0.0069444,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.22235,-0.036518,-0.06511,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.39858,-0.036757,-0.023968,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.33812,-0.036764,-0.085618,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.036948,-0.03721,-0.066589,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.52594,-0.037264,-0.041021,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.53167,-0.037285,-0.068386,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.91987,-0.037293,0.021636,0,0
2,GO OVULATION CYCLE PROCESS,0.29586,-0.037392,-0.066853,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.28785,-0.037407,-0.037762,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.54321,-0.037444,-0.035772,0,0
2,GO BIOMINERALIZATION,0.72313,-0.037551,-0.020229,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.63978,-0.03757,-0.02814,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.74288,-0.03759,0.02769,0,0
2,GO CONVERGENT EXTENSION,0.53742,-0.037648,0.093839,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.94073,-0.037755,0.042653,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.44924,-0.038084,0.12727,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.58456,-0.038117,-0.014262,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.74288,-0.038189,-0.020988,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.3746,-0.03824,-0.057171,0,0
2,GO PROTEIN METHYLATION,0.35153,-0.038343,-0.0023235,0,0
2,GO VASCULAR TRANSPORT,0.83713,-0.038771,-0.056258,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.11841,-0.038808,-0.050262,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.32077,-0.038879,-0.11814,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.76948,-0.038947,-0.024056,0,0
2,GO DRINKING BEHAVIOR,0.67776,-0.03898,-0.021519,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.85082,-0.03913,-0.013463,0,0
2,GO BONE MINERALIZATION,0.54321,-0.039265,-0.041039,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.30815,-0.039487,-0.034949,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.47588,-0.039529,0.083077,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.62113,-0.039694,-0.0076823,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.62113,-0.039878,-0.0085033,0,0
2,GO MICROTUBULE BASED PROCESS,0.059411,-0.039897,-0.053799,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.4598,-0.039905,-0.043306,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.92682,-0.039973,-0.00054065,0,0
2,GO FIBROBLAST MIGRATION,0.66501,-0.04003,-0.0031958,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.087232,-0.040161,-0.09229,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.052669,-0.040211,-0.091297,0,0
2,GO RESPONSE TO BMP,0.56075,-0.040383,-0.012051,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.65866,-0.040402,-0.021507,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.62732,-0.040516,-0.018611,0,0
2,GO HISTONE METHYLATION,0.62732,-0.040562,0.007613,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.74288,-0.040678,0.14302,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.83713,-0.040953,0.0048196,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.72969,-0.041013,-0.0092193,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.15264,-0.041051,-0.1424,0,0
2,GO NEURON APOPTOTIC PROCESS,0.15517,-0.041265,-0.045071,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.90599,-0.041279,0.022986,0,0
2,GO HEART GROWTH,0.63978,-0.04134,-0.0012359,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.47049,-0.041353,-0.041073,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.42855,-0.041376,-0.068246,0,0
2,GO RESPONSE TO NICOTINE,0.8303,-0.041397,-0.013962,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.56075,-0.041408,-0.096703,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.46512,-0.041419,-0.043169,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.14048,-0.041497,-0.19022,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.91987,-0.041505,-0.0047314,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.62732,-0.041556,-0.042587,0,0
2,GO REGULATION OF TUBE SIZE,0.090515,-0.041671,-0.094235,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.76948,-0.041764,-0.012519,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.8303,-0.042196,-0.030476,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.43883,-0.042332,-0.048422,0,0
2,GO RESPONSE TO HYDROXYUREA,0.67776,-0.042466,0.064806,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.24288,-0.042648,-0.042295,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.56666,-0.042656,-0.017121,0,0
2,GO IMMUNOGLOBULIN SECRETION,0.35153,-0.042681,-0.10178,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.23245,-0.042688,-0.060059,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.64605,-0.042759,-0.051666,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.12908,-0.042767,-0.046912,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.29184,-0.042776,-0.040407,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.37932,-0.042777,-0.071257,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.9686,-0.042829,0.010893,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.19393,-0.043006,-0.091415,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.24288,-0.043095,-0.094169,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.188,-0.043108,-0.038699,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.52594,-0.043119,0.065409,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.26471,-0.043124,-0.03211,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.29992,-0.043126,-0.053331,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.029719,-0.043189,-0.06776,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.46512,-0.04328,-0.031461,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.22568,-0.043329,-0.087702,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.63354,-0.043511,0.093846,0,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.48131,-0.04352,-0.18563,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.30402,-0.043753,-0.031607,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.60883,-0.04377,-0.036521,0,0
2,GO VITAMIN TRANSPORT,0.5726,-0.043911,-0.032751,0,0
2,GO T CELL EXTRAVASATION,0.53742,-0.044242,-0.11609,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.33812,-0.044317,-0.07286,0,0
2,GO NUCLEOTIDE TRANSPORT,0.35607,-0.044327,-0.058104,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.80989,-0.044465,-0.014862,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.31653,-0.044658,-0.046312,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.29184,-0.044716,-0.052618,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.96163,-0.044845,0.028676,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.75615,-0.044921,-0.031363,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.73628,-0.045561,0.0099406,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.076492,-0.045595,-0.079691,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.53167,-0.045813,-0.018454,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.78962,-0.045905,-0.070768,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.78962,-0.046144,0.014306,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.44402,-0.046309,-0.076337,0,0
2,GO SLEEP,0.90599,-0.04635,0.015661,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.31653,-0.046361,-0.078942,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.085627,-0.046407,-0.074577,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.64605,-0.046539,-0.031003,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.94769,-0.046753,0.053765,0,0
2,GO STEROID HORMONE SECRETION,0.81668,-0.046811,-0.0034402,0,0
2,GO GLIAL CELL MIGRATION,0.60272,-0.046915,-0.03668,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.94073,-0.046986,0.0025958,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.35607,-0.047091,-0.057023,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.12049,-0.047461,-0.07392,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.76281,-0.047479,-0.071572,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.047515,-0.060863,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.36526,-0.047807,-0.12861,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.26098,-0.04785,-0.076417,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.73628,-0.047918,0.0024697,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.65234,-0.047973,-0.076357,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.59664,-0.048114,-0.064801,0,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.25001,-0.04812,-0.10515,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.44402,-0.048197,-0.022639,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.36064,-0.048275,-0.050733,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.78962,-0.048321,-0.021271,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.32938,-0.048366,-0.025031,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.32077,-0.048452,-0.08072,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.78289,-0.048464,-0.069727,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.61497,-0.048585,-0.0081955,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.21579,-0.048606,-0.048249,0,0
2,GO ORGANIC ACID TRANSPORT,0.39858,-0.04865,-0.032892,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.57857,-0.048882,-0.047604,0,0
2,GO REGULATION OF VASCULOGENESIS,0.43367,-0.048933,-0.093609,0,0
2,GO PHOSPHATE ION TRANSPORT,0.17374,-0.049287,-0.064524,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.072231,-0.049316,-0.11286,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.3746,-0.04933,-0.019956,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.34256,-0.04952,-0.069631,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.32506,-0.049604,-0.058278,0,0
2,GO MRNA SPLICE SITE SELECTION,0.30815,-0.04968,-0.074057,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.72313,-0.049702,-0.010827,0,0
2,GO ORGANELLE LOCALIZATION,0.41842,-0.049821,-0.02336,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.35153,-0.049876,-0.07581,0,0
2,GO FEAR RESPONSE,0.17653,-0.049974,-0.086328,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.25363,-0.049981,-0.042491,0,0
2,GO AXON DEVELOPMENT,0.027188,-0.05,-0.11601,0,0
2,GO REGULATION OF MITOPHAGY,0.38408,-0.050176,-0.041551,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.10654,-0.050204,-0.093228,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29586,-0.050284,-0.083042,0,0
2,GO VISUAL BEHAVIOR,0.65866,-0.050588,-0.041894,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.23589,-0.050746,-0.041812,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.27999,-0.050831,-0.073485,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.24643,-0.050863,-0.15608,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.12049,-0.051029,-0.16651,0,0
2,GO RHYTHMIC PROCESS,0.17934,-0.051278,-0.037433,0,0
2,GO GLIOGENESIS,0.33812,-0.051301,-0.04807,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.16032,-0.051408,-0.059323,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.34702,-0.051486,-0.045499,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.62732,-0.051598,-0.029285,0,0
2,GO HEART MORPHOGENESIS,0.74288,-0.051725,0.0065058,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.91987,-0.051915,-0.0023221,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.21579,-0.052116,-0.122,0,0
2,GO FUCOSE METABOLIC PROCESS,0.83713,-0.052126,0.010346,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.98953,-0.052147,0.0001915,0,0
2,GO REGULATION OF EXCRETION,0.92682,-0.052292,0.02275,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.84397,-0.052333,0.023461,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.47049,-0.05234,-0.030538,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.23937,-0.052366,-0.070511,0,0
2,GO GENETIC IMPRINTING,0.54903,-0.052394,-0.029883,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.15015,-0.052667,-0.0041501,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.17099,-0.052686,-0.068813,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.39371,-0.05283,-0.099401,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.51459,-0.052842,-0.025487,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.52025,-0.05297,-0.02871,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.20937,-0.05302,-0.063677,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.88523,-0.053109,0.075423,0,0
2,GO RESPONSE TO REDOX STATE,0.83713,-0.053199,-0.035364,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.69061,-0.053209,-0.032671,0,0
2,GO SEGMENT SPECIFICATION,0.47588,-0.053396,-0.073367,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.17653,-0.053648,-0.11972,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26471,-0.054117,-0.061617,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.18219,-0.054231,-0.091229,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.61497,-0.054273,-0.018718,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.042857,-0.054346,-0.10022,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.56666,-0.054518,-0.0049012,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.55487,-0.054544,-0.02049,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.91987,-0.054681,-0.0060025,0,0
2,GO FUCOSYLATION,0.76281,-0.054727,-0.024176,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.46512,-0.054766,-0.048431,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.49227,-0.054816,-0.019358,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.65234,-0.054866,-0.015468,0,0
2,GO MITOTIC RECOMBINATION,0.59664,-0.054928,-0.0135,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.19695,-0.05523,-0.097568,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.66501,-0.055476,-0.015374,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.70355,-0.055477,-0.078541,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.49227,-0.055647,-0.040412,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.36991,-0.055798,-0.050289,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.32938,-0.055891,-0.060499,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.42347,-0.055975,-0.088756,0,0
2,GO TRANSFERRIN TRANSPORT,0.16828,-0.056007,-0.089237,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.23937,-0.056098,-0.078395,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.40843,-0.056118,-0.066943,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.95466,-0.056143,0.062333,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.63354,-0.056165,-0.041181,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.079444,-0.056255,-0.085288,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.47049,-0.056256,0.0013533,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0695,-0.056357,-0.082793,0,0
2,GO THYMIC T CELL SELECTION,0.35607,-0.056415,-0.034567,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.15015,-0.056496,-0.059368,0,0
2,GO T CELL LINEAGE COMMITMENT,0.69707,-0.056604,0.04526,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.85082,-0.056683,0.012197,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.38888,-0.057385,-0.062773,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.12049,-0.057401,-0.07608,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.63978,-0.057588,-0.039618,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.48131,-0.057799,-0.046698,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.15015,-0.058063,-0.12741,0,0
2,GO CARBOHYDRATE TRANSPORT,0.11235,-0.058121,-0.07518,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.21256,-0.058171,-0.075738,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.25363,-0.058238,-0.052013,0,0
2,GO CELL MORPHOGENESIS,0.18508,-0.058274,-0.060732,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.33812,-0.058322,-0.040414,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.67776,-0.058476,-0.00038622,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.35153,-0.058538,-0.059904,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.33373,-0.058543,-0.032744,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.029068,-0.058558,-0.1074,0,0
2,GO RESPONSE TO METAL ION,0.38888,-0.058676,-0.038335,0,0
2,GO NUCLEOSOME ASSEMBLY,0.28785,-0.058719,-0.029281,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.080955,-0.058789,-0.13867,0,0
2,GO RESPONSE TO LEUCINE,0.2,-0.058793,-0.13906,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.40349,-0.058825,-0.048915,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.76281,-0.05898,-0.019204,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39858,-0.059078,-0.044626,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.69061,-0.05919,-0.0090011,0,0
2,GO SPERM MOTILITY,0.011047,-0.059231,-0.12238,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.19393,-0.059266,-0.09481,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.40349,-0.0593,-0.058973,0,0
2,GO RESPONSE TO FOOD,0.12259,-0.059567,-0.074421,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.8303,-0.059622,-0.045867,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.41842,-0.06011,-0.089681,0,0
2,GO DRUG METABOLIC PROCESS,0.44402,-0.060116,-0.030207,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.91293,-0.060124,-0.012635,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.17099,-0.060165,-0.074423,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.71006,-0.060185,0.033064,0,0
2,GO DOSAGE COMPENSATION,0.82348,-0.060471,0.036966,0,0
2,GO DNA DEMETHYLATION,0.36991,-0.060559,-0.037285,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.28785,-0.060697,-0.049294,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.28785,-0.060964,-0.11029,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.90599,-0.061029,0.077876,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.90599,-0.061175,0.011151,0,0
2,GO NEURON PROJECTION GUIDANCE,0.042857,-0.0612,-0.11661,0,0
2,GO CELL FATE SPECIFICATION,0.32938,-0.061208,-0.067401,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.8303,-0.061412,0.0039516,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.94073,-0.061426,0.043455,0,0
2,GO RESPONSE TO WATER,0.86455,-0.061494,-0.0039454,0,0
2,GO LYSOSOMAL TRANSPORT,0.54321,-0.061674,-0.028724,0,0
2,GO AXON EXTENSION,0.047551,-0.0617,-0.12079,0,0
2,GO REGULATION OF HORMONE LEVELS,0.13355,-0.061874,-0.071426,0,0
2,GO PROSTAGLANDIN SECRETION,0.93377,-0.061884,-0.0055076,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.05824,-0.061962,-0.081488,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.61497,-0.061967,-0.018121,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.20621,-0.062208,-0.070945,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.40349,-0.06223,-0.084241,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.14526,-0.062234,-0.062208,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.52594,-0.062237,-0.032572,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.46512,-0.062704,-0.053821,0,0
2,GO AMYLOID FIBRIL FORMATION,0.21256,-0.062709,-0.12213,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.76281,-0.062951,-0.028025,0,0
2,GO RECEPTOR CLUSTERING,0.36526,-0.063017,-0.062479,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.67776,-0.06305,0.0023569,0,0
2,GO REGULATION OF OSSIFICATION,0.87833,-0.063279,0.015308,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.4598,-0.063321,-0.051239,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.12473,-0.063335,-0.069012,0,0
2,GO MEMBRANE REPOLARIZATION,0.12908,-0.063438,-0.10516,0,0
2,GO FIBRINOLYSIS,0.39371,-0.06357,-0.10365,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.54321,-0.063727,-0.026126,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.43367,-0.063816,-0.029598,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.39858,-0.063827,-0.050873,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.42347,-0.063894,-0.023601,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.077957,-0.063938,-0.064654,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.38888,-0.064142,-0.058166,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.8303,-0.064185,0.007146,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.17653,-0.064187,-0.053701,0,0
2,GO BONE CELL DEVELOPMENT,0.42347,-0.06423,-0.030892,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.61497,-0.064419,-0.075831,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.44402,-0.064531,-0.077703,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.2,-0.064583,-0.087977,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.30402,-0.064641,-0.043484,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.91987,-0.064742,-0.018855,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.11841,-0.064745,-0.09419,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.8303,-0.065233,0.011237,0,0
2,GO HISTONE H3 K27 METHYLATION,0.26471,-0.065842,-0.043383,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.37932,-0.065867,-0.11975,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.31232,-0.066085,-0.074268,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.36526,-0.066175,-0.082852,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.56666,-0.066247,-0.03021,0,0
2,GO ION TRANSPORT,0.11841,-0.066432,-0.054666,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.40843,-0.066576,-0.034388,0,0
2,GO PHAGOSOME ACIDIFICATION,0.34702,-0.066644,-0.05983,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.084046,-0.066655,-0.071699,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.60883,-0.066681,0.0036353,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0060989,-0.066696,-0.13022,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.54903,-0.066759,-0.021923,0,0
2,GO INTEGRIN ACTIVATION,0.66501,-0.067115,-0.05459,0,0
2,GO RESPONSE TO COLD,0.080955,-0.067722,-0.15856,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.43883,-0.067756,-0.039545,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.066855,-0.06778,-0.075099,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.52594,-0.067937,-0.037146,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.79636,-0.067942,0.037378,0,0
2,GO MESENCHYME MORPHOGENESIS,0.50896,-0.067983,-0.015512,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.85768,-0.068004,-0.0058731,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.43367,-0.068006,-0.049576,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.52594,-0.068165,-0.012873,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.084046,-0.068441,-0.11927,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.81668,-0.068683,0.012217,0,0
2,GO PROTEIN DEMETHYLATION,0.87144,-0.069229,-0.00071634,0,0
2,GO ANIMAL ORGAN MATURATION,0.42855,-0.069337,-0.033435,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.27227,-0.069449,-0.049235,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.054842,-0.069796,-0.10508,0,0
2,GO HISTONE H3 K4 METHYLATION,0.92682,-0.069888,0.032452,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.188,-0.069904,-0.055566,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.30402,-0.069981,-0.13486,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,-0.070035,-0.0033915,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.090515,-0.070104,-0.14274,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.52025,-0.070137,-0.051949,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.077957,-0.070235,-0.061064,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.16559,-0.070246,-0.092238,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.21256,-0.070428,-0.067536,0,0
2,GO ECTODERM DEVELOPMENT,0.22568,-0.070568,-0.037931,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0030654,-0.070686,-0.12969,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.085627,-0.070754,-0.06516,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.62113,-0.070772,-0.013928,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.3746,-0.07093,-0.034389,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.1313,-0.07118,-0.095478,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.30815,-0.071273,-0.066993,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.27611,-0.071309,-0.077487,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.26847,-0.07136,-0.076054,0,0
2,GO RESPONSE TO CAMP,0.17374,-0.071387,-0.076767,0,0
2,GO DIET INDUCED THERMOGENESIS,0.11434,-0.071429,-0.13541,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.36526,-0.071749,-0.042204,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.47049,-0.071909,-0.049592,0,0
2,GO ODONTOGENESIS,0.98255,-0.071949,0.022524,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.1313,-0.072038,-0.097283,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.097379,-0.07222,-0.10355,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.26471,-0.072229,-0.074008,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.39858,-0.072324,-0.15827,0,0
2,GO CELL JUNCTION MAINTENANCE,0.64605,-0.072356,0.00049972,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.27999,-0.072785,-0.052788,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.090515,-0.072846,-0.08593,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.22905,-0.073045,-0.20508,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.42855,-0.07312,-0.038369,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.75615,-0.073257,-0.011674,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.088862,-0.073317,-0.10543,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.58456,-0.073666,-0.029965,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.29586,-0.073904,-0.061276,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.84397,-0.073952,0.017877,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.50337,-0.074043,-0.024404,0,0
2,GO ONE CARBON COMPOUND TRANSPORT,0.71006,-0.074057,-0.032444,0,0
2,GO PIRNA METABOLIC PROCESS,0.12259,-0.074253,-0.16493,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.10654,-0.074542,-0.071821,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.86455,-0.07459,0.039198,0,0
2,GO PROTEIN MANNOSYLATION,0.22905,-0.074832,-0.088045,0,0
2,GO KINETOCHORE ORGANIZATION,0.41341,-0.074957,-0.046109,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.013465,-0.074964,-0.11139,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.28785,-0.075694,-0.12642,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.16294,-0.075881,-0.05764,0,0
2,GO REGULATION OF TRANSPOSITION,0.76281,-0.076174,0.0034603,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.70355,-0.07647,-0.0037593,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.3746,-0.076593,-0.043037,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.0064317,-0.076697,-0.095808,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.0025817,-0.077089,-0.12579,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.04854,-0.077137,-0.11034,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.81668,-0.077329,0.030608,0,0
2,GO REGULATION OF GLIOGENESIS,0.32938,-0.077357,-0.056142,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.19393,-0.07738,-0.083842,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.16559,-0.077435,-0.078343,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.39858,-0.077507,-0.043413,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.54903,-0.077611,-0.040971,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.16559,-0.077632,-0.11681,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.52594,-0.077686,-0.0077949,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.35153,-0.077771,-0.098723,0,0
2,GO RESPONSE TO AMPHETAMINE,0.37932,-0.077881,-0.046712,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.36526,-0.078016,-0.032147,0,0
2,GO REGIONALIZATION,0.21905,-0.078053,-0.059805,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.36526,-0.0781,-0.056543,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.99651,-0.078245,0.011173,0,0
2,GO RENAL WATER HOMEOSTASIS,0.2839,-0.078432,-0.057563,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.23937,-0.078542,-0.062674,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.64605,-0.07924,-0.031308,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.1313,-0.079517,-0.04816,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.16032,-0.07958,-0.055923,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.26471,-0.079661,-0.078798,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.20937,-0.079728,-0.099014,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.12908,-0.079781,-0.076325,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.78289,-0.079878,0.033862,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.21905,-0.080014,-0.047885,0,0
2,GO MICROTUBULE POLYMERIZATION,0.12259,-0.080307,-0.099593,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.44402,-0.08032,-0.044395,0,0
2,GO CELLULAR ANION HOMEOSTASIS,0.32938,-0.08037,-0.069209,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.23245,-0.080373,-0.085206,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.39371,-0.080883,-0.03514,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.43367,-0.081153,-0.046809,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.15773,-0.081179,-0.062468,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.33373,-0.081275,-0.12444,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.35153,-0.081647,-0.049547,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.44924,-0.082113,-0.043179,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.79636,-0.082126,-0.051814,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.22235,-0.082405,0.073161,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.025994,-0.082475,-0.14914,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.26847,-0.082588,-0.06767,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.32938,-0.083142,-0.055598,0,0
2,GO DEVELOPMENTAL INDUCTION,0.1028,-0.083171,-0.13337,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.22235,-0.0832,-0.063513,0,0
2,GO CELL PART MORPHOGENESIS,0.0031536,-0.08337,-0.13165,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.61497,-0.083432,-0.028535,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.53742,-0.08362,-0.057749,0,0
2,GO HEART PROCESS,0.059411,-0.083676,-0.086449,0,0
2,GO AMINO ACID IMPORT,0.36526,-0.083962,-0.025843,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.26471,-0.084116,-0.099346,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.38408,-0.084333,-0.081126,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.15773,-0.0847,-0.10594,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.48131,-0.084862,-0.0257,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.060602,-0.08489,-0.074278,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.11039,-0.08512,-0.078282,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.095625,-0.085132,-0.053184,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.29992,-0.085278,-0.10449,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.060602,-0.085285,-0.075663,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.29992,-0.085793,-0.069012,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.13814,-0.085879,-0.080272,0,0
2,GO HEPARIN METABOLIC PROCESS,0.50896,-0.086115,-0.072655,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.17099,-0.086158,-0.089138,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.85768,-0.08632,-0.034243,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.51459,-0.086828,-0.029669,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.85082,-0.087032,0.031978,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.29586,-0.087145,-0.067516,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.030383,-0.087304,-0.1128,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.32077,-0.087957,-0.050434,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.19095,-0.087964,-0.093406,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.087232,-0.088046,-0.13302,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.40349,-0.088122,-0.092263,0,0
2,GO AXO DENDRITIC TRANSPORT,0.027188,-0.08822,-0.092793,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.097379,-0.088323,-0.097057,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.52594,-0.088426,-0.056623,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.044685,-0.088659,-0.081907,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.014841,-0.088718,-0.10032,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.24288,-0.088728,-0.065243,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.58456,-0.088881,-0.036773,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.70355,-0.088961,-0.043729,0,0
2,GO ENERGY HOMEOSTASIS,0.065563,-0.089324,-0.14088,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.34702,-0.089375,-0.12395,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.94769,-0.089452,0.051183,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.2839,-0.089595,-0.074824,0,0
2,GO CILIUM ORGANIZATION,0.0099891,-0.089797,-0.10144,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0031536,-0.089809,-0.15562,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.02166,-0.090171,-0.11587,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.20309,-0.090186,-0.13271,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.11039,-0.090298,-0.074736,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.13814,-0.090673,-0.15105,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.040234,-0.090954,-0.18739,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.082489,-0.09106,-0.064619,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.079444,-0.09163,-0.1203,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.21256,-0.091747,-0.05296,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.19695,-0.091799,-0.085274,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.029719,-0.09189,-0.086409,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.092194,-0.092051,-0.10884,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.023741,-0.092091,-0.12079,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.090515,-0.092497,-0.14385,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.26098,-0.092509,-0.078134,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.2,-0.092517,-0.098011,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.27227,-0.092612,-0.063258,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.23589,-0.093177,-0.11066,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.39371,-0.093276,-0.082669,0,0
2,GO COLLATERAL SPROUTING,0.085627,-0.093495,-0.15539,0,0
2,GO CILIUM MOVEMENT,0.007729,-0.093585,-0.12342,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.12473,-0.093766,-0.12771,0,0
2,GO ANIMAL ORGAN FORMATION,0.30815,-0.094013,-0.039168,0,0
2,GO N GLYCAN PROCESSING,0.093897,-0.094133,-0.17837,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.14285,-0.09424,-0.097322,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.037747,-0.094331,-0.15279,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.065563,-0.094471,-0.11673,0,0
2,GO MYELIN MAINTENANCE,0.092194,-0.094505,-0.1618,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.27611,-0.094654,-0.16255,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.53742,-0.094871,-0.040409,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.054842,-0.094911,-0.1035,0,0
2,GO REGULATION OF AXONOGENESIS,0.0045306,-0.095234,-0.16083,0,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.064293,-0.095324,-0.11169,0,0
2,GO STEROID CATABOLIC PROCESS,0.11841,-0.095932,-0.11305,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.8303,-0.096206,0.0040578,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.15264,-0.096873,-0.070582,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.059411,-0.097119,-0.13924,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.11235,-0.097186,-0.099812,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.53742,-0.097388,-0.050615,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.072231,-0.097555,-0.12898,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.65234,-0.097601,0.0046579,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.11235,-0.097875,-0.085659,0,0
2,GO RESPONSE TO AXON INJURY,0.13583,-0.098014,-0.099957,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.097379,-0.098039,-0.080186,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.15517,-0.098206,-0.061658,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.25729,-0.09848,-0.11052,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.11636,-0.09865,-0.093201,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.19393,-0.098799,-0.076522,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.41842,-0.098933,0.18174,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.66501,-0.098958,-0.031871,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.43883,-0.099052,-0.02682,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.24288,-0.099141,-0.14661,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.56666,-0.099435,-0.085178,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.14048,-0.09944,-0.050669,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.2,-0.099545,-0.09223,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.12689,-0.099707,-0.14774,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.04854,-0.099758,-0.094063,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.037747,-0.099835,-0.14012,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.1313,-0.099881,-0.087136,0,0
2,GO NEUROBLAST PROLIFERATION,0.065563,-0.1,-0.13132,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.26847,-0.10011,-0.039065,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.43367,-0.10012,-0.12131,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.63978,-0.10014,-0.021791,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.17374,-0.10024,-0.076932,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.068167,-0.10036,-0.086183,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.14769,-0.10043,-0.087137,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.035393,-0.10046,-0.089247,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.16294,-0.10077,-0.17336,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.3746,-0.10086,-0.071361,0,0
2,GO PARTURITION,0.26471,-0.10091,-0.11502,0,0
2,GO REGULATION OF HEART RATE,0.1028,-0.10117,-0.089009,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.16828,-0.10128,-0.075038,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.21905,-0.10135,-0.05965,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.78289,-0.10185,-0.020188,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.87833,-0.10188,0.012128,0,0
2,GO RESPONSE TO EPINEPHRINE,0.64605,-0.10213,-0.031207,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.29184,-0.10233,-0.09382,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.2,-0.10245,-0.12623,0,0
2,GO SPERMATID DIFFERENTIATION,0.0045306,-0.10263,-0.10175,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.36526,-0.10284,-0.048422,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.072231,-0.10315,-0.076243,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.56666,-0.10374,-0.056877,0,0
2,GO MICROTUBULE SEVERING,0.14526,-0.10412,-0.13436,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.67776,-0.10421,-0.029774,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.009256,-0.10435,-0.20613,0,0
2,GO TORC1 SIGNALING,0.017549,-0.10456,-0.084651,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.30815,-0.10496,-0.11001,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.093897,-0.10499,-0.10487,0,0
2,GO ORGANIC CATION TRANSPORT,0.34702,-0.10543,-0.054027,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.055956,-0.10584,-0.097105,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.39858,-0.10618,-0.10503,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0075304,-0.10626,-0.1482,0,0
2,GO RELAXATION OF MUSCLE,0.20621,-0.10667,-0.098049,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.15773,-0.10712,-0.12259,0,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.15517,-0.10715,-0.090363,0,0
2,GO PANCREAS DEVELOPMENT,0.15264,-0.1072,-0.093905,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.13583,-0.10747,-0.0637,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.020205,-0.10793,-0.14959,0,0
2,GO ORGAN INDUCTION,0.12259,-0.10798,-0.12214,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.12473,-0.10802,-0.19197,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.31232,-0.10811,-0.11409,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.080955,-0.10847,-0.081786,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.42347,-0.10864,-0.035184,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.36991,-0.1087,-0.10601,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.20621,-0.10884,-0.058291,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.26098,-0.10918,-0.10774,0,0
2,GO NEURON DEVELOPMENT,0.0019282,-0.10935,-0.13927,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.55487,-0.10946,-0.050482,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.42855,-0.10962,-0.048535,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.2,-0.11005,-0.11908,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.16032,-0.11013,-0.11419,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.29586,-0.11015,-0.071262,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.20309,-0.11028,-0.070412,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.035393,-0.1105,-0.10841,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.54903,-0.11075,-0.039061,0,0
2,GO MITOCHONDRION LOCALIZATION,0.011047,-0.111,-0.13528,0,0
2,GO ESTROUS CYCLE,0.38408,-0.11138,-0.074696,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.1028,-0.11191,-0.088509,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0056288,-0.11212,-0.20565,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.59059,-0.11253,-0.038544,0,0
2,GO RESPONSE TO ALKALOID,0.0069616,-0.11263,-0.13927,0,0
2,GO NEURON DIFFERENTIATION,0.0017123,-0.11306,-0.13152,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.061812,-0.11321,-0.14976,0,0
2,GO OVULATION CYCLE,0.3746,-0.11331,-0.049759,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.29586,-0.11336,-0.085588,0,0
2,GO FEEDING BEHAVIOR,0.053746,-0.11338,-0.092453,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.4978,-0.11395,-0.028467,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.18219,-0.11398,-0.12792,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.23937,-0.11409,-0.10284,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.10845,-0.11416,-0.12725,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.52025,-0.11427,-0.0058229,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.53167,-0.11464,-0.10743,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.065563,-0.11473,-0.22654,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.5726,-0.11493,-0.049902,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.24288,-0.1152,-0.058774,0,0
2,GO ACTION POTENTIAL,0.065563,-0.1155,-0.10579,0,0
2,GO L AMINO ACID TRANSPORT,0.025414,-0.11595,-0.083014,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.28785,-0.11633,-0.092056,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.22568,-0.11652,-0.13399,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.24643,-0.1168,-0.063665,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.019283,-0.1173,-0.1371,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.3746,-0.11741,-0.076794,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.94769,-0.11756,0.0040028,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.14769,-0.11795,-0.088882,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.066855,-0.11797,-0.08671,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.0066042,-0.11848,-0.15034,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.25363,-0.11903,-0.056627,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.095625,-0.11913,-0.098124,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.3746,-0.11939,-0.082515,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.77618,-0.11941,0.01629,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15264,-0.11962,-0.054246,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.070855,-0.11963,-0.0847,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.065563,-0.11971,-0.23502,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.023741,-0.12014,-0.0010532,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.29992,-0.12021,-0.038826,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.10845,-0.12043,-0.1075,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.19695,-0.12072,-0.1338,0,0
2,GO MITOTIC DNA REPLICATION,0.088862,-0.121,-0.078633,0,0
2,GO MEMBRANE DOCKING,0.0014738,-0.12124,-0.10438,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.17934,-0.12154,-0.059277,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.67776,-0.12171,-0.068097,0,0
2,GO PHAGOSOME MATURATION,0.10096,-0.12281,-0.091038,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.061812,-0.12291,-0.14037,0,0
2,GO REGULATION OF NEURON MIGRATION,0.029719,-0.12298,-0.16213,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.18219,-0.12331,-0.069971,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.070855,-0.12408,-0.087007,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.51459,-0.12442,-0.050798,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.43367,-0.12475,-0.074349,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.62113,-0.12545,0.067738,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.05824,-0.12554,-0.14082,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.090515,-0.12592,-0.11655,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.15517,-0.12607,-0.13574,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.022165,-0.12617,-0.16624,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.22235,-0.12665,-0.14007,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.96163,-0.12679,0.0093432,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.0046564,-0.12736,-0.13702,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.076492,-0.12768,-0.12262,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.18219,-0.12774,-0.089097,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.010773,-0.12785,-0.11846,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.092194,-0.12841,-0.096748,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.31653,-0.12919,-0.066759,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.37932,-0.12924,-0.093896,0,0
2,GO EXTRACELLULAR TRANSPORT,0.14048,-0.12951,-0.11626,0,0
2,GO NEURON PROJECTION REGENERATION,0.11235,-0.12984,-0.10481,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.12689,-0.13075,-0.14622,0,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.22235,-0.13148,-0.10074,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.10845,-0.13173,-0.09986,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.016339,-0.13234,-0.2109,0,0
2,GO AXONAL TRANSPORT,0.012203,-0.13237,-0.12528,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.14526,-0.13273,-0.068723,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.37932,-0.13324,-0.055189,0,0
2,GO TRANSPOSITION,0.35153,-0.13347,-0.09833,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.1313,-0.13373,-0.11991,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.4545,-0.13375,-0.062264,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.077957,-0.13482,-0.11841,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0015189,-0.13543,-0.16831,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.064293,-0.13572,-0.11269,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.42347,-0.13589,-0.036377,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.96163,-0.13596,0.074661,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.54903,-0.1361,-0.028147,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.007729,-0.13617,-0.12665,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.30402,-0.13623,-0.047756,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.92682,-0.13659,0.065792,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.4978,-0.13706,-0.088108,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.18219,-0.13793,-0.071636,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.21579,-0.13849,-0.076694,0,0
2,GO DENDRITE MORPHOGENESIS,0.0032441,-0.13885,-0.15684,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.076492,-0.1394,-0.14104,0,0
2,GO LOCOMOTOR RHYTHM,0.31653,-0.13949,-0.074566,0,0
2,GO POLYOL TRANSPORT,0.12049,-0.13966,-0.11352,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.11235,-0.14091,-0.11076,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.27999,-0.14137,-0.080348,0,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.066855,-0.14155,-0.17658,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.40843,-0.14174,-0.094223,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.072231,-0.14216,-0.24311,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.43883,-0.14283,-0.11842,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.11235,-0.14363,-0.14795,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.16032,-0.14379,-0.14586,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.36526,-0.14418,-0.072774,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.099158,-0.14445,-0.1379,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0064317,-0.14452,-0.15153,0,0
2,GO ADULT HEART DEVELOPMENT,0.188,-0.14493,-0.10864,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.15264,-0.1456,-0.072488,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.1313,-0.14565,-0.1463,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.16294,-0.14591,-0.13753,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.076492,-0.14684,-0.15905,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.20309,-0.14692,-0.12076,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.26098,-0.14701,-0.10159,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.4598,-0.14714,-0.1015,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.13814,-0.14727,-0.13389,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.11841,-0.14773,-0.14182,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.042857,-0.14797,-0.15023,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.29184,-0.14837,-0.076838,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.068167,-0.15047,-0.18969,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.10845,-0.15123,-0.12227,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12908,-0.15216,-0.14626,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.088862,-0.15233,-0.11641,0,0
2,GO DENDRITE SELF AVOIDANCE,0.035393,-0.15251,-0.20665,0,0
2,GO SEROTONIN TRANSPORT,0.072231,-0.15256,-0.1502,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.080955,-0.15285,-0.20337,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.015953,-0.15355,-0.16147,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.11434,-0.15388,-0.23924,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.2839,-0.15525,-0.047982,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.0050528,-0.15588,-0.19041,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.22905,-0.15631,-0.067598,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.26847,-0.15742,-0.051292,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.13583,-0.15784,-0.22537,0,0
2,GO REGULATION OF INSULIN SECRETION,0.010506,-0.15835,-0.12371,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.018836,-0.15953,-0.13448,0,0
2,GO REGULATION OF OOGENESIS,0.0064317,-0.15987,-0.16671,0,0
2,GO CGMP METABOLIC PROCESS,0.088862,-0.16022,-0.18154,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.17374,-0.16033,-0.086828,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.016339,-0.16064,-0.19673,0,0
2,GO SPINAL CORD DEVELOPMENT,0.0075304,-0.1611,-0.14967,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.11636,-0.16212,-0.10515,0,0
2,GO LONG TERM MEMORY,0.027803,-0.16264,-0.14751,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.30815,-0.1627,-0.042584,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.10654,-0.16368,-0.15458,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.057089,-0.16414,-0.11863,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.03939,-0.16504,-0.17528,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.15015,-0.16536,-0.15492,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.021165,-0.16641,-0.15652,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0073363,-0.16656,-0.17685,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.43883,-0.16769,-0.07779,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.015203,-0.16814,-0.1613,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.057089,-0.16827,-0.22606,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15015,-0.16831,-0.1265,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.015953,-0.1686,-0.17602,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.093897,-0.16898,-0.15925,0,0
2,GO CARDIAC CHAMBER FORMATION,0.59664,-0.16921,-0.072117,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0059384,-0.16946,-0.16507,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.0040578,-0.16946,-0.25782,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.24643,-0.17009,-0.091487,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.20937,-0.17013,-0.15406,0,0
2,GO RESPONSE TO FORSKOLIN,0.16294,-0.1702,-0.18278,0,0
2,GO RESPONSE TO ACIDIC PH,0.21256,-0.17072,-0.075048,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.12473,-0.17136,-0.25829,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.066855,-0.17161,-0.23609,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.095625,-0.17249,-0.21678,0,0
2,GO FAT CELL PROLIFERATION,0.036164,-0.17292,-0.16883,0,0
2,GO ACROSOME ASSEMBLY,0.0083534,-0.17352,-0.19573,0,0
2,GO FOREBRAIN CELL MIGRATION,0.001191,-0.17409,-0.18936,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.30815,-0.17428,-0.033504,0,0
2,GO PALLIUM DEVELOPMENT,0.0015653,-0.17567,-0.14705,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.13355,-0.17615,-0.10735,0,0
2,GO DENDRITE DEVELOPMENT,0.0022992,-0.17664,-0.15363,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.070855,-0.17745,-0.18714,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.36064,-0.17825,-0.05041,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.20621,-0.17842,-0.18358,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.068167,-0.17932,-0.18819,0,0
2,GO INSULIN SECRETION,0.013139,-0.17994,-0.13275,0,0
2,GO SEROTONIN SECRETION,0.14769,-0.1808,-0.14028,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17374,-0.18088,-0.11426,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0073363,-0.18115,-0.2833,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.050569,-0.18235,-0.11761,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.011904,-0.18306,-0.13291,0,0
2,GO SYNAPSE ORGANIZATION,0.0071468,-0.18421,-0.15646,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0071468,-0.18535,-0.22766,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.010245,-0.18536,-0.1464,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00069957,-0.18536,-0.1909,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.014841,-0.18565,-0.18024,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.072231,-0.18568,-0.12709,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.14769,-0.18571,-0.093435,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.1313,-0.18582,-0.11611,0,0
2,GO NEURON PROJECTION EXTENSION,0.00052342,-0.18718,-0.19068,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.47049,-0.18869,-0.044765,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.033894,-0.18877,-0.13608,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.063042,-0.18951,-0.13265,0,0
2,GO COGNITION,0.00049035,-0.18983,-0.17907,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.043763,-0.19244,-0.2046,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.015203,-0.19252,-0.25942,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.13355,-0.19306,-0.20037,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.036164,-0.19337,-0.21023,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.11235,-0.19393,-0.12321,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.099158,-0.19448,-0.11954,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.23589,-0.19481,-0.076242,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.011904,-0.19533,-0.15912,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.070855,-0.19537,-0.1644,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00059588,-0.19557,-0.18503,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.00024286,-0.1956,-0.21812,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.04854,-0.19607,-0.12202,0,0
2,GO RESPONSE TO CAFFEINE,0.2,-0.19619,-0.081134,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.0021062,-0.19639,-0.15376,0,0
2,GO FOREBRAIN DEVELOPMENT,0.00063551,-0.19685,-0.153,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.072231,-0.19783,-0.18831,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0013054,-0.19823,-0.26044,0,0
2,GO GLYCINE TRANSPORT,0.16828,-0.19857,-0.11215,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.32077,-0.19871,-0.1085,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.025994,-0.19873,-0.12033,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.00055855,-0.20079,-0.17795,0,0
2,GO RESPONSE TO COCAINE,0.0056288,-0.20091,-0.19284,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.31232,-0.20125,-0.11076,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.075049,-0.20219,-0.19945,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.14769,-0.20318,-0.25056,0,0
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.14769,-0.20486,-0.1663,0,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.070855,-0.20529,-0.25252,0,0
2,GO CALCIUM ION IMPORT,0.00059588,-0.20609,-0.20042,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.24288,-0.20747,-0.062903,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0047853,-0.20868,-0.18962,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.32938,-0.20928,-0.085681,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.072231,-0.20931,-0.12411,0,0
2,GO METENCEPHALON DEVELOPMENT,0.00024286,-0.20958,-0.21474,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.059411,-0.20975,-0.22862,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.084046,-0.21006,-0.13761,0,0
2,GO DENDRITIC TRANSPORT,0.042857,-0.21053,-0.14966,0,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.033166,-0.21069,-0.21072,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00090094,-0.21099,-0.22898,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0011199,-0.21193,-0.15183,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,-0.21357,-0.17754,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.022165,-0.2148,-0.27049,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0019282,-0.21561,-0.20128,0,0
2,GO DIVALENT METAL ION EXPORT,0.014486,-0.21757,-0.20642,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.0046564,-0.21902,-0.22337,0,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.12689,-0.22088,-0.16998,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.1028,-0.22333,-0.13178,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0062634,-0.22368,-0.26946,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.023205,-0.22605,-0.20727,0,0
2,GO REGULATION OF MICROTUBULE BINDING,5.4121e-05,-0.22612,-0.30663,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.064293,-0.22825,-0.16631,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0036303,-0.22963,-0.22529,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.007729,-0.2301,-0.1993,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.092194,-0.23087,-0.14966,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.17653,-0.23097,-0.1239,0,0
2,GO SYNAPSE ASSEMBLY,0.0036303,-0.23157,-0.18532,0,0
2,GO RESPONSE TO POTASSIUM ION,0.007729,-0.23341,-0.22375,0,0
2,GO MALE MEIOSIS I,0.0037331,-0.23344,-0.24029,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.62732,-0.23429,-0.085272,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.5726,-0.23449,-0.042311,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.053746,-0.23517,-0.20494,0,0
2,GO NEURON PROJECTION ARBORIZATION,0.00034072,-0.23614,-0.29599,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.64605,-0.23701,-0.10036,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.14526,-0.23703,-0.21982,0,0
2,GO VESICLE DOCKING,8.4205e-05,-0.23716,-0.24263,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0019282,-0.23742,-0.22486,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0013054,-0.23778,-0.271,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.15015,-0.23978,-0.14812,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0023671,-0.24055,-0.23122,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.092194,-0.2423,-0.17733,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.033894,-0.24343,-0.25084,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.0015653,-0.24434,-0.2488,0,0
2,GO SIALYLATION,0.079444,-0.24466,-0.17385,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.001228,-0.24626,-0.19075,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00065623,-0.24627,-0.27358,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.013798,-0.2513,-0.19657,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.00017796,-0.25131,-0.2831,0,0
2,GO PRESYNAPSE ORGANIZATION,0.0025817,-0.25142,-0.24451,0,0
2,GO CELL FATE DETERMINATION,0.0042883,-0.2516,-0.20779,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.00010845,-0.25222,-0.25972,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.007729,-0.25304,-0.31442,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.25001,-0.25362,-0.10568,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.019283,-0.25741,-0.24244,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.001191,-0.2593,-0.21367,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.15517,-0.25951,-0.16165,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.0085714,-0.26083,-0.26862,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.0090226,-0.26098,-0.20008,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.0071468,-0.26726,-0.23054,0,0
2,GO INTRACILIARY TRANSPORT,0.0036303,-0.27263,-0.22285,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0010206,-0.27272,-0.29532,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.015953,-0.27494,-0.22759,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.044685,-0.27534,-0.18456,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.11039,-0.27672,-0.17588,0,0
2,GO RETINA LAYER FORMATION,0.0050528,-0.27678,-0.28371,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.073629,-0.27972,-0.17909,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.7118e-05,-0.27999,-0.27541,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0022332,-0.28015,-0.22576,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0026572,-0.28148,-0.29187,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.019739,-0.2815,-0.26656,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.0028957,-0.28163,-0.30722,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.00019753,-0.28186,-0.25031,0,0
2,GO NEURON RECOGNITION,0.0010206,-0.2826,-0.28251,0,0
2,GO SYNAPTIC SIGNALING,0.00010845,-0.28428,-0.2449,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.13583,-0.28436,-0.19438,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.001228,-0.28675,-0.22839,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.016734,-0.28714,-0.24216,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.00021167,-0.28806,-0.2765,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.010245,-0.2916,-0.22982,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0010206,-0.29337,-0.24955,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,8.1192e-05,-0.29679,-0.27793,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.01282,-0.29809,-0.19251,0,0
2,GO GROOMING BEHAVIOR,0.0085714,-0.29981,-0.25225,0,0
2,GO NEURON MIGRATION,0.00025131,-0.30015,-0.25331,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00050664,-0.3014,-0.31495,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,5.4121e-05,-0.302,-0.30495,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.088862,-0.30236,-0.21449,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.00014418,-0.30255,-0.23676,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.25363,-0.30284,-0.22861,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0041716,-0.30539,-0.23943,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0060989,-0.30568,-0.1973,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.17934,-0.30645,-0.1702,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0045306,-0.30917,-0.28263,0,0
2,GO TOXIN METABOLIC PROCESS,0.05824,-0.3095,-0.19951,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.014841,-0.31029,-0.39114,0,0
2,GO HEART FORMATION,0.0013872,-0.31205,-0.32478,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00098941,-0.31355,-0.25829,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.015953,-0.31731,-0.3371,0,0
2,GO PROTEIN POLYGLUTAMYLATION,0.00021167,-0.31768,-0.26319,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.0184e-05,-0.32164,-0.3321,0,0
2,GO MAST CELL MIGRATION,0.30815,-0.32279,-0.10288,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,3.6228e-06,-0.32295,-0.32551,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00049035,-0.32348,-0.30899,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0011199,-0.32514,-0.33104,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0023671,-0.32647,-0.31336,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0054795,-0.32695,-0.2334,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00057693,-0.32843,-0.2827,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.0010206,-0.32902,-0.25897,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0021062,-0.32945,-0.37048,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.017549,-0.3314,-0.23062,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,7.2754e-05,-0.33144,-0.33873,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.00036427,-0.33336,-0.32851,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.4609e-05,-0.34302,-0.3324,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00084609,-0.34441,-0.29044,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,1.1964e-05,-0.34653,-0.32267,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.29992,-0.34683,-0.035639,0,0
2,GO HEART INDUCTION,0.0059384,-0.34827,-0.50427,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00029782,-0.34831,-0.34391,0,0
2,GO ADULT BEHAVIOR,3.1888e-05,-0.34936,-0.28256,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.095625,-0.35229,-0.23167,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,5.6174e-05,-0.35298,-0.27815,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.0075304,-0.3543,-0.22714,0,0
2,GO SYNAPTIC VESICLE RECYCLING,3.4421e-05,-0.35485,-0.33623,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,1.5816e-05,-0.35697,-0.35393,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.00050664,-0.35804,-0.3358,0,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0087944,-0.36049,-0.39278,0,0
2,GO EXPLORATION BEHAVIOR,3.0689e-05,-0.36184,-0.42087,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.025414,-0.36232,-0.257,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.00092958,-0.36423,-0.48135,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0067808,-0.3694,-0.27375,0,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00010845,-0.37203,-0.34103,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00081984,-0.37208,-0.38575,0,0
2,GO LUNG CELL DIFFERENTIATION,0.23937,-0.37364,-0.16087,0,0
2,GO CATECHOLAMINE UPTAKE,0.0046564,-0.3765,-0.26627,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00016023,-0.37882,-0.31114,0,0
2,GO REGULATION OF VESICLE FUSION,0.0081404,-0.38038,-0.28864,0,0
2,GO AXONEME ASSEMBLY,3.4421e-05,-0.38059,-0.34053,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00018427,-0.38707,-0.30568,0,0
2,GO SPERM AXONEME ASSEMBLY,0.00026003,-0.38965,-0.32646,0,0
2,GO CARDIOBLAST PROLIFERATION,0.033894,-0.39484,-0.36108,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.00010845,-0.40049,-0.33681,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.00025131,-0.40645,-0.35278,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.00014418,-0.4078,-0.40737,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00079435,-0.41032,-0.46631,0,0
2,GO INCLUSION BODY ASSEMBLY,0.00018427,-0.41345,-0.3703,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00045924,-0.41444,-0.36095,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,6.2786e-05,-0.4209,-0.33205,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00036427,-0.42106,-0.36199,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.017549,-0.42591,-0.33704,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00034072,-0.43245,-0.43805,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00013433,-0.4381,-0.34884,0,0
2,GO NEUROTRANSMITTER SECRETION,0.00032948,-0.43911,-0.37555,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,5.0226e-05,-0.44506,-0.40873,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.00040247,-0.44954,-0.48373,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,7.6603e-06,-0.45012,-0.42152,0,0
2,GO NEURON FATE COMMITMENT,0.00038934,-0.45028,-0.36083,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00031859,-0.45114,-0.38953,0,0
2,GO SPINAL CORD PATTERNING,0.00012512,-0.45579,-0.43945,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.7346e-05,-0.45657,-0.45603,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,8.7323e-05,-0.4634,-0.5653,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00021167,-0.46975,-0.51629,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.0604e-05,-0.47011,-0.4904,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.349e-05,-0.47385,-0.48564,0,0
2,GO DENSE CORE GRANULE TRANSPORT,0.00016595,-0.47581,-0.55274,0,0
2,GO PARENTAL BEHAVIOR,0.0001165,-0.4833,-0.42934,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00079435,-0.48431,-0.35538,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0024367,-0.48435,-0.36658,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0066042,-0.50635,-0.36939,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,9.0179e-06,-0.51025,-0.46609,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00012512,-0.51125,-0.4357,0,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.0022332,-0.51477,-0.45491,0,0
2,GO NEURON FATE SPECIFICATION,0.0022332,-0.5165,-0.3905,0,0
2,GO GLUTAMATE SECRETION,4.8612e-06,-0.52196,-0.46084,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.4609e-05,-0.53818,-0.42839,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00016023,-0.54078,-0.51434,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0039469,-0.54333,-0.52374,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00081984,-0.55378,-0.43883,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,3.9418e-06,-0.56376,-0.51056,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,4.3218e-05,-0.57795,-0.45474,0,0
2,GO HEART FIELD SPECIFICATION,0.00014935,-0.57834,-0.5204,0,0
2,GO SYNAPTIC MEMBRANE ADHESION,4.3218e-05,-0.58357,-0.54784,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.1663e-05,-0.58792,-0.49029,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00014418,-0.58816,-0.42427,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,5.0226e-05,-0.58871,-0.57588,0,0
2,GO PREPULSE INHIBITION,0.0042883,-0.59001,-0.44761,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.59077,-0.54935,0,0
2,GO DENDRITE EXTENSION,6.7728e-06,-0.59498,-0.50986,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.9532e-05,-0.59663,-0.61714,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,2.3418e-05,-0.63175,-0.58078,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0027346,-0.63626,-0.52974,0,0
2,GO GROWTH HORMONE SECRETION,6.8936e-07,-0.64066,-0.57578,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,7.0571e-06,-0.64924,-0.59559,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,7.013e-05,-0.64945,-0.5738,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0028957,-0.65138,-0.48739,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,3.6228e-06,-0.67931,-0.61885,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00040247,-0.68225,-0.57906,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.00036427,-0.68598,-0.56704,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.6623e-06,-0.69416,-0.66073,0,0
2,GO VOCALIZATION BEHAVIOR,5.8301e-05,-0.71991,-0.62233,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,5.9841e-06,-0.76196,-0.64503,0,0
2,GO CATECHOLAMINE SECRETION,0.00022676,-0.76913,-0.56227,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.9263e-05,-0.79706,-0.78369,0,0
2,GO REGULATION OF DOPAMINE SECRETION,0.0013457,-0.81198,-0.59623,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,5.508e-06,-0.84992,-0.78528,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00023468,-0.88588,-0.67055,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00019753,-1.2367,-0.91664,0,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0064317,0.27528,0.21508,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO COLLAGEN METABOLIC PROCESS,0.020205,0.24009,0.14035,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031059,0.20867,0.18668,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
3,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.049546,0.18136,0.15569,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.042857,0.15178,0.12137,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
3,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,1,1
3,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO NUCLEAR EXPORT,0.024846,0.070434,0.06326,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.047551,0.068477,0.092842,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00081984,0.49751,0.48283,1,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,1,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,1,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.0081404,0.35604,0.31425,1,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,1,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0047853,0.3128,0.27844,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0073363,0.30895,0.2251,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.01282,0.30544,0.21362,1,0
3,GO PHAGOCYTOSIS RECOGNITION,0.052669,0.29655,0.16095,1,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.29312,0.23126,1,0
3,GO BONE TRABECULA FORMATION,0.016339,0.29217,0.28867,1,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.015953,0.28339,0.195,1,0
3,GO ARGININE METABOLIC PROCESS,0.0079323,0.27497,0.29089,1,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.018398,0.27165,0.20893,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.013465,0.26825,0.30375,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.03245,0.26305,0.1703,1,0
3,GO BONE GROWTH,0.009256,0.2629,0.2313,1,0
3,GO GTP METABOLIC PROCESS,0.0021689,0.26286,0.23585,1,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038387,0.25753,0.34078,1,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0026572,0.23251,0.2819,1,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.22828,0.26749,1,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0016129,0.22746,0.18799,1,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,1,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,0
3,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,1,0
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.0037331,0.21351,0.17163,1,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019283,0.20829,0.13889,1,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0062634,0.20156,0.21024,1,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0079323,0.20082,0.20231,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.014486,0.19694,0.17506,1,0
3,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.014138,0.19562,0.16247,1,0
3,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,1,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,1,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013798,0.18278,0.18877,1,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0045306,0.18258,0.17858,1,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,1,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.011904,0.18024,0.16927,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.045624,0.17967,0.12845,1,0
3,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17726,0.17885,1,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,0.17692,0.23384,1,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.1762,0.13534,1,0
3,GO POSITIVE REGULATION OF HEART RATE,0.040234,0.16813,0.18861,1,0
3,GO FATTY ACID HOMEOSTASIS,0.044685,0.16644,0.20355,1,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.010506,0.16562,0.19049,1,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,1,0
3,GO RESPONSE TO AMINE,0.0094949,0.16148,0.17707,1,0
3,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,1,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041967,0.16069,0.13783,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,0
3,GO HEPARIN METABOLIC PROCESS,0.045624,0.15858,0.22973,1,0
3,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.042857,0.15679,0.097057,1,0
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,0
3,GO COPPER ION HOMEOSTASIS,0.024846,0.15663,0.14424,1,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.02068,0.15485,0.11071,1,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.015203,0.15295,0.097831,1,0
3,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,1,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,1,0
3,GO RESPIRATORY SYSTEM PROCESS,0.010506,0.14997,0.14022,1,0
3,GO MEMBRANE REPOLARIZATION,0.014138,0.14965,0.13738,1,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0069616,0.14894,0.15764,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0087944,0.14827,0.14805,1,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.14759,0.15602,1,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.047551,0.14515,0.10055,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0026572,0.14459,0.15038,1,0
3,GO DEVELOPMENTAL CELL GROWTH,0.00074557,0.14342,0.149,1,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.04854,0.13973,0.12553,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,1,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0094949,0.13631,0.16419,1,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.009256,0.13573,0.11999,1,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043763,0.13544,0.12947,1,0
3,GO LIVER REGENERATION,0.040234,0.13541,0.077176,1,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0038387,0.13277,0.1505,1,0
3,GO NEUROMUSCULAR PROCESS,0.0060989,0.13239,0.14602,1,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.0087944,0.13195,0.11512,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.02166,0.12912,0.12848,1,0
3,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,1,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0025083,0.12726,0.12677,1,0
3,GO MEMORY,0.0067808,0.12525,0.13818,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,0
3,GO MRNA SPLICE SITE SELECTION,0.042857,0.123,0.13568,1,0
3,GO GLUTAMINE METABOLIC PROCESS,0.0031536,0.12242,0.15681,1,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11981,0.10207,1,0
3,GO PEPTIDE METABOLIC PROCESS,0.024846,0.11942,0.091635,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.015574,0.11796,0.081204,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026586,0.11785,0.1383,1,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,1,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.11532,0.078129,1,0
3,GO RNA 5 END PROCESSING,0.035393,0.11506,0.12281,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.022165,0.11502,0.13665,1,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.010506,0.11484,0.11228,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.043763,0.1138,0.13072,1,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.03245,0.11289,0.1031,1,0
3,GO GLIAL CELL MIGRATION,0.052669,0.11218,0.13199,1,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.0037331,0.11212,0.17851,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.018836,0.11181,0.17577,1,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,0
3,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11156,0.096039,1,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.045624,0.11137,0.11873,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11107,0.10628,1,0
3,GO TRNA METABOLIC PROCESS,0.0034322,0.10892,0.14407,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047551,0.1078,0.085432,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.015953,0.10552,0.11118,1,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.016734,0.1037,0.11503,1,0
3,GO RESPONSE TO AMYLOID BETA,0.0094949,0.10326,0.1324,1,0
3,GO POTASSIUM ION TRANSPORT,0.035393,0.10273,0.1169,1,0
3,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,1,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0023671,0.10243,0.09872,1,0
3,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.011047,0.10155,0.11642,1,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.024846,0.099707,0.083464,1,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0060989,0.098297,0.099857,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015953,0.09826,0.081023,1,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.029068,0.097005,0.08091,1,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.038561,0.096255,0.11449,1,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.020205,0.095754,0.083423,1,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0079323,0.09519,0.12173,1,0
3,GO RNA MODIFICATION,0.0075304,0.09438,0.12402,1,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.021165,0.093074,0.086229,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.089731,0.099952,1,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02843,0.089345,0.091656,1,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,1,0
3,GO RESPONSE TO CALCIUM ION,0.050569,0.088902,0.089481,1,0
3,GO RESPONSE TO HEAT,0.017969,0.088863,0.079789,1,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,1,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.010245,0.088589,0.06583,1,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.033166,0.088546,0.11543,1,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,0
3,GO ORGANIC CATION TRANSPORT,0.02268,0.085963,0.1203,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.041093,0.080665,0.085237,1,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.026586,0.073598,0.10531,1,0
3,GO CELL CYCLE DNA REPLICATION,0.044685,0.07298,0.079722,1,0
3,GO LOCOMOTORY BEHAVIOR,0.036164,0.072435,0.13478,1,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.024846,0.067091,0.096255,1,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.03245,0.066848,0.090725,1,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.024288,0.065336,0.096793,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.016734,0.063443,0.10185,1,0
3,GO RNA EXPORT FROM NUCLEUS,0.041967,0.063385,0.083155,1,0
3,GO BEHAVIOR,0.013139,0.062013,0.11244,1,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,0.061913,0.066182,1,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.060199,0.081212,1,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.041093,0.060038,0.10921,1,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.044685,0.060003,0.063979,1,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.045624,0.057252,0.082736,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031059,0.056379,0.062983,1,0
3,GO NUCLEAR TRANSPORT,0.023741,0.052646,0.053247,1,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.035393,0.052448,0.055266,1,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,1,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.041093,0.036656,0.074008,1,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.031748,0.035939,0.067457,1,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.050569,0.032713,0.064769,1,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.019739,-0.024923,-0.086715,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.049546,-0.031431,-0.054434,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.036167,-0.13545,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.047551,-0.037358,-0.049977,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.049546,-0.03837,-0.055105,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.049546,-0.04202,-0.041943,1,0
3,GO TISSUE MORPHOGENESIS,0.047551,-0.042047,-0.080539,1,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.004408,-0.042958,-0.071349,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.027803,-0.046405,-0.057805,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.025414,-0.046584,-0.13269,1,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.030383,-0.047395,-0.0479,1,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.025994,-0.047781,-0.15593,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,-0.048096,-0.056265,1,0
3,GO NON RECOMBINATIONAL REPAIR,0.029719,-0.049058,-0.070112,1,0
3,GO ACTIN FILAMENT BASED PROCESS,0.036948,-0.05139,-0.072544,1,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.047551,-0.052509,-0.059863,1,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.052873,-0.041961,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037747,-0.053669,-0.068959,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.014138,-0.053852,-0.15297,1,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.037747,-0.055403,-0.066143,1,0
3,GO CYTOSKELETON ORGANIZATION,0.04854,-0.055548,-0.051262,1,0
3,GO POSITIVE REGULATION OF SIGNALING,0.033166,-0.055813,-0.065149,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,-0.056332,-0.085675,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.03245,-0.056358,-0.056157,1,0
3,GO MACROAUTOPHAGY,0.0054795,-0.057538,-0.080368,1,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019283,-0.057979,-0.084699,1,0
3,GO ACTIN FILAMENT ORGANIZATION,0.017549,-0.058128,-0.094691,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.038561,-0.058545,-0.10222,1,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.019739,-0.058587,-0.081149,1,0
3,GO SEXUAL REPRODUCTION,0.0025817,-0.059443,-0.071044,1,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024288,-0.059497,-0.077715,1,0
3,GO ORGANELLE FISSION,0.019283,-0.060777,-0.053453,1,0
3,GO HISTONE UBIQUITINATION,0.041093,-0.061309,-0.066636,1,0
3,GO PROTEIN AUTOUBIQUITINATION,0.027188,-0.061491,-0.065572,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.013139,-0.061745,-0.099152,1,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.05161,-0.061757,-0.075136,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.03939,-0.061936,-0.17826,1,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.012203,-0.062843,-0.080199,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.0013872,-0.063414,-0.13611,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.06359,-0.11612,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.023741,-0.063699,-0.12651,1,0
3,GO VACUOLE ORGANIZATION,0.049546,-0.063873,-0.080909,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0067808,-0.064341,-0.1042,1,0
3,GO CELL MOTILITY,0.036948,-0.064481,-0.079393,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.024288,-0.065264,-0.08581,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.042857,-0.065369,-0.13007,1,0
3,GO TUBE MORPHOGENESIS,0.041093,-0.06564,-0.099175,1,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033894,-0.065921,-0.067849,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.011047,-0.066015,-0.10214,1,0
3,GO MULTICELLULAR ORGANISM AGING,0.017549,-0.066565,-0.12547,1,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.05161,-0.067007,-0.10693,1,0
3,GO SECRETION,0.012508,-0.067035,-0.08332,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.03245,-0.067433,-0.079096,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,-0.06747,-0.092176,1,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.024846,-0.067811,-0.070702,1,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.030383,-0.067849,-0.11162,1,0
3,GO TUBE DEVELOPMENT,0.033894,-0.069626,-0.094207,1,0
3,GO MUSCLE ADAPTATION,0.05161,-0.070042,-0.090495,1,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0079323,-0.070156,-0.080998,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.04854,-0.07016,-0.070453,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.070793,-0.12646,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.02166,-0.071389,-0.099685,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.025994,-0.071424,-0.085065,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.014138,-0.071536,-0.11367,1,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0038387,-0.072065,-0.074907,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.03245,-0.072305,-0.11245,1,0
3,GO LYMPHOCYTE ACTIVATION,0.0075304,-0.072443,-0.11104,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0085714,-0.072665,-0.087308,1,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.013139,-0.074079,-0.11156,1,0
3,GO MULTI ORGANISM PROCESS,0.009256,-0.074202,-0.06881,1,0
3,GO PEPTIDE SECRETION,0.025414,-0.074792,-0.08505,1,0
3,GO NEGATIVE T CELL SELECTION,0.0027346,-0.075183,-0.16075,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.0064317,-0.075297,-0.092052,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.038561,-0.076032,-0.079738,1,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017969,-0.07604,-0.099561,1,0
3,GO EAR DEVELOPMENT,0.035393,-0.0763,-0.099769,1,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.023205,-0.076905,-0.071375,1,0
3,GO DEPHOSPHORYLATION,0.021165,-0.077657,-0.058171,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.0097392,-0.07785,-0.076389,1,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011326,-0.077982,-0.078376,1,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.041967,-0.078097,-0.11692,1,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.041967,-0.078222,-0.095114,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.031748,-0.078364,-0.079138,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.03245,-0.078499,-0.10286,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039469,-0.078562,-0.08408,1,0
3,GO EXOCYTOSIS,0.011047,-0.078638,-0.10281,1,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.018836,-0.078865,-0.058864,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.045624,-0.079261,-0.13395,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.017549,-0.079405,-0.10827,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0015653,-0.079454,-0.10403,1,0
3,GO CHROMOSOME LOCALIZATION,0.0025817,-0.079572,-0.11324,1,0
3,GO DETECTION OF STIMULUS,0.0010859,-0.079666,-0.097326,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.0049174,-0.079687,-0.077954,1,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.049546,-0.08022,-0.12088,1,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.027188,-0.080418,-0.06057,1,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015574,-0.080753,-0.10773,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.037747,-0.080788,-0.11695,1,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.019739,-0.080956,-0.12703,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.042857,-0.081063,-0.10309,1,0
3,GO GAMETE GENERATION,0.0010206,-0.081244,-0.088169,1,0
3,GO TUBE FORMATION,0.023205,-0.081475,-0.096162,1,0
3,GO REGULATION OF HEMOPOIESIS,0.010773,-0.081738,-0.105,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.044685,-0.081822,-0.10828,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0064317,-0.08192,-0.10728,1,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.045624,-0.081921,-0.088216,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,-0.081932,-0.096147,1,0
3,GO ENDOSOMAL TRANSPORT,0.00028792,-0.082157,-0.10138,1,0
3,GO REGULATION OF IMMUNE RESPONSE,0.010773,-0.082422,-0.11106,1,0
3,GO VACUOLAR TRANSPORT,0.0094949,-0.082562,-0.1011,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.049546,-0.082713,-0.09224,1,0
3,GO FATTY ACID METABOLIC PROCESS,0.031059,-0.082955,-0.10209,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038561,-0.083001,-0.11834,1,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,-0.083325,-0.12337,1,0
3,GO FAT CELL DIFFERENTIATION,0.0067808,-0.083727,-0.12377,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014486,-0.084075,-0.1136,1,0
3,GO MAST CELL MEDIATED IMMUNITY,0.019739,-0.084268,-0.18989,1,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.027803,-0.08431,-0.14589,1,0
3,GO GLUCOSE METABOLIC PROCESS,0.044685,-0.084349,-0.067101,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.084664,-0.10493,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035393,-0.084752,-0.069618,1,0
3,GO EXIT FROM MITOSIS,0.022165,-0.084988,-0.10847,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.010773,-0.085104,-0.11029,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.013139,-0.085154,-0.12442,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0056288,-0.08531,-0.10888,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011904,-0.08548,-0.080851,1,0
3,GO RESPONSE TO ANTIBIOTIC,0.037747,-0.085625,-0.11302,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.04854,-0.085844,-0.10889,1,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.011047,-0.085863,-0.17353,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.050569,-0.086101,-0.12924,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0094949,-0.086271,-0.12897,1,0
3,GO REGULATION OF PROTEOLYSIS,0.0057817,-0.086679,-0.112,1,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.014486,-0.086788,-0.13458,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.041967,-0.08685,-0.069253,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.009256,-0.087266,-0.095113,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013798,-0.087488,-0.13861,1,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.036948,-0.08754,-0.090013,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00081984,-0.087676,-0.10881,1,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033166,-0.087948,-0.13159,1,0
3,GO EMBRYONIC MORPHOGENESIS,0.012203,-0.088139,-0.10272,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.047551,-0.088301,-0.081081,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.014841,-0.088522,-0.1165,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,-0.088558,-0.11587,1,0
3,GO PROTEOLYSIS,0.00044439,-0.089362,-0.10478,1,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.04854,-0.089702,-0.075698,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.011904,-0.089745,-0.13561,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.043763,-0.089812,-0.09272,1,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02268,-0.089912,-0.090142,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,-0.090064,-0.10809,1,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.030383,-0.090119,-0.20065,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0064317,-0.090415,-0.098557,1,0
3,GO REGULATION OF CELLULAR PH,0.0049174,-0.090578,-0.097889,1,0
3,GO CELL CELL ADHESION,0.004408,-0.09071,-0.12249,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0069616,-0.09084,-0.1134,1,0
3,GO CELLULAR PIGMENTATION,0.0036303,-0.09092,-0.13554,1,0
3,GO REGULATION OF NUCLEAR DIVISION,0.0050528,-0.091131,-0.08089,1,0
3,GO CELL MATRIX ADHESION,0.038561,-0.091166,-0.1199,1,0
3,GO GERM CELL DEVELOPMENT,0.0056288,-0.091316,-0.088962,1,0
3,GO REGULATION OF PH,0.0062634,-0.091444,-0.094954,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02268,-0.091575,-0.10198,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.010245,-0.091642,-0.12579,1,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.030383,-0.091662,-0.14272,1,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.015953,-0.091744,-0.12223,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.016339,-0.092052,-0.097263,1,0
3,GO MALE SEX DIFFERENTIATION,0.0069616,-0.092178,-0.10836,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012508,-0.092218,-0.10432,1,0
3,GO RESPONSE TO GAMMA RADIATION,0.036948,-0.092257,-0.093986,1,0
3,GO GLAND DEVELOPMENT,0.013139,-0.092267,-0.099714,1,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0099891,-0.092299,-0.10271,1,0
3,GO ERBB SIGNALING PATHWAY,0.02843,-0.092544,-0.11082,1,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.042857,-0.092571,-0.14696,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.012203,-0.092747,-0.12479,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.092966,-0.091004,1,0
3,GO PROTEIN MATURATION,0.015574,-0.092989,-0.10116,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.017137,-0.093242,-0.1859,1,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.019739,-0.093259,-0.14598,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.018836,-0.093434,-0.18171,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0024367,-0.093456,-0.1471,1,0
3,GO LIPID LOCALIZATION,0.0079323,-0.09371,-0.11778,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.017969,-0.093974,-0.093809,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0042883,-0.09409,-0.12622,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013798,-0.094359,-0.11699,1,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.04854,-0.094558,-0.099281,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010245,-0.094843,-0.12706,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,-0.094888,-0.15669,1,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02268,-0.095105,-0.13525,1,0
3,GO RESPONSE TO ALCOHOL,0.044685,-0.095276,-0.077525,1,0
3,GO GOLGI VESICLE BUDDING,0.0081404,-0.095367,-0.11661,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0097392,-0.095573,-0.10692,1,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0013872,-0.095585,-0.121,1,0
3,GO POSTREPLICATION REPAIR,0.011904,-0.096376,-0.08894,1,0
3,GO COPII COATED VESICLE BUDDING,0.0053338,-0.096385,-0.11379,1,0
3,GO RESPONSE TO BMP,0.042857,-0.096422,-0.11419,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.052669,-0.096441,-0.12145,1,0
3,GO REGULATION OF BODY FLUID LEVELS,0.0010859,-0.096588,-0.1364,1,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.038561,-0.09677,-0.13006,1,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.03939,-0.096774,-0.14335,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.041967,-0.097474,-0.17357,1,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.0032441,-0.097681,-0.12134,1,0
3,GO GOLGI ORGANIZATION,0.0025083,-0.097875,-0.11643,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015574,-0.098282,-0.13644,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027803,-0.098302,-0.10269,1,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.098544,-0.10396,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.017549,-0.098956,-0.093767,1,0
3,GO ORGANELLE DISASSEMBLY,0.0087944,-0.099028,-0.092583,1,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023205,-0.099219,-0.1092,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0069616,-0.099376,-0.12092,1,0
3,GO COAGULATION,0.0051916,-0.099857,-0.13878,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.009256,-0.099859,-0.13181,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00044439,-0.099918,-0.12903,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.022165,-0.099988,-0.15007,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.010773,-0.099989,-0.13459,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.10043,-0.1099,1,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.022165,-0.1009,-0.15697,1,0
3,GO ERAD PATHWAY,0.010506,-0.10131,-0.11486,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,-0.10153,-0.12119,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.03939,-0.10185,-0.078305,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00054072,-0.10187,-0.1406,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0060989,-0.10191,-0.14091,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.10192,-0.14426,1,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0054795,-0.10192,-0.097993,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.014486,-0.10213,-0.14414,1,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.034637,-0.10216,-0.10785,1,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.047551,-0.10217,-0.13505,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.045624,-0.10218,-0.10611,1,0
3,GO REGULATION OF CELL ADHESION,0.0026572,-0.10247,-0.1538,1,0
3,GO REGULATION OF CELL ACTIVATION,0.0022992,-0.10248,-0.13089,1,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023671,-0.10265,-0.10487,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.015574,-0.10293,-0.1546,1,0
3,GO ENDOCYTIC RECYCLING,0.0020453,-0.10297,-0.1284,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0053338,-0.10314,-0.1281,1,0
3,GO EAR MORPHOGENESIS,0.012203,-0.1035,-0.12465,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,-0.10358,-0.137,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,-0.10358,-0.14937,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0025083,-0.10375,-0.13773,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00092958,-0.10393,-0.11064,1,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.026586,-0.10435,-0.085846,1,0
3,GO PH REDUCTION,0.0021689,-0.10437,-0.14997,1,0
3,GO CELL ACTIVATION,0.0027346,-0.10443,-0.13744,1,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.023741,-0.10443,-0.11891,1,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.033166,-0.10445,-0.079391,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.015574,-0.10467,-0.13052,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.03245,-0.10489,-0.13769,1,0
3,GO ADAPTIVE THERMOGENESIS,0.02268,-0.10497,-0.09286,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.043763,-0.10516,-0.10536,1,0
3,GO HISTONE MONOUBIQUITINATION,0.00026903,-0.10577,-0.13101,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02166,-0.10578,-0.18634,1,0
3,GO DIGESTIVE SYSTEM PROCESS,0.033894,-0.10582,-0.12398,1,0
3,GO T CELL DIFFERENTIATION,0.0046564,-0.10597,-0.12217,1,0
3,GO PROTEIN POLYUBIQUITINATION,7.547e-05,-0.10635,-0.12601,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.10682,-0.21834,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.038561,-0.10693,-0.11031,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011326,-0.10731,-0.18883,1,0
3,GO RESPONSE TO OSMOTIC STRESS,0.023205,-0.10739,-0.11405,1,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0069616,-0.10748,-0.13913,1,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,-0.10761,-0.18224,1,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.012508,-0.10772,-0.16527,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.033894,-0.10795,-0.1079,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.00049035,-0.10805,-0.13497,1,0
3,GO PROTEIN KINASE B SIGNALING,0.0042883,-0.10819,-0.13353,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0049174,-0.10864,-0.10882,1,0
3,GO LIPID DIGESTION,0.012508,-0.10865,-0.28191,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.030383,-0.10907,-0.14524,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.026586,-0.10914,-0.17042,1,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.025414,-0.1093,-0.17811,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0037331,-0.10936,-0.13087,1,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.042857,-0.10946,-0.09126,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,8.7323e-05,-0.10953,-0.14344,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016734,-0.1097,-0.10881,1,0
3,GO REPRODUCTION,0.0007696,-0.10999,-0.092536,1,0
3,GO REGULATION OF PEPTIDE SECRETION,0.0083534,-0.11015,-0.099042,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.031748,-0.11072,-0.18395,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.00087311,-0.11132,-0.14441,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.1115,-0.082264,1,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00095906,-0.11176,-0.15167,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.0023671,-0.11176,-0.13851,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.020205,-0.11203,-0.13579,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00042998,-0.11209,-0.15393,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.041093,-0.1121,-0.089285,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0071468,-0.11215,-0.088894,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00087311,-0.11217,-0.14572,1,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.0023671,-0.11228,-0.11441,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00090094,-0.11244,-0.15274,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.010506,-0.11274,-0.16972,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014486,-0.11296,-0.11908,1,0
3,GO INNATE IMMUNE RESPONSE,0.00092958,-0.11297,-0.16868,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.001662,-0.11298,-0.15534,1,0
3,GO CARBOHYDRATE TRANSPORT,0.0067808,-0.11335,-0.10615,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00052342,-0.11337,-0.19464,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.014138,-0.11384,-0.10532,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.044685,-0.11432,-0.19369,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037331,-0.11433,-0.10729,1,0
3,GO MYELOID CELL DIFFERENTIATION,0.00025131,-0.11435,-0.12563,1,0
3,GO MITOTIC CYTOKINESIS,0.0030654,-0.11455,-0.12727,1,0
3,GO PLATELET MORPHOGENESIS,0.0051916,-0.11539,-0.20988,1,0
3,GO RESPONSE TO UV C,0.030383,-0.11551,-0.1629,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.049546,-0.11558,-0.19466,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.00087311,-0.11577,-0.14916,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0019282,-0.11619,-0.11366,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.017969,-0.11697,-0.13148,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0064317,-0.11699,-0.1915,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.02268,-0.11734,-0.11495,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,-0.11734,-0.21546,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02166,-0.11741,-0.21897,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0021689,-0.11744,-0.21493,1,0
3,GO MYOBLAST DIFFERENTIATION,0.00353,-0.1177,-0.18566,1,0
3,GO DENDRITIC CELL MIGRATION,0.03939,-0.11815,-0.17082,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0042883,-0.11821,-0.15809,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.020205,-0.11829,-0.15136,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0030654,-0.1183,-0.175,1,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0071468,-0.11846,-0.13149,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00079435,-0.11849,-0.1507,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0046564,-0.11865,-0.10903,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00037661,-0.11881,-0.14684,1,0
3,GO LYMPHOCYTE COSTIMULATION,0.016734,-0.1192,-0.12062,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,-0.11925,-0.16242,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014138,-0.11938,-0.17878,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.030383,-0.1196,-0.11207,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00057693,-0.1198,-0.17694,1,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0062634,-0.12015,-0.103,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00065623,-0.12034,-0.1434,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.049546,-0.12065,-0.13147,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.036948,-0.12079,-0.19372,1,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.036948,-0.12122,-0.16682,1,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.038561,-0.12132,-0.16502,1,0
3,GO DIGESTION,0.0037331,-0.12135,-0.15953,1,0
3,GO NOTCH SIGNALING PATHWAY,0.0041716,-0.12161,-0.12592,1,0
3,GO T CELL ACTIVATION,0.00084609,-0.1218,-0.15324,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010245,-0.12181,-0.091078,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.027188,-0.12199,-0.11447,1,0
3,GO RESPONSE TO WOUNDING,0.0097392,-0.12206,-0.13851,1,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,-0.12209,-0.13789,1,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.052669,-0.12216,-0.15298,1,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.036164,-0.12218,-0.12394,1,0
3,GO SPINDLE LOCALIZATION,0.001228,-0.12219,-0.14155,1,0
3,GO RESPONSE TO BACTERIUM,0.011612,-0.12235,-0.12854,1,0
3,GO PROTEIN DESTABILIZATION,0.0045306,-0.1224,-0.12012,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.036164,-0.12245,-0.17099,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0073363,-0.1225,-0.12381,1,0
3,GO TISSUE MIGRATION,0.052669,-0.12264,-0.10693,1,0
3,GO CYTOKINE PRODUCTION,0.00021167,-0.12282,-0.17499,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.0045306,-0.1229,-0.11055,1,0
3,GO TISSUE HOMEOSTASIS,5.508e-06,-0.12321,-0.18363,1,0
3,GO EPITHELIUM DEVELOPMENT,4.6597e-05,-0.12322,-0.15616,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014418,-0.12327,-0.15893,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0045306,-0.12336,-0.10713,1,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.012508,-0.12338,-0.14282,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00041602,-0.12341,-0.1536,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00010845,-0.12354,-0.12675,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.015203,-0.12356,-0.19931,1,0
3,GO REGULATION OF DEFENSE RESPONSE,0.00049035,-0.12387,-0.14928,1,0
3,GO VIRAL LATENCY,0.024288,-0.12407,-0.12119,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.038561,-0.12409,-0.20943,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00013433,-0.12422,-0.14223,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.0026572,-0.12426,-0.16489,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.0028141,-0.12432,-0.19311,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0085714,-0.1248,-0.21404,1,0
3,GO TRANSLESION SYNTHESIS,0.004408,-0.12481,-0.11409,1,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.031748,-0.12484,-0.12044,1,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.04854,-0.12484,-0.15094,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.1252,-0.19543,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.0064317,-0.12528,-0.19474,1,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.04854,-0.12536,-0.11375,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.042857,-0.12547,-0.24358,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0014738,-0.12559,-0.16921,1,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.00017186,-0.12589,-0.15114,1,0
3,GO VESICLE TARGETING,0.0010859,-0.12596,-0.15258,1,0
3,GO DEFENSE RESPONSE,0.00067758,-0.12607,-0.14936,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.05161,-0.12688,-0.10507,1,0
3,GO RESPIRATORY BURST,0.0030654,-0.12709,-0.24633,1,0
3,GO DNA DEALKYLATION,0.021165,-0.12709,-0.13663,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.0073363,-0.12709,-0.13064,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0050528,-0.12729,-0.17163,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.00024286,-0.12733,-0.1873,1,0
3,GO REGULATION OF PINOCYTOSIS,0.0049174,-0.12742,-0.21435,1,0
3,GO VIRAL LIFE CYCLE,0.0006154,-0.12754,-0.18525,1,0
3,GO INFLAMMATORY RESPONSE,0.0010528,-0.12767,-0.14813,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.029719,-0.1277,-0.13862,1,0
3,GO RESPONSE TO IRON ION,0.017969,-0.12784,-0.15696,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0014738,-0.12842,-0.14968,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013465,-0.12854,-0.12884,1,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.0046564,-0.12856,-0.12382,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,-0.1286,-0.17838,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023468,-0.12895,-0.16558,1,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.042857,-0.12913,-0.2315,1,0
3,GO WOUND HEALING,0.0054795,-0.1293,-0.15726,1,0
3,GO FIBROBLAST MIGRATION,0.007729,-0.12942,-0.17907,1,0
3,GO REGULATION OF CELL SHAPE,0.007729,-0.12957,-0.13399,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.014138,-0.12982,-0.14473,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00084609,-0.12995,-0.18643,1,0
3,GO RESPONSE TO INTERLEUKIN 6,0.0012662,-0.13027,-0.18833,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00042998,-0.13033,-0.17338,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024288,-0.13054,-0.14495,1,0
3,GO PHAGOSOME ACIDIFICATION,0.011047,-0.13061,-0.16997,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.004408,-0.13062,-0.18148,1,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019739,-0.13104,-0.13652,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.042857,-0.13113,-0.13624,1,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.05161,-0.13174,-0.18714,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00050664,-0.132,-0.16849,1,0
3,GO REGULATION OF CHEMOTAXIS,0.0025817,-0.13201,-0.13346,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0083534,-0.13223,-0.22541,1,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.042857,-0.13227,-0.10183,1,0
3,GO NEURAL TUBE DEVELOPMENT,0.00079435,-0.13232,-0.14758,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.013465,-0.13233,-0.11869,1,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00067758,-0.13237,-0.17463,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0032441,-0.13243,-0.12134,1,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10656,1,0
3,GO PEPTIDE CROSS LINKING,0.031059,-0.1329,-0.19153,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031536,-0.1334,-0.14323,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0083534,-0.13365,-0.18128,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.004408,-0.13383,-0.18717,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.13394,-0.14216,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,-0.13405,-0.18566,1,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00037661,-0.1343,-0.18074,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0071468,-0.13466,-0.25989,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00045924,-0.13472,-0.18616,1,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,-0.1348,-0.14885,1,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03245,-0.13487,-0.15042,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0073363,-0.13507,-0.13492,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0034322,-0.1352,-0.20747,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0010206,-0.13529,-0.18728,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00012512,-0.13531,-0.11985,1,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028957,-0.13533,-0.18301,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017549,-0.1354,-0.11915,1,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.00044439,-0.13553,-0.14304,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.035393,-0.13556,-0.122,1,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.018398,-0.13599,-0.16919,1,0
3,GO B CELL ACTIVATION,1.349e-05,-0.13627,-0.16989,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00034072,-0.13627,-0.17261,1,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.025994,-0.13635,-0.1584,1,0
3,GO PIGMENT GRANULE LOCALIZATION,0.01282,-0.13658,-0.1564,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0057817,-0.13663,-0.16375,1,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.044685,-0.13707,-0.10245,1,0
3,GO RESPONSE TO CYTOKINE,0.0015653,-0.13722,-0.15304,1,0
3,GO LEUKOCYTE PROLIFERATION,5.2139e-05,-0.13752,-0.18262,1,0
3,GO CYTOKINE SECRETION,0.00036427,-0.13774,-0.16718,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00059588,-0.13782,-0.13632,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.017969,-0.13784,-0.13105,1,0
3,GO ATP BIOSYNTHETIC PROCESS,0.017137,-0.13838,-0.12921,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015653,-0.13838,-0.16625,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0036303,-0.13851,-0.13108,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.13857,-0.19007,1,0
3,GO B CELL PROLIFERATION,0.0047853,-0.13915,-0.14366,1,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.025414,-0.13941,-0.14385,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.0013457,-0.13943,-0.17667,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0011199,-0.13949,-0.21885,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.13965,-0.1945,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.019283,-0.14022,-0.1494,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.0085714,-0.14029,-0.15571,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,-0.14034,-0.14479,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011549,-0.14036,-0.19254,1,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.019739,-0.14046,-0.16668,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,-0.14116,-0.15776,1,0
3,GO T CELL PROLIFERATION,0.00047456,-0.14122,-0.17393,1,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0028141,-0.14125,-0.16001,1,0
3,GO GRANULOCYTE MIGRATION,0.0039469,-0.14139,-0.1513,1,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.030383,-0.14149,-0.14655,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.016734,-0.14167,-0.18334,1,0
3,GO RESPONSE TO ETHER,0.024288,-0.14185,-0.11441,1,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0057817,-0.14203,-0.15264,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00035231,-0.14214,-0.22517,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012512,-0.14214,-0.20648,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029782,-0.14289,-0.16849,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.0025083,-0.14291,-0.18684,1,0
3,GO V D J RECOMBINATION,0.011904,-0.14309,-0.19634,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0047853,-0.14328,-0.23072,1,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0024367,-0.14331,-0.18293,1,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.035393,-0.14355,-0.18871,1,0
3,GO BLOOD VESSEL REMODELING,0.0053338,-0.14366,-0.2213,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0028957,-0.1439,-0.19045,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,-0.14393,-0.18759,1,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.00013917,-0.14424,-0.15291,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14432,-0.21244,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.14442,-0.18871,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.014486,-0.14453,-0.12149,1,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.042857,-0.14456,-0.15514,1,0
3,GO INTERLEUKIN 4 PRODUCTION,0.0014299,-0.14457,-0.20697,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0037331,-0.14465,-0.17389,1,0
3,GO EPITHELIAL TUBE FORMATION,0.00022676,-0.14479,-0.15709,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14492,-0.17924,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00022676,-0.14503,-0.1583,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.014841,-0.14516,-0.13223,1,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.035393,-0.14517,-0.18809,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.017137,-0.14525,-0.11333,1,0
3,GO CHEMOKINE PRODUCTION,0.00035231,-0.14531,-0.21654,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0018173,-0.14548,-0.14576,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0014738,-0.14601,-0.16132,1,0
3,GO MAST CELL ACTIVATION,0.0090226,-0.14638,-0.18771,1,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.017549,-0.14655,-0.14279,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0010528,-0.14678,-0.18093,1,0
3,GO SENSORY PERCEPTION OF TASTE,0.00087311,-0.14694,-0.17863,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,-0.14704,-0.21074,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00019079,-0.14753,-0.18056,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00027832,-0.14789,-0.19066,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001872,-0.14792,-0.17967,1,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.033166,-0.14877,-0.19191,1,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.05161,-0.1488,-0.1726,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.9904e-06,-0.14883,-0.18084,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0015653,-0.14894,-0.18765,1,0
3,GO ENDOTHELIUM DEVELOPMENT,0.0013872,-0.14899,-0.16446,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.011904,-0.14926,-0.19602,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.015574,-0.1494,-0.12683,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.009256,-0.14942,-0.17523,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00353,-0.14945,-0.15172,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.00057693,-0.14947,-0.2105,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14956,-0.1439,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.6174e-05,-0.14956,-0.17964,1,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00059588,-0.14964,-0.12514,1,0
3,GO MICROTUBULE BUNDLE FORMATION,0.00087311,-0.14969,-0.16357,1,0
3,GO RENAL TUBULE DEVELOPMENT,0.001191,-0.14991,-0.17985,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.14994,-0.20246,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,-0.14999,-0.11888,1,0
3,GO NUCLEOTIDE TRANSPORT,0.033166,-0.15011,-0.098094,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00032948,-0.15014,-0.18851,1,0
3,GO SECRETION BY TISSUE,0.013465,-0.15017,-0.16291,1,0
3,GO SECONDARY METABOLIC PROCESS,0.0029794,-0.15038,-0.21197,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.02166,-0.15049,-0.19718,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.00028792,-0.15059,-0.17344,1,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0038387,-0.15116,-0.14668,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00027832,-0.15117,-0.17891,1,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.0075304,-0.1512,-0.1891,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.0015653,-0.15155,-0.14694,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0032441,-0.15164,-0.14705,1,0
3,GO LEUKOCYTE MIGRATION,0.00052342,-0.15167,-0.16869,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.0007696,-0.15171,-0.20216,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013433,-0.15188,-0.18461,1,0
3,GO CELL PROJECTION ASSEMBLY,5.4121e-05,-0.15189,-0.12875,1,0
3,GO PINOCYTOSIS,0.017549,-0.15217,-0.18144,1,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00037661,-0.15284,-0.21262,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019079,-0.15285,-0.22724,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.007729,-0.15288,-0.25354,1,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.031748,-0.15312,-0.2892,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.045624,-0.15342,-0.1403,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.03939,-0.15348,-0.13741,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0039469,-0.15351,-0.21867,1,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00012074,-0.15356,-0.20431,1,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,-0.15376,-0.16147,1,0
3,GO REGULATION OF CELL CELL ADHESION,0.00019753,-0.15387,-0.18583,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00036427,-0.15402,-0.19018,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.15411,-0.20674,1,0
3,GO INTESTINAL LIPID ABSORPTION,0.0057817,-0.15426,-0.30133,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0066042,-0.15435,-0.18217,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.004408,-0.15444,-0.14176,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,5.0226e-05,-0.15451,-0.18967,1,0
3,GO IMMUNE EFFECTOR PROCESS,0.00027832,-0.15462,-0.18866,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010528,-0.15478,-0.19313,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032441,-0.15482,-0.23943,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.01282,-0.15482,-0.17457,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00027832,-0.15485,-0.20869,1,0
3,GO ACTIN NUCLEATION,9.3916e-06,-0.15517,-0.17974,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,-0.15535,-0.19323,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.00084609,-0.15538,-0.14248,1,0
3,GO EYE MORPHOGENESIS,0.0007696,-0.15573,-0.15378,1,0
3,GO GENETIC IMPRINTING,0.001662,-0.1559,-0.18531,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.012508,-0.15608,-0.25662,1,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.020205,-0.15641,-0.32179,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.001191,-0.15661,-0.24229,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0056288,-0.15663,-0.43877,1,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,-0.15667,-0.12284,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00021909,-0.15674,-0.17691,1,0
3,GO RESPONSE TO REDOX STATE,0.042857,-0.15686,-0.15179,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00074557,-0.15704,-0.18448,1,0
3,GO INTERACTION WITH HOST,0.00019079,-0.15709,-0.20914,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.019739,-0.1571,-0.15153,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00079435,-0.15766,-0.18699,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,-0.15773,-0.2157,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014486,-0.15774,-0.12947,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00057693,-0.15783,-0.1292,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,-0.15786,-0.21085,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00067758,-0.15788,-0.18079,1,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.035393,-0.15803,-0.10595,1,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0026572,-0.15807,-0.2037,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0087944,-0.15853,-0.16251,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0038387,-0.15858,-0.15479,1,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.041967,-0.15888,-0.19555,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00034072,-0.1591,-0.19399,1,0
3,GO FOAM CELL DIFFERENTIATION,0.019283,-0.15919,-0.17345,1,0
3,GO RESPONSE TO DSRNA,0.0051916,-0.1593,-0.15298,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,-0.15932,-0.20877,1,0
3,GO HISTAMINE TRANSPORT,0.02843,-0.15977,-0.22185,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0060989,-0.15995,-0.27992,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010092,-0.16008,-0.19963,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00017796,-0.16016,-0.18245,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.8379e-05,-0.16017,-0.21337,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.020205,-0.16021,-0.17337,1,0
3,GO MALE GENITALIA DEVELOPMENT,0.036164,-0.16024,-0.16504,1,0
3,GO CELL KILLING,0.00074557,-0.16039,-0.18127,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,-0.16045,-0.19554,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5816e-05,-0.16078,-0.24415,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.017549,-0.16089,-0.24785,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0025083,-0.16094,-0.13679,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00026903,-0.16179,-0.2271,1,0
3,GO ENDOTHELIAL CELL MIGRATION,0.017137,-0.16179,-0.13681,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0036303,-0.16222,-0.20852,1,0
3,GO RESPONSE TO VIRUS,7.2754e-05,-0.16236,-0.22056,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,8.7323e-05,-0.16304,-0.15477,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.023205,-0.16307,-0.22829,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0037331,-0.16314,-0.18802,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024286,-0.16323,-0.17159,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0039469,-0.16341,-0.16958,1,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.017549,-0.16375,-0.15881,1,0
3,GO BONE RESORPTION,0.001662,-0.16393,-0.2021,1,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0050528,-0.16395,-0.16202,1,0
3,GO EPITHELIAL CELL DEVELOPMENT,4.0073e-05,-0.16412,-0.20926,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.16446,-0.21357,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.16459,-0.23974,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014138,-0.16466,-0.14851,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,8.6584e-06,-0.16481,-0.16849,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.019739,-0.16498,-0.16212,1,0
3,GO PROTEIN PROCESSING,0.00031859,-0.16503,-0.17643,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016339,-0.16508,-0.20976,1,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.030383,-0.16509,-0.17813,1,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,-0.16521,-0.21723,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00035231,-0.16611,-0.20067,1,0
3,GO PROTEIN DEMANNOSYLATION,0.016734,-0.16667,-0.1826,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,-0.16682,-0.20585,1,0
3,GO REGULATION OF ICOSANOID SECRETION,0.043763,-0.16685,-0.13495,1,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0053338,-0.16686,-0.18038,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,5.4121e-05,-0.16691,-0.21403,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,4.4712e-06,-0.1672,-0.18873,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0090226,-0.16723,-0.18053,1,0
3,GO ALPHA BETA T CELL ACTIVATION,1.5816e-05,-0.16759,-0.22358,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072223,-0.16822,-0.19688,1,0
3,GO RESPONSE TO ISCHEMIA,0.001986,-0.16838,-0.16397,1,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042883,-0.1685,-0.20823,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.16857,-0.18176,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.0037331,-0.16864,-0.19095,1,0
3,GO RESPONSE TO PROGESTERONE,0.0049174,-0.1687,-0.22083,1,0
3,GO MESONEPHROS DEVELOPMENT,0.012508,-0.16888,-0.15112,1,0
3,GO REGULATION OF CHROMATIN BINDING,0.00095906,-0.16935,-0.21586,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.0014299,-0.16935,-0.16125,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,-0.16944,-0.1757,1,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0033369,-0.16957,-0.33203,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.038561,-0.17029,-0.16591,1,0
3,GO ZYMOGEN ACTIVATION,0.0051916,-0.17036,-0.27421,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.049546,-0.17037,-0.23522,1,0
3,GO RIG I SIGNALING PATHWAY,0.0025083,-0.17043,-0.18276,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0010859,-0.17043,-0.23775,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,1.0184e-05,-0.17048,-0.1646,1,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,-0.17053,-0.3756,1,0
3,GO ENTRY INTO HOST,0.00050664,-0.17066,-0.26205,1,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00035231,-0.17079,-0.15974,1,0
3,GO ACUTE PHASE RESPONSE,0.0031536,-0.17081,-0.1885,1,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.013465,-0.17095,-0.14719,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0022332,-0.17123,-0.19664,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0028141,-0.17125,-0.20777,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1617e-05,-0.17141,-0.24649,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.0024367,-0.17178,-0.21932,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0015653,-0.17192,-0.16732,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00037661,-0.17193,-0.21364,1,0
3,GO DIOL METABOLIC PROCESS,0.019739,-0.17195,-0.17019,1,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.004408,-0.17196,-0.17018,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.00055855,-0.17215,-0.159,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0025817,-0.17218,-0.21653,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00063551,-0.17254,-0.21976,1,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.033894,-0.17272,-0.17615,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0029794,-0.17299,-0.21201,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.17333,-0.18159,1,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0028957,-0.17377,-0.17369,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.012508,-0.17408,-0.20794,1,0
3,GO ERYTHROCYTE DEVELOPMENT,0.0032441,-0.17411,-0.13457,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0051916,-0.1742,-0.17726,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0014738,-0.17422,-0.17904,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.019283,-0.17445,-0.2578,1,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0075304,-0.17471,-0.2284,1,0
3,GO CYTOLYSIS,0.0054795,-0.17473,-0.22888,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013872,-0.17476,-0.1755,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0045306,-0.17502,-0.19628,1,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0022992,-0.17542,-0.16577,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.7596e-05,-0.17559,-0.19025,1,0
3,GO MYOTUBE CELL DEVELOPMENT,0.016339,-0.17563,-0.15797,1,0
3,GO ENDOCRINE HORMONE SECRETION,0.0056288,-0.17573,-0.15316,1,0
3,GO O GLYCAN PROCESSING,0.0031536,-0.17579,-0.2369,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.00079435,-0.17596,-0.1982,1,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0025083,-0.17613,-0.17621,1,0
3,GO DNA DEMETHYLATION,0.00029782,-0.17626,-0.19988,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001228,-0.17636,-0.17727,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2139e-05,-0.17658,-0.2252,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015574,-0.17694,-0.22061,1,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0047853,-0.17737,-0.19456,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001165,-0.17743,-0.194,1,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.00052342,-0.17744,-0.15958,1,0
3,GO EPOXYGENASE P450 PATHWAY,0.03939,-0.17744,-0.19399,1,0
3,GO PLATELET ACTIVATION,4.1617e-05,-0.17749,-0.21602,1,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018836,-0.17791,-0.15795,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.013465,-0.17804,-0.23875,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.17827,-0.19891,1,0
3,GO B CELL DIFFERENTIATION,4.1112e-06,-0.17886,-0.20911,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,-0.1789,-0.24823,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.17895,-0.21136,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00036427,-0.17899,-0.16736,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.17912,-0.19717,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017186,-0.17933,-0.24299,1,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036164,-0.17974,-0.1366,1,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,-0.17976,-0.23816,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,-0.1798,-0.18452,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0034322,-0.17994,-0.15644,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011549,-0.18011,-0.26679,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0018173,-0.18039,-0.20622,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031536,-0.18041,-0.17537,1,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0056288,-0.1806,-0.16351,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0067808,-0.18146,-0.20684,1,0
3,GO PHOSPHOLIPID TRANSPORT,9.7346e-05,-0.18173,-0.18523,1,0
3,GO NEPHRON DEVELOPMENT,0.00034072,-0.18181,-0.18869,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00052342,-0.18189,-0.2359,1,0
3,GO CELLULAR RESPONSE TO VIRUS,3.5759e-05,-0.18208,-0.22268,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0081404,-0.18208,-0.18681,1,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00081984,-0.18246,-0.19194,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00036427,-0.18249,-0.21438,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.18284,-0.21292,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00019753,-0.18286,-0.20857,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00017796,-0.18323,-0.26212,1,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0053338,-0.1835,-0.18746,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00049035,-0.18353,-0.2607,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,-0.18402,-0.23911,1,0
3,GO MYELOID CELL HOMEOSTASIS,1.7806e-05,-0.18416,-0.19416,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00090094,-0.18552,-0.17905,1,0
3,GO DEFENSE RESPONSE TO VIRUS,3.6228e-06,-0.18591,-0.29096,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0011549,-0.18602,-0.16315,1,0
3,GO ENDOSOME ORGANIZATION,5.7413e-06,-0.18602,-0.1872,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0027346,-0.18632,-0.20252,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.7118e-05,-0.18636,-0.21519,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.18666,-0.16861,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,-0.18693,-0.22136,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0028957,-0.18694,-0.3128,1,0
3,GO REGULATION OF TISSUE REMODELING,0.00353,-0.18727,-0.18813,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.2786e-05,-0.18748,-0.24241,1,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00017796,-0.18756,-0.15865,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00010845,-0.18759,-0.23729,1,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.010245,-0.18772,-0.19643,1,0
3,GO PRO B CELL DIFFERENTIATION,0.03939,-0.18773,-0.17599,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0039469,-0.18868,-0.22033,1,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.029068,-0.18875,-0.28838,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,3.6228e-06,-0.18876,-0.24018,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0087944,-0.18891,-0.22537,1,0
3,GO IMMUNOGLOBULIN SECRETION,5.8301e-05,-0.18902,-0.32871,1,0
3,GO KERATINOCYTE PROLIFERATION,0.023741,-0.18905,-0.1901,1,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.020205,-0.18916,-0.18951,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0053338,-0.18936,-0.20841,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,-0.18937,-0.20372,1,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,4.6597e-05,-0.18985,-0.20809,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,2.3418e-05,-0.19054,-0.23827,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.042857,-0.19116,-0.1446,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.1617e-05,-0.19125,-0.20666,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.0079323,-0.19127,-0.24139,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042998,-0.19132,-0.18364,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045924,-0.19145,-0.25472,1,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,-0.19155,-0.18675,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.0039469,-0.19155,-0.20908,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.009256,-0.1917,-0.21063,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0014738,-0.19173,-0.19582,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0007696,-0.19186,-0.24411,1,0
3,GO CELL MIGRATION IN HINDBRAIN,0.041093,-0.19215,-0.19747,1,0
3,GO HISTONE H4 DEACETYLATION,0.0083534,-0.19221,-0.18168,1,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,-0.19228,-0.17259,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.025994,-0.19261,-0.19316,1,0
3,GO MACROPHAGE MIGRATION,0.016734,-0.19285,-0.15018,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,-0.19285,-0.19495,1,0
3,GO REGULATION OF GASTRULATION,0.0036303,-0.19303,-0.19391,1,0
3,GO TYPE I INTERFERON PRODUCTION,0.00012512,-0.19307,-0.22172,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,-0.19317,-0.20567,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,-0.19418,-0.24207,1,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.0030654,-0.19429,-0.21205,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0053338,-0.1944,-0.18269,1,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.030383,-0.19452,-0.19046,1,0
3,GO RESPONSE TO INTERLEUKIN 2,0.0024367,-0.19464,-0.21173,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.00034072,-0.19467,-0.17473,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.0022992,-0.19468,-0.25638,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00020448,-0.19474,-0.22513,1,0
3,GO LIPID DROPLET ORGANIZATION,0.00057693,-0.19506,-0.24384,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0083534,-0.19517,-0.14355,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00052342,-0.19534,-0.26544,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0041716,-0.19545,-0.23709,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.013798,-0.19553,-0.16904,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0028141,-0.19558,-0.17657,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,-0.19644,-0.24342,1,0
3,GO B CELL MEDIATED IMMUNITY,4.1617e-05,-0.19658,-0.25168,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013465,-0.19668,-0.20185,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.0027346,-0.19669,-0.18498,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0053338,-0.19672,-0.37465,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0001165,-0.19674,-0.23763,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025817,-0.19709,-0.1548,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,-0.1971,-0.17857,1,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,2.8418e-05,-0.19715,-0.20872,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.00031859,-0.19742,-0.19113,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,1.5201e-05,-0.19811,-0.24424,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024367,-0.19818,-0.25076,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,-0.19822,-0.26604,1,0
3,GO SARCOMERE ORGANIZATION,0.0040578,-0.19847,-0.18119,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.021165,-0.19857,-0.19446,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0031536,-0.19869,-0.15963,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0034322,-0.19925,-0.25923,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.050569,-0.19937,-0.14583,1,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00035231,-0.1996,-0.20529,1,0
3,GO VIRAL GENOME REPLICATION,0.00019079,-0.19966,-0.25058,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.017549,-0.19969,-0.24726,1,0
3,GO CELL CHEMOTAXIS,0.00014935,-0.19992,-0.19702,1,0
3,GO MICROVILLUS ORGANIZATION,0.0040578,-0.20036,-0.24987,1,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0047853,-0.20082,-0.23713,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0038387,-0.20094,-0.21145,1,0
3,GO VASCULAR WOUND HEALING,0.047551,-0.20094,-0.1695,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,4.0073e-05,-0.20127,-0.26159,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010092,-0.20136,-0.21635,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.20164,-0.24896,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0027346,-0.20192,-0.23749,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,3.1888e-05,-0.20196,-0.18645,1,0
3,GO ETHANOL METABOLIC PROCESS,0.018836,-0.20221,-0.22088,1,0
3,GO ENDOCRINE PROCESS,0.0021689,-0.20277,-0.19742,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.0015189,-0.2029,-0.20107,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,-0.20301,-0.21454,1,0
3,GO VIRION ASSEMBLY,4.8612e-06,-0.20303,-0.20821,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.019739,-0.20305,-0.31241,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.018836,-0.2032,-0.29272,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0032441,-0.20377,-0.19792,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1702e-06,-0.20405,-0.22395,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00090094,-0.20412,-0.23801,1,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.035393,-0.20415,-0.19456,1,0
3,GO RESPONSE TO COPPER ION,0.0094949,-0.20454,-0.28372,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.015574,-0.20459,-0.15958,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.00027832,-0.20468,-0.24762,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,8.3127e-06,-0.20517,-0.19981,1,0
3,GO BONE REMODELING,0.0067808,-0.20576,-0.18857,1,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.043763,-0.20577,-0.115,1,0
3,GO CELLULAR DEFENSE RESPONSE,3.0576e-06,-0.20588,-0.28847,1,0
3,GO REGULATION OF RESPIRATORY BURST,0.0011549,-0.20635,-0.22913,1,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.389e-05,-0.2064,-0.21255,1,0
3,GO CYTOKINETIC PROCESS,1.1493e-05,-0.20698,-0.2535,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.001872,-0.20732,-0.23,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,4.3218e-05,-0.20756,-0.21244,1,0
3,GO LIPID STORAGE,0.0019282,-0.20795,-0.18547,1,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0016129,-0.20814,-0.22175,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0006154,-0.20853,-0.23021,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.00031859,-0.2086,-0.20416,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,-0.2088,-0.23571,1,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00014935,-0.2089,-0.20287,1,0
3,GO CENTROSOME SEPARATION,0.0067808,-0.20902,-0.19563,1,0
3,GO REPLICATIVE SENESCENCE,0.037747,-0.2091,-0.18202,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00072223,-0.20911,-0.22309,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,-0.20922,-0.2255,1,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0034322,-0.20965,-0.15386,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,-0.20979,-0.26298,1,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.0024367,-0.21051,-0.25494,1,0
3,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,-0.21059,-0.23706,1,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010462,-0.21082,-0.26754,1,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.026586,-0.21085,-0.2233,1,0
3,GO MONOCYTE CHEMOTAXIS,0.00098941,-0.21086,-0.24741,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.21109,-0.17954,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.21165,-0.21018,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017969,-0.21172,-0.29752,1,0
3,GO B CELL APOPTOTIC PROCESS,0.00049035,-0.21179,-0.25333,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00081984,-0.21195,-0.26482,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,-0.21209,-0.27498,1,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0013054,-0.2125,-0.18284,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.024846,-0.21262,-0.19456,1,0
3,GO POSITIVE T CELL SELECTION,0.0020453,-0.21266,-0.17666,1,0
3,GO HORMONE CATABOLIC PROCESS,0.0040578,-0.21298,-0.268,1,0
3,GO REGULATION OF CENTROSOME CYCLE,7.6603e-06,-0.21304,-0.1946,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00016595,-0.21323,-0.23457,1,0
3,GO ACTIVATED T CELL PROLIFERATION,0.00090094,-0.21349,-0.20102,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0039469,-0.2135,-0.28308,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,-0.21379,-0.2708,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.8301e-05,-0.21386,-0.22757,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,-0.21438,-0.24567,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.0015189,-0.21458,-0.24055,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0027346,-0.21505,-0.19654,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0022332,-0.21511,-0.20742,1,0
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0073363,-0.21563,-0.22312,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00023468,-0.21583,-0.2611,1,0
3,GO NEURAL TUBE FORMATION,5.508e-06,-0.21605,-0.21581,1,0
3,GO ERBB2 SIGNALING PATHWAY,2.0833e-05,-0.21644,-0.26576,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.547e-05,-0.21684,-0.28659,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,-0.21721,-0.20417,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.036948,-0.21748,-0.15889,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.00026903,-0.21769,-0.26574,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.21769,-0.26093,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.018836,-0.21834,-0.1872,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0067808,-0.2186,-0.188,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.023741,-0.21892,-0.25559,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040234,-0.21923,-0.20719,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024286,-0.21992,-0.23488,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018836,-0.22005,-0.2922,1,0
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0085714,-0.22029,-0.24136,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.013139,-0.22034,-0.24011,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0020453,-0.22041,-0.21338,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00014935,-0.22042,-0.22091,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00074557,-0.22052,-0.23118,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,6.7596e-05,-0.22062,-0.24206,1,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.0014738,-0.22117,-0.26106,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0042883,-0.22129,-0.15994,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0050528,-0.22173,-0.1835,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,-0.22194,-0.24205,1,0
3,GO INTERLEUKIN 12 PRODUCTION,3.4728e-06,-0.22211,-0.29373,1,0
3,GO REGULATION OF CELL KILLING,4.8379e-05,-0.22214,-0.25679,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0032441,-0.22215,-0.3142,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00063551,-0.22233,-0.19661,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0083534,-0.22244,-0.24134,1,0
3,GO MALE SEX DETERMINATION,0.0038387,-0.22247,-0.24751,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,5.8301e-05,-0.22287,-0.2445,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.011326,-0.22309,-0.29545,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.046579,-0.2238,-0.16822,1,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.017137,-0.22444,-0.21637,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.508e-06,-0.22459,-0.26358,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.016734,-0.22463,-0.21877,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012203,-0.2247,-0.24322,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0038387,-0.2247,-0.22273,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00021167,-0.22558,-0.22814,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00084609,-0.22566,-0.24754,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.015203,-0.22589,-0.30842,1,0
3,GO AUTOPHAGOSOME MATURATION,8.3127e-06,-0.22632,-0.24604,1,0
3,GO AMYLOID BETA CLEARANCE,0.00098941,-0.22633,-0.22719,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,3.5759e-05,-0.22635,-0.21966,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.8583e-05,-0.22652,-0.25966,1,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00011241,-0.22664,-0.19871,1,0
3,GO ICOSANOID METABOLIC PROCESS,4.8612e-06,-0.22668,-0.29497,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011326,-0.2269,-0.28724,1,0
3,GO HAIR CELL DIFFERENTIATION,0.00067758,-0.22705,-0.30225,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00018427,-0.22775,-0.31642,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.034637,-0.22817,-0.22697,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.015574,-0.22819,-0.32833,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,1.349e-05,-0.22914,-0.21975,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025083,-0.22917,-0.21106,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00019079,-0.22951,-0.28921,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013433,-0.22958,-0.24524,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00018427,-0.22973,-0.26764,1,0
3,GO INTERFERON BETA PRODUCTION,7.8282e-05,-0.22975,-0.2223,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.0011199,-0.23004,-0.21837,1,0
3,GO SPERM CAPACITATION,0.00035231,-0.23005,-0.20641,1,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0014299,-0.23007,-0.22609,1,0
3,GO TISSUE REMODELING,0.00045924,-0.23097,-0.22321,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,-0.23157,-0.25202,1,0
3,GO ESTROUS CYCLE,0.0071468,-0.23163,-0.24358,1,0
3,GO T CELL MEDIATED IMMUNITY,0.00022676,-0.23181,-0.28114,1,0
3,GO LIVER MORPHOGENESIS,0.0060989,-0.23202,-0.26133,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001872,-0.23253,-0.22796,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,6.5149e-05,-0.23294,-0.30385,1,0
3,GO PLACENTA DEVELOPMENT,5.2837e-06,-0.23308,-0.24538,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.011612,-0.23334,-0.22078,1,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.05161,-0.23341,-0.20904,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.4346e-05,-0.23393,-0.25058,1,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.02268,-0.23406,-0.20338,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0013457,-0.23426,-0.22204,1,0
3,GO REGULATION OF COAGULATION,0.00042998,-0.23454,-0.28661,1,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0018173,-0.23487,-0.22772,1,0
3,GO GLOMERULUS DEVELOPMENT,0.00040247,-0.23508,-0.27223,1,0
3,GO PIGMENT ACCUMULATION,0.00069957,-0.23533,-0.24213,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00011241,-0.23554,-0.26285,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.00016595,-0.2363,-0.24885,1,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.0032441,-0.23642,-0.22832,1,0
3,GO SKELETAL MUSCLE ADAPTATION,0.04854,-0.23652,-0.1312,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.011326,-0.23688,-0.29969,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00084609,-0.23692,-0.31663,1,0
3,GO RESPONSE TO LEPTIN,0.014841,-0.23696,-0.21683,1,0
3,GO BILE ACID METABOLIC PROCESS,0.0001547,-0.23739,-0.24479,1,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0040578,-0.23753,-0.29836,1,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099891,-0.23757,-0.19277,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,1.0311e-06,-0.23775,-0.24534,1,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.029068,-0.23779,-0.17505,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,-0.23804,-0.24279,1,0
3,GO REGULATION OF BONE REMODELING,0.0059384,-0.23806,-0.20804,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.013798,-0.23846,-0.24683,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0011549,-0.2385,-0.23034,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0016129,-0.23864,-0.21939,1,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0024367,-0.2387,-0.29907,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.23954,-0.27036,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,9.3916e-06,-0.24069,-0.31282,1,0
3,GO RUFFLE ORGANIZATION,5.753e-07,-0.2416,-0.25942,1,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0066042,-0.24254,-0.23492,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00023468,-0.24255,-0.22243,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.007729,-0.24275,-0.27836,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,5.2139e-05,-0.24295,-0.32085,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.4421e-05,-0.24328,-0.26399,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00044439,-0.24388,-0.23842,1,0
3,GO REGULATION OF RECEPTOR BINDING,0.0051916,-0.24406,-0.24122,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,-0.2446,-0.21774,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,3.4728e-06,-0.24465,-0.27055,1,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00049035,-0.24546,-0.21638,1,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.017549,-0.24561,-0.25071,1,0
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0053338,-0.24622,-0.29305,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0031536,-0.24657,-0.19922,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00069957,-0.2476,-0.32612,1,0
3,GO RUFFLE ASSEMBLY,7.889e-07,-0.24772,-0.25036,1,0
3,GO MAGNESIUM ION TRANSPORT,5.7413e-06,-0.24806,-0.30052,1,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00011241,-0.24842,-0.29403,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00032948,-0.24865,-0.22503,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0013457,-0.24887,-0.22264,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.00092958,-0.24896,-0.26571,1,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00084609,-0.24956,-0.22203,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.016734,-0.24956,-0.38989,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00018427,-0.24982,-0.23766,1,0
3,GO INTERLEUKIN 6 PRODUCTION,1.0311e-06,-0.24986,-0.25164,1,0
3,GO SKIN DEVELOPMENT,3.1888e-05,-0.25008,-0.24267,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.014486,-0.25132,-0.20024,1,0
3,GO INTERLEUKIN 8 PRODUCTION,3.4421e-05,-0.25161,-0.26375,1,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0067808,-0.25167,-0.24715,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,-0.25182,-0.21858,1,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.040234,-0.25236,-0.22468,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,5.7413e-06,-0.25266,-0.30234,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00016023,-0.25312,-0.30547,1,0
3,GO EOSINOPHIL MIGRATION,0.0039469,-0.25314,-0.33673,1,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.040234,-0.25318,-0.31809,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031748,-0.2535,-0.21394,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,8.2505e-07,-0.25363,-0.32642,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.8379e-05,-0.25406,-0.28955,1,0
3,GO EPIDERMIS DEVELOPMENT,2.2524e-05,-0.2541,-0.2431,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00041602,-0.25555,-0.29162,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0038387,-0.25562,-0.29218,1,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0015189,-0.25565,-0.26237,1,0
3,GO BIOLOGICAL PHASE,0.033166,-0.2559,-0.32727,1,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0001165,-0.25592,-0.26039,1,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00036427,-0.25617,-0.26599,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0045306,-0.25629,-0.38517,1,0
3,GO GERMINAL CENTER FORMATION,0.017969,-0.25681,-0.28634,1,0
3,GO TRANSCYTOSIS,6.7596e-05,-0.25794,-0.24346,1,0
3,GO VIRAL RELEASE FROM HOST CELL,4.5813e-07,-0.25822,-0.27857,1,0
3,GO T CELL SELECTION,0.0025817,-0.25841,-0.17252,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,5.0226e-05,-0.25842,-0.31036,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0016129,-0.25925,-0.26186,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.5331e-06,-0.25932,-0.29812,1,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016734,-0.26101,-0.26029,1,0
3,GO NECROTIC CELL DEATH,0.00069957,-0.26175,-0.24807,1,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0007696,-0.2618,-0.30188,1,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013917,-0.26277,-0.25581,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,4.4712e-06,-0.26339,-0.28481,1,0
3,GO ER OVERLOAD RESPONSE,0.033166,-0.26405,-0.20384,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042998,-0.26408,-0.32444,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00012074,-0.26412,-0.24638,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.012203,-0.26518,-0.2249,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.26547,-0.32186,1,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.015574,-0.26558,-0.25503,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,-0.26567,-0.28976,1,0
3,GO WATER HOMEOSTASIS,0.0010859,-0.2666,-0.24307,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0030654,-0.26752,-0.26249,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0099891,-0.26796,-0.43197,1,0
3,GO REGULATION OF WOUND HEALING,6.5149e-05,-0.26837,-0.28992,1,0
3,GO INTERLEUKIN 10 PRODUCTION,1.1964e-05,-0.26843,-0.2883,1,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.029719,-0.26862,-0.19443,1,0
3,GO ENDOCARDIUM DEVELOPMENT,0.018398,-0.2693,-0.2307,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.0006154,-0.26939,-0.31114,1,0
3,GO INTERLEUKIN 13 PRODUCTION,0.0059384,-0.26991,-0.26897,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.27,-0.25704,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0046564,-0.27219,-0.35907,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0018173,-0.27289,-0.32491,1,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.036164,-0.2733,-0.22995,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0576e-06,-0.27331,-0.32003,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.00036427,-0.27386,-0.27448,1,0
3,GO SIGNAL PEPTIDE PROCESSING,6.2786e-05,-0.27455,-0.35918,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,1.8251e-06,-0.2747,-0.28631,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.2533e-07,-0.27599,-0.30411,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.27599,-0.27453,1,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.043763,-0.2761,-0.25581,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.1112e-06,-0.27697,-0.2946,1,0
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.019739,-0.27818,-0.22433,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.9532e-05,-0.27823,-0.2547,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,6.2367e-06,-0.27843,-0.31747,1,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.02068,-0.2801,-0.36336,1,0
3,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,-0.28027,-0.3648,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0010528,-0.28029,-0.33755,1,0
3,GO INTERLEUKIN 5 PRODUCTION,0.011047,-0.28092,-0.21074,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00072223,-0.28173,-0.30843,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.7145e-05,-0.2822,-0.29097,1,0
3,GO ACTIN FILAMENT SEVERING,0.0047853,-0.2824,-0.31525,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4674e-06,-0.28415,-0.31777,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.7596e-05,-0.28487,-0.29067,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00019079,-0.28537,-0.35242,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,2.7343e-05,-0.28633,-0.34976,1,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.041967,-0.28645,-0.22356,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,-0.28692,-0.30594,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026903,-0.28802,-0.26272,1,0
3,GO INTERLEUKIN 1 PRODUCTION,2.2658e-06,-0.2884,-0.34316,1,0
3,GO PLATELET AGGREGATION,2.6307e-05,-0.28918,-0.28722,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.1702e-06,-0.28972,-0.2868,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019079,-0.28997,-0.36913,1,0
3,GO POSITIVE REGULATION OF CELL SIZE,0.00012512,-0.29019,-0.33138,1,0
3,GO MUSCLE CELL MIGRATION,5.0226e-05,-0.29145,-0.2889,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00013433,-0.29179,-0.3439,1,0
3,GO INTESTINAL ABSORPTION,0.00014935,-0.29193,-0.32136,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.0013872,-0.29235,-0.36432,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.00010462,-0.29321,-0.32558,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,4.1617e-05,-0.29375,-0.31832,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.018836,-0.29395,-0.20767,1,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.027803,-0.29423,-0.30208,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00067758,-0.29434,-0.31884,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,7.0571e-06,-0.29463,-0.30316,1,0
3,GO SPLEEN DEVELOPMENT,1.4044e-06,-0.29584,-0.28265,1,0
3,GO OSTEOBLAST PROLIFERATION,0.00010462,-0.29629,-0.3177,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.0179e-06,-0.29686,-0.29205,1,0
3,GO DECIDUALIZATION,0.0038387,-0.29723,-0.29606,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9904e-06,-0.29804,-0.33319,1,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.32016,1,0
3,GO ANOIKIS,1.104e-05,-0.29847,-0.32652,1,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.020205,-0.29852,-0.27063,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00054072,-0.29897,-0.33388,1,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.019283,-0.29926,-0.345,1,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,-0.29949,-0.23421,1,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0075304,-0.30162,-0.26013,1,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0028957,-0.3024,-0.25799,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.0184e-05,-0.30264,-0.28678,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0054795,-0.30381,-0.29111,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,1.7806e-05,-0.30409,-0.34839,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0059384,-0.30429,-0.41633,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042998,-0.30511,-0.32144,1,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.02843,-0.30537,-0.18731,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9926e-07,-0.3054,-0.31235,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.017137,-0.30542,-0.47191,1,0
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,-0.30585,-0.29082,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0079323,-0.30608,-0.25945,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.7145e-05,-0.30622,-0.36877,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.3132e-05,-0.30958,-0.33903,1,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0087944,-0.31152,-0.43355,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.0504e-05,-0.31164,-0.4274,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2367e-06,-0.31241,-0.29558,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.00010092,-0.31387,-0.41922,1,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.011612,-0.3153,-0.23936,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,-0.316,-0.30444,1,0
3,GO T CELL LINEAGE COMMITMENT,3.7145e-05,-0.31675,-0.28651,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010528,-0.31782,-0.3985,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.014138,-0.31831,-0.24614,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,-0.3189,-0.30745,1,0
3,GO NATURAL KILLER CELL PROLIFERATION,0.00022676,-0.31933,-0.35296,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012512,-0.31948,-0.27264,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,9.7346e-05,-0.32053,-0.26301,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,2.5774e-06,-0.32067,-0.35368,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,-0.32067,-0.4067,1,0
3,GO ETHER METABOLIC PROCESS,0.00024286,-0.32158,-0.3238,1,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0081404,-0.32171,-0.29305,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010092,-0.32231,-0.41032,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.00022676,-0.32293,-0.31857,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.32306,-0.3267,1,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0053338,-0.32368,-0.23044,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00087311,-0.32478,-0.33323,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.4346e-05,-0.32514,-0.37414,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.17e-07,-0.32574,-0.36739,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.906e-06,-0.32644,-0.35873,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,9.0551e-05,-0.32649,-0.49659,1,0
3,GO LIPOXYGENASE PATHWAY,0.0015653,-0.32839,-0.35137,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,-0.32858,-0.25416,1,0
3,GO LEFT RIGHT PATTERN FORMATION,0.00012964,-0.32909,-0.30426,1,0
3,GO KERATINOCYTE DEVELOPMENT,0.025414,-0.33042,-0.28399,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.031059,-0.33255,-0.23364,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,3.5759e-05,-0.33346,-0.36409,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.3916e-06,-0.33422,-0.36738,1,0
3,GO PROGESTERONE METABOLIC PROCESS,0.00044439,-0.3345,-0.46742,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,-0.33785,-0.39231,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.8301e-05,-0.33818,-0.3144,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.4044e-06,-0.33845,-0.33214,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0010206,-0.33953,-0.36921,1,0
3,GO SUPEROXIDE ANION GENERATION,0.00017186,-0.34021,-0.32774,1,0
3,GO TRANSPOSITION,1.7118e-05,-0.34022,-0.41665,1,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0019282,-0.34024,-0.27362,1,0
3,GO ZYMOGEN INHIBITION,0.00018427,-0.34126,-0.40275,1,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00054072,-0.3422,-0.34746,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.0024367,-0.34261,-0.46016,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3218e-05,-0.34314,-0.35544,1,0
3,GO PROSTANOID METABOLIC PROCESS,2.3418e-05,-0.34391,-0.43093,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.017969,-0.34458,-0.29141,1,0
3,GO DETECTION OF OTHER ORGANISM,4.3218e-05,-0.34508,-0.39188,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,-0.34512,-0.34359,1,0
3,GO REFLEX,0.00087311,-0.34684,-0.36676,1,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0069616,-0.34711,-0.41594,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.7596e-05,-0.34729,-0.42145,1,0
3,GO LIPID TRANSLOCATION,1.8251e-06,-0.34769,-0.32187,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.1192e-05,-0.34789,-0.33195,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,9.7801e-06,-0.34994,-0.32441,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0031536,-0.3503,-0.31511,1,0
3,GO HISTAMINE SECRETION,0.004408,-0.35224,-0.34449,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,5.2533e-07,-0.35314,-0.34367,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,5.1671e-08,-0.35462,-0.38135,1,0
3,GO KERATINOCYTE DIFFERENTIATION,1.104e-05,-0.35542,-0.33714,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0021062,-0.35735,-0.34442,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.8891e-07,-0.35749,-0.37725,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.35752,-0.4848,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,-0.35926,-0.38583,1,0
3,GO PROTEIN ADP RIBOSYLATION,1.1493e-05,-0.35936,-0.31088,1,0
3,GO POSITIVE REGULATION OF COAGULATION,2.8077e-06,-0.35968,-0.36426,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.0039469,-0.35989,-0.27633,1,0
3,GO VIRAL BUDDING,4.1802e-07,-0.36018,-0.30959,1,0
3,GO REGULATION OF ANOIKIS,3.5759e-05,-0.36079,-0.41494,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0014299,-0.36235,-0.41913,1,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021062,-0.36436,-0.37608,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00016595,-0.36442,-0.39438,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0079323,-0.36585,-0.46838,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,5.4977e-07,-0.36655,-0.37184,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.00072223,-0.36744,-0.33667,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0073e-05,-0.36865,-0.39858,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0021062,-0.36881,-0.41526,1,0
3,GO RESPONSE TO INTERFERON BETA,0.0015189,-0.36925,-0.47942,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.2837e-06,-0.36938,-0.38245,1,0
3,GO ADRENAL GLAND DEVELOPMENT,0.00045924,-0.36996,-0.30908,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00016595,-0.3702,-0.37092,1,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0099891,-0.37217,-0.32764,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.3528e-06,-0.37291,-0.4365,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00027832,-0.37409,-0.36678,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.6455e-05,-0.37503,-0.39173,1,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.0010528,-0.37541,-0.29342,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,2.9532e-05,-0.37623,-0.38386,1,0
3,GO GAP JUNCTION ASSEMBLY,3.8583e-05,-0.37954,-0.47572,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.37995,-0.37162,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9263e-05,-0.3813,-0.36927,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,3.3132e-05,-0.38141,-0.47901,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0014738,-0.38151,-0.48088,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.5201e-05,-0.3827,-0.38461,1,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0017641,-0.38506,-0.33924,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00017186,-0.38724,-0.38847,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2879e-07,-0.38762,-0.46097,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,-0.38891,-0.42751,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,6.0504e-05,-0.38909,-0.49545,1,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00092958,-0.39007,-0.34123,1,0
3,GO INTERFERON ALPHA PRODUCTION,9.4334e-07,-0.39028,-0.38184,1,0
3,GO TOXIN METABOLIC PROCESS,0.010506,-0.39189,-0.28136,1,0
3,GO DNA DEAMINATION,0.001191,-0.39408,-0.37956,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.5816e-05,-0.3966,-0.39359,1,0
3,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,-0.3972,-0.51811,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0194e-07,-0.40082,-0.44143,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.0689e-05,-0.40384,-0.38688,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,2.5774e-06,-0.40399,-0.41128,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3287e-06,-0.40454,-0.44126,1,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.038561,-0.40676,-0.32394,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.00040247,-0.4106,-0.35141,1,0
3,GO GLIAL CELL FATE COMMITMENT,0.0079323,-0.41107,-0.33351,1,0
3,GO VASCULAR TRANSPORT,0.00032948,-0.41351,-0.43145,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,-0.41442,-0.5307,1,0
3,GO REGULATION OF PLATELET AGGREGATION,7.8282e-05,-0.41461,-0.4927,1,0
3,GO REGULATION OF TRANSPOSITION,7.9801e-06,-0.4174,-0.47822,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.1888e-05,-0.41765,-0.35528,1,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,2.2879e-07,-0.41917,-0.37594,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0025817,-0.41948,-0.3296,1,0
3,GO TOLERANCE INDUCTION,0.00035231,-0.41976,-0.4532,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.4994e-06,-0.42159,-0.52534,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,6.2786e-05,-0.42252,-0.46546,1,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0085714,-0.42279,-0.3354,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.6015e-06,-0.4252,-0.49017,1,0
3,GO KERATINIZATION,2.7343e-05,-0.42753,-0.36981,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,5.2533e-07,-0.42842,-0.47284,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,3.7145e-05,-0.4294,-0.39364,1,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,-0.43125,-0.3942,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.1192e-05,-0.4321,-0.41443,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.2366e-07,-0.43419,-0.49423,1,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00013917,-0.43491,-0.44366,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.00017796,-0.43898,-0.42635,1,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0019282,-0.43953,-0.34183,1,0
3,GO LEYDIG CELL DIFFERENTIATION,0.001986,-0.44113,-0.40441,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00074557,-0.44239,-0.4068,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,2.6902e-06,-0.44317,-0.50979,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4268e-07,-0.44578,-0.45789,1,0
3,GO RESPONSE TO INTERLEUKIN 18,0.00017796,-0.44644,-0.5171,1,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,6.7728e-06,-0.44842,-0.39402,1,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012662,-0.45043,-0.52504,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7801e-06,-0.45496,-0.55607,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00042998,-0.45839,-0.45926,1,0
3,GO CORNIFICATION,3.5759e-05,-0.45883,-0.41776,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.0226e-05,-0.45926,-0.63387,1,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.7413e-06,-0.46129,-0.46877,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,1.2962e-05,-0.46211,-0.39934,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00017186,-0.46555,-0.43602,1,0
3,GO RESPONSE TO WATER,6.7596e-05,-0.46905,-0.42596,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0013872,-0.4696,-0.39297,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,-0.47305,-0.4793,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.508e-06,-0.47602,-0.47528,1,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.00036427,-0.48016,-0.39339,1,0
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.1964e-05,-0.48384,-0.45744,1,0
3,GO MIDBODY ABSCISSION,1.5691e-07,-0.48641,-0.48507,1,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.038561,-0.49499,-0.24544,1,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.9418e-06,-0.49691,-0.52259,1,0
3,GO RESPONSE TO LITHIUM ION,3.7145e-05,-0.49709,-0.47986,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,-0.50367,-0.36502,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,9.3916e-06,-0.50832,-0.45937,1,0
3,GO SEROTONIN METABOLIC PROCESS,0.011326,-0.50881,-0.31563,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.4692e-06,-0.51142,-0.47635,1,0
3,GO NOTCH RECEPTOR PROCESSING,8.6584e-06,-0.52724,-0.48523,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00050664,-0.52989,-0.49198,1,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0045306,-0.53873,-0.35833,1,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.00024286,-0.54336,-0.47666,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.2837e-06,-0.55036,-0.52776,1,0
3,GO EPITHELIAL CELL MORPHOGENESIS,4.1112e-06,-0.5572,-0.53601,1,0
3,GO APICAL JUNCTION ASSEMBLY,4.9191e-08,-0.56098,-0.52845,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00016595,-0.56502,-0.52614,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.00032948,-0.57307,-0.47633,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.57605,-0.58621,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,2.8077e-06,-0.57759,-0.60574,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3418e-05,-0.57882,-0.57934,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049035,-0.5793,-0.43966,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,-0.58673,-0.52029,1,0
3,GO PSEUDOPODIUM ORGANIZATION,0.00020448,-0.5905,-0.44339,1,0
3,GO GAMMA DELTA T CELL ACTIVATION,1.4044e-06,-0.59862,-0.56138,1,0
3,GO MUCUS SECRETION,0.00084609,-0.60014,-0.52376,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.1702e-06,-0.61866,-0.60316,1,0
3,GO CYTIDINE TO URIDINE EDITING,0.0001165,-0.61921,-0.65655,1,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0025817,-0.63422,-0.53362,1,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,6.4994e-06,-0.63775,-0.59594,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.3218e-05,-0.64222,-0.63275,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.2754e-05,-0.64706,-0.7541,1,0
3,GO LUNG CELL DIFFERENTIATION,0.00012074,-0.65646,-0.51701,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,9.4334e-07,-0.67958,-0.63089,1,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,7.6603e-06,-0.72682,-0.57253,1,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.6322e-07,-0.74931,-0.65572,1,0
3,GO EPITHELIAL CELL CELL ADHESION,1.5691e-07,-0.7504,-0.79986,1,0
3,GO LIPID DROPLET FORMATION,7.3528e-06,-0.767,-0.68572,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,6.0504e-05,-0.8094,-0.88752,1,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8891e-07,-0.92382,-0.82664,1,0
3,GO NOSE DEVELOPMENT,0.0001547,-0.96706,-0.65925,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,5.0194e-07,-0.96787,-0.81736,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,7.8282e-05,-0.99536,-1.0952,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,1.8084e-07,-0.99605,-1.0676,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,3.0264e-07,-1.0047,-0.89157,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.2308e-06,-1.1075,-0.9977,1,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.14048,0.3332,0.13527,0,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.079444,0.32819,0.20651,0,1
3,GO REGULATION OF HIPPO SIGNALING,0.087232,0.30609,0.1616,0,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.060602,0.30348,0.18271,0,1
3,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,0,1
3,GO TOOTH MINERALIZATION,0.075049,0.29597,0.14282,0,1
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,0,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.10465,0.27498,0.12566,0,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,0,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.23858,0.17847,0,1
3,GO ENAMEL MINERALIZATION,0.19393,0.22049,0.12673,0,1
3,GO THALAMUS DEVELOPMENT,0.42347,0.211,0.095315,0,1
3,GO NEUROBLAST DIVISION,0.10465,0.20113,0.16202,0,1
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.29586,0.20077,0.089066,0,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.14285,0.19643,0.11303,0,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.10654,0.19335,0.18023,0,1
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.30402,0.18828,0.071766,0,1
3,GO RESPONSE TO MANGANESE ION,0.095625,0.18754,0.10711,0,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.2839,0.18712,0.13208,0,1
3,GO COCHLEA MORPHOGENESIS,0.070855,0.185,0.11256,0,1
3,GO RESPONSE TO VITAMIN A,0.15015,0.18388,0.10886,0,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.12908,0.18381,0.11776,0,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0695,0.18298,0.16604,0,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.065563,0.17947,0.11335,0,1
3,GO BASIC AMINO ACID TRANSPORT,0.13583,0.17471,0.16587,0,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.1745,0.11047,0,1
3,GO PROSTATE GLAND GROWTH,0.17099,0.17216,0.068806,0,1
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.51459,0.17098,0.078423,0,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20937,0.16977,0.091043,0,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.099158,0.1652,0.11653,0,1
3,GO ODONTOGENESIS,0.13814,0.16051,0.075846,0,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.061812,0.15431,0.10314,0,1
3,GO NUCLEUS LOCALIZATION,0.082489,0.15271,0.095375,0,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072231,0.14838,0.1029,0,1
3,GO BONE MORPHOGENESIS,0.10654,0.1475,0.072442,0,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.26098,0.14593,0.088138,0,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.11235,0.13913,0.10017,0,1
3,GO MESODERMAL CELL FATE COMMITMENT,0.28785,0.13813,0.055579,0,1
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.060602,0.13743,0.11847,0,1
3,GO PARENTAL BEHAVIOR,0.27611,0.13494,0.093322,0,1
3,GO T CELL HOMEOSTASIS,0.12689,0.13464,0.053061,0,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.064293,0.1315,0.14118,0,1
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.075049,0.12975,0.11657,0,1
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20937,0.12905,0.064557,0,1
3,GO AORTIC VALVE DEVELOPMENT,0.18508,0.12903,0.083409,0,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.52594,0.12846,0.04104,0,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12908,0.1266,0.11207,0,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.057089,0.12452,0.17914,0,1
3,GO SMOOTH MUSCLE CONTRACTION,0.11636,0.12434,0.063471,0,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.11039,0.12311,0.08545,0,1
3,GO NEUROBLAST PROLIFERATION,0.14048,0.12256,0.087126,0,1
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.093897,0.12094,0.068757,0,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.19695,0.12009,0.063184,0,1
3,GO LYMPH VESSEL DEVELOPMENT,0.14769,0.11937,0.073455,0,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.16294,0.11889,0.09017,0,1
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.30402,0.11099,0.064195,0,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.25001,0.11002,0.084059,0,1
3,GO SLEEP,0.29184,0.10954,0.05629,0,1
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.066855,0.10823,0.083208,0,1
3,GO HEART VALVE DEVELOPMENT,0.27227,0.10804,0.063939,0,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.21905,0.1076,0.065025,0,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.26847,0.10608,0.07133,0,1
3,GO SECRETORY GRANULE ORGANIZATION,0.22568,0.10553,0.055856,0,1
3,GO GROWTH HORMONE SECRETION,0.16294,0.10466,0.10545,0,1
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.59059,0.10414,0.032692,0,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.075049,0.10372,0.095769,0,1
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17099,0.10112,0.059583,0,1
3,GO RESPONSE TO LEAD ION,0.2,0.099167,0.066486,0,1
3,GO ACROSOME ASSEMBLY,0.15773,0.098843,0.14126,0,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.70355,0.098621,0.01751,0,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.2,0.093725,0.074412,0,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.070855,0.093583,0.11512,0,1
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.44402,0.093148,0.037235,0,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.072231,0.09215,0.069895,0,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.12908,0.091841,0.068493,0,1
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27999,0.091737,0.027537,0,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.073629,0.090744,0.0655,0,1
3,GO RRNA 3 END PROCESSING,0.1313,0.090271,0.099363,0,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.15264,0.089392,0.1084,0,1
3,GO RNA STABILIZATION,0.13583,0.088143,0.071223,0,1
3,GO CELLULAR RESPONSE TO UV,0.090515,0.086893,0.060283,0,1
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.30815,0.085366,0.044127,0,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.075049,0.084777,0.056319,0,1
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.14526,0.084508,0.05929,0,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.38408,0.084446,0.047501,0,1
3,GO MESODERMAL CELL DIFFERENTIATION,0.31232,0.082899,0.010792,0,1
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.11434,0.082719,0.083548,0,1
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25363,0.081677,0.04365,0,1
3,GO REGULATION OF DNA METHYLATION,0.55487,0.078676,0.022381,0,1
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.3746,0.078174,0.024524,0,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.082489,0.076793,0.056017,0,1
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.55487,0.076436,0.026264,0,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.17653,0.075733,0.040967,0,1
3,GO CATION TRANSPORT,0.05824,0.075116,0.060237,0,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068167,0.073734,0.06478,0,1
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.12049,0.071179,0.052823,0,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.60272,0.070872,0.029586,0,1
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.059411,0.068576,0.062462,0,1
3,GO LENS FIBER CELL DEVELOPMENT,0.40349,0.067964,0.057793,0,1
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.060602,0.065935,0.06487,0,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.063042,0.064006,0.038941,0,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.3746,0.06199,0.028828,0,1
3,GO MISMATCH REPAIR,0.26098,0.061634,0.040266,0,1
3,GO PRENYLATION,0.43883,0.060469,0.026651,0,1
3,GO CHROMOSOME CONDENSATION,0.10465,0.056019,0.064779,0,1
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.079444,0.055331,0.075593,0,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.32506,0.052067,0.043894,0,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.33373,0.048465,0.043883,0,1
3,GO MRNA TRANSPORT,0.095625,0.047191,0.05429,0,1
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.082489,0.045935,0.10175,0,1
3,GO POSITIVE REGULATION OF DNA BINDING,0.10465,0.045604,0.064125,0,1
3,GO ELECTRON TRANSPORT CHAIN,0.37932,0.040798,0.031763,0,1
3,GO MITOCHONDRION ORGANIZATION,0.17653,0.038028,0.029368,0,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,0.58202,0.62154,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00059588,0.56333,0.5821,0,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,0,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.00038934,0.44341,0.47686,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.020205,0.4197,0.32519,0,0
3,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,0,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.0049174,0.37793,0.30971,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.0551e-05,0.37466,0.4369,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00028792,0.37316,0.34224,0,0
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,0,0
3,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00090094,0.36122,0.49279,0,0
3,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,0,0
3,GO SHORT TERM MEMORY,0.0022332,0.35017,0.32134,0,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,0,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,2.1663e-05,0.32993,0.32988,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.013798,0.32666,0.44768,0,0
3,GO REGULATION OF NEURON MIGRATION,0.00036427,0.32467,0.28077,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0067808,0.32231,0.3593,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.053746,0.31706,0.17246,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.027188,0.31677,0.24137,0,0
3,GO PREPULSE INHIBITION,0.011047,0.31329,0.33627,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,0.30979,0.37234,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00017186,0.30909,0.303,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0010528,0.30801,0.47087,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,0,0
3,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.21256,0.29727,0.11575,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.031748,0.29573,0.37958,0,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0075304,0.28483,0.24571,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0010859,0.28339,0.25764,0,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0027346,0.28208,0.29485,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,0,0
3,GO VOCALIZATION BEHAVIOR,0.030383,0.27735,0.35457,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.029068,0.27701,0.172,0,0
3,GO GLUTAMATE SECRETION,0.00029782,0.27482,0.30144,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016023,0.27422,0.2883,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0010859,0.27257,0.30115,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.077957,0.2721,0.20978,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.012203,0.2705,0.32617,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.0551e-05,0.2694,0.31875,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0031536,0.26779,0.27331,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019739,0.2609,0.27203,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.2,0.25982,0.18244,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,0,0
3,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.11235,0.2487,0.20634,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00035231,0.24686,0.23419,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,0,0
3,GO REGULATION OF DOPAMINE SECRETION,0.025414,0.24193,0.30834,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0015653,0.2416,0.24139,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,2.0033e-05,0.2415,0.25324,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0059384,0.24118,0.17636,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.0012662,0.23757,0.23734,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0056288,0.23754,0.21434,0,0
3,GO RESPONSE TO HYPEROXIA,0.21905,0.23675,0.093777,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.033166,0.2364,0.23571,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,0,0
3,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.034637,0.2307,0.16896,0,0
3,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.7596e-05,0.22515,0.29582,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.097379,0.22447,0.14673,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1888e-05,0.22368,0.30447,0,0
3,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,0,0
3,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,0,0
3,GO POSTSYNAPSE ORGANIZATION,7.8282e-05,0.22101,0.24513,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0087944,0.2208,0.20689,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.05824,0.21712,0.14067,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0027346,0.2165,0.26938,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.095625,0.21504,0.16926,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.033894,0.21116,0.18694,0,0
3,GO NEURON RECOGNITION,0.014841,0.21085,0.20202,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.097379,0.21014,0.1369,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00021909,0.20953,0.26645,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.05824,0.2088,0.19463,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.00087311,0.20663,0.2178,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.00016023,0.20566,0.23771,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.1028,0.20502,0.1412,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00044439,0.20471,0.21521,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0056288,0.20426,0.24748,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.036948,0.20256,0.14063,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.0695,0.20112,0.27288,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.3746,0.20026,0.1234,0,0
3,GO SEROTONIN TRANSPORT,0.092194,0.19987,0.13843,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.066855,0.19852,0.15497,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.12689,0.19843,0.1108,0,0
3,GO AMP METABOLIC PROCESS,0.14769,0.19832,0.097326,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0022332,0.1974,0.26312,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.064293,0.197,0.15482,0,0
3,GO CGMP MEDIATED SIGNALING,0.022165,0.19695,0.13884,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.015203,0.19653,0.20902,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.15773,0.19313,0.1908,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.26471,0.19306,0.087065,0,0
3,GO DENDRITE SELF AVOIDANCE,0.041967,0.19194,0.1856,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00024286,0.19188,0.24956,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.00012074,0.19017,0.20882,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.01282,0.18917,0.28102,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.31232,0.18914,0.10494,0,0
3,GO AXONAL FASCICULATION,0.066855,0.18785,0.20241,0,0
3,GO NEURAL CREST CELL MIGRATION,0.064293,0.18719,0.12956,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18219,0.18645,0.15957,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0013054,0.18509,0.20822,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25001,0.18443,0.067083,0,0
3,GO FOREBRAIN CELL MIGRATION,0.00049035,0.18415,0.23235,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.11434,0.18411,0.11316,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.013139,0.18303,0.13074,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.045624,0.18289,0.16825,0,0
3,GO NEURON PROJECTION GUIDANCE,0.0056288,0.18235,0.16389,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.013798,0.18198,0.12879,0,0
3,GO PRESYNAPSE ORGANIZATION,0.007729,0.18186,0.20793,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.030383,0.18146,0.16576,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.15264,0.18144,0.16619,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.18508,0.18137,0.13887,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.045624,0.18131,0.1476,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0099891,0.18129,0.18737,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12473,0.18122,0.10465,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.19095,0.1812,0.11729,0,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.055956,0.17964,0.1357,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.012203,0.17899,0.17322,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.00084609,0.17881,0.23235,0,0
3,GO NEURON PROJECTION EXTENSION,0.00065623,0.1778,0.17702,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.1313,0.17674,0.16827,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00069957,0.17671,0.2571,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0081404,0.17668,0.20275,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.00014935,0.17661,0.21319,0,0
3,GO LONG TERM MEMORY,0.0041716,0.17645,0.19976,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.1313,0.17567,0.12315,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.092194,0.17496,0.12255,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.41341,0.17478,0.035279,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21256,0.17362,0.047425,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.20309,0.17338,0.15988,0,0
3,GO RELAXATION OF MUSCLE,0.082489,0.17281,0.12867,0,0
3,GO LEUKOCYTE AGGREGATION,0.077957,0.17168,0.13519,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.077957,0.17053,0.092339,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.027803,0.17038,0.1883,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.22905,0.17035,0.096224,0,0
3,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011549,0.17007,0.27365,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,0,0
3,GO NEUROTRANSMITTER SECRETION,0.0013054,0.16961,0.24314,0,0
3,GO NADH METABOLIC PROCESS,0.0020453,0.16892,0.23118,0,0
3,GO HEME METABOLIC PROCESS,0.13814,0.16832,0.099533,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0073363,0.1681,0.19008,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.059411,0.16806,0.13846,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.092194,0.16715,0.09528,0,0
3,GO DENDRITIC TRANSPORT,0.010506,0.16695,0.24093,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0075304,0.16634,0.16894,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.04854,0.16384,0.18446,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10654,0.163,0.088909,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.13583,0.16295,0.09286,0,0
3,GO DENDRITE MORPHOGENESIS,0.0014738,0.16149,0.18245,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.082489,0.16141,0.11853,0,0
3,GO RECEPTOR CLUSTERING,0.065563,0.16141,0.10745,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.16023,0.13459,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.18508,0.16014,0.11315,0,0
3,GO RESPONSE TO PROTOZOAN,0.55487,0.15933,0.020455,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.11235,0.1591,0.15054,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00081984,0.15747,0.20098,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015203,0.15686,0.17096,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.1313,0.15494,0.20744,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.15474,0.11877,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.20937,0.15455,0.1298,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.30815,0.15376,0.0535,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13814,0.15332,0.096099,0,0
3,GO VASCULOGENESIS,0.32077,0.15279,0.034338,0,0
3,GO RESPONSE TO CAFFEINE,0.10096,0.15263,0.1189,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.029068,0.15185,0.30318,0,0
3,GO NERVE DEVELOPMENT,0.11841,0.15175,0.09633,0,0
3,GO DENDRITE DEVELOPMENT,0.00087311,0.15132,0.17742,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,0.14983,0.13446,0,0
3,GO XENOBIOTIC TRANSPORT,0.23937,0.14962,0.036327,0,0
3,GO AXON EXTENSION,0.0028957,0.14933,0.15833,0,0
3,GO SYNAPSE ASSEMBLY,0.012203,0.1488,0.16867,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.043763,0.14864,0.13656,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12908,0.14773,0.09882,0,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.054842,0.14706,0.17956,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.68418,0.14644,0.042439,0,0
3,GO COLLATERAL SPROUTING,0.02843,0.14592,0.15473,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.34702,0.14582,0.067119,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.12259,0.14555,0.1142,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.2839,0.14515,0.061047,0,0
3,GO FIBRINOLYSIS,0.27227,0.14489,-0.014555,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.084046,0.14438,0.14979,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16294,0.14334,0.094518,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.20621,0.14262,0.15547,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.47588,0.14236,-0.15827,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.68418,0.14226,-0.019158,0,0
3,GO REGULATION OF AXON GUIDANCE,0.059411,0.14205,0.091043,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18219,0.14187,0.077712,0,0
3,GO LIPID IMPORT INTO CELL,0.27999,0.14127,0.061506,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.24643,0.14089,0.051468,0,0
3,GO REGULATION OF AXONOGENESIS,0.012203,0.13962,0.14762,0,0
3,GO CELL AGGREGATION,0.073629,0.13892,0.10884,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0011549,0.13884,0.15637,0,0
3,GO ALANINE TRANSPORT,0.14048,0.13877,0.13747,0,0
3,GO RESPONSE TO UV B,0.89215,0.13872,-0.044541,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.26471,0.13871,0.055067,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.097379,0.13833,0.14589,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.10096,0.13825,0.077172,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.47049,0.13733,-0.044057,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.033894,0.13709,0.18228,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0033369,0.13635,0.21006,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13583,0.13599,0.14502,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0090226,0.13417,0.19615,0,0
3,GO STARTLE RESPONSE,0.22235,0.13404,0.12204,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.092194,0.1338,0.0909,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.18219,0.13362,0.096613,0,0
3,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.15773,0.13179,0.072583,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.0030654,0.13151,0.15901,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.11841,0.13124,0.05568,0,0
3,GO PROTEIN OXIDATION,0.12049,0.13088,0.072808,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.17374,0.13022,0.10472,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.034637,0.13006,0.14386,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.20621,0.12996,0.08712,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.085627,0.12959,0.12237,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.054842,0.12954,0.15753,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.49227,0.12951,0.027337,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.27999,0.1293,0.10607,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54903,0.12856,0.062475,0,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0695,0.1279,0.11656,0,0
3,GO CATECHOLAMINE UPTAKE,0.16828,0.12781,0.13783,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0010528,0.12762,0.16732,0,0
3,GO SYNAPTIC SIGNALING,0.001986,0.12747,0.172,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27611,0.12734,0.10221,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.8303,0.1273,0.00708,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.077957,0.12711,0.08124,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.13583,0.12709,0.104,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.064293,0.12701,0.11209,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077957,0.127,0.090624,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.23589,0.12658,0.067219,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.29184,0.12632,0.084081,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.20937,0.1263,0.14382,0,0
3,GO ENDODERM DEVELOPMENT,0.2839,0.12617,0.025249,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.099158,0.12532,0.16393,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.13355,0.12514,0.23131,0,0
3,GO REGULATION OF ODONTOGENESIS,0.40843,0.12506,0.031587,0,0
3,GO METENCEPHALON DEVELOPMENT,0.0054795,0.12488,0.16011,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.097379,0.12458,0.11837,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.070855,0.12428,0.11219,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.53167,0.12415,0.026669,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.10096,0.12406,0.11849,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.59059,0.12406,0.0070754,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.10654,0.12351,0.24502,0,0
3,GO REGULATION OF HEART RATE,0.10465,0.12348,0.095051,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.39858,0.12348,0.09055,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.041093,0.12291,0.091021,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.11235,0.12275,0.11146,0,0
3,GO NEURAL CREST FORMATION,0.36991,0.12272,0.07721,0,0
3,GO CAMP METABOLIC PROCESS,0.31232,0.12264,0.054026,0,0
3,GO MATING,0.033166,0.12237,0.091484,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17099,0.12222,0.077015,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.34702,0.12148,0.1034,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.20937,0.12099,0.079371,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.070855,0.12077,0.10228,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.14769,0.12009,0.1245,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.014841,0.11988,0.19226,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.0060989,0.11975,0.1029,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.099158,0.11908,0.091544,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.12689,0.11897,0.11581,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.20937,0.11875,0.13745,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.188,0.11867,0.089562,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.36526,0.1182,0.17894,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.10096,0.11796,0.079862,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080955,0.1175,0.098141,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.23245,0.11711,0.078572,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.11235,0.11693,0.064552,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.014138,0.1168,0.11783,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.14285,0.11668,0.19877,0,0
3,GO MITOCHONDRIAL RNA PROCESSING,0.070855,0.11661,0.15768,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.066855,0.11658,0.080127,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.44402,0.11647,0.034577,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.91987,0.11642,0.029245,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.14526,0.11641,0.08259,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,0,0
3,GO AXON DEVELOPMENT,0.0050528,0.11594,0.15111,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.059411,0.11573,0.1537,0,0
3,GO CELL PART MORPHOGENESIS,0.0024367,0.11485,0.1479,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.21256,0.11469,0.12975,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.066855,0.11431,0.13884,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,0.11422,0.1157,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.017137,0.11306,0.15792,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26098,0.11301,0.14473,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,0.11274,0.14697,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.35607,0.11239,0.068419,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.17653,0.11182,0.05138,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.20621,0.11179,0.051553,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.25729,0.1117,0.072017,0,0
3,GO URETER DEVELOPMENT,0.41842,0.11161,0.072538,0,0
3,GO COGNITION,0.0031536,0.11159,0.15657,0,0
3,GO SEQUESTERING OF METAL ION,0.11841,0.11155,0.077539,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.34256,0.11099,0.048058,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.061812,0.11097,0.13005,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.16828,0.11045,0.16887,0,0
3,GO NEURON MIGRATION,0.042857,0.11025,0.14875,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.2,0.11014,0.02765,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26471,0.10971,0.089985,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.088862,0.10951,0.10544,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.015203,0.10934,0.19385,0,0
3,GO MYELIN MAINTENANCE,0.46512,0.10871,0.05417,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10845,0.10842,0.17539,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.10831,0.12606,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.30402,0.10773,0.091316,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.064293,0.10773,0.10406,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.004408,0.10765,0.16898,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.10761,0.13606,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.24288,0.10736,0.086646,0,0
3,GO ANION HOMEOSTASIS,0.17934,0.10723,0.076362,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.19393,0.10666,0.1672,0,0
3,GO DOPAMINE TRANSPORT,0.33812,0.10662,0.15678,0,0
3,GO ASYMMETRIC CELL DIVISION,0.39371,0.10648,0.0629,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.14526,0.10629,0.11146,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.39858,0.10609,0.041172,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,0.10605,0.11104,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.15264,0.10543,0.064202,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.20621,0.10501,0.038164,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.11434,0.105,0.12598,0,0
3,GO TOXIN TRANSPORT,0.10096,0.10474,0.067394,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.27227,0.10464,0.079484,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12908,0.10451,0.12432,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.076492,0.1043,0.078154,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.36064,0.10427,0.032545,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.34702,0.10387,0.057386,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,0.10371,0.094687,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.016734,0.10328,0.12458,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.19095,0.10319,0.058589,0,0
3,GO TRNA 5 END PROCESSING,0.12473,0.10284,0.079239,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.60272,0.1027,0.03177,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.084046,0.10254,0.11759,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.097379,0.10248,0.094569,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.05824,0.10243,0.090781,0,0
3,GO WALKING BEHAVIOR,0.004408,0.10242,0.20944,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.26098,0.10238,0.15396,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.060602,0.10188,0.083724,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38408,0.10184,0.054856,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.44924,0.1016,0.14169,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.32506,0.10158,0.057278,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.082489,0.10141,0.067514,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.049546,0.10137,0.11162,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.19393,0.10101,-0.010585,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.22235,0.10099,0.074943,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14048,0.1007,0.081393,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,0.10064,0.1404,0,0
3,GO AXO DENDRITIC TRANSPORT,0.043763,0.10041,0.10129,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.65866,0.10026,0.046327,0,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,0.10018,0.11791,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.57857,0.10015,-0.021418,0,0
3,GO PROSTAGLANDIN SECRETION,0.17099,0.10012,0.085141,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.5726,0.099913,0.02916,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.29992,0.099778,0.059685,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.63978,0.099585,0.039394,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.41341,0.099415,0.015277,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.17653,0.099388,0.090573,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.22235,0.099251,0.049878,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14285,0.098716,0.046371,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.031059,0.098422,0.099572,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.4545,0.097984,0.073768,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.25363,0.097836,0.044028,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.16032,0.097756,0.10818,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.097516,0.041001,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.065563,0.097368,0.064835,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23245,0.097273,0.072781,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.18219,0.09686,0.12136,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,0.09671,0.085387,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.99651,0.096493,-0.042264,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.72969,0.096301,-0.0135,0,0
3,GO RENAL SODIUM EXCRETION,0.095625,0.096118,0.077543,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.10654,0.096015,0.079689,0,0
3,GO BICARBONATE TRANSPORT,0.16828,0.095931,0.057661,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.36526,0.095619,0.024502,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.18508,0.095579,0.15747,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.068167,0.09548,0.080124,0,0
3,GO ENDODERM FORMATION,0.25363,0.095455,0.025382,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.05824,0.095351,0.080819,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.070855,0.095187,0.082986,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.060602,0.095126,0.071842,0,0
3,GO PIGMENT METABOLIC PROCESS,0.13355,0.094987,0.079327,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.18219,0.094937,0.063127,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.29586,0.094911,0.033694,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011326,0.094873,0.17996,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.4978,0.094615,0.011696,0,0
3,GO CELL RECOGNITION,0.057089,0.094592,0.072826,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.14048,0.094365,0.078247,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.54903,0.09376,0.037638,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.32938,0.093651,0.17063,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.27227,0.0934,0.11352,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.010773,0.092962,0.11854,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0024367,0.092894,0.131,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.44402,0.092883,0.11071,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.054842,0.092556,0.08351,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.092194,0.09236,0.080909,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.11636,0.092058,0.10672,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.095625,0.091975,0.14316,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0695,0.091905,0.040213,0,0
3,GO MEMBRANE DEPOLARIZATION,0.14769,0.091862,0.10733,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.63354,0.09169,0.023899,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,0.091628,-0.035297,0,0
3,GO AMELOGENESIS,0.72313,0.091497,0.017454,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.29992,0.091025,0.062368,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.079444,0.090943,0.089883,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.12908,0.090858,0.07639,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.19393,0.090771,0.067024,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.42855,0.090715,0.051687,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.36526,0.090547,0.066859,0,0
3,GO NUCLEOTIDE SALVAGE,0.16032,0.090474,0.12384,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.14769,0.090338,0.086928,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.036164,0.089277,0.11426,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.079444,0.089231,0.081202,0,0
3,GO AMINO ACID ACTIVATION,0.17099,0.089177,0.096164,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.17653,0.089087,0.13757,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,0.088542,0.06317,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.064293,0.088449,0.097257,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.43367,0.088351,0.053667,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15773,0.088278,0.063281,0,0
3,GO CATECHOLAMINE SECRETION,0.070855,0.088274,0.21533,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.94769,0.088241,-0.017123,0,0
3,GO RECEPTOR INTERNALIZATION,0.049546,0.088196,0.094469,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.060602,0.088074,0.064686,0,0
3,GO GROOMING BEHAVIOR,0.20621,0.088031,0.11623,0,0
3,GO COPPER ION TRANSPORT,0.19695,0.087859,0.074573,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.47588,0.087791,0.047237,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.39371,0.087635,0.037074,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25363,0.087382,0.067867,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.72969,0.087255,0.00042408,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.32938,0.087207,0.028107,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.39858,0.086961,0.037733,0,0
3,GO PALLIUM DEVELOPMENT,0.011612,0.086703,0.12236,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.047551,0.086679,0.097788,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.11039,0.086276,0.085481,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.36526,0.085893,0.021861,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.13814,0.08582,0.079721,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.17099,0.085525,0.043005,0,0
3,GO REGULATION OF ION TRANSPORT,0.14285,0.085163,0.060629,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0099891,0.085126,0.18506,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.28785,0.085014,0.067548,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.74288,0.084953,-0.011379,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.5726,0.084937,0.0074552,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.084792,0.1637,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.10845,0.084391,0.088945,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.38408,0.084332,0.03121,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.34256,0.084212,0.065424,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.088862,0.084073,0.16487,0,0
3,GO BLASTOCYST FORMATION,0.10465,0.083901,0.07186,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.29184,0.083715,0.0484,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.093897,0.083683,0.095142,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.67776,0.083643,-0.0021424,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.3746,0.083425,0.053785,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.016734,0.083355,0.11394,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.083289,0.099556,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,0,0
3,GO PLASMINOGEN ACTIVATION,0.46512,0.082181,-0.039713,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.75615,0.082149,-0.074696,0,0
3,GO LACTATION,0.036948,0.081867,0.11724,0,0
3,GO PODOSOME ASSEMBLY,0.67137,0.081675,-0.064838,0,0
3,GO ZINC ION TRANSPORT,0.23937,0.081671,0.059316,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.28785,0.081668,0.10687,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.25001,0.081626,0.029616,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.74288,0.08162,0.0065297,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.23937,0.081615,0.073582,0,0
3,GO TONGUE MORPHOGENESIS,0.4598,0.081393,0.12758,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17934,0.081261,0.082883,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.064293,0.081174,0.14722,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.60272,0.080998,0.035328,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.059411,0.080954,0.067854,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.42347,0.080935,0.03634,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.22235,0.080834,0.17572,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32077,0.080806,0.049153,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.32077,0.080729,0.029259,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.50896,0.080652,0.027984,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.31232,0.08065,0.072418,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.095625,0.080499,0.080015,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.55487,0.080271,0.037342,0,0
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.2,0.080203,0.10426,0,0
3,GO GLIAL CELL ACTIVATION,0.69707,0.080002,0.010975,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.14526,0.079913,0.088509,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.52594,0.079881,0.033788,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.23245,0.079584,0.11512,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.36991,0.079189,0.044649,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18508,0.078595,0.066106,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12049,0.078554,0.08366,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.31653,0.078538,0.044265,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5726,0.07847,0.015,0,0
3,GO CELL GROWTH,0.075049,0.078358,0.049189,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0695,0.078322,0.089378,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.11039,0.078308,0.051503,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.30402,0.078271,0.048713,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.078262,0.069084,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.078197,0.048157,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.084046,0.078058,0.085615,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.21905,0.07805,0.047038,0,0
3,GO NUCLEAR MIGRATION,0.093897,0.077994,0.098162,0,0
3,GO TRABECULA FORMATION,0.22568,0.077658,0.066652,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.043763,0.077645,0.10789,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25729,0.077515,0.06121,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.29184,0.077403,0.034278,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.87833,0.077391,-0.031794,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.4598,0.077289,0.012326,0,0
3,GO ADULT BEHAVIOR,0.055956,0.077249,0.14414,0,0
3,GO DRUG CATABOLIC PROCESS,0.085627,0.077231,0.084308,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.070855,0.077169,0.095196,0,0
3,GO AXONAL TRANSPORT,0.070855,0.077143,0.10062,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.26098,0.077094,0.10614,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.56075,0.077027,0.080368,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.4545,0.076803,0.039002,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.19095,0.076794,0.038257,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.47049,0.076733,0.087098,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.46512,0.076668,0.05701,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.23937,0.076611,0.073465,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,0.076578,0.019408,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.52594,0.076353,0.023953,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.67776,0.076184,0.045548,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.88523,0.076182,-0.051929,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.31653,0.075882,0.091314,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.32938,0.075861,0.085015,0,0
3,GO REGULATION OF EXCRETION,0.12259,0.075844,0.11051,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.3746,0.075674,0.0491,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.35607,0.075559,0.08742,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.37932,0.075513,0.046886,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.082489,0.07523,0.11739,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.30815,0.07504,0.048406,0,0
3,GO IRON ION HOMEOSTASIS,0.20309,0.074902,0.055373,0,0
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.14769,0.074629,0.10781,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76281,0.074518,0.0086407,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.77618,0.074206,-0.012709,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.66501,0.074091,-0.012677,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.085627,0.074082,0.062271,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11636,0.07407,0.079286,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.1313,0.073811,0.11994,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.21905,0.073492,0.093333,0,0
3,GO THIOESTER METABOLIC PROCESS,0.25729,0.073276,0.052488,0,0
3,GO PROTEIN KINASE A SIGNALING,0.2839,0.07278,0.047207,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.94073,0.072656,-0.016114,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.33812,0.072441,0.057914,0,0
3,GO HISTONE H3 K36 METHYLATION,0.51459,0.07244,0.031562,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23245,0.072351,0.14897,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.48131,0.072182,0.03863,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.085627,0.07167,0.091229,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.27999,0.071191,0.043413,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.17099,0.07079,0.06219,0,0
3,GO RESPONSE TO COCAINE,0.47049,0.070694,0.053782,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.32506,0.070677,0.023749,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.054842,0.070652,0.070367,0,0
3,GO CELL JUNCTION ORGANIZATION,0.188,0.07046,0.04718,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.17934,0.070351,0.051365,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34702,0.070264,0.030359,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4545,0.070237,0.023566,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.14526,0.070001,0.11623,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.075049,0.069941,0.066948,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.090515,0.069754,0.13252,0,0
3,GO TRABECULA MORPHOGENESIS,0.68418,0.069601,0.00042882,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.37932,0.069578,0.054866,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32506,0.069519,0.047766,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.065563,0.069382,0.070423,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.78962,0.069356,-0.046214,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12908,0.069332,0.057547,0,0
3,GO RESPONSE TO ACIDIC PH,0.61497,0.069269,-0.0041426,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.33812,0.068977,0.040546,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.068946,0.054595,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.05824,0.068821,0.071223,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.22905,0.068786,0.12685,0,0
3,GO REGULATION OF DNA BINDING,0.32506,0.068703,0.035944,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.092194,0.068576,0.10112,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.40349,0.068368,0.034789,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.054842,0.06832,0.13079,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.32506,0.067907,0.051331,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.39371,0.067675,0.031582,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.16559,0.067378,0.083294,0,0
3,GO MITOCHONDRIAL FISSION,0.17934,0.066962,0.067096,0,0
3,GO ACTION POTENTIAL,0.31653,0.066927,0.062919,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.092194,0.066661,0.065468,0,0
3,GO NEURON DEVELOPMENT,0.015574,0.066648,0.10551,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.11039,0.066519,0.060207,0,0
3,GO RECOMBINATIONAL REPAIR,0.084046,0.066379,0.049275,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.4545,0.066267,0.05857,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.22235,0.066172,0.060251,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63354,0.066041,-0.0040107,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.14048,0.065507,0.039674,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.85768,0.065444,-0.0028137,0,0
3,GO HIPPO SIGNALING,0.68418,0.065365,-0.024942,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.4598,0.065182,0.035594,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.17653,0.065071,0.077566,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.3746,0.064971,0.040328,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.41842,0.064863,0.016317,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.073629,0.064843,0.15596,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.064814,0.067937,0,0
3,GO HISTONE H3 K27 METHYLATION,0.40349,0.064767,0.041694,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.30402,0.064586,0.12124,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.12689,0.064443,0.07886,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.21905,0.064149,0.10092,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.11434,0.063924,0.11139,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.42855,0.063734,0.056971,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.93377,0.063732,-0.0072338,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.72969,0.063652,0.0051246,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.082489,0.063571,0.083382,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.05824,0.063493,0.061114,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.39371,0.063293,0.046665,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.54903,0.063118,0.086518,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.32938,0.062669,0.024869,0,0
3,GO RESPONSE TO SALT,0.92682,0.062643,0.00048644,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.22235,0.06263,0.0745,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.28785,0.062444,0.041102,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.58456,0.062265,0.054427,0,0
3,GO NEURON MATURATION,0.073629,0.062192,0.1618,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.50337,0.062074,0.015222,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.90599,0.062055,-0.0055476,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.31232,0.062028,0.069046,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.52025,0.062015,0.00011165,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.15264,0.061525,0.032862,0,0
3,GO SNRNA PROCESSING,0.15773,0.061408,-0.0063667,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.63978,0.061342,0.018724,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.44924,0.061284,0.069574,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.58456,0.061271,0.021532,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.76281,0.061217,0.038906,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13355,0.061175,0.11112,0,0
3,GO NEURON DIFFERENTIATION,0.033166,0.061143,0.09311,0,0
3,GO RNA CAPPING,0.087232,0.061067,0.064207,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.40349,0.061015,0.054946,0,0
3,GO HEART PROCESS,0.12259,0.06089,0.068836,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.2,0.060871,0.062917,0,0
3,GO CERAMIDE TRANSPORT,0.11434,0.060835,0.045107,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.32938,0.060655,0.088409,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10654,0.060355,0.045853,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.060279,-0.055547,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.5726,0.060194,0.011848,0,0
3,GO REGULATION OF CELL SIZE,0.027803,0.06009,0.078054,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.12049,0.060029,0.062462,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.36526,0.059805,0.094879,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.12908,0.059782,0.047589,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.26098,0.059782,0.039865,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.49227,0.059684,0.069472,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.87144,0.059626,-0.016596,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.12689,0.059588,0.062803,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38888,0.059495,0.059975,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,0.059474,0.0074326,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1028,0.059414,0.067347,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.71006,0.059403,-0.061317,0,0
3,GO REGULATION OF EXOCYTOSIS,0.12908,0.059169,0.083328,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.69061,0.059045,0.016918,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.23245,0.058912,0.051956,0,0
3,GO PROTEIN FOLDING,0.19695,0.058895,0.037073,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21905,0.05883,0.18293,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,0.058732,0.057713,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.36991,0.058589,0.04793,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.48678,0.058587,0.043292,0,0
3,GO HISTONE DEUBIQUITINATION,0.22905,0.058474,0.029267,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.42855,0.058445,0.01996,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.40349,0.058248,0.034762,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.17934,0.057919,0.052955,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.059411,0.057863,0.069993,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.188,0.057766,0.070135,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.67137,0.057761,-0.0024584,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.088862,0.057756,0.05304,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32938,0.057662,0.027942,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.03109,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12908,0.057514,0.096921,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.83713,0.057268,-0.011995,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.25001,0.057197,0.081448,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.12689,0.056973,0.054069,0,0
3,GO FEEDING BEHAVIOR,0.088862,0.056843,0.084705,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.92682,0.056737,-0.0044084,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.44924,0.056697,0.032179,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56666,0.056407,0.022729,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.72969,0.05629,-0.0008014,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.11636,0.05621,0.064125,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.14526,0.056149,0.057714,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85768,0.056012,-0.042994,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.47049,0.055942,0.047177,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.16032,0.055811,0.040261,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48678,0.055774,-0.077812,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.05573,0.0054114,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.23589,0.055727,0.111,0,0
3,GO NEPHRON TUBULE FORMATION,0.79636,0.055653,0.036197,0,0
3,GO NOREPINEPHRINE SECRETION,0.37932,0.055307,0.052206,0,0
3,GO REGULATION OF HEART GROWTH,0.23589,0.055286,0.066202,0,0
3,GO DNA GEOMETRIC CHANGE,0.054842,0.055228,0.060255,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.25729,0.055025,0.049114,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.065563,0.055002,0.04809,0,0
3,GO ANIMAL ORGAN REGENERATION,0.4978,0.054878,-0.0026538,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,0.054837,-0.034905,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.71006,0.054812,0.0049911,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.68418,0.0548,0.015893,0,0
3,GO G0 TO G1 TRANSITION,0.43367,0.05475,0.036869,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.24643,0.054744,0.073746,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.40349,0.054687,0.035538,0,0
3,GO TRACHEA DEVELOPMENT,0.4598,0.054649,0.060868,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34702,0.054639,0.074693,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29992,0.054492,0.03947,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.56666,0.054206,0.020814,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.58456,0.05399,0.016902,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.26471,0.053979,0.072737,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.71658,0.053975,0.017606,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.71658,0.053807,-0.021909,0,0
3,GO PROTEASOME ASSEMBLY,0.2,0.053773,0.053468,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.76948,0.053703,0.016269,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.11841,0.053664,0.080307,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.14526,0.053577,0.068468,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.42347,0.053419,0.04701,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.14526,0.053381,0.070599,0,0
3,GO PROTEIN NEDDYLATION,0.12049,0.053309,0.067427,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.26098,0.053132,0.13369,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.14048,0.05306,0.053304,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.33373,0.052918,0.067288,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.1313,0.052863,0.075474,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.29184,0.052824,0.043541,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.41842,0.05282,0.050627,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.84397,0.052755,-0.028331,0,0
3,GO NEURON CELL CELL ADHESION,0.61497,0.052642,0.10326,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.36064,0.052559,0.035699,0,0
3,GO MYELIN ASSEMBLY,0.49227,0.052436,0.042426,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.83713,0.05231,-0.055094,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.63354,0.052278,0.024987,0,0
3,GO NUCLEOSOME ORGANIZATION,0.14526,0.052174,0.050352,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.72969,0.052144,0.013265,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.47588,0.051724,0.0425,0,0
3,GO MUSCLE CONTRACTION,0.13814,0.051623,0.053266,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.63978,0.05139,0.023118,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.14769,0.05134,0.11065,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.2839,0.051251,0.057719,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.59664,0.051103,-0.044502,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.71658,0.051083,0.0022241,0,0
3,GO MONOAMINE TRANSPORT,0.55487,0.051073,0.10533,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.16294,0.051029,0.064254,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.050937,0.02684,0,0
3,GO RESPONSE TO POTASSIUM ION,0.59059,0.050913,0.052922,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.96163,0.050771,-0.026791,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.11434,0.050566,0.041946,0,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.24288,0.050528,0.091945,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.38408,0.050521,0.079565,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.5726,0.050321,0.033531,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.15015,0.050316,0.06293,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.33812,0.050176,0.083192,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.94769,0.050105,-0.0076313,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.53167,0.050087,0.016322,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.40349,0.049989,0.026336,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.25363,0.049893,0.036914,0,0
3,GO RHYTHMIC BEHAVIOR,0.47049,0.049745,0.042894,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.11434,0.049733,0.11575,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.69061,0.049532,0.0085766,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98953,0.049408,-0.006554,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.15015,0.049344,0.041168,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70355,0.049297,-0.011863,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.11841,0.049215,0.040787,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.98255,0.049192,-0.017618,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.16294,0.049185,0.099555,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.83713,0.049162,-0.0024512,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.91987,0.049093,-0.019411,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.42347,0.049075,0.01986,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.72313,0.048968,0.017815,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.86455,0.048931,0.016773,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,0,0
3,GO CHROMATIN DISASSEMBLY,0.22235,0.048408,0.125,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.42347,0.048374,0.038189,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.33812,0.048365,0.058467,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.43883,0.048133,0.06176,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.087232,0.048035,0.062806,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.17099,0.048005,0.046503,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,0.047761,0.0094245,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.38888,0.04765,0.031904,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.42855,0.047545,0.038869,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.58456,0.04754,0.013204,0,0
3,GO REGULATION OF ORGAN GROWTH,0.35607,0.04754,0.035379,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.25729,0.047341,0.061132,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.23937,0.047273,0.047214,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62732,0.047146,0.030781,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.62113,0.047105,0.047123,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,0.04698,0.0037934,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86455,0.046963,-0.036538,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.22905,0.046955,0.076249,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.62113,0.046823,0.028654,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.9686,0.046602,-0.055373,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43883,0.046447,0.052152,0,0
3,GO ACROSOME REACTION,0.54321,0.046437,0.028279,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.65234,0.046422,-0.0089847,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.41842,0.046411,0.052284,0,0
3,GO NEUROGENESIS,0.075049,0.046395,0.071918,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.55487,0.046293,0.032767,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.15773,0.046282,0.068317,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60883,0.046193,0.036286,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.35153,0.046032,0.060186,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.60883,0.04592,0.03141,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.045851,0.068885,0,0
3,GO MICROTUBULE POLYMERIZATION,0.044685,0.045838,0.11001,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.63978,0.045735,0.048536,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.71006,0.045453,-0.0036157,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.33812,0.045402,0.066379,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.21905,0.045383,0.045223,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.95466,0.045349,-0.026062,0,0
3,GO MYOBLAST FUSION,0.89215,0.045198,-0.025843,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.69707,0.045174,0.0098476,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.31232,0.044919,0.059493,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.093897,0.044885,0.10197,0,0
3,GO RESPONSE TO DOPAMINE,0.61497,0.044837,0.033992,0,0
3,GO CHROMATIN SILENCING,0.46512,0.044804,0.026672,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.71006,0.044783,0.016251,0,0
3,GO ORGAN GROWTH,0.54903,0.044716,0.018631,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.86455,0.044645,-0.072866,0,0
3,GO RRNA CATABOLIC PROCESS,0.62732,0.044437,0.04833,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78962,0.044324,0.0072863,0,0
3,GO HEART TRABECULA FORMATION,0.95466,0.044239,-0.0041626,0,0
3,GO HISTONE METHYLATION,0.1028,0.044139,0.047003,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.81668,0.044039,-0.020328,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16828,0.043899,0.12862,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.061812,0.043714,0.131,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32077,0.043609,0.049395,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.95466,0.043547,-0.012278,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,0.04348,0.037169,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.38888,0.043411,0.05894,0,0
3,GO MICROTUBULE NUCLEATION,0.67137,0.043043,0.030211,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10654,0.042921,0.09844,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.22905,0.042914,0.041127,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.48678,0.042716,0.033185,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.042581,0.023569,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.50896,0.042552,-0.11406,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.20621,0.042531,0.072654,0,0
3,GO PROTEIN HYDROXYLATION,0.78289,0.042499,0.014227,0,0
3,GO PROTEIN PALMITOYLATION,0.30815,0.042405,0.061275,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.21256,0.04236,0.096539,0,0
3,GO BONE DEVELOPMENT,0.3746,0.042278,0.014209,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.89907,0.042198,-0.021191,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.14285,0.041947,0.040574,0,0
3,GO TRNA 5 LEADER REMOVAL,0.63354,0.041775,0.01211,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.092194,0.041691,0.050936,0,0
3,GO PROTEIN STABILIZATION,0.52025,0.041628,0.017604,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.69707,0.041617,0.042231,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1,0.041609,-0.013308,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.60272,0.04137,-0.015169,0,0
3,GO LYMPHANGIOGENESIS,0.26098,0.041195,0.057051,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.41341,0.041186,0.027773,0,0
3,GO NADP METABOLIC PROCESS,0.70355,0.041152,-0.016033,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.05824,0.041143,0.037228,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.10654,0.040787,0.053955,0,0
3,GO CARTILAGE MORPHOGENESIS,0.35153,0.04077,0.14204,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.4598,0.040627,0.046269,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.75615,0.040613,-0.040405,0,0
3,GO SNRNA METABOLIC PROCESS,0.25001,0.040524,-0.0053469,0,0
3,GO PROTEIN IMPORT,0.58456,0.040337,0.0071906,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.64605,0.039969,-0.042298,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,0.039865,-0.0085776,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.86455,0.039813,-0.0023915,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.78962,0.039672,-0.0087641,0,0
3,GO RESPONSE TO UV,0.12259,0.039584,0.042676,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.99651,0.039419,-0.019693,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80989,0.03933,0.024745,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.84397,0.039168,-0.0045513,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.91293,0.039067,-0.013666,0,0
3,GO CELL MORPHOGENESIS,0.14526,0.038997,0.058199,0,0
3,GO REGULATION OF URINE VOLUME,0.65234,0.038963,0.011216,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.95466,0.038951,-0.010853,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29184,0.038797,0.040875,0,0
3,GO POLYOL METABOLIC PROCESS,0.24288,0.038771,0.036067,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.96163,0.03877,-0.010743,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42855,0.038761,0.046427,0,0
3,GO OXIDATIVE DEMETHYLATION,0.15517,0.038625,0.072435,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.20621,0.038547,0.030599,0,0
3,GO ION TRANSPORT,0.23937,0.038322,0.031685,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.25729,0.038216,0.080229,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.76948,0.038215,0.0055821,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.78962,0.03819,-0.0078515,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.33373,0.038161,0.031432,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.76948,0.038053,0.035254,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.72969,0.038013,-0.01894,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.30402,0.037981,0.042514,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.9686,0.037969,-0.025374,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.41842,0.03795,0.046741,0,0
3,GO CELL CELL SIGNALING,0.13355,0.037895,0.047582,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.17099,0.037849,0.099701,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.50896,0.037847,0.02657,0,0
3,GO REGULATION OF GENE SILENCING,0.28785,0.037828,0.031926,0,0
3,GO PROTEIN KINASE C SIGNALING,0.98953,0.037794,-0.0076044,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.090515,0.037701,0.056622,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.073629,0.037433,0.12602,0,0
3,GO DNA REPAIR,0.077957,0.037393,0.035463,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.68418,0.037332,0.015243,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.67137,0.037196,0.016443,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49227,0.037067,0.057624,0,0
3,GO DEVELOPMENTAL GROWTH,0.14285,0.037026,0.047565,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.38888,0.037015,0.016176,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.78289,0.036885,0.008726,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.71658,0.036778,-0.0092596,0,0
3,GO BLASTOCYST GROWTH,0.47049,0.036748,0.016377,0,0
3,GO COENZYME A METABOLIC PROCESS,0.80312,0.03672,0.013962,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56075,0.036493,0.040761,0,0
3,GO RESPONSE TO RETINOIC ACID,0.76948,0.036452,-0.016635,0,0
3,GO RESPONSE TO LEUCINE,0.4978,0.03628,0.078433,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,0.036273,0.026461,0,0
3,GO GMP METABOLIC PROCESS,0.80989,0.03627,0.042603,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.15773,0.036244,0.048961,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.8303,0.036212,0.032197,0,0
3,GO REGULATION OF DNA REPAIR,0.7495,0.036026,0.0030106,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.67776,0.036019,0.00746,0,0
3,GO REGULATION OF ACROSOME REACTION,0.39371,0.035938,0.070154,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.13814,0.035896,0.10478,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.4598,0.035834,0.062649,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.89907,0.035827,-0.026239,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.21905,0.035753,0.10856,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.69707,0.035704,-0.011069,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.67137,0.035667,-0.061516,0,0
3,GO CHLORIDE TRANSPORT,0.49227,0.035636,0.025545,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.29184,0.035526,0.036014,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.020826,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.34702,0.035361,0.020919,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.47049,0.035198,0.041503,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,0.035074,-0.014027,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.63354,0.035062,0.0040174,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.17099,0.034998,0.078447,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010887,0,0
3,GO RESPONSE TO ESTROGEN,0.48678,0.034711,0.0087973,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.98953,0.034662,-0.030051,0,0
3,GO AMYLOID BETA FORMATION,0.84397,0.034629,0.0047639,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.16828,0.034385,0.030482,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.11434,0.034342,0.062309,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.71006,0.034128,0.023519,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.36991,0.034056,0.024522,0,0
3,GO AORTA MORPHOGENESIS,0.89215,0.034007,-0.028269,0,0
3,GO GROWTH,0.51459,0.033947,0.014628,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.63978,0.033925,0.0085486,0,0
3,GO REGULATION OF FERTILIZATION,0.39371,0.033886,0.034041,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.50337,0.033874,-0.070401,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.89907,0.033782,0.011946,0,0
3,GO TORC1 SIGNALING,0.088862,0.033763,0.062223,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,0.033624,0.05577,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.0333,0.029814,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,0.03326,0.034975,0,0
3,GO CHOLESTEROL EFFLUX,0.70355,0.033257,-0.045448,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.12473,0.033246,0.058581,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.43367,0.033047,0.036882,0,0
3,GO CELLULAR HOMEOSTASIS,0.23589,0.033012,0.031681,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.74288,0.032724,-0.042776,0,0
3,GO CARTILAGE DEVELOPMENT,0.73628,0.032683,-0.0058453,0,0
3,GO PORE COMPLEX ASSEMBLY,0.80989,0.032664,-0.034393,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.85768,0.032642,-0.01039,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.56075,0.032546,0.027683,0,0
3,GO DNA CONFORMATION CHANGE,0.16032,0.032404,0.03942,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.70355,0.032357,-0.046804,0,0
3,GO RNA INTERFERENCE,0.20621,0.03234,0.069483,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.47588,0.032237,0.011778,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.4978,0.032095,0.0372,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.55487,0.03197,0.044068,0,0
3,GO PROTEIN ACETYLATION,0.26847,0.031965,0.017669,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.52594,0.031952,0.059015,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.3746,0.031909,0.033044,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.031803,0.021365,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.71658,0.031783,0.0052435,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.24643,0.031667,0.018889,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.85082,0.031627,9.4196e-05,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.75615,0.031621,-0.0013877,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.097379,0.031562,0.062583,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.53167,0.031557,0.022321,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.2,0.031533,0.02891,0,0
3,GO NADPH REGENERATION,0.97557,0.03146,-0.014396,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68418,0.031428,0.018659,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.86455,0.031386,0.010408,0,0
3,GO FOREBRAIN DEVELOPMENT,0.15773,0.031358,0.064155,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.25001,0.031311,0.038895,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44402,0.031263,0.018939,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.67137,0.031137,0.014411,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.26847,0.030901,0.038266,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.42855,0.030871,0.025901,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.92682,0.030773,0.0029153,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.80989,0.030645,-0.0048553,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.78962,0.030489,0.0047626,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.51459,0.030433,0.023195,0,0
3,GO MUSCLE SYSTEM PROCESS,0.23937,0.030397,0.038068,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.78962,0.030362,0.0039012,0,0
3,GO ION HOMEOSTASIS,0.53742,0.030339,0.017595,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.20937,0.030078,0.067402,0,0
3,GO OVULATION CYCLE PROCESS,0.40349,0.030026,0.040106,0,0
3,GO DNA PACKAGING,0.33373,0.029913,0.028574,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.81668,0.029894,-0.012265,0,0
3,GO ENERGY HOMEOSTASIS,0.55487,0.029863,0.050136,0,0
3,GO QUINONE METABOLIC PROCESS,0.32938,0.029856,-0.15592,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.50896,0.029631,0.028245,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.58456,0.029594,0.057225,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.94769,0.029519,0.0078431,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96163,0.029503,-0.013801,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.14769,0.02944,0.043423,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.9686,0.029394,-0.0081614,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.44924,0.029312,0.026918,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.91987,0.029294,-0.067343,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.71006,0.029261,-0.043304,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.82348,0.029227,0.024267,0,0
3,GO RESPONSE TO GONADOTROPIN,0.92682,0.029167,-0.018143,0,0
3,GO MIRNA METABOLIC PROCESS,0.95466,0.029152,-0.00043178,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.66501,0.029119,0.0058449,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.94073,0.029071,-0.037658,0,0
3,GO DEVELOPMENTAL MATURATION,0.22905,0.028994,0.059102,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.96163,0.028993,0.013514,0,0
3,GO HISTONE EXCHANGE,0.31653,0.028887,0.039289,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.62113,0.028843,-0.063157,0,0
3,GO LYMPH NODE DEVELOPMENT,0.87144,0.028811,-0.013562,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.94769,0.028809,-0.0032546,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.67137,0.028734,0.051423,0,0
3,GO CONVERGENT EXTENSION,0.56666,0.028632,0.041216,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.4978,0.028512,0.02142,0,0
3,GO CHYLOMICRON ASSEMBLY,0.78962,0.028507,-0.019807,0,0
3,GO DNA REPLICATION,0.17653,0.028502,0.033985,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29184,0.028124,0.017059,0,0
3,GO MIDBRAIN DEVELOPMENT,0.76281,0.028068,-0.035876,0,0
3,GO OXIDATION REDUCTION PROCESS,0.68418,0.028046,0.0095475,0,0
3,GO INORGANIC ANION TRANSPORT,0.42347,0.027832,0.015758,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.42855,0.027774,0.047455,0,0
3,GO METAL ION HOMEOSTASIS,0.84397,0.02774,0.0037628,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.23245,0.027726,0.10127,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.94073,0.027714,0.004058,0,0
3,GO CELL CYCLE ARREST,0.33373,0.027653,0.025913,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.42347,0.027639,0.031295,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.61497,0.027606,0.0067171,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.89907,0.027545,-0.023932,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.56075,0.027486,0.042877,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.52594,0.027418,0.038913,0,0
3,GO IRON ION TRANSPORT,0.77618,0.027225,-0.0098631,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.47049,0.027036,0.011729,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.46512,0.027007,0.03849,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36526,0.026823,0.032309,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.5726,0.026772,0.026549,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.22568,0.026735,-0.14412,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.42347,0.026586,0.049709,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25363,0.026583,0.047106,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42347,0.026536,0.024151,0,0
3,GO PROTEIN ACYLATION,0.13583,0.026497,0.027667,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.80989,0.026417,0.0048714,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.88523,0.026403,-0.0021909,0,0
3,GO MRNA CLEAVAGE,0.22235,0.026381,0.051584,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.72969,0.026187,0.014482,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.72313,0.026019,-0.0023432,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.56075,0.026014,0.010009,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.12689,0.025895,0.046954,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55487,0.025797,0.023933,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.55487,0.025671,0.027042,0,0
3,GO SEGMENTATION,0.48678,0.025492,0.021605,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87833,0.025299,-0.040874,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.92682,0.025244,-0.012407,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.41842,0.025238,0.03403,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.87144,0.025062,-0.039824,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58456,0.024944,-0.06273,0,0
3,GO NERVOUS SYSTEM PROCESS,0.34702,0.024861,0.038292,0,0
3,GO REGULATION OF GLIOGENESIS,0.78289,0.024815,0.012054,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.38408,0.024716,0.01842,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.54321,0.02446,0.042752,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.82348,0.024273,0.004358,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.9686,0.02426,-0.035691,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.70355,0.02423,-0.006168,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.81668,0.024143,-0.031975,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.68418,0.024101,-0.09294,0,0
3,GO FILOPODIUM ASSEMBLY,0.46512,0.023969,0.037676,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.88523,0.023937,-0.016667,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.63978,0.02391,0.020487,0,0
3,GO CHROMOSOME SEPARATION,0.42855,0.02386,0.025272,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.98255,0.023852,-0.025406,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.39371,0.023753,0.024745,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72969,0.023648,0.032474,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.34256,0.023635,0.060195,0,0
3,GO HISTONE H3 K4 METHYLATION,0.95466,0.023547,0.0012104,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.65234,0.023542,0.012827,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.83713,0.023357,-0.018905,0,0
3,GO REGULATION OF GROWTH,0.90599,0.023354,-0.00044268,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.96163,0.023258,-0.033939,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.13814,0.023166,0.084946,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.96163,0.02307,-0.010031,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86455,0.023017,-0.017188,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.13583,0.022928,0.060352,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.70355,0.022912,0.010331,0,0
3,GO INTERACTION WITH SYMBIONT,0.4545,0.022889,0.0019219,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.72313,0.022857,-0.06373,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.62732,0.022769,0.022613,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.98953,0.022752,-0.017444,0,0
3,GO WATER TRANSPORT,0.91293,0.022676,-0.0035743,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.61497,0.022614,-0.038741,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.16828,0.022592,0.024635,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.64605,0.022425,0.03981,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.61497,0.022396,0.049255,0,0
3,GO REGULATION OF RNA SPLICING,0.2,0.021959,0.036933,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.61497,0.021905,0.09446,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.95466,0.021783,-0.0027989,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.37932,0.02162,0.035968,0,0
3,GO DNA METABOLIC PROCESS,0.39858,0.021597,0.015568,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.60272,0.021583,0.044211,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.72313,0.021456,0.004522,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.60272,0.021411,-0.075543,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79636,0.021405,-0.0081328,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.71006,0.021397,-0.059285,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.73628,0.021363,-0.015008,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.26471,0.021339,0.07162,0,0
3,GO PROTEIN METHYLATION,0.59059,0.021317,0.020162,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.39371,0.021265,0.10921,0,0
3,GO REGULATION OF BEHAVIOR,0.67137,0.021183,0.017133,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.98953,0.021103,0.002342,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.13814,0.020855,0.082401,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.53167,0.020774,0.023525,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.70355,0.020711,0.020402,0,0
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.36064,0.020512,0.024503,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.70355,0.020481,0.0053225,0,0
3,GO DNA RECOMBINATION,0.50896,0.020447,0.011395,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.17653,0.020436,0.12032,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.32938,0.02037,-0.10796,0,0
3,GO SNRNA TRANSCRIPTION,0.23937,0.020297,0.025213,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.85082,0.02027,0.0037798,0,0
3,GO FOREGUT MORPHOGENESIS,0.8303,0.02027,-0.019063,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.72313,0.020237,-0.00023766,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.39371,0.020216,0.097113,0,0
3,GO CHROMATIN REMODELING,0.23589,0.020082,0.036679,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.36991,0.020018,0.057893,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57857,0.019838,0.017424,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.94769,0.019723,-0.004214,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.56666,0.01962,-0.096087,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.68418,0.019617,0.028103,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.66501,0.019419,0.0024772,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.27999,0.019343,0.048686,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.42347,0.019231,0.069953,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.31653,0.01916,0.034708,0,0
3,GO NEURAL TUBE PATTERNING,0.98953,0.019061,-0.0099716,0,0
3,GO REGULATION OF MYELINATION,0.51459,0.019049,0.051814,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.78962,0.018996,-0.01939,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.53167,0.018966,-0.057617,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.91293,0.018898,0.0007021,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.30402,0.018874,0.14205,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.95466,0.018871,-0.019809,0,0
3,GO BRAIN MORPHOGENESIS,0.67776,0.018857,0.044687,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.67776,0.018855,0.01276,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48678,0.018828,0.059431,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.50896,0.018781,0.026803,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.92682,0.0187,0.014684,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.67776,0.018616,-0.066419,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.42855,0.018591,0.029812,0,0
3,GO DENDRITE EXTENSION,0.34702,0.018508,0.14333,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.43883,0.018494,0.025655,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.42347,0.018441,0.05027,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.4598,0.018052,0.021581,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.94073,0.018001,0.039363,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.87833,0.017889,-0.011816,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24643,0.017792,0.042424,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.47588,0.017532,0.01762,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.86455,0.017507,-0.0079791,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.27611,0.017285,0.039654,0,0
3,GO PROSTATIC BUD FORMATION,0.83713,0.017271,-0.094231,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.63354,0.017071,-0.059135,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.80312,0.017066,-0.0033325,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.85768,0.017032,-0.022861,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46512,0.016925,0.02599,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.56075,0.016895,0.015071,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.84397,0.016853,0.0044396,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.26847,0.016798,0.038712,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.27611,0.016703,0.053101,0,0
3,GO REGULATION OF OOGENESIS,0.44924,0.01662,-0.056119,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.90599,0.01645,0.007407,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.71006,0.016362,0.020384,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.53167,0.016183,0.025218,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.63354,0.016057,0.035845,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.48131,0.0159,0.044241,0,0
3,GO ORGANELLE FUSION,0.80989,0.015796,-0.0066239,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.89215,0.015664,-0.032996,0,0
3,GO NODAL SIGNALING PATHWAY,0.9686,0.015654,-0.016513,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.015603,0.049487,0,0
3,GO VESICLE DOCKING,0.48678,0.015435,0.035588,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.85082,0.015429,-0.010858,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.35607,0.015387,0.027589,0,0
3,GO ENSHEATHMENT OF NEURONS,0.75615,0.015249,0.0062892,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.38888,0.015212,0.045411,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.015163,0.026909,0,0
3,GO SOMATIC STEM CELL DIVISION,0.87144,0.015116,0.024833,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.95466,0.015107,-0.01713,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69707,0.015035,-0.00017288,0,0
3,GO RESPONSE TO CAMP,0.29184,0.014955,0.047401,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.64605,0.014931,0.018597,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.78289,0.014886,-0.048514,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.99651,0.014794,-0.053607,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.014788,0.015365,0,0
3,GO COMPLEMENT ACTIVATION,0.8303,0.014705,-0.056068,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.4598,0.014615,0.040127,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.94073,0.014529,-0.013746,0,0
3,GO LYSOSOME LOCALIZATION,0.43883,0.014507,-0.054235,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.54903,0.014507,0.016201,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.93377,0.014461,-0.018421,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.92682,0.014395,-0.020453,0,0
3,GO HISTONE DEACETYLATION,0.86455,0.014311,-0.0095593,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.81668,0.014272,-0.058788,0,0
3,GO SYNCYTIUM FORMATION,0.91293,0.014208,-0.00773,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.78962,0.014174,0.0070492,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.98953,0.014172,-0.014974,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.63354,0.014161,0.030027,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.36064,0.014122,0.06788,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.91987,0.01403,-0.0022613,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.73628,0.014016,-0.00043295,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.78962,0.013994,-0.0028564,0,0
3,GO MEMBRANE BIOGENESIS,0.91293,0.013919,-0.016019,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.56075,0.013905,0.031828,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.97557,0.013786,-0.000796,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98953,0.013741,9.2521e-05,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.99651,0.013716,0.0016867,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.23937,0.013563,0.0867,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.63354,0.013491,0.030871,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.48131,0.013438,0.010475,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.49227,0.013319,-0.052704,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.41341,0.013302,0.020149,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.65234,0.012963,0.019026,0,0
3,GO TERPENOID METABOLIC PROCESS,0.53167,0.012959,-0.048455,0,0
3,GO CELL CELL SIGNALING BY WNT,0.67776,0.012924,0.0040329,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1,0.012924,-0.010853,0,0
3,GO SOMITOGENESIS,0.75615,0.012884,-0.013891,0,0
3,GO NCRNA CATABOLIC PROCESS,0.92682,0.012874,-0.00061769,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.50337,0.012845,-0.03428,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.8303,0.012791,-0.0018795,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.68418,0.012757,0.015022,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.93377,0.012426,-0.011165,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.5726,0.012155,-0.022016,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.22905,0.01208,0.023931,0,0
3,GO HINDBRAIN DEVELOPMENT,0.34702,0.012054,0.056454,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.97557,0.011896,-0.010103,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.85768,0.011887,0.0023157,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.82348,0.01186,0.010332,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.79636,0.011832,-0.0006604,0,0
3,GO VASODILATION,0.30402,0.011816,0.058037,0,0
3,GO MITOCHONDRIAL TRNA PROCESSING,0.29184,0.011812,0.1047,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.68418,0.011693,0.037641,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.72313,0.011683,0.0096705,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62732,0.011669,-0.044504,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.52025,0.011663,-0.060471,0,0
3,GO MANNOSYLATION,0.72313,0.01166,-0.041711,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.57857,0.011623,0.0083721,0,0
3,GO MESENCHYME DEVELOPMENT,0.92682,0.011533,-0.017653,0,0
3,GO HEAD DEVELOPMENT,0.38888,0.011522,0.035896,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.85768,0.011515,-0.0063422,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.97557,0.011501,-0.0084849,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.70355,0.011466,0.010564,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.76948,0.011348,0.00081077,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.40843,0.011263,-0.051516,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.95466,0.011262,-0.0044998,0,0
3,GO RESPONSE TO ATP,0.54321,0.011184,0.023555,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.90599,0.011106,-0.077073,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.57857,0.011054,-0.021601,0,0
3,GO VISUAL BEHAVIOR,0.48678,0.011038,0.036199,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.76948,0.011037,-0.010956,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9686,0.010961,-0.042987,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.92682,0.010889,-0.0036678,0,0
3,GO DNA LIGATION,0.97557,0.010881,-0.0011536,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.71006,0.010711,0.0058404,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.9686,0.0107,-0.01829,0,0
3,GO SOMITE DEVELOPMENT,0.72969,0.010665,0.01032,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.57857,0.010611,0.05109,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.69707,0.010605,0.01992,0,0
3,GO CELL FATE COMMITMENT,0.77618,0.01056,-0.019383,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.56666,0.010495,0.017299,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.98953,0.010484,-0.0071665,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.5726,0.010333,0.045606,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.19095,0.010159,0.10225,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87833,0.010127,-0.010742,0,0
3,GO MITOTIC DNA REPLICATION,0.90599,0.010126,-0.013772,0,0
3,GO THYMUS DEVELOPMENT,0.93377,0.010049,-0.0022784,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.78289,0.010027,0.0062207,0,0
3,GO RHYTHMIC PROCESS,0.90599,0.0097994,0.002983,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.0097513,0.011355,0,0
3,GO STEM CELL DIFFERENTIATION,0.76281,0.0096906,-0.018138,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,0.0096897,-0.0073922,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.65866,0.0095956,0.0069814,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.81668,0.0094596,0.0014535,0,0
3,GO GLIAL CELL PROLIFERATION,0.72969,0.0093701,-0.038691,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.59059,0.0093476,0.01958,0,0
3,GO RESPONSE TO DRUG,0.57857,0.0091927,0.020593,0,0
3,GO INTRACELLULAR TRANSPORT,0.9686,0.0091498,-0.0026833,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.89907,0.0091333,-0.010242,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.91987,0.0091104,0.0022079,0,0
3,GO HEAD MORPHOGENESIS,0.73628,0.0090675,-0.054164,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.82348,0.0090306,0.012044,0,0
3,GO INSEMINATION,0.56666,0.0090097,-0.071983,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.83713,0.0088583,-0.029768,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.60272,0.0086388,-0.036803,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.78289,0.0085554,-0.042887,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.86455,0.0083696,-0.047653,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,0.0083209,-0.041158,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63978,0.0083131,-0.031907,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.73628,0.0082851,0.011449,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.52594,0.0082561,0.044908,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.9686,0.0081832,-0.010798,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.87144,0.0081344,-0.0070383,0,0
3,GO FIBROBLAST ACTIVATION,0.80312,0.0081279,-0.041497,0,0
3,GO NUCLEOSOME ASSEMBLY,0.55487,0.0080678,0.024743,0,0
3,GO RESPONSE TO FATTY ACID,0.63354,0.007977,0.014849,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.32077,0.0079634,-0.06499,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.5726,0.0078482,0.013017,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.39858,0.0078203,-0.050042,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.96163,0.0078085,-0.0010393,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.5726,0.0077551,0.11384,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.62732,0.0077524,0.039512,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.61497,0.0077184,-0.037848,0,0
3,GO POSITIVE REGULATION OF BINDING,0.89215,0.0076239,0.005204,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.76948,0.0075946,-0.023653,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.59059,0.007441,-0.043833,0,0
3,GO ENDOCYTOSIS,0.73628,0.0073062,0.0071156,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.41341,0.0072445,0.032636,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.78289,0.0070853,0.00025501,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.91987,0.0070363,-0.024636,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.43883,0.0069035,0.021505,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.96163,0.0068807,-0.025694,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.91987,0.0068506,-0.020342,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.72969,0.0068365,0.021299,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.90599,0.0067852,-0.0039021,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.73628,0.0067294,-0.0023183,0,0
3,GO DNA STRAND ELONGATION,0.79636,0.0066817,0.033476,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.40349,0.006628,0.032395,0,0
3,GO SPINAL CORD DEVELOPMENT,0.56666,0.0065917,0.036106,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,0.0064893,-0.02342,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.41842,0.0064745,-0.050097,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.39858,0.0064415,-0.082113,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.71006,0.0064107,-0.062065,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.81668,0.0064007,-0.0014967,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3746,0.0063876,0.036079,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.9686,0.0062893,-0.012317,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.69707,0.0062535,-0.03318,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.9686,0.0061402,0.0075368,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.85768,0.0060765,-0.0030939,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.71658,0.0059511,-0.039991,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50337,0.0059337,-0.048614,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.96163,0.0058761,-0.011583,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.74288,0.005827,0.038529,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.74288,0.005808,-0.056682,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.98953,0.0056344,0.0085193,0,0
3,GO VESICLE CARGO LOADING,0.96163,0.0055976,-0.034602,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.47049,0.0055959,-0.076542,0,0
3,GO STEROL TRANSPORT,0.5726,0.0055668,-0.042278,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.84397,0.0055293,0.0032237,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.98953,0.0053946,0.0052026,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0053581,-0.0010191,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.79636,0.005149,-0.026913,0,0
3,GO MIDGUT DEVELOPMENT,0.96163,0.0051445,-0.015151,0,0
3,GO CHONDROCYTE PROLIFERATION,0.91987,0.0051153,0.0016201,0,0
3,GO CELLULAR RESPONSE TO ATP,0.3746,0.0050817,0.047175,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.41842,0.0050806,0.031823,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.72969,0.0050624,-0.043073,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94073,0.0050359,-0.0048989,0,0
3,GO HEART GROWTH,0.2839,0.0050315,0.056927,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.30815,0.0050261,0.037477,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.63354,0.0049954,0.013793,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.61497,0.0049698,0.037935,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.97557,0.0049425,-0.0017851,0,0
3,GO CHROMATIN ORGANIZATION,0.98255,0.004924,-0.0017387,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.85082,0.0049136,-0.061184,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48131,0.0048492,0.023663,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.52025,0.0048344,0.01364,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.66501,0.0047222,-0.063692,0,0
3,GO MACROMOLECULE DEACYLATION,0.65866,0.0047171,0.015379,0,0
3,GO CELL CYCLE PROCESS,0.89215,0.0046228,-0.003076,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.74288,0.0046221,-0.027191,0,0
3,GO RECEPTOR RECYCLING,0.91293,0.004562,-0.012386,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.38408,0.0044266,0.080401,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.31653,0.0043766,0.044046,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.69061,0.0042673,-0.0027631,0,0
3,GO REGULATION OF BINDING,0.62732,0.0042594,-0.01871,0,0
3,GO HYPEROSMOTIC RESPONSE,0.78289,0.0042529,-0.031204,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.90599,0.004252,0.011128,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.33812,0.0041312,-0.028558,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.62732,0.0041212,-0.016858,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.90599,0.0039969,-0.011779,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.52594,0.0038315,0.034647,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.85082,0.0037939,-0.0089701,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.7495,0.0037598,0.0014151,0,0
3,GO DRUG METABOLIC PROCESS,0.7495,0.0037539,-0.0068088,0,0
3,GO METHIONINE METABOLIC PROCESS,0.91293,0.0036902,-0.018883,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.73628,0.0036781,-0.043312,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63978,0.0034803,-0.040616,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.63354,0.0034268,0.01767,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.72313,0.0033832,0.014453,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.97557,0.0033497,-0.0034348,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.33812,0.0033183,0.048085,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.77618,0.0032772,-0.0396,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.53167,0.0032278,0.045445,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.91293,0.0032274,-0.017486,0,0
3,GO MAST CELL MIGRATION,0.79636,0.0030541,-0.057608,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.9686,0.0030387,-0.0057029,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.72969,0.0030025,0.01727,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.75615,0.0029931,0.03214,0,0
3,GO MITOTIC CELL CYCLE,0.87144,0.0029303,-0.009113,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.96163,0.0028974,0.028137,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.93377,0.0028891,-0.0074689,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.89215,0.0028527,-0.012984,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.59059,0.0027225,-0.033148,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.68418,0.0026018,0.0055043,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75615,0.0024251,0.011794,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56666,0.0021858,0.027748,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66501,0.0021491,-0.012893,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.96163,0.0020983,-0.00019962,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.42855,0.0020975,0.092799,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.65234,0.0019754,0.060867,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.49227,0.0019008,-0.065546,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.76948,0.0018088,-0.0023158,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,0.0017719,0.0062413,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.69061,0.001762,0.016804,0,0
3,GO CELL PROJECTION ORGANIZATION,0.66501,0.0017527,0.018766,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.71658,0.0017109,0.023363,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.75615,0.0015939,-0.042717,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.9686,0.0014908,-0.0014358,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.9686,0.0014733,-0.0091945,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85082,0.0014074,-0.034616,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.52025,0.0012349,0.026247,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.89907,0.0012121,-0.012278,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.31232,0.0011984,-0.059052,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.59059,0.0011784,-0.036901,0,0
3,GO IMPORT INTO NUCLEUS,0.93377,0.0011547,-0.0035695,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.78289,0.0011132,-0.048874,0,0
3,GO LIPID PHOSPHORYLATION,0.50337,0.0010831,0.041144,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.53167,0.0010643,-0.039973,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.65866,0.0010595,0.033711,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.44402,0.00094454,0.029056,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.78962,0.00092425,-0.029875,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.72969,0.00085306,-0.076354,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.87144,0.00066066,0.0056869,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.97557,0.00061569,-0.001468,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.80312,0.00058415,0.013009,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.83713,0.00054748,-0.013983,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.85768,0.00049936,-0.030225,0,0
3,GO RESPONSE TO NICOTINE,0.69061,0.00045567,0.027831,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.54321,0.00034335,-0.014881,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.41341,0.00014907,0.021634,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,0.00013118,0.00040004,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.75615,0.00011039,0.014211,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.83713,5.2757e-05,-0.039116,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.5726,-4.8057e-05,-0.016782,0,0
3,GO MAINTENANCE OF LOCATION,0.78289,-6.148e-05,0.0098354,0,0
3,GO PROTEIN AUTOPROCESSING,0.98953,-0.00016379,-0.022545,0,0
3,GO PIRNA METABOLIC PROCESS,0.48131,-0.0002303,-0.10914,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.52025,-0.00023226,-0.028183,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.77618,-0.00036335,0.0048093,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.63354,-0.000428,-0.044165,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.96163,-0.00048452,0.0017186,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.80312,-0.00049308,-0.05234,0,0
3,GO MUSCLE HYPERTROPHY,0.72969,-0.00058105,-0.028925,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.41842,-0.0007005,-0.034803,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1,-0.00076563,-0.031239,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.76948,-0.00085104,-0.029858,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,-0.00086836,0.019572,0,0
3,GO FEVER GENERATION,0.53742,-0.0010039,0.030955,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.69061,-0.001153,-0.019731,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.80989,-0.0011931,-0.0028538,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0012676,-0.044833,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.0012742,0.0056948,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.96163,-0.0012755,-0.0061296,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.52594,-0.0013027,0.025534,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.78962,-0.001415,-0.014481,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.89215,-0.0014205,0.011426,0,0
3,GO BODY FLUID SECRETION,0.81668,-0.0014761,0.0029811,0,0
3,GO RESPONSE TO GLUCAGON,0.91987,-0.0015068,-0.014708,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.60883,-0.0015098,-0.030795,0,0
3,GO OVULATION CYCLE,0.4978,-0.0015213,0.032306,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.97557,-0.0016361,0.0037829,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.63354,-0.0016612,-0.02543,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.85768,-0.0016885,-0.0014084,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.94769,-0.0017264,-0.012812,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.67137,-0.0017465,-0.066126,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.59664,-0.0019113,-0.030114,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39858,-0.0019951,0.039776,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.85768,-0.0020953,-0.059625,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.78962,-0.0021106,-0.043574,0,0
3,GO REGULATION OF CYTOKINESIS,0.43883,-0.002141,-0.032988,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.78289,-0.0021447,0.0050345,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.97557,-0.0021541,-0.011407,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.7495,-0.0021752,-0.039342,0,0
3,GO NUCLEOSIDE SALVAGE,0.36991,-0.0022156,0.039444,0,0
3,GO EXOCYTIC PROCESS,0.56666,-0.002245,0.062948,0,0
3,GO PIGMENT GRANULE MATURATION,0.85768,-0.0023048,-0.054706,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.97557,-0.0023323,-0.0083782,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.84397,-0.0023651,-0.025005,0,0
3,GO TAXIS,0.7495,-0.0024014,-0.010814,0,0
3,GO NEURON DEATH,0.92682,-0.0025196,-0.0017035,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.95466,-0.0026231,-0.013383,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.83713,-0.0030017,0.0066233,0,0
3,GO DOSAGE COMPENSATION,0.8303,-0.0030349,-0.013877,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.58456,-0.0030703,-0.15633,0,0
3,GO CHROMOSOME ORGANIZATION,0.87833,-0.0030851,0.0056816,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.37932,-0.0032129,-0.048803,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.40349,-0.003424,0.021385,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.93377,-0.0035655,-0.017228,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.60883,-0.0037699,0.020089,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.80989,-0.0038033,0.010839,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.68418,-0.0038524,-0.013559,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.53742,-0.0038826,0.035653,0,0
3,GO CHEMICAL HOMEOSTASIS,0.95466,-0.003967,-0.0080533,0,0
3,GO HEART MORPHOGENESIS,0.99651,-0.0041449,-0.018148,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.54903,-0.0041466,-0.019115,0,0
3,GO ORGANIC ACID TRANSPORT,0.55487,-0.0042215,0.017458,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.94073,-0.004325,-0.0048182,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.97557,-0.0043475,-0.013154,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.94769,-0.0043516,-0.016717,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.80312,-0.0043878,-0.024818,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.67776,-0.0045072,0.0046049,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.52025,-0.0047153,-0.030987,0,0
3,GO RESPONSE TO PH,0.76948,-0.004738,-0.027486,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.69707,-0.0047639,-0.021699,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.71658,-0.0048014,-0.013175,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.80312,-0.0048961,-0.015413,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.75615,-0.0049049,-0.025801,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.97557,-0.005009,0.0067403,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.72313,-0.005061,-0.052126,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.55487,-0.0050735,0.08997,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.90599,-0.0050959,-0.0070516,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.0051145,-0.021377,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87144,-0.0051889,0.013658,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.72313,-0.0052208,-0.050558,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.82348,-0.0052434,-0.0048747,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.65866,-0.0052449,-0.048825,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.66501,-0.005382,-0.043445,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.20621,-0.0057439,-0.059669,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.87144,-0.0061845,-0.014707,0,0
3,GO LIPID CATABOLIC PROCESS,0.47588,-0.0062484,-0.037588,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65234,-0.0063962,-0.022471,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.56666,-0.0064213,-0.021922,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.3746,-0.0064736,0.045386,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91293,-0.0065886,-0.010019,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95466,-0.0066102,-0.030804,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,-0.0067242,0.0015205,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.48131,-0.0067761,0.044148,0,0
3,GO HEAT GENERATION,0.62113,-0.0067979,-0.041792,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.76281,-0.0068298,-0.040138,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.49227,-0.0068596,-0.061985,0,0
3,GO BLASTODERM SEGMENTATION,0.4978,-0.0069007,0.08959,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.44402,-0.0069391,-0.061373,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,-0.006964,-0.10786,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.58456,-0.0069784,-0.030028,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.76948,-0.0071088,-0.0088894,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.86455,-0.0071364,0.018294,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.87833,-0.007325,-0.045401,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7495,-0.0073674,-0.011251,0,0
3,GO HINDLIMB MORPHOGENESIS,0.66501,-0.0074091,0.010561,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.86455,-0.0074578,-0.016199,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.84397,-0.0076558,-0.01464,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.76281,-0.0076769,-0.0092746,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.92682,-0.0077309,-0.018139,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.80989,-0.008001,-0.01596,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,-0.0080193,-0.0045908,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.70355,-0.0080197,-0.011913,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.65234,-0.0080541,-0.025212,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.89215,-0.0080773,0.020725,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.83713,-0.0081249,-0.022048,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,-0.0081736,-0.041355,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.61497,-0.008546,0.029044,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80989,-0.0085715,-0.015401,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.54321,-0.0086583,-0.029287,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.82348,-0.0088617,-0.082832,0,0
3,GO ERK1 AND ERK2 CASCADE,0.51459,-0.0089105,-0.046951,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.85768,-0.0089968,-0.012245,0,0
3,GO TRACHEA MORPHOGENESIS,0.89907,-0.0091072,-0.018687,0,0
3,GO DRINKING BEHAVIOR,0.7495,-0.0093318,-0.0030326,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.97557,-0.0093498,0.0090277,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.69707,-0.009508,-0.004935,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.87144,-0.00953,-0.011361,0,0
3,GO RESPONSE TO X RAY,0.60272,-0.0096007,-0.065705,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0096237,-0.068419,0,0
3,GO FIBROBLAST PROLIFERATION,0.54903,-0.0097005,0.024163,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.59664,-0.00975,-0.0624,0,0
3,GO PERICARDIUM DEVELOPMENT,0.94073,-0.0097832,-0.011658,0,0
3,GO RESPONSE TO ETHANOL,0.99651,-0.0098929,-0.00047781,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.60883,-0.010035,-0.049841,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.65866,-0.01009,-0.037508,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,-0.010112,-0.030351,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.53167,-0.010163,-0.041355,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.69707,-0.010221,-0.027857,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.49227,-0.010278,0.037499,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.8303,-0.010279,-0.010079,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.73628,-0.010351,-0.018502,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.81668,-0.010369,0.0030049,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.65234,-0.010619,-0.0232,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97557,-0.010684,-0.013915,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.60272,-0.010713,-0.10836,0,0
3,GO HEART DEVELOPMENT,0.48678,-0.010727,-0.037599,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,-0.010749,-0.084745,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.99651,-0.010795,-0.023231,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.31653,-0.010802,-0.029142,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.80989,-0.010999,-0.0041155,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95466,-0.011084,0.01409,0,0
3,GO GENE SILENCING,0.40843,-0.011122,-0.021814,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.44924,-0.011182,-0.034949,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.67776,-0.011203,-0.1668,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.68418,-0.011264,-0.036411,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.64605,-0.011307,0.058723,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.19095,-0.011431,-0.080238,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.4545,-0.011468,-0.032258,0,0
3,GO RESPONSE TO AXON INJURY,0.91293,-0.011778,-0.0012456,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.62113,-0.011837,-0.034786,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.44402,-0.011893,0.12852,0,0
3,GO VESICLE LOCALIZATION,0.26847,-0.012029,-0.033037,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.47049,-0.012085,-0.032097,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.69061,-0.012213,-0.018482,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.40843,-0.012282,-0.041562,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.44924,-0.012391,-0.031789,0,0
3,GO MESODERM DEVELOPMENT,0.44924,-0.012459,-0.050142,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.56075,-0.012515,-0.022809,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.62732,-0.012588,0.025694,0,0
3,GO PROTEIN SUMOYLATION,0.77618,-0.012736,-0.0075734,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.50337,-0.012781,-0.022183,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.87833,-0.012867,-0.0079675,0,0
3,GO BIOMINERALIZATION,0.89215,-0.012871,-0.020201,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34256,-0.012913,-0.031051,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.55487,-0.012973,0.085402,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.17934,-0.013086,-0.058279,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.21579,-0.013223,-0.045768,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.33812,-0.01325,-0.059833,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.93377,-0.013264,0.0035065,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.57857,-0.013331,-0.027579,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.65866,-0.013388,-0.013358,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.76948,-0.013403,0.024341,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.20309,-0.013471,-0.05008,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.56666,-0.013499,-0.066469,0,0
3,GO POLYOL CATABOLIC PROCESS,0.78962,-0.013535,-0.024826,0,0
3,GO GASTRULATION,0.65866,-0.013544,-0.044904,0,0
3,GO MICROTUBULE ANCHORING,0.63978,-0.013549,-0.024947,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.56666,-0.013641,-0.035936,0,0
3,GO PHOTOPERIODISM,0.88523,-0.013648,-0.015083,0,0
3,GO BLASTOCYST DEVELOPMENT,0.60272,-0.013652,-0.018421,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.98255,-0.013772,-0.0020253,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.36064,-0.013815,-0.055739,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.7495,-0.013861,-0.027981,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.96163,-0.013871,-5.346e-05,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.93377,-0.013925,0.012308,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.65866,-0.013971,0.046057,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.8303,-0.013999,0.0024329,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.36526,-0.014096,-0.039662,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.72969,-0.014098,-0.032344,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.59664,-0.014158,-0.038722,0,0
3,GO MITOPHAGY,0.33812,-0.014368,-0.059769,0,0
3,GO VITAMIN TRANSPORT,0.78289,-0.01444,0.035671,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.96163,-0.014539,-0.053293,0,0
3,GO HISTONE PHOSPHORYLATION,0.5726,-0.014694,-0.040065,0,0
3,GO HISTONE H3 K9 METHYLATION,0.59664,-0.01473,-0.027067,0,0
3,GO CELL DIVISION,0.48131,-0.014868,-0.022416,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.80312,-0.015031,-0.031949,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60272,-0.015053,-0.043052,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.60272,-0.015136,-0.0088106,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.89215,-0.015318,-0.0092663,0,0
3,GO REGULATION OF T CELL MIGRATION,0.42347,-0.015403,-0.054232,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,-0.015546,-0.019983,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.87144,-0.015547,-0.015575,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.81668,-0.015593,-0.0057824,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.15517,-0.015865,-0.045594,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.98255,-0.015901,-0.023011,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39371,-0.015977,-0.05669,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4545,-0.016055,-0.03357,0,0
3,GO SPINDLE ORGANIZATION,0.39858,-0.016137,-0.028088,0,0
3,GO GLIOGENESIS,0.74288,-0.016142,-0.017504,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.59664,-0.016208,-0.068997,0,0
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.61497,-0.016301,0.028317,0,0
3,GO RESPONSE TO STEROL,0.77618,-0.016342,-0.017548,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.56666,-0.016354,-0.024477,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.39371,-0.016433,-0.052615,0,0
3,GO ORGAN INDUCTION,0.4978,-0.016484,-0.074804,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15264,-0.016519,-0.058883,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.24288,-0.016529,-0.032371,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.50337,-0.016546,-0.015016,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.50896,-0.016593,-0.053644,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20937,-0.016604,-0.065645,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.44924,-0.016703,-0.027995,0,0
3,GO SISTER CHROMATID COHESION,0.92682,-0.016719,0.0106,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,-0.016808,-0.052488,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.72313,-0.016871,-0.073009,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.46512,-0.016947,-0.030799,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.80312,-0.01708,-0.062657,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.4545,-0.017094,-0.030825,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.83713,-0.017231,-0.034079,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.33373,-0.017298,-0.048122,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72969,-0.017307,-0.013092,0,0
3,GO AUTOPHAGIC CELL DEATH,0.52594,-0.017344,-0.05563,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.70355,-0.017345,-0.030833,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,-0.017359,-0.012146,0,0
3,GO REGULATION OF TRANSPORT,0.61497,-0.017377,-0.014246,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.53742,-0.017379,-0.029342,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.5726,-0.01739,-0.0339,0,0
3,GO GLAND MORPHOGENESIS,0.46512,-0.017413,-0.092293,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27611,-0.017446,-0.045449,0,0
3,GO CALCIUM ION IMPORT,0.65866,-0.017459,0.027533,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.89907,-0.01748,0.01167,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.53167,-0.017485,-0.019121,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.77618,-0.017605,-0.041129,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.86455,-0.017617,-0.029001,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.74288,-0.017803,0.024424,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.58456,-0.017903,-0.012086,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.72313,-0.017932,-0.0043403,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.47049,-0.017987,-0.049102,0,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.36991,-0.01823,-0.09678,0,0
3,GO SISTER CHROMATID SEGREGATION,0.60272,-0.018329,-0.011517,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.91293,-0.01838,-0.080202,0,0
3,GO ANION TRANSPORT,0.7495,-0.018423,-0.010151,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.94769,-0.018629,0.018076,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.88523,-0.018726,-0.024389,0,0
3,GO RESPONSE TO ZINC ION,0.62113,-0.018737,-0.069647,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.58456,-0.018831,0.020753,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.53742,-0.018839,-0.060528,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.71006,-0.018859,-0.010004,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.34702,-0.018873,-0.071356,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.32506,-0.018886,-0.078006,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.53167,-0.01915,-0.046456,0,0
3,GO REGULATION OF CELL CYCLE,0.30815,-0.019229,-0.020215,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.41341,-0.019283,-0.022807,0,0
3,GO ORGANELLE INHERITANCE,0.49227,-0.019439,-0.037226,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.48131,-0.019447,-0.032394,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.49227,-0.019517,-0.042666,0,0
3,GO VASCULATURE DEVELOPMENT,0.25363,-0.019522,-0.066452,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48678,-0.019665,-0.050587,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.58456,-0.019705,0.028858,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.23589,-0.019711,-0.054555,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.39858,-0.019807,-0.060449,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.56666,-0.019892,-0.028081,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2,-0.019967,-0.071375,0,0
3,GO REGULATION OF AUTOPHAGY,0.4978,-0.019997,-0.022612,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.68418,-0.020077,-0.014108,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.50896,-0.020125,0.067618,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.67776,-0.020305,-0.012599,0,0
3,GO REGULATION OF PHOSPHORYLATION,0.20937,-0.020325,-0.042632,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.15264,-0.020357,-0.080097,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.23245,-0.020431,-0.059592,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.77618,-0.02049,-0.033878,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65234,-0.020664,-0.02965,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.24643,-0.020679,-0.10669,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65866,-0.021099,-0.030584,0,0
3,GO MEMBRANE FUSION,0.27999,-0.021176,-0.048341,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89907,-0.021317,0.071593,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25363,-0.02133,-0.028237,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.27227,-0.021344,-0.033256,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.89907,-0.021446,-0.0045247,0,0
3,GO MUSCLE FILAMENT SLIDING,0.91987,-0.021468,-0.016047,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.81668,-0.021567,-0.016558,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.4598,-0.021573,-0.051162,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67776,-0.021645,-0.032571,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.51459,-0.021663,-0.03962,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.4545,-0.021732,-0.015393,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.53167,-0.021734,-0.026713,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.67776,-0.021846,-0.0047164,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.70355,-0.021862,-0.021587,0,0
3,GO REGULATION OF VASCULOGENESIS,0.33373,-0.021997,-0.093101,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.50337,-0.022015,-0.027923,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.78289,-0.022044,-0.03604,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.67137,-0.022119,-0.031084,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.72313,-0.02213,-0.051099,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.59664,-0.022203,-0.017086,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21905,-0.022287,-0.090021,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.47588,-0.022386,-0.021315,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.80312,-0.022407,-0.038593,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.93377,-0.022455,-0.013078,0,0
3,GO FERTILIZATION,0.26098,-0.022487,-0.028927,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.188,-0.022569,-0.04408,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29586,-0.022607,-0.034894,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.18219,-0.02268,-0.13403,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.50337,-0.022701,-0.035619,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.89907,-0.022744,-0.020357,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.92682,-0.022747,-0.0033542,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.77618,-0.02277,-0.02659,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.61497,-0.02287,-0.023392,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.32938,-0.022926,-0.066363,0,0
3,GO BODY MORPHOGENESIS,0.31653,-0.022946,-0.081159,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.72313,-0.023015,-0.049528,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.59664,-0.023039,-0.081571,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.21579,-0.023048,-0.1047,0,0
3,GO P BODY ASSEMBLY,0.61497,-0.023064,-0.018746,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.95466,-0.023077,0.00022288,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.36991,-0.023133,-0.057583,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.32506,-0.023137,-0.056151,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.78962,-0.023186,-0.082528,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.29586,-0.023214,-0.038719,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.36064,-0.02324,-0.063778,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.40349,-0.023243,-0.049346,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17374,-0.023355,-0.046619,0,0
3,GO FATTY ACID TRANSPORT,0.72969,-0.023384,-0.024542,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.49227,-0.023425,-0.050692,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.49227,-0.023635,-0.021057,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38408,-0.023652,-0.068116,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049024,0,0
3,GO AMINE CATABOLIC PROCESS,0.44924,-0.024209,-0.093456,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.30402,-0.024269,-0.1025,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.27611,-0.024315,-0.054826,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.32938,-0.024508,-0.030476,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.52025,-0.024594,-0.023625,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35607,-0.024607,-0.033533,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.80989,-0.024674,-0.0090311,0,0
3,GO REGULATION OF DNA REPLICATION,0.92682,-0.02468,-0.0045385,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.65866,-0.024829,-0.01931,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.36064,-0.024879,-0.07039,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.41341,-0.024891,-0.055045,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.67137,-0.024914,-0.030866,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.30815,-0.024951,-0.031347,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.98255,-0.024992,0.01505,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35153,-0.025158,-0.071753,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.38888,-0.025203,-0.024403,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.41842,-0.025215,-0.021795,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.43367,-0.025222,-0.056351,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.78962,-0.025276,-0.01593,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.2839,-0.025285,-0.029132,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.44924,-0.025338,-0.030402,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.60272,-0.025653,-0.045093,0,0
3,GO AMINE TRANSPORT,0.99651,-0.025839,0.064469,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.98953,-0.025852,0.045742,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.53742,-0.025889,-0.011043,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99651,-0.025897,0.0025506,0,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.5726,-0.02593,-0.053479,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.11841,-0.025953,-0.040729,0,0
3,GO CELL CYCLE,0.25001,-0.025977,-0.022523,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.27227,-0.026075,-0.049069,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.24288,-0.026102,-0.018355,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.72313,-0.02615,0.0020184,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.87144,-0.026156,-0.015939,0,0
3,GO MEMBRANE DOCKING,0.20309,-0.026247,-0.029645,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.20621,-0.026289,-0.071253,0,0
3,GO RESPONSE TO RADIATION,0.65866,-0.02629,-0.0067871,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.24643,-0.026311,-0.028875,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.40349,-0.026345,-0.042672,0,0
3,GO MACROPHAGE ACTIVATION,0.84397,-0.026365,-0.024553,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.56075,-0.026375,-0.047339,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,1,-0.026387,-0.012159,0,0
3,GO T CELL MIGRATION,0.43367,-0.026446,-0.06959,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.9686,-0.026471,0.027409,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.25363,-0.026567,-0.076366,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.36064,-0.026647,-0.055413,0,0
3,GO BLEB ASSEMBLY,0.33373,-0.026684,-0.25347,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15773,-0.026729,-0.097364,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.43367,-0.026904,-0.028678,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.50337,-0.026967,-0.044751,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.36064,-0.027007,-0.033968,0,0
3,GO AXIS SPECIFICATION,0.69707,-0.027023,-0.00131,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46512,-0.027051,-0.040504,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.62732,-0.027099,-0.023682,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.87144,-0.027157,-0.0027098,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.85082,-0.02721,-0.0089129,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.17934,-0.027252,-0.048935,0,0
3,GO HOMEOSTATIC PROCESS,0.26847,-0.02729,-0.030685,0,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.027331,-0.13456,0,0
3,GO MUSCLE ATROPHY,0.51459,-0.027353,-0.093716,0,0
3,GO FACE DEVELOPMENT,0.2,-0.027398,-0.098459,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.81668,-0.02754,-0.022786,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.34256,-0.027581,-0.03578,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33373,-0.027635,-0.03034,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.67776,-0.027651,-0.017569,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.78289,-0.027837,-0.022079,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.56075,-0.027854,-0.10173,0,0
3,GO RESPONSE TO INSULIN,0.23937,-0.027872,-0.040946,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.95466,-0.027884,0.0057815,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.7495,-0.027931,-0.0022154,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.96163,-0.028046,-0.020998,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34256,-0.028056,-0.028641,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.61497,-0.028077,-0.044532,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.68418,-0.028218,-0.021905,0,0
3,GO RESPONSE TO STARVATION,0.69707,-0.028266,-0.019755,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32077,-0.028559,-0.044567,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.32938,-0.028631,-0.061288,0,0
3,GO CHROMOSOME SEGREGATION,0.4598,-0.028657,-0.022158,0,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12473,-0.028662,-0.054169,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.83713,-0.028844,-0.0091235,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.67776,-0.028846,0.028935,0,0
3,GO ORGANIC ANION TRANSPORT,0.52594,-0.028995,-0.022643,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.87144,-0.029194,-0.039638,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.69707,-0.0292,-0.0099276,0,0
3,GO CELL SUBSTRATE ADHESION,0.56666,-0.029225,-0.050192,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.88523,-0.029295,-0.023462,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.5726,-0.029314,-0.027981,0,0
3,GO OSSIFICATION,0.33373,-0.029494,-0.057957,0,0
3,GO REGULATION OF CELL DIVISION,0.25729,-0.029523,-0.04194,0,0
3,GO MUSCLE CELL PROLIFERATION,0.61497,-0.029577,-0.039756,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.43883,-0.029639,-0.064164,0,0
3,GO LEUKOCYTE HOMEOSTASIS,0.28785,-0.02964,-0.067543,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20937,-0.029771,-0.10267,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.27227,-0.029816,-0.030102,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.25729,-0.029835,-0.058054,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.25729,-0.029843,-0.056505,0,0
3,GO NIK NF KAPPAB SIGNALING,0.27227,-0.029898,-0.085049,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.059411,-0.02991,-0.065,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.070855,-0.030125,-0.036356,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.25001,-0.030207,-0.042938,0,0
3,GO MOLTING CYCLE,0.63354,-0.030221,-0.044955,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31653,-0.03029,-0.057567,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.62113,-0.030407,-0.03705,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21256,-0.030434,-0.071756,0,0
3,GO CELL JUNCTION ASSEMBLY,0.31232,-0.030441,-0.050339,0,0
3,GO STEM CELL DIVISION,0.94769,-0.03047,-0.0068845,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.4978,-0.030495,-0.053634,0,0
3,GO ACID SECRETION,0.90599,-0.030511,-0.0013233,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.77618,-0.030557,-0.010788,0,0
3,GO CELLULAR EXTRAVASATION,0.56075,-0.030612,-0.031455,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.50896,-0.030648,-0.056695,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.91987,-0.030648,-0.02002,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.40349,-0.030654,-0.052955,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.30402,-0.030756,-0.068411,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.080955,-0.030783,-0.083591,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.76948,-0.030822,-0.021881,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69707,-0.030851,-0.027205,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14526,-0.03092,-0.079507,0,0
3,GO REGULATION OF CELL AGING,0.32506,-0.030984,-0.064828,0,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.14526,-0.031013,-0.041615,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.20621,-0.031033,-0.058887,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22568,-0.031154,-0.053133,0,0
3,GO AGING,0.1028,-0.031162,-0.074528,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.54321,-0.031173,-0.040351,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.23589,-0.031365,-0.062076,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69707,-0.031397,-0.026546,0,0
3,GO HAIR FOLLICLE MATURATION,0.27611,-0.031505,-0.10466,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.095625,-0.031539,-0.052693,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.47588,-0.031565,-0.039208,0,0
3,GO SKIN MORPHOGENESIS,0.39371,-0.031647,-0.14764,0,0
3,GO SULFATE TRANSPORT,0.073629,-0.031684,-0.062673,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.69061,-0.03171,-0.032563,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.38888,-0.031726,-0.06098,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.068167,-0.031776,-0.037793,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.4545,-0.031787,-0.045034,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0695,-0.031794,-0.043171,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.44402,-0.031798,-0.036458,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65234,-0.031911,-0.028526,0,0
3,GO DNA CATABOLIC PROCESS,0.15773,-0.032259,-0.067355,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.23245,-0.032418,-0.05419,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.78962,-0.032572,-0.052148,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.03268,-0.16772,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.51459,-0.032754,-0.026166,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.22235,-0.032766,-0.090831,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24643,-0.032795,-0.071503,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.90599,-0.032901,-0.019411,0,0
3,GO SODIUM ION HOMEOSTASIS,0.27999,-0.032947,-0.046438,0,0
3,GO REGULATION OF PROTEIN BINDING,0.36064,-0.03295,-0.037602,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.89907,-0.033011,0.01014,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.22568,-0.033062,-0.068204,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.61497,-0.033134,-0.010585,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.23245,-0.033202,-0.07845,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.11039,-0.033212,-0.03158,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.60272,-0.033233,-0.022539,0,0
3,GO HISTONE H2B UBIQUITINATION,0.19095,-0.033276,-0.077911,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.36064,-0.033339,-0.15957,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.15517,-0.033368,-0.037576,0,0
3,GO DNA METHYLATION,0.59664,-0.033528,-0.014798,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.60883,-0.033558,-0.077682,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.85768,-0.03357,0.0008337,0,0
3,GO LYSOSOMAL TRANSPORT,0.32506,-0.033694,-0.053499,0,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.46512,-0.033767,-0.044268,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.32938,-0.033798,-0.055461,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.5726,-0.033834,-0.029344,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.22905,-0.033836,-0.080209,0,0
3,GO RESPONSE TO METAL ION,0.29184,-0.033855,-0.042174,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,-0.033886,-0.03698,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.89907,-0.033909,0.016014,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.69707,-0.033941,-0.029167,0,0
3,GO DETOXIFICATION,0.53167,-0.033965,-0.044965,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.48678,-0.033968,-0.067663,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,-0.034059,-0.10266,0,0
3,GO FLUID TRANSPORT,0.25363,-0.034061,-0.074638,0,0
3,GO SIGNAL RELEASE,0.65866,-0.034071,-0.0010474,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.20309,-0.034174,-0.10134,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.57857,-0.034258,-0.055949,0,0
3,GO MICROTUBULE BASED PROCESS,0.38408,-0.034271,-0.014227,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.12259,-0.034518,-0.043649,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.81668,-0.034534,0.0091153,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.62113,-0.03477,-0.047274,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.38408,-0.034804,-0.028389,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.034977,-0.0036248,0,0
3,GO CYTOSOLIC TRANSPORT,0.36526,-0.03502,-0.030797,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.51459,-0.035137,-0.030078,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.2,-0.035363,-0.031391,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.79636,-0.03559,-0.02196,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.39371,-0.035609,-0.026577,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.67776,-0.035659,-0.014561,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.43367,-0.035699,-0.042587,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.21256,-0.035736,-0.040174,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.093897,-0.035767,-0.054094,0,0
3,GO RESPONSE TO PEPTIDE,0.25729,-0.035808,-0.036664,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.22235,-0.035875,-0.065438,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.89215,-0.035892,0.015056,0,0
3,GO CIRCADIAN RHYTHM,0.24643,-0.035946,-0.029111,0,0
3,GO RESPONSE TO HYDROXYUREA,0.27999,-0.035971,-0.074191,0,0
3,GO REGULATION OF HEAT GENERATION,0.54903,-0.036122,-0.056632,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.58456,-0.036219,-0.018153,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.31653,-0.036249,-0.052113,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.55487,-0.03626,-0.098518,0,0
3,GO CELL REDOX HOMEOSTASIS,0.92682,-0.036266,-0.024957,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.54321,-0.03635,-0.019318,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.38408,-0.036384,-0.055867,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.95466,-0.03645,-0.0058813,0,0
3,GO NEURON APOPTOTIC PROCESS,0.63978,-0.036481,-0.0072482,0,0
3,GO RESPONSE TO THYROID HORMONE,0.82348,-0.036511,-0.029967,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.38408,-0.036559,-0.050379,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.72313,-0.036686,0.025592,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.13583,-0.036791,-0.10331,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.38408,-0.036805,-0.071526,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26471,-0.036864,-0.060497,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.36991,-0.036872,-0.066441,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.80989,-0.036963,-0.013388,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.14769,-0.037064,-0.045112,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.27999,-0.037255,-0.097812,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.93377,-0.03729,-0.0008696,0,0
3,GO VESICLE ORGANIZATION,0.053746,-0.037366,-0.070643,0,0
3,GO NEPHRON MORPHOGENESIS,0.20309,-0.037413,-0.073062,0,0
3,GO LIPID MODIFICATION,0.061812,-0.037429,-0.071872,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.28785,-0.037451,-0.044029,0,0
3,GO GLIAL CELL DEVELOPMENT,0.40349,-0.037506,-0.044883,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.73628,-0.037519,-0.033958,0,0
3,GO LOCOMOTOR RHYTHM,0.94073,-0.037552,0.010264,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.51459,-0.037629,-0.069764,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.12049,-0.037645,-0.032588,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.29992,-0.03767,-0.062206,0,0
3,GO RENAL SYSTEM PROCESS,0.084046,-0.037818,-0.092098,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.84397,-0.038001,-0.039616,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.2,-0.038061,-0.10665,0,0
3,GO DE NOVO PROTEIN FOLDING,0.31653,-0.038069,-0.038373,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.59664,-0.038191,-0.018397,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.53167,-0.038201,-0.051807,0,0
3,GO RESPONSE TO ACTIVITY,0.23937,-0.03821,-0.067827,0,0
3,GO CYTOKINESIS,0.046579,-0.038365,-0.070188,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54903,-0.038384,-0.041155,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.20309,-0.03839,-0.059884,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.51459,-0.038394,-0.014103,0,0
3,GO N GLYCAN PROCESSING,0.39858,-0.038396,-0.10408,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.11841,-0.038424,-0.059097,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.49227,-0.038452,-0.11563,0,0
3,GO APPENDAGE DEVELOPMENT,0.12689,-0.038465,-0.09591,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.3746,-0.038467,-0.10747,0,0
3,GO CARNITINE SHUTTLE,0.91293,-0.038579,0.013771,0,0
3,GO ORGANELLE LOCALIZATION,0.05824,-0.038687,-0.039002,0,0
3,GO TRANSFERRIN TRANSPORT,0.2839,-0.038787,-0.062721,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.084046,-0.038791,-0.06953,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.073629,-0.038847,-0.04078,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.48678,-0.038902,-0.067253,0,0
3,GO DIET INDUCED THERMOGENESIS,0.73628,-0.038937,0.06081,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29586,-0.039185,-0.04237,0,0
3,GO DNA MODIFICATION,0.17653,-0.039344,-0.043046,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.057089,-0.039424,-0.10535,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12473,-0.039426,-0.062679,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.099158,-0.03947,-0.056999,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.84397,-0.039504,0.013789,0,0
3,GO REGENERATION,0.44924,-0.039542,-0.050252,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.061812,-0.039547,-0.085658,0,0
3,GO PEROXISOMAL TRANSPORT,0.33812,-0.039597,-0.047467,0,0
3,GO REGULATION OF INSULIN SECRETION,0.91987,-0.039604,-0.00057665,0,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.22905,-0.039639,-0.047706,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59664,-0.039711,-0.031453,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.86455,-0.03972,-0.00070276,0,0
3,GO NEURON PROJECTION REGENERATION,0.89215,-0.039762,0.010796,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.84397,-0.039803,-0.0012998,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.71658,-0.039815,-0.06205,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.11039,-0.0399,-0.060889,0,0
3,GO AXIS ELONGATION,0.43883,-0.039958,-0.092542,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.27611,-0.039994,-0.057518,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.80312,-0.039999,-0.020449,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.26847,-0.04001,-0.029269,0,0
3,GO LIPID OXIDATION,0.39371,-0.040258,-0.057369,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.51459,-0.040537,-0.031294,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.20309,-0.040573,-0.078009,0,0
3,GO METANEPHROS DEVELOPMENT,0.18219,-0.040599,-0.08717,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,-0.040689,-0.083843,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.9686,-0.040872,-0.0072722,0,0
3,GO VAGINA DEVELOPMENT,0.66501,-0.040942,-0.065526,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.30402,-0.040996,-0.030411,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.74288,-0.041092,-0.053444,0,0
3,GO ANIMAL ORGAN FORMATION,0.64605,-0.041307,-0.04753,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.62113,-0.041312,-0.014243,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.070855,-0.041433,-0.062038,0,0
3,GO CHOLESTEROL STORAGE,0.55487,-0.041642,-0.043475,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.43367,-0.041695,-0.070172,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.31232,-0.041744,-0.037809,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.11841,-0.041768,-0.1354,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.41341,-0.041783,-0.041813,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.5726,-0.041792,-0.0294,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13355,-0.041859,-0.046722,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.47588,-0.04197,-0.025186,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.65234,-0.041986,-0.10079,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.98953,-0.042116,0.020262,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.12049,-0.042272,-0.079071,0,0
3,GO PEROXISOME ORGANIZATION,0.22905,-0.04234,-0.053457,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,-0.042351,-0.032161,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.042466,-0.059192,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.71658,-0.042635,0.017626,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.19695,-0.042642,-0.054506,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.96163,-0.042652,-0.013778,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.21256,-0.042748,-0.068053,0,0
3,GO OOGENESIS,0.093897,-0.042759,-0.089788,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.53167,-0.042766,-0.062195,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.53742,-0.042845,-0.027221,0,0
3,GO CD40 SIGNALING PATHWAY,0.34702,-0.042873,-0.12019,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1313,-0.04288,-0.061497,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.061812,-0.042892,-0.10529,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.61497,-0.04295,-0.0063505,0,0
3,GO REGULATION OF APPETITE,0.31232,-0.042951,-0.063649,0,0
3,GO ZINC ION HOMEOSTASIS,0.52594,-0.042958,-0.094631,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.72969,-0.043058,-0.013679,0,0
3,GO ASTROCYTE ACTIVATION,0.30402,-0.043064,-0.078155,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.38408,-0.043199,-0.024521,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29184,-0.043241,-0.051012,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.19095,-0.043286,-0.058209,0,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.064293,-0.04336,-0.054893,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.53167,-0.043416,-0.034598,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.1028,-0.043477,-0.074725,0,0
3,GO MEMBRANE ORGANIZATION,0.33812,-0.043611,-0.030583,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.082489,-0.043676,-0.056599,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.79636,-0.043696,-0.0084209,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.78289,-0.043801,-0.027243,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.36991,-0.043886,-0.054294,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16294,-0.044033,-0.045415,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.46512,-0.044044,-0.047773,0,0
3,GO REGULATION OF MITOPHAGY,0.25729,-0.044058,-0.068177,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.55487,-0.044097,-0.048412,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.56666,-0.04418,-0.033172,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.21256,-0.044222,-0.038824,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.14526,-0.044224,-0.094239,0,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.44924,-0.044239,-0.077296,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05824,-0.044253,-0.04826,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,-0.044285,-0.058075,0,0
3,GO PROTEIN POLYMERIZATION,0.42855,-0.044392,-0.022277,0,0
3,GO TOR SIGNALING,0.15517,-0.044434,-0.034649,0,0
3,GO RESPONSE TO HORMONE,0.29184,-0.044482,-0.03894,0,0
3,GO REGULATION OF SECRETION,0.17099,-0.044584,-0.046648,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.31232,-0.044735,-0.068603,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.04854,-0.044763,-0.052471,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.52025,-0.044783,-0.023919,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29586,-0.044801,-0.12579,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.78962,-0.044913,0.036864,0,0
3,GO SPINDLE ASSEMBLY,0.05824,-0.044964,-0.053659,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.41842,-0.04497,-0.073289,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.088862,-0.044973,-0.10864,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.85082,-0.045019,-0.013569,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.21905,-0.045074,-0.044078,0,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.054842,-0.045134,-0.14388,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.8303,-0.045257,-0.051683,0,0
3,GO ORGANELLE ASSEMBLY,0.0066042,-0.045259,-0.058024,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.42347,-0.045265,-0.037511,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.72969,-0.04527,-0.037436,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17099,-0.045311,-0.073217,0,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.1313,-0.045372,-0.06962,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.14769,-0.045383,-0.037579,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83713,-0.045384,-0.031136,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.94769,-0.045392,-0.018674,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.44402,-0.045482,-0.055209,0,0
3,GO RESPONSE TO KETONE,0.17099,-0.045567,-0.077068,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.69061,-0.045643,-0.045265,0,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.079444,-0.045653,-0.065112,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0695,-0.045681,-0.090317,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.045849,-0.066294,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.22568,-0.045864,-0.093317,0,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.055956,-0.046016,-0.073182,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.62113,-0.046024,0.076036,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.48678,-0.046026,-0.060973,0,0
3,GO ASTROCYTE DEVELOPMENT,0.43883,-0.046047,-0.057739,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.73628,-0.046056,-0.023494,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,-0.04608,-0.052696,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.23937,-0.046175,-0.13623,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18219,-0.046193,-0.029822,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.24643,-0.046277,-0.050009,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12259,-0.0464,-0.055246,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.60272,-0.046604,-0.025664,0,0
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.27999,-0.046728,-0.2537,0,0
3,GO BONE MINERALIZATION,0.59664,-0.046734,-0.031952,0,0
3,GO RESPONSE TO NUTRIENT,0.32938,-0.046753,-0.060608,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.29586,-0.046767,-0.05418,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.44402,-0.046786,-0.032654,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.24643,-0.046825,-0.039587,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.046875,-0.044578,0,0
3,GO RESPONSE TO PAIN,0.65866,-0.047002,-0.062546,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.077957,-0.047005,-0.087691,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.13814,-0.047021,-0.037595,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13583,-0.047041,-0.062751,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.25363,-0.047043,-0.053979,0,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.085627,-0.047119,-0.056345,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.7495,-0.047182,0.022279,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.047234,-0.072339,0,0
3,GO LIPID HOMEOSTASIS,0.18508,-0.047324,-0.072075,0,0
3,GO METAPHASE PLATE CONGRESSION,0.014138,-0.047354,-0.09609,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.54903,-0.047375,-0.017306,0,0
3,GO JNK CASCADE,0.17653,-0.047471,-0.046982,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.9686,-0.047642,0.0054404,0,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,-0.047734,-0.074036,0,0
3,GO NUCLEUS ORGANIZATION,0.066855,-0.047765,-0.048761,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.43367,-0.047786,-0.033608,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.59664,-0.047815,-0.013753,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.077957,-0.048062,-0.084675,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.25729,-0.048159,-0.055455,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.98255,-0.048185,0.0053542,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.29992,-0.048244,-0.041564,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.8303,-0.048266,-0.017858,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.15015,-0.048332,-0.12801,0,0
3,GO GLUCOSE IMPORT,0.25363,-0.048497,-0.047554,0,0
3,GO PENILE ERECTION,0.74288,-0.048522,-0.028242,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.12049,-0.048531,-0.082053,0,0
3,GO VACUOLAR ACIDIFICATION,0.16294,-0.048637,-0.11439,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.18219,-0.048821,-0.045107,0,0
3,GO MANGANESE ION TRANSPORT,0.72313,-0.048862,-0.010146,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.21905,-0.048885,-0.066053,0,0
3,GO HISTONE H3 ACETYLATION,0.13583,-0.048885,-0.042872,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.092194,-0.049001,-0.069983,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.3746,-0.049032,-0.15971,0,0
3,GO RESPONSE TO TUMOR CELL,0.26098,-0.049036,-0.1034,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.64605,-0.049193,-0.053361,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.11039,-0.049196,-0.049893,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.82348,-0.049413,-0.061782,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.26847,-0.049473,-0.043069,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.060602,-0.049595,-0.054655,0,0
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.22905,-0.049611,-0.14107,0,0
3,GO INTEGRIN ACTIVATION,0.35153,-0.049632,-0.079514,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.83713,-0.049665,0.00089528,0,0
3,GO MEMBRANE INVAGINATION,0.20937,-0.049668,-0.072821,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15517,-0.049676,-0.13311,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.10096,-0.049693,-0.16087,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.43883,-0.04979,-0.039119,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22568,-0.049796,-0.044982,0,0
3,GO SINGLE FERTILIZATION,0.090515,-0.049836,-0.05013,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.1313,-0.04992,-0.059113,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.049942,-0.013333,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.075049,-0.049967,-0.085534,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.44402,-0.049996,-0.022489,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.7495,-0.050075,-0.022681,0,0
3,GO BIOLOGICAL ADHESION,0.13355,-0.050117,-0.073472,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23589,-0.050222,-0.094412,0,0
3,GO LYMPHOCYTE MIGRATION,0.24288,-0.050246,-0.078135,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21905,-0.050306,-0.091423,0,0
3,GO ARACHIDONIC ACID SECRETION,0.26847,-0.050416,-0.084436,0,0
3,GO REGIONALIZATION,0.29992,-0.050447,-0.039031,0,0
3,GO KINETOCHORE ORGANIZATION,0.41341,-0.050601,-0.055677,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.053746,-0.050618,-0.10607,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.20937,-0.050746,-0.1183,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.70355,-0.050754,-0.029724,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.004387,0,0
3,GO RESPONSE TO ALKALOID,0.33373,-0.050782,-0.045193,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.17653,-0.050807,-0.069296,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.26471,-0.05083,-0.039678,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.12689,-0.050997,-0.040191,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.99651,-0.051017,-0.015055,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11434,-0.051027,-0.046379,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.91987,-0.051057,-0.0029276,0,0
3,GO STRESS FIBER ASSEMBLY,0.40349,-0.051068,-0.051594,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.32077,-0.051105,-0.056605,0,0
3,GO REGULATION OF TUBE SIZE,0.19393,-0.051248,-0.067098,0,0
3,GO CELL CYCLE CHECKPOINT,0.082489,-0.05134,-0.045361,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.19393,-0.051372,-0.079947,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.28785,-0.051375,-0.076763,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.50337,-0.051386,-0.034784,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.14526,-0.051479,-0.072734,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48678,-0.05157,-0.073262,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25729,-0.051725,-0.090823,0,0
3,GO PIGMENTATION,0.12908,-0.051755,-0.068555,0,0
3,GO OVULATION,0.44402,-0.051842,-0.081234,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.20309,-0.05186,-0.10054,0,0
3,GO RESPONSE TO CHEMOKINE,0.54903,-0.051865,-0.045098,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.093897,-0.051995,-0.11452,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.24643,-0.052098,-0.041733,0,0
3,GO REGULATION OF CELL DEATH,0.079444,-0.052102,-0.059277,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.15517,-0.052159,-0.046643,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.33373,-0.052205,-0.060209,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.35153,-0.052596,-0.088513,0,0
3,GO RESPONSE TO VITAMIN,0.55487,-0.052661,-0.045344,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.54321,-0.052702,-0.047104,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.3746,-0.052811,-0.037548,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.71006,-0.052823,-0.083316,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.17374,-0.052919,-0.042604,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.75615,-0.053214,-0.024949,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.13583,-0.053266,-0.066299,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.38888,-0.0533,-0.023923,0,0
3,GO PHAGOCYTOSIS,0.2839,-0.053521,-0.068683,0,0
3,GO NEGATIVE REGULATION OF SECRETION,0.12473,-0.053615,-0.055788,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.46512,-0.053724,-0.024273,0,0
3,GO ATP TRANSPORT,0.89907,-0.053776,0.0065594,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.52594,-0.053879,-0.040107,0,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.10096,-0.053887,-0.04293,0,0
3,GO EMBRYO DEVELOPMENT,0.1028,-0.053924,-0.053059,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.22235,-0.053968,-0.061382,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.27227,-0.054029,-0.073494,0,0
3,GO THYMIC T CELL SELECTION,0.20309,-0.054055,-0.050215,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.27999,-0.054061,-0.15296,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.5726,-0.05411,-0.066397,0,0
3,GO SYMBIOTIC PROCESS,0.087232,-0.054117,-0.079782,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.20309,-0.054237,-0.035746,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.093897,-0.054293,-0.060521,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.63354,-0.054364,-0.021443,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43367,-0.054601,-0.011595,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11039,-0.054657,-0.054942,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077944,0,0
3,GO MESENCHYME MORPHOGENESIS,0.092194,-0.054741,-0.13341,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.48131,-0.054777,-0.025516,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.43367,-0.054815,-0.060493,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.32938,-0.054824,-0.034578,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.2,-0.05483,-0.098465,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,-0.055013,-0.013454,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.2,-0.055256,-0.055429,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.076492,-0.055397,-0.065251,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.39858,-0.055449,-0.042461,0,0
3,GO PRE MIRNA PROCESSING,0.51459,-0.055494,-0.034901,0,0
3,GO SELECTIVE AUTOPHAGY,0.19695,-0.055543,-0.07192,0,0
3,GO APOPTOTIC PROCESS,0.1028,-0.055601,-0.054798,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.41842,-0.055681,-0.052568,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.25001,-0.055796,-0.043774,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.14769,-0.055822,-0.076351,0,0
3,GO DEMETHYLATION,0.088862,-0.055835,-0.051845,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.47588,-0.05587,-0.023843,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.2839,-0.056102,-0.05852,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.10654,-0.056109,-0.057024,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13355,-0.056217,-0.044563,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.53742,-0.056224,0.12115,0,0
3,GO MALE GAMETE GENERATION,0.0045306,-0.056225,-0.08556,0,0
3,GO CELL CELL RECOGNITION,0.11841,-0.056289,-0.073026,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.93377,-0.056476,-0.015392,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.34702,-0.05653,-0.031693,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.43367,-0.056572,-0.024253,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14048,-0.056629,-0.12413,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74288,-0.056701,-0.022079,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.38408,-0.056713,-0.047228,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.22235,-0.056787,-0.051562,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.60272,-0.057025,-0.0053905,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16032,-0.05722,-0.075605,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.12259,-0.057266,-0.061562,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.32506,-0.057299,-0.06991,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.065563,-0.05744,-0.13976,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.43367,-0.057444,-0.057828,0,0
3,GO RESPONSE TO TESTOSTERONE,0.4598,-0.057452,-0.053363,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.33812,-0.057477,-0.081057,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.11039,-0.057543,-0.13967,0,0
3,GO PROTEIN MANNOSYLATION,0.69707,-0.057564,-0.020375,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.16828,-0.05759,-0.040918,0,0
3,GO HISTONE H4 ACETYLATION,0.087232,-0.057684,-0.047474,0,0
3,GO SENSORY PERCEPTION,0.11841,-0.057936,-0.04304,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.32077,-0.058163,-0.063558,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.12908,-0.058167,-0.06074,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.30402,-0.058198,-0.055448,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.38408,-0.058241,-0.092118,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.042857,-0.058243,-0.13615,0,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.077957,-0.058284,-0.05069,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.49227,-0.058314,-0.050802,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.18219,-0.058361,-0.082675,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.91987,-0.058464,0.0099453,0,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.15517,-0.058631,-0.077146,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.31653,-0.05865,-0.095502,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.059411,-0.058702,-0.086829,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.11434,-0.058703,-0.11516,0,0
3,GO GLYCOSYLATION,0.15517,-0.058708,-0.07068,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32077,-0.058723,-0.035755,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.16828,-0.058764,-0.069985,0,0
3,GO FATTY ACID BETA OXIDATION,0.32077,-0.058862,-0.064597,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.085627,-0.059026,-0.091971,0,0
3,GO CAMP BIOSYNTHETIC PROCESS,0.36064,-0.059118,-0.096058,0,0
3,GO NEURONAL ACTION POTENTIAL,0.25001,-0.059138,-0.076407,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.76948,-0.059148,-0.0038809,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.19095,-0.05917,-0.1236,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.35607,-0.059229,-0.048949,0,0
3,GO TONGUE DEVELOPMENT,0.41341,-0.059263,-0.085089,0,0
3,GO GOLGI RIBBON FORMATION,0.38888,-0.059418,-0.062741,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.059444,-0.068701,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.24643,-0.059615,-0.15713,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12049,-0.059713,-0.082747,0,0
3,GO RESPONSE TO FUNGUS,0.30815,-0.059877,-0.047315,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.18219,-0.05992,-0.097341,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.095625,-0.059945,-0.069165,0,0
3,GO T CELL CHEMOTAXIS,0.12049,-0.059949,-0.082357,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.98953,-0.059995,0.029895,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.23937,-0.060031,-0.081232,0,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.059411,-0.060173,-0.10032,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.26098,-0.06027,-0.040523,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.12473,-0.060364,-0.082909,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.13583,-0.06039,-0.067139,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.20309,-0.0604,-0.10067,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.12259,-0.060446,-0.085593,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.36991,-0.060454,-0.041694,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.92682,-0.060632,0.0018042,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.12908,-0.060711,-0.11151,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.14048,-0.060887,-0.052195,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.17653,-0.060934,-0.11468,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.44402,-0.061,-0.041059,0,0
3,GO APPENDAGE MORPHOGENESIS,0.15773,-0.061007,-0.10467,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.53742,-0.061014,-0.037754,0,0
3,GO SEX DIFFERENTIATION,0.11636,-0.061016,-0.050249,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,-0.061072,-0.057507,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.36991,-0.061221,-0.056979,0,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.082489,-0.061364,-0.077825,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.2,-0.061378,-0.1525,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.25729,-0.061488,-0.067297,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.63978,-0.061547,-0.025898,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.15517,-0.061581,-0.11519,0,0
3,GO REGULATION OF TOR SIGNALING,0.15015,-0.061624,-0.047396,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11841,-0.0617,-0.068346,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.25001,-0.061778,-0.080982,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.24288,-0.061829,-0.1638,0,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.059411,-0.061852,-0.081493,0,0
3,GO RENAL FILTRATION,0.55487,-0.061867,-0.041388,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.33812,-0.06193,-0.0471,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.51459,-0.062005,-0.030543,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.16294,-0.062178,-0.10012,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.22235,-0.062194,-0.090051,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.16559,-0.062198,-0.044743,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.80312,-0.062241,-0.021675,0,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.045624,-0.0624,-0.12938,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.44402,-0.062587,-0.02347,0,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.053746,-0.062759,-0.071512,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.33373,-0.062824,-0.10819,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.19695,-0.062861,-0.070382,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.019739,-0.062998,-0.085776,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.32077,-0.063034,-0.033723,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.35153,-0.063039,-0.069863,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.15015,-0.063307,-0.057595,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.1028,-0.063568,-0.11919,0,0
3,GO OOCYTE MATURATION,0.66501,-0.063675,-0.020409,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.065563,-0.063757,-0.063544,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.13583,-0.0638,-0.086583,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.25001,-0.063803,-0.094649,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.85768,-0.063809,0.0040887,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36064,-0.063845,-0.049305,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.23589,-0.063872,-0.10514,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.70355,-0.064012,-0.031214,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.14048,-0.06404,-0.070882,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13583,-0.064134,-0.12509,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.27611,-0.064153,-0.061548,0,0
3,GO REGULATION OF CELL MATURATION,0.087232,-0.064441,-0.072833,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.55487,-0.064485,0.094908,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.066855,-0.06483,-0.10504,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.18219,-0.064888,-0.10029,0,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.053746,-0.064966,-0.079914,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.43367,-0.065007,-0.031353,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.18219,-0.065068,-0.11325,0,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.060602,-0.065325,-0.070494,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.16294,-0.065333,-0.050958,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.065418,-0.049418,0,0
3,GO PRIMARY MIRNA PROCESSING,0.48131,-0.065474,-0.048068,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.52594,-0.065615,-0.050706,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,-0.065623,-0.042442,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.14048,-0.065695,-0.089292,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.76948,-0.065715,0.0055686,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18219,-0.065767,-0.079642,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.11434,-0.065784,-0.15275,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.068167,-0.065843,-0.055671,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.088862,-0.066178,-0.098585,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.059411,-0.066245,-0.086528,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.12259,-0.066303,-0.10011,0,0
3,GO REGULATION OF ANION TRANSPORT,0.092194,-0.066316,-0.072435,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.24643,-0.066361,-0.08214,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.22568,-0.06646,-0.10443,0,0
3,GO EPIBOLY,0.29184,-0.066593,-0.129,0,0
3,GO EATING BEHAVIOR,0.21905,-0.066676,-0.069817,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.69061,-0.06671,0.0053828,0,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.061812,-0.066742,-0.086157,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.05824,-0.066789,-0.083841,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.65866,-0.066992,-0.020116,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.12049,-0.06706,-0.076101,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59664,-0.067076,-0.059338,0,0
3,GO VITAMIN METABOLIC PROCESS,0.98255,-0.067183,0.0024998,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.74288,-0.067271,-0.035863,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.78289,-0.067299,-0.0081928,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.082489,-0.067305,-0.089652,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.4598,-0.067345,-0.088499,0,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.095625,-0.067411,-0.069622,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.095625,-0.067649,-0.063693,0,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.10845,-0.067715,-0.05579,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.4545,-0.06773,-0.059121,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.064293,-0.067756,-0.080653,0,0
3,GO HISTONE H2A ACETYLATION,0.22235,-0.067757,-0.061376,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.16559,-0.067791,-0.08264,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.81668,-0.067959,0.006514,0,0
3,GO REGULATION OF MAPK CASCADE,0.21256,-0.068029,-0.055321,0,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.097379,-0.068033,-0.14833,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.4598,-0.068115,-0.19913,0,0
3,GO STEROID HORMONE SECRETION,0.25001,-0.068121,-0.099478,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.39858,-0.068122,-0.048999,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.25363,-0.068167,-0.091611,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27611,-0.068202,-0.070329,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94769,-0.06822,0.063735,0,0
3,GO STEROID CATABOLIC PROCESS,0.4545,-0.068223,-0.067968,0,0
3,GO LIPID METABOLIC PROCESS,0.082489,-0.06838,-0.061218,0,0
3,GO BONE MATURATION,0.39371,-0.068413,-0.070685,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.10465,-0.068465,-0.090477,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.17653,-0.068646,-0.067613,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.38888,-0.068737,-0.15186,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.24643,-0.068763,-0.17683,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11636,-0.068841,-0.13751,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11039,-0.068864,-0.084924,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.15773,-0.068878,-0.087709,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.49227,-0.069196,-0.09461,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.25729,-0.069239,-0.044835,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44924,-0.069307,-0.059768,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.32938,-0.069376,-0.083875,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.14048,-0.069387,-0.10439,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.10845,-0.069552,-0.097558,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063042,-0.069572,-0.07148,0,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.055956,-0.069583,-0.079324,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14285,-0.06961,-0.12077,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.52025,-0.069614,-0.072431,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.65866,-0.069665,-0.029161,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.42347,-0.069711,-0.12189,0,0
3,GO STEM CELL PROLIFERATION,0.085627,-0.069873,-0.088511,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.49227,-0.069902,-0.047194,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.14048,-0.069984,-0.069522,0,0
3,GO RESPONSE TO EPINEPHRINE,1,-0.070059,0.0084342,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.36526,-0.070127,-0.11902,0,0
3,GO L PHENYLALANINE METABOLIC PROCESS,0.34256,-0.070147,-0.16427,0,0
3,GO RESPONSE TO SALT STRESS,0.17099,-0.070179,-0.097227,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.55487,-0.07019,-0.051358,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.32077,-0.070281,-0.075533,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.070396,-0.15765,0,0
3,GO OOCYTE DIFFERENTIATION,0.088862,-0.070457,-0.11075,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23589,-0.070469,-0.048612,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.077957,-0.070546,-0.10172,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.076492,-0.070944,-0.075557,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.52025,-0.071008,-0.14249,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.18508,-0.071112,-0.073072,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12473,-0.071121,-0.13684,0,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.088862,-0.07116,-0.081142,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.26471,-0.071183,-0.050459,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.41842,-0.07124,-0.038872,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.34702,-0.071327,-0.081445,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.66501,-0.071361,-0.014335,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19393,-0.071443,-0.10888,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.12908,-0.071506,-0.057411,0,0
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.16032,-0.071682,-0.19393,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.20309,-0.071726,-0.19148,0,0
3,GO RESPONSE TO STEROID HORMONE,0.090515,-0.071862,-0.082773,0,0
3,GO REGULATION OF ERAD PATHWAY,0.11039,-0.072218,-0.056497,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.088862,-0.072555,-0.076916,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.079444,-0.072652,-0.096508,0,0
3,GO CELL MATURATION,0.095625,-0.072739,-0.059033,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.26098,-0.072774,-0.040754,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.22905,-0.072841,-0.10171,0,0
3,GO FEMALE GAMETE GENERATION,0.05824,-0.072977,-0.071017,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.073112,-0.063294,0,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.11636,-0.073163,-0.12615,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.38888,-0.073195,-0.069182,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.42855,-0.073636,-0.063622,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.31232,-0.073693,-0.086789,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.19695,-0.073724,-0.14012,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.084046,-0.073751,-0.072273,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.059411,-0.073851,-0.076544,0,0
3,GO REGULATION OF HORMONE SECRETION,0.17653,-0.074032,-0.05161,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.13583,-0.074207,-0.10346,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.19695,-0.074241,-0.085051,0,0
3,GO SPERM EGG RECOGNITION,0.14526,-0.07425,-0.060326,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.015203,-0.074726,-0.069842,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25729,-0.074747,-0.10372,0,0
3,GO FUCOSE METABOLIC PROCESS,0.33812,-0.074971,-0.086857,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.082489,-0.075002,-0.073294,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27999,-0.075064,-0.074805,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.29586,-0.075212,-0.11366,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.075306,-0.11015,0,0
3,GO SPERM MOTILITY,0.012203,-0.075329,-0.091459,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.16559,-0.075576,-0.098151,0,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.077957,-0.075608,-0.077803,0,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.42347,-0.075615,-0.030029,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.095625,-0.075639,-0.089565,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.076492,-0.075751,-0.2086,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.10096,-0.075787,-0.081429,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.34256,-0.075824,-0.063825,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.66501,-0.075893,-0.013919,0,0
3,GO HISTONE H3 DEACETYLATION,0.16294,-0.076023,-0.060796,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.068167,-0.07605,-0.079694,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.27227,-0.076241,-0.12255,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.188,-0.076252,-0.099063,0,0
3,GO OXALATE TRANSPORT,0.18508,-0.076339,-0.070137,0,0
3,GO STEROL METABOLIC PROCESS,0.36991,-0.076559,-0.044179,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.28785,-0.076608,-0.048475,0,0
3,GO GOLGI VESICLE TRANSPORT,0.064293,-0.076635,-0.067156,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.12259,-0.076699,-0.13211,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.14285,-0.076791,-0.075534,0,0
3,GO PEPTIDE HORMONE SECRETION,0.53167,-0.077103,-0.0186,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.25363,-0.077124,-0.059487,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,-0.077268,-0.064251,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.077274,-0.06012,0,0
3,GO KIDNEY MORPHOGENESIS,0.054842,-0.077294,-0.10155,0,0
3,GO RESPONSE TO LIPID,0.13355,-0.077308,-0.066226,0,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070855,-0.077435,-0.099518,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031059,-0.07751,-0.091504,0,0
3,GO RESPONSE TO VITAMIN D,0.80989,-0.077594,0.039877,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.53167,-0.077645,-0.031668,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40349,-0.077647,-0.11588,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.19095,-0.077662,-0.098862,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.084046,-0.077666,-0.067344,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.16294,-0.077716,-0.099133,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.21905,-0.077791,-0.1154,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63354,-0.07786,0.021852,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.16559,-0.077919,-0.073781,0,0
3,GO NEUTROPHIL MIGRATION,0.082489,-0.078095,-0.096768,0,0
3,GO CELL AGING,0.061812,-0.078269,-0.080006,0,0
3,GO ARTERY MORPHOGENESIS,0.11039,-0.078324,-0.10161,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.1313,-0.078506,-0.057484,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.093897,-0.078605,-0.17566,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21579,-0.078614,-0.08538,0,0
3,GO REGULATION OF HORMONE LEVELS,0.095625,-0.078628,-0.068587,0,0
3,GO DEVELOPMENTAL INDUCTION,0.17099,-0.078658,-0.1118,0,0
3,GO REGULATION OF OSSIFICATION,0.12049,-0.078785,-0.0924,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.10845,-0.07879,-0.13168,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15517,-0.078833,-0.093369,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077957,-0.078852,-0.08791,0,0
3,GO FOREBRAIN MORPHOGENESIS,0.82348,-0.078887,-0.0056324,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.17653,-0.078912,-0.081512,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.087232,-0.079113,-0.065285,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.13814,-0.079144,-0.091213,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.072231,-0.079169,-0.082162,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.39858,-0.079174,-0.063072,0,0
3,GO INCLUSION BODY ASSEMBLY,0.89907,-0.079179,0.033338,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.082489,-0.079539,-0.095341,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.62732,-0.079689,-0.12377,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.17653,-0.079723,-0.071325,0,0
3,GO STEROID ESTERIFICATION,0.11434,-0.079851,-0.19435,0,0
3,GO EMBRYO IMPLANTATION,0.24643,-0.079902,-0.10811,0,0
3,GO CENTRIOLE ASSEMBLY,0.13814,-0.079905,-0.068935,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10096,-0.079933,-0.089764,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.15517,-0.079957,-0.097999,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.66501,-0.079977,-0.12878,0,0
3,GO PHOSPHOLIPID EFFLUX,0.21905,-0.080125,-0.1366,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.088862,-0.080256,-0.13641,0,0
3,GO HORMONE TRANSPORT,0.19695,-0.080339,-0.05185,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32938,-0.080418,-0.079,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.21256,-0.08045,-0.092696,0,0
3,GO KERATINOCYTE MIGRATION,0.61497,-0.08049,-0.039674,0,0
3,GO AMINE METABOLIC PROCESS,0.12049,-0.080577,-0.079885,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.60883,-0.080587,-0.0053089,0,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,-0.08078,-0.068347,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14285,-0.08084,-0.24794,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.17934,-0.080883,-0.082861,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.38888,-0.081216,-0.039415,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.89907,-0.08135,0.012913,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0021062,-0.081483,-0.10326,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.79636,-0.081497,-0.014733,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.36064,-0.081499,-0.088131,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.46512,-0.081511,-0.043248,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.21905,-0.081737,-0.10744,0,0
3,GO MALE MEIOSIS I,0.14526,-0.081746,-0.16335,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.0018173,-0.081769,-0.08676,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.27999,-0.081823,-0.079765,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36991,-0.081949,-0.11858,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.11039,-0.081967,-0.073009,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.17934,-0.082008,-0.068604,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.98953,-0.082031,0.0090464,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.057089,-0.082351,-0.1822,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.12908,-0.082473,-0.10733,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.11636,-0.082782,-0.07921,0,0
3,GO REGULATION OF LIPID STORAGE,0.087232,-0.082949,-0.091851,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.14526,-0.082951,-0.092192,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21579,-0.082956,-0.10327,0,0
3,GO ERYTHROCYTE MATURATION,0.12049,-0.08344,-0.088107,0,0
3,GO PROTEIN DEGLYCOSYLATION,0.11039,-0.08417,-0.14361,0,0
3,GO REGULATION OF HAIR CYCLE,0.20937,-0.084269,-0.10289,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.20937,-0.084536,-0.056248,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.39858,-0.084864,-0.049769,0,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.12473,-0.0849,-0.10945,0,0
3,GO GASTRIC ACID SECRETION,0.60883,-0.08499,-0.037888,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.20309,-0.085085,-0.06729,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.55487,-0.085163,-0.041185,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.10654,-0.085236,-0.081822,0,0
3,GO B CELL HOMEOSTASIS,0.32506,-0.085482,-0.0654,0,0
3,GO P38MAPK CASCADE,0.095625,-0.085628,-0.11232,0,0
3,GO INNER EAR MORPHOGENESIS,0.055956,-0.085652,-0.10908,0,0
3,GO CILIUM MOVEMENT,0.0020453,-0.085741,-0.127,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.18508,-0.085753,-0.10198,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.076492,-0.086105,-0.076304,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.36064,-0.086299,-0.092187,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.29586,-0.086473,-0.083811,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.082489,-0.086596,-0.067863,0,0
3,GO TEMPERATURE HOMEOSTASIS,0.087232,-0.086657,-0.064314,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25363,-0.086693,-0.11179,0,0
3,GO INOSITOL METABOLIC PROCESS,0.060602,-0.086994,-0.11438,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.13814,-0.087059,-0.083389,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.059411,-0.0872,-0.13205,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.67776,-0.087223,-0.074606,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.092194,-0.087339,-0.18318,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.13814,-0.087407,-0.19943,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.057089,-0.087547,-0.16547,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.68418,-0.087736,-0.044953,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.080955,-0.087739,-0.094854,0,0
3,GO ACTIN CROSSLINK FORMATION,0.87144,-0.087869,0.077755,0,0
3,GO STEROL HOMEOSTASIS,0.20621,-0.088167,-0.089323,0,0
3,GO TISSUE REGENERATION,0.1028,-0.088299,-0.11001,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.13814,-0.088552,-0.066869,0,0
3,GO CELLULAR SENESCENCE,0.017549,-0.088653,-0.11054,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.13583,-0.088655,-0.096032,0,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10096,-0.088765,-0.076278,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.095625,-0.088786,-0.10801,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13355,-0.088807,-0.1344,0,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.072231,-0.089101,-0.11879,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16559,-0.089316,-0.093759,0,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.053746,-0.089326,-0.087658,0,0
3,GO POSITIVE CHEMOTAXIS,0.068167,-0.089478,-0.12492,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.15015,-0.089579,-0.11969,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.28785,-0.089763,-0.11846,0,0
3,GO RNA DESTABILIZATION,0.087232,-0.090047,-0.076442,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.91987,-0.090175,-0.0011283,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.87144,-0.090279,-0.050626,0,0
3,GO FUCOSYLATION,0.42347,-0.090311,-0.05878,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.12473,-0.090507,-0.078158,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,-0.090544,-0.089967,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.26098,-0.09056,-0.093363,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.084046,-0.09068,-0.10219,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21256,-0.090789,-0.040896,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.89907,-0.090943,-0.0083277,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.087232,-0.091064,-0.091989,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.0087944,-0.091301,-0.11058,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.054842,-0.091353,-0.054921,0,0
3,GO INSULIN SECRETION,0.41842,-0.091501,-0.034162,0,0
3,GO MEIOTIC CELL CYCLE,0.00037661,-0.091734,-0.09741,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.072231,-0.091962,-0.18076,0,0
3,GO MACROPHAGE PROLIFERATION,0.43883,-0.091977,-0.11518,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.073629,-0.092056,-0.086216,0,0
3,GO LUNG MORPHOGENESIS,0.072231,-0.092227,-0.14341,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.015203,-0.092248,-0.10601,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.21256,-0.092277,-0.063994,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.095625,-0.092371,-0.060268,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.12908,-0.092676,-0.074987,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.063042,-0.0929,-0.13949,0,0
3,GO RNA DECAPPING,0.063042,-0.093165,-0.084048,0,0
3,GO RESPONSE TO FOOD,0.064293,-0.093167,-0.092211,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.12689,-0.093304,-0.11504,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.38408,-0.093305,-0.080008,0,0
3,GO PHAGOSOME MATURATION,0.14526,-0.093437,-0.085654,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.14285,-0.093568,-0.094321,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.10096,-0.093605,-0.091261,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.48678,-0.093985,-0.065317,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.12049,-0.094103,-0.18566,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.09437,-0.026685,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.080955,-0.094409,-0.083872,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.21905,-0.094589,-0.086714,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.094642,-0.11428,0,0
3,GO KINETOCHORE ASSEMBLY,0.57857,-0.094721,-0.053244,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.15264,-0.095036,-0.13654,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.090515,-0.095162,-0.13351,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.44402,-0.095188,-0.03795,0,0
3,GO STEROID METABOLIC PROCESS,0.079444,-0.095191,-0.083801,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.099158,-0.095222,-0.11135,0,0
3,GO PROTEIN REFOLDING,0.29586,-0.09544,-0.053965,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.99651,-0.095512,-0.06923,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.18508,-0.095779,-0.12623,0,0
3,GO MITOCHONDRIAL FUSION,0.031748,-0.0959,-0.098395,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30402,-0.096014,-0.34622,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16294,-0.096559,-0.099548,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.44402,-0.09674,-0.097956,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.23937,-0.097144,-0.072208,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.20309,-0.097336,-0.073089,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.070855,-0.097522,-0.078017,0,0
3,GO CYTOPLASM ORGANIZATION,0.084046,-0.097634,-0.12684,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.64605,-0.097792,-0.053434,0,0
3,GO GENITALIA DEVELOPMENT,0.031748,-0.097801,-0.11878,0,0
3,GO RENAL WATER HOMEOSTASIS,0.13355,-0.097948,-0.091902,0,0
3,GO ECTODERM DEVELOPMENT,0.015574,-0.09795,-0.11081,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.15264,-0.09813,-0.10051,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.81668,-0.098187,0.018086,0,0
3,GO SPROUTING ANGIOGENESIS,0.073629,-0.098418,-0.10615,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.054842,-0.098654,-0.13863,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.19695,-0.098759,-0.10064,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.001986,-0.098769,-0.11462,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.5726,-0.098813,-0.040628,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.12473,-0.098825,-0.1131,0,0
3,GO MESODERM MORPHOGENESIS,0.077957,-0.098903,-0.11643,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.060602,-0.099032,-0.18398,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.080955,-0.099088,-0.11472,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.47588,-0.09924,-0.057015,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.23937,-0.099259,-0.062738,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.26098,-0.099356,-0.063304,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.25363,-0.099511,-0.10718,0,0
3,GO T CELL APOPTOTIC PROCESS,0.084046,-0.099884,-0.11709,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.12259,-0.099893,-0.08762,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.62732,-0.10003,-0.082911,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.085627,-0.10012,-0.096106,0,0
3,GO HEART INDUCTION,0.36064,-0.10018,-0.082211,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0023671,-0.1002,-0.15959,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.4978,-0.10032,-0.068885,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.33812,-0.10033,-0.061251,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.072231,-0.10036,-0.1479,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.32938,-0.10056,-0.14047,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.097379,-0.10059,-0.072517,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.64605,-0.10088,-0.066347,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.20309,-0.10109,-0.14733,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.092194,-0.10111,-0.078679,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.60883,-0.10114,-0.049575,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.34256,-0.10131,-0.11721,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.46512,-0.10141,-0.083864,0,0
3,GO NOTOCHORD DEVELOPMENT,0.39371,-0.10143,-0.12899,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.11434,-0.10143,-0.12999,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00050664,-0.1016,-0.097924,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.11636,-0.1018,-0.11731,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.15773,-0.10298,-0.10393,0,0
3,GO GOLGI LOCALIZATION,0.095625,-0.10299,-0.088866,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.35607,-0.10336,-0.057254,0,0
3,GO RESPONSE TO COLD,0.090515,-0.10342,-0.13864,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20621,-0.10359,-0.083018,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.34256,-0.10408,-0.054531,0,0
3,GO SULFATION,0.11235,-0.10413,-0.13199,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16828,-0.10432,-0.20675,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.23937,-0.10438,-0.14381,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.10845,-0.10455,-0.077879,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.041093,-0.10467,-0.12192,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.85768,-0.10474,-0.010847,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,-0.10487,-0.049168,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.05824,-0.10505,-0.15867,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.0060989,-0.10518,-0.13486,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.47049,-0.10567,-0.069096,0,0
3,GO PANCREATIC JUICE SECRETION,0.24288,-0.10591,-0.073648,0,0
3,GO RESPONSE TO ESTRADIOL,0.093897,-0.10593,-0.083027,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.55487,-0.10596,-0.081441,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.40843,-0.10605,-0.070457,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.22235,-0.10614,-0.084726,0,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.12049,-0.1064,-0.078279,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.1313,-0.1066,-0.088014,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.7495,-0.10672,-0.023395,0,0
3,GO SPERMATID DIFFERENTIATION,0.0087944,-0.1071,-0.10775,0,0
3,GO SEX DETERMINATION,0.033894,-0.10741,-0.13898,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.092194,-0.10818,-0.10951,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.25363,-0.10856,-0.05197,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.38408,-0.10867,-0.090366,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.27227,-0.10892,-0.076187,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.097379,-0.10894,-0.1109,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.24643,-0.1092,-0.076207,0,0
3,GO MRNA TRANSCRIPTION,0.25363,-0.10935,-0.072209,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.41341,-0.10941,-0.042975,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.053746,-0.10949,-0.15808,0,0
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.63978,-0.10983,-0.14513,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.016734,-0.11011,-0.10868,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.082489,-0.11013,-0.081344,0,0
3,GO FAT CELL PROLIFERATION,0.26098,-0.11081,-0.081584,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.16828,-0.11097,-0.14394,0,0
3,GO REPLACEMENT OSSIFICATION,0.035393,-0.11165,-0.16091,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.072231,-0.11222,-0.16981,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.75615,-0.11251,-0.048589,0,0
3,GO KETONE CATABOLIC PROCESS,0.070855,-0.11282,-0.1894,0,0
3,GO RESPONSE TO INSECTICIDE,0.80989,-0.11311,-0.013078,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.079444,-0.11333,-0.084827,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.12049,-0.1136,-0.28901,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.068167,-0.11386,-0.18963,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.031748,-0.11388,-0.22195,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.47588,-0.11402,-0.045653,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.21579,-0.1141,-0.11565,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.099158,-0.11447,-0.17675,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.91293,-0.11454,0.022408,0,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.12259,-0.11456,-0.16197,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.0085714,-0.1146,-0.11829,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.060602,-0.11507,-0.16772,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.14285,-0.11514,-0.10287,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.072231,-0.11557,-0.12803,0,0
3,GO MYOTUBE DIFFERENTIATION,0.10096,-0.11618,-0.088465,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.11621,-0.17828,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23937,-0.11666,-0.12927,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.042857,-0.11675,-0.12906,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.088862,-0.11691,-0.12826,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.25001,-0.11722,-0.16384,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.2,-0.11725,-0.11246,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.092194,-0.11832,-0.1604,0,0
3,GO NEURON FATE COMMITMENT,0.41341,-0.11835,-0.040205,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15015,-0.11851,-0.15717,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.095625,-0.11896,-0.12616,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.17934,-0.11901,-0.068565,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090515,-0.11902,-0.13531,0,0
3,GO HORMONE METABOLIC PROCESS,0.11434,-0.1193,-0.098397,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.72313,-0.11935,-0.041044,0,0
3,GO STEROL IMPORT,0.34702,-0.11938,-0.055777,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.085627,-0.11962,-0.18799,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.25729,-0.11971,-0.079686,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.054842,-0.11977,-0.10854,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.27611,-0.12024,-0.076403,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.016339,-0.12098,-0.13489,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.087232,-0.12111,-0.15455,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.11434,-0.12172,-0.08329,0,0
3,GO HEART FORMATION,0.25001,-0.12187,-0.08206,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.41842,-0.12194,-0.056898,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.085627,-0.12254,-0.10509,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.33373,-0.12264,-0.19267,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.36064,-0.12265,-0.09638,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.16828,-0.12326,-0.14239,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.25001,-0.12327,-0.12467,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.082489,-0.12343,-0.094469,0,0
3,GO BONE CELL DEVELOPMENT,0.021165,-0.12346,-0.13918,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.15015,-0.12357,-0.10189,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.63354,-0.12361,-0.079345,0,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.22568,-0.12369,-0.10727,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.35153,-0.12382,-0.085274,0,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.084046,-0.12411,-0.18517,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,-0.12419,-0.11158,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0036303,-0.12448,-0.13972,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.13583,-0.12451,-0.12157,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.21579,-0.12457,-0.073951,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12908,-0.125,-0.10917,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10096,-0.12573,-0.1186,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18219,-0.126,-0.11398,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.036948,-0.12609,-0.18719,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.05161,-0.12619,-0.18499,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.054842,-0.12653,-0.11945,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.56666,-0.12668,-0.065246,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.054842,-0.12674,-0.11463,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.46512,-0.12681,-0.073083,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.15264,-0.12731,-0.085475,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.076492,-0.1274,-0.17121,0,0
3,GO RESPONSE TO CADMIUM ION,0.11039,-0.12778,-0.12653,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.075049,-0.12815,-0.11737,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.060602,-0.12853,-0.15283,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.29992,-0.12898,-0.14992,0,0
3,GO CILIUM ORGANIZATION,0.00052342,-0.12901,-0.13345,0,0
3,GO REGULATION OF GTP BINDING,0.40843,-0.12916,-0.069615,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.090515,-0.12965,-0.19235,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.12689,-0.12983,-0.19409,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.076492,-0.1303,-0.10402,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.095625,-0.13039,-0.10267,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.017549,-0.13045,-0.11113,0,0
3,GO AMMONIUM TRANSPORT,0.10845,-0.13054,-0.19741,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.072231,-0.1308,-0.1429,0,0
3,GO LIPID EXPORT FROM CELL,0.076492,-0.1312,-0.11281,0,0
3,GO SPECIFICATION OF SYMMETRY,0.001986,-0.13171,-0.11453,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.057089,-0.13195,-0.10423,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.077957,-0.13235,-0.13666,0,0
3,GO HISTONE H2A UBIQUITINATION,0.0036303,-0.13238,-0.12349,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12908,-0.13297,-0.23336,0,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.12689,-0.13369,-0.12255,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13355,-0.13395,-0.18851,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.099158,-0.13406,-0.087686,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.32938,-0.13435,-0.081308,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.0010206,-0.13467,-0.13057,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010245,-0.13504,-0.138,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.066855,-0.1352,-0.15909,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.072231,-0.13536,-0.10553,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00040247,-0.13585,-0.15198,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.1313,-0.13603,-0.097823,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29992,-0.13626,-0.13545,0,0
3,GO REGULATION OF NEURON MATURATION,0.4598,-0.13662,-0.043819,0,0
3,GO RETINOL METABOLIC PROCESS,0.057089,-0.13684,-0.17424,0,0
3,GO PLASMA MEMBRANE FUSION,0.13814,-0.13697,-0.13578,0,0
3,GO FORELIMB MORPHOGENESIS,0.15264,-0.137,-0.11631,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19695,-0.13708,-0.070767,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.2839,-0.13874,-0.069496,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.00026003,-0.13967,-0.1549,0,0
3,GO UTERUS DEVELOPMENT,0.27999,-0.14048,-0.068691,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.12473,-0.14058,-0.11492,0,0
3,GO MEMBRANE FISSION,0.055956,-0.14069,-0.11701,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.0028957,-0.14073,-0.1457,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24288,-0.14184,-0.10259,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.37932,-0.1419,-0.095205,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.05824,-0.14226,-0.10691,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.013465,-0.14252,-0.17536,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.052669,-0.14262,-0.11501,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.097379,-0.14286,-0.1077,0,0
3,GO PHOTOTRANSDUCTION,0.0073363,-0.14296,-0.14348,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,-0.14298,-0.17715,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.21905,-0.14358,-0.11073,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16294,-0.14358,-0.17508,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.082489,-0.14419,-0.11358,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.24288,-0.14552,-0.19843,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.15264,-0.14566,-0.16436,0,0
3,GO ANIMAL ORGAN MATURATION,0.13355,-0.14576,-0.10707,0,0
3,GO CARNITINE METABOLIC PROCESS,0.38888,-0.14588,-0.064017,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26847,-0.14619,-0.090231,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.53742,-0.14649,-0.16679,0,0
3,GO MYELOID CELL DEVELOPMENT,0.00041602,-0.14679,-0.14912,0,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.10845,-0.14707,-0.17964,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.35607,-0.1471,-0.082958,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.066855,-0.14727,-0.1549,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.19393,-0.14817,-0.10305,0,0
3,GO PLATELET DEGRANULATION,0.20621,-0.1483,-0.1132,0,0
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.21256,-0.14852,-0.17387,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.48131,-0.14951,-0.075744,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.32506,-0.14965,-0.11279,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.093897,-0.14977,-0.11086,0,0
3,GO COPULATION,0.068167,-0.1504,-0.11843,0,0
3,GO REGULATION OF MYOBLAST FUSION,0.12049,-0.15075,-0.17769,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.20309,-0.15141,-0.14563,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.15142,-0.14635,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21579,-0.15203,-0.12687,0,0
3,GO DETECTION OF CALCIUM ION,0.2,-0.15249,-0.13043,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.22568,-0.15254,-0.10321,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023205,-0.15258,-0.1816,0,0
3,GO MICROTUBULE SEVERING,0.024846,-0.15297,-0.14641,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.20309,-0.15304,-0.15205,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12689,-0.15324,-0.15939,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0028957,-0.15332,-0.18154,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.070855,-0.15402,-0.13608,0,0
3,GO MYOFIBRIL ASSEMBLY,0.0013054,-0.15403,-0.1654,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.15015,-0.15425,-0.13189,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0049174,-0.1545,-0.18074,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.17099,-0.1547,-0.067165,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.29586,-0.15483,-0.054061,0,0
3,GO AMYLOID FIBRIL FORMATION,0.33373,-0.15512,-0.11336,0,0
3,GO SEROTONIN SECRETION,0.14526,-0.15553,-0.095884,0,0
3,GO GANGLION DEVELOPMENT,0.1313,-0.15648,-0.18093,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.20309,-0.15652,-0.16605,0,0
3,GO EPITHELIAL CELL MATURATION,0.070855,-0.1566,-0.13123,0,0
3,GO T CELL EXTRAVASATION,0.13583,-0.15669,-0.23466,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.073629,-0.15673,-0.15122,0,0
3,GO TELOMERE CAPPING,0.0041716,-0.15682,-0.11467,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.23589,-0.15705,-0.067929,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.007729,-0.1573,-0.18045,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0037331,-0.15743,-0.14227,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.18508,-0.15763,-0.13072,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0017641,-0.15846,-0.16745,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.12259,-0.15903,-0.20717,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.25363,-0.15953,-0.13287,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.054842,-0.1597,-0.22913,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.070855,-0.16018,-0.14161,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.033894,-0.16114,-0.19282,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.25001,-0.16144,-0.11423,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.16191,-0.19482,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.42347,-0.1623,-0.10631,0,0
3,GO CELL FATE DETERMINATION,0.0094949,-0.16255,-0.18638,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.21256,-0.16348,-0.1121,0,0
3,GO LACTATE METABOLIC PROCESS,0.077957,-0.16484,-0.14518,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.74288,-0.16555,-0.03071,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.011904,-0.16609,-0.13149,0,0
3,GO LYSINE METABOLIC PROCESS,0.082489,-0.16717,-0.21034,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.20621,-0.16786,-0.12081,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.080955,-0.16839,-0.11155,0,0
3,GO TRNA CATABOLIC PROCESS,0.24643,-0.16872,-0.13514,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10465,-0.16995,-0.22625,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.024846,-0.17045,-0.16178,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.18219,-0.17115,-0.077585,0,0
3,GO CENTROSOME DUPLICATION,9.389e-05,-0.17204,-0.17864,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.53167,-0.17269,-0.038424,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.036164,-0.17361,-0.19823,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.23245,-0.17407,-0.10281,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.044685,-0.17453,-0.14119,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.0037331,-0.17487,-0.14148,0,0
3,GO METANEPHROS MORPHOGENESIS,0.25001,-0.17581,-0.075415,0,0
3,GO RETINA HOMEOSTASIS,0.00032948,-0.17619,-0.14676,0,0
3,GO SPERM AXONEME ASSEMBLY,0.018398,-0.17897,-0.14658,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.11039,-0.17905,-0.12555,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.14769,-0.17951,-0.12749,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.21256,-0.17955,-0.1377,0,0
3,GO BRONCHUS DEVELOPMENT,0.20309,-0.18006,-0.13595,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.013139,-0.18018,-0.17527,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.27999,-0.18063,-0.10727,0,0
3,GO CELL FATE SPECIFICATION,0.013798,-0.18077,-0.14292,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.12689,-0.18205,-0.097632,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.10654,-0.18215,-0.1864,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.080955,-0.18238,-0.2116,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0029794,-0.18274,-0.23216,0,0
3,GO RESPONSE TO INACTIVITY,0.02166,-0.18324,-0.15967,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.0025083,-0.18534,-0.14784,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.12689,-0.18625,-0.15532,0,0
3,GO INTRACILIARY TRANSPORT,0.0025083,-0.18655,-0.20942,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00032948,-0.18658,-0.16686,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.16032,-0.1866,-0.18686,0,0
3,GO GENITALIA MORPHOGENESIS,0.1028,-0.18737,-0.14642,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0069616,-0.18822,-0.15997,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.072231,-0.18966,-0.20207,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.22235,-0.18976,-0.20246,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.080955,-0.18988,-0.14246,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.32938,-0.18998,-0.11467,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.11235,-0.19042,-0.13911,0,0
3,GO RENAL ABSORPTION,0.082489,-0.19141,-0.23081,0,0
3,GO ETHANOL OXIDATION,0.15773,-0.19142,-0.23688,0,0
3,GO REGULATION OF CHLORIDE TRANSPORT,0.05824,-0.19226,-0.1733,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0040578,-0.19241,-0.17525,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.019283,-0.19244,-0.19172,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.10465,-0.19284,-0.15601,0,0
3,GO SEGMENT SPECIFICATION,0.016734,-0.1934,-0.22752,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17934,-0.19379,-0.14419,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.0062634,-0.19384,-0.15592,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.19414,-0.17633,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00072223,-0.19512,-0.22377,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.18508,-0.19669,-0.13112,0,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0090226,-0.19698,-0.16844,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17934,-0.19725,-0.1207,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12473,-0.1974,-0.18682,0,0
3,GO MICROVILLUS ASSEMBLY,0.053746,-0.19753,-0.20991,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.073629,-0.19844,-0.1825,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.075049,-0.20108,-0.12896,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.10654,-0.20179,-0.12994,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.11636,-0.20224,-0.095155,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.1313,-0.20253,-0.1455,0,0
3,GO PARTURITION,0.082489,-0.2036,-0.1589,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0016129,-0.20414,-0.21579,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.070855,-0.20441,-0.18912,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.17374,-0.20468,-0.1526,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.017549,-0.20492,-0.26988,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.049546,-0.20493,-0.15013,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00090094,-0.20534,-0.19398,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.036948,-0.2058,-0.3584,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.11039,-0.20747,-0.10216,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.25729,-0.20766,-0.15062,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033166,-0.20879,-0.1891,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.12259,-0.20926,-0.10614,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.13583,-0.20935,-0.15585,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00030804,-0.21007,-0.19438,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.40349,-0.21308,-0.034826,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12473,-0.2133,-0.15283,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16828,-0.21457,-0.11528,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.05161,-0.21646,-0.16836,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.0049174,-0.21697,-0.17376,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0028141,-0.21714,-0.20972,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.076492,-0.21747,-0.23213,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.059411,-0.21796,-0.28744,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.044685,-0.21924,-0.23152,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.22055,-0.073047,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,9.0179e-06,-0.22561,-0.22652,0,0
3,GO PANCREAS DEVELOPMENT,0.00079435,-0.22667,-0.21684,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10845,-0.22751,-0.16087,0,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011047,-0.22869,-0.19893,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.060602,-0.22914,-0.31862,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.063042,-0.22994,-0.19183,0,0
3,GO CELL JUNCTION MAINTENANCE,0.0011549,-0.23176,-0.2268,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.079444,-0.23252,-0.16641,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.12689,-0.23289,-0.19345,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.21905,-0.23403,-0.11081,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.084046,-0.23463,-0.20178,0,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0020453,-0.23597,-0.2163,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.076492,-0.23651,-0.24512,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.17934,-0.23766,-0.081558,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.23937,-0.23921,-0.13675,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.15264,-0.23973,-0.14753,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.03245,-0.23999,-0.22587,0,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0014738,-0.24015,-0.29273,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.001191,-0.24059,-0.28135,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.8521e-05,-0.24306,-0.24897,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047853,-0.24528,-0.28865,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.027188,-0.24568,-0.13963,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00081984,-0.24588,-0.26629,0,0
3,GO RETINAL METABOLIC PROCESS,0.077957,-0.25064,-0.21635,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.03245,-0.25371,-0.31817,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,7.3528e-06,-0.25391,-0.26491,0,0
3,GO SPINAL CORD PATTERNING,0.0087944,-0.25563,-0.24283,0,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.054842,-0.25594,-0.24168,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.001228,-0.2566,-0.21903,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.001986,-0.25694,-0.27516,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.19393,-0.25813,-0.1016,0,0
3,GO MYOBLAST MIGRATION,0.082489,-0.2586,-0.2141,0,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,7.013e-05,-0.26277,-0.25226,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.00087311,-0.26765,-0.27725,0,0
3,GO HEART FIELD SPECIFICATION,0.060602,-0.26833,-0.17541,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.061812,-0.26905,-0.21526,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017123,-0.26948,-0.25984,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.079444,-0.2717,-0.24901,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.00050664,-0.2724,-0.26348,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00055855,-0.27266,-0.22664,0,0
3,GO GDP METABOLIC PROCESS,0.0099891,-0.27545,-0.23466,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.068167,-0.27576,-0.22095,0,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.00014418,-0.2852,-0.26135,0,0
3,GO EXTRACELLULAR TRANSPORT,1.104e-05,-0.28703,-0.35817,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0081404,-0.28721,-0.20979,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0024367,-0.28859,-0.21119,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.070855,-0.29173,-0.17678,0,0
3,GO HETEROTYPIC CELL CELL ADHESION,3.0576e-06,-0.29252,-0.34378,0,0
3,GO CARDIOBLAST PROLIFERATION,0.43883,-0.2964,-0.11467,0,0
3,GO T HELPER CELL LINEAGE COMMITMENT,4.8379e-05,-0.30004,-0.27867,0,0
3,GO AXONEME ASSEMBLY,3.1888e-05,-0.30878,-0.31671,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00052342,-0.31439,-0.28122,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.057089,-0.31534,-0.16377,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.0019282,-0.31535,-0.23545,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081984,-0.31857,-0.24577,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.00013433,-0.32177,-0.30842,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.095625,-0.32207,-0.1348,0,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.097379,-0.32331,-0.24581,0,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.3528e-06,-0.33772,-0.40042,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00010462,-0.35389,-0.41795,0,0
3,GO GONADOTROPIN SECRETION,0.00055855,-0.35713,-0.35836,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,7.0571e-06,-0.35948,-0.3418,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.00059588,-0.36813,-0.30731,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0025083,-0.36907,-0.34298,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.035393,-0.37892,-0.28382,0,0
3,GO RESPONSE TO MUSCLE INACTIVITY,2.9532e-05,-0.38095,-0.37791,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.00028792,-0.38116,-0.38153,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.12689,-0.38618,-0.17745,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0059384,-0.3883,-0.31908,0,0
3,GO NEURON FATE SPECIFICATION,0.0081404,-0.43561,-0.28917,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.04854,-0.43791,-0.27687,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00016595,-0.44235,-0.4661,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.41235,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.2754e-05,-0.46042,-0.40321,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00065623,-0.46852,-0.37734,0,0
3,GO RETINA LAYER FORMATION,0.00010845,-0.48066,-0.42623,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.48127,-0.48072,0,0
3,GO RESPONSE TO FORSKOLIN,4.2876e-06,-0.50527,-0.46257,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.0027346,-0.52433,-0.42865,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00020448,-0.53073,-0.48748,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6597e-05,-0.5309,-0.47422,0,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,5.6174e-05,-0.53712,-0.45348,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,5.7413e-06,-0.53986,-0.59671,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,2.2524e-05,-0.55124,-0.4387,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00021909,-0.56212,-0.45463,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,8.3127e-06,-0.66246,-0.65678,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.1904e-06,-0.77652,-0.71411,0,0
4,GO PROGESTERONE METABOLIC PROCESS,5.4121e-05,1.0766,0.99758,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0042883,1.0527,0.75898,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0011549,1.0302,0.94087,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.6455e-05,0.9558,0.99005,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00021909,0.91669,0.70731,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.349e-05,0.88751,0.64558,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.017137,0.88237,0.5785,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,1.0604e-05,0.87073,0.84821,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,4.8379e-05,0.84853,0.6048,1,1
4,GO MUCUS SECRETION,9.0551e-05,0.81178,0.68051,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.025414,0.81089,0.4475,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.5201e-05,0.76213,0.68204,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,6.5149e-05,0.75763,0.60614,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.2837e-06,0.75103,0.65666,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00049035,0.7507,0.6438,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,8.628e-07,0.74473,0.65624,1,1
4,GO RETINAL METABOLIC PROCESS,0.0007696,0.73513,0.63253,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.013798,0.72591,0.49786,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,2.1663e-05,0.72476,0.69115,1,1
4,GO GERMINAL CENTER FORMATION,3.8583e-05,0.71939,0.56938,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,7.013e-05,0.71562,0.62404,1,1
4,GO QUINONE METABOLIC PROCESS,5.0226e-05,0.71406,0.70729,1,1
4,GO HISTAMINE SECRETION,2.3654e-06,0.70834,0.66515,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00030804,0.70799,0.60806,1,1
4,GO RENAL ABSORPTION,1.7806e-05,0.70322,0.66983,1,1
4,GO INTESTINAL LIPID ABSORPTION,3.1904e-06,0.7002,0.72989,1,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0013457,0.69911,0.4898,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,5.2139e-05,0.69389,0.63014,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0001547,0.69215,0.5979,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,3.8583e-05,0.67914,0.67037,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,3.4421e-05,0.66382,0.54357,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00098941,0.65675,0.44475,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.013798,0.641,0.31424,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00021167,0.63568,0.47259,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.2454e-05,0.63089,0.62182,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00025131,0.63072,0.63263,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.00037661,0.62705,0.59367,1,1
4,GO HISTAMINE TRANSPORT,8.628e-07,0.62544,0.65145,1,1
4,GO ACTIN FILAMENT SEVERING,0.00031859,0.62538,0.48457,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00012512,0.6186,0.50755,1,1
4,GO RESPONSE TO INTERFERON BETA,0.0017641,0.61321,0.41224,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.00067758,0.61181,0.50161,1,1
4,GO LIPID DROPLET FORMATION,2.7343e-05,0.60532,0.60929,1,1
4,GO T CELL EXTRAVASATION,0.00090094,0.60292,0.53314,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0032441,0.60162,0.40122,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.0001165,0.601,0.61103,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0032441,0.5917,0.46336,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.4044e-06,0.5899,0.59145,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,1.8521e-05,0.58705,0.64446,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00013433,0.5786,0.45865,1,1
4,GO REGULATION OF FIBRINOLYSIS,6.5149e-05,0.57454,0.52685,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00057693,0.57231,0.46911,1,1
4,GO LIPID DIGESTION,2.0033e-05,0.57141,0.64062,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,5.4121e-05,0.57014,0.42529,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00059588,0.5664,0.60161,1,1
4,GO RESPONSE TO TYPE I INTERFERON,0.00063551,0.56463,0.46943,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,1.1964e-05,0.56344,0.55926,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,8.3127e-06,0.56256,0.52594,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,1.7806e-05,0.5582,0.54047,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.00016023,0.55657,0.66666,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.00079435,0.55619,0.53226,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00019753,0.55601,0.55299,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00353,0.55132,0.49825,1,1
4,GO TOXIN METABOLIC PROCESS,2.1702e-06,0.55021,0.53436,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00019079,0.54933,0.43993,1,1
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0010528,0.54933,0.37246,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0017641,0.54557,0.42245,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.013465,0.54461,0.62294,1,1
4,GO TOLERANCE INDUCTION,0.012203,0.54289,0.42092,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,6.4994e-06,0.54156,0.51079,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,9.0551e-05,0.53559,0.42019,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00081984,0.53518,0.38783,1,1
4,GO MATURE B CELL DIFFERENTIATION,4.8379e-05,0.53457,0.42688,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.014486,0.53226,0.35464,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.00042998,0.52928,0.48236,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.00079435,0.52894,0.445,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00034072,0.52569,0.47529,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,1.8521e-05,0.52558,0.46711,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,7.547e-05,0.52462,0.50156,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,5.4121e-05,0.5233,0.47333,1,1
4,GO INTESTINAL ABSORPTION,5.2837e-06,0.51996,0.60292,1,1
4,GO VASCULAR TRANSPORT,0.00028792,0.51844,0.45818,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.5308e-05,0.51562,0.49146,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.001191,0.51271,0.37178,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0011199,0.51266,0.43322,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00016023,0.51213,0.44221,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00018427,0.51147,0.50187,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0094949,0.51096,0.41353,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,0.00059588,0.50912,0.4394,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.5774e-06,0.50785,0.52562,1,1
4,GO SUPEROXIDE ANION GENERATION,2.9532e-05,0.50745,0.49204,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,6.0504e-05,0.50211,0.51045,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,5.6174e-05,0.50118,0.63979,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00026003,0.49977,0.38453,1,1
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.007729,0.49719,0.30305,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0013457,0.49532,0.46117,1,1
4,GO NADP METABOLIC PROCESS,0.00010845,0.49437,0.38077,1,1
4,GO STEROID ESTERIFICATION,4.3218e-05,0.49283,0.59599,1,1
4,GO KETONE CATABOLIC PROCESS,0.0013872,0.4921,0.39973,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00353,0.48961,0.39653,1,1
4,GO RESPONSE TO PAIN,2.7343e-05,0.4882,0.43468,1,1
4,GO GALACTOSE METABOLIC PROCESS,2.3418e-05,0.48813,0.59205,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.1493e-05,0.4835,0.44747,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,4.1802e-07,0.48196,0.52734,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.00013917,0.47665,0.37921,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.2454e-05,0.47648,0.45514,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,0.00050664,0.47607,0.43532,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,6.2786e-05,0.47307,0.38419,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00037661,0.4726,0.37508,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.0833e-05,0.46857,0.45773,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.7343e-05,0.46805,0.45317,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00013917,0.46618,0.4055,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0013054,0.46587,0.41268,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00028792,0.46584,0.40163,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00353,0.46513,0.44244,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.1112e-06,0.46333,0.47226,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0022332,0.4612,0.34199,1,1
4,GO RESPONSE TO COLD,2.4692e-06,0.46013,0.40903,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.0689e-05,0.45982,0.41015,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00024286,0.45845,0.40863,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00017796,0.45845,0.41421,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0049174,0.45378,0.32094,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.0016129,0.44945,0.34848,1,1
4,GO RESPONSE TO DIETARY EXCESS,4.0073e-05,0.44852,0.44137,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.013e-05,0.44718,0.41195,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,2.2524e-05,0.44543,0.38772,1,1
4,GO NADPH REGENERATION,0.001872,0.44404,0.30138,1,1
4,GO PROTEIN DEGLYCOSYLATION,1.1493e-05,0.44129,0.43773,1,1
4,GO REGULATION OF ANOIKIS,0.00023468,0.44121,0.3963,1,1
4,GO CERAMIDE TRANSPORT,0.0026572,0.44065,0.37948,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00030804,0.44011,0.34377,1,1
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.0054795,0.43959,0.376,1,1
4,GO LYSINE METABOLIC PROCESS,0.0071468,0.43942,0.291,1,1
4,GO O GLYCAN PROCESSING,0.00081984,0.43918,0.32492,1,1
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.016734,0.43832,0.29995,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00013917,0.43628,0.42324,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0042883,0.43576,0.35565,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.3528e-06,0.43573,0.34939,1,1
4,GO REGULATION OF NEURON MATURATION,0.0050528,0.43491,0.28041,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0015653,0.43486,0.2987,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.00041602,0.43274,0.40089,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.0083534,0.43267,0.33233,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.00044439,0.43195,0.48513,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0083534,0.43157,0.24445,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,2.9532e-05,0.43137,0.58615,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00040247,0.4312,0.36762,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00074557,0.43108,0.52275,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00090094,0.42834,0.41759,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00353,0.42828,0.31754,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00010845,0.42632,0.4089,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0032441,0.42625,0.30794,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00012964,0.42471,0.40044,1,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00081984,0.42434,0.44237,1,1
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.027803,0.42401,0.33904,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,8.1192e-05,0.42246,0.44907,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,9.0551e-05,0.42099,0.38828,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,4.1617e-05,0.4207,0.36794,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00067758,0.42022,0.38484,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0026572,0.42002,0.3087,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00050664,0.41991,0.41526,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5816e-05,0.41896,0.41547,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00035231,0.41893,0.45952,1,1
4,GO PLASMINOGEN ACTIVATION,0.0015653,0.41852,0.44699,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,3.8583e-05,0.4183,0.37075,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.00353,0.41821,0.30933,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00042998,0.41676,0.35432,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00014935,0.41522,0.3823,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0019282,0.41361,0.34656,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0011199,0.41277,0.38325,1,1
4,GO DETECTION OF OTHER ORGANISM,0.001986,0.41201,0.36097,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.547e-05,0.41091,0.43544,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,5.2139e-05,0.41074,0.45627,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00012512,0.40855,0.37651,1,1
4,GO KETONE BODY METABOLIC PROCESS,0.0034322,0.40625,0.32925,1,1
4,GO NUCLEOTIDE SALVAGE,0.00036427,0.40564,0.37051,1,1
4,GO EOSINOPHIL MIGRATION,0.001191,0.40498,0.36055,1,1
4,GO CELLULAR DEFENSE RESPONSE,1.104e-05,0.40399,0.40383,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00035231,0.40398,0.3917,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.3916e-06,0.40394,0.38174,1,1
4,GO VASODILATION,0.00010462,0.40384,0.53233,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,5.6174e-05,0.40303,0.30251,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0037331,0.40153,0.34936,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00028792,0.4011,0.33973,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,9.7346e-05,0.40106,0.505,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.6902e-06,0.40096,0.41884,1,1
4,GO RESPONSE TO ACIDIC PH,0.00074557,0.40059,0.32079,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00023468,0.40049,0.3971,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,3.3132e-05,0.40016,0.38112,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00074557,0.39982,0.34096,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,3.1888e-05,0.39978,0.34873,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0010528,0.39724,0.40167,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00016595,0.39639,0.34106,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,9.7801e-06,0.39533,0.39725,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00050664,0.39433,0.37232,1,1
4,GO B CELL APOPTOTIC PROCESS,3.1888e-05,0.39426,0.34616,1,1
4,GO HEPARIN METABOLIC PROCESS,0.018836,0.39269,0.27091,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0069616,0.39113,0.41551,1,1
4,GO PHAGOSOME ACIDIFICATION,8.3127e-06,0.39112,0.37326,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00017796,0.39099,0.30116,1,1
4,GO GAP JUNCTION ASSEMBLY,0.01282,0.39086,0.27062,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.4878e-05,0.3906,0.45474,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.026586,0.39015,0.25954,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00029782,0.39011,0.43828,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0012662,0.38964,0.31964,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,0.00090094,0.38932,0.29075,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.00067758,0.38744,0.39518,1,1
4,GO BLOOD VESSEL REMODELING,0.00020448,0.38715,0.32102,1,1
4,GO STEROL TRANSPORT,7.8282e-05,0.38704,0.28547,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,5.6174e-05,0.38703,0.34046,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00021909,0.38681,0.40938,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,2.4346e-05,0.38602,0.32666,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00012512,0.38503,0.39148,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00025131,0.38482,0.39089,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.041093,0.3848,0.30698,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.0064317,0.3847,0.29385,1,1
4,GO PROTEIN AUTOPROCESSING,4.2876e-06,0.38415,0.45527,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,5.508e-06,0.38413,0.37233,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00072223,0.38413,0.37912,1,1
4,GO REGULATION OF MYOBLAST FUSION,7.013e-05,0.38326,0.37136,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00024286,0.38308,0.28032,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,0.00013917,0.38207,0.41644,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,3.7145e-05,0.38187,0.30517,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.0018173,0.3814,0.35344,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00017186,0.38137,0.35398,1,1
4,GO ZYMOGEN ACTIVATION,0.00049035,0.38087,0.36621,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00030804,0.38006,0.35593,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00037661,0.37976,0.32877,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,2.1663e-05,0.37755,0.39291,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0019282,0.37723,0.31947,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0017641,0.37665,0.25551,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0010528,0.37594,0.33488,1,1
4,GO PROTEIN DEMANNOSYLATION,3.1888e-05,0.37576,0.42793,1,1
4,GO ETHANOL METABOLIC PROCESS,0.00047456,0.3754,0.3273,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.03939,0.37464,0.20678,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0030654,0.37339,0.29903,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00013917,0.37339,0.36662,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,0.00098941,0.37179,0.30369,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00021167,0.3715,0.4816,1,1
4,GO FOAM CELL DIFFERENTIATION,6.0504e-05,0.3705,0.31824,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.0033e-05,0.36967,0.33134,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00025131,0.36898,0.34908,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00014418,0.36734,0.29183,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0022992,0.3669,0.28298,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.011326,0.36681,0.31542,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0081404,0.3659,0.49934,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.017137,0.3657,0.23338,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00047456,0.36393,0.33072,1,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.02068,0.3638,0.20036,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00021909,0.36376,0.29526,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00042998,0.36356,0.38212,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,4.6597e-05,0.36241,0.3277,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.011326,0.36184,0.40844,1,1
4,GO REGULATION OF TISSUE REMODELING,6.4994e-06,0.36148,0.37909,1,1
4,GO REGULATION OF COAGULATION,0.00038934,0.36136,0.30815,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0049174,0.36097,0.27501,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.00063551,0.35881,0.28548,1,1
4,GO DIGESTION,7.8282e-05,0.35871,0.30516,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,1.8521e-05,0.35864,0.36278,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00026003,0.35842,0.38442,1,1
4,GO REGULATION OF BONE REMODELING,4.4712e-06,0.35805,0.42285,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.3132e-05,0.35803,0.33868,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00021167,0.3579,0.29037,1,1
4,GO INTEGRIN ACTIVATION,4.4712e-06,0.35733,0.37786,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0083534,0.35706,0.29146,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.018836,0.35476,0.2575,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.02068,0.35402,0.27824,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00030804,0.35327,0.30523,1,1
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0057817,0.35205,0.30478,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.0022332,0.35145,0.29562,1,1
4,GO VACUOLAR ACIDIFICATION,5.2533e-07,0.3506,0.40566,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,7.013e-05,0.35055,0.40742,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.010245,0.35033,0.24235,1,1
4,GO BONE RESORPTION,2.6902e-06,0.35023,0.41345,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.9301e-06,0.34938,0.3454,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00047456,0.34928,0.40715,1,1
4,GO SIGNAL PEPTIDE PROCESSING,3.7145e-05,0.34923,0.41607,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,2.9532e-05,0.34885,0.40124,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00014418,0.34883,0.29542,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00028792,0.34882,0.34411,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0024367,0.34813,0.28525,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0047853,0.34798,0.3718,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00065623,0.34735,0.25255,1,1
4,GO ICOSANOID METABOLIC PROCESS,4.8379e-05,0.34705,0.34109,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00049035,0.34678,0.34573,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.010245,0.34579,0.18962,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0011199,0.34493,0.30868,1,1
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0028957,0.34492,0.30476,1,1
4,GO ANOIKIS,0.00014935,0.34435,0.27716,1,1
4,GO BILE ACID METABOLIC PROCESS,3.1888e-05,0.34411,0.39911,1,1
4,GO ETHER METABOLIC PROCESS,0.0030654,0.34374,0.22748,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00052342,0.34348,0.27496,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0034322,0.34308,0.26133,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00050664,0.34296,0.27267,1,1
4,GO INSEMINATION,0.00050664,0.3424,0.33374,1,1
4,GO CARNITINE METABOLIC PROCESS,0.00092958,0.3422,0.2881,1,1
4,GO RESPONSE TO GROWTH HORMONE,2.1663e-05,0.34148,0.369,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00011241,0.34106,0.27892,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.0504e-05,0.34043,0.31883,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,9.7801e-06,0.33964,0.29784,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0023671,0.33916,0.29345,1,1
4,GO FATTY ACID CATABOLIC PROCESS,6.2985e-07,0.33907,0.34003,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0031536,0.33861,0.25782,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0006154,0.3373,0.27987,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00081984,0.33721,0.25694,1,1
4,GO RETINOL METABOLIC PROCESS,0.00038934,0.3372,0.45943,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.013465,0.33719,0.33888,1,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.0021689,0.33718,0.2651,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0012662,0.33696,0.32205,1,1
4,GO RESPONSE TO LITHIUM ION,6.2786e-05,0.33664,0.42317,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00010462,0.33641,0.33369,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00055855,0.33635,0.28534,1,1
4,GO RESPONSE TO THYROID HORMONE,0.001872,0.33591,0.26146,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00026903,0.33577,0.30864,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.00098941,0.33551,0.37142,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,5.6174e-05,0.3352,0.42938,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.009256,0.33444,0.30852,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00012074,0.33408,0.30568,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.001228,0.33386,0.28511,1,1
4,GO N GLYCAN PROCESSING,0.010245,0.33327,0.23618,1,1
4,GO TRICARBOXYLIC ACID CYCLE,0.0028957,0.33322,0.25928,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0075304,0.333,0.32007,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0011549,0.33297,0.28356,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.00036427,0.33275,0.32285,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0017641,0.33261,0.28243,1,1
4,GO CELL REDOX HOMEOSTASIS,8.7323e-05,0.33226,0.31179,1,1
4,GO LIVER MORPHOGENESIS,0.001662,0.33211,0.28029,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0022332,0.33175,0.31872,1,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00065623,0.33111,0.34881,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,7.6603e-06,0.33045,0.33273,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00065623,0.33032,0.28226,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00067758,0.33028,0.43389,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00074557,0.33017,0.31955,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0064317,0.33003,0.25951,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.038561,0.32991,0.24444,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,1.9263e-05,0.32925,0.32987,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00098941,0.32839,0.30448,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,0.32829,0.27656,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.00063551,0.32801,0.36072,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0079323,0.32764,0.32594,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0025817,0.32733,0.1948,1,1
4,GO TISSUE REMODELING,6.5149e-05,0.32706,0.28763,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0046564,0.32594,0.31692,1,1
4,GO UBIQUINONE METABOLIC PROCESS,6.7728e-06,0.32536,0.33387,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00029782,0.32519,0.28492,1,1
4,GO MACROPHAGE PROLIFERATION,0.014841,0.32415,0.25394,1,1
4,GO RESPONSE TO MUSCLE ACTIVITY,0.01282,0.32367,0.22524,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.2962e-05,0.32365,0.28873,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.0060989,0.32338,0.20684,1,1
4,GO RESPONSE TO ANGIOTENSIN,0.0023671,0.32334,0.28619,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.013465,0.32331,0.20694,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.7596e-05,0.32302,0.28533,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.007729,0.32247,0.32537,1,1
4,GO FATTY ACID BETA OXIDATION,1.1493e-05,0.32141,0.29366,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0010528,0.32139,0.24096,1,1
4,GO STEROID HORMONE SECRETION,0.00353,0.32121,0.26633,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.7413e-06,0.32106,0.35467,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001986,0.32062,0.26987,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.2754e-05,0.32053,0.25484,1,1
4,GO ACUTE PHASE RESPONSE,0.00024286,0.32048,0.30135,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.014138,0.32027,0.22053,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00037661,0.32014,0.34434,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00014418,0.32001,0.30972,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.0099891,0.31961,0.35702,1,1
4,GO STEROID METABOLIC PROCESS,1.2454e-05,0.31933,0.30719,1,1
4,GO PENTOSE METABOLIC PROCESS,0.014486,0.31912,0.21401,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0012662,0.31891,0.31971,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00031859,0.31834,0.36362,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.017549,0.31679,0.24182,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00087311,0.31544,0.3235,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0006154,0.31542,0.26646,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.31542,0.2603,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.3441e-06,0.31519,0.30812,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.00090094,0.31492,0.27329,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.00065623,0.31483,0.23155,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00023468,0.31452,0.30658,1,1
4,GO RESPONSE TO FATTY ACID,0.00036427,0.3143,0.24179,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0057817,0.3141,0.18979,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0036303,0.31386,0.27569,1,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.001986,0.31314,0.35843,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0011549,0.31276,0.2873,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.023205,0.31249,0.26461,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0069616,0.31214,0.23013,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0028957,0.31191,0.33151,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0083534,0.31157,0.40063,1,1
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.024846,0.31143,0.23731,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,2.5774e-06,0.31088,0.36689,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00034072,0.3106,0.30619,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00032948,0.30927,0.27765,1,1
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0042883,0.30921,0.20836,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00040247,0.30908,0.27267,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0066042,0.30891,0.36583,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.012508,0.30856,0.21168,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00079435,0.30802,0.26062,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.011612,0.30768,0.23033,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013872,0.30658,0.22241,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.001662,0.30655,0.27198,1,1
4,GO INOSITOL METABOLIC PROCESS,7.0571e-06,0.30602,0.33514,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.02268,0.30547,0.24675,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.8282e-05,0.30531,0.24442,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0034322,0.30522,0.26136,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00092958,0.30445,0.25072,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.30368,0.2836,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.013139,0.30354,0.19407,1,1
4,GO MICROVILLUS ORGANIZATION,0.012508,0.30268,0.28067,1,1
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.001228,0.30255,0.20251,1,1
4,GO PHOSPHOLIPID EFFLUX,0.0017641,0.30176,0.33809,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,2.6307e-05,0.30166,0.26195,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00042998,0.30156,0.34337,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00017186,0.30155,0.272,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00063551,0.30078,0.3238,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.025994,0.30001,0.23565,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0071468,0.29945,0.24986,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0034322,0.29938,0.27965,1,1
4,GO TRANSCYTOSIS,0.00021909,0.29937,0.28932,1,1
4,GO PLATELET DEGRANULATION,0.0015653,0.29931,0.2366,1,1
4,GO POSITIVE REGULATION OF CELL SIZE,0.00084609,0.2982,0.29265,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.011326,0.2982,0.28043,1,1
4,GO METHIONINE METABOLIC PROCESS,0.00057693,0.29794,0.28716,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.016734,0.29722,0.31071,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00035231,0.29661,0.21228,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0010528,0.29643,0.30828,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.7791e-06,0.29637,0.2804,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0001165,0.29628,0.29522,1,1
4,GO ZYMOGEN INHIBITION,0.0066042,0.29614,0.20035,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.00030804,0.29564,0.26324,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.00057693,0.29535,0.2235,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0030654,0.2948,0.23506,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.0046564,0.2948,0.27239,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0028141,0.29479,0.26795,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00034072,0.29466,0.21516,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00098941,0.29453,0.24481,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0097392,0.29429,0.16286,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0021689,0.29421,0.20718,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.02268,0.29334,0.24768,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0026572,0.29326,0.38366,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00084609,0.29262,0.24053,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.0010528,0.29201,0.2711,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,5.4121e-05,0.29165,0.27039,1,1
4,GO AMINE METABOLIC PROCESS,6.5896e-07,0.29138,0.30438,1,1
4,GO CHYLOMICRON ASSEMBLY,0.017969,0.29125,0.29123,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00024286,0.29116,0.24478,1,1
4,GO REGULATION OF WOUND HEALING,0.00044439,0.29114,0.26314,1,1
4,GO STEROL METABOLIC PROCESS,0.00023468,0.291,0.2456,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.001191,0.29099,0.30055,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00055855,0.29073,0.34881,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00016595,0.29067,0.36056,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.037747,0.29062,0.21557,1,1
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0037331,0.29028,0.25124,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0010859,0.29026,0.25369,1,1
4,GO BONE REMODELING,3.8583e-05,0.29001,0.32403,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.016339,0.28952,0.26258,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0046564,0.28936,0.2878,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.0023671,0.28932,0.23341,1,1
4,GO ENDOCRINE PROCESS,0.00050664,0.28882,0.24419,1,1
4,GO ANIMAL ORGAN REGENERATION,0.0010859,0.28873,0.2043,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,6.0504e-05,0.28871,0.28823,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.00087311,0.28864,0.25606,1,1
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0041716,0.28854,0.34246,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0060989,0.28831,0.29277,1,1
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.016339,0.28801,0.3361,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0010528,0.2873,0.20827,1,1
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.015574,0.28706,0.22736,1,1
4,GO REGULATION OF ICOSANOID SECRETION,0.0029794,0.287,0.26984,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00040247,0.28649,0.2888,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0015653,0.28638,0.27445,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,3.0689e-05,0.28622,0.29224,1,1
4,GO OXALATE TRANSPORT,0.00024286,0.28604,0.26582,1,1
4,GO LIPID LOCALIZATION,4.2876e-06,0.28593,0.27614,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.0073e-05,0.28554,0.28524,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.02843,0.28542,0.1678,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0017123,0.28533,0.23935,1,1
4,GO HYALURONAN CATABOLIC PROCESS,0.014486,0.28521,0.14724,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,2.8418e-05,0.28511,0.25292,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0041716,0.28498,0.21552,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00067758,0.28467,0.22649,1,1
4,GO LYTIC VACUOLE ORGANIZATION,1.9904e-06,0.28465,0.31027,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0045306,0.28436,0.18323,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,8.1192e-05,0.28429,0.24131,1,1
4,GO RESPONSE TO LEUCINE,0.036164,0.28405,0.21408,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0064317,0.28403,0.29061,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.023205,0.28402,0.30278,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0062634,0.28385,0.22425,1,1
4,GO AMYLOID BETA CLEARANCE,0.0026572,0.2837,0.20228,1,1
4,GO RESPONSE TO GONADOTROPIN,0.00055855,0.2834,0.26368,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0024367,0.28325,0.24578,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,1.6455e-05,0.28309,0.24785,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.017137,0.28297,0.21347,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.009256,0.28291,0.20846,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.0059384,0.28275,0.20902,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00059588,0.28272,0.22605,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0006154,0.28262,0.26759,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.004408,0.28246,0.21387,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00030804,0.28236,0.31508,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0049174,0.28167,0.25414,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,2.0833e-05,0.28156,0.24713,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0038387,0.28149,0.21728,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00035231,0.28142,0.29904,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.001662,0.28072,0.2279,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0057817,0.28064,0.22271,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00021909,0.28032,0.27987,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.0024367,0.28025,0.30527,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.8521e-05,0.28012,0.29595,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00027832,0.27972,0.3107,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00084609,0.27944,0.20534,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0056288,0.27909,0.1936,1,1
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0054795,0.27901,0.30837,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0028141,0.27896,0.2912,1,1
4,GO AEROBIC RESPIRATION,0.00026003,0.2788,0.25757,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00041602,0.27872,0.30744,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.0073e-05,0.27835,0.26923,1,1
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.03939,0.27823,0.16371,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.042857,0.27815,0.20769,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.014138,0.27807,0.2052,1,1
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0081404,0.27789,0.23076,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.00044439,0.27774,0.27033,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.2454e-05,0.27772,0.25772,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.052669,0.27758,0.23438,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0014299,0.27733,0.20531,1,1
4,GO REGULATION OF B CELL PROLIFERATION,8.7323e-05,0.27594,0.23512,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00014935,0.27587,0.28694,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00030804,0.27561,0.18838,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,4.8379e-05,0.27488,0.30251,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.010773,0.27487,0.20328,1,1
4,GO PH REDUCTION,0.00010845,0.27416,0.23855,1,1
4,GO MAST CELL ACTIVATION,0.00020448,0.27415,0.25458,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00047456,0.27406,0.2368,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00021909,0.27301,0.34337,1,1
4,GO STEROL HOMEOSTASIS,0.0006154,0.27301,0.31018,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.004408,0.27289,0.25838,1,1
4,GO HEME METABOLIC PROCESS,0.0056288,0.27255,0.30069,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0051916,0.27238,0.18099,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00092958,0.27238,0.29334,1,1
4,GO HORMONE METABOLIC PROCESS,0.00010462,0.2723,0.30607,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0034322,0.27228,0.2947,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00065623,0.27219,0.31927,1,1
4,GO FLUID TRANSPORT,2.2524e-05,0.27208,0.25777,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0057817,0.27199,0.25423,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0017123,0.2714,0.19425,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.001662,0.27139,0.21813,1,1
4,GO RESPONSE TO PROTOZOAN,0.00034072,0.2711,0.23699,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.026586,0.27089,0.21698,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0032441,0.27088,0.18119,1,1
4,GO PHAGOSOME MATURATION,5.8301e-05,0.27027,0.29524,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00095906,0.27022,0.24025,1,1
4,GO FUCOSE METABOLIC PROCESS,0.031059,0.27019,0.26478,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.0041716,0.27005,0.25808,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0013457,0.27002,0.22902,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0012662,0.26983,0.19161,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0022992,0.26971,0.30301,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,4.6597e-05,0.26955,0.25269,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00041602,0.26941,0.33044,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.001872,0.26865,0.17649,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0036303,0.26864,0.22213,1,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.0094949,0.26843,0.23705,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.004408,0.26816,0.26412,1,1
4,GO PEROXISOMAL TRANSPORT,2.6307e-05,0.2679,0.26189,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,8.7323e-05,0.26752,0.23489,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.00026903,0.26751,0.27578,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0010206,0.26721,0.20107,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00019753,0.26714,0.2851,1,1
4,GO ALCOHOL METABOLIC PROCESS,5.2139e-05,0.26687,0.24783,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0039469,0.26647,0.23069,1,1
4,GO VIRAL GENOME REPLICATION,0.018398,0.26645,0.14544,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00081984,0.26614,0.19023,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0021689,0.26571,0.29517,1,1
4,GO REGULATION OF CELL KILLING,0.0022992,0.26546,0.20179,1,1
4,GO LIPID DROPLET ORGANIZATION,0.00034072,0.2654,0.26652,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0067808,0.26497,0.19314,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,2.0833e-05,0.26495,0.25284,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.010506,0.26485,0.38572,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00021167,0.26484,0.20995,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00050664,0.26475,0.2578,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.02843,0.26472,0.17475,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.00037661,0.26467,0.25772,1,1
4,GO MUSCLE CELL MIGRATION,0.0081404,0.26447,0.19244,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0042883,0.26425,0.20304,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.043763,0.26406,0.19093,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.013e-05,0.26379,0.25506,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0032441,0.26343,0.19768,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00065623,0.26321,0.28268,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0038387,0.26311,0.20415,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00035231,0.2631,0.33202,1,1
4,GO GRANULOCYTE DIFFERENTIATION,0.049546,0.26308,0.17498,1,1
4,GO CELL KILLING,0.00030804,0.2628,0.20557,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00031859,0.26275,0.25529,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,2.9301e-06,0.26249,0.31965,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.0050528,0.26244,0.18916,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0039469,0.26218,0.21074,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0012662,0.26181,0.18031,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00092958,0.26131,0.20694,1,1
4,GO XENOBIOTIC TRANSPORT,9.7346e-05,0.26099,0.41078,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00023468,0.26098,0.21782,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,2.9532e-05,0.26097,0.33661,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0090226,0.26086,0.25224,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.0551e-05,0.2608,0.23647,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0041716,0.26055,0.2516,1,1
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.031059,0.2604,0.2377,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.012508,0.26036,0.28197,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0015189,0.2603,0.16815,1,1
4,GO LIPID OXIDATION,2.9532e-05,0.26008,0.24921,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.7801e-06,0.25938,0.30587,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00013433,0.25894,0.25543,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.025414,0.25879,0.1975,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00067758,0.25861,0.2386,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0023671,0.2584,0.18831,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.02843,0.258,0.18143,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0024367,0.25764,0.19668,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.001228,0.2573,0.19091,1,1
4,GO AMINO ACID ACTIVATION,0.0053338,0.25714,0.21174,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,6.2786e-05,0.2569,0.23571,1,1
4,GO SECRETION BY TISSUE,0.0011199,0.25686,0.24608,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00074557,0.25645,0.26196,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0047853,0.25628,0.37898,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.001986,0.25606,0.24268,1,1
4,GO ER OVERLOAD RESPONSE,0.0015653,0.25601,0.29676,1,1
4,GO FIBROBLAST PROLIFERATION,0.025994,0.25593,0.13823,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.030383,0.25577,0.19,1,1
4,GO ELECTRON TRANSPORT CHAIN,6.7596e-05,0.2555,0.2644,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.031059,0.25542,0.18585,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,8.7323e-05,0.25501,0.2535,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00050664,0.25482,0.33374,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0012662,0.25455,0.29706,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00054072,0.25431,0.22231,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.025414,0.25431,0.25577,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0013457,0.25408,0.22291,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00063551,0.25376,0.2836,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.044685,0.25332,0.2077,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00018427,0.25325,0.27636,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001986,0.25308,0.24735,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00017796,0.25304,0.24437,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.0011549,0.253,0.24483,1,1
4,GO ARGININE METABOLIC PROCESS,0.0075304,0.25293,0.36045,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0090226,0.25262,0.18772,1,1
4,GO NEUTROPHIL MIGRATION,1.349e-05,0.25238,0.2195,1,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0010206,0.25224,0.26206,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00052342,0.25207,0.22505,1,1
4,GO MAST CELL MEDIATED IMMUNITY,0.00084609,0.25195,0.23359,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0020453,0.25169,0.23778,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0031536,0.25122,0.21939,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00021909,0.25115,0.25679,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0007696,0.25033,0.23534,1,1
4,GO PROTEIN HYDROXYLATION,0.0056288,0.25019,0.24195,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.00084609,0.25009,0.25118,1,1
4,GO B CELL PROLIFERATION,0.00018427,0.25002,0.19386,1,1
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0064317,0.24988,0.25063,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.040234,0.24984,0.1393,1,1
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.041093,0.24961,0.19353,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0038387,0.24935,0.17221,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00027832,0.24878,0.28043,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0049174,0.24844,0.20782,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0017123,0.2484,0.2252,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00012964,0.24838,0.2199,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.013798,0.24835,0.21032,1,1
4,GO RESPONSE TO PH,0.001191,0.24827,0.20553,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.0037331,0.24821,0.25472,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0057817,0.24811,0.16228,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.03939,0.24781,0.23416,1,1
4,GO MUSCLE HYPERTROPHY,0.00040247,0.24771,0.20815,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00050664,0.24766,0.26949,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012662,0.2475,0.1806,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00032948,0.24744,0.23125,1,1
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.029719,0.24742,0.15926,1,1
4,GO CARNITINE SHUTTLE,0.00098941,0.24728,0.25693,1,1
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.033166,0.24704,0.18347,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0007696,0.24692,0.26238,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0050528,0.24692,0.20309,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.016339,0.24691,0.14906,1,1
4,GO OSTEOBLAST PROLIFERATION,0.0019282,0.24683,0.26323,1,1
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.036164,0.24671,0.16294,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.029068,0.24669,0.17826,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0016129,0.24666,0.30152,1,1
4,GO TRANSFERRIN TRANSPORT,6.7596e-05,0.2466,0.29838,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.034637,0.24658,0.13168,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.019739,0.24649,0.17668,1,1
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0015189,0.24642,0.23125,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0029794,0.2464,0.20373,1,1
4,GO GOLGI VESICLE BUDDING,9.0551e-05,0.24615,0.23647,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.24553,0.23532,1,1
4,GO RENAL SODIUM EXCRETION,0.0024367,0.24542,0.20412,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0028957,0.24525,0.36847,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.00079435,0.24504,0.17968,1,1
4,GO RESPONSE TO INSECTICIDE,0.018398,0.24477,0.31181,1,1
4,GO AMINO ACID IMPORT,0.015953,0.24465,0.18768,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0069616,0.24444,0.26446,1,1
4,GO PEPTIDE CATABOLIC PROCESS,0.0021062,0.24438,0.25031,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0045306,0.24436,0.19719,1,1
4,GO ENTRY INTO HOST,0.0039469,0.24429,0.19834,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.021165,0.24415,0.1449,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.001662,0.24402,0.18037,1,1
4,GO DOPAMINE TRANSPORT,0.013798,0.24398,0.26966,1,1
4,GO NOREPINEPHRINE SECRETION,0.0090226,0.24374,0.23448,1,1
4,GO COPII COATED VESICLE BUDDING,0.00017796,0.24364,0.22438,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.2962e-05,0.24358,0.23066,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001547,0.24346,0.20156,1,1
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.0046564,0.24306,0.23582,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0028141,0.24301,0.21421,1,1
4,GO RESPONSE TO PROGESTERONE,0.0050528,0.24299,0.1946,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0010528,0.24286,0.23467,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0057817,0.2423,0.20015,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0064317,0.24212,0.1836,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,0.00010845,0.24192,0.23108,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00054072,0.24172,0.23618,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00032948,0.24133,0.24276,1,1
4,GO AUTOPHAGOSOME MATURATION,0.0006154,0.24116,0.22136,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.0032441,0.24101,0.36002,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0099891,0.2409,0.36562,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.00021909,0.24016,0.28682,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0053338,0.23979,0.20247,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0032441,0.23958,0.17941,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0021689,0.23954,0.24741,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.0022992,0.23936,0.26143,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0010859,0.23924,0.20086,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00047456,0.2392,0.225,1,1
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.036948,0.239,0.17368,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.00059588,0.23895,0.25348,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.052669,0.2389,0.30166,1,1
4,GO ALANINE TRANSPORT,0.0014299,0.23867,0.31602,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,9.0551e-05,0.23867,0.23354,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00013433,0.23853,0.21063,1,1
4,GO LOCOMOTOR RHYTHM,0.010773,0.23835,0.20083,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00021909,0.23796,0.21813,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00029782,0.23791,0.27511,1,1
4,GO MITOCHONDRIAL GENE EXPRESSION,0.010245,0.23777,0.16465,1,1
4,GO SPERM CAPACITATION,0.00098941,0.23735,0.23419,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.4121e-05,0.23725,0.25978,1,1
4,GO RESPONSE TO NUTRIENT,0.0047853,0.23701,0.16319,1,1
4,GO COPULATION,0.0030654,0.23662,0.21508,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00021167,0.23659,0.2281,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.00014418,0.23656,0.4418,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.050569,0.23651,0.18163,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00010845,0.23602,0.22552,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00038934,0.23598,0.19106,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.013139,0.23577,0.18794,1,1
4,GO REGULATION OF B CELL ACTIVATION,7.013e-05,0.23559,0.21174,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.0049174,0.23542,0.18282,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0010859,0.2354,0.27165,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0079323,0.23539,0.17416,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0034322,0.23534,0.26414,1,1
4,GO P38MAPK CASCADE,0.0046564,0.23502,0.17546,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0015189,0.235,0.17041,1,1
4,GO TYPE 2 IMMUNE RESPONSE,0.01282,0.23488,0.17323,1,1
4,GO MAGNESIUM ION TRANSPORT,0.0014738,0.23468,0.23281,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0013054,0.2344,0.19923,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0022992,0.23432,0.19216,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00055855,0.23418,0.19897,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,8.3127e-06,0.23406,0.27612,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.00029782,0.23404,0.20259,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00032948,0.23404,0.24946,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.045624,0.23392,0.13912,1,1
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0025083,0.23391,0.18632,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.0045306,0.23371,0.18348,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.040234,0.23366,0.20853,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0071468,0.23362,0.17712,1,1
4,GO RESPONSE TO ACTIVITY,0.00084609,0.23348,0.21281,1,1
4,GO PEROXISOME ORGANIZATION,3.1888e-05,0.23344,0.24321,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00065623,0.23342,0.20885,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00021167,0.2334,0.23838,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00021909,0.23326,0.3007,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0040578,0.23294,0.19625,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0028141,0.23258,0.42134,1,1
4,GO MITOCHONDRIAL TRANSLATION,0.024846,0.23245,0.1526,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0010528,0.23238,0.1883,1,1
4,GO IMMUNE EFFECTOR PROCESS,0.00021909,0.23227,0.20821,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.015574,0.2321,0.15896,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.03939,0.23188,0.26514,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,8.1192e-05,0.23135,0.2316,1,1
4,GO VESICLE TARGETING,0.0015653,0.23129,0.21625,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.0013054,0.231,0.23423,1,1
4,GO REGULATION OF FERTILIZATION,0.0021689,0.23082,0.28783,1,1
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.030383,0.23066,0.16566,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0024367,0.23037,0.20199,1,1
4,GO GRANULOCYTE MIGRATION,5.2139e-05,0.23028,0.21917,1,1
4,GO LEUKOCYTE MIGRATION,0.0010528,0.23017,0.16697,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.0022332,0.23011,0.18591,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,4.6623e-06,0.22966,0.23985,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0039469,0.22947,0.24512,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,1.0604e-05,0.22941,0.23547,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00084609,0.22933,0.21927,1,1
4,GO MITOCHONDRIAL TRANSCRIPTION,0.013465,0.22929,0.19861,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0056288,0.22897,0.2084,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00010845,0.22897,0.29419,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.001986,0.22894,0.24921,1,1
4,GO MANNOSYLATION,1.7806e-05,0.22889,0.25401,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0066042,0.22865,0.16407,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0032441,0.22864,0.18806,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00013433,0.22852,0.22679,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.00012074,0.22833,0.21037,1,1
4,GO MITOCHONDRIAL TRNA PROCESSING,0.0060989,0.22822,0.23762,1,1
4,GO PHOSPHOLIPID TRANSPORT,3.5759e-05,0.2282,0.22214,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0025817,0.22806,0.15918,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.0021062,0.22784,0.17472,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0014299,0.22777,0.19584,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0087944,0.22744,0.25516,1,1
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0066042,0.2273,0.20787,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0012662,0.22725,0.19253,1,1
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0081404,0.22701,0.18331,1,1
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.038561,0.22696,0.15334,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.0039469,0.22665,0.14767,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0023671,0.22659,0.18119,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0041716,0.22598,0.20894,1,1
4,GO RESPONSE TO ISCHEMIA,0.0011549,0.22554,0.22015,1,1
4,GO COMPLEMENT ACTIVATION,0.0081404,0.2255,0.18098,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00023468,0.22549,0.19206,1,1
4,GO LIPID STORAGE,0.0012662,0.22532,0.22454,1,1
4,GO AMELOGENESIS,0.02843,0.22513,0.19336,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0067808,0.22509,0.16136,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00021909,0.22496,0.23722,1,1
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0049174,0.2249,0.21525,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.013798,0.22464,0.16289,1,1
4,GO LIPID EXPORT FROM CELL,0.001872,0.22463,0.25883,1,1
4,GO SELECTIVE AUTOPHAGY,3.5759e-05,0.2246,0.24307,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.00353,0.22415,0.18448,1,1
4,GO LIPID HOMEOSTASIS,0.00087311,0.22409,0.23868,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0036303,0.2237,0.2034,1,1
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.024288,0.2235,0.15366,1,1
4,GO INNATE IMMUNE RESPONSE,0.00027832,0.22343,0.19633,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0010206,0.22338,0.22187,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.0006154,0.22326,0.19154,1,1
4,GO CELL CHEMOTAXIS,0.00054072,0.22302,0.175,1,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.037747,0.223,0.13317,1,1
4,GO MITOPHAGY,0.001191,0.22291,0.19361,1,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.041967,0.22276,0.15002,1,1
4,GO ACETYL COA METABOLIC PROCESS,0.0022332,0.22264,0.20508,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00017796,0.22246,0.18186,1,1
4,GO CHEMOKINE PRODUCTION,0.011047,0.2224,0.14259,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.0020453,0.22235,0.22122,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.00050664,0.22197,0.17626,1,1
4,GO RESPONSE TO CYTOKINE,0.00049035,0.22196,0.16877,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,6.5149e-05,0.22162,0.24349,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00098941,0.22162,0.21457,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.8379e-05,0.22122,0.22735,1,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.033894,0.2212,0.16639,1,1
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0083534,0.22082,0.21389,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0059384,0.22075,0.21178,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.020205,0.22058,0.15145,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.013465,0.22041,0.14707,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.00087311,0.22038,0.21053,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00028792,0.22037,0.17507,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.012508,0.22035,0.17705,1,1
4,GO CD40 SIGNALING PATHWAY,0.0033369,0.22024,0.16743,1,1
4,GO T CELL MEDIATED IMMUNITY,0.017969,0.21989,0.18456,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.03939,0.21966,0.14452,1,1
4,GO COAGULATION,0.0017123,0.21938,0.16313,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.0028141,0.21936,0.16932,1,1
4,GO WOUND HEALING,0.0067808,0.21933,0.14088,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00014935,0.21902,0.21841,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.026586,0.21894,0.13569,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00012964,0.21881,0.21557,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00074557,0.21876,0.18665,1,1
4,GO HYALURONAN METABOLIC PROCESS,0.0026572,0.21868,0.14977,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0050528,0.21861,0.18319,1,1
4,GO VITAMIN TRANSPORT,0.0081404,0.21861,0.2239,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0010859,0.21835,0.21687,1,1
4,GO CORNIFICATION,0.0021689,0.21827,0.24425,1,1
4,GO REGULATION OF PH,0.00012074,0.21811,0.19975,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.020205,0.21803,0.14643,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.030383,0.21748,0.237,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00065623,0.21737,0.2433,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.029068,0.21723,0.13517,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.031748,0.21719,0.19435,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00012964,0.21674,0.2025,1,1
4,GO REGULATION OF CELLULAR PH,0.00012074,0.21672,0.20037,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,8.6584e-06,0.21645,0.2367,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0026572,0.21629,0.19272,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0021062,0.21625,0.18652,1,1
4,GO MYOBLAST FUSION,0.0034322,0.21617,0.20007,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00034072,0.21605,0.21385,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00074557,0.21585,0.19911,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0054795,0.21561,0.17097,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.0047853,0.21548,0.17874,1,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.02843,0.21512,0.20223,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00026003,0.21504,0.24242,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.013465,0.21442,0.14528,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.041093,0.21416,0.1732,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.037747,0.21415,0.15777,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.02268,0.21414,0.20872,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0006154,0.21412,0.24571,1,1
4,GO GLYCOSYLATION,0.00016595,0.21392,0.22016,1,1
4,GO NUCLEOTIDE TRANSPORT,0.00026003,0.21385,0.21154,1,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0010206,0.21372,0.22737,1,1
4,GO ERK1 AND ERK2 CASCADE,0.015574,0.21353,0.12753,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.013798,0.21307,0.15014,1,1
4,GO INTERLEUKIN 12 PRODUCTION,0.00069957,0.21299,0.19345,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.6455e-05,0.21277,0.22058,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0017123,0.21257,0.16991,1,1
4,GO SPLEEN DEVELOPMENT,0.0056288,0.21229,0.15921,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00028792,0.21206,0.19074,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0026572,0.21205,0.16474,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0028141,0.21198,0.19229,1,1
4,GO REGULATION OF EXCRETION,0.03939,0.21196,0.15348,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.017549,0.2118,0.15417,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0013457,0.21176,0.19283,1,1
4,GO OXIDATION REDUCTION PROCESS,2.5308e-05,0.21174,0.22039,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.017137,0.21167,0.15841,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0040578,0.21165,0.41009,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.030383,0.21161,0.12726,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.0097392,0.21154,0.16443,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00092958,0.21149,0.15191,1,1
4,GO DEFENSE RESPONSE,0.00019079,0.2113,0.18629,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00052342,0.21085,0.21969,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.010245,0.21073,0.13822,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.041967,0.21067,0.211,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0033369,0.21064,0.14557,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.0099891,0.21063,0.23548,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.015574,0.21063,0.20218,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.0081404,0.21061,0.17106,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0025817,0.21043,0.25331,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0060989,0.21039,0.23524,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.5201e-05,0.21036,0.22656,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.001872,0.21025,0.15888,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00353,0.21018,0.1622,1,1
4,GO CELLULAR RESPONSE TO STARVATION,1.4039e-05,0.21014,0.23317,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,1.5816e-05,0.2098,0.23506,1,1
4,GO LYMPHOCYTE MIGRATION,0.0024367,0.20978,0.16305,1,1
4,GO KERATINIZATION,0.0027346,0.2097,0.2022,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0036303,0.20962,0.15979,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0028957,0.20951,0.20859,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.036948,0.20943,0.16374,1,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0073363,0.20941,0.17826,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.037747,0.20936,0.12821,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010506,0.20913,0.14953,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0012662,0.20883,0.18909,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0049174,0.20881,0.18459,1,1
4,GO FATTY ACID TRANSPORT,3.5759e-05,0.20874,0.23105,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0036303,0.20873,0.26461,1,1
4,GO AMINE CATABOLIC PROCESS,0.001986,0.2087,0.31683,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0013872,0.20807,0.16184,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0025817,0.20797,0.15325,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0001165,0.20785,0.18996,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0024367,0.20773,0.19757,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,2.6307e-05,0.20767,0.2128,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00010092,0.20761,0.21528,1,1
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.010773,0.20754,0.17821,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.00018427,0.20754,0.19433,1,1
4,GO RESPONSE TO INTERLEUKIN 1,0.00025131,0.20754,0.17645,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0047853,0.2075,0.16387,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0033369,0.20748,0.18989,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.010773,0.20709,0.14447,1,1
4,GO CELLULAR RESPIRATION,0.00055855,0.207,0.21546,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.019283,0.20699,0.12514,1,1
4,GO PLATELET MORPHOGENESIS,0.001872,0.20679,0.22124,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00034072,0.20674,0.19063,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0025817,0.20672,0.18095,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0047853,0.2067,0.20693,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.013465,0.20667,0.17975,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00026003,0.20657,0.22324,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.010773,0.20656,0.21288,1,1
4,GO REGULATION OF TUBE SIZE,0.00049035,0.2061,0.20925,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0031536,0.20602,0.16054,1,1
4,GO MUSCLE ADAPTATION,0.00353,0.20553,0.15203,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.0013457,0.20522,0.15565,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00020448,0.20509,0.2656,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0045306,0.20502,0.27174,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0017641,0.20475,0.19192,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.010773,0.20462,0.21348,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.0054795,0.20455,0.27801,1,1
4,GO RESPONSE TO CHEMOKINE,0.00013917,0.20447,0.19817,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0036303,0.20416,0.24509,1,1
4,GO FATTY ACID METABOLIC PROCESS,7.2754e-05,0.20344,0.2327,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0047853,0.20342,0.17383,1,1
4,GO PROTEIN KINASE B SIGNALING,0.0064317,0.20342,0.13327,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.009256,0.20341,0.15832,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0067808,0.20335,0.24362,1,1
4,GO RESPONSE TO KETONE,0.001986,0.20303,0.16719,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0029794,0.20301,0.167,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.01282,0.20295,0.1676,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0027346,0.20287,0.18094,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0015189,0.20268,0.21263,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00035231,0.20252,0.19769,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.034637,0.20246,0.10893,1,1
4,GO REGULATION OF LIPID STORAGE,0.0021689,0.20219,0.18497,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,0.0032441,0.20211,0.26645,1,1
4,GO ERAD PATHWAY,0.0075304,0.20208,0.15612,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.001662,0.20198,0.19026,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,0.00057693,0.20192,0.16297,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.0027346,0.20173,0.19888,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0056288,0.20171,0.16382,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00018427,0.20155,0.16871,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.7346e-05,0.20149,0.21548,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00063551,0.20149,0.24128,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.0020453,0.20146,0.19408,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0038387,0.20129,0.13687,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.017969,0.20112,0.23397,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,3.7145e-05,0.20102,0.22256,1,1
4,GO REGULATION OF ISOTYPE SWITCHING,0.013139,0.20079,0.10642,1,1
4,GO T CELL MIGRATION,0.018398,0.2005,0.14443,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0079323,0.20039,0.15348,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00052342,0.20012,0.2057,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00081984,0.2,0.17423,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.05161,0.19989,0.13864,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0014299,0.19989,0.18971,1,1
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0049174,0.19942,0.23417,1,1
4,GO DETECTION OF BIOTIC STIMULUS,0.00353,0.19924,0.24534,1,1
4,GO TRNA 5 LEADER REMOVAL,0.01282,0.19922,0.16476,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.00038934,0.19914,0.17444,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0056288,0.19889,0.20907,1,1
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.035393,0.19876,0.24657,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00027832,0.19871,0.23288,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00079435,0.19868,0.21394,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.0047853,0.19852,0.16187,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00014418,0.19848,0.22972,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.00353,0.19832,0.18227,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.016734,0.19821,0.19299,1,1
4,GO MANGANESE ION TRANSPORT,0.00074557,0.19811,0.2143,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.0097392,0.1981,0.19978,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.001191,0.19785,0.23327,1,1
4,GO REGULATION OF MITOPHAGY,0.0030654,0.19772,0.18235,1,1
4,GO SYNCYTIUM FORMATION,0.0067808,0.1977,0.14886,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.004408,0.1975,0.15799,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.015574,0.19738,0.12651,1,1
4,GO INFLAMMATORY RESPONSE,0.00019079,0.19724,0.18489,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0032441,0.19717,0.15555,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.021165,0.19711,0.10918,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.013465,0.19697,0.14859,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.018836,0.19689,0.15282,1,1
4,GO PROTEASOME ASSEMBLY,0.0028141,0.19671,0.19793,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.020205,0.19654,0.28122,1,1
4,GO CARDIOLIPIN METABOLIC PROCESS,0.050569,0.19647,0.095083,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.011612,0.19623,0.12435,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.033166,0.19602,0.12085,1,1
4,GO CYTOKINE PRODUCTION,0.00087311,0.19565,0.16771,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0007696,0.19541,0.20527,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00025131,0.19521,0.22547,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.00022676,0.19511,0.1768,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.023741,0.19508,0.19439,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.011904,0.1948,0.17543,1,1
4,GO WATER HOMEOSTASIS,0.0081404,0.19471,0.18846,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.023205,0.19444,0.1161,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.01282,0.19436,0.16561,1,1
4,GO DRUG METABOLIC PROCESS,0.0011199,0.19428,0.27799,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.010245,0.19428,0.1622,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.015953,0.19415,0.14316,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.017549,0.19393,0.13001,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0047853,0.19372,0.12832,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.014138,0.19351,0.20818,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.014486,0.1933,0.14431,1,1
4,GO TERPENOID METABOLIC PROCESS,0.018836,0.19326,0.17796,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.049546,0.19317,0.14242,1,1
4,GO HUMORAL IMMUNE RESPONSE,4.6597e-05,0.19299,0.19256,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.011047,0.19296,0.21273,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0011199,0.19278,0.15013,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0079323,0.19265,0.13132,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00079435,0.19188,0.19461,1,1
4,GO PIGMENT METABOLIC PROCESS,0.007729,0.19185,0.18545,1,1
4,GO RESPONSE TO ETHER,0.00095906,0.19157,0.20592,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00050664,0.19147,0.16809,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0020453,0.19134,0.18798,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.014138,0.19134,0.19544,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0034322,0.19097,0.20177,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.00049035,0.19094,0.23477,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00010845,0.19054,0.21089,1,1
4,GO REGULATION OF HORMONE LEVELS,3.5759e-05,0.19042,0.20901,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00012964,0.19037,0.17474,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0062634,0.19021,0.18416,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0023671,0.1902,0.18858,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.0027346,0.19004,0.19984,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0021689,0.19001,0.18871,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00013917,0.18951,0.19902,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.029068,0.18934,0.12182,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0067808,0.1892,0.1824,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00049035,0.18917,0.16872,1,1
4,GO PLATELET AGGREGATION,0.019283,0.18909,0.13658,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.012203,0.18909,0.17243,1,1
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0028957,0.18908,0.26736,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0031536,0.18905,0.17228,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00013917,0.18898,0.18319,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.5816e-05,0.18893,0.24587,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.03939,0.18832,0.18897,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0029794,0.1883,0.15909,1,1
4,GO OSTEOBLAST DEVELOPMENT,0.031748,0.18828,0.089506,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,9.0551e-05,0.18818,0.20162,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0010528,0.1879,0.16899,1,1
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.046579,0.18786,0.21381,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0083534,0.18773,0.12449,1,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.035393,0.18697,0.15899,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.001228,0.18693,0.15815,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.001872,0.1869,0.14404,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00021909,0.18685,0.19643,1,1
4,GO REGULATION OF ANION TRANSPORT,0.00057693,0.1867,0.21464,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0041716,0.18669,0.15903,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.001228,0.18663,0.20154,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.045624,0.1866,0.1292,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0015653,0.18629,0.15117,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00054072,0.18627,0.17049,1,1
4,GO RESPONSE TO VIRUS,0.0045306,0.18597,0.15919,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.00022676,0.18595,0.17305,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.013139,0.1859,0.14055,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.0071468,0.1857,0.21192,1,1
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.031748,0.18569,0.16577,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0059384,0.18513,0.2103,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.0019282,0.18513,0.16761,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.0021689,0.18499,0.15808,1,1
4,GO RESPONSE TO STARVATION,3.5759e-05,0.18491,0.21878,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0054795,0.18475,0.12944,1,1
4,GO B CELL DIFFERENTIATION,0.0001165,0.18459,0.18928,1,1
4,GO POSITIVE CHEMOTAXIS,0.017549,0.18439,0.13029,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.004408,0.18427,0.13681,1,1
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0062634,0.18414,0.19338,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.0036303,0.18397,0.23881,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00030804,0.18369,0.18054,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.013465,0.18361,0.1706,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0038387,0.18331,0.13355,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.00026903,0.18307,0.14785,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.049546,0.183,0.18669,1,1
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.016734,0.18298,0.22473,1,1
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00063551,0.18295,0.21703,1,1
4,GO NOREPINEPHRINE TRANSPORT,0.0062634,0.18291,0.21471,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00069957,0.18262,0.15361,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0021062,0.18247,0.14707,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.023205,0.18246,0.1714,1,1
4,GO CELL ACTIVATION,0.00057693,0.18211,0.1595,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00044439,0.18196,0.16018,1,1
4,GO RESPONSE TO BACTERIUM,0.00045924,0.18173,0.17318,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0017641,0.18149,0.17743,1,1
4,GO FUCOSYLATION,0.041093,0.18136,0.21705,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00028792,0.18134,0.19414,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.017137,0.18125,0.19486,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0042883,0.18082,0.17884,1,1
4,GO NIK NF KAPPAB SIGNALING,0.0014299,0.18082,0.14288,1,1
4,GO RESPONSE TO TESTOSTERONE,0.027803,0.18072,0.13746,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0085714,0.18067,0.17083,1,1
4,GO RESPONSE TO WOUNDING,0.015574,0.18059,0.11337,1,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.024846,0.18016,0.15656,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.0073e-05,0.17983,0.24354,1,1
4,GO LIPID CATABOLIC PROCESS,1.0184e-05,0.17976,0.24028,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0045306,0.17969,0.15962,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0032441,0.17965,0.13049,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.00014418,0.17957,0.18409,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0017641,0.17949,0.23369,1,1
4,GO REGULATION OF PEPTIDE SECRETION,0.00016023,0.17892,0.15827,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00037661,0.17888,0.18217,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00040247,0.17885,0.16308,1,1
4,GO MEMBRANE FUSION,0.00079435,0.17876,0.17356,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.5308e-05,0.17864,0.24447,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.010245,0.17859,0.12224,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.001662,0.1785,0.17607,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.0010528,0.17846,0.16798,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.00023468,0.17801,0.21005,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.0090226,0.17789,0.14569,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0013054,0.17788,0.16604,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.0025083,0.17785,0.15009,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.018836,0.17773,0.14918,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.017549,0.17767,0.12557,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0013054,0.17766,0.17514,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.012508,0.17762,0.19551,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.17761,0.17858,1,1
4,GO LIPID METABOLIC PROCESS,0.00016023,0.17747,0.1807,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00038934,0.17747,0.19372,1,1
4,GO VACUOLE ORGANIZATION,1.8521e-05,0.17745,0.21304,1,1
4,GO ORGANELLE FUSION,0.00021909,0.17736,0.17887,1,1
4,GO RENAL SYSTEM PROCESS,0.0021689,0.17733,0.18061,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0037331,0.17727,0.14498,1,1
4,GO ENERGY HOMEOSTASIS,0.025414,0.17708,0.15722,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0045306,0.17687,0.14023,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0075304,0.17678,0.17709,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.023741,0.17675,0.14516,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,7.547e-05,0.17675,0.13733,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.015953,0.17651,0.16154,1,1
4,GO ORGANIC ANION TRANSPORT,1.7806e-05,0.17644,0.20965,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,3.5759e-05,0.17641,0.23236,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.17636,0.1743,1,1
4,GO RESPONSE TO ALCOHOL,0.001191,0.17624,0.1402,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.017549,0.17598,0.15528,1,1
4,GO PEPTIDE SECRETION,9.7346e-05,0.17589,0.1671,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.009256,0.17583,0.17463,1,1
4,GO LEUKOCYTE PROLIFERATION,0.0016129,0.17577,0.15584,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0001547,0.17571,0.16165,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00072223,0.17517,0.16713,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0037331,0.17516,0.18604,1,1
4,GO B CELL ACTIVATION,0.00027832,0.17504,0.16499,1,1
4,GO EXOCYTOSIS,0.00012074,0.17491,0.18353,1,1
4,GO PLATELET ACTIVATION,0.013465,0.17477,0.12695,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0010206,0.17457,0.16856,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0069616,0.17385,0.14535,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.033894,0.17365,0.12819,1,1
4,GO VIRION ASSEMBLY,0.0025817,0.17347,0.14134,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.001191,0.17331,0.14115,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.011047,0.17324,0.17601,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0046564,0.17318,0.13945,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00047456,0.17302,0.16891,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.001228,0.17297,0.20139,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00036427,0.17293,0.14985,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00030804,0.17291,0.15023,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.0024367,0.17248,0.14971,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.02166,0.17242,0.14316,1,1
4,GO CARBOHYDRATE TRANSPORT,0.00024286,0.17239,0.20128,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0032441,0.17181,0.18379,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0075304,0.17159,0.17769,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,0.00040247,0.17159,0.14518,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0028957,0.17144,0.14546,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.030383,0.17127,0.17314,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.017969,0.171,0.16618,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.040234,0.1706,0.16048,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.00072223,0.1706,0.15048,1,1
4,GO VASCULAR WOUND HEALING,0.046579,0.17059,0.23192,1,1
4,GO DIOL METABOLIC PROCESS,0.010506,0.17035,0.24148,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.011904,0.16994,0.1853,1,1
4,GO TOXIN TRANSPORT,0.0047853,0.16989,0.18854,1,1
4,GO REGULATION OF HORMONE SECRETION,0.0013872,0.16963,0.1507,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00032948,0.16955,0.18449,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00027832,0.16918,0.15644,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00018427,0.16902,0.17565,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0012662,0.16879,0.14875,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0028957,0.16865,0.16542,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.030383,0.16859,0.14867,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.011047,0.16841,0.1535,1,1
4,GO EXCRETION,0.0015653,0.16788,0.17518,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.014841,0.16771,0.16743,1,1
4,GO B CELL HOMEOSTASIS,0.011326,0.16762,0.16865,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0050528,0.16756,0.15549,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.011612,0.16734,0.14521,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00026903,0.16702,0.21833,1,1
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.03245,0.167,0.17792,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.007729,0.16658,0.1423,1,1
4,GO THIOESTER METABOLIC PROCESS,0.0010859,0.16634,0.18927,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,8.1192e-05,0.16633,0.19926,1,1
4,GO CELLULAR PIGMENTATION,0.0049174,0.16632,0.14625,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0030654,0.16629,0.17599,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0025083,0.16609,0.15411,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.02843,0.16579,0.12343,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00010462,0.16578,0.16918,1,1
4,GO PROTEIN PROCESSING,5.4121e-05,0.16573,0.23066,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00049035,0.16564,0.18998,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.00040247,0.16525,0.18376,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.018398,0.16508,0.1562,1,1
4,GO PROTEIN REFOLDING,0.014841,0.165,0.19134,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0015189,0.16482,0.14957,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0034322,0.16447,0.14753,1,1
4,GO GLUCOSE METABOLIC PROCESS,5.508e-06,0.1641,0.22733,1,1
4,GO VIRAL LIFE CYCLE,0.0045306,0.16388,0.12551,1,1
4,GO NECROTIC CELL DEATH,0.0046564,0.16388,0.17365,1,1
4,GO COPPER ION TRANSPORT,0.018398,0.16378,0.16067,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0057817,0.16375,0.12666,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.012203,0.16342,0.12493,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0031536,0.16291,0.12113,1,1
4,GO CHOLESTEROL STORAGE,0.03245,0.16267,0.17254,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.014138,0.16255,0.11044,1,1
4,GO RESPONSE TO STEROL,0.0071468,0.16225,0.21831,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00055855,0.1618,0.19192,1,1
4,GO OXIDATIVE PHOSPHORYLATION,0.0014738,0.16174,0.20209,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.042857,0.16168,0.13837,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.001191,0.16164,0.12877,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,4.8379e-05,0.16151,0.20132,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00019753,0.16134,0.15323,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.014138,0.16131,0.12988,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0026572,0.1612,0.12887,1,1
4,GO T CELL DIFFERENTIATION,0.0019282,0.16118,0.12167,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0071468,0.16089,0.1847,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.02166,0.16088,0.10679,1,1
4,GO ADAPTIVE THERMOGENESIS,0.00069957,0.1607,0.15225,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00095906,0.16063,0.16609,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0067808,0.16061,0.166,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.010506,0.16045,0.1947,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.014138,0.16045,0.12972,1,1
4,GO ATP TRANSPORT,0.043763,0.16036,0.098806,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.00017796,0.16032,0.22778,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.018836,0.15986,0.095919,1,1
4,GO TISSUE HOMEOSTASIS,0.0045306,0.15979,0.14965,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0067808,0.1596,0.10437,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.011326,0.1591,0.10549,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0087944,0.15904,0.11582,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0014299,0.15841,0.13061,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00036427,0.15824,0.15548,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0024367,0.15822,0.12242,1,1
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.024288,0.15818,0.12924,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0054795,0.15804,0.11689,1,1
4,GO REGULATION OF PROTEIN FOLDING,0.038561,0.15789,0.11019,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.013465,0.15766,0.12558,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0085714,0.15715,0.15956,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.010773,0.15714,0.1416,1,1
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0046564,0.15678,0.167,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00021909,0.15676,0.19117,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0013872,0.15648,0.18602,1,1
4,GO REGULATION OF VASOCONSTRICTION,0.0016129,0.15646,0.19814,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.018398,0.15626,0.1213,1,1
4,GO PROTEIN MANNOSYLATION,0.0028141,0.15617,0.16445,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00047456,0.15615,0.20418,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.011612,0.15605,0.13044,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.043763,0.15591,0.12368,1,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0054795,0.15489,0.14951,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.013465,0.15486,0.15658,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.025994,0.15484,0.13765,1,1
4,GO PROTEIN MATURATION,0.00016023,0.15424,0.19098,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.00022676,0.15391,0.18422,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0066042,0.15388,0.15998,1,1
4,GO SODIUM ION HOMEOSTASIS,0.03939,0.15376,0.13046,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.0031536,0.15372,0.18175,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0012662,0.15368,0.19699,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,0.15366,0.15593,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00072223,0.15361,0.17365,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.001228,0.15356,0.16085,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0054795,0.15346,0.11423,1,1
4,GO RESPONSE TO DSRNA,0.0037331,0.15297,0.13685,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0031536,0.15273,0.1308,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.042857,0.15263,0.1325,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0007696,0.15259,0.16304,1,1
4,GO T CELL APOPTOTIC PROCESS,0.020205,0.15249,0.13354,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.025414,0.15243,0.13378,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0064317,0.15223,0.15137,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.050569,0.15216,0.15286,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0041716,0.15193,0.15829,1,1
4,GO DE NOVO PROTEIN FOLDING,0.00353,0.15189,0.16804,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00022676,0.15184,0.18554,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.0025817,0.15184,0.10719,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0045306,0.15178,0.11347,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.010245,0.15153,0.1496,1,1
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0032441,0.15122,0.20075,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00044439,0.15116,0.15244,1,1
4,GO GOLGI ORGANIZATION,4.8379e-05,0.15093,0.18175,1,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0018173,0.1508,0.25606,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00012964,0.15078,0.18979,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0040578,0.15074,0.1606,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0012662,0.15061,0.13623,1,1
4,GO MACROPHAGE ACTIVATION,0.0011549,0.15041,0.14348,1,1
4,GO ANION TRANSPORT,4.4878e-05,0.1504,0.18256,1,1
4,GO MITOCHONDRIAL FISSION,0.021165,0.15028,0.17224,1,1
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.033894,0.14984,0.12826,1,1
4,GO BICARBONATE TRANSPORT,0.0067808,0.14928,0.17816,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.007729,0.14925,0.14809,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0066042,0.14912,0.15971,1,1
4,GO CHOLESTEROL EFFLUX,0.0094949,0.14909,0.1785,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0066042,0.14818,0.14413,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.013139,0.14814,0.121,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00081984,0.148,0.17444,1,1
4,GO AGING,0.0013457,0.14787,0.12882,1,1
4,GO RESPONSE TO GAMMA RADIATION,0.007729,0.1477,0.11618,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0083534,0.14756,0.14887,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.052669,0.14749,0.10156,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0021689,0.14748,0.16734,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.047551,0.14744,0.093164,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.030383,0.14743,0.11604,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0026572,0.14741,0.16723,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0019282,0.14738,0.16024,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.00035231,0.14722,0.16301,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00079435,0.14654,0.13758,1,1
4,GO ORGANELLE DISASSEMBLY,0.00014935,0.14649,0.16851,1,1
4,GO DEFENSE RESPONSE TO FUNGUS,0.017137,0.14645,0.11059,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.024288,0.14638,0.13723,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014486,0.14622,0.18376,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0056288,0.14595,0.14513,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00095906,0.14555,0.18044,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0051916,0.14538,0.11311,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.038561,0.14495,0.20164,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.011047,0.14484,0.097693,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00095906,0.14478,0.13272,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00067758,0.14459,0.16162,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00014935,0.14454,0.1665,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.036164,0.1443,0.13224,1,1
4,GO REPLICATIVE SENESCENCE,0.015574,0.14421,0.18991,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.015574,0.14402,0.13986,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0087944,0.14379,0.12479,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0045306,0.14338,0.15357,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.02166,0.14321,0.16438,1,1
4,GO ORGANIC ACID TRANSPORT,5.4121e-05,0.14295,0.21312,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.0060989,0.1424,0.1758,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.023741,0.14236,0.14159,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.011326,0.14219,0.16105,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.010245,0.14191,0.11189,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.015574,0.14141,0.12195,1,1
4,GO T CELL ACTIVATION,0.0071468,0.14124,0.11801,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0015653,0.14104,0.14243,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0014738,0.14097,0.16492,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.012203,0.14094,0.14471,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.0010528,0.14084,0.15859,1,1
4,GO CHEMICAL HOMEOSTASIS,0.00050664,0.14063,0.13659,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00021167,0.14039,0.17915,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0085714,0.14038,0.10249,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0027346,0.14029,0.14521,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.029719,0.14025,0.17597,1,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.034637,0.14023,0.20955,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.021165,0.14023,0.086235,1,1
4,GO RESPONSE TO HORMONE,0.0015653,0.13995,0.13183,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.009256,0.13994,0.1309,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.015953,0.13962,0.12957,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00041602,0.13943,0.1488,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00044439,0.13923,0.1258,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0023671,0.13911,0.15636,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00095906,0.13905,0.12694,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0085714,0.13899,0.10646,1,1
4,GO VITAMIN METABOLIC PROCESS,0.013465,0.1389,0.1773,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00092958,0.13888,0.14623,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0028141,0.13884,0.14626,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0071468,0.13865,0.14147,1,1
4,GO IRON ION TRANSPORT,0.00026003,0.13853,0.21441,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.0025083,0.13846,0.13199,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00084609,0.13806,0.16915,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.015203,0.13789,0.089584,1,1
4,GO PHAGOCYTOSIS,0.024846,0.13778,0.10361,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.00019079,0.1375,0.14775,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0053338,0.13734,0.16139,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0030654,0.13718,0.12704,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.020205,0.13701,0.13156,1,1
4,GO RESPONSE TO DRUG,0.007729,0.13693,0.12666,1,1
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.033894,0.13668,0.11844,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.019283,0.13658,0.13296,1,1
4,GO VESICLE ORGANIZATION,0.001228,0.13599,0.14859,1,1
4,GO SECRETION,0.00028792,0.13587,0.15079,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.019283,0.13585,0.15675,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.015953,0.13578,0.19212,1,1
4,GO RESPONSE TO LIPID,0.0042883,0.13571,0.11749,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0041716,0.13551,0.12509,1,1
4,GO WATER TRANSPORT,0.026586,0.1355,0.10024,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.037747,0.13514,0.13909,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.036164,0.13511,0.12198,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00087311,0.1351,0.15115,1,1
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.001662,0.13499,0.14318,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.007729,0.13493,0.10025,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0049174,0.13467,0.15487,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,9.7346e-05,0.13467,0.18052,1,1
4,GO LYSOSOME LOCALIZATION,0.0067808,0.13462,0.13117,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0049174,0.13427,0.11797,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.052669,0.13386,0.11288,1,1
4,GO T CELL PROLIFERATION,0.012508,0.13374,0.12469,1,1
4,GO GOLGI RIBBON FORMATION,0.021165,0.13356,0.15571,1,1
4,GO LIPID MODIFICATION,0.00055855,0.13355,0.16072,1,1
4,GO PROTEIN FOLDING,0.010245,0.1333,0.12876,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0022992,0.13273,0.16455,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00353,0.1326,0.11266,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0081404,0.13238,0.13701,1,1
4,GO REGULATION OF APPETITE,0.047551,0.13186,0.092237,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0097392,0.13134,0.11755,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0024367,0.13128,0.20244,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00032948,0.13125,0.1447,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.001191,0.13104,0.14043,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.01282,0.13057,0.16101,1,1
4,GO RESPONSE TO UV C,0.041093,0.13043,0.14477,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.020205,0.12975,0.12065,1,1
4,GO VIRAL BUDDING,0.0073363,0.12945,0.13853,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0037331,0.12927,0.1198,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.021165,0.12881,0.13004,1,1
4,GO REGULATION OF HEMOPOIESIS,0.0033369,0.12816,0.10881,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.041093,0.12809,0.096513,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0014299,0.12777,0.15001,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00079435,0.12753,0.17929,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0030654,0.12745,0.11409,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00084609,0.12717,0.16575,1,1
4,GO INORGANIC ANION TRANSPORT,0.0006154,0.12715,0.13338,1,1
4,GO MUSCLE CELL PROLIFERATION,0.050569,0.12713,0.080805,1,1
4,GO METAL ION HOMEOSTASIS,0.012508,0.12698,0.1005,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0007696,0.12692,0.14627,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.019283,0.12683,0.091322,1,1
4,GO BODY FLUID SECRETION,0.023741,0.12667,0.098303,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0039469,0.12645,0.12756,1,1
4,GO REGULATION OF CELL ADHESION,0.017969,0.12625,0.10705,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0025083,0.12615,0.1169,1,1
4,GO TEMPERATURE HOMEOSTASIS,0.0066042,0.12604,0.12082,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0016129,0.12601,0.11356,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.033166,0.12595,0.13095,1,1
4,GO ION HOMEOSTASIS,0.0040578,0.12579,0.1143,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.050569,0.12546,0.10784,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.0038387,0.12447,0.1291,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.014486,0.1243,0.11433,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.023741,0.12421,0.1292,1,1
4,GO CYTOKINE SECRETION,0.011047,0.12417,0.12603,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00353,0.12416,0.13233,1,1
4,GO RESPONSE TO FUNGUS,0.013465,0.12399,0.10503,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0045306,0.12395,0.12912,1,1
4,GO LYMPHOCYTE ACTIVATION,0.0067808,0.12379,0.10376,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.041093,0.12369,0.097727,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.004408,0.12313,0.1307,1,1
4,GO STEROL IMPORT,0.009256,0.12309,0.28995,1,1
4,GO SYMBIOTIC PROCESS,0.010245,0.12303,0.092802,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0041716,0.12298,0.09939,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00031859,0.12289,0.14778,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.011612,0.12274,0.12337,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0013054,0.12252,0.12831,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0050528,0.12182,0.12835,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.026586,0.12162,0.11154,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00045924,0.12157,0.19705,1,1
4,GO RESPONSE TO INSULIN,0.001191,0.12157,0.14092,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0010859,0.12102,0.12546,1,1
4,GO PROTEOLYSIS,0.00050664,0.12012,0.12381,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.02268,0.12008,0.12086,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0042883,0.11998,0.12181,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.041093,0.11988,0.10679,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.001191,0.11974,0.15894,1,1
4,GO PEPTIDE METABOLIC PROCESS,0.037747,0.11972,0.089605,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00026903,0.11963,0.15804,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.0071468,0.11942,0.139,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0099891,0.11906,0.09211,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0028957,0.11851,0.12109,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.025414,0.11829,0.1058,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0025817,0.11754,0.13418,1,1
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0099891,0.11741,0.11588,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00092958,0.11709,0.11867,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.024846,0.11695,0.1099,1,1
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.017969,0.11645,0.14456,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.034637,0.11608,0.090024,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.0017123,0.11598,0.17431,1,1
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.031059,0.11587,0.072181,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.001872,0.11579,0.10093,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00013433,0.11574,0.16257,1,1
4,GO PROTEIN DESTABILIZATION,0.014138,0.11572,0.10118,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.045624,0.1155,0.11867,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0023671,0.11541,0.11905,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.012203,0.11519,0.10875,1,1
4,GO URONIC ACID METABOLIC PROCESS,0.0067808,0.1145,0.19911,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.009256,0.11436,0.12076,1,1
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11393,0.095372,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.010506,0.11389,0.11113,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0045306,0.11332,0.099897,1,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.02268,0.1133,0.091653,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.010506,0.11328,0.10974,1,1
4,GO ATP METABOLIC PROCESS,0.0045306,0.11301,0.13321,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.00072223,0.1127,0.11168,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0047853,0.11261,0.1176,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0039469,0.11251,0.10167,1,1
4,GO ENDOSOME ORGANIZATION,0.0046564,0.11243,0.14184,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0054795,0.11237,0.11392,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0075304,0.11217,0.13546,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.00032948,0.11163,0.14537,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.012508,0.11038,0.09534,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.00034072,0.11032,0.14784,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.013798,0.11017,0.14044,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0028141,0.1101,0.11619,1,1
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.03245,0.10962,0.13103,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.043763,0.10961,0.11069,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0064317,0.10942,0.1056,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.018836,0.10927,0.097589,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0047853,0.10918,0.10888,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.010773,0.10916,0.096674,1,1
4,GO BLASTOCYST FORMATION,0.031748,0.1089,0.14096,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.013798,0.10884,0.099417,1,1
4,GO REGULATION OF PROTEIN BINDING,0.014138,0.10817,0.10933,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0015653,0.10805,0.13702,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.047551,0.10803,0.091949,1,1
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.017137,0.10788,0.12353,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0012662,0.10764,0.11934,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.029719,0.10723,0.093752,1,1
4,GO DETECTION OF STIMULUS,0.0046564,0.10718,0.088749,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.015203,0.10713,0.10042,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00353,0.10712,0.15427,1,1
4,GO TISSUE MIGRATION,0.017969,0.10698,0.12031,1,1
4,GO EPITHELIUM DEVELOPMENT,0.013798,0.10633,0.087919,1,1
4,GO RESPONSE TO PEPTIDE,0.0064317,0.10601,0.094036,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.019283,0.1056,0.11492,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.03939,0.10518,0.095703,1,1
4,GO GLAND DEVELOPMENT,0.045624,0.1051,0.067318,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0069616,0.10485,0.11043,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.030383,0.10478,0.10545,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0067808,0.10463,0.1897,1,1
4,GO SOMITOGENESIS,0.013139,0.10429,0.10753,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.045624,0.10425,0.094761,1,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.013139,0.10336,0.13466,1,1
4,GO REGULATION OF CELL DEATH,0.010773,0.10288,0.083823,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0029794,0.10287,0.10305,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.004408,0.10284,0.10222,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.010506,0.10276,0.088639,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.027803,0.10271,0.073213,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.014138,0.10267,0.10256,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00074557,0.10244,0.14583,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.0081404,0.10216,0.10865,1,1
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.0097392,0.10175,0.10913,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.017549,0.10129,0.10299,1,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.029719,0.10095,0.086133,1,1
4,GO LYMPH NODE DEVELOPMENT,0.02843,0.10033,0.16296,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0071468,0.1003,0.10717,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.0099891,0.10006,0.10944,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.009256,0.1,0.093125,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0067808,0.09997,0.084744,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.019739,0.099872,0.083354,1,1
4,GO RESPONSE TO ESTRADIOL,0.04854,0.099803,0.079487,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0049174,0.099753,0.12591,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.019283,0.099523,0.096254,1,1
4,GO HOMEOSTATIC PROCESS,0.00049035,0.099521,0.11233,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.022165,0.099191,0.10324,1,1
4,GO FEEDING BEHAVIOR,0.041967,0.098187,0.11078,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.046579,0.097672,0.065138,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.0046564,0.09737,0.11058,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0029794,0.097107,0.11889,1,1
4,GO TOR SIGNALING,0.0057817,0.096753,0.078851,1,1
4,GO CELL MATURATION,0.017137,0.096314,0.089084,1,1
4,GO PROTEIN STABILIZATION,0.011904,0.096232,0.092506,1,1
4,GO MACROPHAGE DIFFERENTIATION,0.047551,0.095982,0.14833,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.033166,0.095842,0.085118,1,1
4,GO APOPTOTIC PROCESS,0.012203,0.09514,0.082211,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.012508,0.094713,0.10858,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0028141,0.09466,0.10723,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.025414,0.094041,0.08104,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0057817,0.093853,0.093783,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.041967,0.09381,0.12731,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0017123,0.093756,0.12428,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.02268,0.093405,0.096739,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.033166,0.093283,0.088096,1,1
4,GO CYTOSOLIC TRANSPORT,0.001986,0.093246,0.11173,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0097392,0.092608,0.10815,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.023741,0.092141,0.069123,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.0034322,0.091686,0.10408,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.015574,0.091644,0.084057,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.034637,0.091122,0.1066,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.040234,0.090071,0.06737,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.0037331,0.089758,0.089863,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0040578,0.089419,0.10312,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.031059,0.088809,0.078274,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0017123,0.088711,0.096205,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.01282,0.088358,0.076629,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.015574,0.08809,0.10185,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.043763,0.087755,0.064542,1,1
4,GO REGULATION OF MAPK CASCADE,0.016339,0.087654,0.09578,1,1
4,GO MYELOID CELL HOMEOSTASIS,0.022165,0.086761,0.095737,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.0085714,0.086685,0.10582,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.025994,0.084637,0.10024,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.027803,0.084144,0.13174,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.044685,0.083502,0.09586,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.019739,0.083293,0.073606,1,1
4,GO MACROMOLECULE CATABOLIC PROCESS,0.015953,0.083107,0.063505,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.025414,0.082442,0.11383,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.010773,0.081256,0.081288,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,0.079932,0.09102,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.01282,0.079797,0.095366,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0057817,0.079525,0.080926,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0081404,0.078815,0.081126,1,1
4,GO SPERM EGG RECOGNITION,0.037747,0.078581,0.10102,1,1
4,GO VESICLE LOCALIZATION,0.030383,0.078508,0.089721,1,1
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.021165,0.077873,0.060323,1,1
4,GO REGULATION OF TOR SIGNALING,0.011326,0.077455,0.085733,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.037747,0.076461,0.070279,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0075304,0.075877,0.1138,1,1
4,GO CELLULAR HOMEOSTASIS,0.007729,0.074895,0.10047,1,1
4,GO MITOCHONDRION ORGANIZATION,0.0030654,0.074121,0.11021,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0083534,0.07412,0.10844,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.013798,0.072705,0.094551,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0042883,0.071136,0.11831,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.013798,0.069171,0.079692,1,1
4,GO DNA CATABOLIC PROCESS,0.017969,0.067745,0.076268,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.025414,0.067342,0.075306,1,1
4,GO POLYOL METABOLIC PROCESS,0.033894,0.066985,0.10431,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.023205,0.065624,0.090241,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.05161,0.064423,0.065301,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.02843,0.064105,0.066887,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.035393,0.063795,0.070517,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.024846,0.06336,0.078795,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.024846,0.062854,0.071982,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.021165,0.058308,0.074103,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.013798,0.05541,0.092012,1,1
4,GO INTRACELLULAR TRANSPORT,0.0051916,0.054562,0.070717,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.02068,0.054076,0.068106,1,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.016339,0.053053,0.056536,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.018398,0.051948,0.067328,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.015953,0.047617,0.074138,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0097392,0.046732,0.071514,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.046579,0.045235,0.062255,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.011047,0.69088,0.79354,1,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.036164,0.46086,0.35554,1,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.0031536,0.42795,0.42405,1,0
4,GO REGULATION OF PLATELET AGGREGATION,0.03939,0.39485,0.22884,1,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0075304,0.38303,0.3582,1,0
4,GO REFLEX,0.0025083,0.37775,0.35188,1,0
4,GO REGULATION OF PLATELET ACTIVATION,0.011326,0.37013,0.24635,1,0
4,GO ETHANOL OXIDATION,0.00059588,0.36287,0.57531,1,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0067808,0.34537,0.29879,1,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00095906,0.34475,0.36957,1,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00098941,0.32215,0.30421,1,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0028141,0.29489,0.34157,1,0
4,GO SEROTONIN METABOLIC PROCESS,0.0037331,0.29033,0.34523,1,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0075304,0.28943,0.24183,1,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0094949,0.28779,0.27695,1,0
4,GO RESPONSE TO REDOX STATE,0.0030654,0.28565,0.26721,1,0
4,GO RESPIRATORY BURST,0.00047456,0.27626,0.26151,1,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00063551,0.2751,0.32246,1,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.026586,0.26627,0.18942,1,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.0040578,0.25955,0.27661,1,0
4,GO RESPONSE TO MAGNESIUM ION,0.016339,0.25637,0.2367,1,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0069616,0.25595,0.2327,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.017137,0.25369,0.33137,1,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.041093,0.24724,0.22519,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.007729,0.24495,0.23335,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.023741,0.24203,0.17906,1,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0007696,0.24123,0.28518,1,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.23659,0.19614,1,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.029719,0.23615,0.17395,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.041093,0.23218,0.24091,1,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0054795,0.23207,0.23972,1,0
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00049035,0.23174,0.22269,1,0
4,GO LUNG CELL DIFFERENTIATION,0.024846,0.23038,0.30355,1,0
4,GO PROTEIN ACTIVATION CASCADE,0.02166,0.22731,0.34389,1,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.020205,0.22681,0.13207,1,0
4,GO LIPID TRANSLOCATION,0.0013054,0.22583,0.2219,1,0
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.013798,0.22557,0.19456,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.004408,0.22038,0.26363,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.025994,0.21983,0.17968,1,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.022165,0.21917,0.22319,1,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.036164,0.21638,0.14417,1,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.027803,0.21355,0.15068,1,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.022165,0.21315,0.28242,1,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.013798,0.20876,0.21806,1,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.024846,0.20366,0.21414,1,0
4,GO MONOCYTE CHEMOTAXIS,0.022165,0.20285,0.14594,1,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0069616,0.20189,0.17692,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0033369,0.19987,0.16222,1,0
4,GO HEPATOCYTE DIFFERENTIATION,0.033894,0.19903,0.18642,1,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.007729,0.19893,0.17212,1,0
4,GO RESPONSE TO INTERLEUKIN 2,0.0085714,0.19877,0.19557,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00092958,0.19769,0.19042,1,0
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0034322,0.19744,0.2036,1,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0049174,0.19732,0.17082,1,0
4,GO RESPONSE TO INTERLEUKIN 15,0.021165,0.19468,0.19905,1,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.011904,0.19441,0.16061,1,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.007729,0.19407,0.27336,1,0
4,GO NEURONAL ACTION POTENTIAL,0.02068,0.19396,0.24156,1,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.02843,0.18886,0.10554,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.18661,0.18751,1,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0017641,0.18656,0.18822,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.050569,0.185,0.15926,1,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0042883,0.1814,0.1634,1,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.014138,0.18069,0.22425,1,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0056288,0.18029,0.22574,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.042857,0.17953,0.19146,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.027803,0.17725,0.18241,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0015653,0.17595,0.15751,1,0
4,GO CELL CELL JUNCTION ASSEMBLY,0.015574,0.17218,0.15964,1,0
4,GO PIGMENTATION,0.0018173,0.17194,0.1455,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.041093,0.1713,0.19127,1,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.044685,0.17058,0.14085,1,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.007729,0.16952,0.13602,1,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0075304,0.16944,0.23577,1,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.024288,0.16681,0.14159,1,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.017137,0.16418,0.23011,1,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.02068,0.16187,0.15012,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.031059,0.16182,0.2279,1,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.045624,0.16166,0.15168,1,0
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16101,0.14938,1,0
4,GO LIPID IMPORT INTO CELL,0.034637,0.16052,0.17466,1,0
4,GO HORMONE TRANSPORT,0.0010206,0.15917,0.15982,1,0
4,GO REGULATION OF HEART RATE,0.03245,0.15679,0.13187,1,0
4,GO ENDOCYTIC RECYCLING,0.031059,0.15677,0.097871,1,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.017549,0.1565,0.20175,1,0
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.017969,0.15637,0.20868,1,0
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.041967,0.1563,0.13119,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.033894,0.15581,0.13568,1,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.012508,0.15515,0.19196,1,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0020453,0.15506,0.1937,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0097392,0.15459,0.17733,1,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0041716,0.15388,0.20173,1,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.045624,0.15385,0.15257,1,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.010245,0.15373,0.22583,1,0
4,GO ADRENAL GLAND DEVELOPMENT,0.020205,0.15267,0.20331,1,0
4,GO PEPTIDE HORMONE SECRETION,0.0022332,0.15256,0.14911,1,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.0097392,0.1513,0.13465,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0022332,0.14938,0.19602,1,0
4,GO RESPONSE TO METAL ION,0.0025817,0.14901,0.14658,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0090226,0.14846,0.16332,1,0
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0021689,0.14711,0.15426,1,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.012203,0.14572,0.23107,1,0
4,GO HAIR CELL DIFFERENTIATION,0.015574,0.14564,0.1655,1,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.024846,0.14539,0.20208,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.029719,0.14313,0.14016,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.011612,0.14182,0.17627,1,0
4,GO RESPONSE TO MECHANICAL STIMULUS,0.0016129,0.14042,0.14034,1,0
4,GO CHLORIDE TRANSPORT,0.0014738,0.14024,0.13387,1,0
4,GO EPIDERMIS DEVELOPMENT,0.013798,0.13949,0.12497,1,0
4,GO CELL CELL JUNCTION ORGANIZATION,0.031059,0.13863,0.14646,1,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.045624,0.13806,0.2566,1,0
4,GO MIDBODY ABSCISSION,0.023205,0.13748,0.17609,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.021165,0.13723,0.11437,1,0
4,GO MYOTUBE DIFFERENTIATION,0.011326,0.13595,0.12121,1,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.015953,0.13489,0.20039,1,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.045624,0.1348,0.17301,1,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.021165,0.13377,0.10741,1,0
4,GO AMYLOID BETA METABOLIC PROCESS,0.031748,0.1327,0.14716,1,0
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.011326,0.13232,0.11366,1,0
4,GO ACTIN NUCLEATION,0.013139,0.12973,0.13808,1,0
4,GO INTERACTION WITH HOST,0.0090226,0.12955,0.13244,1,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.024846,0.12852,0.14195,1,0
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.019283,0.12801,0.15342,1,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.03939,0.1279,0.18283,1,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0069616,0.1276,0.1573,1,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0083534,0.12759,0.12051,1,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.02166,0.12732,0.13802,1,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.027803,0.12694,0.2026,1,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.043763,0.12677,0.103,1,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.021165,0.12625,0.23093,1,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.011326,0.12493,0.1165,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.011326,0.12476,0.13119,1,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.052669,0.12446,0.10634,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.017969,0.12426,0.095795,1,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0029794,0.12406,0.22713,1,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0025083,0.12372,0.17325,1,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.013465,0.12341,0.1299,1,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.013465,0.12331,0.11522,1,0
4,GO SKIN DEVELOPMENT,0.014486,0.12325,0.12077,1,0
4,GO MONONUCLEAR CELL MIGRATION,0.029068,0.12313,0.10605,1,0
4,GO ACID SECRETION,0.02068,0.12089,0.14191,1,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.041967,0.12038,0.096551,1,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0062634,0.11989,0.10832,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.05161,0.11934,0.086714,1,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.047551,0.11732,0.10906,1,0
4,GO MACROPHAGE CHEMOTAXIS,0.049546,0.11516,0.081813,1,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.041093,0.11497,0.11589,1,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.015203,0.11441,0.17166,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.021165,0.11404,0.21365,1,0
4,GO INTERLEUKIN 6 PRODUCTION,0.015203,0.11122,0.13374,1,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.042857,0.1084,0.12713,1,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.007729,0.10822,0.10966,1,0
4,GO EATING BEHAVIOR,0.025414,0.10766,0.12055,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.02068,0.10679,0.11164,1,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.027188,0.10619,0.15125,1,0
4,GO RESPONSE TO IRON ION,0.023205,0.10595,0.16341,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.041967,0.10539,0.099784,1,0
4,GO EXECUTION PHASE OF APOPTOSIS,0.00055855,0.10511,0.15444,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.017549,0.10469,0.093796,1,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.023741,0.10446,0.11614,1,0
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.1044,0.21895,1,0
4,GO MAINTENANCE OF LOCATION,0.013798,0.10388,0.10006,1,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0053338,0.10314,0.11309,1,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.029719,0.10296,0.14325,1,0
4,GO STEROID CATABOLIC PROCESS,0.037747,0.10249,0.22454,1,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.012508,0.10128,0.13167,1,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.031059,0.10104,0.14806,1,0
4,GO IRON ION HOMEOSTASIS,0.026586,0.099012,0.13555,1,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.034637,0.098799,0.11316,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.03939,0.097667,0.15432,1,0
4,GO ION TRANSPORT,0.0031536,0.097666,0.11907,1,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.03939,0.0976,0.091992,1,0
4,GO ORGANELLE INHERITANCE,0.027803,0.09665,0.10913,1,0
4,GO VACUOLAR TRANSPORT,0.001986,0.096403,0.14679,1,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.050569,0.095497,0.086398,1,0
4,GO NOTCH SIGNALING PATHWAY,0.011612,0.094949,0.11643,1,0
4,GO VIRAL RELEASE FROM HOST CELL,0.023205,0.094532,0.13128,1,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.03245,0.093606,0.15759,1,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.04854,0.09294,0.12144,1,0
4,GO RESPONSE TO CALCIUM ION,0.0083534,0.092715,0.14643,1,0
4,GO CIRCULATORY SYSTEM PROCESS,0.0090226,0.092586,0.10505,1,0
4,GO TRANSMEMBRANE TRANSPORT,0.0023671,0.092555,0.11911,1,0
4,GO REGULATION OF SECRETION,0.0027346,0.092275,0.11674,1,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.025994,0.090493,0.18607,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.044685,0.089894,0.09638,1,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.010773,0.089075,0.090712,1,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.037747,0.088907,0.083482,1,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.019739,0.088575,0.11378,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.036948,0.088033,0.15249,1,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0079323,0.087382,0.11887,1,0
4,GO ION TRANSMEMBRANE TRANSPORT,0.022165,0.083883,0.092448,1,0
4,GO REGULATION OF CHEMOTAXIS,0.052669,0.08288,0.068263,1,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.043763,0.081508,0.090808,1,0
4,GO REGULATION OF HYDROLASE ACTIVITY,0.033166,0.081411,0.074549,1,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.025994,0.080818,0.10872,1,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.031059,0.080528,0.089925,1,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.024288,0.080077,0.094193,1,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.024846,0.080051,0.12757,1,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.018836,0.079486,0.087089,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0083534,0.076955,0.12097,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.035393,0.076953,0.073469,1,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.015574,0.076909,0.087422,1,0
4,GO RESPONSE TO NITROGEN COMPOUND,0.0056288,0.076745,0.088607,1,0
4,GO ENDOSOMAL TRANSPORT,0.0053338,0.074986,0.083348,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE,0.010773,0.074366,0.092986,1,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.023741,0.073304,0.1572,1,0
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.02166,0.072951,0.10855,1,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.052669,0.072654,0.082405,1,0
4,GO CATION TRANSPORT,0.047551,0.070602,0.083693,1,0
4,GO LYSOSOMAL TRANSPORT,0.014486,0.070567,0.13364,1,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.025414,0.068168,0.10715,1,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.025994,0.06815,0.070831,1,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.038561,0.066515,0.088955,1,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.041093,0.06476,0.088517,1,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.019283,0.064283,0.095713,1,0
4,GO TRANSEPITHELIAL TRANSPORT,0.046579,0.064059,0.17437,1,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.036948,0.061242,0.052971,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.031059,0.059997,0.080192,1,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.015953,0.059143,0.076852,1,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.037747,0.057886,0.080965,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0015189,0.057644,0.11626,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.015203,0.055271,0.078431,1,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.033894,0.055066,0.10425,1,0
4,GO MACROAUTOPHAGY,0.0021689,0.05403,0.11899,1,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.044685,0.049726,0.063743,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.036948,0.045458,0.046077,1,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.030383,0.045415,0.071062,1,0
4,GO REGULATION OF TRANSPORT,0.034637,0.044451,0.063723,1,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.041093,0.043983,0.061041,1,0
4,GO REGULATION OF AUTOPHAGY,0.0067808,0.042983,0.10079,1,0
4,GO MEMBRANE ORGANIZATION,0.023741,0.040325,0.080229,1,0
4,GO REGULATION OF MACROAUTOPHAGY,0.035393,0.021805,0.089176,1,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.025414,-0.045449,-0.057036,1,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0090226,-0.045596,-0.059002,1,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.036948,-0.047834,-0.04351,1,0
4,GO DNA REPAIR,0.010245,-0.051486,-0.055881,1,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.041967,-0.055629,-0.08284,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.0083534,-0.057225,-0.065663,1,0
4,GO HISTONE MONOUBIQUITINATION,0.027803,-0.057483,-0.098995,1,0
4,GO CELL CYCLE PROCESS,0.036164,-0.05883,-0.039539,1,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.02268,-0.058878,-0.11042,1,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.035393,-0.062475,-0.092723,1,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.0013054,-0.062932,-0.064211,1,0
4,GO HISTONE UBIQUITINATION,0.034637,-0.064558,-0.078895,1,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.016339,-0.065809,-0.1161,1,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.041093,-0.066031,-0.10332,1,0
4,GO DNA GEOMETRIC CHANGE,0.026586,-0.066069,-0.078455,1,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.045624,-0.066477,-0.077602,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.0041716,-0.067062,-0.079845,1,0
4,GO CHROMOSOME ORGANIZATION,0.0032441,-0.067222,-0.058262,1,0
4,GO DNA RECOMBINATION,0.02166,-0.067718,-0.055124,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.02166,-0.067734,-0.091762,1,0
4,GO PROTEIN ACETYLATION,0.0042883,-0.067754,-0.053243,1,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.027188,-0.06776,-0.097033,1,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0099891,-0.068114,-0.068024,1,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.042857,-0.06831,-0.098832,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.038561,-0.068353,-0.074534,1,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.046579,-0.068884,-0.093867,1,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.038561,-0.069537,-0.059869,1,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.034637,-0.070068,-0.17721,1,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.038561,-0.071212,-0.060366,1,0
4,GO CHROMOSOME SEPARATION,0.036164,-0.07144,-0.080916,1,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.026586,-0.071651,-0.15196,1,0
4,GO SENSORY ORGAN DEVELOPMENT,0.052669,-0.07244,-0.074766,1,0
4,GO PROTEIN MONOUBIQUITINATION,0.0060989,-0.073837,-0.080951,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.001872,-0.074589,-0.097534,1,0
4,GO MRNA PROCESSING,0.0024367,-0.07522,-0.084211,1,0
4,GO COVALENT CHROMATIN MODIFICATION,0.0015189,-0.076087,-0.080653,1,0
4,GO REGULATION OF DNA BINDING,0.013798,-0.076314,-0.089035,1,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.052669,-0.07649,-0.09915,1,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.019283,-0.076839,-0.07672,1,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.050569,-0.076851,-0.13068,1,0
4,GO DNA CONFORMATION CHANGE,0.0023671,-0.076972,-0.088285,1,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.011047,-0.078255,-0.10595,1,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.010245,-0.08083,-0.11914,1,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.041093,-0.081295,-0.14028,1,0
4,GO DEVELOPMENTAL GROWTH,0.026586,-0.082189,-0.084302,1,0
4,GO REGULATION OF RNA SPLICING,0.0036303,-0.082841,-0.091044,1,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.0026572,-0.085238,-0.081851,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.034637,-0.085342,-0.073101,1,0
4,GO MUSCLE FILAMENT SLIDING,0.046579,-0.086033,-0.17539,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.041093,-0.086848,-0.14715,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0064317,-0.087247,-0.093098,1,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.010245,-0.087493,-0.1095,1,0
4,GO MAINTENANCE OF CELL NUMBER,0.0022992,-0.08885,-0.13336,1,0
4,GO RNA SPLICING,0.00050664,-0.089446,-0.10129,1,0
4,GO CELLULAR RESPONSE TO X RAY,0.017969,-0.08953,-0.19339,1,0
4,GO INNER EAR MORPHOGENESIS,0.052669,-0.090533,-0.095818,1,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.026586,-0.092964,-0.11231,1,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.03245,-0.093511,-0.08417,1,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.049546,-0.094122,-0.082826,1,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.041093,-0.094324,-0.13141,1,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.033166,-0.094757,-0.14794,1,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.018398,-0.095657,-0.080285,1,0
4,GO MRNA 3 END PROCESSING,0.0050528,-0.095754,-0.10615,1,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.049546,-0.096146,-0.093669,1,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.017969,-0.096314,-0.17264,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0054795,-0.096734,-0.10177,1,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.00353,-0.096855,-0.097618,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.045624,-0.097068,-0.14426,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00041602,-0.097226,-0.11574,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.015953,-0.097756,-0.09348,1,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0071468,-0.098915,-0.15673,1,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0085714,-0.099642,-0.08905,1,0
4,GO PEPTIDYL LYSINE METHYLATION,0.0011199,-0.10038,-0.11092,1,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0025083,-0.10087,-0.091216,1,0
4,GO CELL CYCLE DNA REPLICATION,0.00069957,-0.10094,-0.14429,1,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.024846,-0.10134,-0.12414,1,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0071468,-0.10157,-0.10095,1,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0064317,-0.10239,-0.090215,1,0
4,GO MRNA TRANSPORT,0.010773,-0.10343,-0.097867,1,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.046579,-0.1042,-0.2053,1,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.047551,-0.10427,-0.068322,1,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0067808,-0.10456,-0.089668,1,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0060989,-0.10467,-0.14006,1,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0067808,-0.10572,-0.08234,1,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.052669,-0.10615,-0.099444,1,0
4,GO HISTONE H3 K4 METHYLATION,0.011047,-0.10635,-0.10764,1,0
4,GO REGULATION OF DNA RECOMBINATION,0.0064317,-0.1068,-0.1011,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.0037331,-0.1071,-0.12628,1,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.041093,-0.10718,-0.088746,1,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.00069957,-0.10754,-0.11631,1,0
4,GO AXIS ELONGATION,0.040234,-0.10784,-0.17776,1,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.0014738,-0.10814,-0.13636,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.027803,-0.10818,-0.13121,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.029719,-0.10847,-0.11346,1,0
4,GO CHROMOSOME SEGREGATION,0.0012662,-0.10855,-0.094152,1,0
4,GO RNA STABILIZATION,0.011326,-0.10886,-0.12362,1,0
4,GO L GLUTAMATE IMPORT,0.037747,-0.10966,-0.15934,1,0
4,GO EYE MORPHOGENESIS,0.024846,-0.11017,-0.10528,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.037747,-0.11138,-0.075167,1,0
4,GO RECOMBINATIONAL REPAIR,0.00042998,-0.11144,-0.11884,1,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.0010859,-0.1116,-0.11281,1,0
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0036303,-0.1118,-0.18159,1,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.027803,-0.11191,-0.18509,1,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.033894,-0.11344,-0.10905,1,0
4,GO DNA STRAND ELONGATION,0.015203,-0.11351,-0.13856,1,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.029068,-0.11579,-0.082756,1,0
4,GO DNA REPLICATION CHECKPOINT,0.0050528,-0.11662,-0.15879,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.024288,-0.11701,-0.10764,1,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.042857,-0.11701,-0.11115,1,0
4,GO CELL DIVISION,0.00072223,-0.11759,-0.093107,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.031059,-0.11772,-0.20178,1,0
4,GO HEAD DEVELOPMENT,0.0025083,-0.11777,-0.10077,1,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.013465,-0.11859,-0.098321,1,0
4,GO CELL PROJECTION ORGANIZATION,0.0023671,-0.11864,-0.10662,1,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0051916,-0.1187,-0.094307,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.012508,-0.1195,-0.10935,1,0
4,GO MICROTUBULE BASED TRANSPORT,0.0047853,-0.11968,-0.11248,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.049546,-0.12025,-0.18409,1,0
4,GO DNA DEPENDENT DNA REPLICATION,0.00074557,-0.1204,-0.12946,1,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.0057817,-0.12071,-0.12259,1,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.015953,-0.12094,-0.15565,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00012512,-0.12205,-0.12987,1,0
4,GO SINGLE STRAND BREAK REPAIR,0.010245,-0.12259,-0.14412,1,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.05161,-0.12294,-0.10012,1,0
4,GO CHROMOSOME CONDENSATION,0.0031536,-0.12306,-0.1448,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.024288,-0.12308,-0.15959,1,0
4,GO DNA REPLICATION INITIATION,0.00032948,-0.12315,-0.17739,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00026903,-0.12481,-0.13039,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0014299,-0.12661,-0.11725,1,0
4,GO HISTONE H4 DEACETYLATION,0.052669,-0.12703,-0.15358,1,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.011904,-0.1273,-0.17675,1,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.00023468,-0.12754,-0.13351,1,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.0018173,-0.12806,-0.19048,1,0
4,GO TRANSPORT ALONG MICROTUBULE,0.00018427,-0.12928,-0.13614,1,0
4,GO REGULATION OF ORGAN GROWTH,0.011326,-0.12999,-0.14175,1,0
4,GO CHROMATIN REMODELING,7.8282e-05,-0.13048,-0.12226,1,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.05161,-0.13054,-0.14623,1,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.026586,-0.13067,-0.10001,1,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.029719,-0.13181,-0.17323,1,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.026586,-0.13363,-0.13512,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0073363,-0.13422,-0.1935,1,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.026586,-0.13523,-0.1328,1,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0094949,-0.13537,-0.11435,1,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00012512,-0.13666,-0.12484,1,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.011612,-0.137,-0.15397,1,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0036303,-0.13796,-0.16431,1,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.031059,-0.1382,-0.096238,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001228,-0.13838,-0.13068,1,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0036303,-0.13839,-0.1128,1,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0062634,-0.13881,-0.20232,1,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00020448,-0.13901,-0.16415,1,0
4,GO STEM CELL PROLIFERATION,0.023205,-0.13985,-0.10814,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0013872,-0.14021,-0.11268,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.014841,-0.14159,-0.085166,1,0
4,GO CELL MORPHOGENESIS,0.0026572,-0.14275,-0.12687,1,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.011612,-0.1433,-0.14468,1,0
4,GO REGULATION OF CELL DEVELOPMENT,0.0028957,-0.14335,-0.10992,1,0
4,GO GTP METABOLIC PROCESS,0.036948,-0.14424,-0.17339,1,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.043763,-0.14477,-0.11327,1,0
4,GO LYMPH VESSEL DEVELOPMENT,0.018836,-0.14555,-0.17204,1,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.0032441,-0.14689,-0.1209,1,0
4,GO NEUROGENESIS,0.0010528,-0.148,-0.12286,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.036948,-0.14895,-0.21063,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.031748,-0.14968,-0.08893,1,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0022332,-0.14976,-0.17131,1,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.0053338,-0.15001,-0.17824,1,0
4,GO DEVELOPMENTAL CELL GROWTH,0.0056288,-0.15033,-0.1348,1,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0032441,-0.15049,-0.21305,1,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.042857,-0.1514,-0.10168,1,0
4,GO REPLICATION FORK PROCESSING,0.0020453,-0.15189,-0.16821,1,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.0083534,-0.15241,-0.17289,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.012508,-0.15292,-0.16159,1,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.011612,-0.15311,-0.10958,1,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.0007696,-0.15315,-0.1484,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.017969,-0.15426,-0.14625,1,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.019283,-0.15458,-0.13249,1,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018398,-0.15507,-0.21921,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00037661,-0.15555,-0.15415,1,0
4,GO REGULATION OF MRNA PROCESSING,5.4121e-05,-0.15586,-0.13757,1,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.0039469,-0.15599,-0.11386,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.025994,-0.15718,-0.15769,1,0
4,GO RETROGRADE AXONAL TRANSPORT,0.027188,-0.15792,-0.18687,1,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0090226,-0.15812,-0.1441,1,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0042883,-0.1583,-0.17103,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.0020453,-0.15881,-0.20505,1,0
4,GO NUCLEOSOME ORGANIZATION,0.00014418,-0.15889,-0.14776,1,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0062634,-0.15895,-0.21453,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0033369,-0.15909,-0.15896,1,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.011326,-0.15932,-0.13849,1,0
4,GO REGULATION OF DNA REPAIR,1.3441e-06,-0.15938,-0.15464,1,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0023671,-0.16047,-0.22716,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0042883,-0.16249,-0.16729,1,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.023205,-0.16298,-0.15423,1,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0045306,-0.16315,-0.13476,1,0
4,GO HISTONE EXCHANGE,0.0050528,-0.16354,-0.13005,1,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.018398,-0.16443,-0.33543,1,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.3654e-06,-0.16496,-0.15308,1,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.0079323,-0.16633,-0.18124,1,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.038561,-0.16679,-0.17561,1,0
4,GO REGULATION OF HEART GROWTH,0.00065623,-0.1672,-0.19341,1,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001228,-0.16767,-0.13725,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00014418,-0.16874,-0.15229,1,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0047853,-0.16991,-0.14365,1,0
4,GO HISTONE H3 K9 ACETYLATION,0.0011199,-0.16999,-0.16334,1,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.014841,-0.17023,-0.10917,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0099891,-0.17141,-0.1649,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0028957,-0.17259,-0.2089,1,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.013798,-0.17318,-0.14611,1,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.02068,-0.17381,-0.12169,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0069616,-0.17412,-0.1516,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.011326,-0.17549,-0.24908,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,1.6455e-05,-0.17661,-0.16768,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.001191,-0.17877,-0.22026,1,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.049546,-0.17915,-0.17958,1,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,2.0833e-05,-0.17971,-0.18535,1,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.02843,-0.17992,-0.31032,1,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.0079323,-0.17995,-0.21837,1,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0013872,-0.18031,-0.16276,1,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.024288,-0.18091,-0.21548,1,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.011612,-0.18108,-0.14012,1,0
4,GO KINETOCHORE ORGANIZATION,0.0062634,-0.18241,-0.19033,1,0
4,GO NUCLEAR PORE ORGANIZATION,0.033166,-0.18296,-0.11937,1,0
4,GO MITOCHONDRION DISTRIBUTION,0.026586,-0.18352,-0.13345,1,0
4,GO REGULATION OF MYELINATION,0.00026003,-0.18365,-0.18962,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0033369,-0.18402,-0.22421,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0081404,-0.18404,-0.25067,1,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0064317,-0.18475,-0.17741,1,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0087944,-0.18496,-0.19107,1,0
4,GO NEURON PROJECTION REGENERATION,0.0021062,-0.18568,-0.18316,1,0
4,GO LEARNING,0.0079323,-0.18648,-0.1649,1,0
4,GO TELENCEPHALON DEVELOPMENT,6.2786e-05,-0.1865,-0.18023,1,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00010092,-0.18691,-0.17629,1,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0051916,-0.18703,-0.23461,1,0
4,GO CELL AGGREGATION,0.02843,-0.18745,-0.17331,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.9263e-05,-0.1875,-0.18148,1,0
4,GO PROTEIN DEMETHYLATION,0.00016595,-0.18779,-0.21423,1,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.025994,-0.18896,-0.19061,1,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0062634,-0.18899,-0.1606,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00079435,-0.18903,-0.20308,1,0
4,GO SNORNA 3 END PROCESSING,0.014841,-0.18904,-0.20036,1,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.00090094,-0.19003,-0.15336,1,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.010773,-0.19076,-0.12649,1,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0094949,-0.19078,-0.2146,1,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.00040247,-0.19262,-0.18735,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.029068,-0.19263,-0.12721,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.030383,-0.19268,-0.20739,1,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.015203,-0.19271,-0.19369,1,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00044439,-0.19299,-0.17273,1,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.017969,-0.19366,-0.13326,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.0010528,-0.19409,-0.23992,1,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00027832,-0.19506,-0.27628,1,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,3.1888e-05,-0.19566,-0.15308,1,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00090094,-0.19623,-0.20171,1,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.052669,-0.19696,-0.11578,1,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.021165,-0.19999,-0.19737,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.011904,-0.20077,-0.16959,1,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.034637,-0.20173,-0.16542,1,0
4,GO KINETOCHORE ASSEMBLY,0.017137,-0.20216,-0.17668,1,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.049546,-0.20237,-0.13187,1,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00090094,-0.20437,-0.23699,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.046579,-0.2049,-0.18002,1,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0022332,-0.20561,-0.1865,1,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.018398,-0.20605,-0.16956,1,0
4,GO LYMPHANGIOGENESIS,0.00074557,-0.20778,-0.25871,1,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.011904,-0.20814,-0.19389,1,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.010773,-0.20889,-0.15456,1,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0023671,-0.20934,-0.16373,1,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00019079,-0.21034,-0.20047,1,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.041093,-0.21146,-0.1845,1,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.045624,-0.21247,-0.17774,1,0
4,GO RESPIRATORY SYSTEM PROCESS,0.0013457,-0.21594,-0.2181,1,0
4,GO NEGATIVE CHEMOTAXIS,0.041093,-0.2171,-0.19884,1,0
4,GO HIPPOCAMPUS DEVELOPMENT,9.0551e-05,-0.21801,-0.22749,1,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.00014418,-0.21842,-0.22932,1,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0015189,-0.21907,-0.18106,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00031859,-0.22194,-0.21585,1,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.017137,-0.22236,-0.19064,1,0
4,GO CARDIOBLAST DIFFERENTIATION,0.0019282,-0.22261,-0.31358,1,0
4,GO THALAMUS DEVELOPMENT,0.024288,-0.22326,-0.20813,1,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,6.2786e-05,-0.22327,-0.26188,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00044439,-0.22369,-0.24535,1,0
4,GO BONE GROWTH,0.0038387,-0.2264,-0.26042,1,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0036303,-0.22686,-0.1498,1,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0010859,-0.22826,-0.20245,1,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.014486,-0.22876,-0.19352,1,0
4,GO NEURAL CREST FORMATION,0.013465,-0.22888,-0.23155,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.001228,-0.2302,-0.26698,1,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.037747,-0.23035,-0.27655,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.0021689,-0.23199,-0.27812,1,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.019283,-0.23339,-0.22916,1,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.029068,-0.23438,-0.18835,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00012074,-0.23632,-0.28941,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0053338,-0.23718,-0.23433,1,0
4,GO NEURAL TUBE PATTERNING,0.00025131,-0.23722,-0.22389,1,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.007729,-0.23762,-0.20379,1,0
4,GO NEUROBLAST PROLIFERATION,0.00037661,-0.23801,-0.23111,1,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0049174,-0.2393,-0.2313,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0036303,-0.23933,-0.1801,1,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.033894,-0.24086,-0.1983,1,0
4,GO GENETIC IMPRINTING,0.0016129,-0.24123,-0.23285,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.007729,-0.24229,-0.16027,1,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.009256,-0.24259,-0.2358,1,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.015953,-0.24326,-0.20891,1,0
4,GO HIPPO SIGNALING,0.0007696,-0.24735,-0.30354,1,0
4,GO MRNA SPLICE SITE SELECTION,0.00025131,-0.24813,-0.23498,1,0
4,GO LEUKOCYTE AGGREGATION,0.018398,-0.24861,-0.32541,1,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0083534,-0.2501,-0.23139,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.022165,-0.25025,-0.26239,1,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.015953,-0.25107,-0.164,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0019282,-0.25194,-0.21488,1,0
4,GO REGULATION OF STEM CELL DIVISION,0.0016129,-0.25242,-0.25358,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00030804,-0.25315,-0.22586,1,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0064317,-0.25832,-0.25201,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00021167,-0.25939,-0.25634,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,4.8379e-05,-0.26014,-0.31099,1,0
4,GO DENTATE GYRUS DEVELOPMENT,0.04854,-0.26221,-0.18486,1,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.00032948,-0.26291,-0.23187,1,0
4,GO MEMBRANE BIOGENESIS,0.0051916,-0.2639,-0.22915,1,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.001228,-0.26441,-0.21661,1,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.033894,-0.26553,-0.17926,1,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.012508,-0.26571,-0.2728,1,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.001872,-0.26896,-0.30901,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00026003,-0.26926,-0.28599,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0015189,-0.2693,-0.21331,1,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0013872,-0.27148,-0.24818,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,6.5149e-05,-0.27432,-0.28777,1,0
4,GO DNA LIGATION,0.0040578,-0.27433,-0.20619,1,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.00017186,-0.27577,-0.23615,1,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0075304,-0.27712,-0.21936,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.00050664,-0.28148,-0.25355,1,0
4,GO COCHLEA DEVELOPMENT,0.00049035,-0.28239,-0.24864,1,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00025131,-0.2847,-0.33921,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.00034072,-0.28601,-0.22527,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.016339,-0.28744,-0.22928,1,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00059588,-0.28787,-0.40617,1,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0056288,-0.29101,-0.32963,1,0
4,GO NEURON PROJECTION ORGANIZATION,0.00022676,-0.29112,-0.25351,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0049174,-0.29259,-0.21028,1,0
4,GO BONE TRABECULA FORMATION,0.013798,-0.29379,-0.37101,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.013465,-0.29404,-0.17607,1,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0021689,-0.29635,-0.25703,1,0
4,GO FOREBRAIN MORPHOGENESIS,0.0028957,-0.2965,-0.22858,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0090226,-0.29843,-0.2687,1,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.0056288,-0.30328,-0.24478,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,5.2139e-05,-0.30595,-0.34884,1,0
4,GO NEPHRON TUBULE FORMATION,0.0075304,-0.30669,-0.30667,1,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0038387,-0.30823,-0.22245,1,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.001986,-0.31058,-0.36484,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.020205,-0.31361,-0.18726,1,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.00035231,-0.31726,-0.27831,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0021689,-0.32062,-0.28254,1,0
4,GO RESPONSE TO L GLUTAMATE,0.00059588,-0.32432,-0.36726,1,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00016023,-0.32876,-0.23635,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00017186,-0.32894,-0.36695,1,0
4,GO MYOBLAST MIGRATION,0.012508,-0.32932,-0.33883,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.0037331,-0.33352,-0.29475,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00040247,-0.33562,-0.32882,1,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0012662,-0.33959,-0.35442,1,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00021909,-0.34173,-0.30533,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00032948,-0.34442,-0.34463,1,0
4,GO CHROMATIN DISASSEMBLY,5.0683e-06,-0.34552,-0.33422,1,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0067808,-0.34682,-0.41803,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00045924,-0.3502,-0.3589,1,0
4,GO FOREBRAIN REGIONALIZATION,0.0006154,-0.35132,-0.32772,1,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0039469,-0.35177,-0.29246,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0045306,-0.3532,-0.26664,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00021909,-0.35654,-0.37192,1,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,4.2876e-06,-0.35692,-0.38786,1,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.00044439,-0.35764,-0.34136,1,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00028792,-0.36006,-0.32495,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.014138,-0.36452,-0.24403,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,7.3528e-06,-0.37522,-0.37822,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00023468,-0.37569,-0.41539,1,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0064317,-0.38022,-0.26733,1,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00353,-0.38215,-0.38275,1,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.019739,-0.38377,-0.32482,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00037661,-0.38405,-0.30052,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,3.1888e-05,-0.39072,-0.39785,1,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,3.5759e-05,-0.392,-0.35924,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00037661,-0.3947,-0.40748,1,0
4,GO HEART VALVE FORMATION,0.0053338,-0.39569,-0.34676,1,0
4,GO LATERAL MESODERM DEVELOPMENT,0.00019753,-0.39612,-0.41901,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,1.0604e-05,-0.40684,-0.41826,1,0
4,GO SYNAPTIC VESICLE MATURATION,0.0054795,-0.43645,-0.2884,1,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,8.6584e-06,-0.43921,-0.45719,1,0
4,GO LIMB BUD FORMATION,0.031059,-0.46676,-0.29961,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.00041602,-0.46685,-0.35138,1,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,8.4205e-05,-0.48092,-0.46939,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00010462,-0.48285,-0.55397,1,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.023741,-0.49378,-0.31909,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00022676,-0.50704,-0.44558,1,0
4,GO TONGUE MORPHOGENESIS,0.0049174,-0.52182,-0.36814,1,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.011326,-0.52602,-0.34476,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,1.0604e-05,-0.52893,-0.53899,1,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00023468,-0.53503,-0.5101,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.9418e-06,-0.54981,-0.55863,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,1.2454e-05,-0.57738,-0.58596,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,1.7118e-05,-0.57738,-0.55454,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,6.0504e-05,-0.58407,-0.48989,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00038934,-0.58818,-0.68582,1,0
4,GO TELENCEPHALON REGIONALIZATION,0.00036427,-0.59831,-0.4799,1,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,8.7323e-05,-0.63619,-0.49461,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,4.3218e-05,-0.64858,-0.59343,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,6.7596e-05,-0.65974,-0.49829,1,0
4,GO CARDIAC CHAMBER FORMATION,0.00017796,-0.66975,-0.57085,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,1.2962e-05,-0.6724,-0.53918,1,0
4,GO POSTSYNAPSE ASSEMBLY,5.8301e-05,-0.71684,-0.5955,1,0
4,GO CARDIAC VENTRICLE FORMATION,0.00028792,-0.72391,-0.61711,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.7343e-05,-0.74414,-0.77234,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.065563,0.64118,0.33172,0,1
4,GO NEGATIVE REGULATION OF CELL KILLING,0.072231,0.54616,0.28223,0,1
4,GO FIBRINOLYSIS,0.073629,0.40486,0.30352,0,1
4,GO ADHESION OF SYMBIONT TO HOST,0.076492,0.40285,0.25132,0,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.14285,0.37463,0.16419,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.070855,0.37167,0.2716,0,1
4,GO RESPONSE TO EPINEPHRINE,0.066855,0.36295,0.2382,0,1
4,GO LIVER REGENERATION,0.1028,0.29859,0.11657,0,1
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.15264,0.29324,0.18148,0,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.12259,0.29186,0.13924,0,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.082489,0.28545,0.070062,0,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.075049,0.28149,0.19464,0,1
4,GO INTERLEUKIN 5 PRODUCTION,0.072231,0.28078,0.17078,0,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.053746,0.27819,0.17958,0,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.14285,0.26848,0.14002,0,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.065563,0.26197,0.17777,0,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.057089,0.2573,0.13193,0,1
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.12473,0.25568,0.14388,0,1
4,GO PANCREATIC JUICE SECRETION,0.066855,0.25285,0.1601,0,1
4,GO IMMATURE T CELL PROLIFERATION,0.082489,0.24945,0.22617,0,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.063042,0.24076,0.1573,0,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.13583,0.2386,0.11852,0,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.073629,0.23845,0.11797,0,1
4,GO IMP METABOLIC PROCESS,0.47049,0.23802,0.067506,0,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.18219,0.23653,0.10106,0,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.088862,0.23585,0.091052,0,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.10654,0.23225,0.14038,0,1
4,GO GLYCINE METABOLIC PROCESS,0.13814,0.23063,0.18826,0,1
4,GO MUSCLE ATROPHY,0.085627,0.23035,0.16436,0,1
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.25363,0.22964,0.030992,0,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.10096,0.22958,0.12046,0,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.054842,0.22872,0.16101,0,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.068167,0.22773,0.2007,0,1
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.14285,0.22566,0.090103,0,1
4,GO ETHER BIOSYNTHETIC PROCESS,0.18508,0.22376,0.059476,0,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.10096,0.22271,0.23502,0,1
4,GO FATTY ACID HOMEOSTASIS,0.12259,0.22058,0.15688,0,1
4,GO STORE OPERATED CALCIUM ENTRY,0.060602,0.21941,0.1644,0,1
4,GO REGULATION OF PROTON TRANSPORT,0.072231,0.21695,0.15298,0,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.2,0.2167,0.12874,0,1
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.21256,0.21554,0.12269,0,1
4,GO REGULATION OF VESICLE FUSION,0.061812,0.21514,0.19079,0,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.090515,0.21481,0.14621,0,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.25001,0.20884,0.046217,0,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.05824,0.2077,0.11238,0,1
4,GO RESPONSE TO PROSTAGLANDIN,0.085627,0.2067,0.18376,0,1
4,GO DORSAL AORTA DEVELOPMENT,0.0695,0.20581,0.15702,0,1
4,GO DETOXIFICATION,0.055956,0.20555,0.16416,0,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.077957,0.20532,0.1753,0,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.32938,0.20483,0.10182,0,1
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.063042,0.20122,0.22949,0,1
4,GO CELLULAR OXIDANT DETOXIFICATION,0.05824,0.19805,0.14219,0,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.11235,0.19788,0.16219,0,1
4,GO PSEUDOURIDINE SYNTHESIS,0.33812,0.19757,0.084162,0,1
4,GO OUTER DYNEIN ARM ASSEMBLY,0.22905,0.19656,0.099335,0,1
4,GO CAMP METABOLIC PROCESS,0.079444,0.19558,0.14573,0,1
4,GO NAD BIOSYNTHETIC PROCESS,0.084046,0.19529,0.1483,0,1
4,GO DENDRITIC CELL MIGRATION,0.053746,0.19404,0.11468,0,1
4,GO TRANSLATIONAL TERMINATION,0.063042,0.19308,0.12032,0,1
4,GO RIBOSOME ASSEMBLY,0.12049,0.19213,0.12469,0,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.25729,0.19146,0.091137,0,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.080955,0.18751,0.15612,0,1
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.26847,0.18641,0.087915,0,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.088862,0.18544,0.11428,0,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.099158,0.18544,0.095771,0,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.072231,0.18496,0.16686,0,1
4,GO LINOLEIC ACID METABOLIC PROCESS,0.14048,0.18432,0.16654,0,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.1028,0.18371,0.10211,0,1
4,GO MYELIN MAINTENANCE,0.1028,0.18319,0.17715,0,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.092194,0.18258,0.12497,0,1
4,GO CYTOLYSIS,0.070855,0.18154,0.14577,0,1
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.15517,0.18129,0.13635,0,1
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.33373,0.1796,0.07271,0,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.22235,0.17766,0.13455,0,1
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.12259,0.1762,0.08269,0,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.064293,0.17566,0.11236,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.054842,0.1756,0.11046,0,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.088862,0.17552,0.17541,0,1
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.26098,0.17516,0.044654,0,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.1028,0.17503,0.1094,0,1
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.066855,0.17493,0.15567,0,1
4,GO MACROPHAGE APOPTOTIC PROCESS,0.05824,0.17478,0.16695,0,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.093897,0.17286,0.16892,0,1
4,GO LYMPHOCYTE CHEMOTAXIS,0.070855,0.17284,0.078021,0,1
4,GO POSITIVE REGULATION OF CELL AGING,0.064293,0.1725,0.15643,0,1
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.099158,0.17218,0.13328,0,1
4,GO PODOSOME ASSEMBLY,0.68418,0.17077,-0.0023683,0,1
4,GO RECEPTOR CATABOLIC PROCESS,0.061812,0.16964,0.091169,0,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.20937,0.16676,0.14283,0,1
4,GO AMMONIUM TRANSPORT,0.10845,0.16649,0.09913,0,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.068167,0.16534,0.1109,0,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.088862,0.16495,0.15862,0,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.059411,0.16471,0.10218,0,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.097379,0.1646,0.10742,0,1
4,GO RNA 5 END PROCESSING,0.10465,0.16337,0.098843,0,1
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.072231,0.16311,0.097893,0,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.054842,0.16293,0.12476,0,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.23589,0.1625,0.080106,0,1
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.22568,0.16125,0.049676,0,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.097379,0.1591,0.15859,0,1
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.093897,0.15861,0.075192,0,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.055956,0.15843,0.10931,0,1
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.10465,0.15761,0.21058,0,1
4,GO ALDITOL METABOLIC PROCESS,0.20309,0.15709,0.077743,0,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.097379,0.15678,0.20615,0,1
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.10845,0.15646,0.15737,0,1
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.15517,0.15617,0.15631,0,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.075049,0.15499,0.16567,0,1
4,GO RIG I SIGNALING PATHWAY,0.079444,0.15313,0.082132,0,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.11235,0.15299,0.092229,0,1
4,GO SECRETORY GRANULE ORGANIZATION,0.072231,0.15242,0.10783,0,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.15015,0.1523,0.064366,0,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.18219,0.15188,0.069246,0,1
4,GO T CELL CYTOKINE PRODUCTION,0.090515,0.15087,0.13493,0,1
4,GO RESPONSE TO LIGHT INTENSITY,0.12473,0.15037,0.082928,0,1
4,GO MONOAMINE TRANSPORT,0.061812,0.15,0.18579,0,1
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.13814,0.14921,0.070431,0,1
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.15517,0.14834,0.10255,0,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.10096,0.14781,0.15045,0,1
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.26847,0.14653,0.07923,0,1
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.14769,0.14614,0.070679,0,1
4,GO LEUKOCYTE HOMEOSTASIS,0.060602,0.14598,0.095141,0,1
4,GO REGULATION OF PROTEIN IMPORT,0.070855,0.14543,0.0893,0,1
4,GO RESPONSE TO VITAMIN,0.31653,0.14511,0.042358,0,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.097379,0.14401,0.074913,0,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.27999,0.14299,0.042444,0,1
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.4978,0.14274,0.04991,0,1
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.27999,0.14232,0.097356,0,1
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.16294,0.14038,0.10016,0,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.32506,0.13945,0.050479,0,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.057089,0.13921,0.095266,0,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.05824,0.13921,0.13313,0,1
4,GO L AMINO ACID TRANSPORT,0.05824,0.13886,0.1373,0,1
4,GO TRNA 5 END PROCESSING,0.066855,0.13877,0.10947,0,1
4,GO LYMPHOCYTE COSTIMULATION,0.087232,0.13836,0.094189,0,1
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.23937,0.13803,0.12214,0,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.059411,0.13783,0.093098,0,1
4,GO MAMMARY GLAND MORPHOGENESIS,0.05824,0.13782,0.13131,0,1
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.2,0.13731,0.09007,0,1
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.21256,0.13727,0.038479,0,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.13355,0.13716,0.11218,0,1
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.064293,0.13648,0.085447,0,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.073629,0.13629,0.13482,0,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.10654,0.13622,0.078967,0,1
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.27227,0.13531,0.063693,0,1
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.093897,0.13463,0.14407,0,1
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.077957,0.13342,0.11088,0,1
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.088862,0.13259,0.10075,0,1
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.30815,0.13259,0.041808,0,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.18219,0.13257,0.066373,0,1
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.057089,0.13231,0.10371,0,1
4,GO RESPONSE TO ETHANOL,0.059411,0.13209,0.08455,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.092194,0.13201,0.1177,0,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.10845,0.13157,0.11099,0,1
4,GO CHLORIDE ION HOMEOSTASIS,0.064293,0.13145,0.12912,0,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.26098,0.1314,0.086469,0,1
4,GO CELLULAR IRON ION HOMEOSTASIS,0.060602,0.13102,0.12438,0,1
4,GO T CELL HOMEOSTASIS,0.060602,0.12911,0.072028,0,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.093897,0.12879,0.094792,0,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.31232,0.12809,0.079547,0,1
4,GO DRUG CATABOLIC PROCESS,0.057089,0.127,0.15558,0,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.12689,0.12695,0.084539,0,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.12908,0.12663,0.12885,0,1
4,GO RESPONSE TO SALT,0.082489,0.12624,0.087646,0,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.11636,0.12564,0.06089,0,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.092194,0.12509,0.043128,0,1
4,GO CELLULAR RESPONSE TO IRON ION,0.22235,0.12497,0.080025,0,1
4,GO KERATINOCYTE MIGRATION,0.11841,0.12486,0.089604,0,1
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.26847,0.12424,0.077588,0,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.59664,0.12407,0.018555,0,1
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.36064,0.12296,0.031824,0,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.12049,0.1228,0.13701,0,1
4,GO RENAL WATER HOMEOSTASIS,0.30402,0.12236,0.04951,0,1
4,GO GLUCOSE CATABOLIC PROCESS,0.15773,0.12211,0.12418,0,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.14048,0.12173,0.051315,0,1
4,GO COENZYME A METABOLIC PROCESS,0.15015,0.12143,0.11434,0,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.27611,0.12071,0.048944,0,1
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.11841,0.12071,0.065138,0,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0695,0.11967,0.11003,0,1
4,GO RNA MODIFICATION,0.063042,0.11693,0.07523,0,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.17934,0.11643,0.08374,0,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.065563,0.11624,0.14356,0,1
4,GO RESPONSE TO INTERLEUKIN 12,0.14526,0.11585,0.081171,0,1
4,GO MITOCHONDRIAL FUSION,0.090515,0.11469,0.10878,0,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.27611,0.11392,0.044825,0,1
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.073629,0.11272,0.21268,0,1
4,GO AMYLOID BETA FORMATION,0.2,0.11204,0.091427,0,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.075049,0.11148,0.10607,0,1
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.43367,0.11106,0.034961,0,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.068167,0.11046,0.097331,0,1
4,GO CELL MATRIX ADHESION,0.072231,0.11015,0.079194,0,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.24643,0.10914,0.024765,0,1
4,GO MRNA MODIFICATION,0.23589,0.1091,0.056545,0,1
4,GO TRNA METABOLIC PROCESS,0.099158,0.109,0.074403,0,1
4,GO TRANSLATIONAL ELONGATION,0.13814,0.10898,0.078133,0,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.23937,0.1088,0.070829,0,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.17934,0.10829,0.16731,0,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.061812,0.10772,0.19723,0,1
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.26847,0.10756,0.060072,0,1
4,GO FEMALE SEX DIFFERENTIATION,0.15015,0.10711,0.052984,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.099158,0.10696,0.080961,0,1
4,GO EPITHELIAL CELL PROLIFERATION,0.090515,0.10673,0.063291,0,1
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.26847,0.10631,0.044024,0,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.12908,0.10584,0.058398,0,1
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.17099,0.10514,0.11674,0,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.40349,0.10507,0.035867,0,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.11841,0.10497,0.054304,0,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.076492,0.10334,0.064951,0,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.060602,0.10206,0.09952,0,1
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.10654,0.10198,0.05715,0,1
4,GO CRISTAE FORMATION,0.053746,0.10182,0.13401,0,1
4,GO REGULATION OF GTP BINDING,0.38408,0.10174,0.05793,0,1
4,GO TRNA PROCESSING,0.27227,0.10165,0.044245,0,1
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.25363,0.10121,0.054754,0,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.057089,0.10089,0.057627,0,1
4,GO AMIDE BIOSYNTHETIC PROCESS,0.076492,0.09817,0.071274,0,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.066855,0.098158,0.061948,0,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.15264,0.097828,0.083891,0,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.065563,0.097377,0.090308,0,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.49227,0.097034,0.11064,0,1
4,GO ENDOCRINE HORMONE SECRETION,0.097379,0.096697,0.080628,0,1
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.061812,0.096002,0.059039,0,1
4,GO REGULATION OF MACROPHAGE MIGRATION,0.065563,0.095855,0.095867,0,1
4,GO PROTEIN IMPORT,0.059411,0.095404,0.070831,0,1
4,GO RIBOSOME BIOGENESIS,0.30402,0.094277,0.054146,0,1
4,GO CATECHOLAMINE SECRETION,0.084046,0.093453,0.21227,0,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.16032,0.092954,0.058895,0,1
4,GO MATURATION OF 5 8S RRNA,0.4978,0.092817,0.029852,0,1
4,GO T CELL SELECTION,0.066855,0.092325,0.067765,0,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.14526,0.092292,0.097121,0,1
4,GO PEPTIDYL METHIONINE MODIFICATION,0.097379,0.091649,0.18089,0,1
4,GO REGULATION OF RESPONSE TO FOOD,0.78962,0.091393,0.0096972,0,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.20621,0.089125,0.044499,0,1
4,GO ENDODERMAL CELL FATE COMMITMENT,0.68418,0.089047,0.021228,0,1
4,GO NCRNA METABOLIC PROCESS,0.19095,0.088833,0.053537,0,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.19095,0.088406,0.099635,0,1
4,GO SPROUTING ANGIOGENESIS,0.62113,0.088004,0.004943,0,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.76281,0.08748,0.0096557,0,1
4,GO RESPONSE TO OXYGEN RADICAL,0.11434,0.087323,0.10597,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.13814,0.086223,0.049456,0,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.1313,0.085856,0.075093,0,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.061812,0.085561,0.13477,0,1
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.068167,0.084655,0.079038,0,1
4,GO NEGATIVE REGULATION OF SECRETION,0.12049,0.084414,0.058781,0,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.29992,0.084047,0.059457,0,1
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.30402,0.082555,0.059093,0,1
4,GO REGULATION OF TELOMERASE ACTIVITY,0.62732,0.082257,0.015498,0,1
4,GO MYELOID CELL APOPTOTIC PROCESS,0.26098,0.080627,0.054922,0,1
4,GO ERYTHROCYTE DEVELOPMENT,0.23937,0.080256,0.053384,0,1
4,GO NCRNA PROCESSING,0.34256,0.079498,0.037833,0,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.093897,0.079365,0.058336,0,1
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.47588,0.079331,0.020308,0,1
4,GO PRIMARY MIRNA PROCESSING,0.43367,0.07902,0.030569,0,1
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.21256,0.078044,0.057489,0,1
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.51459,0.077837,0.051355,0,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.066855,0.077307,0.077524,0,1
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.10654,0.076995,0.050219,0,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0695,0.076624,0.07148,0,1
4,GO RETINA HOMEOSTASIS,0.32506,0.07575,0.030398,0,1
4,GO CELL CELL RECOGNITION,0.075049,0.074924,0.10278,0,1
4,GO PROTEIN PALMITOYLATION,0.48678,0.074614,0.046333,0,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.14048,0.073497,0.06944,0,1
4,GO PROTEIN HOMOTETRAMERIZATION,0.13583,0.072692,0.065532,0,1
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.13355,0.072231,0.084191,0,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.59664,0.071834,0.012195,0,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.12259,0.07025,0.048079,0,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.27611,0.068828,0.024703,0,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.057089,0.068362,0.081968,0,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.088862,0.068336,0.065929,0,1
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.085627,0.068304,0.065577,0,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.41842,0.067413,0.014893,0,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.068167,0.067368,0.055459,0,1
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.4545,0.067094,0.00401,0,1
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.48131,0.066338,0.070548,0,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.10096,0.065622,0.069423,0,1
4,GO RESPONSE TO CAMP,0.10654,0.065226,0.10871,0,1
4,GO SINGLE FERTILIZATION,0.11636,0.064767,0.060709,0,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.3746,0.064717,0.022829,0,1
4,GO PRENYLATION,0.17374,0.06232,0.056216,0,1
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.27227,0.061563,0.037152,0,1
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.31232,0.061472,0.023618,0,1
4,GO REGULATION OF OSSIFICATION,0.10465,0.060906,0.053377,0,1
4,GO INTERACTION WITH SYMBIONT,0.24288,0.060316,0.0274,0,1
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.26847,0.059084,0.037391,0,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.11841,0.05807,0.048285,0,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.05824,0.057166,0.060742,0,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.095625,0.056279,0.061844,0,1
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.20937,0.055665,0.04938,0,1
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.52025,0.053734,0.0090518,0,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.068167,0.05255,0.060399,0,1
4,GO SEX DIFFERENTIATION,0.48131,0.048219,0.013404,0,1
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.25729,0.048137,0.035113,0,1
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.053746,0.047251,0.05184,0,1
4,GO FERTILIZATION,0.18219,0.047173,0.046018,0,1
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.12689,0.041793,0.03233,0,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.10654,0.04054,0.05155,0,1
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.16828,0.039632,0.019821,0,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.188,0.03085,0.037431,0,1
4,GO AMMONIUM ION METABOLIC PROCESS,0.00035231,0.3556,0.40084,0,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.0094949,0.34848,0.29052,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.072231,0.34641,0.24082,0,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.063042,0.33528,0.26339,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.20309,0.32591,0.13604,0,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.064293,0.32478,0.2541,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.053746,0.31937,0.20398,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.14769,0.31754,0.19787,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.065563,0.29746,0.19261,0,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.11434,0.29318,0.13041,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.090515,0.29115,0.19866,0,0
4,GO POLYOL TRANSPORT,0.0021689,0.28821,0.33248,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.092194,0.28352,0.20857,0,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0050528,0.27836,0.23805,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.063042,0.27758,0.13191,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0010859,0.27495,0.27429,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.16032,0.26006,0.12987,0,0
4,GO MEMBRANE RAFT ORGANIZATION,0.10845,0.25977,0.12496,0,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00028792,0.25675,0.25635,0,0
4,GO RESPONSE TO HISTAMINE,0.057089,0.25396,0.19277,0,0
4,GO OXYGEN TRANSPORT,0.19095,0.25115,0.13411,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.13355,0.24979,0.15018,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.064293,0.24869,0.15541,0,0
4,GO RESPONSE TO COPPER ION,0.13814,0.2417,0.14801,0,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.10465,0.23628,0.16794,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.36526,0.23568,0.059257,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.088862,0.23468,0.18652,0,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.095625,0.23389,0.22752,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.31232,0.23326,0.087531,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.69707,0.23296,0.037793,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.12259,0.23291,0.11935,0,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.18508,0.23212,0.17958,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.22235,0.23037,0.13449,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.10845,0.22495,0.13541,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.095625,0.22427,0.1927,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.34256,0.22045,0.060133,0,0
4,GO DIET INDUCED THERMOGENESIS,0.049546,0.21952,0.15771,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.12689,0.2183,0.16393,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.10096,0.21806,0.12694,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.061812,0.21727,0.22045,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.25363,0.21557,0.10066,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.092194,0.21494,0.14215,0,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.055956,0.21364,0.14567,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.37932,0.21119,0.081578,0,0
4,GO INCLUSION BODY ASSEMBLY,0.0094949,0.20974,0.25923,0,0
4,GO RESPONSE TO WATER,0.18219,0.20589,0.1446,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.053746,0.2057,0.15451,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23589,0.20473,0.1123,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.17374,0.20367,0.089051,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.065563,0.20278,0.17812,0,0
4,GO DNA DEAMINATION,0.084046,0.1997,0.16594,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.35153,0.19963,0.098085,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.16032,0.19766,0.060274,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.057089,0.19741,0.29832,0,0
4,GO RESPONSE TO CADMIUM ION,0.15773,0.19581,0.099309,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.15015,0.19567,0.1173,0,0
4,GO ENAMEL MINERALIZATION,0.14048,0.19423,0.14318,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.18219,0.1927,0.12191,0,0
4,GO DRINKING BEHAVIOR,0.018398,0.1925,0.18124,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.061812,0.19133,0.13268,0,0
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.077957,0.19022,0.2104,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.054842,0.18933,0.11125,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.092194,0.18779,0.19519,0,0
4,GO CELLULAR RESPONSE TO ALKALOID,0.00090094,0.18757,0.18606,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.25001,0.18673,0.16748,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.055956,0.18581,0.16207,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.90599,0.18448,-0.054713,0,0
4,GO REGULATION OF VASCULOGENESIS,0.29992,0.184,0.080178,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.10654,0.18383,0.12894,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.20309,0.18322,0.12117,0,0
4,GO RESPONSE TO TUMOR CELL,0.14769,0.18269,0.17165,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.13814,0.18189,0.18206,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.52594,0.18141,0.077169,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.015953,0.18094,0.21726,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.053746,0.18093,0.12538,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.36991,0.18059,0.0809,0,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.015953,0.17868,0.19945,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.013465,0.17808,0.21569,0,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.16032,0.17766,0.12795,0,0
4,GO ENDODERM DEVELOPMENT,0.17653,0.17702,0.074028,0,0
4,GO LIPOXYGENASE PATHWAY,0.12689,0.17635,0.15896,0,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.16294,0.17625,0.13725,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.10465,0.17513,0.24802,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.05161,0.17292,0.20925,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.30815,0.17197,0.070977,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.12689,0.17108,0.11442,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.2839,0.17067,0.027542,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.71658,0.16997,-0.024938,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.39371,0.16866,0.093663,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.12908,0.16821,0.11619,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.076492,0.16817,0.13093,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.27227,0.16763,0.10363,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.22235,0.16642,0.079879,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.11636,0.16593,0.043116,0,0
4,GO L SERINE METABOLIC PROCESS,0.29992,0.1652,0.099522,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.188,0.16433,0.072147,0,0
4,GO PENILE ERECTION,0.20309,0.16332,0.10236,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.26847,0.16304,-0.00066594,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.072231,0.16294,0.10316,0,0
4,GO REGULATION OF ACROSOME REACTION,0.063042,0.16186,0.27851,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.12908,0.16139,0.21489,0,0
4,GO CATECHOLAMINE UPTAKE,0.05161,0.15983,0.20035,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.11841,0.15935,0.14709,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.23589,0.15869,0.11716,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.090515,0.15804,0.054542,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.054842,0.15678,0.15626,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.21579,0.15656,0.25968,0,0
4,GO DETECTION OF CALCIUM ION,0.28785,0.15642,0.12906,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.13583,0.1558,0.11368,0,0
4,GO REGULATION OF BONE DEVELOPMENT,0.188,0.15537,0.081858,0,0
4,GO RESPONSE TO HYPEROXIA,0.22568,0.15529,0.052601,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.36991,0.15462,0.021601,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.47588,0.15457,0.06134,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.10465,0.15402,0.073529,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.072231,0.15381,0.12574,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.11039,0.15365,0.13137,0,0
4,GO INSULIN SECRETION,0.0025083,0.1528,0.15928,0,0
4,GO ENDODERM FORMATION,0.29992,0.15271,0.045514,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.36526,0.15243,0.055351,0,0
4,GO PROTEIN OXIDATION,0.52594,0.15194,0.0307,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.30402,0.15189,0.074644,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.13355,0.15145,0.12997,0,0
4,GO MEMBRANE DEPOLARIZATION,0.23589,0.15107,0.077271,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.12908,0.151,0.065601,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.4598,0.15001,-0.00878,0,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.12473,0.14996,0.14084,0,0
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.040234,0.14934,0.16048,0,0
4,GO RESPONSE TO FORSKOLIN,0.44402,0.14925,0.076265,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.099158,0.1489,0.15874,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.065563,0.14889,0.19812,0,0
4,GO RESPONSE TO CAFFEINE,0.095625,0.14811,0.12927,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.11039,0.14789,0.14354,0,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.22235,0.14663,0.065689,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.62113,0.14553,-0.020377,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.073629,0.14545,0.12976,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.10465,0.14456,0.16965,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.54321,0.14406,0.03531,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.093897,0.14398,0.061832,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.19095,0.14389,0.17496,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.11434,0.14324,0.073163,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.17099,0.1428,0.046399,0,0
4,GO REGULATION OF RECEPTOR BINDING,0.11636,0.1425,0.1452,0,0
4,GO CYTOPLASM ORGANIZATION,0.21256,0.14211,0.13219,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.23589,0.14207,0.093952,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.084046,0.1419,0.17465,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.21256,0.1416,0.045606,0,0
4,GO ANION HOMEOSTASIS,0.057089,0.14155,0.15546,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.23589,0.1412,0.055014,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.063042,0.14023,0.16063,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.38888,0.13963,0.022315,0,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.25001,0.13834,0.13311,0,0
4,GO SKIN MORPHOGENESIS,0.83713,0.13795,-0.078991,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.38888,0.13789,0.064414,0,0
4,GO POSITIVE REGULATION OF HEART RATE,0.12689,0.13769,0.12857,0,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.064293,0.13714,0.10138,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.39371,0.13681,0.0067035,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.14048,0.13663,0.07007,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.22905,0.13588,0.11905,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.05824,0.13576,0.14669,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.072231,0.13528,0.1702,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.15015,0.13527,0.11079,0,0
4,GO URETER DEVELOPMENT,0.21905,0.13524,0.045957,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.10096,0.13466,0.16116,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.11235,0.13354,0.17132,0,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.034637,0.13347,0.13276,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.19393,0.13343,0.11937,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.28785,0.13318,0.089574,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.44402,0.13299,0.075506,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.22568,0.13295,0.043061,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.084046,0.13293,0.099024,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.079444,0.13254,0.095468,0,0
4,GO TRANSPOSITION,0.085627,0.13218,0.1557,0,0
4,GO RESPONSE TO ESTROGEN,0.11841,0.13213,0.10419,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.059411,0.13039,0.11229,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.41341,0.12986,0.08329,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.87833,0.12978,0.0058368,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.63978,0.12839,0.021786,0,0
4,GO AMYLOID FIBRIL FORMATION,0.27227,0.12781,0.090646,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.31232,0.12771,0.044461,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.0695,0.12758,0.081297,0,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.10465,0.12753,0.062319,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.16828,0.12707,0.069002,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.40843,0.12686,0.055294,0,0
4,GO GLYCINE TRANSPORT,0.50337,0.12676,0.063606,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.63978,0.12622,0.041211,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.15015,0.12617,0.27561,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.082489,0.12585,0.056952,0,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.068167,0.12577,0.12669,0,0
4,GO REGULATION OF DOPAMINE SECRETION,0.22568,0.12567,0.20537,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.054842,0.12518,0.096011,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.27999,0.12454,0.13024,0,0
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.12908,0.12418,0.10865,0,0
4,GO REGULATION OF CELL MATURATION,0.085627,0.12405,0.11801,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.10845,0.12404,0.17747,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.22905,0.12382,0.079408,0,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.22905,0.1237,0.078102,0,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.1028,0.12292,0.18326,0,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.41341,0.12247,0.037977,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.12689,0.12217,0.12037,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.1028,0.12208,0.11171,0,0
4,GO CALCIUM ION IMPORT,0.087232,0.12147,0.071047,0,0
4,GO GLIAL CELL ACTIVATION,0.11636,0.12114,0.079949,0,0
4,GO TRNA MODIFICATION,0.20937,0.12098,0.055124,0,0
4,GO PARTURITION,0.14769,0.12089,0.12556,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.21579,0.12076,0.11281,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.25363,0.12048,0.15792,0,0
4,GO ZINC ION HOMEOSTASIS,0.51459,0.12046,0.045976,0,0
4,GO REGENERATION,0.14769,0.11994,0.049752,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.060602,0.11911,0.092673,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.20621,0.11855,0.090574,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.23245,0.11808,0.068086,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.29184,0.11778,0.044801,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.11636,0.1175,0.15487,0,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.080955,0.11746,0.113,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.24643,0.11709,0.071519,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.23589,0.11696,0.081453,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.30402,0.11682,0.045376,0,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.11841,0.1165,0.068855,0,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.20937,0.11646,0.12455,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.05161,0.11639,0.062412,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.19095,0.116,0.078064,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.23589,0.1158,0.088124,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.82348,0.11567,0.012715,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.17653,0.11565,0.11998,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.14048,0.11532,0.10095,0,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.12473,0.11527,0.062817,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.72313,0.11523,0.04899,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.11841,0.11519,0.086702,0,0
4,GO CYTOKINETIC PROCESS,0.057089,0.11501,0.091042,0,0
4,GO GLOMERULUS DEVELOPMENT,0.12473,0.11491,0.086413,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.077957,0.11485,0.12916,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.068167,0.11482,0.1046,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.53167,0.11398,0.012777,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.31232,0.11384,0.049375,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.073629,0.11336,0.10854,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.59664,0.11306,-0.031881,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.48678,0.1128,0.072958,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.093897,0.11272,0.080207,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.20621,0.11185,0.020236,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.077957,0.11092,0.080321,0,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.080955,0.11057,0.065608,0,0
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.61497,0.1105,0.012142,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.58456,0.11039,0.033054,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.30815,0.11036,0.040544,0,0
4,GO REGULATION OF INSULIN SECRETION,0.0039469,0.11025,0.14186,0,0
4,GO TRNA METHYLATION,0.27999,0.1099,0.055542,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.20621,0.10966,0.063678,0,0
4,GO AMINE TRANSPORT,0.1028,0.10955,0.15677,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.83713,0.10934,-0.018506,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.50337,0.10927,0.019719,0,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.30402,0.10917,0.12358,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.073629,0.10879,0.097636,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.14285,0.10872,0.056772,0,0
4,GO MIDGUT DEVELOPMENT,0.084046,0.10862,0.19808,0,0
4,GO ERYTHROCYTE MATURATION,0.7495,0.10814,-8.4778e-05,0,0
4,GO MACROPHAGE MIGRATION,0.32506,0.10812,0.044262,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.70355,0.10759,0.024787,0,0
4,GO NEGATIVE T CELL SELECTION,0.14769,0.10759,0.055143,0,0
4,GO INTERFERON BETA PRODUCTION,0.080955,0.10685,0.084348,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.10654,0.10684,0.11096,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.13355,0.10671,0.11306,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.2839,0.10665,0.07217,0,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.15264,0.10657,0.079941,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.60883,0.10631,-0.10547,0,0
4,GO COPPER ION HOMEOSTASIS,0.4598,0.10601,0.021948,0,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.89215,0.10587,-0.036773,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.33812,0.10545,0.044759,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.34702,0.10516,0.044687,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.57857,0.10515,0.0061414,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.076492,0.1045,0.1151,0,0
4,GO OOCYTE DIFFERENTIATION,0.046579,0.10434,0.09272,0,0
4,GO REGULATION OF TRANSPOSITION,0.14526,0.10422,0.1444,0,0
4,GO RESPONSE TO SALT STRESS,0.55487,0.10421,0.010693,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.55487,0.10417,0.058822,0,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.14285,0.10361,0.14279,0,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.047551,0.10274,0.15333,0,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.059411,0.10248,0.10489,0,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.065563,0.10224,0.092008,0,0
4,GO REGULATION OF DENDRITE EXTENSION,0.27227,0.1021,0.15144,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.37932,0.10208,0.14133,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.26098,0.10204,0.036593,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.084046,0.10156,0.10257,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.32506,0.1015,0.041003,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.70355,0.10149,0.084807,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.080955,0.10142,0.12542,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.13355,0.10126,0.069182,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.25001,0.10124,0.033388,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.57857,0.10114,0.020076,0,0
4,GO REGULATION OF AMYLOID BETA FORMATION,0.18508,0.10105,0.10667,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.47049,0.10082,0.030015,0,0
4,GO NCRNA CATABOLIC PROCESS,0.10465,0.10061,0.081197,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.37932,0.099857,0.074435,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.31653,0.099561,0.055241,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.17934,0.099322,0.068761,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.17653,0.099002,0.077214,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.2,0.098792,0.0089554,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.10465,0.098653,0.1304,0,0
4,GO HEAD MORPHOGENESIS,0.52594,0.098599,0.013393,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.74288,0.09856,0.011601,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.4545,0.09842,0.032074,0,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.20937,0.098232,0.080468,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.23937,0.097958,0.075682,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.13583,0.097915,0.090391,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.188,0.097689,0.052735,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.61497,0.096876,0.0042674,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.39371,0.096687,-0.0072199,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.46512,0.096573,0.008743,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.1028,0.096026,0.05335,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.32506,0.095974,0.060134,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.16828,0.095506,0.11052,0,0
4,GO RESPONSE TO RETINOIC ACID,0.57857,0.095495,0.022127,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.65866,0.095485,0.034051,0,0
4,GO HEART INDUCTION,0.67776,0.095325,0.038271,0,0
4,GO ERBB SIGNALING PATHWAY,0.17099,0.095267,0.079889,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.12259,0.095155,0.10634,0,0
4,GO LACTATE METABOLIC PROCESS,0.16828,0.09489,0.091223,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.60272,0.09479,0.020858,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.63354,0.094673,0.012699,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.4978,0.094345,0.0072059,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.56666,0.094294,0.003072,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.085627,0.093937,0.16948,0,0
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.099158,0.093806,0.2579,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.2,0.093685,0.058074,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.36064,0.093484,0.051347,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.83713,0.093359,0.010891,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.24288,0.093316,0.054753,0,0
4,GO CELLULAR EXTRAVASATION,0.188,0.09316,0.05653,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.17374,0.093145,0.11145,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.87833,0.09312,0.021382,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.2,0.093077,0.088832,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0054795,0.092765,0.15108,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.39858,0.092719,0.062278,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.35153,0.092603,-0.0048824,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.37932,0.092276,0.072533,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.41341,0.092211,0.07124,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.054842,0.091951,0.08144,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.12689,0.091909,0.098807,0,0
4,GO GAS TRANSPORT,0.34702,0.09157,0.05974,0,0
4,GO PANCREAS DEVELOPMENT,0.10096,0.091369,0.12464,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.097379,0.090911,0.1059,0,0
4,GO NAD METABOLIC PROCESS,0.27999,0.090888,0.084569,0,0
4,GO SPHINGOID METABOLIC PROCESS,0.084046,0.090885,0.1672,0,0
4,GO PROTEIN DENEDDYLATION,0.4978,0.090683,0.046202,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.22235,0.09058,0.067917,0,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.055956,0.090499,0.11383,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.95466,0.090466,-0.025203,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.56666,0.090213,0.025072,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.21256,0.090187,0.078972,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.65234,0.08991,0.011864,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.29586,0.089353,0.12852,0,0
4,GO PROTEIN ADP RIBOSYLATION,0.33812,0.089171,0.07198,0,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.10465,0.088971,0.070559,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.055956,0.08886,0.083219,0,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.18508,0.08879,0.068191,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.36064,0.088724,0.049893,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.05824,0.088591,0.15172,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.5726,0.088577,0.023895,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.22568,0.088323,0.056047,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.13355,0.088194,0.11648,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.62113,0.08817,-0.025086,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.46512,0.087959,0.053007,0,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.18219,0.087873,0.051769,0,0
4,GO MATURATION OF SSU RRNA,0.47588,0.087864,0.034985,0,0
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.25001,0.087797,0.19096,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.17099,0.087591,0.13472,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.79636,0.08755,-0.001119,0,0
4,GO EPIBOLY,0.52594,0.087474,-0.01723,0,0
4,GO OVULATION CYCLE PROCESS,0.28785,0.087354,0.068162,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.59664,0.087057,-0.040956,0,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.23937,0.087005,0.066672,0,0
4,GO VESICLE DOCKING,0.099158,0.08679,0.11403,0,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.079444,0.086651,0.093175,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.15015,0.086598,0.067086,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.068167,0.086456,0.080402,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.23937,0.085674,0.049255,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.084046,0.085492,0.12146,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.092194,0.085297,0.067199,0,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.19393,0.085284,0.11313,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.13355,0.084984,0.079993,0,0
4,GO PIRNA METABOLIC PROCESS,0.22905,0.084956,0.1587,0,0
4,GO PROTEIN TARGETING,0.085627,0.084244,0.071374,0,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.090515,0.084147,0.073141,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.3746,0.084042,0.038176,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.36064,0.083727,0.019047,0,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.045624,0.083243,0.074656,0,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.079444,0.083202,0.11919,0,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.24643,0.083052,0.055284,0,0
4,GO HISTONE ARGININE METHYLATION,0.16032,0.082982,0.06968,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.14769,0.082834,0.11365,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.35607,0.08271,0.04775,0,0
4,GO PIGMENT GRANULE MATURATION,0.32077,0.08265,0.060926,0,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.2839,0.08258,0.069209,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.060602,0.082256,0.093207,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.27227,0.082219,0.057667,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.26471,0.081568,0.085307,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0695,0.081501,0.072537,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.33373,0.081495,0.066235,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.35153,0.081443,0.064536,0,0
4,GO NUCLEOSIDE SALVAGE,0.40843,0.081356,0.030998,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.13355,0.081064,0.074741,0,0
4,GO BONE CELL DEVELOPMENT,0.42347,0.080911,0.053136,0,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0695,0.080662,0.071158,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.74288,0.080385,0.02542,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.29184,0.079945,0.064231,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.53167,0.079788,0.075839,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.17653,0.079588,0.14595,0,0
4,GO MAMMARY GLAND DEVELOPMENT,0.059411,0.07934,0.081775,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.89907,0.079309,-0.023513,0,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.69707,0.079242,0.015231,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.39371,0.079222,0.057315,0,0
4,GO REGULATION OF ION TRANSPORT,0.16294,0.079141,0.057434,0,0
4,GO RESPONSE TO ALKALOID,0.20621,0.079115,0.044931,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.54903,0.079027,0.035627,0,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.10465,0.079009,0.10376,0,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.12259,0.078963,0.077445,0,0
4,GO RNA CATABOLIC PROCESS,0.54321,0.078903,0.014283,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.39371,0.078822,0.041186,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.21579,0.078813,0.11283,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.34256,0.078751,0.028329,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.24288,0.078558,0.035996,0,0
4,GO CELL CELL ADHESION,0.077957,0.078517,0.073803,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.59059,0.07833,0.021225,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.1313,0.078252,0.066632,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.27999,0.07811,0.088463,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.47588,0.077603,0.042684,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.59059,0.077376,0.030201,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.7495,0.077159,-0.0015182,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.66501,0.077159,0.0073857,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.25001,0.077148,0.15953,0,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.87833,0.077098,-0.0051809,0,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.080955,0.077,0.076863,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.4598,0.076961,0.054909,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.13814,0.076831,0.08981,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.2,0.076815,0.028679,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.1313,0.076765,0.10043,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.47049,0.076647,0.040959,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.88523,0.076638,-0.049733,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.27999,0.076395,0.093116,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22905,0.076252,0.070523,0,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.080955,0.076209,0.09845,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.60272,0.075966,0.013407,0,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.16828,0.075921,0.11078,0,0
4,GO PROTEIN KINASE C SIGNALING,0.30402,0.075601,0.059502,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.9686,0.075566,-0.0065796,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.10654,0.075447,0.076705,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.29992,0.075334,0.037192,0,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.21256,0.074916,0.10426,0,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.10654,0.07478,0.1421,0,0
4,GO HYPEROSMOTIC RESPONSE,0.54321,0.074612,0.048484,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.94073,0.074556,-0.018441,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.89215,0.074497,0.01607,0,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.12049,0.074386,0.12793,0,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.15517,0.074192,0.064037,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.47588,0.073832,-0.020854,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0695,0.07348,0.075173,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.33373,0.073401,0.095667,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.068167,0.07339,0.064812,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.41341,0.07339,0.043055,0,0
4,GO BIOLOGICAL ADHESION,0.097379,0.073348,0.061546,0,0
4,GO ACTIVATED T CELL PROLIFERATION,0.16294,0.073187,0.070587,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.26471,0.073137,0.038024,0,0
4,GO NUCLEUS LOCALIZATION,0.62732,0.073105,0.012356,0,0
4,GO ANIMAL ORGAN MATURATION,0.42855,0.072887,0.038921,0,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.44402,0.072879,0.029175,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.55487,0.072831,0.045389,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.14769,0.07277,0.076974,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.67776,0.072599,0.020132,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.084046,0.072578,0.066288,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.29992,0.072298,0.046765,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.75615,0.072297,-0.0054628,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.11235,0.072207,0.12644,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.48678,0.072086,0.021548,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.066855,0.071835,0.10668,0,0
4,GO SIGNAL RELEASE,0.066855,0.071758,0.078736,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.69061,0.071395,0.01433,0,0
4,GO BIOMINERALIZATION,0.11039,0.0713,0.064299,0,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.39858,0.071229,0.020273,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.21905,0.071228,0.050778,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.082489,0.071096,0.079997,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.67137,0.071074,0.0050386,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.093897,0.071007,0.10148,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.93377,0.070978,-0.00095754,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.068167,0.070963,0.083026,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.46512,0.070911,0.12015,0,0
4,GO PROSTAGLANDIN SECRETION,0.03939,0.070906,0.16986,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.8303,0.070894,-0.023578,0,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0695,0.070842,0.054401,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.20309,0.07081,0.056411,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.25001,0.07074,0.077942,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.079444,0.070682,0.15835,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.50337,0.070676,0.053696,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.40349,0.070575,0.071335,0,0
4,GO REGULATION OF MRNA BINDING,0.67137,0.070395,-0.0022812,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.74288,0.070335,-0.010885,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.15773,0.070219,0.060658,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.34256,0.070092,0.031825,0,0
4,GO NEURON REMODELING,0.66501,0.07008,-0.013541,0,0
4,GO GLIAL CELL PROLIFERATION,0.35607,0.070048,0.080429,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.068167,0.070032,0.068295,0,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.066855,0.070012,0.10665,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.22905,0.069873,0.064426,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0695,0.069679,0.052585,0,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.053746,0.069597,0.064327,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.63978,0.069559,0.10301,0,0
4,GO METAL ION TRANSPORT,0.088862,0.069421,0.071182,0,0
4,GO MYOFIBRIL ASSEMBLY,0.052669,0.069361,0.08191,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.16294,0.069262,0.049312,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.31653,0.069259,0.064872,0,0
4,GO FAT CELL DIFFERENTIATION,0.077957,0.069201,0.059512,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.60883,0.0692,0.049167,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.44402,0.069153,0.042715,0,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.1028,0.06908,0.070168,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.36526,0.06904,0.029301,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.16828,0.068956,0.084812,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.14048,0.068787,0.071767,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.035393,0.068754,0.12263,0,0
4,GO DNA DEMETHYLATION,0.62113,0.068732,0.015418,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.60272,0.068714,0.065808,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.89907,0.068696,0.031639,0,0
4,GO GLUCOSE IMPORT,0.077957,0.068676,0.10607,0,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.075049,0.068367,0.061134,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.15773,0.068352,0.04981,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.52594,0.0683,0.02381,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.36064,0.068297,0.025575,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.36064,0.068283,0.020427,0,0
4,GO EMBRYO IMPLANTATION,0.4545,0.06824,0.053563,0,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.092194,0.068234,0.076814,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.55487,0.068207,0.038727,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.27611,0.067932,0.054595,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.12049,0.067879,0.07541,0,0
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.9686,0.067701,-0.057404,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.26847,0.067694,0.082124,0,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.96163,0.067686,-0.031107,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.12049,0.067542,0.099327,0,0
4,GO RNA INTERFERENCE,0.55487,0.067491,0.041337,0,0
4,GO SULFATE TRANSPORT,0.097379,0.06741,0.079262,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.80989,0.067355,0.018186,0,0
4,GO RESPONSE TO MANGANESE ION,0.22905,0.067323,0.1054,0,0
4,GO NADH METABOLIC PROCESS,0.38888,0.067102,0.08549,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.48678,0.067003,0.026357,0,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.15015,0.066976,0.071416,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.32506,0.066921,0.062638,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.4978,0.066854,0.022865,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.54903,0.066693,0.025516,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.36526,0.066677,0.074925,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.2839,0.066585,0.066766,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.25729,0.066563,0.085024,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.36526,0.066523,0.022067,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.17934,0.066469,0.061902,0,0
4,GO STRESS FIBER ASSEMBLY,0.74288,0.066364,0.0007497,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.21905,0.066341,0.047293,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.11434,0.066132,0.089667,0,0
4,GO OVULATION CYCLE,0.39371,0.066084,0.038386,0,0
4,GO REGULATION OF T CELL MIGRATION,0.19095,0.066083,0.081829,0,0
4,GO MUSCLE SYSTEM PROCESS,0.11636,0.066017,0.064953,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.4598,0.065882,0.03123,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.62732,0.065675,-0.018838,0,0
4,GO SODIUM ION TRANSPORT,0.10654,0.065674,0.076085,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.77618,0.065105,0.069054,0,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.15773,0.065033,0.054514,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.12908,0.064903,0.076147,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.82348,0.064731,0.027947,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.4545,0.064457,0.053425,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.76948,0.064316,0.013371,0,0
4,GO PROTEIN TETRAMERIZATION,0.18508,0.064066,0.055751,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.4545,0.063995,0.055288,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.44402,0.063916,0.052315,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.33373,0.063838,0.065245,0,0
4,GO KERATINOCYTE PROLIFERATION,0.27227,0.063636,0.033711,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.42347,0.063616,0.019938,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.33812,0.063609,0.038806,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.13355,0.063475,0.057078,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.20937,0.063382,0.057884,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.05824,0.063056,0.18229,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.088862,0.06295,0.094629,0,0
4,GO RESPONSE TO HEAT,0.057089,0.062934,0.092552,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.96163,0.062831,-0.035166,0,0
4,GO RNA METHYLATION,0.47588,0.06265,0.02413,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.30815,0.062603,0.10948,0,0
4,GO TISSUE REGENERATION,0.27227,0.062457,0.05351,0,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.32506,0.06243,0.089413,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.14285,0.062429,0.08536,0,0
4,GO RRNA METABOLIC PROCESS,0.41341,0.062069,0.040622,0,0
4,GO GASTRULATION,0.25001,0.061538,0.052309,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.080955,0.061371,0.11587,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.82348,0.061293,0.032371,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.18219,0.061227,0.038222,0,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.11434,0.06112,0.058478,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.066855,0.061087,0.061265,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.5726,0.061042,0.021532,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.25363,0.061,0.098273,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.32077,0.060839,0.048081,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.12908,0.060734,0.084953,0,0
4,GO MEMBRANE INVAGINATION,0.16559,0.06052,0.063932,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.14285,0.060487,0.074076,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.18219,0.06045,0.073509,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.21579,0.060332,0.045169,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.31653,0.060273,0.05014,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.61497,0.060156,0.066641,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.10654,0.059942,0.12226,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.095625,0.059462,0.049202,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.99651,0.059328,-0.022137,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.17374,0.059265,0.022248,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.21905,0.059107,0.030315,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.23589,0.0589,0.080063,0,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.42855,0.058417,0.042234,0,0
4,GO PHOTOTRANSDUCTION,0.68418,0.058376,-0.011954,0,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.12049,0.058167,0.060329,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.50896,0.058121,0.019557,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.78289,0.058001,0.050834,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.34256,0.057926,0.089142,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.17099,0.057826,0.060594,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.21579,0.057764,0.036896,0,0
4,GO TRANSITION METAL ION HOMEOSTASIS,0.10654,0.057743,0.089219,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.26471,0.057713,0.039518,0,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.24288,0.05747,0.072003,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.30815,0.057449,0.035326,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.57857,0.057429,0.044028,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.11039,0.057409,0.15129,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.27999,0.05712,0.039628,0,0
4,GO PIGMENT GRANULE ORGANIZATION,0.29992,0.057078,0.053632,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.27227,0.057064,0.068302,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.69707,0.057043,-0.009549,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.37932,0.057024,0.044098,0,0
4,GO VESICLE CARGO LOADING,0.48678,0.057016,0.077472,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.24288,0.056945,0.040437,0,0
4,GO REGULATION OF BLOOD CIRCULATION,0.12259,0.056889,0.074007,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.23589,0.056591,0.027915,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.37932,0.056541,0.056625,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.12908,0.056292,0.069819,0,0
4,GO AMINO ACID TRANSPORT,0.099158,0.056209,0.11745,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.20621,0.056055,0.049932,0,0
4,GO CELL SUBSTRATE ADHESION,0.32938,0.056006,0.025485,0,0
4,GO REGULATION OF ERAD PATHWAY,0.48131,0.055932,0.042009,0,0
4,GO RRNA TRANSCRIPTION,0.68418,0.055918,0.011069,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.53742,0.055651,0.024341,0,0
4,GO AXONEME ASSEMBLY,0.38888,0.055618,0.051052,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.76948,0.055339,0.026507,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.41341,0.055303,0.025858,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.21579,0.055225,0.051354,0,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.48678,0.055187,0.01651,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.25363,0.055057,0.024812,0,0
4,GO ORGANIC CATION TRANSPORT,0.11841,0.055024,0.10065,0,0
4,GO PINOCYTOSIS,0.30815,0.055014,0.02954,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.079444,0.054973,0.10109,0,0
4,GO GLAND MORPHOGENESIS,0.25363,0.054949,0.047647,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.41842,0.054821,0.061146,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.33373,0.054594,0.072403,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.077957,0.054517,0.067641,0,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.090515,0.054507,0.057115,0,0
4,GO RESPONSE TO AMPHETAMINE,0.92682,0.054283,-0.020985,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.38888,0.05426,0.034846,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.64605,0.054225,0.0056762,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.88523,0.054207,0.0070032,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.44402,0.054171,0.033667,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.46512,0.054084,0.027397,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.39371,0.054009,0.027655,0,0
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.16828,0.053954,0.11821,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.70355,0.053658,0.027691,0,0
4,GO CIRCADIAN RHYTHM,0.076492,0.05365,0.046641,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.075049,0.053596,0.080912,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.33373,0.053556,0.030991,0,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.12908,0.05348,0.063163,0,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.11434,0.053438,0.09225,0,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.87144,0.053342,0.041261,0,0
4,GO NOTOCHORD DEVELOPMENT,0.60272,0.053316,-0.13276,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.21579,0.05331,0.031889,0,0
4,GO BLASTOCYST DEVELOPMENT,0.033166,0.053001,0.073703,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.99651,0.052709,-0.030017,0,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.11636,0.052591,0.049393,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.78289,0.052537,0.0044602,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.33812,0.052294,0.023541,0,0
4,GO EXTRACELLULAR TRANSPORT,0.32077,0.052048,0.067309,0,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.080955,0.051927,0.053994,0,0
4,GO POLYOL CATABOLIC PROCESS,0.053746,0.051622,0.11816,0,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.13355,0.051608,0.11199,0,0
4,GO ENDOCYTOSIS,0.23589,0.051392,0.049,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.94769,0.051359,-0.037542,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.39858,0.051096,0.033335,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.79636,0.051045,0.03723,0,0
4,GO RESPONSE TO LEPTIN,0.25001,0.050924,0.092334,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.26471,0.050916,0.044549,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.4598,0.050914,0.029676,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.36064,0.050838,0.032398,0,0
4,GO DNA DEALKYLATION,0.94769,0.050825,-0.012093,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.4598,0.050773,0.010904,0,0
4,GO JNK CASCADE,0.076492,0.05066,0.061437,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.66501,0.050504,-0.081354,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.44402,0.050424,0.11764,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.84397,0.050376,0.017809,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.52025,0.05031,0.05515,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.91987,0.050255,0.049811,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.1313,0.050222,0.10398,0,0
4,GO VASCULATURE DEVELOPMENT,0.53742,0.050166,0.005541,0,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.90599,0.050156,-0.013518,0,0
4,GO RNA DECAPPING,0.96163,0.050027,-0.0064044,0,0
4,GO PIGMENT ACCUMULATION,0.27227,0.04968,0.070023,0,0
4,GO RELAXATION OF MUSCLE,0.43367,0.049109,0.054837,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.32077,0.048995,0.05321,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.15015,0.048981,0.061823,0,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.48678,0.048905,0.051519,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.88523,0.048889,-0.0047621,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.91293,0.048817,0.0065111,0,0
4,GO SENSORY PERCEPTION,0.17374,0.04874,0.039612,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.46512,0.048716,0.035408,0,0
4,GO VIRAL GENE EXPRESSION,0.71006,0.048694,0.012045,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.80312,0.048576,0.01349,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.83713,0.04856,0.016722,0,0
4,GO AMP METABOLIC PROCESS,0.36064,0.048417,0.10558,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.71658,0.048367,0.021573,0,0
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.22235,0.048337,0.075563,0,0
4,GO RESPONSE TO MUSCLE INACTIVITY,0.29992,0.048299,0.11919,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.17934,0.048285,0.11304,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.89215,0.048094,-0.0090498,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.077957,0.047988,0.05834,0,0
4,GO LUNG MORPHOGENESIS,0.42855,0.047956,0.028844,0,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.58456,0.047539,-0.080041,0,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.35153,0.047231,0.042618,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.39371,0.047184,0.041753,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.13583,0.047143,0.066111,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.67137,0.047143,0.026526,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65234,0.047077,0.024819,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.61497,0.047013,0.012049,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.3746,0.046749,0.033826,0,0
4,GO CELL MOTILITY,0.15264,0.046643,0.051464,0,0
4,GO OSSIFICATION,0.23245,0.046587,0.028835,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.69061,0.046491,-0.018853,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.4978,0.046482,0.017973,0,0
4,GO CYTOPLASMIC TRANSLATION,0.67137,0.046467,0.0099923,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.23937,0.04646,0.067404,0,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.15015,0.046332,0.14846,0,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.13814,0.046298,0.060048,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.87144,0.046264,-0.024703,0,0
4,GO MACROMOLECULE DEACYLATION,0.2839,0.046253,0.029519,0,0
4,GO EXOCYTIC PROCESS,0.079444,0.046168,0.13377,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.57857,0.045784,-0.0049041,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.19695,0.045263,0.03284,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.85768,0.045252,0.0056684,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.11235,0.045205,0.079589,0,0
4,GO ASTROCYTE ACTIVATION,0.91293,0.045181,-0.035312,0,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.059411,0.045168,0.1088,0,0
4,GO PRO B CELL DIFFERENTIATION,0.33373,0.045148,0.067763,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.78962,0.045064,-0.011286,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.43367,0.045001,0.03498,0,0
4,GO ANATOMICAL STRUCTURE MATURATION,0.13355,0.044959,0.052803,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.34702,0.044833,0.07677,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.75615,0.04483,0.0032576,0,0
4,GO RESPONSE TO AMINE,0.88523,0.044798,0.0047868,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.11235,0.044759,0.084515,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.29586,0.044626,0.045845,0,0
4,GO ACTION POTENTIAL,0.39371,0.044268,0.055477,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.73628,0.044225,0.011584,0,0
4,GO TORC1 SIGNALING,0.19695,0.044211,0.046841,0,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.15517,0.044211,0.055882,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.98953,0.044111,0.005829,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.29586,0.044007,0.034003,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.27999,0.043954,0.03549,0,0
4,GO CARDIAC CONDUCTION,0.71658,0.043952,0.015753,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.47588,0.043856,0.013752,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.57857,0.043762,0.053361,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.26847,0.043676,0.051709,0,0
4,GO REGULATION OF GASTRULATION,0.82348,0.043568,-0.0078874,0,0
4,GO HISTONE DEACETYLATION,0.75615,0.043477,0.0049304,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.89907,0.043447,-0.036212,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.53167,0.043412,0.018188,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.2839,0.043409,0.10359,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.86455,0.043402,-0.0039,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.50896,0.043147,0.048221,0,0
4,GO DECIDUALIZATION,0.80312,0.043028,-0.037397,0,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.2,0.04292,0.038964,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.17374,0.042879,0.056994,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.41341,0.042816,0.055572,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.78962,0.042763,-0.01813,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.54321,0.042362,0.00016856,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.84397,0.042205,-0.001969,0,0
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.33812,0.042123,0.062118,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.15015,0.041987,0.026517,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.33812,0.04189,0.033197,0,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.85082,0.041846,0.00093693,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.49227,0.041799,0.01243,0,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.95466,0.041732,-0.025914,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.27611,0.04166,0.020827,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.30402,0.04158,0.038182,0,0
4,GO TRANSLATIONAL INITIATION,0.78962,0.04157,0.0061628,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.54903,0.04157,0.026245,0,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.1313,0.041553,0.035933,0,0
4,GO ARTERY MORPHOGENESIS,0.47049,0.04155,0.0037701,0,0
4,GO BONE MINERALIZATION,0.41842,0.041468,0.020471,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.22905,0.041426,0.12836,0,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.14285,0.041348,0.095438,0,0
4,GO MYOBLAST DIFFERENTIATION,0.84397,0.041219,-0.015018,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.37932,0.041208,0.066587,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.92682,0.041173,-0.046376,0,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.31232,0.040975,0.048401,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.4545,0.040765,0.0099664,0,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.079444,0.040756,0.051088,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.29992,0.040595,0.10679,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.188,0.040429,0.048587,0,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.12473,0.040285,0.036114,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.56666,0.040281,0.026971,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.82348,0.040242,-0.011419,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.50896,0.039974,0.01578,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.74288,0.039944,0.0061716,0,0
4,GO TUBE MORPHOGENESIS,0.50337,0.039924,0.0072269,0,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.32938,0.039875,0.037893,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.17374,0.039841,0.068729,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.44402,0.039809,0.0011876,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.59059,0.039771,0.016642,0,0
4,GO MESONEPHROS DEVELOPMENT,0.48131,0.039601,0.023892,0,0
4,GO MUSCLE CONTRACTION,0.23589,0.039582,0.050022,0,0
4,GO CELL AGING,0.31653,0.039566,0.03992,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.87833,0.039248,-0.0017234,0,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.11039,0.039218,0.10634,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.85082,0.038838,-0.032618,0,0
4,GO RESPONSE TO GLUCAGON,0.33812,0.038719,0.070605,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.11636,0.038607,0.06988,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.56075,0.038561,0.016907,0,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.066855,0.038505,0.078245,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.77618,0.038325,-0.048803,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.44924,0.038293,0.071713,0,0
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.83713,0.03806,0.005706,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.14526,0.038039,0.065693,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.26471,0.037978,0.054987,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.48678,0.037947,0.024489,0,0
4,GO TUBE DEVELOPMENT,0.39371,0.037872,0.018053,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.67137,0.037819,0.038246,0,0
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.51459,0.037735,0.034464,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.4978,0.037703,0.01061,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.52025,0.037657,0.047594,0,0
4,GO SOMITE DEVELOPMENT,0.19095,0.037651,0.053259,0,0
4,GO REGULATION OF BINDING,0.32077,0.037617,0.030128,0,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.50896,0.03757,0.028318,0,0
4,GO RESPONSE TO POTASSIUM ION,0.93377,0.037545,-0.011109,0,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.89907,0.03749,-0.0016338,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.57857,0.037318,0.020421,0,0
4,GO DEPHOSPHORYLATION,0.4598,0.037298,0.0187,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.60883,0.037232,0.031159,0,0
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.23245,0.037219,0.029226,0,0
4,GO POSITIVE T CELL SELECTION,0.29992,0.037185,0.046137,0,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.29992,0.037032,0.036665,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.16032,0.036841,0.067793,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.20937,0.036832,0.101,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.32077,0.036741,0.028169,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.56666,0.036541,0.053866,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.61497,0.036392,0.035268,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.98255,0.03633,-0.011876,0,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.65866,0.036295,0.023191,0,0
4,GO MYELOID CELL DEVELOPMENT,0.23245,0.036262,0.047963,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.31232,0.036146,0.019278,0,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.077957,0.036125,0.060715,0,0
4,GO REGULATION OF DNA METHYLATION,0.94073,0.036124,-0.0028463,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.89215,0.035803,-0.0030004,0,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.088862,0.035785,0.06576,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.22568,0.035771,0.077517,0,0
4,GO REGULATION OF EXOCYTOSIS,0.26098,0.035676,0.070518,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.51459,0.035641,0.041902,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.37932,0.035623,0.033608,0,0
4,GO MEMBRANE FISSION,0.80312,0.035597,0.01476,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.25001,0.035516,0.034223,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.51459,0.03547,0.037951,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.15015,0.035441,0.047491,0,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.32938,0.035366,0.024296,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.35607,0.03536,0.033656,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.31232,0.034995,0.12515,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.23937,0.034881,0.041944,0,0
4,GO RESPONSE TO ATP,0.71658,0.034782,0.024478,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.79636,0.034494,0.0030616,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.68418,0.034322,0.0029556,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.12473,0.034311,0.064069,0,0
4,GO MESODERM MORPHOGENESIS,0.75615,0.034266,-0.0029506,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.25729,0.034134,0.064544,0,0
4,GO PLASMA MEMBRANE FUSION,0.47049,0.034094,0.068372,0,0
4,GO MALE MEIOSIS I,0.3746,0.034026,0.1155,0,0
4,GO RESPONSE TO HYDROXYUREA,0.71658,0.033952,0.011335,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.48131,0.033933,0.019247,0,0
4,GO TOOTH MINERALIZATION,0.76281,0.033911,-0.0367,0,0
4,GO MALE SEX DETERMINATION,0.33812,0.033881,0.089499,0,0
4,GO PEPTIDE CROSS LINKING,0.35153,0.033795,0.052042,0,0
4,GO RESPONSE TO INACTIVITY,0.53742,0.033491,0.077807,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.56075,0.03336,0.01383,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.86455,0.033243,-0.015715,0,0
4,GO MALE SEX DIFFERENTIATION,0.31653,0.03324,0.028185,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.90599,0.033141,0.010021,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.22905,0.033123,0.041407,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.23245,0.033062,0.037822,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.49227,0.032939,0.022593,0,0
4,GO SEGMENTATION,0.56666,0.032898,0.02715,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.77618,0.032854,0.034221,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.62732,0.032759,-0.003013,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.51459,0.032689,0.013996,0,0
4,GO OOCYTE MATURATION,0.61497,0.032661,0.026541,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.43367,0.03256,0.037985,0,0
4,GO REGULATION OF ENDOCYTOSIS,0.27611,0.032516,0.04161,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.93377,0.032326,-0.050853,0,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.32506,0.032311,0.056237,0,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.39858,0.032268,-0.14864,0,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.17934,0.032202,0.076657,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.43883,0.032001,0.03601,0,0
4,GO POTASSIUM ION HOMEOSTASIS,0.67137,0.031981,0.021273,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.42347,0.03195,0.017231,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.72969,0.031841,0.039666,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.087232,0.031708,0.036564,0,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.23589,0.031702,0.052452,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.78289,0.031655,0.021617,0,0
4,GO POSITIVE REGULATION OF BINDING,0.32938,0.031452,0.032582,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.22568,0.031452,0.034128,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.78289,0.031333,-0.014935,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.23937,0.031184,0.056827,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.36064,0.031158,0.11083,0,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.36991,0.031008,0.026078,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.60272,0.030976,0.01922,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.26098,0.030951,0.073048,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.41842,0.030917,0.022589,0,0
4,GO PLACENTA DEVELOPMENT,0.52594,0.03091,0.029127,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.54903,0.030875,0.021526,0,0
4,GO MULTI ORGANISM PROCESS,0.20937,0.030867,0.035281,0,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.57857,0.03082,0.0093698,0,0
4,GO CELL CYCLE ARREST,0.50337,0.030815,0.019714,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.41842,0.030726,0.02935,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.61497,0.030676,0.0069963,0,0
4,GO AUTOPHAGIC CELL DEATH,0.29184,0.030618,0.064612,0,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.26471,0.030486,0.070033,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21905,0.030457,0.049854,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.40349,0.030419,0.024819,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.13583,0.030235,0.044493,0,0
4,GO REPRODUCTION,0.24643,0.030103,0.030923,0,0
4,GO FACE DEVELOPMENT,0.89907,0.030001,-0.0019066,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.82348,0.029959,0.029768,0,0
4,GO TRNA CATABOLIC PROCESS,0.77618,0.029958,0.029426,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.32938,0.029927,0.032425,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.27611,0.029895,0.081634,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.39371,0.029854,0.028347,0,0
4,GO RESPONSE TO NICOTINE,0.95466,0.029832,-0.017838,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.42855,0.029788,0.025477,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.41842,0.029768,0.062034,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.79636,0.029445,-0.014604,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.4545,0.029433,0.063454,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.43367,0.02923,0.12499,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.75615,0.029206,0.0022672,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.34256,0.029185,0.052374,0,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.082489,0.029132,0.042825,0,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.53742,0.029086,0.0080923,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.38888,0.029039,0.053752,0,0
4,GO IMPORT INTO NUCLEUS,0.17099,0.029021,0.048012,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.94073,0.028996,-0.031658,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.4545,0.028891,0.031084,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.29992,0.028458,0.073763,0,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.11841,0.028382,0.053806,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.28785,0.028338,0.033821,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.65866,0.028329,0.029997,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.80312,0.028311,-0.013332,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.84397,0.028257,0.015093,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.97557,0.028222,-0.014529,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.40843,0.028071,0.053403,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.62732,0.028058,0.01943,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.48131,0.028008,0.13586,0,0
4,GO MEMBRANE REPOLARIZATION,0.84397,0.027927,-0.00389,0,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.29992,0.027615,0.031305,0,0
4,GO CELLULAR SENESCENCE,0.26471,0.027559,0.041423,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.67776,0.027522,0.0033876,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.4545,0.02748,0.013566,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.017549,0.027474,0.16139,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.72969,0.027391,0.025724,0,0
4,GO MEIOTIC CELL CYCLE,0.54321,0.027383,0.011839,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.7495,0.027367,0.0058759,0,0
4,GO ZINC ION TRANSPORT,0.16828,0.027357,0.11626,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.55487,0.027255,0.047324,0,0
4,GO BODY MORPHOGENESIS,0.92682,0.027249,-0.013776,0,0
4,GO CILIUM MOVEMENT,0.31232,0.027179,0.020087,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.81668,0.02705,-0.020475,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.85768,0.026999,-0.041551,0,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.3746,0.026976,0.029343,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.27227,0.026952,0.1906,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.76948,0.026759,-0.0033551,0,0
4,GO SNRNA PROCESSING,0.38408,0.026652,0.0073628,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.86455,0.02664,0.0088107,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.69707,0.026604,0.018954,0,0
4,GO CAMP BIOSYNTHETIC PROCESS,0.31232,0.02652,0.093771,0,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.053746,0.026443,0.066824,0,0
4,GO HISTONE H2B UBIQUITINATION,0.37932,0.026375,0.036517,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.9686,0.02635,-0.0075579,0,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.88523,0.026112,0.020896,0,0
4,GO HEART PROCESS,0.48678,0.026109,0.032075,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.80312,0.026056,-0.018584,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.87833,0.025881,-0.0090304,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.78289,0.025784,-0.040195,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.78962,0.025657,0.0050381,0,0
4,GO PROTEIN TRIMERIZATION,0.72969,0.025605,0.012364,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.73628,0.025578,0.031281,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.47049,0.025573,0.036397,0,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.63354,0.025569,-0.025972,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.67137,0.025467,0.014449,0,0
4,GO CELLULAR RESPONSE TO ATP,0.49227,0.025225,0.048709,0,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.67776,0.025076,0.0027358,0,0
4,GO SARCOMERE ORGANIZATION,0.27611,0.025073,0.066905,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.52594,0.024829,0.033418,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.36064,0.024578,0.016514,0,0
4,GO BRONCHUS DEVELOPMENT,0.53742,0.024547,0.099674,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.33373,0.024535,0.033641,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.53167,0.024534,0.027221,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.81668,0.024411,-0.0011188,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.8303,0.024408,-0.014672,0,0
4,GO MALE GAMETE GENERATION,0.69061,0.024268,0.0060828,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.41341,0.024047,0.04706,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.67776,0.024002,0.025703,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.46512,0.023984,0.029845,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.71006,0.023868,-0.027786,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.47588,0.023748,0.087238,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.58456,0.023725,0.040766,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.87144,0.023554,0.0046452,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.4978,0.023278,0.045517,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.29184,0.023214,0.077379,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,1,0.023112,0.0041203,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.80989,0.023109,-0.067703,0,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.16559,0.0231,0.050958,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.78962,0.023043,0.007337,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.98953,0.023011,-0.0087919,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.40349,0.022858,0.077265,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.65866,0.022781,0.0056863,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.95466,0.022765,-0.0047804,0,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.22905,0.022698,0.048908,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.9686,0.022674,-0.048099,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.2,0.022515,0.054469,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.15773,0.022469,0.11298,0,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.65234,0.02241,0.042971,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.42347,0.022271,0.054135,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.87833,0.022182,-0.018312,0,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.21256,0.022103,0.035505,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.42855,0.022059,0.084633,0,0
4,GO METHYLATION,0.80312,0.021973,-0.0058231,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.58456,0.02197,-0.10189,0,0
4,GO FEAR RESPONSE,0.98953,0.02191,-0.0075942,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.30815,0.021855,0.01826,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.56075,0.021844,0.016544,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.44924,0.021547,0.04195,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.26847,0.021433,0.042309,0,0
4,GO MATING,0.22568,0.021361,0.059364,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.72969,0.021284,-0.044161,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.91987,0.020849,-0.015307,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.77618,0.020798,-0.0069253,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.91293,0.020762,-0.0089106,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.99651,0.020715,-0.038174,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.69707,0.020581,0.013427,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.43367,0.020557,0.090796,0,0
4,GO SNRNA METABOLIC PROCESS,0.35607,0.020247,0.020017,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.78289,0.020141,0.0036058,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.81668,0.020108,-0.0062093,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.28785,0.020101,0.052814,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.75615,0.019961,0.071868,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.71006,0.01981,-0.020478,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.87833,0.01955,-0.0025687,0,0
4,GO GROOMING BEHAVIOR,0.41341,0.019189,0.069674,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.84397,0.019101,-0.024557,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.94769,0.019053,-0.0067689,0,0
4,GO POSITIVE REGULATION OF CELL GROWTH,0.4545,0.019035,0.031681,0,0
4,GO PHOTOPERIODISM,0.66501,0.018874,0.025186,0,0
4,GO SEXUAL REPRODUCTION,0.52025,0.018743,0.012572,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.92682,0.018719,0.010904,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.58456,0.018715,0.0053462,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.72313,0.01867,0.0033595,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.51459,0.018641,0.027674,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.79636,0.018441,0.0044258,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65866,0.018423,0.011565,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.83713,0.018415,0.017264,0,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.38408,0.018384,0.023964,0,0
4,GO PRE MIRNA PROCESSING,0.90599,0.018313,-0.018015,0,0
4,GO CELL FATE DETERMINATION,0.80312,0.018261,0.017211,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.56075,0.017896,0.11848,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.89907,0.017847,-0.010289,0,0
4,GO REGULATION OF SYSTEM PROCESS,0.67776,0.017819,0.01659,0,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.32938,0.017815,0.026057,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.27611,0.017755,0.037044,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.36526,0.017733,0.024497,0,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.35607,0.017711,0.027276,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.93377,0.017699,-0.0036861,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.49227,0.017671,0.018722,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.80312,0.017669,-0.028772,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.87833,0.017603,-0.022446,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.70355,0.017453,-0.0055694,0,0
4,GO PHOSPHATE ION TRANSPORT,0.60883,0.017364,0.017435,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.46512,0.017257,0.025507,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.41341,0.017244,0.006726,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.28785,0.017137,0.10618,0,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.17653,0.016808,0.074138,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.67776,0.016745,0.03191,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.87144,0.016709,0.0033569,0,0
4,GO SENSORY PERCEPTION OF PAIN,0.7495,0.016607,0.018127,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.5726,0.016553,0.014309,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.71658,0.016513,0.018042,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.79636,0.016495,-0.0030227,0,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.41341,0.01648,0.024807,0,0
4,GO ORGANELLE LOCALIZATION,0.69061,0.016025,0.010399,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.70355,0.015913,0.013983,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.86455,0.015886,0.012205,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.75615,0.015771,0.005117,0,0
4,GO REGULATION OF HAIR CYCLE,0.47588,0.015558,0.069622,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.78962,0.015549,0.0067747,0,0
4,GO MEMBRANE RAFT ASSEMBLY,0.56075,0.015503,0.037294,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.35607,0.015419,0.022758,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.53742,0.015299,0.020066,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.65234,0.015178,0.019337,0,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,0.015172,0.053559,0,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.9686,0.015107,-0.0058675,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.47588,0.014978,0.026779,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.52025,0.014975,0.0078536,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.58456,0.014969,0.028063,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.92682,0.014916,-0.050223,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.89907,0.014892,-0.0082718,0,0
4,GO REGULATION OF METAL ION TRANSPORT,0.4598,0.014667,0.030605,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.92682,0.014599,0.0012123,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.98255,0.014568,0.0067622,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.91293,0.014537,-0.023471,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.59664,0.014497,0.059493,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.66501,0.014061,0.09401,0,0
4,GO REGULATION OF URINE VOLUME,0.84397,0.014058,-0.011737,0,0
4,GO GAMETE GENERATION,0.78962,0.013992,0.0024545,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.57857,0.013914,0.029973,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.59664,0.013899,-0.067441,0,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.60883,0.013821,0.025693,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.93377,0.013783,-0.00068126,0,0
4,GO RUFFLE ORGANIZATION,0.20309,0.013727,0.099485,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.57857,0.013552,0.058426,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.85768,0.013421,-0.0042819,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.94769,0.013415,-0.004108,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.99651,0.013355,-0.0049807,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.65866,0.013326,0.00054191,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.85768,0.013243,0.020638,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.77618,0.01323,0.0060013,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.82348,0.013198,-0.00675,0,0
4,GO RHYTHMIC PROCESS,0.48131,0.01316,0.017758,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,1,0.013111,-0.0088213,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.56666,0.013104,0.017459,0,0
4,GO GLIAL CELL DEVELOPMENT,0.69061,0.013037,0.011275,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.97557,0.012962,-0.00045195,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.88523,0.012919,-0.014209,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.70355,0.01285,0.0029063,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.91293,0.012737,0.039187,0,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.54321,0.01269,0.014856,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.60272,0.01268,0.057946,0,0
4,GO POTASSIUM ION TRANSPORT,0.74288,0.012558,-0.014843,0,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.94073,0.012506,-0.0068767,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.87833,0.012475,0.0068344,0,0
4,GO NEPHRON DEVELOPMENT,0.39371,0.012434,0.024343,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.63978,0.012241,-0.024136,0,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.62113,0.012162,0.073508,0,0
4,GO THYMIC T CELL SELECTION,0.74288,0.012075,0.01366,0,0
4,GO ESTROUS CYCLE,0.71658,0.012015,-0.029592,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.58456,0.011958,0.054572,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.82348,0.01162,0.0071325,0,0
4,GO T CELL CHEMOTAXIS,0.65234,0.011522,0.023591,0,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.60883,0.011515,0.025881,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.27999,0.011315,0.090216,0,0
4,GO REGULATION OF PINOCYTOSIS,0.91987,0.011296,-0.048553,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.62732,0.011017,0.025916,0,0
4,GO AORTA MORPHOGENESIS,0.93377,0.010985,-0.011445,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.41842,0.010842,0.056489,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.53742,0.010607,0.02031,0,0
4,GO NEURON MATURATION,0.83713,0.0106,0.035035,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.99651,0.010463,0.010402,0,0
4,GO GLIAL CELL MIGRATION,0.76281,0.0103,-0.037201,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.71006,0.010263,-0.013664,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.66501,0.010205,0.011338,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.52594,0.00993,-0.039817,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.77618,0.0098461,-0.044587,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.84397,0.009758,-0.0055168,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.27227,0.009481,0.1011,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.76948,0.0093923,-0.00056756,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.83713,0.0093804,0.021662,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.98953,0.0092685,0.012399,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.90599,0.0092429,-0.0027828,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.67137,0.0092344,0.015946,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.23245,0.0092231,-0.23145,0,0
4,GO MRNA TRANSCRIPTION,0.62732,0.0089846,0.016783,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.82348,0.0088488,-0.00047311,0,0
4,GO RRNA CATABOLIC PROCESS,0.71658,0.0087623,0.0048875,0,0
4,GO PROTEIN NITROSYLATION,0.92682,0.0086565,-0.039672,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.86455,0.0084961,0.025465,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.38888,0.0084857,-0.12432,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.67137,0.0084548,-0.033532,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.68418,0.0083088,0.029754,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.72969,0.0082705,-0.019739,0,0
4,GO CARTILAGE DEVELOPMENT,0.51459,0.0082319,-0.053898,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.69707,0.0081917,-0.031833,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.64605,0.0081764,-0.036333,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.81668,0.0077584,-0.019407,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.83713,0.0077175,-0.031171,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.60883,0.0077102,-0.10035,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.19095,0.0076463,-0.075317,0,0
4,GO GOLGI LOCALIZATION,0.96163,0.0074917,0.0017597,0,0
4,GO POSTREPLICATION REPAIR,0.74288,0.0074536,-0.0012841,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.82348,0.00727,-0.00052328,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.94769,0.0071841,-0.010072,0,0
4,GO RESPONSE TO BMP,0.65234,0.0071136,-0.050646,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.98953,0.0068594,0.0020914,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.30815,0.0068155,0.059679,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.69707,0.0067718,0.016774,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.91293,0.0067175,-0.025449,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.58456,0.0065645,-0.028498,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.98953,0.0064815,-0.0031024,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.52594,0.0064689,-0.041435,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.85082,0.0064053,0.034776,0,0
4,GO TELOMERE ORGANIZATION,0.93377,0.0062505,-0.016803,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.78289,0.0061552,-0.0023548,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.86455,0.0061428,-0.0046164,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.89907,0.0061097,-0.0052405,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.70355,0.006049,0.018598,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.94073,0.0060192,-0.0055162,0,0
4,GO CELL JUNCTION ASSEMBLY,0.99651,0.0060004,-0.0023873,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.83713,0.0058957,-0.0088473,0,0
4,GO MOLTING CYCLE,0.79636,0.0057631,-0.00072815,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.70355,0.0055894,-0.021563,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.41341,0.0055142,-0.11223,0,0
4,GO LACTATION,0.88523,0.0054735,0.020374,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.75615,0.005397,0.021421,0,0
4,GO TISSUE MORPHOGENESIS,0.51459,0.0053877,0.0081628,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.66501,0.0053731,0.0058334,0,0
4,GO CGMP MEDIATED SIGNALING,0.94769,0.005355,0.012965,0,0
4,GO TRANSLESION SYNTHESIS,0.43883,0.0053308,0.022353,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.90599,0.0053209,-0.00010361,0,0
4,GO SEX DETERMINATION,0.98255,0.0051718,-0.0030732,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.60272,0.0050081,0.041778,0,0
4,GO PROTEIN NEDDYLATION,0.82348,0.0049875,-0.015071,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.62113,0.0049498,-0.026456,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.77618,0.0044032,-0.011322,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,0.0043363,-0.0054669,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.7495,0.0042591,-0.025934,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.78289,0.0042154,0.0043766,0,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.92682,0.0041631,0.014801,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.76281,0.0040359,-0.021278,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.85082,0.0038496,0.010955,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.92682,0.0037871,-0.014995,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.71006,0.0035969,0.015736,0,0
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.4545,0.0033351,0.087923,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.44402,0.0032827,0.034321,0,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.31653,0.0031752,0.057978,0,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.68418,0.0031734,0.016287,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.44924,0.0029988,0.028949,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.71006,0.0029291,0.013704,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.61497,0.0029268,-0.036294,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.76281,0.0028856,-0.0015958,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.53742,0.0028438,-0.049693,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.79636,0.0027427,0.023051,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.71006,0.0025417,-0.053831,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.31232,0.0023741,0.1122,0,0
4,GO VIRAL TRANSLATION,0.80312,0.0023326,-0.042724,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.8303,0.0022849,0.0047525,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.98255,0.0022433,-0.0041373,0,0
4,GO NCRNA TRANSCRIPTION,0.91987,0.0022379,-0.020365,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.69061,0.0020603,0.030062,0,0
4,GO ASSOCIATIVE LEARNING,0.79636,0.0020057,0.010751,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.67776,0.0019369,0.015417,0,0
4,GO RESPONSE TO VITAMIN A,0.76281,0.001889,0.0058859,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.64605,0.0015459,-0.020348,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.72313,0.0015269,0.021233,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.75615,0.0014936,0.071285,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.93377,0.0013996,-0.0025999,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.75615,0.0013511,-0.010076,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.3746,0.0010561,-0.061359,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.36991,0.00076853,-0.031787,0,0
4,GO SPERMATID DIFFERENTIATION,0.85082,0.00065402,-0.0079376,0,0
4,GO NERVE DEVELOPMENT,0.95466,0.00057494,-0.0067458,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.53742,0.00046792,0.026477,0,0
4,GO DNA MODIFICATION,0.80989,0.00045038,0.0073328,0,0
4,GO NEURON DEATH,0.51459,0.00043302,0.021024,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.36991,0.00040217,0.081609,0,0
4,GO IMPORT INTO CELL,0.33373,0.00030582,0.054988,0,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.97557,0.00021749,0.0032485,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.84397,3.5005e-05,0.014708,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.75615,-0.00011486,-0.038497,0,0
4,GO NCRNA 3 END PROCESSING,0.89215,-0.00013552,-0.024007,0,0
4,GO NEPHRON MORPHOGENESIS,0.63978,-0.00026506,-0.030496,0,0
4,GO RESPONSE TO RADIATION,0.91293,-0.00070074,-0.0029638,0,0
4,GO AXIS SPECIFICATION,0.70355,-0.0010198,-0.029298,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.60272,-0.0012455,0.046238,0,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.62732,-0.0015384,0.0042201,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.87833,-0.0015936,0.0028856,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.47588,-0.0019786,0.0744,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.7495,-0.00203,0.01255,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.88523,-0.0020417,0.10916,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,-0.0022044,0.04363,0,0
4,GO GENITALIA DEVELOPMENT,0.76281,-0.0022159,-0.024438,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.88523,-0.0023041,-0.00073044,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.87833,-0.0024018,-0.025664,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.76948,-0.0024818,-0.040734,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.41341,-0.0024903,-0.036831,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.87833,-0.0025847,-0.025682,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.72313,-0.0026482,0.01452,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.71006,-0.002752,0.098013,0,0
4,GO STRIATUM DEVELOPMENT,0.65234,-0.0027939,0.04611,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.36064,-0.0027974,0.045553,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.92682,-0.0030053,-0.0035052,0,0
4,GO PARENTAL BEHAVIOR,0.65234,-0.0030838,0.05226,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.90599,-0.003175,0.0047651,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.39858,-0.0032109,0.023347,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.94769,-0.003249,0.0067868,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.76948,-0.0033367,-0.030404,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.78289,-0.0033739,0.01576,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.57857,-0.0035711,0.028438,0,0
4,GO HISTONE H3 ACETYLATION,0.47049,-0.0035999,-0.028224,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87144,-0.0037216,-0.0078181,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.89907,-0.0037767,-0.023091,0,0
4,GO FAT CELL PROLIFERATION,0.76948,-0.0039363,-0.022188,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.92682,-0.0040207,-0.027021,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.98255,-0.0040801,-0.0040194,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.69707,-0.0042473,0.018549,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.87144,-0.0042786,0.0027201,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.89907,-0.0043654,-0.028127,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.47588,-0.0043829,0.10922,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.52025,-0.0044087,-0.10706,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.78289,-0.0045818,0.013564,0,0
4,GO SNRNA TRANSCRIPTION,0.35153,-0.004593,-0.038324,0,0
4,GO REGULATION OF GROWTH,0.95466,-0.0045968,0.00065646,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.95466,-0.0048199,0.00020294,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.98953,-0.0051652,0.011124,0,0
4,GO OVULATION,0.56666,-0.0052538,0.10002,0,0
4,GO PROTEIN KINASE A SIGNALING,0.84397,-0.0053306,-0.025734,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.85768,-0.0054238,-0.018474,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.97557,-0.0054709,-0.00045436,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.98953,-0.0055067,-0.0021756,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.72969,-0.0055118,-0.017586,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.76948,-0.0055207,-0.028187,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.47049,-0.0056754,0.039144,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.73628,-0.0058936,-0.0099117,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.76948,-0.0059654,0.0015816,0,0
4,GO MYOBLAST PROLIFERATION,0.99651,-0.0059937,-0.0063764,0,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.9686,-0.0060495,0.0057925,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.89215,-0.0060714,0.018074,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.63978,-0.0061337,0.015512,0,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.88523,-0.0064338,0.0043679,0,0
4,GO RNA PROCESSING,0.71658,-0.0065808,-0.023837,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.70355,-0.0067547,0.012401,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.95466,-0.0067698,0.0049483,0,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.86455,-0.0068017,0.0049173,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.87144,-0.0068262,0.014283,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.69707,-0.0069023,-0.035636,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.88523,-0.0072585,0.011167,0,0
4,GO PORE COMPLEX ASSEMBLY,0.69707,-0.0073171,-0.019547,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.70355,-0.0073838,-0.0076421,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.47588,-0.007442,-0.021923,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.91987,-0.0074425,-0.0051677,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.85082,-0.0074557,-0.002462,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.56666,-0.0074728,0.016708,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.80989,-0.0074947,-0.036321,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.87144,-0.0077853,-0.0021327,0,0
4,GO MYELIN ASSEMBLY,0.94073,-0.0077859,-0.0063723,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.89907,-0.007832,0.0073906,0,0
4,GO MATURATION OF LSU RRNA,0.85768,-0.0078557,0.00084396,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.84397,-0.0078823,0.0085361,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.4978,-0.0081024,0.01649,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.60272,-0.0081058,0.026435,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.91293,-0.0081151,-0.0012556,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.69061,-0.0082983,0.011748,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.91987,-0.0083187,0.048288,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.74288,-0.0084644,-0.043873,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.98255,-0.0087586,-0.0049941,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.98255,-0.0088544,-0.00080746,0,0
4,GO DOSAGE COMPENSATION,0.34702,-0.008928,-0.05321,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.78962,-0.0089867,0.07492,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,1,-0.009028,0.020197,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.97557,-0.0092445,-0.013527,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.72313,-0.0092672,-0.044149,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.54321,-0.0093593,-0.025792,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.64605,-0.0094096,-0.0076232,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.86455,-0.009529,-0.0007421,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.2,-0.0095886,-0.035386,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.78962,-0.0096833,0.015638,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.32506,-0.0097168,-0.038506,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95466,-0.0098141,0.0024227,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.79636,-0.010131,-0.044083,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.29586,-0.010211,-0.075815,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.72313,-0.010326,-0.014814,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.7495,-0.010435,-0.079731,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.93377,-0.010584,0.0088202,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.86455,-0.010675,0.0067706,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.89907,-0.010697,-0.028445,0,0
4,GO NUCLEUS ORGANIZATION,0.90599,-0.01086,0.007723,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.7495,-0.010878,0.021837,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.66501,-0.010894,-0.060441,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.85768,-0.011124,0.019216,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.48131,-0.011233,-0.039597,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.3746,-0.011604,0.11891,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.63978,-0.011722,-0.052365,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.22568,-0.011825,0.047263,0,0
4,GO INNERVATION,0.70355,-0.011843,0.0072982,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.62113,-0.01211,0.010048,0,0
4,GO ASTROCYTE DEVELOPMENT,0.57857,-0.012154,-0.047874,0,0
4,GO ODONTOGENESIS,0.36526,-0.01216,-0.075941,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.69061,-0.012196,-0.011306,0,0
4,GO RECEPTOR RECYCLING,0.9686,-0.012315,0.015671,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.7495,-0.012459,-0.040601,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.80989,-0.01251,-0.020564,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.76948,-0.01261,0.0098597,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.51459,-0.012714,0.020025,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.99651,-0.012788,0.0048516,0,0
4,GO MIRNA METABOLIC PROCESS,0.50896,-0.013207,-0.032612,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.49227,-0.013292,-0.016548,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.78962,-0.013366,-0.011296,0,0
4,GO ORGANELLE FISSION,0.44402,-0.013419,-0.017467,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.69061,-0.01354,-0.017375,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.92682,-0.013692,-0.0032811,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.89907,-0.013743,0.013685,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.50896,-0.0138,-0.046664,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.93377,-0.01385,-0.016108,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.56666,-0.013898,-0.069876,0,0
4,GO DEVELOPMENTAL MATURATION,0.77618,-0.014064,0.022487,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.9686,-0.014147,0.0099324,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.77618,-0.014189,0.081531,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.66501,-0.014195,-0.027799,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.40843,-0.014219,-0.027155,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.59664,-0.01423,0.011949,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.58456,-0.014269,-0.038385,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.95466,-0.014473,0.006561,0,0
4,GO REGULATION OF ODONTOGENESIS,0.84397,-0.014601,-0.068191,0,0
4,GO SPERM AXONEME ASSEMBLY,0.47049,-0.014703,-0.040067,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.65866,-0.014836,-0.03775,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.5726,-0.014859,0.065122,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.63978,-0.014868,-0.018448,0,0
4,GO GENE SILENCING,0.47588,-0.01489,-0.031877,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.89907,-0.014905,0.00023565,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.44924,-0.015113,0.041791,0,0
4,GO CELLULAR RESPONSE TO PH,0.58456,-0.015291,-0.043242,0,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.66501,-0.015317,-0.022374,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.93377,-0.015368,-0.01816,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.72313,-0.015475,0.018273,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.52025,-0.015657,-0.022259,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.99651,-0.015723,-0.017499,0,0
4,GO REGULATION OF GENE SILENCING,0.86455,-0.015886,-0.0052268,0,0
4,GO DEVELOPMENTAL INDUCTION,0.89907,-0.015899,-0.0254,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.43367,-0.01593,-0.035672,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.79636,-0.016047,0.054054,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.93377,-0.016178,-0.010035,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.50896,-0.016393,0.040192,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.91293,-0.016401,-0.001063,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.86455,-0.016523,0.0019278,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.19695,-0.016534,-0.10496,0,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.33373,-0.016574,0.03535,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.64605,-0.016683,-0.085357,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.53742,-0.016941,0.026528,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.65234,-0.017078,-0.034691,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.78962,-0.017132,0.00036844,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.47588,-0.017273,-0.028223,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.64605,-0.017284,-0.012734,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.34702,-0.017421,-0.043491,0,0
4,GO GONADOTROPIN SECRETION,0.84397,-0.017682,0.015855,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.62732,-0.017735,-0.054049,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.4978,-0.017789,-0.024683,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.99651,-0.017938,-0.012721,0,0
4,GO NUCLEAR EXPORT,0.63978,-0.017963,-0.033435,0,0
4,GO PEPTIDYL SERINE MODIFICATION,0.58456,-0.018136,0.01931,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.61497,-0.018146,-0.032727,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.86455,-0.018164,0.030457,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.49227,-0.018181,-0.053601,0,0
4,GO NUCLEAR TRANSPORT,0.79636,-0.018181,-0.00082065,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.80989,-0.018315,-0.006575,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.96163,-0.01842,-0.0037154,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.75615,-0.018441,-0.026404,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.79636,-0.018457,-0.020515,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.83713,-0.018635,0.022348,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.68418,-0.018673,-0.030655,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.77618,-0.018674,-0.030324,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.96163,-0.018684,-0.011494,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.47588,-0.018716,-0.082023,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.80312,-0.018716,-0.028644,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.84397,-0.018825,-0.0080306,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.87833,-0.018888,0.0016265,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.80312,-0.018892,-0.024962,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.54903,-0.01898,-0.032341,0,0
4,GO RESPONSE TO X RAY,0.42347,-0.018992,-0.087153,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.76948,-0.019011,0.00038332,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.83713,-0.019244,-0.044138,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.59059,-0.019304,-0.017716,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.65234,-0.0194,-0.012987,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.76948,-0.019426,0.018612,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.84397,-0.019656,0.011303,0,0
4,GO VISUAL BEHAVIOR,0.87833,-0.019724,0.025294,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.98255,-0.019782,-0.0004963,0,0
4,GO SPERM MOTILITY,0.76281,-0.019804,-0.01231,0,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.76281,-0.019827,0.010381,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.97557,-0.019827,-0.00053248,0,0
4,GO METANEPHROS DEVELOPMENT,0.54903,-0.01987,-0.040715,0,0
4,GO P BODY ASSEMBLY,0.62732,-0.020003,-0.022942,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.25363,-0.020012,-0.031412,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.89215,-0.020079,-0.017865,0,0
4,GO RESPONSE TO FOOD,0.74288,-0.020122,0.014273,0,0
4,GO RHYTHMIC BEHAVIOR,0.69061,-0.020152,-0.010992,0,0
4,GO CHROMOSOME LOCALIZATION,0.27999,-0.020239,-0.040236,0,0
4,GO ACROSOME REACTION,0.50896,-0.020284,0.08675,0,0
4,GO FEVER GENERATION,0.56075,-0.020317,-0.056071,0,0
4,GO GROWTH HORMONE SECRETION,0.67776,-0.020351,-0.0021075,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.76281,-0.020641,0.02954,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.99651,-0.020655,-0.0031651,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.26471,-0.021027,-0.029211,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.5726,-0.021133,-0.029336,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.77618,-0.021231,0.16922,0,0
4,GO ACTIN FILAMENT BASED PROCESS,0.90599,-0.02131,0.00018235,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.47049,-0.021381,0.16449,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.87144,-0.021404,-0.0331,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.90599,-0.021547,-0.019555,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.74288,-0.021608,-0.010338,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.74288,-0.021621,0.012446,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.52025,-0.021702,-0.059679,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.43367,-0.021802,-0.031549,0,0
4,GO METAPHASE PLATE CONGRESSION,0.48678,-0.021871,-0.022689,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.22905,-0.021885,-0.057011,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.55487,-0.022109,-0.048118,0,0
4,GO GERM CELL DEVELOPMENT,0.78289,-0.02221,-0.0084506,0,0
4,GO MISMATCH REPAIR,0.40349,-0.022306,-0.031412,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.86455,-0.022321,-0.01703,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.90599,-0.022461,0.026249,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.48131,-0.02253,-0.047553,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.47049,-0.022719,-0.043898,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.60272,-0.022905,0.085907,0,0
4,GO RNA SURVEILLANCE,0.87833,-0.023094,-0.005586,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.94769,-0.023141,-0.018167,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.9686,-0.023359,0.012015,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.53167,-0.02351,-0.065056,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.5726,-0.023609,-0.021723,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.88523,-0.023679,0.0029661,0,0
4,GO BLASTODERM SEGMENTATION,0.80989,-0.023719,-0.045075,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.69707,-0.023737,-0.040078,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.43367,-0.023871,-0.069201,0,0
4,GO OXIDATIVE DEMETHYLATION,0.25729,-0.023947,-0.04864,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.32506,-0.023958,-0.091162,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.54903,-0.024082,-0.0097707,0,0
4,GO KIDNEY MORPHOGENESIS,0.76281,-0.024226,-0.032241,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.27999,-0.024307,-0.11151,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.72969,-0.024544,-0.017225,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.83713,-0.024643,0.0040416,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.30815,-0.024685,-0.0656,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.99651,-0.024697,0.018654,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.88523,-0.024782,-0.051422,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.67776,-0.024899,-0.028209,0,0
4,GO RESPONSE TO ZINC ION,0.68418,-0.02491,-0.037664,0,0
4,GO EAR DEVELOPMENT,0.43367,-0.024917,-0.047732,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.62113,-0.024946,0.097492,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.88523,-0.025241,-0.03353,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.99651,-0.025424,-0.00049297,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.93377,-0.025495,-0.0035471,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.69707,-0.025686,-0.01009,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.80989,-0.025737,-0.01151,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.85768,-0.025754,0.036043,0,0
4,GO HEART DEVELOPMENT,0.29586,-0.02577,-0.047852,0,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.76281,-0.025823,0.014761,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.21256,-0.025916,-0.039143,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.46512,-0.026018,-0.028908,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.40349,-0.026047,-0.028018,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.79636,-0.026088,-0.0015114,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.40843,-0.026095,-0.028657,0,0
4,GO RNA LOCALIZATION,0.11841,-0.026196,-0.072909,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.67776,-0.026237,-0.025205,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.16828,-0.026469,-0.042644,0,0
4,GO EPITHELIAL TUBE FORMATION,0.188,-0.026676,-0.082259,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.65866,-0.026698,0.0026338,0,0
4,GO DNA METHYLATION,0.32077,-0.026878,-0.04087,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.23589,-0.026974,-0.062242,0,0
4,GO EMBRYO DEVELOPMENT,0.31653,-0.027067,-0.034703,0,0
4,GO FEMALE GAMETE GENERATION,0.72313,-0.027092,-0.009039,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.85082,-0.027181,-0.0044082,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.82348,-0.027204,-0.034863,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.94769,-0.027601,-0.010439,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.29992,-0.02763,-0.043867,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.53742,-0.027799,-0.042294,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.67137,-0.027905,-0.020336,0,0
4,GO REGULATION OF CELL AGING,0.56075,-0.028064,-0.034282,0,0
4,GO REGULATION OF CELL SHAPE,0.72313,-0.028065,-0.00046387,0,0
4,GO RECEPTOR INTERNALIZATION,0.32506,-0.028176,-0.064444,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.68418,-0.028237,-0.044775,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.72313,-0.028375,0.053666,0,0
4,GO REGULATION OF CELL CYCLE,0.46512,-0.028421,-0.012863,0,0
4,GO MESENCHYME MORPHOGENESIS,0.29586,-0.028521,-0.10202,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.94073,-0.028562,0.00037836,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.46512,-0.028772,-0.030048,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.94073,-0.028958,0.020279,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.28785,-0.029029,-0.035527,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.76281,-0.029113,0.03093,0,0
4,GO SULFATION,0.77618,-0.029114,0.011607,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.11636,-0.029314,-0.0702,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.84397,-0.029351,-0.01001,0,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.54903,-0.029678,-0.087798,0,0
4,GO ORGAN INDUCTION,0.66501,-0.02999,-0.052305,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.61497,-0.029991,0.031905,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.89215,-0.030218,-0.007089,0,0
4,GO RNA POLYADENYLATION,0.20309,-0.030233,-0.05994,0,0
4,GO ADULT HEART DEVELOPMENT,0.61497,-0.030389,-0.076083,0,0
4,GO MRNA CLEAVAGE,0.54903,-0.030407,-0.027094,0,0
4,GO CELL CYCLE CHECKPOINT,0.22905,-0.030439,-0.030356,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.62732,-0.030445,-0.014127,0,0
4,GO SEQUESTERING OF METAL ION,0.80989,-0.030489,0.018208,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.85768,-0.0307,-0.013853,0,0
4,GO ORGANELLE ASSEMBLY,0.44924,-0.030872,-0.016589,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.20621,-0.030917,-0.037779,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.54903,-0.030949,-0.033041,0,0
4,GO CYTOKINESIS,0.11039,-0.030988,-0.049954,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.97557,-0.031021,-0.002206,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.56075,-0.031066,-0.049864,0,0
4,GO MRNA METHYLATION,0.44924,-0.031276,-0.05805,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.40349,-0.031317,-0.061783,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.18508,-0.031457,-0.037572,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.73628,-0.031471,0.00063067,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.27227,-0.031553,-0.048815,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.21579,-0.031575,-0.096146,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.3746,-0.031833,-0.033799,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.26847,-0.03189,-0.05698,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.19695,-0.031905,-0.052116,0,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.29992,-0.032161,-0.069775,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.068167,-0.032195,-0.041761,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63354,-0.032373,0.044523,0,0
4,GO NEURON APOPTOTIC PROCESS,0.29586,-0.032454,-0.025078,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.54321,-0.032473,-0.033743,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.96163,-0.032623,-0.037196,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.27999,-0.032719,-0.17586,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.7495,-0.033099,-0.005099,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.79636,-0.033348,-0.02328,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.25363,-0.033385,-0.026283,0,0
4,GO MRNA METABOLIC PROCESS,0.35607,-0.033394,-0.038253,0,0
4,GO DNA METABOLIC PROCESS,0.13583,-0.033431,-0.031616,0,0
4,GO CELL CELL SIGNALING,0.36526,-0.033613,-0.028072,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.91987,-0.033621,0.016092,0,0
4,GO CELL GROWTH,0.36991,-0.033713,-0.025926,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.23937,-0.033748,-0.037757,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.17934,-0.033969,-0.10723,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.80989,-0.034035,-0.0057244,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.27999,-0.034044,-0.051811,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.80312,-0.034094,-0.053698,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.44924,-0.034146,-0.031996,0,0
4,GO ENSHEATHMENT OF NEURONS,0.32077,-0.034184,-0.045959,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.80312,-0.034298,-0.016542,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.93377,-0.03452,-0.058999,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.69707,-0.034771,0.0017751,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.76948,-0.034807,-0.0030144,0,0
4,GO REGULATION OF RNA BINDING,0.28785,-0.034835,-0.083693,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.89907,-0.034842,0.022776,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.19095,-0.035234,-0.091699,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.88523,-0.035304,-0.015054,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.070855,-0.035373,-0.15505,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.63354,-0.035385,-0.085495,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.70355,-0.035874,-0.036506,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.35607,-0.036164,-0.05047,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.71658,-0.036363,-0.010533,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.43367,-0.036399,-0.079107,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.35153,-0.036504,-0.044146,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.67776,-0.036625,-0.02397,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.84397,-0.036705,-0.041352,0,0
4,GO BONE DEVELOPMENT,0.095625,-0.036974,-0.092479,0,0
4,GO OOGENESIS,0.57857,-0.037038,-0.014338,0,0
4,GO RRNA MODIFICATION,0.86455,-0.037129,-0.020343,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.83713,-0.03728,-0.009265,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.8303,-0.037372,0.017306,0,0
4,GO MICROVILLUS ASSEMBLY,0.64605,-0.037472,-0.064935,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.19695,-0.037658,-0.031703,0,0
4,GO METANEPHROS MORPHOGENESIS,0.7495,-0.037772,-0.02097,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.67137,-0.037846,0.0075141,0,0
4,GO TAXIS,0.27227,-0.037956,-0.044141,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.63354,-0.037984,-0.024634,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.87144,-0.038042,-0.025333,0,0
4,GO PROTEIN ACYLATION,0.034637,-0.038193,-0.035095,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.33812,-0.038225,-0.049739,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.11434,-0.038236,-0.082028,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.87833,-0.038449,-0.010461,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.67776,-0.038475,-0.015647,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.50896,-0.038477,-0.075378,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.188,-0.038553,-0.033118,0,0
4,GO SEGMENT SPECIFICATION,0.37932,-0.038625,-0.1177,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.78289,-0.038732,-0.032754,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.50337,-0.038931,-0.017489,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.40843,-0.038937,-0.089348,0,0
4,GO MITOTIC CYTOKINESIS,0.32938,-0.039119,-0.040959,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.29586,-0.039134,-0.17333,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.47588,-0.039172,-0.0069885,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.58456,-0.039504,-0.035192,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.33373,-0.039525,-0.025027,0,0
4,GO MESENCHYME DEVELOPMENT,0.24288,-0.039668,-0.071259,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.43883,-0.039687,-0.10263,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.22235,-0.039689,-0.076976,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.13814,-0.040045,-0.063179,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.85768,-0.040285,0.022991,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.20621,-0.040415,-0.054726,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.18219,-0.040525,-0.042889,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.73628,-0.040595,-0.018102,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.65866,-0.040801,-0.072767,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.67137,-0.040909,-0.041945,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.32077,-0.040917,-0.087206,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.47588,-0.040921,-0.040348,0,0
4,GO CELL CYCLE,0.21579,-0.041019,-0.024679,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.15517,-0.041161,-0.039306,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.24643,-0.041224,-0.06509,0,0
4,GO HISTONE H4 ACETYLATION,0.059411,-0.041231,-0.06517,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.072231,-0.041328,-0.050668,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.72313,-0.041499,-0.015044,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.33812,-0.041623,-0.032196,0,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.62732,-0.041634,0.052528,0,0
4,GO PROTEIN SUMOYLATION,0.16032,-0.041721,-0.038822,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.57857,-0.04173,-0.038812,0,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.65234,-0.041936,-0.031553,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.44402,-0.041992,-0.020188,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.12259,-0.042187,-0.075362,0,0
4,GO FOREGUT MORPHOGENESIS,0.34702,-0.042194,-0.087225,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.099158,-0.042247,-0.057498,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.38888,-0.042335,-0.054736,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.73628,-0.042429,-0.013668,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.43367,-0.042543,-0.047277,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.14285,-0.042664,-0.029149,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.23245,-0.042688,-0.04874,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.66501,-0.042894,-0.023039,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.63978,-0.042926,0.0006155,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.40843,-0.042954,-0.087736,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.22568,-0.043138,-0.090253,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.7495,-0.043198,0.012968,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.63354,-0.043345,-0.095899,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.23245,-0.043352,-0.11125,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.61497,-0.043523,-0.034954,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.095625,-0.04361,-0.080344,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.095625,-0.043622,-0.06555,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.33812,-0.043714,-0.051923,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.41341,-0.043817,-0.071028,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.85768,-0.043927,-0.009564,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.86455,-0.044049,0.014907,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.188,-0.044274,-0.047604,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.36526,-0.044408,-0.032561,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.10096,-0.044449,-0.036876,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.29992,-0.044538,-0.11757,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.17374,-0.044545,-0.090388,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.4978,-0.044639,-0.033081,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.53742,-0.044678,0.072314,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.1313,-0.044712,-0.16797,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.075049,-0.044714,-0.074664,0,0
4,GO RRNA METHYLATION,0.68418,-0.044876,-0.019633,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.060602,-0.044938,-0.051166,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.90599,-0.045104,0.0016278,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.23589,-0.04522,-0.025887,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.16032,-0.045241,-0.06669,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.71006,-0.045317,-0.035912,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.27611,-0.045406,-0.069833,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.4545,-0.045562,-0.024862,0,0
4,GO RNA DESTABILIZATION,0.5726,-0.04561,-0.029925,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.18508,-0.045631,-0.041363,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.5726,-0.045685,-0.023191,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.60883,-0.045702,-0.014885,0,0
4,GO TRABECULA MORPHOGENESIS,0.25001,-0.045813,-0.079795,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.26098,-0.045826,-0.13943,0,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.85768,-0.045831,-0.00074735,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.91987,-0.046175,-0.047564,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.27227,-0.046216,-0.065392,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.085627,-0.046301,-0.037421,0,0
4,GO TRNA TRANSPORT,0.46512,-0.046353,-0.044621,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.25363,-0.046433,-0.085867,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.34702,-0.046496,-0.049255,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.18219,-0.046651,-0.058442,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.29184,-0.046673,-0.064578,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.4978,-0.046797,-0.04429,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.52025,-0.04685,-0.05733,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.71006,-0.046944,0.084755,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.94769,-0.046979,-0.019211,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.063042,-0.047008,-0.069617,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.49227,-0.047112,-0.026312,0,0
4,GO ACTIN CROSSLINK FORMATION,0.21905,-0.047141,-0.10018,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.89215,-0.047241,-0.029315,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.25363,-0.047275,-0.044584,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.19695,-0.0473,-0.051768,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.71006,-0.047443,0.029621,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.29586,-0.047448,-0.065307,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.97557,-0.047509,-0.0054257,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.98255,-0.047696,0.0087261,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.47588,-0.047744,-0.062917,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.34702,-0.047861,-0.030725,0,0
4,GO PROTEIN POLYMERIZATION,0.29992,-0.047899,-0.03786,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.16294,-0.04799,-0.047306,0,0
4,GO REGULATION OF OOGENESIS,0.9686,-0.048139,0.034041,0,0
4,GO RNA CAPPING,0.48131,-0.04816,-0.031671,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.27999,-0.048185,-0.034952,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.54903,-0.048219,0.023572,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.73628,-0.048245,0.022028,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.49227,-0.048344,-0.047608,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.10096,-0.04842,-0.088383,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.72313,-0.048559,-0.035343,0,0
4,GO NOSE DEVELOPMENT,0.70355,-0.048631,0.06072,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.12049,-0.04868,-0.048205,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.26098,-0.048848,-0.062475,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.46512,-0.04893,-0.053455,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.80312,-0.049023,-0.037229,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.47588,-0.049101,-0.0079207,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.14285,-0.049471,-0.076683,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.30815,-0.049588,-0.03902,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.4978,-0.049671,-0.06679,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.4598,-0.049725,-0.091333,0,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.11636,-0.050479,-0.097843,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.74288,-0.050482,-0.040098,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.56666,-0.050529,-0.025433,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.092194,-0.050844,-0.056391,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.48678,-0.050899,-0.052309,0,0
4,GO GLIOGENESIS,0.32938,-0.050988,-0.043579,0,0
4,GO NERVOUS SYSTEM PROCESS,0.59059,-0.050991,-0.013512,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.11841,-0.051096,-0.065715,0,0
4,GO RESPONSE TO UV,0.14048,-0.051241,-0.05181,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.043763,-0.051251,-0.11685,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.66501,-0.051481,-0.037251,0,0
4,GO TUBE FORMATION,0.11636,-0.051533,-0.086433,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.15773,-0.051565,-0.11615,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.38408,-0.051596,-0.11284,0,0
4,GO CELL PROJECTION ASSEMBLY,0.057089,-0.051906,-0.057694,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.15773,-0.051909,-0.090183,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.28785,-0.05193,-0.038827,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.82348,-0.051997,-0.0048446,0,0
4,GO CELL JUNCTION ORGANIZATION,0.28785,-0.052024,-0.046695,0,0
4,GO FIBROBLAST MIGRATION,0.22235,-0.052361,-0.075828,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.30402,-0.052387,-0.052486,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.30815,-0.05242,-0.058783,0,0
4,GO CELL FATE COMMITMENT,0.13355,-0.052679,-0.050281,0,0
4,GO GROWTH,0.25729,-0.052696,-0.037541,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.072231,-0.052767,-0.096116,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.23245,-0.052948,-0.036152,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.32077,-0.052992,-0.062201,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.8303,-0.053131,-0.00083413,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.082489,-0.053209,-0.054471,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.38408,-0.053399,-0.064676,0,0
4,GO DEMETHYLATION,0.34702,-0.053415,-0.040118,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.42855,-0.053537,-0.053191,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.80312,-0.053714,0.0017022,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.21256,-0.053803,-0.078064,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.63354,-0.053843,-0.015494,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.5726,-0.053888,0.0013075,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.082489,-0.054161,-0.081778,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.12049,-0.054274,-0.064552,0,0
4,GO STEM CELL DIFFERENTIATION,0.23937,-0.0544,-0.046441,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.43367,-0.054482,-0.038993,0,0
4,GO VIRAL LATENCY,0.092194,-0.054541,-0.13195,0,0
4,GO HISTONE PHOSPHORYLATION,0.25729,-0.054591,-0.037854,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.81668,-0.054611,-0.035949,0,0
4,GO MESODERM DEVELOPMENT,0.0695,-0.054622,-0.087161,0,0
4,GO FIBROBLAST ACTIVATION,0.69707,-0.054627,-0.02933,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.95466,-0.054797,0.010303,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.76948,-0.054993,-0.030869,0,0
4,GO WALKING BEHAVIOR,0.20621,-0.055108,-0.093636,0,0
4,GO LOCOMOTORY BEHAVIOR,0.49227,-0.055406,-0.014709,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.12259,-0.055492,-0.074983,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.15773,-0.055536,-0.2295,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.84397,-0.05555,0.069876,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.57857,-0.055671,-0.069731,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.40843,-0.055994,-0.067562,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.62732,-0.05611,-0.056832,0,0
4,GO MITOTIC CELL CYCLE,0.093897,-0.056195,-0.037292,0,0
4,GO HEART TRABECULA FORMATION,0.75615,-0.05621,-0.0060076,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.22905,-0.056215,-0.063531,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.62113,-0.056235,-0.020758,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.33373,-0.056316,-0.068956,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.99651,-0.056591,0.066355,0,0
4,GO LIPID PHOSPHORYLATION,0.72969,-0.056625,0.015007,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.79636,-0.056765,-0.029041,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.67776,-0.05678,-0.01185,0,0
4,GO MEMBRANE DOCKING,0.17653,-0.056853,-0.03583,0,0
4,GO PROTEIN METHYLATION,0.012508,-0.056981,-0.061497,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.24643,-0.057038,-0.05537,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.30402,-0.057132,-0.094759,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.27999,-0.05722,-0.071829,0,0
4,GO BASE EXCISION REPAIR,0.14048,-0.057227,-0.070297,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.18508,-0.057307,-0.064817,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.33373,-0.057585,-0.012564,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.91987,-0.057917,-0.031786,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.17653,-0.058243,-0.10638,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.22568,-0.058432,-0.052633,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.097379,-0.058502,-0.097504,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.15264,-0.058599,-0.074243,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.56075,-0.058609,-0.033836,0,0
4,GO MATING BEHAVIOR,0.61497,-0.059407,-0.036758,0,0
4,GO SPINDLE ASSEMBLY,0.017137,-0.059623,-0.064901,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.51459,-0.059721,-0.057408,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.44402,-0.059795,-0.073432,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.20937,-0.059842,-0.06361,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.46512,-0.060022,-0.074842,0,0
4,GO NEURAL TUBE FORMATION,0.099158,-0.060251,-0.09599,0,0
4,GO GANGLION DEVELOPMENT,0.76281,-0.060432,0.021375,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.57857,-0.060506,-0.039859,0,0
4,GO SLEEP,0.4598,-0.060765,-0.041054,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.47588,-0.061435,-0.028404,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.41842,-0.061508,-0.051649,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.32938,-0.061789,-0.043947,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.055956,-0.061823,-0.041098,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.34256,-0.062051,-0.080744,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.44402,-0.062142,-0.029711,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.26847,-0.062172,-0.1831,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.41341,-0.062364,-0.036143,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.063042,-0.062465,-0.060674,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.30402,-0.062565,-0.13322,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.11235,-0.062843,-0.067277,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.41341,-0.062847,-0.021283,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.188,-0.06293,-0.059191,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.097379,-0.063075,-0.089052,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.02843,-0.063146,-0.091843,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.87144,-0.063148,-0.00096143,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.17934,-0.06337,-0.065523,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.42347,-0.063443,-0.10994,0,0
4,GO MEMBRANE DISASSEMBLY,0.19695,-0.06392,-0.10147,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.16032,-0.063924,-0.10994,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.29586,-0.064048,-0.07418,0,0
4,GO SPINDLE LOCALIZATION,0.05824,-0.064422,-0.07715,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.30815,-0.064451,-0.05671,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.46512,-0.064723,-0.019628,0,0
4,GO HEART VALVE DEVELOPMENT,0.30402,-0.064731,-0.068487,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.25001,-0.064745,-0.04628,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.37932,-0.064913,-0.07968,0,0
4,GO RNA 3 END PROCESSING,0.059411,-0.064943,-0.078827,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,-0.064984,-0.10025,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.20309,-0.06514,-0.10693,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.84397,-0.065224,-0.0020535,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.56075,-0.065273,-0.050937,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.87833,-0.065777,-0.025968,0,0
4,GO VASCULOGENESIS,0.25729,-0.065787,-0.12025,0,0
4,GO RESPONSE TO UV B,0.65866,-0.065926,-0.079428,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.60272,-0.066091,-0.026188,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.35607,-0.066148,-0.10183,0,0
4,GO SPECIFICATION OF SYMMETRY,0.060602,-0.0668,-0.079495,0,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.34256,-0.06683,-0.030075,0,0
4,GO EXIT FROM MITOSIS,0.17099,-0.067065,-0.055638,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.29586,-0.067113,-0.058486,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.60883,-0.067198,-0.044712,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.088862,-0.067199,-0.079883,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.29586,-0.067273,-0.044603,0,0
4,GO EAR MORPHOGENESIS,0.087232,-0.067415,-0.086179,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.11434,-0.067887,-0.076934,0,0
4,GO NUCLEAR MIGRATION,0.43367,-0.067975,-0.059673,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.26847,-0.068243,-0.057265,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.32938,-0.068623,-0.047258,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.62113,-0.068729,-0.014662,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.47588,-0.068802,-0.034912,0,0
4,GO ARTERY DEVELOPMENT,0.23245,-0.068897,-0.082268,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.099158,-0.068938,-0.080459,0,0
4,GO CENTROSOME SEPARATION,0.39371,-0.069028,-0.022125,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.15517,-0.069125,-0.078431,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.76948,-0.069422,-0.026728,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.55487,-0.069531,-0.061617,0,0
4,GO HEART MORPHOGENESIS,0.15264,-0.069578,-0.067866,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.22568,-0.06962,-0.15593,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.099158,-0.069802,-0.082523,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.054842,-0.069844,-0.055028,0,0
4,GO REGULATION OF CELL DIVISION,0.095625,-0.070282,-0.0517,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.92682,-0.070476,0.075456,0,0
4,GO HISTONE H2A ACETYLATION,0.10465,-0.070527,-0.098452,0,0
4,GO VAGINA DEVELOPMENT,0.60272,-0.070709,-0.079317,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.053746,-0.070807,-0.075874,0,0
4,GO MICROTUBULE ANCHORING,0.15015,-0.070942,-0.062201,0,0
4,GO ORGAN GROWTH,0.041967,-0.071005,-0.096868,0,0
4,GO MIDBRAIN DEVELOPMENT,0.076492,-0.071663,-0.065801,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.4545,-0.07191,-0.082877,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.38888,-0.071966,-0.042697,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.27611,-0.072564,-0.13646,0,0
4,GO CYTOSKELETON ORGANIZATION,0.18508,-0.072609,-0.039071,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.14769,-0.072682,-0.063553,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.29992,-0.072839,-0.020129,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.73628,-0.072847,-0.007566,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.19695,-0.072891,-0.14252,0,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.56075,-0.072989,-0.012891,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.14285,-0.073016,-0.058315,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.44402,-0.073032,-0.023774,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.061812,-0.073124,-0.091819,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.061812,-0.073366,-0.073414,0,0
4,GO REGULATION OF CYTOKINESIS,0.024288,-0.073406,-0.067106,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.43367,-0.073412,-0.044729,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.038561,-0.07357,-0.10928,0,0
4,GO CHROMATIN ORGANIZATION,0.00069957,-0.073838,-0.078148,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.16032,-0.073991,-0.063553,0,0
4,GO REGULATION OF GLIOGENESIS,0.12689,-0.074286,-0.069216,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.055956,-0.074603,-0.097188,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.080955,-0.074776,-0.073664,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.23937,-0.074795,-0.081029,0,0
4,GO CELL CELL SIGNALING BY WNT,0.064293,-0.074882,-0.067299,0,0
4,GO MITOTIC DNA REPLICATION,0.52025,-0.075538,-0.042091,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.063042,-0.075656,-0.08113,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.4978,-0.075758,-0.051883,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.47049,-0.075863,-0.036678,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.71658,-0.076066,-0.035479,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.46512,-0.076244,-0.033445,0,0
4,GO ECTODERM DEVELOPMENT,0.25363,-0.076304,-0.081964,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.43367,-0.076507,-0.071455,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.12908,-0.076583,-0.13435,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.060602,-0.076584,-0.12789,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.30815,-0.076619,-0.063428,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.29992,-0.076631,-0.081901,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.77618,-0.076952,-0.026228,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.15773,-0.077071,-0.12562,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.043763,-0.077207,-0.083762,0,0
4,GO BLEB ASSEMBLY,0.81668,-0.077231,-0.17257,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.14048,-0.077388,-0.16076,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.65866,-0.077566,-0.044656,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.59059,-0.07772,-0.048713,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.088862,-0.07797,-0.17699,0,0
4,GO HISTONE H3 DEACETYLATION,0.16032,-0.077982,-0.071232,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.031059,-0.078085,-0.07917,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.34702,-0.078138,-0.064884,0,0
4,GO HINDBRAIN DEVELOPMENT,0.19095,-0.078142,-0.055922,0,0
4,GO MICROTUBULE NUCLEATION,0.093897,-0.078206,-0.073337,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.32077,-0.078212,-0.047762,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.84397,-0.07832,0.0019612,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.04854,-0.078473,-0.15636,0,0
4,GO HISTONE DEUBIQUITINATION,0.36991,-0.078587,-0.030015,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.20937,-0.078628,-0.04192,0,0
4,GO BEHAVIOR,0.32077,-0.078722,-0.034699,0,0
4,GO THYROID GLAND DEVELOPMENT,0.064293,-0.078767,-0.18118,0,0
4,GO ASYMMETRIC CELL DIVISION,0.29184,-0.078832,-0.097562,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.4545,-0.079273,-0.027069,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.51459,-0.079301,-0.036089,0,0
4,GO RUFFLE ASSEMBLY,0.62732,-0.079415,-0.0058762,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.25363,-0.079849,-0.090563,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.34702,-0.079905,-0.048494,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.20309,-0.079956,-0.094272,0,0
4,GO EPITHELIAL CELL MATURATION,0.69707,-0.080147,0.001456,0,0
4,GO GASTRIC ACID SECRETION,0.8303,-0.080284,-0.023274,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.15015,-0.080322,-0.082944,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.85082,-0.080671,-0.028868,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.14769,-0.080906,-0.18183,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.26847,-0.080946,-0.071198,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.13583,-0.081165,-0.085704,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.20309,-0.081329,-0.080576,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.063042,-0.081531,-0.079879,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.76281,-0.081569,-0.031313,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.60272,-0.082123,-0.056813,0,0
4,GO PREPULSE INHIBITION,0.55487,-0.082202,-0.074099,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.20309,-0.082302,-0.054924,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.58456,-0.082719,-0.010419,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.39371,-0.083142,-0.13897,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.22568,-0.083196,-0.10328,0,0
4,GO PROSTATE GLAND GROWTH,0.22568,-0.083206,-0.13088,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.03939,-0.083336,-0.08755,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.64605,-0.083367,-0.02136,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.03245,-0.083386,-0.06519,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.23589,-0.083439,-0.15543,0,0
4,GO NODAL SIGNALING PATHWAY,0.10465,-0.083677,-0.11875,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.25363,-0.083821,-0.07212,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.36526,-0.083902,-0.066775,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.36991,-0.084269,-0.064446,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.065563,-0.084552,-0.19504,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.072231,-0.084604,-0.13213,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.010506,-0.084922,-0.10978,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.73628,-0.084991,-0.022232,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.23245,-0.085562,-0.071603,0,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0021062,-0.085672,-0.11847,0,0
4,GO GENITALIA MORPHOGENESIS,0.21905,-0.086316,-0.1351,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.21905,-0.086684,-0.056933,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.38408,-0.08673,-0.073037,0,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.20937,-0.086854,-0.068359,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.43883,-0.087343,0.11351,0,0
4,GO HEART GROWTH,0.085627,-0.087875,-0.083156,0,0
4,GO MAST CELL MIGRATION,0.50896,-0.088381,-0.079031,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.095625,-0.088409,-0.10769,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.013139,-0.088434,-0.11096,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.23589,-0.088435,-0.17664,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.12689,-0.088561,-0.0654,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.12473,-0.088621,-0.13002,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.15015,-0.088641,-0.08088,0,0
4,GO MEMORY,0.10096,-0.088765,-0.081771,0,0
4,GO STRESS GRANULE ASSEMBLY,0.054842,-0.088883,-0.1114,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.10654,-0.089318,-0.06325,0,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.00092958,-0.089409,-0.080554,0,0
4,GO AORTA DEVELOPMENT,0.097379,-0.08952,-0.12343,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.044685,-0.089598,-0.072968,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.10465,-0.089653,-0.096956,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.025414,-0.089945,-0.090648,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.13583,-0.090028,-0.10986,0,0
4,GO BLASTOCYST GROWTH,0.71006,-0.090089,-0.0053509,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.4545,-0.090126,-0.074725,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.28785,-0.090202,-0.077689,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.35153,-0.090265,-0.058358,0,0
4,GO RRNA 3 END PROCESSING,0.70355,-0.090503,-0.014898,0,0
4,GO CHONDROCYTE PROLIFERATION,0.26847,-0.090585,-0.12838,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.27999,-0.090645,-0.083876,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.22568,-0.090795,-0.13661,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.13583,-0.090844,-0.10705,0,0
4,GO SISTER CHROMATID SEGREGATION,0.0066042,-0.090938,-0.085479,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.94769,-0.090986,-0.043974,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.26098,-0.091279,-0.13084,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.32077,-0.091352,-0.037745,0,0
4,GO HISTONE METHYLATION,0.00055855,-0.091494,-0.10662,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.11636,-0.091506,-0.1632,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.10845,-0.091804,-0.1108,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.16559,-0.091817,-0.068421,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.14526,-0.091841,-0.16001,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.066855,-0.091873,-0.094519,0,0
4,GO HAIR FOLLICLE MATURATION,0.21579,-0.091971,-0.10503,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.41842,-0.092047,-0.06492,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.087232,-0.092126,-0.10952,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.03939,-0.092228,-0.14364,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.05824,-0.092532,-0.19013,0,0
4,GO REGULATION OF BEHAVIOR,0.015203,-0.092579,-0.13227,0,0
4,GO MICROTUBULE BASED PROCESS,0.0010528,-0.092585,-0.083635,0,0
4,GO TELOMERE CAPPING,0.39371,-0.09263,-0.025591,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.20621,-0.092643,-0.077708,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.22905,-0.092815,-0.045278,0,0
4,GO REGIONALIZATION,0.1028,-0.092891,-0.062115,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.11434,-0.093385,-0.082214,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.082489,-0.09369,-0.10999,0,0
4,GO HINDLIMB MORPHOGENESIS,0.045624,-0.093906,-0.16185,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.2839,-0.094231,-0.11394,0,0
4,GO DNA REPLICATION,0.00090094,-0.094244,-0.101,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.021165,-0.09455,-0.14067,0,0
4,GO SPINDLE ORGANIZATION,0.00063551,-0.09461,-0.09737,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.22568,-0.094629,-0.098868,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.41341,-0.094797,-0.18123,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00063551,-0.094927,-0.090272,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,6.5149e-05,-0.09558,-0.11757,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.47588,-0.095619,-0.033626,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.097379,-0.095643,-0.089254,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.32938,-0.096063,-0.070714,0,0
4,GO OTIC VESICLE MORPHOGENESIS,0.19695,-0.09607,-0.16294,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.43367,-0.096071,-0.030068,0,0
4,GO NEUROMUSCULAR PROCESS,0.085627,-0.0963,-0.081242,0,0
4,GO REGULATION OF DNA REPLICATION,0.17099,-0.096523,-0.051459,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.37932,-0.096648,-0.072887,0,0
4,GO LONG TERM MEMORY,0.090515,-0.097218,-0.12622,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.11235,-0.097399,-0.126,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.24288,-0.097431,-0.14391,0,0
4,GO CELLULAR RESPONSE TO UV,0.10096,-0.098278,-0.067934,0,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.14048,-0.098418,-0.20311,0,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.26098,-0.098452,-0.12652,0,0
4,GO MITOCHONDRION LOCALIZATION,0.019739,-0.098782,-0.09899,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.21905,-0.098907,-0.10063,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.56075,-0.099126,-0.032703,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.085627,-0.099357,-0.10211,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.89215,-0.099599,0.045553,0,0
4,GO CELL JUNCTION MAINTENANCE,0.39371,-0.10002,-0.042063,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.10845,-0.10017,-0.12461,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.50337,-0.10022,-0.062953,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.1028,-0.10048,-0.10736,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.11841,-0.1005,-0.17452,0,0
4,GO CILIUM ORGANIZATION,0.020205,-0.10061,-0.084869,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.12259,-0.10136,-0.14784,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.19695,-0.10138,-0.1062,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.4978,-0.10151,-0.027366,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.51459,-0.10202,-0.11052,0,0
4,GO PROSTATIC BUD FORMATION,0.027188,-0.10203,-0.3066,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.041093,-0.10218,-0.1882,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.10096,-0.10273,-0.098865,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.090515,-0.10275,-0.14541,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.19393,-0.10281,-0.12246,0,0
4,GO RESPONSE TO AMYLOID BETA,0.075049,-0.1029,-0.094715,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.15517,-0.10293,-0.035762,0,0
4,GO PERICARDIUM DEVELOPMENT,0.49227,-0.10305,-0.075826,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.093897,-0.10314,-0.096841,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.0046564,-0.10355,-0.11331,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.2839,-0.10361,-0.067487,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.034637,-0.1037,-0.1409,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.050569,-0.10398,-0.08639,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.26847,-0.10427,-0.085754,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12689,-0.10428,-0.186,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0083534,-0.10553,-0.11367,0,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.10465,-0.10594,-0.11686,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.16294,-0.10662,-0.070373,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.36991,-0.10674,-0.070967,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.10465,-0.10706,-0.13364,0,0
4,GO GDP METABOLIC PROCESS,0.48678,-0.10706,-0.06765,0,0
4,GO CHROMATIN SILENCING,0.001986,-0.10718,-0.14119,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.38408,-0.10719,-0.053135,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.37932,-0.10759,-0.033249,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.4545,-0.1084,-0.064617,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.084046,-0.10877,-0.18013,0,0
4,GO MITOTIC RECOMBINATION,0.055956,-0.10902,-0.10435,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.19393,-0.10946,-0.10089,0,0
4,GO HYPOTONIC RESPONSE,0.076492,-0.10961,-0.15816,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.14526,-0.10981,-0.15053,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.22235,-0.11027,-0.02183,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.15015,-0.11077,-0.072966,0,0
4,GO BONE MATURATION,0.066855,-0.11096,-0.14424,0,0
4,GO HEAT GENERATION,0.16032,-0.11111,-0.08905,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0053338,-0.11144,-0.12798,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.14769,-0.11146,-0.14403,0,0
4,GO DIVALENT METAL ION EXPORT,0.21256,-0.1116,-0.15047,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.11434,-0.11171,-0.11908,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.82348,-0.1122,-0.0082558,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.099158,-0.11232,-0.087679,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.33373,-0.11265,-0.077139,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.26098,-0.11325,-0.10337,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.16294,-0.11331,-0.071608,0,0
4,GO RESPONSE TO DOPAMINE,0.1313,-0.11331,-0.06849,0,0
4,GO THYMUS DEVELOPMENT,0.29992,-0.11379,-0.066236,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,3.3132e-05,-0.11418,-0.13456,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.52594,-0.11465,-0.041496,0,0
4,GO CENTROSOME DUPLICATION,0.033894,-0.11493,-0.086386,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.014486,-0.11534,-0.09732,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.2,-0.11547,-0.052029,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.10845,-0.11553,-0.17146,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.17934,-0.11576,-0.083871,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.1313,-0.11577,-0.14362,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.00032948,-0.11578,-0.17278,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.085627,-0.11598,-0.05058,0,0
4,GO BONE MORPHOGENESIS,0.017549,-0.11649,-0.15562,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.65866,-0.11658,-0.0018847,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.23937,-0.11669,-0.071471,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.054842,-0.11696,-0.1332,0,0
4,GO CELL RECOGNITION,0.061812,-0.11744,-0.10092,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.35153,-0.1181,-0.064109,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.04854,-0.11817,-0.088678,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.015203,-0.11871,-0.11553,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.054842,-0.11875,-0.12395,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.67137,-0.11905,-0.016498,0,0
4,GO RESPONSE TO COCAINE,0.092194,-0.1194,-0.10158,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.093897,-0.11949,-0.13383,0,0
4,GO UV PROTECTION,0.33373,-0.11986,-0.1109,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.25363,-0.12006,-0.15401,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.05824,-0.12019,-0.085247,0,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.14048,-0.12036,-0.20771,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.057089,-0.12082,-0.084215,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.26847,-0.12104,-0.08996,0,0
4,GO HISTONE H2A UBIQUITINATION,0.016339,-0.12129,-0.13255,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.064293,-0.12256,-0.11978,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.25729,-0.12274,-0.11773,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.017137,-0.12297,-0.12757,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.12473,-0.12323,-0.12941,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.50337,-0.12337,-0.066173,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.007729,-0.12432,-0.12756,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.1313,-0.12474,-0.062317,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.00353,-0.12485,-0.138,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.0695,-0.1249,-0.17001,0,0
4,GO TUBULIN DEACETYLATION,0.064293,-0.1249,-0.11359,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.0094949,-0.12502,-0.19036,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0025083,-0.12541,-0.143,0,0
4,GO ADULT BEHAVIOR,0.17374,-0.12557,-0.039591,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.0025817,-0.1256,-0.14416,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.10465,-0.12583,-0.081203,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.29184,-0.12643,-0.041675,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.4978,-0.12657,-0.10394,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.18219,-0.12709,-0.11219,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.011326,-0.12714,-0.14263,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.088862,-0.12726,-0.1393,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.097379,-0.1275,-0.11104,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.33373,-0.12784,-0.10742,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.02166,-0.12817,-0.15019,0,0
4,GO ADULT FEEDING BEHAVIOR,0.25729,-0.12863,-0.072499,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.084046,-0.12882,-0.10998,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.00042998,-0.12922,-0.10471,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.10096,-0.12931,-0.14555,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.090515,-0.12933,-0.11486,0,0
4,GO SHORT TERM MEMORY,0.13814,-0.13038,-0.1676,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.019283,-0.13115,-0.14951,0,0
4,GO SEROTONIN TRANSPORT,0.12908,-0.1314,-0.11499,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.082489,-0.13196,-0.061612,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.070855,-0.13202,-0.091308,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.38888,-0.13231,-0.068757,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.29992,-0.13236,-0.069982,0,0
4,GO NEUROBLAST DIVISION,0.15773,-0.13274,-0.16002,0,0
4,GO RETINA LAYER FORMATION,0.088862,-0.13299,-0.13286,0,0
4,GO SUCKLING BEHAVIOR,0.17099,-0.13319,-0.13294,0,0
4,GO TRACHEA DEVELOPMENT,0.14769,-0.13362,-0.13375,0,0
4,GO REGULATION OF CELL SIZE,0.016339,-0.13381,-0.1096,0,0
4,GO RESPONSE TO AXON INJURY,0.076492,-0.13406,-0.090175,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26847,-0.13485,-0.11308,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.34702,-0.13488,-0.063934,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.15015,-0.13494,-0.095706,0,0
4,GO COGNITION,0.0099891,-0.13605,-0.11931,0,0
4,GO STARTLE RESPONSE,0.27999,-0.13645,-0.094076,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.024288,-0.13648,-0.13291,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.041967,-0.13664,-0.14062,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.10845,-0.13677,-0.1858,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.11841,-0.13677,-0.16521,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.099158,-0.13677,-0.093671,0,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0066042,-0.13735,-0.24745,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0017641,-0.13756,-0.12989,0,0
4,GO REGULATION OF HEAT GENERATION,0.15517,-0.1379,-0.11818,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.22568,-0.1388,-0.084393,0,0
4,GO METENCEPHALON DEVELOPMENT,0.13583,-0.13913,-0.051846,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.0014299,-0.13942,-0.15161,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.14285,-0.14005,-0.12666,0,0
4,GO SYNAPSE MATURATION,0.11235,-0.1405,-0.22492,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.19393,-0.14083,-0.18133,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0011549,-0.14116,-0.19528,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.087232,-0.14175,-0.14773,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.0028141,-0.14202,-0.16594,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.25363,-0.14218,-0.23608,0,0
4,GO ANIMAL ORGAN FORMATION,0.0038387,-0.14219,-0.16181,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.59664,-0.14219,-0.075563,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.03939,-0.14269,-0.18041,0,0
4,GO SNORNA METABOLIC PROCESS,0.057089,-0.14304,-0.14683,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.073629,-0.1431,-0.11339,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.026586,-0.14317,-0.18731,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0059384,-0.14323,-0.17655,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.049546,-0.14342,-0.054305,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.25729,-0.14346,-0.050741,0,0
4,GO ACROSOME ASSEMBLY,0.05161,-0.14369,-0.13035,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.099158,-0.14402,-0.10377,0,0
4,GO INTRACILIARY TRANSPORT,0.0015653,-0.14417,-0.20518,0,0
4,GO DNA PACKAGING,6.7596e-05,-0.14421,-0.1218,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.13583,-0.14425,-0.10197,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.033894,-0.14455,-0.13469,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.092194,-0.14499,-0.074903,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.00041602,-0.14576,-0.19966,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.027188,-0.14585,-0.18722,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.10654,-0.14635,-0.15366,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.16828,-0.14636,-0.14673,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.0022332,-0.14658,-0.14351,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.11434,-0.14698,-0.12186,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.14769,-0.14718,-0.13912,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.29992,-0.14731,-0.09437,0,0
4,GO G0 TO G1 TRANSITION,0.00028792,-0.14746,-0.18086,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.014486,-0.14819,-0.13425,0,0
4,GO GLUTAMATE SECRETION,0.085627,-0.1487,-0.10089,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.097379,-0.14882,-0.1482,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.029068,-0.14975,-0.13929,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.053746,-0.14982,-0.16511,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.0057817,-0.15051,-0.15235,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.001191,-0.151,-0.12735,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.0695,-0.15149,-0.15175,0,0
4,GO RESPONSE TO VITAMIN D,0.16032,-0.15196,-0.12001,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0057817,-0.15227,-0.10895,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0015189,-0.15276,-0.15517,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0081404,-0.15311,-0.13386,0,0
4,GO DENDRITE EXTENSION,0.188,-0.15312,-0.093936,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00010845,-0.15373,-0.21964,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0045306,-0.15376,-0.1772,0,0
4,GO RESPONSE TO LEAD ION,0.01282,-0.15385,-0.12693,0,0
4,GO APPENDAGE DEVELOPMENT,0.0056288,-0.15468,-0.146,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.23245,-0.15481,-0.08696,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.018836,-0.15483,-0.10367,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.03245,-0.15484,-0.14625,0,0
4,GO TRABECULA FORMATION,0.10465,-0.15491,-0.1428,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,4.1617e-05,-0.15496,-0.1738,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.03245,-0.15501,-0.14386,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.033894,-0.15548,-0.26527,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.047551,-0.1562,-0.24009,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.11039,-0.15686,-0.14841,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.12259,-0.15713,-0.091034,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.14769,-0.15832,-0.12082,0,0
4,GO V D J RECOMBINATION,0.20621,-0.15839,-0.12275,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.20937,-0.15848,-0.12713,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.71658,-0.15849,0.039469,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.027803,-0.15894,-0.093401,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.090515,-0.16039,-0.19101,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0013457,-0.16044,-0.15494,0,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.024288,-0.16084,-0.10533,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0049174,-0.16118,-0.12665,0,0
4,GO CENTRIOLE ASSEMBLY,0.0007696,-0.16125,-0.13964,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.11636,-0.16166,-0.1076,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.3746,-0.16182,-0.090455,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.00032948,-0.16191,-0.20617,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.19095,-0.16243,-0.13646,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.26471,-0.16312,-0.16508,0,0
4,GO SEROTONIN SECRETION,0.1313,-0.16412,-0.11324,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.053746,-0.1644,-0.23576,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.0022992,-0.16464,-0.16594,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.0029794,-0.16509,-0.17043,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0026572,-0.16522,-0.18304,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.32938,-0.16588,-0.020404,0,0
4,GO FOREBRAIN DEVELOPMENT,0.00017796,-0.16588,-0.15721,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.046579,-0.16622,-0.15389,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.061812,-0.1664,-0.14565,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.011326,-0.16717,-0.16599,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.27999,-0.16734,-0.089843,0,0
4,GO MICROTUBULE POLYMERIZATION,0.00030804,-0.16739,-0.17455,0,0
4,GO REGULATION OF AXON GUIDANCE,0.027188,-0.16753,-0.1619,0,0
4,GO BIOLOGICAL PHASE,0.73628,-0.16768,-0.013612,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.045624,-0.16809,-0.33715,0,0
4,GO COLLATERAL SPROUTING,0.03245,-0.16819,-0.17118,0,0
4,GO PALLIUM DEVELOPMENT,7.8282e-05,-0.16922,-0.1676,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.038561,-0.17005,-0.16006,0,0
4,GO FILOPODIUM ASSEMBLY,0.014486,-0.1701,-0.16726,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.010245,-0.17015,-0.11171,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.33812,-0.17017,-0.12513,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0010528,-0.17136,-0.15461,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.079444,-0.17237,-0.10021,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.14285,-0.17288,-0.11613,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.11235,-0.17333,-0.15678,0,0
4,GO AXO DENDRITIC TRANSPORT,0.0049174,-0.17501,-0.14596,0,0
4,GO NEURON DEVELOPMENT,0.00079435,-0.17579,-0.14233,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.061812,-0.1758,-0.12665,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00016595,-0.17593,-0.1695,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.14285,-0.1763,-0.098354,0,0
4,GO AXONAL TRANSPORT,0.0060989,-0.17649,-0.14475,0,0
4,GO NEURON DIFFERENTIATION,0.00052342,-0.17694,-0.14351,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.073629,-0.17713,-0.15154,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.017137,-0.17721,-0.13598,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.068167,-0.1774,-0.16634,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.14526,-0.17798,-0.13288,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.19095,-0.17982,-0.080657,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0087944,-0.17988,-0.22144,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0064317,-0.18036,-0.20176,0,0
4,GO TRACHEA MORPHOGENESIS,0.28785,-0.1806,-0.073555,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.21905,-0.18092,-0.094935,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0020453,-0.18096,-0.20373,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.0067808,-0.18107,-0.15095,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.10654,-0.18151,-0.19535,0,0
4,GO HISTONE H3 K9 METHYLATION,0.0020453,-0.18227,-0.16933,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.0050528,-0.18298,-0.17342,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.024288,-0.18359,-0.1898,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.21579,-0.18449,-0.10307,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.1028,-0.18452,-0.12557,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.092194,-0.18494,-0.13514,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00021167,-0.18495,-0.18344,0,0
4,GO STEM CELL DIVISION,0.027803,-0.18567,-0.15809,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.48678,-0.18598,-0.08261,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.019739,-0.18622,-0.13291,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.040234,-0.1864,-0.18852,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00029782,-0.1867,-0.17628,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.065563,-0.18742,-0.1617,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.00014418,-0.1883,-0.20952,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00090094,-0.1884,-0.18381,0,0
4,GO NEUROTRANSMITTER SECRETION,0.025414,-0.18878,-0.089156,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.12473,-0.18995,-0.14138,0,0
4,GO CELL FATE SPECIFICATION,0.013798,-0.19037,-0.13416,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.0069616,-0.19048,-0.15028,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.0049174,-0.19098,-0.16688,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.070855,-0.19099,-0.16921,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.39858,-0.19158,-0.085821,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,8.4205e-05,-0.19249,-0.18939,0,0
4,GO NUCLEOSOME ASSEMBLY,0.00047456,-0.19386,-0.16587,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.00024286,-0.19452,-0.17926,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0083534,-0.19461,-0.17855,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.36064,-0.19483,-0.076621,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.2,-0.19621,-0.090202,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0054795,-0.19633,-0.17667,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.014486,-0.19642,-0.16173,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.05161,-0.19646,-0.11399,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.095625,-0.19753,-0.19491,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.32938,-0.19764,-0.094977,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.00038934,-0.19824,-0.18624,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0090226,-0.19845,-0.16352,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00052342,-0.19858,-0.22715,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.017137,-0.19864,-0.19709,0,0
4,GO HISTONE H3 K27 METHYLATION,0.00017796,-0.19907,-0.21791,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.41842,-0.19933,-0.090618,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00012964,-0.19973,-0.20357,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.00029782,-0.19983,-0.19509,0,0
4,GO SOMATIC STEM CELL DIVISION,0.017969,-0.19999,-0.3995,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.023741,-0.20003,-0.15392,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.78962,-0.20006,0.011694,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.12689,-0.20053,-0.10626,0,0
4,GO APPENDAGE MORPHOGENESIS,0.0011199,-0.20112,-0.18948,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00037661,-0.20123,-0.20401,0,0
4,GO HEART FORMATION,0.009256,-0.20201,-0.21167,0,0
4,GO NEURAL CREST CELL MIGRATION,0.001872,-0.20212,-0.24109,0,0
4,GO RENAL FILTRATION,0.31232,-0.20262,-0.12391,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.080955,-0.20279,-0.14131,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.019283,-0.20318,-0.21414,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.34702,-0.20333,-0.09411,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0025817,-0.20349,-0.18308,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00012074,-0.20581,-0.23265,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.00098941,-0.20607,-0.17996,0,0
4,GO HEART FIELD SPECIFICATION,0.093897,-0.20622,-0.17852,0,0
4,GO FOREBRAIN CELL MIGRATION,0.0001547,-0.20652,-0.24447,0,0
4,GO AXONAL FASCICULATION,0.021165,-0.20655,-0.24737,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.30402,-0.20754,-0.13378,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0023671,-0.20755,-0.19977,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.001191,-0.20787,-0.18221,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.31232,-0.20815,-0.10451,0,0
4,GO SISTER CHROMATID COHESION,0.00032948,-0.20824,-0.15332,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.053746,-0.20834,-0.23369,0,0
4,GO SYNAPTIC SIGNALING,0.024288,-0.20911,-0.11727,0,0
4,GO GMP METABOLIC PROCESS,0.25001,-0.20939,-0.10276,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0037331,-0.20957,-0.28486,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0021689,-0.20961,-0.1928,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.14048,-0.21018,-0.091687,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0056288,-0.21051,-0.23305,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0011199,-0.21056,-0.19163,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.0071468,-0.21095,-0.17583,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.045624,-0.21095,-0.20771,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.047551,-0.21103,-0.15709,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.0025083,-0.21141,-0.25559,0,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,5.6174e-05,-0.21171,-0.19798,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0028957,-0.21326,-0.20061,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.030383,-0.21376,-0.19761,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00074557,-0.21434,-0.18053,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.00012074,-0.21437,-0.20336,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,3.1888e-05,-0.21462,-0.19914,0,0
4,GO SIALYLATION,0.14526,-0.21479,-0.14984,0,0
4,GO DENDRITE DEVELOPMENT,0.00014418,-0.21483,-0.19742,0,0
4,GO UTERUS DEVELOPMENT,0.10845,-0.21532,-0.17596,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.03939,-0.21541,-0.15638,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.05161,-0.21649,-0.22336,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.095625,-0.21703,-0.14114,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.16559,-0.21705,-0.17839,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00050664,-0.21788,-0.18263,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00047456,-0.21866,-0.19505,0,0
4,GO NEURON FATE COMMITMENT,0.02268,-0.21927,-0.19314,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.054842,-0.21954,-0.16515,0,0
4,GO HISTONE H4 K16 ACETYLATION,0.00052342,-0.21965,-0.22714,0,0
4,GO SYNAPSE ORGANIZATION,0.0041716,-0.2197,-0.17454,0,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.0013054,-0.22005,-0.18731,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.055956,-0.22058,-0.2097,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.0017641,-0.22098,-0.20329,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.013798,-0.22589,-0.21038,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.016339,-0.22595,-0.16572,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.28785,-0.22595,-0.11742,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.00024286,-0.22597,-0.23092,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.031059,-0.22651,-0.25833,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.015574,-0.22659,-0.1964,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.00353,-0.22749,-0.17336,0,0
4,GO CELL PART MORPHOGENESIS,5.8301e-05,-0.22836,-0.21211,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.0025083,-0.22838,-0.25504,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.046579,-0.22957,-0.2116,0,0
4,GO FORELIMB MORPHOGENESIS,0.0028141,-0.23104,-0.25135,0,0
4,GO SYNAPSE ASSEMBLY,0.016734,-0.23143,-0.15539,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.001872,-0.2316,-0.26137,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,5.0226e-05,-0.2323,-0.23869,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0012662,-0.23273,-0.29397,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00081984,-0.23382,-0.22521,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0021689,-0.23492,-0.21576,0,0
4,GO NEURON PROJECTION EXTENSION,0.0021062,-0.23606,-0.19504,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,4.0073e-05,-0.23668,-0.23654,0,0
4,GO COCHLEA MORPHOGENESIS,0.0010859,-0.23704,-0.29601,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0085714,-0.23705,-0.145,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.054842,-0.23885,-0.16242,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.035393,-0.2394,-0.23429,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.10845,-0.23989,-0.13099,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0083534,-0.24094,-0.15604,0,0
4,GO SPINAL CORD DEVELOPMENT,0.00035231,-0.24157,-0.22206,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.0011549,-0.24159,-0.18687,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0085714,-0.2427,-0.21611,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,5.0226e-05,-0.24323,-0.22512,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0038387,-0.2438,-0.1963,0,0
4,GO AXON EXTENSION,0.00057693,-0.24439,-0.24567,0,0
4,GO HISTONE H3 K36 METHYLATION,0.0062634,-0.24568,-0.16793,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0079323,-0.24594,-0.24428,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.040234,-0.24648,-0.25777,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.015203,-0.24917,-0.2106,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,7.8282e-05,-0.24953,-0.26768,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.027803,-0.24986,-0.17964,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.00032948,-0.25039,-0.27111,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.025994,-0.25068,-0.17779,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,3.6228e-06,-0.25129,-0.26238,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.010245,-0.25159,-0.28371,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.00084609,-0.25223,-0.22803,0,0
4,GO NEURON MIGRATION,0.00018427,-0.25379,-0.26856,0,0
4,GO REPLACEMENT OSSIFICATION,0.0018173,-0.25384,-0.24713,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.01282,-0.2542,-0.18896,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00030804,-0.25423,-0.25039,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.055956,-0.25485,-0.25757,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0022332,-0.25532,-0.2497,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.0021062,-0.25613,-0.2323,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.00084609,-0.25762,-0.23533,0,0
4,GO REGULATION OF AXONOGENESIS,0.00038934,-0.25808,-0.25536,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.017137,-0.25842,-0.188,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.00021909,-0.25844,-0.24824,0,0
4,GO CGMP METABOLIC PROCESS,0.063042,-0.25966,-0.16207,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.012203,-0.25971,-0.25892,0,0
4,GO AXON DEVELOPMENT,6.0504e-05,-0.25998,-0.25402,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.05824,-0.26004,-0.43558,0,0
4,GO PLASMA MEMBRANE REPAIR,0.097379,-0.26061,-0.15567,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18219,-0.26277,-0.17927,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00059588,-0.26362,-0.29657,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.00098941,-0.26512,-0.42178,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00041602,-0.26519,-0.22426,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.00020448,-0.26646,-0.23968,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.7118e-05,-0.26766,-0.30629,0,0
4,GO SPINAL CORD PATTERNING,0.036948,-0.26796,-0.18191,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.00034072,-0.26805,-0.26271,0,0
4,GO BRAIN MORPHOGENESIS,2.6307e-05,-0.26825,-0.24557,0,0
4,GO DENDRITE MORPHOGENESIS,4.8379e-05,-0.26899,-0.25056,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.3218e-05,-0.27457,-0.28497,0,0
4,GO REGULATION OF NEURON MIGRATION,5.4121e-05,-0.27587,-0.32699,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.36064,-0.2773,-0.10633,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.0062634,-0.27799,-0.22239,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.0034322,-0.27808,-0.31504,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.00024286,-0.2784,-0.26826,0,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,3.4421e-05,-0.27909,-0.28801,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00018427,-0.27988,-0.24287,0,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.00017186,-0.28041,-0.24866,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.0007696,-0.28052,-0.33844,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0025817,-0.28118,-0.34354,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00013433,-0.28163,-0.22643,0,0
4,GO EXPLORATION BEHAVIOR,0.0097392,-0.28779,-0.25142,0,0
4,GO MICROTUBULE SEVERING,0.009256,-0.28877,-0.18613,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.015574,-0.28993,-0.23929,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.026586,-0.29021,-0.22044,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.40349,-0.29086,-0.097452,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.0054795,-0.29199,-0.29668,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0026572,-0.29209,-0.25322,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0073363,-0.29226,-0.20881,0,0
4,GO NEURON PROJECTION GUIDANCE,3.3132e-05,-0.29237,-0.28124,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.001986,-0.29389,-0.27341,0,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,2.3418e-05,-0.29542,-0.31159,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00074557,-0.29618,-0.27766,0,0
4,GO CONVERGENT EXTENSION,0.0033369,-0.29664,-0.25903,0,0
4,GO DENDRITE SELF AVOIDANCE,0.001986,-0.29874,-0.2942,0,0
4,GO TONGUE DEVELOPMENT,0.0033369,-0.2995,-0.30104,0,0
4,GO RECEPTOR CLUSTERING,1.9263e-05,-0.29986,-0.30729,0,0
4,GO NEURON CELL CELL ADHESION,0.060602,-0.30114,-0.28336,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.30402,-0.3027,-0.081058,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0013872,-0.30488,-0.27743,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0028141,-0.30576,-0.23563,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00019753,-0.3062,-0.24951,0,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,4.0073e-05,-0.30679,-0.3287,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.00042998,-0.3094,-0.4275,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.15015,-0.3114,-0.20094,0,0
4,GO NEURON RECOGNITION,0.0011549,-0.31243,-0.30608,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.0034322,-0.31507,-0.25595,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.0024367,-0.31779,-0.30044,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0017123,-0.31833,-0.33069,0,0
4,GO PRESYNAPSE ORGANIZATION,0.0039469,-0.32186,-0.23645,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,4.6597e-05,-0.32479,-0.29141,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.017969,-0.32575,-0.31957,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00028792,-0.32638,-0.27795,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00026003,-0.32998,-0.29777,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,6.4994e-06,-0.33181,-0.36685,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.01282,-0.33367,-0.29711,0,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0020453,-0.33536,-0.40119,0,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0014738,-0.33578,-0.32498,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00065623,-0.33922,-0.24385,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0025083,-0.34022,-0.27941,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,3.0576e-06,-0.34084,-0.33408,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.8301e-05,-0.34128,-0.28964,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.017137,-0.34196,-0.23296,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00040247,-0.34357,-0.28595,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,9.389e-05,-0.34537,-0.34799,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,1.2962e-05,-0.3454,-0.3168,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00042998,-0.34726,-0.28102,0,0
4,GO EMBRYONIC EYE MORPHOGENESIS,9.3916e-06,-0.35143,-0.34765,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,2.0833e-05,-0.35769,-0.35529,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,4.3218e-05,-0.35929,-0.3157,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,3.5759e-05,-0.36299,-0.37333,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.00040247,-0.36904,-0.30874,0,0
4,GO NEURON FATE SPECIFICATION,0.10465,-0.36921,-0.17163,0,0
4,GO CARDIOBLAST PROLIFERATION,0.0087944,-0.37345,-0.45987,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.065563,-0.37413,-0.25216,0,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00042998,-0.37488,-0.47891,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0073363,-0.37901,-0.26648,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.001872,-0.37937,-0.3826,0,0
4,GO CENTRIOLE CENTRIOLE COHESION,3.4728e-06,-0.3797,-0.39547,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0030654,-0.38225,-0.36201,0,0
4,GO DENDRITIC TRANSPORT,3.0689e-05,-0.39151,-0.40525,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.2754e-05,-0.3921,-0.36213,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.076492,-0.39568,-0.27644,0,0
4,GO CARTILAGE MORPHOGENESIS,0.0075304,-0.40555,-0.34521,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.012203,-0.4125,-0.28515,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00025131,-0.41735,-0.39797,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.014138,-0.4178,-0.34864,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,8.1192e-05,-0.42408,-0.35106,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.00030804,-0.42632,-0.41906,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,2.9532e-05,-0.43071,-0.3337,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0014738,-0.43119,-0.36759,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00031859,-0.43244,-0.32504,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00041602,-0.44194,-0.42528,0,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.0032441,-0.45399,-0.43605,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,1.104e-05,-0.46505,-0.45161,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00017796,-0.47354,-0.40728,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,4.4878e-05,-0.51376,-0.50376,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.5308e-05,-0.52005,-0.61375,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0013872,-0.52332,-0.4542,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,1.4609e-05,-0.52825,-0.5361,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0067808,-0.53407,-0.52089,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.00025131,-0.55978,-0.48926,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0030654,-0.57208,-0.43677,0,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00020448,-0.58462,-0.57176,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,4.1617e-05,-0.60368,-0.53671,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,4.8612e-06,-0.62918,-0.66071,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,2.6902e-06,-0.63199,-0.68438,0,0
4,GO VOCALIZATION BEHAVIOR,6.7596e-05,-0.67833,-0.61988,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00055855,-0.69886,-0.60906,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,6.0504e-05,-0.70842,-0.55827,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,7.8282e-05,-0.79277,-0.65711,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00020448,1.4705,1.1646,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,7.8282e-05,1.3173,1.0222,1,1
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.3132e-05,1.2543,1.1181,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,2.5774e-06,1.0832,1.0892,1,1
5,GO CYTIDINE TO URIDINE EDITING,5.2837e-06,0.93805,0.83425,1,1
5,GO RESPONSE TO INTERFERON ALPHA,8.1192e-05,0.92742,0.68837,1,1
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.2786e-05,0.8948,0.77637,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00032948,0.88604,0.64996,1,1
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,1.349e-05,0.84157,0.6488,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,1.5816e-05,0.82332,0.66799,1,1
5,GO TOLERANCE INDUCTION,3.3132e-05,0.81912,0.67817,1,1
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00044439,0.80821,0.53176,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00047456,0.77503,0.55048,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.5308e-05,0.76102,0.62228,1,1
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,2.0833e-05,0.74274,0.72212,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00010462,0.70658,0.49538,1,1
5,GO EOSINOPHIL CHEMOTAXIS,2.5308e-05,0.69579,0.61334,1,1
5,GO T CELL MEDIATED CYTOTOXICITY,0.00026003,0.69462,0.47661,1,1
5,GO LIVER MORPHOGENESIS,5.0683e-06,0.69023,0.54822,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,7.9801e-06,0.68781,0.60753,1,1
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.0226e-05,0.68182,0.48411,1,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,2.0784e-06,0.66579,0.69104,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,2.1702e-06,0.66507,0.66652,1,1
5,GO HISTAMINE SECRETION,6.2786e-05,0.66461,0.59162,1,1
5,GO RESPONSE TO TYPE I INTERFERON,3.3287e-06,0.66205,0.69163,1,1
5,GO NEGATIVE REGULATION OF CELL KILLING,0.0014299,0.65871,0.439,1,1
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.05161,0.65647,0.395,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,0.64697,0.51244,1,1
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.1888e-05,0.64213,0.53944,1,1
5,GO EOSINOPHIL MIGRATION,2.3418e-05,0.64069,0.58485,1,1
5,GO RESPONSE TO INTERFERON BETA,0.00021167,0.64055,0.58417,1,1
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00065623,0.63915,0.49305,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00026903,0.63881,0.47549,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,2.3654e-06,0.63785,0.56909,1,1
5,GO LIPID DROPLET FORMATION,4.8612e-06,0.62311,0.65657,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,1.0604e-05,0.62058,0.6632,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.8583e-05,0.61642,0.61357,1,1
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0056288,0.60684,0.41438,1,1
5,GO GERMINAL CENTER FORMATION,0.00017186,0.60366,0.56319,1,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00010462,0.60081,0.43707,1,1
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,5.8301e-05,0.59918,0.43524,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.508e-06,0.59859,0.5251,1,1
5,GO SEROTONIN METABOLIC PROCESS,1.349e-05,0.59785,0.63979,1,1
5,GO GLIAL CELL FATE COMMITMENT,9.7346e-05,0.5951,0.53258,1,1
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,4.0073e-05,0.58946,0.59411,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.3528e-06,0.58839,0.55535,1,1
5,GO TYPE B PANCREATIC CELL PROLIFERATION,5.2837e-06,0.58824,0.60024,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00063551,0.58527,0.62323,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,4.8612e-06,0.58259,0.57817,1,1
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00013917,0.57923,0.45995,1,1
5,GO DETECTION OF OTHER ORGANISM,5.8301e-05,0.57735,0.49828,1,1
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.6307e-05,0.57247,0.55676,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.9301e-06,0.56821,0.56148,1,1
5,GO REGULATION OF TRANSPOSITION,5.0226e-05,0.56742,0.44872,1,1
5,GO HISTAMINE TRANSPORT,8.7323e-05,0.56624,0.51612,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00013433,0.56445,0.51594,1,1
5,GO REGULATION OF PLATELET AGGREGATION,2.0833e-05,0.56407,0.47336,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.0045306,0.56288,0.35026,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,0.56174,0.45506,1,1
5,GO DNA DEAMINATION,0.00011241,0.55903,0.48017,1,1
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,6.2786e-05,0.55839,0.44717,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,6.2786e-05,0.55828,0.4071,1,1
5,GO REGULATION OF VASCULOGENESIS,3.8583e-05,0.5562,0.51185,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.2786e-05,0.55472,0.4257,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0060989,0.55281,0.40849,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00024286,0.55168,0.45587,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,2.8891e-07,0.5512,0.52409,1,1
5,GO MUCUS SECRETION,0.0031536,0.5498,0.4776,1,1
5,GO RESPONSE TO IMMOBILIZATION STRESS,7.2754e-05,0.54918,0.44933,1,1
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00010092,0.54651,0.46933,1,1
5,GO NEGATIVE REGULATION OF ANOIKIS,7.0571e-06,0.54616,0.66086,1,1
5,GO LABYRINTHINE LAYER MORPHOGENESIS,3.8583e-05,0.53865,0.58562,1,1
5,GO IMMUNOGLOBULIN SECRETION,0.00017796,0.53794,0.40043,1,1
5,GO KERATINOCYTE DEVELOPMENT,0.00016595,0.53753,0.45122,1,1
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0028957,0.53733,0.38053,1,1
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00045924,0.53687,0.46362,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00012074,0.53431,0.42373,1,1
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.00035231,0.53367,0.55881,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,9.389e-05,0.53187,0.37543,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,0.0001547,0.53139,0.41084,1,1
5,GO INDOLALKYLAMINE METABOLIC PROCESS,6.0504e-05,0.52981,0.4535,1,1
5,GO TRANSPOSITION,7.0571e-06,0.5296,0.45051,1,1
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.0226e-05,0.52958,0.41531,1,1
5,GO MICROVILLUS ASSEMBLY,0.00024286,0.5295,0.43184,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00011241,0.5291,0.4758,1,1
5,GO LIPOXYGENASE PATHWAY,0.00012964,0.52719,0.46051,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,1.906e-06,0.52674,0.63948,1,1
5,GO O GLYCAN PROCESSING,2.0833e-05,0.52388,0.43156,1,1
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00031859,0.52338,0.42528,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.7801e-06,0.52306,0.40584,1,1
5,GO LUNG CELL DIFFERENTIATION,5.8301e-05,0.52117,0.51601,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00057693,0.52093,0.43612,1,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0037331,0.52027,0.49247,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0015189,0.51997,0.59087,1,1
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,5.6174e-05,0.51735,0.48249,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.1493e-05,0.51607,0.44416,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,7.0571e-06,0.51605,0.45958,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,3.9418e-06,0.51411,0.47357,1,1
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,7.0571e-06,0.51396,0.53785,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00021909,0.5121,0.45443,1,1
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,7.547e-05,0.51207,0.51624,1,1
5,GO KETONE CATABOLIC PROCESS,0.00054072,0.51108,0.42908,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00090094,0.51022,0.38369,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0028957,0.50993,0.40691,1,1
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,7.2754e-05,0.50976,0.51268,1,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,9.0179e-06,0.50735,0.45892,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.001662,0.50731,0.32139,1,1
5,GO REFLEX,0.0090226,0.50357,0.42062,1,1
5,GO RESPONSE TO WATER,2.3418e-05,0.49941,0.45953,1,1
5,GO REGULATION OF RECEPTOR CLUSTERING,6.5149e-05,0.49909,0.47741,1,1
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00041602,0.49783,0.47044,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.2962e-05,0.4975,0.47154,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.389e-05,0.49717,0.41019,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.8282e-05,0.49695,0.36213,1,1
5,GO RENAL ABSORPTION,0.00035231,0.49553,0.50615,1,1
5,GO RESPONSE TO INTERLEUKIN 18,0.0025817,0.49506,0.36324,1,1
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0007696,0.4949,0.42787,1,1
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.007729,0.49465,0.44519,1,1
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.7343e-05,0.49178,0.44831,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.00010462,0.4909,0.34519,1,1
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.4039e-05,0.48935,0.4351,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.9263e-05,0.48716,0.42443,1,1
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,7.2754e-05,0.48692,0.41376,1,1
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0015189,0.48588,0.40432,1,1
5,GO MEMBRANE RAFT ORGANIZATION,0.0021062,0.48411,0.34255,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0015189,0.48066,0.34248,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.5201e-05,0.47748,0.49463,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,9.3916e-06,0.47624,0.40944,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00041602,0.4757,0.32122,1,1
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00084609,0.47316,0.35297,1,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.7118e-05,0.47206,0.37362,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,0.00012512,0.47008,0.43399,1,1
5,GO RESPONSE TO MUSCLE STRETCH,0.00087311,0.46911,0.37171,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,2.6902e-06,0.4678,0.40391,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1112e-06,0.46666,0.44692,1,1
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00032948,0.46535,0.5202,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.6307e-05,0.46387,0.43858,1,1
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00047456,0.46382,0.40868,1,1
5,GO T CELL MEDIATED IMMUNITY,0.0001165,0.46362,0.32062,1,1
5,GO MICROVILLUS ORGANIZATION,0.00045924,0.46335,0.35166,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,5.4121e-05,0.46294,0.50303,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.6228e-06,0.46176,0.351,1,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00010462,0.46015,0.44402,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.4878e-05,0.46011,0.3607,1,1
5,GO CORTICOSTEROID HORMONE SECRETION,0.00074557,0.45903,0.37312,1,1
5,GO REGULATION OF VIRAL LIFE CYCLE,0.00013917,0.45863,0.34599,1,1
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,8.1192e-05,0.45684,0.54596,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.0018173,0.45627,0.44335,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.349e-05,0.45591,0.56484,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00055855,0.45548,0.35291,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00034072,0.45449,0.43271,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0057817,0.45205,0.29791,1,1
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,4.8379e-05,0.45171,0.32474,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,3.4728e-06,0.45137,0.40583,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00079435,0.45053,0.28846,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.4609e-05,0.44943,0.51287,1,1
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00098941,0.44924,0.34454,1,1
5,GO GLYCOLIPID CATABOLIC PROCESS,0.00029782,0.44801,0.33793,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.00029782,0.44739,0.41009,1,1
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00014418,0.44695,0.50002,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00029782,0.44668,0.29941,1,1
5,GO RESPONSE TO PAIN,0.00027832,0.44636,0.32956,1,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00049035,0.44613,0.42497,1,1
5,GO MYOBLAST FUSION,1.1493e-05,0.44564,0.3898,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.011047,0.44548,0.3046,1,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00353,0.44519,0.37133,1,1
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00012964,0.44458,0.34978,1,1
5,GO REGULATION OF MYOBLAST FUSION,0.00029782,0.44424,0.36219,1,1
5,GO B CELL APOPTOTIC PROCESS,0.00028792,0.44408,0.3946,1,1
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013917,0.44103,0.40557,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00014418,0.44097,0.32791,1,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0017123,0.43951,0.33613,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0007696,0.43929,0.33409,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,7.013e-05,0.4389,0.37842,1,1
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00016595,0.43886,0.29047,1,1
5,GO VIRAL GENOME REPLICATION,6.0504e-05,0.43809,0.33322,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,6.0504e-05,0.43739,0.44521,1,1
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0022332,0.43715,0.35139,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0014299,0.4364,0.39016,1,1
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.2754e-05,0.43627,0.35208,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00016023,0.43568,0.35659,1,1
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0054795,0.43523,0.38319,1,1
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00092958,0.43506,0.38465,1,1
5,GO RESPONSE TO INTERFERON GAMMA,1.5201e-05,0.43426,0.43393,1,1
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.104e-05,0.43194,0.37554,1,1
5,GO T CELL EXTRAVASATION,0.00081984,0.43177,0.41252,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,7.8282e-05,0.42941,0.36127,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.001662,0.42938,0.37316,1,1
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,8.1192e-05,0.42933,0.38006,1,1
5,GO REGULATION OF EXOSOMAL SECRETION,6.5149e-05,0.42821,0.31458,1,1
5,GO RESPONSE TO DIETARY EXCESS,9.389e-05,0.42755,0.42521,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0021062,0.42692,0.34849,1,1
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00047456,0.42617,0.32307,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016129,0.42562,0.28944,1,1
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.011326,0.42553,0.33005,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00055855,0.42536,0.4127,1,1
5,GO MYELIN MAINTENANCE,7.547e-05,0.42535,0.407,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00022676,0.42506,0.43014,1,1
5,GO ZYMOGEN ACTIVATION,0.00047456,0.42489,0.37159,1,1
5,GO REGULATION OF PLATELET ACTIVATION,3.3132e-05,0.42458,0.38877,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,3.6228e-06,0.4241,0.31863,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00017186,0.42355,0.35299,1,1
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00040247,0.42349,0.41969,1,1
5,GO FUCOSE METABOLIC PROCESS,2.8418e-05,0.4229,0.34072,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.007729,0.42223,0.28647,1,1
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.001191,0.42188,0.39526,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.00037661,0.42156,0.35675,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0030654,0.42131,0.3105,1,1
5,GO N GLYCAN PROCESSING,8.1192e-05,0.42099,0.41949,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,4.6623e-06,0.4208,0.44657,1,1
5,GO DEFENSE RESPONSE TO VIRUS,3.3132e-05,0.42044,0.32573,1,1
5,GO ENTRY INTO HOST,0.00028792,0.41968,0.27426,1,1
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00030804,0.41966,0.34162,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.7806e-05,0.41959,0.40941,1,1
5,GO REGULATION OF B CELL PROLIFERATION,2.1663e-05,0.41947,0.34596,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,1.4609e-05,0.41938,0.31907,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.1702e-06,0.41852,0.36644,1,1
5,GO CELLULAR DEFENSE RESPONSE,0.00057693,0.41847,0.27642,1,1
5,GO GLIAL CELL APOPTOTIC PROCESS,0.00030804,0.41763,0.46665,1,1
5,GO TOXIN METABOLIC PROCESS,4.1617e-05,0.41639,0.41758,1,1
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00090094,0.41623,0.55203,1,1
5,GO REGULATION OF ANOIKIS,4.0073e-05,0.41545,0.47975,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00013433,0.41481,0.29637,1,1
5,GO CAMP BIOSYNTHETIC PROCESS,0.00019753,0.41468,0.36325,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,2.1702e-06,0.41434,0.34574,1,1
5,GO RESPONSE TO COLD,2.5308e-05,0.4143,0.37095,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.001191,0.41418,0.38333,1,1
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0015653,0.41363,0.35775,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,6.4994e-06,0.41302,0.44398,1,1
5,GO INTERLEUKIN 10 PRODUCTION,2.6307e-05,0.41222,0.30304,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0013872,0.41221,0.31801,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.009256,0.4122,0.32726,1,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0024367,0.41089,0.43306,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.2786e-05,0.41075,0.31333,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00016023,0.41072,0.32207,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,9.389e-05,0.41019,0.47285,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.40996,0.43091,1,1
5,GO MYELIN ASSEMBLY,0.00042998,0.40967,0.31313,1,1
5,GO REGULATION OF TISSUE REMODELING,2.1663e-05,0.40913,0.32461,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.7323e-05,0.40906,0.28569,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,5.9841e-06,0.40798,0.40553,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,7.6603e-06,0.40782,0.31054,1,1
5,GO GALACTOSE METABOLIC PROCESS,0.0050528,0.40761,0.27911,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,0.00065623,0.40694,0.38303,1,1
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00052342,0.40669,0.43381,1,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,2.0833e-05,0.40657,0.3586,1,1
5,GO AMINE BIOSYNTHETIC PROCESS,7.3528e-06,0.40629,0.40937,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,1.3441e-06,0.40589,0.39082,1,1
5,GO SMOOTH MUSCLE CELL MIGRATION,5.6174e-05,0.40486,0.34708,1,1
5,GO REGULATION OF BONE REMODELING,2.0033e-05,0.40482,0.34605,1,1
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.026586,0.40471,0.29763,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,3.1888e-05,0.40396,0.34513,1,1
5,GO STEROID ESTERIFICATION,6.5149e-05,0.40268,0.4744,1,1
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00055855,0.40176,0.29175,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,8.7323e-05,0.40012,0.37348,1,1
5,GO STEROID HORMONE SECRETION,0.00098941,0.39896,0.30407,1,1
5,GO AMYLOID FIBRIL FORMATION,0.0006154,0.39882,0.33744,1,1
5,GO RELAXATION OF CARDIAC MUSCLE,0.001662,0.39857,0.34998,1,1
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,8.1192e-05,0.39846,0.39691,1,1
5,GO MAGNESIUM ION TRANSPORT,6.0504e-05,0.39815,0.30021,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.5774e-06,0.39744,0.51238,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00014935,0.3966,0.32364,1,1
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.00024286,0.39646,0.45538,1,1
5,GO MEMBRANE LIPID CATABOLIC PROCESS,1.0604e-05,0.39593,0.34578,1,1
5,GO PHOSPHOLIPID EFFLUX,0.0011199,0.39561,0.25794,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,1.5816e-05,0.39544,0.32901,1,1
5,GO RESPONSE TO THYROID HORMONE,0.00065623,0.39334,0.33894,1,1
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,6.2786e-05,0.39232,0.39519,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,6.5149e-05,0.39207,0.46675,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,4.4878e-05,0.39184,0.31043,1,1
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0032441,0.39143,0.29691,1,1
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0012662,0.39101,0.31068,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,0.001872,0.39059,0.37452,1,1
5,GO ESTROUS CYCLE,7.8282e-05,0.39026,0.36873,1,1
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00025131,0.39006,0.31332,1,1
5,GO VASCULAR WOUND HEALING,4.8379e-05,0.38848,0.42409,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.00047456,0.38803,0.38321,1,1
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.001872,0.38731,0.37847,1,1
5,GO BONE RESORPTION,3.5759e-05,0.38696,0.3022,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,3.8583e-05,0.38675,0.3268,1,1
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.001228,0.38669,0.30927,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,0.00031859,0.38622,0.37494,1,1
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0015189,0.38615,0.36034,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.2754e-05,0.38574,0.38218,1,1
5,GO TYPE 2 IMMUNE RESPONSE,0.00012074,0.38474,0.43451,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.8521e-05,0.38462,0.3828,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,0.0001165,0.38431,0.30561,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0006154,0.38428,0.43877,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,7.8282e-05,0.38399,0.32618,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0067808,0.38357,0.28798,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,2.4346e-05,0.38324,0.35723,1,1
5,GO PROTEIN KINASE C SIGNALING,0.00050664,0.38308,0.3205,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.00034072,0.38267,0.32053,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00012512,0.38258,0.32374,1,1
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00031859,0.38205,0.29404,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.5308e-05,0.38173,0.3651,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.508e-06,0.38154,0.32863,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,2.7343e-05,0.38152,0.37966,1,1
5,GO PROSTATE GLAND MORPHOGENESIS,0.033166,0.38108,0.24795,1,1
5,GO LUNG EPITHELIUM DEVELOPMENT,5.6174e-05,0.38034,0.37719,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00013433,0.37983,0.30344,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00012512,0.37938,0.3138,1,1
5,GO SIALYLATION,0.02268,0.37902,0.23042,1,1
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00018427,0.37876,0.36756,1,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00012964,0.37853,0.27539,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.1964e-05,0.37815,0.31398,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.001191,0.37814,0.318,1,1
5,GO VITAMIN D METABOLIC PROCESS,1.6455e-05,0.37792,0.37024,1,1
5,GO ADRENAL GLAND DEVELOPMENT,2.7343e-05,0.37729,0.43447,1,1
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.0016129,0.3767,0.34279,1,1
5,GO RESPONSE TO COPPER ION,0.00026003,0.37641,0.39671,1,1
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.011047,0.37563,0.26629,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00025131,0.37548,0.37974,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.036948,0.37544,0.2133,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.7801e-06,0.37531,0.38627,1,1
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.0551e-05,0.37478,0.31514,1,1
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00021909,0.3746,0.36507,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00010462,0.37378,0.38348,1,1
5,GO LIPID DROPLET ORGANIZATION,7.0571e-06,0.37349,0.34146,1,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0010528,0.37307,0.33598,1,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.0054795,0.37286,0.3244,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.036948,0.37205,0.19452,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0018173,0.37194,0.32597,1,1
5,GO MECHANOSENSORY BEHAVIOR,0.020205,0.37174,0.3536,1,1
5,GO ASYMMETRIC CELL DIVISION,0.0036303,0.3715,0.27367,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.001191,0.37108,0.39204,1,1
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0037331,0.37076,0.32775,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,8.1192e-05,0.37039,0.25088,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.8418e-05,0.36895,0.36279,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,3.5759e-05,0.36894,0.34606,1,1
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00037661,0.3688,0.2786,1,1
5,GO TISSUE REMODELING,4.1617e-05,0.36879,0.29407,1,1
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.6174e-05,0.36853,0.25107,1,1
5,GO VASODILATION,0.001662,0.36823,0.27577,1,1
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0029794,0.36744,0.26651,1,1
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00032948,0.36739,0.24994,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.7145e-05,0.36709,0.36206,1,1
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.0047853,0.36648,0.31203,1,1
5,GO OSTEOBLAST PROLIFERATION,6.0504e-05,0.36629,0.35166,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0031536,0.36577,0.36607,1,1
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.365,0.24527,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00040247,0.36482,0.31082,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.00054072,0.36464,0.39031,1,1
5,GO MAST CELL MEDIATED IMMUNITY,3.1888e-05,0.36463,0.31671,1,1
5,GO GLYCINE TRANSPORT,0.049546,0.3641,0.23209,1,1
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00027832,0.36389,0.31511,1,1
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00018427,0.36338,0.26661,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.013e-05,0.36334,0.31219,1,1
5,GO NERVE DEVELOPMENT,1.7806e-05,0.36274,0.31883,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00044439,0.36126,0.32713,1,1
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0017641,0.36091,0.3219,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00026003,0.36075,0.26912,1,1
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00081984,0.36048,0.29595,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0062634,0.36024,0.25847,1,1
5,GO SEQUESTERING OF ACTIN MONOMERS,7.013e-05,0.36018,0.46403,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.01282,0.36004,0.29753,1,1
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00010092,0.35925,0.47633,1,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.029068,0.35916,0.26856,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00041602,0.35913,0.31496,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.0046564,0.3591,0.31586,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00012074,0.35876,0.27798,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0025817,0.35876,0.33179,1,1
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010859,0.35871,0.40011,1,1
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00074557,0.35866,0.33736,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.7791e-06,0.35756,0.30481,1,1
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.026586,0.35734,0.26631,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00030804,0.35675,0.31176,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.4609e-05,0.35669,0.38597,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,3.9418e-06,0.35627,0.3233,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0025817,0.35625,0.32461,1,1
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00010845,0.35614,0.28258,1,1
5,GO LYMPHOCYTE MEDIATED IMMUNITY,4.6597e-05,0.35571,0.29605,1,1
5,GO B CELL MEDIATED IMMUNITY,9.389e-05,0.35547,0.34664,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,2.6307e-05,0.35545,0.32362,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00017796,0.35516,0.25002,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,9.7801e-06,0.35503,0.32231,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,6.4994e-06,0.35485,0.27688,1,1
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.010245,0.35482,0.28184,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00014418,0.3546,0.24452,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,1.4609e-05,0.35444,0.33018,1,1
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,8.1192e-05,0.35413,0.25324,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.3418e-05,0.35358,0.29624,1,1
5,GO MAST CELL ACTIVATION,1.104e-05,0.35331,0.30876,1,1
5,GO BONE REMODELING,2.4346e-05,0.35275,0.32373,1,1
5,GO CELL MIGRATION IN HINDBRAIN,0.0017641,0.35252,0.34587,1,1
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,6.0504e-05,0.35237,0.3038,1,1
5,GO AMMONIUM TRANSPORT,0.00014418,0.35196,0.32534,1,1
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00012512,0.35166,0.29467,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.5331e-06,0.35151,0.34321,1,1
5,GO RESPONSE TO VIRUS,4.8379e-05,0.35135,0.27013,1,1
5,GO REGULATION OF GTP BINDING,0.0085714,0.35129,0.25864,1,1
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0018173,0.35102,0.23539,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00036427,0.35074,0.26347,1,1
5,GO GLAND MORPHOGENESIS,0.00025131,0.35039,0.30211,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,3.5759e-05,0.35001,0.36427,1,1
5,GO FOAM CELL DIFFERENTIATION,0.00012074,0.34981,0.35988,1,1
5,GO NEGATIVE REGULATION OF COAGULATION,0.0057817,0.34936,0.22486,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.0015653,0.34897,0.26954,1,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00026003,0.34881,0.35653,1,1
5,GO INTERLEUKIN 13 PRODUCTION,0.0022332,0.34861,0.3125,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,5.6174e-05,0.34846,0.33604,1,1
5,GO SYNCYTIUM FORMATION,4.8379e-05,0.34846,0.28918,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0030654,0.34787,0.23691,1,1
5,GO MOVEMENT IN HOST ENVIRONMENT,0.00034072,0.34776,0.23917,1,1
5,GO T CELL CYTOKINE PRODUCTION,0.00010462,0.34742,0.24742,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.004408,0.34741,0.28213,1,1
5,GO RESPONSE TO MAGNESIUM ION,0.0026572,0.34739,0.28717,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00026903,0.34731,0.26608,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00024286,0.3473,0.32384,1,1
5,GO ANOIKIS,1.349e-05,0.34697,0.38408,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.00042998,0.34563,0.27625,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.5816e-05,0.34544,0.27779,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00017186,0.3454,0.27505,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,1.8521e-05,0.34534,0.3041,1,1
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,6.7596e-05,0.34508,0.24994,1,1
5,GO SYNAPSE MATURATION,0.0081404,0.34483,0.36337,1,1
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.014138,0.34444,0.23873,1,1
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0047853,0.34443,0.31085,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0099891,0.34402,0.35636,1,1
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,9.7346e-05,0.34346,0.39373,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0046564,0.34341,0.27936,1,1
5,GO BLOOD VESSEL REMODELING,0.0016129,0.34341,0.22928,1,1
5,GO THALAMUS DEVELOPMENT,0.0033369,0.34325,0.31347,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00036427,0.34286,0.27365,1,1
5,GO B CELL PROLIFERATION,6.2786e-05,0.34254,0.2585,1,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00049035,0.34246,0.28378,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.00029782,0.34218,0.39991,1,1
5,GO LEUKOCYTE PROLIFERATION,1.2454e-05,0.34201,0.25792,1,1
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00042998,0.3418,0.33636,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00026903,0.34169,0.27608,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00037661,0.3416,0.22281,1,1
5,GO ENGULFMENT OF APOPTOTIC CELL,3.8583e-05,0.34149,0.35138,1,1
5,GO PLASMINOGEN ACTIVATION,0.050569,0.34098,0.22065,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0090226,0.34024,0.26882,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00041602,0.34012,0.3268,1,1
5,GO REGULATION OF B CELL ACTIVATION,3.1904e-06,0.33997,0.29317,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,1.104e-05,0.33996,0.335,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00055855,0.33994,0.25193,1,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,9.389e-05,0.3398,0.34518,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,9.3916e-06,0.33976,0.33437,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.2139e-05,0.33969,0.26785,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,6.5149e-05,0.33913,0.35296,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00040247,0.33883,0.3232,1,1
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.8282e-05,0.33866,0.27981,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,7.547e-05,0.33839,0.3111,1,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00049035,0.33835,0.28126,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00019753,0.3381,0.28572,1,1
5,GO RESPONSE TO INTERLEUKIN 2,0.00018427,0.33808,0.28229,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.3132e-05,0.33749,0.42261,1,1
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00021167,0.33742,0.275,1,1
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0047853,0.33737,0.24423,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.8282e-05,0.33721,0.23645,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00021167,0.33664,0.27947,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.4121e-05,0.33593,0.33948,1,1
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,7.2754e-05,0.3359,0.28173,1,1
5,GO PROTEIN DEMANNOSYLATION,0.00017796,0.33557,0.27775,1,1
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0054795,0.33466,0.25262,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0018173,0.33445,0.28628,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,5.6174e-05,0.33428,0.25642,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0071468,0.33413,0.24615,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,7.9801e-06,0.33386,0.26288,1,1
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00063551,0.33383,0.28719,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.3127e-06,0.33381,0.31059,1,1
5,GO CRANIAL NERVE DEVELOPMENT,1.4609e-05,0.33355,0.3158,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00032948,0.33345,0.32688,1,1
5,GO POSITIVE REGULATION OF FERTILIZATION,0.0090226,0.33335,0.254,1,1
5,GO LIPID TRANSLOCATION,1.1267e-06,0.33301,0.34664,1,1
5,GO EPITHELIAL CELL MATURATION,0.0011199,0.33298,0.31592,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00023468,0.33209,0.28499,1,1
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00081984,0.3319,0.29263,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,9.3916e-06,0.33144,0.27422,1,1
5,GO INTERLEUKIN 8 PRODUCTION,0.001986,0.33093,0.2275,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00036427,0.33057,0.43282,1,1
5,GO MONOCYTE CHEMOTAXIS,0.00098941,0.33054,0.22285,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.7145e-05,0.33027,0.37626,1,1
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0028957,0.33008,0.24472,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,7.3528e-06,0.32978,0.27713,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0014738,0.32944,0.26738,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0042883,0.32912,0.23487,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021062,0.32903,0.27379,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00026903,0.32884,0.22112,1,1
5,GO IMMUNE EFFECTOR PROCESS,8.1192e-05,0.3288,0.23537,1,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0024367,0.32863,0.2271,1,1
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.038561,0.32855,0.25559,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.9532e-05,0.32825,0.27189,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0081404,0.32806,0.26961,1,1
5,GO RESPONSE TO LITHIUM ION,0.00031859,0.32768,0.35829,1,1
5,GO RESPONSE TO INTERLEUKIN 15,0.0022992,0.32716,0.26869,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.2139e-05,0.32663,0.26583,1,1
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00037661,0.32629,0.22541,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00040247,0.32618,0.26817,1,1
5,GO APICAL JUNCTION ASSEMBLY,6.4994e-06,0.32562,0.33969,1,1
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00095906,0.32557,0.34352,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.2962e-05,0.3254,0.3224,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00019753,0.32511,0.23874,1,1
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010528,0.32507,0.22515,1,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00035231,0.3249,0.33778,1,1
5,GO INNATE IMMUNE RESPONSE,4.0073e-05,0.32418,0.24791,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00035231,0.32399,0.3621,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00018427,0.32382,0.28696,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00057693,0.32351,0.29617,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00021909,0.32341,0.30178,1,1
5,GO INTESTINAL ABSORPTION,0.00036427,0.32303,0.32993,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.0184e-05,0.32288,0.34002,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00087311,0.32206,0.2005,1,1
5,GO PRO B CELL DIFFERENTIATION,0.0054795,0.32193,0.25494,1,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00016023,0.32157,0.26503,1,1
5,GO GLIAL CELL PROLIFERATION,0.00081984,0.32141,0.25512,1,1
5,GO ENDOTHELIAL CELL DEVELOPMENT,4.8379e-05,0.32134,0.26878,1,1
5,GO MEMBRANE DEPOLARIZATION,0.00013433,0.32132,0.27888,1,1
5,GO ENDOCARDIUM DEVELOPMENT,0.0017641,0.32105,0.32818,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0014738,0.32105,0.30875,1,1
5,GO T CELL PROLIFERATION,1.8521e-05,0.32094,0.25857,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,6.7728e-06,0.32082,0.28128,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00040247,0.32066,0.31305,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.0689e-05,0.32064,0.31184,1,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0006154,0.32049,0.30621,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,2.8418e-05,0.32033,0.34289,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.00017186,0.32028,0.25954,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,8.3127e-06,0.32021,0.3019,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0018173,0.3202,0.29864,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.023205,0.31938,0.29737,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.0226e-05,0.31937,0.26061,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.00081984,0.31911,0.3373,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0060989,0.3185,0.34766,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4878e-05,0.31759,0.28082,1,1
5,GO REGULATION OF COAGULATION,0.0025083,0.31742,0.23515,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0018173,0.31716,0.1925,1,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0017641,0.31711,0.24638,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.00353,0.31694,0.27217,1,1
5,GO ACTIN FILAMENT NETWORK FORMATION,0.04854,0.3169,0.27609,1,1
5,GO REGULATION OF AMYLOID BETA FORMATION,8.7323e-05,0.31668,0.35667,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,7.3528e-06,0.31656,0.31106,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,5.8301e-05,0.31653,0.27101,1,1
5,GO PLATELET DEGRANULATION,0.0007696,0.31645,0.25598,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.0833e-05,0.31625,0.28375,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,9.3916e-06,0.31623,0.25664,1,1
5,GO STRIATED MUSCLE ADAPTATION,0.00034072,0.31611,0.24351,1,1
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00010092,0.31611,0.29579,1,1
5,GO AMYLOID BETA FORMATION,1.5816e-05,0.31609,0.337,1,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00019079,0.31559,0.27312,1,1
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.015203,0.31545,0.3365,1,1
5,GO REGULATION OF T CELL ACTIVATION,9.7801e-06,0.31544,0.24328,1,1
5,GO REGULATION OF CELL KILLING,0.00032948,0.3154,0.25767,1,1
5,GO INTERFERON ALPHA PRODUCTION,1.1493e-05,0.31481,0.32786,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.8418e-05,0.31476,0.26692,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,8.2505e-07,0.31474,0.33009,1,1
5,GO INTERLEUKIN 4 PRODUCTION,2.9532e-05,0.31439,0.29089,1,1
5,GO REGULATION OF WOUND HEALING,0.00074557,0.31428,0.24835,1,1
5,GO ENDOTHELIUM DEVELOPMENT,9.7801e-06,0.31412,0.26749,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0007696,0.31411,0.29519,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,9.0179e-06,0.31405,0.26619,1,1
5,GO REGULATION OF RESPIRATORY BURST,0.00065623,0.31345,0.31743,1,1
5,GO INTERFERON BETA PRODUCTION,9.0551e-05,0.31276,0.25191,1,1
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.001228,0.31261,0.25177,1,1
5,GO MUSCLE CELL MIGRATION,0.00021167,0.31245,0.28585,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.0001165,0.31236,0.2286,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.2862e-06,0.3121,0.29548,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.2962e-05,0.31206,0.26252,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,2.2524e-05,0.31171,0.25455,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00025131,0.31122,0.32714,1,1
5,GO METANEPHROS MORPHOGENESIS,0.0001165,0.31058,0.28647,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.010506,0.31024,0.16747,1,1
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0019282,0.31006,0.36052,1,1
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00027832,0.31005,0.2617,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0006154,0.31001,0.27856,1,1
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,2.8418e-05,0.30983,0.32296,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00028792,0.30955,0.23464,1,1
5,GO RESPONSE TO PROTOZOAN,0.00059588,0.30944,0.27616,1,1
5,GO ALPHA BETA T CELL ACTIVATION,5.0226e-05,0.30899,0.25003,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00095906,0.30882,0.27757,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0011199,0.30864,0.40348,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0025817,0.3079,0.20124,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.6455e-05,0.30783,0.26052,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,1.7118e-05,0.30762,0.27367,1,1
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0014738,0.30746,0.32822,1,1
5,GO LIPID STORAGE,9.389e-05,0.30741,0.2404,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00017186,0.30735,0.32237,1,1
5,GO SKELETAL MUSCLE ADAPTATION,0.00011241,0.30721,0.29189,1,1
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.00050664,0.30721,0.26662,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.0022332,0.30718,0.21766,1,1
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0010859,0.30716,0.27843,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0067808,0.3066,0.22296,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00092958,0.30659,0.19701,1,1
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00090094,0.30645,0.25989,1,1
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00090094,0.30638,0.36884,1,1
5,GO GLIAL CELL DEVELOPMENT,9.3916e-06,0.30637,0.27045,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,5.2139e-05,0.30625,0.22909,1,1
5,GO REGULATION OF CELL CELL ADHESION,3.4728e-06,0.30604,0.26887,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.5759e-05,0.30589,0.32304,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,7.2754e-05,0.30588,0.23361,1,1
5,GO REGULATION OF SYMBIOTIC PROCESS,0.00028792,0.30585,0.235,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,6.2985e-07,0.3056,0.30183,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.2754e-05,0.30545,0.24775,1,1
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00024286,0.30495,0.23721,1,1
5,GO MYOTUBE DIFFERENTIATION,5.9841e-06,0.30438,0.26659,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,1.8251e-06,0.30365,0.25262,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,1.4039e-05,0.30354,0.26223,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.8251e-06,0.30331,0.30241,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00010845,0.30319,0.26171,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.7118e-05,0.30314,0.28602,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0025817,0.30313,0.27755,1,1
5,GO INTERLEUKIN 12 PRODUCTION,1.2962e-05,0.30274,0.28117,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00014935,0.30271,0.27284,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0031536,0.30268,0.23583,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00052342,0.30257,0.19837,1,1
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0075304,0.30253,0.24362,1,1
5,GO SPHINGOID METABOLIC PROCESS,7.6603e-06,0.30251,0.30966,1,1
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00069957,0.30211,0.34376,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.2454e-05,0.30211,0.28007,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0024367,0.30165,0.2399,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00024286,0.30104,0.27665,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,9.7346e-05,0.30103,0.46113,1,1
5,GO ASTROCYTE DIFFERENTIATION,0.00057693,0.30083,0.25339,1,1
5,GO MACROPHAGE DIFFERENTIATION,0.00013917,0.30058,0.22728,1,1
5,GO ADAPTIVE IMMUNE RESPONSE,4.0073e-05,0.30053,0.30262,1,1
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00065623,0.3005,0.28822,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00095906,0.30046,0.20683,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,9.3916e-06,0.30042,0.27129,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0083534,0.30037,0.26492,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.5759e-05,0.30004,0.24334,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00038934,0.3,0.35605,1,1
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0011199,0.29994,0.35414,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,5.753e-07,0.29935,0.30462,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.9263e-05,0.29926,0.26843,1,1
5,GO LUNG MORPHOGENESIS,0.0036303,0.29921,0.21329,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.00011241,0.29919,0.30381,1,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,1.7118e-05,0.29907,0.27046,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.00012964,0.29897,0.23971,1,1
5,GO MALE SEX DETERMINATION,0.014138,0.29888,0.22679,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,6.5149e-05,0.29869,0.28049,1,1
5,GO DETECTION OF CALCIUM ION,0.0075304,0.29858,0.29724,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.2962e-05,0.29848,0.24615,1,1
5,GO RENAL TUBULE DEVELOPMENT,0.00031859,0.29778,0.21901,1,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0031536,0.29767,0.23664,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00020448,0.29757,0.23916,1,1
5,GO RESPONSE TO IRON ION,0.00017796,0.29709,0.24951,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,8.7323e-05,0.29697,0.26007,1,1
5,GO TYPE I INTERFERON PRODUCTION,0.00012964,0.2969,0.2433,1,1
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0051916,0.29661,0.22364,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,3.8583e-05,0.29639,0.2689,1,1
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.0016129,0.29621,0.4199,1,1
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00055855,0.29603,0.21049,1,1
5,GO INTERLEUKIN 5 PRODUCTION,0.011612,0.29598,0.23039,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0007696,0.29591,0.23059,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00084609,0.29582,0.26327,1,1
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00047456,0.29566,0.30095,1,1
5,GO CHEMOKINE PRODUCTION,7.013e-05,0.29549,0.27912,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,7.8282e-05,0.29544,0.23909,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,3.4421e-05,0.29541,0.25822,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,6.5149e-05,0.29537,0.21292,1,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0085714,0.29531,0.27858,1,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.026586,0.29514,0.24891,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020448,0.29498,0.21442,1,1
5,GO PROTEIN TARGETING TO LYSOSOME,0.0017123,0.29493,0.27078,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.7596e-05,0.29483,0.30564,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00050664,0.29439,0.23383,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.00034072,0.29426,0.24479,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,4.2876e-06,0.29414,0.27502,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.007729,0.29407,0.24775,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.001228,0.29397,0.21469,1,1
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00044439,0.29396,0.23041,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0021689,0.29381,0.25894,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0011199,0.29381,0.23857,1,1
5,GO ASTROCYTE ACTIVATION,0.00012964,0.29368,0.33651,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,5.2139e-05,0.29316,0.30463,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00049035,0.29309,0.25184,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,7.8282e-05,0.29292,0.32508,1,1
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0017123,0.2929,0.25698,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.8301e-05,0.29288,0.22586,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,0.0022992,0.2926,0.25293,1,1
5,GO RESPONSE TO AMPHETAMINE,0.0030654,0.29257,0.24773,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.29245,0.18387,1,1
5,GO ICOSANOID METABOLIC PROCESS,0.00013917,0.29238,0.2685,1,1
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0017641,0.29215,0.2934,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,7.3528e-06,0.29178,0.27049,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00040247,0.29173,0.26609,1,1
5,GO REGULATION OF NEURON MATURATION,0.0022332,0.29163,0.27721,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,3.5759e-05,0.29157,0.23904,1,1
5,GO REGULATION OF CELL MATRIX ADHESION,6.7596e-05,0.29156,0.27179,1,1
5,GO DETECTION OF BIOTIC STIMULUS,0.00084609,0.29146,0.32463,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,1.5201e-05,0.29136,0.2476,1,1
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.018836,0.29124,0.19045,1,1
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0014299,0.29118,0.24766,1,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.0011199,0.29106,0.25608,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,8.1192e-05,0.29104,0.36029,1,1
5,GO LEUKOCYTE MIGRATION,1.7118e-05,0.29077,0.24479,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.00065623,0.29069,0.28088,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,6.0504e-05,0.29057,0.24811,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00011241,0.29025,0.24088,1,1
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0075304,0.29018,0.28479,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.5308e-05,0.29011,0.25191,1,1
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0029794,0.2899,0.24147,1,1
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00023468,0.2895,0.30091,1,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,5.8301e-05,0.28946,0.28676,1,1
5,GO TISSUE REGENERATION,0.0050528,0.28932,0.20576,1,1
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0010206,0.28931,0.38194,1,1
5,GO REGULATION OF ACROSOME REACTION,0.0019282,0.2893,0.2596,1,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.0833e-05,0.2891,0.26182,1,1
5,GO NEURON CELL CELL ADHESION,0.018836,0.28893,0.37372,1,1
5,GO PARAXIAL MESODERM DEVELOPMENT,0.0027346,0.28883,0.28268,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00063551,0.28874,0.33731,1,1
5,GO GLYCOSYLATION,1.6015e-06,0.28817,0.26351,1,1
5,GO BEHAVIORAL RESPONSE TO PAIN,0.0060989,0.28794,0.28792,1,1
5,GO HEART TRABECULA FORMATION,0.0036303,0.28756,0.28626,1,1
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.014841,0.28755,0.22097,1,1
5,GO T CELL ACTIVATION,2.8418e-05,0.28749,0.22834,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00019079,0.28746,0.24327,1,1
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0031536,0.28744,0.22848,1,1
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0001547,0.28741,0.28292,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,7.2754e-05,0.2874,0.27917,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0017641,0.28734,0.23228,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00065623,0.28678,0.21144,1,1
5,GO PLATELET ACTIVATION,0.00018427,0.28675,0.20993,1,1
5,GO STEROID METABOLIC PROCESS,2.5308e-05,0.28671,0.22419,1,1
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0049174,0.28669,0.18161,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00050664,0.28666,0.28334,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0067808,0.2866,0.291,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00019079,0.28645,0.21487,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,5.9841e-06,0.28642,0.26079,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,5.753e-07,0.28622,0.28512,1,1
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0028141,0.28618,0.59781,1,1
5,GO PROTEIN DEGLYCOSYLATION,0.0010528,0.28611,0.24247,1,1
5,GO PLASMA MEMBRANE FUSION,0.00074557,0.28596,0.26398,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00018427,0.28584,0.2737,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,7.013e-05,0.28578,0.31386,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.389e-05,0.2856,0.28242,1,1
5,GO VIRAL LIFE CYCLE,0.00045924,0.28548,0.20097,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0049174,0.28528,0.23261,1,1
5,GO RESPONSE TO ACIDIC PH,0.00084609,0.28467,0.27708,1,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.044685,0.28456,0.15818,1,1
5,GO TOOTH MINERALIZATION,0.0040578,0.28423,0.25656,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,1.8251e-06,0.28414,0.2642,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.0689e-05,0.28397,0.23313,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0087944,0.28396,0.22588,1,1
5,GO EPITHELIAL CELL PROLIFERATION,8.1192e-05,0.28389,0.22681,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00044439,0.28357,0.1903,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,0.00055855,0.28339,0.23213,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.00019753,0.28318,0.21098,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,2.9301e-06,0.28316,0.24636,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,6.7728e-06,0.28291,0.26223,1,1
5,GO POSITIVE REGULATION OF OSSIFICATION,0.00030804,0.28287,0.29956,1,1
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.013465,0.28287,0.21983,1,1
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00020448,0.28242,0.2199,1,1
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00030804,0.28227,0.24732,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,1.5816e-05,0.28224,0.22995,1,1
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00067758,0.28204,0.20081,1,1
5,GO FAT CELL DIFFERENTIATION,5.9841e-06,0.28199,0.25933,1,1
5,GO REGULATION OF CELL ADHESION,4.1617e-05,0.28193,0.23188,1,1
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.8521e-05,0.28153,0.25507,1,1
5,GO REGULATION OF CELL ACTIVATION,2.0833e-05,0.28133,0.214,1,1
5,GO B CELL ACTIVATION,2.6307e-05,0.28122,0.2206,1,1
5,GO DIOL METABOLIC PROCESS,5.508e-06,0.28118,0.30561,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00019753,0.28116,0.25282,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.019739,0.28065,0.21359,1,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0019282,0.2805,0.20078,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,4.1617e-05,0.28048,0.24643,1,1
5,GO RESPONSE TO GROWTH HORMONE,0.00017796,0.28047,0.27006,1,1
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.00063551,0.2803,0.22514,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00090094,0.28025,0.25912,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012074,0.28021,0.2187,1,1
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0013457,0.28004,0.25268,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.8251e-06,0.28,0.25431,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.7806e-05,0.27982,0.34968,1,1
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0059384,0.27961,0.24165,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00031859,0.27959,0.20858,1,1
5,GO B CELL HOMEOSTASIS,0.00044439,0.27951,0.26466,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,8.3127e-06,0.27891,0.25571,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.025994,0.27888,0.20356,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.0030654,0.27882,0.23348,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,3.3132e-05,0.27878,0.2572,1,1
5,GO GLIAL CELL DIFFERENTIATION,4.6597e-05,0.27872,0.22012,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,2.2658e-06,0.27849,0.27258,1,1
5,GO STEROL HOMEOSTASIS,3.7145e-05,0.27832,0.237,1,1
5,GO FUCOSYLATION,2.7343e-05,0.27821,0.27374,1,1
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00013433,0.27816,0.24774,1,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0073363,0.27789,0.2483,1,1
5,GO INTERLEUKIN 1 PRODUCTION,0.00079435,0.27785,0.23437,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.6307e-05,0.27784,0.24841,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,2.2658e-06,0.27782,0.24244,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00016595,0.27741,0.20514,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0024367,0.2774,0.26578,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.9263e-05,0.27696,0.2569,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.2454e-05,0.27683,0.24178,1,1
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,6.0504e-05,0.27677,0.25232,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0085714,0.27677,0.21297,1,1
5,GO DEFENSE RESPONSE,2.2524e-05,0.27676,0.22489,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0017123,0.27673,0.2222,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0018173,0.27668,0.2818,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.00017186,0.27668,0.21562,1,1
5,GO CAMP METABOLIC PROCESS,0.0026572,0.27652,0.19789,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00090094,0.27647,0.22431,1,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.0066042,0.27646,0.26205,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00040247,0.27634,0.27875,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00045924,0.27601,0.24327,1,1
5,GO STEROL METABOLIC PROCESS,8.4205e-05,0.27594,0.21867,1,1
5,GO INTERACTION WITH HOST,0.00049035,0.27573,0.19586,1,1
5,GO CERAMIDE METABOLIC PROCESS,2.9301e-06,0.27549,0.24481,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00037661,0.27548,0.23411,1,1
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0040578,0.27527,0.28506,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00034072,0.2749,0.25813,1,1
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0021062,0.27488,0.25662,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.00010092,0.27488,0.27971,1,1
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00050664,0.27475,0.30078,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00021909,0.27462,0.24873,1,1
5,GO DEVELOPMENTAL INDUCTION,1.4039e-05,0.2744,0.27523,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00014935,0.2744,0.22903,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.015203,0.27434,0.16558,1,1
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0053338,0.27414,0.18438,1,1
5,GO MEMBRANE REPOLARIZATION,0.00063551,0.2738,0.2449,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0013457,0.27348,0.22603,1,1
5,GO SECONDARY PALATE DEVELOPMENT,0.00010092,0.27344,0.3003,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,3.8583e-05,0.27337,0.25807,1,1
5,GO CELL CHEMOTAXIS,1.4609e-05,0.27325,0.25438,1,1
5,GO REGULATION OF AMINO ACID TRANSPORT,0.00044439,0.27318,0.27764,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.00032948,0.27312,0.20241,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,5.4121e-05,0.27282,0.29657,1,1
5,GO KERATINOCYTE PROLIFERATION,0.02268,0.27233,0.17122,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0073363,0.27227,0.21969,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00057693,0.27221,0.21995,1,1
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.00049035,0.27202,0.23644,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,2.9532e-05,0.27163,0.21337,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,1.1964e-05,0.2713,0.22172,1,1
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0038387,0.27107,0.27611,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.7806e-05,0.27102,0.25362,1,1
5,GO CYTOKINE PRODUCTION,5.8301e-05,0.27086,0.22334,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.040234,0.27073,0.20072,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,0.025994,0.27073,0.21528,1,1
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0025083,0.27061,0.20793,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1.8521e-05,0.27042,0.24416,1,1
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0016129,0.27041,0.23123,1,1
5,GO DNA DEMETHYLATION,0.00013433,0.27039,0.25812,1,1
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.00067758,0.27033,0.2243,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,4.4878e-05,0.2703,0.2111,1,1
5,GO CYTOKINE SECRETION,6.5149e-05,0.27029,0.22671,1,1
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.00030804,0.27027,0.21262,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0032441,0.27026,0.22207,1,1
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.05161,0.27026,0.26094,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,0.2701,0.234,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0081404,0.26997,0.37179,1,1
5,GO HAIR CELL DIFFERENTIATION,6.2786e-05,0.26977,0.25201,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.009256,0.26961,0.18983,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00087311,0.26943,0.18786,1,1
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00012964,0.2694,0.21399,1,1
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.015203,0.26937,0.20361,1,1
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.014486,0.26932,0.31546,1,1
5,GO AMINO SUGAR CATABOLIC PROCESS,0.0038387,0.26928,0.21731,1,1
5,GO CELL KILLING,8.4205e-05,0.26923,0.22218,1,1
5,GO METANEPHROS DEVELOPMENT,0.00059588,0.26921,0.20432,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.00024286,0.26921,0.21417,1,1
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.029068,0.26912,0.21286,1,1
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0017123,0.26908,0.29308,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0026572,0.26887,0.29564,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,0.0021689,0.26851,0.20704,1,1
5,GO CELL ACTIVATION,8.4205e-05,0.26831,0.1977,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010845,0.26829,0.19694,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0069616,0.26821,0.31804,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.0013872,0.26815,0.24972,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,0.0019282,0.26772,0.23235,1,1
5,GO LEUKOCYTE CHEMOTAXIS,4.6597e-05,0.26764,0.22406,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00016023,0.26749,0.29174,1,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0075304,0.26749,0.16876,1,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00084609,0.26744,0.2195,1,1
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,6.5149e-05,0.26735,0.22517,1,1
5,GO WATER HOMEOSTASIS,2.0033e-05,0.26729,0.27494,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0099891,0.26708,0.26454,1,1
5,GO AXIS ELONGATION,0.017969,0.26665,0.16978,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,5.4121e-05,0.26637,0.25987,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.02843,0.26632,0.21634,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,8.7323e-05,0.26631,0.21393,1,1
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00065623,0.26628,0.20797,1,1
5,GO RESPONSE TO CYTOKINE,8.1192e-05,0.26609,0.20586,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,0.0049174,0.26608,0.22942,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,4.4878e-05,0.26594,0.21819,1,1
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00074557,0.26576,0.20611,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0053338,0.26567,0.27867,1,1
5,GO FATTY ACID HOMEOSTASIS,0.013139,0.26557,0.26618,1,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1.7118e-05,0.2654,0.25686,1,1
5,GO SODIUM ION TRANSPORT,1.5816e-05,0.26528,0.21911,1,1
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.7145e-05,0.26525,0.24536,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.9418e-06,0.26518,0.23515,1,1
5,GO RESPONSE TO PEPTIDOGLYCAN,0.00098941,0.26515,0.20682,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00081984,0.26497,0.18886,1,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0057817,0.26458,0.21777,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00087311,0.26456,0.31396,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,9.0221e-07,0.26455,0.25646,1,1
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0033369,0.26451,0.14642,1,1
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0067808,0.26437,0.1924,1,1
5,GO RESPONSE TO TUMOR CELL,0.0013457,0.26424,0.27992,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.6597e-05,0.26408,0.262,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.00013917,0.26399,0.22032,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.050569,0.26399,0.13728,1,1
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00024286,0.26387,0.25936,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0037331,0.26378,0.21494,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0025083,0.26373,0.22807,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.007729,0.26332,0.29663,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0021689,0.26307,0.21106,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,3.0689e-05,0.26298,0.19668,1,1
5,GO ENDOTHELIAL CELL PROLIFERATION,0.00026903,0.26298,0.22439,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.025994,0.26288,0.20492,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,2.6307e-05,0.26288,0.23368,1,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00054072,0.26284,0.27611,1,1
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.029719,0.26252,0.2041,1,1
5,GO MULTICELLULAR ORGANISM AGING,3.3132e-05,0.26244,0.22318,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00012964,0.26228,0.22688,1,1
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0007696,0.26209,0.32007,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,8.7323e-05,0.26193,0.216,1,1
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.025414,0.26191,0.29179,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0024367,0.26176,0.26777,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0042883,0.26133,0.17633,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.4994e-06,0.26096,0.2362,1,1
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.0026572,0.26094,0.24105,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,1.0779e-06,0.26066,0.25918,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.019283,0.2605,0.17931,1,1
5,GO ETHER METABOLIC PROCESS,0.017549,0.26002,0.17596,1,1
5,GO PLACENTA DEVELOPMENT,0.00047456,0.25997,0.20704,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.035393,0.25991,0.25317,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0081404,0.2597,0.1892,1,1
5,GO SERTOLI CELL DEVELOPMENT,0.0034322,0.25938,0.33394,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0075304,0.25933,0.34888,1,1
5,GO CYTOKINE METABOLIC PROCESS,0.00084609,0.2593,0.24817,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0039469,0.25925,0.33587,1,1
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.041093,0.25903,0.17302,1,1
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0015653,0.25897,0.26486,1,1
5,GO MANNOSYLATION,0.0010859,0.25887,0.19394,1,1
5,GO INFLAMMATORY RESPONSE,2.7343e-05,0.25875,0.22726,1,1
5,GO CELL CELL ADHESION,1.349e-05,0.25853,0.21376,1,1
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00036427,0.25844,0.20916,1,1
5,GO ENAMEL MINERALIZATION,0.011326,0.25844,0.24156,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,4.0073e-05,0.2584,0.22327,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0015189,0.25819,0.21431,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.104e-05,0.25816,0.26577,1,1
5,GO INTERLEUKIN 6 PRODUCTION,3.1888e-05,0.25816,0.21178,1,1
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,9.3916e-06,0.25803,0.29708,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0053338,0.25784,0.25637,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0013872,0.25765,0.2739,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010845,0.25751,0.23042,1,1
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00017186,0.25748,0.26213,1,1
5,GO GRANULOCYTE DIFFERENTIATION,0.0011199,0.25741,0.20597,1,1
5,GO RESPONSE TO CORTICOSTERONE,0.0094949,0.25739,0.2324,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.7118e-05,0.25716,0.26641,1,1
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0040578,0.25705,0.3461,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,3.8583e-05,0.25697,0.22853,1,1
5,GO MUSCLE ATROPHY,0.027188,0.25671,0.17251,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0060989,0.25654,0.15681,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,8.3127e-06,0.25647,0.28115,1,1
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00069957,0.25645,0.21935,1,1
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.0041716,0.25634,0.20454,1,1
5,GO PROGRAMMED NECROTIC CELL DEATH,0.00054072,0.25613,0.26943,1,1
5,GO ALANINE TRANSPORT,0.004408,0.25609,0.18741,1,1
5,GO RESPONSE TO WOUNDING,0.00098941,0.25603,0.1894,1,1
5,GO STEROL TRANSPORT,0.00072223,0.25591,0.18699,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00036427,0.25579,0.23877,1,1
5,GO GLIOGENESIS,0.00010845,0.2556,0.19764,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,5.2139e-05,0.25556,0.22451,1,1
5,GO CELL MATRIX ADHESION,0.00024286,0.25516,0.20833,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,0.00012074,0.25513,0.19354,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.0018173,0.25489,0.17134,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.2786e-05,0.25476,0.20429,1,1
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.030383,0.25473,0.20825,1,1
5,GO OXALATE TRANSPORT,0.0057817,0.25468,0.17459,1,1
5,GO MESONEPHROS DEVELOPMENT,2.6307e-05,0.25424,0.25632,1,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0006154,0.25421,0.21221,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00098941,0.25416,0.24294,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.1964e-05,0.2541,0.22507,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,8.4205e-05,0.25396,0.22888,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,3.1904e-06,0.25386,0.25658,1,1
5,GO NECROTIC CELL DEATH,0.00044439,0.25362,0.26554,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,8.3127e-06,0.25318,0.24395,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0071468,0.25286,0.32074,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,3.3132e-05,0.25283,0.23313,1,1
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.011612,0.25282,0.21277,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0037331,0.25262,0.20095,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00050664,0.2523,0.26375,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.4712e-06,0.25219,0.21789,1,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,8.1192e-05,0.25193,0.32819,1,1
5,GO LYMPHOCYTE ACTIVATION,2.8418e-05,0.25177,0.19625,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00017186,0.25157,0.30949,1,1
5,GO MYOTUBE CELL DEVELOPMENT,0.0064317,0.25149,0.18614,1,1
5,GO REGULATION OF SYNAPSE MATURATION,0.04854,0.25136,0.2052,1,1
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0010206,0.25122,0.28703,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,9.7346e-05,0.25115,0.20521,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.0011199,0.25109,0.24353,1,1
5,GO RENAL SYSTEM PROCESS,9.0551e-05,0.25089,0.20471,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.7323e-05,0.25064,0.27208,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,6.5149e-05,0.25064,0.19065,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.00047456,0.25063,0.23862,1,1
5,GO ENDOCRINE HORMONE SECRETION,1.9263e-05,0.25061,0.28364,1,1
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.0022332,0.25049,0.21308,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,9.0551e-05,0.25036,0.25676,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.029068,0.2502,0.19594,1,1
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.024846,0.25003,0.26015,1,1
5,GO NOTCH SIGNALING PATHWAY,5.508e-06,0.24999,0.24072,1,1
5,GO AMELOGENESIS,0.0022332,0.24986,0.26158,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00063551,0.24976,0.18713,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.00013433,0.24974,0.19615,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0031536,0.24957,0.23204,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00042998,0.24942,0.21407,1,1
5,GO T CELL MIGRATION,0.0020453,0.24939,0.19028,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,7.013e-05,0.24923,0.22281,1,1
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0047853,0.24898,0.32363,1,1
5,GO SODIUM ION HOMEOSTASIS,5.0226e-05,0.24895,0.23885,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.0551e-05,0.24889,0.19965,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.010245,0.24882,0.21097,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.0051916,0.24881,0.24594,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.9532e-05,0.2488,0.18753,1,1
5,GO LYMPHOCYTE MIGRATION,0.00012964,0.24834,0.21109,1,1
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0015189,0.24825,0.27028,1,1
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.027803,0.24817,0.18652,1,1
5,GO DIOL BIOSYNTHETIC PROCESS,1.9263e-05,0.2481,0.27041,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,7.2754e-05,0.24807,0.20655,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0022332,0.24797,0.30804,1,1
5,GO TUBE MORPHOGENESIS,0.00031859,0.24777,0.16746,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00017796,0.24776,0.20434,1,1
5,GO POSITIVE CHEMOTAXIS,0.00042998,0.24776,0.23854,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0023671,0.24773,0.17282,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,7.2754e-05,0.24758,0.24734,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,7.013e-05,0.24745,0.23106,1,1
5,GO KIDNEY MORPHOGENESIS,0.00063551,0.24733,0.20581,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.00022676,0.2473,0.23293,1,1
5,GO RESPONSE TO NUTRIENT,0.00040247,0.24723,0.18971,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0075304,0.24722,0.16928,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,9.7346e-05,0.24718,0.19601,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,4.1112e-06,0.24718,0.24651,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,5.2139e-05,0.24714,0.27348,1,1
5,GO FIBROBLAST PROLIFERATION,0.0020453,0.247,0.24732,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,7.547e-05,0.24672,0.28467,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00092958,0.24625,0.21394,1,1
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0047853,0.24619,0.23273,1,1
5,GO REGULATION OF ODONTOGENESIS,0.015203,0.24592,0.28673,1,1
5,GO RESPONSE TO INSECTICIDE,0.0028141,0.24585,0.30196,1,1
5,GO LYTIC VACUOLE ORGANIZATION,2.1663e-05,0.24546,0.20777,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.8301e-05,0.24542,0.20275,1,1
5,GO ANION HOMEOSTASIS,0.0018173,0.24538,0.1796,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,3.7145e-05,0.24533,0.23169,1,1
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.001872,0.24532,0.18182,1,1
5,GO PLATELET AGGREGATION,0.00050664,0.2451,0.23644,1,1
5,GO GRANULOCYTE MIGRATION,0.00029782,0.24483,0.19702,1,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0020453,0.24479,0.24723,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00013917,0.24478,0.23437,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.012508,0.2444,0.18405,1,1
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.045624,0.24437,0.18843,1,1
5,GO LYMPHOCYTE CHEMOTAXIS,0.00063551,0.24429,0.19858,1,1
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.027188,0.24419,0.14344,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0071468,0.24385,0.15988,1,1
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00353,0.24376,0.22666,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00010092,0.2436,0.1969,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,7.2754e-05,0.24352,0.19327,1,1
5,GO LIPID LOCALIZATION,2.0033e-05,0.24345,0.19893,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.001228,0.24316,0.17416,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.00047456,0.24303,0.2163,1,1
5,GO PROTEIN N LINKED GLYCOSYLATION,4.6597e-05,0.24295,0.23119,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00013917,0.24292,0.18976,1,1
5,GO BLOOD VESSEL MORPHOGENESIS,0.0013872,0.24273,0.16138,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0017123,0.24265,0.26707,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,0.00057693,0.24254,0.22941,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00012964,0.24252,0.22165,1,1
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00081984,0.24241,0.18143,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,6.0504e-05,0.24208,0.18259,1,1
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.046579,0.24199,0.26953,1,1
5,GO CELLULAR KETONE METABOLIC PROCESS,0.001986,0.24194,0.14264,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.00050664,0.24181,0.18473,1,1
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.01282,0.24175,0.15811,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.00069957,0.24172,0.21377,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.0036303,0.24156,0.2428,1,1
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0001547,0.24152,0.21217,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00014935,0.24086,0.2361,1,1
5,GO PHOSPHOLIPID HOMEOSTASIS,0.0087944,0.24073,0.18685,1,1
5,GO MACROPHAGE CHEMOTAXIS,0.0013872,0.2406,0.2569,1,1
5,GO EATING BEHAVIOR,2.7343e-05,0.24059,0.23948,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.00038934,0.24049,0.20825,1,1
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0011549,0.24046,0.18275,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.1617e-05,0.24038,0.20832,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.010245,0.24021,0.14477,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00032948,0.24011,0.18269,1,1
5,GO CARNITINE METABOLIC PROCESS,0.03245,0.2401,0.17851,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0016129,0.24008,0.25869,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00052342,0.23992,0.18834,1,1
5,GO PROTEIN PROCESSING,0.00019079,0.23977,0.19036,1,1
5,GO B CELL DIFFERENTIATION,1.1493e-05,0.23959,0.19584,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00072223,0.23951,0.18885,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00014418,0.23943,0.22335,1,1
5,GO NEURONAL ACTION POTENTIAL,0.011047,0.23913,0.29516,1,1
5,GO PROTEIN KINASE B SIGNALING,0.00019753,0.23904,0.18067,1,1
5,GO REGULATION OF GONAD DEVELOPMENT,0.047551,0.23897,0.14858,1,1
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.00013433,0.23892,0.28844,1,1
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0011199,0.23889,0.17922,1,1
5,GO INACTIVATION OF MAPK ACTIVITY,0.001872,0.23882,0.27265,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.014138,0.23881,0.16715,1,1
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.011326,0.23875,0.2016,1,1
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.00084609,0.23872,0.18086,1,1
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0010528,0.23864,0.22194,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00049035,0.23846,0.16781,1,1
5,GO EPIDERMIS DEVELOPMENT,8.7323e-05,0.23846,0.20661,1,1
5,GO REGULATION OF FATTY ACID TRANSPORT,3.1888e-05,0.23846,0.28429,1,1
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0066042,0.23845,0.19732,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.001228,0.23834,0.22588,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.001986,0.23834,0.17954,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00044439,0.23828,0.18166,1,1
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0079323,0.23789,0.19459,1,1
5,GO BIOLOGICAL ADHESION,9.7346e-05,0.23774,0.19145,1,1
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.0071468,0.23764,0.19781,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0079323,0.23734,0.14263,1,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00072223,0.2373,0.26223,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,8.1192e-05,0.23724,0.21101,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00095906,0.23722,0.18711,1,1
5,GO MYELOID CELL APOPTOTIC PROCESS,0.0040578,0.23675,0.20089,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00079435,0.23657,0.19176,1,1
5,GO NOTCH RECEPTOR PROCESSING,0.0022332,0.23653,0.35146,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.00036427,0.23625,0.22363,1,1
5,GO ERBB SIGNALING PATHWAY,0.0006154,0.23621,0.17896,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,1.1493e-05,0.23616,0.22183,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.1888e-05,0.23599,0.18178,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0011549,0.23592,0.19725,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00010092,0.23586,0.19012,1,1
5,GO WOUND HEALING,0.0013872,0.23575,0.17687,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.038561,0.23565,0.2124,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.00012964,0.2356,0.20915,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00057693,0.23559,0.24406,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.014841,0.23472,0.18599,1,1
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00028792,0.23466,0.20234,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0011549,0.23462,0.24585,1,1
5,GO REGULATION OF RESPONSE TO FOOD,0.0014299,0.23456,0.19795,1,1
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0083534,0.23431,0.19364,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0033369,0.23429,0.24113,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0030654,0.23426,0.19474,1,1
5,GO BILE ACID METABOLIC PROCESS,0.0012662,0.23398,0.18887,1,1
5,GO MUSCLE ADAPTATION,0.00090094,0.2338,0.18155,1,1
5,GO STARTLE RESPONSE,0.0071468,0.2337,0.24128,1,1
5,GO MYELOID CELL HOMEOSTASIS,0.00026903,0.23351,0.16915,1,1
5,GO TISSUE HOMEOSTASIS,0.00010092,0.23309,0.16754,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0013457,0.23308,0.21591,1,1
5,GO REGULATION OF GLIOGENESIS,8.1192e-05,0.23304,0.20328,1,1
5,GO NEPHRON MORPHOGENESIS,0.00065623,0.23303,0.19333,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.0833e-05,0.23301,0.24675,1,1
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00050664,0.23297,0.18456,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.6174e-05,0.23292,0.19267,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0017123,0.23292,0.16845,1,1
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0057817,0.23288,0.25042,1,1
5,GO NEUROINFLAMMATORY RESPONSE,0.00092958,0.2328,0.19961,1,1
5,GO REGULATION OF ICOSANOID SECRETION,0.00019753,0.23264,0.25666,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00035231,0.23255,0.20325,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00042998,0.23247,0.20016,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,3.3132e-05,0.23233,0.16919,1,1
5,GO ENDOTHELIAL CELL MIGRATION,0.00055855,0.23209,0.21266,1,1
5,GO CELLULAR RESPONSE TO VITAMIN,0.024288,0.23206,0.22529,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0017641,0.23168,0.22689,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00059588,0.23131,0.17741,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.0056288,0.23129,0.17306,1,1
5,GO REGULATION OF DENDRITE EXTENSION,0.0071468,0.23128,0.32867,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00032948,0.23113,0.2029,1,1
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0014299,0.23102,0.2637,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.02268,0.23099,0.13879,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0062634,0.23095,0.2132,1,1
5,GO TISSUE MIGRATION,0.0014738,0.23088,0.19047,1,1
5,GO PEPTIDYL TYROSINE MODIFICATION,9.0551e-05,0.23088,0.20547,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,7.6603e-06,0.23087,0.22034,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,9.389e-05,0.23083,0.17312,1,1
5,GO MOLTING CYCLE,0.001191,0.23081,0.15337,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.00040247,0.23079,0.20003,1,1
5,GO ORGANELLE MEMBRANE FUSION,0.00098941,0.23061,0.16795,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.00010462,0.2306,0.18729,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013139,0.23053,0.18869,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.012203,0.23047,0.19998,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0038387,0.23033,0.22408,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.02843,0.23032,0.21732,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00022676,0.23002,0.1808,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.045624,0.22999,0.27248,1,1
5,GO PHOSPHOLIPID TRANSPORT,7.9801e-06,0.22998,0.21818,1,1
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.014841,0.22997,0.20475,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.00012074,0.22966,0.22175,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.4878e-05,0.22964,0.22226,1,1
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0079323,0.22961,0.17996,1,1
5,GO EPIDERMIS MORPHOGENESIS,0.016734,0.22939,0.15204,1,1
5,GO CORNIFICATION,0.0034322,0.22937,0.21935,1,1
5,GO INTEGRIN ACTIVATION,0.00034072,0.22889,0.24674,1,1
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.019283,0.22888,0.18207,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0017641,0.22863,0.21649,1,1
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00026003,0.22857,0.22389,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,4.4878e-05,0.22854,0.2285,1,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0069616,0.22844,0.16508,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,2.1663e-05,0.22814,0.18733,1,1
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00092958,0.22799,0.18151,1,1
5,GO CARDIAC CONDUCTION,0.00042998,0.22773,0.22628,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00014418,0.22716,0.19629,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,3.4421e-05,0.22714,0.21448,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00014418,0.22655,0.22928,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0066042,0.22654,0.19271,1,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0075304,0.22648,0.17025,1,1
5,GO INTESTINAL LIPID ABSORPTION,0.01282,0.22645,0.2393,1,1
5,GO POTASSIUM ION HOMEOSTASIS,0.00013433,0.22641,0.22913,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00021167,0.22638,0.18966,1,1
5,GO TUBE DEVELOPMENT,0.00017796,0.22613,0.1668,1,1
5,GO RESPONSE TO FATTY ACID,0.0022332,0.22591,0.17574,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0019282,0.2259,0.18388,1,1
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.035393,0.22588,0.26108,1,1
5,GO POSITIVE REGULATION OF HEART RATE,0.0025817,0.22577,0.28099,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,3.4421e-05,0.2256,0.23189,1,1
5,GO REGULATION OF RECEPTOR BINDING,0.021165,0.22553,0.18052,1,1
5,GO THYMIC T CELL SELECTION,8.4205e-05,0.22552,0.20014,1,1
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0039469,0.22544,0.2314,1,1
5,GO FIBROBLAST MIGRATION,0.001986,0.22541,0.18233,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00021167,0.2254,0.25264,1,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.00019079,0.22532,0.18607,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0059384,0.22531,0.16724,1,1
5,GO EXOCYTOSIS,4.6597e-05,0.22509,0.18928,1,1
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0046564,0.22506,0.19282,1,1
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001662,0.22506,0.21937,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.035393,0.22489,0.13633,1,1
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0094949,0.2248,0.21461,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00021909,0.22475,0.16321,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.0023671,0.22454,0.20648,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.001986,0.22452,0.17827,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00026003,0.22442,0.17247,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0026572,0.22437,0.19907,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.025414,0.22357,0.18567,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00059588,0.22357,0.21941,1,1
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0016129,0.22344,0.22943,1,1
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0025083,0.22336,0.18512,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.013465,0.22301,0.17838,1,1
5,GO CARDIAC CELL DEVELOPMENT,0.00092958,0.22297,0.16961,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.00025131,0.22288,0.17941,1,1
5,GO ENDOCRINE PROCESS,0.0030654,0.22283,0.17814,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,2.9532e-05,0.22279,0.20225,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.02166,0.22279,0.18062,1,1
5,GO RESPONSE TO CAFFEINE,0.012508,0.2227,0.18662,1,1
5,GO VASCULATURE DEVELOPMENT,0.0023671,0.22267,0.14029,1,1
5,GO MACROPHAGE MIGRATION,0.001662,0.22256,0.19915,1,1
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0031536,0.22246,0.19405,1,1
5,GO IMMUNOGLOBULIN PRODUCTION,0.00092958,0.22244,0.14576,1,1
5,GO MUSCLE HYPERTROPHY,0.00065623,0.22226,0.18729,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.00019079,0.22214,0.19435,1,1
5,GO QUINONE METABOLIC PROCESS,0.010773,0.22204,0.19392,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.012203,0.22203,0.33055,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00045924,0.22194,0.21893,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00018427,0.22192,0.21122,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0042883,0.22183,0.1725,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00057693,0.22173,0.21307,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00026003,0.22163,0.25328,1,1
5,GO OLIGOPEPTIDE TRANSPORT,0.013139,0.22159,0.16366,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00012512,0.22156,0.19679,1,1
5,GO BIOMINERALIZATION,0.00017796,0.22147,0.20712,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00022676,0.22142,0.15979,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0066042,0.22139,0.17131,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0022992,0.22138,0.22543,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,6.2786e-05,0.22136,0.16759,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.031748,0.22132,0.19539,1,1
5,GO GLAND DEVELOPMENT,1.2962e-05,0.22126,0.19499,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.0069616,0.22123,0.18551,1,1
5,GO REGULATION OF OSSIFICATION,0.00014418,0.221,0.24464,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.0025083,0.22094,0.15819,1,1
5,GO DIENCEPHALON DEVELOPMENT,0.00016595,0.22093,0.2565,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.0011199,0.22081,0.20478,1,1
5,GO PHAGOCYTOSIS,0.0021689,0.22079,0.15853,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,1.0184e-05,0.22056,0.18513,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00045924,0.22031,0.25562,1,1
5,GO REGULATION OF EXIT FROM MITOSIS,0.0029794,0.2203,0.14968,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00069957,0.2203,0.16945,1,1
5,GO COAGULATION,0.0025083,0.22018,0.15387,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0013872,0.22014,0.16037,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0045306,0.21972,0.15904,1,1
5,GO REGULATION OF FERTILIZATION,0.0027346,0.2197,0.18118,1,1
5,GO MONONUCLEAR CELL MIGRATION,0.0013872,0.21948,0.19461,1,1
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00038934,0.21946,0.20941,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00031859,0.21928,0.19614,1,1
5,GO MEMBRANE FISSION,0.0040578,0.21917,0.24001,1,1
5,GO BONE MINERALIZATION,0.00069957,0.21916,0.20974,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.7806e-05,0.21908,0.19125,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0022992,0.21903,0.23284,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.015953,0.21892,0.22127,1,1
5,GO ANIMAL ORGAN REGENERATION,0.0053338,0.21886,0.1516,1,1
5,GO TRANSFERRIN TRANSPORT,0.00090094,0.21873,0.15915,1,1
5,GO ENDOCYTIC RECYCLING,0.00026003,0.21858,0.1801,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0027346,0.21849,0.22155,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00010092,0.21835,0.21242,1,1
5,GO LEUKOCYTE DIFFERENTIATION,1.6455e-05,0.218,0.188,1,1
5,GO NEURON MATURATION,0.00030804,0.21797,0.2472,1,1
5,GO ACTIVATED T CELL PROLIFERATION,4.0073e-05,0.21778,0.21823,1,1
5,GO GPI ANCHOR METABOLIC PROCESS,3.4421e-05,0.21761,0.21272,1,1
5,GO REGULATION OF HEMOPOIESIS,4.8379e-05,0.21759,0.17383,1,1
5,GO SKIN DEVELOPMENT,0.00014418,0.21755,0.20791,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,4.3218e-05,0.21739,0.19649,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00012074,0.21738,0.15305,1,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.012508,0.21721,0.19556,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,6.0504e-05,0.21716,0.18922,1,1
5,GO LACTATE METABOLIC PROCESS,0.0099891,0.21685,0.21939,1,1
5,GO DETERMINATION OF ADULT LIFESPAN,0.0036303,0.21684,0.18719,1,1
5,GO DRUG CATABOLIC PROCESS,0.01282,0.21683,0.14551,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,1.4039e-05,0.21669,0.2033,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.024846,0.21653,0.2495,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.00026903,0.21639,0.18102,1,1
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.011326,0.21621,0.26527,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.001228,0.21606,0.24548,1,1
5,GO NEPHRON DEVELOPMENT,0.00037661,0.21603,0.18753,1,1
5,GO NEPHRIC DUCT DEVELOPMENT,0.049546,0.21596,0.17387,1,1
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.037747,0.21591,0.2024,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0022992,0.21584,0.22523,1,1
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00054072,0.21583,0.26021,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,4.1617e-05,0.21535,0.20379,1,1
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,1.7806e-05,0.21522,0.22748,1,1
5,GO VITAMIN CATABOLIC PROCESS,0.046579,0.21503,0.13811,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00069957,0.21482,0.15339,1,1
5,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0073363,0.21461,0.20034,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0028957,0.21448,0.15369,1,1
5,GO RESPONSE TO AXON INJURY,0.00079435,0.21445,0.21823,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0057817,0.21431,0.1757,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,7.2754e-05,0.21429,0.21451,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0050528,0.21427,0.14783,1,1
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.014841,0.21426,0.15524,1,1
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.0010859,0.21424,0.21185,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00098941,0.21417,0.17099,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.017137,0.21399,0.23364,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,3.1904e-06,0.21396,0.19185,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0047853,0.2139,0.2034,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.036948,0.21384,0.23842,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,2.6902e-06,0.21377,0.20901,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.001662,0.21375,0.15419,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0019282,0.21375,0.2007,1,1
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00054072,0.21364,0.30761,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00084609,0.21357,0.19858,1,1
5,GO BODY MORPHOGENESIS,0.017137,0.21348,0.16506,1,1
5,GO LIPID OXIDATION,0.00084609,0.21337,0.18159,1,1
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0036303,0.21336,0.20654,1,1
5,GO REGULATION OF ANION TRANSPORT,0.00065623,0.21331,0.172,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0034322,0.21327,0.16212,1,1
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.023205,0.21313,0.17265,1,1
5,GO L PHENYLALANINE METABOLIC PROCESS,0.017137,0.21307,0.21034,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.013465,0.21287,0.1903,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040247,0.21275,0.19752,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,6.7728e-06,0.2125,0.20872,1,1
5,GO PROTEIN PALMITOYLATION,9.0551e-05,0.21247,0.23526,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0059384,0.21243,0.2371,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,4.1617e-05,0.2122,0.16709,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0017123,0.21211,0.22857,1,1
5,GO AUTOPHAGY OF NUCLEUS,0.030383,0.21206,0.14064,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.00042998,0.21194,0.16305,1,1
5,GO OSSIFICATION,0.00026003,0.2119,0.20808,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00029782,0.21176,0.24224,1,1
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0057817,0.2117,0.14643,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0042883,0.21165,0.15733,1,1
5,GO MUSCLE CELL DIFFERENTIATION,5.8301e-05,0.2115,0.17478,1,1
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00021909,0.21147,0.24013,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0027346,0.21136,0.21935,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0056288,0.21116,0.16161,1,1
5,GO TERPENOID METABOLIC PROCESS,0.00092958,0.2111,0.17434,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00021909,0.21093,0.17202,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00054072,0.21056,0.187,1,1
5,GO POSITIVE REGULATION OF SECRETION,3.3287e-06,0.21054,0.20523,1,1
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.01282,0.21034,0.17357,1,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0031536,0.21028,0.16243,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00010845,0.21017,0.16718,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0054795,0.21,0.16953,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,2.9532e-05,0.20978,0.21446,1,1
5,GO RESPONSE TO AMINE,0.015203,0.20951,0.14995,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.00074557,0.20946,0.19297,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,7.547e-05,0.20934,0.1837,1,1
5,GO CELL SUBSTRATE ADHESION,0.0022992,0.20929,0.17695,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00017796,0.20924,0.2238,1,1
5,GO CELL MOTILITY,0.00010092,0.20919,0.17215,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00069957,0.20914,0.17431,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,5.2139e-05,0.20902,0.17761,1,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.00030804,0.20894,0.16007,1,1
5,GO RESPONSE TO BACTERIUM,0.00050664,0.2089,0.17164,1,1
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.001228,0.2088,0.16973,1,1
5,GO PROTEIN LOCALIZATION TO AXON,0.046579,0.20875,0.29162,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.00030804,0.20869,0.17955,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0038387,0.20865,0.1857,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.0041716,0.20824,0.2276,1,1
5,GO NUCLEOTIDE TRANSPORT,0.0011199,0.20817,0.16365,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0060989,0.20807,0.15353,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00054072,0.20805,0.17061,1,1
5,GO PROTEIN AUTOPROCESSING,0.010506,0.20787,0.17835,1,1
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0097392,0.20784,0.16084,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.009256,0.20784,0.23433,1,1
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0028957,0.20782,0.19555,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.00054072,0.20765,0.19284,1,1
5,GO LIPID HOMEOSTASIS,6.7596e-05,0.20757,0.17071,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00079435,0.20748,0.17289,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0060989,0.2073,0.1766,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.00037661,0.20701,0.16676,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00042998,0.20697,0.18125,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00045924,0.20681,0.16937,1,1
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0029794,0.20662,0.14603,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,7.547e-05,0.20644,0.19372,1,1
5,GO ISOPRENOID METABOLIC PROCESS,0.00063551,0.2064,0.17553,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.016339,0.20636,0.15517,1,1
5,GO T CELL DIFFERENTIATION,5.4121e-05,0.20616,0.17771,1,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0029794,0.20595,0.20729,1,1
5,GO SPERM CAPACITATION,0.0013457,0.20595,0.18563,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0013457,0.20591,0.19235,1,1
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00074557,0.20582,0.17634,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.022165,0.20581,0.13284,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.0026572,0.2058,0.20501,1,1
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.011904,0.20571,0.16722,1,1
5,GO RESPONSE TO DEXAMETHASONE,0.0032441,0.20558,0.16353,1,1
5,GO POSITIVE REGULATION OF CELL SIZE,0.038561,0.20519,0.12923,1,1
5,GO KETONE BIOSYNTHETIC PROCESS,0.007729,0.20513,0.16526,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00055855,0.20457,0.26168,1,1
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0090226,0.20423,0.17692,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0051916,0.20417,0.19045,1,1
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,6.2786e-05,0.20412,0.26469,1,1
5,GO RESPONSE TO VITAMIN,0.014486,0.20409,0.17019,1,1
5,GO REGULATION OF DEFENSE RESPONSE,6.7596e-05,0.20408,0.18414,1,1
5,GO AMINE TRANSPORT,0.0037331,0.20397,0.24988,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.0012662,0.20389,0.20428,1,1
5,GO REGULATION OF PROTEOLYSIS,0.00045924,0.20386,0.16569,1,1
5,GO ER OVERLOAD RESPONSE,0.013465,0.20358,0.17215,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00017796,0.20351,0.17173,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0064317,0.20343,0.21306,1,1
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.019283,0.20342,0.19602,1,1
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.018836,0.20337,0.17437,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.010506,0.20321,0.15566,1,1
5,GO MEMBRANE FUSION,6.5149e-05,0.20319,0.19412,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.0033e-05,0.20307,0.26521,1,1
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.029719,0.20301,0.15601,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.0016129,0.20279,0.14199,1,1
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.017137,0.20277,0.16736,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0013457,0.20274,0.16239,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,5.508e-06,0.2027,0.18589,1,1
5,GO ORGAN INDUCTION,0.00074557,0.20267,0.20065,1,1
5,GO PSEUDOPODIUM ORGANIZATION,0.014138,0.20266,0.29183,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0036303,0.20265,0.17288,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0016129,0.20255,0.19346,1,1
5,GO REGULATION OF TUBE SIZE,0.00084609,0.20253,0.15475,1,1
5,GO REGULATION OF CHEMOTAXIS,7.2754e-05,0.20245,0.21067,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.00013433,0.20238,0.1561,1,1
5,GO SECRETION BY TISSUE,0.0024367,0.20196,0.20795,1,1
5,GO RESPONSE TO UV C,0.0059384,0.20189,0.14994,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,0.0022992,0.20182,0.24098,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0011199,0.20176,0.17019,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0024367,0.20163,0.2038,1,1
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.042857,0.20157,0.16666,1,1
5,GO TUMOR NECROSIS FACTOR SECRETION,0.001228,0.20135,0.15555,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00067758,0.2013,0.17203,1,1
5,GO EPITHELIUM DEVELOPMENT,4.3218e-05,0.20116,0.17279,1,1
5,GO MAMMARY GLAND DEVELOPMENT,0.00029782,0.20105,0.1766,1,1
5,GO PEPTIDE SECRETION,2.6902e-06,0.20093,0.20171,1,1
5,GO ACUTE PHASE RESPONSE,0.00074557,0.20065,0.18714,1,1
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00034072,0.20064,0.17224,1,1
5,GO REGULATION OF PEPTIDE SECRETION,1.906e-06,0.2004,0.19827,1,1
5,GO AMINE METABOLIC PROCESS,5.4121e-05,0.19991,0.18936,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0028957,0.19991,0.15089,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00017796,0.1997,0.19724,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,0.0021062,0.19969,0.16446,1,1
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0099891,0.19964,0.26219,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.024288,0.19955,0.19428,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0094949,0.19946,0.16788,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0024367,0.19942,0.16789,1,1
5,GO MESENCHYMAL CELL PROLIFERATION,0.018836,0.19936,0.19919,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00014935,0.19927,0.14653,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.011326,0.1991,0.2221,1,1
5,GO RESPONSE TO GONADOTROPIN,0.0079323,0.19897,0.16148,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.0038387,0.19893,0.15786,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,0.0011199,0.19891,0.16688,1,1
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0081404,0.19881,0.25635,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0040578,0.19878,0.1869,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,2.1663e-05,0.19873,0.16491,1,1
5,GO CELLULAR RESPONSE TO VIRUS,0.0029794,0.1987,0.14343,1,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,2.6307e-05,0.19855,0.19761,1,1
5,GO POSITIVE REGULATION OF SIGNALING,1.1964e-05,0.19853,0.15652,1,1
5,GO REGENERATION,0.0045306,0.19852,0.14328,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00041602,0.19843,0.14781,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.01282,0.19842,0.13288,1,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0011199,0.19821,0.23294,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,7.2754e-05,0.19817,0.22013,1,1
5,GO PROTEIN MATURATION,0.00041602,0.19814,0.14452,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0023671,0.19814,0.15424,1,1
5,GO REGULATION OF BLOOD CIRCULATION,6.7596e-05,0.19798,0.1988,1,1
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0016129,0.19796,0.16786,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016339,0.19768,0.21047,1,1
5,GO SUPEROXIDE METABOLIC PROCESS,0.001872,0.19761,0.18541,1,1
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.030383,0.19749,0.20942,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0038387,0.19746,0.19959,1,1
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00090094,0.19737,0.22369,1,1
5,GO UBIQUINONE METABOLIC PROCESS,0.013465,0.19733,0.10426,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00092958,0.19732,0.13972,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00023468,0.19717,0.16007,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.010245,0.197,0.17775,1,1
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00019753,0.19696,0.26875,1,1
5,GO SECRETION,7.6603e-06,0.19689,0.17521,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.02166,0.19686,0.18098,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,9.389e-05,0.19669,0.17901,1,1
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.03939,0.1965,0.13084,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010206,0.19635,0.1622,1,1
5,GO NATURAL KILLER CELL ACTIVATION,0.00072223,0.19634,0.17896,1,1
5,GO ASTROCYTE DEVELOPMENT,0.010506,0.19632,0.22849,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00010462,0.19616,0.16714,1,1
5,GO LIPID METABOLIC PROCESS,2.9532e-05,0.196,0.16162,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.00044439,0.19563,0.21282,1,1
5,GO GLUTAMATE METABOLIC PROCESS,0.00038934,0.19556,0.16969,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0006154,0.19549,0.1674,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0030654,0.19547,0.12653,1,1
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.001872,0.19544,0.22612,1,1
5,GO GLIAL CELL MIGRATION,0.017969,0.19539,0.14177,1,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.010245,0.19529,0.14717,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.0014299,0.19522,0.20165,1,1
5,GO LEFT RIGHT PATTERN FORMATION,0.010506,0.19516,0.16953,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.1617e-05,0.19502,0.20449,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0051916,0.19499,0.17876,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00055855,0.1949,0.16915,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.0001547,0.19476,0.15798,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001986,0.19474,0.23902,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0017641,0.19471,0.16763,1,1
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.009256,0.19448,0.2389,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00059588,0.19441,0.19712,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.7474e-06,0.19432,0.21444,1,1
5,GO HUMORAL IMMUNE RESPONSE,1.2454e-05,0.19426,0.25163,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0029794,0.19425,0.15146,1,1
5,GO CELL MATURATION,1.1267e-06,0.19411,0.20013,1,1
5,GO MUSCLE CELL DEVELOPMENT,0.00065623,0.19398,0.17735,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,9.389e-05,0.19397,0.21475,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0017641,0.19396,0.15632,1,1
5,GO INNER EAR MORPHOGENESIS,0.0010206,0.1939,0.15433,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,5.6174e-05,0.19375,0.15052,1,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.047551,0.19372,0.097815,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0010859,0.19372,0.13131,1,1
5,GO REGULATION OF LIPID STORAGE,0.0016129,0.19371,0.17304,1,1
5,GO RESPONSE TO DRUG,0.00054072,0.1937,0.15937,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.0021689,0.19358,0.14868,1,1
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.027188,0.19343,0.3347,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.02166,0.19342,0.19312,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00029782,0.19333,0.21105,1,1
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.010245,0.19315,0.21618,1,1
5,GO RESPONSE TO METAL ION,1.2962e-05,0.19299,0.19484,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,6.2786e-05,0.19288,0.17309,1,1
5,GO RESPONSE TO BMP,0.00095906,0.19287,0.16761,1,1
5,GO TRANSLESION SYNTHESIS,0.00021909,0.19286,0.17082,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00029782,0.19285,0.16071,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0023671,0.19265,0.1654,1,1
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00032948,0.19243,0.19328,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,4.3218e-05,0.19242,0.16851,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0015653,0.19239,0.18761,1,1
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00034072,0.19219,0.19825,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00032948,0.19213,0.15533,1,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0075304,0.19197,0.11379,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0090226,0.19188,0.13228,1,1
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00059588,0.19186,0.16314,1,1
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0015189,0.19168,0.17404,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00036427,0.19164,0.18895,1,1
5,GO CYTOPLASM ORGANIZATION,0.014841,0.19149,0.15691,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,3.8583e-05,0.19141,0.16598,1,1
5,GO NEUTROPHIL MIGRATION,0.00067758,0.19139,0.15134,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0011549,0.19138,0.1505,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00019753,0.19136,0.15195,1,1
5,GO MEMBRANE BIOGENESIS,0.0050528,0.19115,0.21397,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.0010528,0.19109,0.16583,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0010206,0.1906,0.19804,1,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00041602,0.19055,0.22885,1,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.010506,0.19043,0.14944,1,1
5,GO FACIAL NERVE MORPHOGENESIS,0.019739,0.19038,0.27798,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,7.6603e-06,0.19036,0.19504,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.0833e-05,0.19029,0.18008,1,1
5,GO STRESS FIBER ASSEMBLY,0.0028141,0.19026,0.17572,1,1
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.022165,0.19022,0.14727,1,1
5,GO FLUID TRANSPORT,0.0064317,0.19017,0.15466,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00065623,0.19002,0.19149,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0010528,0.18986,0.19504,1,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0010859,0.18977,0.13629,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0012662,0.18956,0.16446,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00010092,0.18926,0.1555,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,8.4205e-05,0.18903,0.15578,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0010859,0.18893,0.15986,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00090094,0.1889,0.23459,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,4.4878e-05,0.18881,0.15969,1,1
5,GO RESPONSE TO ISCHEMIA,0.00074557,0.18878,0.17945,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.0001165,0.18866,0.1611,1,1
5,GO VESICLE TARGETING,0.0037331,0.18862,0.12456,1,1
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.037747,0.18851,0.142,1,1
5,GO ERK1 AND ERK2 CASCADE,0.0039469,0.18849,0.20142,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0073363,0.18848,0.17363,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00010462,0.18823,0.17516,1,1
5,GO RESPONSE TO STEROL,0.0040578,0.18797,0.17289,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00013433,0.18791,0.16824,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00022676,0.18785,0.22828,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00021167,0.18783,0.13873,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0057817,0.18777,0.13556,1,1
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.033166,0.1875,0.1321,1,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0029794,0.18743,0.16262,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0032441,0.1874,0.17418,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.016339,0.18726,0.12501,1,1
5,GO CARBOHYDRATE TRANSPORT,3.4421e-05,0.18724,0.17385,1,1
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0034322,0.18712,0.16824,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.042857,0.18709,0.21154,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.00353,0.18707,0.16362,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.00010845,0.18687,0.14206,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0041716,0.18683,0.13769,1,1
5,GO REGULATION OF HEART RATE,0.0013054,0.18673,0.20508,1,1
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00059588,0.18672,0.14981,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,7.8282e-05,0.18669,0.13902,1,1
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.014841,0.18659,0.13121,1,1
5,GO T CELL APOPTOTIC PROCESS,0.013139,0.18643,0.16518,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0015189,0.18631,0.19032,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0030654,0.18631,0.16655,1,1
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00081984,0.1861,0.14439,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.00059588,0.18605,0.14082,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017137,0.18584,0.19691,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00030804,0.18551,0.18242,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0053338,0.18544,0.18258,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.03939,0.18526,0.15214,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,5.8301e-05,0.18525,0.15889,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.050569,0.18507,0.15397,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00019079,0.18498,0.14308,1,1
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00017186,0.18483,0.1831,1,1
5,GO INORGANIC ANION TRANSPORT,8.4205e-05,0.18477,0.16739,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.18423,0.19509,1,1
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00036427,0.18408,0.20405,1,1
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0028957,0.18385,0.12886,1,1
5,GO ER NUCLEUS SIGNALING PATHWAY,0.00074557,0.18384,0.1762,1,1
5,GO ACTION POTENTIAL,0.001228,0.18381,0.188,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.9263e-05,0.18376,0.1531,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.00074557,0.1836,0.15916,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0010206,0.18358,0.1696,1,1
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,4.6597e-05,0.18355,0.1813,1,1
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.033166,0.18337,0.24109,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00027832,0.18323,0.15051,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00036427,0.18297,0.15274,1,1
5,GO EAR DEVELOPMENT,0.00081984,0.18295,0.15136,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00016595,0.18289,0.1316,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00037661,0.18276,0.15737,1,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00092958,0.18274,0.15461,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.019739,0.18274,0.18323,1,1
5,GO CHLORIDE TRANSPORT,0.00024286,0.18273,0.17842,1,1
5,GO ACROSOME REACTION,0.0067808,0.18257,0.15862,1,1
5,GO HORMONE TRANSPORT,1.9263e-05,0.18255,0.20574,1,1
5,GO VESICLE BUDDING FROM MEMBRANE,0.001872,0.18252,0.13397,1,1
5,GO RESPONSE TO CATECHOLAMINE,0.0028957,0.18238,0.15684,1,1
5,GO CELLULAR RESPONSE TO IRON ION,0.012203,0.18226,0.20778,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.3132e-05,0.18225,0.19868,1,1
5,GO CHONDROCYTE DIFFERENTIATION,0.0099891,0.18217,0.17403,1,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00069957,0.18209,0.14571,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0022332,0.18207,0.18205,1,1
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.0081404,0.18204,0.16504,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00032948,0.18192,0.25738,1,1
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0094949,0.18187,0.1283,1,1
5,GO DIGESTION,0.00065623,0.18182,0.18522,1,1
5,GO DEVELOPMENTAL MATURATION,4.4878e-05,0.18178,0.17908,1,1
5,GO REGULATION OF BIOMINERALIZATION,0.0026572,0.18167,0.16991,1,1
5,GO GLIAL CELL ACTIVATION,0.0049174,0.18164,0.19559,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00019079,0.18145,0.15888,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.1964e-05,0.18144,0.18183,1,1
5,GO REGULATION OF MAPK CASCADE,0.00023468,0.18136,0.18341,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,9.389e-05,0.18135,0.1758,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0083534,0.18128,0.13285,1,1
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.024846,0.18114,0.14095,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.00036427,0.18102,0.15496,1,1
5,GO HEART PROCESS,0.00010462,0.18102,0.18994,1,1
5,GO CHOLESTEROL STORAGE,0.001986,0.18064,0.22588,1,1
5,GO POSITIVE REGULATION OF CELL DIVISION,0.00027832,0.18062,0.19561,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00026903,0.18055,0.1416,1,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0011199,0.18035,0.18913,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.044685,0.18032,0.13178,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,3.0689e-05,0.1803,0.18517,1,1
5,GO REGULATION OF PH,0.0001165,0.18027,0.13197,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00025131,0.18025,0.13718,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00063551,0.18011,0.16541,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.01282,0.18008,0.21997,1,1
5,GO REGULATION OF HORMONE LEVELS,4.8612e-06,0.17995,0.19442,1,1
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0001165,0.17988,0.15726,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.00040247,0.17988,0.18724,1,1
5,GO CELL AGGREGATION,0.011612,0.17981,0.17371,1,1
5,GO LIPID CATABOLIC PROCESS,0.0001547,0.17976,0.14807,1,1
5,GO DECIDUALIZATION,0.036164,0.17968,0.17061,1,1
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0028957,0.17962,0.1287,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.00012074,0.17936,0.17197,1,1
5,GO FEMALE GENITALIA DEVELOPMENT,0.0097392,0.17935,0.18121,1,1
5,GO REGULATION OF HORMONE SECRETION,5.8301e-05,0.17927,0.19068,1,1
5,GO RESPONSE TO LIPID,0.0011549,0.17924,0.14562,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,4.8379e-05,0.17903,0.15435,1,1
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.015574,0.17873,0.12823,1,1
5,GO HYPOTHALAMUS DEVELOPMENT,0.014841,0.17861,0.1889,1,1
5,GO P38MAPK CASCADE,0.024846,0.1786,0.1327,1,1
5,GO KERATINOCYTE MIGRATION,0.007729,0.1785,0.15622,1,1
5,GO RESPONSE TO INTERLEUKIN 1,0.0045306,0.1784,0.11925,1,1
5,GO MALE SEX DIFFERENTIATION,0.00059588,0.17834,0.15619,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0021689,0.17798,0.1262,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.024846,0.17798,0.13947,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00087311,0.17793,0.176,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.0022992,0.17724,0.14933,1,1
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0069616,0.17714,0.23203,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00010462,0.17711,0.18666,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,8.1192e-05,0.17704,0.15716,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00050664,0.17689,0.14964,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00016023,0.17686,0.13812,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00069957,0.17676,0.18163,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00074557,0.17657,0.22435,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.004408,0.17634,0.14795,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00012074,0.1761,0.13049,1,1
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.042857,0.17595,0.13101,1,1
5,GO LIPID MODIFICATION,5.2139e-05,0.17584,0.15345,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00049035,0.17577,0.22044,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.036164,0.17577,0.14865,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.00028792,0.17542,0.16963,1,1
5,GO REGULATION OF SECRETION,5.7413e-06,0.17536,0.17357,1,1
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0030654,0.17536,0.13337,1,1
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.013139,0.17522,0.19532,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0079323,0.17481,0.1389,1,1
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.020205,0.17481,0.15512,1,1
5,GO REGULATION OF CELL SHAPE,0.00072223,0.17474,0.1713,1,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.0039469,0.17464,0.17464,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,0.00012964,0.17455,0.13595,1,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0024367,0.17453,0.14692,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,6.5149e-05,0.17449,0.14726,1,1
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.03939,0.17439,0.17677,1,1
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0073363,0.17439,0.20967,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.013798,0.17421,0.1884,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.031059,0.17419,0.13356,1,1
5,GO INTERFERON GAMMA PRODUCTION,0.0022332,0.17401,0.15353,1,1
5,GO REGULATION OF ION TRANSPORT,0.00037661,0.17394,0.1454,1,1
5,GO MEMORY,0.0057817,0.17392,0.14281,1,1
5,GO REGULATION OF LIPID TRANSPORT,0.00067758,0.17375,0.16502,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.00037661,0.17374,0.1277,1,1
5,GO REGULATION OF LIPID LOCALIZATION,0.0027346,0.17373,0.14315,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.001191,0.17362,0.19222,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0022992,0.17356,0.15976,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.018398,0.1735,0.16844,1,1
5,GO CHEMICAL HOMEOSTASIS,8.3127e-06,0.17343,0.15985,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.010773,0.17333,0.15346,1,1
5,GO ACID SECRETION,0.0014299,0.17328,0.17653,1,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0017123,0.17292,0.17455,1,1
5,GO PURINE NUCLEOTIDE TRANSPORT,0.0046564,0.17292,0.1445,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.0033369,0.17288,0.15215,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0015653,0.17282,0.13379,1,1
5,GO CELL JUNCTION ASSEMBLY,0.00034072,0.1728,0.16382,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00072223,0.17278,0.11902,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0015189,0.17273,0.12119,1,1
5,GO IRON ION TRANSPORT,0.00034072,0.1727,0.1296,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.00055855,0.17258,0.14215,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.046579,0.17239,0.15314,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00353,0.17215,0.23555,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0030654,0.17215,0.16583,1,1
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.034637,0.17198,0.14153,1,1
5,GO ORGANIC CATION TRANSPORT,0.0028141,0.17198,0.20283,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.017137,0.17191,0.13391,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.04854,0.17182,0.16252,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0011199,0.17149,0.24029,1,1
5,GO CELL GROWTH,0.00054072,0.17138,0.14541,1,1
5,GO REGULATION OF T CELL MIGRATION,0.001986,0.17137,0.19289,1,1
5,GO LYSOSOME LOCALIZATION,0.00021167,0.17113,0.1711,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.00023468,0.17106,0.14708,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,8.4205e-05,0.17104,0.19083,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0015189,0.17102,0.131,1,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.00067758,0.171,0.18047,1,1
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0027346,0.17097,0.1805,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00017796,0.17059,0.12359,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,0.17059,0.25528,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.4039e-05,0.1705,0.15598,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.04854,0.17043,0.16603,1,1
5,GO VACUOLAR TRANSPORT,0.001662,0.17028,0.11773,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00054072,0.16999,0.17017,1,1
5,GO RESPONSE TO ANTIBIOTIC,0.00047456,0.16991,0.17914,1,1
5,GO GLOMERULUS DEVELOPMENT,0.0071468,0.16969,0.1883,1,1
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.044685,0.16966,0.16396,1,1
5,GO SECONDARY METABOLIC PROCESS,0.0054795,0.16951,0.17948,1,1
5,GO MONOAMINE TRANSPORT,0.010773,0.1695,0.22958,1,1
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.01282,0.16945,0.20269,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0017123,0.16942,0.17563,1,1
5,GO CHOLESTEROL EFFLUX,0.0014299,0.16925,0.14768,1,1
5,GO POSITIVE T CELL SELECTION,0.0022332,0.16918,0.142,1,1
5,GO DNA DEALKYLATION,0.0022332,0.16913,0.17525,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.00025131,0.16911,0.12649,1,1
5,GO CELLULAR RESPONSE TO STARVATION,9.0551e-05,0.16911,0.17509,1,1
5,GO RESPONSE TO INSULIN,6.7596e-05,0.1691,0.1519,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0069616,0.16908,0.16638,1,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0038387,0.16889,0.11718,1,1
5,GO REGULATION OF BONE MINERALIZATION,0.007729,0.16884,0.18112,1,1
5,GO RESPONSE TO AMYLOID BETA,0.0030654,0.16877,0.17471,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00012074,0.16877,0.13608,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0097392,0.16874,0.14973,1,1
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00017796,0.16866,0.20928,1,1
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.047551,0.16853,0.1219,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,0.0010859,0.16846,0.11423,1,1
5,GO REGULATION OF MACROPHAGE MIGRATION,0.00087311,0.1684,0.18872,1,1
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0025083,0.16834,0.14674,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,8.7323e-05,0.16817,0.21307,1,1
5,GO ENDOSOME ORGANIZATION,0.001191,0.1677,0.12429,1,1
5,GO RESPONSE TO RETINOIC ACID,0.011326,0.16763,0.13501,1,1
5,GO LOCOMOTORY BEHAVIOR,0.0066042,0.16757,0.15489,1,1
5,GO NEGATIVE REGULATION OF GROWTH,0.00020448,0.16754,0.15435,1,1
5,GO PIGMENTATION,0.0013054,0.16752,0.1264,1,1
5,GO DETECTION OF STIMULUS,6.7596e-05,0.16735,0.14051,1,1
5,GO AUTOPHAGOSOME ORGANIZATION,0.00036427,0.16729,0.15111,1,1
5,GO PEPTIDE HORMONE SECRETION,0.00016595,0.16724,0.18799,1,1
5,GO SLEEP,0.0015653,0.16715,0.16279,1,1
5,GO DRUG METABOLIC PROCESS,0.0038387,0.16713,0.18783,1,1
5,GO CELL JUNCTION ORGANIZATION,0.0013054,0.16705,0.13822,1,1
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0034322,0.16698,0.15948,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.029719,0.1668,0.22562,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.007729,0.16673,0.19669,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0090226,0.16671,0.17977,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00081984,0.16659,0.13528,1,1
5,GO ION HOMEOSTASIS,6.5149e-05,0.1664,0.13466,1,1
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.03939,0.16639,0.11552,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00016023,0.16629,0.12399,1,1
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.031748,0.16627,0.12986,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.0059384,0.16625,0.12676,1,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.0057817,0.16622,0.13314,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.00038934,0.16594,0.14423,1,1
5,GO RESPONSE TO FUNGUS,0.0007696,0.16593,0.15837,1,1
5,GO VACUOLE ORGANIZATION,6.2786e-05,0.16593,0.15416,1,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.0042883,0.16592,0.12753,1,1
5,GO SARCOMERE ORGANIZATION,0.001986,0.1658,0.16734,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0042883,0.16579,0.15779,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00019753,0.16576,0.13819,1,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.011047,0.16566,0.17161,1,1
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0024367,0.16557,0.16805,1,1
5,GO RELAXATION OF MUSCLE,0.013798,0.16556,0.17423,1,1
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0030654,0.16537,0.27808,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0050528,0.16534,0.14204,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.012508,0.16525,0.10492,1,1
5,GO METAL ION HOMEOSTASIS,9.7346e-05,0.16525,0.13596,1,1
5,GO HOMEOSTATIC PROCESS,3.8583e-05,0.16516,0.12745,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16499,0.14231,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00014418,0.16498,0.16504,1,1
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0047853,0.16493,0.17846,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00010092,0.16482,0.14797,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0056288,0.16482,0.11619,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,1.2454e-05,0.16479,0.16313,1,1
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.00045924,0.16471,0.12177,1,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0028141,0.16468,0.17856,1,1
5,GO DIGESTIVE SYSTEM PROCESS,0.00087311,0.16458,0.18342,1,1
5,GO RETINOIC ACID METABOLIC PROCESS,0.01282,0.16444,0.18434,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00034072,0.16413,0.17598,1,1
5,GO RESPONSE TO CALCIUM ION,0.0015189,0.16408,0.15582,1,1
5,GO NIK NF KAPPAB SIGNALING,0.0094949,0.16398,0.10438,1,1
5,GO DETECTION OF MECHANICAL STIMULUS,0.0011199,0.16389,0.17537,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,5.8301e-05,0.16386,0.1383,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,9.0551e-05,0.16374,0.13587,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0007696,0.16373,0.12328,1,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00035231,0.1637,0.13807,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00021909,0.16362,0.1439,1,1
5,GO SKELETAL MUSCLE CONTRACTION,0.011612,0.16361,0.14384,1,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00029782,0.16357,0.15873,1,1
5,GO DEFINITIVE HEMOPOIESIS,0.044685,0.16351,0.13347,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0024367,0.16349,0.14134,1,1
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.02268,0.16348,0.095119,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.013798,0.16345,0.10874,1,1
5,GO VESICLE ORGANIZATION,0.00018427,0.1634,0.13696,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0027346,0.16322,0.17402,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00032948,0.16301,0.16266,1,1
5,GO PROTEIN DESTABILIZATION,0.00016595,0.16294,0.17074,1,1
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.018398,0.16291,0.17649,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00037661,0.16283,0.19859,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,1.2454e-05,0.1628,0.16271,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0057817,0.16269,0.16762,1,1
5,GO T CELL SELECTION,0.0011199,0.16268,0.14949,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00069957,0.16266,0.13855,1,1
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0015653,0.16258,0.12494,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0012662,0.16256,0.11994,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0053338,0.16255,0.14274,1,1
5,GO GLYCOSIDE METABOLIC PROCESS,0.030383,0.16247,0.19925,1,1
5,GO PROTEOLYSIS,0.00026903,0.16243,0.11842,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00090094,0.16238,0.11411,1,1
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0025083,0.16229,0.11516,1,1
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.023741,0.16216,0.12303,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0001547,0.16214,0.13357,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.0014738,0.16205,0.13948,1,1
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.021165,0.16194,0.13322,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,2.6307e-05,0.16187,0.14467,1,1
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.0099891,0.16182,0.23346,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0067808,0.16169,0.16551,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,2.2524e-05,0.16167,0.25268,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.0033369,0.16156,0.18939,1,1
5,GO TISSUE MORPHOGENESIS,0.0010206,0.16122,0.13172,1,1
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.017549,0.16121,0.10736,1,1
5,GO CIRCULATORY SYSTEM PROCESS,6.5149e-05,0.1612,0.15631,1,1
5,GO RESPONSE TO STEROID HORMONE,0.001228,0.16115,0.14437,1,1
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.047551,0.16112,0.14606,1,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.00023468,0.16106,0.18306,1,1
5,GO RESPONSE TO GROWTH FACTOR,0.0014299,0.16105,0.13591,1,1
5,GO REGULATION OF CHROMATIN BINDING,0.0090226,0.16095,0.14735,1,1
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.001986,0.1609,0.13567,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00067758,0.16089,0.12848,1,1
5,GO NEGATIVE T CELL SELECTION,0.00090094,0.16073,0.22337,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.046579,0.16073,0.15871,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00041602,0.16065,0.14314,1,1
5,GO FATTY ACID CATABOLIC PROCESS,0.0033369,0.1605,0.14554,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.00081984,0.16037,0.11444,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00040247,0.1603,0.13185,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.03245,0.16025,0.14799,1,1
5,GO OSTEOBLAST DIFFERENTIATION,0.0038387,0.16008,0.17365,1,1
5,GO REGULATION OF GLUTAMATE SECRETION,0.041093,0.15997,0.18627,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.04854,0.1598,0.14108,1,1
5,GO RESPONSE TO HORMONE,0.00037661,0.15957,0.13231,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0031536,0.15947,0.17548,1,1
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.025994,0.15945,0.10398,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00074557,0.15932,0.14595,1,1
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,9.7346e-05,0.15903,0.22079,1,1
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.021165,0.15888,0.20217,1,1
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.015953,0.15885,0.13929,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.052669,0.1588,0.15847,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0012662,0.15854,0.14915,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.007729,0.15843,0.13328,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0037331,0.1584,0.12486,1,1
5,GO RUFFLE ORGANIZATION,0.004408,0.15829,0.16854,1,1
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.00014418,0.15824,0.12783,1,1
5,GO GLUCOSE METABOLIC PROCESS,1.8521e-05,0.15813,0.16586,1,1
5,GO OSTEOCLAST DIFFERENTIATION,0.0039469,0.15805,0.12338,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.2754e-05,0.15795,0.16681,1,1
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.001872,0.15792,0.14402,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00027832,0.15788,0.15274,1,1
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028141,0.15768,0.1507,1,1
5,GO REGULATION OF SYSTEM PROCESS,0.00016023,0.15748,0.14734,1,1
5,GO GOLGI VESICLE BUDDING,0.001872,0.15741,0.11179,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00019079,0.15728,0.15012,1,1
5,GO SIGNAL PEPTIDE PROCESSING,0.040234,0.1572,0.15403,1,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.001872,0.15695,0.12155,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0013872,0.15673,0.17202,1,1
5,GO POLYAMINE METABOLIC PROCESS,0.03245,0.15662,0.14393,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0073363,0.15659,0.14235,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,0.00050664,0.15657,0.13453,1,1
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0010206,0.15632,0.14657,1,1
5,GO CIRCADIAN RHYTHM,2.5774e-06,0.15615,0.16897,1,1
5,GO POSITIVE THYMIC T CELL SELECTION,0.00065623,0.15614,0.25206,1,1
5,GO ENSHEATHMENT OF NEURONS,0.00067758,0.15612,0.17054,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00028792,0.15573,0.15289,1,1
5,GO EXCRETION,0.00025131,0.15568,0.17336,1,1
5,GO EAR MORPHOGENESIS,0.0020453,0.15562,0.12082,1,1
5,GO SPROUTING ANGIOGENESIS,0.019739,0.15559,0.11418,1,1
5,GO STRIATED MUSCLE CONTRACTION,0.0015653,0.15558,0.1451,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.4878e-05,0.15558,0.16499,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,6.2786e-05,0.15549,0.16294,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.040234,0.15545,0.14788,1,1
5,GO NEURON PROJECTION REGENERATION,0.02166,0.15544,0.13338,1,1
5,GO COCHLEA DEVELOPMENT,0.007729,0.15538,0.18654,1,1
5,GO ORGANIC ANION TRANSPORT,4.1617e-05,0.15516,0.13547,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00026903,0.15502,0.13218,1,1
5,GO REGULATION OF TRANSPORT,4.1617e-05,0.15476,0.13071,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00020448,0.15465,0.12014,1,1
5,GO RUFFLE ASSEMBLY,0.0064317,0.15461,0.1689,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0036303,0.15459,0.13381,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.014138,0.1545,0.10178,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.0011199,0.15442,0.17531,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.00028792,0.1542,0.13572,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.00090094,0.15414,0.13184,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00017186,0.15394,0.1404,1,1
5,GO REGULATION OF CELLULAR PH,0.00023468,0.15384,0.1181,1,1
5,GO FEEDING BEHAVIOR,0.0030654,0.15381,0.12815,1,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0020453,0.15376,0.14647,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0013872,0.15376,0.15258,1,1
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00095906,0.15363,0.12818,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00022676,0.15352,0.14927,1,1
5,GO LYSOSOMAL TRANSPORT,0.011047,0.15332,0.11313,1,1
5,GO VITAMIN TRANSPORT,0.019283,0.15329,0.10766,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0029794,0.15308,0.16945,1,1
5,GO HORMONE METABOLIC PROCESS,0.00036427,0.15274,0.16249,1,1
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0038387,0.15269,0.15994,1,1
5,GO ANION TRANSPORT,2.3418e-05,0.15257,0.13841,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.02068,0.15244,0.24368,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.00035231,0.15237,0.11165,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0034322,0.15233,0.20284,1,1
5,GO RESPONSE TO KETONE,0.0064317,0.15224,0.12534,1,1
5,GO REGULATION OF CELL DEATH,0.00027832,0.15221,0.12448,1,1
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0028141,0.15219,0.10954,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0071468,0.15204,0.1332,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0050528,0.15204,0.10426,1,1
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.02843,0.15199,0.11647,1,1
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.025414,0.15192,0.17228,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.02843,0.15192,0.12126,1,1
5,GO TEMPERATURE HOMEOSTASIS,3.4421e-05,0.15183,0.17917,1,1
5,GO CELLULAR PIGMENTATION,0.0034322,0.15179,0.11734,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0047853,0.15174,0.13012,1,1
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.023205,0.15173,0.17899,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0042883,0.15171,0.13329,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0015653,0.1517,0.13587,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.0057817,0.15129,0.17917,1,1
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.031748,0.15121,0.13184,1,1
5,GO APOPTOTIC PROCESS,0.00018427,0.15097,0.1285,1,1
5,GO IMPORT INTO CELL,0.0025817,0.15085,0.15041,1,1
5,GO ORGANELLE FUSION,0.001662,0.15062,0.12795,1,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0047853,0.15062,0.11764,1,1
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.041967,0.15057,0.13012,1,1
5,GO ENDOCYTOSIS,0.0026572,0.1502,0.11055,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0011199,0.15014,0.12165,1,1
5,GO ZINC ION TRANSPORT,0.020205,0.15,0.11393,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,0.0039469,0.14993,0.13492,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,6.2367e-06,0.14979,0.14579,1,1
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.02068,0.14978,0.091906,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.045624,0.14972,0.14676,1,1
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.029068,0.14958,0.11716,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0001547,0.14952,0.15532,1,1
5,GO ION TRANSPORT,6.5149e-05,0.14951,0.1389,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.0028141,0.1495,0.14322,1,1
5,GO JNK CASCADE,0.00032948,0.14949,0.14201,1,1
5,GO ADAPTIVE THERMOGENESIS,2.4346e-05,0.14949,0.18642,1,1
5,GO RESPONSE TO TESTOSTERONE,0.033166,0.14932,0.15641,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.00017186,0.14904,0.12725,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0029794,0.14868,0.11947,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00031859,0.14865,0.12368,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021689,0.14862,0.19674,1,1
5,GO POSITIVE REGULATION OF NEURON DEATH,0.00065623,0.14858,0.17081,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00027832,0.14856,0.12503,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0050528,0.1485,0.12536,1,1
5,GO MEMBRANE ORGANIZATION,0.00019753,0.14843,0.12836,1,1
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.014138,0.14838,0.11172,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.00012074,0.14835,0.1413,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.007729,0.14803,0.088762,1,1
5,GO COPII COATED VESICLE BUDDING,0.0031536,0.14794,0.094563,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.010245,0.14775,0.10108,1,1
5,GO RESPONSE TO PEPTIDE,0.00019753,0.14758,0.13166,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.0049174,0.14735,0.15779,1,1
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.00032948,0.14706,0.14436,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00079435,0.14704,0.1181,1,1
5,GO POTASSIUM ION TRANSPORT,0.0031536,0.14698,0.15779,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,8.7323e-05,0.14695,0.12313,1,1
5,GO METAL ION TRANSPORT,0.00029782,0.1469,0.13104,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,9.0551e-05,0.14686,0.23108,1,1
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.010506,0.14667,0.12921,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00019753,0.14647,0.11697,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00031859,0.14637,0.16535,1,1
5,GO PHAGOSOME MATURATION,0.007729,0.14629,0.1225,1,1
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0039469,0.146,0.13182,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0033369,0.14581,0.11103,1,1
5,GO NEGATIVE REGULATION OF SECRETION,0.00019079,0.14555,0.12403,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.020205,0.14542,0.14374,1,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.00353,0.1454,0.16806,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00054072,0.14523,0.1224,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.00055855,0.14518,0.13016,1,1
5,GO RESPONSE TO STARVATION,0.00031859,0.14495,0.1613,1,1
5,GO HEART TRABECULA MORPHOGENESIS,0.017137,0.1449,0.13823,1,1
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0025083,0.14485,0.14529,1,1
5,GO DNA CATABOLIC PROCESS,4.4878e-05,0.14474,0.1444,1,1
5,GO REGULATION OF HAIR CYCLE,0.019739,0.14474,0.11765,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.001986,0.14471,0.23043,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.00016023,0.14446,0.13391,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.0073363,0.1443,0.11121,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0029794,0.14428,0.13899,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.0001165,0.14383,0.12415,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00037661,0.14381,0.11832,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.011047,0.14348,0.10895,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.012203,0.14348,0.1351,1,1
5,GO CATION TRANSPORT,0.00036427,0.14348,0.12784,1,1
5,GO MAINTENANCE OF LOCATION,0.0015653,0.14345,0.12315,1,1
5,GO SULFATE TRANSPORT,0.029068,0.14344,0.11518,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.042857,0.14337,0.1289,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.00065623,0.14325,0.12943,1,1
5,GO LIPID EXPORT FROM CELL,0.019739,0.14322,0.14148,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0020453,0.14309,0.099261,1,1
5,GO FC RECEPTOR SIGNALING PATHWAY,0.012508,0.14306,0.09817,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0021689,0.14305,0.12033,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.015953,0.14303,0.12062,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.14279,0.12113,1,1
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.05161,0.14271,0.13336,1,1
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.033894,0.14264,0.095866,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00059588,0.14251,0.15184,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0010528,0.14246,0.12471,1,1
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.047551,0.14234,0.19943,1,1
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.029719,0.14216,0.11196,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00095906,0.14213,0.16186,1,1
5,GO MICROTUBULE BUNDLE FORMATION,0.015574,0.14192,0.11369,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0030654,0.14177,0.14362,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0041716,0.1416,0.12114,1,1
5,GO RESPONSE TO DSRNA,0.0069616,0.14157,0.12359,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.00074557,0.14143,0.12301,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0030654,0.14131,0.12692,1,1
5,GO STEROID CATABOLIC PROCESS,0.025994,0.1413,0.16831,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0013054,0.14106,0.11154,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00028792,0.14101,0.14477,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,0.00072223,0.14096,0.14281,1,1
5,GO RESPONSE TO ESTRADIOL,0.0023671,0.14093,0.13319,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0010206,0.14093,0.12506,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.0014299,0.14086,0.13435,1,1
5,GO RESPONSE TO ETHANOL,0.0017641,0.1405,0.1326,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00023468,0.14047,0.11145,1,1
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.043763,0.14047,0.095348,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0051916,0.14029,0.11866,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0011199,0.14002,0.10773,1,1
5,GO DENDRITIC SPINE MAINTENANCE,0.034637,0.14001,0.11755,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0020453,0.13986,0.12386,1,1
5,GO REPRODUCTION,0.00044439,0.13966,0.10795,1,1
5,GO RESPONSE TO DOPAMINE,0.0073363,0.13965,0.13729,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.0030654,0.13948,0.11785,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0079323,0.13925,0.15815,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.0033369,0.13912,0.19466,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.00012074,0.13898,0.12213,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00045924,0.13896,0.14,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0046564,0.13888,0.11719,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.0050528,0.13887,0.084399,1,1
5,GO REGULATION OF GROWTH,0.00011241,0.13878,0.13858,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0083534,0.13857,0.16737,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.00026003,0.13849,0.1201,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.0023671,0.13824,0.11712,1,1
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.00034072,0.13821,0.17619,1,1
5,GO CALCIUM MEDIATED SIGNALING,4.4878e-05,0.13813,0.14218,1,1
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0094949,0.1379,0.1097,1,1
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.016339,0.13784,0.14585,1,1
5,GO TAXIS,0.00035231,0.13778,0.14356,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0012662,0.13754,0.11887,1,1
5,GO DEMETHYLATION,0.00024286,0.1375,0.14098,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.0010206,0.13741,0.12127,1,1
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.011326,0.13739,0.13378,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00013433,0.13707,0.12663,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.00014935,0.13704,0.13006,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.010245,0.13701,0.096748,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,0.019283,0.13701,0.095947,1,1
5,GO RESPONSE TO NICOTINE,0.01282,0.13654,0.16703,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0040578,0.13647,0.10015,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0021689,0.13627,0.12874,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00081984,0.13625,0.13257,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.012508,0.13617,0.10258,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.0032441,0.13614,0.14375,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00087311,0.13607,0.12997,1,1
5,GO NEUROBLAST PROLIFERATION,0.033166,0.13582,0.10814,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,7.013e-05,0.1358,0.14042,1,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.0026572,0.13569,0.15021,1,1
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.017137,0.13566,0.13804,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.034637,0.13554,0.10487,1,1
5,GO NEURON DEATH,0.00012964,0.13531,0.13279,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,0.00079435,0.13528,0.14005,1,1
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.02068,0.13526,0.094622,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0087944,0.13511,0.14042,1,1
5,GO HINDBRAIN DEVELOPMENT,0.0032441,0.13511,0.15474,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0022332,0.13488,0.093794,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0073363,0.13485,0.11733,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0064317,0.13476,0.095138,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.00036427,0.13464,0.11788,1,1
5,GO MIDBODY ABSCISSION,0.031748,0.13462,0.15468,1,1
5,GO AGING,0.0034322,0.13457,0.11218,1,1
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.037747,0.13438,0.15391,1,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0022332,0.13435,0.12661,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0045306,0.13422,0.21592,1,1
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.041093,0.13417,0.12159,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,0.031059,0.13414,0.11773,1,1
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0030654,0.1338,0.16493,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00013433,0.13367,0.12212,1,1
5,GO GROWTH,0.00045924,0.13364,0.12524,1,1
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00016023,0.13354,0.13644,1,1
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.011326,0.13352,0.12788,1,1
5,GO OXIDATION REDUCTION PROCESS,0.0029794,0.13341,0.10999,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0028957,0.13327,0.11382,1,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.02166,0.13317,0.11724,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0085714,0.13301,0.16472,1,1
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.041967,0.13291,0.07389,1,1
5,GO BEHAVIOR,0.0099891,0.13289,0.10641,1,1
5,GO REGULATION OF PROTEIN BINDING,0.00047456,0.13281,0.13918,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00098941,0.13275,0.14711,1,1
5,GO NERVOUS SYSTEM PROCESS,0.0013054,0.13274,0.10947,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0041716,0.13267,0.17523,1,1
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0041716,0.13265,0.12647,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.014841,0.13255,0.17179,1,1
5,GO SIGNAL RELEASE,0.00014935,0.13255,0.15705,1,1
5,GO MITOTIC CELL CYCLE ARREST,0.049546,0.13226,0.14649,1,1
5,GO STEROL BIOSYNTHETIC PROCESS,0.036164,0.13226,0.089315,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0067808,0.13223,0.094754,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0022332,0.1321,0.17761,1,1
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.00019753,0.1315,0.14187,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00044439,0.13109,0.10641,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00031859,0.13107,0.1279,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.014486,0.13103,0.13667,1,1
5,GO EXOCYTIC PROCESS,0.0060989,0.13101,0.16182,1,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.015203,0.1309,0.099801,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00072223,0.13064,0.13313,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.012508,0.13039,0.12586,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0059384,0.13034,0.10798,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.013798,0.13023,0.15219,1,1
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0053338,0.13003,0.15214,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.00026003,0.13001,0.11431,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0059384,0.13,0.16104,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00095906,0.12998,0.14755,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0023671,0.12994,0.13074,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00092958,0.12993,0.099224,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.02268,0.12989,0.09043,1,1
5,GO NEGATIVE REGULATION OF CELL DEATH,0.0010528,0.12989,0.11524,1,1
5,GO SINGLE FERTILIZATION,0.0020453,0.12967,0.10655,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.0024367,0.12963,0.1153,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0010528,0.12955,0.1298,1,1
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.00028792,0.12934,0.12901,1,1
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.036164,0.12921,0.12281,1,1
5,GO REGULATION OF AUTOPHAGY,0.00030804,0.12919,0.10882,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.033894,0.12909,0.11382,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.00036427,0.12873,0.10963,1,1
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0029794,0.12867,0.23004,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.0057817,0.12859,0.10352,1,1
5,GO PHOSPHATE ION TRANSPORT,0.010245,0.12828,0.12797,1,1
5,GO MUSCLE SYSTEM PROCESS,0.0022992,0.12824,0.11438,1,1
5,GO MACROPHAGE ACTIVATION,0.0022332,0.12824,0.20513,1,1
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.019739,0.12816,0.10909,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0022992,0.12741,0.12723,1,1
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.0075304,0.12712,0.15124,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,8.1192e-05,0.12703,0.14306,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.015574,0.12698,0.087276,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0022992,0.12698,0.10258,1,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.02843,0.12695,0.11673,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0056288,0.12693,0.089886,1,1
5,GO MUSCLE FIBER DEVELOPMENT,0.047551,0.12692,0.1125,1,1
5,GO FATTY ACID TRANSPORT,0.0057817,0.12673,0.10819,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0016129,0.1267,0.15725,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.02268,0.1267,0.10236,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.0067808,0.1266,0.11308,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0017641,0.12657,0.12062,1,1
5,GO RETINOL METABOLIC PROCESS,0.02268,0.12642,0.13907,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0071468,0.12631,0.094623,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.049546,0.12569,0.071004,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.011047,0.12568,0.1098,1,1
5,GO SENSORY PERCEPTION,0.00022676,0.1251,0.11237,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0066042,0.12507,0.12623,1,1
5,GO MUSCLE CELL PROLIFERATION,0.041093,0.12506,0.094495,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.001872,0.12487,0.10795,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0049174,0.12477,0.11657,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,0.001872,0.12472,0.10174,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.031748,0.12421,0.12074,1,1
5,GO FATTY ACYL COA METABOLIC PROCESS,0.012203,0.12416,0.1547,1,1
5,GO CARDIAC MUSCLE CONTRACTION,0.007729,0.12415,0.12959,1,1
5,GO ASSOCIATIVE LEARNING,0.02268,0.1241,0.11571,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00087311,0.12392,0.12001,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.016734,0.12358,0.10245,1,1
5,GO SEX DIFFERENTIATION,0.00095906,0.12322,0.11094,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.007729,0.12321,0.12356,1,1
5,GO RESPONSE TO ALCOHOL,0.0087944,0.1232,0.10499,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0083534,0.12313,0.11798,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0045306,0.12302,0.12051,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.043763,0.12294,0.11903,1,1
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.018398,0.12285,0.12578,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.010773,0.12271,0.17281,1,1
5,GO POSTREPLICATION REPAIR,0.0041716,0.12249,0.10994,1,1
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00035231,0.12237,0.13404,1,1
5,GO REGULATION OF VASOCONSTRICTION,0.0075304,0.12218,0.11805,1,1
5,GO GOLGI ORGANIZATION,0.001986,0.12201,0.097043,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.014138,0.12177,0.092022,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.0057817,0.12174,0.10837,1,1
5,GO ACTIN MEDIATED CELL CONTRACTION,0.024288,0.12148,0.1058,1,1
5,GO TRANSCYTOSIS,0.038561,0.12136,0.11458,1,1
5,GO CELL CELL SIGNALING,0.00098941,0.12133,0.11756,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00018427,0.12116,0.10249,1,1
5,GO T CELL LINEAGE COMMITMENT,0.017969,0.12,0.10587,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0083534,0.11994,0.092807,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0015189,0.11989,0.11577,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,0.0079323,0.11985,0.099369,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0054795,0.11969,0.099659,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0049174,0.1194,0.12428,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0013457,0.11923,0.14106,1,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.02268,0.11887,0.1299,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.014486,0.11886,0.099915,1,1
5,GO CELLULAR HOMEOSTASIS,0.00047456,0.11839,0.10763,1,1
5,GO PROTEIN INSERTION INTO MEMBRANE,0.0013872,0.11835,0.13017,1,1
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0030654,0.11805,0.11574,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0087944,0.11793,0.0888,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0021689,0.11768,0.17384,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.033166,0.11743,0.096848,1,1
5,GO RHYTHMIC BEHAVIOR,0.0097392,0.11742,0.12939,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0011549,0.11738,0.12083,1,1
5,GO RESPONSE TO CHEMOKINE,0.0037331,0.11727,0.11593,1,1
5,GO PROTEIN CATABOLIC PROCESS,0.0024367,0.11726,0.076987,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.001986,0.11723,0.075691,1,1
5,GO ORGANIC ACID METABOLIC PROCESS,0.0085714,0.11717,0.087633,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00028792,0.117,0.11946,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.016339,0.11693,0.083529,1,1
5,GO REGULATION OF CILIUM MOVEMENT,0.0085714,0.11692,0.12051,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0066042,0.11678,0.10912,1,1
5,GO REGULATION OF MUSCLE CONTRACTION,0.0099891,0.11673,0.10129,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0075304,0.11597,0.094924,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0013457,0.11559,0.14403,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.027803,0.11553,0.09998,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0017641,0.11551,0.11329,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.02268,0.11542,0.16119,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.0059384,0.11533,0.10776,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0099891,0.11526,0.09138,1,1
5,GO STEM CELL PROLIFERATION,0.0050528,0.11521,0.12661,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.0062634,0.11517,0.13123,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.0071468,0.11472,0.093351,1,1
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.046579,0.11459,0.0947,1,1
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.03939,0.11448,0.068631,1,1
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.030383,0.11419,0.11781,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.033894,0.11386,0.12094,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0025083,0.11378,0.12511,1,1
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.031748,0.11367,0.10345,1,1
5,GO CARTILAGE DEVELOPMENT,0.026586,0.11337,0.10927,1,1
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.024846,0.11305,0.094958,1,1
5,GO MESENCHYME DEVELOPMENT,0.013798,0.11302,0.10919,1,1
5,GO POLYOL METABOLIC PROCESS,0.0026572,0.1128,0.097304,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0060989,0.11223,0.11669,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.02843,0.11222,0.11942,1,1
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.046579,0.11222,0.09849,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0033369,0.11221,0.095461,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0079323,0.11211,0.13578,1,1
5,GO INTRACELLULAR LIPID TRANSPORT,0.019283,0.11158,0.12956,1,1
5,GO SCHWANN CELL DEVELOPMENT,0.041093,0.11149,0.10982,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.0013872,0.11131,0.14232,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0017123,0.11116,0.11579,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00353,0.11077,0.099058,1,1
5,GO EYE MORPHOGENESIS,0.0073363,0.11055,0.10066,1,1
5,GO CELLULAR RESPONSE TO CAMP,0.0012662,0.11051,0.15268,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.017137,0.11043,0.099768,1,1
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0025817,0.11038,0.18413,1,1
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,0.11033,0.1385,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.00074557,0.11023,0.11499,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0042883,0.11018,0.087611,1,1
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0054795,0.11017,0.11167,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0014299,0.10999,0.10808,1,1
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.021165,0.10985,0.12084,1,1
5,GO ANDROGEN METABOLIC PROCESS,0.010245,0.1096,0.14781,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0023671,0.10942,0.12727,1,1
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0097392,0.10913,0.091914,1,1
5,GO REGULATION OF CELL DEVELOPMENT,0.0057817,0.10875,0.10265,1,1
5,GO EMBRYONIC MORPHOGENESIS,0.0015653,0.10867,0.11227,1,1
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.010506,0.10801,0.10372,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.0026572,0.10766,0.10485,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,0.025994,0.10764,0.1047,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.001228,0.10746,0.11188,1,1
5,GO PEPTIDYL SERINE MODIFICATION,0.0059384,0.10737,0.079925,1,1
5,GO DEPHOSPHORYLATION,0.0019282,0.10732,0.082501,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,0.10727,0.099702,1,1
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.02843,0.10703,0.085781,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0040578,0.10702,0.11759,1,1
5,GO DEVELOPMENTAL CELL GROWTH,0.031059,0.10696,0.11228,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.034637,0.10695,0.09267,1,1
5,GO ARACHIDONIC ACID SECRETION,0.031059,0.10686,0.0896,1,1
5,GO ORGANIC ACID TRANSPORT,0.00012964,0.10675,0.10567,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0036303,0.10674,0.10763,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00095906,0.10651,0.097767,1,1
5,GO ENDOSOMAL TRANSPORT,0.0033369,0.10628,0.084976,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0087944,0.10623,0.073456,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.041967,0.10607,0.12331,1,1
5,GO MULTI ORGANISM PROCESS,0.0047853,0.10555,0.078655,1,1
5,GO RHYTHMIC PROCESS,0.00012512,0.10521,0.11908,1,1
5,GO DEVELOPMENTAL GROWTH,0.0047853,0.10509,0.10465,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.010506,0.10508,0.076188,1,1
5,GO REGULATION OF GLIAL CELL MIGRATION,0.014841,0.10504,0.12045,1,1
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.007729,0.10498,0.093384,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0031536,0.10492,0.081936,1,1
5,GO FEMALE SEX DIFFERENTIATION,0.0045306,0.10453,0.10757,1,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.037747,0.10441,0.10092,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.03245,0.10427,0.096175,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.05161,0.10404,0.075255,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.0090226,0.10391,0.13405,1,1
5,GO REGULATION OF BINDING,0.00087311,0.10318,0.11246,1,1
5,GO TUBE FORMATION,0.0099891,0.10312,0.086683,1,1
5,GO FATTY ACID BETA OXIDATION,0.046579,0.10286,0.084291,1,1
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.011612,0.10252,0.07681,1,1
5,GO REGULATION OF GLUCONEOGENESIS,0.0042883,0.10242,0.1071,1,1
5,GO MIDBRAIN DEVELOPMENT,0.0053338,0.10206,0.1007,1,1
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.013465,0.10164,0.082055,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.037747,0.10146,0.10577,1,1
5,GO CELL CELL SIGNALING BY WNT,0.0081404,0.10092,0.089439,1,1
5,GO VIRAL BUDDING,0.024846,0.10062,0.1166,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.00087311,0.099999,0.12412,1,1
5,GO MUSCLE CONTRACTION,0.0051916,0.099934,0.10962,1,1
5,GO CELLULAR EXTRAVASATION,0.031059,0.099706,0.10029,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0042883,0.099633,0.11536,1,1
5,GO GOLGI LOCALIZATION,0.030383,0.099326,0.12115,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.023205,0.099199,0.090636,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.042857,0.099151,0.098815,1,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.050569,0.098776,0.07834,1,1
5,GO CELL PROJECTION ASSEMBLY,0.02166,0.0974,0.076557,1,1
5,GO HEART DEVELOPMENT,0.013465,0.09738,0.080618,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,0.017137,0.096275,0.077238,1,1
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0073363,0.09613,0.086431,1,1
5,GO POSITIVE REGULATION OF GROWTH,0.0015653,0.095901,0.1141,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,0.011612,0.095811,0.084163,1,1
5,GO REGULATION OF DNA BINDING,0.015574,0.095747,0.08843,1,1
5,GO EXIT FROM MITOSIS,0.017549,0.095593,0.1013,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0081404,0.09548,0.094472,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.0024367,0.095433,0.083648,1,1
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0053338,0.095258,0.11881,1,1
5,GO REGULATION OF CIRCADIAN RHYTHM,0.0081404,0.095093,0.11118,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.00065623,0.095057,0.12037,1,1
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.041967,0.094909,0.12672,1,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.036948,0.094264,0.078636,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,0.025994,0.093903,0.10203,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.015203,0.093751,0.079387,1,1
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.010245,0.093389,0.10187,1,1
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.023205,0.093201,0.06733,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0069616,0.092488,0.1006,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.031059,0.092416,0.088807,1,1
5,GO ONE CARBON COMPOUND TRANSPORT,0.050569,0.092101,0.12613,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.050569,0.091793,0.070491,1,1
5,GO REGULATION OF CATABOLIC PROCESS,0.02166,0.091391,0.058011,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0060989,0.091347,0.10805,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.010245,0.091039,0.072019,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0073363,0.090935,0.072165,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.015953,0.090619,0.094685,1,1
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.05161,0.090424,0.081463,1,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.0051916,0.090329,0.087101,1,1
5,GO SKELETAL SYSTEM DEVELOPMENT,0.010506,0.090085,0.088798,1,1
5,GO SENSORY ORGAN DEVELOPMENT,0.0021062,0.089969,0.096408,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00017186,0.089888,0.10031,1,1
5,GO GERM CELL DEVELOPMENT,0.029719,0.089672,0.062838,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00081984,0.089504,0.081984,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.016339,0.089292,0.063667,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0047853,0.089008,0.076742,1,1
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.01282,0.088521,0.15315,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.014841,0.088278,0.076976,1,1
5,GO HEAD DEVELOPMENT,0.0079323,0.087996,0.096564,1,1
5,GO REGULATION OF TOR SIGNALING,0.0017641,0.087951,0.09458,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.045624,0.087474,0.061077,1,1
5,GO EMBRYO DEVELOPMENT,0.0039469,0.087284,0.083075,1,1
5,GO LEUKOCYTE TETHERING OR ROLLING,0.013139,0.087183,0.10364,1,1
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.027803,0.086999,0.042502,1,1
5,GO REGULATION OF EXOCYTOSIS,0.0062634,0.086981,0.14386,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.015953,0.086778,0.070064,1,1
5,GO PEROXISOMAL TRANSPORT,0.029719,0.086422,0.12174,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00087311,0.086231,0.096111,1,1
5,GO PROTEIN DEPHOSPHORYLATION,0.025414,0.086202,0.058046,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.014138,0.085832,0.083322,1,1
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0027346,0.085676,0.09416,1,1
5,GO NEURON APOPTOTIC PROCESS,0.0023671,0.08562,0.10507,1,1
5,GO TOR SIGNALING,0.0038387,0.083974,0.070581,1,1
5,GO OVULATION CYCLE,0.041967,0.083103,0.088727,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00022676,0.082849,0.092875,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.040234,0.082269,0.054653,1,1
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.013465,0.08205,0.08419,1,1
5,GO NEUROMUSCULAR PROCESS,0.03245,0.081721,0.11759,1,1
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.013465,0.081686,0.087739,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.01282,0.081412,0.10013,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,0.025414,0.081401,0.064582,1,1
5,GO RESPONSE TO CAMP,0.010773,0.080733,0.10464,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0020453,0.080609,0.092274,1,1
5,GO POSITIVE REGULATION OF BINDING,0.023741,0.080253,0.081549,1,1
5,GO NEUROGENESIS,0.02068,0.079796,0.085079,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.015953,0.07946,0.070917,1,1
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.036948,0.079242,0.081777,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.014138,0.079238,0.089816,1,1
5,GO PEROXISOME ORGANIZATION,0.042857,0.079016,0.10817,1,1
5,GO PROTEIN POLYUBIQUITINATION,0.0056288,0.077992,0.072605,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.026586,0.077866,0.087621,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00095906,0.0771,0.076126,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.02166,0.076789,0.076488,1,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0050528,0.075801,0.059256,1,1
5,GO CELL PROJECTION ORGANIZATION,0.018398,0.075551,0.082806,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0041716,0.075032,0.064697,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0014299,0.075003,0.071231,1,1
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.045624,0.074715,0.082297,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.042857,0.074539,0.081363,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.018398,0.074265,0.068271,1,1
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.031748,0.073719,0.073822,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.035393,0.073531,0.087579,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.038561,0.072644,0.053439,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0036303,0.072489,0.059806,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.027188,0.071784,0.057126,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.014486,0.071713,0.057656,1,1
5,GO CELL FATE COMMITMENT,0.016339,0.071462,0.083146,1,1
5,GO SEXUAL REPRODUCTION,0.009256,0.070116,0.064925,1,1
5,GO FERTILIZATION,0.0099891,0.068929,0.08094,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0069616,0.068666,0.066356,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.05161,0.068536,0.10782,1,1
5,GO CYTOSKELETON ORGANIZATION,0.015953,0.068387,0.071135,1,1
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.025414,0.066712,0.05941,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.017969,0.066072,0.11036,1,1
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.041093,0.065888,0.12159,1,1
5,GO CELL MORPHOGENESIS,0.037747,0.063794,0.08073,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.025414,0.063431,0.063469,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,0.023741,0.062626,0.058169,1,1
5,GO MACROMOLECULE DEACYLATION,0.023741,0.061741,0.064271,1,1
5,GO HEART MORPHOGENESIS,0.024846,0.061695,0.0708,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.011904,0.061456,0.050852,1,1
5,GO NEGATIVE REGULATION OF BINDING,0.0025817,0.061413,0.11207,1,1
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.016734,0.061295,0.054867,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.045624,0.057993,0.067129,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.012508,0.057458,0.077685,1,1
5,GO GAMETE GENERATION,0.027803,0.05744,0.054792,1,1
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.026586,0.055635,0.068779,1,1
5,GO REGULATION OF CELL DIVISION,0.040234,0.055588,0.072944,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.018398,0.054149,0.045756,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.05161,0.053786,0.044332,1,1
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.044685,0.047385,0.035662,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE,0.030383,0.03669,0.050373,1,1
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00072223,0.7052,0.47167,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0019282,0.63487,0.58333,1,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0036303,0.50277,0.37702,1,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00074557,0.48402,0.45308,1,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.02268,0.479,0.34736,1,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.0017641,0.47209,0.34581,1,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.018836,0.44931,0.33877,1,0
5,GO MEMBRANE RAFT ASSEMBLY,0.041967,0.44205,0.3066,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00044439,0.41491,0.4101,1,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.010245,0.41219,0.28895,1,0
5,GO BLEB ASSEMBLY,0.030383,0.39657,0.45952,1,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.015203,0.38992,0.27918,1,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.00014935,0.37654,0.33635,1,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.0083534,0.37501,0.37697,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0021062,0.35202,0.36276,1,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00027832,0.34975,0.33422,1,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00011241,0.34351,0.25498,1,0
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00098941,0.34337,0.25145,1,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00040247,0.34335,0.26616,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0026572,0.34179,0.24585,1,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00065623,0.34148,0.36682,1,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0017641,0.34105,0.20793,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0017123,0.33949,0.22924,1,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00032948,0.33766,0.29938,1,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.014486,0.33661,0.30127,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.013798,0.33643,0.24744,1,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.043763,0.32673,0.19795,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0014299,0.32659,0.23772,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,9.0551e-05,0.32595,0.31662,1,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00045924,0.3256,0.32965,1,0
5,GO GAP JUNCTION ASSEMBLY,0.02843,0.32421,0.22062,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001165,0.32392,0.29375,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.7346e-05,0.3232,0.25934,1,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0021062,0.31829,0.23568,1,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0017123,0.3134,0.23898,1,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.02068,0.31188,0.39003,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.00040247,0.30722,0.28636,1,0
5,GO ZYMOGEN INHIBITION,0.00353,0.30101,0.23851,1,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.00065623,0.30047,0.26948,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0024367,0.30015,0.30568,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.024288,0.29965,0.16387,1,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.016339,0.29777,0.31006,1,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.001986,0.29303,0.27705,1,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0039469,0.28948,0.23809,1,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0056288,0.28896,0.26195,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.016339,0.28349,0.23207,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.017969,0.27641,0.14743,1,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.015953,0.27546,0.17748,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.018398,0.27442,0.17217,1,0
5,GO LEYDIG CELL DIFFERENTIATION,0.010506,0.27275,0.30692,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0057817,0.27093,0.18061,1,0
5,GO INNERVATION,0.030383,0.27011,0.25904,1,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.011047,0.26957,0.25241,1,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.0062634,0.26562,0.324,1,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.014841,0.26359,0.25943,1,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.016734,0.26182,0.17129,1,0
5,GO AMYLOID BETA CLEARANCE,0.011047,0.25742,0.1626,1,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.049546,0.25536,0.19546,1,0
5,GO MACROPHAGE PROLIFERATION,0.018398,0.25418,0.28564,1,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,9.7346e-05,0.25137,0.29936,1,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.02843,0.2506,0.25105,1,0
5,GO ENERGY HOMEOSTASIS,0.00072223,0.24807,0.23168,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.004408,0.24798,0.24635,1,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.016734,0.24796,0.27171,1,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.02843,0.24692,0.13756,1,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.047551,0.24537,0.21852,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00353,0.24269,0.19238,1,0
5,GO VASCULOGENESIS,0.011326,0.24124,0.16896,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0014738,0.23969,0.18671,1,0
5,GO COLLAGEN CATABOLIC PROCESS,0.0085714,0.23507,0.1597,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.024288,0.23467,0.21195,1,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.004408,0.23255,0.18879,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.052669,0.23085,0.20909,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.011326,0.23076,0.19831,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.010773,0.22994,0.15508,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.038561,0.22971,0.1745,1,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0025083,0.2291,0.19912,1,0
5,GO APOPTOTIC CELL CLEARANCE,0.0069616,0.2276,0.30442,1,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.013139,0.22758,0.28284,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.019739,0.22675,0.17491,1,0
5,GO COPPER ION HOMEOSTASIS,0.0073363,0.22441,0.19919,1,0
5,GO STORE OPERATED CALCIUM ENTRY,0.011904,0.22354,0.16825,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0094949,0.22292,0.14,1,0
5,GO EPITHELIAL CELL CELL ADHESION,0.017137,0.22175,0.27182,1,0
5,GO HYALURONAN METABOLIC PROCESS,0.015203,0.221,0.13518,1,0
5,GO PROTEIN TARGETING TO VACUOLE,0.0042883,0.21819,0.15568,1,0
5,GO CELLULAR RESPONSE TO DSRNA,0.004408,0.21674,0.18269,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0056288,0.21563,0.17255,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.013798,0.21489,0.17953,1,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.011612,0.21469,0.16439,1,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0051916,0.21259,0.21835,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0047853,0.21249,0.23177,1,0
5,GO KERATINIZATION,0.0012662,0.21041,0.20954,1,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014841,0.21039,0.23697,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0054795,0.21028,0.19176,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.011904,0.20929,0.19567,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0032441,0.20651,0.16503,1,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.045624,0.2032,0.15842,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0041716,0.2031,0.19412,1,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0026572,0.20207,0.22042,1,0
5,GO CYTOLYSIS,0.0094949,0.20097,0.19823,1,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.046579,0.1965,0.17827,1,0
5,GO RESPONSE TO PH,0.001986,0.19527,0.17283,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.03245,0.19474,0.30953,1,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.02166,0.19339,0.21063,1,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.029719,0.1933,0.18986,1,0
5,GO REGULATION OF APPETITE,0.0022332,0.19176,0.17052,1,0
5,GO SALIVARY GLAND DEVELOPMENT,0.023205,0.19112,0.17777,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.024288,0.19041,0.14995,1,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.050569,0.18981,0.11415,1,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.050569,0.18936,0.22703,1,0
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0047853,0.18909,0.14588,1,0
5,GO NEUTROPHIL HOMEOSTASIS,0.045624,0.18905,0.1217,1,0
5,GO CELLULAR ANION HOMEOSTASIS,0.020205,0.18807,0.20749,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,0.010245,0.18679,0.11486,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0090226,0.18668,0.25779,1,0
5,GO RECEPTOR CATABOLIC PROCESS,0.0047853,0.18661,0.13611,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.038561,0.18557,0.15131,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0056288,0.18395,0.18147,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.024846,0.18335,0.11395,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.015203,0.18329,0.21079,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.040234,0.17868,0.15051,1,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.016734,0.17843,0.15377,1,0
5,GO HORMONE BIOSYNTHETIC PROCESS,0.0073363,0.17677,0.15965,1,0
5,GO REGULATION OF INTEGRIN ACTIVATION,0.00065623,0.17627,0.2529,1,0
5,GO NOSE DEVELOPMENT,0.038561,0.17459,0.31707,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00072223,0.1745,0.31166,1,0
5,GO DOPAMINE METABOLIC PROCESS,0.0087944,0.1745,0.22306,1,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.014841,0.17391,0.12809,1,0
5,GO LIPID IMPORT INTO CELL,0.044685,0.17119,0.16001,1,0
5,GO REGULATION OF PROTEIN FOLDING,0.019739,0.17053,0.10855,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0038387,0.16901,0.10753,1,0
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.016339,0.16797,0.168,1,0
5,GO CELL CELL RECOGNITION,0.0085714,0.16742,0.13766,1,0
5,GO REGULATION OF PHAGOCYTOSIS,0.018836,0.16696,0.14594,1,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0032441,0.16681,0.32852,1,0
5,GO PHAGOSOME ACIDIFICATION,0.0083534,0.16576,0.13193,1,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0024367,0.16534,0.11222,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0015189,0.16394,0.15999,1,0
5,GO RESPONSE TO CADMIUM ION,0.029068,0.16312,0.15088,1,0
5,GO DOPAMINE TRANSPORT,0.046579,0.16252,0.25303,1,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.030383,0.16139,0.10382,1,0
5,GO MYOBLAST DIFFERENTIATION,0.0062634,0.16092,0.17701,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0017123,0.16037,0.23834,1,0
5,GO SPERM EGG RECOGNITION,0.03245,0.15959,0.093317,1,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00038934,0.15945,0.13674,1,0
5,GO RIG I SIGNALING PATHWAY,0.041967,0.15755,0.096755,1,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.001872,0.15662,0.10603,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.012508,0.15661,0.14629,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.014486,0.15515,0.15899,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.050569,0.15478,0.14008,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0094949,0.1545,0.12488,1,0
5,GO COMPLEMENT ACTIVATION,0.0083534,0.15387,0.27473,1,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.036948,0.15226,0.069903,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.040234,0.15041,0.14717,1,0
5,GO IRON ION HOMEOSTASIS,0.024288,0.14985,0.11047,1,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.025414,0.14954,0.15109,1,0
5,GO REGULATION OF STEROL TRANSPORT,0.013465,0.14752,0.12241,1,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.041093,0.14745,0.12821,1,0
5,GO ERAD PATHWAY,0.0022992,0.14687,0.088486,1,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.029719,0.14416,0.092609,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.024288,0.14394,0.10422,1,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.041093,0.14361,0.10129,1,0
5,GO GASTRIC ACID SECRETION,0.052669,0.14289,0.13801,1,0
5,GO NATURAL KILLER CELL PROLIFERATION,0.011047,0.14261,0.22739,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.038561,0.14187,0.14025,1,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.045624,0.13984,0.28959,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.025994,0.13923,0.095939,1,0
5,GO VIRAL RNA GENOME REPLICATION,0.017549,0.13803,0.12825,1,0
5,GO MEMBRANE INVAGINATION,0.049546,0.13798,0.089889,1,0
5,GO AMINE CATABOLIC PROCESS,0.015203,0.13793,0.17727,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.041093,0.13793,0.17699,1,0
5,GO RESPONSE TO PROGESTERONE,0.018836,0.13711,0.16001,1,0
5,GO CYTOKINETIC PROCESS,0.044685,0.137,0.090936,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.014138,0.13577,0.16299,1,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.044685,0.13529,0.14027,1,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.031748,0.13403,0.18034,1,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.015953,0.13233,0.16829,1,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.052669,0.13206,0.12648,1,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.013465,0.13138,0.12774,1,0
5,GO REPLICATIVE SENESCENCE,0.049546,0.13117,0.14569,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.0054795,0.12696,0.10757,1,0
5,GO HEPATOCYTE DIFFERENTIATION,0.04854,0.12691,0.17127,1,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.017137,0.12531,0.11881,1,0
5,GO SULFUR COMPOUND TRANSPORT,0.0046564,0.12467,0.11272,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.041093,0.1233,0.11794,1,0
5,GO RESPONSE TO LEPTIN,0.026586,0.12309,0.13574,1,0
5,GO CHEMOSENSORY BEHAVIOR,0.014841,0.12253,0.21115,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0021689,0.12181,0.081661,1,0
5,GO PH REDUCTION,0.0075304,0.12135,0.095077,1,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.05161,0.1197,0.15867,1,0
5,GO INTRACELLULAR STEROL TRANSPORT,0.02268,0.11876,0.1795,1,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.013465,0.11774,0.098834,1,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.044685,0.11601,0.10375,1,0
5,GO SYMBIOTIC PROCESS,0.052669,0.11599,0.061433,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,0.0064317,0.11558,0.10215,1,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.03939,0.11514,0.10831,1,0
5,GO PIGMENT GRANULE LOCALIZATION,0.011326,0.11505,0.12656,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.017549,0.11261,0.21626,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.038561,0.10976,0.08386,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.033894,0.10917,0.1545,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.017549,0.1085,0.086039,1,0
5,GO VIRION ASSEMBLY,0.035393,0.10822,0.086122,1,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.014486,0.10792,0.09594,1,0
5,GO EPITHELIAL TUBE FORMATION,0.011612,0.10776,0.085186,1,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0097392,0.10768,0.15499,1,0
5,GO THIOESTER METABOLIC PROCESS,0.025414,0.10569,0.093909,1,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.030383,0.10489,0.15056,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.041967,0.10399,0.17151,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.02068,0.10302,0.13394,1,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.050569,0.10052,0.10285,1,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.03245,0.10042,0.13634,1,0
5,GO SOMITOGENESIS,0.016339,0.09987,0.088307,1,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.031059,0.099764,0.22062,1,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.05161,0.097918,0.15774,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.037747,0.097911,0.081684,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.03245,0.097579,0.089626,1,0
5,GO WATER TRANSPORT,0.042857,0.097031,0.1032,1,0
5,GO NEURAL TUBE DEVELOPMENT,0.040234,0.096726,0.074388,1,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.05161,0.096554,0.11149,1,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.011904,0.095527,0.11925,1,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.043763,0.094675,0.11719,1,0
5,GO ACTIVATION OF GTPASE ACTIVITY,0.035393,0.094235,0.076643,1,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.031059,0.09203,0.22311,1,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.033894,0.088156,0.053475,1,0
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.012508,0.085424,0.10226,1,0
5,GO GOLGI VESICLE TRANSPORT,0.009256,0.084428,0.07174,1,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.040234,0.081007,0.050375,1,0
5,GO SCHWANN CELL DIFFERENTIATION,0.041093,0.078206,0.099764,1,0
5,GO GOLGI RIBBON FORMATION,0.041967,0.073964,0.13547,1,0
5,GO BICARBONATE TRANSPORT,0.024846,0.073937,0.16792,1,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.010245,0.070121,0.12619,1,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.019739,0.06984,0.1433,1,0
5,GO REGULATION OF PROTEIN TARGETING,0.018398,0.06583,0.082565,1,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.037747,0.064195,0.075652,1,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.017969,0.055709,0.041907,1,0
5,GO MACROAUTOPHAGY,0.011612,0.048532,0.063526,1,0
5,GO REGULATION OF VACUOLE ORGANIZATION,0.040234,0.047602,0.092699,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.031748,-0.034401,-0.088056,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.043763,-0.045698,-0.076946,1,0
5,GO NUCLEAR TRANSPORT,0.045624,-0.047199,-0.070808,1,0
5,GO HISTONE UBIQUITINATION,0.045624,-0.050158,-0.056703,1,0
5,GO REGULATION OF DNA METABOLIC PROCESS,0.033166,-0.054142,-0.056807,1,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.040234,-0.056621,-0.11136,1,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0054795,-0.058684,-0.052836,1,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.050569,-0.059902,-0.084332,1,0
5,GO SNRNA TRANSCRIPTION,0.011047,-0.060592,-0.074759,1,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.019283,-0.065168,-0.08491,1,0
5,GO DNA REPAIR,0.030383,-0.065424,-0.050378,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.013465,-0.065734,-0.056052,1,0
5,GO BASE EXCISION REPAIR,0.013798,-0.065763,-0.09129,1,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.022165,-0.067906,-0.084638,1,0
5,GO PROTEIN SUMOYLATION,0.05161,-0.068411,-0.070135,1,0
5,GO MIRNA METABOLIC PROCESS,0.015953,-0.07017,-0.13546,1,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.029068,-0.070218,-0.073145,1,0
5,GO NUCLEAR EXPORT,0.023741,-0.071637,-0.091637,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.011904,-0.072468,-0.11633,1,0
5,GO REGULATION OF DNA REPAIR,0.0069616,-0.075023,-0.086613,1,0
5,GO CHROMOSOME ORGANIZATION,0.023205,-0.077857,-0.045292,1,0
5,GO REGULATION OF GENE SILENCING,0.025414,-0.079244,-0.10532,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0030654,-0.081427,-0.11663,1,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.027803,-0.082017,-0.077538,1,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.02268,-0.085694,-0.14273,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.047551,-0.08693,-0.081169,1,0
5,GO METHYLATION,0.0033369,-0.088499,-0.077896,1,0
5,GO CHROMOSOME SEGREGATION,0.050569,-0.092198,-0.053956,1,0
5,GO HISTONE H3 ACETYLATION,0.02268,-0.093157,-0.058096,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.038561,-0.093409,-0.09155,1,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.02166,-0.093506,-0.070489,1,0
5,GO CHROMATIN REMODELING,0.033894,-0.094524,-0.060295,1,0
5,GO REPLICATION FORK PROCESSING,0.033166,-0.095055,-0.10338,1,0
5,GO RNA MODIFICATION,0.0024367,-0.095532,-0.12085,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.016339,-0.095769,-0.12592,1,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.049546,-0.09603,-0.05689,1,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.029068,-0.097241,-0.081283,1,0
5,GO DNA DEPENDENT DNA REPLICATION,0.012203,-0.097253,-0.097878,1,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.024846,-0.09795,-0.079865,1,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.027188,-0.098903,-0.097929,1,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0087944,-0.098967,-0.14154,1,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0067808,-0.10055,-0.10671,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,6.2786e-05,-0.10216,-0.15407,1,0
5,GO PEPTIDE METABOLIC PROCESS,0.027803,-0.10231,-0.097982,1,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.036164,-0.10243,-0.085178,1,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0059384,-0.10246,-0.11168,1,0
5,GO OXIDATIVE DEMETHYLATION,0.033166,-0.1028,-0.081806,1,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0060989,-0.10289,-0.11211,1,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.029719,-0.10327,-0.11002,1,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.03245,-0.10357,-0.10142,1,0
5,GO RNA POLYADENYLATION,0.010506,-0.1037,-0.10484,1,0
5,GO TELOMERE ORGANIZATION,0.00028792,-0.10484,-0.12849,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0051916,-0.10562,-0.10617,1,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0062634,-0.10637,-0.1543,1,0
5,GO PEPTIDYL ARGININE METHYLATION,0.012508,-0.10695,-0.12646,1,0
5,GO RECOMBINATIONAL REPAIR,0.010506,-0.10814,-0.080293,1,0
5,GO NCRNA TRANSCRIPTION,0.00012964,-0.10846,-0.13038,1,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.013139,-0.10908,-0.075406,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,3.5759e-05,-0.11084,-0.16024,1,0
5,GO DNA CONFORMATION CHANGE,0.0060989,-0.11129,-0.082841,1,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.045624,-0.11213,-0.06302,1,0
5,GO TRNA METHYLATION,0.0049174,-0.11218,-0.14982,1,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.033166,-0.11334,-0.11222,1,0
5,GO MRNA 3 END PROCESSING,0.0036303,-0.11366,-0.10454,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.015953,-0.11374,-0.10989,1,0
5,GO DNA GEOMETRIC CHANGE,0.0030654,-0.11408,-0.11773,1,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.00049035,-0.11521,-0.1186,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,6.7596e-05,-0.11583,-0.13004,1,0
5,GO MRNA TRANSPORT,0.0051916,-0.11715,-0.11234,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0013872,-0.11804,-0.11569,1,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.00052342,-0.1186,-0.10937,1,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.0090226,-0.11913,-0.13783,1,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0041716,-0.11975,-0.14198,1,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.03939,-0.12004,-0.17556,1,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.050569,-0.12005,-0.17594,1,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.03245,-0.12018,-0.086825,1,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00042998,-0.12018,-0.14296,1,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0011199,-0.1208,-0.11696,1,0
5,GO AMIDE BIOSYNTHETIC PROCESS,0.02166,-0.12176,-0.10247,1,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.009256,-0.12187,-0.13838,1,0
5,GO REGULATION OF RNA SPLICING,0.0041716,-0.12203,-0.088453,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.033166,-0.12282,-0.17127,1,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.02068,-0.12296,-0.15657,1,0
5,GO PROTEASOME ASSEMBLY,0.013139,-0.12307,-0.1627,1,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.035393,-0.12345,-0.13999,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00022676,-0.12358,-0.12594,1,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.0032441,-0.12367,-0.15169,1,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.010506,-0.12483,-0.16862,1,0
5,GO TRANSLATIONAL TERMINATION,0.020205,-0.12487,-0.14343,1,0
5,GO RNA 5 END PROCESSING,0.017969,-0.12564,-0.15596,1,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.00027832,-0.12597,-0.14758,1,0
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0026572,-0.12715,-0.14311,1,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.04854,-0.12739,-0.18236,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE,2.5308e-05,-0.12778,-0.16898,1,0
5,GO MITOCHONDRIAL TRANSLATION,0.012508,-0.12856,-0.15355,1,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,5.508e-06,-0.12904,-0.17536,1,0
5,GO HISTONE H3 K9 ACETYLATION,0.015203,-0.12955,-0.12978,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.027803,-0.1307,-0.11889,1,0
5,GO MRNA METHYLATION,0.024846,-0.13109,-0.14379,1,0
5,GO TRANSLATIONAL ELONGATION,0.010506,-0.13143,-0.15143,1,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.021165,-0.13176,-0.14619,1,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.021165,-0.13188,-0.1371,1,0
5,GO REGULATION OF DNA METHYLATION,0.042857,-0.13213,-0.10411,1,0
5,GO RNA CAPPING,0.00031859,-0.1325,-0.13225,1,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,7.2754e-05,-0.13389,-0.14247,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00072223,-0.13533,-0.17919,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00032948,-0.13653,-0.12256,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.035393,-0.1371,-0.18167,1,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.029719,-0.13743,-0.12786,1,0
5,GO RNA STABILIZATION,0.0081404,-0.13759,-0.13335,1,0
5,GO PEPTIDYL ARGININE N METHYLATION,0.043763,-0.13921,-0.1359,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.040234,-0.13992,-0.12472,1,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0022332,-0.14064,-0.13348,1,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0064317,-0.1407,-0.14261,1,0
5,GO HISTONE ARGININE METHYLATION,0.0083534,-0.14075,-0.13301,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.037747,-0.14197,-0.14535,1,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00063551,-0.14245,-0.16909,1,0
5,GO DNA METHYLATION,0.018398,-0.14258,-0.096689,1,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.029068,-0.14354,-0.18184,1,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.012508,-0.14423,-0.093147,1,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.00065623,-0.14427,-0.15738,1,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00087311,-0.1449,-0.11757,1,0
5,GO TRNA METABOLIC PROCESS,0.00063551,-0.14554,-0.15453,1,0
5,GO TRNA TRANSPORT,0.0027346,-0.14569,-0.18288,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.031059,-0.14589,-0.17495,1,0
5,GO RNA LOCALIZATION,0.00036427,-0.14619,-0.14839,1,0
5,GO CHROMOSOME SEPARATION,0.00063551,-0.14669,-0.13469,1,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0036303,-0.14672,-0.11929,1,0
5,GO REGULATION OF MRNA PROCESSING,0.0023671,-0.14813,-0.10862,1,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.004408,-0.14991,-0.14769,1,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0054795,-0.15004,-0.12828,1,0
5,GO PROTEIN DENEDDYLATION,0.0033369,-0.15101,-0.17673,1,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.001986,-0.15108,-0.14297,1,0
5,GO DNA STRAND ELONGATION,0.0099891,-0.15147,-0.13057,1,0
5,GO NUCLEOSOME ORGANIZATION,0.0030654,-0.15149,-0.1076,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0013054,-0.15286,-0.12846,1,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0053338,-0.1534,-0.16671,1,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0018173,-0.15436,-0.1465,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.015574,-0.15441,-0.21255,1,0
5,GO MRNA EXPORT FROM NUCLEUS,0.00031859,-0.15477,-0.143,1,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.010506,-0.15504,-0.1302,1,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.0066042,-0.15538,-0.20237,1,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.009256,-0.15614,-0.14898,1,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0017123,-0.15632,-0.12945,1,0
5,GO TRNA MODIFICATION,0.00017796,-0.15733,-0.19577,1,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.009256,-0.15874,-0.1582,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00057693,-0.15874,-0.1536,1,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.031059,-0.1597,-0.1493,1,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.0012662,-0.16176,-0.1476,1,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0069616,-0.16229,-0.11655,1,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.03245,-0.16243,-0.129,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,6.2786e-05,-0.1625,-0.23394,1,0
5,GO SNRNA METABOLIC PROCESS,5.4121e-05,-0.16293,-0.19758,1,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0023671,-0.16323,-0.11494,1,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.046579,-0.16343,-0.086401,1,0
5,GO FEVER GENERATION,0.02843,-0.16414,-0.17224,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00011241,-0.16509,-0.18152,1,0
5,GO RNA CATABOLIC PROCESS,0.0032441,-0.16594,-0.16063,1,0
5,GO MRNA PROCESSING,0.00023468,-0.16675,-0.12304,1,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00019079,-0.16682,-0.17361,1,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.040234,-0.16694,-0.12565,1,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.02843,-0.16696,-0.17334,1,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.0010859,-0.1671,-0.25248,1,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0073363,-0.1676,-0.16699,1,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.018398,-0.16765,-0.13561,1,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.0039469,-0.1678,-0.1784,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00014935,-0.16785,-0.1444,1,0
5,GO RNA METHYLATION,3.5759e-05,-0.168,-0.18506,1,0
5,GO TRNA PROCESSING,8.4205e-05,-0.16802,-0.18494,1,0
5,GO RNA 3 END PROCESSING,0.00010092,-0.16839,-0.15217,1,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.00353,-0.16871,-0.17991,1,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.02843,-0.16889,-0.16135,1,0
5,GO STRESS GRANULE ASSEMBLY,0.001662,-0.16891,-0.17078,1,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.001986,-0.16947,-0.17938,1,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0022992,-0.16948,-0.15927,1,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.047551,-0.17029,-0.23001,1,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.019739,-0.17068,-0.13092,1,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,1.5201e-05,-0.17101,-0.1802,1,0
5,GO MRNA METABOLIC PROCESS,0.00021167,-0.17273,-0.14921,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.02843,-0.17309,-0.14187,1,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0020453,-0.17495,-0.18618,1,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.027803,-0.17533,-0.16888,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0041716,-0.17653,-0.20233,1,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00019753,-0.17677,-0.13523,1,0
5,GO RNA EXPORT FROM NUCLEUS,0.00022676,-0.17704,-0.15733,1,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.040234,-0.17714,-0.14836,1,0
5,GO RNA SPLICING,0.00017186,-0.17717,-0.13266,1,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00049035,-0.17764,-0.13486,1,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.029719,-0.17836,-0.19729,1,0
5,GO MRNA SPLICE SITE SELECTION,0.02268,-0.18095,-0.13114,1,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0017641,-0.18202,-0.17406,1,0
5,GO RNA PROCESSING,1.349e-05,-0.18235,-0.16803,1,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.001191,-0.18399,-0.15104,1,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00013917,-0.18468,-0.14877,1,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.026586,-0.18523,-0.11299,1,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.049546,-0.18575,-0.17267,1,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.007729,-0.18676,-0.16862,1,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.023741,-0.1873,-0.13743,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00010092,-0.18734,-0.18354,1,0
5,GO HISTONE DEUBIQUITINATION,0.00019079,-0.18904,-0.15638,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.004408,-0.19,-0.1465,1,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.010773,-0.19053,-0.17034,1,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0021689,-0.19057,-0.19747,1,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0006154,-0.1916,-0.1706,1,0
5,GO BLASTOCYST GROWTH,0.0016129,-0.19181,-0.18303,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00057693,-0.19347,-0.19473,1,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.011612,-0.19921,-0.17436,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00023468,-0.20022,-0.18268,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0041716,-0.20118,-0.15845,1,0
5,GO RRNA 3 END PROCESSING,0.0087944,-0.20215,-0.16999,1,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.01282,-0.20282,-0.20786,1,0
5,GO PEPTIDYL HISTIDINE MODIFICATION,0.00027832,-0.203,-0.22717,1,0
5,GO MEMBRANE DISASSEMBLY,0.011326,-0.2059,-0.16261,1,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00016023,-0.20646,-0.32058,1,0
5,GO SNRNA PROCESSING,0.00026003,-0.20684,-0.21857,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0060989,-0.20841,-0.18158,1,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,7.547e-05,-0.20885,-0.23229,1,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0030654,-0.20901,-0.15022,1,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0038387,-0.20955,-0.24551,1,0
5,GO NUCLEAR PORE ORGANIZATION,0.007729,-0.2101,-0.23507,1,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.011612,-0.21134,-0.14805,1,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,9.7346e-05,-0.2117,-0.28729,1,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00041602,-0.21172,-0.22219,1,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.0034322,-0.21209,-0.20161,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,3.0689e-05,-0.21259,-0.21394,1,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00018427,-0.21568,-0.21341,1,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00012512,-0.21819,-0.17889,1,0
5,GO NCRNA 3 END PROCESSING,8.1192e-05,-0.21832,-0.23412,1,0
5,GO NCRNA METABOLIC PROCESS,2.9532e-05,-0.21955,-0.21963,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.017969,-0.22104,-0.22586,1,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.0057817,-0.22123,-0.20122,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00032948,-0.22258,-0.2625,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00037661,-0.2237,-0.19394,1,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.00353,-0.22479,-0.35262,1,0
5,GO MATURATION OF 5 8S RRNA,7.013e-05,-0.22557,-0.29464,1,0
5,GO AMINO ACID ACTIVATION,0.0013457,-0.22652,-0.22023,1,0
5,GO DNA REPLICATION CHECKPOINT,0.0033369,-0.22675,-0.21236,1,0
5,GO MRNA MODIFICATION,0.001191,-0.22877,-0.20284,1,0
5,GO DNA REPLICATION INITIATION,2.6307e-05,-0.2317,-0.22893,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.00065623,-0.23345,-0.21521,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,1.1964e-05,-0.23376,-0.2925,1,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.013798,-0.23593,-0.1754,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,4.4878e-05,-0.23663,-0.20576,1,0
5,GO IMP METABOLIC PROCESS,0.0090226,-0.2376,-0.27563,1,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00031859,-0.23942,-0.27045,1,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00016023,-0.24258,-0.2422,1,0
5,GO DNA LIGATION,0.02843,-0.24316,-0.15676,1,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0024367,-0.24369,-0.1986,1,0
5,GO NCRNA PROCESSING,8.6584e-06,-0.24381,-0.25258,1,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,1.9263e-05,-0.24614,-0.26319,1,0
5,GO PSEUDOURIDINE SYNTHESIS,0.00021909,-0.24731,-0.29481,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0056288,-0.24748,-0.16714,1,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0031536,-0.24851,-0.21371,1,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.0060989,-0.2493,-0.21631,1,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00019753,-0.2506,-0.30991,1,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0019282,-0.25189,-0.18272,1,0
5,GO REGULATION OF RNA BINDING,0.00025131,-0.25307,-0.24012,1,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.0050528,-0.25494,-0.26555,1,0
5,GO SECRETORY GRANULE LOCALIZATION,0.037747,-0.25583,-0.1974,1,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0021062,-0.26002,-0.3235,1,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.036948,-0.2604,-0.2376,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00016595,-0.26066,-0.33997,1,0
5,GO RRNA METHYLATION,9.0179e-06,-0.26289,-0.27496,1,0
5,GO CHROMATIN DISASSEMBLY,0.0031536,-0.26319,-0.19847,1,0
5,GO RRNA TRANSCRIPTION,4.0073e-05,-0.26611,-0.26371,1,0
5,GO RRNA MODIFICATION,8.3127e-06,-0.26952,-0.2926,1,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.00012512,-0.27084,-0.21943,1,0
5,GO REGULATION OF MRNA BINDING,0.00013433,-0.2714,-0.2933,1,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.031748,-0.27352,-0.25286,1,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,1.3441e-06,-0.27551,-0.28301,1,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.046579,-0.2781,-0.15293,1,0
5,GO MITOCHONDRIAL TRNA PROCESSING,0.0042883,-0.27904,-0.22249,1,0
5,GO ADULT HEART DEVELOPMENT,0.001986,-0.27941,-0.25992,1,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,5.7413e-06,-0.27947,-0.29064,1,0
5,GO RETROGRADE AXONAL TRANSPORT,0.00067758,-0.28174,-0.22375,1,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,8.4205e-05,-0.28534,-0.2708,1,0
5,GO RRNA METABOLIC PROCESS,2.2524e-05,-0.28623,-0.28049,1,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.011326,-0.28729,-0.28276,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,2.4692e-06,-0.28739,-0.27832,1,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.0087944,-0.28985,-0.2326,1,0
5,GO VIRAL GENE EXPRESSION,0.00059588,-0.29297,-0.30324,1,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.0025083,-0.29418,-0.23292,1,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.00079435,-0.29915,-0.38628,1,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.8301e-05,-0.31031,-0.39435,1,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,9.0551e-05,-0.31107,-0.35211,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00041602,-0.31125,-0.28375,1,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.027188,-0.3121,-0.27599,1,0
5,GO MATURATION OF SSU RRNA,3.3287e-06,-0.31768,-0.37157,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0013872,-0.31799,-0.3125,1,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.0683e-06,-0.31869,-0.36423,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,3.9418e-06,-0.31906,-0.29568,1,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00020448,-0.32059,-0.31618,1,0
5,GO TELOMERASE RNA LOCALIZATION,1.8251e-06,-0.33036,-0.41401,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,1.4609e-05,-0.33186,-0.32829,1,0
5,GO TRANSLATIONAL INITIATION,0.00069957,-0.33233,-0.33771,1,0
5,GO RIBOSOME BIOGENESIS,7.3528e-06,-0.3388,-0.32339,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,6.0504e-05,-0.34418,-0.32452,1,0
5,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0036303,-0.3446,-0.2615,1,0
5,GO CARDIAC VENTRICLE FORMATION,0.031748,-0.34471,-0.26821,1,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.0576e-06,-0.34874,-0.39284,1,0
5,GO RRNA PSEUDOURIDINE SYNTHESIS,1.1493e-05,-0.35109,-0.38271,1,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,3.1904e-06,-0.35546,-0.34501,1,0
5,GO L SERINE METABOLIC PROCESS,0.025994,-0.35694,-0.26352,1,0
5,GO RNA SURVEILLANCE,9.7801e-06,-0.3598,-0.28778,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0015653,-0.37685,-0.42204,1,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,4.4878e-05,-0.37738,-0.43939,1,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,1.349e-05,-0.3878,-0.3982,1,0
5,GO CYTOPLASMIC TRANSLATION,9.7346e-05,-0.38871,-0.40309,1,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,3.6228e-06,-0.39078,-0.43196,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,1.349e-05,-0.39344,-0.42247,1,0
5,GO VIRAL TRANSLATION,1.5816e-05,-0.39693,-0.39852,1,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.6455e-05,-0.39713,-0.42738,1,0
5,GO RIBOSOME ASSEMBLY,1.0604e-05,-0.4006,-0.43082,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,2.2524e-05,-0.40439,-0.38356,1,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0010528,-0.40467,-0.36193,1,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,5.2139e-05,-0.40699,-0.3562,1,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00017186,-0.41605,-0.38437,1,0
5,GO SNORNA METABOLIC PROCESS,2.1663e-05,-0.41864,-0.38061,1,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,3.4421e-05,-0.42034,-0.45567,1,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.00027832,-0.43015,-0.32556,1,0
5,GO SNORNA 3 END PROCESSING,7.0571e-06,-0.43965,-0.43448,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00035231,-0.44168,-0.44897,1,0
5,GO MATURATION OF LSU RRNA,2.1663e-05,-0.4436,-0.41196,1,0
5,GO CARDIAC CHAMBER FORMATION,0.02068,-0.45221,-0.29449,1,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,5.2139e-05,-0.45512,-0.50834,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,1.1493e-05,-0.45644,-0.46896,1,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0010528,-0.47353,-0.48262,1,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.05824,0.40708,0.36562,0,1
5,GO SYNAPTIC MEMBRANE ADHESION,0.054842,0.37545,0.24288,0,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.054842,0.36333,0.22103,0,1
5,GO NEPHRIC DUCT MORPHOGENESIS,0.093897,0.35784,0.17565,0,1
5,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.26471,0.34576,0.16878,0,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.063042,0.34542,0.17781,0,1
5,GO XENOBIOTIC CATABOLIC PROCESS,0.087232,0.34109,0.21865,0,1
5,GO TONGUE DEVELOPMENT,0.15015,0.33187,0.17686,0,1
5,GO SHORT TERM MEMORY,0.061812,0.32585,0.19043,0,1
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.088862,0.31606,0.27106,0,1
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.061812,0.29756,0.25866,0,1
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.075049,0.29743,0.37008,0,1
5,GO PROGESTERONE METABOLIC PROCESS,0.061812,0.27449,0.23376,0,1
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.10096,0.26467,0.17961,0,1
5,GO RESPONSE TO EPINEPHRINE,0.077957,0.26011,0.19089,0,1
5,GO HEART VALVE FORMATION,0.19095,0.25828,0.13052,0,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.057089,0.25666,0.25298,0,1
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.14526,0.25663,0.15737,0,1
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.27611,0.25659,0.038217,0,1
5,GO CGMP METABOLIC PROCESS,0.080955,0.2508,0.16085,0,1
5,GO RETINAL ROD CELL DIFFERENTIATION,0.084046,0.24916,0.19009,0,1
5,GO CELLULAR RESPONSE TO VITAMIN D,0.10096,0.24613,0.17183,0,1
5,GO ANATOMICAL STRUCTURE REGRESSION,0.085627,0.23977,0.22074,0,1
5,GO MACROPHAGE APOPTOTIC PROCESS,0.13355,0.23104,0.12877,0,1
5,GO MAGNESIUM ION HOMEOSTASIS,0.080955,0.22861,0.13797,0,1
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.52025,0.22859,0.071783,0,1
5,GO BASIC AMINO ACID TRANSPORT,0.15264,0.22853,0.044803,0,1
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.084046,0.22553,0.11045,0,1
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.054842,0.22249,0.15766,0,1
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.30815,0.22148,0.098782,0,1
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.10096,0.22099,0.18183,0,1
5,GO REGULATION OF TUBULIN DEACETYLATION,0.068167,0.21724,0.1904,0,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.16559,0.21697,0.19255,0,1
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.070855,0.21653,0.14098,0,1
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.087232,0.21106,0.1432,0,1
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.10096,0.20894,0.18095,0,1
5,GO RESPONSE TO LIGHT INTENSITY,0.095625,0.20871,0.12782,0,1
5,GO SKIN MORPHOGENESIS,0.13355,0.20847,0.11561,0,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.16828,0.2058,0.10755,0,1
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.068167,0.20319,0.19781,0,1
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.077957,0.2017,0.13315,0,1
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.12908,0.2014,0.11262,0,1
5,GO RESPONSE TO MINERALOCORTICOID,0.0695,0.20093,0.11998,0,1
5,GO RESPONSE TO REDOX STATE,0.13814,0.19665,0.14309,0,1
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.063042,0.19646,0.10755,0,1
5,GO PROTEIN HYDROXYLATION,0.099158,0.19167,0.13166,0,1
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.055956,0.1911,0.19028,0,1
5,GO PROSTATE GLAND DEVELOPMENT,0.11039,0.18873,0.10918,0,1
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.073629,0.18723,0.12047,0,1
5,GO LOCOMOTOR RHYTHM,0.099158,0.18461,0.11879,0,1
5,GO I KAPPAB PHOSPHORYLATION,0.059411,0.18438,0.12841,0,1
5,GO STEM CELL DIVISION,0.053746,0.17962,0.1255,0,1
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.12259,0.1781,0.098061,0,1
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.097379,0.17783,0.14891,0,1
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.16559,0.17648,0.14807,0,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.14526,0.17421,0.14675,0,1
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.093897,0.17395,0.12105,0,1
5,GO BRAIN MORPHOGENESIS,0.21256,0.17117,0.075668,0,1
5,GO T HELPER CELL LINEAGE COMMITMENT,0.10845,0.16968,0.092597,0,1
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.05824,0.16869,0.1135,0,1
5,GO INCLUSION BODY ASSEMBLY,0.19695,0.16842,0.10286,0,1
5,GO AMINO ACID IMPORT,0.064293,0.16774,0.12132,0,1
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.093897,0.16427,0.13967,0,1
5,GO RESPONSE TO MUSCLE ACTIVITY,0.32077,0.16087,0.091627,0,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.11235,0.16038,0.11028,0,1
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.077957,0.16005,0.11048,0,1
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.095625,0.15797,0.10827,0,1
5,GO REGULATION OF FIBRINOLYSIS,0.05824,0.1565,0.18454,0,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.13583,0.1518,0.12277,0,1
5,GO REGULATION OF CALCIUM ION IMPORT,0.060602,0.14948,0.097463,0,1
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.10096,0.14818,0.10783,0,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.17653,0.14769,0.082441,0,1
5,GO CGMP MEDIATED SIGNALING,0.12689,0.14761,0.087997,0,1
5,GO URETER DEVELOPMENT,0.075049,0.14733,0.16242,0,1
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.54321,0.14705,0.029144,0,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.48678,0.14683,0.037517,0,1
5,GO DRINKING BEHAVIOR,0.073629,0.14388,0.27907,0,1
5,GO REGULATION OF BONE DEVELOPMENT,0.21256,0.14084,0.059997,0,1
5,GO DETOXIFICATION,0.10845,0.14067,0.083456,0,1
5,GO MITOTIC CYTOKINETIC PROCESS,0.17934,0.13963,0.076245,0,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.057089,0.13932,0.15311,0,1
5,GO REPRODUCTIVE BEHAVIOR,0.11235,0.13878,0.10387,0,1
5,GO HEPARIN METABOLIC PROCESS,0.54321,0.1384,0.034777,0,1
5,GO RESPONSE TO PROSTAGLANDIN,0.14285,0.13811,0.10508,0,1
5,GO PANCREATIC JUICE SECRETION,0.068167,0.13796,0.13354,0,1
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.060602,0.13767,0.13321,0,1
5,GO TUBULIN DEACETYLATION,0.054842,0.13765,0.14779,0,1
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.10845,0.13762,0.09414,0,1
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.15773,0.13696,0.16221,0,1
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.084046,0.13619,0.079603,0,1
5,GO COLLATERAL SPROUTING,0.061812,0.13432,0.12095,0,1
5,GO REGULATION OF EXCRETION,0.12908,0.13403,0.1003,0,1
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.1313,0.13372,0.14044,0,1
5,GO REGULATION OF MEMBRANE INVAGINATION,0.34256,0.13292,0.052502,0,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.072231,0.13229,0.095413,0,1
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.10845,0.12973,0.086797,0,1
5,GO POSITIVE REGULATION OF MYELINATION,0.25729,0.12925,0.050234,0,1
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.060602,0.12919,0.24241,0,1
5,GO FIBROBLAST APOPTOTIC PROCESS,0.064293,0.12883,0.12559,0,1
5,GO MALE GENITALIA DEVELOPMENT,0.13583,0.12795,0.097179,0,1
5,GO EXPLORATION BEHAVIOR,0.1028,0.12739,0.098695,0,1
5,GO DEVELOPMENTAL PIGMENTATION,0.055956,0.12727,0.074925,0,1
5,GO GLUTATHIONE METABOLIC PROCESS,0.073629,0.12576,0.080623,0,1
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.22905,0.12576,0.078908,0,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.12908,0.1256,0.094089,0,1
5,GO SYNAPSE ORGANIZATION,0.082489,0.12502,0.10232,0,1
5,GO MANGANESE ION TRANSPORT,0.0695,0.12471,0.077858,0,1
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.064293,0.12435,0.087141,0,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.14526,0.12413,0.070387,0,1
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.061812,0.12383,0.079038,0,1
5,GO RESPONSE TO INACTIVITY,0.21579,0.12349,0.086138,0,1
5,GO HEAD MORPHOGENESIS,0.076492,0.12339,0.11835,0,1
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.10096,0.12321,0.076033,0,1
5,GO APPENDAGE DEVELOPMENT,0.085627,0.12286,0.085584,0,1
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.10845,0.12284,0.074832,0,1
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.066855,0.12242,0.075793,0,1
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.063042,0.12232,0.099468,0,1
5,GO LOCALIZATION WITHIN MEMBRANE,0.12908,0.11905,0.079121,0,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.14285,0.11702,0.094538,0,1
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.23937,0.11527,0.062367,0,1
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.054842,0.11487,0.21795,0,1
5,GO RESPONSE TO INTERLEUKIN 4,0.17099,0.11253,0.049913,0,1
5,GO FACE DEVELOPMENT,0.065563,0.11078,0.11568,0,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.10654,0.10959,0.088655,0,1
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.14769,0.10925,0.07656,0,1
5,GO ALCOHOL CATABOLIC PROCESS,0.085627,0.10923,0.067356,0,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.055956,0.10757,0.12717,0,1
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10096,0.10524,0.080607,0,1
5,GO CHONDROCYTE DEVELOPMENT,0.14048,0.10486,0.10305,0,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.11434,0.10472,0.099639,0,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.088862,0.10372,0.062258,0,1
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.28785,0.10364,0.03891,0,1
5,GO MULTIVESICULAR BODY ORGANIZATION,0.066855,0.10346,0.077661,0,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.093897,0.10276,0.093149,0,1
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.2839,0.10249,0.081048,0,1
5,GO RESPONSE TO PROSTAGLANDIN E,0.188,0.10153,0.088611,0,1
5,GO ORGANIC ACID CATABOLIC PROCESS,0.055956,0.099116,0.068364,0,1
5,GO ARTERY MORPHOGENESIS,0.11434,0.097865,0.047378,0,1
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.065563,0.09599,0.070345,0,1
5,GO PROSTAGLANDIN TRANSPORT,0.088862,0.094676,0.093242,0,1
5,GO VESICLE DOCKING,0.084046,0.094542,0.090859,0,1
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.10096,0.094501,0.12313,0,1
5,GO RENAL SODIUM EXCRETION,0.11039,0.092513,0.11893,0,1
5,GO PROTEIN POLYGLUTAMYLATION,0.33373,0.092026,0.053886,0,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.072231,0.091327,0.11283,0,1
5,GO THYMUS DEVELOPMENT,0.13583,0.090522,0.073453,0,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.17934,0.090467,0.051726,0,1
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.13814,0.090407,0.060304,0,1
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.12473,0.089929,0.096446,0,1
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.17653,0.088923,0.074943,0,1
5,GO PHOTOTRANSDUCTION,0.076492,0.08737,0.049068,0,1
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.44924,0.086317,0.017195,0,1
5,GO LENS FIBER CELL DEVELOPMENT,0.16559,0.085367,0.13756,0,1
5,GO REGULATION OF CELL SIZE,0.057089,0.085007,0.092624,0,1
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.10654,0.084096,0.072245,0,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.0695,0.083432,0.065283,0,1
5,GO TRABECULA MORPHOGENESIS,0.24288,0.083335,0.031044,0,1
5,GO COGNITION,0.064293,0.081599,0.085912,0,1
5,GO DENDRITIC SPINE DEVELOPMENT,0.32077,0.08135,0.04938,0,1
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.081203,0.082439,0,1
5,GO PROTEIN STABILIZATION,0.092194,0.079399,0.055839,0,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.064293,0.077751,0.063718,0,1
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.14285,0.076745,0.056486,0,1
5,GO RECEPTOR INTERNALIZATION,0.14526,0.076509,0.060512,0,1
5,GO PROSTAGLANDIN SECRETION,0.32938,0.0762,0.055863,0,1
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.29586,0.075684,0.078194,0,1
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.14769,0.075562,0.047801,0,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.068167,0.074955,0.052507,0,1
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.36064,0.072782,0.045933,0,1
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.12689,0.07156,0.052948,0,1
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.077957,0.071387,0.048284,0,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.079444,0.07069,0.074464,0,1
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.054842,0.068827,0.077451,0,1
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.063042,0.06821,0.063874,0,1
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.079444,0.067809,0.10168,0,1
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.14526,0.066512,0.064783,0,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.053746,0.066079,0.08585,0,1
5,GO MAINTENANCE OF CELL NUMBER,0.23589,0.064246,0.027696,0,1
5,GO DENDRITE EXTENSION,0.066855,0.064016,0.21991,0,1
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0695,0.062062,0.043163,0,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.13355,0.061195,0.072091,0,1
5,GO NEURON DEVELOPMENT,0.090515,0.059485,0.078305,0,1
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.37932,0.057858,0.0096908,0,1
5,GO NEURON DIFFERENTIATION,0.073629,0.05759,0.076818,0,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.061812,0.054883,0.058108,0,1
5,GO POLYOL CATABOLIC PROCESS,0.085627,0.05466,0.10103,0,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.060602,0.054637,0.045058,0,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.21579,0.05246,0.07209,0,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.11434,0.052336,0.07745,0,1
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.25001,0.050588,0.032219,0,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.43367,0.050233,0.033955,0,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.063042,0.04954,0.034856,0,1
5,GO CELL CYCLE ARREST,0.061812,0.04549,0.051821,0,1
5,GO REGULATION OF CELL CYCLE,0.072231,0.041165,0.035288,0,1
5,GO REGULATION OF MITOTIC CELL CYCLE,0.21905,0.035633,0.02747,0,1
5,GO INTRACELLULAR TRANSPORT,0.10465,0.035124,0.025602,0,1
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.16828,0.034951,0.037369,0,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.16828,0.03487,0.023277,0,1
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.055956,0.35448,0.23084,0,0
5,GO EPIBOLY,0.085627,0.33893,0.15953,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0067808,0.32292,0.339,0,0
5,GO RESPONSE TO FORSKOLIN,0.010245,0.31877,0.27697,0,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.11636,0.31648,0.2535,0,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.084046,0.31213,0.16954,0,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.00090094,0.3081,0.30368,0,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.13355,0.30598,0.22876,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.093897,0.30511,0.15464,0,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.001986,0.29521,0.33168,0,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.23245,0.29518,0.19587,0,0
5,GO PARENTAL BEHAVIOR,0.035393,0.29315,0.2,0,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.064293,0.2876,0.35002,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0028957,0.28489,0.34342,0,0
5,GO MIDGUT DEVELOPMENT,0.0075304,0.28409,0.29013,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.0012662,0.27714,0.287,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.060602,0.27424,0.42919,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.21579,0.27018,0.10906,0,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.093897,0.26802,0.10411,0,0
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0041716,0.2678,0.22032,0,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.02068,0.25323,0.29353,0,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00020448,0.25262,0.29764,0,0
5,GO BRONCHUS DEVELOPMENT,0.0053338,0.25143,0.36381,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.014138,0.25124,0.21713,0,0
5,GO SPINAL CORD PATTERNING,0.049546,0.24945,0.20305,0,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.48678,0.24806,0.054213,0,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.045624,0.24673,0.21985,0,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.011904,0.24613,0.32348,0,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.10096,0.24507,0.19369,0,0
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.041093,0.24244,0.29657,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.12473,0.24166,0.13611,0,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.033166,0.23866,0.23982,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00069957,0.23572,0.3104,0,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.065563,0.23474,0.12754,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.11039,0.23385,0.17282,0,0
5,GO ADENOHYPOPHYSIS DEVELOPMENT,0.054842,0.23242,0.27415,0,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.054842,0.23225,0.36654,0,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.11235,0.23216,0.15806,0,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.090515,0.23206,0.16404,0,0
5,GO CD40 SIGNALING PATHWAY,0.064293,0.227,0.10996,0,0
5,GO HYALURONAN CATABOLIC PROCESS,0.1028,0.22684,0.10592,0,0
5,GO POLYOL TRANSPORT,0.016734,0.22431,0.16688,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.054842,0.22268,0.15874,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30815,0.21948,0.21481,0,0
5,GO REGULATION OF DOPAMINE SECRETION,0.045624,0.21882,0.29793,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0027346,0.21854,0.2426,0,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.034637,0.21837,0.27718,0,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.037747,0.21722,0.16725,0,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.1028,0.215,0.18581,0,0
5,GO EMBRYONIC HEMOPOIESIS,0.017969,0.21491,0.16719,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.057089,0.21427,0.2545,0,0
5,GO RESPIRATORY BURST,0.080955,0.21315,0.13887,0,0
5,GO NEUROBLAST DIVISION,0.084046,0.20918,0.16658,0,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.20621,0.20843,0.084691,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.2,0.20809,0.072435,0,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.05161,0.20692,0.19088,0,0
5,GO GDP METABOLIC PROCESS,0.030383,0.20675,0.21258,0,0
5,GO SEX DETERMINATION,0.0017641,0.2067,0.19811,0,0
5,GO RETINAL METABOLIC PROCESS,0.054842,0.20486,0.21881,0,0
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0016129,0.20474,0.2543,0,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.53742,0.20374,0.058074,0,0
5,GO GANGLION DEVELOPMENT,0.085627,0.2031,0.26249,0,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.4978,0.2019,0.023832,0,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00047456,0.20067,0.19491,0,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.022165,0.2,0.16312,0,0
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.001872,0.19946,0.26463,0,0
5,GO LIPID DIGESTION,0.061812,0.19822,0.17119,0,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.27227,0.19786,0.12012,0,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.36526,0.19661,0.081985,0,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.068167,0.19641,0.1126,0,0
5,GO BARBED END ACTIN FILAMENT CAPPING,0.076492,0.19632,0.1381,0,0
5,GO SNARE COMPLEX ASSEMBLY,0.16294,0.19622,0.13794,0,0
5,GO PARTURITION,0.031059,0.1961,0.21811,0,0
5,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.35153,0.1948,0.10039,0,0
5,GO ACTIN FILAMENT SEVERING,0.2839,0.1929,0.098102,0,0
5,GO PREPULSE INHIBITION,0.075049,0.1926,0.23997,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.22905,0.19189,0.073006,0,0
5,GO PANCREAS DEVELOPMENT,0.0085714,0.19083,0.15493,0,0
5,GO MAINTENANCE OF CELL POLARITY,0.029719,0.19078,0.14267,0,0
5,GO CELL FATE DETERMINATION,0.11636,0.19047,0.11984,0,0
5,GO SEGMENT SPECIFICATION,0.14526,0.18995,0.14778,0,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.053746,0.18794,0.20585,0,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.17099,0.18771,0.10685,0,0
5,GO GONADOTROPIN SECRETION,0.014138,0.18653,0.21792,0,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.16032,0.18649,0.15698,0,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.188,0.18437,0.032867,0,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0094949,0.18354,0.19276,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.097379,0.18307,0.24847,0,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.12049,0.18068,0.21537,0,0
5,GO HEART INDUCTION,0.12049,0.17983,0.20669,0,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.10465,0.17937,0.093406,0,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.11434,0.17897,0.083733,0,0
5,GO CATECHOLAMINE UPTAKE,0.05824,0.17863,0.18096,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.16294,0.17762,0.10237,0,0
5,GO PROSTANOID METABOLIC PROCESS,0.076492,0.1769,0.13057,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.097379,0.17648,0.099603,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.13583,0.1761,0.12587,0,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.17099,0.17579,0.084156,0,0
5,GO MAST CELL MIGRATION,0.17934,0.17569,0.15962,0,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.068167,0.17501,0.17408,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.12259,0.17475,0.16535,0,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0013054,0.17366,0.16567,0,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.19695,0.17275,0.14364,0,0
5,GO RESPONSE TO POTASSIUM ION,0.011612,0.17258,0.21963,0,0
5,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.082489,0.17224,0.12309,0,0
5,GO GROWTH HORMONE SECRETION,0.019283,0.17221,0.22428,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0033369,0.17196,0.23087,0,0
5,GO CARDIAC ATRIUM DEVELOPMENT,0.043763,0.17149,0.13832,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.034637,0.17117,0.17831,0,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.12908,0.17115,0.11451,0,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.033166,0.17091,0.14133,0,0
5,GO ACTIN CROSSLINK FORMATION,0.022165,0.17063,0.15227,0,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.2839,0.17036,0.071942,0,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.19095,0.16996,0.08497,0,0
5,GO RESPONSE TO UV B,0.13355,0.16966,0.12143,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.097379,0.16839,0.12882,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.080955,0.16599,0.16025,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.38888,0.16508,0.045186,0,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.093897,0.16481,0.093313,0,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.054842,0.1631,0.09743,0,0
5,GO MUSCLE CELL FATE COMMITMENT,0.33812,0.16294,0.070645,0,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.099158,0.16206,0.15229,0,0
5,GO PROTEIN OXIDATION,0.076492,0.16153,0.14129,0,0
5,GO INSULIN SECRETION,0.00031859,0.16104,0.18151,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.1028,0.16096,0.14608,0,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.011904,0.1604,0.15888,0,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.019739,0.16008,0.18641,0,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.087232,0.15975,0.09764,0,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.57857,0.15956,0.016491,0,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.10096,0.15948,0.14708,0,0
5,GO DIET INDUCED THERMOGENESIS,0.030383,0.15938,0.12844,0,0
5,GO AXONEME ASSEMBLY,0.014138,0.15922,0.1546,0,0
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.0081404,0.15909,0.23988,0,0
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.040234,0.15869,0.19036,0,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.05161,0.15836,0.15431,0,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.044685,0.15828,0.16384,0,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.055956,0.15769,0.1891,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.088862,0.15586,0.075373,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.12689,0.1555,0.2511,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.12908,0.15526,0.10374,0,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.1028,0.15491,0.076308,0,0
5,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.11841,0.15491,0.075589,0,0
5,GO BLASTODERM SEGMENTATION,0.36064,0.15402,0.094023,0,0
5,GO CELLULAR RESPONSE TO ALKALOID,0.00087311,0.15381,0.18446,0,0
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.060602,0.15307,0.26126,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.17099,0.15305,0.16525,0,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.35153,0.15199,0.086742,0,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.016339,0.1507,0.17248,0,0
5,GO NUCLEOTIDE SALVAGE,0.33812,0.15001,0.050081,0,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.14285,0.14993,0.09671,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.14048,0.14976,0.09457,0,0
5,GO RESPONSE TO HYPEROXIA,0.14285,0.14959,0.10827,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.082489,0.14823,0.1191,0,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.61497,0.14731,0.029807,0,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.090515,0.14726,0.14911,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.12049,0.14723,0.16039,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.036948,0.1463,0.12786,0,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.18508,0.14621,0.073454,0,0
5,GO INTERMEMBRANE LIPID TRANSFER,0.072231,0.14617,0.062634,0,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.061812,0.14614,0.18337,0,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.061812,0.14586,0.13405,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.065563,0.14579,0.1887,0,0
5,GO TETRAPYRROLE METABOLIC PROCESS,0.066855,0.14505,0.08873,0,0
5,GO REGULATION OF PROTEIN MATURATION,0.090515,0.14484,0.09778,0,0
5,GO CATECHOLAMINE SECRETION,0.035393,0.14469,0.24362,0,0
5,GO LEFT RIGHT AXIS SPECIFICATION,0.16032,0.14413,0.11696,0,0
5,GO MEMBRANE HYPERPOLARIZATION,0.019739,0.14388,0.19121,0,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.084046,0.14384,0.15533,0,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0081404,0.14283,0.1684,0,0
5,GO RETINA LAYER FORMATION,0.16032,0.14241,0.19596,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.18219,0.14196,0.12888,0,0
5,GO ELASTIC FIBER ASSEMBLY,0.71006,0.14183,0.027352,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.59664,0.14163,0.076919,0,0
5,GO VAGINA DEVELOPMENT,0.10096,0.14144,0.11031,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0079323,0.14113,0.17476,0,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.02068,0.14097,0.15611,0,0
5,GO TONGUE MORPHOGENESIS,0.21579,0.14055,0.18507,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.13814,0.1404,0.074699,0,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.1313,0.13945,0.1636,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.046579,0.13931,0.16585,0,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.090515,0.13904,0.14951,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.17653,0.13897,0.040431,0,0
5,GO REGULATION OF INSULIN SECRETION,0.0010859,0.13821,0.15312,0,0
5,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.10096,0.13818,0.11228,0,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.087232,0.13814,0.10658,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.088862,0.13807,0.20709,0,0
5,GO ENDODERM DEVELOPMENT,0.12689,0.13797,0.095362,0,0
5,GO FAT CELL PROLIFERATION,0.12908,0.13786,0.16997,0,0
5,GO POSTSYNAPSE ORGANIZATION,0.16294,0.13729,0.091073,0,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.093897,0.13725,0.16518,0,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.69061,0.13684,0.018321,0,0
5,GO FORELIMB MORPHOGENESIS,0.17099,0.1368,0.12275,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.17934,0.13677,0.10757,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.085627,0.13641,0.11647,0,0
5,GO TRABECULA FORMATION,0.42855,0.13592,0.030104,0,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.073629,0.13572,0.091596,0,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.14526,0.13545,0.097575,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.13583,0.13537,0.19947,0,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.070855,0.13516,0.11253,0,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.054842,0.13514,0.11375,0,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0039469,0.13495,0.11849,0,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.079444,0.13484,0.088156,0,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.32938,0.13457,0.098163,0,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.26471,0.13436,0.050088,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.13355,0.13394,0.053569,0,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.052669,0.13379,0.12917,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.23245,0.13289,0.091406,0,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.033894,0.13276,0.16211,0,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.059411,0.13254,0.093673,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.25001,0.13253,0.12828,0,0
5,GO RECEPTOR CLUSTERING,0.10096,0.13229,0.1045,0,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.049546,0.13197,0.1296,0,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.016734,0.13183,0.11728,0,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.22235,0.13171,0.064193,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0079323,0.13066,0.17716,0,0
5,GO FOREBRAIN MORPHOGENESIS,0.64605,0.13028,0.014272,0,0
5,GO RESPONSE TO ACETYLCHOLINE,0.11235,0.13014,0.12454,0,0
5,GO CEREBELLAR CORTEX FORMATION,0.19695,0.13005,0.10314,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.52594,0.13002,5.0148e-06,0,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.068167,0.12993,0.097126,0,0
5,GO TRNA CATABOLIC PROCESS,0.073629,0.12963,0.23333,0,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.076492,0.12951,0.13049,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING,0.038561,0.1292,0.1089,0,0
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.33812,0.12901,0.06156,0,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.12259,0.1288,0.12794,0,0
5,GO NOTOCHORD DEVELOPMENT,0.10465,0.12862,0.13019,0,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.054842,0.1283,0.13529,0,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.041093,0.12803,0.16789,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.16294,0.12769,0.13521,0,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.44402,0.1272,0.083828,0,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.15264,0.12703,0.074291,0,0
5,GO COCHLEA MORPHOGENESIS,0.11039,0.12699,0.14981,0,0
5,GO INSEMINATION,0.11841,0.12697,0.20566,0,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.188,0.12694,0.21335,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.37932,0.12693,0.073023,0,0
5,GO RESPONSE TO FOOD,0.011326,0.12692,0.11665,0,0
5,GO RENAL FILTRATION,0.10845,0.1263,0.21089,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.30815,0.12515,0.057727,0,0
5,GO HINDBRAIN MORPHOGENESIS,0.057089,0.12508,0.08645,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.17374,0.12499,0.20365,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.50896,0.12472,0.025166,0,0
5,GO DENDRITIC CELL MIGRATION,0.085627,0.12452,0.15531,0,0
5,GO ARGININE METABOLIC PROCESS,0.22568,0.12411,0.088168,0,0
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0097392,0.12407,0.098809,0,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.50896,0.12394,0.021151,0,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.11841,0.12327,0.12508,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.31232,0.12321,0.13832,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.14526,0.12303,0.14021,0,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.25729,0.12293,0.057205,0,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.050569,0.12281,0.1139,0,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.077957,0.12277,0.11038,0,0
5,GO INTERLEUKIN 2 PRODUCTION,0.05824,0.12257,0.080041,0,0
5,GO SENSORY PERCEPTION OF PAIN,0.02843,0.12252,0.10877,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0695,0.12244,0.092255,0,0
5,GO ANIMAL ORGAN MATURATION,0.015203,0.12235,0.16771,0,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.40349,0.12227,0.059536,0,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.095625,0.12221,0.096298,0,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.2839,0.12183,0.135,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.22568,0.12182,0.32862,0,0
5,GO HORMONE CATABOLIC PROCESS,0.29586,0.12152,0.082309,0,0
5,GO SYNAPSE ASSEMBLY,0.034637,0.12129,0.14575,0,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.064293,0.12118,0.10189,0,0
5,GO FIBRINOLYSIS,0.19695,0.12086,0.068957,0,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.11235,0.12033,0.10072,0,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.095625,0.11915,0.11236,0,0
5,GO CHYLOMICRON ASSEMBLY,0.065563,0.1187,0.061323,0,0
5,GO NUCLEOSIDE SALVAGE,0.25363,0.11816,0.035367,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.053746,0.11797,0.089314,0,0
5,GO FIBROBLAST ACTIVATION,0.48131,0.11788,0.04271,0,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.1028,0.11695,0.088116,0,0
5,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.22905,0.11682,0.036592,0,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.073629,0.11671,0.094484,0,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.082489,0.11662,0.13268,0,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.15264,0.11642,0.068869,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.18219,0.11637,0.16265,0,0
5,GO RESPONSE TO MUSCLE INACTIVITY,0.4978,0.11616,0.056787,0,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.35153,0.11609,0.10265,0,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.19695,0.11589,0.076296,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.090515,0.11576,0.14979,0,0
5,GO NOREPINEPHRINE SECRETION,0.22235,0.11556,0.12165,0,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.055956,0.11551,0.082685,0,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0081404,0.11536,0.11711,0,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.26847,0.11534,0.083108,0,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.72969,0.11532,0.029086,0,0
5,GO REGIONALIZATION,0.0021062,0.11488,0.12141,0,0
5,GO REGULATION OF ACTION POTENTIAL,0.0695,0.11448,0.12013,0,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.57857,0.11448,0.012879,0,0
5,GO RENAL WATER HOMEOSTASIS,0.043763,0.11424,0.10131,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077957,0.11409,0.090226,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.022165,0.11405,0.086744,0,0
5,GO NEUROTRANSMITTER UPTAKE,0.42855,0.11377,0.059102,0,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.02166,0.11346,0.06758,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.21905,0.11337,0.13294,0,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.14048,0.11324,0.14377,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.084046,0.11278,0.15485,0,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.19695,0.11251,0.13499,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.080955,0.1124,0.15073,0,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.054842,0.11206,0.10382,0,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.22568,0.11141,0.047183,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.29992,0.11133,0.067417,0,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.070855,0.11102,0.093606,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.073629,0.11087,0.33701,0,0
5,GO POSTSYNAPSE ASSEMBLY,0.36526,0.11085,0.11756,0,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.070855,0.11076,0.12996,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.17934,0.11062,0.12207,0,0
5,GO RESPONSE TO ALKALOID,0.0066042,0.11057,0.12328,0,0
5,GO BONE MATURATION,0.20621,0.1103,0.070507,0,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.16294,0.11007,0.025889,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.21256,0.11005,0.11241,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.188,0.10998,0.096232,0,0
5,GO CELL REDOX HOMEOSTASIS,0.19393,0.1098,0.062561,0,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.1313,0.10975,0.079533,0,0
5,GO CALCIUM ION IMPORT,0.023205,0.10964,0.12589,0,0
5,GO STEROL IMPORT,0.16559,0.10917,0.055045,0,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,0.16828,0.10892,0.12231,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.034637,0.10848,0.18551,0,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.018398,0.10829,0.11291,0,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.055956,0.108,0.095627,0,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.40843,0.10781,0.087985,0,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.079444,0.10776,0.12754,0,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.17099,0.10766,0.065204,0,0
5,GO APICAL PROTEIN LOCALIZATION,0.087232,0.10757,0.15236,0,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.70355,0.10716,0.035954,0,0
5,GO VOCALIZATION BEHAVIOR,0.17934,0.10701,0.21945,0,0
5,GO PLASMA MEMBRANE TUBULATION,0.21579,0.10695,0.075083,0,0
5,GO NEURAL TUBE PATTERNING,0.47588,0.10693,0.021293,0,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.090515,0.10681,0.091188,0,0
5,GO MOTILE CILIUM ASSEMBLY,0.62732,0.10679,0.034514,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.35607,0.10659,0.1129,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.059411,0.10649,0.10721,0,0
5,GO PROTEIN MANNOSYLATION,0.16032,0.10623,0.08478,0,0
5,GO EMBRYO IMPLANTATION,0.2,0.10531,0.056839,0,0
5,GO RESPONSE TO ESTROGEN,0.063042,0.10484,0.075253,0,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.02068,0.10469,0.0935,0,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.20309,0.10461,0.070523,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.12689,0.1043,0.17211,0,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.26471,0.10373,0.07244,0,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.23937,0.10336,0.17352,0,0
5,GO MITRAL VALVE DEVELOPMENT,0.40349,0.10229,0.073713,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03245,0.10229,0.11964,0,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.10096,0.10221,0.078695,0,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.26847,0.10193,0.054528,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0040578,0.10183,0.14016,0,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.16294,0.10167,0.036482,0,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.12259,0.10167,0.090661,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.10654,0.1016,0.08188,0,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.3746,0.10146,0.056705,0,0
5,GO SUCKLING BEHAVIOR,0.63354,0.10145,0.019777,0,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.075049,0.10124,0.075771,0,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.29586,0.1012,0.095811,0,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.15773,0.10111,0.083087,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.084046,0.10109,0.078502,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.32938,0.101,0.04917,0,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.32077,0.10099,0.084949,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.4978,0.10086,0.045313,0,0
5,GO COLLAGEN METABOLIC PROCESS,0.17374,0.10086,0.067548,0,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.14526,0.10085,0.12264,0,0
5,GO PRESYNAPSE ORGANIZATION,0.13355,0.10052,0.1148,0,0
5,GO NEURAL RETINA DEVELOPMENT,0.36526,0.10043,0.060718,0,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.38888,0.10036,0.07142,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.090515,0.1003,0.093025,0,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.33373,0.099888,0.069106,0,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.088862,0.099702,0.095736,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.48131,0.099621,0.036806,0,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.20937,0.099496,0.095601,0,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.21579,0.098944,0.050297,0,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.35607,0.098864,0.08537,0,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.18508,0.098777,0.054644,0,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.24643,0.098593,0.040052,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.14048,0.098391,0.12836,0,0
5,GO SEQUESTERING OF TRIGLYCERIDE,0.21905,0.098346,0.09043,0,0
5,GO NEUROTRANSMITTER REUPTAKE,0.54321,0.098314,0.051924,0,0
5,GO NEURON PROJECTION ORGANIZATION,0.58456,0.098198,0.034272,0,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.16294,0.098086,0.069594,0,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.084046,0.098068,0.074365,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.05824,0.097983,0.12668,0,0
5,GO ROOF OF MOUTH DEVELOPMENT,0.053746,0.097877,0.096687,0,0
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.055956,0.097709,0.11061,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.66501,0.097506,0.043891,0,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.32077,0.097407,0.10013,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.31653,0.097183,0.099296,0,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.19393,0.096973,0.19649,0,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.14285,0.0969,0.062442,0,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.29586,0.096786,0.077571,0,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.39371,0.096588,0.080024,0,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.36991,0.095592,0.0090546,0,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.80989,0.095414,-0.016206,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.1313,0.095275,0.14115,0,0
5,GO SOMATIC STEM CELL DIVISION,0.53742,0.095179,0.082663,0,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.30402,0.095019,0.049529,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.14769,0.09496,0.070614,0,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.11841,0.094942,0.096212,0,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.16559,0.094715,0.041715,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.52025,0.094568,0.047798,0,0
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.16032,0.094549,0.065626,0,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.13814,0.094496,0.14008,0,0
5,GO REGULATION OF VESICLE FUSION,0.47588,0.094335,0.06966,0,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.087232,0.094293,0.079922,0,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.12908,0.094278,0.07501,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.25729,0.094096,0.049611,0,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.18508,0.094035,0.060877,0,0
5,GO OOCYTE DIFFERENTIATION,0.013465,0.094006,0.11223,0,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.41341,0.093889,0.046413,0,0
5,GO GLUCOSE IMPORT,0.054842,0.093829,0.085832,0,0
5,GO GOLGI TO ENDOSOME TRANSPORT,0.34256,0.093809,0.046347,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.47588,0.093801,0.072363,0,0
5,GO RESPONSE TO COCAINE,0.036948,0.093679,0.13403,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.13355,0.093574,0.11079,0,0
5,GO PYRUVATE METABOLIC PROCESS,0.1028,0.093374,0.072711,0,0
5,GO AUTOPHAGIC CELL DEATH,0.035393,0.093218,0.15756,0,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.11434,0.093155,0.12112,0,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.055956,0.093044,0.13398,0,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.41842,0.092863,0.030604,0,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.13814,0.092759,0.11275,0,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.65234,0.092434,0.012343,0,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.079444,0.092293,0.09852,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.71658,0.092149,0.027822,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.092019,0.075842,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.48678,0.092006,0.038171,0,0
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.11039,0.091495,0.11706,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.37932,0.091325,0.099369,0,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.12473,0.091085,0.14578,0,0
5,GO EMBRYONIC EYE MORPHOGENESIS,0.24643,0.091008,0.080484,0,0
5,GO AXIS SPECIFICATION,0.040234,0.090977,0.087155,0,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.031748,0.09095,0.06821,0,0
5,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.32077,0.090935,0.057948,0,0
5,GO SEROTONIN TRANSPORT,0.48678,0.090908,0.062653,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.053746,0.090769,0.10316,0,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.43367,0.090759,0.024961,0,0
5,GO REGULATION OF ACTIN NUCLEATION,0.20937,0.090668,0.091919,0,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.59664,0.090647,0.020209,0,0
5,GO OOGENESIS,0.038561,0.090617,0.077173,0,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.32938,0.09057,0.05111,0,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.092194,0.090415,0.12845,0,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.072231,0.090403,0.19837,0,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.4598,0.090257,0.043838,0,0
5,GO FOREBRAIN REGIONALIZATION,0.22235,0.090125,0.13287,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.20937,0.089706,0.085544,0,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.053746,0.089527,0.056239,0,0
5,GO COPPER ION TRANSPORT,0.16294,0.089497,0.14632,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.15517,0.089451,0.13083,0,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.16294,0.08902,0.12367,0,0
5,GO BONE CELL DEVELOPMENT,0.29586,0.089018,0.076624,0,0
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.093897,0.088987,0.14234,0,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0695,0.088763,0.060538,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.33373,0.088705,0.11438,0,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.55487,0.088647,-0.0077786,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.092194,0.088471,0.077365,0,0
5,GO ADHERENS JUNCTION ORGANIZATION,0.057089,0.08845,0.10414,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,0.041093,0.088366,0.10108,0,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.10465,0.088174,0.085017,0,0
5,GO REGULATION OF GLUCOSE IMPORT,0.13355,0.087673,0.068195,0,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.12473,0.087559,0.081093,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.27611,0.08711,0.066203,0,0
5,GO RESPONSE TO ACTIVITY,0.070855,0.086929,0.078865,0,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0049174,0.086814,0.082399,0,0
5,GO RESPONSE TO VITAMIN A,0.11841,0.086472,0.11304,0,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.095625,0.086428,0.068932,0,0
5,GO OXYGEN TRANSPORT,0.99651,0.086421,-0.063735,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.066855,0.086152,0.10335,0,0
5,GO ACTIN FILAMENT BASED TRANSPORT,0.19393,0.085911,0.11477,0,0
5,GO XENOBIOTIC TRANSPORT,0.17934,0.085758,0.051401,0,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.19393,0.085587,0.066951,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59059,0.085555,0.042547,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.26847,0.0854,0.077193,0,0
5,GO CELLULAR RESPONSE TO ATP,0.11039,0.085345,0.077441,0,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.047551,0.085291,0.094761,0,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.030383,0.08519,0.11768,0,0
5,GO L AMINO ACID TRANSPORT,0.188,0.084721,0.055259,0,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.17653,0.084651,0.084533,0,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.14048,0.084562,0.091158,0,0
5,GO GASTRULATION,0.12473,0.084302,0.067827,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.27611,0.084201,0.073804,0,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.18219,0.084164,0.059819,0,0
5,GO RESPONSE TO ATP,0.076492,0.084119,0.093975,0,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.15773,0.084062,0.06607,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.12908,0.083976,0.069454,0,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.4545,0.083931,0.05014,0,0
5,GO ACTIN NUCLEATION,0.13355,0.083793,0.079376,0,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.027188,0.083733,0.095607,0,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.19695,0.083719,0.062336,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.67776,0.083709,0.009302,0,0
5,GO ATRIAL SEPTUM DEVELOPMENT,0.21579,0.083573,0.1191,0,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.47588,0.083414,0.062058,0,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.25363,0.083388,0.099035,0,0
5,GO CILIUM MOVEMENT,0.019739,0.083212,0.074834,0,0
5,GO CELL FATE SPECIFICATION,0.16559,0.083165,0.10329,0,0
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.69061,0.083003,0.15747,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0067808,0.082997,0.12608,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.20621,0.08278,0.12346,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.10096,0.082528,0.082331,0,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.39858,0.082447,0.049142,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.20621,0.082268,0.066387,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.29184,0.082195,0.082208,0,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.095625,0.082142,0.077313,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.91293,0.08208,-0.039191,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.33812,0.082021,0.048912,0,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0695,0.081815,0.27532,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.25001,0.081666,0.043355,0,0
5,GO RNA DESTABILIZATION,0.36991,0.081534,0.012462,0,0
5,GO ECTODERM DEVELOPMENT,0.046579,0.081501,0.10002,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.35607,0.081386,0.046727,0,0
5,GO ESTROGEN BIOSYNTHETIC PROCESS,0.11434,0.081318,0.080301,0,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.26098,0.081311,0.084548,0,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.5726,0.08125,0.033727,0,0
5,GO SPERM MOTILITY,0.018398,0.081242,0.071994,0,0
5,GO MICROTUBULE SEVERING,0.53167,0.08119,0.034298,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.14285,0.080988,0.12098,0,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.30815,0.080949,0.11513,0,0
5,GO CELLULAR RESPONSE TO DRUG,0.188,0.080903,0.062341,0,0
5,GO SYNAPTIC SIGNALING,0.16294,0.080831,0.08707,0,0
5,GO RETINA HOMEOSTASIS,0.036948,0.080778,0.069131,0,0
5,GO ESTROGEN METABOLIC PROCESS,0.075049,0.080611,0.073688,0,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.16294,0.080562,0.053373,0,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.19095,0.080288,0.072084,0,0
5,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.20937,0.080213,0.090674,0,0
5,GO VACUOLAR ACIDIFICATION,0.059411,0.080086,0.071122,0,0
5,GO GENITALIA DEVELOPMENT,0.090515,0.080083,0.072543,0,0
5,GO NEGATIVE CHEMOTAXIS,0.2839,0.079861,0.077834,0,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.15015,0.079807,0.036123,0,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.080955,0.079674,0.11162,0,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.44924,0.079603,0.076223,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.21256,0.079502,0.065181,0,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.41341,0.079238,0.022242,0,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.073629,0.079032,0.21255,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.59664,0.079025,0.082855,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.80312,0.078857,-0.0076004,0,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.43883,0.07875,0.063734,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.013465,0.078635,0.10302,0,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.96163,0.078616,-0.079721,0,0
5,GO HEART GROWTH,0.085627,0.078598,0.069494,0,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.51459,0.078573,-0.0028943,0,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.019283,0.078395,0.13147,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.61497,0.078354,0.022541,0,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.17099,0.078288,0.04241,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.78289,0.078251,-0.081598,0,0
5,GO RESPONSE TO MANGANESE ION,0.35153,0.077851,0.045136,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.8303,0.077826,-0.06887,0,0
5,GO CELL RECOGNITION,0.27227,0.07744,0.04548,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.045624,0.07732,0.073937,0,0
5,GO SEGMENTATION,0.10096,0.077151,0.070135,0,0
5,GO ODONTOGENESIS,0.040234,0.076871,0.14091,0,0
5,GO ORGAN GROWTH,0.11039,0.07665,0.05067,0,0
5,GO RESPONSE TO SALT,0.20937,0.076588,0.057204,0,0
5,GO CELL JUNCTION DISASSEMBLY,0.41842,0.076566,0.0355,0,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.059411,0.07656,0.11102,0,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.076492,0.076488,0.10577,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.41341,0.076484,0.05783,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.39858,0.076411,0.068118,0,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.29184,0.076281,0.039718,0,0
5,GO NEURAL TUBE FORMATION,0.066855,0.076279,0.066976,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.41842,0.076279,0.042175,0,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.030383,0.076245,0.14064,0,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.27227,0.076116,0.16125,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.52594,0.076047,0.05479,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.52025,0.075934,0.027751,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.22568,0.07592,0.095187,0,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.36526,0.075839,0.11977,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.15264,0.07576,0.095993,0,0
5,GO NADP METABOLIC PROCESS,0.11434,0.075659,0.081685,0,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.21256,0.075605,0.14063,0,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.19095,0.075597,0.050684,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.26847,0.07547,0.08217,0,0
5,GO CARDIOCYTE DIFFERENTIATION,0.10096,0.075427,0.066847,0,0
5,GO DORSAL VENTRAL PATTERN FORMATION,0.050569,0.075292,0.11022,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.47588,0.075042,0.018402,0,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.099158,0.07493,0.12522,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.14285,0.074919,0.16197,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.033166,0.074858,0.16364,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.29184,0.074729,0.048743,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.13814,0.074703,0.1208,0,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.10654,0.074642,0.082507,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.12259,0.07454,0.080804,0,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.024846,0.074304,0.16026,0,0
5,GO MESODERM DEVELOPMENT,0.066855,0.074123,0.065221,0,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.16294,0.07332,0.076855,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.14285,0.073194,0.12156,0,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.25729,0.073123,0.057859,0,0
5,GO LEARNING,0.23589,0.073048,0.073529,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.21905,0.07293,0.07349,0,0
5,GO NUCLEOTIDE PHOSPHORYLATION,0.12689,0.072705,0.066731,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.20937,0.072668,0.027908,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.087232,0.072591,0.072347,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.30815,0.072223,0.07625,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.19393,0.072183,0.069449,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.15517,0.072182,0.20411,0,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.32506,0.072,0.094355,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.18219,0.071766,0.21095,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.44924,0.071737,0.056959,0,0
5,GO MESODERM MORPHOGENESIS,0.13814,0.071575,0.071755,0,0
5,GO PERICARDIUM DEVELOPMENT,0.28785,0.0715,0.066986,0,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.93377,0.071328,-0.012769,0,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.10096,0.071183,0.086625,0,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.14048,0.071145,0.092132,0,0
5,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.34256,0.070974,0.063526,0,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.15773,0.070867,0.093988,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.77618,0.070865,0.002615,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.080955,0.070719,0.15835,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.32506,0.070588,0.041443,0,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.11841,0.070533,0.055769,0,0
5,GO VITAMIN METABOLIC PROCESS,0.054842,0.070448,0.079907,0,0
5,GO MEGAKARYOCYTE DEVELOPMENT,0.63354,0.070249,0.07312,0,0
5,GO PHOTOPERIODISM,0.077957,0.070162,0.12733,0,0
5,GO LONG TERM MEMORY,0.084046,0.070138,0.11633,0,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.77618,0.070112,0.0016466,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.98953,0.070102,-0.025341,0,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.061812,0.069879,0.24143,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.76281,0.069647,0.029885,0,0
5,GO INTERLEUKIN 17 PRODUCTION,0.060602,0.069584,0.093873,0,0
5,GO MYOFIBRIL ASSEMBLY,0.05161,0.069526,0.0846,0,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.14526,0.069494,0.10784,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.74288,0.06932,-0.053764,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.23245,0.069183,0.060055,0,0
5,GO REGULATION OF CELL MATURATION,0.05824,0.069044,0.092246,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.4598,0.069022,0.015494,0,0
5,GO HISTONE H3 DEACETYLATION,0.44402,0.068993,0.038061,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.63978,0.068958,-0.11229,0,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.090515,0.068798,0.072935,0,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.019739,0.068784,0.090528,0,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.38888,0.068737,0.01361,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.19095,0.068513,0.25785,0,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.26471,0.068437,0.052656,0,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.31653,0.068244,0.019358,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.86455,0.068214,0.045869,0,0
5,GO PATTERN SPECIFICATION PROCESS,0.033166,0.068162,0.076854,0,0
5,GO LIMBIC SYSTEM DEVELOPMENT,0.23589,0.068148,0.071939,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.80989,0.068138,-0.078798,0,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.71006,0.06811,0.020314,0,0
5,GO SENSORY SYSTEM DEVELOPMENT,0.019283,0.068017,0.082917,0,0
5,GO HINDLIMB MORPHOGENESIS,0.52594,0.067658,0.033513,0,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.076492,0.06761,0.048101,0,0
5,GO ARTERY DEVELOPMENT,0.61497,0.067436,-0.011512,0,0
5,GO NEPHRON TUBULE FORMATION,0.52025,0.06708,0.063135,0,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.35607,0.066909,0.030747,0,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.78962,0.066589,0.0056523,0,0
5,GO RESPONSE TO ETHER,0.33373,0.066392,0.034592,0,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.24643,0.066287,0.059516,0,0
5,GO CILIUM ORGANIZATION,0.082489,0.06612,0.059032,0,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.47049,0.066033,-0.0096686,0,0
5,GO ADULT FEEDING BEHAVIOR,0.27999,0.066032,0.064945,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12473,0.066029,0.061363,0,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.39371,0.065993,0.078649,0,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.98953,0.065895,-0.018312,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.17374,0.065765,0.098274,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.47049,0.06576,0.061325,0,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.097379,0.06521,0.086159,0,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.10096,0.065102,0.084761,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.24643,0.065073,0.12205,0,0
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.13355,0.065025,0.09699,0,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.079444,0.064983,0.092459,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.20309,0.064932,0.10566,0,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.23937,0.064906,0.038729,0,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.52025,0.064788,-0.052764,0,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.35153,0.064754,0.049798,0,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.24643,0.064705,0.056134,0,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.48131,0.064569,0.030706,0,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.055956,0.064515,0.10928,0,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.48678,0.064397,0.048848,0,0
5,GO ERBB2 SIGNALING PATHWAY,0.61497,0.064225,0.010927,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.37932,0.064169,0.077297,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.16828,0.064106,0.067718,0,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.3746,0.064072,0.05785,0,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.58456,0.063865,0.058272,0,0
5,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.20309,0.063842,0.082483,0,0
5,GO APPENDAGE MORPHOGENESIS,0.17653,0.06383,0.076075,0,0
5,GO CHONDROCYTE PROLIFERATION,0.90599,0.063797,-0.042515,0,0
5,GO RECEPTOR RECYCLING,0.15264,0.063779,0.066122,0,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.36991,0.063775,0.097696,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.10465,0.063723,0.072316,0,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.78962,0.063496,0.002721,0,0
5,GO COENZYME A METABOLIC PROCESS,0.51459,0.063468,0.041132,0,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.97557,0.063411,-0.034054,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.73628,0.063406,0.033857,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.55487,0.06333,0.049871,0,0
5,GO CARDIAC CHAMBER DEVELOPMENT,0.18508,0.063319,0.050779,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.39371,0.063167,0.1221,0,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.19393,0.063144,0.067121,0,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.17374,0.063076,0.067106,0,0
5,GO BODY FLUID SECRETION,0.11636,0.063065,0.053947,0,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.4545,0.062988,0.027576,0,0
5,GO SEQUESTERING OF METAL ION,0.85768,0.062972,-0.049423,0,0
5,GO AORTA MORPHOGENESIS,0.24288,0.062963,0.054767,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.20621,0.062781,0.093101,0,0
5,GO SYNAPTIC VESICLE MATURATION,0.67137,0.06278,0.11377,0,0
5,GO HEART FIELD SPECIFICATION,0.78289,0.062734,0.033266,0,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.52594,0.062597,0.026346,0,0
5,GO T CELL HOMEOSTASIS,0.0695,0.062549,0.1103,0,0
5,GO SEQUESTERING OF CALCIUM ION,0.12908,0.062355,0.08317,0,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.22905,0.062335,0.043129,0,0
5,GO IMMATURE B CELL DIFFERENTIATION,0.64605,0.062334,0.030612,0,0
5,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.71658,0.062302,0.02251,0,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.17099,0.062256,0.10431,0,0
5,GO BONE GROWTH,0.94769,0.062219,-0.028637,0,0
5,GO SMOOTHENED SIGNALING PATHWAY,0.47588,0.062199,0.025936,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.21579,0.062192,0.059383,0,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.088862,0.062047,0.098798,0,0
5,GO AMINO ACID TRANSPORT,0.095625,0.061984,0.069627,0,0
5,GO SELECTIVE AUTOPHAGY,0.070855,0.061935,0.05302,0,0
5,GO ANIMAL ORGAN FORMATION,0.33373,0.06174,0.023854,0,0
5,GO VIRAL RELEASE FROM HOST CELL,0.16559,0.061631,0.060663,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.38408,0.061438,0.03414,0,0
5,GO ADULT BEHAVIOR,0.050569,0.060994,0.13162,0,0
5,GO METENCEPHALON DEVELOPMENT,0.14048,0.060756,0.096076,0,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.64605,0.060733,0.013935,0,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.43367,0.060679,0.015378,0,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.33812,0.060642,0.050024,0,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.55487,0.060465,0.020223,0,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.22568,0.060437,0.036569,0,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.26471,0.060316,0.063072,0,0
5,GO RESPONSE TO VITAMIN D,0.26471,0.060241,0.082097,0,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.036948,0.060143,0.067146,0,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.29184,0.060131,0.052983,0,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.28785,0.060126,0.067563,0,0
5,GO RESPONSE TO ZINC ION,0.066855,0.060116,0.13781,0,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.035393,0.06005,0.053287,0,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.17653,0.059877,0.071759,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.27999,0.059863,0.1823,0,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.21905,0.059819,0.087589,0,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.65866,0.05974,0.023891,0,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.36064,0.059638,0.067753,0,0
5,GO CORPUS CALLOSUM DEVELOPMENT,0.51459,0.059636,0.068755,0,0
5,GO MITOCHONDRIAL FUSION,0.63978,0.059577,0.009166,0,0
5,GO PEPTIDE CATABOLIC PROCESS,0.27999,0.0594,0.038011,0,0
5,GO CYTOSOLIC TRANSPORT,0.11841,0.059376,0.04624,0,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.19695,0.059213,0.06152,0,0
5,GO OSTEOCLAST DEVELOPMENT,0.41341,0.059081,0.079739,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.41842,0.059053,0.055967,0,0
5,GO HEART VALVE DEVELOPMENT,0.12689,0.059022,0.082165,0,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.21905,0.058599,0.062053,0,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.11039,0.058511,0.090462,0,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.23245,0.058094,0.084452,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.14048,0.057928,0.046965,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.53742,0.057671,0.023287,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.25363,0.057667,0.083189,0,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.097379,0.057639,0.11217,0,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.12908,0.057603,0.078005,0,0
5,GO SMOOTH MUSCLE CONTRACTION,0.12473,0.057454,0.075909,0,0
5,GO REGULATION OF GTPASE ACTIVITY,0.036948,0.057383,0.074811,0,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.2,0.057264,0.097751,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.57857,0.057185,0.0036538,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.23937,0.057022,0.10504,0,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.21256,0.056978,0.041386,0,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.021165,0.056934,0.093138,0,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.27999,0.05692,0.12095,0,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.73628,0.056814,0.0054924,0,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.30402,0.056751,0.05232,0,0
5,GO AORTIC VALVE DEVELOPMENT,0.43883,0.056676,0.029552,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.33812,0.056672,0.051763,0,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.62732,0.056647,0.032773,0,0
5,GO GENITALIA MORPHOGENESIS,0.41842,0.056632,0.057959,0,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.22905,0.056413,0.030698,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.35607,0.056355,0.035227,0,0
5,GO NOREPINEPHRINE TRANSPORT,0.32506,0.056352,0.080903,0,0
5,GO FOREGUT MORPHOGENESIS,0.28785,0.056177,0.067747,0,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.89907,0.056147,-0.016631,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.57857,0.055835,0.054712,0,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.20309,0.055747,0.051923,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.05824,0.055735,0.06173,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.085627,0.055634,0.044601,0,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.17099,0.055341,0.22926,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.56075,0.055087,-0.060472,0,0
5,GO LYMPH VESSEL DEVELOPMENT,0.50896,0.054876,0.013016,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.17934,0.054857,0.066419,0,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.27611,0.054591,0.073327,0,0
5,GO DETECTION OF LIGHT STIMULUS,0.047551,0.054523,0.057128,0,0
5,GO NADPH REGENERATION,0.62113,0.054391,0.033648,0,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.34702,0.054323,0.020128,0,0
5,GO IMMATURE T CELL PROLIFERATION,0.87144,0.054287,-0.031665,0,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.90599,0.054071,-0.015118,0,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.17934,0.054043,0.04716,0,0
5,GO OUTFLOW TRACT MORPHOGENESIS,0.55487,0.054014,0.01132,0,0
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.15264,0.053872,0.055979,0,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.24288,0.053733,0.060476,0,0
5,GO PULMONARY VALVE DEVELOPMENT,0.26471,0.053435,0.096679,0,0
5,GO BLASTOCYST DEVELOPMENT,0.1028,0.053022,0.046549,0,0
5,GO ENDODERM FORMATION,0.32077,0.053009,0.042207,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.60272,0.052986,0.046591,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.52025,0.052864,0.010781,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.62113,0.052743,0.031665,0,0
5,GO EXTRACELLULAR TRANSPORT,0.32938,0.0526,0.051879,0,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.72969,0.052586,0.044521,0,0
5,GO PROTEIN FOLDING,0.44402,0.052498,0.012649,0,0
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.034637,0.052478,0.071098,0,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.14526,0.052463,0.10302,0,0
5,GO CARNITINE SHUTTLE,0.4598,0.052403,0.050631,0,0
5,GO PLATELET MORPHOGENESIS,0.72969,0.052364,0.0069157,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.11235,0.052251,0.0724,0,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.26471,0.052223,0.089987,0,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.31232,0.051642,0.033388,0,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.29586,0.051608,0.041574,0,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.23589,0.051605,0.083307,0,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.2,0.051438,0.06691,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.71006,0.051138,0.00032121,0,0
5,GO REGULATION OF AXONOGENESIS,0.23937,0.051033,0.07627,0,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.36064,0.050723,0.061898,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.7495,0.050698,0.015731,0,0
5,GO RESPONSE TO IONIZING RADIATION,0.34702,0.050467,0.022257,0,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.19695,0.050409,0.058312,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.52025,0.050354,0.022075,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.25729,0.050258,0.086958,0,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.19393,0.050232,0.064387,0,0
5,GO MACROMOLECULE CATABOLIC PROCESS,0.25363,0.050144,0.020402,0,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.29992,0.050075,0.12077,0,0
5,GO FEMALE GAMETE GENERATION,0.33373,0.049949,0.032422,0,0
5,GO ZINC ION HOMEOSTASIS,0.17374,0.049719,0.11144,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.67137,0.049576,0.046184,0,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.35607,0.049497,0.085399,0,0
5,GO PIGMENT GRANULE ORGANIZATION,0.32938,0.04944,0.037231,0,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.65866,0.049416,0.12057,0,0
5,GO RESPONSE TO ANGIOTENSIN,0.46512,0.049116,0.022382,0,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.11039,0.049064,0.08264,0,0
5,GO REGULATION OF CHLORIDE TRANSPORT,0.73628,0.049039,0.014171,0,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.33812,0.048865,0.034913,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.33812,0.048779,0.052712,0,0
5,GO RESPONSE TO HEAT,0.67137,0.048467,0.0086862,0,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.98953,0.048414,0.014769,0,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.9686,0.048364,-0.043029,0,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.83713,0.048323,-0.0074838,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.21256,0.048273,0.03162,0,0
5,GO RESPONSE TO GLUCAGON,0.59059,0.048097,0.021241,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.12049,0.048004,0.13326,0,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.20937,0.047894,0.079557,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.35607,0.047739,0.053748,0,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.29586,0.047681,0.066357,0,0
5,GO SPERM AXONEME ASSEMBLY,0.065563,0.047554,0.15974,0,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.66501,0.047378,0.070596,0,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.35153,0.047343,0.064647,0,0
5,GO DIVALENT METAL ION EXPORT,0.69707,0.047271,-0.0028324,0,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.27611,0.047213,0.029271,0,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.39371,0.047074,0.060515,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.44402,0.046998,0.0059392,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.53742,0.046876,0.023052,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.4978,0.046759,0.021568,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.10845,0.046661,0.06659,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.42347,0.04661,0.049106,0,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.90599,0.046583,-0.0087004,0,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.20937,0.046438,0.04986,0,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.22568,0.046386,0.043792,0,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.25729,0.04638,0.059732,0,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.21256,0.046194,0.03353,0,0
5,GO NEURAL CREST CELL DIFFERENTIATION,0.15264,0.04613,0.09842,0,0
5,GO MALE GAMETE GENERATION,0.057089,0.046047,0.050378,0,0
5,GO L GLUTAMATE IMPORT,0.50337,0.046022,0.033549,0,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.30815,0.045964,0.060895,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.20937,0.045914,0.053242,0,0
5,GO VISUAL BEHAVIOR,0.12473,0.045879,0.083747,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.53742,0.045603,0.02452,0,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.34702,0.045513,0.074632,0,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.7495,0.045467,-0.0098856,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.057089,0.045412,0.054504,0,0
5,GO VESICLE LOCALIZATION,0.085627,0.045295,0.051095,0,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.10465,0.045112,0.094137,0,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.9686,0.045094,-0.038248,0,0
5,GO CELLULAR RESPONSE TO SALT STRESS,0.84397,0.044989,0.0043817,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.50337,0.044759,0.036594,0,0
5,GO FOREBRAIN DEVELOPMENT,0.1028,0.04466,0.079301,0,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.26098,0.044503,0.084666,0,0
5,GO AUTOPHAGOSOME MATURATION,0.087232,0.044424,0.087647,0,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.49227,0.044362,0.066292,0,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.53742,0.044332,0.0048626,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.56666,0.044274,0.023663,0,0
5,GO PIGMENT METABOLIC PROCESS,0.74288,0.044052,-0.009,0,0
5,GO RENAL VESICLE DEVELOPMENT,0.41341,0.04366,0.05682,0,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.21579,0.043653,0.045898,0,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.30402,0.04356,0.029717,0,0
5,GO RNA DECAPPING,0.54321,0.043558,0.023253,0,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.46512,0.043548,0.027802,0,0
5,GO SPLEEN DEVELOPMENT,0.10654,0.043328,0.097776,0,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.94073,0.043034,-0.023045,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.78289,0.042967,0.036555,0,0
5,GO INOSITOL METABOLIC PROCESS,0.21256,0.042924,0.078701,0,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.39371,0.042899,0.049772,0,0
5,GO TRACHEA DEVELOPMENT,0.32077,0.042854,0.15003,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.67137,0.04212,0.0059285,0,0
5,GO REGULATION OF CILIUM BEAT FREQUENCY,0.87144,0.042037,-0.016899,0,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.14048,0.041895,0.099218,0,0
5,GO FEAR RESPONSE,0.21905,0.041869,0.050144,0,0
5,GO HISTONE DEACETYLATION,0.15773,0.041794,0.048832,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.26847,0.041753,0.075719,0,0
5,GO NEURON REMODELING,0.34256,0.041746,0.10262,0,0
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.10465,0.041563,0.15078,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.68418,0.041559,-0.041888,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.27227,0.041414,0.07075,0,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.56666,0.041377,-0.00067473,0,0
5,GO REGULATION OF STEM CELL PROLIFERATION,0.46512,0.04136,0.034253,0,0
5,GO NAD BIOSYNTHETIC PROCESS,0.23245,0.041351,0.096039,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.24643,0.041073,0.033233,0,0
5,GO CELLULAR RESPONSE TO PH,0.65234,0.041017,0.020648,0,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.38408,0.040801,0.02715,0,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.30402,0.040796,0.028394,0,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.26098,0.040771,0.048166,0,0
5,GO BONE DEVELOPMENT,0.39371,0.040725,0.018303,0,0
5,GO PROTEIN POLYMERIZATION,0.17099,0.040666,0.051161,0,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.48678,0.040365,0.17385,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.4545,0.04035,0.039962,0,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.9686,0.040302,-0.02898,0,0
5,GO POST EMBRYONIC DEVELOPMENT,0.25729,0.040003,0.071769,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.25001,0.039547,0.082262,0,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.23589,0.039441,0.038749,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.24643,0.039435,0.055548,0,0
5,GO BONE MORPHOGENESIS,0.56075,0.039315,0.01186,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.15015,0.039303,0.060415,0,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.17653,0.039236,0.052927,0,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.94769,0.039109,-0.022539,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.42347,0.039066,0.036989,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.60883,0.038889,0.057553,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.26847,0.038792,0.031467,0,0
5,GO NEURON FATE COMMITMENT,0.79636,0.038618,0.08585,0,0
5,GO STEM CELL DIFFERENTIATION,0.17653,0.038421,0.054439,0,0
5,GO ORGANELLE DISASSEMBLY,0.15517,0.038411,0.049677,0,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.14526,0.038257,0.066576,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.14769,0.038239,0.11844,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.78289,0.038179,-0.0072876,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.084046,0.038165,0.065592,0,0
5,GO LYMPH NODE DEVELOPMENT,0.22235,0.037976,0.066856,0,0
5,GO MATING BEHAVIOR,0.66501,0.037945,0.027039,0,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.55487,0.037705,0.060145,0,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.40843,0.037636,0.083128,0,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.66501,0.037585,0.033405,0,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.48678,0.03747,0.021167,0,0
5,GO REGULATION OF ATPASE ACTIVITY,0.38888,0.037437,0.016579,0,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.84397,0.037315,-0.01483,0,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.16559,0.037209,0.070459,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.92682,0.03717,0.00095617,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.29184,0.036924,0.055079,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.082489,0.03688,0.081985,0,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.31653,0.036871,0.049473,0,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.33373,0.036746,0.058274,0,0
5,GO SPERMATID DIFFERENTIATION,0.22905,0.036667,0.03178,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.17099,0.036606,0.077713,0,0
5,GO PEPTIDYL PROLINE MODIFICATION,0.47049,0.036282,0.016473,0,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.16294,0.036275,0.17199,0,0
5,GO RESPONSE TO LIGHT STIMULUS,0.093897,0.036173,0.038152,0,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.83713,0.036028,-0.066617,0,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.27999,0.035778,0.081563,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.10096,0.035693,0.075723,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.31653,0.035669,0.02597,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.27999,0.035574,0.057295,0,0
5,GO LIPID PHOSPHORYLATION,0.25001,0.035384,0.048347,0,0
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.059411,0.035249,0.069086,0,0
5,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.89907,0.035235,-0.060094,0,0
5,GO PINOCYTOSIS,0.76948,0.035207,-0.0094893,0,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.78962,0.035147,-0.0084962,0,0
5,GO HYPEROSMOTIC RESPONSE,0.71658,0.035099,0.043095,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.41341,0.034963,0.033136,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.92682,0.034947,-0.036984,0,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.69061,0.034928,0.013444,0,0
5,GO REGULATION OF LIPASE ACTIVITY,0.20621,0.034918,0.058794,0,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.89215,0.034855,0.0020005,0,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.63354,0.034663,0.012404,0,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.62113,0.034544,0.020713,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.20621,0.034477,0.028362,0,0
5,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.64605,0.034287,0.038886,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.39371,0.034255,0.022046,0,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.94769,0.034174,-0.01971,0,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.67776,0.034156,-0.029998,0,0
5,GO SEROTONIN SECRETION,0.37932,0.034129,0.094724,0,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.71658,0.034105,0.027241,0,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.47049,0.03399,0.073142,0,0
5,GO REGULATION OF URINE VOLUME,0.58456,0.033508,0.021319,0,0
5,GO AXONAL FASCICULATION,0.44402,0.033385,0.10048,0,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.23937,0.033323,0.034402,0,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.36991,0.033139,0.049174,0,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.69061,0.033024,0.028665,0,0
5,GO PROTEIN TETRAMERIZATION,0.23589,0.032801,0.046946,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.9686,0.032647,-0.0081177,0,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,1,0.032531,-0.0093825,0,0
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.89907,0.032309,-0.017859,0,0
5,GO TRACHEA MORPHOGENESIS,0.3746,0.032189,0.11234,0,0
5,GO CELLULAR RESPONSE TO HEAT,0.80989,0.032045,-0.021131,0,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.8303,0.032032,-0.004793,0,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.1313,0.031966,0.048467,0,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.31653,0.03188,0.023304,0,0
5,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.41842,0.031845,0.084945,0,0
5,GO ALDITOL METABOLIC PROCESS,0.67137,0.031765,0.019399,0,0
5,GO REGULATION OF MICROTUBULE BINDING,0.61497,0.031666,0.030614,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.4598,0.031587,0.13482,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.39371,0.031555,0.038582,0,0
5,GO DENDRITIC CELL CHEMOTAXIS,0.27999,0.031545,0.11776,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.67137,0.031412,0.026454,0,0
5,GO RESPONSE TO OXYGEN RADICAL,0.16559,0.031387,0.073219,0,0
5,GO HEMOGLOBIN METABOLIC PROCESS,0.72313,0.03137,-0.010403,0,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.21579,0.031369,0.056051,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.51459,0.031351,0.011162,0,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.20621,0.031346,0.073088,0,0
5,GO NUCLEOSIDE METABOLIC PROCESS,0.41341,0.031343,0.026181,0,0
5,GO MITOCHONDRIAL TRANSPORT,0.72969,0.031253,0.0028083,0,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.93377,0.031201,-0.0037585,0,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.32506,0.031116,0.070649,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.80989,0.031032,-0.056019,0,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.75615,0.030955,-0.013141,0,0
5,GO TOXIN TRANSPORT,0.71006,0.030954,0.0093367,0,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.84397,0.03082,-0.035979,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.32506,0.030744,0.035672,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.61497,0.030674,0.020941,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.29992,0.03062,0.036561,0,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.68418,0.030527,-0.00041483,0,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.55487,0.030505,0.030586,0,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.55487,0.030451,0.017748,0,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.36526,0.030394,0.095046,0,0
5,GO MITOPHAGY,0.34702,0.03034,0.046949,0,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.51459,0.030337,0.03719,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.47588,0.030321,0.063536,0,0
5,GO REPLACEMENT OSSIFICATION,0.54903,0.030318,0.044958,0,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.74288,0.030308,-0.014942,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.25363,0.029963,0.036466,0,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.30402,0.029853,0.031234,0,0
5,GO GAS TRANSPORT,0.93377,0.029841,-0.045857,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.22568,0.029827,0.11333,0,0
5,GO HEME METABOLIC PROCESS,0.53167,0.029785,0.0042218,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.78962,0.029779,-0.001522,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.43883,0.02953,0.095065,0,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.87833,0.029481,-0.022677,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.25363,0.029405,0.083379,0,0
5,GO SOMITE DEVELOPMENT,0.11636,0.029272,0.058354,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.74288,0.029243,-0.022438,0,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.82348,0.029237,-0.010936,0,0
5,GO GENETIC IMPRINTING,0.47588,0.029222,0.062675,0,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.71006,0.029213,-0.022264,0,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.27227,0.029124,0.050458,0,0
5,GO NEURON FATE SPECIFICATION,0.43883,0.028971,0.20096,0,0
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.96163,0.028934,-0.0059008,0,0
5,GO MESENCHYME MORPHOGENESIS,0.27611,0.028912,0.026459,0,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.59664,0.028716,0.0083738,0,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.20309,0.02855,0.10553,0,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.64605,0.028541,0.022098,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.72313,0.02844,-0.026341,0,0
5,GO ORGANELLE INHERITANCE,0.56666,0.028369,0.039982,0,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.72969,0.028305,0.00085412,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.24643,0.028146,0.12335,0,0
5,GO MICROTUBULE ANCHORING,0.91987,0.028142,0.014783,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.68418,0.028082,0.029042,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.33812,0.028018,0.040286,0,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.9686,0.027798,-0.0003917,0,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.4978,0.027767,0.028699,0,0
5,GO HEAT GENERATION,0.91987,0.027669,-0.0063056,0,0
5,GO SPECIFICATION OF SYMMETRY,0.47588,0.027477,0.013971,0,0
5,GO REGULATION OF DNA RECOMBINATION,0.80312,0.027411,0.0074556,0,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.22905,0.027341,0.04545,0,0
5,GO PORE COMPLEX ASSEMBLY,0.83713,0.027234,0.012416,0,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.48131,0.027125,0.070545,0,0
5,GO UV DAMAGE EXCISION REPAIR,0.69707,0.02704,0.018335,0,0
5,GO DENDRITIC SPINE MORPHOGENESIS,0.87144,0.026921,-0.012754,0,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.39371,0.02686,0.036487,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.53742,0.026645,0.12783,0,0
5,GO NEURON PROJECTION ARBORIZATION,0.27227,0.026557,0.10784,0,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.94073,0.026436,0.020359,0,0
5,GO REGULATION OF MYELINATION,0.93377,0.026304,0.015068,0,0
5,GO CELL JUNCTION MAINTENANCE,0.84397,0.02612,0.016946,0,0
5,GO PROSTATIC BUD FORMATION,0.78962,0.026107,0.055003,0,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.96163,0.025893,-0.033474,0,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.36991,0.025856,0.06421,0,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.4545,0.025799,0.040881,0,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.92682,0.025726,-0.020252,0,0
5,GO HISTONE H4 DEACETYLATION,0.62113,0.025708,0.046745,0,0
5,GO RESPONSE TO RADIATION,0.072231,0.02543,0.04038,0,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.64605,0.025327,-0.0062391,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.77618,0.025213,0.016009,0,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.11841,0.025197,0.1358,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.22568,0.025194,0.12623,0,0
5,GO HEMIDESMOSOME ASSEMBLY,0.80989,0.02512,-0.036806,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.65234,0.02504,0.040249,0,0
5,GO ORGANELLE LOCALIZATION,0.075049,0.024998,0.049899,0,0
5,GO REGULATION OF OOGENESIS,0.72313,0.024705,0.00047078,0,0
5,GO PEPTIDYL THREONINE MODIFICATION,0.036948,0.024346,0.077541,0,0
5,GO MITOCHONDRIAL FISSION,0.72313,0.024283,0.014216,0,0
5,GO NEURON PROJECTION EXTENSION,0.25363,0.024261,0.084379,0,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.9686,0.024236,-0.0075736,0,0
5,GO HISTONE H2B UBIQUITINATION,0.53742,0.023654,0.019004,0,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.91293,0.023571,-0.029734,0,0
5,GO TRANSEPITHELIAL TRANSPORT,0.89907,0.023498,-0.017877,0,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.4978,0.023447,0.0037794,0,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.2839,0.023405,0.036376,0,0
5,GO MICROTUBULE BASED MOVEMENT,0.69707,0.023399,0.0060469,0,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.31653,0.023364,0.064189,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.91987,0.023289,-0.013805,0,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.56666,0.02325,0.030914,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.23245,0.023235,0.055754,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.63978,0.02301,0.029072,0,0
5,GO REGULATION OF MACROAUTOPHAGY,0.080955,0.022978,0.057173,0,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.74288,0.022809,0.00035548,0,0
5,GO CELL PART MORPHOGENESIS,0.53742,0.022765,0.043512,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY,0.56666,0.022734,0.009375,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.62732,0.022696,0.0092295,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.77618,0.02261,-0.022918,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.9686,0.022394,-0.031723,0,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.71006,0.022115,0.041047,0,0
5,GO PROTEIN DEMETHYLATION,0.88523,0.021943,0.0012791,0,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.46512,0.021935,0.021583,0,0
5,GO MEMBRANE DOCKING,0.17653,0.021826,0.055017,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.54321,0.021807,0.096551,0,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.84397,0.021792,-0.011202,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.90599,0.021762,0.0051839,0,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.34256,0.021678,0.055223,0,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.69061,0.021622,-0.027639,0,0
5,GO BIOLOGICAL PHASE,0.63978,0.02151,0.04562,0,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.16828,0.02136,0.068185,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.56075,0.021299,0.011202,0,0
5,GO OTIC VESICLE MORPHOGENESIS,0.54903,0.021198,-0.087632,0,0
5,GO HEART FORMATION,0.98953,0.020916,0.0011179,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.92682,0.020624,0.0062384,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.48131,0.020535,0.033455,0,0
5,GO OVULATION,0.73628,0.020487,-0.061208,0,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.70355,0.02046,0.0032516,0,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.3746,0.020413,0.027885,0,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.26098,0.020402,0.054025,0,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.44402,0.020302,0.10918,0,0
5,GO REGULATION OF ORGAN GROWTH,0.71658,0.020249,0.0054728,0,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.36991,0.020062,0.040711,0,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.31232,0.020053,0.0361,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.52594,0.020019,0.027429,0,0
5,GO MEIOTIC CELL CYCLE,0.50896,0.019943,0.027409,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.94073,0.019725,-0.00077984,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.69061,0.019657,0.018157,0,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.56666,0.019587,0.029582,0,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.89215,0.019518,0.012767,0,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.71006,0.019425,-0.0010288,0,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.68418,0.0194,-0.022451,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.62113,0.019356,0.024311,0,0
5,GO CARDIAC SEPTUM DEVELOPMENT,0.41341,0.019144,0.041492,0,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.85768,0.018896,-0.018527,0,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.93377,0.01886,-0.00047567,0,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.68418,0.018779,0.049285,0,0
5,GO MYELOID CELL DEVELOPMENT,0.25363,0.018612,0.05626,0,0
5,GO REGULATION OF HEAT GENERATION,0.90599,0.018484,-0.016717,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.50337,0.018284,0.028278,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.78962,0.018146,-0.016054,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.61497,0.01807,-0.032653,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.56666,0.017934,0.0097084,0,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.14526,0.017708,0.079241,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.90599,0.0174,0.013664,0,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.63354,0.017385,0.038906,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.89907,0.016929,0.012709,0,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.56666,0.016845,0.041041,0,0
5,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.81668,0.01632,0.0039431,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.2839,0.016245,0.20696,0,0
5,GO RESPONSE TO LEUCINE,0.59059,0.01624,0.063773,0,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.76281,0.016237,-0.0066153,0,0
5,GO CELL CYCLE,0.50337,0.016136,0.015919,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.67137,0.016056,-0.044605,0,0
5,GO REGULATION OF HEART GROWTH,0.89907,0.016049,-0.016861,0,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.80989,0.015997,0.010576,0,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,1,0.015925,-0.0015385,0,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.91987,0.015865,-0.001796,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.68418,0.015536,0.017234,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.91987,0.015362,0.023805,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.72313,0.0153,0.026886,0,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.65234,0.015289,-0.0013964,0,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.37932,0.015244,0.017878,0,0
5,GO DNA MODIFICATION,0.61497,0.015043,0.016485,0,0
5,GO NEURAL CREST FORMATION,0.47049,0.014937,-0.085557,0,0
5,GO AXON DEVELOPMENT,0.41341,0.014922,0.053592,0,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.74288,0.014915,0.0028064,0,0
5,GO THYROID GLAND DEVELOPMENT,0.64605,0.014518,0.050386,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.40843,0.014426,0.062811,0,0
5,GO T CELL CHEMOTAXIS,0.62113,0.014393,-0.0018488,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.42855,0.014369,0.01932,0,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.56075,0.014233,0.072769,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.66501,0.014124,-0.08573,0,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.31653,0.013954,0.049533,0,0
5,GO NEGATIVE REGULATION OF CELL SIZE,0.79636,0.013915,-0.011035,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.98953,0.0137,-0.02192,0,0
5,GO PROTEIN ACTIVATION CASCADE,0.26847,0.013544,0.083846,0,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.78289,0.013216,-0.035937,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.41842,0.013117,0.028689,0,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.7495,0.013106,0.0030297,0,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.50337,0.013092,0.086922,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.78289,0.013052,0.0030717,0,0
5,GO REGULATION OF BEHAVIOR,0.58456,0.012728,0.03196,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.73628,0.012695,-0.0047224,0,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.50337,0.012623,0.033163,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.69061,0.012545,0.04019,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.73628,0.012541,-0.027408,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.85082,0.012512,-0.002284,0,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.65866,0.012495,0.018646,0,0
5,GO OVULATION CYCLE PROCESS,0.7495,0.01248,-0.0019476,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.69707,0.012293,-0.032007,0,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.43367,0.012176,0.062569,0,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.59664,0.012078,0.047759,0,0
5,GO URONIC ACID METABOLIC PROCESS,0.62732,0.011974,-0.0491,0,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.75615,0.01193,0.0029913,0,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.68418,0.011713,0.015989,0,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.88523,0.011598,-0.010531,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.79636,0.011141,0.0041889,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.87144,0.011133,-0.0011263,0,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.99651,0.010938,0.0068368,0,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.68418,0.010861,0.078165,0,0
5,GO REGULATION OF ERAD PATHWAY,0.87144,0.010795,-0.0010938,0,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.53167,0.010753,0.069947,0,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.38408,0.010746,0.068267,0,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.47588,0.010735,-0.056945,0,0
5,GO MITOTIC CYTOKINESIS,0.92682,0.010485,-0.010821,0,0
5,GO METHIONINE METABOLIC PROCESS,0.4545,0.010425,0.065463,0,0
5,GO MISMATCH REPAIR,0.33373,0.010172,0.034187,0,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.3746,0.010144,0.13695,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.52025,0.01005,0.061045,0,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.82348,0.010026,-0.0073117,0,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.49227,0.0098216,-0.081675,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.89907,0.0097295,-0.0044058,0,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.85768,0.0097014,-0.017314,0,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.43883,0.0095207,0.039227,0,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.68418,0.009481,-0.013148,0,0
5,GO HISTONE H4 ACETYLATION,0.74288,0.009477,0.01899,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.57857,0.009265,0.01593,0,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.77618,0.0091433,-0.0023793,0,0
5,GO PODOSOME ASSEMBLY,0.59664,0.0090167,0.036299,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.60272,0.0088104,0.029944,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.71006,0.0085864,0.010368,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.54321,0.0085485,0.035468,0,0
5,GO COPULATION,0.85082,0.0084931,0.028506,0,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.84397,0.0084894,-0.02189,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.62732,0.0080584,0.017804,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.87833,0.0078963,-0.006201,0,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.80989,0.0078535,-0.03803,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.57857,0.0076228,0.022778,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.43367,0.0075274,0.035438,0,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.94769,0.0071665,-0.011403,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.86455,0.0071662,-0.0071496,0,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.94769,0.0071235,-0.014187,0,0
5,GO MULTI ORGANISM LOCALIZATION,0.7495,0.0070005,-0.043782,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.49227,0.0069197,-0.034222,0,0
5,GO AXON EXTENSION,0.91293,0.006892,0.026106,0,0
5,GO REGULATION OF HISTONE MODIFICATION,0.40843,0.006835,0.035604,0,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.56666,0.0066935,0.039608,0,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.60883,0.0065189,-0.035223,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.89907,0.0064189,-0.0017383,0,0
5,GO LIVER REGENERATION,0.53742,0.006402,-0.012216,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.80312,0.0062383,0.016563,0,0
5,GO MALE MEIOSIS I,0.99651,0.0061312,0.024671,0,0
5,GO REGULATION OF MITOPHAGY,0.46512,0.0061136,0.04545,0,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.82348,0.0060238,-0.012471,0,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.60272,0.0056765,0.052208,0,0
5,GO HISTONE MONOUBIQUITINATION,0.92682,0.005439,0.00084421,0,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.99651,0.0053134,0.0088713,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.43367,0.0052576,-0.062672,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.71006,0.005044,0.030833,0,0
5,GO SYNAPTIC VESICLE RECYCLING,0.24288,0.0049504,0.10983,0,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.87833,0.0045551,-0.034673,0,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.79636,0.004545,-0.013071,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.71658,0.0044712,-0.011957,0,0
5,GO REGULATION OF PODOSOME ASSEMBLY,0.72313,0.0044098,0.031019,0,0
5,GO DENDRITE MORPHOGENESIS,0.78962,0.0043389,0.018562,0,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.63354,0.0041395,0.013717,0,0
5,GO MITOTIC CELL CYCLE,0.87144,0.0041378,-0.0039036,0,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.9686,0.0040304,-0.013232,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.99651,0.003996,0.0076314,0,0
5,GO SYNAPTIC VESICLE DOCKING,0.52025,0.0039778,0.12415,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.9686,0.0039324,-0.0058642,0,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.60272,0.0038205,-0.033202,0,0
5,GO MITOCHONDRION ORGANIZATION,0.43883,0.0037335,0.017819,0,0
5,GO FOREBRAIN CELL MIGRATION,0.67137,0.0034872,0.029933,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.31653,0.003421,0.044441,0,0
5,GO NEUROTRANSMITTER TRANSPORT,0.72969,0.0031471,0.063213,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.5726,0.0031101,-0.025327,0,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.62732,0.0028668,-0.0019675,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.64605,0.0027717,0.013598,0,0
5,GO MATING,0.59664,0.0027419,0.031829,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.91293,0.0026367,0.015209,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.86455,0.0025743,0.025561,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.76948,0.0022911,0.048379,0,0
5,GO CELL CYCLE PROCESS,0.79636,0.0021171,-0.0044783,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.99651,0.0019301,-0.028873,0,0
5,GO RESPONSE TO X RAY,0.81668,0.0019045,-0.042982,0,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.91293,0.001763,-0.019551,0,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.70355,0.0017329,0.0349,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.60883,0.001723,0.060036,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.88523,0.0017165,-0.0071441,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.70355,0.0016444,0.018224,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.3746,0.0015094,0.053434,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.60272,0.0014836,0.011074,0,0
5,GO NUCLEUS ORGANIZATION,0.80312,0.0014587,-0.012059,0,0
5,GO FILOPODIUM ASSEMBLY,0.60883,0.0014486,0.050587,0,0
5,GO MUSCLE FILAMENT SLIDING,1,0.0013358,-0.0090762,0,0
5,GO ELECTRON TRANSPORT CHAIN,0.76948,0.0011729,0.00089184,0,0
5,GO CYTOKINESIS,0.89907,0.00095921,-0.0023695,0,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.85082,0.00093001,-0.032459,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.78962,0.00070462,-0.00063575,0,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.71006,0.00058742,-0.020424,0,0
5,GO TORC1 SIGNALING,0.74288,0.00056952,-0.021035,0,0
5,GO CELL DIVISION,0.97557,0.00042258,0.0024482,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.19695,0.00028497,0.23776,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,0.9686,5.0366e-05,-0.019014,0,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.60883,4.7901e-06,-0.068588,0,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.94769,-0.00036671,-0.0077501,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.47049,-0.00038376,0.050616,0,0
5,GO PIGMENT ACCUMULATION,0.82348,-0.00097995,0.020505,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.5726,-0.0010789,0.056664,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.98953,-0.0011313,-0.0075085,0,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.42347,-0.0011571,-0.067986,0,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.73628,-0.0012769,-0.025909,0,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.47049,-0.0013297,0.10612,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.83713,-0.0013503,-0.0034435,0,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.81668,-0.0018012,-0.017001,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.83713,-0.001949,-0.0075605,0,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.85768,-0.002128,-0.029373,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.94769,-0.0021995,-0.0059515,0,0
5,GO CYCLOOXYGENASE PATHWAY,0.87833,-0.0022576,-0.021697,0,0
5,GO HISTONE H4 K16 ACETYLATION,0.89907,-0.0025923,0.0010926,0,0
5,GO HISTONE H4 K5 ACETYLATION,0.79636,-0.0028982,0.039244,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.25363,-0.0032839,-0.097526,0,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.94769,-0.0035322,-0.0081038,0,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.55487,-0.0035435,-0.044043,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.27999,-0.0039815,-0.090639,0,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.95466,-0.0039916,0.0049975,0,0
5,GO RESPONSE TO INTERLEUKIN 7,0.79636,-0.0040011,-0.02283,0,0
5,GO CELLULAR RESPONSE TO X RAY,0.33373,-0.0040015,-0.107,0,0
5,GO HYPOTONIC RESPONSE,0.88523,-0.0040491,0.02727,0,0
5,GO PROTEIN LOCALIZATION TO CILIUM,0.49227,-0.0041339,-0.047487,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.37932,-0.0042745,-0.068142,0,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.96163,-0.0043363,-0.020582,0,0
5,GO GROOMING BEHAVIOR,0.81668,-0.004434,-0.0040858,0,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.2839,-0.004499,-0.042791,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.50896,-0.00451,0.062319,0,0
5,GO DETECTION OF VISIBLE LIGHT,0.72969,-0.0045675,-0.011918,0,0
5,GO RESPONSE TO SALT STRESS,0.76948,-0.0048858,-0.02903,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.9686,-0.0049953,-0.0055529,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.15264,-0.0053788,-0.056198,0,0
5,GO MRNA TRANSCRIPTION,0.78962,-0.0053852,0.0043489,0,0
5,GO HIPPOCAMPUS DEVELOPMENT,0.97557,-0.0053904,0.0031004,0,0
5,GO BASEMENT MEMBRANE ASSEMBLY,0.44402,-0.0056366,0.16643,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.79636,-0.005645,0.055486,0,0
5,GO REGULATION OF PINOCYTOSIS,0.86455,-0.0057159,-0.01102,0,0
5,GO STRIATUM DEVELOPMENT,0.78962,-0.0057324,-0.021989,0,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.53167,-0.0059223,0.064375,0,0
5,GO PEPTIDYL LYSINE ACETYLATION,0.54321,-0.006028,-0.0035292,0,0
5,GO ORGANELLE ASSEMBLY,0.80989,-0.0061711,0.0098785,0,0
5,GO TELENCEPHALON DEVELOPMENT,0.44924,-0.0062495,0.044052,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.4598,-0.0063646,0.03778,0,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.93377,-0.0068043,-0.020904,0,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.55487,-0.007305,0.032763,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.94769,-0.0073488,-0.0062991,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.44924,-0.0073633,0.035853,0,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.54903,-0.0077123,0.023895,0,0
5,GO CONVERGENT EXTENSION,0.85768,-0.0078408,-0.0086701,0,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.98953,-0.0078888,0.0098861,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.91293,-0.0078917,-0.0024609,0,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.73628,-0.0079089,0.022787,0,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.87144,-0.0079641,-0.018581,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.97557,-0.0080194,-0.01053,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.90599,-0.0081408,-0.0056362,0,0
5,GO PRIMARY MIRNA PROCESSING,0.88523,-0.0084191,-0.007104,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.94769,-0.0086979,0.013725,0,0
5,GO PROTEIN IMPORT,0.48678,-0.0088856,-0.031596,0,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.60272,-0.0088884,-0.067884,0,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.42855,-0.0089777,-0.053072,0,0
5,GO REGULATION OF LYASE ACTIVITY,0.76281,-0.0090328,-0.017671,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.21905,-0.009115,-0.057521,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.98255,-0.0092026,0.0018528,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.99651,-0.0092587,-0.016769,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.98255,-0.0093135,0.0092651,0,0
5,GO MYOBLAST MIGRATION,0.94073,-0.0094497,-0.020308,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.97557,-0.009654,0.0019579,0,0
5,GO RESPONSE TO INTERLEUKIN 12,0.59664,-0.009708,-0.045713,0,0
5,GO AORTA DEVELOPMENT,0.94769,-0.0097455,-0.027523,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.88523,-0.010048,-0.0089011,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.31653,-0.010263,0.0098982,0,0
5,GO RRNA CATABOLIC PROCESS,0.36991,-0.010332,0.065519,0,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.70355,-0.01036,0.071283,0,0
5,GO P BODY ASSEMBLY,0.53167,-0.010482,-0.027804,0,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.50337,-0.010535,-0.045231,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.73628,-0.010595,0.0097632,0,0
5,GO INTRACILIARY TRANSPORT,0.91987,-0.010726,0.019878,0,0
5,GO ATP TRANSPORT,0.43367,-0.011078,0.036325,0,0
5,GO ATP METABOLIC PROCESS,0.49227,-0.011309,0.021825,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.88523,-0.011334,-0.011056,0,0
5,GO REGULATION OF DNA REPLICATION,0.58456,-0.01158,0.015817,0,0
5,GO HISTONE H3 K9 MODIFICATION,0.90599,-0.011622,0.0088195,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.59059,-0.011692,-0.059962,0,0
5,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.59059,-0.011772,0.074777,0,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.54903,-0.011793,0.091644,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.41341,-0.01186,-0.050551,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.94073,-0.012116,-0.010759,0,0
5,GO HISTONE H2A UBIQUITINATION,0.91987,-0.012191,0.0043745,0,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.94769,-0.012245,0.022999,0,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.73628,-0.012404,0.0031822,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.90599,-0.012404,0.021123,0,0
5,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.43883,-0.012439,-0.074508,0,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.69707,-0.01244,-0.040912,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.99651,-0.012451,0.012463,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.98953,-0.012459,0.0023377,0,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.85768,-0.012509,-0.025932,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.88523,-0.012761,-0.021106,0,0
5,GO HISTONE H3 K36 METHYLATION,0.40843,-0.012872,-0.047008,0,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.69707,-0.012887,-0.022913,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.56666,-0.013059,-0.051836,0,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.39371,-0.013095,-0.081871,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.86455,-0.013146,0.013857,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.85768,-0.013284,-0.0076879,0,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.62113,-0.013383,-0.033848,0,0
5,GO PRE MIRNA PROCESSING,0.33812,-0.013962,-0.085348,0,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.54903,-0.014045,-0.075161,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.66501,-0.014154,-0.048955,0,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.89907,-0.014196,-0.0090146,0,0
5,GO DOSAGE COMPENSATION,0.57857,-0.014245,-0.024146,0,0
5,GO ACETYL COA METABOLIC PROCESS,0.85082,-0.014352,-0.0097617,0,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.4978,-0.01438,0.041515,0,0
5,GO SULFATION,0.77618,-0.014634,-0.030967,0,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.69707,-0.01478,0.052981,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.29184,-0.01484,-0.044733,0,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.49227,-0.014843,-0.027563,0,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.91987,-0.014846,0.0090215,0,0
5,GO MICROTUBULE BASED TRANSPORT,0.59059,-0.014957,-0.021844,0,0
5,GO REGULATION OF NEURON MIGRATION,0.57857,-0.015283,-0.053999,0,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.83713,-0.015391,-0.02762,0,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.56075,-0.015489,0.074423,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.44402,-0.015879,-0.020427,0,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.52025,-0.016066,-0.03899,0,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.78289,-0.016121,-0.00050855,0,0
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.17374,-0.016252,0.29262,0,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.55487,-0.016455,-0.047022,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.89215,-0.016486,-0.0045522,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.92682,-0.016495,-0.029827,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.60272,-0.016561,-0.031807,0,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.89215,-0.016564,0.010651,0,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.60883,-0.016696,-0.053555,0,0
5,GO G2 DNA DAMAGE CHECKPOINT,0.87833,-0.01672,0.0085423,0,0
5,GO PROTEIN ACYLATION,0.91987,-0.016976,0.013974,0,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.77618,-0.017207,-0.038117,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.31232,-0.017328,-0.082569,0,0
5,GO PROTEIN TRIMERIZATION,0.50337,-0.01733,-0.072144,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.60272,-0.017438,-0.0069678,0,0
5,GO COVALENT CHROMATIN MODIFICATION,0.47049,-0.017662,-0.010372,0,0
5,GO DENDRITE DEVELOPMENT,0.72313,-0.017815,0.034978,0,0
5,GO INTERACTION WITH SYMBIONT,0.90599,-0.017908,-0.025987,0,0
5,GO LYSINE METABOLIC PROCESS,0.32938,-0.018032,-0.12169,0,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.58456,-0.018154,-0.024425,0,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.81668,-0.018167,0.051415,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.95466,-0.018192,-0.0078502,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.88523,-0.018347,0.010712,0,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.98953,-0.018953,-0.018395,0,0
5,GO CHROMATIN ORGANIZATION,0.34256,-0.01899,-0.020198,0,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.65866,-0.019016,-0.035815,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.34702,-0.019268,-0.040427,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.8303,-0.019465,-0.0016292,0,0
5,GO COLLECTING DUCT DEVELOPMENT,0.72969,-0.019672,0.030278,0,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.39371,-0.019843,-0.084054,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.78289,-0.019999,-0.060451,0,0
5,GO SPINAL CORD DEVELOPMENT,0.38408,-0.020051,0.067452,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.8303,-0.020303,-0.0214,0,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.36526,-0.020347,-0.058326,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.79636,-0.020585,0.011782,0,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.2839,-0.020638,-0.032668,0,0
5,GO MICROTUBULE BASED PROCESS,0.67776,-0.02066,0.0018438,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.8303,-0.020732,-0.0063668,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.72969,-0.020846,-0.018062,0,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.85768,-0.020916,0.0089566,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.57857,-0.021302,-0.024062,0,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.87144,-0.021484,0.001895,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.32077,-0.021497,-0.039125,0,0
5,GO NEURON PROJECTION GUIDANCE,0.72313,-0.02168,0.034913,0,0
5,GO CARTILAGE MORPHOGENESIS,0.62732,-0.021741,-0.064916,0,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.35153,-0.022007,-0.10242,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.74288,-0.022371,-0.018113,0,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.99651,-0.022391,0.018784,0,0
5,GO RESPIRATORY SYSTEM PROCESS,0.36526,-0.022622,-0.058499,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.62113,-0.022759,-0.035308,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.78289,-0.022998,-0.018128,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.43367,-0.023193,-0.088962,0,0
5,GO LEUKOCYTE AGGREGATION,0.65866,-0.023204,-0.10201,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.94073,-0.02348,-0.037673,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.70355,-0.023506,0.031653,0,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.78962,-0.023525,-0.0088926,0,0
5,GO SPINDLE LOCALIZATION,0.59059,-0.023804,-0.016443,0,0
5,GO PROTEIN KINASE A SIGNALING,0.59059,-0.024051,-0.033596,0,0
5,GO ONE CARBON METABOLIC PROCESS,0.84397,-0.024158,-0.0031953,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,1,-0.024168,0.012095,0,0
5,GO GLUCOSE CATABOLIC PROCESS,0.7495,-0.024238,-0.022593,0,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.87144,-0.024347,0.0044839,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.29586,-0.024452,-0.064823,0,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.69061,-0.024722,0.0026892,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.33812,-0.024726,-0.07821,0,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.188,-0.024749,-0.056289,0,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.85082,-0.024873,-0.04905,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.78962,-0.024896,-0.0061454,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.91293,-0.024927,0.0056408,0,0
5,GO OOCYTE MATURATION,0.89215,-0.025233,0.013979,0,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.71006,-0.025277,-0.052376,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.88523,-0.025401,0.013322,0,0
5,GO DNA INTEGRITY CHECKPOINT,0.38888,-0.025527,-0.022688,0,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.36991,-0.025866,-0.033581,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.65866,-0.025905,-0.047381,0,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.26098,-0.025934,-0.040038,0,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.85768,-0.026239,-0.00083037,0,0
5,GO AEROBIC RESPIRATION,0.32077,-0.026306,-0.066291,0,0
5,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.70355,-0.026404,-0.03859,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.63354,-0.026552,-0.0086907,0,0
5,GO IMPORT INTO NUCLEUS,0.32938,-0.026864,-0.041765,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.64605,-0.027004,-0.042785,0,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.74288,-0.027101,-0.010854,0,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.62113,-0.02715,-0.027008,0,0
5,GO RESPONSE TO LEAD ION,0.54321,-0.027152,-0.033233,0,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.87833,-0.027403,0.001259,0,0
5,GO ERYTHROCYTE DEVELOPMENT,0.92682,-0.027452,0.011652,0,0
5,GO PEPTIDE CROSS LINKING,0.62113,-0.027485,0.015643,0,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.35607,-0.027625,-0.025556,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.21579,-0.027651,-0.050139,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.7495,-0.027713,0.023312,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.92682,-0.027725,-0.0044866,0,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.76281,-0.02779,-0.028886,0,0
5,GO DNA REPLICATION,0.41341,-0.027791,-0.021536,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.93377,-0.027891,-0.013099,0,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.41842,-0.028139,-0.061166,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.78289,-0.028175,0.013769,0,0
5,GO PEPTIDYL LYSINE MODIFICATION,0.077957,-0.02854,-0.026246,0,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.51459,-0.028557,0.086364,0,0
5,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.93377,-0.02907,-0.037728,0,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.8303,-0.02921,-0.027419,0,0
5,GO RESPONSE TO UV,0.72313,-0.029621,-0.008767,0,0
5,GO RESPONSE TO HYDROXYUREA,0.78962,-0.029622,-0.0010377,0,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.41341,-0.029629,-0.066718,0,0
5,GO CENTROSOME DUPLICATION,0.56075,-0.029813,-0.015292,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.59664,-0.029913,-0.0098322,0,0
5,GO TRANSPORT ALONG MICROTUBULE,0.31653,-0.03006,-0.030797,0,0
5,GO NCRNA CATABOLIC PROCESS,0.86455,-0.030126,-0.0057477,0,0
5,GO NADH METABOLIC PROCESS,0.5726,-0.030459,-0.033124,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.62113,-0.030638,0.080295,0,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.35153,-0.03095,-0.042559,0,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.72969,-0.030999,0.030631,0,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.22905,-0.031011,-0.10946,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.34702,-0.031119,-0.023695,0,0
5,GO LIPOPROTEIN LOCALIZATION,0.42347,-0.031213,-0.072937,0,0
5,GO PIGMENT GRANULE MATURATION,0.62732,-0.031278,-0.052705,0,0
5,GO HISTONE H3 K9 METHYLATION,0.90599,-0.031406,0.015536,0,0
5,GO NEUROTRANSMITTER SECRETION,0.84397,-0.031435,0.0426,0,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.55487,-0.031545,-0.033164,0,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.54903,-0.031562,-0.034284,0,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.65234,-0.031593,-0.049257,0,0
5,GO PALLIUM DEVELOPMENT,0.92682,-0.031605,0.0062035,0,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.48131,-0.031762,-0.024669,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.55487,-0.031771,-0.022251,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.76281,-0.031808,0.060906,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.2839,-0.031982,-0.037104,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.96163,-0.032651,-0.019985,0,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.86455,-0.032766,0.0082037,0,0
5,GO MOTOR NEURON AXON GUIDANCE,0.52025,-0.033362,-0.016122,0,0
5,GO NEURON RECOGNITION,0.77618,-0.033415,-0.0098393,0,0
5,GO GLUTAMATE SECRETION,0.96163,-0.033544,0.03061,0,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.72313,-0.033582,-0.045766,0,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.47588,-0.033631,-0.069623,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.49227,-0.033979,-0.00066243,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.64605,-0.034104,-0.04759,0,0
5,GO CENTROSOME SEPARATION,0.98255,-0.034272,0.01882,0,0
5,GO PROTEIN MONOUBIQUITINATION,0.85768,-0.034344,-0.0078545,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.37932,-0.034497,-0.067871,0,0
5,GO REGULATION OF PROTEIN IMPORT,0.78962,-0.034535,-0.039823,0,0
5,GO RESPONSE TO HISTAMINE,0.4598,-0.034639,0.11126,0,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.76948,-0.035203,-0.029821,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.57857,-0.035262,-0.061145,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.079444,-0.035335,-0.10486,0,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.59059,-0.035373,-0.002631,0,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.54903,-0.035523,-0.060277,0,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.25001,-0.035961,-0.011716,0,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.17374,-0.036002,-0.065149,0,0
5,GO COPII COATED VESICLE CARGO LOADING,0.79636,-0.036101,-0.021522,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.092194,-0.036343,-0.11987,0,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.35153,-0.036444,-0.057893,0,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.75615,-0.036576,0.0014177,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27999,-0.037249,-0.024986,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.30402,-0.037321,-0.033632,0,0
5,GO DNA METABOLIC PROCESS,0.188,-0.037516,-0.029127,0,0
5,GO GMP METABOLIC PROCESS,0.87144,-0.037842,0.028579,0,0
5,GO CELLULAR RESPONSE TO RADIATION,0.64605,-0.038098,-0.010012,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.94073,-0.038132,0.025791,0,0
5,GO HEXOSE CATABOLIC PROCESS,0.64605,-0.038327,-0.018326,0,0
5,GO HISTONE METHYLATION,0.12473,-0.038678,-0.067312,0,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.47049,-0.038912,-0.06587,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.65234,-0.038934,-0.038553,0,0
5,GO CELL AGING,0.71658,-0.038954,-0.021325,0,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.72313,-0.039085,-0.01823,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.38408,-0.039107,-0.026371,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.89907,-0.039229,0.0010009,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.33812,-0.039832,-0.06723,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.32506,-0.040152,0.20599,0,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.68418,-0.040261,0.0017079,0,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.99651,-0.040339,-0.01196,0,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.66501,-0.040471,-0.034447,0,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.94073,-0.040694,-0.039546,0,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.39371,-0.040696,-0.054804,0,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,1,-0.040708,-0.013311,0,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.44924,-0.040745,-0.077333,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.4545,-0.041001,-0.045867,0,0
5,GO POSITIVE REGULATION OF CELL AGING,0.53742,-0.041086,0.063676,0,0
5,GO MITOTIC DNA REPLICATION,0.92682,-0.041226,-0.0050848,0,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.44924,-0.04143,-0.040367,0,0
5,GO REGULATION OF CELL AGING,0.35607,-0.041578,-0.058522,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.053746,-0.041784,-0.041874,0,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.53742,-0.041831,-0.066277,0,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.56075,-0.041864,-0.025715,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.89215,-0.041916,0.029382,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.94073,-0.041925,0.010261,0,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.71006,-0.041943,0.02082,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.17099,-0.041949,-0.063174,0,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.87144,-0.04208,0.059517,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.4978,-0.042183,-0.023485,0,0
5,GO NUCLEAR MIGRATION,0.51459,-0.042411,-0.035554,0,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.56666,-0.042461,-0.041392,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.11235,-0.042478,-0.03956,0,0
5,GO POSITIVE REGULATION OF DNA REPAIR,0.19095,-0.042526,-0.048051,0,0
5,GO VASCULAR TRANSPORT,0.99651,-0.042937,-0.055403,0,0
5,GO HISTONE PHOSPHORYLATION,0.36526,-0.043043,-0.048448,0,0
5,GO TRICARBOXYLIC ACID CYCLE,0.33373,-0.043359,-0.064476,0,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.40349,-0.043892,-0.038948,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.53742,-0.043903,-0.039263,0,0
5,GO DE NOVO PROTEIN FOLDING,0.91987,-0.043985,-0.0022475,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.91987,-0.04411,-0.0050021,0,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.47049,-0.04425,-0.039498,0,0
5,GO TROPHOBLAST CELL MIGRATION,0.34256,-0.044949,-0.17164,0,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.13355,-0.045287,-0.072424,0,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.46512,-0.045324,-0.063523,0,0
5,GO HAIR FOLLICLE MATURATION,0.72313,-0.045369,-0.060346,0,0
5,GO REGULATION OF CYCLASE ACTIVITY,0.46512,-0.045492,-0.034412,0,0
5,GO PROTEIN ACETYLATION,0.075049,-0.045612,-0.0249,0,0
5,GO MITOTIC RECOMBINATION,0.56075,-0.04563,-0.042272,0,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.51459,-0.045708,-0.011945,0,0
5,GO ORGANELLE FISSION,0.46512,-0.045726,-0.0077838,0,0
5,GO LACTATION,0.66501,-0.045792,-0.023803,0,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.23589,-0.046149,-0.048865,0,0
5,GO LAMELLIPODIUM ASSEMBLY,0.90599,-0.046355,0.0076527,0,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.23589,-0.046522,-0.065809,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.39858,-0.046528,-0.041442,0,0
5,GO CELL CYCLE DNA REPLICATION,0.17099,-0.046587,-0.065038,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.064293,-0.046666,-0.084964,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.38888,-0.047047,0.098068,0,0
5,GO CELLULAR SENESCENCE,0.16559,-0.04728,-0.05483,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.4545,-0.047443,-0.030534,0,0
5,GO CELL CYCLE CHECKPOINT,0.20937,-0.047742,-0.028622,0,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.94073,-0.047811,0.040442,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.63354,-0.047825,-0.019276,0,0
5,GO METAPHASE PLATE CONGRESSION,0.4545,-0.048138,-0.0096767,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.82348,-0.048708,0.03855,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.34702,-0.048749,-0.02939,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.68418,-0.048761,-0.012526,0,0
5,GO DNA RECOMBINATION,0.11841,-0.048825,-0.034275,0,0
5,GO CERAMIDE TRANSPORT,0.98255,-0.049064,-0.0020575,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.61497,-0.049229,-0.018769,0,0
5,GO TRNA 5 LEADER REMOVAL,0.27227,-0.049409,-0.081431,0,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.41341,-0.049678,-0.034127,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.093897,-0.050457,-0.058417,0,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.60272,-0.050484,-0.069125,0,0
5,GO HISTONE H2A MONOUBIQUITINATION,0.39858,-0.050534,-0.027456,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.24288,-0.050535,-0.080885,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.20309,-0.050682,-0.025287,0,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.17374,-0.050718,-0.058656,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.24288,-0.051379,-0.07462,0,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.43883,-0.051599,-0.068299,0,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.90599,-0.051789,0.018513,0,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.70355,-0.051872,-0.026203,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.17653,-0.052371,-0.043818,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.21579,-0.052526,-0.10785,0,0
5,GO G0 TO G1 TRANSITION,0.14285,-0.05259,-0.055326,0,0
5,GO UV PROTECTION,0.35153,-0.052656,-0.11087,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.50896,-0.053276,-0.047413,0,0
5,GO GENE SILENCING,0.082489,-0.053389,-0.062881,0,0
5,GO CRISTAE FORMATION,0.27611,-0.053413,-0.076662,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.89907,-0.053415,0.039907,0,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.44402,-0.053479,-0.02986,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.98953,-0.053787,-0.037263,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.38888,-0.053982,-0.10288,0,0
5,GO CHROMOSOME LOCALIZATION,0.24643,-0.054094,-0.025192,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.32077,-0.054254,-0.037504,0,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.55487,-0.054451,0.10261,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.31232,-0.054481,-0.09617,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.23245,-0.054545,-0.06726,0,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.24643,-0.054696,-0.043784,0,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.89215,-0.055751,0.034685,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.25363,-0.055808,-0.09505,0,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.060602,-0.055854,-0.10865,0,0
5,GO BLASTOCYST FORMATION,0.71006,-0.055925,-0.024372,0,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.62732,-0.056287,-0.018045,0,0
5,GO MICROTUBULE POLYMERIZATION,0.46512,-0.056466,-0.0097964,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.56666,-0.056674,-0.022762,0,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.4545,-0.056743,-0.055258,0,0
5,GO LYMPHANGIOGENESIS,0.15264,-0.056881,-0.11694,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.59664,-0.056936,-0.049557,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.29184,-0.056988,-0.055119,0,0
5,GO MYOBLAST PROLIFERATION,0.15264,-0.057099,-0.14012,0,0
5,GO DOUBLE STRAND BREAK REPAIR,0.079444,-0.057156,-0.05405,0,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.9686,-0.057374,0.034404,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.26098,-0.057448,-0.050766,0,0
5,GO PEPTIDYL LYSINE METHYLATION,0.22235,-0.05804,-0.042862,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17099,-0.058105,-0.034727,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.097379,-0.058485,-0.053704,0,0
5,GO CELLULAR RESPIRATION,0.29992,-0.058609,-0.056675,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.20621,-0.059104,-0.046409,0,0
5,GO PROTEIN METHYLATION,0.13583,-0.059292,-0.052671,0,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.099158,-0.05937,-0.084991,0,0
5,GO ERYTHROCYTE MATURATION,0.15517,-0.059468,-0.097274,0,0
5,GO NUCLEUS LOCALIZATION,0.40349,-0.059707,-0.041017,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.19095,-0.059781,-0.073433,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.67137,-0.060027,-0.026472,0,0
5,GO NEURAL CREST CELL MIGRATION,0.94073,-0.060154,0.028306,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.15773,-0.060239,-0.087326,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.14769,-0.060619,-0.090511,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.59059,-0.060965,-0.040437,0,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.15015,-0.061106,-0.064084,0,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.94769,-0.061212,-0.017604,0,0
5,GO TELOMERIC LOOP DISASSEMBLY,0.084046,-0.061396,-0.11301,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.30815,-0.06148,-0.084219,0,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.55487,-0.061522,-0.011829,0,0
5,GO LAMELLIPODIUM ORGANIZATION,0.98255,-0.061712,0.0010184,0,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.68418,-0.062013,-0.037118,0,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.34256,-0.062059,-0.054421,0,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.18508,-0.06222,-0.045996,0,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.20937,-0.062261,-0.089374,0,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.053746,-0.062724,-0.082523,0,0
5,GO REGULATION OF CYTOKINESIS,0.32938,-0.062758,-0.021178,0,0
5,GO ACROSOME ASSEMBLY,0.48678,-0.062858,-0.043659,0,0
5,GO AXO DENDRITIC TRANSPORT,0.11841,-0.062864,-0.069255,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.088862,-0.063161,-0.08713,0,0
5,GO REGULATION OF CILIUM ASSEMBLY,0.12259,-0.063359,-0.055645,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.11636,-0.063477,-0.10114,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.40843,-0.063758,-0.085412,0,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.4545,-0.063989,-0.056196,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.03245,-0.063992,-0.083385,0,0
5,GO KETONE BODY METABOLIC PROCESS,0.38888,-0.06416,-0.079717,0,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.75615,-0.064221,-0.050366,0,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.67137,-0.064691,-0.0058451,0,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.3746,-0.065177,-0.064566,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.4978,-0.0653,-0.0037035,0,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.16828,-0.065738,-0.04979,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.15773,-0.065837,-0.034658,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.15264,-0.065868,-0.060596,0,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.25363,-0.06592,-0.14365,0,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.061812,-0.06605,-0.056955,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.51459,-0.066356,-0.019258,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.30815,-0.066686,-0.065795,0,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.99651,-0.066699,0.0067455,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.98255,-0.067075,0.029532,0,0
5,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.65866,-0.067088,-0.029009,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.75615,-0.067352,0.0431,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.20937,-0.067688,-0.070736,0,0
5,GO MRNA CLEAVAGE,0.077957,-0.067928,-0.062725,0,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.52025,-0.06814,-0.073674,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.070855,-0.068385,-0.091508,0,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.075049,-0.068709,-0.10015,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.13814,-0.068764,-0.1,0,0
5,GO MITOCHONDRION LOCALIZATION,0.46512,-0.068811,-0.02048,0,0
5,GO HIPPO SIGNALING,0.54903,-0.068811,-0.084838,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.11039,-0.069106,-0.053119,0,0
5,GO VIRAL LATENCY,0.31653,-0.06918,-0.060078,0,0
5,GO CELLULAR RESPONSE TO UV,0.1313,-0.069336,-0.056104,0,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.72969,-0.069904,-0.062571,0,0
5,GO AMP METABOLIC PROCESS,0.32506,-0.069949,-0.098205,0,0
5,GO HISTONE H3 K4 METHYLATION,0.15264,-0.070409,-0.071943,0,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.18508,-0.070575,-0.09263,0,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.16032,-0.070726,-0.094662,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.073629,-0.071052,-0.10039,0,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.1028,-0.071202,-0.10509,0,0
5,GO LONG TERM SYNAPTIC DEPRESSION,0.19695,-0.071584,-0.07336,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.188,-0.071695,-0.081468,0,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.78962,-0.07238,-5.5478e-05,0,0
5,GO PROTEIN TARGETING,0.13583,-0.073707,-0.066351,0,0
5,GO NEURON MIGRATION,0.78962,-0.073715,0.0069504,0,0
5,GO OSTEOBLAST DEVELOPMENT,0.60883,-0.074523,-0.072211,0,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.099158,-0.074532,-0.075005,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.036164,-0.074786,-0.095967,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.063042,-0.075077,-0.14099,0,0
5,GO CENTRIOLE ASSEMBLY,0.0695,-0.075196,-0.075567,0,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.30402,-0.075196,-0.079547,0,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.27227,-0.075934,-0.12461,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.31653,-0.076133,-0.04526,0,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.10654,-0.076522,-0.13464,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.44402,-0.076611,-0.050999,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.50337,-0.07692,-0.053261,0,0
5,GO MITOCHONDRION DISTRIBUTION,0.25001,-0.077057,-0.029959,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.055956,-0.077225,-0.094323,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.10465,-0.07739,-0.077689,0,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.44924,-0.077537,-0.10918,0,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.054842,-0.077581,-0.11009,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.39858,-0.07759,-0.022699,0,0
5,GO HISTONE EXCHANGE,0.29184,-0.077982,-0.047495,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.93377,-0.078484,0.058756,0,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.066855,-0.078834,-0.046853,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.14285,-0.079127,-0.14331,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.41842,-0.079157,-0.04331,0,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.080955,-0.0792,-0.08965,0,0
5,GO REGULATION OF CENTROSOME CYCLE,0.36991,-0.079245,-0.016403,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.32077,-0.079245,-0.08379,0,0
5,GO PROSTATE GLAND GROWTH,0.14048,-0.07953,-0.17917,0,0
5,GO NUCLEOSOME ASSEMBLY,0.10654,-0.079701,-0.06811,0,0
5,GO SISTER CHROMATID COHESION,0.26471,-0.079768,-0.046591,0,0
5,GO VESICLE CARGO LOADING,0.47049,-0.080304,-0.056776,0,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.13583,-0.08037,-0.039268,0,0
5,GO OXIDATIVE PHOSPHORYLATION,0.41842,-0.080785,-0.05362,0,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.41842,-0.08083,-0.054313,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.30815,-0.080953,-0.12012,0,0
5,GO PLASMA MEMBRANE REPAIR,0.42347,-0.081421,-0.084525,0,0
5,GO PIRNA METABOLIC PROCESS,0.24643,-0.081757,-0.095968,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.14526,-0.081853,-0.088036,0,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.52594,-0.082257,-0.050329,0,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.65866,-0.082371,-0.025067,0,0
5,GO HISTONE H3 K9 DEMETHYLATION,0.60883,-0.082636,-0.029127,0,0
5,GO PENTOSE METABOLIC PROCESS,0.12259,-0.083462,-0.11998,0,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.10845,-0.083527,-0.088954,0,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.054842,-0.08461,-0.076632,0,0
5,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.10845,-0.084629,-0.19585,0,0
5,GO HISTONE H3 K27 METHYLATION,0.60883,-0.084851,-0.010095,0,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.44402,-0.084881,-0.056203,0,0
5,GO LATERAL MESODERM DEVELOPMENT,0.71006,-0.085013,-0.055655,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.40843,-0.08522,-0.027407,0,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.14526,-0.085257,-0.040612,0,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.26847,-0.085508,-0.02863,0,0
5,GO CHROMATIN SILENCING,0.0060989,-0.085525,-0.14953,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0069616,-0.085615,-0.075664,0,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.98953,-0.085836,0.019642,0,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.33373,-0.087099,-0.071702,0,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.46512,-0.087377,0.014707,0,0
5,GO AXONAL TRANSPORT,0.087232,-0.087405,-0.08602,0,0
5,GO REGULATION OF GASTRULATION,0.22568,-0.088881,-0.08424,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.03245,-0.089261,-0.093561,0,0
5,GO RESPONSE TO L GLUTAMATE,0.4545,-0.089805,-0.088648,0,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.95466,-0.090076,0.0057584,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.87833,-0.091116,-0.0065022,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.19393,-0.091596,-0.11066,0,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.13814,-0.091952,-0.072044,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.095625,-0.09226,-0.080079,0,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.065563,-0.092582,-0.11826,0,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.25729,-0.092921,-0.085494,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.11235,-0.093699,-0.046896,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.60272,-0.093728,-0.037872,0,0
5,GO TELOMERE CAPPING,0.0066042,-0.094648,-0.083244,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.80989,-0.094682,-0.010343,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.087232,-0.095251,-0.064423,0,0
5,GO WALKING BEHAVIOR,0.10096,-0.09543,-0.076884,0,0
5,GO RESPONSE TO NITRIC OXIDE,0.26471,-0.095582,-0.029529,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.62113,-0.095658,-0.05771,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.54321,-0.095744,0.0075096,0,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.2,-0.095755,-0.054536,0,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.25001,-0.095772,-0.0083788,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.19393,-0.095851,-0.13236,0,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.14526,-0.096038,-0.13165,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.80312,-0.09604,0.013642,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.85768,-0.096119,-0.010185,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.90599,-0.096143,0.0068179,0,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.39858,-0.096179,-0.050035,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.17653,-0.096558,-0.19027,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.1028,-0.097076,-0.091625,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.48678,-0.097149,-0.043343,0,0
5,GO NODAL SIGNALING PATHWAY,0.072231,-0.097983,-0.084972,0,0
5,GO PROTEIN NEDDYLATION,0.057089,-0.098196,-0.082662,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.16559,-0.098277,-0.039904,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.22235,-0.098324,-0.066986,0,0
5,GO REGULATION OF PROTEIN ACETYLATION,0.031059,-0.098553,-0.077129,0,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.98255,-0.098992,0.0010081,0,0
5,GO NAD METABOLIC PROCESS,0.38888,-0.09951,-0.058532,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.34256,-0.099877,-0.044376,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.11235,-0.10044,-0.098637,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.22235,-0.10044,-0.068729,0,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.29184,-0.10051,-0.031825,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.13814,-0.10053,-0.094651,0,0
5,GO RNA INTERFERENCE,0.065563,-0.10102,-0.11503,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.87833,-0.10141,-0.005618,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.97557,-0.10372,0.011491,0,0
5,GO CHROMOSOME CONDENSATION,0.15015,-0.10466,-0.054608,0,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.2839,-0.10622,-0.0763,0,0
5,GO DNA PACKAGING,0.034637,-0.10662,-0.063549,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.16828,-0.10822,-0.097687,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.21905,-0.10823,-0.079609,0,0
5,GO MICROTUBULE NUCLEATION,0.02843,-0.10896,-0.072407,0,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.38408,-0.10939,-0.05583,0,0
5,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.27611,-0.1097,-0.11657,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.17374,-0.11088,-0.11578,0,0
5,GO SPINDLE ASSEMBLY,0.0094949,-0.11115,-0.082382,0,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.47588,-0.11121,-0.045452,0,0
5,GO GLYCINE METABOLIC PROCESS,0.057089,-0.11144,-0.18771,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.15264,-0.11147,-0.083758,0,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.12473,-0.11169,-0.11104,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.2839,-0.11194,-0.043695,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.090515,-0.11215,-0.085355,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.88523,-0.11392,-0.020742,0,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.059411,-0.11457,-0.089154,0,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.13583,-0.11459,-0.13305,0,0
5,GO REGULATION OF AXON GUIDANCE,0.50896,-0.11473,-0.0071093,0,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.36526,-0.11475,-0.12408,0,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.35153,-0.11519,-0.044629,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.34702,-0.11538,-0.077414,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.18508,-0.11559,-0.086368,0,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.12908,-0.11578,-0.093276,0,0
5,GO TRNA 5 END PROCESSING,0.070855,-0.11706,-0.12228,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.057089,-0.11721,-0.10283,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.20309,-0.11738,-0.071563,0,0
5,GO PROTEIN REFOLDING,0.12259,-0.11771,-0.10983,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.030383,-0.11844,-0.093761,0,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.060602,-0.11866,-0.14456,0,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.12689,-0.11871,-0.096249,0,0
5,GO SPINDLE ORGANIZATION,0.014841,-0.1188,-0.073868,0,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.27611,-0.11892,-0.14837,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.12049,-0.11933,-0.07804,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.007729,-0.12001,-0.10549,0,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.059411,-0.12026,-0.092254,0,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.38888,-0.12074,-0.043531,0,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.19695,-0.12092,-0.062996,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.28785,-0.12115,-0.14946,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.044685,-0.12143,-0.10106,0,0
5,GO LIMB BUD FORMATION,0.65234,-0.12211,0.025105,0,0
5,GO SYNAPTIC VESICLE LOCALIZATION,0.20621,-0.12234,-0.028047,0,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.15015,-0.1234,-0.085475,0,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.16294,-0.12352,-0.11585,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.56666,-0.12437,-0.067267,0,0
5,GO FOLIC ACID METABOLIC PROCESS,0.041093,-0.1255,-0.16593,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.035393,-0.12576,-0.098747,0,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.087232,-0.12603,-0.073696,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.054842,-0.12614,-0.12429,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.082489,-0.12719,-0.13017,0,0
5,GO SISTER CHROMATID SEGREGATION,0.025994,-0.12721,-0.081436,0,0
5,GO REGULATION OF HIPPO SIGNALING,0.093897,-0.12733,-0.16243,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.33373,-0.12857,-0.063158,0,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.11039,-0.12894,-0.12564,0,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.43883,-0.12971,-0.047724,0,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.16032,-0.1312,-0.17057,0,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.13355,-0.13159,-0.085834,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.27227,-0.13256,-0.043196,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.55487,-0.13281,-0.0085216,0,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.32077,-0.13336,-0.099702,0,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.24643,-0.1335,-0.13122,0,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.62732,-0.134,-0.02853,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.033894,-0.13404,-0.079443,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.10096,-0.13416,-0.10817,0,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.085627,-0.13457,-0.13541,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.16294,-0.13595,-0.12191,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.2839,-0.13722,-0.06889,0,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.055956,-0.13725,-0.11377,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.010773,-0.13747,-0.099762,0,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.12473,-0.1376,-0.12596,0,0
5,GO UTERUS DEVELOPMENT,0.40349,-0.13895,-0.063866,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.15773,-0.13955,-0.13061,0,0
5,GO CARDIOBLAST PROLIFERATION,0.35607,-0.14003,-0.17234,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.016339,-0.14038,-0.10575,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.060602,-0.14132,-0.12219,0,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.18219,-0.14175,-0.080751,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.055956,-0.14368,-0.1159,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.3746,-0.14456,-0.088495,0,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.084046,-0.1461,-0.094354,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.12689,-0.14659,-0.13234,0,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.11434,-0.14677,-0.13481,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.41341,-0.14746,-0.11288,0,0
5,GO V D J RECOMBINATION,0.099158,-0.14746,-0.10518,0,0
5,GO PENILE ERECTION,0.14526,-0.14994,-0.12863,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.65866,-0.15268,0.069075,0,0
5,GO KINETOCHORE ORGANIZATION,0.33812,-0.15491,-0.050245,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.085627,-0.15507,-0.14241,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.053746,-0.15643,-0.11115,0,0
5,GO GLUTAMINE METABOLIC PROCESS,0.097379,-0.15701,-0.11373,0,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.017137,-0.15997,-0.10794,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.072231,-0.16179,-0.10156,0,0
5,GO ETHANOL CATABOLIC PROCESS,0.02166,-0.16213,-0.18085,0,0
5,GO PROTEIN NITROSYLATION,0.05824,-0.16238,-0.19083,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.4545,-0.16289,-0.16528,0,0
5,GO CARDIOBLAST DIFFERENTIATION,0.16828,-0.16726,-0.13277,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.036948,-0.16839,-0.086685,0,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.64605,-0.16934,-0.056314,0,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.52594,-0.17021,-0.060486,0,0
5,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.20309,-0.17101,-0.1079,0,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.077957,-0.17108,-0.18175,0,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.21579,-0.17253,-0.093865,0,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.082489,-0.17322,-0.17668,0,0
5,GO CYSTEINE METABOLIC PROCESS,0.19393,-0.17439,-0.19048,0,0
5,GO ETHANOL METABOLIC PROCESS,0.12259,-0.17466,-0.14805,0,0
5,GO HISTONE H2A ACETYLATION,0.0025817,-0.1748,-0.1451,0,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.34702,-0.17512,-0.12078,0,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.29184,-0.17561,-0.082561,0,0
5,GO FRUCTOSE METABOLIC PROCESS,0.53742,-0.17595,-0.074307,0,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.56666,-0.17651,-0.055712,0,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.05824,-0.17651,-0.17478,0,0
5,GO DENDRITE SELF AVOIDANCE,0.11039,-0.18002,-0.13496,0,0
5,GO KINETOCHORE ASSEMBLY,0.22905,-0.18016,-0.072193,0,0
5,GO PYRAMIDAL NEURON DIFFERENTIATION,0.10845,-0.18069,-0.18459,0,0
5,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.47049,-0.18353,-0.081774,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.15264,-0.18483,-0.11698,0,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.090515,-0.1858,-0.12582,0,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.23589,-0.18639,-0.126,0,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.080955,-0.18784,-0.13842,0,0
5,GO GTP METABOLIC PROCESS,0.099158,-0.18863,-0.14293,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.097379,-0.19212,-0.1179,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0041716,-0.19293,-0.13979,0,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.23589,-0.19413,-0.13501,0,0
5,GO PHAGOCYTOSIS RECOGNITION,0.24288,-0.19465,-0.13009,0,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.064293,-0.19617,-0.11995,0,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.073629,-0.19721,-0.12144,0,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.073629,-0.19749,-0.20031,0,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.19695,-0.19794,-0.13423,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.20621,-0.19844,-0.15496,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.022165,-0.19974,-0.13209,0,0
5,GO CENTRIOLE CENTRIOLE COHESION,0.023741,-0.20677,-0.12195,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.093897,-0.2217,-0.12351,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.025414,-0.22241,-0.18597,0,0
5,GO ETHANOL OXIDATION,0.085627,-0.22269,-0.25109,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0090226,-0.22449,-0.21604,0,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.085627,-0.23131,-0.21733,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.20621,-0.23322,-0.1068,0,0
5,GO DISTAL TUBULE DEVELOPMENT,0.082489,-0.23886,-0.12063,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0031536,-0.2417,-0.23559,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.010773,-0.24614,-0.1547,0,0
5,GO BONE TRABECULA FORMATION,0.11636,-0.24788,-0.2545,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.018398,-0.25252,-0.16953,0,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.32077,-0.25828,-0.18887,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.014486,-0.26261,-0.23547,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.20937,-0.26549,-0.12952,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.00074557,-0.27302,-0.25229,0,0
5,GO PRENYLATION,0.0073363,-0.27344,-0.18746,0,0
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.13355,-0.27486,-0.11654,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.14769,-0.27827,-0.16734,0,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.066855,-0.28298,-0.1921,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.02068,-0.28576,-0.19458,0,0
5,GO DENDRITIC TRANSPORT,0.017969,-0.32404,-0.16983,0,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0029794,-0.44517,-0.34607,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.0021062,-0.64913,-0.41579,0,0
6,GO FOREBRAIN NEURON FATE COMMITMENT,3.0576e-06,0.98878,0.99125,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00026903,0.58053,0.47844,1,1
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0013054,0.54973,0.74098,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0016129,0.54258,0.46878,1,1
6,GO GABAERGIC NEURON DIFFERENTIATION,0.0057817,0.39736,0.47462,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00021909,0.37869,0.41641,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00035231,0.37288,0.35664,1,1
6,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00010092,0.33182,0.47085,1,1
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0018173,0.32244,0.42684,1,1
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0053338,0.31953,0.31315,1,1
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0033369,0.30474,0.33375,1,1
6,GO GANGLION DEVELOPMENT,0.010773,0.2964,0.34376,1,1
6,GO OLFACTORY LOBE DEVELOPMENT,0.0025817,0.2798,0.28489,1,1
6,GO SUBPALLIUM DEVELOPMENT,0.0026572,0.27094,0.30187,1,1
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.018836,0.25476,0.27518,1,1
6,GO MRNA SPLICE SITE SELECTION,4.3218e-05,0.25158,0.27561,1,1
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.015203,0.25157,0.19459,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0021062,0.24951,0.22468,1,1
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.02268,0.24689,0.24448,1,1
6,GO V D J RECOMBINATION,0.0045306,0.24638,0.20857,1,1
6,GO SINGLE STRAND BREAK REPAIR,0.00014935,0.24637,0.21682,1,1
6,GO KINETOCHORE ASSEMBLY,0.0016129,0.24464,0.20327,1,1
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0037331,0.24026,0.21647,1,1
6,GO NOSE DEVELOPMENT,0.0066042,0.23606,0.41348,1,1
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.017137,0.22605,0.1794,1,1
6,GO VIRAL LATENCY,0.0062634,0.22526,0.1721,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.00045924,0.22114,0.19978,1,1
6,GO RETROGRADE AXONAL TRANSPORT,0.0028957,0.21995,0.21868,1,1
6,GO CHROMATIN REMODELING AT CENTROMERE,5.6174e-05,0.21952,0.23471,1,1
6,GO REGULATION OF HELICASE ACTIVITY,0.016339,0.21849,0.18357,1,1
6,GO KINETOCHORE ORGANIZATION,0.001662,0.21827,0.19721,1,1
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00057693,0.2104,0.18627,1,1
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00012074,0.20797,0.1886,1,1
6,GO CEREBELLAR CORTEX FORMATION,0.004408,0.20385,0.22448,1,1
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0036303,0.19711,0.19138,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.016339,0.19681,0.14589,1,1
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,3.3132e-05,0.19464,0.21411,1,1
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.017549,0.19322,0.18573,1,1
6,GO GENETIC IMPRINTING,0.00057693,0.19089,0.22916,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00026903,0.18507,0.18746,1,1
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.001872,0.18489,0.20003,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,3.1888e-05,0.18424,0.18917,1,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00031859,0.1839,0.18276,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00069957,0.17772,0.17136,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00035231,0.16572,0.13189,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0028957,0.1599,0.14792,1,1
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0023671,0.15923,0.17049,1,1
6,GO DNA STRAND ELONGATION,0.00030804,0.1562,0.17042,1,1
6,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.047551,0.15426,0.16048,1,1
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.011904,0.15391,0.107,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00044439,0.15106,0.13171,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,5.8301e-05,0.15058,0.15896,1,1
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.029068,0.14833,0.14133,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00087311,0.14749,0.12818,1,1
6,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0094949,0.14606,0.13787,1,1
6,GO RESPIRATORY SYSTEM PROCESS,0.015203,0.14577,0.14181,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00067758,0.14262,0.15863,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0010859,0.1406,0.18555,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,0.0021689,0.13897,0.18892,1,1
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.031059,0.13788,0.10255,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.015953,0.13696,0.10886,1,1
6,GO POSITIVE REGULATION OF MRNA PROCESSING,0.001872,0.13638,0.11401,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0026572,0.13584,0.10492,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.014486,0.13507,0.10539,1,1
6,GO REPLICATION FORK PROCESSING,0.0017641,0.13166,0.12222,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,0.00036427,0.13152,0.14497,1,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.014486,0.13086,0.118,1,1
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.046579,0.12794,0.065176,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0036303,0.12562,0.12064,1,1
6,GO CELL CYCLE DNA REPLICATION,0.0067808,0.12507,0.095582,1,1
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.027188,0.1239,0.14549,1,1
6,GO MITOTIC DNA REPLICATION,0.025994,0.12369,0.13513,1,1
6,GO HISTONE EXCHANGE,0.0013872,0.12336,0.13257,1,1
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0031536,0.1228,0.13621,1,1
6,GO REGULATION OF CILIUM ASSEMBLY,0.014841,0.12004,0.096587,1,1
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.013798,0.11984,0.093438,1,1
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.013798,0.11866,0.2089,1,1
6,GO DNA REPLICATION INITIATION,0.0073363,0.11663,0.11185,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0017641,0.11603,0.099468,1,1
6,GO TRANSPORT ALONG MICROTUBULE,0.0083534,0.11569,0.095753,1,1
6,GO DNA REPLICATION CHECKPOINT,0.011326,0.11568,0.1187,1,1
6,GO HISTONE H4 ACETYLATION,0.00019079,0.1154,0.12172,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0067808,0.11442,0.10907,1,1
6,GO CENTROSOME SEPARATION,0.0099891,0.11394,0.14539,1,1
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.02068,0.11285,0.12099,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.011904,0.11097,0.09473,1,1
6,GO MRNA EXPORT FROM NUCLEUS,0.0081404,0.10585,0.086061,1,1
6,GO CHROMOSOME LOCALIZATION,0.007729,0.10428,0.084987,1,1
6,GO MITOTIC SPINDLE ASSEMBLY,0.011904,0.10342,0.096323,1,1
6,GO NUCLEOSOME ORGANIZATION,0.0010859,0.10203,0.11582,1,1
6,GO DNA DEPENDENT DNA REPLICATION,0.0066042,0.10161,0.083307,1,1
6,GO HISTONE H3 K4 METHYLATION,0.0087944,0.1009,0.11518,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00059588,0.09998,0.098875,1,1
6,GO INTERSTRAND CROSS LINK REPAIR,0.0020453,0.099231,0.093849,1,1
6,GO DNA GEOMETRIC CHANGE,0.033894,0.098822,0.061153,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.010773,0.098429,0.087364,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.001986,0.095807,0.11022,1,1
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.038561,0.095458,0.080167,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0066042,0.092912,0.079044,1,1
6,GO REGULATION OF MRNA PROCESSING,0.018398,0.091774,0.07923,1,1
6,GO RNA EXPORT FROM NUCLEUS,0.038561,0.091709,0.065445,1,1
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.017969,0.091324,0.092756,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0026572,0.090921,0.10507,1,1
6,GO NCRNA TRANSCRIPTION,0.029068,0.088617,0.054293,1,1
6,GO REGULATION OF CENTROSOME CYCLE,0.0073363,0.088416,0.10505,1,1
6,GO HISTONE MONOUBIQUITINATION,0.01282,0.087175,0.10365,1,1
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.007729,0.086217,0.07496,1,1
6,GO NEGATIVE REGULATION OF RNA SPLICING,0.013465,0.085304,0.1036,1,1
6,GO RNA SPLICING,0.0087944,0.083108,0.069885,1,1
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.015953,0.082754,0.087849,1,1
6,GO RECOMBINATIONAL REPAIR,0.0046564,0.079864,0.077808,1,1
6,GO MICROTUBULE BASED TRANSPORT,0.042857,0.077316,0.077854,1,1
6,GO PROTEIN MONOUBIQUITINATION,0.049546,0.076883,0.059084,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0027346,0.074724,0.094324,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0025817,0.073418,0.098168,1,1
6,GO SNRNA TRANSCRIPTION,0.0059384,0.072347,0.057945,1,1
6,GO PEPTIDYL LYSINE METHYLATION,0.036948,0.070762,0.062537,1,1
6,GO DNA CONFORMATION CHANGE,0.018836,0.070499,0.060525,1,1
6,GO CHROMOSOME SEGREGATION,0.017137,0.069977,0.060049,1,1
6,GO PROTEIN ACETYLATION,0.0056288,0.069468,0.05945,1,1
6,GO DNA RECOMBINATION,0.02068,0.065687,0.049044,1,1
6,GO MRNA PROCESSING,0.013798,0.065163,0.061273,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.01282,0.062736,0.069795,1,1
6,GO DNA REPAIR,0.0094949,0.061001,0.045533,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,0.009256,0.058153,0.090754,1,1
6,GO DOUBLE STRAND BREAK REPAIR,0.015953,0.056257,0.054584,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,0.012203,0.055082,0.045141,1,1
6,GO NUCLEAR CHROMOSOME SEGREGATION,0.02843,0.054375,0.056813,1,1
6,GO CHROMATIN REMODELING,0.029068,0.049453,0.067825,1,1
6,GO REGULATION OF RNA SPLICING,0.036948,0.046168,0.05361,1,1
6,GO CHROMOSOME ORGANIZATION,0.025994,0.036852,0.036348,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0018173,0.22706,0.31073,1,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.026586,0.19996,0.20739,1,0
6,GO DNA LIGATION,0.0075304,0.19197,0.2096,1,0
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.043763,0.16661,0.25716,1,0
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.046579,0.15959,0.17787,1,0
6,GO FOREBRAIN REGIONALIZATION,0.0099891,0.14322,0.21716,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.010506,0.14059,0.1472,1,0
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.03245,0.13819,0.091145,1,0
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.044685,0.12472,0.13993,1,0
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.013465,0.12456,0.11451,1,0
6,GO CARDIOBLAST DIFFERENTIATION,0.042857,0.11839,0.15511,1,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.031059,0.11315,0.11063,1,0
6,GO SNORNA 3 END PROCESSING,0.043763,0.10225,0.15167,1,0
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.009256,0.089901,0.075803,1,0
6,GO MRNA 3 END PROCESSING,0.024846,0.086845,0.069298,1,0
6,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.041967,0.080031,0.077623,1,0
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.047551,0.068002,0.078382,1,0
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.029719,0.067461,0.051517,1,0
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.047551,0.055702,0.06847,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE,0.02843,-0.028787,-0.053969,1,0
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.036948,-0.032311,-0.060166,1,0
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.03939,-0.041827,-0.077458,1,0
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.013798,-0.043397,-0.05422,1,0
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.024846,-0.046769,-0.066338,1,0
6,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.017137,-0.04764,-0.11903,1,0
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.049546,-0.048677,-0.047216,1,0
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0060989,-0.048859,-0.064925,1,0
6,GO VACUOLAR TRANSPORT,0.037747,-0.050128,-0.089561,1,0
6,GO CYTOSOLIC TRANSPORT,0.013139,-0.051341,-0.082825,1,0
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0083534,-0.052077,-0.070265,1,0
6,GO REGULATION OF VIRAL TRANSCRIPTION,0.038561,-0.05278,-0.10186,1,0
6,GO REGULATION OF CELL DIFFERENTIATION,0.0036303,-0.053832,-0.089382,1,0
6,GO SENSORY PERCEPTION OF SMELL,0.036948,-0.054567,-0.091417,1,0
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.026586,-0.055648,-0.056638,1,0
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.012508,-0.056634,-0.13141,1,0
6,GO ERAD PATHWAY,0.01282,-0.058738,-0.11896,1,0
6,GO MULTI ORGANISM PROCESS,0.0064317,-0.06071,-0.070552,1,0
6,GO REGULATION OF SECRETION,0.031059,-0.060812,-0.078882,1,0
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00041602,-0.061356,-0.07675,1,0
6,GO ORGANELLE DISASSEMBLY,0.041967,-0.064764,-0.069397,1,0
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.027188,-0.064895,-0.11371,1,0
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0049174,-0.06569,-0.071075,1,0
6,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.033894,-0.065907,-0.12096,1,0
6,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.013465,-0.066355,-0.076198,1,0
6,GO TISSUE HOMEOSTASIS,0.013798,-0.066619,-0.1001,1,0
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0071468,-0.066704,-0.062183,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0017641,-0.067255,-0.078403,1,0
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.012203,-0.06727,-0.10473,1,0
6,GO CELLULAR RESPONSE TO KETONE,0.011904,-0.067476,-0.12688,1,0
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.012508,-0.067836,-0.089285,1,0
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.019739,-0.068214,-0.0744,1,0
6,GO IMMUNOGLOBULIN PRODUCTION,0.019283,-0.068339,-0.10671,1,0
6,GO CYTOSKELETON ORGANIZATION,0.023205,-0.068749,-0.073217,1,0
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.020205,-0.068883,-0.081402,1,0
6,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.03245,-0.069057,-0.10219,1,0
6,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.033894,-0.069244,-0.10595,1,0
6,GO MITOCHONDRION ORGANIZATION,0.011612,-0.069283,-0.075091,1,0
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.03245,-0.069301,-0.11828,1,0
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0090226,-0.069468,-0.10824,1,0
6,GO INTRACELLULAR TRANSPORT,0.0013872,-0.069821,-0.070111,1,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011612,-0.07012,-0.080278,1,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0045306,-0.070426,-0.086647,1,0
6,GO POSITIVE REGULATION OF GROWTH,0.0051916,-0.070846,-0.087008,1,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0081404,-0.070887,-0.096958,1,0
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.046579,-0.071474,-0.10845,1,0
6,GO SENSORY PERCEPTION,0.021165,-0.071594,-0.071702,1,0
6,GO METHIONINE METABOLIC PROCESS,0.03939,-0.071631,-0.12371,1,0
6,GO PROTEIN CATABOLIC PROCESS,0.0019282,-0.071665,-0.082937,1,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.036948,-0.072851,-0.11634,1,0
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.001986,-0.073214,-0.079694,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0037331,-0.074168,-0.11169,1,0
6,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0020453,-0.074335,-0.06859,1,0
6,GO INTRACELLULAR PROTEIN TRANSPORT,0.0017641,-0.07446,-0.071833,1,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.035393,-0.074656,-0.095338,1,0
6,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0011549,-0.074933,-0.085923,1,0
6,GO REGULATION OF TRANSLATIONAL INITIATION,0.019283,-0.075348,-0.08771,1,0
6,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.025414,-0.075755,-0.14443,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.041093,-0.076196,-0.076131,1,0
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0087944,-0.076354,-0.18749,1,0
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.036948,-0.076485,-0.057616,1,0
6,GO CELLULAR RESPIRATION,0.047551,-0.077093,-0.10664,1,0
6,GO MYELOID DENDRITIC CELL ACTIVATION,0.052669,-0.077224,-0.12275,1,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.015953,-0.077489,-0.1065,1,0
6,GO MACROMOLECULE DEACYLATION,0.024288,-0.077693,-0.061201,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.022165,-0.077841,-0.099764,1,0
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.041967,-0.077949,-0.075491,1,0
6,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.02068,-0.077993,-0.11909,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0022992,-0.078614,-0.090581,1,0
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0017641,-0.078633,-0.10628,1,0
6,GO REGULATION OF HORMONE LEVELS,0.041967,-0.079322,-0.090884,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.043763,-0.079375,-0.11966,1,0
6,GO HISTONE PHOSPHORYLATION,0.0097392,-0.079917,-0.11801,1,0
6,GO PROTEIN DEPHOSPHORYLATION,0.045624,-0.080088,-0.059645,1,0
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.046579,-0.080428,-0.093512,1,0
6,GO PLASMA MEMBRANE TUBULATION,0.046579,-0.080452,-0.12684,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.033166,-0.080673,-0.11807,1,0
6,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0060989,-0.080787,-0.096306,1,0
6,GO REPRODUCTION,0.0059384,-0.081082,-0.078559,1,0
6,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.013798,-0.081134,-0.1342,1,0
6,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.050569,-0.081374,-0.12824,1,0
6,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.050569,-0.081448,-0.087586,1,0
6,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0075304,-0.081539,-0.080787,1,0
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.031748,-0.081572,-0.084771,1,0
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.0019282,-0.081648,-0.072787,1,0
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.045624,-0.081657,-0.11897,1,0
6,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.052669,-0.082051,-0.175,1,0
6,GO ACTIN CYTOSKELETON REORGANIZATION,0.025414,-0.082343,-0.099986,1,0
6,GO NEURAL TUBE DEVELOPMENT,0.020205,-0.082569,-0.10816,1,0
6,GO DEVELOPMENTAL GROWTH,0.0027346,-0.082688,-0.097145,1,0
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.01282,-0.082827,-0.17371,1,0
6,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0014738,-0.082871,-0.10958,1,0
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.034637,-0.083274,-0.084001,1,0
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0017641,-0.083367,-0.12282,1,0
6,GO PROTEOLYSIS,0.00079435,-0.083491,-0.10652,1,0
6,GO RNA CATABOLIC PROCESS,0.026586,-0.083559,-0.098018,1,0
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0053338,-0.083882,-0.11196,1,0
6,GO SULFATE TRANSPORT,0.0071468,-0.083894,-0.13544,1,0
6,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0081404,-0.083897,-0.1365,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.034637,-0.083955,-0.063566,1,0
6,GO ACTIVATION OF GTPASE ACTIVITY,0.010773,-0.084032,-0.10891,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0025817,-0.08411,-0.10781,1,0
6,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0033369,-0.084132,-0.090395,1,0
6,GO EMBRYO DEVELOPMENT,0.0042883,-0.084547,-0.094967,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.026586,-0.08492,-0.13206,1,0
6,GO RESPONSE TO IONIZING RADIATION,0.0054795,-0.085001,-0.097036,1,0
6,GO DEPHOSPHORYLATION,0.020205,-0.085525,-0.07152,1,0
6,GO POSITIVE REGULATION OF SECRETION,0.010245,-0.085688,-0.093819,1,0
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.02068,-0.085858,-0.10218,1,0
6,GO SKIN EPIDERMIS DEVELOPMENT,0.0075304,-0.085998,-0.15043,1,0
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.016734,-0.086005,-0.095208,1,0
6,GO DEVELOPMENTAL MATURATION,0.04854,-0.086088,-0.078828,1,0
6,GO PROTEIN IMPORT,0.0050528,-0.086129,-0.093567,1,0
6,GO CELL AGING,0.0099891,-0.086598,-0.095125,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.033166,-0.086609,-0.1094,1,0
6,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00079435,-0.086664,-0.11689,1,0
6,GO PROTEIN TARGETING TO LYSOSOME,0.024846,-0.08671,-0.17707,1,0
6,GO AMINE METABOLIC PROCESS,0.026586,-0.086768,-0.10174,1,0
6,GO AUTOPHAGY OF MITOCHONDRION,0.010245,-0.086921,-0.098255,1,0
6,GO OVULATION CYCLE,0.040234,-0.086951,-0.10569,1,0
6,GO CRANIAL NERVE DEVELOPMENT,0.027803,-0.087102,-0.16449,1,0
6,GO EAR DEVELOPMENT,0.009256,-0.087108,-0.10949,1,0
6,GO TAXIS,0.0014738,-0.087174,-0.11589,1,0
6,GO GLIOGENESIS,0.03245,-0.08745,-0.098472,1,0
6,GO MALE SEX DIFFERENTIATION,0.0062634,-0.087539,-0.12507,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION,0.0099891,-0.087646,-0.078822,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.036164,-0.087667,-0.084458,1,0
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.010773,-0.087768,-0.077767,1,0
6,GO REGULATION OF CELLULAR LOCALIZATION,0.02166,-0.087842,-0.063996,1,0
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.040234,-0.088018,-0.095454,1,0
6,GO IMMUNE SYSTEM DEVELOPMENT,0.00095906,-0.088152,-0.11457,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.034637,-0.088796,-0.14895,1,0
6,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00037661,-0.08939,-0.10898,1,0
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.011047,-0.089725,-0.081012,1,0
6,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0033369,-0.089863,-0.067029,1,0
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0019282,-0.089958,-0.12821,1,0
6,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.014841,-0.090291,-0.096156,1,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.023205,-0.090303,-0.14416,1,0
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.012508,-0.090479,-0.11953,1,0
6,GO CELL GROWTH,0.0018173,-0.09076,-0.11414,1,0
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.011612,-0.090869,-0.073697,1,0
6,GO PEPTIDYL SERINE MODIFICATION,0.0081404,-0.090907,-0.077284,1,0
6,GO REGULATION OF TRANSPORT,0.00353,-0.091165,-0.09639,1,0
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.04854,-0.091217,-0.069863,1,0
6,GO ORGANIC ACID TRANSPORT,0.0013054,-0.091238,-0.11093,1,0
6,GO T CELL RECEPTOR SIGNALING PATHWAY,0.015203,-0.091254,-0.10889,1,0
6,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.016734,-0.091515,-0.088233,1,0
6,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0049174,-0.091601,-0.14052,1,0
6,GO LEUKOCYTE TETHERING OR ROLLING,0.010245,-0.091604,-0.10606,1,0
6,GO GOLGI ORGANIZATION,0.0056288,-0.091656,-0.10852,1,0
6,GO EPITHELIAL TUBE FORMATION,0.017137,-0.091722,-0.10257,1,0
6,GO LYMPHOCYTE HOMEOSTASIS,0.04854,-0.092394,-0.080923,1,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.023741,-0.09243,-0.10593,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.016339,-0.092452,-0.14561,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.041093,-0.092965,-0.061024,1,0
6,GO MACROMOLECULE CATABOLIC PROCESS,0.00016023,-0.092974,-0.10047,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.027803,-0.093015,-0.077952,1,0
6,GO HORMONE MEDIATED SIGNALING PATHWAY,0.001662,-0.093176,-0.097258,1,0
6,GO REGULATION OF SYSTEM PROCESS,0.0036303,-0.093606,-0.12129,1,0
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.024288,-0.093856,-0.06222,1,0
6,GO PROTEIN LOCALIZATION TO VACUOLE,0.03939,-0.093893,-0.10732,1,0
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0073363,-0.094062,-0.11874,1,0
6,GO MULTI ORGANISM LOCALIZATION,0.024288,-0.09443,-0.11787,1,0
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015203,-0.09453,-0.092121,1,0
6,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00042998,-0.09462,-0.11204,1,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.014841,-0.094684,-0.066416,1,0
6,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.009256,-0.094705,-0.090969,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.011326,-0.094886,-0.14307,1,0
6,GO COPII COATED VESICLE BUDDING,0.0015653,-0.094937,-0.13963,1,0
6,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.033166,-0.094968,-0.11776,1,0
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.013465,-0.095124,-0.12249,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0094949,-0.095168,-0.10738,1,0
6,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.041093,-0.095186,-0.15249,1,0
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0062634,-0.095227,-0.083415,1,0
6,GO SEX DIFFERENTIATION,0.0016129,-0.095424,-0.10673,1,0
6,GO VESICLE CARGO LOADING,0.03245,-0.095535,-0.13332,1,0
6,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0018173,-0.095559,-0.1159,1,0
6,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.01282,-0.095623,-0.10033,1,0
6,GO REGULATION OF GROWTH,0.00017796,-0.095781,-0.12177,1,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.042857,-0.095875,-0.094134,1,0
6,GO CELLULAR RESPONSE TO NUTRIENT,0.020205,-0.095932,-0.18394,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.030383,-0.09609,-0.13731,1,0
6,GO GLYCOSYLATION,0.001986,-0.096107,-0.13421,1,0
6,GO REGULATION OF URINE VOLUME,0.041967,-0.096208,-0.11335,1,0
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0085714,-0.09636,-0.084472,1,0
6,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.043763,-0.096374,-0.1078,1,0
6,GO STEROL BIOSYNTHETIC PROCESS,0.043763,-0.096513,-0.13023,1,0
6,GO FEMALE SEX DIFFERENTIATION,0.007729,-0.096572,-0.12306,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.024288,-0.096703,-0.13645,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.011904,-0.096728,-0.12924,1,0
6,GO ALPHA BETA T CELL DIFFERENTIATION,0.010506,-0.096781,-0.13558,1,0
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.04854,-0.097494,-0.13171,1,0
6,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.013139,-0.097596,-0.15535,1,0
6,GO PENTOSE METABOLIC PROCESS,0.043763,-0.097622,-0.17265,1,0
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.014841,-0.097801,-0.091036,1,0
6,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.010773,-0.097843,-0.12951,1,0
6,GO CALCIUM MEDIATED SIGNALING,0.0032441,-0.097926,-0.094793,1,0
6,GO REGULATION OF CELLULAR COMPONENT SIZE,0.010245,-0.097946,-0.090173,1,0
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.011904,-0.097957,-0.10664,1,0
6,GO NEURON PROJECTION REGENERATION,0.03939,-0.098114,-0.11967,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.013798,-0.098275,-0.071261,1,0
6,GO NEGATIVE REGULATION OF OSSIFICATION,0.025414,-0.098307,-0.14409,1,0
6,GO DEFENSE RESPONSE TO VIRUS,0.043763,-0.098327,-0.16167,1,0
6,GO NEUTROPHIL CHEMOTAXIS,0.0047853,-0.098408,-0.13395,1,0
6,GO REGULATION OF ANION TRANSPORT,0.0066042,-0.098495,-0.11554,1,0
6,GO PROTEIN KINASE A SIGNALING,0.011326,-0.098507,-0.12017,1,0
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.018398,-0.098631,-0.14746,1,0
6,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.012508,-0.098706,-0.15492,1,0
6,GO INTERLEUKIN 12 PRODUCTION,0.018836,-0.098716,-0.10888,1,0
6,GO PEPTIDE SECRETION,0.0079323,-0.098724,-0.10286,1,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.031059,-0.098859,-0.12079,1,0
6,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0010859,-0.098963,-0.15857,1,0
6,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0017123,-0.098987,-0.11583,1,0
6,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0040578,-0.099251,-0.14961,1,0
6,GO RESPONSE TO ESTRADIOL,0.0021062,-0.099389,-0.12397,1,0
6,GO NIK NF KAPPAB SIGNALING,0.041093,-0.099389,-0.12228,1,0
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.04854,-0.099423,-0.11594,1,0
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.022165,-0.099503,-0.10127,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.013798,-0.099607,-0.072067,1,0
6,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.041967,-0.099768,-0.095214,1,0
6,GO ARACHIDONIC ACID SECRETION,0.02068,-0.099958,-0.12156,1,0
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.00047456,-0.099974,-0.1374,1,0
6,GO GROWTH,0.00044439,-0.09998,-0.10855,1,0
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00092958,-0.10013,-0.1144,1,0
6,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.012203,-0.10024,-0.10588,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.011904,-0.10028,-0.087289,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013465,-0.10043,-0.13927,1,0
6,GO EAR MORPHOGENESIS,0.02268,-0.10059,-0.10107,1,0
6,GO ESTROGEN METABOLIC PROCESS,0.012203,-0.10062,-0.1762,1,0
6,GO ORGANIC ACID CATABOLIC PROCESS,0.00353,-0.10063,-0.14606,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00050664,-0.10063,-0.097144,1,0
6,GO NEURAL TUBE FORMATION,0.013798,-0.10071,-0.11461,1,0
6,GO REGULATION OF MITOCHONDRIAL FISSION,0.046579,-0.10073,-0.10351,1,0
6,GO ALPHA BETA T CELL ACTIVATION,0.001872,-0.10082,-0.15653,1,0
6,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0033369,-0.10119,-0.10762,1,0
6,GO VESICLE ORGANIZATION,0.00092958,-0.10123,-0.12968,1,0
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00022676,-0.10123,-0.11579,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0014738,-0.10125,-0.1513,1,0
6,GO TUBE FORMATION,0.0066042,-0.10138,-0.11624,1,0
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0032441,-0.10139,-0.086517,1,0
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0013457,-0.1019,-0.11441,1,0
6,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.047551,-0.10193,-0.15026,1,0
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0099891,-0.10208,-0.11837,1,0
6,GO PEPTIDYL ASPARAGINE MODIFICATION,0.027188,-0.10213,-0.11182,1,0
6,GO SKELETAL SYSTEM MORPHOGENESIS,0.0041716,-0.10215,-0.13734,1,0
6,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0034322,-0.10258,-0.11561,1,0
6,GO CELLULAR COMPONENT DISASSEMBLY,0.0010859,-0.10263,-0.10428,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.015203,-0.10266,-0.12857,1,0
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.014841,-0.1027,-0.11758,1,0
6,GO INTERFERON BETA PRODUCTION,0.047551,-0.10278,-0.12493,1,0
6,GO AORTA DEVELOPMENT,0.030383,-0.10281,-0.14596,1,0
6,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.010506,-0.10285,-0.15567,1,0
6,GO EXCRETION,0.007729,-0.10286,-0.13742,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.040234,-0.10315,-0.09283,1,0
6,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.012203,-0.10335,-0.13536,1,0
6,GO LIPOSACCHARIDE METABOLIC PROCESS,0.010506,-0.10338,-0.13198,1,0
6,GO EXTRACELLULAR VESICLE BIOGENESIS,0.037747,-0.10342,-0.11363,1,0
6,GO NEGATIVE REGULATION OF TRANSPORT,0.0012662,-0.10344,-0.10327,1,0
6,GO TOR SIGNALING,0.00017186,-0.10356,-0.10555,1,0
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00037661,-0.10367,-0.11392,1,0
6,GO CATION TRANSPORT,0.0040578,-0.10392,-0.10876,1,0
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.011326,-0.10403,-0.094094,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0032441,-0.10406,-0.1017,1,0
6,GO REGULATION OF LIPID KINASE ACTIVITY,0.014138,-0.10417,-0.1101,1,0
6,GO NEPHRON MORPHOGENESIS,0.050569,-0.10426,-0.095312,1,0
6,GO FEAR RESPONSE,0.007729,-0.10428,-0.14309,1,0
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0081404,-0.10435,-0.11643,1,0
6,GO EPITHELIUM DEVELOPMENT,0.0019282,-0.10437,-0.12676,1,0
6,GO REGULATION OF INNATE IMMUNE RESPONSE,0.013798,-0.10446,-0.12401,1,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00084609,-0.10449,-0.11805,1,0
6,GO PROTEIN N LINKED GLYCOSYLATION,0.0039469,-0.10481,-0.13713,1,0
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0013872,-0.10488,-0.13038,1,0
6,GO GOLGI VESICLE TRANSPORT,0.0022332,-0.10497,-0.097825,1,0
6,GO LYSOSOME LOCALIZATION,0.013798,-0.10524,-0.099972,1,0
6,GO ELECTRON TRANSPORT CHAIN,0.02843,-0.10531,-0.10445,1,0
6,GO MITOCHONDRIAL TRANSPORT,0.02268,-0.10554,-0.075139,1,0
6,GO CELLULAR IRON ION HOMEOSTASIS,0.024846,-0.10564,-0.11361,1,0
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.012508,-0.10576,-0.096364,1,0
6,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0073363,-0.10612,-0.12378,1,0
6,GO RESPONSE TO ABIOTIC STIMULUS,0.00010462,-0.1062,-0.12337,1,0
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.013465,-0.10622,-0.13052,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0053338,-0.10638,-0.11221,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.015953,-0.10647,-0.1441,1,0
6,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.027188,-0.10662,-0.11655,1,0
6,GO PHAGOSOME MATURATION,0.041967,-0.10664,-0.096663,1,0
6,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0097392,-0.10671,-0.096195,1,0
6,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00087311,-0.10677,-0.12545,1,0
6,GO DRUG CATABOLIC PROCESS,0.0010206,-0.1068,-0.19563,1,0
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.014138,-0.10681,-0.13667,1,0
6,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.012203,-0.10683,-0.12221,1,0
6,GO REGULATION OF PEPTIDE TRANSPORT,0.0053338,-0.10691,-0.083974,1,0
6,GO MUSCLE ORGAN DEVELOPMENT,0.00028792,-0.10692,-0.12353,1,0
6,GO CELLULAR PIGMENTATION,0.0045306,-0.10696,-0.12678,1,0
6,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.03245,-0.10697,-0.15686,1,0
6,GO MUSCLE CELL MIGRATION,0.024846,-0.10698,-0.17053,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.038561,-0.10699,-0.12146,1,0
6,GO AGING,7.2754e-05,-0.10708,-0.14636,1,0
6,GO INTERFERON ALPHA PRODUCTION,0.037747,-0.10718,-0.13759,1,0
6,GO MITOCHONDRIAL FISSION,0.041967,-0.10721,-0.096009,1,0
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.031748,-0.10726,-0.13492,1,0
6,GO MACROAUTOPHAGY,0.00024286,-0.10736,-0.11419,1,0
6,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.018398,-0.10737,-0.11216,1,0
6,GO CHYLOMICRON ASSEMBLY,0.0011199,-0.10741,-0.2038,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0017123,-0.10748,-0.14826,1,0
6,GO MODULATION BY VIRUS OF HOST PROCESS,0.022165,-0.1075,-0.10639,1,0
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.025414,-0.10757,-0.17811,1,0
6,GO MOLTING CYCLE,0.001191,-0.10765,-0.1567,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0056288,-0.10771,-0.12914,1,0
6,GO VESICLE BUDDING FROM MEMBRANE,0.004408,-0.10786,-0.13275,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0060989,-0.10802,-0.15292,1,0
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0059384,-0.10804,-0.10922,1,0
6,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00090094,-0.1081,-0.1396,1,0
6,GO MESODERM DEVELOPMENT,0.00050664,-0.10812,-0.14416,1,0
6,GO VIRAL RELEASE FROM HOST CELL,0.031748,-0.10815,-0.10709,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.050569,-0.10828,-0.087413,1,0
6,GO MESENCHYME DEVELOPMENT,0.00084609,-0.10841,-0.14996,1,0
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00019753,-0.10843,-0.13523,1,0
6,GO RESPONSE TO BMP,0.011326,-0.10852,-0.11674,1,0
6,GO SODIUM ION TRANSPORT,0.016339,-0.10862,-0.10866,1,0
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.027803,-0.10864,-0.11976,1,0
6,GO HOMEOSTATIC PROCESS,7.2754e-05,-0.10865,-0.11642,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0020453,-0.10871,-0.17682,1,0
6,GO LYMPH VESSEL MORPHOGENESIS,0.036164,-0.10878,-0.15645,1,0
6,GO T CELL DIFFERENTIATION,0.0028141,-0.1088,-0.12048,1,0
6,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0099891,-0.10887,-0.12122,1,0
6,GO STRIATED MUSCLE CELL PROLIFERATION,0.022165,-0.10888,-0.12216,1,0
6,GO ANATOMICAL STRUCTURE MATURATION,0.036164,-0.10889,-0.076561,1,0
6,GO INTERLEUKIN 10 PRODUCTION,0.031059,-0.10891,-0.11941,1,0
6,GO MIDBRAIN DEVELOPMENT,0.007729,-0.10923,-0.097096,1,0
6,GO LYSOSOMAL TRANSPORT,0.014138,-0.10924,-0.11025,1,0
6,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.02166,-0.10933,-0.17947,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.011612,-0.10935,-0.11781,1,0
6,GO WHITE FAT CELL DIFFERENTIATION,0.031748,-0.10943,-0.15306,1,0
6,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0037331,-0.10952,-0.17244,1,0
6,GO INTERLEUKIN 6 PRODUCTION,0.0029794,-0.1096,-0.13687,1,0
6,GO ER NUCLEUS SIGNALING PATHWAY,0.019739,-0.10961,-0.14272,1,0
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0049174,-0.10967,-0.11739,1,0
6,GO REGULATION OF CATION CHANNEL ACTIVITY,0.033894,-0.10971,-0.12562,1,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.015574,-0.10979,-0.11283,1,0
6,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00032948,-0.11003,-0.12123,1,0
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.040234,-0.11011,-0.10817,1,0
6,GO SPERM CAPACITATION,0.047551,-0.11021,-0.10149,1,0
6,GO CATION TRANSMEMBRANE TRANSPORT,0.0030654,-0.11065,-0.11106,1,0
6,GO T CELL DIFFERENTIATION IN THYMUS,0.0094949,-0.11067,-0.11967,1,0
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.036948,-0.11069,-0.10503,1,0
6,GO NEGATIVE REGULATION OF CELL DEATH,0.00047456,-0.11072,-0.1191,1,0
6,GO LIVER REGENERATION,0.0013872,-0.1109,-0.21209,1,0
6,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0083534,-0.11093,-0.10732,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0047853,-0.111,-0.12652,1,0
6,GO COCHLEA DEVELOPMENT,0.027803,-0.11104,-0.10496,1,0
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0073363,-0.11125,-0.10261,1,0
6,GO REGULATION OF CELL POPULATION PROLIFERATION,5.6174e-05,-0.1113,-0.14214,1,0
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0054795,-0.11131,-0.14891,1,0
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.02166,-0.11139,-0.061617,1,0
6,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.016734,-0.1114,-0.12028,1,0
6,GO EMBRYONIC ORGAN DEVELOPMENT,0.0012662,-0.11149,-0.12694,1,0
6,GO RECEPTOR RECYCLING,0.022165,-0.11173,-0.12694,1,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00026003,-0.11174,-0.1205,1,0
6,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00353,-0.11175,-0.11482,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00034072,-0.11192,-0.13515,1,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0006154,-0.11214,-0.095831,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0073363,-0.11218,-0.15932,1,0
6,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00038934,-0.11223,-0.12274,1,0
6,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0039469,-0.11229,-0.1102,1,0
6,GO REGULATION OF GASTRULATION,0.019739,-0.1124,-0.14828,1,0
6,GO ION TRANSMEMBRANE TRANSPORT,0.0014738,-0.11242,-0.11565,1,0
6,GO POSITIVE REGULATION OF ANION TRANSPORT,0.012508,-0.11257,-0.13997,1,0
6,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0013054,-0.11276,-0.15934,1,0
6,GO REGULATION OF MITOPHAGY,0.046579,-0.11288,-0.099359,1,0
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.044685,-0.11297,-0.15018,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0049174,-0.113,-0.16084,1,0
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.0010859,-0.11336,-0.12229,1,0
6,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.014486,-0.11343,-0.12314,1,0
6,GO ANIMAL ORGAN MORPHOGENESIS,0.00052342,-0.1135,-0.129,1,0
6,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0046564,-0.1135,-0.14586,1,0
6,GO NEGATIVE REGULATION OF SIGNALING,0.00087311,-0.11369,-0.1116,1,0
6,GO REGULATION OF CATABOLIC PROCESS,3.4421e-05,-0.11369,-0.11604,1,0
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0015653,-0.11374,-0.11075,1,0
6,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.015574,-0.11384,-0.15928,1,0
6,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.010245,-0.11397,-0.13308,1,0
6,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012508,-0.114,-0.12781,1,0
6,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0056288,-0.11419,-0.10153,1,0
6,GO EMBRYONIC MORPHOGENESIS,0.0012662,-0.11423,-0.13265,1,0
6,GO PROTEIN STABILIZATION,6.5149e-05,-0.11436,-0.13293,1,0
6,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.011047,-0.11437,-0.15013,1,0
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0027346,-0.11444,-0.18199,1,0
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0047853,-0.11447,-0.16228,1,0
6,GO LEUKOCYTE HOMEOSTASIS,0.0060989,-0.11465,-0.1245,1,0
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00030804,-0.11473,-0.11513,1,0
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,8.4205e-05,-0.11483,-0.09954,1,0
6,GO LYMPHOCYTE DIFFERENTIATION,0.00055855,-0.1149,-0.12264,1,0
6,GO REGULATION OF B CELL ACTIVATION,0.0010206,-0.11492,-0.16601,1,0
6,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00079435,-0.11495,-0.11917,1,0
6,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.4609e-05,-0.11501,-0.15011,1,0
6,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.029719,-0.1151,-0.23952,1,0
6,GO REGULATION OF PROTEIN STABILITY,9.389e-05,-0.1152,-0.12444,1,0
6,GO GOLGI VESICLE BUDDING,0.00037661,-0.11523,-0.15409,1,0
6,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00084609,-0.11524,-0.13597,1,0
6,GO OLIGODENDROCYTE DEVELOPMENT,0.025414,-0.11528,-0.13005,1,0
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.022165,-0.11533,-0.17762,1,0
6,GO SKELETAL SYSTEM DEVELOPMENT,0.00037661,-0.1154,-0.13599,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0042883,-0.11541,-0.13101,1,0
6,GO HAIR CELL DIFFERENTIATION,0.047551,-0.11555,-0.12152,1,0
6,GO REGULATION OF CELL DEATH,0.0001547,-0.11576,-0.12165,1,0
6,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.033894,-0.11584,-0.14392,1,0
6,GO POSITIVE REGULATION OF SIGNALING,0.00014418,-0.11586,-0.12126,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.027803,-0.1159,-0.16704,1,0
6,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00042998,-0.11595,-0.15276,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.004408,-0.11596,-0.15,1,0
6,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00065623,-0.11611,-0.17059,1,0
6,GO PROTEIN FOLDING,0.0066042,-0.11617,-0.1202,1,0
6,GO ESTABLISHMENT OF TISSUE POLARITY,0.016339,-0.11625,-0.095952,1,0
6,GO ALCOHOL CATABOLIC PROCESS,0.0007696,-0.11629,-0.15114,1,0
6,GO NEUTROPHIL MIGRATION,0.0013457,-0.1163,-0.15393,1,0
6,GO REGULATION OF HYDROLASE ACTIVITY,0.00055855,-0.11637,-0.12412,1,0
6,GO REGULATION OF RESPONSE TO STRESS,0.00017796,-0.11638,-0.12603,1,0
6,GO RESPONSE TO ORGANOPHOSPHORUS,0.0010859,-0.11641,-0.14572,1,0
6,GO CELLULAR HORMONE METABOLIC PROCESS,0.018398,-0.11673,-0.16828,1,0
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00024286,-0.11695,-0.1237,1,0
6,GO ORGANIC ANION TRANSPORT,0.00025131,-0.117,-0.13198,1,0
6,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0040578,-0.11713,-0.16796,1,0
6,GO REGULATION OF SODIUM ION TRANSPORT,0.038561,-0.11713,-0.13118,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.018398,-0.11714,-0.14649,1,0
6,GO ACTIVATION OF JNKK ACTIVITY,0.041093,-0.11718,-0.11327,1,0
6,GO PROTEIN TARGETING TO MEMBRANE,0.019283,-0.11721,-0.14725,1,0
6,GO DIGESTIVE SYSTEM DEVELOPMENT,0.050569,-0.11722,-0.10004,1,0
6,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0069616,-0.11723,-0.14477,1,0
6,GO REGULATION OF TOR SIGNALING,0.00044439,-0.11727,-0.10824,1,0
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00029782,-0.11734,-0.13916,1,0
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0028141,-0.11735,-0.15122,1,0
6,GO REGULATION OF HEMOPOIESIS,0.00020448,-0.11737,-0.14707,1,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.050569,-0.1174,-0.088298,1,0
6,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.04854,-0.1175,-0.12887,1,0
6,GO REGULATION OF CELL AGING,0.017137,-0.1175,-0.12687,1,0
6,GO REGULATION OF B CELL PROLIFERATION,0.0040578,-0.11758,-0.18144,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.001191,-0.11759,-0.13952,1,0
6,GO URONIC ACID METABOLIC PROCESS,0.033166,-0.11768,-0.11588,1,0
6,GO AEROBIC RESPIRATION,0.010506,-0.11787,-0.14827,1,0
6,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.015953,-0.11789,-0.16993,1,0
6,GO SINGLE FERTILIZATION,0.0023671,-0.11794,-0.11974,1,0
6,GO MONOVALENT INORGANIC CATION TRANSPORT,0.02166,-0.118,-0.091847,1,0
6,GO MYELOID CELL DIFFERENTIATION,0.00026003,-0.11815,-0.14469,1,0
6,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.02268,-0.11822,-0.13328,1,0
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00013917,-0.11823,-0.14293,1,0
6,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00026903,-0.11839,-0.12603,1,0
6,GO TRANSMEMBRANE TRANSPORT,0.00045924,-0.11842,-0.11851,1,0
6,GO APOPTOTIC PROCESS,5.2139e-05,-0.11846,-0.12517,1,0
6,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.014841,-0.11854,-0.13067,1,0
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00013917,-0.11863,-0.11728,1,0
6,GO POSITIVE REGULATION OF TRANSLATION,0.0041716,-0.11874,-0.14761,1,0
6,GO REGULATION OF PEPTIDE SECRETION,0.0057817,-0.11879,-0.10353,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0019282,-0.11891,-0.16235,1,0
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0001547,-0.11913,-0.14671,1,0
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0054795,-0.11918,-0.15735,1,0
6,GO SUPEROXIDE METABOLIC PROCESS,0.015953,-0.11945,-0.15138,1,0
6,GO METAL ION TRANSPORT,0.0020453,-0.11948,-0.11616,1,0
6,GO CYTOKINE SECRETION,0.0060989,-0.11951,-0.12931,1,0
6,GO TISSUE MORPHOGENESIS,0.0001165,-0.11953,-0.14737,1,0
6,GO RESPONSE TO VIRUS,0.015953,-0.11956,-0.15227,1,0
6,GO RENAL SODIUM EXCRETION,0.046579,-0.11957,-0.12003,1,0
6,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00042998,-0.11963,-0.16096,1,0
6,GO ERBB SIGNALING PATHWAY,0.010506,-0.11965,-0.12805,1,0
6,GO MITOPHAGY,0.031059,-0.11966,-0.10355,1,0
6,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0081404,-0.11983,-0.16907,1,0
6,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0006154,-0.11983,-0.14489,1,0
6,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.03939,-0.11985,-0.14225,1,0
6,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0051916,-0.11992,-0.11295,1,0
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00059588,-0.11993,-0.14937,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,5.0226e-05,-0.11998,-0.13879,1,0
6,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.012203,-0.12001,-0.15293,1,0
6,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0021689,-0.1201,-0.11323,1,0
6,GO CD40 SIGNALING PATHWAY,0.026586,-0.12016,-0.201,1,0
6,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.013465,-0.12042,-0.18711,1,0
6,GO RESPONSE TO MONOSACCHARIDE,0.00029782,-0.12045,-0.13329,1,0
6,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0014299,-0.1205,-0.13422,1,0
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0023671,-0.12057,-0.12602,1,0
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00026903,-0.1207,-0.13591,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0083534,-0.12071,-0.20649,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.011904,-0.12075,-0.13374,1,0
6,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0015189,-0.12078,-0.13819,1,0
6,GO CELLULAR EXTRAVASATION,0.011047,-0.1208,-0.13357,1,0
6,GO CELLULAR KETONE METABOLIC PROCESS,0.0027346,-0.12082,-0.14282,1,0
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.033166,-0.12089,-0.27253,1,0
6,GO ANION TRANSPORT,7.013e-05,-0.12092,-0.13639,1,0
6,GO RESPONSE TO SALT STRESS,0.034637,-0.121,-0.14196,1,0
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00036427,-0.12104,-0.16728,1,0
6,GO REGULATION OF TRANSPORTER ACTIVITY,0.0090226,-0.12111,-0.12844,1,0
6,GO TERPENOID METABOLIC PROCESS,0.019739,-0.12117,-0.15302,1,0
6,GO VIRAL RNA GENOME REPLICATION,0.043763,-0.1212,-0.12707,1,0
6,GO OVARIAN FOLLICLE DEVELOPMENT,0.025994,-0.1212,-0.12051,1,0
6,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.042857,-0.12131,-0.1278,1,0
6,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.026586,-0.12141,-0.1833,1,0
6,GO FATTY ACID CATABOLIC PROCESS,0.0040578,-0.12154,-0.15317,1,0
6,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00084609,-0.12161,-0.17298,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION,0.00087311,-0.12169,-0.13158,1,0
6,GO RESPONSE TO GROWTH FACTOR,0.00067758,-0.1217,-0.13122,1,0
6,GO POSITIVE REGULATION OF TRANSPORT,0.00072223,-0.12181,-0.11238,1,0
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0066042,-0.12188,-0.11449,1,0
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.010245,-0.12198,-0.13348,1,0
6,GO INTERFERON GAMMA PRODUCTION,0.00054072,-0.12204,-0.17628,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.023741,-0.1221,-0.16985,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00054072,-0.1221,-0.12631,1,0
6,GO OSTEOCLAST DIFFERENTIATION,0.0007696,-0.1222,-0.14472,1,0
6,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0015189,-0.12223,-0.14098,1,0
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0021689,-0.12226,-0.11425,1,0
6,GO PIGMENT GRANULE ORGANIZATION,0.014486,-0.12231,-0.15136,1,0
6,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0025817,-0.12276,-0.16534,1,0
6,GO REGULATION OF T CELL ACTIVATION,0.00040247,-0.12291,-0.15829,1,0
6,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00018427,-0.12318,-0.12666,1,0
6,GO AMINO ACID IMPORT,0.013465,-0.12331,-0.16413,1,0
6,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.018836,-0.12333,-0.1961,1,0
6,GO POSITIVE REGULATION OF CELL AGING,0.0049174,-0.12346,-0.23712,1,0
6,GO TRANSITION METAL ION TRANSPORT,0.00026003,-0.12364,-0.12449,1,0
6,GO VESICLE TARGETING,0.0024367,-0.1238,-0.15796,1,0
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0094949,-0.12385,-0.19787,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0031536,-0.1239,-0.16324,1,0
6,GO EPIDERMIS MORPHOGENESIS,0.0071468,-0.12392,-0.21953,1,0
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.017137,-0.12397,-0.17715,1,0
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0046564,-0.12415,-0.11179,1,0
6,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0027346,-0.12415,-0.13004,1,0
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0081404,-0.12416,-0.16839,1,0
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0027346,-0.12421,-0.13387,1,0
6,GO HEME METABOLIC PROCESS,0.027803,-0.12441,-0.23346,1,0
6,GO NEGATIVE REGULATION OF CELL GROWTH,0.0006154,-0.12443,-0.13866,1,0
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0087944,-0.12444,-0.19478,1,0
6,GO CELLULAR ION HOMEOSTASIS,8.4205e-05,-0.12444,-0.1354,1,0
6,GO REGULATION OF PINOCYTOSIS,0.011047,-0.12459,-0.20035,1,0
6,GO MESONEPHROS DEVELOPMENT,0.025994,-0.12472,-0.1386,1,0
6,GO PLACENTA DEVELOPMENT,0.0069616,-0.12478,-0.15712,1,0
6,GO GOLGI TO ENDOSOME TRANSPORT,0.020205,-0.12493,-0.14867,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00037661,-0.12513,-0.12623,1,0
6,GO NEUROINFLAMMATORY RESPONSE,0.0040578,-0.1252,-0.16966,1,0
6,GO REGULATION OF RENAL SYSTEM PROCESS,0.03245,-0.1253,-0.16736,1,0
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,5.0226e-05,-0.12533,-0.14885,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0032441,-0.12537,-0.15233,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.033894,-0.12547,-0.15286,1,0
6,GO OSTEOBLAST DIFFERENTIATION,0.00049035,-0.12548,-0.17895,1,0
6,GO REGULATION OF PROTEIN IMPORT,0.011326,-0.12564,-0.1562,1,0
6,GO REGULATION OF ION TRANSPORT,0.0038387,-0.12565,-0.12662,1,0
6,GO CARDIAC MUSCLE CELL PROLIFERATION,0.029719,-0.12582,-0.12523,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION,0.00098941,-0.12582,-0.13127,1,0
6,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0015653,-0.12583,-0.18872,1,0
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0038387,-0.12587,-0.13843,1,0
6,GO EPITHELIAL TUBE MORPHOGENESIS,0.0028141,-0.12593,-0.12414,1,0
6,GO ORGAN INDUCTION,0.02166,-0.12596,-0.15159,1,0
6,GO RESPONSE TO ENDOGENOUS STIMULUS,3.1888e-05,-0.12597,-0.13438,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.001191,-0.12602,-0.11397,1,0
6,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,6.0504e-05,-0.12607,-0.13424,1,0
6,GO REPLICATIVE SENESCENCE,0.025994,-0.12608,-0.2239,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0040578,-0.12625,-0.091483,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.019739,-0.12627,-0.14943,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00040247,-0.1263,-0.13437,1,0
6,GO PEPTIDE BIOSYNTHETIC PROCESS,0.02268,-0.12634,-0.11363,1,0
6,GO OSSIFICATION,0.00017796,-0.12635,-0.16698,1,0
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,6.7596e-05,-0.12643,-0.13787,1,0
6,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0038387,-0.12664,-0.11951,1,0
6,GO SMOOTH MUSCLE CELL MIGRATION,0.012203,-0.12665,-0.20772,1,0
6,GO MESODERMAL CELL DIFFERENTIATION,0.0039469,-0.12691,-0.20176,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00014935,-0.12692,-0.1347,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0013872,-0.12701,-0.19106,1,0
6,GO CELLULAR RESPONSE TO CALCIUM ION,0.05161,-0.12703,-0.15226,1,0
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.00057693,-0.1272,-0.1536,1,0
6,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0031536,-0.12723,-0.11992,1,0
6,GO RESPONSE TO INTERLEUKIN 1,0.00087311,-0.12727,-0.15975,1,0
6,GO CELLULAR RESPONSE TO ALCOHOL,0.014138,-0.12728,-0.11186,1,0
6,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.012508,-0.12731,-0.16711,1,0
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0050528,-0.12738,-0.1269,1,0
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.011904,-0.12742,-0.13576,1,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.047551,-0.12746,-0.11926,1,0
6,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0062634,-0.12748,-0.1545,1,0
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0010206,-0.12752,-0.13228,1,0
6,GO FATTY ACID BETA OXIDATION,0.042857,-0.12761,-0.12159,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0056288,-0.12766,-0.16681,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,-0.12768,-0.1715,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00054072,-0.12771,-0.11877,1,0
6,GO UROGENITAL SYSTEM DEVELOPMENT,0.0025083,-0.12773,-0.1401,1,0
6,GO NUCLEOTIDE TRANSPORT,0.035393,-0.1278,-0.10404,1,0
6,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0050528,-0.12791,-0.11524,1,0
6,GO RENAL TUBULE DEVELOPMENT,0.0090226,-0.1281,-0.1406,1,0
6,GO LYMPHOCYTE ACTIVATION,0.00019079,-0.12818,-0.14899,1,0
6,GO CERAMIDE METABOLIC PROCESS,0.0001165,-0.12821,-0.16822,1,0
6,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.001662,-0.12828,-0.11968,1,0
6,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.015953,-0.12836,-0.15537,1,0
6,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0060989,-0.12848,-0.21223,1,0
6,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.020205,-0.12849,-0.14269,1,0
6,GO ISOPRENOID METABOLIC PROCESS,0.016734,-0.12858,-0.14116,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00065623,-0.12859,-0.12767,1,0
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,2.7343e-05,-0.12868,-0.143,1,0
6,GO LEUKOCYTE DIFFERENTIATION,7.547e-05,-0.12872,-0.15499,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0025083,-0.12875,-0.20128,1,0
6,GO REGULATION OF RUFFLE ASSEMBLY,0.023205,-0.12888,-0.13381,1,0
6,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.007729,-0.12888,-0.17616,1,0
6,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0040578,-0.12901,-0.14453,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.014486,-0.12904,-0.12547,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00021909,-0.12908,-0.1404,1,0
6,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.4346e-05,-0.1291,-0.1308,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.022165,-0.12912,-0.15118,1,0
6,GO ENDOCYTIC RECYCLING,0.0041716,-0.12913,-0.13553,1,0
6,GO TRANSEPITHELIAL TRANSPORT,0.0064317,-0.12917,-0.14906,1,0
6,GO ION TRANSPORT,0.00072223,-0.12922,-0.12568,1,0
6,GO PROTEIN HOMOOLIGOMERIZATION,0.0040578,-0.12922,-0.10249,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.018836,-0.12937,-0.21277,1,0
6,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.001191,-0.12957,-0.16525,1,0
6,GO INTERLEUKIN 4 PRODUCTION,0.0036303,-0.12989,-0.17922,1,0
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0029794,-0.12992,-0.13144,1,0
6,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,9.0551e-05,-0.12996,-0.11536,1,0
6,GO SECRETION,0.0001165,-0.13003,-0.14415,1,0
6,GO RESPONSE TO CARBOHYDRATE,0.00010845,-0.13005,-0.14283,1,0
6,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0032441,-0.13005,-0.1238,1,0
6,GO GLAND DEVELOPMENT,0.00013917,-0.13017,-0.14814,1,0
6,GO SYMBIOTIC PROCESS,0.00010092,-0.13019,-0.1496,1,0
6,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00081984,-0.13022,-0.18328,1,0
6,GO RESPONSE TO ACTIVITY,0.0015189,-0.1307,-0.13985,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.014486,-0.13077,-0.13564,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0042883,-0.13081,-0.13538,1,0
6,GO ACTIN FILAMENT DEPOLYMERIZATION,0.027803,-0.13096,-0.11581,1,0
6,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00013917,-0.13099,-0.14634,1,0
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.0090226,-0.13118,-0.12376,1,0
6,GO RESPONSE TO AXON INJURY,0.0069616,-0.13124,-0.13855,1,0
6,GO REGULATION OF BINDING,6.2786e-05,-0.13145,-0.13206,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0028141,-0.13148,-0.22493,1,0
6,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.004408,-0.13155,-0.11858,1,0
6,GO BASIC AMINO ACID TRANSPORT,0.012508,-0.13159,-0.22197,1,0
6,GO IRON ION TRANSPORT,0.00049035,-0.13168,-0.14267,1,0
6,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00010845,-0.13169,-0.18177,1,0
6,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0022992,-0.13179,-0.16717,1,0
6,GO CARBOHYDRATE TRANSPORT,0.00025131,-0.13184,-0.14494,1,0
6,GO MESENCHYMAL CELL DIFFERENTIATION,0.00081984,-0.13223,-0.1729,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.024846,-0.13229,-0.15541,1,0
6,GO MONOCARBOXYLIC ACID TRANSPORT,0.00069957,-0.13231,-0.13299,1,0
6,GO LIPOPROTEIN CATABOLIC PROCESS,0.016339,-0.13242,-0.18665,1,0
6,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00067758,-0.13255,-0.14919,1,0
6,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.052669,-0.13257,-0.14656,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,3.8583e-05,-0.13272,-0.13248,1,0
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.001228,-0.13273,-0.15817,1,0
6,GO BILE ACID METABOLIC PROCESS,0.011612,-0.13277,-0.17485,1,0
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0023671,-0.13282,-0.13932,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.004408,-0.13285,-0.18837,1,0
6,GO CELLULAR DEFENSE RESPONSE,0.0062634,-0.1329,-0.20313,1,0
6,GO REGULATION OF REPRODUCTIVE PROCESS,3.8583e-05,-0.13292,-0.13622,1,0
6,GO CERAMIDE TRANSPORT,0.036948,-0.13306,-0.16623,1,0
6,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0020453,-0.13307,-0.37106,1,0
6,GO CIRCULATORY SYSTEM PROCESS,0.00017796,-0.13328,-0.1517,1,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00353,-0.13334,-0.099018,1,0
6,GO REGULATION OF TRANSFERASE ACTIVITY,0.00014935,-0.13335,-0.12677,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0006154,-0.13337,-0.15264,1,0
6,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00044439,-0.13338,-0.15345,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0085714,-0.13345,-0.10448,1,0
6,GO T CELL ACTIVATION,0.00021909,-0.13356,-0.16319,1,0
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.047551,-0.13366,-0.16257,1,0
6,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0014738,-0.13371,-0.18628,1,0
6,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0042883,-0.13371,-0.12282,1,0
6,GO APOPTOTIC SIGNALING PATHWAY,0.00014418,-0.13376,-0.14389,1,0
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.03245,-0.13378,-0.23392,1,0
6,GO PROTEIN TARGETING TO VACUOLE,0.0064317,-0.13378,-0.1471,1,0
6,GO REGULATION OF CELL ACTIVATION,0.00022676,-0.13401,-0.15953,1,0
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00055855,-0.13412,-0.13352,1,0
6,GO FATTY ACID DERIVATIVE TRANSPORT,0.0013872,-0.13437,-0.15119,1,0
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.00079435,-0.13453,-0.12387,1,0
6,GO LIPOPROTEIN METABOLIC PROCESS,0.00034072,-0.1347,-0.1487,1,0
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0081404,-0.13476,-0.14354,1,0
6,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.047551,-0.13483,-0.10739,1,0
6,GO PROTEIN TARGETING,0.0025083,-0.13492,-0.12788,1,0
6,GO RESPONSE TO ALCOHOL,2.2524e-05,-0.13496,-0.16798,1,0
6,GO REGULATION OF PROTEIN MATURATION,0.00037661,-0.1351,-0.19285,1,0
6,GO PRIMARY MIRNA PROCESSING,0.0071468,-0.13521,-0.17827,1,0
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0022992,-0.13528,-0.11953,1,0
6,GO NEGATIVE REGULATION OF SECRETION,0.00063551,-0.13539,-0.12296,1,0
6,GO PROTEIN COMPLEX OLIGOMERIZATION,0.00087311,-0.1354,-0.11947,1,0
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0064317,-0.13554,-0.13374,1,0
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.031748,-0.1356,-0.17593,1,0
6,GO RESPONSE TO LEPTIN,0.017549,-0.13562,-0.14843,1,0
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00074557,-0.13562,-0.12952,1,0
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0021689,-0.13564,-0.1436,1,0
6,GO REGULATION OF MUSCLE CONTRACTION,0.0015653,-0.13571,-0.14929,1,0
6,GO REGULATION OF BMP SIGNALING PATHWAY,0.019739,-0.13578,-0.13842,1,0
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,5.0226e-05,-0.13583,-0.13306,1,0
6,GO REGULATION OF NUCLEASE ACTIVITY,0.02068,-0.13586,-0.12055,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.011326,-0.13587,-0.18383,1,0
6,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.0054795,-0.13598,-0.14532,1,0
6,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.017549,-0.13606,-0.18695,1,0
6,GO REGULATION OF MACROAUTOPHAGY,3.3132e-05,-0.13612,-0.13827,1,0
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0059384,-0.13618,-0.14541,1,0
6,GO VACUOLAR ACIDIFICATION,0.0028957,-0.13624,-0.16956,1,0
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00018427,-0.13626,-0.14233,1,0
6,GO ACTIN FILAMENT ORGANIZATION,0.0006154,-0.13635,-0.14217,1,0
6,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0064317,-0.13642,-0.16938,1,0
6,GO FERTILIZATION,0.00044439,-0.13652,-0.13202,1,0
6,GO VIRAL GENOME REPLICATION,0.0050528,-0.13656,-0.20884,1,0
6,GO MEMBRANE LIPID METABOLIC PROCESS,4.3218e-05,-0.13669,-0.18269,1,0
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.011326,-0.13674,-0.1803,1,0
6,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,8.1192e-05,-0.1368,-0.14184,1,0
6,GO CELLULAR RESPONSE TO FATTY ACID,0.043763,-0.13695,-0.14756,1,0
6,GO ZINC ION TRANSPORT,0.00353,-0.13705,-0.16149,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE,1.5816e-05,-0.1371,-0.14779,1,0
6,GO CELLULAR HOMEOSTASIS,4.4878e-05,-0.13717,-0.13231,1,0
6,GO METAL ION HOMEOSTASIS,4.0073e-05,-0.1372,-0.14702,1,0
6,GO REGULATION OF MUSCLE ADAPTATION,0.0027346,-0.13736,-0.15441,1,0
6,GO EPITHELIAL CELL DEVELOPMENT,0.00081984,-0.13739,-0.17141,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.010245,-0.13748,-0.14934,1,0
6,GO OXIDATIVE PHOSPHORYLATION,0.0075304,-0.13757,-0.15097,1,0
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,6.0504e-05,-0.13758,-0.15356,1,0
6,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0028957,-0.13758,-0.14396,1,0
6,GO MODIFIED AMINO ACID TRANSPORT,0.0064317,-0.13766,-0.16811,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00045924,-0.13773,-0.14421,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00055855,-0.13783,-0.13919,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00019753,-0.13784,-0.16231,1,0
6,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.5759e-05,-0.13786,-0.16898,1,0
6,GO TRANSFERRIN TRANSPORT,0.004408,-0.13788,-0.15421,1,0
6,GO INTERLEUKIN 2 PRODUCTION,0.0017641,-0.13792,-0.16914,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.021165,-0.13792,-0.15487,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00027832,-0.13794,-0.19278,1,0
6,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.6597e-05,-0.13798,-0.11943,1,0
6,GO JNK CASCADE,6.7596e-05,-0.13804,-0.14876,1,0
6,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,5.6174e-05,-0.13807,-0.14817,1,0
6,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00074557,-0.13808,-0.22664,1,0
6,GO VIRAL LIFE CYCLE,0.00055855,-0.13817,-0.18286,1,0
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.00054072,-0.13824,-0.13008,1,0
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0010528,-0.13827,-0.1471,1,0
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00030804,-0.13829,-0.1496,1,0
6,GO NEGATIVE REGULATION OF CELL SIZE,0.0094949,-0.13831,-0.16959,1,0
6,GO MUSCLE TISSUE DEVELOPMENT,0.0001165,-0.13851,-0.12799,1,0
6,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.04854,-0.13852,-0.13211,1,0
6,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,5.8301e-05,-0.13854,-0.14859,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0075304,-0.13858,-0.1202,1,0
6,GO PURINE NUCLEOTIDE TRANSPORT,0.036948,-0.13865,-0.11464,1,0
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0025083,-0.13874,-0.13846,1,0
6,GO NEGATIVE REGULATION OF BINDING,0.00095906,-0.13877,-0.12281,1,0
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00016023,-0.13878,-0.19072,1,0
6,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.017969,-0.1388,-0.1887,1,0
6,GO POSITIVE REGULATION OF CELL DEATH,3.0689e-05,-0.13909,-0.14463,1,0
6,GO CELL AGGREGATION,0.024288,-0.13911,-0.15941,1,0
6,GO REGULATION OF B CELL DIFFERENTIATION,0.04854,-0.13917,-0.13901,1,0
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.02268,-0.13944,-0.15987,1,0
6,GO TUBE DEVELOPMENT,7.2754e-05,-0.13946,-0.16625,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00012964,-0.13946,-0.18673,1,0
6,GO PHOSPHOLIPID METABOLIC PROCESS,2.0833e-05,-0.13955,-0.14445,1,0
6,GO POSITIVE REGULATION OF BINDING,0.00012964,-0.13957,-0.1451,1,0
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0013872,-0.13965,-0.13398,1,0
6,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.017137,-0.13965,-0.11312,1,0
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.025994,-0.13972,-0.13668,1,0
6,GO CELL MOTILITY,7.2754e-05,-0.13974,-0.15472,1,0
6,GO RESPONSE TO NITROGEN COMPOUND,3.8583e-05,-0.13974,-0.13018,1,0
6,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0014299,-0.13975,-0.1144,1,0
6,GO ORGANELLE FUSION,0.0031536,-0.13979,-0.11345,1,0
6,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.7343e-05,-0.1398,-0.13853,1,0
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00044439,-0.1398,-0.12626,1,0
6,GO RESPONSE TO HEAT,0.007729,-0.14006,-0.11032,1,0
6,GO ACTIN FILAMENT BASED PROCESS,0.00022676,-0.14022,-0.14302,1,0
6,GO ACTIVATION OF IMMUNE RESPONSE,0.0028957,-0.14033,-0.12979,1,0
6,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.020205,-0.14059,-0.1888,1,0
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0021062,-0.14088,-0.13509,1,0
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,4.3218e-05,-0.14105,-0.1627,1,0
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0053338,-0.1411,-0.14469,1,0
6,GO RESPONSE TO FUNGUS,0.034637,-0.14117,-0.092691,1,0
6,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.004408,-0.14121,-0.13771,1,0
6,GO EPIDERMIS DEVELOPMENT,0.0033369,-0.14126,-0.1595,1,0
6,GO PIGMENTATION,0.0028957,-0.14133,-0.13902,1,0
6,GO MAST CELL MEDIATED IMMUNITY,0.04854,-0.14136,-0.12046,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.025994,-0.14142,-0.18606,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00059588,-0.14145,-0.16197,1,0
6,GO CELLULAR RESPONSE TO ATP,0.013798,-0.14154,-0.13525,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.016339,-0.14156,-0.14773,1,0
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00049035,-0.14161,-0.17963,1,0
6,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00072223,-0.14163,-0.14694,1,0
6,GO REGULATION OF PHOSPHORYLATION,4.4878e-05,-0.14164,-0.14114,1,0
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00010092,-0.14164,-0.14326,1,0
6,GO PEPTIDYL PROLINE MODIFICATION,0.00038934,-0.14172,-0.21234,1,0
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,9.7346e-05,-0.1418,-0.13611,1,0
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,8.1192e-05,-0.14192,-0.15417,1,0
6,GO LIPID BIOSYNTHETIC PROCESS,5.508e-06,-0.14229,-0.1703,1,0
6,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0014738,-0.14238,-0.18836,1,0
6,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0007696,-0.14239,-0.1022,1,0
6,GO REGULATION OF BLOOD CIRCULATION,0.0034322,-0.14243,-0.1472,1,0
6,GO POSITIVE REGULATION OF ION TRANSPORT,0.00079435,-0.14247,-0.14644,1,0
6,GO PIGMENT METABOLIC PROCESS,0.02166,-0.14254,-0.1566,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0018173,-0.14274,-0.21357,1,0
6,GO IRON ION TRANSMEMBRANE TRANSPORT,0.02268,-0.14277,-0.14755,1,0
6,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0010528,-0.14278,-0.14184,1,0
6,GO LUNG MORPHOGENESIS,0.001191,-0.14286,-0.20572,1,0
6,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00035231,-0.1429,-0.17478,1,0
6,GO RESPONSE TO INTERLEUKIN 4,0.0066042,-0.14291,-0.13153,1,0
6,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,1.7118e-05,-0.14293,-0.14806,1,0
6,GO CHEMICAL HOMEOSTASIS,2.1663e-05,-0.1431,-0.14731,1,0
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00019753,-0.14321,-0.15249,1,0
6,GO PEPTIDE CATABOLIC PROCESS,0.030383,-0.14329,-0.1514,1,0
6,GO MYOBLAST DIFFERENTIATION,0.0099891,-0.14332,-0.16245,1,0
6,GO CELL JUNCTION ASSEMBLY,0.0016129,-0.14343,-0.13032,1,0
6,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0021689,-0.14352,-0.13796,1,0
6,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00042998,-0.14353,-0.1726,1,0
6,GO MYELOID CELL HOMEOSTASIS,0.00059588,-0.14358,-0.15354,1,0
6,GO MEMBRANE ORGANIZATION,9.7346e-05,-0.14361,-0.13286,1,0
6,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,4.6597e-05,-0.14368,-0.1773,1,0
6,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0090226,-0.14374,-0.14192,1,0
6,GO RESPONSE TO ISCHEMIA,0.011904,-0.1439,-0.13699,1,0
6,GO CELL JUNCTION ORGANIZATION,0.0025083,-0.14415,-0.12753,1,0
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0040578,-0.14425,-0.17843,1,0
6,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,7.8282e-05,-0.14429,-0.15848,1,0
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.040234,-0.14436,-0.10995,1,0
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,6.2786e-05,-0.14439,-0.13026,1,0
6,GO CELL CELL JUNCTION ORGANIZATION,0.0081404,-0.14441,-0.14785,1,0
6,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.013798,-0.14446,-0.22817,1,0
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0053338,-0.14448,-0.13631,1,0
6,GO REGULATION OF DEFENSE RESPONSE,0.00036427,-0.14449,-0.15146,1,0
6,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,8.1192e-05,-0.1445,-0.15927,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011326,-0.1445,-0.18941,1,0
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0017123,-0.14454,-0.20622,1,0
6,GO NUCLEOSIDE METABOLIC PROCESS,0.0056288,-0.14454,-0.11191,1,0
6,GO LIPID HOMEOSTASIS,0.00010845,-0.14455,-0.17585,1,0
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00074557,-0.14457,-0.14885,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0047853,-0.14465,-0.12012,1,0
6,GO B CELL DIFFERENTIATION,0.00074557,-0.14485,-0.14528,1,0
6,GO REGULATION OF TUBE SIZE,0.0049174,-0.14485,-0.13595,1,0
6,GO RESPONSE TO FATTY ACID,0.0016129,-0.14499,-0.17564,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00035231,-0.14501,-0.1374,1,0
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.349e-05,-0.14502,-0.15273,1,0
6,GO RESPONSE TO IMMOBILIZATION STRESS,0.025414,-0.14505,-0.19288,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0036303,-0.14507,-0.12324,1,0
6,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0045306,-0.14515,-0.16241,1,0
6,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00021167,-0.14537,-0.15268,1,0
6,GO ENSHEATHMENT OF NEURONS,0.0011199,-0.14569,-0.14486,1,0
6,GO REGULATION OF MYELOID CELL DIFFERENTIATION,9.0551e-05,-0.14572,-0.17015,1,0
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0015653,-0.14573,-0.14134,1,0
6,GO DIVALENT INORGANIC CATION TRANSPORT,0.00035231,-0.14574,-0.13428,1,0
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00069957,-0.14586,-0.15961,1,0
6,GO TETRAPYRROLE METABOLIC PROCESS,0.0045306,-0.14605,-0.1829,1,0
6,GO EPIDERMAL CELL DIFFERENTIATION,0.011047,-0.14622,-0.14673,1,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.029068,-0.14626,-0.14134,1,0
6,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.00038934,-0.14629,-0.15641,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0019282,-0.14638,-0.19299,1,0
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.018398,-0.14646,-0.14462,1,0
6,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.045624,-0.14665,-0.1404,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.007729,-0.14671,-0.21182,1,0
6,GO HEART DEVELOPMENT,8.4205e-05,-0.14672,-0.14779,1,0
6,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00063551,-0.14681,-0.17443,1,0
6,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00036427,-0.14694,-0.18874,1,0
6,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00014935,-0.14694,-0.13008,1,0
6,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.050569,-0.14697,-0.16402,1,0
6,GO KERATINOCYTE PROLIFERATION,0.015203,-0.14701,-0.19786,1,0
6,GO MUSCLE FIBER DEVELOPMENT,0.0024367,-0.14704,-0.1439,1,0
6,GO REGULATION OF PROTEOLYSIS,9.7346e-05,-0.14729,-0.15618,1,0
6,GO SPHINGOLIPID METABOLIC PROCESS,5.0226e-05,-0.14754,-0.19242,1,0
6,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0022332,-0.14788,-0.16701,1,0
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.041093,-0.14792,-0.12236,1,0
6,GO HORMONE METABOLIC PROCESS,0.0051916,-0.14793,-0.15397,1,0
6,GO CARTILAGE DEVELOPMENT,0.00044439,-0.14795,-0.16953,1,0
6,GO LIPID MODIFICATION,0.00010845,-0.14807,-0.1612,1,0
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.014138,-0.1481,-0.18132,1,0
6,GO METANEPHROS DEVELOPMENT,0.0047853,-0.14811,-0.15268,1,0
6,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00069957,-0.14813,-0.15657,1,0
6,GO LYMPH NODE DEVELOPMENT,0.013798,-0.14819,-0.13817,1,0
6,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0073363,-0.1482,-0.16055,1,0
6,GO NOTCH SIGNALING PATHWAY,0.016339,-0.14824,-0.12732,1,0
6,GO RESPONSE TO PEPTIDE,1.906e-06,-0.14834,-0.16327,1,0
6,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0056288,-0.14843,-0.16172,1,0
6,GO POSITIVE REGULATION OF TOR SIGNALING,9.3916e-06,-0.14846,-0.161,1,0
6,GO PIGMENT GRANULE MATURATION,0.0046564,-0.14854,-0.23613,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0056288,-0.14854,-0.15066,1,0
6,GO RESPONSE TO CAMP,0.00098941,-0.14857,-0.1592,1,0
6,GO CONNECTIVE TISSUE DEVELOPMENT,7.8282e-05,-0.14861,-0.17368,1,0
6,GO REGULATION OF VASOCONSTRICTION,0.0073363,-0.14865,-0.1475,1,0
6,GO ENERGY HOMEOSTASIS,0.0054795,-0.14866,-0.1942,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00055855,-0.14871,-0.16506,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.014841,-0.14877,-0.14073,1,0
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0047853,-0.14898,-0.10877,1,0
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00050664,-0.14923,-0.14214,1,0
6,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0028957,-0.14934,-0.15788,1,0
6,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0042883,-0.14937,-0.17874,1,0
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.00092958,-0.14938,-0.2026,1,0
6,GO CELL CELL JUNCTION ASSEMBLY,0.0024367,-0.14939,-0.16282,1,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0020453,-0.14939,-0.12926,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0099891,-0.14945,-0.16266,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.02268,-0.14946,-0.11464,1,0
6,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00022676,-0.14951,-0.14655,1,0
6,GO NUCLEOSIDE CATABOLIC PROCESS,0.035393,-0.14952,-0.16404,1,0
6,GO MUSCLE CELL DIFFERENTIATION,0.0001165,-0.14959,-0.1432,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0094949,-0.1496,-0.20263,1,0
6,GO T CELL CHEMOTAXIS,0.0022992,-0.14987,-0.16978,1,0
6,GO CHEMOKINE PRODUCTION,0.00042998,-0.14997,-0.21836,1,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.010506,-0.15016,-0.18138,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.014841,-0.15019,-0.14112,1,0
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,3.5759e-05,-0.15037,-0.17596,1,0
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00353,-0.15039,-0.13184,1,0
6,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0046564,-0.15041,-0.18152,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0075304,-0.15043,-0.1238,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.007729,-0.15057,-0.18171,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.045624,-0.1506,-0.14589,1,0
6,GO RESPONSE TO IRON ION,0.0094949,-0.15064,-0.15678,1,0
6,GO IRON ION HOMEOSTASIS,0.0041716,-0.15067,-0.15304,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00095906,-0.15072,-0.16626,1,0
6,GO CELL CELL ADHESION,0.00010092,-0.15078,-0.16843,1,0
6,GO GLIAL CELL ACTIVATION,0.0012662,-0.1508,-0.20679,1,0
6,GO GRANULOCYTE MIGRATION,7.8282e-05,-0.15081,-0.20509,1,0
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010859,-0.15088,-0.17881,1,0
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,1.8521e-05,-0.15104,-0.16243,1,0
6,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,7.8282e-05,-0.15107,-0.14937,1,0
6,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00012964,-0.15109,-0.14057,1,0
6,GO HUMORAL IMMUNE RESPONSE,7.3528e-06,-0.15111,-0.19253,1,0
6,GO GLYCEROLIPID METABOLIC PROCESS,1.2454e-05,-0.15114,-0.15765,1,0
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00069957,-0.15139,-0.16189,1,0
6,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.00069957,-0.15147,-0.15071,1,0
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00072223,-0.15171,-0.18945,1,0
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00045924,-0.15176,-0.14727,1,0
6,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0097392,-0.15178,-0.27343,1,0
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0057817,-0.15188,-0.13173,1,0
6,GO PINOCYTOSIS,0.001228,-0.15213,-0.23039,1,0
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00072223,-0.15215,-0.16319,1,0
6,GO INORGANIC ANION TRANSPORT,2.8418e-05,-0.15217,-0.16013,1,0
6,GO LAMELLIPODIUM MORPHOGENESIS,0.012508,-0.15218,-0.22429,1,0
6,GO ION HOMEOSTASIS,4.0073e-05,-0.15235,-0.14734,1,0
6,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0064317,-0.15244,-0.23668,1,0
6,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0013872,-0.15246,-0.16531,1,0
6,GO LIPID OXIDATION,0.0027346,-0.15249,-0.16526,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00038934,-0.15251,-0.12383,1,0
6,GO B CELL PROLIFERATION,0.0014299,-0.15258,-0.17225,1,0
6,GO MUSCLE STRUCTURE DEVELOPMENT,1.9263e-05,-0.15271,-0.15554,1,0
6,GO ENDOTHELIUM DEVELOPMENT,0.00081984,-0.15274,-0.17555,1,0
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.00065623,-0.15276,-0.16916,1,0
6,GO REGULATION OF CELL SHAPE,0.0042883,-0.15276,-0.13306,1,0
6,GO DIGESTION,0.019283,-0.15285,-0.12611,1,0
6,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00079435,-0.15288,-0.15852,1,0
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0090226,-0.15291,-0.15195,1,0
6,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,8.4205e-05,-0.15301,-0.14163,1,0
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,5.8301e-05,-0.15304,-0.14073,1,0
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0028141,-0.15305,-0.16885,1,0
6,GO LINOLEIC ACID METABOLIC PROCESS,0.016734,-0.15306,-0.28477,1,0
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00018427,-0.15322,-0.16036,1,0
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,8.4205e-05,-0.15332,-0.16104,1,0
6,GO NEPHRON DEVELOPMENT,0.0041716,-0.15333,-0.14826,1,0
6,GO SKIN DEVELOPMENT,0.0031536,-0.15338,-0.178,1,0
6,GO RESPONSE TO TEMPERATURE STIMULUS,0.00065623,-0.15345,-0.12888,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0015189,-0.1535,-0.1882,1,0
6,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.016734,-0.15359,-0.15497,1,0
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.043763,-0.15364,-0.18674,1,0
6,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00010845,-0.15369,-0.13372,1,0
6,GO REGULATION OF BLOOD PRESSURE,0.00010845,-0.15372,-0.17219,1,0
6,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.001191,-0.15376,-0.13172,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.1192e-05,-0.15376,-0.16791,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0067808,-0.1538,-0.24987,1,0
6,GO CRANIAL NERVE MORPHOGENESIS,0.024846,-0.15386,-0.22315,1,0
6,GO MACROPHAGE DIFFERENTIATION,0.00010845,-0.15397,-0.23057,1,0
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.033894,-0.15399,-0.12946,1,0
6,GO INNATE IMMUNE RESPONSE,0.00027832,-0.154,-0.19015,1,0
6,GO LEUKOCYTE CELL CELL ADHESION,5.0226e-05,-0.15404,-0.19486,1,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.011326,-0.15407,-0.1725,1,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0023671,-0.15418,-0.17678,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00040247,-0.15426,-0.19401,1,0
6,GO GRANULOCYTE CHEMOTAXIS,0.00014935,-0.15436,-0.19784,1,0
6,GO REGULATION OF SYMBIOTIC PROCESS,0.001986,-0.15443,-0.18678,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0036303,-0.15447,-0.15387,1,0
6,GO DENDRITIC CELL MIGRATION,0.012203,-0.15456,-0.18745,1,0
6,GO BONE RESORPTION,0.0015653,-0.15462,-0.19234,1,0
6,GO PEPTIDE METABOLIC PROCESS,0.0023671,-0.15462,-0.13819,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.031748,-0.15466,-0.20073,1,0
6,GO ADIPOSE TISSUE DEVELOPMENT,0.0057817,-0.15474,-0.13721,1,0
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.00055855,-0.15477,-0.16058,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.001872,-0.15482,-0.15469,1,0
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.027188,-0.15486,-0.12819,1,0
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.3218e-05,-0.15493,-0.15491,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.010245,-0.15505,-0.15486,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00029782,-0.15513,-0.19037,1,0
6,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00025131,-0.15515,-0.17707,1,0
6,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.001872,-0.15523,-0.21918,1,0
6,GO AUTOPHAGOSOME ORGANIZATION,0.00059588,-0.15524,-0.16611,1,0
6,GO RESPONSE TO PEPTIDE HORMONE,2.8077e-06,-0.15527,-0.16324,1,0
6,GO REGULATION OF MACROPHAGE MIGRATION,0.00037661,-0.15532,-0.20059,1,0
6,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0022332,-0.15532,-0.18201,1,0
6,GO ORGANOPHOSPHATE METABOLIC PROCESS,5.2139e-05,-0.15537,-0.13466,1,0
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.011904,-0.15538,-0.14178,1,0
6,GO AUTOPHAGOSOME MATURATION,0.0007696,-0.15539,-0.18822,1,0
6,GO REGULATION OF METAL ION TRANSPORT,0.0001547,-0.1555,-0.15117,1,0
6,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010092,-0.15552,-0.15531,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.023205,-0.15566,-0.26692,1,0
6,GO RESPONSE TO LEUCINE,0.037747,-0.15569,-0.14935,1,0
6,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00049035,-0.1557,-0.1762,1,0
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.034637,-0.15571,-0.13846,1,0
6,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00057693,-0.15571,-0.15869,1,0
6,GO CELLULAR RESPONSE TO DSRNA,0.022165,-0.15574,-0.17205,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.030383,-0.15575,-0.19347,1,0
6,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.15582,-0.23589,1,0
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0031536,-0.15586,-0.15977,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION,0.0037331,-0.15596,-0.1409,1,0
6,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0025083,-0.1562,-0.18525,1,0
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00044439,-0.15629,-0.23297,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION,0.0013054,-0.15632,-0.20127,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.03245,-0.15637,-0.18816,1,0
6,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.9263e-05,-0.15638,-0.19014,1,0
6,GO ANION TRANSMEMBRANE TRANSPORT,4.6597e-05,-0.1564,-0.1512,1,0
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0046564,-0.15643,-0.18758,1,0
6,GO REGULATION OF MULTI ORGANISM PROCESS,0.001191,-0.15645,-0.15778,1,0
6,GO BLOOD VESSEL REMODELING,0.0041716,-0.15666,-0.23143,1,0
6,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.047551,-0.15674,-0.19811,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0025083,-0.15677,-0.15482,1,0
6,GO KIDNEY EPITHELIUM DEVELOPMENT,0.007729,-0.15682,-0.14904,1,0
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0010528,-0.15697,-0.17047,1,0
6,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00022676,-0.15701,-0.18521,1,0
6,GO INTRACELLULAR STEROL TRANSPORT,0.0022992,-0.15705,-0.24175,1,0
6,GO PROTEIN TETRAMERIZATION,0.0025083,-0.15719,-0.12208,1,0
6,GO INTERLEUKIN 17 PRODUCTION,0.001191,-0.15731,-0.20515,1,0
6,GO AMINO ACID BETAINE METABOLIC PROCESS,0.025414,-0.15731,-0.19635,1,0
6,GO PROTEIN KINASE B SIGNALING,0.0010206,-0.15733,-0.15045,1,0
6,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0016129,-0.15739,-0.22072,1,0
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00087311,-0.15744,-0.19012,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0016129,-0.15745,-0.15982,1,0
6,GO VITAMIN METABOLIC PROCESS,0.012508,-0.15748,-0.12856,1,0
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00026903,-0.15752,-0.16964,1,0
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.024288,-0.15764,-0.15052,1,0
6,GO AMIDE BIOSYNTHETIC PROCESS,0.0047853,-0.15776,-0.12309,1,0
6,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00092958,-0.15782,-0.18485,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0071468,-0.15789,-0.15764,1,0
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0022332,-0.15793,-0.17708,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00019753,-0.15798,-0.15939,1,0
6,GO ATP METABOLIC PROCESS,0.00013433,-0.15799,-0.14915,1,0
6,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0046564,-0.15814,-0.18813,1,0
6,GO RESPONSE TO AMPHETAMINE,0.031748,-0.1584,-0.18046,1,0
6,GO TEMPERATURE HOMEOSTASIS,2.1663e-05,-0.15843,-0.17392,1,0
6,GO COLLAGEN FIBRIL ORGANIZATION,0.014841,-0.15846,-0.2272,1,0
6,GO RESPONSE TO ACID CHEMICAL,8.7323e-05,-0.15852,-0.17326,1,0
6,GO GLYCOPROTEIN METABOLIC PROCESS,0.00018427,-0.15868,-0.1565,1,0
6,GO RESPONSE TO STEROL,0.0014299,-0.15874,-0.20999,1,0
6,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.015953,-0.15876,-0.18363,1,0
6,GO ENDOCRINE PANCREAS DEVELOPMENT,0.030383,-0.15888,-0.13808,1,0
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.017137,-0.15895,-0.1551,1,0
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00353,-0.15905,-0.22301,1,0
6,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00017186,-0.15917,-0.20008,1,0
6,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0047853,-0.15919,-0.24588,1,0
6,GO TUBE MORPHOGENESIS,3.8583e-05,-0.15924,-0.18301,1,0
6,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00027832,-0.15927,-0.14473,1,0
6,GO RESPONSE TO HORMONE,2.8077e-06,-0.15934,-0.17295,1,0
6,GO SMALL MOLECULE CATABOLIC PROCESS,0.00055855,-0.15936,-0.15073,1,0
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0062634,-0.15941,-0.1525,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE,9.7346e-05,-0.15953,-0.23341,1,0
6,GO CIRCULATORY SYSTEM DEVELOPMENT,4.8379e-05,-0.15959,-0.17317,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0010206,-0.15962,-0.22796,1,0
6,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0083534,-0.15963,-0.2634,1,0
6,GO IMMUNOGLOBULIN SECRETION,0.00095906,-0.15968,-0.23779,1,0
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.014138,-0.15977,-0.27859,1,0
6,GO GLIAL CELL PROLIFERATION,0.0062634,-0.1599,-0.16387,1,0
6,GO REGULATION OF HEART GROWTH,0.0045306,-0.1599,-0.1497,1,0
6,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.00013917,-0.15993,-0.14582,1,0
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0099891,-0.15999,-0.22473,1,0
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00030804,-0.16001,-0.15264,1,0
6,GO ENGULFMENT OF APOPTOTIC CELL,0.031748,-0.16004,-0.1629,1,0
6,GO B CELL ACTIVATION,0.00040247,-0.16016,-0.15259,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.001228,-0.16016,-0.18568,1,0
6,GO RESPONSE TO MUSCLE ACTIVITY,0.046579,-0.16036,-0.15543,1,0
6,GO CELLULAR RESPONSE TO LIPID,1.5201e-05,-0.16038,-0.17407,1,0
6,GO ORGANIC ACID METABOLIC PROCESS,0.00013917,-0.1605,-0.15229,1,0
6,GO REGULATION OF IMMUNE RESPONSE,0.00031859,-0.16057,-0.15603,1,0
6,GO REGULATION OF CALCIUM ION IMPORT,0.00023468,-0.16058,-0.19675,1,0
6,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0001547,-0.16062,-0.22314,1,0
6,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,-0.16067,-0.18863,1,0
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,1.7806e-05,-0.16068,-0.15954,1,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00021167,-0.16071,-0.28046,1,0
6,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,5.2837e-06,-0.1608,-0.16052,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0007696,-0.16091,-0.13419,1,0
6,GO PLATELET ACTIVATION,0.00044439,-0.16091,-0.18096,1,0
6,GO NEUTRAL LIPID METABOLIC PROCESS,1.4039e-05,-0.16096,-0.19516,1,0
6,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0083534,-0.16097,-0.17737,1,0
6,GO RESPONSE TO INTERLEUKIN 2,0.026586,-0.16097,-0.1785,1,0
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0040578,-0.16098,-0.13955,1,0
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0013054,-0.16113,-0.14405,1,0
6,GO SULFUR COMPOUND TRANSPORT,0.00081984,-0.16114,-0.16536,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00021167,-0.16116,-0.19783,1,0
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0001547,-0.16117,-0.1465,1,0
6,GO RESPONSE TO INSULIN,1.1964e-05,-0.16118,-0.16782,1,0
6,GO SKELETAL MUSCLE ADAPTATION,0.04854,-0.1612,-0.14553,1,0
6,GO RESPONSE TO MECHANICAL STIMULUS,0.00032948,-0.16127,-0.173,1,0
6,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.042857,-0.16149,-0.13876,1,0
6,GO DIVALENT INORGANIC CATION HOMEOSTASIS,8.7323e-05,-0.16151,-0.15224,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION,0.00032948,-0.16156,-0.19007,1,0
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0017641,-0.16161,-0.12035,1,0
6,GO ASTROCYTE DIFFERENTIATION,0.0062634,-0.16173,-0.16971,1,0
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00074557,-0.16185,-0.22194,1,0
6,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0050528,-0.16188,-0.19289,1,0
6,GO DETOXIFICATION,0.00069957,-0.16189,-0.20941,1,0
6,GO MEMBRANE FUSION,2.0033e-05,-0.16191,-0.18507,1,0
6,GO PROSTATE GLAND MORPHOGENESIS,0.009256,-0.16193,-0.28695,1,0
6,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0024367,-0.16195,-0.19646,1,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0026572,-0.16205,-0.14025,1,0
6,GO REGULATION OF T CELL MIGRATION,9.389e-05,-0.16216,-0.20566,1,0
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,2.3418e-05,-0.16218,-0.15451,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0020453,-0.16224,-0.16186,1,0
6,GO GLIAL CELL DEVELOPMENT,0.0013054,-0.16231,-0.1649,1,0
6,GO MEMBRANE REPOLARIZATION,0.001662,-0.16237,-0.18405,1,0
6,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.03245,-0.16244,-0.15848,1,0
6,GO LIPOPROTEIN LOCALIZATION,0.0045306,-0.16247,-0.17499,1,0
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0015653,-0.16275,-0.15453,1,0
6,GO STEROID BIOSYNTHETIC PROCESS,5.0226e-05,-0.16281,-0.19309,1,0
6,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00010092,-0.16282,-0.21606,1,0
6,GO PHOSPHOLIPID TRANSPORT,0.00016595,-0.16295,-0.17993,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00021167,-0.16298,-0.18453,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,5.4121e-05,-0.16302,-0.15468,1,0
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.036948,-0.16315,-0.11169,1,0
6,GO SERTOLI CELL DEVELOPMENT,0.011326,-0.16315,-0.22058,1,0
6,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00013433,-0.16319,-0.14484,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.043763,-0.16323,-0.12152,1,0
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00079435,-0.16329,-0.20372,1,0
6,GO POSITIVE REGULATION OF COAGULATION,0.011612,-0.16343,-0.18043,1,0
6,GO B CELL HOMEOSTASIS,0.0066042,-0.16343,-0.15345,1,0
6,GO CHONDROCYTE DIFFERENTIATION,0.0011549,-0.16349,-0.17742,1,0
6,GO AMINO SUGAR CATABOLIC PROCESS,0.0071468,-0.16369,-0.21484,1,0
6,GO ETHER METABOLIC PROCESS,0.031748,-0.16381,-0.16906,1,0
6,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0075304,-0.16423,-0.17627,1,0
6,GO PROTEIN MATURATION,0.00034072,-0.16425,-0.15165,1,0
6,GO PROTEIN AUTOPHOSPHORYLATION,0.0025083,-0.16432,-0.12376,1,0
6,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0099891,-0.16435,-0.27209,1,0
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,5.6174e-05,-0.16436,-0.21361,1,0
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0016129,-0.16437,-0.16194,1,0
6,GO REGULATION OF AUTOPHAGY,1.2962e-05,-0.16448,-0.16317,1,0
6,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0056288,-0.16471,-0.12748,1,0
6,GO ENDOCYTOSIS,6.5149e-05,-0.16492,-0.15603,1,0
6,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0069616,-0.16494,-0.16141,1,0
6,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00020448,-0.16494,-0.15397,1,0
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0066042,-0.16496,-0.22464,1,0
6,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0006154,-0.16497,-0.17439,1,0
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.02068,-0.1651,-0.16884,1,0
6,GO HYALURONAN METABOLIC PROCESS,9.0551e-05,-0.16513,-0.2327,1,0
6,GO COAGULATION,0.0001165,-0.16523,-0.19057,1,0
6,GO OSTEOBLAST DEVELOPMENT,0.017137,-0.16531,-0.17965,1,0
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00034072,-0.1654,-0.16242,1,0
6,GO PIGMENT ACCUMULATION,0.011612,-0.16541,-0.17885,1,0
6,GO INTERACTION WITH SYMBIONT,4.8612e-06,-0.16546,-0.19341,1,0
6,GO NERVE DEVELOPMENT,0.0066042,-0.16548,-0.18154,1,0
6,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.00020448,-0.16557,-0.13929,1,0
6,GO EPITHELIAL CELL PROLIFERATION,1.1493e-05,-0.16559,-0.21175,1,0
6,GO CARBOHYDRATE HOMEOSTASIS,0.00012512,-0.16559,-0.16067,1,0
6,GO ACUTE PHASE RESPONSE,0.00028792,-0.16562,-0.22763,1,0
6,GO INTESTINAL ABSORPTION,0.031748,-0.1659,-0.1944,1,0
6,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0022992,-0.16592,-0.21273,1,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0037331,-0.16598,-0.19112,1,0
6,GO REGULATION OF BODY FLUID LEVELS,4.0073e-05,-0.16601,-0.18067,1,0
6,GO CELL ACTIVATION,3.7145e-05,-0.16603,-0.1826,1,0
6,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0027346,-0.1661,-0.20608,1,0
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00010462,-0.16613,-0.14724,1,0
6,GO REGULATION OF TISSUE REMODELING,0.019283,-0.16615,-0.1441,1,0
6,GO REGULATION OF ATP METABOLIC PROCESS,0.00010092,-0.16616,-0.15293,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00027832,-0.16617,-0.18211,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00049035,-0.16634,-0.15823,1,0
6,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,9.7801e-06,-0.16635,-0.15665,1,0
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00042998,-0.16635,-0.14724,1,0
6,GO REGULATION OF VIRAL GENOME REPLICATION,0.011612,-0.16638,-0.21827,1,0
6,GO RESPONSE TO KETONE,2.1663e-05,-0.16648,-0.19135,1,0
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0046564,-0.16649,-0.20206,1,0
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.02268,-0.16657,-0.13388,1,0
6,GO RESPONSE TO INORGANIC SUBSTANCE,0.00029782,-0.16688,-0.15935,1,0
6,GO LAMELLIPODIUM ORGANIZATION,0.00034072,-0.16692,-0.18162,1,0
6,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.020205,-0.167,-0.17605,1,0
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00059588,-0.16701,-0.16491,1,0
6,GO REGULATION OF GLUCONEOGENESIS,0.00027832,-0.16705,-0.15783,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0050528,-0.16708,-0.15448,1,0
6,GO RESPONSE TO PROSTAGLANDIN E,0.011904,-0.1672,-0.135,1,0
6,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.030383,-0.16723,-0.14764,1,0
6,GO REGULATION OF ICOSANOID SECRETION,0.041093,-0.16736,-0.12701,1,0
6,GO RESPONSE TO CALCIUM ION,0.0024367,-0.16742,-0.17051,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00029782,-0.1675,-0.17727,1,0
6,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00037661,-0.16756,-0.19758,1,0
6,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.02268,-0.16767,-0.27239,1,0
6,GO RESPONSE TO OXYGEN LEVELS,9.7801e-06,-0.16772,-0.19697,1,0
6,GO REGULATION OF OSSIFICATION,0.00041602,-0.16784,-0.1856,1,0
6,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0050528,-0.16802,-0.20337,1,0
6,GO BIOLOGICAL ADHESION,1.349e-05,-0.16819,-0.19054,1,0
6,GO DEFENSE RESPONSE TO BACTERIUM,1.8521e-05,-0.16826,-0.19886,1,0
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.012508,-0.16827,-0.15109,1,0
6,GO RENAL SYSTEM PROCESS,0.0025083,-0.16827,-0.16511,1,0
6,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,1.1964e-05,-0.16833,-0.18184,1,0
6,GO CELLULAR AMIDE METABOLIC PROCESS,0.00045924,-0.16835,-0.14035,1,0
6,GO LIPID LOCALIZATION,1.906e-06,-0.16845,-0.2067,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0042883,-0.16853,-0.17624,1,0
6,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0064317,-0.16884,-0.20496,1,0
6,GO CHLORIDE ION HOMEOSTASIS,0.010773,-0.16887,-0.16918,1,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00041602,-0.1689,-0.20934,1,0
6,GO ADAPTIVE THERMOGENESIS,4.6597e-05,-0.16898,-0.17787,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE,1.104e-05,-0.16905,-0.20526,1,0
6,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.4039e-05,-0.1691,-0.21438,1,0
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00031859,-0.16913,-0.17651,1,0
6,GO IMPORT INTO CELL,0.0026572,-0.16917,-0.14844,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,6.0504e-05,-0.1692,-0.15682,1,0
6,GO RESPONSE TO ANTIBIOTIC,0.0062634,-0.16922,-0.13459,1,0
6,GO DIGESTIVE SYSTEM PROCESS,0.0081404,-0.16925,-0.13303,1,0
6,GO IMPORT ACROSS PLASMA MEMBRANE,0.00052342,-0.16942,-0.16923,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.014841,-0.16944,-0.17732,1,0
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.042857,-0.16946,-0.22441,1,0
6,GO VACUOLE ORGANIZATION,4.1617e-05,-0.16948,-0.16651,1,0
6,GO RESPONSE TO BIOTIC STIMULUS,3.8583e-05,-0.1695,-0.18615,1,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.0047853,-0.16951,-0.19168,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00019079,-0.16955,-0.16197,1,0
6,GO GLUCOSE METABOLIC PROCESS,7.8282e-05,-0.1698,-0.15742,1,0
6,GO DEFINITIVE HEMOPOIESIS,0.010245,-0.16989,-0.16997,1,0
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014841,-0.16991,-0.14095,1,0
6,GO CELLULAR RESPONSE TO PH,0.00353,-0.17,-0.17935,1,0
6,GO RESPONSE TO AMYLOID BETA,0.00095906,-0.17,-0.17446,1,0
6,GO RECEPTOR SIGNALING PATHWAY VIA STAT,1.1493e-05,-0.17006,-0.2111,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.013798,-0.17041,-0.1879,1,0
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0007696,-0.17046,-0.19485,1,0
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,3.1888e-05,-0.17047,-0.17128,1,0
6,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00092958,-0.17048,-0.15481,1,0
6,GO LEUKOCYTE CHEMOTAXIS,0.0010206,-0.17051,-0.17243,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0011199,-0.17064,-0.18199,1,0
6,GO FATTY ACID TRANSPORT,3.8583e-05,-0.17073,-0.17895,1,0
6,GO SELECTIVE AUTOPHAGY,0.00010462,-0.17076,-0.18842,1,0
6,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0018173,-0.17077,-0.18373,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.015574,-0.17081,-0.1496,1,0
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,1.1964e-05,-0.17084,-0.17966,1,0
6,GO CELL KILLING,0.00011241,-0.17092,-0.19608,1,0
6,GO REGULATION OF ORGAN GROWTH,0.0031536,-0.17093,-0.15069,1,0
6,GO TRANSITION METAL ION HOMEOSTASIS,0.00025131,-0.17094,-0.17908,1,0
6,GO RESPONSE TO ANGIOTENSIN,0.0087944,-0.17099,-0.20109,1,0
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.025414,-0.1711,-0.13737,1,0
6,GO LIPID CATABOLIC PROCESS,9.7346e-05,-0.17123,-0.1695,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0017641,-0.17123,-0.21957,1,0
6,GO RESPONSE TO NUTRIENT,0.00024286,-0.17123,-0.18554,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.1617e-05,-0.17126,-0.22709,1,0
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0039469,-0.1713,-0.13955,1,0
6,GO FAT CELL DIFFERENTIATION,1.7118e-05,-0.17135,-0.20029,1,0
6,GO RESPONSE TO DEXAMETHASONE,0.0013872,-0.17136,-0.22619,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00030804,-0.17139,-0.20298,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0032441,-0.17154,-0.15576,1,0
6,GO RECEPTOR METABOLIC PROCESS,0.00044439,-0.17157,-0.14289,1,0
6,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00012512,-0.17167,-0.16372,1,0
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,6.5149e-05,-0.17179,-0.16286,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0090226,-0.17205,-0.24853,1,0
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,9.7346e-05,-0.17214,-0.16864,1,0
6,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0019282,-0.17216,-0.19215,1,0
6,GO REGULATION OF VIRAL LIFE CYCLE,0.0047853,-0.17232,-0.22288,1,0
6,GO POSITIVE REGULATION OF CELL KILLING,0.001986,-0.17234,-0.20611,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.00013917,-0.1725,-0.17158,1,0
6,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00032948,-0.17264,-0.17836,1,0
6,GO PLATELET MORPHOGENESIS,0.0014738,-0.17288,-0.17766,1,0
6,GO MUSCLE CELL PROLIFERATION,4.3218e-05,-0.17302,-0.20692,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.018836,-0.17302,-0.22355,1,0
6,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.001191,-0.17308,-0.18884,1,0
6,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0075304,-0.17311,-0.23801,1,0
6,GO RESPONSE TO METAL ION,0.00030804,-0.17311,-0.16345,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0006154,-0.17319,-0.18481,1,0
6,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0024367,-0.17332,-0.19097,1,0
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.00022676,-0.17338,-0.15641,1,0
6,GO GLIAL CELL MIGRATION,0.00029782,-0.17338,-0.2256,1,0
6,GO GLYCEROL ETHER METABOLIC PROCESS,0.029719,-0.1734,-0.16137,1,0
6,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00059588,-0.17342,-0.23786,1,0
6,GO EXOCYTOSIS,3.1888e-05,-0.17343,-0.18465,1,0
6,GO REGULATION OF PEPTIDASE ACTIVITY,0.00019079,-0.17347,-0.18237,1,0
6,GO CELLULAR LIPID METABOLIC PROCESS,5.0226e-05,-0.17361,-0.16897,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00045924,-0.1737,-0.21128,1,0
6,GO PROTEIN LIPID COMPLEX ASSEMBLY,9.0551e-05,-0.17375,-0.19589,1,0
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0057817,-0.17375,-0.15624,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0017123,-0.17376,-0.21559,1,0
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.020205,-0.17381,-0.16695,1,0
6,GO INTERACTION WITH HOST,7.013e-05,-0.17384,-0.2136,1,0
6,GO RESPONSE TO ESTROGEN,0.00016023,-0.17386,-0.22428,1,0
6,GO FOCAL ADHESION ASSEMBLY,0.0041716,-0.17386,-0.19205,1,0
6,GO RESPONSE TO DSRNA,0.0053338,-0.17396,-0.15811,1,0
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00074557,-0.17405,-0.23843,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0028141,-0.1741,-0.2689,1,0
6,GO HEART MORPHOGENESIS,0.00040247,-0.17417,-0.15316,1,0
6,GO IMMATURE T CELL PROLIFERATION,0.0053338,-0.17433,-0.20688,1,0
6,GO ACTIVATION OF MAPK ACTIVITY,1.7806e-05,-0.17451,-0.17072,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00042998,-0.17453,-0.17158,1,0
6,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00011241,-0.17471,-0.2202,1,0
6,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0056288,-0.17471,-0.24082,1,0
6,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0053338,-0.17473,-0.18437,1,0
6,GO REGULATION OF LIPID METABOLIC PROCESS,3.9418e-06,-0.17474,-0.18979,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.010506,-0.17484,-0.19253,1,0
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00031859,-0.17496,-0.16972,1,0
6,GO PROTEIN AUTOPROCESSING,0.013139,-0.17506,-0.18081,1,0
6,GO DIOL METABOLIC PROCESS,0.012203,-0.17516,-0.17649,1,0
6,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0047853,-0.1752,-0.19423,1,0
6,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.2524e-05,-0.17525,-0.20219,1,0
6,GO INTERLEUKIN 1 BETA PRODUCTION,0.0017641,-0.17536,-0.22925,1,0
6,GO STRESS FIBER ASSEMBLY,0.00069957,-0.17546,-0.20748,1,0
6,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.0015189,-0.17561,-0.25127,1,0
6,GO RESPONSE TO OXIDATIVE STRESS,0.00028792,-0.17561,-0.16069,1,0
6,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0049174,-0.17568,-0.15624,1,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00047456,-0.17577,-0.17154,1,0
6,GO HEART GROWTH,0.00032948,-0.17591,-0.16791,1,0
6,GO REGULATION OF GLIAL CELL PROLIFERATION,0.013465,-0.17593,-0.1677,1,0
6,GO REGULATION OF LIPASE ACTIVITY,1.9263e-05,-0.17594,-0.20024,1,0
6,GO RESPONSE TO RETINOIC ACID,6.5149e-05,-0.17601,-0.22638,1,0
6,GO PROTEIN PROCESSING,0.00030804,-0.17604,-0.17251,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS,3.5759e-05,-0.1761,-0.16733,1,0
6,GO CHONDROCYTE DEVELOPMENT,0.010773,-0.17618,-0.2067,1,0
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0021062,-0.17622,-0.22481,1,0
6,GO RESPONSE TO VITAMIN,0.009256,-0.17641,-0.16601,1,0
6,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,1.4039e-05,-0.17648,-0.18713,1,0
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0010528,-0.17651,-0.16791,1,0
6,GO VITAMIN TRANSPORT,0.00022676,-0.17656,-0.23191,1,0
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,8.1192e-05,-0.17658,-0.21223,1,0
6,GO MESENCHYMAL CELL PROLIFERATION,0.0050528,-0.17668,-0.22707,1,0
6,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0053338,-0.17673,-0.15843,1,0
6,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.017549,-0.17687,-0.17654,1,0
6,GO OXALATE TRANSPORT,0.00021909,-0.17691,-0.26019,1,0
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00092958,-0.17702,-0.15362,1,0
6,GO ERYTHROCYTE HOMEOSTASIS,0.0006154,-0.17713,-0.14965,1,0
6,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.0226e-05,-0.17727,-0.2146,1,0
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.0073e-05,-0.17728,-0.16225,1,0
6,GO RESPONSE TO OSMOTIC STRESS,0.00027832,-0.17746,-0.18834,1,0
6,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0010528,-0.1775,-0.18332,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0006154,-0.17754,-0.26091,1,0
6,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0027346,-0.1777,-0.19436,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.027188,-0.17772,-0.20831,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0024367,-0.17774,-0.2111,1,0
6,GO HEART TRABECULA MORPHOGENESIS,0.0030654,-0.17785,-0.20846,1,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.040234,-0.17792,-0.19575,1,0
6,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00026003,-0.17807,-0.21466,1,0
6,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.011326,-0.17809,-0.16405,1,0
6,GO CELLULAR RESPONSE TO AMYLOID BETA,0.00021167,-0.17813,-0.20967,1,0
6,GO REGULATION OF BONE MINERALIZATION,0.00065623,-0.17814,-0.20188,1,0
6,GO AUTOPHAGY OF NUCLEUS,0.017969,-0.17826,-0.15873,1,0
6,GO REGULATION OF ACROSOME REACTION,0.043763,-0.17826,-0.2044,1,0
6,GO REGULATION OF JUN KINASE ACTIVITY,0.00067758,-0.17833,-0.15578,1,0
6,GO VASCULATURE DEVELOPMENT,3.8583e-05,-0.17846,-0.20542,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0038387,-0.17857,-0.17648,1,0
6,GO CELLULAR OXIDANT DETOXIFICATION,0.0085714,-0.17858,-0.1464,1,0
6,GO METANEPHRIC NEPHRON DEVELOPMENT,0.047551,-0.17864,-0.1379,1,0
6,GO HOMOCYSTEINE METABOLIC PROCESS,0.033166,-0.17872,-0.2267,1,0
6,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00095906,-0.1788,-0.21335,1,0
6,GO COMPLEMENT ACTIVATION,0.00027832,-0.17891,-0.226,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,9.7801e-06,-0.17903,-0.22134,1,0
6,GO STRIATED MUSCLE CELL DIFFERENTIATION,5.8301e-05,-0.17907,-0.15985,1,0
6,GO LAMELLIPODIUM ASSEMBLY,0.0015189,-0.17919,-0.1573,1,0
6,GO NEGATIVE REGULATION OF GROWTH,3.0689e-05,-0.17926,-0.18515,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0033369,-0.17927,-0.20248,1,0
6,GO POLYOL METABOLIC PROCESS,5.2139e-05,-0.17937,-0.18747,1,0
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00026903,-0.17938,-0.20756,1,0
6,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.00034072,-0.17944,-0.16121,1,0
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,2.7343e-05,-0.17946,-0.19269,1,0
6,GO INTESTINAL LIPID ABSORPTION,0.043763,-0.17948,-0.21796,1,0
6,GO RESPONSE TO INTERLEUKIN 12,0.0038387,-0.17952,-0.20754,1,0
6,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00024286,-0.17956,-0.2008,1,0
6,GO LEUKOTRIENE METABOLIC PROCESS,0.0019282,-0.17956,-0.21889,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0028957,-0.17958,-0.19003,1,0
6,GO REGULATION OF CALCIUM ION TRANSPORT,4.6597e-05,-0.17964,-0.18255,1,0
6,GO RESPONSE TO LIPID,5.2837e-06,-0.17964,-0.18818,1,0
6,GO LUNG ALVEOLUS DEVELOPMENT,0.0022992,-0.17976,-0.20255,1,0
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.013798,-0.17984,-0.19018,1,0
6,GO REGULATION OF RESPONSE TO TUMOR CELL,0.010506,-0.17987,-0.19606,1,0
6,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.023205,-0.18006,-0.173,1,0
6,GO REGULATION OF CELL CELL ADHESION,7.2754e-05,-0.18018,-0.20135,1,0
6,GO VIRAL GENE EXPRESSION,0.024288,-0.18019,-0.17458,1,0
6,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.015203,-0.18024,-0.23909,1,0
6,GO REGULATION OF CELL ADHESION,4.0073e-05,-0.18025,-0.20682,1,0
6,GO AMINO SUGAR METABOLIC PROCESS,0.00072223,-0.18057,-0.18792,1,0
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,5.8301e-05,-0.18059,-0.1702,1,0
6,GO CYTOKINE PRODUCTION,0.00035231,-0.18062,-0.17784,1,0
6,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0020453,-0.18062,-0.164,1,0
6,GO EMBRYONIC PLACENTA DEVELOPMENT,0.013798,-0.18071,-0.17631,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.024846,-0.18076,-0.18456,1,0
6,GO REGULATION OF PLATELET AGGREGATION,0.0085714,-0.18084,-0.28576,1,0
6,GO T CELL PROLIFERATION,2.1663e-05,-0.18092,-0.22042,1,0
6,GO LIPID EXPORT FROM CELL,0.0022992,-0.18102,-0.16708,1,0
6,GO CELLULAR LIPID CATABOLIC PROCESS,9.389e-05,-0.18103,-0.18804,1,0
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00021167,-0.18111,-0.21499,1,0
6,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0099891,-0.18119,-0.20455,1,0
6,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0033369,-0.18126,-0.23346,1,0
6,GO MAST CELL ACTIVATION,0.0069616,-0.18127,-0.15915,1,0
6,GO REGULATION OF EXOSOMAL SECRETION,0.0062634,-0.18129,-0.1942,1,0
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00014418,-0.18158,-0.19701,1,0
6,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00014935,-0.18173,-0.16556,1,0
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00027832,-0.18176,-0.17946,1,0
6,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0018173,-0.18218,-0.22441,1,0
6,GO COPPER ION TRANSPORT,0.031059,-0.18231,-0.15509,1,0
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.010245,-0.18233,-0.18475,1,0
6,GO PROTEIN OXIDATION,0.0060989,-0.18234,-0.27223,1,0
6,GO BONE MINERALIZATION,0.00013433,-0.18239,-0.21017,1,0
6,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.050569,-0.18242,-0.20365,1,0
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00090094,-0.18243,-0.27838,1,0
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0097392,-0.18284,-0.189,1,0
6,GO RESPONSE TO STEROID HORMONE,4.1112e-06,-0.18295,-0.20495,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,2.3418e-05,-0.18306,-0.20146,1,0
6,GO MECHANORECEPTOR DIFFERENTIATION,0.00063551,-0.18307,-0.19735,1,0
6,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0049174,-0.18307,-0.19405,1,0
6,GO FLUID TRANSPORT,0.00025131,-0.18312,-0.22406,1,0
6,GO REGULATION OF CELL KILLING,0.0023671,-0.18318,-0.19425,1,0
6,GO DENDRITIC CELL DIFFERENTIATION,0.0017641,-0.1832,-0.28915,1,0
6,GO NEGATIVE REGULATION OF GENE SILENCING,0.0045306,-0.18322,-0.1821,1,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.015574,-0.18334,-0.16139,1,0
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,3.7145e-05,-0.18341,-0.17321,1,0
6,GO OXIDATION REDUCTION PROCESS,9.7346e-05,-0.18345,-0.16617,1,0
6,GO LABYRINTHINE LAYER DEVELOPMENT,0.029068,-0.18356,-0.15848,1,0
6,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.001662,-0.18366,-0.19659,1,0
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,1.5816e-05,-0.18374,-0.22576,1,0
6,GO REGULATION OF STEROL TRANSPORT,6.0504e-05,-0.18387,-0.24641,1,0
6,GO MUSCLE CONTRACTION,2.3418e-05,-0.18399,-0.18324,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.010773,-0.18403,-0.18992,1,0
6,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00044439,-0.18415,-0.17451,1,0
6,GO PROTEIN HOMOTETRAMERIZATION,0.0015189,-0.18426,-0.12476,1,0
6,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00029782,-0.18428,-0.2347,1,0
6,GO HEART PROCESS,0.0014299,-0.18452,-0.16397,1,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,1.104e-05,-0.18455,-0.19456,1,0
6,GO TRIGLYCERIDE METABOLIC PROCESS,7.9801e-06,-0.18456,-0.21636,1,0
6,GO LIPID METABOLIC PROCESS,2.9532e-05,-0.1846,-0.16884,1,0
6,GO POLYOL BIOSYNTHETIC PROCESS,0.00057693,-0.1846,-0.16778,1,0
6,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.3287e-06,-0.18464,-0.23942,1,0
6,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0012662,-0.1847,-0.15896,1,0
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0087944,-0.18474,-0.18913,1,0
6,GO REGULATION OF KIDNEY DEVELOPMENT,0.00353,-0.18476,-0.18547,1,0
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,4.4878e-05,-0.18494,-0.20353,1,0
6,GO RESPONSE TO WATER,0.023741,-0.18508,-0.21552,1,0
6,GO CARBOHYDRATE METABOLIC PROCESS,6.2367e-06,-0.18516,-0.17842,1,0
6,GO STEROID METABOLIC PROCESS,2.0833e-05,-0.18518,-0.20234,1,0
6,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.00017796,-0.18518,-0.22044,1,0
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,4.8612e-06,-0.18519,-0.18026,1,0
6,GO CELLULAR RESPONSE TO STARVATION,0.00010462,-0.1852,-0.16808,1,0
6,GO RESPONSE TO PH,9.0551e-05,-0.18526,-0.23667,1,0
6,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.5201e-05,-0.18538,-0.23449,1,0
6,GO HAIR FOLLICLE MATURATION,0.0054795,-0.18562,-0.25841,1,0
6,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00024286,-0.18568,-0.15482,1,0
6,GO MACROPHAGE CHEMOTAXIS,0.00055855,-0.18577,-0.22504,1,0
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0026572,-0.1858,-0.21285,1,0
6,GO DEFENSE RESPONSE,5.0226e-05,-0.18594,-0.18659,1,0
6,GO REGULATION OF HAIR CYCLE,0.0011199,-0.18604,-0.22637,1,0
6,GO MACROPHAGE MIGRATION,6.7596e-05,-0.18609,-0.24277,1,0
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.6228e-06,-0.18614,-0.19052,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0014299,-0.18629,-0.15916,1,0
6,GO LYTIC VACUOLE ORGANIZATION,0.00057693,-0.18635,-0.17443,1,0
6,GO REGULATION OF MACROPHAGE ACTIVATION,0.0016129,-0.18635,-0.17998,1,0
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0038387,-0.18637,-0.21141,1,0
6,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00069957,-0.18657,-0.17146,1,0
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00052342,-0.18668,-0.20089,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0028957,-0.1867,-0.24476,1,0
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.046579,-0.18705,-0.19476,1,0
6,GO TISSUE REMODELING,0.0010859,-0.18713,-0.20936,1,0
6,GO NEGATIVE REGULATION OF HEMOPOIESIS,4.3218e-05,-0.18728,-0.21606,1,0
6,GO ADHERENS JUNCTION ASSEMBLY,0.037747,-0.18731,-0.12493,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00028792,-0.18734,-0.27337,1,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0023671,-0.18738,-0.15047,1,0
6,GO MYOBLAST PROLIFERATION,0.0015189,-0.1874,-0.20524,1,0
6,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0049174,-0.18746,-0.17274,1,0
6,GO RESPONSE TO CADMIUM ION,0.0032441,-0.18751,-0.24314,1,0
6,GO LYMPHOCYTE CHEMOTAXIS,2.6307e-05,-0.18754,-0.21508,1,0
6,GO RESPONSE TO TOXIC SUBSTANCE,0.0014299,-0.18769,-0.16263,1,0
6,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00029782,-0.18772,-0.2049,1,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0067808,-0.1878,-0.20919,1,0
6,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00016023,-0.18783,-0.25749,1,0
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,2.7343e-05,-0.18796,-0.16712,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.7806e-05,-0.18798,-0.23731,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0064317,-0.18805,-0.19794,1,0
6,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0029794,-0.18836,-0.15603,1,0
6,GO THIOESTER METABOLIC PROCESS,0.00027832,-0.18847,-0.18698,1,0
6,GO RESPONSE TO ETHANOL,8.3127e-06,-0.18855,-0.19469,1,0
6,GO DENDRITIC CELL CHEMOTAXIS,0.012508,-0.18862,-0.17461,1,0
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0059384,-0.18863,-0.20896,1,0
6,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0014299,-0.18863,-0.19889,1,0
6,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7791e-06,-0.18874,-0.22667,1,0
6,GO ASTROCYTE DEVELOPMENT,0.007729,-0.18877,-0.22025,1,0
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0010528,-0.18877,-0.24902,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0059384,-0.18877,-0.19477,1,0
6,GO PROSTATE GLAND DEVELOPMENT,0.00067758,-0.18881,-0.26084,1,0
6,GO INTRACELLULAR LIPID TRANSPORT,0.0006154,-0.18883,-0.2029,1,0
6,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0071468,-0.18883,-0.18627,1,0
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.031748,-0.18885,-0.13022,1,0
6,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.049546,-0.18895,-0.12165,1,0
6,GO REGULATION OF RECEPTOR BINDING,0.02268,-0.18919,-0.23031,1,0
6,GO MEMBRANE BIOGENESIS,0.021165,-0.18932,-0.17197,1,0
6,GO PYRUVATE METABOLIC PROCESS,4.1617e-05,-0.18939,-0.18381,1,0
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.024846,-0.18939,-0.26504,1,0
6,GO MYELOID LEUKOCYTE MIGRATION,0.00052342,-0.18941,-0.19176,1,0
6,GO MONOSACCHARIDE METABOLIC PROCESS,2.4346e-05,-0.18946,-0.18901,1,0
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00017186,-0.18966,-0.18465,1,0
6,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,7.6603e-06,-0.18971,-0.2125,1,0
6,GO ETHANOL METABOLIC PROCESS,0.045624,-0.18978,-0.18892,1,0
6,GO CORTICAL CYTOSKELETON ORGANIZATION,0.013465,-0.18985,-0.14448,1,0
6,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00035231,-0.18993,-0.21666,1,0
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.7413e-06,-0.19002,-0.17584,1,0
6,GO ONE CARBON COMPOUND TRANSPORT,0.0015653,-0.19005,-0.22114,1,0
6,GO KERATINOCYTE DIFFERENTIATION,0.0090226,-0.19006,-0.1724,1,0
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00014935,-0.19009,-0.23752,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00065623,-0.19014,-0.22899,1,0
6,GO REGULATION OF FATTY ACID TRANSPORT,0.00057693,-0.19021,-0.19848,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.9263e-05,-0.19022,-0.17088,1,0
6,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0025817,-0.19027,-0.20215,1,0
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.001228,-0.1903,-0.19272,1,0
6,GO RESPONSE TO INTERLEUKIN 7,0.00021909,-0.19033,-0.19335,1,0
6,GO CARNITINE SHUTTLE,0.049546,-0.19035,-0.14664,1,0
6,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00019079,-0.19037,-0.22066,1,0
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.035393,-0.19058,-0.17885,1,0
6,GO PHAGOLYSOSOME ASSEMBLY,0.022165,-0.19059,-0.19117,1,0
6,GO AXIS ELONGATION,0.017969,-0.1906,-0.21891,1,0
6,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0066042,-0.1906,-0.27837,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0006154,-0.19067,-0.1715,1,0
6,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00052342,-0.19073,-0.21631,1,0
6,GO MEMBRANE INVAGINATION,0.0021689,-0.19076,-0.19149,1,0
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,2.6307e-05,-0.1908,-0.16882,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,7.0571e-06,-0.19089,-0.17816,1,0
6,GO IMMUNE EFFECTOR PROCESS,9.7346e-05,-0.19092,-0.19923,1,0
6,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00074557,-0.19098,-0.14465,1,0
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,9.389e-05,-0.19111,-0.16852,1,0
6,GO CHLORIDE TRANSPORT,3.7145e-05,-0.19114,-0.17484,1,0
6,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001547,-0.19118,-0.1937,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.010245,-0.19118,-0.16373,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00014418,-0.19126,-0.27195,1,0
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00353,-0.19126,-0.16151,1,0
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.017969,-0.19132,-0.21012,1,0
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0032441,-0.19138,-0.25497,1,0
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00010462,-0.19161,-0.16352,1,0
6,GO REGULATION OF ENDOCYTOSIS,0.00017186,-0.19182,-0.15852,1,0
6,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0049174,-0.19183,-0.18021,1,0
6,GO LONG CHAIN FATTY ACID TRANSPORT,2.7343e-05,-0.19186,-0.18339,1,0
6,GO MUSCLE ADAPTATION,6.5149e-05,-0.19191,-0.2116,1,0
6,GO REGULATION OF VASCULAR PERMEABILITY,0.00042998,-0.19206,-0.21017,1,0
6,GO REGULATION OF ACTION POTENTIAL,0.0026572,-0.19207,-0.18788,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0013054,-0.19207,-0.21689,1,0
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00065623,-0.19209,-0.2288,1,0
6,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.4121e-05,-0.19219,-0.21032,1,0
6,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0018173,-0.19237,-0.22633,1,0
6,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00017796,-0.19262,-0.18689,1,0
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0023671,-0.19265,-0.25094,1,0
6,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00010462,-0.19268,-0.28584,1,0
6,GO REGULATION OF VASCULATURE DEVELOPMENT,9.7346e-05,-0.19274,-0.21499,1,0
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0032441,-0.19286,-0.18095,1,0
6,GO LYMPHOCYTE MIGRATION,2.3654e-06,-0.19294,-0.22322,1,0
6,GO NEGATIVE REGULATION OF CELL ACTIVATION,1.7118e-05,-0.19301,-0.22614,1,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0041716,-0.1931,-0.18851,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00031859,-0.19326,-0.25807,1,0
6,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,7.9801e-06,-0.1937,-0.17315,1,0
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0042883,-0.1937,-0.18217,1,0
6,GO SERTOLI CELL DIFFERENTIATION,0.012508,-0.19375,-0.20204,1,0
6,GO T HELPER 1 CELL DIFFERENTIATION,0.013465,-0.19384,-0.3052,1,0
6,GO MUSCLE SYSTEM PROCESS,4.8612e-06,-0.19385,-0.18881,1,0
6,GO PROTEIN ACTIVATION CASCADE,5.4121e-05,-0.19387,-0.27519,1,0
6,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.024288,-0.19388,-0.15182,1,0
6,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0021689,-0.19403,-0.22778,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0031536,-0.19413,-0.19162,1,0
6,GO CELLULAR RESPONSE TO DRUG,0.0022332,-0.19417,-0.15198,1,0
6,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00016595,-0.19437,-0.27303,1,0
6,GO RESPONSE TO MURAMYL DIPEPTIDE,0.013139,-0.19451,-0.26205,1,0
6,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.016339,-0.19455,-0.20166,1,0
6,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0081404,-0.19457,-0.16747,1,0
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0050528,-0.19479,-0.13648,1,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0022332,-0.19488,-0.26999,1,0
6,GO ORGANELLE MEMBRANE FUSION,0.00055855,-0.19503,-0.16122,1,0
6,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,3.3287e-06,-0.19507,-0.2411,1,0
6,GO INFLAMMATORY RESPONSE,1.4039e-05,-0.19513,-0.20899,1,0
6,GO BLOOD VESSEL MORPHOGENESIS,1.7118e-05,-0.19515,-0.22346,1,0
6,GO T CELL CYTOKINE PRODUCTION,0.0021062,-0.19515,-0.19967,1,0
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00069957,-0.19516,-0.18664,1,0
6,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,1.2962e-05,-0.1954,-0.25236,1,0
6,GO CARBOHYDRATE PHOSPHORYLATION,0.014138,-0.19546,-0.14339,1,0
6,GO POLYSACCHARIDE METABOLIC PROCESS,4.8379e-05,-0.19569,-0.2081,1,0
6,GO ORGANIC CATION TRANSPORT,0.001662,-0.19572,-0.19143,1,0
6,GO RESPONSE TO CYTOKINE,5.6174e-05,-0.196,-0.19674,1,0
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0016129,-0.19606,-0.18607,1,0
6,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,4.6597e-05,-0.19607,-0.2099,1,0
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0006154,-0.19609,-0.20417,1,0
6,GO RESPIRATORY BURST,0.00079435,-0.19609,-0.25463,1,0
6,GO REGULATION OF ENDOCRINE PROCESS,0.0010206,-0.19612,-0.18474,1,0
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00044439,-0.19619,-0.23379,1,0
6,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0057817,-0.19637,-0.21216,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.011904,-0.19645,-0.27767,1,0
6,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.1964e-05,-0.1965,-0.24667,1,0
6,GO INTEGRIN ACTIVATION,0.0012662,-0.19655,-0.22735,1,0
6,GO POSITIVE REGULATION OF OSSIFICATION,0.00081984,-0.19656,-0.21608,1,0
6,GO NAD METABOLIC PROCESS,0.0050528,-0.19664,-0.24216,1,0
6,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.0073363,-0.1968,-0.20197,1,0
6,GO POSITIVE CHEMOTAXIS,5.2139e-05,-0.19723,-0.24428,1,0
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0042883,-0.19725,-0.226,1,0
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.019739,-0.19747,-0.1953,1,0
6,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,9.389e-05,-0.19753,-0.21614,1,0
6,GO ANTIMICROBIAL HUMORAL RESPONSE,9.3916e-06,-0.19758,-0.21842,1,0
6,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0079323,-0.19759,-0.18008,1,0
6,GO RESPONSE TO AMINE,0.010506,-0.1976,-0.18238,1,0
6,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.016339,-0.19764,-0.27074,1,0
6,GO REGULATION OF T CELL CHEMOTAXIS,0.0010528,-0.19766,-0.20139,1,0
6,GO REGULATION OF MAST CELL ACTIVATION,0.001872,-0.19767,-0.19483,1,0
6,GO BONE GROWTH,0.021165,-0.19771,-0.20374,1,0
6,GO FIBROBLAST APOPTOTIC PROCESS,0.015953,-0.19788,-0.17838,1,0
6,GO REGULATION OF BIOMINERALIZATION,0.00032948,-0.19806,-0.1997,1,0
6,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0085714,-0.19811,-0.22976,1,0
6,GO SPHINGOID METABOLIC PROCESS,0.00047456,-0.19822,-0.24961,1,0
6,GO INTERLEUKIN 1 PRODUCTION,0.0013054,-0.19839,-0.24447,1,0
6,GO REGULATION OF PROTEIN BINDING,4.4712e-06,-0.1984,-0.19726,1,0
6,GO T CELL APOPTOTIC PROCESS,0.0028141,-0.19854,-0.18059,1,0
6,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00027832,-0.19855,-0.25566,1,0
6,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00028792,-0.19856,-0.24622,1,0
6,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.017969,-0.19869,-0.20794,1,0
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.026586,-0.19873,-0.29217,1,0
6,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0054795,-0.19894,-0.2301,1,0
6,GO REGENERATION,2.8077e-06,-0.19902,-0.2328,1,0
6,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00036427,-0.19916,-0.21749,1,0
6,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00063551,-0.19939,-0.26056,1,0
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00014935,-0.19942,-0.21794,1,0
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,8.1192e-05,-0.19944,-0.19437,1,0
6,GO RESPONSE TO CHEMOKINE,1.4674e-06,-0.19946,-0.21676,1,0
6,GO LEUKOCYTE MEDIATED CYTOTOXICITY,7.2754e-05,-0.19963,-0.24722,1,0
6,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00032948,-0.19967,-0.20201,1,0
6,GO POSITIVE REGULATION OF MITOPHAGY,0.017549,-0.19971,-0.15323,1,0
6,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0006154,-0.19971,-0.16066,1,0
6,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0001165,-0.19972,-0.21522,1,0
6,GO NUCLEOTIDE PHOSPHORYLATION,3.3132e-05,-0.19975,-0.19254,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00054072,-0.19986,-0.20766,1,0
6,GO RESPONSE TO COLD,0.0018173,-0.19996,-0.25722,1,0
6,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00019753,-0.2,-0.22497,1,0
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00018427,-0.20003,-0.22182,1,0
6,GO B CELL MEDIATED IMMUNITY,0.00026903,-0.20023,-0.22254,1,0
6,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00012512,-0.20026,-0.23421,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00027832,-0.20026,-0.20579,1,0
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00010845,-0.20034,-0.21875,1,0
6,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0012662,-0.2005,-0.19754,1,0
6,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00017186,-0.20063,-0.2629,1,0
6,GO REGULATION OF CHLORIDE TRANSPORT,0.0083534,-0.20064,-0.24721,1,0
6,GO REGULATION OF PHAGOCYTOSIS,5.4121e-05,-0.20084,-0.22699,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00044439,-0.20097,-0.25138,1,0
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,8.7323e-05,-0.20106,-0.25232,1,0
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.031059,-0.20113,-0.16229,1,0
6,GO ACYLGLYCEROL HOMEOSTASIS,0.00021909,-0.20128,-0.22402,1,0
6,GO REGULATION OF VACUOLE ORGANIZATION,7.6603e-06,-0.2013,-0.24416,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.010506,-0.20131,-0.18361,1,0
6,GO CHRONIC INFLAMMATORY RESPONSE,0.011904,-0.20141,-0.25648,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION,3.0689e-05,-0.20143,-0.2287,1,0
6,GO REGULATION OF MYOTUBE DIFFERENTIATION,3.0689e-05,-0.20152,-0.22757,1,0
6,GO MUSCLE CELL APOPTOTIC PROCESS,0.00012512,-0.20166,-0.20505,1,0
6,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0079323,-0.20167,-0.16371,1,0
6,GO DENDRITIC SPINE MAINTENANCE,0.013465,-0.20178,-0.17601,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0014738,-0.20201,-0.22941,1,0
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.018398,-0.20202,-0.21735,1,0
6,GO TRANSLATIONAL INITIATION,0.020205,-0.20208,-0.186,1,0
6,GO LEUKOCYTE MEDIATED IMMUNITY,2.9532e-05,-0.20212,-0.22046,1,0
6,GO MYOTUBE DIFFERENTIATION,8.7323e-05,-0.20235,-0.1902,1,0
6,GO REGULATION OF FAT CELL DIFFERENTIATION,2.6307e-05,-0.20245,-0.23227,1,0
6,GO REGULATION OF FIBRINOLYSIS,1.4609e-05,-0.20249,-0.36981,1,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00047456,-0.20267,-0.22482,1,0
6,GO CELL REDOX HOMEOSTASIS,0.00049035,-0.20288,-0.21917,1,0
6,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,3.3132e-05,-0.20288,-0.19773,1,0
6,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0021689,-0.20296,-0.20703,1,0
6,GO TOOTH MINERALIZATION,0.014841,-0.20298,-0.23704,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00023468,-0.20339,-0.20482,1,0
6,GO MACROPHAGE ACTIVATION,9.389e-05,-0.20351,-0.20586,1,0
6,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0030654,-0.20363,-0.22539,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.034637,-0.20379,-0.1606,1,0
6,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00044439,-0.20393,-0.19262,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00081984,-0.20417,-0.26215,1,0
6,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,6.7728e-06,-0.20428,-0.25418,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00055855,-0.20439,-0.22188,1,0
6,GO BONE REMODELING,0.0029794,-0.20443,-0.20566,1,0
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.023205,-0.20444,-0.20058,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00050664,-0.20451,-0.34178,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,6.2367e-06,-0.20451,-0.23819,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.007729,-0.20452,-0.18475,1,0
6,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.547e-05,-0.2047,-0.29355,1,0
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0017123,-0.20475,-0.27779,1,0
6,GO REGULATION OF LIPID TRANSPORT,2.5774e-06,-0.20476,-0.21852,1,0
6,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0097392,-0.20479,-0.15067,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00029782,-0.20494,-0.23624,1,0
6,GO ENDODERMAL CELL DIFFERENTIATION,0.0010859,-0.20512,-0.32124,1,0
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.4609e-05,-0.20515,-0.21407,1,0
6,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001662,-0.20546,-0.25466,1,0
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.049546,-0.20547,-0.18414,1,0
6,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,2.2658e-06,-0.20548,-0.22431,1,0
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0023671,-0.2055,-0.28932,1,0
6,GO CELLULAR RESPONSE TO STEROL,0.0051916,-0.20567,-0.21247,1,0
6,GO AMYLOID BETA CLEARANCE,0.0001547,-0.20575,-0.26577,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,6.5149e-05,-0.20584,-0.21054,1,0
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00020448,-0.20591,-0.16996,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00052342,-0.20593,-0.3586,1,0
6,GO MUSCLE CELL DEVELOPMENT,5.508e-06,-0.20593,-0.20927,1,0
6,GO PHAGOCYTOSIS RECOGNITION,0.034637,-0.20597,-0.217,1,0
6,GO RESPONSE TO BACTERIUM,4.1112e-06,-0.20621,-0.22034,1,0
6,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0010206,-0.20622,-0.22043,1,0
6,GO PROTEIN KINASE C SIGNALING,0.0040578,-0.20632,-0.2046,1,0
6,GO PEPTIDYL TYROSINE MODIFICATION,3.3132e-05,-0.20638,-0.1896,1,0
6,GO REGULATION OF FATTY ACID METABOLIC PROCESS,5.8301e-05,-0.2064,-0.21067,1,0
6,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00014935,-0.20661,-0.33575,1,0
6,GO ASYMMETRIC CELL DIVISION,0.038561,-0.20666,-0.16043,1,0
6,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.007729,-0.20669,-0.16016,1,0
6,GO PEROXISOME ORGANIZATION,0.00095906,-0.2067,-0.19446,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.001191,-0.20676,-0.22984,1,0
6,GO LEUKOCYTE PROLIFERATION,0.00010092,-0.20677,-0.20192,1,0
6,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.024846,-0.20679,-0.20621,1,0
6,GO POSITIVE REGULATION OF CELL SIZE,0.020205,-0.20689,-0.17705,1,0
6,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.0090226,-0.20712,-0.18788,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,2.4692e-06,-0.20718,-0.21966,1,0
6,GO RESPONSE TO STARVATION,2.6307e-05,-0.20732,-0.18683,1,0
6,GO REGULATION OF MAPK CASCADE,1.9263e-05,-0.2074,-0.1859,1,0
6,GO LEUKOCYTE MIGRATION,0.00018427,-0.20767,-0.19824,1,0
6,GO ENDOCRINE HORMONE SECRETION,0.00031859,-0.20772,-0.19713,1,0
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.3132e-05,-0.20784,-0.23212,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,7.8282e-05,-0.20792,-0.22692,1,0
6,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.035393,-0.20803,-0.16869,1,0
6,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,4.0073e-05,-0.20812,-0.22326,1,0
6,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00013917,-0.20813,-0.17987,1,0
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,2.9301e-06,-0.20817,-0.21267,1,0
6,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.0017641,-0.20819,-0.23693,1,0
6,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00031859,-0.20821,-0.24864,1,0
6,GO MAINTENANCE OF LOCATION,1.4609e-05,-0.20836,-0.18372,1,0
6,GO SMOOTH MUSCLE CELL PROLIFERATION,2.0833e-05,-0.2084,-0.25097,1,0
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00020448,-0.20841,-0.29292,1,0
6,GO RESPONSE TO FLUID SHEAR STRESS,0.001228,-0.20849,-0.23814,1,0
6,GO ALCOHOL METABOLIC PROCESS,2.5308e-05,-0.2086,-0.19077,1,0
6,GO REGULATION OF GONAD DEVELOPMENT,0.011612,-0.20866,-0.1877,1,0
6,GO CYTOKINE MEDIATED SIGNALING PATHWAY,6.0504e-05,-0.20883,-0.22368,1,0
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00045924,-0.20902,-0.20913,1,0
6,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.019283,-0.2091,-0.25439,1,0
6,GO SULFUR COMPOUND METABOLIC PROCESS,2.9532e-05,-0.20914,-0.19335,1,0
6,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00013433,-0.20914,-0.18433,1,0
6,GO REGULATION OF CHEMOTAXIS,0.00022676,-0.20916,-0.17891,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00038934,-0.20919,-0.26463,1,0
6,GO MYELOID LEUKOCYTE ACTIVATION,1.5816e-05,-0.20938,-0.22809,1,0
6,GO DRUG METABOLIC PROCESS,0.0017123,-0.20944,-0.24657,1,0
6,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,7.8282e-05,-0.20958,-0.21022,1,0
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00041602,-0.20978,-0.23234,1,0
6,GO SPROUTING ANGIOGENESIS,0.00049035,-0.20985,-0.19991,1,0
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0025817,-0.20993,-0.21725,1,0
6,GO STRIATED MUSCLE CONTRACTION,0.00013917,-0.20995,-0.20343,1,0
6,GO CHAPERONE MEDIATED AUTOPHAGY,0.0094949,-0.21003,-0.31899,1,0
6,GO ADAPTIVE IMMUNE RESPONSE,0.00011241,-0.21008,-0.22833,1,0
6,GO PHAGOCYTOSIS,3.5759e-05,-0.21011,-0.22423,1,0
6,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0014738,-0.21032,-0.28505,1,0
6,GO POSITIVE REGULATION OF LIPID TRANSPORT,2.2524e-05,-0.21032,-0.19599,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00010462,-0.21042,-0.23057,1,0
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.010245,-0.21044,-0.28341,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02843,-0.21051,-0.1415,1,0
6,GO RESPONSE TO PROGESTERONE,0.0014299,-0.21053,-0.23275,1,0
6,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.03939,-0.21072,-0.18387,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.036164,-0.21076,-0.18154,1,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0066042,-0.21077,-0.18887,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,7.8282e-05,-0.21087,-0.2833,1,0
6,GO CELL CELL RECOGNITION,2.6902e-06,-0.21096,-0.25953,1,0
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,8.4205e-05,-0.21135,-0.27287,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.2786e-05,-0.21137,-0.20014,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.349e-05,-0.21165,-0.26794,1,0
6,GO FATTY ACID METABOLIC PROCESS,6.2786e-05,-0.21166,-0.19523,1,0
6,GO REGULATION OF LIPID LOCALIZATION,5.0194e-07,-0.21176,-0.2432,1,0
6,GO ALPHA BETA T CELL PROLIFERATION,0.0019282,-0.2118,-0.21962,1,0
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00095906,-0.21181,-0.26044,1,0
6,GO MOVEMENT IN HOST ENVIRONMENT,5.6174e-05,-0.21189,-0.25417,1,0
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0039469,-0.21195,-0.16356,1,0
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0037331,-0.21205,-0.17697,1,0
6,GO SPERM EGG RECOGNITION,1.2962e-05,-0.21206,-0.24132,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00074557,-0.2121,-0.23908,1,0
6,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.014138,-0.21213,-0.21162,1,0
6,GO VITAMIN BIOSYNTHETIC PROCESS,0.011612,-0.21225,-0.19888,1,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,9.0551e-05,-0.21233,-0.21346,1,0
6,GO HISTONE SERINE PHOSPHORYLATION,0.0046564,-0.21247,-0.20346,1,0
6,GO REGULATION OF STEROID METABOLIC PROCESS,2.3418e-05,-0.21281,-0.25523,1,0
6,GO ANTIBACTERIAL HUMORAL RESPONSE,1.7806e-05,-0.21287,-0.29617,1,0
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0027346,-0.21291,-0.18195,1,0
6,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024286,-0.21294,-0.24845,1,0
6,GO REGULATION OF MUSCLE HYPERTROPHY,0.00063551,-0.21301,-0.19506,1,0
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0013054,-0.2131,-0.19477,1,0
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.1663e-05,-0.21311,-0.2385,1,0
6,GO RESPONSE TO REDOX STATE,0.017969,-0.21318,-0.17848,1,0
6,GO APICAL JUNCTION ASSEMBLY,0.0071468,-0.21338,-0.17535,1,0
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.0050528,-0.21366,-0.20582,1,0
6,GO CHEMOSENSORY BEHAVIOR,0.00098941,-0.21376,-0.20703,1,0
6,GO RESPONSE TO WOUNDING,1.4609e-05,-0.21377,-0.22349,1,0
6,GO EPITHELIAL CELL MORPHOGENESIS,0.03939,-0.21391,-0.19109,1,0
6,GO STEROID HORMONE SECRETION,0.0010528,-0.214,-0.25465,1,0
6,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.1663e-05,-0.2141,-0.26585,1,0
6,GO L ASCORBIC ACID METABOLIC PROCESS,0.030383,-0.21447,-0.2618,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.011612,-0.21452,-0.23172,1,0
6,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.004408,-0.21471,-0.27479,1,0
6,GO HYALURONAN CATABOLIC PROCESS,0.0026572,-0.215,-0.34328,1,0
6,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.014841,-0.21508,-0.19389,1,0
6,GO NEGATIVE CHEMOTAXIS,0.00047456,-0.2151,-0.27542,1,0
6,GO FIBRINOLYSIS,0.00055855,-0.21527,-0.33222,1,0
6,GO CHONDROCYTE PROLIFERATION,0.030383,-0.21527,-0.22446,1,0
6,GO FEVER GENERATION,0.0017641,-0.21536,-0.21725,1,0
6,GO STEROL HOMEOSTASIS,4.1617e-05,-0.21549,-0.24182,1,0
6,GO CELLULAR RESPONSE TO IRON ION,0.013465,-0.21573,-0.24724,1,0
6,GO AMINE CATABOLIC PROCESS,0.00059588,-0.21577,-0.31134,1,0
6,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0013457,-0.21588,-0.23246,1,0
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.007729,-0.21594,-0.19783,1,0
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.031748,-0.21597,-0.22382,1,0
6,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,-0.216,-0.23336,1,0
6,GO GOLGI RIBBON FORMATION,0.0054795,-0.21603,-0.15951,1,0
6,GO MITOCHONDRIAL DEPOLARIZATION,0.0015189,-0.21609,-0.24923,1,0
6,GO CELL CHEMOTAXIS,0.00026903,-0.21618,-0.2039,1,0
6,GO FATTY ACID BIOSYNTHETIC PROCESS,2.3654e-06,-0.21623,-0.25301,1,0
6,GO MUSCLE ORGAN MORPHOGENESIS,3.8583e-05,-0.21632,-0.20393,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0050528,-0.21647,-0.22122,1,0
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0075304,-0.2165,-0.215,1,0
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0045306,-0.21661,-0.21911,1,0
6,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.0013054,-0.21664,-0.24758,1,0
6,GO POSITIVE REGULATION OF T CELL PROLIFERATION,1.349e-05,-0.21672,-0.24679,1,0
6,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0001165,-0.21687,-0.23927,1,0
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00021167,-0.2169,-0.2239,1,0
6,GO POSITIVE REGULATION OF JNK CASCADE,1.1964e-05,-0.21712,-0.19712,1,0
6,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.349e-05,-0.21717,-0.29213,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00021167,-0.21718,-0.2739,1,0
6,GO ICOSANOID METABOLIC PROCESS,0.00087311,-0.21742,-0.22323,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0006154,-0.21759,-0.22881,1,0
6,GO ANION HOMEOSTASIS,0.0022992,-0.2177,-0.18985,1,0
6,GO POSITIVE REGULATION OF BLOOD CIRCULATION,9.0551e-05,-0.21776,-0.1979,1,0
6,GO SKELETAL MUSCLE CONTRACTION,0.0023671,-0.2178,-0.2053,1,0
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00098941,-0.21794,-0.2345,1,0
6,GO MAMMARY GLAND DEVELOPMENT,5.0683e-06,-0.21813,-0.21874,1,0
6,GO RESPONSE TO ACIDIC PH,0.00074557,-0.21817,-0.27384,1,0
6,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00353,-0.21834,-0.21522,1,0
6,GO RESPONSE TO MANGANESE ION,0.0021689,-0.21844,-0.2167,1,0
6,GO MYELOID CELL APOPTOTIC PROCESS,7.547e-05,-0.21866,-0.30254,1,0
6,GO REGULATION OF MAP KINASE ACTIVITY,5.0226e-05,-0.21879,-0.1808,1,0
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00074557,-0.21888,-0.22437,1,0
6,GO KETONE BIOSYNTHETIC PROCESS,0.0054795,-0.21909,-0.20644,1,0
6,GO AMMONIUM TRANSPORT,0.027188,-0.21911,-0.15963,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.6174e-05,-0.21913,-0.24875,1,0
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.3441e-06,-0.21924,-0.24951,1,0
6,GO POSITIVE REGULATION OF MAPK CASCADE,9.0179e-06,-0.21926,-0.19846,1,0
6,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.017137,-0.21929,-0.25122,1,0
6,GO I KAPPAB KINASE NF KAPPAB SIGNALING,6.5149e-05,-0.21936,-0.22727,1,0
6,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0041716,-0.2195,-0.23667,1,0
6,GO CYTOKINE METABOLIC PROCESS,4.4878e-05,-0.21953,-0.24832,1,0
6,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0081404,-0.21957,-0.24794,1,0
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0013872,-0.21958,-0.26797,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0025083,-0.21967,-0.21595,1,0
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.023741,-0.21981,-0.14342,1,0
6,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0067808,-0.22004,-0.19852,1,0
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00017796,-0.22011,-0.24585,1,0
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0011549,-0.22012,-0.25177,1,0
6,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00034072,-0.22018,-0.19135,1,0
6,GO SUPEROXIDE ANION GENERATION,0.0097392,-0.22021,-0.2563,1,0
6,GO REGULATION OF CARDIAC CONDUCTION,0.00045924,-0.22033,-0.20856,1,0
6,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.024288,-0.22037,-0.25583,1,0
6,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0025083,-0.22059,-0.24675,1,0
6,GO PEROXISOMAL TRANSPORT,0.0014738,-0.2208,-0.20597,1,0
6,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0037331,-0.22083,-0.25597,1,0
6,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.014486,-0.22088,-0.18228,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.22122,-0.2466,1,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00032948,-0.22171,-0.23674,1,0
6,GO SPHINGOMYELIN METABOLIC PROCESS,0.0025083,-0.22178,-0.24923,1,0
6,GO RELAXATION OF MUSCLE,0.016339,-0.2218,-0.18172,1,0
6,GO WOUND HEALING,1.1964e-05,-0.22183,-0.23954,1,0
6,GO ACTION POTENTIAL,0.011326,-0.22184,-0.15043,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00019753,-0.22231,-0.24724,1,0
6,GO TROPHOBLAST CELL MIGRATION,0.001228,-0.22232,-0.35578,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0066042,-0.22254,-0.22884,1,0
6,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0046564,-0.22256,-0.18101,1,0
6,GO ENDODERM DEVELOPMENT,0.00059588,-0.22267,-0.28111,1,0
6,GO GLYCEROLIPID CATABOLIC PROCESS,0.00018427,-0.22281,-0.20016,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0042883,-0.22296,-0.1979,1,0
6,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.012508,-0.22302,-0.18832,1,0
6,GO P38MAPK CASCADE,4.8612e-06,-0.22313,-0.27181,1,0
6,GO CARDIAC MUSCLE CONTRACTION,0.00022676,-0.22317,-0.20013,1,0
6,GO CORNIFICATION,0.023741,-0.22319,-0.19178,1,0
6,GO REGULATION OF ANOIKIS,0.030383,-0.22325,-0.22968,1,0
6,GO LOCOMOTOR RHYTHM,0.0028141,-0.22355,-0.25415,1,0
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0026572,-0.22364,-0.20893,1,0
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00010462,-0.22366,-0.24727,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00014418,-0.22368,-0.28085,1,0
6,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00023468,-0.22388,-0.21279,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0069616,-0.22396,-0.29138,1,0
6,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.6455e-05,-0.224,-0.20923,1,0
6,GO ALDITOL METABOLIC PROCESS,0.00017186,-0.22404,-0.26432,1,0
6,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00025131,-0.22411,-0.21169,1,0
6,GO SCHWANN CELL DIFFERENTIATION,0.00023468,-0.22412,-0.18663,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0022992,-0.22413,-0.18449,1,0
6,GO ERK1 AND ERK2 CASCADE,3.8583e-05,-0.22423,-0.21987,1,0
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0007696,-0.22427,-0.21323,1,0
6,GO MESODERM MORPHOGENESIS,0.00013433,-0.2243,-0.23412,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.012508,-0.22432,-0.22001,1,0
6,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.015574,-0.22436,-0.18059,1,0
6,GO RECEPTOR MEDIATED ENDOCYTOSIS,6.7596e-05,-0.22461,-0.16787,1,0
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0033369,-0.22463,-0.23588,1,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.001872,-0.22464,-0.19716,1,0
6,GO APOPTOTIC CELL CLEARANCE,8.7323e-05,-0.22478,-0.3119,1,0
6,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0041716,-0.2249,-0.27319,1,0
6,GO CARDIAC CHAMBER MORPHOGENESIS,0.00010845,-0.22491,-0.2154,1,0
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0036303,-0.225,-0.27862,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.011904,-0.22505,-0.17171,1,0
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,6.7596e-05,-0.22512,-0.21245,1,0
6,GO RESPONSE TO DRUG,1.4039e-05,-0.22532,-0.21636,1,0
6,GO PROSTAGLANDIN TRANSPORT,0.0032441,-0.22539,-0.18519,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.021165,-0.22541,-0.23564,1,0
6,GO NEGATIVE REGULATION OF PROTEIN BINDING,7.013e-05,-0.22544,-0.18614,1,0
6,GO CHOLESTEROL EFFLUX,1.2962e-05,-0.22566,-0.23891,1,0
6,GO RESPONSE TO PROTOZOAN,0.00014418,-0.22582,-0.2508,1,0
6,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00050664,-0.22589,-0.21597,1,0
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.00065623,-0.22602,-0.30158,1,0
6,GO CARDIAC MUSCLE CELL CONTRACTION,0.00034072,-0.22612,-0.21948,1,0
6,GO STEROL METABOLIC PROCESS,8.6584e-06,-0.22613,-0.2119,1,0
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00012964,-0.22622,-0.24191,1,0
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0064317,-0.22627,-0.34045,1,0
6,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0012662,-0.22627,-0.20892,1,0
6,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00010845,-0.2266,-0.21984,1,0
6,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.024846,-0.22665,-0.2764,1,0
6,GO RESPONSE TO MISFOLDED PROTEIN,0.0023671,-0.22665,-0.19183,1,0
6,GO HEXOSE CATABOLIC PROCESS,0.0013872,-0.22668,-0.24308,1,0
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00067758,-0.22671,-0.26756,1,0
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.024846,-0.22673,-0.16751,1,0
6,GO ENERGY RESERVE METABOLIC PROCESS,0.0010206,-0.22675,-0.1869,1,0
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,8.6584e-06,-0.22687,-0.20458,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0013457,-0.22695,-0.21205,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00010462,-0.22695,-0.2681,1,0
6,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0027346,-0.22698,-0.40773,1,0
6,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.05161,-0.22713,-0.16717,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00023468,-0.2272,-0.29941,1,0
6,GO CARDIAC CONDUCTION,0.0015653,-0.2273,-0.18879,1,0
6,GO SARCOMERE ORGANIZATION,0.0069616,-0.22735,-0.15966,1,0
6,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00030804,-0.22742,-0.22566,1,0
6,GO INTERLEUKIN 8 PRODUCTION,9.7346e-05,-0.22755,-0.25147,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0090226,-0.22768,-0.2173,1,0
6,GO FOAM CELL DIFFERENTIATION,1.9263e-05,-0.2282,-0.29643,1,0
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0001547,-0.2283,-0.20251,1,0
6,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0085714,-0.22858,-0.26251,1,0
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.02166,-0.22861,-0.23073,1,0
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,4.3218e-05,-0.22861,-0.25377,1,0
6,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00055855,-0.22887,-0.21811,1,0
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0081404,-0.22897,-0.23893,1,0
6,GO STEROID CATABOLIC PROCESS,0.0045306,-0.22897,-0.19554,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.029719,-0.22908,-0.18751,1,0
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0081404,-0.22911,-0.24086,1,0
6,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00047456,-0.22912,-0.20515,1,0
6,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,3.0576e-06,-0.2292,-0.23133,1,0
6,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00079435,-0.23026,-0.1951,1,0
6,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,4.4878e-05,-0.23046,-0.21586,1,0
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,2.4346e-05,-0.23051,-0.19822,1,0
6,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0066042,-0.23067,-0.18563,1,0
6,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0001547,-0.2308,-0.28978,1,0
6,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.00012964,-0.23081,-0.27338,1,0
6,GO ACTIN FILAMENT BASED MOVEMENT,5.4121e-05,-0.23082,-0.23034,1,0
6,GO DETECTION OF OTHER ORGANISM,0.0060989,-0.23083,-0.30506,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0090226,-0.23107,-0.43982,1,0
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.00026903,-0.23128,-0.22406,1,0
6,GO LIPID STORAGE,4.6597e-05,-0.23132,-0.25635,1,0
6,GO GLUCOCORTICOID METABOLIC PROCESS,0.0041716,-0.23136,-0.21467,1,0
6,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0013457,-0.23145,-0.26237,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00010092,-0.23148,-0.25603,1,0
6,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.001872,-0.23149,-0.2427,1,0
6,GO BROWN FAT CELL DIFFERENTIATION,0.00021909,-0.2315,-0.23245,1,0
6,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00081984,-0.23174,-0.22729,1,0
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.017137,-0.232,-0.1657,1,0
6,GO BIOMINERALIZATION,9.0551e-05,-0.23201,-0.20483,1,0
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.026586,-0.23205,-0.15667,1,0
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.001872,-0.23213,-0.30935,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,7.0571e-06,-0.23223,-0.26069,1,0
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00019753,-0.23231,-0.22501,1,0
6,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.012203,-0.23237,-0.27172,1,0
6,GO ENTRY INTO HOST,1.4039e-05,-0.23242,-0.30371,1,0
6,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.03245,-0.23257,-0.21693,1,0
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.044685,-0.2327,-0.17713,1,0
6,GO FIBROBLAST PROLIFERATION,1.7118e-05,-0.23273,-0.28746,1,0
6,GO REGULATION OF GTP BINDING,0.011047,-0.2328,-0.22386,1,0
6,GO MAINTENANCE OF LOCATION IN CELL,2.5308e-05,-0.23282,-0.18379,1,0
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.03939,-0.23283,-0.25361,1,0
6,GO B CELL APOPTOTIC PROCESS,0.00052342,-0.23286,-0.24576,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.013798,-0.23301,-0.29351,1,0
6,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00047456,-0.23307,-0.24656,1,0
6,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010859,-0.23327,-0.24634,1,0
6,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00036427,-0.23346,-0.20034,1,0
6,GO PROGRAMMED NECROTIC CELL DEATH,0.00020448,-0.2335,-0.29366,1,0
6,GO STORE OPERATED CALCIUM ENTRY,0.0045306,-0.23395,-0.20838,1,0
6,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0030654,-0.23395,-0.28886,1,0
6,GO ZINC ION HOMEOSTASIS,0.0090226,-0.23429,-0.2509,1,0
6,GO EMBRYO IMPLANTATION,0.0053338,-0.23434,-0.20528,1,0
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.007729,-0.23452,-0.266,1,0
6,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00035231,-0.23454,-0.27439,1,0
6,GO SEQUESTERING OF CALCIUM ION,0.00029782,-0.23456,-0.19393,1,0
6,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0015189,-0.23475,-0.24649,1,0
6,GO AMEBOIDAL TYPE CELL MIGRATION,5.508e-06,-0.23505,-0.24002,1,0
6,GO PROTEIN HYDROXYLATION,0.00029782,-0.2351,-0.32448,1,0
6,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014935,-0.2352,-0.22004,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00016595,-0.23531,-0.22129,1,0
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0037331,-0.23557,-0.27353,1,0
6,GO GASTRULATION,3.1888e-05,-0.23559,-0.23906,1,0
6,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00011241,-0.23564,-0.24111,1,0
6,GO NEGATIVE REGULATION OF CELL KILLING,0.0047853,-0.23575,-0.42657,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.3218e-05,-0.23586,-0.33968,1,0
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0046564,-0.236,-0.2042,1,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00010092,-0.23612,-0.31688,1,0
6,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00014935,-0.23634,-0.21724,1,0
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00079435,-0.23638,-0.24011,1,0
6,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0023671,-0.23639,-0.22513,1,0
6,GO PROSTANOID METABOLIC PROCESS,0.0022332,-0.2365,-0.27706,1,0
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,4.4712e-06,-0.23651,-0.26992,1,0
6,GO RESPONSE TO CORTICOSTEROID,1.0779e-06,-0.2366,-0.27335,1,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.018836,-0.23661,-0.2633,1,0
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0037331,-0.23669,-0.21497,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0010528,-0.23697,-0.21612,1,0
6,GO POSITIVE REGULATION OF HEART GROWTH,0.00052342,-0.23727,-0.22156,1,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00012512,-0.23732,-0.26211,1,0
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.00044439,-0.23736,-0.23802,1,0
6,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00010462,-0.23766,-0.27908,1,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0015189,-0.23772,-0.21612,1,0
6,GO MUSCLE HYPERTROPHY,1.7118e-05,-0.238,-0.23452,1,0
6,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0083534,-0.23807,-0.35467,1,0
6,GO HYPOTONIC RESPONSE,0.00081984,-0.23814,-0.27196,1,0
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.001662,-0.23817,-0.2949,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00067758,-0.23835,-0.20818,1,0
6,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.7118e-05,-0.2384,-0.23711,1,0
6,GO SYNCYTIUM FORMATION,1.104e-05,-0.23847,-0.28377,1,0
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.00353,-0.23852,-0.19826,1,0
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.001228,-0.23857,-0.24467,1,0
6,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00035231,-0.23867,-0.23177,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.012508,-0.23886,-0.2972,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00037661,-0.2391,-0.26074,1,0
6,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00067758,-0.23927,-0.22827,1,0
6,GO CARDIAC CELL DEVELOPMENT,1.0184e-05,-0.23939,-0.2341,1,0
6,GO RETINOL METABOLIC PROCESS,0.0018173,-0.23967,-0.25473,1,0
6,GO REGULATION OF LIPID CATABOLIC PROCESS,3.7145e-05,-0.23972,-0.19894,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,6.2786e-05,-0.2398,-0.26259,1,0
6,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.001662,-0.23983,-0.21998,1,0
6,GO RESPONSE TO PAIN,0.0025817,-0.23985,-0.26432,1,0
6,GO RESPONSE TO INTERFERON ALPHA,0.026586,-0.23986,-0.39677,1,0
6,GO NECROTIC CELL DEATH,0.00022676,-0.2404,-0.28011,1,0
6,GO CAMP METABOLIC PROCESS,0.0062634,-0.24042,-0.18968,1,0
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.013139,-0.24076,-0.19978,1,0
6,GO MODULATION BY HOST OF VIRAL PROCESS,2.4692e-06,-0.24087,-0.29528,1,0
6,GO AMELOGENESIS,0.0040578,-0.241,-0.24898,1,0
6,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,5.8301e-05,-0.24103,-0.25224,1,0
6,GO BICARBONATE TRANSPORT,6.0504e-05,-0.24116,-0.23608,1,0
6,GO REGULATION OF LEUKOCYTE MIGRATION,2.9532e-05,-0.24133,-0.21493,1,0
6,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0099891,-0.2416,-0.49085,1,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00026903,-0.2416,-0.28096,1,0
6,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.02068,-0.2417,-0.25945,1,0
6,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.033166,-0.24188,-0.28658,1,0
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.010773,-0.24211,-0.20782,1,0
6,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.016734,-0.24216,-0.2543,1,0
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00017796,-0.24228,-0.21116,1,0
6,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00018427,-0.24231,-0.31855,1,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0083534,-0.24235,-0.21622,1,0
6,GO RESPONSE TO TESTOSTERONE,0.00069957,-0.24235,-0.221,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0022332,-0.24243,-0.30984,1,0
6,GO MITOTIC CELL CYCLE ARREST,0.0022332,-0.24254,-0.20492,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0017641,-0.2428,-0.38179,1,0
6,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.010773,-0.24284,-0.18761,1,0
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0025083,-0.24291,-0.32793,1,0
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00095906,-0.24311,-0.26722,1,0
6,GO GLUCOSE CATABOLIC PROCESS,0.0046564,-0.24312,-0.24186,1,0
6,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0021689,-0.24313,-0.23445,1,0
6,GO LIVER MORPHOGENESIS,0.0069616,-0.24327,-0.26234,1,0
6,GO CHOLESTEROL STORAGE,2.8418e-05,-0.24328,-0.31932,1,0
6,GO NEGATIVE REGULATION OF AUTOPHAGY,4.8612e-06,-0.24343,-0.23763,1,0
6,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00012512,-0.24378,-0.26341,1,0
6,GO T CELL MEDIATED IMMUNITY,8.7323e-05,-0.24383,-0.30345,1,0
6,GO POSITIVE REGULATION OF P38MAPK CASCADE,7.2754e-05,-0.24386,-0.27203,1,0
6,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00011241,-0.24386,-0.24455,1,0
6,GO POSITIVE REGULATION OF AUTOPHAGY,1.349e-05,-0.2441,-0.22395,1,0
6,GO ENDOTHELIAL CELL PROLIFERATION,5.2837e-06,-0.24419,-0.25593,1,0
6,GO CELL JUNCTION DISASSEMBLY,0.0027346,-0.24421,-0.21192,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0054795,-0.24432,-0.19932,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,5.8301e-05,-0.2445,-0.24589,1,0
6,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,1.8521e-05,-0.24473,-0.30672,1,0
6,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00036427,-0.24485,-0.24348,1,0
6,GO T CELL MIGRATION,1.0184e-05,-0.24498,-0.27105,1,0
6,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.017969,-0.24512,-0.24893,1,0
6,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0062634,-0.24549,-0.26705,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00045924,-0.24568,-0.18732,1,0
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0039469,-0.24573,-0.2877,1,0
6,GO CERAMIDE CATABOLIC PROCESS,0.00049035,-0.24627,-0.33905,1,0
6,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00059588,-0.24697,-0.18094,1,0
6,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00012512,-0.24715,-0.25383,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0029794,-0.24727,-0.25712,1,0
6,GO GLAND MORPHOGENESIS,0.00012964,-0.24765,-0.2878,1,0
6,GO CELL MATRIX ADHESION,6.5149e-05,-0.2477,-0.25467,1,0
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0047853,-0.24776,-0.22507,1,0
6,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0013457,-0.2479,-0.19839,1,0
6,GO STEROL TRANSPORT,3.6228e-06,-0.24792,-0.27122,1,0
6,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0094949,-0.24844,-0.211,1,0
6,GO OSTEOBLAST PROLIFERATION,0.0041716,-0.24851,-0.25381,1,0
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0015653,-0.24861,-0.30723,1,0
6,GO EXPORT ACROSS PLASMA MEMBRANE,0.0006154,-0.24876,-0.22884,1,0
6,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.1493e-05,-0.24897,-0.27236,1,0
6,GO REGULATION OF HEART RATE,0.0011549,-0.24923,-0.2136,1,0
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.011047,-0.24957,-0.23639,1,0
6,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,8.4205e-05,-0.24964,-0.30838,1,0
6,GO BODY FLUID SECRETION,5.0683e-06,-0.24967,-0.23324,1,0
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0019282,-0.2497,-0.23689,1,0
6,GO STRIATED MUSCLE ADAPTATION,1.2962e-05,-0.2497,-0.26391,1,0
6,GO REGULATION OF LIPID STORAGE,7.9801e-06,-0.24995,-0.28076,1,0
6,GO RESPONSE TO INCREASED OXYGEN LEVELS,4.0073e-05,-0.25006,-0.26897,1,0
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001986,-0.25034,-0.21843,1,0
6,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,9.0551e-05,-0.2504,-0.24861,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00044439,-0.25043,-0.28958,1,0
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0001547,-0.25054,-0.26407,1,0
6,GO SCHWANN CELL DEVELOPMENT,0.00010092,-0.25082,-0.21238,1,0
6,GO PLASMA MEMBRANE ORGANIZATION,7.8282e-05,-0.25082,-0.22358,1,0
6,GO FATTY ACYL COA METABOLIC PROCESS,0.00098941,-0.25086,-0.22049,1,0
6,GO LEUKOCYTE APOPTOTIC PROCESS,7.2754e-05,-0.25108,-0.23258,1,0
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0011549,-0.25135,-0.33014,1,0
6,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00057693,-0.25162,-0.23102,1,0
6,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0064317,-0.25174,-0.31662,1,0
6,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00037661,-0.25178,-0.30086,1,0
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0059384,-0.25185,-0.19728,1,0
6,GO POSITIVE REGULATION OF T CELL MIGRATION,7.889e-07,-0.25193,-0.27535,1,0
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0029794,-0.25214,-0.2745,1,0
6,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.050569,-0.25222,-0.2267,1,0
6,GO POSITIVE REGULATION OF PROTEIN BINDING,6.7728e-06,-0.25235,-0.22289,1,0
6,GO AMYLOID FIBRIL FORMATION,0.0049174,-0.25244,-0.25719,1,0
6,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0012662,-0.25264,-0.29896,1,0
6,GO NUCLEOTIDE SALVAGE,0.007729,-0.25275,-0.26586,1,0
6,GO POSITIVE REGULATION OF LIPID LOCALIZATION,4.8612e-06,-0.25287,-0.25184,1,0
6,GO REGULATION OF CHOLESTEROL EFFLUX,0.00021167,-0.25326,-0.20868,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,6.7596e-05,-0.25343,-0.26092,1,0
6,GO HORMONE BIOSYNTHETIC PROCESS,9.0551e-05,-0.25377,-0.2572,1,0
6,GO CELL SUBSTRATE ADHESION,1.6455e-05,-0.25397,-0.26342,1,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.015203,-0.25401,-0.18094,1,0
6,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.010773,-0.25436,-0.20782,1,0
6,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,7.013e-05,-0.25445,-0.25648,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00055855,-0.25448,-0.3539,1,0
6,GO VITAMIN D METABOLIC PROCESS,0.0015653,-0.25474,-0.25057,1,0
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,9.389e-05,-0.25491,-0.21574,1,0
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.037747,-0.25491,-0.1996,1,0
6,GO ADAPTATION OF SIGNALING PATHWAY,0.0087944,-0.25546,-0.19113,1,0
6,GO XENOBIOTIC TRANSPORT,3.4421e-05,-0.25567,-0.26406,1,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS,0.00012074,-0.2563,-0.27787,1,0
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00010092,-0.25633,-0.25607,1,0
6,GO VASCULAR TRANSPORT,0.011904,-0.25634,-0.29093,1,0
6,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0013872,-0.25649,-0.2624,1,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,4.0073e-05,-0.25693,-0.25472,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.5308e-05,-0.25709,-0.33931,1,0
6,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00028792,-0.25709,-0.21176,1,0
6,GO MINERALOCORTICOID METABOLIC PROCESS,0.02068,-0.2571,-0.26873,1,0
6,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.5149e-05,-0.25733,-0.22439,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,-0.25739,-0.21474,1,0
6,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.5759e-05,-0.25764,-0.28767,1,0
6,GO THIOESTER BIOSYNTHETIC PROCESS,9.7346e-05,-0.25797,-0.23956,1,0
6,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0016129,-0.25807,-0.24157,1,0
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.024846,-0.25819,-0.25678,1,0
6,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,7.2754e-05,-0.25839,-0.27848,1,0
6,GO AMINOGLYCAN METABOLIC PROCESS,1.0604e-05,-0.25855,-0.25142,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0034322,-0.25869,-0.24169,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0059384,-0.25886,-0.29498,1,0
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,7.3528e-06,-0.25898,-0.30759,1,0
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00092958,-0.25908,-0.24912,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0021689,-0.25937,-0.28711,1,0
6,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,3.7145e-05,-0.2595,-0.26241,1,0
6,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.010245,-0.25994,-0.19382,1,0
6,GO COLLAGEN CATABOLIC PROCESS,0.00019079,-0.26012,-0.28947,1,0
6,GO REGULATION OF CELLULAR RESPIRATION,0.00012512,-0.26012,-0.27151,1,0
6,GO REGULATION OF CELL MATRIX ADHESION,0.00065623,-0.26069,-0.2561,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0007696,-0.26072,-0.26339,1,0
6,GO ANIMAL ORGAN REGENERATION,1.1267e-06,-0.26074,-0.3067,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.019739,-0.2608,-0.26535,1,0
6,GO HEPATOCYTE DIFFERENTIATION,0.0069616,-0.26086,-0.28228,1,0
6,GO RESPONSE TO PEPTIDOGLYCAN,5.6174e-05,-0.26094,-0.30178,1,0
6,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.024846,-0.26099,-0.23309,1,0
6,GO CARBOHYDRATE CATABOLIC PROCESS,3.7791e-06,-0.26115,-0.21676,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0037331,-0.26144,-0.19633,1,0
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00034072,-0.26198,-0.30922,1,0
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00042998,-0.26317,-0.30914,1,0
6,GO RESPONSE TO MINERALOCORTICOID,2.0833e-05,-0.26334,-0.28987,1,0
6,GO LENS FIBER CELL DIFFERENTIATION,0.00029782,-0.26347,-0.25466,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00017796,-0.26355,-0.2815,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00010092,-0.26384,-0.28043,1,0
6,GO ENDODERM FORMATION,0.00038934,-0.26387,-0.31744,1,0
6,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,2.2658e-06,-0.26393,-0.26163,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0010859,-0.26405,-0.34424,1,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0020453,-0.26416,-0.37754,1,0
6,GO VAGINA DEVELOPMENT,0.029068,-0.26448,-0.19489,1,0
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00014418,-0.2646,-0.22734,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0015189,-0.26463,-0.25111,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.016734,-0.26465,-0.23157,1,0
6,GO CELLULAR RESPONSE TO COPPER ION,0.0057817,-0.26507,-0.38335,1,0
6,GO ACTIN FILAMENT NETWORK FORMATION,0.011047,-0.26513,-0.30535,1,0
6,GO EXTRACELLULAR STRUCTURE ORGANIZATION,1.5331e-06,-0.26514,-0.30809,1,0
6,GO RESPONSE TO TUMOR CELL,7.8282e-05,-0.26539,-0.33888,1,0
6,GO MUSCLE CELL FATE COMMITMENT,0.0011549,-0.26566,-0.27432,1,0
6,GO MICROVILLUS ASSEMBLY,0.0064317,-0.26571,-0.26286,1,0
6,GO FUCOSYLATION,0.0023671,-0.26578,-0.23283,1,0
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.00057693,-0.26604,-0.25019,1,0
6,GO RESPONSE TO ZINC ION,0.00098941,-0.26605,-0.26679,1,0
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.8521e-05,-0.26607,-0.26829,1,0
6,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0017641,-0.26638,-0.25609,1,0
6,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00057693,-0.26664,-0.29499,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,5.2139e-05,-0.26725,-0.25557,1,0
6,GO REGULATION OF MYOBLAST FUSION,0.0011549,-0.26729,-0.29998,1,0
6,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,1.1267e-06,-0.26741,-0.35701,1,0
6,GO REGULATION OF MICROVILLUS ORGANIZATION,0.011047,-0.26742,-0.2966,1,0
6,GO PROTEIN DEMANNOSYLATION,4.1617e-05,-0.26742,-0.32828,1,0
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,2.8418e-05,-0.26766,-0.28489,1,0
6,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,6.2786e-05,-0.26777,-0.29743,1,0
6,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,5.4121e-05,-0.26788,-0.32164,1,0
6,GO FORMATION OF PRIMARY GERM LAYER,3.5759e-05,-0.26828,-0.28567,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,2.9532e-05,-0.26845,-0.30788,1,0
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00026003,-0.26848,-0.26968,1,0
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00019753,-0.2686,-0.24609,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0056288,-0.2688,-0.21989,1,0
6,GO HEART VALVE FORMATION,0.04854,-0.26887,-0.23403,1,0
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00072223,-0.26909,-0.30007,1,0
6,GO PULMONARY VALVE MORPHOGENESIS,0.00069957,-0.26911,-0.46643,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0027346,-0.26914,-0.22114,1,0
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00069957,-0.26925,-0.35749,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,5.0683e-06,-0.26997,-0.34095,1,0
6,GO ENDOCRINE PROCESS,3.0689e-05,-0.27023,-0.23972,1,0
6,GO REGULATION OF COAGULATION,0.00017186,-0.27027,-0.2976,1,0
6,GO POLYSACCHARIDE CATABOLIC PROCESS,2.7343e-05,-0.27029,-0.25732,1,0
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,9.0551e-05,-0.27031,-0.29243,1,0
6,GO REGULATION OF PLATELET ACTIVATION,0.00017186,-0.27037,-0.32843,1,0
6,GO POSITIVE REGULATION OF WOUND HEALING,0.0010206,-0.27046,-0.26235,1,0
6,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00014418,-0.27049,-0.26692,1,0
6,GO MUSCLE FILAMENT SLIDING,0.00090094,-0.27055,-0.25609,1,0
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00026003,-0.27063,-0.30614,1,0
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.2862e-06,-0.27072,-0.38756,1,0
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00353,-0.27097,-0.26033,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,6.0504e-05,-0.27113,-0.29264,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00012074,-0.2712,-0.32458,1,0
6,GO TYPE 2 IMMUNE RESPONSE,0.00010845,-0.2713,-0.32905,1,0
6,GO RESPONSE TO TYPE I INTERFERON,0.0027346,-0.27144,-0.38104,1,0
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,2.0833e-05,-0.27153,-0.29358,1,0
6,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00050664,-0.27168,-0.35555,1,0
6,GO PURINE CONTAINING COMPOUND SALVAGE,0.017549,-0.27168,-0.20638,1,0
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00028792,-0.27259,-0.23329,1,0
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0001547,-0.27262,-0.25302,1,0
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.009256,-0.27262,-0.28633,1,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.010245,-0.27273,-0.27548,1,0
6,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0010859,-0.2729,-0.27555,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00012964,-0.27315,-0.30172,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.023205,-0.27316,-0.28487,1,0
6,GO SKELETAL MUSCLE TISSUE REGENERATION,3.7791e-06,-0.27317,-0.33444,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,2.2524e-05,-0.27322,-0.37592,1,0
6,GO REVERSE CHOLESTEROL TRANSPORT,0.00098941,-0.27325,-0.29313,1,0
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,2.5308e-05,-0.2733,-0.28383,1,0
6,GO MYOBLAST FUSION,1.7118e-05,-0.27356,-0.31403,1,0
6,GO RECEPTOR CATABOLIC PROCESS,7.547e-05,-0.27372,-0.26359,1,0
6,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.00030804,-0.27383,-0.25287,1,0
6,GO TISSUE REGENERATION,1.8521e-05,-0.2739,-0.28732,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,4.3218e-05,-0.27423,-0.29203,1,0
6,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0001547,-0.27425,-0.30215,1,0
6,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,6.5149e-05,-0.27427,-0.32994,1,0
6,GO REGULATION OF NECROTIC CELL DEATH,0.0007696,-0.27557,-0.29801,1,0
6,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.8418e-05,-0.27577,-0.2606,1,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00013433,-0.27582,-0.30032,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.010773,-0.27594,-0.21252,1,0
6,GO MYELIN ASSEMBLY,0.00028792,-0.27618,-0.27086,1,0
6,GO URETER DEVELOPMENT,0.00035231,-0.27666,-0.31989,1,0
6,GO MACROPHAGE CYTOKINE PRODUCTION,0.0010528,-0.27738,-0.3058,1,0
6,GO PHOSPHOLIPID EFFLUX,0.00041602,-0.27791,-0.30893,1,0
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00027832,-0.27822,-0.28586,1,0
6,GO MALE GENITALIA DEVELOPMENT,0.0027346,-0.27868,-0.19653,1,0
6,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.016339,-0.27931,-0.27414,1,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,7.8282e-05,-0.27943,-0.37816,1,0
6,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00044439,-0.28002,-0.3318,1,0
6,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00010462,-0.28006,-0.27975,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00049035,-0.28035,-0.37239,1,0
6,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00098941,-0.28045,-0.27832,1,0
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00035231,-0.28055,-0.27414,1,0
6,GO PODOSOME ASSEMBLY,0.001191,-0.28073,-0.26062,1,0
6,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,5.4121e-05,-0.28117,-0.27288,1,0
6,GO DETECTION OF BIOTIC STIMULUS,0.00016023,-0.28132,-0.32504,1,0
6,GO BLASTOCYST FORMATION,5.0683e-06,-0.28138,-0.24281,1,0
6,GO RELAXATION OF CARDIAC MUSCLE,0.017549,-0.28141,-0.23512,1,0
6,GO COPPER ION HOMEOSTASIS,0.0010206,-0.28214,-0.24891,1,0
6,GO RESPONSE TO GONADOTROPIN,4.3218e-05,-0.28276,-0.31222,1,0
6,GO GLYCOLIPID CATABOLIC PROCESS,0.00024286,-0.28288,-0.39905,1,0
6,GO PULMONARY VALVE DEVELOPMENT,0.00041602,-0.28338,-0.39642,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0036303,-0.28346,-0.26731,1,0
6,GO PLATELET DEGRANULATION,6.2985e-07,-0.28368,-0.33829,1,0
6,GO COLLAGEN METABOLIC PROCESS,0.00032948,-0.28377,-0.28609,1,0
6,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00021167,-0.28435,-0.43816,1,0
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00026003,-0.28451,-0.29829,1,0
6,GO PEPTIDE CROSS LINKING,1.104e-05,-0.28504,-0.3656,1,0
6,GO INACTIVATION OF MAPK ACTIVITY,0.009256,-0.28509,-0.24244,1,0
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00032948,-0.28519,-0.34506,1,0
6,GO CELL ADHESION MEDIATED BY INTEGRIN,3.3287e-06,-0.28523,-0.41482,1,0
6,GO RESPONSE TO INTERFERON GAMMA,2.2524e-05,-0.28567,-0.37245,1,0
6,GO THYMOCYTE APOPTOTIC PROCESS,0.0013872,-0.28568,-0.29386,1,0
6,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0030654,-0.28577,-0.31114,1,0
6,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00038934,-0.28623,-0.32463,1,0
6,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.031059,-0.28641,-0.27935,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.1964e-05,-0.28702,-0.28668,1,0
6,GO SEMI LUNAR VALVE DEVELOPMENT,2.0033e-05,-0.28707,-0.35342,1,0
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0022992,-0.28709,-0.23661,1,0
6,GO RESPONSE TO INTERLEUKIN 15,1.1493e-05,-0.2873,-0.36954,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.025994,-0.28736,-0.25862,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00092958,-0.28741,-0.28695,1,0
6,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.040234,-0.28745,-0.36127,1,0
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.011047,-0.28753,-0.22933,1,0
6,GO NEURON REMODELING,0.0036303,-0.28832,-0.30051,1,0
6,GO ARACHIDONIC ACID METABOLIC PROCESS,8.7323e-05,-0.28849,-0.28336,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00025131,-0.28858,-0.32727,1,0
6,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001986,-0.28874,-0.2533,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.00031859,-0.28882,-0.35211,1,0
6,GO INTERLEUKIN 5 PRODUCTION,0.043763,-0.28899,-0.20518,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00020448,-0.28904,-0.3632,1,0
6,GO REGULATION OF MACROPHAGE DIFFERENTIATION,4.6623e-06,-0.2893,-0.42203,1,0
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0025083,-0.28932,-0.25801,1,0
6,GO AORTIC VALVE DEVELOPMENT,7.0571e-06,-0.28932,-0.37088,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.019739,-0.28939,-0.31772,1,0
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,2.1702e-06,-0.28965,-0.33468,1,0
6,GO GAP JUNCTION ASSEMBLY,0.0010206,-0.2897,-0.33463,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0054795,-0.28982,-0.29333,1,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00026003,-0.28991,-0.3163,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.0033e-05,-0.28997,-0.35436,1,0
6,GO REGULATION OF FATTY ACID OXIDATION,3.0689e-05,-0.29,-0.27711,1,0
6,GO VASCULOGENESIS,4.4878e-05,-0.29005,-0.34001,1,0
6,GO REGULATION OF RESPONSE TO WOUNDING,0.00017796,-0.29009,-0.23921,1,0
6,GO EXOCRINE SYSTEM DEVELOPMENT,0.00090094,-0.29031,-0.28167,1,0
6,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00016595,-0.29037,-0.34558,1,0
6,GO KERATAN SULFATE CATABOLIC PROCESS,2.2524e-05,-0.29062,-0.35224,1,0
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,2.0833e-05,-0.29141,-0.39381,1,0
6,GO NEGATIVE REGULATION OF ANOIKIS,0.03245,-0.29182,-0.26382,1,0
6,GO PLATELET AGGREGATION,3.5759e-05,-0.29201,-0.29117,1,0
6,GO RESPONSE TO STEROL DEPLETION,0.00057693,-0.29208,-0.28454,1,0
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0001547,-0.29306,-0.34439,1,0
6,GO RESPONSE TO MAGNESIUM ION,0.0053338,-0.29307,-0.27767,1,0
6,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00019753,-0.29313,-0.24545,1,0
6,GO REGULATION OF GLOMERULAR FILTRATION,0.030383,-0.29378,-0.30016,1,0
6,GO AMYLOID BETA FORMATION,0.00031859,-0.29391,-0.26987,1,0
6,GO MITOCHONDRIAL TRANSCRIPTION,0.00063551,-0.29391,-0.29709,1,0
6,GO GLOMERULUS DEVELOPMENT,0.00016595,-0.29402,-0.28866,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0054795,-0.2944,-0.34181,1,0
6,GO RENAL ABSORPTION,0.0097392,-0.2944,-0.32911,1,0
6,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0060989,-0.29447,-0.26525,1,0
6,GO GLUTATHIONE METABOLIC PROCESS,0.00035231,-0.29466,-0.3275,1,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0029794,-0.29487,-0.27969,1,0
6,GO ACUTE INFLAMMATORY RESPONSE,1.906e-06,-0.29504,-0.3375,1,0
6,GO BEHAVIORAL RESPONSE TO PAIN,0.00019753,-0.29517,-0.37444,1,0
6,GO PROTEIN DEGLYCOSYLATION,1.2454e-05,-0.29558,-0.35118,1,0
6,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0049174,-0.29569,-0.33615,1,0
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0021689,-0.29629,-0.23514,1,0
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,3.0576e-06,-0.29636,-0.33307,1,0
6,GO VITAMIN D BIOSYNTHETIC PROCESS,0.013465,-0.29686,-0.27865,1,0
6,GO POSITIVE REGULATION OF HAIR CYCLE,0.00031859,-0.29713,-0.37092,1,0
6,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00353,-0.29752,-0.2739,1,0
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,9.7346e-05,-0.29754,-0.27552,1,0
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00010462,-0.29763,-0.25135,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00092958,-0.29824,-0.30031,1,0
6,GO REGULATION OF B CELL APOPTOTIC PROCESS,1.104e-05,-0.29847,-0.33934,1,0
6,GO ZYMOGEN INHIBITION,0.0054795,-0.2986,-0.28325,1,0
6,GO MICROVILLUS ORGANIZATION,0.011326,-0.29863,-0.24606,1,0
6,GO RESPONSE TO THYROID HORMONE,0.00063551,-0.29865,-0.30859,1,0
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00026903,-0.29866,-0.2894,1,0
6,GO MUSCLE ATROPHY,0.0075304,-0.2987,-0.23236,1,0
6,GO PSEUDOPODIUM ORGANIZATION,0.017969,-0.29932,-0.28546,1,0
6,GO KERATINOCYTE MIGRATION,0.00017796,-0.2995,-0.25597,1,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00024286,-0.29973,-0.33227,1,0
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,8.2505e-07,-0.29974,-0.30796,1,0
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00013917,-0.29975,-0.28447,1,0
6,GO REGULATION OF CELLULAR EXTRAVASATION,0.00047456,-0.29993,-0.27663,1,0
6,GO OVULATION,0.011047,-0.29996,-0.23252,1,0
6,GO RESPONSE TO GROWTH HORMONE,0.00016023,-0.30002,-0.29581,1,0
6,GO CELLULAR RESPONSE TO SALT STRESS,0.00353,-0.30009,-0.27672,1,0
6,GO AMINOGLYCAN CATABOLIC PROCESS,0.00031859,-0.3003,-0.30957,1,0
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0015189,-0.30053,-0.32059,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0020453,-0.30091,-0.26731,1,0
6,GO MEMBRANE LIPID CATABOLIC PROCESS,4.8379e-05,-0.30112,-0.32305,1,0
6,GO RESPONSE TO CORTICOSTERONE,5.8301e-05,-0.3013,-0.33618,1,0
6,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.001872,-0.30194,-0.36306,1,0
6,GO REGULATION OF KERATINOCYTE MIGRATION,0.00055855,-0.30237,-0.24105,1,0
6,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0007696,-0.30247,-0.38158,1,0
6,GO SKIN MORPHOGENESIS,0.0049174,-0.30263,-0.33505,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,1.8521e-05,-0.30263,-0.26702,1,0
6,GO FATTY ACID HOMEOSTASIS,0.00030804,-0.30282,-0.34472,1,0
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0006154,-0.30288,-0.29409,1,0
6,GO AMP METABOLIC PROCESS,0.0011199,-0.30321,-0.28704,1,0
6,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.0833e-05,-0.30341,-0.34,1,0
6,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0018173,-0.30376,-0.33397,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.2367e-06,-0.30439,-0.35934,1,0
6,GO ACTIN FILAMENT SEVERING,0.012508,-0.30468,-0.27892,1,0
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0064317,-0.30485,-0.22737,1,0
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0022992,-0.30493,-0.35362,1,0
6,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0042883,-0.30505,-0.25985,1,0
6,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.011904,-0.30507,-0.2867,1,0
6,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,6.5149e-05,-0.30604,-0.46185,1,0
6,GO NEPHRIC DUCT DEVELOPMENT,0.0021689,-0.30651,-0.28328,1,0
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,3.3132e-05,-0.3069,-0.43082,1,0
6,GO CELLULAR COPPER ION HOMEOSTASIS,0.00087311,-0.30728,-0.28602,1,0
6,GO LIPID IMPORT INTO CELL,3.7145e-05,-0.30747,-0.29972,1,0
6,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,1.0184e-05,-0.30794,-0.28561,1,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.018836,-0.30859,-0.244,1,0
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.7806e-05,-0.30862,-0.37151,1,0
6,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00069957,-0.30867,-0.26835,1,0
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.036948,-0.31038,-0.21814,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.001986,-0.3107,-0.24934,1,0
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,6.0198e-07,-0.31075,-0.3239,1,0
6,GO SNARE COMPLEX ASSEMBLY,0.0036303,-0.31078,-0.23217,1,0
6,GO ACTIN MEDIATED CELL CONTRACTION,2.1663e-05,-0.31093,-0.27372,1,0
6,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00017796,-0.31131,-0.31173,1,0
6,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,9.7346e-05,-0.31152,-0.28137,1,0
6,GO RESPONSE TO CAFFEINE,0.0017123,-0.31157,-0.24669,1,0
6,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00010462,-0.31208,-0.36828,1,0
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0017641,-0.31213,-0.30643,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,8.4205e-05,-0.31225,-0.40038,1,0
6,GO REGULATION OF RESPIRATORY BURST,0.014486,-0.31256,-0.21956,1,0
6,GO TISSUE MIGRATION,3.3287e-06,-0.31262,-0.29144,1,0
6,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.00038934,-0.31365,-0.3159,1,0
6,GO OLIGOPEPTIDE TRANSPORT,0.0016129,-0.31391,-0.34556,1,0
6,GO GENITALIA MORPHOGENESIS,0.0015653,-0.31426,-0.30899,1,0
6,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.00069957,-0.31468,-0.29587,1,0
6,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0056288,-0.31499,-0.26002,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00031859,-0.31556,-0.401,1,0
6,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.025414,-0.31577,-0.28565,1,0
6,GO GAS TRANSPORT,0.0053338,-0.31617,-0.32134,1,0
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00025131,-0.31644,-0.33384,1,0
6,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00072223,-0.31667,-0.32649,1,0
6,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00038934,-0.31728,-0.37207,1,0
6,GO MONONUCLEAR CELL MIGRATION,0.00020448,-0.31802,-0.2555,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0015653,-0.31819,-0.38009,1,0
6,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00092958,-0.31829,-0.28284,1,0
6,GO FUCOSE METABOLIC PROCESS,0.001191,-0.3187,-0.26758,1,0
6,GO IMMUNE RESPONSE TO TUMOR CELL,0.00047456,-0.3188,-0.38228,1,0
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.0833e-05,-0.31888,-0.32066,1,0
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,9.389e-05,-0.31959,-0.35648,1,0
6,GO HYPEROSMOTIC RESPONSE,0.0010528,-0.32025,-0.23948,1,0
6,GO REGULATION OF WATER LOSS VIA SKIN,0.0079323,-0.32054,-0.28807,1,0
6,GO SECRETION BY TISSUE,9.0551e-05,-0.32073,-0.29551,1,0
6,GO NEGATIVE REGULATION OF WOUND HEALING,7.0571e-06,-0.32105,-0.3406,1,0
6,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0054795,-0.32162,-0.2806,1,0
6,GO NEGATIVE REGULATION OF BONE REMODELING,0.02068,-0.32177,-0.25057,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00040247,-0.32211,-0.34459,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.0033e-05,-0.32269,-0.3524,1,0
6,GO ENDOTHELIAL CELL MIGRATION,1.8251e-06,-0.32332,-0.31005,1,0
6,GO MACROPHAGE PROLIFERATION,0.0099891,-0.32404,-0.30053,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00017796,-0.3242,-0.32137,1,0
6,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0025083,-0.32424,-0.33835,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.2524e-05,-0.32482,-0.38166,1,0
6,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00027832,-0.32496,-0.33923,1,0
6,GO CORTICOSTEROID HORMONE SECRETION,0.00018427,-0.32585,-0.34576,1,0
6,GO HEMIDESMOSOME ASSEMBLY,0.012508,-0.32605,-0.40932,1,0
6,GO GTP METABOLIC PROCESS,0.0011549,-0.32665,-0.27099,1,0
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,8.2505e-07,-0.32743,-0.34496,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00012964,-0.32781,-0.38396,1,0
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,9.8628e-07,-0.32842,-0.35483,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.02068,-0.32909,-0.23199,1,0
6,GO RESPONSE TO COPPER ION,0.00074557,-0.32964,-0.36963,1,0
6,GO KERATAN SULFATE METABOLIC PROCESS,2.5122e-07,-0.33013,-0.3779,1,0
6,GO CELLULAR RESPONSE TO OSMOTIC STRESS,4.4712e-06,-0.33032,-0.33279,1,0
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.016734,-0.33061,-0.28665,1,0
6,GO AMYLOID BETA METABOLIC PROCESS,0.00030804,-0.33094,-0.24671,1,0
6,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00025131,-0.33109,-0.38541,1,0
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0017641,-0.3312,-0.35064,1,0
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00026903,-0.33187,-0.37722,1,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0010206,-0.3321,-0.3227,1,0
6,GO PLASMINOGEN ACTIVATION,0.00017186,-0.33275,-0.38463,1,0
6,GO MATURE B CELL DIFFERENTIATION,0.00098941,-0.33375,-0.31192,1,0
6,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00084609,-0.33401,-0.30839,1,0
6,GO REGULATION OF PODOSOME ASSEMBLY,0.0046564,-0.33407,-0.27905,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.7596e-05,-0.33519,-0.28003,1,0
6,GO T CELL MEDIATED CYTOTOXICITY,8.1192e-05,-0.3361,-0.46972,1,0
6,GO REGULATION OF WOUND HEALING,6.7596e-05,-0.33708,-0.28865,1,0
6,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00047456,-0.3372,-0.31651,1,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.00013917,-0.33768,-0.26263,1,0
6,GO SALIVARY GLAND DEVELOPMENT,0.0015189,-0.33926,-0.28621,1,0
6,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014299,-0.33936,-0.38048,1,0
6,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00027832,-0.33983,-0.31743,1,0
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00040247,-0.33998,-0.32782,1,0
6,GO GERMINAL CENTER FORMATION,2.5308e-05,-0.34042,-0.46166,1,0
6,GO RESPONSE TO MUSCLE STRETCH,0.00023468,-0.34106,-0.35972,1,0
6,GO LENS FIBER CELL DEVELOPMENT,9.7346e-05,-0.34114,-0.36779,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.4674e-06,-0.34121,-0.39224,1,0
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00092958,-0.34172,-0.37199,1,0
6,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00016023,-0.34185,-0.29876,1,0
6,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00034072,-0.34201,-0.34213,1,0
6,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00042998,-0.34304,-0.33143,1,0
6,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0057817,-0.3436,-0.2668,1,0
6,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0017641,-0.34361,-0.35428,1,0
6,GO STEROID ESTERIFICATION,2.9532e-05,-0.34377,-0.40361,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0006154,-0.34379,-0.27759,1,0
6,GO GLYCOPROTEIN CATABOLIC PROCESS,0.00072223,-0.34398,-0.42204,1,0
6,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.001662,-0.34439,-0.31636,1,0
6,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00044439,-0.34461,-0.40905,1,0
6,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0031536,-0.34496,-0.33405,1,0
6,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.023741,-0.34506,-0.21654,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,9.8628e-07,-0.3453,-0.36554,1,0
6,GO RESPONSE TO INTERFERON BETA,0.0041716,-0.3454,-0.43027,1,0
6,GO INTERLEUKIN 13 PRODUCTION,0.0025083,-0.34582,-0.29283,1,0
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.001986,-0.34593,-0.31438,1,0
6,GO MYELIN MAINTENANCE,0.00090094,-0.34684,-0.34332,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0038387,-0.34727,-0.25394,1,0
6,GO VASODILATION,0.0024367,-0.34782,-0.28206,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00054072,-0.34837,-0.35786,1,0
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.00092958,-0.34939,-0.30985,1,0
6,GO MAMMARY GLAND MORPHOGENESIS,9.389e-05,-0.3499,-0.3188,1,0
6,GO RESPONSE TO HYPEROXIA,5.508e-06,-0.35019,-0.3925,1,0
6,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.0571e-06,-0.35095,-0.34396,1,0
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.00034072,-0.35104,-0.41887,1,0
6,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0066042,-0.35115,-0.29053,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0028141,-0.35157,-0.31371,1,0
6,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00030804,-0.35163,-0.34565,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0021689,-0.35212,-0.38007,1,0
6,GO ENAMEL MINERALIZATION,0.0062634,-0.35232,-0.2991,1,0
6,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00021909,-0.35292,-0.27458,1,0
6,GO MONOCYTE CHEMOTAXIS,0.00030804,-0.3531,-0.2841,1,0
6,GO REGULATION OF AMYLOID BETA FORMATION,0.00029782,-0.35597,-0.31081,1,0
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0059384,-0.35614,-0.25031,1,0
6,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,1.8521e-05,-0.35621,-0.36834,1,0
6,GO ENDOTHELIAL CELL CHEMOTAXIS,9.0551e-05,-0.35627,-0.34905,1,0
6,GO HOMOTYPIC CELL CELL ADHESION,4.8379e-05,-0.35654,-0.31511,1,0
6,GO EPIBOLY,2.5308e-05,-0.3575,-0.39632,1,0
6,GO NEGATIVE REGULATION OF COAGULATION,2.0033e-05,-0.35807,-0.38714,1,0
6,GO POSITIVE REGULATION OF ACTION POTENTIAL,2.2524e-05,-0.35889,-0.38687,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00044439,-0.35891,-0.41002,1,0
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0018173,-0.35918,-0.38549,1,0
6,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00098941,-0.36025,-0.37841,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,2.4346e-05,-0.36109,-0.33257,1,0
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00014418,-0.36138,-0.49149,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00057693,-0.3625,-0.40336,1,0
6,GO MEMBRANE RAFT ORGANIZATION,0.00019753,-0.36318,-0.49873,1,0
6,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.1663e-05,-0.36387,-0.38794,1,0
6,GO ARGININE METABOLIC PROCESS,0.0028957,-0.36415,-0.30813,1,0
6,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0079323,-0.36425,-0.32292,1,0
6,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,2.0033e-05,-0.36428,-0.39494,1,0
6,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.001191,-0.36457,-0.31739,1,0
6,GO EXTRACELLULAR MATRIX DISASSEMBLY,5.0683e-06,-0.36486,-0.35995,1,0
6,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0021062,-0.36648,-0.42368,1,0
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0013054,-0.36667,-0.38458,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012512,-0.36706,-0.35858,1,0
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00047456,-0.36959,-0.33176,1,0
6,GO CYSTEINE METABOLIC PROCESS,0.0030654,-0.37011,-0.36057,1,0
6,GO MULTI ORGANISM CELLULAR PROCESS,0.00010845,-0.37013,-0.41963,1,0
6,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00012074,-0.37109,-0.40491,1,0
6,GO BASEMENT MEMBRANE ORGANIZATION,0.00018427,-0.37128,-0.38972,1,0
6,GO T CELL EXTRAVASATION,0.00040247,-0.37133,-0.41731,1,0
6,GO ZYMOGEN ACTIVATION,2.0033e-05,-0.37143,-0.4134,1,0
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.1663e-05,-0.37213,-0.41155,1,0
6,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,4.1617e-05,-0.37377,-0.3614,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0066042,-0.37438,-0.29505,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0010859,-0.37489,-0.44447,1,0
6,GO NEUTROPHIL HOMEOSTASIS,0.00050664,-0.37499,-0.39089,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.2308e-06,-0.37504,-0.35062,1,0
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0036303,-0.37539,-0.34842,1,0
6,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,4.0073e-05,-0.37616,-0.4141,1,0
6,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,5.9841e-06,-0.3769,-0.39159,1,0
6,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0013457,-0.3771,-0.47965,1,0
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0021689,-0.37875,-0.31693,1,0
6,GO REGULATION OF TOLERANCE INDUCTION,0.0011549,-0.3789,-0.37446,1,0
6,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0013054,-0.37897,-0.28183,1,0
6,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.8379e-05,-0.3798,-0.3326,1,0
6,GO VASCULAR WOUND HEALING,0.0031536,-0.38183,-0.29188,1,0
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00045924,-0.38381,-0.38792,1,0
6,GO DISACCHARIDE METABOLIC PROCESS,4.1617e-05,-0.38505,-0.34521,1,0
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0021689,-0.38571,-0.3152,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,4.1617e-05,-0.38574,-0.38042,1,0
6,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00011241,-0.38749,-0.43354,1,0
6,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00017186,-0.38873,-0.36474,1,0
6,GO EPOXYGENASE P450 PATHWAY,0.00040247,-0.38878,-0.33747,1,0
6,GO T HELPER 2 CELL DIFFERENTIATION,0.00028792,-0.38919,-0.4547,1,0
6,GO POSITIVE REGULATION OF HEART RATE,0.00013433,-0.39038,-0.36869,1,0
6,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0013872,-0.39118,-0.41968,1,0
6,GO CELLULAR RESPONSE TO ETHANOL,0.00012964,-0.39147,-0.33198,1,0
6,GO EOSINOPHIL MIGRATION,0.00027832,-0.39178,-0.40659,1,0
6,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0020453,-0.39259,-0.33803,1,0
6,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00021909,-0.39279,-0.41853,1,0
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00055855,-0.39725,-0.47308,1,0
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.001191,-0.39799,-0.3619,1,0
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,2.6902e-06,-0.3984,-0.3728,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00035231,-0.39841,-0.39213,1,0
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.3132e-05,-0.39872,-0.50859,1,0
6,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00028792,-0.39895,-0.44916,1,0
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,8.6584e-06,-0.39964,-0.43512,1,0
6,GO MACROPHAGE APOPTOTIC PROCESS,0.00021909,-0.39972,-0.32511,1,0
6,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,3.9926e-07,-0.40183,-0.51832,1,0
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0024367,-0.40334,-0.38788,1,0
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.6455e-05,-0.40362,-0.43882,1,0
6,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0025083,-0.40378,-0.34314,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0034322,-0.40552,-0.31751,1,0
6,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,9.8628e-07,-0.40582,-0.40416,1,0
6,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0028141,-0.40627,-0.41306,1,0
6,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.2454e-05,-0.40721,-0.49766,1,0
6,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00041602,-0.40737,-0.3961,1,0
6,GO HEPARIN METABOLIC PROCESS,0.00037661,-0.40901,-0.39043,1,0
6,GO HEART TRABECULA FORMATION,0.00038934,-0.40962,-0.37573,1,0
6,GO INFLAMMATORY RESPONSE TO WOUNDING,0.049546,-0.41209,-0.30342,1,0
6,GO STEROL IMPORT,3.1888e-05,-0.41233,-0.37675,1,0
6,GO BIOLOGICAL PHASE,0.0017641,-0.41335,-0.45491,1,0
6,GO L PHENYLALANINE METABOLIC PROCESS,0.0019282,-0.41547,-0.33299,1,0
6,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0013457,-0.41719,-0.3715,1,0
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00020448,-0.41806,-0.44962,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0024367,-0.41807,-0.32235,1,0
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,2.1702e-06,-0.41929,-0.43947,1,0
6,GO NOTOCHORD DEVELOPMENT,4.8612e-06,-0.41955,-0.45878,1,0
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,2.0033e-05,-0.42346,-0.44322,1,0
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00034072,-0.42631,-0.41254,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,5.6174e-05,-0.42721,-0.47923,1,0
6,GO PEPTIDYL PROLINE HYDROXYLATION,5.2139e-05,-0.43008,-0.45504,1,0
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0007696,-0.43066,-0.44739,1,0
6,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00081984,-0.43088,-0.54367,1,0
6,GO SEQUESTERING OF TRIGLYCERIDE,0.00059588,-0.43142,-0.40984,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00028792,-0.43311,-0.32569,1,0
6,GO EOSINOPHIL CHEMOTAXIS,0.00036427,-0.43386,-0.43596,1,0
6,GO CYCLOOXYGENASE PATHWAY,0.00016595,-0.43573,-0.53243,1,0
6,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.7118e-05,-0.43619,-0.53913,1,0
6,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,1.8521e-05,-0.43753,-0.40224,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00049035,-0.44006,-0.57727,1,0
6,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00016023,-0.44091,-0.46,1,0
6,GO RESPONSE TO INTERLEUKIN 18,0.00081984,-0.44471,-0.47724,1,0
6,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.5774e-06,-0.44477,-0.55266,1,0
6,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0016129,-0.44629,-0.33925,1,0
6,GO MONONUCLEAR CELL DIFFERENTIATION,1.5816e-05,-0.44978,-0.43456,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.8379e-05,-0.44997,-0.39575,1,0
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0051916,-0.45183,-0.40151,1,0
6,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.011904,-0.4526,-0.34869,1,0
6,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00074557,-0.45271,-0.43085,1,0
6,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,2.6307e-05,-0.45341,-0.50797,1,0
6,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00074557,-0.45421,-0.44774,1,0
6,GO DENDRITIC CELL APOPTOTIC PROCESS,7.0571e-06,-0.45706,-0.48347,1,0
6,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00081984,-0.45778,-0.42955,1,0
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00087311,-0.46747,-0.47469,1,0
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00044439,-0.46871,-0.39078,1,0
6,GO PLASMA MEMBRANE FUSION,3.17e-07,-0.46924,-0.46427,1,0
6,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,1.4674e-06,-0.47157,-0.50773,1,0
6,GO OXYGEN TRANSPORT,0.011326,-0.47959,-0.39566,1,0
6,GO POSITIVE REGULATION OF LIPID STORAGE,3.0689e-05,-0.4834,-0.37925,1,0
6,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.00047456,-0.49094,-0.48127,1,0
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0010528,-0.49348,-0.42155,1,0
6,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,2.9532e-05,-0.49518,-0.55813,1,0
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,4.2876e-06,-0.49908,-0.54488,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0059384,-0.50134,-0.65713,1,0
6,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0020453,-0.5059,-0.42353,1,0
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.4421e-05,-0.50639,-0.4576,1,0
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0075304,-0.50739,-0.56036,1,0
6,GO HISTAMINE TRANSPORT,1.906e-06,-0.50771,-0.551,1,0
6,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,2.7343e-05,-0.50868,-0.56281,1,0
6,GO ADHESION OF SYMBIONT TO HOST,9.3916e-06,-0.51177,-0.46345,1,0
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00079435,-0.51258,-0.39984,1,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,7.3528e-06,-0.51426,-0.56338,1,0
6,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00010092,-0.5252,-0.46855,1,0
6,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0028957,-0.52683,-0.48104,1,0
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00013433,-0.53686,-0.4446,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.2876e-06,-0.53756,-0.47052,1,0
6,GO GALACTOSE METABOLIC PROCESS,4.3763e-07,-0.53972,-0.56605,1,0
6,GO CYTIDINE TO URIDINE EDITING,0.017549,-0.55066,-0.40152,1,0
6,GO TOLERANCE INDUCTION,7.547e-05,-0.55613,-0.51989,1,0
6,GO MONOACYLGLYCEROL METABOLIC PROCESS,1.6729e-06,-0.55895,-0.50262,1,0
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,2.1663e-05,-0.56005,-0.52938,1,0
6,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00032948,-0.56833,-0.39756,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0090226,-0.58398,-0.797,1,0
6,GO HISTAMINE SECRETION,4.2876e-06,-0.58455,-0.56259,1,0
6,GO REGULATION OF VASCULOGENESIS,1.349e-05,-0.587,-0.55466,1,0
6,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00067758,-0.61537,-0.49732,1,0
6,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,9.0551e-05,-0.61875,-0.49239,1,0
6,GO MUCUS SECRETION,6.2786e-05,-0.67923,-0.64081,1,0
6,GO BLEB ASSEMBLY,0.00014935,-0.70029,-0.6612,1,0
6,GO MEMBRANE RAFT ASSEMBLY,0.00069957,-0.73571,-0.73201,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,7.013e-05,-0.73708,-0.60158,1,0
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.084046,0.26098,0.18877,0,1
6,GO NEPHRON TUBULE FORMATION,0.14526,0.22988,0.12276,0,1
6,GO MEGAKARYOCYTE DEVELOPMENT,0.057089,0.18923,0.18054,0,1
6,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.14526,0.18828,0.18375,0,1
6,GO TONGUE DEVELOPMENT,0.2839,0.15527,0.085684,0,1
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.39858,0.15504,0.049817,0,1
6,GO REGULATION OF CENTRIOLE REPLICATION,0.063042,0.14852,0.085934,0,1
6,GO COPULATION,0.073629,0.14744,0.12295,0,1
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.057089,0.14586,0.13508,0,1
6,GO DNA DOUBLE STRAND BREAK PROCESSING,0.064293,0.14086,0.083578,0,1
6,GO MITOTIC RECOMBINATION,0.084046,0.13937,0.0937,0,1
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.14526,0.13779,0.087226,0,1
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.47049,0.13272,0.056594,0,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.14285,0.13213,0.089593,0,1
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.15517,0.13076,0.081013,0,1
6,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.085627,0.12751,0.093472,0,1
6,GO RESPONSE TO FOOD,0.053746,0.12709,0.094063,0,1
6,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.12473,0.12512,0.069391,0,1
6,GO REGULATION OF HISTONE H4 ACETYLATION,0.11235,0.12075,0.10026,0,1
6,GO HISTONE H3 K4 TRIMETHYLATION,0.05824,0.11634,0.091832,0,1
6,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.14769,0.1095,0.098336,0,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.12908,0.10646,0.054204,0,1
6,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.31232,0.10381,0.082067,0,1
6,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.13814,0.10125,0.06268,0,1
6,GO SPERMATID NUCLEUS DIFFERENTIATION,0.084046,0.10115,0.086301,0,1
6,GO HIPPOCAMPUS DEVELOPMENT,0.16828,0.09844,0.062705,0,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.13583,0.098061,0.073458,0,1
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.060602,0.095898,0.078187,0,1
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.10654,0.090911,0.051812,0,1
6,GO MICROTUBULE NUCLEATION,0.22905,0.087783,0.05598,0,1
6,GO HISTONE H2A UBIQUITINATION,0.054842,0.08383,0.099466,0,1
6,GO MITOCHONDRION MORPHOGENESIS,0.1313,0.080651,0.07051,0,1
6,GO REGULATION OF PROTEIN ACETYLATION,0.1028,0.078311,0.050332,0,1
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.89907,0.07499,0.012868,0,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.19095,0.072299,0.055422,0,1
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.56666,0.070728,0.033345,0,1
6,GO HISTONE UBIQUITINATION,0.0695,0.068938,0.061904,0,1
6,GO PEPTIDYL LYSINE TRIMETHYLATION,0.11434,0.068376,0.054247,0,1
6,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.10096,0.067528,0.066442,0,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.10096,0.067324,0.042144,0,1
6,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.38888,0.066638,0.037079,0,1
6,GO REGULATION OF SPINDLE ORGANIZATION,0.21579,0.065517,0.047245,0,1
6,GO MICROTUBULE BASED MOVEMENT,0.17653,0.063332,0.044672,0,1
6,GO LIMBIC SYSTEM DEVELOPMENT,0.5726,0.062538,0.024185,0,1
6,GO DOSAGE COMPENSATION,0.073629,0.061287,0.073101,0,1
6,GO REGULATION OF DNA REPAIR,0.055956,0.060867,0.052486,0,1
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.20621,0.060785,0.055758,0,1
6,GO MICROTUBULE BASED PROCESS,0.21905,0.057211,0.030908,0,1
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.072231,0.05041,0.062042,0,1
6,GO MRNA TRANSPORT,0.17653,0.049076,0.034369,0,1
6,GO DNA REPLICATION,0.068167,0.047115,0.03369,0,1
6,GO SPINDLE ORGANIZATION,0.18219,0.044539,0.034288,0,1
6,GO HISTONE METHYLATION,0.17653,0.042373,0.038169,0,1
6,GO PROTEIN METHYLATION,0.11636,0.037398,0.037672,0,1
6,GO CHROMATIN ORGANIZATION,0.060602,0.027985,0.040122,0,1
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25729,0.023652,0.026869,0,1
6,GO TRIGEMINAL NERVE DEVELOPMENT,0.0073363,0.52309,0.32229,0,0
6,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.066855,0.41261,0.31458,0,0
6,GO NEURON FATE SPECIFICATION,0.015953,0.35521,0.36052,0,0
6,GO NEURON FATE COMMITMENT,0.00022676,0.35285,0.37296,0,0
6,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10654,0.34252,0.30098,0,0
6,GO CARDIOBLAST PROLIFERATION,0.11039,0.33743,0.18214,0,0
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0038387,0.30899,0.38692,0,0
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0049174,0.29476,0.31666,0,0
6,GO POSITIVE REGULATION OF BEHAVIOR,0.0037331,0.2886,0.22725,0,0
6,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.007729,0.28644,0.32577,0,0
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.023741,0.285,0.31507,0,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.085627,0.26792,0.26521,0,0
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.027803,0.26107,0.3423,0,0
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.059411,0.24932,0.20047,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.010506,0.24867,0.25896,0,0
6,GO ADENOHYPOPHYSIS DEVELOPMENT,0.057089,0.24748,0.27281,0,0
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17099,0.2369,0.1265,0,0
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.035393,0.23373,0.17184,0,0
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.012508,0.23182,0.17665,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.033166,0.2313,0.22225,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.015953,0.21794,0.23054,0,0
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.10654,0.2149,0.17497,0,0
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0057817,0.21489,0.26627,0,0
6,GO RETINAL GANGLION CELL AXON GUIDANCE,0.090515,0.21304,0.23446,0,0
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0007696,0.21071,0.34546,0,0
6,GO MYOBLAST MIGRATION,0.4598,0.21007,0.015398,0,0
6,GO CELL DIFFERENTIATION IN SPINAL CORD,0.001872,0.20679,0.18345,0,0
6,GO MICROTUBULE DEPOLYMERIZATION,0.029719,0.20008,0.16137,0,0
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.033894,0.19327,0.16154,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.035393,0.19162,0.15661,0,0
6,GO DENSE CORE GRANULE TRANSPORT,0.17099,0.18728,0.22819,0,0
6,GO GLIAL CELL FATE COMMITMENT,0.11039,0.1871,0.23398,0,0
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.099158,0.18601,0.17086,0,0
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.41341,0.18554,0.066003,0,0
6,GO FOREBRAIN NEURON DIFFERENTIATION,0.018836,0.18396,0.24835,0,0
6,GO REGULATION OF GROWTH HORMONE SECRETION,0.044685,0.18392,0.23626,0,0
6,GO REGULATION OF MICROTUBULE BINDING,0.0073363,0.17963,0.19495,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.011047,0.17937,0.21344,0,0
6,GO COMMISSURAL NEURON AXON GUIDANCE,0.084046,0.17934,0.16959,0,0
6,GO LACTATE METABOLIC PROCESS,0.24643,0.17635,0.078736,0,0
6,GO RETINA LAYER FORMATION,0.063042,0.17037,0.22757,0,0
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.31232,0.16781,0.10829,0,0
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.097379,0.16701,0.10708,0,0
6,GO REGULATION OF SISTER CHROMATID COHESION,0.014841,0.16684,0.13314,0,0
6,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.2839,0.16615,0.11101,0,0
6,GO REGULATION OF MESODERM DEVELOPMENT,0.20309,0.15991,0.082509,0,0
6,GO LONG TERM SYNAPTIC DEPRESSION,0.049546,0.15844,0.1545,0,0
6,GO FAT CELL PROLIFERATION,0.13355,0.15722,0.12314,0,0
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.044685,0.15511,0.24061,0,0
6,GO INTRACILIARY TRANSPORT,0.0051916,0.15481,0.19435,0,0
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.068167,0.15372,0.16286,0,0
6,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.63354,0.15311,0.034273,0,0
6,GO CELL MIGRATION IN HINDBRAIN,0.090515,0.15287,0.16255,0,0
6,GO CEREBELLAR CORTEX MORPHOGENESIS,0.017969,0.15188,0.1465,0,0
6,GO RESPONSE TO L GLUTAMATE,0.29184,0.1518,0.11198,0,0
6,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.068167,0.15177,0.15861,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.15015,0.15153,0.091227,0,0
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0029794,0.15065,0.17734,0,0
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0050528,0.15051,0.17302,0,0
6,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.15517,0.15018,0.15687,0,0
6,GO REGULATION OF STEM CELL DIVISION,0.13355,0.14915,0.10248,0,0
6,GO HISTONE H4 K16 ACETYLATION,0.0025817,0.1487,0.15597,0,0
6,GO SPINAL CORD PATTERNING,0.041093,0.14786,0.21791,0,0
6,GO ESCRT COMPLEX DISASSEMBLY,0.029719,0.14782,0.14483,0,0
6,GO TELENCEPHALON REGIONALIZATION,0.13583,0.14751,0.19321,0,0
6,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.17099,0.14658,0.13991,0,0
6,GO FOREBRAIN GENERATION OF NEURONS,0.016734,0.14636,0.21267,0,0
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.19695,0.14542,0.086476,0,0
6,GO ECTODERMAL PLACODE DEVELOPMENT,0.50896,0.14539,0.057236,0,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.093897,0.14537,0.1076,0,0
6,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.32506,0.14455,0.085822,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.57857,0.14452,0.055157,0,0
6,GO DENDRITE SELF AVOIDANCE,0.12473,0.14393,0.11035,0,0
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.017969,0.14288,0.16605,0,0
6,GO NUCLEOSOME ASSEMBLY,0.00052342,0.14248,0.15989,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.10654,0.14202,0.13012,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.31232,0.14096,0.057397,0,0
6,GO CEREBELLAR CORTEX DEVELOPMENT,0.057089,0.1404,0.12744,0,0
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.16828,0.13998,0.19524,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.42347,0.13887,0.032772,0,0
6,GO RESPONSE TO ACETYLCHOLINE,0.066855,0.13615,0.17069,0,0
6,GO AXONAL TRANSPORT,0.021165,0.13486,0.13264,0,0
6,GO CELL JUNCTION MAINTENANCE,0.050569,0.13459,0.13481,0,0
6,GO PROTEIN LOCALIZATION TO CHROMATIN,0.015203,0.13322,0.092135,0,0
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.02268,0.1332,0.23579,0,0
6,GO SYNAPTIC VESICLE CLUSTERING,0.17374,0.13173,0.28543,0,0
6,GO ANTEROGRADE AXONAL TRANSPORT,0.059411,0.13163,0.099979,0,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.69707,0.13111,-0.027411,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.034637,0.12691,0.16213,0,0
6,GO NON MOTILE CILIUM ASSEMBLY,0.013798,0.12655,0.1376,0,0
6,GO CARDIAC CHAMBER FORMATION,0.53742,0.12533,0.1104,0,0
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.063042,0.12518,0.094931,0,0
6,GO REGULATION OF GLUTAMATE SECRETION,0.088862,0.12518,0.19604,0,0
6,GO PROTEIN LOCALIZATION TO SYNAPSE,0.15264,0.12488,0.10754,0,0
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.4598,0.12429,0.089384,0,0
6,GO CARDIAC CELL FATE COMMITMENT,0.15015,0.12255,0.15162,0,0
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.25729,0.11995,0.25872,0,0
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.14526,0.11972,0.19677,0,0
6,GO MOTOR NEURON AXON GUIDANCE,0.4978,0.1194,0.046986,0,0
6,GO CENTRIOLE ASSEMBLY,0.019283,0.11913,0.096619,0,0
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.11039,0.11911,0.14654,0,0
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.12049,0.11885,0.11077,0,0
6,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.076492,0.11858,0.10519,0,0
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.20309,0.11827,0.065185,0,0
6,GO NEURAL RETINA DEVELOPMENT,0.13583,0.11816,0.093134,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.1313,0.1169,0.098622,0,0
6,GO CENTROSOME DUPLICATION,0.022165,0.11642,0.10344,0,0
6,GO CELL CELL JUNCTION MAINTENANCE,0.077957,0.11632,0.18875,0,0
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0037331,0.11555,0.13669,0,0
6,GO REGULATION OF LIGASE ACTIVITY,0.39371,0.11493,0.044378,0,0
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.31653,0.11431,0.033344,0,0
6,GO HISTONE H2A ACETYLATION,0.0056288,0.11417,0.1531,0,0
6,GO NOREPINEPHRINE METABOLIC PROCESS,0.21256,0.11384,0.14904,0,0
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.21905,0.11345,0.097007,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.15264,0.11339,0.11198,0,0
6,GO MICROTUBULE ANCHORING AT CENTROSOME,0.024288,0.11334,0.13638,0,0
6,GO AXO DENDRITIC PROTEIN TRANSPORT,0.16294,0.1127,0.12288,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.11235,0.11182,0.090697,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.36064,0.1104,0.12053,0,0
6,GO HISTONE H4 K5 ACETYLATION,0.034637,0.11022,0.12982,0,0
6,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.11636,0.11016,0.1045,0,0
6,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.61497,0.10966,0.015242,0,0
6,GO SYNAPTIC VESICLE TRANSPORT,0.04854,0.1096,0.12678,0,0
6,GO MRNA METHYLATION,0.080955,0.10939,0.094585,0,0
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.36064,0.10907,0.058626,0,0
6,GO MAGNESIUM ION HOMEOSTASIS,0.37932,0.1087,0.041576,0,0
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.27227,0.10749,0.07049,0,0
6,GO INNER CELL MASS CELL PROLIFERATION,0.13814,0.10747,0.074796,0,0
6,GO NOREPINEPHRINE SECRETION,0.31232,0.1068,0.073435,0,0
6,GO CELL DIFFERENTIATION IN HINDBRAIN,0.11434,0.10631,0.11804,0,0
6,GO SECRETORY GRANULE LOCALIZATION,0.27611,0.10584,0.1127,0,0
6,GO RDNA HETEROCHROMATIN ASSEMBLY,0.033894,0.10369,0.12558,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.25001,0.10339,0.08586,0,0
6,GO DENDRITIC TRANSPORT,0.10096,0.10329,0.13897,0,0
6,GO RESPONSE TO POTASSIUM ION,0.30402,0.10325,0.11459,0,0
6,GO DORSAL VENTRAL PATTERN FORMATION,0.029068,0.10307,0.11988,0,0
6,GO SYNAPTIC VESICLE LOCALIZATION,0.029068,0.10167,0.17856,0,0
6,GO POST ANAL TAIL MORPHOGENESIS,0.22568,0.10139,0.061131,0,0
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.41842,0.10107,0.1538,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.10654,0.101,0.13653,0,0
6,GO SEROTONIN SECRETION,0.61497,0.10056,0.048884,0,0
6,GO AXO DENDRITIC TRANSPORT,0.046579,0.10014,0.10144,0,0
6,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.4978,0.099696,0.023404,0,0
6,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.43367,0.098835,0.030986,0,0
6,GO RETINAL ROD CELL DIFFERENTIATION,0.33373,0.098642,0.090888,0,0
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.17934,0.098405,0.059457,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.090515,0.098147,0.059341,0,0
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.1028,0.098113,0.10215,0,0
6,GO RESPONSE TO FORSKOLIN,0.33373,0.097161,0.09679,0,0
6,GO MITOTIC SISTER CHROMATID COHESION,0.22235,0.096745,0.075824,0,0
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.045624,0.096627,0.11056,0,0
6,GO DETECTION OF VISIBLE LIGHT,0.047551,0.096561,0.056463,0,0
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.097379,0.096325,0.073462,0,0
6,GO GAMMA DELTA T CELL DIFFERENTIATION,0.51459,0.096123,0.14413,0,0
6,GO G0 TO G1 TRANSITION,0.034637,0.094799,0.088326,0,0
6,GO INTRACILIARY RETROGRADE TRANSPORT,0.52025,0.093948,0.080152,0,0
6,GO TELOMERIC LOOP DISASSEMBLY,0.33812,0.093257,0.05095,0,0
6,GO CELL PROLIFERATION IN HINDBRAIN,0.3746,0.092902,0.072564,0,0
6,GO APICAL PROTEIN LOCALIZATION,0.16294,0.092784,0.092621,0,0
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.4598,0.091884,0.026736,0,0
6,GO BLASTOCYST GROWTH,0.25001,0.091794,0.059286,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0695,0.091664,0.11183,0,0
6,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.91987,0.091434,-0.026011,0,0
6,GO RETINAL CONE CELL DIFFERENTIATION,0.39858,0.091245,0.044489,0,0
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.14285,0.0903,0.086112,0,0
6,GO TELOMERASE RNA LOCALIZATION,0.33812,0.090187,0.042329,0,0
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.17099,0.090185,0.10882,0,0
6,GO PHOTORECEPTOR CELL DEVELOPMENT,0.088862,0.089855,0.096827,0,0
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.25363,0.088578,0.13998,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.087232,0.08839,0.094803,0,0
6,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.17374,0.088339,0.065257,0,0
6,GO SNORNA METABOLIC PROCESS,0.097379,0.088178,0.097917,0,0
6,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.40349,0.088001,0.059265,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.34256,0.087864,0.052152,0,0
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.52594,0.087105,0.057722,0,0
6,GO REGULATION OF CENTROSOME DUPLICATION,0.20621,0.085027,0.06219,0,0
6,GO NEURON PROJECTION ARBORIZATION,0.17099,0.084741,0.10568,0,0
6,GO CELLULAR RESPONSE TO LITHIUM ION,0.46512,0.084214,0.057165,0,0
6,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.18219,0.084021,0.0937,0,0
6,GO PROXIMAL DISTAL PATTERN FORMATION,0.54903,0.083921,0.05517,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.072231,0.083489,0.077447,0,0
6,GO METAPHASE PLATE CONGRESSION,0.034637,0.083245,0.067353,0,0
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.39371,0.08324,0.12561,0,0
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.092194,0.083006,0.11708,0,0
6,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.34256,0.082833,0.078505,0,0
6,GO HISTONE H3 K9 TRIMETHYLATION,0.02166,0.082516,0.106,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.2839,0.081815,0.05294,0,0
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.17653,0.081601,0.053071,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.58456,0.081595,0.016731,0,0
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.29184,0.08155,0.076133,0,0
6,GO AXONAL FASCICULATION,0.63978,0.080398,0.043998,0,0
6,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.077957,0.080185,0.072668,0,0
6,GO PROTEIN K11 LINKED UBIQUITINATION,0.1028,0.079853,0.065783,0,0
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.58456,0.079702,0.049173,0,0
6,GO LIMB BUD FORMATION,0.70355,0.078952,0.018069,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.65234,0.07891,0.041822,0,0
6,GO PROTEIN NEDDYLATION,0.12259,0.078868,0.052192,0,0
6,GO GROWTH HORMONE SECRETION,0.17374,0.078672,0.13437,0,0
6,GO THALAMUS DEVELOPMENT,0.48131,0.078332,0.075828,0,0
6,GO VENTRAL SPINAL CORD DEVELOPMENT,0.15015,0.077658,0.096926,0,0
6,GO RNA CAPPING,0.11434,0.076884,0.04697,0,0
6,GO EMBRYONIC HEMOPOIESIS,0.32938,0.076784,0.07093,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.71658,0.075588,-0.0010646,0,0
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.5726,0.075284,0.11097,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.43883,0.075017,0.035575,0,0
6,GO SISTER CHROMATID COHESION,0.017969,0.074856,0.10519,0,0
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.064293,0.074804,0.064367,0,0
6,GO MEIOTIC CHROMOSOME SEPARATION,0.49227,0.074488,0.034302,0,0
6,GO PEPTIDYL LYSINE ACETYLATION,0.0021689,0.074355,0.074311,0,0
6,GO REGULATION OF PROTON TRANSPORT,0.88523,0.07379,0.017296,0,0
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.063042,0.073628,0.096988,0,0
6,GO MICROTUBULE ANCHORING,0.16559,0.072966,0.059475,0,0
6,GO C4 DICARBOXYLATE TRANSPORT,0.0695,0.07275,0.10465,0,0
6,GO BRANCHING MORPHOGENESIS OF A NERVE,0.52025,0.072517,0.081228,0,0
6,GO ENDODERMAL CELL FATE COMMITMENT,0.98255,0.071806,0.0032706,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.84397,0.071679,-0.025625,0,0
6,GO SIALYLATION,0.86455,0.071561,-0.021519,0,0
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.082489,0.071405,0.063504,0,0
6,GO MITOTIC CHROMOSOME CONDENSATION,0.075049,0.070956,0.11112,0,0
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.48678,0.070835,0.024502,0,0
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.14048,0.070832,0.080116,0,0
6,GO NEURAL TUBE PATTERNING,0.80989,0.070361,-0.010661,0,0
6,GO GDP METABOLIC PROCESS,0.50896,0.069948,0.056331,0,0
6,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.20937,0.069727,0.076261,0,0
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.24643,0.069611,0.13665,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.62113,0.069469,0.055926,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.51459,0.069346,0.017725,0,0
6,GO REGULATION OF TELOMERE MAINTENANCE,0.11235,0.06765,0.044112,0,0
6,GO REGULATION OF RECEPTOR CLUSTERING,0.31653,0.067364,0.11939,0,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.17099,0.067263,0.030263,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.41341,0.067121,0.029586,0,0
6,GO METENCEPHALON DEVELOPMENT,0.20937,0.066848,0.071988,0,0
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.059411,0.066672,0.16809,0,0
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.97557,0.066622,-0.019442,0,0
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.21905,0.066553,0.034255,0,0
6,GO ERROR PRONE TRANSLESION SYNTHESIS,0.092194,0.065969,0.074772,0,0
6,GO RNA 3 END PROCESSING,0.12049,0.065025,0.045561,0,0
6,GO REGULATION OF STEM CELL PROLIFERATION,0.35153,0.065022,0.016314,0,0
6,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.54321,0.064965,0.032264,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.23589,0.064613,0.032801,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.96163,0.064543,-0.017443,0,0
6,GO NEURON RECOGNITION,0.44924,0.064218,0.062213,0,0
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.83713,0.064001,0.014545,0,0
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.27999,0.063881,0.19127,0,0
6,GO HISTONE MRNA METABOLIC PROCESS,0.18508,0.063779,0.047965,0,0
6,GO SPERM AXONEME ASSEMBLY,0.29184,0.063689,0.072919,0,0
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.188,0.063662,0.085026,0,0
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.27999,0.063611,0.07834,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.73628,0.063254,0.010842,0,0
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.20937,0.063106,0.034319,0,0
6,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.27611,0.062645,0.035803,0,0
6,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.41842,0.062283,0.029532,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.075049,0.06222,0.067458,0,0
6,GO MICROTUBULE SEVERING,0.21256,0.062175,0.10044,0,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.29184,0.062093,0.031389,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.26471,0.061956,0.072675,0,0
6,GO RRNA PSEUDOURIDINE SYNTHESIS,0.85082,0.061803,-0.017027,0,0
6,GO OXIDATIVE DEMETHYLATION,0.073629,0.061774,0.072181,0,0
6,GO HISTONE H3 K9 MODIFICATION,0.15015,0.060383,0.053082,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0099891,0.060148,0.10587,0,0
6,GO PENILE ERECTION,0.19095,0.060085,0.12721,0,0
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.26847,0.059888,0.12313,0,0
6,GO MITOTIC SPINDLE ORGANIZATION,0.077957,0.05966,0.050826,0,0
6,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.82348,0.059614,-0.00081136,0,0
6,GO RESPONSE TO HYDROXYUREA,0.082489,0.059611,0.12342,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.4978,0.059547,0.022864,0,0
6,GO PROTEIN SUMOYLATION,0.12908,0.059496,0.042124,0,0
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.57857,0.058885,0.032069,0,0
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.63978,0.058286,0.021199,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.84397,0.058206,-0.039632,0,0
6,GO DNA PACKAGING,0.0067808,0.058161,0.086296,0,0
6,GO CARDIAC VENTRICLE FORMATION,0.53167,0.057687,0.13076,0,0
6,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.65866,0.05766,0.022359,0,0
6,GO LYSINE METABOLIC PROCESS,0.89215,0.057521,-0.012135,0,0
6,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.54903,0.0574,0.064956,0,0
6,GO CHROMATIN DISASSEMBLY,0.41842,0.057267,0.058608,0,0
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.53742,0.057238,0.033663,0,0
6,GO RESPONSE TO LITHIUM ION,0.41341,0.057022,0.14081,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.17934,0.056933,0.081474,0,0
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.42347,0.056897,0.047241,0,0
6,GO PHOTORECEPTOR CELL MAINTENANCE,0.25001,0.056636,0.040611,0,0
6,GO HISTONE H3 K9 METHYLATION,0.061812,0.05635,0.076216,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.72313,0.056232,-0.024749,0,0
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.56075,0.056132,0.064619,0,0
6,GO MAST CELL MIGRATION,0.40843,0.056005,0.11575,0,0
6,GO REGULATION OF CIRCADIAN RHYTHM,0.095625,0.05531,0.046285,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.53742,0.054745,0.024456,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE,0.22905,0.05474,0.067961,0,0
6,GO RESPONSE TO DOPAMINE,0.76948,0.054291,0.018932,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.48131,0.05428,0.030589,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.40843,0.054199,0.018015,0,0
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.48678,0.05406,0.078582,0,0
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.53742,0.053918,0.031469,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE I,0.67137,0.053634,0.015284,0,0
6,GO SISTER CHROMATID SEGREGATION,0.015203,0.053564,0.076013,0,0
6,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.4978,0.053204,0.047472,0,0
6,GO REGULATION OF NEUROBLAST PROLIFERATION,0.53742,0.053128,0.030153,0,0
6,GO SPINAL CORD DEVELOPMENT,0.15264,0.052885,0.073755,0,0
6,GO NEURAL NUCLEUS DEVELOPMENT,0.61497,0.052459,0.063846,0,0
6,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.27227,0.051978,0.067796,0,0
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.98255,0.051939,0.0024256,0,0
6,GO REGULATION OF MICROTUBULE BASED PROCESS,0.2,0.051713,0.046417,0,0
6,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.76948,0.051703,-0.0045104,0,0
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.41842,0.051553,0.06618,0,0
6,GO ACROSOME ASSEMBLY,0.47049,0.051321,0.026099,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.12473,0.05115,0.085735,0,0
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.36991,0.051093,0.04943,0,0
6,GO PALLIUM DEVELOPMENT,0.43883,0.050946,0.031661,0,0
6,GO HISTONE H3 K9 ACETYLATION,0.42855,0.050926,0.02542,0,0
6,GO NON RECOMBINATIONAL REPAIR,0.40349,0.050804,0.016699,0,0
6,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.85768,0.050655,0.030994,0,0
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.19695,0.050273,0.062831,0,0
6,GO POSITIVE REGULATION OF RNA SPLICING,0.097379,0.050054,0.05192,0,0
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.32506,0.049852,0.090732,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.67137,0.049514,0.031992,0,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.23937,0.049493,0.045345,0,0
6,GO ERYTHROCYTE DEVELOPMENT,0.17374,0.049103,0.057431,0,0
6,GO T HELPER CELL LINEAGE COMMITMENT,0.67137,0.048889,0.0058897,0,0
6,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.61497,0.048841,0.030852,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.68418,0.048793,0.015372,0,0
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.16294,0.048545,0.039589,0,0
6,GO RNA SURVEILLANCE,0.19095,0.048521,0.096336,0,0
6,GO BONE CELL DEVELOPMENT,0.64605,0.048151,0.015842,0,0
6,GO HINDBRAIN MORPHOGENESIS,0.19393,0.048026,0.071695,0,0
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.38408,0.047849,0.12294,0,0
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.4978,0.047844,0.02633,0,0
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.58456,0.04782,0.04008,0,0
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.17099,0.047535,0.075925,0,0
6,GO MYELOID CELL DEVELOPMENT,0.32077,0.047523,0.037683,0,0
6,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87144,0.047399,-0.014309,0,0
6,GO ERYTHROCYTE MATURATION,0.67776,0.047276,0.021738,0,0
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.91293,0.047274,-0.007209,0,0
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.91987,0.047262,-0.0064992,0,0
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.043763,0.047181,0.056591,0,0
6,GO EPITHELIAL CELL FATE COMMITMENT,0.63978,0.046873,-0.042174,0,0
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.94769,0.046713,0.014999,0,0
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.33812,0.046236,0.032231,0,0
6,GO NUCLEOTIDE EXCISION REPAIR,0.097379,0.046088,0.043815,0,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.91987,0.045977,-0.019759,0,0
6,GO REGULATION OF RECEPTOR INTERNALIZATION,0.69707,0.04577,-0.0017234,0,0
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.4545,0.045555,0.10095,0,0
6,GO CELL FATE SPECIFICATION,0.19095,0.045453,0.080696,0,0
6,GO REGULATION OF CILIUM BEAT FREQUENCY,0.30402,0.045242,0.081909,0,0
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.73628,0.045072,0.00057684,0,0
6,GO MALE SEX DETERMINATION,0.89215,0.044559,0.010444,0,0
6,GO UV DAMAGE EXCISION REPAIR,0.51459,0.044542,0.027572,0,0
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.73628,0.044432,-0.032966,0,0
6,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.96163,0.044348,0.076824,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.76948,0.044273,-0.040832,0,0
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.27611,0.044153,0.055552,0,0
6,GO MITOCHONDRIAL FUSION,0.076492,0.044092,0.071533,0,0
6,GO MALE MEIOSIS I,0.98255,0.044001,-0.02702,0,0
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.29184,0.043917,0.07168,0,0
6,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.50337,0.043905,0.030259,0,0
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.97557,0.043593,-0.0027165,0,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.32077,0.043572,0.058009,0,0
6,GO REGULATION OF SPINDLE ASSEMBLY,0.32506,0.043517,0.035346,0,0
6,GO REGULATION OF CYTOKINESIS,0.25363,0.043308,0.037967,0,0
6,GO CELL PROLIFERATION IN FOREBRAIN,0.86455,0.043303,-0.010407,0,0
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.25001,0.042789,0.084458,0,0
6,GO SPINDLE ASSEMBLY,0.095625,0.04246,0.042965,0,0
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.36064,0.04205,0.13162,0,0
6,GO PROTEIN AUTO ADP RIBOSYLATION,0.62732,0.04188,0.060854,0,0
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.42347,0.041846,0.1108,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.98953,0.041313,0.077166,0,0
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.56075,0.041266,0.0034097,0,0
6,GO REGULATION OF CHROMOSOME SEPARATION,0.25729,0.041212,0.044166,0,0
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.51459,0.041112,0.033567,0,0
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.40349,0.040908,0.045505,0,0
6,GO PYRAMIDAL NEURON DIFFERENTIATION,0.64605,0.040899,0.046058,0,0
6,GO TELOMERE CAPPING,0.27999,0.040474,0.034498,0,0
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.66501,0.040378,0.018625,0,0
6,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.87144,0.039989,-0.079212,0,0
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.35607,0.039828,0.042499,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.30402,0.039695,0.040666,0,0
6,GO NUCLEAR PORE ORGANIZATION,0.49227,0.039684,0.023934,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.5726,0.039485,0.072716,0,0
6,GO DNA METHYLATION,0.47588,0.039479,0.032066,0,0
6,GO HISTONE H3 ACETYLATION,0.092194,0.039145,0.041639,0,0
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.93377,0.039029,0.0047244,0,0
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.093897,0.038956,0.074432,0,0
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.58456,0.038793,0.034187,0,0
6,GO DETECTION OF LIGHT STIMULUS,0.26847,0.038776,0.015147,0,0
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.16032,0.03871,0.043663,0,0
6,GO CILIUM ORGANIZATION,0.085627,0.038619,0.070044,0,0
6,GO SECONDARY HEART FIELD SPECIFICATION,0.7495,0.038462,0.040602,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.36991,0.038416,0.012771,0,0
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.56075,0.038377,0.01746,0,0
6,GO RRNA TRANSCRIPTION,0.70355,0.038361,0.0043893,0,0
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.15264,0.038348,0.041623,0,0
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.92682,0.038241,-0.0089261,0,0
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.20937,0.038163,0.076518,0,0
6,GO FORELIMB MORPHOGENESIS,0.93377,0.038063,-0.01352,0,0
6,GO ATRIAL SEPTUM MORPHOGENESIS,0.72969,0.037789,-0.0048157,0,0
6,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.65234,0.037735,0.019416,0,0
6,GO SYNAPTIC VESICLE PRIMING,0.80989,0.037672,0.093465,0,0
6,GO AMINE TRANSPORT,0.87144,0.037498,0.018552,0,0
6,GO MICROTUBULE POLYMERIZATION,0.56666,0.037474,0.027127,0,0
6,GO DNA METABOLIC PROCESS,0.15015,0.03743,0.018628,0,0
6,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.81668,0.037089,-0.0071171,0,0
6,GO CENTRIOLE CENTRIOLE COHESION,0.15517,0.036753,0.092938,0,0
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.94073,0.036742,0.00050568,0,0
6,GO UTERUS DEVELOPMENT,0.81668,0.036397,0.02467,0,0
6,GO BRAIN MORPHOGENESIS,0.32077,0.03638,0.046239,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.53742,0.035944,0.054877,0,0
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.93377,0.035725,0.017046,0,0
6,GO RNA LOCALIZATION,0.34702,0.035723,0.015109,0,0
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.44924,0.035644,0.063392,0,0
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.47588,0.035633,0.026712,0,0
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.97557,0.035587,-0.0096233,0,0
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.67137,0.035526,0.010642,0,0
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.72313,0.035313,0.0011192,0,0
6,GO PROTEIN DENEDDYLATION,0.53742,0.035234,0.028245,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.43883,0.035168,0.011898,0,0
6,GO MITOCHONDRIAL TRNA PROCESSING,0.80312,0.034724,0.025612,0,0
6,GO PHOTOTRANSDUCTION,0.27611,0.034694,0.022259,0,0
6,GO SMOOTHENED SIGNALING PATHWAY,0.95466,0.034386,-0.011206,0,0
6,GO GLUTAMATE SECRETION,0.44402,0.033987,0.079142,0,0
6,GO REGULATION OF ACTIN NUCLEATION,0.89215,0.033935,-0.027387,0,0
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.38408,0.033873,0.035777,0,0
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.52025,0.033762,0.026262,0,0
6,GO RESPONSE TO ETHER,0.69707,0.033697,0.01776,0,0
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.75615,0.033657,-0.039137,0,0
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.11841,0.033539,0.095326,0,0
6,GO NEUROTRANSMITTER SECRETION,0.71658,0.033307,0.064778,0,0
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.56075,0.032958,0.050745,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.85082,0.032941,0.012662,0,0
6,GO NUCLEOSIDE SALVAGE,0.86455,0.032919,-0.017267,0,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.44924,0.032825,0.025106,0,0
6,GO REGULATION OF CHROMOSOME SEGREGATION,0.15517,0.032445,0.052292,0,0
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.27227,0.032217,0.024692,0,0
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.80989,0.03169,0.018024,0,0
6,GO DNA METHYLATION OR DEMETHYLATION,0.27227,0.031532,0.023795,0,0
6,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.95466,0.031523,-0.025202,0,0
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.78289,0.03138,-0.0012065,0,0
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.42855,0.031191,0.037944,0,0
6,GO REGULATION OF FIBROBLAST MIGRATION,0.80989,0.031003,-0.011286,0,0
6,GO REGULATION OF DNA METABOLIC PROCESS,0.24288,0.030822,0.016811,0,0
6,GO ESTABLISHMENT OF RNA LOCALIZATION,0.43367,0.030629,0.0085475,0,0
6,GO CHROMATIN SILENCING AT TELOMERE,0.80989,0.030476,-0.0089033,0,0
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.4978,0.030435,0.046393,0,0
6,GO PITUITARY GLAND DEVELOPMENT,0.59664,0.030434,0.052445,0,0
6,GO TRNA PROCESSING,0.95466,0.030401,-0.013628,0,0
6,GO ACTIN CROSSLINK FORMATION,0.65866,0.03037,-0.053197,0,0
6,GO RNA PROCESSING,0.71006,0.0301,0.0024561,0,0
6,GO VISUAL BEHAVIOR,0.88523,0.029983,0.0057543,0,0
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.26847,0.029912,0.099927,0,0
6,GO POSITIVE REGULATION OF AXONOGENESIS,0.69061,0.029844,0.022848,0,0
6,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.72969,0.029832,-0.0043253,0,0
6,GO APOPTOTIC DNA FRAGMENTATION,0.40843,0.029793,0.028346,0,0
6,GO NEURAL CREST FORMATION,0.61497,0.029727,0.035724,0,0
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.66501,0.029368,0.023487,0,0
6,GO HISTONE H3 K27 METHYLATION,0.52594,0.028965,0.015746,0,0
6,GO INHIBITORY SYNAPSE ASSEMBLY,0.5726,0.028959,0.08892,0,0
6,GO REGULATION OF CHROMATIN BINDING,0.60883,0.028881,0.031692,0,0
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.32506,0.028832,0.065371,0,0
6,GO CYTOKINESIS,0.87833,0.02868,-0.0012541,0,0
6,GO CELLULAR COMPONENT MAINTENANCE,0.71658,0.028612,0.018533,0,0
6,GO CELL CYCLE CHECKPOINT,0.23589,0.028567,0.024592,0,0
6,GO REGULATION OF CELL MATURATION,0.77618,0.028479,0.019605,0,0
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.80312,0.028367,0.0020537,0,0
6,GO SNRNA METABOLIC PROCESS,0.47588,0.028021,0.0033565,0,0
6,GO HISTONE DEUBIQUITINATION,0.36526,0.027977,0.026196,0,0
6,GO MATURATION OF LSU RRNA,0.79636,0.02775,-0.051986,0,0
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.46512,0.027713,0.023653,0,0
6,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.31232,0.027388,0.059384,0,0
6,GO HINDBRAIN DEVELOPMENT,0.70355,0.027375,0.026976,0,0
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.65866,0.02723,-0.0021706,0,0
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.85768,0.026998,0.0038001,0,0
6,GO REGULATION OF HISTONE METHYLATION,0.43883,0.026996,0.032661,0,0
6,GO MEMBRANE DOCKING,0.84397,0.026949,-0.00080077,0,0
6,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.89215,0.026924,-0.027173,0,0
6,GO MEIOSIS I CELL CYCLE PROCESS,0.30402,0.026868,0.04812,0,0
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.95466,0.026636,-0.0079566,0,0
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.63354,0.026632,-0.017632,0,0
6,GO VOCALIZATION BEHAVIOR,0.60272,0.026623,0.10729,0,0
6,GO REGULATION OF TELOMERE CAPPING,0.86455,0.026229,0.0051341,0,0
6,GO REGULATION OF DNA RECOMBINATION,0.23245,0.026223,0.020546,0,0
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.28785,0.026207,0.033956,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.89907,0.026091,-0.00874,0,0
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.89907,0.026081,-0.019025,0,0
6,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.85082,0.026066,-0.018425,0,0
6,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.94769,0.02596,0.0062743,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.94073,0.025901,-0.010149,0,0
6,GO MITOTIC CELL CYCLE CHECKPOINT,0.40843,0.02568,0.019281,0,0
6,GO NUCLEUS ORGANIZATION,0.64605,0.025516,-0.005197,0,0
6,GO MICROTUBULE BUNDLE FORMATION,0.41842,0.025443,0.060699,0,0
6,GO CEREBRAL CORTEX DEVELOPMENT,0.91987,0.02542,0.0030845,0,0
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.63978,0.025398,0.060982,0,0
6,GO DNA DEMETHYLATION,0.63354,0.025313,0.016841,0,0
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.68418,0.025309,0.024299,0,0
6,GO NUCLEAR EXPORT,0.69061,0.025176,0.0025452,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.61497,0.024645,0.039523,0,0
6,GO REGULATION OF SPINDLE CHECKPOINT,0.63354,0.024531,0.025947,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.42347,0.024471,0.030776,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.59059,0.02412,0.025125,0,0
6,GO FIBROBLAST ACTIVATION,0.64605,0.023975,-0.064209,0,0
6,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.33373,0.023936,0.027923,0,0
6,GO POSTREPLICATION REPAIR,0.86455,0.023867,0.0091801,0,0
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.53742,0.023762,0.0098499,0,0
6,GO RESPONSE TO COCAINE,0.46512,0.02374,0.05474,0,0
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.43883,0.023701,0.032474,0,0
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.92682,0.023676,-0.0052175,0,0
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.90599,0.023638,-0.017039,0,0
6,GO MRNA CLEAVAGE,0.42347,0.02361,0.032184,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.67776,0.023496,0.010347,0,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.69707,0.023491,0.0071506,0,0
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.63978,0.023372,0.0062809,0,0
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.89907,0.023367,-0.010607,0,0
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.54903,0.023294,0.019295,0,0
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.27611,0.022815,0.044448,0,0
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.89215,0.022623,-0.049823,0,0
6,GO NCRNA 3 END PROCESSING,0.47049,0.022101,0.021127,0,0
6,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.35153,0.022071,0.023841,0,0
6,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.80312,0.022047,-0.040636,0,0
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.67776,0.021964,0.0068153,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.72969,0.021336,0.006719,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.9686,0.021171,-0.026568,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.39858,0.021116,0.043626,0,0
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.38888,0.021045,0.0071948,0,0
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.43883,0.020954,0.018255,0,0
6,GO TELOMERE ORGANIZATION,0.35153,0.020878,0.020842,0,0
6,GO COLLECTING DUCT DEVELOPMENT,0.59059,0.020833,0.020142,0,0
6,GO PORE COMPLEX ASSEMBLY,0.76948,0.02082,0.0022276,0,0
6,GO CHROMATIN SILENCING,0.24288,0.020746,0.050092,0,0
6,GO HOMOLOGOUS RECOMBINATION,0.98255,0.020352,-0.0013639,0,0
6,GO PROTEIN LOCALIZATION TO CILIUM,0.44924,0.0203,0.053059,0,0
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.78289,0.020203,-0.015432,0,0
6,GO PROTEIN INSERTION INTO MEMBRANE,0.27611,0.020155,0.042702,0,0
6,GO REGULATION OF PROTEIN SUMOYLATION,0.62113,0.020095,0.033712,0,0
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.3746,0.019648,0.037594,0,0
6,GO RNA STABILIZATION,0.85768,0.019425,-0.0031421,0,0
6,GO TRNA TRANSPORT,0.98255,0.019317,-0.0043603,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.61497,0.018793,0.011653,0,0
6,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.88523,0.018685,-0.0052054,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS,0.72313,0.018606,0.063364,0,0
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.62113,0.018533,0.017377,0,0
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.83713,0.018523,-0.018125,0,0
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.60272,0.018521,0.043482,0,0
6,GO ASTRAL MICROTUBULE ORGANIZATION,0.43367,0.018313,0.060284,0,0
6,GO REGULATION OF MITOTIC CELL CYCLE,0.95466,0.018241,-0.012022,0,0
6,GO AROMATIC AMINO ACID TRANSPORT,0.56075,0.018062,0.022431,0,0
6,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.94769,0.018026,-0.009686,0,0
6,GO EMBRYONIC BRAIN DEVELOPMENT,0.57857,0.017968,0.025264,0,0
6,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.29992,0.017934,0.055836,0,0
6,GO RESPONSE TO CATECHOLAMINE,0.72969,0.017835,-0.022926,0,0
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.90599,0.017775,0.013481,0,0
6,GO NEURAL PRECURSOR CELL PROLIFERATION,0.44924,0.017762,0.035018,0,0
6,GO FOREBRAIN NEURON DEVELOPMENT,0.36526,0.01769,0.13698,0,0
6,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.59664,0.017518,0.040029,0,0
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.47588,0.017458,-0.074566,0,0
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.77618,0.017398,-0.0025638,0,0
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.73628,0.017338,-0.045976,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.69707,0.017268,-0.019995,0,0
6,GO PRENYLATION,0.17934,0.017251,0.095065,0,0
6,GO MITOTIC CELL CYCLE,0.89907,0.017023,-0.0086718,0,0
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.54903,0.016936,0.099677,0,0
6,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.71658,0.016868,-0.014217,0,0
6,GO REGULATION OF AMINO ACID TRANSPORT,0.87833,0.016819,0.016701,0,0
6,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.53742,0.01681,0.038933,0,0
6,GO MULTICELLULAR ORGANISM AGING,1,0.016768,-0.0064583,0,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.77618,0.016372,0.025988,0,0
6,GO INSEMINATION,0.91293,0.016158,-0.023012,0,0
6,GO CELL CYCLE PHASE TRANSITION,0.4978,0.015805,0.002593,0,0
6,GO BASE EXCISION REPAIR,0.20309,0.015642,0.042634,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56075,0.015513,0.038239,0,0
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.30402,0.015385,0.052412,0,0
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.2839,0.014976,0.075035,0,0
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.68418,0.014969,0.060606,0,0
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.96163,0.014956,-0.022262,0,0
6,GO SNRNA PROCESSING,0.50337,0.014902,0.011523,0,0
6,GO REGULATION OF CELL CYCLE PROCESS,0.70355,0.01488,-7.046e-05,0,0
6,GO NUCLEAR BODY ORGANIZATION,0.57857,0.014801,0.033012,0,0
6,GO CIRCADIAN RHYTHM,0.4978,0.01457,-0.038526,0,0
6,GO REGULATION OF CHROMOSOME ORGANIZATION,0.38888,0.014126,0.017082,0,0
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.83713,0.014105,0.0016314,0,0
6,GO TELENCEPHALON DEVELOPMENT,0.55487,0.014041,0.018835,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.61497,0.013961,0.027862,0,0
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.79636,0.013959,0.013374,0,0
6,GO REGULATION OF MRNA POLYADENYLATION,0.18219,0.013905,0.054875,0,0
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.96163,0.013849,-0.0016033,0,0
6,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,1,0.013602,0.0033967,0,0
6,GO COGNITION,1,0.013474,-0.0010695,0,0
6,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.8303,0.013473,0.10474,0,0
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.74288,0.013394,0.0092287,0,0
6,GO ORGANELLE LOCALIZATION,0.88523,0.013349,-0.0065213,0,0
6,GO PROTEIN MANNOSYLATION,0.92682,0.013301,-0.013752,0,0
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.78962,0.013164,0.015095,0,0
6,GO RRNA MODIFICATION,0.90599,0.013079,-0.01112,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.73628,0.013029,0.023874,0,0
6,GO REGULATION OF AXONOGENESIS,0.91293,0.01298,-0.0096354,0,0
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.43367,0.012973,0.011717,0,0
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.50337,0.012872,-0.084058,0,0
6,GO MATURATION OF 5 8S RRNA,0.97557,0.012861,-0.026543,0,0
6,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.89907,0.012853,0.022325,0,0
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.68418,0.012815,0.020141,0,0
6,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.80989,0.012579,-0.029889,0,0
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.80989,0.012457,0.010907,0,0
6,GO ORGANELLE FISSION,0.39371,0.012289,0.011302,0,0
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.85082,0.012143,0.035019,0,0
6,GO CELL DIVISION,0.51459,0.012122,0.010363,0,0
6,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.56666,0.012121,0.033805,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.58456,0.012055,0.053908,0,0
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.44924,0.011885,-0.04714,0,0
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.63978,0.011817,0.021062,0,0
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.3746,0.011676,0.022849,0,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.80312,0.011581,-0.048382,0,0
6,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.86455,0.011332,-0.031047,0,0
6,GO PROTEIN ACYLATION,0.22568,0.011258,0.02753,0,0
6,GO SLEEP,0.94769,0.011145,-0.012026,0,0
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.2,0.010865,0.047003,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.85082,0.010685,0.0018297,0,0
6,GO CHROMOSOME SEPARATION,0.15517,0.010644,0.048021,0,0
6,GO DNA INTEGRITY CHECKPOINT,0.54321,0.010384,0.010174,0,0
6,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.51459,0.010318,-0.051654,0,0
6,GO DNA MODIFICATION,0.76948,0.010078,0.0015102,0,0
6,GO MITOTIC NUCLEAR DIVISION,0.37932,0.010072,0.026182,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.90599,0.010041,-0.021244,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.3746,0.010011,0.015433,0,0
6,GO RRNA 3 END PROCESSING,0.73628,0.0099771,0.019276,0,0
6,GO NCRNA EXPORT FROM NUCLEUS,0.89215,0.0099294,-0.016731,0,0
6,GO REGULATION OF MYELINATION,0.92682,0.009756,-0.0030598,0,0
6,GO SECRETORY GRANULE ORGANIZATION,0.97557,0.0096383,-0.0057991,0,0
6,GO SENSORY PERCEPTION OF BITTER TASTE,0.86455,0.0096284,-0.01831,0,0
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.47049,0.0095586,-0.054727,0,0
6,GO DETECTION OF ABIOTIC STIMULUS,0.7495,0.0095221,0.016162,0,0
6,GO LOCALIZATION WITHIN MEMBRANE,0.84397,0.0094891,0.0028171,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.70355,0.0093484,0.037145,0,0
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.31232,0.0093356,0.042333,0,0
6,GO PROTEIN POLYGLUTAMYLATION,0.34256,0.0088745,0.099801,0,0
6,GO NEGATIVE T CELL SELECTION,0.71658,0.0088261,-0.068977,0,0
6,GO TRNA WOBBLE BASE MODIFICATION,0.92682,0.0085894,-0.01235,0,0
6,GO CAMERA TYPE EYE MORPHOGENESIS,0.59664,0.0084658,0.016364,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.95466,0.0083907,0.010977,0,0
6,GO CEREBRAL CORTEX CELL MIGRATION,0.98953,0.008349,-0.0013204,0,0
6,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.4978,0.0081902,0.011628,0,0
6,GO PSEUDOURIDINE SYNTHESIS,0.59059,0.0080282,-0.073244,0,0
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.67776,0.0080185,0.010287,0,0
6,GO IMMATURE B CELL DIFFERENTIATION,0.36991,0.007977,0.11216,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.91293,0.0078837,-0.015455,0,0
6,GO MULTIVESICULAR BODY ORGANIZATION,0.85768,0.0078544,0.0099946,0,0
6,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.52025,0.0077571,0.013535,0,0
6,GO LATERAL MESODERM DEVELOPMENT,0.56666,0.0076403,0.011446,0,0
6,GO PROTEIN DEPOLYMERIZATION,0.91293,0.0076,0.0062424,0,0
6,GO RESPONSE TO VITAMIN A,0.36991,0.0075861,-0.088161,0,0
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.88523,0.0075009,-0.0054627,0,0
6,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.72969,0.0074715,-0.037327,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94073,0.0074307,-0.0066773,0,0
6,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.40843,0.0074134,0.057464,0,0
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.63354,0.0071355,0.024699,0,0
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.60883,0.0070239,0.01287,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.89215,0.0069311,-0.016336,0,0
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.9686,0.0069197,0.0034415,0,0
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.87833,0.0069112,0.0092291,0,0
6,GO ECTODERM DEVELOPMENT,0.72313,0.0068406,-0.0058293,0,0
6,GO SOMITE DEVELOPMENT,0.94073,0.0067351,-0.023715,0,0
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.77618,0.0066939,-0.002108,0,0
6,GO MRNA MODIFICATION,0.71658,0.0065665,0.0082762,0,0
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.59059,0.0065413,0.11805,0,0
6,GO GLIAL CELL APOPTOTIC PROCESS,0.53742,0.0064241,-0.060433,0,0
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.68418,0.00626,0.017228,0,0
6,GO STEM CELL PROLIFERATION,0.77618,0.0062396,0.0017266,0,0
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.25001,0.0061658,0.051572,0,0
6,GO CELL CYCLE,0.48131,0.0060078,-0.018947,0,0
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.95466,0.0059934,0.0051655,0,0
6,GO NEURON MIGRATION,0.43367,0.005961,0.080262,0,0
6,GO DNA DEALKYLATION,0.61497,0.0058135,0.021395,0,0
6,GO SYNAPTIC SIGNALING,0.89907,0.005738,0.01164,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.40843,0.0057269,0.019119,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.95466,0.0056635,-0.014673,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.44402,0.0056483,-0.082594,0,0
6,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.53167,0.0056204,-0.052648,0,0
6,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.25729,0.0056003,-0.07517,0,0
6,GO REGULATION OF BEHAVIOR,0.9686,0.0054936,-0.0049473,0,0
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.91987,0.0054391,-0.0062044,0,0
6,GO T CELL HOMEOSTASIS,0.99651,0.0054213,-0.0037888,0,0
6,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.69707,0.0053734,-0.055202,0,0
6,GO RNA POLYADENYLATION,0.59059,0.0052376,0.0035198,0,0
6,GO FOREBRAIN DEVELOPMENT,0.63354,0.0050633,0.021516,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.9686,0.0050296,0.022047,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.4598,0.00498,0.045692,0,0
6,GO CELL CYCLE PROCESS,0.75615,0.0048952,-0.016627,0,0
6,GO HYPOTHALAMUS DEVELOPMENT,0.83713,0.0047549,0.035689,0,0
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.81668,0.004664,-0.021827,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.72969,0.0046267,0.012475,0,0
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.84397,0.0045164,-0.027512,0,0
6,GO REGULATION OF CELL FATE COMMITMENT,0.90599,0.0044075,-0.0042615,0,0
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.92682,0.0043223,0.011132,0,0
6,GO COVALENT CHROMATIN MODIFICATION,0.42855,0.0041808,0.017381,0,0
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.78962,0.0041796,0.022519,0,0
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.66501,0.0040638,0.028634,0,0
6,GO DISTAL TUBULE DEVELOPMENT,0.91987,0.0039225,-0.024154,0,0
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.78962,0.0038975,-0.014097,0,0
6,GO EMBRYONIC PATTERN SPECIFICATION,0.60883,0.0038908,-0.03188,0,0
6,GO RESPONSE TO UV C,0.72313,0.003631,-0.026967,0,0
6,GO CATECHOLAMINE SECRETION,0.72313,0.003625,0.027482,0,0
6,GO QUINONE METABOLIC PROCESS,0.79636,0.0034662,-0.071213,0,0
6,GO REGULATION OF ATPASE ACTIVITY,0.95466,0.0032883,-0.0060039,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.94769,0.0029435,-0.0060016,0,0
6,GO REGULATION OF CELL FATE SPECIFICATION,0.98255,0.0028904,0.01278,0,0
6,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.62113,0.0027676,-0.057088,0,0
6,GO LEFT RIGHT AXIS SPECIFICATION,0.52025,0.002747,-0.090723,0,0
6,GO POSITIVE REGULATION OF ERAD PATHWAY,0.53167,0.0027068,-0.071261,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.74288,0.0025759,0.020746,0,0
6,GO MITOCHONDRIAL DNA REPLICATION,0.81668,0.0025165,-0.011727,0,0
6,GO DNA CATABOLIC PROCESS,0.98953,0.0024965,0.0049032,0,0
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.75615,0.0023594,0.023844,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.8303,0.0016255,-0.010634,0,0
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.84397,0.001567,0.039953,0,0
6,GO OLIGODENDROCYTE DIFFERENTIATION,0.88523,0.0014682,-0.01022,0,0
6,GO REGULATION OF EXTENT OF CELL GROWTH,0.60883,0.0013691,-0.04118,0,0
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.94769,0.0012776,0.047269,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.86455,0.0012269,-0.0030821,0,0
6,GO SULFATION,0.74288,0.001101,-0.03942,0,0
6,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29586,0.001082,0.12268,0,0
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.90599,0.0010814,-0.0067635,0,0
6,GO NEURON CELL CELL ADHESION,0.71006,0.0010438,0.11024,0,0
6,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.40349,0.00086654,-0.14524,0,0
6,GO MITOCHONDRION LOCALIZATION,0.82348,0.00081338,0.020169,0,0
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.54321,0.00081043,0.078641,0,0
6,GO MESODERMAL CELL FATE SPECIFICATION,0.84397,0.00078954,0.024445,0,0
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.78962,0.00059449,-0.013,0,0
6,GO KERATINOCYTE DEVELOPMENT,0.78962,0.0005772,0.037715,0,0
6,GO MRNA METABOLIC PROCESS,0.78289,0.00056988,-0.012269,0,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.23589,0.00048514,-0.15591,0,0
6,GO REGULATION OF CELL DIVISION,0.91293,0.00040656,-0.00254,0,0
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.57857,0.00028271,-0.059157,0,0
6,GO RESPONSE TO NICOTINE,0.97557,0.00018943,0.023141,0,0
6,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.91987,0.00014078,-0.0091524,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.72313,-7.469e-05,-0.017596,0,0
6,GO MEIOTIC CELL CYCLE,0.69707,-0.00024082,0.012589,0,0
6,GO CELLULAR RESPONSE TO VITAMIN D,0.54321,-0.00033488,-0.094656,0,0
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.92682,-0.00055312,-0.0080602,0,0
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.41842,-0.00058989,-0.18193,0,0
6,GO CHROMOSOME CONDENSATION,0.29184,-0.00063146,0.051424,0,0
6,GO ATP BIOSYNTHETIC PROCESS,0.55487,-0.00064676,-0.061285,0,0
6,GO GRANULOCYTE DIFFERENTIATION,0.42347,-0.0007958,-0.06669,0,0
6,GO REGULATION OF STEM CELL DIFFERENTIATION,0.4978,-0.00081108,-0.058568,0,0
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.89907,-0.00083132,-0.065192,0,0
6,GO SEROTONIN TRANSPORT,0.65866,-0.00084754,-0.06102,0,0
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.86455,-0.00092931,-0.02372,0,0
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.81668,-0.00099012,-0.046889,0,0
6,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.58456,-0.001072,0.041301,0,0
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.67776,-0.0010875,-0.017949,0,0
6,GO PHAGOSOME ACIDIFICATION,0.98255,-0.0014326,-0.020516,0,0
6,GO TRANSLESION SYNTHESIS,0.73628,-0.0015763,-0.014565,0,0
6,GO NOTCH RECEPTOR PROCESSING,0.62113,-0.0016218,0.054564,0,0
6,GO MEIOTIC CHROMOSOME SEGREGATION,0.77618,-0.0017797,0.026747,0,0
6,GO DIENCEPHALON DEVELOPMENT,0.76948,-0.0018012,0.03063,0,0
6,GO TRNA METABOLIC PROCESS,0.62113,-0.0018427,-0.035362,0,0
6,GO RESPONSE TO MUSCLE INACTIVITY,0.78289,-0.00193,0.016669,0,0
6,GO NEUROBLAST PROLIFERATION,0.75615,-0.0019991,0.023711,0,0
6,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.94769,-0.0020716,-0.046479,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.67776,-0.0022295,0.027832,0,0
6,GO GENE SILENCING,0.82348,-0.0022358,-0.0078215,0,0
6,GO RECEPTOR CLUSTERING,0.75615,-0.0023596,0.013862,0,0
6,GO LYMPHANGIOGENESIS,0.56075,-0.0024288,-0.072992,0,0
6,GO VENTRICULAR SYSTEM DEVELOPMENT,0.90599,-0.0024344,0.013599,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.23937,-0.0024588,-0.035554,0,0
6,GO REGULATION OF TRANSPOSITION,0.26847,-0.0026404,-0.12858,0,0
6,GO POSITIVE REGULATION OF BONE RESORPTION,0.72313,-0.0026907,-0.036922,0,0
6,GO REGULATION OF RNA BINDING,0.4978,-0.0027594,0.024374,0,0
6,GO CELL VOLUME HOMEOSTASIS,0.16559,-0.002972,-0.06721,0,0
6,GO VESICLE LOCALIZATION,0.26847,-0.0030959,-0.040143,0,0
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.68418,-0.0031082,-0.062898,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.65234,-0.0031439,0.044954,0,0
6,GO HISTONE H3 K14 ACETYLATION,0.7495,-0.0031469,0.01807,0,0
6,GO NEUROTRANSMITTER TRANSPORT,0.79636,-0.0031471,0.024122,0,0
6,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.57857,-0.0032209,-0.033984,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.92682,-0.003248,-0.011114,0,0
6,GO REGULATION OF CELL CYCLE,0.28785,-0.003533,-0.027348,0,0
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.98953,-0.0035601,-0.013804,0,0
6,GO ADULT BEHAVIOR,0.74288,-0.0036812,0.0099249,0,0
6,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.8303,-0.0037153,-0.0014021,0,0
6,GO REGULATION OF OOGENESIS,0.69707,-0.0037428,0.035926,0,0
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.52025,-0.0038709,-0.060069,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.30815,-0.003903,-0.044241,0,0
6,GO CELL PROJECTION ASSEMBLY,0.71006,-0.0039729,-0.015267,0,0
6,GO HETEROCHROMATIN ORGANIZATION,0.52594,-0.0040202,0.027587,0,0
6,GO RESPONSE TO NERVE GROWTH FACTOR,0.57857,-0.0040255,0.036738,0,0
6,GO PROTEASOME ASSEMBLY,0.59059,-0.0041915,-0.050355,0,0
6,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.99651,-0.0042407,0.021348,0,0
6,GO RRNA METHYLATION,0.95466,-0.0046482,-0.014605,0,0
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.88523,-0.0046524,-0.024831,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.93377,-0.0049711,-0.0084975,0,0
6,GO MEIOTIC CELL CYCLE PROCESS,0.87833,-0.0050754,0.0079297,0,0
6,GO REGULATION OF DNA CATABOLIC PROCESS,0.89215,-0.0051163,-0.0091935,0,0
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.96163,-0.0051302,0.0062809,0,0
6,GO SYNAPTIC VESICLE DOCKING,0.79636,-0.0052154,0.088202,0,0
6,GO NUCLEAR TRANSPORT,0.43367,-0.0052769,-0.028088,0,0
6,GO MESODERMAL CELL FATE COMMITMENT,0.89215,-0.0055297,-0.016251,0,0
6,GO SODIUM ION HOMEOSTASIS,0.90599,-0.0055459,-0.016349,0,0
6,GO ACIDIC AMINO ACID TRANSPORT,0.79636,-0.0055786,0.03209,0,0
6,GO GERM CELL DEVELOPMENT,0.91987,-0.0058289,0.0060147,0,0
6,GO REGULATION OF SYNAPTIC PLASTICITY,0.81668,-0.0058958,-0.00052226,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.56075,-0.005925,-0.063951,0,0
6,GO SYNAPTIC VESICLE EXOCYTOSIS,0.83713,-0.0063782,0.048085,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.75615,-0.0065416,-0.014961,0,0
6,GO CELLULAR ANION HOMEOSTASIS,0.93377,-0.0065832,-0.02634,0,0
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.78289,-0.00659,-0.001406,0,0
6,GO DENDRITE MORPHOGENESIS,0.48678,-0.0067479,0.062036,0,0
6,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.56075,-0.0068806,-0.035224,0,0
6,GO POSITIVE REGULATION OF TISSUE REMODELING,0.57857,-0.007062,-0.041639,0,0
6,GO REGULATION OF ERAD PATHWAY,0.44402,-0.0073572,-0.041111,0,0
6,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.69707,-0.0074505,-0.045376,0,0
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.59664,-0.0074707,-0.027709,0,0
6,GO ADULT HEART DEVELOPMENT,0.92682,-0.0075896,-0.032097,0,0
6,GO ER OVERLOAD RESPONSE,0.80312,-0.0076793,-0.012977,0,0
6,GO METHYLATION,0.56075,-0.0077301,-0.01444,0,0
6,GO CELLULAR RESPONSE TO RADIATION,0.33373,-0.0077613,-0.041447,0,0
6,GO ERBB2 SIGNALING PATHWAY,0.71006,-0.007836,-0.038617,0,0
6,GO RETINOIC ACID METABOLIC PROCESS,0.78962,-0.0081722,0.0023391,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.74288,-0.0081936,-0.018766,0,0
6,GO PEPTIDYL ARGININE N METHYLATION,0.69707,-0.008271,-0.03403,0,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.76948,-0.008317,-0.023188,0,0
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.17099,-0.0085649,-0.060115,0,0
6,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.97557,-0.0086239,0.0043024,0,0
6,GO AXON EXTENSION,0.55487,-0.0088253,-0.040063,0,0
6,GO MIDDLE EAR MORPHOGENESIS,0.48131,-0.0088361,-0.076004,0,0
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.80312,-0.0088735,0.060467,0,0
6,GO AMINE BIOSYNTHETIC PROCESS,0.57857,-0.009029,-0.042712,0,0
6,GO DORSAL SPINAL CORD DEVELOPMENT,0.32506,-0.0090501,0.1426,0,0
6,GO MALE MEIOTIC NUCLEAR DIVISION,0.94073,-0.0091018,-0.026112,0,0
6,GO DENDRITE DEVELOPMENT,0.73628,-0.0091736,0.031709,0,0
6,GO T CELL SELECTION,0.56666,-0.0094872,-0.021902,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.28785,-0.0094897,-0.11147,0,0
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.77618,-0.0097403,-0.040262,0,0
6,GO ESTROUS CYCLE,0.78289,-0.0097792,0.030774,0,0
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.58456,-0.0098696,-0.054695,0,0
6,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.60883,-0.010064,-0.031644,0,0
6,GO NCRNA PROCESSING,0.67137,-0.010142,-0.046045,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.82348,-0.010171,0.0078539,0,0
6,GO AXONEME ASSEMBLY,0.52594,-0.010344,0.066141,0,0
6,GO TERPENOID BIOSYNTHETIC PROCESS,0.67137,-0.010356,-0.050571,0,0
6,GO REGULATION OF GENE SILENCING,0.24288,-0.01036,-0.054554,0,0
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.91293,-0.010392,0.021933,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.56075,-0.010472,-0.05804,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.55487,-0.010819,-0.059056,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.9686,-0.010843,-0.016971,0,0
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.68418,-0.01088,-0.019684,0,0
6,GO L SERINE METABOLIC PROCESS,0.9686,-0.011018,0.0025434,0,0
6,GO REGULATION OF GASTRIC ACID SECRETION,0.36991,-0.011021,-0.10403,0,0
6,GO TRANSPOSITION,0.30815,-0.011037,-0.095656,0,0
6,GO MITOTIC CYTOKINETIC PROCESS,0.84397,-0.011084,-0.002509,0,0
6,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.69707,-0.011331,0.027129,0,0
6,GO THYMIC T CELL SELECTION,0.38888,-0.011343,-0.055816,0,0
6,GO OTIC VESICLE DEVELOPMENT,0.87833,-0.01145,0.01065,0,0
6,GO SEGMENT SPECIFICATION,0.7495,-0.011529,0.051617,0,0
6,GO NATURAL KILLER CELL PROLIFERATION,0.94769,-0.011558,-0.016147,0,0
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.77618,-0.011644,0.0038162,0,0
6,GO CELL PART MORPHOGENESIS,0.93377,-0.011655,0.0016112,0,0
6,GO MEMBRANE DISASSEMBLY,0.54903,-0.011801,-0.053047,0,0
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.79636,-0.011919,-0.0011097,0,0
6,GO WALKING BEHAVIOR,0.44924,-0.012,0.073635,0,0
6,GO MEGAKARYOCYTE DIFFERENTIATION,0.69707,-0.012011,-0.013957,0,0
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.85082,-0.012377,0.063179,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.60272,-0.012388,-0.032736,0,0
6,GO POSITIVE T CELL SELECTION,0.86455,-0.012428,-0.012419,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.89215,-0.012541,-0.013043,0,0
6,GO IMMUNOLOGICAL MEMORY PROCESS,0.36064,-0.01265,-0.067326,0,0
6,GO P BODY ASSEMBLY,0.91987,-0.012716,0.0025028,0,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.42855,-0.012883,-0.041661,0,0
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.84397,-0.012916,-0.0093445,0,0
6,GO RIG I SIGNALING PATHWAY,0.28785,-0.012927,-0.085444,0,0
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.91293,-0.012971,0.00098366,0,0
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.98953,-0.01332,0.017183,0,0
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.54903,-0.01334,-0.023516,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.78962,-0.013381,0.053059,0,0
6,GO REGULATION OF MITOCHONDRIAL FUSION,0.40843,-0.013456,0.077215,0,0
6,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.76948,-0.013485,-0.019289,0,0
6,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.86455,-0.013592,-0.016658,0,0
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.87833,-0.013639,0.0025355,0,0
6,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.43367,-0.013651,-0.03337,0,0
6,GO HEAD DEVELOPMENT,0.59059,-0.013686,-0.010637,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.71658,-0.013712,-0.0050123,0,0
6,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.8303,-0.013712,-0.014111,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.79636,-0.013729,0.018159,0,0
6,GO VITAMIN CATABOLIC PROCESS,0.78289,-0.013861,-0.064502,0,0
6,GO RHYTHMIC PROCESS,0.14048,-0.013864,-0.054261,0,0
6,GO REGULATION OF APPETITE,0.48678,-0.013945,-0.051609,0,0
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.82348,-0.014096,0.021547,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.72313,-0.014289,-0.0067368,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.98255,-0.014465,0.029222,0,0
6,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.4978,-0.014486,-0.11654,0,0
6,GO ADRENAL GLAND DEVELOPMENT,0.85082,-0.01493,-0.0097137,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.26471,-0.01501,-0.036537,0,0
6,GO PROTEIN POLYUBIQUITINATION,0.52594,-0.015112,-0.026825,0,0
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.89907,-0.015143,0.024724,0,0
6,GO MISMATCH REPAIR,0.85768,-0.015182,-0.018718,0,0
6,GO RNA 5 END PROCESSING,0.4598,-0.015213,-0.06686,0,0
6,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.76281,-0.015219,-0.023324,0,0
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.46512,-0.015418,-0.025341,0,0
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.36991,-0.01556,-0.0224,0,0
6,GO MELANOCYTE DIFFERENTIATION,0.98255,-0.015835,-0.0047365,0,0
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.71006,-0.015838,-0.055847,0,0
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.32938,-0.015861,-0.023739,0,0
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.50337,-0.015913,-0.11384,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.88523,-0.015921,-0.00050573,0,0
6,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.74288,-0.015923,-0.089999,0,0
6,GO RESPONSE TO UV,0.58456,-0.016114,-0.017572,0,0
6,GO RESPONSE TO LIGHT STIMULUS,0.48131,-0.016314,-0.021321,0,0
6,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.35153,-0.016323,-0.11723,0,0
6,GO REGULATION OF DNA REPLICATION,0.94073,-0.016398,-0.0066629,0,0
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.98953,-0.01642,-0.0014888,0,0
6,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.85768,-0.016461,-0.0082211,0,0
6,GO NEURON PROJECTION GUIDANCE,0.85768,-0.016565,-0.0050955,0,0
6,GO MITOTIC CYTOKINESIS,0.7495,-0.016576,-0.018873,0,0
6,GO REGULATION OF GOLGI ORGANIZATION,0.92682,-0.016796,0.010343,0,0
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.95466,-0.016856,-0.0056541,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.57857,-0.016911,0.025342,0,0
6,GO STRESS GRANULE ASSEMBLY,0.54903,-0.016951,-0.040066,0,0
6,GO POSITIVE REGULATION OF CELL DIVISION,0.69061,-0.017043,-0.031744,0,0
6,GO EXIT FROM MITOSIS,0.44924,-0.017137,-0.031683,0,0
6,GO G2 DNA DAMAGE CHECKPOINT,0.50896,-0.017213,-0.035757,0,0
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.20309,-0.017264,-0.057428,0,0
6,GO TRNA MODIFICATION,0.71006,-0.017313,-0.035144,0,0
6,GO CELLULAR RESPONSE TO ALKALOID,0.89907,-0.0175,0.0064704,0,0
6,GO REGULATION OF HISTONE UBIQUITINATION,0.98255,-0.017534,0.002737,0,0
6,GO RESPONSE TO AUDITORY STIMULUS,0.75615,-0.017657,0.078687,0,0
6,GO TRANSLATIONAL TERMINATION,0.40349,-0.017707,-0.066399,0,0
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.65866,-0.017881,-0.020841,0,0
6,GO RESPONSE TO ALKALOID,0.63978,-0.017959,-0.01695,0,0
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.64605,-0.018017,0.011822,0,0
6,GO NEGATIVE REGULATION OF NEURON DEATH,0.69707,-0.018077,-0.014026,0,0
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.85768,-0.018112,-0.002839,0,0
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.4978,-0.01831,-0.051278,0,0
6,GO DICARBOXYLIC ACID TRANSPORT,0.64605,-0.018399,-0.0045367,0,0
6,GO MEIOTIC SPINDLE ORGANIZATION,0.89215,-0.018415,0.0014347,0,0
6,GO CGMP METABOLIC PROCESS,0.50896,-0.018527,-0.06282,0,0
6,GO MIDBODY ABSCISSION,0.99651,-0.018559,0.033145,0,0
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.43883,-0.018795,-0.01933,0,0
6,GO CELLULAR RESPONSE TO VITAMIN,0.22235,-0.018879,-0.14777,0,0
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.46512,-0.018884,-0.072992,0,0
6,GO ROOF OF MOUTH DEVELOPMENT,0.96163,-0.01892,0.0069791,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.59664,-0.019064,0.034227,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.91987,-0.019098,-0.0072889,0,0
6,GO LEARNING,0.8303,-0.019282,-0.010964,0,0
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.56666,-0.01937,-0.030439,0,0
6,GO NCRNA METABOLIC PROCESS,0.48131,-0.019474,-0.050072,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.74288,-0.019492,0.02089,0,0
6,GO DNA BIOSYNTHETIC PROCESS,0.42855,-0.019736,-0.022222,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.059411,-0.019798,-0.045587,0,0
6,GO NEURON PROJECTION EXTENSION,0.60272,-0.019839,-0.034201,0,0
6,GO INTRA S DNA DAMAGE CHECKPOINT,0.57857,-0.019854,-0.026811,0,0
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.5726,-0.019874,-0.044848,0,0
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.33373,-0.020036,-0.026352,0,0
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.81668,-0.020118,0.021526,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.14285,-0.020156,-0.085966,0,0
6,GO NEUTRAL AMINO ACID TRANSPORT,0.63978,-0.020264,-0.054872,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.65866,-0.020339,-0.028964,0,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.43367,-0.020444,-0.023337,0,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION,0.40349,-0.020461,-0.035612,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.62113,-0.020569,-0.023932,0,0
6,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.29586,-0.02068,-0.05037,0,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.69061,-0.02072,-0.0060897,0,0
6,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.40349,-0.020756,-0.057017,0,0
6,GO NEURON APOPTOTIC PROCESS,0.94073,-0.020814,0.0053342,0,0
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.4978,-0.020853,-0.026908,0,0
6,GO REPRODUCTIVE BEHAVIOR,0.35607,-0.020876,-0.066987,0,0
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.4545,-0.020952,-0.031562,0,0
6,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.69707,-0.020984,-0.019009,0,0
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.76948,-0.021019,-0.011882,0,0
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.47049,-0.021068,-0.020118,0,0
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.81668,-0.021107,-0.028297,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.27611,-0.021188,-0.048816,0,0
6,GO RUFFLE ASSEMBLY,0.38888,-0.021232,-0.043214,0,0
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.35153,-0.021381,-0.058041,0,0
6,GO REGULATION OF CHROMATIN ASSEMBLY,0.3746,-0.02167,-0.035559,0,0
6,GO MITOCHONDRIAL RNA PROCESSING,0.78289,-0.021734,-0.017693,0,0
6,GO MALE GAMETE GENERATION,0.25363,-0.022031,-0.027596,0,0
6,GO GMP METABOLIC PROCESS,0.88523,-0.022067,-0.036767,0,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.49227,-0.022139,-0.034999,0,0
6,GO HISTONE H3 K36 METHYLATION,0.69061,-0.022159,-0.020474,0,0
6,GO SUBSTANTIA NIGRA DEVELOPMENT,0.74288,-0.022211,-0.017281,0,0
6,GO NEURON DIFFERENTIATION,0.63354,-0.022386,-0.010772,0,0
6,GO REGULATION OF TORC1 SIGNALING,0.11434,-0.022416,-0.076669,0,0
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.85768,-0.022504,-0.015965,0,0
6,GO CYTOKINETIC PROCESS,0.27611,-0.022833,-0.076486,0,0
6,GO SPINDLE LOCALIZATION,0.9686,-0.022845,-0.00091148,0,0
6,GO RENAL WATER HOMEOSTASIS,0.83713,-0.022854,0.0086603,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.69707,-0.023075,-0.001743,0,0
6,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.99651,-0.023154,0.014759,0,0
6,GO LIPID DROPLET FORMATION,0.52594,-0.023158,-0.090469,0,0
6,GO DENDRITE EXTENSION,0.76281,-0.023245,0.1083,0,0
6,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.63978,-0.023278,-0.033257,0,0
6,GO RNA DECAPPING,0.47588,-0.023323,-0.054273,0,0
6,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.19393,-0.023521,-0.065685,0,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.49227,-0.023523,-0.078699,0,0
6,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.98953,-0.023544,-0.0114,0,0
6,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.74288,-0.023557,-0.031071,0,0
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.29184,-0.023586,-0.043128,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.33812,-0.023654,-0.08371,0,0
6,GO GOLGI LOCALIZATION,0.39371,-0.023676,-0.061299,0,0
6,GO MAINTENANCE OF CELL NUMBER,0.47049,-0.024077,-0.043553,0,0
6,GO SPERM MOTILITY,0.84397,-0.024196,-0.0054111,0,0
6,GO NEGATIVE REGULATION OF DNA BINDING,0.80989,-0.024271,-0.0078782,0,0
6,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.58456,-0.024385,-0.017889,0,0
6,GO VIRAL BUDDING,0.81668,-0.024504,0.029429,0,0
6,GO ORGANELLE ASSEMBLY,0.31653,-0.024722,-0.025185,0,0
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.70355,-0.024788,-0.016906,0,0
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.25001,-0.024789,-0.099862,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.60883,-0.024838,0.025646,0,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.82348,-0.024887,-0.02828,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.58456,-0.024891,-0.037673,0,0
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.76948,-0.024903,-0.030717,0,0
6,GO REGULATION OF NUCLEAR DIVISION,0.63978,-0.025338,-0.016113,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.35607,-0.025415,-0.053076,0,0
6,GO APPENDAGE MORPHOGENESIS,0.67137,-0.025447,-0.028122,0,0
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.37932,-0.025484,-0.043889,0,0
6,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.82348,-0.025539,-0.060928,0,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.188,-0.025543,-0.037561,0,0
6,GO RRNA METABOLIC PROCESS,0.59664,-0.02557,-0.059784,0,0
6,GO GAMETE GENERATION,0.32077,-0.025608,-0.021797,0,0
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.072231,-0.025621,-0.041325,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.69707,-0.02582,-0.045991,0,0
6,GO CELL FATE COMMITMENT,0.44402,-0.025849,-0.023877,0,0
6,GO EYE MORPHOGENESIS,0.65234,-0.025886,-0.022923,0,0
6,GO TRICARBOXYLIC ACID CYCLE,0.20937,-0.025911,-0.10507,0,0
6,GO RNA MODIFICATION,0.46512,-0.025945,-0.051721,0,0
6,GO POSITIVE REGULATION OF DNA REPLICATION,0.53167,-0.025969,-0.015327,0,0
6,GO MEMORY,0.25001,-0.026024,-0.058149,0,0
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.48678,-0.02603,-0.053897,0,0
6,GO NUCLEAR MIGRATION,0.99651,-0.026036,-0.013175,0,0
6,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.18508,-0.02614,-0.062918,0,0
6,GO POSITIVE REGULATION OF CELL GROWTH,0.19393,-0.026225,-0.046143,0,0
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.90599,-0.026332,0.010361,0,0
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.69707,-0.02639,0.035811,0,0
6,GO AXON DEVELOPMENT,0.62732,-0.026612,-0.011346,0,0
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.2,-0.026625,-0.038284,0,0
6,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.34702,-0.026642,-0.051705,0,0
6,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.3746,-0.026837,-0.058644,0,0
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.43883,-0.026922,-0.023035,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.58456,-0.027077,-0.014435,0,0
6,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.2,-0.027567,-0.10733,0,0
6,GO NAD BIOSYNTHETIC PROCESS,0.87833,-0.027674,-0.012995,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.1313,-0.027744,-0.035793,0,0
6,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.075049,-0.027783,-0.072012,0,0
6,GO REGULATION OF CHROMATIN ORGANIZATION,0.30815,-0.027798,-0.023905,0,0
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.64605,-0.027843,-0.036705,0,0
6,GO POSTSYNAPSE ORGANIZATION,0.79636,-0.027863,-0.018198,0,0
6,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.30402,-0.027892,-0.037518,0,0
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.87144,-0.027896,-0.013005,0,0
6,GO SEXUAL REPRODUCTION,0.16294,-0.028312,-0.033827,0,0
6,GO SPERMATID DIFFERENTIATION,0.76948,-0.028352,0.0044724,0,0
6,GO ALDEHYDE CATABOLIC PROCESS,0.96163,-0.028476,-0.011411,0,0
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.54321,-0.028691,-0.040889,0,0
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.36991,-0.028714,-0.081166,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.1313,-0.028895,-0.05181,0,0
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.93377,-0.028924,0.0034117,0,0
6,GO TRNA METHYLATION,0.42855,-0.028939,-0.055149,0,0
6,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.25001,-0.028964,-0.093372,0,0
6,GO EXCITATORY SYNAPSE ASSEMBLY,0.87144,-0.028978,-0.016347,0,0
6,GO RNA METHYLATION,0.48678,-0.028978,-0.041971,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.26098,-0.029074,-0.07281,0,0
6,GO REGULATION OF ODONTOGENESIS,0.2839,-0.029151,-0.1084,0,0
6,GO DENDRITIC SPINE MORPHOGENESIS,0.86455,-0.029191,-0.016127,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.8303,-0.029346,0.0042987,0,0
6,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.4978,-0.0294,-0.04226,0,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.43883,-0.029419,-0.069303,0,0
6,GO CELLULAR COMPONENT MORPHOGENESIS,0.53742,-0.029442,-0.018571,0,0
6,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.26098,-0.029471,-0.078225,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.64605,-0.029642,-0.022736,0,0
6,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.32506,-0.029773,-0.078817,0,0
6,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.34256,-0.030106,-0.14631,0,0
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.77618,-0.030123,-0.022953,0,0
6,GO NEUROGENESIS,0.47049,-0.030233,-0.022817,0,0
6,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.54903,-0.030459,-0.035423,0,0
6,GO DETECTION OF MECHANICAL STIMULUS,0.2839,-0.030536,-0.028885,0,0
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.26471,-0.030938,-0.058445,0,0
6,GO PEPTIDYL ARGININE METHYLATION,0.50896,-0.031012,-0.047655,0,0
6,GO EMBRYONIC AXIS SPECIFICATION,0.88523,-0.031036,-0.015989,0,0
6,GO PANCREAS DEVELOPMENT,0.31232,-0.031076,-0.069942,0,0
6,GO EMBRYONIC EYE MORPHOGENESIS,0.65234,-0.031291,-0.038575,0,0
6,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.88523,-0.031403,-0.060973,0,0
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.43367,-0.031419,-0.03623,0,0
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.84397,-0.031535,0.040702,0,0
6,GO DEVELOPMENTAL PIGMENTATION,0.15015,-0.031587,-0.071888,0,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.98953,-0.031621,0.017777,0,0
6,GO REGULATION OF DENDRITE MORPHOGENESIS,0.93377,-0.031665,0.0033223,0,0
6,GO CELLULAR RESPONSE TO UV,0.48131,-0.031805,-0.028599,0,0
6,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.22905,-0.031968,-0.093531,0,0
6,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.74288,-0.032087,-0.069157,0,0
6,GO REGULATION OF MRNA CATABOLIC PROCESS,0.25729,-0.032089,-0.062387,0,0
6,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.40843,-0.032127,-0.08374,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.19393,-0.03219,-0.038785,0,0
6,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.40843,-0.032428,-0.090549,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.71006,-0.032496,0.05016,0,0
6,GO HISTONE H3 K9 DEMETHYLATION,0.2,-0.032575,-0.091804,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.73628,-0.032579,-0.041391,0,0
6,GO POSTSYNAPSE ASSEMBLY,0.94769,-0.032589,0.0097836,0,0
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.60883,-0.032599,-0.026075,0,0
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.36991,-0.032733,-0.062323,0,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.72313,-0.032768,-0.020595,0,0
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.47049,-0.032961,-0.040359,0,0
6,GO REGULATION OF CYCLASE ACTIVITY,0.22568,-0.032981,-0.078261,0,0
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.90599,-0.033197,-0.0078999,0,0
6,GO REGULATION OF MRNA 3 END PROCESSING,0.70355,-0.033204,-0.022715,0,0
6,GO STEM CELL DIFFERENTIATION,0.22235,-0.033254,-0.047648,0,0
6,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.83713,-0.033429,-0.022751,0,0
6,GO POSITIVE REGULATION OF DNA BINDING,0.44924,-0.033583,-0.033314,0,0
6,GO POSITIVE REGULATION OF CYTOKINESIS,0.63354,-0.033615,-0.010396,0,0
6,GO PH REDUCTION,0.93377,-0.033854,-0.014642,0,0
6,GO RESPONSE TO RADIATION,0.084046,-0.033864,-0.04363,0,0
6,GO REGULATION OF GLUCOSE IMPORT,0.35153,-0.03408,-0.040969,0,0
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.40843,-0.034109,-0.038389,0,0
6,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.70355,-0.034236,-0.031462,0,0
6,GO RIBOSOME BIOGENESIS,0.53167,-0.034476,-0.068065,0,0
6,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.65866,-0.034601,-0.029992,0,0
6,GO OOGENESIS,0.53167,-0.03464,-0.0058412,0,0
6,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.16032,-0.034683,-0.11309,0,0
6,GO RESPONSE TO VITAMIN D,0.43367,-0.034862,-0.10348,0,0
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.71006,-0.034924,-0.0069632,0,0
6,GO PIGMENT BIOSYNTHETIC PROCESS,0.10654,-0.035116,-0.10756,0,0
6,GO REGULATION OF RIBOSOME BIOGENESIS,0.24288,-0.03515,-0.1322,0,0
6,GO CARDIOLIPIN METABOLIC PROCESS,0.26098,-0.035153,-0.09552,0,0
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.47588,-0.035163,-0.032749,0,0
6,GO MAGNESIUM ION TRANSPORT,0.73628,-0.035174,-0.017465,0,0
6,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.62113,-0.035185,-0.042319,0,0
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.17374,-0.035241,-0.059494,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.29586,-0.035277,-0.037368,0,0
6,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.89215,-0.035371,-0.0065297,0,0
6,GO OOCYTE MATURATION,0.49227,-0.035392,-0.022977,0,0
6,GO CELL CYCLE G1 S PHASE TRANSITION,0.2839,-0.035577,-0.034995,0,0
6,GO POSITIVE THYMIC T CELL SELECTION,0.42855,-0.035637,-0.051118,0,0
6,GO MYOTUBE CELL DEVELOPMENT,0.32077,-0.035637,-0.0691,0,0
6,GO DEVELOPMENTAL CELL GROWTH,0.16559,-0.035763,-0.064734,0,0
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.188,-0.035791,-0.19425,0,0
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.24643,-0.035795,-0.083823,0,0
6,GO MITOCHONDRIAL TRANSLATION,0.22905,-0.035862,-0.090358,0,0
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.3746,-0.035906,-0.10318,0,0
6,GO REGULATION OF DOPAMINE SECRETION,0.31653,-0.036045,-0.065252,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.188,-0.036063,-0.04357,0,0
6,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.15517,-0.036092,-0.13252,0,0
6,GO REGULATION OF NEURON DIFFERENTIATION,0.43883,-0.036118,-0.025625,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.36526,-0.036173,-0.068747,0,0
6,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.60883,-0.036183,0.14049,0,0
6,GO RESPONSE TO GLUCAGON,0.41842,-0.036217,-0.041047,0,0
6,GO T CELL LINEAGE COMMITMENT,0.63978,-0.036233,-0.0088431,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.57857,-0.036262,-0.016675,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.42855,-0.036311,-0.050144,0,0
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.51459,-0.036431,-0.028958,0,0
6,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.60883,-0.036667,-0.047416,0,0
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.15517,-0.03681,-0.074241,0,0
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.38888,-0.036937,-0.028706,0,0
6,GO IMP METABOLIC PROCESS,0.56075,-0.036939,-0.085239,0,0
6,GO PROTEIN K63 LINKED UBIQUITINATION,0.16559,-0.036963,-0.050507,0,0
6,GO CELL CELL SIGNALING,0.13583,-0.037107,-0.048918,0,0
6,GO SPECIFICATION OF SYMMETRY,0.58456,-0.037154,-0.016744,0,0
6,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.38408,-0.037157,-0.11399,0,0
6,GO PATTERN SPECIFICATION PROCESS,0.26471,-0.037302,-0.045819,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.29184,-0.037303,-0.11106,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.42855,-0.03732,-0.066083,0,0
6,GO REGULATION OF HISTONE MODIFICATION,0.40349,-0.037322,-0.02351,0,0
6,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.15264,-0.037358,-0.045272,0,0
6,GO MULTICELLULAR ORGANISM GROWTH,0.068167,-0.037376,-0.060613,0,0
6,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.65234,-0.037449,-0.052438,0,0
6,GO CARNITINE METABOLIC PROCESS,0.44924,-0.037666,-0.056541,0,0
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.66501,-0.037676,-0.0091909,0,0
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.33812,-0.037788,-0.031748,0,0
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.55487,-0.037901,-0.017109,0,0
6,GO REGULATION OF CELL DEVELOPMENT,0.30402,-0.038063,-0.039542,0,0
6,GO REGULATION OF COLLATERAL SPROUTING,0.67776,-0.038104,0.043936,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.89215,-0.038199,-0.0030075,0,0
6,GO REGULATION OF DNA METHYLATION,0.32077,-0.038282,-0.060285,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.30402,-0.03872,-0.14267,0,0
6,GO REGULATION OF TELOMERASE ACTIVITY,0.65234,-0.038767,-0.01647,0,0
6,GO POST EMBRYONIC DEVELOPMENT,0.43367,-0.038792,-0.024811,0,0
6,GO SEX DETERMINATION,0.96163,-0.038881,0.01038,0,0
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.25001,-0.038891,-0.057432,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE,0.054842,-0.039052,-0.037105,0,0
6,GO PEPTIDYL HISTIDINE MODIFICATION,0.92682,-0.039303,-0.024358,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.064293,-0.039391,-0.041752,0,0
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.10096,-0.039393,-0.13232,0,0
6,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.12473,-0.039477,-0.045168,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.35153,-0.039591,-0.059249,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.12473,-0.039841,-0.097716,0,0
6,GO PROTEIN TARGETING TO MITOCHONDRION,0.11039,-0.039918,-0.071255,0,0
6,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.17099,-0.040218,-0.072301,0,0
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.26098,-0.04029,-0.10326,0,0
6,GO RESPONSE TO GAMMA RADIATION,0.19695,-0.04054,-0.064693,0,0
6,GO REGULATION OF ORGANIC ACID TRANSPORT,0.17653,-0.040547,-0.090391,0,0
6,GO UBIQUINONE METABOLIC PROCESS,0.31653,-0.040715,-0.066206,0,0
6,GO NEGATIVE REGULATION OF CELL DIVISION,0.5726,-0.040822,0.029188,0,0
6,GO NEURON PROJECTION ORGANIZATION,0.4598,-0.040919,-0.051507,0,0
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.080955,-0.04093,-0.059596,0,0
6,GO DIGESTIVE TRACT MORPHOGENESIS,0.29184,-0.040941,-0.074742,0,0
6,GO RESPONSE TO ELECTRICAL STIMULUS,0.70355,-0.04097,-0.02114,0,0
6,GO POSITIVE REGULATION OF GLIOGENESIS,0.50896,-0.041013,-0.021471,0,0
6,GO RHYTHMIC BEHAVIOR,0.11434,-0.041029,-0.0668,0,0
6,GO DENDRITIC SPINE DEVELOPMENT,0.38408,-0.041219,-0.053167,0,0
6,GO REGULATION OF MRNA BINDING,0.98255,-0.041302,-0.021309,0,0
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.14526,-0.041319,-0.0963,0,0
6,GO SOMATIC STEM CELL DIVISION,0.8303,-0.041384,0.052534,0,0
6,GO BEHAVIOR,0.40349,-0.041521,-0.03443,0,0
6,GO FOREBRAIN MORPHOGENESIS,0.9686,-0.041527,-0.012314,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.77618,-0.041619,-0.011216,0,0
6,GO DETECTION OF STIMULUS,0.12049,-0.041664,-0.049741,0,0
6,GO STRIATUM DEVELOPMENT,0.73628,-0.041696,-0.022723,0,0
6,GO REGULATION OF NEURON MIGRATION,0.86455,-0.041837,-0.016902,0,0
6,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.67776,-0.041897,-0.025314,0,0
6,GO EXPLORATION BEHAVIOR,0.72313,-0.041897,-0.022215,0,0
6,GO ENDOSOMAL TRANSPORT,0.10096,-0.04197,-0.053708,0,0
6,GO CELLULAR RESPONSE TO X RAY,0.188,-0.042028,-0.12484,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.43367,-0.042044,-0.12085,0,0
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.070855,-0.042124,-0.1241,0,0
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.082489,-0.042282,-0.075945,0,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.26847,-0.042305,-0.045036,0,0
6,GO CATECHOLAMINE METABOLIC PROCESS,0.63978,-0.042417,-0.0047598,0,0
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.84397,-0.042485,-0.0012575,0,0
6,GO BASE EXCISION REPAIR AP SITE FORMATION,0.50337,-0.042528,-0.046199,0,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.59664,-0.042569,-0.014833,0,0
6,GO SEQUESTERING OF ACTIN MONOMERS,0.72313,-0.042593,0.04199,0,0
6,GO MEMBRANE FISSION,0.56666,-0.042597,-0.038779,0,0
6,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.20621,-0.042608,-0.094938,0,0
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.12473,-0.042686,-0.050777,0,0
6,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.13814,-0.042698,-0.082748,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.50337,-0.042708,-0.031163,0,0
6,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.055956,-0.04272,-0.083958,0,0
6,GO CALCINEURIN MEDIATED SIGNALING,0.12689,-0.042735,-0.076731,0,0
6,GO SPLEEN DEVELOPMENT,0.40843,-0.042813,-0.04114,0,0
6,GO REGULATION OF DNA BINDING,0.15517,-0.042814,-0.044906,0,0
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.67776,-0.042881,-0.037139,0,0
6,GO REGULATION OF CELLULAR PH,0.070855,-0.042908,-0.069096,0,0
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.67776,-0.043085,0.0065142,0,0
6,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.25729,-0.043145,-0.067229,0,0
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.17653,-0.043223,-0.086567,0,0
6,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.71658,-0.043353,-0.031712,0,0
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.85082,-0.04343,0.019735,0,0
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.23245,-0.043571,-0.05197,0,0
6,GO REGULATION OF DENDRITE EXTENSION,0.35153,-0.043576,-0.007649,0,0
6,GO SENSORY PERCEPTION OF TASTE,0.23937,-0.043687,-0.075905,0,0
6,GO DETERMINATION OF ADULT LIFESPAN,0.39858,-0.043737,-0.052477,0,0
6,GO NUCLEUS LOCALIZATION,0.52594,-0.043739,-0.0425,0,0
6,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.67137,-0.043826,-0.032554,0,0
6,GO GOLGI TO VACUOLE TRANSPORT,0.41341,-0.043941,-0.059326,0,0
6,GO REGULATION OF GLIOGENESIS,0.93377,-0.043994,-0.0094158,0,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.89215,-0.04406,-0.012666,0,0
6,GO SENSORY SYSTEM DEVELOPMENT,0.11039,-0.044131,-0.053514,0,0
6,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.23937,-0.044172,-0.085613,0,0
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.85082,-0.044347,-0.008685,0,0
6,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.26847,-0.044452,-0.052383,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.085627,-0.044472,-0.04427,0,0
6,GO CAMERA TYPE EYE DEVELOPMENT,0.14526,-0.044521,-0.052432,0,0
6,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.26847,-0.044556,-0.10324,0,0
6,GO CELL FATE DETERMINATION,0.53742,-0.044573,-0.038822,0,0
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.40349,-0.04465,-0.045407,0,0
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.90599,-0.044754,-0.00032314,0,0
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.055956,-0.044762,-0.056355,0,0
6,GO EATING BEHAVIOR,0.21256,-0.04489,-0.058959,0,0
6,GO IMPORT INTO NUCLEUS,0.073629,-0.044972,-0.060064,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.30815,-0.045016,-0.12123,0,0
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.58456,-0.045064,-0.031519,0,0
6,GO FOREBRAIN CELL MIGRATION,0.36991,-0.045096,-0.035915,0,0
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.11235,-0.045099,-0.096247,0,0
6,GO DEVELOPMENTAL INDUCTION,0.1313,-0.045121,-0.090139,0,0
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.16294,-0.045138,-0.085377,0,0
6,GO HORMONE CATABOLIC PROCESS,0.69061,-0.045235,-0.021345,0,0
6,GO REGULATION OF DENDRITE DEVELOPMENT,0.62113,-0.045261,-0.015073,0,0
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.77618,-0.045264,-0.045523,0,0
6,GO ACTIVATION OF MAPKK ACTIVITY,0.19695,-0.045489,-0.084375,0,0
6,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0695,-0.045617,-0.043148,0,0
6,GO RETINA HOMEOSTASIS,0.21256,-0.045644,-0.049825,0,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.16559,-0.045693,-0.046829,0,0
6,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.89215,-0.045769,-0.0054423,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.33373,-0.04583,-0.095788,0,0
6,GO KETONE BODY METABOLIC PROCESS,0.0695,-0.045917,-0.18303,0,0
6,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.23245,-0.046028,-0.093415,0,0
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.52594,-0.046246,-0.037395,0,0
6,GO ASTROCYTE ACTIVATION,0.26471,-0.046494,-0.10525,0,0
6,GO REGULATION OF ORGANELLE ORGANIZATION,0.024288,-0.046562,-0.051643,0,0
6,GO NEURON DEVELOPMENT,0.44402,-0.046719,-0.027271,0,0
6,GO ACTIN NUCLEATION,0.27227,-0.046804,-0.045476,0,0
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.15773,-0.046996,-0.064473,0,0
6,GO POSITIVE REGULATION OF HORMONE SECRETION,0.26098,-0.047026,-0.042698,0,0
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.94073,-0.047325,0.033454,0,0
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.12049,-0.047422,-0.081729,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.27227,-0.047505,-0.11054,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.11636,-0.04757,-0.088431,0,0
6,GO PROTEIN O LINKED GLYCOSYLATION,0.11039,-0.047589,-0.11479,0,0
6,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.52025,-0.047623,-0.10393,0,0
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.42855,-0.047674,-0.01549,0,0
6,GO CELLULAR SENESCENCE,0.10654,-0.047735,-0.062819,0,0
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.26471,-0.047797,-0.057965,0,0
6,GO EMBRYONIC BODY MORPHOGENESIS,0.48131,-0.047898,-0.048459,0,0
6,GO REGULATION OF PROTEIN TARGETING,0.059411,-0.04793,-0.073742,0,0
6,GO AMINO ACID TRANSPORT,0.43883,-0.04793,-0.02295,0,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.63978,-0.047943,-0.034531,0,0
6,GO PROTEIN DEMETHYLATION,0.32077,-0.047969,-0.049314,0,0
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.81668,-0.048076,-0.042029,0,0
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.33373,-0.04843,-0.043701,0,0
6,GO LIPID DROPLET ORGANIZATION,0.11636,-0.048617,-0.10718,0,0
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.46512,-0.048626,-0.039478,0,0
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.72313,-0.048684,-0.046811,0,0
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.80312,-0.048716,-0.00077715,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.19695,-0.048736,-0.093739,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.4978,-0.048821,-0.035637,0,0
6,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.20621,-0.048853,-0.093618,0,0
6,GO VIRION ASSEMBLY,0.18219,-0.04889,-0.05457,0,0
6,GO COLLATERAL SPROUTING,0.71006,-0.048899,-0.012237,0,0
6,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.16294,-0.048966,-0.15865,0,0
6,GO ARTERY MORPHOGENESIS,0.050569,-0.049081,-0.11826,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.41842,-0.049492,-0.025665,0,0
6,GO GAMMA DELTA T CELL ACTIVATION,0.7495,-0.049509,0.05805,0,0
6,GO RESPONSE TO OXYGEN RADICAL,0.49227,-0.049513,-0.049796,0,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.40349,-0.04956,-0.067968,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.16294,-0.049638,-0.095961,0,0
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.12259,-0.049684,-0.13045,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.36991,-0.049807,-0.031272,0,0
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.2839,-0.049918,-0.052523,0,0
6,GO HORMONE TRANSPORT,0.17099,-0.050014,-0.057187,0,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.038561,-0.050026,-0.074207,0,0
6,GO CELL CELL SIGNALING BY WNT,0.075049,-0.050056,-0.067693,0,0
6,GO ASSOCIATIVE LEARNING,0.15773,-0.050205,-0.063295,0,0
6,GO REGULATION OF EXCRETION,0.50896,-0.050214,-0.036722,0,0
6,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.075049,-0.050237,-0.063257,0,0
6,GO POSITIVE REGULATION OF AXON EXTENSION,0.40843,-0.050249,-0.046201,0,0
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.10096,-0.050305,-0.089187,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.62113,-0.050358,-0.017984,0,0
6,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.41842,-0.05038,-0.048438,0,0
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.30402,-0.050419,-0.050187,0,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.11434,-0.050461,-0.096605,0,0
6,GO NUCLEAR ENVELOPE REASSEMBLY,0.33373,-0.050463,-0.05236,0,0
6,GO CELL PROJECTION ORGANIZATION,0.28785,-0.050759,-0.034871,0,0
6,GO NEGATIVE REGULATION OF GLIOGENESIS,0.62113,-0.05104,-0.039521,0,0
6,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15773,-0.051147,-0.1373,0,0
6,GO HISTONE ARGININE METHYLATION,0.30815,-0.051165,-0.046572,0,0
6,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.14526,-0.051308,-0.082599,0,0
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.27999,-0.05134,-0.075897,0,0
6,GO VESICLE FUSION TO PLASMA MEMBRANE,0.91987,-0.051441,0.081325,0,0
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.088862,-0.051507,-0.066587,0,0
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.13355,-0.051568,-0.047399,0,0
6,GO MAINTENANCE OF ORGANELLE LOCATION,0.96163,-0.051638,-0.0057085,0,0
6,GO NERVOUS SYSTEM PROCESS,0.188,-0.051733,-0.041894,0,0
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.093897,-0.051844,-0.12156,0,0
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.13814,-0.051909,-0.059525,0,0
6,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.70355,-0.051964,-0.026482,0,0
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.11434,-0.051977,-0.059272,0,0
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.14769,-0.052,-0.11926,0,0
6,GO PIGMENT CELL DIFFERENTIATION,0.26847,-0.052013,-0.072793,0,0
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.68418,-0.052015,-0.042135,0,0
6,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.085627,-0.052168,-0.12328,0,0
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.25729,-0.052179,-0.091272,0,0
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.44402,-0.05224,-0.047937,0,0
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.36526,-0.052245,-0.049405,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.054842,-0.052274,-0.074207,0,0
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.48678,-0.052331,-0.02811,0,0
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.26098,-0.052449,-0.075921,0,0
6,GO ENDOCARDIUM DEVELOPMENT,0.52594,-0.052452,-0.017514,0,0
6,GO ORGANELLE INHERITANCE,0.097379,-0.05249,-0.075202,0,0
6,GO CYTOPLASM ORGANIZATION,0.42855,-0.052521,-0.063748,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.25729,-0.052594,-0.1101,0,0
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.30402,-0.052611,-0.082403,0,0
6,GO REGULATION OF PH,0.064293,-0.052937,-0.070104,0,0
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.25729,-0.053077,-0.062237,0,0
6,GO REGULATION OF CELL CYCLE ARREST,0.087232,-0.053111,-0.048579,0,0
6,GO MITOCHONDRIAL GENE EXPRESSION,0.17653,-0.053119,-0.097598,0,0
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.070855,-0.053269,-0.081678,0,0
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.27611,-0.053271,-0.082804,0,0
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.41341,-0.053327,-0.12627,0,0
6,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.32506,-0.053335,-0.077808,0,0
6,GO PHOSPHOLIPID HOMEOSTASIS,0.35153,-0.053408,-0.095521,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.22235,-0.053428,-0.093149,0,0
6,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.55487,-0.0536,-0.081918,0,0
6,GO IRON COORDINATION ENTITY TRANSPORT,0.4598,-0.053663,-0.053692,0,0
6,GO ENDOSOME ORGANIZATION,0.11039,-0.053742,-0.072367,0,0
6,GO GROOMING BEHAVIOR,0.91293,-0.053794,0.033176,0,0
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.25001,-0.053799,-0.12412,0,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.56666,-0.053849,-0.036331,0,0
6,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.98953,-0.05389,0.013944,0,0
6,GO PEPTIDYL METHIONINE MODIFICATION,0.95466,-0.053916,-0.012512,0,0
6,GO SENSORY ORGAN DEVELOPMENT,0.092194,-0.053932,-0.058709,0,0
6,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.23245,-0.053945,-0.089755,0,0
6,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.076492,-0.054054,-0.094638,0,0
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.23245,-0.054251,-0.026734,0,0
6,GO NOREPINEPHRINE TRANSPORT,0.38408,-0.054308,-0.057026,0,0
6,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.33373,-0.054437,-0.071098,0,0
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.059411,-0.054657,-0.056419,0,0
6,GO PROTEIN AUTOUBIQUITINATION,0.057089,-0.054693,-0.061149,0,0
6,GO PEPTIDYL LYSINE DIMETHYLATION,0.20937,-0.054706,-0.033678,0,0
6,GO MATURATION OF SSU RRNA,0.31653,-0.054757,-0.10229,0,0
6,GO REGULATION OF EXOCYTOSIS,0.1028,-0.05483,-0.05478,0,0
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.20621,-0.054842,-0.043262,0,0
6,GO SENSORY ORGAN MORPHOGENESIS,0.23245,-0.054902,-0.048992,0,0
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.32506,-0.05496,-0.0095197,0,0
6,GO NEURONAL ION CHANNEL CLUSTERING,0.56075,-0.054965,-0.075623,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.12259,-0.055071,-0.073609,0,0
6,GO MATING,0.75615,-0.055087,-0.0093698,0,0
6,GO GLUTAMATE METABOLIC PROCESS,0.38408,-0.055092,-0.037575,0,0
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.36526,-0.055157,-0.051779,0,0
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.066855,-0.055202,-0.12099,0,0
6,GO RRNA CATABOLIC PROCESS,0.91987,-0.05543,0.0057874,0,0
6,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.53167,-0.055435,-0.053566,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.12049,-0.055575,-0.03961,0,0
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.21905,-0.055671,-0.078699,0,0
6,GO APPENDAGE DEVELOPMENT,0.2,-0.055759,-0.057004,0,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.73628,-0.055782,0.077903,0,0
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.29992,-0.055846,-0.077608,0,0
6,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.065563,-0.055848,-0.13227,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.34702,-0.056024,-0.062796,0,0
6,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.3746,-0.056101,-0.058495,0,0
6,GO PROTEIN DESTABILIZATION,0.090515,-0.056168,-0.072833,0,0
6,GO POSITIVE REGULATION OF NEURON DEATH,0.14285,-0.056203,-0.055061,0,0
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.48131,-0.05621,-0.051645,0,0
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.3746,-0.05622,-0.054899,0,0
6,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.60272,-0.056324,-0.045064,0,0
6,GO CELL MATURATION,0.054842,-0.056411,-0.06737,0,0
6,GO ADULT FEEDING BEHAVIOR,0.56075,-0.056425,-0.056097,0,0
6,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.31653,-0.056435,-0.066527,0,0
6,GO CELLULAR RESPONSE TO VIRUS,0.34256,-0.056687,-0.062848,0,0
6,GO CELL MORPHOGENESIS,0.12473,-0.056767,-0.056063,0,0
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.18508,-0.056944,-0.054127,0,0
6,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.24288,-0.057039,-0.045856,0,0
6,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.068167,-0.057077,-0.072962,0,0
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.061812,-0.057081,-0.070197,0,0
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.12689,-0.057118,-0.065635,0,0
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.61497,-0.057241,-0.021957,0,0
6,GO HISTONE DEACETYLATION,0.053746,-0.057352,-0.065829,0,0
6,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.084046,-0.057367,-0.13706,0,0
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.070855,-0.057524,-0.054319,0,0
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.55487,-0.057586,-0.02522,0,0
6,GO TETRAHYDROFOLATE INTERCONVERSION,0.39858,-0.057692,-0.063285,0,0
6,GO GPI ANCHOR METABOLIC PROCESS,0.060602,-0.057802,-0.10694,0,0
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.17653,-0.057852,-0.085821,0,0
6,GO MITOCHONDRION DISTRIBUTION,0.72969,-0.057874,-0.0059904,0,0
6,GO REGULATION OF HORMONE SECRETION,0.11039,-0.057944,-0.067206,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.21256,-0.05804,-0.054247,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.03245,-0.058187,-0.10256,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.057089,-0.058196,-0.088482,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.25363,-0.058487,-0.085025,0,0
6,GO MIRNA METABOLIC PROCESS,0.20309,-0.058515,-0.050036,0,0
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.064293,-0.058833,-0.1359,0,0
6,GO PEPTIDE HORMONE SECRETION,0.16559,-0.058878,-0.05286,0,0
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.27611,-0.058903,-0.063239,0,0
6,GO IRON SULFUR CLUSTER ASSEMBLY,0.21256,-0.059041,-0.08981,0,0
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.12259,-0.059295,-0.09738,0,0
6,GO CILIUM MOVEMENT,0.50337,-0.059519,-0.0168,0,0
6,GO MACROMOLECULE DEPALMITOYLATION,0.32506,-0.059623,-0.080412,0,0
6,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.40349,-0.059648,-0.061108,0,0
6,GO CARTILAGE MORPHOGENESIS,0.92682,-0.059913,0.01258,0,0
6,GO DOPAMINE METABOLIC PROCESS,0.48131,-0.059936,-0.016963,0,0
6,GO LIPID DIGESTION,0.20309,-0.06018,-0.15334,0,0
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.24643,-0.06021,-0.078615,0,0
6,GO NUCLEAR ENVELOPE ORGANIZATION,0.070855,-0.060257,-0.071843,0,0
6,GO SIGNAL RELEASE,0.23245,-0.060472,-0.035975,0,0
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.94769,-0.060588,-0.019225,0,0
6,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.26471,-0.060682,-0.12392,0,0
6,GO REGULATION OF CILIUM MOVEMENT,0.53742,-0.060693,-0.014083,0,0
6,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.40843,-0.060964,-0.052461,0,0
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.33373,-0.061043,-0.043658,0,0
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.38888,-0.061147,-0.027635,0,0
6,GO PEPTIDYL ARGININE MODIFICATION,0.054842,-0.061219,-0.095393,0,0
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.4598,-0.061294,-0.058278,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.56075,-0.061398,-0.029933,0,0
6,GO FEMALE GAMETE GENERATION,0.099158,-0.06144,-0.045327,0,0
6,GO SECONDARY METABOLIC PROCESS,0.18508,-0.061575,-0.10157,0,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.72969,-0.061609,-0.0085069,0,0
6,GO DEMETHYLATION,0.27227,-0.061654,-0.04433,0,0
6,GO TOXIN TRANSPORT,0.18219,-0.061667,-0.067794,0,0
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.2839,-0.061769,-0.10996,0,0
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.77618,-0.061912,-0.022622,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.43367,-0.061943,-0.057064,0,0
6,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.38408,-0.062063,-0.055669,0,0
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.28785,-0.06212,-0.075219,0,0
6,GO LEUKOCYTE AGGREGATION,0.46512,-0.062194,-0.084424,0,0
6,GO PROSTATE GLAND GROWTH,0.26471,-0.062319,-0.13311,0,0
6,GO THYMUS DEVELOPMENT,0.21905,-0.062434,-0.051963,0,0
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.188,-0.06254,-0.090604,0,0
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.74288,-0.062553,-0.024681,0,0
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.20937,-0.062714,-0.076192,0,0
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.29184,-0.062739,-0.062221,0,0
6,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.62732,-0.063045,-0.069129,0,0
6,GO NEURON DEATH,0.22905,-0.063111,-0.036481,0,0
6,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0695,-0.063167,-0.15516,0,0
6,GO MULTIVESICULAR BODY SORTING PATHWAY,0.27999,-0.063192,-0.048677,0,0
6,GO REGULATION OF PROTEIN POLYMERIZATION,0.17934,-0.063275,-0.046913,0,0
6,GO PROTEIN O LINKED MANNOSYLATION,0.70355,-0.063377,-0.020652,0,0
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.084046,-0.063467,-0.058785,0,0
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.29586,-0.063537,-0.071382,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.15015,-0.063548,-0.062083,0,0
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.21256,-0.063663,-0.14502,0,0
6,GO RESPONSE TO NITROSATIVE STRESS,0.26098,-0.063739,-0.16021,0,0
6,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.21256,-0.063744,-0.076379,0,0
6,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.10654,-0.063863,-0.088189,0,0
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.12259,-0.063943,-0.096596,0,0
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.30402,-0.063959,-0.035055,0,0
6,GO NEGATIVE REGULATION OF JNK CASCADE,0.087232,-0.06401,-0.088767,0,0
6,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.11235,-0.064032,-0.11461,0,0
6,GO TRANSLATIONAL ELONGATION,0.23937,-0.064163,-0.080437,0,0
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.017137,-0.064164,-0.090118,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.84397,-0.064177,-0.00027322,0,0
6,GO ACTIVATED T CELL PROLIFERATION,0.13814,-0.064417,-0.07978,0,0
6,GO COBALAMIN METABOLIC PROCESS,0.25001,-0.064556,-0.094879,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.087232,-0.064588,-0.0547,0,0
6,GO MIDGUT DEVELOPMENT,0.32506,-0.064848,-0.1275,0,0
6,GO LIPID PHOSPHORYLATION,0.040234,-0.064956,-0.077245,0,0
6,GO LYMPHOCYTE COSTIMULATION,0.27611,-0.064983,-0.059334,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.084046,-0.065163,-0.13077,0,0
6,GO SYNAPTIC MEMBRANE ADHESION,0.78962,-0.065181,-0.037063,0,0
6,GO NEGATIVE REGULATION OF DNA REPLICATION,0.53167,-0.065182,-0.055765,0,0
6,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.14048,-0.065227,-0.069711,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.25363,-0.065295,-0.097433,0,0
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.097379,-0.065309,-0.12643,0,0
6,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.068167,-0.065344,-0.094939,0,0
6,GO HISTONE H4 DEACETYLATION,0.14285,-0.065355,-0.082433,0,0
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.16294,-0.065385,-0.080692,0,0
6,GO REGULATION OF DEPHOSPHORYLATION,0.085627,-0.065422,-0.04593,0,0
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.38408,-0.065433,-0.062353,0,0
6,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.88523,-0.065437,-0.0018105,0,0
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.19393,-0.065526,-0.072237,0,0
6,GO DETECTION OF CALCIUM ION,0.85082,-0.065596,0.017671,0,0
6,GO ETHANOL CATABOLIC PROCESS,0.38888,-0.065634,-0.081264,0,0
6,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.075049,-0.065655,-0.094193,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.69061,-0.065704,-0.043747,0,0
6,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.30402,-0.065834,-0.11419,0,0
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.20621,-0.065912,-0.087065,0,0
6,GO MAINTENANCE OF CELL POLARITY,0.24643,-0.066076,-0.081131,0,0
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.75615,-0.06618,-0.028479,0,0
6,GO ACID SECRETION,0.15773,-0.066208,-0.10102,0,0
6,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.17374,-0.066365,-0.066226,0,0
6,GO POSITIVE REGULATION OF URINE VOLUME,0.39371,-0.06656,-0.061232,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.076492,-0.066574,-0.13334,0,0
6,GO REGULATION OF DEACETYLASE ACTIVITY,0.26471,-0.06668,-0.071697,0,0
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.56075,-0.066937,-0.031599,0,0
6,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.49227,-0.066977,-0.049065,0,0
6,GO MONOAMINE TRANSPORT,0.38408,-0.067059,-0.014079,0,0
6,GO PROTON TRANSMEMBRANE TRANSPORT,0.072231,-0.067213,-0.072249,0,0
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.36064,-0.067814,-0.041133,0,0
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.17099,-0.068017,-0.055506,0,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.54903,-0.068114,-0.063616,0,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.46512,-0.06832,-0.086927,0,0
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.24288,-0.068419,-0.053456,0,0
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.85082,-0.068428,-0.021452,0,0
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0054795,-0.068511,-0.090834,0,0
6,GO GASTRIC ACID SECRETION,0.30402,-0.068548,-0.08222,0,0
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.35607,-0.06865,-0.058515,0,0
6,GO RESPONSE TO INACTIVITY,0.57857,-0.06892,-0.065863,0,0
6,GO REGULATION OF CELL MORPHOGENESIS,0.082489,-0.068971,-0.070682,0,0
6,GO WATER TRANSPORT,0.093897,-0.069055,-0.10024,0,0
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.98255,-0.069056,0.0013028,0,0
6,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.23589,-0.069304,-0.10334,0,0
6,GO CALCIUM ION IMPORT,0.029068,-0.069358,-0.099899,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.33812,-0.069415,-0.055541,0,0
6,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.064293,-0.069579,-0.056567,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.19095,-0.069608,-0.072772,0,0
6,GO REGULATION OF LYASE ACTIVITY,0.077957,-0.069678,-0.10789,0,0
6,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.055956,-0.069714,-0.12628,0,0
6,GO COENZYME A METABOLIC PROCESS,0.23589,-0.069736,-0.084557,0,0
6,GO REPLACEMENT OSSIFICATION,0.084046,-0.06996,-0.14759,0,0
6,GO DERMATAN SULFATE METABOLIC PROCESS,0.29586,-0.069964,-0.18498,0,0
6,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.068167,-0.069985,-0.09622,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.14048,-0.070118,-0.091697,0,0
6,GO EXECUTION PHASE OF APOPTOSIS,0.099158,-0.070179,-0.054265,0,0
6,GO KETONE CATABOLIC PROCESS,0.44402,-0.070358,-0.13111,0,0
6,GO NEPHRIC DUCT MORPHOGENESIS,0.065563,-0.070396,-0.23841,0,0
6,GO HIPPO SIGNALING,0.43367,-0.070419,-0.11331,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.36991,-0.070467,-0.068577,0,0
6,GO PEPTIDYL THREONINE MODIFICATION,0.090515,-0.0705,-0.053334,0,0
6,GO REGULATION OF ISOTYPE SWITCHING,0.39371,-0.070528,-0.10313,0,0
6,GO BRANCH ELONGATION OF AN EPITHELIUM,0.077957,-0.070547,-0.28185,0,0
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.27227,-0.070574,-0.050816,0,0
6,GO SECONDARY PALATE DEVELOPMENT,0.44402,-0.070578,-0.063911,0,0
6,GO METHIONINE BIOSYNTHETIC PROCESS,0.092194,-0.070738,-0.14714,0,0
6,GO PARENTAL BEHAVIOR,0.65234,-0.070774,-0.015016,0,0
6,GO PRESYNAPSE ORGANIZATION,0.50896,-0.070781,-0.033644,0,0
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.39858,-0.071016,-0.060314,0,0
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.16294,-0.071103,-0.16653,0,0
6,GO REGULATION OF CELL SIZE,0.034637,-0.071417,-0.085146,0,0
6,GO LOCOMOTORY BEHAVIOR,0.27999,-0.071433,-0.038373,0,0
6,GO REGULATION OF PHOSPHATASE ACTIVITY,0.088862,-0.071461,-0.049435,0,0
6,GO PARAXIAL MESODERM DEVELOPMENT,0.38888,-0.071644,-0.088039,0,0
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.57857,-0.071737,-0.046911,0,0
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.31232,-0.071788,-0.079093,0,0
6,GO VESICLE DOCKING,0.065563,-0.071941,-0.087655,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.085627,-0.072274,-0.13925,0,0
6,GO MANNOSYLATION,0.19695,-0.072524,-0.070288,0,0
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.2839,-0.072788,-0.063011,0,0
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.090515,-0.072851,-0.090687,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.30815,-0.072929,-0.033702,0,0
6,GO CRISTAE FORMATION,0.19095,-0.072951,-0.092288,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.13583,-0.072986,-0.092794,0,0
6,GO SHORT TERM MEMORY,0.61497,-0.073022,-0.055621,0,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.60272,-0.07308,-0.047094,0,0
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.4598,-0.073154,-0.050636,0,0
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.063042,-0.073161,-0.065211,0,0
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.188,-0.073161,-0.091703,0,0
6,GO EPITHELIAL CELL CELL ADHESION,0.78289,-0.073214,-0.019279,0,0
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.063042,-0.073257,-0.06849,0,0
6,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.36526,-0.073283,-0.13866,0,0
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.80989,-0.073296,-0.00706,0,0
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.1028,-0.073381,-0.076801,0,0
6,GO HEAD MORPHOGENESIS,0.188,-0.073394,-0.071708,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.095625,-0.073396,-0.13105,0,0
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.19695,-0.073497,-0.086771,0,0
6,GO RNA INTERFERENCE,0.32938,-0.073526,-0.043995,0,0
6,GO REGULATION OF MEMBRANE POTENTIAL,0.16294,-0.073603,-0.061308,0,0
6,GO AXIS SPECIFICATION,0.052669,-0.073712,-0.099474,0,0
6,GO REGIONALIZATION,0.13814,-0.073729,-0.064242,0,0
6,GO PHOSPHATE ION TRANSPORT,0.31653,-0.073736,-0.050204,0,0
6,GO REGULATION OF PROTEIN FOLDING,0.085627,-0.073744,-0.083654,0,0
6,GO COENZYME A BIOSYNTHETIC PROCESS,0.063042,-0.073799,-0.14563,0,0
6,GO REGULATION OF POTASSIUM ION TRANSPORT,0.29992,-0.074131,-0.061032,0,0
6,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.41842,-0.074223,-0.051547,0,0
6,GO TRANSMISSION OF NERVE IMPULSE,0.13355,-0.074267,-0.090064,0,0
6,GO ACETYL COA METABOLIC PROCESS,0.12049,-0.074389,-0.09381,0,0
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.48131,-0.074399,-0.027834,0,0
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.41341,-0.074545,-0.059286,0,0
6,GO 3 UTR MEDIATED MRNA STABILIZATION,0.67137,-0.07464,-0.048829,0,0
6,GO CANONICAL WNT SIGNALING PATHWAY,0.063042,-0.074669,-0.077364,0,0
6,GO FILOPODIUM ASSEMBLY,0.55487,-0.074699,-0.028105,0,0
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.087232,-0.074725,-0.092455,0,0
6,GO REGULATION OF FERTILIZATION,0.15264,-0.074745,-0.11401,0,0
6,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.60883,-0.074811,-0.030088,0,0
6,GO RESPONSE TO INTERLEUKIN 6,0.13355,-0.074937,-0.093312,0,0
6,GO PROTEIN HETEROTETRAMERIZATION,0.11841,-0.075184,-0.080821,0,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.065563,-0.075246,-0.13592,0,0
6,GO CELLULAR RESPONSE TO CAMP,0.188,-0.075272,-0.072696,0,0
6,GO LUNG CELL DIFFERENTIATION,0.54903,-0.0753,-0.025792,0,0
6,GO REGULATION OF PROTEIN DEACETYLATION,0.17653,-0.07551,-0.054905,0,0
6,GO CELLULAR RESPONSE TO MANGANESE ION,0.70355,-0.075514,-0.027189,0,0
6,GO TUMOR NECROSIS FACTOR SECRETION,0.10096,-0.075642,-0.078468,0,0
6,GO COPII COATED VESICLE CARGO LOADING,0.092194,-0.075645,-0.087969,0,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.47049,-0.076054,-0.064962,0,0
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.71006,-0.076055,-0.011227,0,0
6,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.85082,-0.076257,-0.018015,0,0
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.085627,-0.076327,-0.12891,0,0
6,GO REGULATION OF ORGANELLE ASSEMBLY,0.014841,-0.076406,-0.065391,0,0
6,GO LEYDIG CELL DIFFERENTIATION,0.4545,-0.076431,-0.085253,0,0
6,GO MANGANESE ION TRANSPORT,0.090515,-0.076559,-0.10348,0,0
6,GO REGULATION OF TRANSLATIONAL TERMINATION,0.36991,-0.076589,-0.085393,0,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.1028,-0.07662,-0.08824,0,0
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.16828,-0.076664,-0.11571,0,0
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.099158,-0.076688,-0.13785,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.077957,-0.076726,-0.065746,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.16294,-0.076743,-0.098208,0,0
6,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.35607,-0.07685,-0.14524,0,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.37932,-0.076878,-0.060975,0,0
6,GO ACTIN FILAMENT BASED TRANSPORT,0.44402,-0.07689,-0.052015,0,0
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.22235,-0.076896,-0.085253,0,0
6,GO SENSORY PERCEPTION OF PAIN,0.17934,-0.076919,-0.050056,0,0
6,GO GLIAL CELL DIFFERENTIATION,0.087232,-0.077032,-0.084275,0,0
6,GO ENDOCRINE SYSTEM DEVELOPMENT,0.35153,-0.077127,-0.034766,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.50896,-0.077162,-0.05038,0,0
6,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.10096,-0.077168,-0.084894,0,0
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.41341,-0.077464,-0.040993,0,0
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.79636,-0.07751,0.0038518,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.055956,-0.077608,-0.078318,0,0
6,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.17099,-0.077612,-0.12343,0,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.1028,-0.077868,-0.11506,0,0
6,GO NUCLEOBASE METABOLIC PROCESS,0.31653,-0.077894,-0.063866,0,0
6,GO BLASTOCYST DEVELOPMENT,0.016734,-0.077949,-0.076544,0,0
6,GO NATURAL KILLER CELL ACTIVATION,0.13814,-0.077985,-0.087096,0,0
6,GO LYMPH VESSEL DEVELOPMENT,0.075049,-0.078187,-0.14025,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.61497,-0.078188,-0.034468,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.13355,-0.078413,-0.066075,0,0
6,GO WATER HOMEOSTASIS,0.073629,-0.078438,-0.10299,0,0
6,GO MATING BEHAVIOR,0.43883,-0.078492,-0.051796,0,0
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.15517,-0.078514,-0.075383,0,0
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.50337,-0.078526,-0.035488,0,0
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.13814,-0.078729,-0.077865,0,0
6,GO NADP METABOLIC PROCESS,0.061812,-0.078887,-0.15068,0,0
6,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.29586,-0.07898,-0.072078,0,0
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.34702,-0.079017,-0.052685,0,0
6,GO NEGATIVE REGULATION OF AXONOGENESIS,0.41842,-0.079065,-0.044138,0,0
6,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.20621,-0.079181,-0.075658,0,0
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.095625,-0.079254,-0.086105,0,0
6,GO GLUCOSE IMPORT,0.053746,-0.079302,-0.078482,0,0
6,GO SYNAPTIC VESICLE BUDDING,0.22568,-0.079316,-0.080838,0,0
6,GO SOMITOGENESIS,0.097379,-0.079319,-0.07718,0,0
6,GO RESPONSE TO ATP,0.029068,-0.07961,-0.10971,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.079444,-0.079756,-0.092105,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.27999,-0.079787,-0.12581,0,0
6,GO STARTLE RESPONSE,0.41842,-0.079813,-0.094003,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.084046,-0.079824,-0.13914,0,0
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.40349,-0.079869,-0.039335,0,0
6,GO UV PROTECTION,0.16559,-0.079925,-0.12344,0,0
6,GO REGULATION OF MEIOTIC CELL CYCLE,0.092194,-0.079952,-0.061997,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.31653,-0.08007,-0.063629,0,0
6,GO RNA DESTABILIZATION,0.13814,-0.08008,-0.070304,0,0
6,GO REGULATION OF SENSORY PERCEPTION,0.26471,-0.080169,-0.067467,0,0
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.14526,-0.080239,-0.070518,0,0
6,GO HISTONE H2B UBIQUITINATION,0.24288,-0.080409,-0.056079,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.05824,-0.080668,-0.13448,0,0
6,GO LONG TERM SYNAPTIC POTENTIATION,0.16828,-0.080916,-0.090555,0,0
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.17099,-0.081007,-0.10846,0,0
6,GO REGULATION OF EXIT FROM MITOSIS,0.12689,-0.081051,-0.078549,0,0
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.17653,-0.081064,-0.091117,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.20937,-0.08124,-0.14757,0,0
6,GO SYNAPSE MATURATION,0.20309,-0.081246,-0.13834,0,0
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.36526,-0.081383,-0.072078,0,0
6,GO SYNAPSE ASSEMBLY,0.32938,-0.081414,-0.028947,0,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.17099,-0.081503,-0.085439,0,0
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.10654,-0.081513,-0.070681,0,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.088862,-0.081526,-0.091869,0,0
6,GO FIBROBLAST MIGRATION,0.35607,-0.081702,-0.059969,0,0
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.36064,-0.081734,-0.068371,0,0
6,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.11434,-0.081796,-0.11094,0,0
6,GO PHOTOPERIODISM,0.20621,-0.081809,-0.058729,0,0
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.060602,-0.081994,-0.080707,0,0
6,GO NEGATIVE REGULATION OF AXON EXTENSION,0.34702,-0.082059,-0.072389,0,0
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.1313,-0.082088,-0.073137,0,0
6,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.25729,-0.082287,-0.1146,0,0
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.89215,-0.082359,-0.030658,0,0
6,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.095625,-0.082428,-0.10416,0,0
6,GO ESTABLISHMENT OF CELL POLARITY,0.088862,-0.082467,-0.060163,0,0
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.30402,-0.082483,-0.069583,0,0
6,GO I KAPPAB PHOSPHORYLATION,0.05824,-0.082586,-0.13409,0,0
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,1,-0.082728,0.021457,0,0
6,GO NEGATIVE REGULATION OF BEHAVIOR,0.3746,-0.082741,-0.060533,0,0
6,GO KIDNEY MESENCHYME DEVELOPMENT,0.30402,-0.082808,-0.094245,0,0
6,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.26098,-0.082887,-0.066155,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.082489,-0.083048,-0.11368,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.33812,-0.08306,-0.10402,0,0
6,GO DECIDUALIZATION,0.42855,-0.083064,-0.070583,0,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0087944,-0.083167,-0.075572,0,0
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.13583,-0.083234,-0.086012,0,0
6,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.52594,-0.083359,-0.024704,0,0
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.15015,-0.083506,-0.0668,0,0
6,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.055956,-0.083531,-0.13895,0,0
6,GO INOSITOL METABOLIC PROCESS,0.33373,-0.083698,-0.069468,0,0
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.084046,-0.08371,-0.10628,0,0
6,GO PROTEIN POLYMERIZATION,0.077957,-0.08376,-0.057808,0,0
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.12689,-0.083783,-0.11516,0,0
6,GO O GLYCAN PROCESSING,0.14769,-0.08387,-0.14092,0,0
6,GO POLYOL CATABOLIC PROCESS,0.085627,-0.083962,-0.086245,0,0
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.56075,-0.084117,-0.10993,0,0
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.26847,-0.084289,-0.10215,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.59664,-0.084383,-0.056445,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.24643,-0.084581,-0.053792,0,0
6,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.22905,-0.084659,-0.061142,0,0
6,GO INTRACELLULAR MRNA LOCALIZATION,0.32506,-0.084831,-0.08263,0,0
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21256,-0.084867,-0.10318,0,0
6,GO POTASSIUM ION HOMEOSTASIS,0.33373,-0.084895,-0.066125,0,0
6,GO OVULATION CYCLE PROCESS,0.05824,-0.084911,-0.11814,0,0
6,GO TRNA 5 END PROCESSING,0.31653,-0.084962,-0.075335,0,0
6,GO FC RECEPTOR SIGNALING PATHWAY,0.11235,-0.085006,-0.065589,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.76281,-0.085062,0.037895,0,0
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.27227,-0.085098,-0.060046,0,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.15264,-0.085252,-0.10424,0,0
6,GO GANGLIOSIDE METABOLIC PROCESS,0.10845,-0.085451,-0.10798,0,0
6,GO RIBOSOME ASSEMBLY,0.12908,-0.085534,-0.15215,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.11039,-0.08555,-0.064188,0,0
6,GO L AMINO ACID TRANSPORT,0.084046,-0.085567,-0.10194,0,0
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.30815,-0.08563,-0.081301,0,0
6,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.3746,-0.085797,-0.042328,0,0
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.33373,-0.08585,-0.092174,0,0
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.057089,-0.085897,-0.097628,0,0
6,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.070855,-0.086154,-0.088793,0,0
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.2,-0.086236,-0.093273,0,0
6,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.087232,-0.086309,-0.19587,0,0
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.070855,-0.086394,-0.11207,0,0
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.068167,-0.086485,-0.10953,0,0
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.055956,-0.086528,-0.071912,0,0
6,GO METANEPHROS MORPHOGENESIS,0.42855,-0.086605,-0.048339,0,0
6,GO SEGMENTATION,0.064293,-0.086623,-0.084432,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.082489,-0.086655,-0.11566,0,0
6,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.56666,-0.086816,-0.02059,0,0
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.015574,-0.087022,-0.072641,0,0
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.15015,-0.08713,-0.13033,0,0
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.068167,-0.087138,-0.09491,0,0
6,GO POSITIVE REGULATION OF FERTILIZATION,0.17653,-0.087211,-0.1425,0,0
6,GO MEMBRANE HYPERPOLARIZATION,0.28785,-0.087248,-0.0741,0,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.021165,-0.087552,-0.089375,0,0
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.67137,-0.087873,-0.025411,0,0
6,GO TORC1 SIGNALING,0.025994,-0.088169,-0.087353,0,0
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.32506,-0.088202,-0.06638,0,0
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.13583,-0.088385,-0.07794,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.097379,-0.088432,-0.066841,0,0
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.060602,-0.088543,-0.062319,0,0
6,GO SPINDLE MIDZONE ASSEMBLY,0.14526,-0.088716,-0.080424,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11636,-0.08873,-0.16321,0,0
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.30402,-0.088744,-0.059305,0,0
6,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.17934,-0.088842,-0.067306,0,0
6,GO REGULATION OF INSULIN SECRETION,0.050569,-0.088905,-0.080009,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.12908,-0.088937,-0.10298,0,0
6,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0071468,-0.089261,-0.10871,0,0
6,GO ADHERENS JUNCTION ORGANIZATION,0.17653,-0.089285,-0.070809,0,0
6,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.068167,-0.0895,-0.13797,0,0
6,GO LAYER FORMATION IN CEREBRAL CORTEX,0.17374,-0.089619,-0.10584,0,0
6,GO VIRAL TRANSLATION,0.14048,-0.089676,-0.12472,0,0
6,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.092194,-0.089805,-0.20902,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.54903,-0.089906,-0.014143,0,0
6,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.15015,-0.090116,-0.098668,0,0
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.19095,-0.09019,-0.12704,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.36991,-0.090269,-0.066933,0,0
6,GO EPITHELIAL CELL MATURATION,0.54903,-0.09057,-0.017038,0,0
6,GO TYPE I INTERFERON PRODUCTION,0.063042,-0.090611,-0.12727,0,0
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.4545,-0.090693,-0.040218,0,0
6,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.18219,-0.090723,-0.11568,0,0
6,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.47588,-0.090878,-0.03478,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.26098,-0.091145,-0.13128,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.35153,-0.091194,-0.085126,0,0
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.18508,-0.091245,-0.12639,0,0
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.32938,-0.09139,-0.025767,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.068167,-0.09147,-0.083165,0,0
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.093897,-0.091534,-0.071866,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.60883,-0.091661,-0.013854,0,0
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.188,-0.091745,-0.10846,0,0
6,GO INNER EAR MORPHOGENESIS,0.073629,-0.091883,-0.090626,0,0
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.75615,-0.092118,-0.019245,0,0
6,GO THYROID HORMONE METABOLIC PROCESS,0.40843,-0.092488,-0.027213,0,0
6,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.16294,-0.092494,-0.17362,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.087232,-0.092505,-0.088591,0,0
6,GO RESPONSE TO INSECTICIDE,0.89907,-0.092688,0.027726,0,0
6,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.075049,-0.092735,-0.080991,0,0
6,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.077957,-0.092745,-0.14789,0,0
6,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.13355,-0.092823,-0.090213,0,0
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0695,-0.092869,-0.073013,0,0
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.3746,-0.092873,-0.11574,0,0
6,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.25001,-0.092909,-0.15333,0,0
6,GO REGULATION OF ANIMAL ORGAN FORMATION,0.56666,-0.093065,-0.067482,0,0
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.10096,-0.093069,-0.27739,0,0
6,GO GLYCINE METABOLIC PROCESS,0.188,-0.093097,-0.15538,0,0
6,GO FEEDING BEHAVIOR,0.082489,-0.093159,-0.074542,0,0
6,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.23245,-0.093283,-0.092427,0,0
6,GO PEROXISOMAL MEMBRANE TRANSPORT,0.073629,-0.093325,-0.083438,0,0
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.031748,-0.093364,-0.085533,0,0
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.061812,-0.09356,-0.13485,0,0
6,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.060602,-0.09382,-0.16957,0,0
6,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.085627,-0.093874,-0.088505,0,0
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.29586,-0.093951,-0.077589,0,0
6,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.059411,-0.093961,-0.090661,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.15264,-0.094136,-0.11508,0,0
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.020205,-0.094144,-0.10512,0,0
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.40349,-0.09431,-0.082765,0,0
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.44402,-0.094403,-0.069858,0,0
6,GO SMOOTH MUSCLE CONTRACTION,0.0062634,-0.094579,-0.14042,0,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.4598,-0.094603,-0.035224,0,0
6,GO SYNAPTIC VESICLE RECYCLING,0.36064,-0.094609,-0.037701,0,0
6,GO HEART FORMATION,0.25729,-0.095033,-0.08425,0,0
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.12689,-0.095124,-0.11574,0,0
6,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.28785,-0.095142,-0.094129,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.064293,-0.095235,-0.15894,0,0
6,GO DEFENSE RESPONSE TO FUNGUS,0.12473,-0.095258,-0.081969,0,0
6,GO GLUTAMINE METABOLIC PROCESS,0.39371,-0.095475,-0.041866,0,0
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.013465,-0.095481,-0.089065,0,0
6,GO FOREGUT MORPHOGENESIS,0.11039,-0.095548,-0.14936,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.188,-0.095632,-0.12055,0,0
6,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.03245,-0.095635,-0.12817,0,0
6,GO RESPONSE TO NITRIC OXIDE,0.034637,-0.095717,-0.089082,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.065563,-0.095887,-0.058419,0,0
6,GO POSITIVE REGULATION OF EXOCYTOSIS,0.061812,-0.096011,-0.087627,0,0
6,GO RUFFLE ORGANIZATION,0.10845,-0.096319,-0.072623,0,0
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.087232,-0.096345,-0.094943,0,0
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.063042,-0.096475,-0.09769,0,0
6,GO BONE TRABECULA MORPHOGENESIS,0.15015,-0.096659,-0.17751,0,0
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.32077,-0.097094,-0.1048,0,0
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.28785,-0.097168,-0.053468,0,0
6,GO CELL RECOGNITION,0.015574,-0.097222,-0.11122,0,0
6,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.188,-0.097258,-0.11282,0,0
6,GO AORTA MORPHOGENESIS,0.16559,-0.097627,-0.10221,0,0
6,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.14526,-0.097677,-0.1564,0,0
6,GO SYNAPTIC VESICLE MATURATION,0.89907,-0.097747,0.036548,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.69061,-0.098342,-0.026142,0,0
6,GO RESPONSE TO PARATHYROID HORMONE,0.188,-0.098403,-0.12066,0,0
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.41341,-0.098679,-0.042099,0,0
6,GO DORSAL AORTA DEVELOPMENT,0.63354,-0.098816,-0.033505,0,0
6,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.10465,-0.098826,-0.096457,0,0
6,GO REGULATION OF MEMBRANE PERMEABILITY,0.22568,-0.098859,-0.052076,0,0
6,GO CAMP BIOSYNTHETIC PROCESS,0.7495,-0.098991,-0.017591,0,0
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.087232,-0.099015,-0.10213,0,0
6,GO HEMOGLOBIN METABOLIC PROCESS,0.073629,-0.099193,-0.1242,0,0
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.042857,-0.099216,-0.12226,0,0
6,GO ALANINE TRANSPORT,0.14769,-0.099245,-0.12499,0,0
6,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.092194,-0.099277,-0.10905,0,0
6,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.053746,-0.099496,-0.20027,0,0
6,GO NEGATIVE REGULATION OF TOR SIGNALING,0.036948,-0.099531,-0.095326,0,0
6,GO POTASSIUM ION TRANSPORT,0.065563,-0.099696,-0.080172,0,0
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.099983,-0.11009,0,0
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.60883,-0.10003,-0.053475,0,0
6,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.38408,-0.10004,-0.083369,0,0
6,GO PROTEIN NITROSYLATION,0.29992,-0.10004,-0.091577,0,0
6,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.18219,-0.10027,-0.068356,0,0
6,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.29184,-0.10028,-0.10041,0,0
6,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.28785,-0.10029,-0.096221,0,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.082489,-0.10031,-0.14115,0,0
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.50896,-0.10055,-0.068943,0,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.063042,-0.101,-0.13783,0,0
6,GO HEART FIELD SPECIFICATION,0.64605,-0.10103,-0.030844,0,0
6,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.087232,-0.10117,-0.12146,0,0
6,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.063042,-0.10145,-0.11495,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.070855,-0.10152,-0.11795,0,0
6,GO OSTEOCLAST DEVELOPMENT,0.059411,-0.1017,-0.13056,0,0
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.060602,-0.10196,-0.15617,0,0
6,GO RESPONSE TO LEAD ION,0.064293,-0.10217,-0.10291,0,0
6,GO MATERNAL PLACENTA DEVELOPMENT,0.31653,-0.10218,-0.062958,0,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10654,-0.10225,-0.12171,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.14048,-0.10229,-0.09646,0,0
6,GO PRESYNAPTIC ENDOCYTOSIS,0.2,-0.10232,-0.059501,0,0
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.13814,-0.10252,-0.10084,0,0
6,GO EXOCYTIC PROCESS,0.14769,-0.10259,-0.052289,0,0
6,GO INSULIN SECRETION,0.040234,-0.10269,-0.085822,0,0
6,GO TRNA 5 LEADER REMOVAL,0.19393,-0.10272,-0.10618,0,0
6,GO PIRNA METABOLIC PROCESS,0.39858,-0.10277,-0.046049,0,0
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.061812,-0.10281,-0.11083,0,0
6,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.080955,-0.10292,-0.065187,0,0
6,GO LIPID TRANSLOCATION,0.15264,-0.10314,-0.10372,0,0
6,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.085627,-0.10315,-0.11049,0,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.054842,-0.10317,-0.11555,0,0
6,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.035393,-0.10321,-0.095656,0,0
6,GO RESPONSE TO X RAY,0.10096,-0.10325,-0.13453,0,0
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.075049,-0.10328,-0.13065,0,0
6,GO DIOL BIOSYNTHETIC PROCESS,0.077957,-0.10331,-0.13005,0,0
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.29586,-0.1034,-0.091915,0,0
6,GO REGULATION OF HEAT GENERATION,0.2839,-0.10387,-0.037523,0,0
6,GO HEPATOCYTE APOPTOTIC PROCESS,0.34702,-0.10393,-0.03333,0,0
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.093897,-0.10394,-0.14005,0,0
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.41842,-0.10394,-0.037689,0,0
6,GO FOLIC ACID METABOLIC PROCESS,0.15015,-0.10401,-0.10246,0,0
6,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.090515,-0.10438,-0.12496,0,0
6,GO REGULATION OF BONE DEVELOPMENT,0.076492,-0.10471,-0.11456,0,0
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.10654,-0.10477,-0.10562,0,0
6,GO GLYCOSIDE METABOLIC PROCESS,0.36526,-0.1049,-0.15008,0,0
6,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.47588,-0.10525,-0.051538,0,0
6,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.19393,-0.10557,-0.15046,0,0
6,GO NODAL SIGNALING PATHWAY,0.34702,-0.10571,-0.060775,0,0
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.072231,-0.10592,-0.194,0,0
6,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.10096,-0.10601,-0.1377,0,0
6,GO DE NOVO PROTEIN FOLDING,0.25001,-0.1061,-0.068999,0,0
6,GO OOCYTE DIFFERENTIATION,0.02068,-0.10624,-0.10596,0,0
6,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.079444,-0.10626,-0.10724,0,0
6,GO KIDNEY MORPHOGENESIS,0.12473,-0.10628,-0.080148,0,0
6,GO CELLULAR RESPONSE TO HEAT,0.061812,-0.10637,-0.081115,0,0
6,GO PROTEIN PALMITOYLATION,0.095625,-0.10641,-0.072037,0,0
6,GO REGULATION OF HISTONE DEACETYLATION,0.15773,-0.10648,-0.078093,0,0
6,GO PRE MIRNA PROCESSING,0.076492,-0.10655,-0.12151,0,0
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.18508,-0.10694,-0.18444,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.15264,-0.10717,-0.11115,0,0
6,GO MITRAL VALVE DEVELOPMENT,0.088862,-0.10717,-0.17049,0,0
6,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.19393,-0.10778,-0.12608,0,0
6,GO RENAL VESICLE DEVELOPMENT,0.42347,-0.10782,-0.058348,0,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.065563,-0.1083,-0.10142,0,0
6,GO REGULATION OF HISTONE PHOSPHORYLATION,0.12473,-0.1084,-0.1191,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.053746,-0.10857,-0.10752,0,0
6,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.11039,-0.10874,-0.095128,0,0
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.21256,-0.10913,-0.11713,0,0
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.10845,-0.10919,-0.17339,0,0
6,GO SYNAPSE ORGANIZATION,0.19095,-0.10943,-0.060276,0,0
6,GO REGULATION OF RESPONSE TO FOOD,0.10654,-0.1095,-0.096191,0,0
6,GO ADULT LOCOMOTORY BEHAVIOR,0.12259,-0.10957,-0.068274,0,0
6,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.12259,-0.10977,-0.099873,0,0
6,GO TELENCEPHALON GLIAL CELL MIGRATION,0.30815,-0.10977,-0.096893,0,0
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0053338,-0.10984,-0.12726,0,0
6,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.025414,-0.10997,-0.14349,0,0
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.14285,-0.11004,-0.066227,0,0
6,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.10465,-0.11029,-0.14379,0,0
6,GO PROTEIN HETEROOLIGOMERIZATION,0.13583,-0.1106,-0.081174,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.16559,-0.11076,-0.10935,0,0
6,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.085627,-0.11099,-0.1228,0,0
6,GO NEURON MATURATION,0.1028,-0.11102,-0.092496,0,0
6,GO EMBRYONIC DIGIT MORPHOGENESIS,0.10845,-0.11106,-0.093216,0,0
6,GO PIGMENT GRANULE LOCALIZATION,0.055956,-0.11107,-0.090769,0,0
6,GO CYTOLYSIS,0.11434,-0.11115,-0.15069,0,0
6,GO PERICARDIUM DEVELOPMENT,0.082489,-0.11139,-0.15961,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.082489,-0.11146,-0.095967,0,0
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.18219,-0.11158,-0.088238,0,0
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.20621,-0.11224,-0.070996,0,0
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.23245,-0.11224,-0.059783,0,0
6,GO LEFT RIGHT PATTERN FORMATION,0.24288,-0.11225,-0.085262,0,0
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.013798,-0.11251,-0.13305,0,0
6,GO FACE DEVELOPMENT,0.072231,-0.11254,-0.11424,0,0
6,GO REGULATION OF FILOPODIUM ASSEMBLY,0.42347,-0.11259,-0.043476,0,0
6,GO BONE DEVELOPMENT,0.0019282,-0.11346,-0.12425,0,0
6,GO NADPH REGENERATION,0.19393,-0.11357,-0.10669,0,0
6,GO REGULATION OF MIRNA METABOLIC PROCESS,0.060602,-0.11406,-0.11147,0,0
6,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.19393,-0.11482,-0.17923,0,0
6,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.31232,-0.11502,-0.10159,0,0
6,GO PROTEIN REFOLDING,0.31232,-0.11502,-0.075501,0,0
6,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.11039,-0.11584,-0.1106,0,0
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.073629,-0.11617,-0.081882,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.24288,-0.11652,-0.068993,0,0
6,GO N GLYCAN PROCESSING,0.12908,-0.11698,-0.12722,0,0
6,GO CELL CYCLE ARREST,0.00014418,-0.11698,-0.11483,0,0
6,GO MOTILE CILIUM ASSEMBLY,0.98255,-0.11702,0.0025924,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.059411,-0.11711,-0.095595,0,0
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.085627,-0.11722,-0.09594,0,0
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.063042,-0.11774,-0.14008,0,0
6,GO DOPAMINE TRANSPORT,0.22235,-0.11775,-0.076233,0,0
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.057089,-0.11799,-0.16331,0,0
6,GO ANDROGEN METABOLIC PROCESS,0.055956,-0.11804,-0.15661,0,0
6,GO MESENCHYME MORPHOGENESIS,0.029068,-0.11812,-0.15075,0,0
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.041093,-0.11813,-0.15133,0,0
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.057089,-0.11822,-0.13799,0,0
6,GO NEURON CELLULAR HOMEOSTASIS,0.32506,-0.11855,-0.09241,0,0
6,GO CGMP MEDIATED SIGNALING,0.0054795,-0.1186,-0.1712,0,0
6,GO POLYAMINE METABOLIC PROCESS,0.14769,-0.11863,-0.079718,0,0
6,GO HEAT GENERATION,0.0695,-0.11876,-0.089739,0,0
6,GO PROTEIN ADP RIBOSYLATION,0.12689,-0.11879,-0.076026,0,0
6,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.17099,-0.11887,-0.113,0,0
6,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.2839,-0.1189,-0.12165,0,0
6,GO ARTERY DEVELOPMENT,0.011326,-0.1192,-0.14324,0,0
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.36064,-0.11925,-0.065764,0,0
6,GO L GLUTAMATE IMPORT,0.080955,-0.11933,-0.112,0,0
6,GO HETEROTYPIC CELL CELL ADHESION,0.0695,-0.11939,-0.12062,0,0
6,GO SEQUESTERING OF METAL ION,0.055956,-0.11943,-0.15103,0,0
6,GO NEUROTRANSMITTER REUPTAKE,0.045624,-0.11986,-0.16723,0,0
6,GO RESPONSE TO PROSTAGLANDIN,0.090515,-0.11989,-0.13927,0,0
6,GO NON CANONICAL WNT SIGNALING PATHWAY,0.049546,-0.11989,-0.088567,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.25001,-0.12021,-0.042296,0,0
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.10096,-0.12063,-0.12529,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.093897,-0.12064,-0.10863,0,0
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.22905,-0.12068,-0.1365,0,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.088862,-0.1207,-0.13683,0,0
6,GO HISTONE H3 DEACETYLATION,0.15517,-0.1208,-0.065501,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.15264,-0.12081,-0.11034,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.095625,-0.1212,-0.069261,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.061812,-0.12122,-0.10093,0,0
6,GO REGULATION OF GLIAL CELL MIGRATION,0.16559,-0.12126,-0.076355,0,0
6,GO FACIAL NERVE MORPHOGENESIS,0.2839,-0.12148,-0.13921,0,0
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.20309,-0.12161,-0.16747,0,0
6,GO REGULATION OF GTPASE ACTIVITY,0.00081984,-0.12162,-0.1211,0,0
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.057089,-0.12174,-0.11494,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.090515,-0.12202,-0.11359,0,0
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.1028,-0.12214,-0.065679,0,0
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.32506,-0.1222,-0.10942,0,0
6,GO TRACHEA MORPHOGENESIS,0.27227,-0.12221,-0.079853,0,0
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.36526,-0.12228,-0.075575,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.17934,-0.12239,-0.1389,0,0
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.023741,-0.12255,-0.10548,0,0
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.20309,-0.12306,-0.14572,0,0
6,GO CYTOCHROME COMPLEX ASSEMBLY,0.05824,-0.12329,-0.13802,0,0
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.12049,-0.1234,-0.17108,0,0
6,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.053746,-0.12357,-0.15682,0,0
6,GO BONE MATURATION,0.31653,-0.12368,-0.016211,0,0
6,GO CLATHRIN COAT ASSEMBLY,0.31232,-0.12393,-0.066491,0,0
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.059411,-0.12458,-0.12795,0,0
6,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.13355,-0.12462,-0.057707,0,0
6,GO LUNG EPITHELIUM DEVELOPMENT,0.23245,-0.12514,-0.093219,0,0
6,GO REGULATION OF FEEDING BEHAVIOR,0.03245,-0.12551,-0.13109,0,0
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.11841,-0.12592,-0.078943,0,0
6,GO TRACHEA DEVELOPMENT,0.12908,-0.12596,-0.14153,0,0
6,GO ATRIAL SEPTUM DEVELOPMENT,0.22905,-0.12599,-0.1027,0,0
6,GO AMINO ACID ACTIVATION,0.065563,-0.12605,-0.13555,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.084046,-0.12605,-0.096641,0,0
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.32506,-0.12612,-0.12949,0,0
6,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.17099,-0.12629,-0.1116,0,0
6,GO REGULATION OF SULFUR METABOLIC PROCESS,0.11039,-0.12719,-0.13089,0,0
6,GO PARTURITION,0.40349,-0.12726,-0.097414,0,0
6,GO PANCREATIC JUICE SECRETION,0.026586,-0.12729,-0.13941,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.10465,-0.1274,-0.21305,0,0
6,GO BODY MORPHOGENESIS,0.0695,-0.12757,-0.099275,0,0
6,GO NEURAL CREST CELL DIFFERENTIATION,0.020205,-0.12765,-0.13279,0,0
6,GO TOXIN METABOLIC PROCESS,0.39371,-0.12773,-0.095057,0,0
6,GO HINDLIMB MORPHOGENESIS,0.060602,-0.12787,-0.13384,0,0
6,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.15517,-0.12798,-0.11679,0,0
6,GO TRANSCYTOSIS,0.22235,-0.12808,-0.080306,0,0
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.1028,-0.12818,-0.10726,0,0
6,GO OUTER DYNEIN ARM ASSEMBLY,0.59059,-0.12821,-0.039462,0,0
6,GO ATP TRANSPORT,0.13814,-0.1286,-0.074093,0,0
6,GO TONGUE MORPHOGENESIS,0.96163,-0.12862,0.010086,0,0
6,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.05824,-0.12887,-0.16438,0,0
6,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.24288,-0.12908,-0.071961,0,0
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.10845,-0.12925,-0.14339,0,0
6,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.28785,-0.12934,-0.1041,0,0
6,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.39858,-0.12937,-0.064342,0,0
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.23589,-0.12953,-0.078902,0,0
6,GO NEUROMUSCULAR PROCESS,0.061812,-0.12957,-0.087056,0,0
6,GO INOSITOL LIPID MEDIATED SIGNALING,0.00065623,-0.13003,-0.14318,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.10096,-0.1305,-0.08151,0,0
6,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.24643,-0.13055,-0.10768,0,0
6,GO OTIC VESICLE MORPHOGENESIS,0.17374,-0.13068,-0.11819,0,0
6,GO REGULATION OF TRANSLATIONAL FIDELITY,0.079444,-0.13068,-0.12848,0,0
6,GO LATERAL VENTRICLE DEVELOPMENT,0.24643,-0.13084,-0.083808,0,0
6,GO RESPONSE TO LIGHT INTENSITY,0.02068,-0.13136,-0.20346,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.087232,-0.13148,-0.11561,0,0
6,GO DORSAL VENTRAL AXIS SPECIFICATION,0.24643,-0.13164,-0.10829,0,0
6,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.12259,-0.13165,-0.066775,0,0
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013798,-0.13206,-0.11713,0,0
6,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.24288,-0.13215,-0.14463,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.43367,-0.1322,-0.046855,0,0
6,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13814,-0.13238,-0.085221,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.1028,-0.13284,-0.13065,0,0
6,GO BARBED END ACTIN FILAMENT CAPPING,0.11434,-0.13291,-0.15779,0,0
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.055956,-0.13302,-0.11231,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.055956,-0.13314,-0.08241,0,0
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.14526,-0.13332,-0.20756,0,0
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.16294,-0.13361,-0.083894,0,0
6,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.15517,-0.13382,-0.11263,0,0
6,GO REGULATION OF NEURON MATURATION,0.20937,-0.13432,-0.094346,0,0
6,GO REGULATORY T CELL DIFFERENTIATION,0.17653,-0.13448,-0.13237,0,0
6,GO BRONCHUS DEVELOPMENT,0.049546,-0.13458,-0.28325,0,0
6,GO CYTOPLASMIC TRANSLATION,0.093897,-0.13468,-0.15257,0,0
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.061812,-0.1352,-0.15228,0,0
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.19393,-0.13546,-0.085311,0,0
6,GO CARDIAC ATRIUM MORPHOGENESIS,0.12259,-0.13561,-0.11635,0,0
6,GO NEUROTRANSMITTER UPTAKE,0.060602,-0.13586,-0.11964,0,0
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.012508,-0.13613,-0.10832,0,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.16032,-0.13639,-0.14667,0,0
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.053746,-0.13644,-0.097562,0,0
6,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.12049,-0.13663,-0.11458,0,0
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.059411,-0.13671,-0.18424,0,0
6,GO PREPULSE INHIBITION,0.26471,-0.13766,-0.1352,0,0
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.19095,-0.13772,-0.094785,0,0
6,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.093897,-0.13789,-0.10924,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.085627,-0.13819,-0.18165,0,0
6,GO ENDOTHELIAL CELL MORPHOGENESIS,0.11434,-0.13824,-0.18799,0,0
6,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.29586,-0.13838,-0.12329,0,0
6,GO REGULATION OF HEART MORPHOGENESIS,0.095625,-0.13839,-0.14697,0,0
6,GO NCRNA CATABOLIC PROCESS,0.075049,-0.13843,-0.094842,0,0
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.064293,-0.13845,-0.14913,0,0
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.073629,-0.13884,-0.093818,0,0
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.080955,-0.13898,-0.15851,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.05824,-0.13926,-0.12104,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.23937,-0.14007,-0.15804,0,0
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.090515,-0.14009,-0.066228,0,0
6,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.085627,-0.14028,-0.10424,0,0
6,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.029068,-0.14044,-0.1043,0,0
6,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.55487,-0.1405,-0.060309,0,0
6,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.00034072,-0.14092,-0.1716,0,0
6,GO ANOIKIS,0.072231,-0.14108,-0.14369,0,0
6,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.28785,-0.14164,-0.10433,0,0
6,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.22568,-0.14167,-0.1271,0,0
6,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00027832,-0.14187,-0.13091,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.059411,-0.14199,-0.16872,0,0
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.12908,-0.14234,-0.12637,0,0
6,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.27227,-0.14306,-0.071369,0,0
6,GO REGULATION OF RECEPTOR RECYCLING,0.065563,-0.14308,-0.13329,0,0
6,GO SUCKLING BEHAVIOR,0.25729,-0.14338,-0.079444,0,0
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.076492,-0.14362,-0.16431,0,0
6,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.38408,-0.14367,-0.078464,0,0
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.0083534,-0.14369,-0.13997,0,0
6,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.093897,-0.14369,-0.10849,0,0
6,GO DNA DEAMINATION,0.40843,-0.14374,-0.13102,0,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15773,-0.14396,-0.12963,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.2,-0.14419,-0.10011,0,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.12049,-0.14433,-0.13342,0,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.066855,-0.14457,-0.10603,0,0
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.065563,-0.14489,-0.1362,0,0
6,GO RESPONSE TO AMINO ACID STARVATION,0.018836,-0.1456,-0.12054,0,0
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.12689,-0.14587,-0.12406,0,0
6,GO SEROTONIN METABOLIC PROCESS,0.35607,-0.14661,-0.096515,0,0
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.25363,-0.14701,-0.096417,0,0
6,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.059411,-0.14704,-0.13706,0,0
6,GO RESPONSE TO HISTAMINE,0.17934,-0.14712,-0.18309,0,0
6,GO RESPONSE TO SALT,0.0039469,-0.14731,-0.14765,0,0
6,GO HYPEROSMOTIC SALINITY RESPONSE,0.13355,-0.14735,-0.089869,0,0
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.13583,-0.14772,-0.13397,0,0
6,GO ONE CARBON METABOLIC PROCESS,0.022165,-0.14819,-0.13242,0,0
6,GO RECEPTOR INTERNALIZATION,0.0029794,-0.14824,-0.12579,0,0
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.27611,-0.14895,-0.083043,0,0
6,GO ODONTOGENESIS,0.015953,-0.14919,-0.15165,0,0
6,GO REGULATION OF LYSOSOMAL LUMEN PH,0.059411,-0.1492,-0.11992,0,0
6,GO POSITIVE REGULATION OF MYELINATION,0.077957,-0.14923,-0.10871,0,0
6,GO TUBULIN DEACETYLATION,0.25363,-0.14939,-0.051209,0,0
6,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.076492,-0.14953,-0.11133,0,0
6,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.13583,-0.14976,-0.11432,0,0
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.066855,-0.15013,-0.19009,0,0
6,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.12259,-0.15062,-0.17291,0,0
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.22905,-0.15064,-0.069085,0,0
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.1028,-0.1509,-0.15241,0,0
6,GO INTERMEMBRANE LIPID TRANSFER,0.00026003,-0.152,-0.17065,0,0
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,5.4121e-05,-0.15263,-0.16812,0,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.11636,-0.15279,-0.21278,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.31232,-0.15292,-0.021776,0,0
6,GO ETHER BIOSYNTHETIC PROCESS,0.099158,-0.15313,-0.18134,0,0
6,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.072231,-0.15348,-0.11569,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.36064,-0.15436,-0.082979,0,0
6,GO CORPUS CALLOSUM DEVELOPMENT,0.085627,-0.15462,-0.15302,0,0
6,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.25001,-0.15492,-0.14056,0,0
6,GO LIPOXYGENASE PATHWAY,0.16828,-0.1551,-0.14295,0,0
6,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.014138,-0.15591,-0.21832,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.017969,-0.15593,-0.15822,0,0
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.075049,-0.15634,-0.11157,0,0
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.21905,-0.15643,-0.12477,0,0
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.21579,-0.15667,-0.065549,0,0
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.090515,-0.15754,-0.12959,0,0
6,GO CARDIOCYTE DIFFERENTIATION,0.0075304,-0.15764,-0.13147,0,0
6,GO STEM CELL DIVISION,0.031748,-0.15807,-0.13078,0,0
6,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17934,-0.15807,-0.12333,0,0
6,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.10096,-0.15841,-0.11643,0,0
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00074557,-0.15845,-0.15519,0,0
6,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.088862,-0.15858,-0.12425,0,0
6,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.04854,-0.15912,-0.17706,0,0
6,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.14769,-0.15914,-0.12726,0,0
6,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.27999,-0.15928,-0.17579,0,0
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.070855,-0.15944,-0.088518,0,0
6,GO BONE MORPHOGENESIS,0.004408,-0.15951,-0.1689,0,0
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.76281,-0.15965,0.0024383,0,0
6,GO REGULATION OF HIPPO SIGNALING,0.099158,-0.15975,-0.1491,0,0
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.65866,-0.15983,0.073783,0,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.019739,-0.15991,-0.13557,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.015953,-0.15994,-0.12333,0,0
6,GO CATECHOLAMINE UPTAKE,0.072231,-0.16019,-0.1489,0,0
6,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,-0.16086,-0.13227,0,0
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.13583,-0.16097,-0.1418,0,0
6,GO ANIMAL ORGAN FORMATION,0.0032441,-0.16111,-0.16934,0,0
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.072231,-0.16177,-0.10816,0,0
6,GO NEURAL CREST CELL MIGRATION,0.033166,-0.16198,-0.16855,0,0
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.010506,-0.16235,-0.14547,0,0
6,GO ORGAN GROWTH,0.0025817,-0.16241,-0.12785,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.073629,-0.1626,-0.15824,0,0
6,GO REGULATION OF AXON GUIDANCE,0.052669,-0.16262,-0.1151,0,0
6,GO RESPONSE TO EPINEPHRINE,0.077957,-0.1627,-0.23253,0,0
6,GO ANATOMICAL STRUCTURE REGRESSION,0.0085714,-0.16314,-0.26315,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32506,-0.16315,-0.09377,0,0
6,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,-0.16373,-0.09172,0,0
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.14526,-0.16425,-0.20666,0,0
6,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.10845,-0.16431,-0.12562,0,0
6,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.02843,-0.16446,-0.12067,0,0
6,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.042857,-0.16448,-0.1575,0,0
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.00353,-0.1649,-0.13046,0,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0041716,-0.16493,-0.14292,0,0
6,GO PROSTATIC BUD FORMATION,0.049546,-0.1651,-0.2639,0,0
6,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.32506,-0.16541,-0.081057,0,0
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.073629,-0.16559,-0.11721,0,0
6,GO EXTRACELLULAR TRANSPORT,0.41842,-0.16687,-0.019019,0,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.16294,-0.16699,-0.1121,0,0
6,GO DOPAMINE BIOSYNTHETIC PROCESS,0.63978,-0.16747,-0.056411,0,0
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.065563,-0.16876,-0.14522,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.053746,-0.16902,-0.17296,0,0
6,GO REGULATION OF MEMBRANE INVAGINATION,0.072231,-0.16905,-0.16049,0,0
6,GO INNER DYNEIN ARM ASSEMBLY,0.71658,-0.16949,0.0072779,0,0
6,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.047551,-0.16952,-0.16902,0,0
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.041967,-0.17005,-0.12519,0,0
6,GO GENITALIA DEVELOPMENT,0.0029794,-0.17049,-0.13596,0,0
6,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.2,-0.171,-0.095203,0,0
6,GO BLASTODERM SEGMENTATION,0.15264,-0.17134,-0.16812,0,0
6,GO REGULATION OF SYNAPSE ASSEMBLY,0.040234,-0.17144,-0.11973,0,0
6,GO PLASMA MEMBRANE REPAIR,0.093897,-0.17163,-0.14861,0,0
6,GO COCHLEA MORPHOGENESIS,0.013139,-0.1722,-0.20518,0,0
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.12473,-0.17301,-0.10387,0,0
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.12689,-0.17354,-0.13739,0,0
6,GO REGULATION OF TUBULIN DEACETYLATION,0.43367,-0.17389,-0.029695,0,0
6,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.32077,-0.17414,-0.10947,0,0
6,GO KERATINIZATION,0.065563,-0.17527,-0.12693,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.075049,-0.1753,-0.17263,0,0
6,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.061812,-0.17572,-0.16904,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.026586,-0.17633,-0.19415,0,0
6,GO MRNA TRANSCRIPTION,0.13355,-0.17634,-0.1018,0,0
6,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0045306,-0.17699,-0.20442,0,0
6,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.05824,-0.17759,-0.14914,0,0
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.12908,-0.17777,-0.12542,0,0
6,GO POSITIVE REGULATION OF NEURON MIGRATION,0.23589,-0.17831,-0.12377,0,0
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.18219,-0.17846,-0.16145,0,0
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0011199,-0.17962,-0.19908,0,0
6,GO THYROID GLAND DEVELOPMENT,0.088862,-0.18028,-0.095171,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.036948,-0.18041,-0.13226,0,0
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0031536,-0.18043,-0.16156,0,0
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.085627,-0.18056,-0.19256,0,0
6,GO PRO B CELL DIFFERENTIATION,0.090515,-0.18198,-0.14989,0,0
6,GO TRIGLYCERIDE CATABOLIC PROCESS,0.044685,-0.18304,-0.1164,0,0
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.055956,-0.18358,-0.1641,0,0
6,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29184,-0.18381,-0.10932,0,0
6,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.02268,-0.18441,-0.25702,0,0
6,GO MECHANOSENSORY BEHAVIOR,0.47049,-0.18483,-0.05984,0,0
6,GO FEMALE GENITALIA DEVELOPMENT,0.17099,-0.18565,-0.08861,0,0
6,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.30815,-0.18613,-0.11262,0,0
6,GO REGULATION OF BONE REMODELING,0.059411,-0.18623,-0.1474,0,0
6,GO CORONARY VASCULATURE DEVELOPMENT,0.0040578,-0.18722,-0.18529,0,0
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00074557,-0.18724,-0.16774,0,0
6,GO DENTATE GYRUS DEVELOPMENT,0.27227,-0.18769,-0.1093,0,0
6,GO ETHANOL OXIDATION,0.15015,-0.18799,-0.22743,0,0
6,GO CARDIAC ATRIUM DEVELOPMENT,0.029719,-0.18883,-0.14093,0,0
6,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.15015,-0.1889,-0.10369,0,0
6,GO REFLEX,0.29586,-0.19049,-0.10113,0,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.10845,-0.19162,-0.15109,0,0
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.001872,-0.19164,-0.19985,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.2,-0.1919,-0.054386,0,0
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.14526,-0.19218,-0.1775,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.015203,-0.19364,-0.28906,0,0
6,GO CARDIAC SEPTUM MORPHOGENESIS,0.0041716,-0.19452,-0.20877,0,0
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.21905,-0.19572,-0.1134,0,0
6,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.32938,-0.19631,-0.15296,0,0
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0067808,-0.19645,-0.19862,0,0
6,GO REGULATION OF INTEGRIN ACTIVATION,0.12259,-0.19662,-0.1292,0,0
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.20621,-0.19727,-0.1038,0,0
6,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.27999,-0.19829,-0.12522,0,0
6,GO CARDIAC CHAMBER DEVELOPMENT,0.00019079,-0.19896,-0.17947,0,0
6,GO PROGESTERONE METABOLIC PROCESS,0.21905,-0.19914,-0.19604,0,0
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0081404,-0.19924,-0.21446,0,0
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.00035231,-0.20039,-0.19187,0,0
6,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.092194,-0.20074,-0.10062,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.31653,-0.20077,-0.069635,0,0
6,GO DIET INDUCED THERMOGENESIS,0.001662,-0.20102,-0.2097,0,0
6,GO MEMBRANE DEPOLARIZATION,0.076492,-0.20104,-0.12557,0,0
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.01282,-0.20122,-0.17538,0,0
6,GO ANIMAL ORGAN MATURATION,0.10465,-0.20144,-0.088394,0,0
6,GO ELASTIC FIBER ASSEMBLY,0.015953,-0.20174,-0.3446,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0027346,-0.20175,-0.20959,0,0
6,GO REGULATION OF CELL PROJECTION SIZE,0.076492,-0.20202,-0.16819,0,0
6,GO CARDIAC SEPTUM DEVELOPMENT,0.0013457,-0.20228,-0.19345,0,0
6,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.031059,-0.20237,-0.21364,0,0
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.10654,-0.20327,-0.16551,0,0
6,GO TRNA CATABOLIC PROCESS,0.33812,-0.20329,-0.11909,0,0
6,GO ACROSOME REACTION,0.063042,-0.20368,-0.14081,0,0
6,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.16032,-0.20374,-0.12725,0,0
6,GO REGULATION OF VESICLE FUSION,0.049546,-0.20447,-0.17839,0,0
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.17374,-0.20477,-0.18876,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.084046,-0.20536,-0.16659,0,0
6,GO CARDIAC MYOFIBRIL ASSEMBLY,0.075049,-0.20574,-0.12054,0,0
6,GO AMMONIUM ION METABOLIC PROCESS,0.054842,-0.20581,-0.1939,0,0
6,GO AUTOPHAGIC CELL DEATH,0.022165,-0.20607,-0.15766,0,0
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0032441,-0.20659,-0.16287,0,0
6,GO POSITIVE REGULATION OF VESICLE FUSION,0.013798,-0.20662,-0.35616,0,0
6,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023468,-0.20677,-0.16569,0,0
6,GO SIGNAL PEPTIDE PROCESSING,0.099158,-0.20716,-0.1328,0,0
6,GO REGULATION OF SYNAPSE MATURATION,0.085627,-0.20776,-0.20432,0,0
6,GO LONG TERM MEMORY,0.077957,-0.20785,-0.12272,0,0
6,GO MYOFIBRIL ASSEMBLY,0.001191,-0.20798,-0.17153,0,0
6,GO RESPONSE TO UV B,0.0062634,-0.20813,-0.19981,0,0
6,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0073363,-0.20821,-0.16006,0,0
6,GO NEURONAL ACTION POTENTIAL,0.29586,-0.20824,-0.074108,0,0
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.072231,-0.20829,-0.19789,0,0
6,GO DRINKING BEHAVIOR,0.13355,-0.2083,-0.14352,0,0
6,GO NEUROBLAST DIVISION,0.0087944,-0.20932,-0.24826,0,0
6,GO LACTATION,0.00010845,-0.21003,-0.22207,0,0
6,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00052342,-0.21014,-0.19748,0,0
6,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.072231,-0.21238,-0.16671,0,0
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.0057817,-0.21334,-0.16834,0,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.12259,-0.21374,-0.13903,0,0
6,GO RETINAL METABOLIC PROCESS,0.1028,-0.21394,-0.22799,0,0
6,GO HEART VALVE DEVELOPMENT,0.00017186,-0.21494,-0.241,0,0
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10465,-0.21623,-0.15017,0,0
6,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.054842,-0.21685,-0.21602,0,0
6,GO OPTIC NERVE DEVELOPMENT,0.17653,-0.2181,-0.14104,0,0
6,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.0022332,-0.21862,-0.20366,0,0
6,GO ENDOCARDIAL CUSHION FORMATION,0.0090226,-0.21885,-0.23218,0,0
6,GO RADIAL GLIAL CELL DIFFERENTIATION,0.059411,-0.22054,-0.20573,0,0
6,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.00019753,-0.22173,-0.18496,0,0
6,GO NEGATIVE REGULATION OF CELL AGING,0.13355,-0.22204,-0.13088,0,0
6,GO INCLUSION BODY ASSEMBLY,0.099158,-0.22299,-0.13754,0,0
6,GO PROTEIN TRIMERIZATION,0.0040578,-0.22315,-0.23841,0,0
6,GO TONIC SMOOTH MUSCLE CONTRACTION,0.0037331,-0.22318,-0.25383,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.068167,-0.22333,-0.16398,0,0
6,GO RESPONSE TO DIETARY EXCESS,0.066855,-0.2243,-0.17318,0,0
6,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0032441,-0.22447,-0.20206,0,0
6,GO GLYCINE TRANSPORT,0.11636,-0.22494,-0.17978,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.054842,-0.2251,-0.18058,0,0
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0031536,-0.22515,-0.22437,0,0
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.15264,-0.22562,-0.1323,0,0
6,GO TRABECULA MORPHOGENESIS,0.0027346,-0.22603,-0.18825,0,0
6,GO INNERVATION,0.15773,-0.22627,-0.11464,0,0
6,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.11235,-0.22721,-0.16949,0,0
6,GO BONE TRABECULA FORMATION,0.054842,-0.22904,-0.31568,0,0
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.26847,-0.23051,-0.085375,0,0
6,GO NADH METABOLIC PROCESS,0.0040578,-0.23111,-0.23583,0,0
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.063042,-0.23137,-0.25449,0,0
6,GO CORONARY VASCULATURE MORPHOGENESIS,0.033166,-0.23154,-0.18432,0,0
6,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.029719,-0.23165,-0.19884,0,0
6,GO CARDIAC VENTRICLE DEVELOPMENT,0.00034072,-0.23228,-0.18531,0,0
6,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,-0.23544,-0.11139,0,0
6,GO OUTFLOW TRACT MORPHOGENESIS,0.00057693,-0.23585,-0.22558,0,0
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.19393,-0.23608,-0.093143,0,0
6,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.00045924,-0.23692,-0.29767,0,0
6,GO CONVERGENT EXTENSION,0.0037331,-0.23804,-0.19752,0,0
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0028957,-0.23822,-0.2294,0,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0097392,-0.23873,-0.20118,0,0
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.13814,-0.2388,-0.16198,0,0
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.00013433,-0.24029,-0.23567,0,0
6,GO CARDIAC VENTRICLE MORPHOGENESIS,0.00042998,-0.24206,-0.1915,0,0
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.070855,-0.24329,-0.26722,0,0
6,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.019283,-0.24384,-0.29772,0,0
6,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.060602,-0.24396,-0.20829,0,0
6,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.16559,-0.24969,-0.22184,0,0
6,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.022165,-0.24994,-0.18175,0,0
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.053746,-0.25024,-0.16317,0,0
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.03939,-0.25231,-0.17162,0,0
6,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.0064317,-0.25476,-0.23519,0,0
6,GO PROSTAGLANDIN SECRETION,0.00098941,-0.25549,-0.23158,0,0
6,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.34702,-0.25753,-0.1113,0,0
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.061812,-0.25884,-0.24605,0,0
6,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.026586,-0.25928,-0.20442,0,0
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00087311,-0.26176,-0.31115,0,0
6,GO PARAXIAL MESODERM MORPHOGENESIS,0.12259,-0.26189,-0.17088,0,0
6,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0067808,-0.26335,-0.21031,0,0
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.001986,-0.26756,-0.3,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.019283,-0.26877,-0.245,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.053746,-0.26888,-0.22576,0,0
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.12689,-0.27219,-0.1638,0,0
6,GO DIVALENT METAL ION EXPORT,0.015203,-0.27224,-0.21422,0,0
6,GO LABYRINTHINE LAYER MORPHOGENESIS,0.054842,-0.27703,-0.20971,0,0
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.072231,-0.27736,-0.17283,0,0
6,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.029068,-0.28131,-0.23474,0,0
6,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.02843,-0.29284,-0.31284,0,0
6,GO BILE ACID AND BILE SALT TRANSPORT,0.085627,-0.29638,-0.16727,0,0
6,GO CELLULAR RESPONSE TO ZINC ION,0.0073363,-0.29816,-0.4078,0,0
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.015203,-0.30128,-0.28481,0,0
6,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.012508,-0.30288,-0.24526,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,1.4039e-05,-0.30332,-0.31979,0,0
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0018173,-0.30874,-0.3359,0,0
6,GO PROTEIN LOCALIZATION TO AXON,0.10096,-0.31001,-0.1928,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.082489,-0.31283,-0.28183,0,0
6,GO FRUCTOSE METABOLIC PROCESS,0.16032,-0.31318,-0.22034,0,0
6,GO DETOXIFICATION OF INORGANIC COMPOUND,0.05824,-0.3141,-0.47872,0,0
6,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.13355,-0.31453,-0.15096,0,0
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.00087311,-0.31823,-0.38611,0,0
6,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0051916,-0.31934,-0.33687,0,0
6,GO POSITIVE REGULATION OF CELL MATURATION,0.054842,-0.32176,-0.23702,0,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00010845,-0.3295,-0.2742,0,0
6,GO BASEMENT MEMBRANE ASSEMBLY,0.0079323,-0.33154,-0.32176,0,0
6,GO RENAL FILTRATION,0.0026572,-0.3317,-0.32516,0,0
6,GO GONADOTROPIN SECRETION,0.0014738,-0.34236,-0.27543,0,0
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.00032948,-0.34385,-0.3029,0,0
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.001191,-0.34395,-0.35642,0,0
6,GO TRABECULA FORMATION,0.00041602,-0.34473,-0.31914,0,0
6,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00095906,-0.34588,-0.42333,0,0
6,GO RESPONSE TO HYDROPEROXIDE,0.030383,-0.3492,-0.22448,0,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.077957,-0.35868,-0.22509,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.00042998,-0.35954,-0.32428,0,0
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.092194,-0.38235,-0.22226,0,0
6,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.068167,-0.40974,-0.29348,0,0
6,GO POLYOL TRANSPORT,2.2524e-05,-0.41383,-0.36269,0,0
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00024286,-0.43892,-0.3805,0,0
6,GO HEART INDUCTION,0.017549,-0.44817,-0.26833,0,0
6,GO XENOBIOTIC CATABOLIC PROCESS,0.00012074,-0.50391,-0.57973,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,2.4346e-05,-0.50894,-0.47463,0,0
